data_6sai_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6sai _Structure_validation_residue.Date_analyzed 2020-01-10 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo . . . . . 0 CA--C 1.519 -0.251 0 N-CA-C 109.045 -1.175 . . . . 0.0 109.045 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.425 ' HB2' HG22 ' A' ' 5' ' ' THR . 15.6 m -68.12 179.84 1.43 Allowed 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 162.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.523 ' CE1' HD12 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -76.76 -52.2 9.99 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.245 -0.982 . . . . 0.0 108.536 166.41 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.472 ' OD1' ' HG ' ' B' ' 41' ' ' LEU . 2.4 p-10 -86.33 4.48 38.99 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.256 -1.338 . . . . 0.0 113.677 -164.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.569 ' O ' ' HG3' ' A' ' 7' ' ' ARG . 0.9 OUTLIER -63.73 -3.12 2.09 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 118.602 0.637 . . . . 0.0 111.532 -176.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.575 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 3.0 m -77.9 119.36 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-O 121.914 0.864 . . . . 0.0 109.824 177.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.777 ' HB3' ' O ' ' A' ' 46' ' ' ASN . 27.1 mtm180 -138.68 150.73 46.51 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 119.078 -1.049 . . . . 0.0 113.292 -170.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.568 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.4 mt-30 -41.99 114.35 0.53 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 112.882 -1.963 . . . . 0.0 113.019 176.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.81 -156.66 27.7 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.065 171.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.0 p -52.26 100.46 0.03 OUTLIER 'General case' 0 C--O 1.233 0.228 0 CA-C-N 117.092 0.446 . . . . 0.0 111.204 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 pttp 42.47 40.87 2.05 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.396 1.078 . . . . 0.0 112.297 -175.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.431 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 59.4 tt0 -59.21 136.44 88.32 Favored Pre-proline 0 C--O 1.235 0.3 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 177.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.513 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 36.8 Cg_exo -51.77 122.83 11.08 Favored 'Trans proline' 0 CA--C 1.508 -0.784 0 C-N-CA 122.121 1.88 . . . . 0.0 109.689 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.788 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 9.3 t80 -69.46 -53.86 12.09 Favored Pre-proline 0 N--CA 1.437 -1.119 0 CA-C-O 118.316 -0.849 . . . . 0.0 112.937 -166.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.55 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 31.3 Cg_exo -55.38 -20.43 25.84 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.435 1.424 . . . . 0.0 111.06 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.513 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 2.7 m-20 -89.87 -39.17 13.22 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.011 -1.45 . . . . 0.0 111.036 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.568 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -55.94 -45.38 78.83 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 175.451 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 14' ' ' TYR . 1.5 p -81.54 -31.79 11.41 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.031 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.57 -177.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . -58.08 -33.8 69.46 Favored 'General case' 0 C--N 1.317 -0.833 0 O-C-N 121.386 -0.821 . . . . 0.0 111.752 176.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.709 ' O ' HG12 ' A' ' 24' ' ' VAL . 15.3 ptt180 -84.36 -26.9 28.08 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 176.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.565 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 6.7 tp -56.52 -46.55 80.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.002 172.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.66 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 32.8 mt-30 -73.39 -44.15 59.12 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.83 178.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.699 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 21.8 t70 -49.55 -56.06 11.23 Favored 'General case' 0 C--N 1.314 -0.942 0 O-C-N 124.239 0.962 . . . . 0.0 111.612 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.709 HG12 ' O ' ' A' ' 20' ' ' ARG . 6.4 p -80.36 -22.29 11.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 C-N-CA 120.538 -0.465 . . . . 0.0 109.923 -173.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.648 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -68.18 -29.09 67.88 Favored 'General case' 0 C--O 1.204 -1.341 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 173.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.456 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -80.04 -36.9 35.07 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.931 -178.406 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.699 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.5 mmtt -66.65 -32.51 73.87 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.483 178.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.8 m -105.34 -11.77 16.33 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.825 -171.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.648 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 88.7 mt -116.83 133.93 61.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.109 -177.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.26 -4.25 35.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.285 0.564 . . . . 0.0 110.521 176.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.515 ' H ' HG21 ' A' ' 29' ' ' ILE . 11.1 t70 -105.48 107.46 18.47 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.752 -178.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.584 ' OE2' ' HG3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -52.86 -32.22 43.53 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.229 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.584 ' HG3' ' OE2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -73.53 -50.47 21.23 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -173.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.473 ' HA ' HG21 ' A' ' 37' ' ' VAL . . . -61.92 -27.84 69.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.525 175.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.839 ' O ' HG12 ' A' ' 39' ' ' VAL . 3.5 tmm_? -67.4 -57.12 7.17 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.485 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 19.4 mtpt -59.11 -54.82 42.7 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.273 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.747 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 19.4 m -54.69 -33.84 28.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.023 -173.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.489 ' O ' ' HG2' ' A' ' 42' ' ' MET . 1.2 tt -86.3 -31.87 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 119.904 -0.719 . . . . 0.0 111.428 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.839 HG12 ' O ' ' A' ' 35' ' ' ARG . 3.0 m -67.4 -49.8 68.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.779 173.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.624 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 63.9 mt-10 -63.76 -26.34 68.6 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.5 0.72 . . . . 0.0 112.62 177.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.747 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -85.63 -52.1 6.03 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.576 177.348 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.601 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 18.7 mmt -64.52 -20.42 66.2 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.809 0.814 . . . . 0.0 109.37 -178.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.668 ' O ' ' HB1' ' A' ' 47' ' ' ALA . . . -50.75 -28.98 10.28 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.539 171.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.516 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 25.0 t80 -104.08 -68.78 0.83 Allowed 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.478 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 10.3 mm-40 -48.21 -32.41 7.09 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 124.13 0.894 . . . . 0.0 112.546 -175.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.777 ' O ' ' HB3' ' A' ' 7' ' ' ARG . 4.5 m-20 -103.28 -17.39 15.33 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.492 -175.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.668 ' HB1' ' O ' ' A' ' 43' ' ' ALA . . . -62.98 178.27 0.49 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.744 0.783 . . . . 0.0 111.911 -177.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.646 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 17.7 m-20 -59.93 142.92 88.41 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.094 172.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -56.25 -21.46 36.23 Favored 'Trans proline' 0 C--O 1.219 -0.463 0 C-N-CA 123.182 2.588 . . . . 0.0 112.557 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.716 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 12.0 pm0 -88.99 -33.01 17.34 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 123.598 0.759 . . . . 0.0 110.727 174.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.716 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 72.2 m -81.21 -38.02 27.7 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.394 -171.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.501 ' HA ' HD13 ' A' ' 55' ' ' ILE . 3.3 pt20 -69.0 -29.89 68.18 Favored 'General case' 0 C--O 1.211 -0.94 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 172.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.472 ' CA ' ' HE2' ' A' ' 56' ' ' LYS . 5.9 m -72.23 -21.26 61.42 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 113.9 -1.5 . . . . 0.0 110.304 176.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 51' ' ' CYS . . . -76.03 -25.91 56.12 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.783 0.801 . . . . 0.0 109.495 168.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.558 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 22.7 mt -90.33 -33.46 5.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -172.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.611 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.39 -39.08 1.96 Allowed Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -172.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 52.5 Cg_endo -63.13 -31.12 75.53 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.164 1.91 . . . . 0.0 112.568 175.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.493 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 2.4 mt -93.92 -17.08 23.36 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.595 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -54.64 108.95 0.44 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.44 179.67 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.09 -23.84 34.41 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.568 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -104.46 113.88 27.74 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.096 0.474 . . . . 0.0 110.418 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.406 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.1 p -123.58 141.6 36.87 Favored Pre-proline 0 C--N 1.308 -1.21 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 168.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo . . . . . 0 C--N 1.343 0.255 0 C-N-CA 122.333 2.022 . . . . 0.0 111.52 170.905 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.515 -0.372 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.591 HG11 ' CD ' ' A' ' 40' ' ' GLU . 0.7 OUTLIER -77.69 -28.1 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 C-N-CA 118.227 -1.389 . . . . 0.0 108.95 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.779 ' O ' HG13 ' A' ' 73' ' ' VAL . 11.3 mm -58.14 -46.54 88.35 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.075 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.124 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 30.7 t -45.95 -38.33 7.5 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.188 176.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -86.2 -32.31 21.27 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 121.254 0.55 . . . . 0.0 111.046 -177.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.595 ' OH ' ' HA ' ' A' ' 59' ' ' LYS . 5.1 m-30 -75.27 -34.38 61.35 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.369 -176.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.788 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.6 m -72.09 -31.7 40.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -68.0 -30.87 70.23 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.25 176.461 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -63.74 -48.94 75.0 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.891 177.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.611 ' SG ' ' HB2' ' A' ' 14' ' ' TYR . 32.3 t -89.89 9.09 28.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.773 177.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.464 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 18.7 t70 . . . . . 0 C--N 1.318 -0.786 0 CA-C-O 121.349 0.595 . . . . 0.0 109.566 173.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 1' ' ' PRO . . . . . 0.489 ' HB2' ' H ' ' B' ' 2' ' ' SER . 84.0 Cg_endo . . . . . 0 CA--C 1.518 -0.306 0 N-CA-C 108.863 -1.245 . . . . 0.0 108.863 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' SER . . . . . 0.489 ' H ' ' HB2' ' B' ' 1' ' ' PRO . 15.8 m -68.48 -179.74 1.43 Allowed 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 162.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.516 ' CE1' HD12 ' B' ' 29' ' ' ILE . 0.1 OUTLIER -77.01 -52.24 9.69 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.29 -0.964 . . . . 0.0 108.522 166.261 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . 0.46 ' OD1' ' HG ' ' A' ' 41' ' ' LEU . 2.4 p-10 -86.31 4.69 37.98 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.708 -164.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' THR . . . . . 0.566 ' O ' ' HG3' ' B' ' 7' ' ' ARG . 0.9 OUTLIER -63.98 -2.88 2.15 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 118.6 0.636 . . . . 0.0 111.557 -176.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.562 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 3.0 m -78.04 119.25 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 121.823 0.82 . . . . 0.0 109.845 176.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . 0.792 ' HB3' ' O ' ' B' ' 46' ' ' ASN . 27.3 mtm180 -138.63 150.72 46.56 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 119.18 -1.008 . . . . 0.0 113.247 -170.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' GLN . . . . . 0.572 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.4 mt-30 -42.15 114.51 0.56 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 112.755 -2.02 . . . . 0.0 112.887 176.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.11 -156.96 28.73 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.13 171.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 15.6 p -51.67 100.35 0.03 OUTLIER 'General case' 0 C--O 1.235 0.306 0 CA-C-N 117.016 0.408 . . . . 0.0 111.274 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 20.8 pttp 42.28 41.06 1.99 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.462 1.105 . . . . 0.0 112.225 -175.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.406 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 58.9 tt0 -59.23 136.43 88.38 Favored Pre-proline 0 C--O 1.234 0.283 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . 0.533 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 37.6 Cg_exo -51.69 123.05 11.43 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.13 1.887 . . . . 0.0 109.652 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' TYR . . . . . 0.788 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 9.5 t80 -69.6 -53.93 11.61 Favored Pre-proline 0 N--CA 1.437 -1.089 0 CA-C-O 118.313 -0.851 . . . . 0.0 112.958 -166.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.558 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 31.2 Cg_exo -55.4 -20.29 25.43 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 121.483 1.455 . . . . 0.0 111.066 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.533 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 3.1 m-20 -89.93 -39.17 13.18 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.019 -1.446 . . . . 0.0 111.023 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' PHE . . . . . 0.572 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -55.81 -45.59 78.26 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.307 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.734 HG12 ' O ' ' B' ' 14' ' ' TYR . 1.5 p -81.46 -31.69 11.48 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.063 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.576 -177.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' B' ' 15' ' ' PRO . . . -58.2 -33.83 69.71 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 121.402 -0.811 . . . . 0.0 111.737 176.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.704 ' O ' HG12 ' B' ' 24' ' ' VAL . 15.2 ptt180 -84.43 -26.47 28.24 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.574 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 6.7 tp -56.86 -46.77 81.57 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.912 172.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' GLN . . . . . 0.672 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 32.5 mt-30 -73.18 -44.31 60.05 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.835 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.72 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 20.5 t70 -49.15 -56.15 10.1 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 124.192 0.932 . . . . 0.0 111.649 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' VAL . . . . . 0.704 HG12 ' O ' ' B' ' 20' ' ' ARG . 6.5 p -80.31 -22.52 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.922 -173.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.66 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -68.15 -28.97 67.76 Favored 'General case' 0 C--O 1.203 -1.342 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 173.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . 0.451 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -80.23 -36.59 34.52 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.359 -1.291 . . . . 0.0 109.962 -178.498 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.72 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.9 mmtt -66.97 -32.35 73.53 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.502 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 16.9 m -105.5 -12.05 16.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.123 0.487 . . . . 0.0 110.765 -171.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.66 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 88.3 mt -116.44 134.24 60.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.083 -177.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.45 -4.27 34.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.382 0.611 . . . . 0.0 110.436 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.497 ' H ' HG21 ' B' ' 29' ' ' ILE . 11.3 t70 -105.43 107.68 18.79 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.722 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 0.572 ' OE2' ' HG3' ' B' ' 33' ' ' LYS . 0.0 OUTLIER -53.01 -32.22 45.45 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.213 179.487 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.572 ' HG3' ' OE2' ' B' ' 32' ' ' GLU . 0.0 OUTLIER -73.58 -50.23 22.32 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -173.593 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.492 ' HA ' HG21 ' B' ' 37' ' ' VAL . . . -62.16 -27.83 69.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.466 175.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.843 ' O ' HG12 ' B' ' 39' ' ' VAL . 3.5 tmm_? -67.43 -57.12 7.13 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.478 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 19.0 mtpt -59.11 -54.76 43.35 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.314 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.745 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 19.6 m -54.73 -33.82 28.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.073 -173.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.497 ' O ' ' HG2' ' B' ' 42' ' ' MET . 1.2 tt -86.41 -31.64 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.462 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.843 HG12 ' O ' ' B' ' 35' ' ' ARG . 3.0 m -67.43 -49.95 66.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 119.039 -1.065 . . . . 0.0 109.809 173.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.635 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 60.8 mt-10 -63.6 -26.5 68.72 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.506 0.722 . . . . 0.0 112.599 177.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.745 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.61 -52.0 6.1 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.436 -0.505 . . . . 0.0 111.469 177.487 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' MET . . . . . 0.594 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 18.7 mmt -64.66 -20.39 66.27 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.75 0.786 . . . . 0.0 109.256 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.658 ' O ' ' HB1' ' B' ' 47' ' ' ALA . . . -50.82 -28.92 10.4 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.563 171.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' TYR . . . . . 0.503 ' CG ' ' HD2' ' B' ' 59' ' ' LYS . 25.1 t80 -104.09 -68.71 0.83 Allowed 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.477 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 10.5 mm-40 -48.39 -31.92 6.86 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.091 0.87 . . . . 0.0 112.687 -175.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.792 ' O ' ' HB3' ' B' ' 7' ' ' ARG . 4.5 m-20 -103.88 -16.91 15.23 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 120.659 0.266 . . . . 0.0 111.533 -175.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.658 ' HB1' ' O ' ' B' ' 43' ' ' ALA . . . -63.24 178.67 0.49 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.909 0.862 . . . . 0.0 111.978 -177.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' ASN . . . . . 0.644 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 17.6 m-20 -60.25 142.74 89.79 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.077 172.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.08 -21.54 35.31 Favored 'Trans proline' 0 C--O 1.218 -0.518 0 C-N-CA 123.19 2.593 . . . . 0.0 112.516 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . 0.699 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 11.7 pm0 -88.95 -32.9 17.44 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 123.557 0.743 . . . . 0.0 110.743 174.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.699 ' N ' ' HG2' ' B' ' 50' ' ' GLU . 72.1 m -81.31 -38.06 27.38 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.41 -171.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . 0.495 ' HA ' HD13 ' B' ' 55' ' ' ILE . 3.3 pt20 -68.89 -30.01 68.41 Favored 'General case' 0 C--O 1.211 -0.927 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 172.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' SER . . . . . 0.485 ' CA ' ' HE2' ' B' ' 56' ' ' LYS . 6.2 m -72.18 -21.16 61.47 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 113.941 -1.481 . . . . 0.0 110.478 176.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' B' ' 51' ' ' CYS . . . -76.21 -25.8 55.48 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.767 0.794 . . . . 0.0 109.466 168.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.564 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 22.7 mt -90.28 -33.5 5.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -172.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . 0.608 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.41 -39.17 2.04 Favored Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -172.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 52.5 Cg_endo -62.95 -31.31 77.14 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.115 1.876 . . . . 0.0 112.554 175.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . 0.508 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 2.5 mt -93.92 -17.07 23.37 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . 0.598 ' HA ' ' OH ' ' B' ' 72' ' ' TYR . 0.0 OUTLIER -54.7 108.96 0.44 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.47 179.71 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.03 -23.86 34.36 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.626 -177.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -104.47 113.89 27.76 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.098 0.475 . . . . 0.0 110.295 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.404 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.2 p -123.48 141.81 37.27 Favored Pre-proline 0 C--N 1.309 -1.162 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 168.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo . . . . . 0 C--O 1.234 0.304 0 C-N-CA 122.296 1.997 . . . . 0.0 111.631 170.836 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.514 -0.406 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . 0.571 HG11 ' CD ' ' B' ' 40' ' ' GLU . 0.7 OUTLIER -77.29 -28.5 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 C-N-CA 118.201 -1.399 . . . . 0.0 108.921 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . 0.775 ' O ' HG13 ' B' ' 73' ' ' VAL . 11.2 mm -57.91 -46.56 87.51 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.112 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.169 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 30.2 t -45.93 -38.38 7.49 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.184 176.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -86.17 -32.25 21.35 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.245 0.545 . . . . 0.0 111.001 -177.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' TYR . . . . . 0.598 ' OH ' ' HA ' ' B' ' 59' ' ' LYS . 5.1 m-30 -75.36 -34.21 61.13 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.374 -176.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . 0.788 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.6 m -72.26 -31.64 39.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 172.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' LYS . . . . . 0.451 ' O ' ' HB3' ' B' ' 77' ' ' ASP . 0.0 OUTLIER -68.08 -30.84 70.12 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.274 176.474 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -63.72 -49.15 74.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.843 -1.072 . . . . 0.0 109.833 177.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.607 ' SG ' ' HB2' ' B' ' 14' ' ' TYR . 32.1 t -89.58 9.14 27.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.78 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . 0.451 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 21.1 t70 . . . . . 0 C--N 1.32 -0.694 0 CA-C-O 121.344 0.592 . . . . 0.0 109.681 174.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo . . . . . 0 CA--C 1.518 -0.301 0 N-CA-C 108.856 -1.248 . . . . 0.0 108.856 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.435 ' HG ' ' HD3' ' B' ' 59' ' ' LYS . 15.0 m -67.26 176.33 2.29 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 162.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.465 ' HE1' ' CD1' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -73.66 -52.69 12.49 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 166.099 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.497 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 2.4 p-10 -85.63 5.78 30.35 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.858 -1.519 . . . . 0.0 113.489 -165.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.07 -4.19 3.3 Favored 'General case' 0 C--N 1.315 -0.904 0 O-C-N 121.94 -0.475 . . . . 0.0 111.615 -176.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.596 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.0 m -77.86 133.01 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.72 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -154.63 159.42 40.8 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -179.671 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.401 ' N ' ' CD2' ' A' ' 17' ' ' PHE . 2.1 tt0 -45.31 112.75 0.48 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 113.268 -1.787 . . . . 0.0 112.57 -177.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.13 -150.59 18.56 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.507 173.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 27.2 m -51.98 95.45 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.95 0.375 . . . . 0.0 111.407 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.1 pttp 37.76 43.47 0.48 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.385 1.074 . . . . 0.0 112.254 -172.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -56.46 138.14 75.8 Favored Pre-proline 0 C--O 1.234 0.241 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.528 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 33.8 Cg_exo -53.68 121.87 10.31 Favored 'Trans proline' 0 CA--C 1.51 -0.722 0 C-N-CA 121.806 1.671 . . . . 0.0 109.476 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.778 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 14.5 t80 -71.91 -52.21 7.98 Favored Pre-proline 0 N--CA 1.438 -1.046 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -165.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.543 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 38.7 Cg_exo -56.52 -18.2 24.73 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 121.447 1.431 . . . . 0.0 110.691 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.528 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.5 m-20 -90.21 -42.34 11.08 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 113.754 -1.566 . . . . 0.0 110.874 178.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.489 ' CE2' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -55.02 -45.55 75.16 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 176.537 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.766 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 1.8 p -78.97 -34.41 16.81 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.402 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . -58.6 -31.82 68.41 Favored 'General case' 0 C--N 1.318 -0.761 0 O-C-N 121.529 -0.732 . . . . 0.0 111.807 177.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.673 ' O ' HG11 ' A' ' 24' ' ' VAL . 15.7 ptt180 -84.3 -26.78 28.28 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 175.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.537 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 5.9 tp -58.27 -46.49 85.92 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.918 173.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.766 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 26.2 mt-30 -70.69 -47.28 60.67 Favored 'General case' 0 CA--C 1.493 -1.247 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.3 177.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.72 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 8.9 t70 -49.77 -51.96 35.37 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.531 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.673 HG11 ' O ' ' A' ' 20' ' ' ARG . 7.2 p -81.08 -23.78 10.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.181 0.515 . . . . 0.0 109.719 -174.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.775 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -72.01 -19.15 61.9 Favored 'General case' 0 C--O 1.204 -1.335 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 174.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.59 -36.36 18.91 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.574 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.72 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.6 mmtt -67.26 -37.86 84.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.95 -1.023 . . . . 0.0 112.015 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.5 m -101.76 -10.38 20.0 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.163 0.506 . . . . 0.0 110.645 -172.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.775 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 85.5 mt -112.38 130.24 66.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.819 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.23 -0.93 57.39 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.068 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.661 ' OD1' ' HD2' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -121.55 127.74 51.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.347 0.594 . . . . 0.0 111.901 -178.09 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -56.49 -31.98 64.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.86 175.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.661 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 26.1 mttt -62.29 -61.12 2.67 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -177.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.444 ' HA ' HG23 ' A' ' 37' ' ' VAL . . . -61.94 -24.55 67.05 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.348 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.846 ' O ' HG12 ' A' ' 39' ' ' VAL . 1.7 tmm_? -69.7 -57.92 4.55 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.408 ' O ' HG23 ' A' ' 39' ' ' VAL . 20.9 mtpt -57.21 -55.65 31.94 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.943 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.723 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 19.7 m -53.93 -36.02 29.7 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.312 -170.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.465 ' CD1' ' HE1' ' A' ' 3' ' ' PHE . 1.2 tt -87.5 -28.97 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.96 -178.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.846 HG12 ' O ' ' A' ' 35' ' ' ARG . 3.0 m -70.1 -49.22 57.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 119.11 -1.036 . . . . 0.0 109.326 175.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.649 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 66.1 mt-10 -63.49 -24.22 67.73 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.805 0.842 . . . . 0.0 112.259 176.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.723 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -86.09 -56.99 3.2 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 177.147 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.497 ' HG3' ' HB2' ' A' ' 4' ' ' ASN . 20.7 mmt -62.44 -20.74 64.82 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.585 0.707 . . . . 0.0 109.792 -177.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.657 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . . . -49.18 -28.23 4.26 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.539 170.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.537 ' CG ' ' HB2' ' A' ' 52' ' ' GLN . 5.7 t80 -108.22 -67.92 0.94 Allowed 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 175.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.663 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 5.2 mm-40 -46.9 -31.89 3.42 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 124.421 1.075 . . . . 0.0 112.179 -173.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.72 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.9 m-20 -104.8 -21.17 13.39 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -176.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.631 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -60.4 -179.13 0.1 Allowed 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.954 0.883 . . . . 0.0 112.974 -173.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -57.01 139.72 78.41 Favored Pre-proline 0 N--CA 1.443 -0.786 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.011 175.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.95 -23.31 42.42 Favored 'Trans proline' 0 C--O 1.222 -0.304 0 C-N-CA 123.209 2.606 . . . . 0.0 112.082 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.469 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -88.12 -30.18 20.04 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.702 0.801 . . . . 0.0 110.505 174.194 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.927 ' SG ' ' HB2' ' A' ' 76' ' ' CYS . 43.8 t -83.24 -36.76 24.32 Favored 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.548 -170.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.537 ' HB2' ' CG ' ' A' ' 44' ' ' TYR . 4.1 pt20 -67.37 -30.35 70.12 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 171.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.474 ' O ' ' HD2' ' A' ' 56' ' ' LYS . 17.1 m -69.95 -20.3 63.34 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 113.377 -1.738 . . . . 0.0 110.852 173.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -81.16 -24.75 37.36 Favored 'General case' 0 C--N 1.312 -1.039 0 O-C-N 121.399 -0.813 . . . . 0.0 110.014 167.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.556 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 25.4 mt -90.3 -30.81 5.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -171.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.609 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.37 -40.03 2.58 Favored Pre-proline 0 N--CA 1.487 1.38 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -174.458 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 49.9 Cg_endo -62.42 -27.5 77.34 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.313 2.009 . . . . 0.0 112.794 176.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.506 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.0 OUTLIER -100.52 -15.86 17.71 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.539 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 0.1 OUTLIER -53.45 109.22 0.42 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.252 -177.924 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.446 ' N ' ' HZ3' ' A' ' 59' ' ' LYS . . . 92.43 -20.64 42.79 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.34 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -103.87 113.63 27.29 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.92 144.15 42.26 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 173.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo . . . . . 0 N--CA 1.463 -0.305 0 C-N-CA 122.153 1.902 . . . . 0.0 111.329 168.944 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.759 ' OD1' ' HB ' ' A' ' 69' ' ' ILE . 5.4 t70 . . . . . 0 CA--C 1.518 -0.269 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.575 HG23 ' HG2' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -79.81 -28.84 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 C-N-CA 118.224 -1.39 . . . . 0.0 109.173 179.218 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.778 ' O ' HG12 ' A' ' 73' ' ' VAL . 11.7 mm -60.57 -46.2 95.97 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.016 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.94 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.3 t -44.58 -38.93 4.56 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.146 175.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.474 ' O ' ' HE2' ' A' ' 74' ' ' LYS . 7.0 mm-40 -85.84 -32.04 21.95 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 123.55 0.74 . . . . 0.0 111.419 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.561 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.0 m-30 -75.41 -34.6 61.04 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.513 0.673 . . . . 0.0 109.421 -176.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.778 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.4 m -71.81 -32.09 43.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 172.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.474 ' HE2' ' O ' ' A' ' 71' ' ' GLU . 13.3 ttpt -71.66 -25.94 62.33 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.406 177.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -65.21 -46.6 80.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.806 174.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.927 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 40.5 t -87.46 0.8 55.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.158 178.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.4 t70 . . . . . 0 C--N 1.323 -0.56 0 CA-C-O 121.64 0.733 . . . . 0.0 109.579 175.066 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 1' ' ' PRO . . . . . 0.472 ' HB2' ' H ' ' B' ' 2' ' ' SER . 88.6 Cg_endo . . . . . 0 CA--C 1.518 -0.297 0 N-CA-C 108.762 -1.284 . . . . 0.0 108.762 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' SER . . . . . 0.472 ' H ' ' HB2' ' B' ' 1' ' ' PRO . 14.7 m -67.56 176.01 2.59 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 162.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.461 ' HE1' ' CD1' ' B' ' 38' ' ' ILE . 0.1 OUTLIER -73.37 -52.65 13.06 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.085 -1.046 . . . . 0.0 108.286 166.265 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . 0.496 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.4 p-10 -85.77 5.84 30.65 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 113.936 -1.483 . . . . 0.0 113.429 -165.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.92 -4.42 3.31 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 118.256 0.48 . . . . 0.0 111.707 -176.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.597 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 1.9 m -77.62 133.16 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . 0.698 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.1 OUTLIER -155.0 159.08 40.08 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -179.65 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -45.01 112.65 0.46 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 113.211 -1.813 . . . . 0.0 112.584 -177.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.08 -150.52 18.3 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.411 173.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 33.3 m -52.07 95.17 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 117.023 0.411 . . . . 0.0 111.49 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 21.0 pttp 37.9 43.93 0.56 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.438 1.095 . . . . 0.0 111.99 -172.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -56.75 138.1 77.84 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.411 177.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . 0.531 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 33.6 Cg_exo -53.67 122.12 10.75 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 121.737 1.625 . . . . 0.0 109.477 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' TYR . . . . . 0.778 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 14.6 t80 -72.17 -52.22 7.44 Favored Pre-proline 0 N--CA 1.438 -1.04 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -165.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.543 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 37.7 Cg_exo -56.52 -18.01 24.06 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 121.547 1.498 . . . . 0.0 110.685 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.531 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.6 m-20 -90.39 -42.52 10.87 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.846 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' PHE . . . . . 0.49 ' CE2' HD23 ' B' ' 21' ' ' LEU . 0.0 OUTLIER -54.91 -45.8 74.78 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.554 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.769 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 1.7 p -78.77 -34.52 17.4 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.289 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.281 -178.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' B' ' 15' ' ' PRO . . . -58.94 -31.23 68.51 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 121.485 -0.76 . . . . 0.0 111.843 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.671 ' O ' HG11 ' B' ' 24' ' ' VAL . 15.6 ptt180 -84.67 -26.41 27.78 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 175.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.547 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 5.9 tp -58.54 -46.53 86.63 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.933 172.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' GLN . . . . . 0.769 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 26.5 mt-30 -70.58 -47.29 60.99 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.256 177.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.726 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 8.3 t70 -49.85 -51.8 37.4 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 124.202 0.938 . . . . 0.0 111.576 -177.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' VAL . . . . . 0.671 HG11 ' O ' ' B' ' 20' ' ' ARG . 7.2 p -81.17 -23.83 10.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -174.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.784 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -71.77 -19.3 62.04 Favored 'General case' 0 C--O 1.204 -1.294 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 174.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.6 -36.31 18.93 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.531 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.726 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.9 mmtt -67.36 -37.61 83.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.142 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 46.5 m -101.85 -10.63 19.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.194 0.521 . . . . 0.0 110.712 -172.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.784 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 85.4 mt -112.36 130.24 66.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.748 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.23 -0.67 57.4 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.001 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.653 ' OD1' ' HD2' ' B' ' 33' ' ' LYS . 0.9 OUTLIER -121.82 127.85 51.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.326 0.584 . . . . 0.0 112.069 -178.172 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -56.66 -31.8 64.76 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.825 176.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.653 ' HD2' ' OD1' ' B' ' 31' ' ' ASP . 25.9 mttt -62.48 -61.0 2.74 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -177.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.468 ' HA ' HG23 ' B' ' 37' ' ' VAL . . . -62.0 -24.51 67.08 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.413 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.85 ' O ' HG12 ' B' ' 39' ' ' VAL . 1.7 tmm_? -69.83 -57.81 4.64 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 20.6 mtpt -57.28 -55.52 33.75 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.948 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.733 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 19.8 m -54.07 -35.92 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.325 -170.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.461 ' CD1' ' HE1' ' B' ' 3' ' ' PHE . 1.2 tt -87.52 -29.13 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 C-N-CA 119.744 -0.783 . . . . 0.0 111.932 -178.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.85 HG12 ' O ' ' B' ' 35' ' ' ARG . 3.0 m -69.88 -49.4 57.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 119.156 -1.018 . . . . 0.0 109.318 175.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.645 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 66.4 mt-10 -63.41 -24.11 67.69 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.812 0.845 . . . . 0.0 112.377 176.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.733 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -86.21 -56.98 3.19 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 177.114 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' MET . . . . . 0.496 ' HG3' ' HB2' ' B' ' 4' ' ' ASN . 20.8 mmt -62.5 -20.76 64.92 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-O 121.524 0.678 . . . . 0.0 109.812 -177.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.667 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . . . -48.88 -28.4 3.75 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.673 -1.148 . . . . 0.0 110.603 170.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' TYR . . . . . 0.544 ' CG ' ' HB2' ' B' ' 52' ' ' GLN . 5.6 t80 -108.17 -67.68 0.95 Allowed 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 175.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.673 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 5.0 mm-40 -46.94 -32.19 3.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 124.433 1.083 . . . . 0.0 112.109 -173.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.698 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 5.0 m-20 -104.59 -21.21 13.45 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -176.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.637 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -60.44 -179.27 0.11 Allowed 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.928 0.87 . . . . 0.0 112.95 -173.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -56.95 139.67 78.09 Favored Pre-proline 0 N--CA 1.444 -0.758 0 CA-C-N 114.403 -1.272 . . . . 0.0 108.892 175.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.78 -23.31 41.07 Favored 'Trans proline' 0 C--O 1.222 -0.321 0 C-N-CA 123.288 2.659 . . . . 0.0 112.12 -177.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . 0.497 ' O ' ' HG3' ' B' ' 50' ' ' GLU . 0.0 OUTLIER -88.16 -30.27 19.92 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.482 174.181 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.92 ' SG ' ' HB2' ' B' ' 76' ' ' CYS . 43.7 t -83.19 -36.53 24.61 Favored 'General case' 0 N--CA 1.426 -1.662 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.614 -170.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . 0.544 ' HB2' ' CG ' ' B' ' 44' ' ' TYR . 4.2 pt20 -67.66 -30.24 69.74 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 171.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' SER . . . . . 0.46 ' O ' ' HD2' ' B' ' 56' ' ' LYS . 14.7 m -69.94 -20.27 63.34 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 113.343 -1.753 . . . . 0.0 110.727 173.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -81.3 -24.73 37.0 Favored 'General case' 0 C--N 1.313 -1.018 0 O-C-N 121.448 -0.782 . . . . 0.0 109.973 167.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.56 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 25.3 mt -90.22 -30.93 5.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -171.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . 0.603 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.29 -40.07 2.51 Favored Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -174.477 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 49.4 Cg_endo -62.39 -27.39 77.4 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.32 2.013 . . . . 0.0 112.801 176.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . 0.518 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.0 OUTLIER -100.87 -15.76 17.46 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . 0.537 ' HE3' ' HB3' ' B' ' 44' ' ' TYR . 0.1 OUTLIER -53.41 109.34 0.43 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.172 -178.098 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . 0.45 ' N ' ' HZ3' ' B' ' 59' ' ' LYS . . . 92.09 -20.54 42.39 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.319 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 10.4 mmmt -103.79 113.54 27.13 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.75 144.19 42.06 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 173.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo . . . . . 0 N--CA 1.462 -0.376 0 C-N-CA 122.14 1.893 . . . . 0.0 111.392 168.84 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' ASP . . . . . 0.76 ' OD1' ' HB ' ' B' ' 69' ' ' ILE . 5.0 t70 . . . . . 0 CA--C 1.518 -0.266 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . 0.573 HG23 ' HG2' ' B' ' 40' ' ' GLU . 0.8 OUTLIER -79.87 -28.96 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 C-N-CA 118.306 -1.357 . . . . 0.0 109.178 179.302 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . 0.772 ' O ' HG12 ' B' ' 73' ' ' VAL . 11.4 mm -60.47 -46.37 95.43 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.988 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.878 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 29.6 t -44.27 -39.09 4.26 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.034 175.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.483 ' O ' ' HE2' ' B' ' 74' ' ' LYS . 6.3 mm-40 -86.16 -31.78 21.61 Favored 'General case' 0 C--O 1.216 -0.694 0 C-N-CA 123.445 0.698 . . . . 0.0 111.364 -177.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' TYR . . . . . 0.556 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.0 m-30 -75.51 -34.65 60.82 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.574 0.702 . . . . 0.0 109.328 -177.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . 0.778 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.4 m -71.79 -31.82 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 173.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' LYS . . . . . 0.483 ' HE2' ' O ' ' B' ' 71' ' ' GLU . 13.4 ttpt -71.76 -26.18 62.34 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.458 -1.247 . . . . 0.0 109.437 177.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -65.28 -46.46 80.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.741 174.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.92 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 39.6 t -87.43 0.55 55.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.167 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 29.8 t70 . . . . . 0 C--N 1.322 -0.593 0 CA-C-O 121.632 0.73 . . . . 0.0 109.551 174.997 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo . . . . . 0 CA--C 1.518 -0.313 0 N-CA-C 108.666 -1.321 . . . . 0.0 108.666 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.407 ' HG ' ' HD3' ' B' ' 59' ' ' LYS . 16.4 m -67.57 -178.9 0.97 Allowed 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 162.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.452 ' HE1' ' CD1' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -77.11 -51.84 10.33 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 164.713 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.488 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 2.3 p-10 -87.28 5.93 35.88 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 113.913 -1.494 . . . . 0.0 113.896 -164.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.403 HG23 ' HB2' ' A' ' 2' ' ' SER . 0.8 OUTLIER -63.77 -5.65 4.53 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 118.784 0.72 . . . . 0.0 111.52 -176.743 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.456 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.0 m -78.16 130.31 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 176.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.673 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -155.72 158.74 38.73 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -178.37 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.454 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.6 mt-30 -39.07 116.65 0.6 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.624 -1.626 . . . . 0.0 113.551 176.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.29 -155.84 32.23 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.573 169.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.6 m -48.25 100.51 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 117.481 0.64 . . . . 0.0 111.678 -177.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.3 pttt 38.24 42.67 0.52 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.295 1.038 . . . . 0.0 112.335 -173.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -57.46 138.26 81.43 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.267 176.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.517 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 37.0 Cg_exo -53.8 122.4 11.28 Favored 'Trans proline' 0 CA--C 1.505 -0.944 0 C-N-CA 121.84 1.693 . . . . 0.0 109.265 177.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.723 ' O ' HG13 ' A' ' 18' ' ' VAL . 11.6 t80 -70.66 -53.92 8.89 Favored Pre-proline 0 N--CA 1.434 -1.241 0 CA-C-O 118.454 -0.784 . . . . 0.0 112.908 -166.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.547 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 36.3 Cg_exo -56.18 -18.2 22.86 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 121.453 1.435 . . . . 0.0 110.825 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.517 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 2.8 m-20 -89.53 -42.79 11.24 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.977 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.678 ' HE2' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -53.78 -46.55 71.06 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 176.63 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.747 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 1.3 p -79.27 -34.52 16.41 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.369 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.615 -177.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . -57.5 -32.61 67.19 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 121.335 -0.853 . . . . 0.0 111.674 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.716 ' O ' HG11 ' A' ' 24' ' ' VAL . 16.6 ptt180 -84.36 -27.12 27.92 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 176.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.617 HD21 ' CE1' ' A' ' 17' ' ' PHE . 6.7 tp -56.56 -47.26 79.88 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.996 172.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.747 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 20.2 mt-30 -71.3 -47.1 58.85 Favored 'General case' 0 CA--C 1.493 -1.236 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.995 177.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.722 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 17.6 t70 -47.22 -54.83 9.82 Favored 'General case' 0 C--N 1.313 -1.015 0 O-C-N 124.297 0.998 . . . . 0.0 111.502 -178.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.716 HG11 ' O ' ' A' ' 20' ' ' ARG . 7.5 p -81.23 -23.31 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.162 0.506 . . . . 0.0 109.983 -174.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.749 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -72.07 -19.5 61.81 Favored 'General case' 0 C--O 1.204 -1.318 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 174.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.421 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -86.25 -36.65 19.25 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.616 178.047 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.722 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 37.8 mmtt -66.9 -38.12 85.66 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.956 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.2 m -101.83 -8.85 21.29 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.166 0.508 . . . . 0.0 110.658 -171.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.749 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 88.7 mt -114.59 135.68 53.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.717 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.56 -2.25 42.14 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.003 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.572 ' H ' HG23 ' A' ' 29' ' ' ILE . 4.8 t0 -117.63 132.38 56.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.11 0.481 . . . . 0.0 111.048 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.581 ' OE1' ' HG3' ' A' ' 33' ' ' LYS . 1.6 pp20? -59.95 -35.39 74.85 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.285 174.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.581 ' HG3' ' OE1' ' A' ' 32' ' ' GLU . 13.2 mttp -61.53 -58.74 6.91 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -175.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.435 ' HA ' HG21 ' A' ' 37' ' ' VAL . . . -61.9 -27.03 68.52 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.494 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.807 ' O ' HG11 ' A' ' 39' ' ' VAL . 5.0 tmm_? -70.4 -58.38 3.79 Favored 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.455 ' HD2' ' OE2' ' A' ' 32' ' ' GLU . 18.4 mtpt -56.14 -55.85 28.09 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.867 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.768 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 22.5 m -53.79 -36.49 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.228 -171.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.46 ' O ' ' HG2' ' A' ' 42' ' ' MET . 1.3 tt -87.0 -29.73 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.826 -177.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.807 HG11 ' O ' ' A' ' 35' ' ' ARG . 3.0 m -69.95 -48.95 60.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 119.089 -1.044 . . . . 0.0 109.488 175.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.589 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 54.1 mt-10 -64.93 -23.33 67.19 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.533 0.733 . . . . 0.0 112.545 176.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.768 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -85.78 -55.45 3.96 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.63 176.391 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.503 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 22.5 mmt -62.65 -20.42 64.79 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.698 0.761 . . . . 0.0 109.372 -178.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.659 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -48.28 -29.48 3.89 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.794 170.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.553 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 10.3 t80 -108.15 -66.39 1.04 Allowed 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.637 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 13.9 mm-40 -48.08 -32.66 7.05 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 124.266 0.979 . . . . 0.0 112.1 -174.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.673 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.9 m-20 -103.75 -20.6 13.89 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.326 -175.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.659 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -59.77 -179.94 0.11 Allowed 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 122.023 0.915 . . . . 0.0 112.681 -174.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.541 ' HB3' ' OE2' ' A' ' 50' ' ' GLU . 13.0 m-20 -58.6 140.52 85.0 Favored Pre-proline 0 N--CA 1.439 -1.016 0 CA-C-N 114.213 -1.358 . . . . 0.0 109.335 174.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -57.73 -20.83 44.78 Favored 'Trans proline' 0 C--O 1.222 -0.321 0 C-N-CA 123.228 2.619 . . . . 0.0 112.166 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.725 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 8.9 pm0 -88.58 -30.92 18.91 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 123.521 0.728 . . . . 0.0 110.255 173.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.97 ' SG ' ' HB2' ' A' ' 76' ' ' CYS . 49.5 t -85.46 -37.08 20.15 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.952 -168.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.499 ' HB2' ' CG ' ' A' ' 44' ' ' TYR . 3.7 pt20 -67.52 -28.94 68.24 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 171.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.465 ' CA ' ' HE2' ' A' ' 56' ' ' LYS . 32.8 m -71.88 -20.97 61.72 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 113.166 -1.834 . . . . 0.0 110.318 174.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.8 -24.32 44.64 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.41 0.624 . . . . 0.0 110.184 167.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.557 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 21.4 mt -90.89 -32.95 5.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -171.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.616 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.28 -38.95 1.79 Allowed Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -173.652 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 43.0 Cg_endo -61.61 -29.72 84.64 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 122.164 1.91 . . . . 0.0 112.636 175.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.509 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.5 mt -98.13 -16.51 19.49 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -179.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.569 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 0.1 OUTLIER -54.73 108.64 0.41 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.597 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.85 -25.37 28.55 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.56 -177.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.3 mmmt -103.99 113.49 27.06 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.046 0.45 . . . . 0.0 110.355 -178.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.42 145.53 49.22 Favored Pre-proline 0 C--N 1.313 -1.016 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 170.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo . . . . . 0 C--O 1.233 0.262 0 C-N-CA 122.395 2.063 . . . . 0.0 111.443 167.746 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.514 -0.411 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.545 HG23 ' HG2' ' A' ' 40' ' ' GLU . 0.7 OUTLIER -75.17 -27.64 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 C-N-CA 119.018 -1.073 . . . . 0.0 108.606 178.736 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.797 ' O ' HG12 ' A' ' 73' ' ' VAL . 17.7 mm -57.15 -47.02 84.7 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.211 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.332 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.9 t -46.77 -36.41 7.25 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.161 0.505 . . . . 0.0 111.237 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.64 ' O ' ' HE3' ' A' ' 74' ' ' LYS . 1.7 mm-40 -85.85 -32.91 21.46 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.45 -177.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.625 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 4.9 m-30 -75.31 -33.46 61.17 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.374 -177.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.797 HG12 ' O ' ' A' ' 69' ' ' ILE . 1.2 m -71.66 -31.15 41.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 171.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.64 ' HE3' ' O ' ' A' ' 71' ' ' GLU . 0.7 OUTLIER -72.0 -24.15 61.52 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.654 176.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -66.33 -47.34 73.84 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.404 173.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.97 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 43.9 t -88.97 7.76 33.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.051 178.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 C--N 1.323 -0.551 0 CA-C-O 121.271 0.558 . . . . 0.0 109.894 172.376 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 1' ' ' PRO . . . . . 0.485 ' HB2' ' H ' ' B' ' 2' ' ' SER . 83.6 Cg_endo . . . . . 0 CA--C 1.517 -0.336 0 N-CA-C 108.725 -1.298 . . . . 0.0 108.725 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' SER . . . . . 0.485 ' H ' ' HB2' ' B' ' 1' ' ' PRO . 16.8 m -67.88 -179.24 1.13 Allowed 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 162.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.453 ' HE1' ' CD1' ' B' ' 38' ' ' ILE . 0.1 OUTLIER -76.7 -51.95 10.53 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 164.761 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . 0.49 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.3 p-10 -87.28 6.09 35.1 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.929 -1.487 . . . . 0.0 113.869 -164.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' THR . . . . . 0.411 HG23 ' HB2' ' B' ' 2' ' ' SER . 0.8 OUTLIER -63.82 -5.89 5.0 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 118.806 0.73 . . . . 0.0 111.467 -176.699 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.458 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 1.9 m -77.89 130.23 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 176.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . 0.669 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.1 OUTLIER -155.71 158.66 38.6 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.11 -1.036 . . . . 0.0 113.765 -178.426 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' GLN . . . . . 0.458 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.6 mt-30 -38.7 116.77 0.59 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 113.612 -1.631 . . . . 0.0 113.597 176.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.27 -155.94 32.32 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 169.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 18.4 m -48.19 100.6 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 117.437 0.619 . . . . 0.0 111.615 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 22.2 pttt 38.46 42.04 0.51 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.411 1.084 . . . . 0.0 112.401 -174.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -56.99 138.23 79.49 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.221 176.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . 0.527 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 37.2 Cg_exo -53.87 122.51 11.49 Favored 'Trans proline' 0 CA--C 1.508 -0.823 0 C-N-CA 121.88 1.72 . . . . 0.0 109.292 177.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' TYR . . . . . 0.716 ' O ' HG13 ' B' ' 18' ' ' VAL . 11.7 t80 -70.82 -54.09 8.28 Favored Pre-proline 0 N--CA 1.435 -1.217 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.833 -166.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.537 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 36.4 Cg_exo -56.05 -18.2 22.09 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 121.432 1.422 . . . . 0.0 110.841 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.527 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 2.3 m-20 -89.62 -42.48 11.36 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.146 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' PHE . . . . . 0.687 ' HE2' ' CE2' ' B' ' 14' ' ' TYR . 0.0 OUTLIER -54.23 -46.48 72.55 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 176.471 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.75 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 1.2 p -79.29 -34.55 16.4 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.366 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.563 -177.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' B' ' 15' ' ' PRO . . . -57.38 -32.71 67.07 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 121.374 -0.829 . . . . 0.0 111.702 178.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.702 ' O ' HG11 ' B' ' 24' ' ' VAL . 16.7 ptt180 -84.36 -27.2 27.86 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.619 HD21 ' CE1' ' B' ' 17' ' ' PHE . 6.8 tp -56.58 -47.27 79.92 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.886 172.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' GLN . . . . . 0.75 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 20.2 mt-30 -71.28 -46.86 59.86 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.028 177.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.732 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 17.4 t70 -47.54 -54.73 10.85 Favored 'General case' 0 C--N 1.315 -0.922 0 O-C-N 124.254 0.971 . . . . 0.0 111.607 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' VAL . . . . . 0.702 HG11 ' O ' ' B' ' 20' ' ' ARG . 7.5 p -81.14 -23.27 10.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.085 0.469 . . . . 0.0 109.921 -174.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.749 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -72.15 -19.47 61.76 Favored 'General case' 0 C--O 1.204 -1.297 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 174.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . 0.415 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -86.4 -36.4 19.19 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.583 -1.189 . . . . 0.0 109.499 178.105 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.732 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.1 mmtt -66.99 -38.09 85.39 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.98 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 50.1 m -101.63 -9.57 20.82 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.269 0.557 . . . . 0.0 110.768 -171.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.749 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 88.2 mt -113.91 135.95 51.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.677 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.03 -1.84 41.66 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.916 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.569 ' H ' HG23 ' B' ' 29' ' ' ILE . 4.5 t0 -118.04 132.31 56.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.205 0.526 . . . . 0.0 111.147 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 0.551 ' OE1' ' HG3' ' B' ' 33' ' ' LYS . 1.5 pp20? -59.82 -35.58 75.01 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.312 174.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.551 ' HG3' ' OE1' ' B' ' 32' ' ' GLU . 13.2 mttp -61.37 -58.75 6.95 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -175.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.435 ' HA ' HG21 ' B' ' 37' ' ' VAL . . . -61.95 -26.88 68.46 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.531 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.828 ' O ' HG11 ' B' ' 39' ' ' VAL . 5.0 tmm_? -70.54 -58.25 3.89 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.446 ' HD2' ' OE2' ' B' ' 32' ' ' GLU . 17.8 mtpt -56.3 -55.49 32.71 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.992 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.747 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 22.8 m -54.0 -36.58 31.67 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.103 -172.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.453 ' CD1' ' HE1' ' B' ' 3' ' ' PHE . 1.3 tt -87.06 -29.62 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.845 -177.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.828 HG11 ' O ' ' B' ' 35' ' ' ARG . 3.0 m -70.02 -49.03 59.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 119.131 -1.028 . . . . 0.0 109.488 175.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.597 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 58.8 mt-10 -64.91 -23.28 67.18 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.514 0.725 . . . . 0.0 112.604 176.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.747 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -85.92 -55.37 3.98 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.555 176.385 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' MET . . . . . 0.504 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 22.5 mmt -62.58 -20.48 64.74 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.614 0.721 . . . . 0.0 109.318 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.669 ' O ' ' HB2' ' B' ' 47' ' ' ALA . . . -48.26 -29.6 3.98 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.832 170.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' TYR . . . . . 0.547 ' CG ' ' HD2' ' B' ' 59' ' ' LYS . 10.4 t80 -108.06 -66.39 1.04 Allowed 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.633 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 14.6 mm-40 -47.97 -33.24 7.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 124.292 0.995 . . . . 0.0 111.905 -174.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.669 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.9 m-20 -103.2 -20.77 14.01 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.366 -175.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -59.72 179.76 0.11 Allowed 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 122.028 0.918 . . . . 0.0 112.683 -174.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' ASN . . . . . 0.53 ' HB3' ' OE2' ' B' ' 50' ' ' GLU . 12.5 m-20 -58.24 140.45 83.37 Favored Pre-proline 0 N--CA 1.438 -1.032 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.362 175.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -57.8 -20.65 44.51 Favored 'Trans proline' 0 C--O 1.221 -0.355 0 C-N-CA 123.211 2.607 . . . . 0.0 112.182 -178.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . 0.721 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 9.1 pm0 -88.66 -30.9 18.81 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 123.541 0.737 . . . . 0.0 110.287 173.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.971 ' SG ' ' HB2' ' B' ' 76' ' ' CYS . 49.5 t -85.52 -37.12 20.02 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.97 -168.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . 0.496 ' HB2' ' CG ' ' B' ' 44' ' ' TYR . 3.9 pt20 -67.46 -29.04 68.4 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 171.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' B' ' 50' ' ' GLU . 34.8 m -71.8 -21.1 61.75 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 113.176 -1.829 . . . . 0.0 110.379 174.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.53 -24.56 45.66 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.501 0.667 . . . . 0.0 110.159 167.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.565 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 21.5 mt -90.8 -32.98 5.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -171.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . 0.606 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.19 -39.24 1.86 Allowed Pre-proline 0 N--CA 1.486 1.365 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -173.612 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 42.9 Cg_endo -61.44 -29.55 85.38 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.216 1.944 . . . . 0.0 112.728 175.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . 0.509 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.4 mt -98.23 -16.54 19.39 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . 0.584 ' HA ' ' OH ' ' B' ' 72' ' ' TYR . 0.1 OUTLIER -54.65 108.81 0.43 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.578 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.72 -25.43 28.3 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.59 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 12.3 mmmt -103.99 113.49 27.06 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.114 0.483 . . . . 0.0 110.322 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.22 145.53 48.8 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.844 170.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo . . . . . 0 C--N 1.345 0.37 0 C-N-CA 122.277 1.985 . . . . 0.0 111.528 167.679 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.515 -0.393 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . 0.548 HG11 ' CD ' ' B' ' 40' ' ' GLU . 0.7 OUTLIER -75.14 -27.49 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 C-N-CA 118.795 -1.162 . . . . 0.0 108.64 178.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . 0.797 ' O ' HG12 ' B' ' 73' ' ' VAL . 17.9 mm -57.21 -46.98 84.95 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.194 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.366 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 30.6 t -46.87 -36.14 7.17 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.32 0.581 . . . . 0.0 111.349 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.635 ' O ' ' HE3' ' B' ' 74' ' ' LYS . 1.7 mm-40 -85.98 -32.83 21.32 Favored 'General case' 0 C--O 1.213 -0.817 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.499 -177.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' TYR . . . . . 0.629 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 4.9 m-30 -75.54 -33.27 60.66 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.376 -177.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . 0.797 HG12 ' O ' ' B' ' 69' ' ' ILE . 1.2 m -71.66 -31.3 41.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 171.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' LYS . . . . . 0.635 ' HE3' ' O ' ' B' ' 71' ' ' GLU . 0.7 OUTLIER -71.89 -24.45 61.66 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.539 177.021 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -66.24 -47.14 74.75 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.438 173.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.971 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 44.2 t -89.12 7.64 34.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.831 178.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 12.3 t70 . . . . . 0 C--N 1.324 -0.53 0 CA-C-O 121.192 0.52 . . . . 0.0 109.896 172.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.4 ' HB2' ' H ' ' A' ' 2' ' ' SER . 97.8 Cg_endo . . . . . 0 N--CA 1.465 -0.202 0 N-CA-C 108.91 -1.227 . . . . 0.0 108.91 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.404 ' HB2' HG23 ' A' ' 5' ' ' THR . 72.0 m -71.34 -178.86 2.23 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 161.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.479 ' CE1' HD13 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -77.02 -53.48 7.75 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 122.096 0.95 . . . . 0.0 109.716 172.77 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.535 ' ND2' ' HE3' ' A' ' 42' ' ' MET . 2.5 p-10 -85.69 5.85 30.26 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.141 -1.39 . . . . 0.0 113.249 -163.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.449 ' CG2' ' HD3' ' B' ' 59' ' ' LYS . 1.1 p -66.83 -3.38 6.72 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 121.935 -0.478 . . . . 0.0 111.428 -176.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.553 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 1.9 m -78.2 133.89 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 173.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.681 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -156.54 160.84 39.86 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -177.863 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -41.94 115.53 0.68 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 113.704 -1.589 . . . . 0.0 113.056 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.58 -151.72 23.78 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 172.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.481 ' C ' ' HD3' ' A' ' 11' ' ' LYS . 22.8 m -54.25 99.13 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 117.319 0.559 . . . . 0.0 111.133 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.481 ' HD3' ' C ' ' A' ' 10' ' ' SER . 0.0 OUTLIER 34.56 46.52 0.18 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.642 1.177 . . . . 0.0 112.269 -171.333 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -59.54 139.54 89.2 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.23 175.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.538 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 52.1 Cg_exo -51.0 122.47 9.99 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 121.942 1.761 . . . . 0.0 109.651 177.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.847 ' HE2' ' SG ' ' A' ' 51' ' ' CYS . 6.1 t80 -70.4 -55.34 7.8 Favored Pre-proline 0 N--CA 1.439 -1.001 0 CA-C-O 118.569 -0.729 . . . . 0.0 112.651 -167.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.509 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 35.0 Cg_exo -55.57 -19.41 23.37 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 121.535 1.49 . . . . 0.0 111.217 -178.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.538 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 0.8 OUTLIER -90.04 -39.39 12.96 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.176 179.505 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.688 ' HE2' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -56.64 -45.68 81.43 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 175.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.726 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 1.3 p -79.01 -33.97 16.38 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.329 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.275 -178.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.64 -32.0 66.84 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 121.386 -0.821 . . . . 0.0 111.624 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.699 ' O ' HG11 ' A' ' 24' ' ' VAL . 14.5 ptt180 -84.96 -26.32 27.24 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 176.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.58 HD22 ' CE1' ' A' ' 17' ' ' PHE . 7.5 tp -56.99 -47.74 80.09 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.639 171.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.726 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 18.2 mt-30 -70.15 -46.62 64.33 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.753 176.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.719 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 18.6 t70 -46.82 -57.13 5.21 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.288 0.992 . . . . 0.0 111.67 -179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.699 HG11 ' O ' ' A' ' 20' ' ' ARG . 7.7 p -79.22 -23.85 12.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.134 0.492 . . . . 0.0 109.816 -173.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.745 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -72.14 -19.69 61.73 Favored 'General case' 0 C--O 1.205 -1.243 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 174.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.467 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -86.66 -36.98 18.45 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.481 178.522 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.719 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.7 mmtt -66.82 -35.27 79.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.8 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.9 t -105.07 -9.11 18.04 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.166 0.508 . . . . 0.0 110.583 -171.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.745 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 88.7 mt -115.11 129.1 71.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.769 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.26 -4.65 59.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.171 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.553 ' H ' HG22 ' A' ' 29' ' ' ILE . 2.8 t0 -116.16 140.57 49.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.233 0.54 . . . . 0.0 111.276 -177.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.528 ' OE2' ' HG3' ' A' ' 33' ' ' LYS . 1.4 pp20? -66.41 -36.14 82.08 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.256 173.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.528 ' HG3' ' OE2' ' A' ' 32' ' ' GLU . 13.0 mttp -60.45 -61.02 2.9 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -174.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.425 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -59.71 -27.04 66.11 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.623 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.805 ' O ' HG12 ' A' ' 39' ' ' VAL . 4.8 tmm_? -69.65 -59.42 2.97 Favored 'General case' 0 C--O 1.221 -0.43 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -56.73 -55.78 29.84 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.217 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.695 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 18.9 m -53.19 -35.36 23.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 O-C-N 123.98 0.8 . . . . 0.0 111.253 -172.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.5 HD13 ' OD1' ' A' ' 4' ' ' ASN . 1.3 tt -87.46 -31.12 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 119.756 -0.778 . . . . 0.0 112.097 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.805 HG12 ' O ' ' A' ' 35' ' ' ARG . 3.0 m -69.19 -48.57 67.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 119.181 -1.008 . . . . 0.0 109.392 175.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.607 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 58.2 mt-10 -63.73 -23.7 67.47 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 123.624 0.77 . . . . 0.0 112.264 176.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.695 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -86.47 -54.74 4.24 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.803 176.343 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.535 ' HE3' ' ND2' ' A' ' 4' ' ' ASN . 18.7 mmt -62.68 -20.46 64.87 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.504 0.669 . . . . 0.0 109.919 -177.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.617 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . . . -48.23 -29.08 3.45 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.024 171.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.619 ' CG ' ' HB2' ' A' ' 52' ' ' GLN . 2.5 t80 -109.05 -65.68 1.12 Allowed 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 175.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.502 ' CG ' HD13 ' A' ' 41' ' ' LEU . 3.3 mm-40 -46.89 -30.39 2.49 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 124.116 0.885 . . . . 0.0 112.713 -175.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.681 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.8 m-20 -106.55 -20.77 13.26 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -175.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.811 ' HB3' ' SG ' ' A' ' 51' ' ' CYS . . . -64.33 -175.96 0.2 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -172.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 51' ' ' CYS . 18.7 m-20 -61.79 141.7 95.1 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 114.526 -1.216 . . . . 0.0 109.447 175.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -55.27 -26.6 52.9 Favored 'Trans proline' 0 C--O 1.219 -0.458 0 C-N-CA 123.592 2.861 . . . . 0.0 112.968 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.518 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -87.31 -29.29 21.7 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.381 0.672 . . . . 0.0 110.247 174.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.847 ' SG ' ' HE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -76.15 -43.67 41.78 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.547 -172.229 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.619 ' HB2' ' CG ' ' A' ' 44' ' ' TYR . 4.3 pt20 -67.75 -29.46 68.69 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 175.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.562 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 4.0 m -69.42 -20.89 63.79 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 113.703 -1.589 . . . . 0.0 110.729 173.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 51' ' ' CYS . . . -80.41 -24.87 39.36 Favored 'General case' 0 C--N 1.309 -1.176 0 O-C-N 121.412 -0.805 . . . . 0.0 109.853 168.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.558 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 25.8 mt -90.73 -31.22 5.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 115.008 1.485 . . . . 0.0 115.008 -172.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.624 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.71 -39.75 2.79 Favored Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -172.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 49.6 Cg_endo -62.69 -29.76 77.83 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.327 2.018 . . . . 0.0 112.799 176.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.519 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.6 mt -97.35 -16.37 20.3 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.595 ' HE3' ' HB3' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -52.94 108.4 0.31 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.02 -178.141 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.9 -22.71 36.6 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.74 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -103.39 114.85 29.45 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.55 138.74 29.76 Favored Pre-proline 0 C--N 1.313 -1.015 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.42 173.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_exo . . . . . 0 C--N 1.344 0.291 0 C-N-CA 122.661 2.241 . . . . 0.0 111.891 169.604 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.513 -0.45 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.566 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.7 OUTLIER -74.33 -28.54 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 C-N-CA 118.462 -1.295 . . . . 0.0 108.669 -177.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.781 ' O ' HG12 ' A' ' 73' ' ' VAL . 14.3 mm -58.49 -46.82 89.56 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.278 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.327 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.526 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 40.3 t -48.77 -36.63 16.96 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.249 0.547 . . . . 0.0 111.098 178.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -86.53 -31.34 21.31 Favored 'General case' 0 CA--C 1.506 -0.719 0 C-N-CA 123.137 0.575 . . . . 0.0 110.517 -176.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.595 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.3 m-30 -75.22 -36.64 61.33 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.285 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.781 HG12 ' O ' ' A' ' 69' ' ' ILE . 1.7 m -69.45 -32.89 54.81 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 173.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 70' ' ' SER . 0.1 OUTLIER -70.23 -32.43 70.3 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.406 178.683 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.411 ' HB3' HD13 ' A' ' 58' ' ' LEU . . . -63.43 -42.76 98.71 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.645 -1.161 . . . . 0.0 108.972 178.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.58 ' SG ' ' SG ' ' A' ' 51' ' ' CYS . 5.0 m -102.21 9.49 40.02 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.34 -175.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.3 t70 . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.069 178.793 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 1' ' ' PRO . . . . . 0.453 ' HB2' ' H ' ' B' ' 2' ' ' SER . 98.9 Cg_endo . . . . . 0 CA--C 1.518 -0.285 0 N-CA-C 108.811 -1.265 . . . . 0.0 108.811 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' SER . . . . . 0.453 ' H ' ' HB2' ' B' ' 1' ' ' PRO . 74.7 m -71.04 -178.75 2.06 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 161.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.474 ' CE1' HD13 ' B' ' 29' ' ' ILE . 0.1 OUTLIER -77.12 -53.5 7.69 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 122.093 0.949 . . . . 0.0 109.646 172.831 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . 0.521 ' ND2' ' HE3' ' B' ' 42' ' ' MET . 2.5 p-10 -85.61 5.77 30.33 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.095 -1.411 . . . . 0.0 113.224 -163.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' THR . . . . . 0.454 ' CG2' ' HD3' ' A' ' 59' ' ' LYS . 1.1 p -66.72 -3.75 7.37 Favored 'General case' 0 C--N 1.312 -1.045 0 O-C-N 121.953 -0.467 . . . . 0.0 111.36 -176.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.556 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.0 m -77.99 133.75 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 173.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . 0.678 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.2 OUTLIER -156.41 160.95 40.09 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -177.925 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -41.98 115.22 0.64 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 113.732 -1.576 . . . . 0.0 113.16 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.44 -151.5 23.12 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 171.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' SER . . . . . 0.49 ' C ' ' HD3' ' B' ' 11' ' ' LYS . 24.0 m -54.73 98.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.369 0.585 . . . . 0.0 111.187 -178.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.49 ' HD3' ' C ' ' B' ' 10' ' ' SER . 0.0 OUTLIER 34.99 46.6 0.21 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.799 1.24 . . . . 0.0 112.129 -171.508 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -59.64 139.51 89.55 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.197 175.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . 0.546 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 51.2 Cg_exo -50.98 122.32 9.72 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 121.955 1.77 . . . . 0.0 109.615 177.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' TYR . . . . . 0.833 ' HE2' ' SG ' ' B' ' 51' ' ' CYS . 6.3 t80 -70.35 -55.22 8.02 Favored Pre-proline 0 N--CA 1.439 -0.98 0 CA-C-O 118.494 -0.765 . . . . 0.0 112.664 -167.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.51 ' HD3' ' HB3' ' B' ' 14' ' ' TYR . 35.2 Cg_exo -55.79 -19.21 24.0 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 121.526 1.484 . . . . 0.0 111.124 -178.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.546 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 0.8 OUTLIER -89.92 -39.79 12.79 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.226 -1.352 . . . . 0.0 111.082 179.579 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' PHE . . . . . 0.686 ' HE2' ' CE2' ' B' ' 14' ' ' TYR . 0.0 OUTLIER -56.59 -45.67 81.24 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.128 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.734 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 1.3 p -78.94 -33.97 16.53 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.354 0 CA-C-N 115.184 -0.917 . . . . 0.0 111.271 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.71 -31.8 66.77 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 121.346 -0.846 . . . . 0.0 111.701 177.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.695 ' O ' HG11 ' B' ' 24' ' ' VAL . 14.7 ptt180 -84.88 -26.61 27.22 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 175.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.581 HD22 ' CE1' ' B' ' 17' ' ' PHE . 7.6 tp -56.84 -47.73 79.67 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.603 172.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' GLN . . . . . 0.734 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 18.5 mt-30 -70.04 -47.09 63.44 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.817 176.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.737 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 19.4 t70 -46.4 -57.06 5.0 Favored 'General case' 0 C--N 1.314 -0.947 0 O-C-N 124.312 1.008 . . . . 0.0 111.721 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' VAL . . . . . 0.695 HG11 ' O ' ' B' ' 20' ' ' ARG . 7.7 p -79.44 -23.65 12.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.169 0.509 . . . . 0.0 109.849 -173.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.759 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -72.25 -19.69 61.66 Favored 'General case' 0 C--O 1.205 -1.274 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 174.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . 0.46 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -86.73 -36.99 18.33 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.494 178.589 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.737 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.9 mmtt -66.77 -35.36 79.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.699 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 36.2 t -105.08 -8.88 18.18 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 120.946 0.403 . . . . 0.0 110.744 -171.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.759 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 88.9 mt -115.38 129.4 71.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.711 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.55 -5.02 58.95 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.102 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.565 ' H ' HG22 ' B' ' 29' ' ' ILE . 2.5 t0 -115.98 140.58 49.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.305 0.574 . . . . 0.0 111.125 -176.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 0.551 ' OE2' ' HG3' ' B' ' 33' ' ' LYS . 1.5 pp20? -66.48 -35.91 81.44 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.183 174.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.551 ' HG3' ' OE2' ' B' ' 32' ' ' GLU . 12.9 mttp -60.49 -61.04 2.88 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -174.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.43 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -59.93 -26.86 66.29 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.582 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.807 ' O ' HG12 ' B' ' 39' ' ' VAL . 4.7 tmm_? -69.69 -59.39 2.98 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -178.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.409 ' HD2' ' OE1' ' B' ' 32' ' ' GLU . 23.8 mtpt -56.84 -55.44 34.4 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.246 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.687 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 19.2 m -53.52 -35.29 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.192 -172.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.494 HD13 ' OD1' ' B' ' 4' ' ' ASN . 1.3 tt -87.42 -31.12 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.159 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.807 HG12 ' O ' ' B' ' 35' ' ' ARG . 3.0 m -69.15 -48.57 68.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 119.078 -1.049 . . . . 0.0 109.418 175.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.612 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 61.9 mt-10 -63.59 -23.94 67.59 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 123.634 0.774 . . . . 0.0 112.229 176.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.687 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -86.27 -54.73 4.28 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.871 176.328 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' MET . . . . . 0.521 ' HE3' ' ND2' ' B' ' 4' ' ' ASN . 18.8 mmt -62.65 -20.41 64.78 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 121.553 0.692 . . . . 0.0 109.971 -177.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.622 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . . . -48.33 -29.03 3.53 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.48 -1.237 . . . . 0.0 110.992 171.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' TYR . . . . . 0.631 ' CG ' ' HB2' ' B' ' 52' ' ' GLN . 2.4 t80 -109.05 -65.63 1.12 Allowed 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 176.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.496 ' CG ' HD13 ' B' ' 41' ' ' LEU . 3.3 mm-40 -46.89 -30.76 2.69 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 124.145 0.903 . . . . 0.0 112.678 -175.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.678 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.8 m-20 -106.13 -20.97 13.25 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -175.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.812 ' HB3' ' SG ' ' B' ' 51' ' ' CYS . . . -64.23 -175.9 0.19 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -172.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' ASN . . . . . 0.48 ' HB2' ' HB3' ' B' ' 51' ' ' CYS . 19.4 m-20 -61.75 141.72 95.01 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.473 175.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -55.27 -26.75 53.65 Favored 'Trans proline' 0 C--O 1.219 -0.446 0 C-N-CA 123.518 2.812 . . . . 0.0 112.948 -176.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . 0.557 ' O ' ' HG3' ' B' ' 50' ' ' GLU . 0.0 OUTLIER -87.17 -29.16 21.98 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.327 0.651 . . . . 0.0 110.351 174.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.833 ' SG ' ' HE2' ' B' ' 14' ' ' TYR . 0.0 OUTLIER -76.04 -43.78 42.27 Favored 'General case' 0 N--CA 1.42 -1.942 0 CA-C-O 121.446 0.641 . . . . 0.0 110.547 -172.229 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . 0.631 ' HB2' ' CG ' ' B' ' 44' ' ' TYR . 4.4 pt20 -67.77 -29.47 68.69 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 175.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' SER . . . . . 0.554 ' O ' ' HE2' ' B' ' 56' ' ' LYS . 4.0 m -69.42 -20.87 63.79 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 113.685 -1.598 . . . . 0.0 110.716 173.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' B' ' 51' ' ' CYS . . . -80.22 -25.26 39.69 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.289 -0.882 . . . . 0.0 109.821 168.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.566 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 25.7 mt -90.67 -31.28 5.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 -172.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . 0.623 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.64 -39.62 2.6 Favored Pre-proline 0 N--CA 1.487 1.399 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -172.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 50.7 Cg_endo -62.81 -29.67 76.98 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.323 2.015 . . . . 0.0 112.828 176.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . 0.533 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.7 mt -97.42 -16.42 20.2 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . 0.596 ' HE3' ' HB3' ' B' ' 44' ' ' TYR . 0.1 OUTLIER -52.92 108.73 0.34 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.955 -178.104 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.55 -22.47 37.24 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.745 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -103.53 115.11 29.9 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -178.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.92 139.0 30.51 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.429 173.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo . . . . . 0 C--N 1.346 0.396 0 C-N-CA 122.708 2.272 . . . . 0.0 111.833 169.77 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.513 -0.444 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . 0.557 HG13 ' CD ' ' B' ' 40' ' ' GLU . 0.7 OUTLIER -74.32 -28.33 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 C-N-CA 118.432 -1.307 . . . . 0.0 108.696 -177.462 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . 0.779 ' O ' HG12 ' B' ' 73' ' ' VAL . 14.4 mm -58.61 -46.83 90.01 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.179 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.319 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' SER . . . . . 0.534 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 37.6 t -48.62 -36.74 16.45 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.165 0.507 . . . . 0.0 111.081 178.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -86.56 -31.23 21.33 Favored 'General case' 0 CA--C 1.506 -0.73 0 C-N-CA 123.206 0.602 . . . . 0.0 110.545 -176.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' TYR . . . . . 0.585 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.3 m-30 -75.36 -36.6 60.95 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.32 -178.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . 0.779 HG12 ' O ' ' B' ' 69' ' ' ILE . 1.7 m -69.36 -33.23 56.65 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 173.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' B' ' 70' ' ' SER . 0.1 OUTLIER -69.94 -32.31 70.51 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.517 178.473 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . 0.415 ' HB3' HD13 ' B' ' 58' ' ' LEU . . . -63.76 -42.07 97.88 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.208 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.58 ' SG ' ' SG ' ' B' ' 51' ' ' CYS . 5.1 m -102.7 9.53 39.13 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 114.101 -1.409 . . . . 0.0 111.318 -175.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 CA--C 1.536 0.437 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.046 178.832 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.406 ' HB2' ' H ' ' A' ' 2' ' ' SER . 86.3 Cg_endo . . . . . 0 CA--C 1.517 -0.35 0 N-CA-C 109.024 -1.183 . . . . 0.0 109.024 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.427 ' HB2' HG23 ' A' ' 5' ' ' THR . 21.2 m -68.41 175.2 3.5 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 161.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.595 ' CE1' HD13 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -71.0 -52.2 21.03 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 164.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.495 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 2.3 p-10 -87.41 5.52 38.39 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.875 -1.512 . . . . 0.0 113.692 -165.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.427 HG23 ' HB2' ' A' ' 2' ' ' SER . 0.7 OUTLIER -64.35 -5.76 5.78 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 118.537 0.608 . . . . 0.0 111.116 -177.37 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.627 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.1 m -76.16 130.94 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.691 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -154.31 158.69 40.52 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.538 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 3.3 mt-30 -42.04 116.61 0.84 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 112.997 -1.91 . . . . 0.0 113.465 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.56 -153.67 21.55 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 170.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.647 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 20.8 t -57.19 99.34 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.166 0.483 . . . . 0.0 110.926 -177.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.647 ' HG2' ' O ' ' A' ' 10' ' ' SER . 4.1 ptpp? 49.18 32.71 4.38 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.602 1.161 . . . . 0.0 112.433 -177.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.405 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 38.7 tt0 -56.06 135.39 74.14 Favored Pre-proline 0 C--O 1.233 0.224 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.533 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 52.0 Cg_exo -51.05 123.08 11.09 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.46 2.107 . . . . 0.0 110.169 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.863 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 15.0 t80 -71.13 -53.51 8.18 Favored Pre-proline 0 N--CA 1.438 -1.061 0 CA-C-O 118.277 -0.868 . . . . 0.0 113.183 -167.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.545 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 33.6 Cg_exo -55.9 -18.43 22.05 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 121.425 1.416 . . . . 0.0 111.041 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.533 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.8 m-20 -89.92 -43.49 10.55 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.93 -1.486 . . . . 0.0 110.829 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.538 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -54.31 -44.43 72.0 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.931 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.697 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 3.0 p -82.19 -31.77 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.386 -177.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 15' ' ' PRO . . . -57.89 -35.86 71.61 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 121.763 -0.585 . . . . 0.0 111.853 175.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.709 ' O ' HG13 ' A' ' 24' ' ' VAL . 15.6 ptt180 -82.97 -27.3 30.56 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 177.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.545 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 6.5 tp -56.89 -45.46 82.57 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.858 173.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.697 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 40.5 mt-30 -74.12 -43.71 56.52 Favored 'General case' 0 CA--C 1.496 -1.112 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.999 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.742 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 8.8 t70 -51.17 -51.68 51.41 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 124.137 0.898 . . . . 0.0 111.47 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 20' ' ' ARG . 7.5 p -82.64 -23.15 8.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -174.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.815 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -71.66 -18.67 62.17 Favored 'General case' 0 C--O 1.206 -1.224 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 174.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.0 -39.11 15.98 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.471 -1.24 . . . . 0.0 109.766 176.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.742 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 36.5 mmtt -66.59 -40.61 88.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.065 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.9 m -98.81 -9.7 24.01 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.153 0.501 . . . . 0.0 110.437 -171.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.815 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 87.5 mt -115.18 125.3 72.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.759 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.56 -4.96 59.25 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.004 0.431 . . . . 0.0 110.529 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.677 ' OD1' ' HD2' ' A' ' 33' ' ' LYS . 3.9 t0 -110.62 122.43 47.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.534 -176.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' A' ' 36' ' ' LYS . 12.6 pt-20 -61.85 -25.11 67.33 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.765 176.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.677 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 24.4 mttt -73.81 -46.74 43.43 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 120.901 0.381 . . . . 0.0 110.146 -176.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.08 -25.11 60.78 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.731 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.823 ' O ' HG12 ' A' ' 39' ' ' VAL . 5.0 tmm_? -64.53 -63.14 1.21 Allowed 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.506 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 6.5 ptmm? -51.9 -60.15 3.51 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.198 0.523 . . . . 0.0 112.224 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.607 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 10.4 m -56.32 -30.87 31.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.353 -170.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.497 ' O ' ' HG2' ' A' ' 42' ' ' MET . 1.2 tt -86.08 -30.45 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.247 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.823 HG12 ' O ' ' A' ' 35' ' ' ARG . 2.3 m -70.13 -47.91 65.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 119.481 -0.887 . . . . 0.0 109.348 175.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.66 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 55.3 mt-10 -60.21 -30.27 69.27 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.665 0.786 . . . . 0.0 112.119 176.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.607 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -86.16 -53.15 5.22 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.484 -0.487 . . . . 0.0 112.189 179.198 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.547 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 22.0 mmt -61.95 -22.08 65.33 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.592 0.71 . . . . 0.0 109.84 -178.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.699 ' HB2' ' OH ' ' A' ' 14' ' ' TYR . . . -48.54 -29.02 3.78 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.043 171.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.579 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 8.4 t80 -107.02 -66.58 1.01 Allowed 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.535 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 15.5 mm-40 -48.23 -31.96 6.55 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 124.141 0.901 . . . . 0.0 112.109 -174.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.691 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.9 m-20 -103.03 -21.49 13.92 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.182 -175.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.597 ' HB1' ' O ' ' A' ' 43' ' ' ALA . . . -62.42 -178.98 0.21 Allowed 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.988 0.899 . . . . 0.0 112.986 -173.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.537 ' HB3' ' OE1' ' A' ' 50' ' ' GLU . 12.2 m-20 -61.34 143.24 93.11 Favored Pre-proline 0 C--N 1.317 -0.811 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.003 175.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -50.83 -28.53 23.66 Favored 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 123.666 2.911 . . . . 0.0 112.996 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.708 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 15.9 pm0 -88.42 -30.99 19.04 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.758 0.823 . . . . 0.0 111.015 176.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.708 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 96.9 m -81.79 -38.99 24.73 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.242 -170.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.48 ' HA ' HD12 ' A' ' 55' ' ' ILE . 4.1 pt20 -69.93 -29.76 66.98 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 172.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.48 ' O ' ' HD2' ' A' ' 56' ' ' LYS . 6.7 m -71.12 -20.32 62.34 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.859 -1.518 . . . . 0.0 110.755 174.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 51' ' ' CYS . . . -77.88 -25.27 48.48 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.691 0.758 . . . . 0.0 109.57 167.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.573 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 24.1 mt -89.76 -33.05 5.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -172.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.605 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.3 -38.71 1.71 Allowed Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -173.363 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 51.5 Cg_endo -63.13 -28.69 73.86 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.188 1.925 . . . . 0.0 112.625 175.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.507 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 2.2 mt -97.58 -16.65 19.95 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.579 ' HD2' ' CG ' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -55.95 108.98 0.51 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.443 -179.146 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.72 -24.9 30.36 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.328 -177.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.0 mmmt -104.54 115.63 30.68 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.853 0.358 . . . . 0.0 110.466 -178.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.77 134.75 24.75 Favored Pre-proline 0 C--N 1.313 -1.0 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 168.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo . . . . . 0 CA--C 1.518 -0.278 0 C-N-CA 122.545 2.163 . . . . 0.0 111.79 172.77 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.8 t70 . . . . . 0 N--CA 1.444 -0.769 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.516 HG23 ' HG2' ' A' ' 40' ' ' GLU . 1.2 m -76.16 -30.29 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 C-N-CA 118.553 -1.259 . . . . 0.0 108.709 -177.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.764 ' O ' HG13 ' A' ' 73' ' ' VAL . 7.0 mm -60.85 -47.88 91.38 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.158 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.413 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.495 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 34.1 t -50.51 -35.22 28.37 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.892 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -86.58 -32.07 20.85 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.081 0.467 . . . . 0.0 110.414 -177.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.526 ' OH ' ' HA ' ' A' ' 59' ' ' LYS . 5.5 m-30 -74.1 -36.18 64.22 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.318 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.863 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 2.2 m -71.21 -32.88 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -68.51 -31.91 71.51 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.516 177.479 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.38 -44.49 94.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.265 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.536 ' SG ' ' HB3' ' A' ' 51' ' ' CYS . 3.8 m -97.77 9.46 42.56 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.11 -177.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.2 t70 . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.653 177.825 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 1' ' ' PRO . . . . . 0.484 ' HB2' ' H ' ' B' ' 2' ' ' SER . 88.4 Cg_endo . . . . . 0 CA--C 1.519 -0.245 0 N-CA-C 108.797 -1.27 . . . . 0.0 108.797 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' SER . . . . . 0.484 ' H ' ' HB2' ' B' ' 1' ' ' PRO . 19.8 m -68.1 175.08 3.37 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 161.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.589 ' CE1' HD13 ' B' ' 29' ' ' ILE . 0.1 OUTLIER -71.08 -52.19 20.83 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 164.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . 0.482 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.2 p-10 -87.5 5.48 38.91 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 113.869 -1.514 . . . . 0.0 113.667 -165.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' THR . . . . . 0.421 HG23 ' HB2' ' B' ' 2' ' ' SER . 0.7 OUTLIER -63.88 -6.52 6.09 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 118.542 0.61 . . . . 0.0 111.086 -177.668 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.627 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.2 m -75.61 131.09 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . 0.704 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -154.32 158.59 40.38 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' GLN . . . . . 0.53 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 3.4 mt-30 -41.82 116.88 0.85 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 113.119 -1.855 . . . . 0.0 113.369 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.77 -153.98 22.63 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.732 170.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' SER . . . . . 0.657 ' O ' ' HG2' ' B' ' 11' ' ' LYS . 19.8 t -56.94 98.8 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 117.116 0.458 . . . . 0.0 110.952 -177.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.657 ' HG2' ' O ' ' B' ' 10' ' ' SER . 4.1 ptpp? 49.41 32.86 4.92 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.688 1.195 . . . . 0.0 112.504 -177.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.404 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 38.4 tt0 -56.12 135.41 74.49 Favored Pre-proline 0 C--O 1.234 0.251 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . 0.551 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 52.2 Cg_exo -50.97 123.0 10.88 Favored 'Trans proline' 0 CA--C 1.509 -0.77 0 C-N-CA 122.343 2.029 . . . . 0.0 110.206 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' TYR . . . . . 0.865 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 14.7 t80 -71.01 -53.53 8.37 Favored Pre-proline 0 N--CA 1.439 -1.019 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -167.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.534 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 34.2 Cg_exo -55.92 -18.48 22.3 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 121.535 1.49 . . . . 0.0 110.999 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.551 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.6 m-20 -89.96 -43.18 10.73 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 113.917 -1.492 . . . . 0.0 110.933 178.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' PHE . . . . . 0.53 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -54.6 -44.43 73.07 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 176.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.704 HG12 ' O ' ' B' ' 14' ' ' TYR . 3.0 p -82.16 -31.86 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.514 -177.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' B' ' 15' ' ' PRO . . . -57.44 -36.39 71.33 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 121.793 -0.567 . . . . 0.0 111.878 175.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.704 ' O ' HG13 ' B' ' 24' ' ' VAL . 15.5 ptt180 -82.72 -27.18 31.32 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.542 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 6.6 tp -57.05 -45.21 83.36 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.87 173.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' GLN . . . . . 0.696 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 40.6 mt-30 -74.36 -44.06 53.87 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.019 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.739 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 9.5 t70 -50.9 -51.44 51.94 Favored 'General case' 0 C--N 1.314 -0.955 0 O-C-N 124.097 0.873 . . . . 0.0 111.495 -178.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' VAL . . . . . 0.704 HG13 ' O ' ' B' ' 20' ' ' ARG . 7.4 p -82.71 -23.41 8.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.201 0.524 . . . . 0.0 109.707 -174.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.808 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -71.37 -18.76 62.35 Favored 'General case' 0 C--O 1.206 -1.206 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 173.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.1 -38.63 16.3 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.845 176.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.739 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 36.2 mmtt -66.89 -40.64 87.82 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.98 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' SER . . . . . 0.414 ' HB2' ' HB3' ' B' ' 3' ' ' PHE . 45.2 m -98.86 -9.27 24.49 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.039 0.447 . . . . 0.0 110.552 -171.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.808 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 87.2 mt -115.33 125.68 72.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.651 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.05 -4.2 59.14 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.977 0.418 . . . . 0.0 110.468 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.666 ' OD1' ' HD2' ' B' ' 33' ' ' LYS . 3.6 t0 -111.45 122.65 48.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.51 -176.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' B' ' 36' ' ' LYS . 12.7 pt-20 -62.03 -25.25 67.55 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.665 176.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.666 ' HD2' ' OD1' ' B' ' 31' ' ' ASP . 24.0 mttt -73.71 -46.54 45.46 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 120.834 0.349 . . . . 0.0 110.082 -176.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.32 -25.04 60.47 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.5 -0.48 . . . . 0.0 109.77 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.82 ' O ' HG12 ' B' ' 39' ' ' VAL . 5.0 tmm_? -64.44 -63.32 1.16 Allowed 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' B' ' 32' ' ' GLU . 6.5 ptmm? -51.71 -60.08 3.56 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.257 0.551 . . . . 0.0 112.31 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.627 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 10.4 m -56.58 -30.57 32.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.713 -1.131 . . . . 0.0 112.496 -170.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.484 ' O ' ' HG2' ' B' ' 42' ' ' MET . 1.2 tt -86.26 -30.45 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 C-N-CA 119.241 -0.984 . . . . 0.0 111.175 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.82 HG12 ' O ' ' B' ' 35' ' ' ARG . 2.3 m -70.04 -47.87 65.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.411 175.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.645 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 56.6 mt-10 -60.31 -29.96 69.19 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 123.69 0.796 . . . . 0.0 112.193 176.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.627 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -86.25 -53.25 5.14 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.367 -0.533 . . . . 0.0 112.16 179.044 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' MET . . . . . 0.556 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 22.0 mmt -61.9 -22.18 65.36 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.594 0.711 . . . . 0.0 109.831 -177.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.689 ' HB2' ' OH ' ' B' ' 14' ' ' TYR . . . -48.5 -29.03 3.73 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.924 171.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' TYR . . . . . 0.577 ' CG ' ' HD2' ' B' ' 59' ' ' LYS . 8.3 t80 -107.24 -66.65 1.01 Allowed 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 176.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.519 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 14.9 mm-40 -48.1 -31.84 6.07 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 124.168 0.917 . . . . 0.0 112.243 -174.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.704 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.9 m-20 -103.21 -21.47 13.86 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 116.754 -0.203 . . . . 0.0 111.265 -175.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.595 ' HB1' ' O ' ' B' ' 43' ' ' ALA . . . -62.38 -179.16 0.22 Allowed 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.982 0.896 . . . . 0.0 112.865 -173.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' ASN . . . . . 0.561 ' HB3' ' OE1' ' B' ' 50' ' ' GLU . 12.4 m-20 -61.16 143.31 92.54 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.037 175.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -50.7 -28.75 23.59 Favored 'Trans proline' 0 C--O 1.218 -0.494 0 C-N-CA 123.54 2.827 . . . . 0.0 113.022 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . 0.718 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 15.9 pm0 -88.26 -30.97 19.27 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.739 0.816 . . . . 0.0 111.015 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.718 ' N ' ' HG2' ' B' ' 50' ' ' GLU . 96.7 m -81.83 -39.06 24.53 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.145 -170.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . 0.479 ' HB2' ' CD1' ' B' ' 44' ' ' TYR . 4.1 pt20 -69.95 -29.64 66.82 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 172.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' SER . . . . . 0.474 ' O ' ' HD2' ' B' ' 56' ' ' LYS . 7.0 m -71.18 -20.28 62.3 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 113.847 -1.524 . . . . 0.0 110.704 174.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' B' ' 51' ' ' CYS . . . -77.72 -25.38 49.26 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.604 0.716 . . . . 0.0 109.683 167.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.567 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 24.3 mt -89.77 -32.87 5.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 -172.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . 0.604 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.22 -38.91 1.71 Allowed Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -173.523 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 51.5 Cg_endo -63.07 -28.85 74.51 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 122.175 1.916 . . . . 0.0 112.716 175.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . 0.503 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 2.2 mt -97.44 -16.4 20.19 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . 0.577 ' HD2' ' CG ' ' B' ' 44' ' ' TYR . 0.1 OUTLIER -56.13 108.91 0.51 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.523 -179.254 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.0 -25.12 29.48 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.265 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 9.9 mmmt -104.52 115.52 30.49 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.961 0.41 . . . . 0.0 110.381 -177.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.8 134.68 24.74 Favored Pre-proline 0 C--N 1.312 -1.055 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 168.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo . . . . . 0 C--O 1.234 0.287 0 C-N-CA 122.502 2.135 . . . . 0.0 111.846 172.958 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 t70 . . . . . 0 N--CA 1.444 -0.728 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . 0.509 HG23 ' HG2' ' B' ' 40' ' ' GLU . 1.2 m -75.99 -30.25 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 C-N-CA 118.556 -1.258 . . . . 0.0 108.709 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . 0.777 ' O ' HG13 ' B' ' 73' ' ' VAL . 6.9 mm -60.87 -47.94 91.14 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.208 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.306 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 35.1 t -50.41 -35.25 27.59 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.745 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -86.55 -32.21 20.82 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.459 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' TYR . . . . . 0.512 ' OH ' ' HA ' ' B' ' 59' ' ' LYS . 5.5 m-30 -74.09 -36.23 64.27 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.325 -178.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . 0.865 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 2.2 m -71.15 -33.04 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' B' ' 70' ' ' SER . 0.0 OUTLIER -68.31 -32.2 72.16 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.459 177.474 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -63.05 -44.67 95.19 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.194 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.525 ' SG ' ' HB3' ' B' ' 51' ' ' CYS . 3.8 m -97.54 9.28 42.86 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 114.22 -1.355 . . . . 0.0 111.052 -177.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 8.3 t70 . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.649 177.888 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 CA--C 1.519 -0.263 0 N-CA-C 108.721 -1.3 . . . . 0.0 108.721 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.447 ' HG ' ' HD3' ' B' ' 59' ' ' LYS . 16.4 m -67.52 -179.76 1.14 Allowed 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 163.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.47 ' HB2' ' HA ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -75.56 -53.38 8.71 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 118.956 -1.098 . . . . 0.0 108.625 166.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.483 ' ND2' ' HE3' ' A' ' 42' ' ' MET . 2.4 p-10 -86.91 5.04 39.02 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.247 -1.342 . . . . 0.0 113.201 -165.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.404 HG21 ' HG ' ' A' ' 2' ' ' SER . 0.5 OUTLIER -63.96 -5.97 5.39 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 118.166 0.439 . . . . 0.0 111.441 -176.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.578 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.4 m -75.62 131.77 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 176.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.708 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -154.63 159.48 40.84 Favored 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 118.693 -1.203 . . . . 0.0 114.228 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.478 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.5 mt-30 -42.32 116.38 0.83 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 112.965 -1.925 . . . . 0.0 112.829 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.46 -139.87 8.15 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.635 173.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.4 p -58.67 95.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.765 0.282 . . . . 0.0 111.133 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.5 pttt 40.75 39.54 0.8 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.238 1.015 . . . . 0.0 111.986 -175.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.411 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 48.5 tt0 -56.86 139.65 77.36 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.234 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.512 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 36.9 Cg_exo -54.33 122.73 12.03 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.988 1.792 . . . . 0.0 109.781 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.787 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 13.2 t80 -70.36 -52.53 11.57 Favored Pre-proline 0 N--CA 1.438 -1.046 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 -166.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.533 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 27.6 Cg_exo -57.18 -17.32 25.11 Favored 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 121.444 1.429 . . . . 0.0 111.062 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.5 m-20 -90.04 -42.11 11.32 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.04 -1.437 . . . . 0.0 110.698 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.478 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -55.5 -44.84 76.96 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.663 HG12 ' O ' ' A' ' 14' ' ' TYR . 2.1 p -78.99 -34.06 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.274 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 15' ' ' PRO . . . -55.88 -38.15 69.79 Favored 'General case' 0 C--N 1.319 -0.744 0 O-C-N 121.833 -0.542 . . . . 0.0 111.488 176.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.709 ' O ' HG13 ' A' ' 24' ' ' VAL . 15.5 ptt180 -80.78 -28.32 36.38 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 6.2 tp -55.87 -43.78 77.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.976 173.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.669 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 24.0 mt-30 -72.72 -52.71 14.02 Favored 'General case' 0 CA--C 1.486 -1.483 0 CA-C-N 114.702 -1.135 . . . . 0.0 111.493 178.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.723 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 38.3 m-20 -46.86 -50.75 18.08 Favored 'General case' 0 C--N 1.313 -0.996 0 O-C-N 124.375 1.047 . . . . 0.0 111.24 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 20' ' ' ARG . 8.3 p -79.58 -26.23 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.77 -172.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.607 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -67.45 -30.54 70.29 Favored 'General case' 0 C--O 1.207 -1.171 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 175.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.96 -34.98 59.83 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.647 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.723 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 40.7 mmtt -67.9 -36.0 79.46 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.774 178.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.448 ' HB2' ' HB3' ' A' ' 3' ' ' PHE . 16.2 m -105.52 -6.33 19.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.362 0.601 . . . . 0.0 110.564 -171.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.607 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 89.0 mt -118.2 124.15 72.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.334 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.21 -4.07 58.58 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.219 0.533 . . . . 0.0 110.582 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.558 ' O ' ' HB2' ' A' ' 35' ' ' ARG . 26.0 t0 -106.59 140.48 39.41 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.565 -177.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -76.23 -32.05 58.71 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.001 174.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.538 ' O ' HG11 ' A' ' 37' ' ' VAL . 6.9 mttp -70.87 -55.51 8.3 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -176.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.467 ' HA ' HG23 ' A' ' 37' ' ' VAL . . . -57.99 -27.87 63.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.976 175.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.843 ' O ' HG11 ' A' ' 39' ' ' VAL . 1.9 tmm_? -67.22 -56.53 9.49 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.487 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 20.8 mtpt -56.22 -57.93 10.13 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.957 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.722 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 20.1 m -53.08 -34.72 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.414 -169.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.467 HD13 ' OD1' ' A' ' 4' ' ' ASN . 1.1 tt -87.97 -30.75 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 C-N-CA 119.765 -0.774 . . . . 0.0 112.316 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.843 HG11 ' O ' ' A' ' 35' ' ' ARG . 2.9 m -67.89 -50.21 61.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 119.413 -0.915 . . . . 0.0 109.688 174.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.672 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 0.9 OUTLIER -63.73 -25.9 68.4 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.76 0.824 . . . . 0.0 111.622 178.46 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.722 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -85.87 -55.14 4.1 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 177.064 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.513 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 22.2 mmt -62.59 -20.87 65.16 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 121.67 0.747 . . . . 0.0 109.822 -176.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.667 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -48.68 -28.89 3.85 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.81 171.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.541 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 11.5 t80 -106.14 -66.53 0.99 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 175.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.479 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 5.7 mm-40 -48.13 -29.56 3.75 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 124.107 0.88 . . . . 0.0 112.937 -175.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.708 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.7 m-20 -106.87 -21.25 13.08 Favored 'General case' 0 N--CA 1.438 -1.071 0 O-C-N 122.22 -0.3 . . . . 0.0 111.19 -176.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 43' ' ' ALA . . . -60.43 179.22 0.16 Allowed 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.889 0.852 . . . . 0.0 112.905 -174.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.479 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 11.5 m-20 -60.12 139.83 91.07 Favored Pre-proline 0 N--CA 1.443 -0.823 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.228 174.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.406 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 1.8 Cg_endo -44.35 -46.38 11.79 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.906 2.404 . . . . 0.0 112.004 -177.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.487 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 0.4 OUTLIER -71.31 -33.51 69.73 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.335 1.054 . . . . 0.0 111.841 177.173 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.529 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 98.4 m -75.7 -36.37 60.03 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 121.243 0.544 . . . . 0.0 109.967 -173.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.472 ' HB2' ' CG ' ' A' ' 44' ' ' TYR . 3.9 pt20 -73.03 -30.95 64.12 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 174.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.529 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 17.4 m -68.87 -20.51 64.27 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.048 173.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 51' ' ' CYS . . . -76.38 -28.74 56.88 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.747 0.784 . . . . 0.0 109.958 168.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.592 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 19.2 mt -89.67 -31.85 5.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -171.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.603 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -40.17 -39.78 1.55 Allowed Pre-proline 0 N--CA 1.487 1.41 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -173.075 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 54.2 Cg_endo -63.04 -30.93 76.46 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.141 1.894 . . . . 0.0 112.781 176.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.537 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 2.6 mt -94.48 -17.06 22.8 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.575 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -55.44 108.67 0.45 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.053 179.359 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.29 -31.66 8.47 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.528 -175.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.2 mmtt -104.12 114.85 29.38 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 122.173 0.987 . . . . 0.0 111.147 -177.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.6 p -120.72 131.67 24.39 Favored Pre-proline 0 C--N 1.294 -1.824 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.826 169.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo . . . . . 0 C--O 1.235 0.326 0 C-N-CA 122.637 2.224 . . . . 0.0 112.078 174.554 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 N--CA 1.446 -0.656 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.672 ' CG2' ' HB3' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -72.25 -34.85 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 118.372 -1.331 . . . . 0.0 108.916 -179.138 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.747 ' O ' HG11 ' A' ' 73' ' ' VAL . 7.2 mm -56.65 -49.77 76.66 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.065 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.676 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 23.0 t -46.14 -38.37 8.09 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.858 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -86.45 -32.27 20.94 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.544 -176.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.575 ' OH ' ' HA ' ' A' ' 59' ' ' LYS . 5.4 m-30 -73.95 -37.53 64.52 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.681 0.753 . . . . 0.0 109.65 -177.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.787 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.7 m -70.1 -32.81 52.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 174.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -68.42 -31.36 70.64 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.567 176.45 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.429 ' HB1' ' O ' ' A' ' 72' ' ' TYR . . . -64.6 -46.35 83.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.492 178.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.529 ' SG ' ' HB3' ' A' ' 51' ' ' CYS . 4.0 m -94.04 9.22 38.51 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.919 -178.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 9.6 t70 . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.201 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 1' ' ' PRO . . . . . 0.451 ' HB2' ' H ' ' B' ' 2' ' ' SER . 97.7 Cg_endo . . . . . 0 CA--C 1.52 -0.189 0 N-CA-C 108.815 -1.263 . . . . 0.0 108.815 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' SER . . . . . 0.475 ' HG ' ' HD3' ' A' ' 59' ' ' LYS . 16.3 m -67.6 179.93 1.24 Allowed 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 163.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.479 ' HB2' ' HA ' ' B' ' 25' ' ' ALA . 0.1 OUTLIER -75.32 -53.6 8.48 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.517 166.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . 0.479 ' ND2' ' HE3' ' B' ' 42' ' ' MET . 2.4 p-10 -86.77 4.98 38.66 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.35 -1.295 . . . . 0.0 113.271 -165.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' THR . . . . . 0.417 ' HA ' ' OE1' ' A' ' 45' ' ' GLU . 0.5 OUTLIER -63.7 -5.9 4.76 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 118.099 0.409 . . . . 0.0 111.572 -177.069 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.581 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.4 m -75.67 131.55 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . 0.705 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -154.4 159.6 41.2 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' GLN . . . . . 0.475 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.5 mt-30 -42.37 116.21 0.81 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 112.941 -1.936 . . . . 0.0 112.852 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.17 -139.69 7.88 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.706 173.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 6.4 p -58.94 95.15 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.706 0.253 . . . . 0.0 111.143 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 56.7 pttt 41.05 39.37 0.85 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.157 0.983 . . . . 0.0 111.976 -175.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.402 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 51.0 tt0 -56.61 139.57 75.61 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.241 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . 0.528 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 35.1 Cg_exo -54.15 122.77 12.04 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.0 1.8 . . . . 0.0 109.743 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' TYR . . . . . 0.796 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 13.1 t80 -70.45 -52.63 11.14 Favored Pre-proline 0 N--CA 1.438 -1.056 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -166.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.545 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 27.9 Cg_exo -56.97 -17.54 24.63 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 121.474 1.449 . . . . 0.0 111.134 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.528 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.3 m-20 -89.91 -42.42 11.22 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.682 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' PHE . . . . . 0.475 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -55.34 -44.75 76.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.803 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.676 HG12 ' O ' ' B' ' 14' ' ' TYR . 2.1 p -78.97 -34.15 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.27 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.91 -38.04 69.7 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 121.765 -0.585 . . . . 0.0 111.516 176.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.704 ' O ' HG13 ' B' ' 24' ' ' VAL . 15.6 ptt180 -80.78 -28.29 36.41 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.536 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 6.1 tp -55.78 -43.88 77.22 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.005 173.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' GLN . . . . . 0.658 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 24.1 mt-30 -72.7 -52.64 14.37 Favored 'General case' 0 CA--C 1.487 -1.472 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.48 178.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.728 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 39.5 m-20 -46.8 -50.79 17.77 Favored 'General case' 0 C--N 1.313 -1.011 0 O-C-N 124.417 1.073 . . . . 0.0 111.234 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' VAL . . . . . 0.704 HG13 ' O ' ' B' ' 20' ' ' ARG . 8.3 p -79.71 -26.06 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.836 -172.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.612 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -67.59 -30.46 70.07 Favored 'General case' 0 C--O 1.205 -1.239 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 175.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.78 -35.27 60.17 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.132 -1.395 . . . . 0.0 109.763 -178.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.728 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 40.9 mmtt -67.67 -36.54 80.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.586 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' SER . . . . . 0.453 ' HB2' ' HB3' ' B' ' 3' ' ' PHE . 16.4 m -105.19 -6.22 19.99 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.33 0.586 . . . . 0.0 110.536 -171.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.612 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 89.0 mt -118.21 124.26 72.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.326 178.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.49 -3.65 58.51 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.236 0.541 . . . . 0.0 110.676 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.559 ' O ' ' HB2' ' B' ' 35' ' ' ARG . 25.9 t0 -106.9 140.46 39.68 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.519 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -76.35 -31.97 58.37 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.867 175.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.536 ' O ' HG11 ' B' ' 37' ' ' VAL . 7.1 mttp -70.73 -55.69 8.09 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -176.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.471 ' HA ' HG23 ' B' ' 37' ' ' VAL . . . -58.08 -27.71 63.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.996 176.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.849 ' O ' HG11 ' B' ' 39' ' ' VAL . 1.9 tmm_? -67.47 -56.45 9.55 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.477 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 21.2 mtpt -56.22 -57.93 10.12 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.997 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.733 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 20.1 m -53.06 -34.66 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.53 -169.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.473 HD13 ' OD1' ' B' ' 4' ' ' ASN . 1.1 tt -88.1 -30.72 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 119.727 -0.789 . . . . 0.0 112.25 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.849 HG11 ' O ' ' B' ' 35' ' ' ARG . 3.0 m -67.87 -49.99 63.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.742 174.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.68 ' HB3' ' CG2' ' B' ' 68' ' ' VAL . 0.9 OUTLIER -64.06 -25.66 68.21 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.68 0.792 . . . . 0.0 111.658 178.452 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.733 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.97 -55.03 4.14 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 176.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' MET . . . . . 0.512 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 22.2 mmt -62.81 -20.66 65.25 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.697 0.76 . . . . 0.0 109.818 -176.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.659 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -48.89 -28.77 4.03 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.779 171.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' TYR . . . . . 0.527 ' CG ' ' HD2' ' B' ' 59' ' ' LYS . 11.5 t80 -106.29 -66.66 0.99 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 175.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.471 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 5.7 mm-40 -48.03 -29.49 3.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 124.138 0.899 . . . . 0.0 112.999 -175.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.705 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.6 m-20 -106.9 -21.09 13.13 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 121.031 -0.267 . . . . 0.0 111.19 -176.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' B' ' 43' ' ' ALA . . . -60.61 179.19 0.17 Allowed 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.844 0.831 . . . . 0.0 112.931 -174.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' ASN . . . . . 0.494 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 11.0 m-20 -60.08 139.69 90.97 Favored Pre-proline 0 N--CA 1.441 -0.888 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.237 174.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . 0.404 ' O ' ' HG2' ' B' ' 52' ' ' GLN . 1.8 Cg_endo -44.27 -46.35 11.63 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.847 2.365 . . . . 0.0 111.985 -177.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . 0.485 ' HA ' ' HB2' ' B' ' 53' ' ' SER . 0.3 OUTLIER -71.32 -33.39 69.6 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.234 1.013 . . . . 0.0 111.96 177.256 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.533 ' HB3' ' SG ' ' B' ' 76' ' ' CYS . 93.0 m -75.78 -36.38 59.8 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 121.258 0.552 . . . . 0.0 110.026 -174.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . 0.471 ' HB2' ' CG ' ' B' ' 44' ' ' TYR . 3.9 pt20 -72.95 -31.14 64.38 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 106.932 -1.506 . . . . 0.0 106.932 174.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' SER . . . . . 0.528 ' O ' ' HE2' ' B' ' 56' ' ' LYS . 17.9 m -68.64 -20.55 64.47 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.066 -1.424 . . . . 0.0 110.07 173.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' B' ' 51' ' ' CYS . . . -76.34 -28.83 57.01 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.813 0.816 . . . . 0.0 109.984 168.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.593 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 19.0 mt -89.76 -31.7 5.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -171.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . 0.599 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -40.33 -39.83 1.66 Allowed Pre-proline 0 N--CA 1.488 1.452 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -173.104 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 52.0 Cg_endo -62.52 -32.19 80.11 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.001 1.801 . . . . 0.0 112.585 176.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . 0.546 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 2.6 mt -93.6 -17.08 23.71 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . 0.565 ' HA ' ' OH ' ' B' ' 72' ' ' TYR . 0.0 OUTLIER -55.49 108.56 0.44 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.966 179.234 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.57 -31.77 8.33 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.41 -175.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 28.4 mmtt -103.84 114.92 29.53 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 122.203 1.001 . . . . 0.0 111.166 -177.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 5.6 p -120.71 131.88 24.33 Favored Pre-proline 0 C--N 1.294 -1.83 0 CA-C-N 113.861 -1.518 . . . . 0.0 109.786 169.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo . . . . . 0 C--O 1.235 0.374 0 C-N-CA 122.656 2.237 . . . . 0.0 112.103 174.555 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.445 -0.694 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . 0.68 ' CG2' ' HB3' ' B' ' 40' ' ' GLU . 0.8 OUTLIER -72.04 -35.12 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 118.41 -1.316 . . . . 0.0 108.908 -179.117 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . 0.762 ' O ' HG11 ' B' ' 73' ' ' VAL . 7.2 mm -56.53 -49.78 76.02 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.992 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.644 -178.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 25.8 t -45.69 -38.82 7.23 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.815 178.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.431 ' H ' ' HG2' ' B' ' 71' ' ' GLU . 2.9 mm-40 -86.4 -32.46 20.89 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.568 -175.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' TYR . . . . . 0.565 ' OH ' ' HA ' ' B' ' 59' ' ' LYS . 5.4 m-30 -73.74 -37.53 65.04 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.6 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . 0.796 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.7 m -70.16 -32.87 52.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 174.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' B' ' 70' ' ' SER . 0.0 OUTLIER -68.3 -31.38 70.78 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.746 -1.116 . . . . 0.0 109.573 176.34 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . 0.435 ' HB1' ' O ' ' B' ' 72' ' ' TYR . . . -64.86 -46.13 83.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.567 178.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.533 ' SG ' ' HB3' ' B' ' 51' ' ' CYS . 4.0 m -94.07 9.18 38.73 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.951 -178.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . 0.401 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 11.3 t70 . . . . . 0 C--N 1.324 -0.542 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.249 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.457 ' HB2' ' H ' ' A' ' 2' ' ' SER . 92.1 Cg_endo . . . . . 0 CA--C 1.517 -0.327 0 N-CA-C 109.171 -1.127 . . . . 0.0 109.171 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.511 ' HG ' ' HD3' ' B' ' 59' ' ' LYS . 12.9 m -64.25 165.94 8.72 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 162.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.488 ' CE1' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -69.86 -54.14 14.85 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.027 -1.069 . . . . 0.0 108.614 167.607 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.551 ' ND2' ' HE2' ' A' ' 42' ' ' MET . 3.2 p-10 -88.31 -3.05 58.91 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 113.947 -1.479 . . . . 0.0 113.403 -164.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.451 ' HB ' ' HB2' ' A' ' 2' ' ' SER . 9.8 t -66.36 -3.58 6.3 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.622 -173.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.525 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 3.0 m -70.7 135.75 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 172.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.721 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -153.86 159.12 41.68 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 -179.781 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.474 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.1 tt0 -41.69 112.1 0.29 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 112.832 -1.986 . . . . 0.0 112.216 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.2 -145.42 6.06 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.756 176.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.7 p -59.79 95.38 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.687 0.279 . . . . 0.0 110.737 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.3 pttt 43.23 41.43 2.97 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.384 1.074 . . . . 0.0 112.3 -176.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -56.58 141.25 72.94 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.801 175.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -51.68 123.1 11.53 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.73 1.62 . . . . 0.0 109.141 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.792 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 11.5 t80 -66.67 -51.47 40.01 Favored Pre-proline 0 N--CA 1.438 -1.052 0 CA-C-O 118.857 -0.592 . . . . 0.0 112.555 -171.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.498 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 20.5 Cg_exo -60.29 -13.77 26.1 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 121.69 1.593 . . . . 0.0 110.413 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -89.45 -46.78 8.46 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 113.903 -1.499 . . . . 0.0 110.282 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.474 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -54.18 -42.88 70.16 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.84 177.682 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.741 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 2.1 p -81.35 -35.22 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.52 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . -56.58 -37.67 70.93 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 121.394 -0.816 . . . . 0.0 111.223 177.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.727 ' O ' HG13 ' A' ' 24' ' ' VAL . 17.4 ptt180 -79.61 -30.05 41.31 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.535 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 7.8 tp -54.2 -46.7 72.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.258 173.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.741 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 28.7 mt-30 -69.94 -53.56 17.31 Favored 'General case' 0 CA--C 1.485 -1.523 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.55 177.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.722 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 56.3 m-20 -45.51 -52.45 10.32 Favored 'General case' 0 C--N 1.314 -0.978 0 O-C-N 124.637 1.21 . . . . 0.0 111.181 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.727 HG13 ' O ' ' A' ' 20' ' ' ARG . 8.2 p -79.67 -26.96 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.745 -171.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.663 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -66.82 -31.2 71.67 Favored 'General case' 0 C--O 1.204 -1.324 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 175.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.61 -35.59 62.95 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.909 -178.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.722 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.6 mmtt -65.86 -40.11 91.38 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.63 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.41 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 40.0 m -101.86 -10.81 19.54 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.32 0.581 . . . . 0.0 110.662 -172.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.663 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 88.4 mt -113.72 122.26 67.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.515 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.85 -1.19 57.82 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.247 0.546 . . . . 0.0 110.317 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.534 ' H ' HG23 ' A' ' 29' ' ' ILE . 11.8 t70 -107.31 119.41 39.33 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.965 -175.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -60.13 -30.35 69.23 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.08 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.561 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -74.31 -53.52 9.53 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -174.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.465 ' HA ' HG23 ' A' ' 37' ' ' VAL . . . -60.56 -27.41 67.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.773 177.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.85 ' O ' HG11 ' A' ' 39' ' ' VAL . 1.9 tmm_? -67.33 -58.47 4.73 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.432 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 32.6 mtpt -54.61 -59.24 4.98 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.123 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.717 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 16.9 m -53.56 -34.14 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.327 -170.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.462 ' O ' ' HG2' ' A' ' 42' ' ' MET . 1.3 tt -87.38 -32.08 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.871 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.85 HG11 ' O ' ' A' ' 35' ' ' ARG . 2.7 m -67.34 -49.14 74.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.156 175.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.635 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 52.0 mt-10 -60.49 -31.72 70.74 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.298 1.039 . . . . 0.0 112.742 175.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.717 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -85.16 -51.29 6.73 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.933 -179.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.566 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 20.5 mmt -64.62 -20.77 66.47 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.553 0.692 . . . . 0.0 109.462 -178.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.663 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -50.26 -30.33 11.52 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.516 171.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.497 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 15.9 t80 -102.91 -66.71 0.92 Allowed 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 174.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.477 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 47.6 mm-40 -50.26 -28.41 7.66 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.725 -1.125 . . . . 0.0 112.713 -172.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.721 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.1 m-20 -106.36 -22.04 12.92 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 121.28 -0.168 . . . . 0.0 111.055 -176.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.62 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -59.56 177.3 0.21 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.8 0.81 . . . . 0.0 112.994 -174.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.589 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 15.2 m-20 -58.89 140.55 86.37 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.93 174.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.64 -23.43 25.81 Favored 'Trans proline' 0 C--O 1.221 -0.35 0 C-N-CA 123.524 2.816 . . . . 0.0 112.731 -176.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -88.3 -35.37 17.27 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.942 0.897 . . . . 0.0 110.788 175.074 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 72.3 m -76.85 -35.87 57.2 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.207 -171.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.513 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.7 pt20 -72.49 -29.89 64.04 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 174.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.492 ' O ' ' HD2' ' A' ' 56' ' ' LYS . 15.9 m -71.81 -19.01 62.05 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 113.715 -1.584 . . . . 0.0 110.387 174.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.455 ' HB1' ' O ' ' A' ' 51' ' ' CYS . . . -77.21 -26.95 53.26 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.813 0.816 . . . . 0.0 109.494 166.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.583 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 25.9 mt -89.27 -31.01 5.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -172.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.598 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.8 -38.77 2.17 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -173.756 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 57.2 Cg_endo -64.49 -30.08 61.87 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.165 1.91 . . . . 0.0 112.765 176.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.497 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 2.2 mt -95.29 -16.35 22.5 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.514 ' HD3' ' HG ' ' B' ' 2' ' ' SER . 0.1 OUTLIER -54.05 108.65 0.38 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.709 -179.522 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.77 -21.98 42.96 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.413 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.9 mmmt -104.17 115.88 31.19 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 120.932 0.396 . . . . 0.0 110.422 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.54 139.72 31.51 Favored Pre-proline 0 C--N 1.311 -1.095 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 169.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo . . . . . 0 N--CA 1.463 -0.306 0 C-N-CA 122.338 2.025 . . . . 0.0 111.423 170.39 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 t70 . . . . . 0 CA--C 1.514 -0.425 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.503 HG23 ' HG2' ' A' ' 40' ' ' GLU . 1.0 OUTLIER -77.38 -29.7 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 C-N-CA 118.651 -1.22 . . . . 0.0 108.813 -179.346 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.787 ' O ' HG13 ' A' ' 73' ' ' VAL . 10.4 mm -60.81 -47.53 92.86 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.117 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.125 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.0 t -46.18 -37.66 7.34 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.017 176.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.453 ' O ' ' HE2' ' A' ' 74' ' ' LYS . 7.2 mm-40 -85.82 -31.85 22.08 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 123.375 0.67 . . . . 0.0 111.014 -177.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.592 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.3 m-30 -75.32 -34.84 61.27 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.555 0.693 . . . . 0.0 109.34 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.792 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.4 m -72.52 -30.17 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 173.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.461 ' HA ' ' HB2' ' A' ' 77' ' ' ASP . 14.8 ttpt -73.52 -25.51 60.45 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.474 177.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -65.89 -46.53 78.03 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.538 174.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' A' ' 14' ' ' TYR . 26.2 t -93.01 8.77 38.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.871 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.461 ' HB2' ' HA ' ' A' ' 74' ' ' LYS . 17.3 t70 . . . . . 0 C--N 1.323 -0.55 0 CA-C-O 121.302 0.572 . . . . 0.0 110.043 176.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 1' ' ' PRO . . . . . 0.407 ' HB2' ' H ' ' B' ' 2' ' ' SER . 93.8 Cg_endo . . . . . 0 CA--C 1.519 -0.248 0 N-CA-C 109.133 -1.141 . . . . 0.0 109.133 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' SER . . . . . 0.514 ' HG ' ' HD3' ' A' ' 59' ' ' LYS . 13.3 m -64.35 166.24 8.47 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 163.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.505 ' CE1' HD11 ' B' ' 29' ' ' ILE . 0.1 OUTLIER -70.12 -54.02 14.81 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.108 -1.037 . . . . 0.0 108.605 167.687 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . 0.541 ' ND2' ' HE2' ' B' ' 42' ' ' MET . 3.2 p-10 -88.5 -2.99 58.9 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.041 -1.436 . . . . 0.0 113.408 -164.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' THR . . . . . 0.469 ' HB ' ' HB2' ' B' ' 2' ' ' SER . 9.5 t -66.37 -3.54 6.22 Favored 'General case' 0 C--N 1.315 -0.911 0 O-C-N 121.644 -0.66 . . . . 0.0 110.634 -173.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.512 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 3.0 m -70.63 135.7 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 171.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . 0.731 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -153.9 159.2 41.66 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' GLN . . . . . 0.453 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.1 tt0 -41.77 112.42 0.32 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 112.776 -2.011 . . . . 0.0 112.106 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.35 -145.64 6.3 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.772 175.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 12.4 p -59.51 95.27 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.64 0.257 . . . . 0.0 110.653 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 64.2 pttt 43.17 41.36 2.84 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.44 1.096 . . . . 0.0 112.402 -176.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.404 ' OE2' ' HA ' ' B' ' 17' ' ' PHE . 62.8 tt0 -56.63 141.37 73.11 Favored Pre-proline 0 C--O 1.235 0.301 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.774 175.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . 0.405 ' O ' ' HB3' ' B' ' 16' ' ' ASP . 22.1 Cg_exo -51.66 122.99 11.29 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.742 1.628 . . . . 0.0 109.204 174.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' TYR . . . . . 0.792 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 11.7 t80 -66.63 -51.64 39.42 Favored Pre-proline 0 N--CA 1.437 -1.078 0 CA-C-O 118.876 -0.583 . . . . 0.0 112.406 -171.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.511 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 20.6 Cg_exo -60.14 -13.79 25.57 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.57 1.513 . . . . 0.0 110.453 -178.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' B' ' 13' ' ' PRO . 18.7 t70 -89.45 -46.74 8.48 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 113.939 -1.482 . . . . 0.0 110.191 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' PHE . . . . . 0.453 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -54.15 -42.85 70.02 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.841 177.675 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.733 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 2.1 p -81.4 -35.27 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.429 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.57 -37.64 70.86 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 121.38 -0.825 . . . . 0.0 111.221 177.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.73 ' O ' HG13 ' B' ' 24' ' ' VAL . 17.4 ptt180 -79.72 -29.72 40.74 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.548 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 7.9 tp -54.47 -46.72 73.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.193 173.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' GLN . . . . . 0.733 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 28.6 mt-30 -69.81 -53.67 17.15 Favored 'General case' 0 CA--C 1.485 -1.556 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.519 177.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.727 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 48.9 m-20 -45.55 -52.49 10.39 Favored 'General case' 0 C--N 1.314 -0.959 0 O-C-N 124.628 1.205 . . . . 0.0 111.042 -178.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' VAL . . . . . 0.73 HG13 ' O ' ' B' ' 20' ' ' ARG . 8.2 p -79.64 -26.97 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.673 -171.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.648 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -66.86 -31.02 71.35 Favored 'General case' 0 C--O 1.206 -1.211 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 175.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -35.65 62.53 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.802 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.727 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.9 mmtt -65.87 -40.13 91.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.643 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' SER . . . . . 0.421 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 37.4 m -101.66 -11.21 19.36 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.186 0.517 . . . . 0.0 110.546 -172.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.648 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 88.0 mt -113.63 122.33 67.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.569 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.93 -1.11 57.78 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.249 0.547 . . . . 0.0 110.439 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.539 ' H ' HG23 ' B' ' 29' ' ' ILE . 11.4 t70 -107.59 119.36 39.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.959 -175.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.2 -30.15 69.18 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.1 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.576 ' O ' HG13 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -74.42 -53.27 9.91 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -174.867 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.467 ' HA ' HG23 ' B' ' 37' ' ' VAL . . . -60.85 -27.32 68.0 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.87 177.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.857 ' O ' HG11 ' B' ' 39' ' ' VAL . 1.9 tmm_? -67.38 -58.52 4.63 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.438 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 32.3 mtpt -54.6 -59.3 4.89 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.081 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.718 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 17.1 m -53.69 -33.88 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.314 -170.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.461 ' O ' ' HG2' ' B' ' 42' ' ' MET . 1.3 tt -87.53 -32.08 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.808 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.857 HG11 ' O ' ' B' ' 35' ' ' ARG . 2.7 m -67.31 -49.11 75.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.101 174.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.632 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 52.2 mt-10 -60.63 -31.72 70.9 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.259 1.023 . . . . 0.0 112.794 176.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.718 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -85.25 -51.17 6.78 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.393 -0.523 . . . . 0.0 112.02 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' MET . . . . . 0.561 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 20.7 mmt -64.63 -20.7 66.43 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 121.545 0.688 . . . . 0.0 109.524 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.659 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -50.39 -30.33 12.12 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.421 171.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' TYR . . . . . 0.5 ' CG ' ' HD2' ' B' ' 59' ' ' LYS . 16.1 t80 -102.85 -66.61 0.92 Allowed 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 174.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.468 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 46.8 mm-40 -50.49 -27.99 7.61 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.696 -1.138 . . . . 0.0 112.739 -172.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.731 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.2 m-20 -106.76 -21.91 12.89 Favored 'General case' 0 N--CA 1.434 -1.265 0 O-C-N 122.371 -0.206 . . . . 0.0 111.1 -176.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -59.51 177.46 0.2 Allowed 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.81 0.814 . . . . 0.0 113.085 -175.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' ASN . . . . . 0.593 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 15.1 m-20 -59.09 140.33 87.31 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.864 174.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.75 -23.21 25.78 Favored 'Trans proline' 0 C--O 1.22 -0.407 0 C-N-CA 123.502 2.801 . . . . 0.0 112.628 -176.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -88.41 -35.27 17.19 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.88 0.872 . . . . 0.0 110.824 174.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.593 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 71.8 m -76.82 -35.83 57.29 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.261 -172.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . 0.493 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.8 pt20 -72.36 -29.99 64.3 Favored 'General case' 0 C--O 1.213 -0.835 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 174.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' SER . . . . . 0.489 ' O ' ' HD2' ' B' ' 56' ' ' LYS . 14.5 m -71.63 -19.26 62.13 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 113.7 -1.591 . . . . 0.0 110.4 174.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.464 ' HB1' ' O ' ' B' ' 51' ' ' CYS . . . -77.16 -27.08 53.62 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.692 0.758 . . . . 0.0 109.484 166.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.584 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 25.9 mt -89.23 -30.99 5.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -172.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . 0.596 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.96 -38.67 2.26 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -173.647 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 57.3 Cg_endo -64.7 -29.76 59.89 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 122.055 1.837 . . . . 0.0 112.688 176.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . 0.517 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 2.2 mt -95.36 -16.26 22.48 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . 0.511 ' HD3' ' HG ' ' A' ' 2' ' ' SER . 0.1 OUTLIER -54.18 108.7 0.39 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.746 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.45 -21.5 45.21 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.503 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 15.8 mmmt -104.49 115.84 31.06 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.865 0.365 . . . . 0.0 110.6 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.4 139.72 31.33 Favored Pre-proline 0 C--N 1.312 -1.059 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 169.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo . . . . . 0 N--CA 1.463 -0.281 0 C-N-CA 122.368 2.045 . . . . 0.0 111.523 170.204 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 1.3 t70 . . . . . 0 CA--C 1.513 -0.446 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . 0.513 HG23 ' HG2' ' B' ' 40' ' ' GLU . 1.0 OUTLIER -77.54 -29.75 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 C-N-CA 118.691 -1.203 . . . . 0.0 108.813 -179.444 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . 0.783 ' O ' HG13 ' B' ' 73' ' ' VAL . 10.4 mm -60.8 -47.4 93.41 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.155 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.166 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 41.0 t -46.63 -37.29 7.99 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 123.847 0.717 . . . . 0.0 110.998 177.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.449 ' O ' ' HE2' ' B' ' 74' ' ' LYS . 7.5 mm-40 -85.89 -31.67 22.08 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.22 0.608 . . . . 0.0 111.051 -177.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' TYR . . . . . 0.579 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.3 m-30 -75.45 -34.89 60.99 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.599 0.714 . . . . 0.0 109.441 -178.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . 0.792 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.4 m -72.65 -30.03 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 173.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' LYS . . . . . 0.471 ' HA ' ' HB2' ' B' ' 77' ' ' ASP . 14.7 ttpt -73.71 -25.18 60.09 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.581 177.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -65.95 -46.57 77.69 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.646 173.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.477 ' SG ' ' HB2' ' B' ' 14' ' ' TYR . 28.3 t -93.03 8.58 39.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.884 177.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . 0.471 ' HB2' ' HA ' ' B' ' 74' ' ' LYS . 18.0 t70 . . . . . 0 C--N 1.324 -0.537 0 CA-C-O 121.296 0.57 . . . . 0.0 110.056 176.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.44 ' HB2' ' H ' ' A' ' 2' ' ' SER . 84.1 Cg_endo . . . . . 0 CA--C 1.516 -0.399 0 N-CA-C 109.525 -0.99 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.44 ' H ' ' HB2' ' A' ' 1' ' ' PRO . 49.8 m -65.74 165.14 13.23 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 163.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.46 ' CE1' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -69.9 -55.17 10.43 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 122.058 0.932 . . . . 0.0 109.907 174.142 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.562 ' ND2' ' HG3' ' A' ' 42' ' ' MET . 2.7 p-10 -86.57 -2.38 58.44 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.308 -1.314 . . . . 0.0 112.762 -164.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.405 ' O ' ' HD3' ' A' ' 7' ' ' ARG . 9.9 t -66.1 -3.03 4.75 Favored 'General case' 0 C--N 1.314 -0.942 0 O-C-N 121.708 -0.62 . . . . 0.0 110.445 -176.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.592 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.3 m -73.7 131.98 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 170.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.685 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 1.3 ptt-85 -156.68 160.04 38.97 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 118.38 -1.328 . . . . 0.0 114.375 -176.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.446 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.3 tt0 -39.12 112.33 0.24 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 113.698 -1.592 . . . . 0.0 112.624 178.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.95 -142.36 7.96 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.689 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.5 m -59.33 95.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.973 0.387 . . . . 0.0 110.837 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.4 ' O ' ' HG3' ' A' ' 11' ' ' LYS . 23.3 pttm 40.73 41.75 1.24 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.495 1.118 . . . . 0.0 112.343 -174.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 65.6 tt0 -57.79 139.65 81.95 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.674 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.52 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 34.3 Cg_exo -53.7 125.0 17.19 Favored 'Trans proline' 0 CA--C 1.511 -0.671 0 C-N-CA 122.026 1.817 . . . . 0.0 109.745 177.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.795 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 6.0 t80 -68.22 -55.48 12.62 Favored Pre-proline 0 N--CA 1.44 -0.934 0 CA-C-O 118.482 -0.77 . . . . 0.0 112.924 -167.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.531 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 26.0 Cg_exo -57.62 -17.7 29.63 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 121.456 1.437 . . . . 0.0 111.145 -177.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.52 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 5.7 m-20 -89.8 -40.16 12.64 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.057 -1.428 . . . . 0.0 110.846 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.638 ' HE2' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -56.63 -45.79 81.32 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 176.106 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.777 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 1.4 p -77.82 -33.46 18.74 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.322 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.347 -178.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.04 -31.57 67.15 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 121.179 -0.951 . . . . 0.0 111.834 177.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.73 ' O ' HG12 ' A' ' 24' ' ' VAL . 15.6 ptt180 -84.86 -28.09 26.26 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 175.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.567 HD22 ' CE1' ' A' ' 17' ' ' PHE . 11.8 tp -54.28 -48.9 70.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.962 172.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.777 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 23.0 mt-30 -70.57 -46.65 63.09 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 114.849 -1.068 . . . . 0.0 111.123 177.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.716 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 19.2 t70 -48.41 -54.63 13.34 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.282 0.989 . . . . 0.0 111.479 -178.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.4 p -81.73 -22.18 10.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.13 0.49 . . . . 0.0 109.734 -173.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.791 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -72.93 -18.85 61.35 Favored 'General case' 0 C--O 1.205 -1.259 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 174.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.44 -38.61 17.16 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.568 -1.196 . . . . 0.0 109.553 177.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.716 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.8 mmtt -67.06 -36.29 81.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.014 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.2 m -103.69 -9.1 19.4 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.088 0.47 . . . . 0.0 110.516 -171.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.791 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 84.3 mt -115.07 126.06 72.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.442 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.47 -4.8 59.27 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.242 0.544 . . . . 0.0 110.502 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.557 ' H ' HG22 ' A' ' 29' ' ' ILE . 25.8 t0 -106.28 139.16 41.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.407 -177.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -75.98 -31.45 58.99 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.445 175.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.512 ' O ' HG13 ' A' ' 37' ' ' VAL . 6.4 mttp -71.88 -55.0 8.31 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -175.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.484 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -58.75 -27.31 64.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.022 176.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.864 ' O ' HG13 ' A' ' 39' ' ' VAL . 1.9 tmm_? -66.0 -59.86 3.41 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 178.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 12.6 mtpp -54.94 -57.58 11.07 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.16 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.768 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 20.6 m -52.8 -34.33 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.975 -170.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.484 ' O ' ' HG2' ' A' ' 42' ' ' MET . 1.0 OUTLIER -88.31 -31.37 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 119.87 -0.732 . . . . 0.0 112.217 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.864 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.4 m -68.52 -48.65 71.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 119.067 -1.053 . . . . 0.0 109.513 176.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.679 ' HB3' ' CG2' ' A' ' 68' ' ' VAL . 0.8 OUTLIER -64.59 -28.46 69.64 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.455 0.702 . . . . 0.0 111.573 178.343 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.768 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -81.4 -54.61 5.32 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 122.19 -0.319 . . . . 0.0 111.432 178.014 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.562 ' HG3' ' ND2' ' A' ' 4' ' ' ASN . 22.3 mmt -63.43 -20.41 65.53 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.707 0.765 . . . . 0.0 109.613 -177.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.656 ' HB1' ' CD1' ' A' ' 69' ' ' ILE . . . -49.07 -32.98 10.61 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.86 172.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.425 ' CG ' ' HB2' ' A' ' 52' ' ' GLN . 17.1 t80 -99.75 -64.99 0.99 Allowed 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 175.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.561 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 39.3 mm-40 -50.06 -33.01 17.0 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.468 -1.242 . . . . 0.0 112.413 -171.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.685 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.6 m-20 -103.72 -20.42 13.96 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.087 -174.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 43' ' ' ALA . . . -59.11 175.03 0.32 Allowed 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.691 0.758 . . . . 0.0 112.121 -177.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.583 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 12.3 m-20 -58.77 141.5 85.0 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.503 174.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -48.32 -29.09 12.45 Favored 'Trans proline' 0 C--O 1.22 -0.397 0 C-N-CA 123.761 2.974 . . . . 0.0 112.893 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.454 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -88.15 -33.82 18.08 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 123.86 0.864 . . . . 0.0 111.053 177.033 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.583 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 78.2 m -78.83 -33.8 45.76 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.504 -172.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.49 ' HA ' HD13 ' A' ' 55' ' ' ILE . 3.5 pt20 -73.08 -29.84 63.24 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 172.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.515 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 16.2 m -70.47 -19.12 62.97 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 113.658 -1.61 . . . . 0.0 110.432 173.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 51' ' ' CYS . . . -76.46 -27.98 56.37 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.169 -0.957 . . . . 0.0 109.458 166.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.61 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 21.8 mt -89.15 -31.5 5.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 115.651 1.722 . . . . 0.0 115.651 -171.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.58 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -40.03 -38.13 0.96 Allowed Pre-proline 0 N--CA 1.492 1.673 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -174.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.61 ' HD2' ' C ' ' A' ' 55' ' ' ILE . 57.7 Cg_endo -65.21 -26.49 56.88 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.139 1.893 . . . . 0.0 113.002 175.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.526 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.8 mt -100.89 -15.61 17.5 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.575 ' NZ ' HD13 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -49.85 109.36 0.28 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.333 -179.215 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.18 -21.4 34.73 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.075 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -103.43 114.04 28.0 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.007 0.432 . . . . 0.0 109.977 -177.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.42 140.67 33.16 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.05 172.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo . . . . . 0 C--O 1.235 0.338 0 C-N-CA 122.598 2.199 . . . . 0.0 111.848 170.119 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.679 ' CG2' ' HB3' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -71.46 -33.45 49.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.222 -179.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.765 ' O ' HG12 ' A' ' 73' ' ' VAL . 11.9 mm -55.71 -47.95 78.53 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.226 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.524 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.59 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 27.7 t -47.91 -36.65 12.63 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.911 178.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -86.59 -31.85 20.95 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.649 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.601 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.2 m-30 -76.13 -36.24 58.91 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.65 -177.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.795 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.8 m -69.63 -33.43 56.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 173.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.59 ' HB2' ' O ' ' A' ' 70' ' ' SER . 0.8 OUTLIER -68.36 -29.9 68.72 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.73 177.132 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 72' ' ' TYR . . . -63.97 -49.04 74.08 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.741 175.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.476 ' SG ' ' HB2' ' A' ' 14' ' ' TYR . 25.4 t -89.44 7.32 36.6 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.931 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.489 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 10.5 t70 . . . . . 0 C--N 1.323 -0.544 0 CA-C-O 121.487 0.66 . . . . 0.0 110.004 174.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo . . . . . 0 CA--C 1.516 -0.413 0 N-CA-C 109.425 -1.029 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 48.4 m -65.51 164.98 12.96 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 163.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.47 ' CE1' HD11 ' B' ' 29' ' ' ILE . 0.1 OUTLIER -69.79 -55.1 10.78 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.909 174.061 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . 0.554 ' ND2' ' HG3' ' B' ' 42' ' ' MET . 2.7 p-10 -86.69 -2.23 58.35 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.852 -164.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' THR . . . . . 0.413 ' O ' ' HD3' ' B' ' 7' ' ' ARG . 9.7 t -66.11 -3.26 5.22 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.439 -176.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.582 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.3 m -73.65 131.97 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 171.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . 0.702 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 1.2 ptt-85 -156.62 160.15 39.14 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -176.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' GLN . . . . . 0.452 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.3 tt0 -39.16 112.28 0.24 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 113.624 -1.626 . . . . 0.0 112.745 178.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.95 -142.72 8.18 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.64 174.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 20.0 m -59.03 95.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.958 0.379 . . . . 0.0 110.85 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 23.2 pttm 41.06 41.38 1.28 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.459 1.103 . . . . 0.0 112.454 -174.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -57.54 139.73 80.75 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.635 176.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . 0.53 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 34.2 Cg_exo -53.73 125.05 17.36 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.053 1.835 . . . . 0.0 109.727 177.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' TYR . . . . . 0.799 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 6.1 t80 -68.42 -55.37 12.25 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-O 118.504 -0.76 . . . . 0.0 112.877 -167.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.543 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 25.4 Cg_exo -57.57 -17.76 29.59 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 121.375 1.383 . . . . 0.0 111.238 -177.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.53 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 5.8 m-20 -89.71 -40.1 12.74 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.966 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' PHE . . . . . 0.635 ' HE2' ' CE2' ' B' ' 14' ' ' TYR . 0.0 OUTLIER -56.68 -45.79 81.52 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.013 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.775 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 1.4 p -77.75 -33.43 18.86 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.278 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.399 -178.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.27 -31.25 67.28 Favored 'General case' 0 C--N 1.31 -1.119 0 O-C-N 121.271 -0.893 . . . . 0.0 111.83 177.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.721 ' O ' HG12 ' B' ' 24' ' ' VAL . 15.8 ptt180 -84.97 -28.31 25.89 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 174.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.57 HD22 ' CE1' ' B' ' 17' ' ' PHE . 11.8 tp -54.0 -48.84 70.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.97 172.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' GLN . . . . . 0.775 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 23.1 mt-30 -70.89 -46.38 62.68 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.077 177.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.73 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 19.1 t70 -48.4 -54.72 12.98 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 124.125 0.891 . . . . 0.0 111.574 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' VAL . . . . . 0.721 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.4 p -81.63 -22.38 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-O 121.278 0.561 . . . . 0.0 109.807 -173.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.778 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -72.85 -18.67 61.42 Favored 'General case' 0 C--O 1.205 -1.252 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 173.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . 0.406 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -86.64 -38.39 17.11 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.546 -1.207 . . . . 0.0 109.596 177.133 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.73 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.8 mmtt -67.23 -36.13 81.02 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.033 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 23.8 m -104.02 -8.73 19.35 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.203 0.525 . . . . 0.0 110.628 -171.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.778 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 83.8 mt -115.35 126.13 72.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.394 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.37 -5.55 59.3 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.109 0.48 . . . . 0.0 110.363 178.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.546 ' H ' HG22 ' B' ' 29' ' ' ILE . 26.0 t0 -105.41 139.47 39.99 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.297 -177.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -76.27 -31.5 58.3 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.499 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.52 ' O ' HG13 ' B' ' 37' ' ' VAL . 6.4 mttp -71.68 -55.01 8.51 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.482 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -58.7 -27.56 64.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.289 -0.868 . . . . 0.0 110.967 176.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.843 ' O ' HG13 ' B' ' 39' ' ' VAL . 1.9 tmm_? -65.85 -59.75 3.55 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 12.5 mtpp -55.18 -57.54 11.37 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.1 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.773 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 20.1 m -52.67 -34.5 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.068 -170.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.477 ' O ' ' HG2' ' B' ' 42' ' ' MET . 1.0 OUTLIER -88.26 -31.26 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 119.942 -0.703 . . . . 0.0 112.195 -179.436 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.843 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.4 m -68.63 -48.64 70.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 119.114 -1.035 . . . . 0.0 109.434 176.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.692 ' HB3' ' CG2' ' B' ' 68' ' ' VAL . 0.8 OUTLIER -64.65 -28.44 69.61 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.49 0.716 . . . . 0.0 111.541 178.388 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.773 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -81.4 -54.62 5.31 Favored 'General case' 0 C--N 1.322 -0.602 0 O-C-N 122.141 -0.349 . . . . 0.0 111.5 177.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' MET . . . . . 0.554 ' HG3' ' ND2' ' B' ' 4' ' ' ASN . 22.2 mmt -63.47 -20.45 65.59 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.691 0.758 . . . . 0.0 109.519 -177.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.649 ' O ' ' HB3' ' B' ' 47' ' ' ALA . . . -49.0 -32.99 10.17 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.832 171.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' TYR . . . . . 0.425 ' CG ' ' HB2' ' B' ' 52' ' ' GLN . 17.6 t80 -99.8 -64.79 1.01 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.577 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 39.4 mm-40 -50.2 -32.97 17.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.419 -1.264 . . . . 0.0 112.312 -171.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.702 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.6 m-20 -103.96 -20.21 13.96 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.031 -174.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' B' ' 43' ' ' ALA . . . -59.55 174.91 0.39 Allowed 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.591 0.71 . . . . 0.0 112.119 -177.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' ASN . . . . . 0.587 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 12.0 m-20 -58.51 141.44 83.73 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 114.755 -1.112 . . . . 0.0 109.496 174.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -48.12 -29.3 12.19 Favored 'Trans proline' 0 C--O 1.221 -0.37 0 C-N-CA 123.715 2.943 . . . . 0.0 112.918 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' B' ' 50' ' ' GLU . 0.3 OUTLIER -88.05 -33.81 18.19 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 123.823 0.849 . . . . 0.0 111.095 177.213 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 78.8 m -78.8 -33.88 45.88 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.457 -172.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . 0.479 ' HA ' HD13 ' B' ' 55' ' ' ILE . 3.7 pt20 -72.93 -29.99 63.54 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 172.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' SER . . . . . 0.523 ' O ' ' HE2' ' B' ' 56' ' ' LYS . 15.8 m -70.45 -19.06 63.0 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 113.654 -1.612 . . . . 0.0 110.416 173.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' B' ' 51' ' ' CYS . . . -76.6 -27.65 55.84 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.271 -0.893 . . . . 0.0 109.545 166.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.602 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 22.0 mt -89.43 -31.41 5.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -171.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . 0.576 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -40.2 -38.15 1.02 Allowed Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -174.756 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.602 ' HD2' ' C ' ' B' ' 55' ' ' ILE . 57.9 Cg_endo -65.21 -26.22 57.08 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.177 1.918 . . . . 0.0 113.069 175.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . 0.544 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.8 mt -100.97 -15.66 17.42 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . 0.561 ' HZ3' HD13 ' B' ' 41' ' ' LEU . 0.2 OUTLIER -49.95 109.36 0.28 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.302 -179.103 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . 0.405 ' HA3' ' C ' ' A' ' 1' ' ' PRO . . . 91.13 -21.23 35.46 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.05 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -103.4 114.01 27.95 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 120.994 0.426 . . . . 0.0 109.972 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.34 140.76 33.22 Favored Pre-proline 0 C--N 1.314 -0.964 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.075 172.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo . . . . . 0 C--N 1.343 0.283 0 C-N-CA 122.576 2.184 . . . . 0.0 111.906 170.029 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 . . . . . 0 N--CA 1.454 -0.261 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . 0.692 ' CG2' ' HB3' ' B' ' 40' ' ' GLU . 0.8 OUTLIER -71.69 -33.35 48.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.198 -179.475 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . 0.773 ' O ' HG12 ' B' ' 73' ' ' VAL . 11.9 mm -55.66 -48.1 78.16 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.215 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.538 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' SER . . . . . 0.582 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 27.2 t -47.83 -36.6 12.17 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.943 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -86.42 -32.11 21.07 Favored 'General case' 0 CA--C 1.507 -0.685 0 C-N-CA 123.231 0.613 . . . . 0.0 110.606 -177.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' TYR . . . . . 0.588 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.2 m-30 -75.94 -36.22 59.43 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.616 -177.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . 0.799 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.8 m -69.62 -33.59 57.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.543 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 173.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' LYS . . . . . 0.582 ' HB2' ' O ' ' B' ' 70' ' ' SER . 0.8 OUTLIER -68.11 -30.12 69.2 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.224 -1.353 . . . . 0.0 109.755 177.117 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' B' ' 72' ' ' TYR . . . -63.75 -49.25 73.74 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.676 175.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' B' ' 14' ' ' TYR . 24.9 t -89.31 7.05 37.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.921 178.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . 0.492 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 8.9 t70 . . . . . 0 C--N 1.323 -0.56 0 CA-C-O 121.374 0.607 . . . . 0.0 110.034 174.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo . . . . . 0 CA--C 1.517 -0.345 0 N-CA-C 109.248 -1.097 . . . . 0.0 109.248 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.457 ' HB2' HG21 ' A' ' 5' ' ' THR . 39.4 m -64.93 171.13 3.71 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 162.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.497 ' HE1' ' CD1' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -69.73 -52.53 24.65 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.118 175.299 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.485 ' ND2' ' HG3' ' A' ' 42' ' ' MET . 2.2 p-10 -86.97 6.45 32.16 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.577 -1.192 . . . . 0.0 113.659 -163.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.626 ' CG2' ' HD3' ' B' ' 59' ' ' LYS . 1.1 p -63.32 -5.99 4.14 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 118.513 0.597 . . . . 0.0 111.787 -176.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.616 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.1 m -75.12 132.04 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 175.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.706 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -155.54 159.22 39.54 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -178.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.434 ' HG2' ' HB3' ' A' ' 12' ' ' GLU . 2.3 tt0 -44.29 115.14 0.79 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 112.929 -1.941 . . . . 0.0 113.02 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.73 -149.98 23.81 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.091 -0.958 . . . . 0.0 111.126 171.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.47 ' C ' ' HD3' ' A' ' 11' ' ' LYS . 6.3 p -50.97 100.36 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.61 0.364 . . . . 0.0 111.592 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER 30.25 48.0 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.764 1.226 . . . . 0.0 112.26 -171.507 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.434 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 53.5 tt0 -60.22 140.63 91.17 Favored Pre-proline 0 C--O 1.234 0.283 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.611 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.552 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 32.0 Cg_exo -54.05 121.54 9.82 Favored 'Trans proline' 0 CA--C 1.509 -0.754 0 C-N-CA 121.947 1.765 . . . . 0.0 109.623 178.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.871 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 13.8 t80 -72.75 -53.36 5.52 Favored Pre-proline 0 N--CA 1.439 -1.022 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -167.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.521 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 34.6 Cg_exo -55.66 -17.04 16.42 Favored 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.43 1.42 . . . . 0.0 110.761 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.552 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 2.2 m-20 -90.6 -43.43 10.18 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 113.981 -1.463 . . . . 0.0 111.038 177.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.466 ' CD2' ' HA ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -53.41 -46.51 69.78 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.772 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 1.8 p -79.26 -34.72 16.56 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.363 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.313 -178.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 15' ' ' PRO . . . -57.89 -32.79 68.06 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 121.344 -0.847 . . . . 0.0 111.762 177.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.695 ' O ' HG11 ' A' ' 24' ' ' VAL . 14.3 ptt180 -84.28 -25.04 29.64 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 176.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.547 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 6.2 tp -59.91 -46.72 88.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.821 172.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.772 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 24.7 mt-30 -69.97 -48.28 58.92 Favored 'General case' 0 CA--C 1.492 -1.282 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.933 177.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.724 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 15.5 t70 -47.44 -54.65 10.82 Favored 'General case' 0 C--N 1.313 -1.017 0 O-C-N 124.265 0.978 . . . . 0.0 111.547 -178.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.695 HG11 ' O ' ' A' ' 20' ' ' ARG . 7.7 p -79.18 -24.9 12.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.948 -173.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.634 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -67.89 -29.58 68.71 Favored 'General case' 0 C--O 1.205 -1.263 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.469 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -78.81 -36.32 42.89 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.723 -178.253 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.724 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 39.2 mmtt -65.92 -34.1 77.34 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.469 177.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.1 m -105.6 -9.89 17.14 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.271 0.558 . . . . 0.0 110.823 -170.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.634 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 87.7 mt -118.07 129.07 74.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.062 -178.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.4 -1.47 53.63 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.246 0.546 . . . . 0.0 110.524 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.526 ' H ' HG22 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -113.71 111.76 22.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.015 -177.338 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.86 -32.05 30.47 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 177.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.49 ' O ' HG12 ' A' ' 37' ' ' VAL . 14.2 mttm -58.46 -61.31 2.68 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.488 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -66.36 -22.84 66.27 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.427 -178.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.833 ' O ' HG12 ' A' ' 39' ' ' VAL . 5.3 tmm_? -72.31 -54.6 9.02 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.436 ' O ' HG21 ' A' ' 39' ' ' VAL . 16.6 mtpt -59.44 -56.5 21.26 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.345 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.805 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 20.9 m -54.15 -36.58 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.997 -171.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.497 ' CD1' ' HE1' ' A' ' 3' ' ' PHE . 1.2 tt -85.78 -30.36 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.811 -176.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.833 HG12 ' O ' ' A' ' 35' ' ' ARG . 3.3 m -69.47 -47.94 69.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 C-N-CA 118.915 -1.114 . . . . 0.0 109.245 174.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.625 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 58.6 mt-10 -64.66 -23.13 67.16 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 123.653 0.781 . . . . 0.0 112.383 175.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.805 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -85.48 -57.21 3.16 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.543 177.251 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.485 ' HG3' ' ND2' ' A' ' 4' ' ' ASN . 20.1 mmt -63.6 -20.96 66.09 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 121.462 0.649 . . . . 0.0 109.734 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.654 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . . . -49.18 -27.65 3.78 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.288 170.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.448 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 11.4 t80 -106.12 -68.1 0.89 Allowed 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.597 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 7.2 mm-40 -47.59 -33.85 7.1 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 124.31 1.007 . . . . 0.0 112.414 -173.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.706 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.8 m-20 -103.46 -21.15 13.83 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 120.501 0.191 . . . . 0.0 110.963 -174.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 43' ' ' ALA . . . -57.35 177.61 0.09 Allowed 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 121.817 0.818 . . . . 0.0 112.511 -176.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -56.21 137.64 74.35 Favored Pre-proline 0 N--CA 1.44 -0.958 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.9 174.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.43 -21.75 31.36 Favored 'Trans proline' 0 C--O 1.219 -0.465 0 C-N-CA 123.273 2.649 . . . . 0.0 111.778 -177.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.506 ' O ' ' HB2' ' A' ' 53' ' ' SER . 0.7 OUTLIER -87.86 -37.4 16.54 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 124.157 0.983 . . . . 0.0 111.055 173.325 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.996 ' SG ' ' HB2' ' A' ' 76' ' ' CYS . 42.4 t -75.33 -36.06 61.11 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-O 121.018 0.437 . . . . 0.0 111.328 -172.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.495 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.9 pt20 -69.62 -29.74 67.32 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 175.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.598 ' HA ' ' CD ' ' A' ' 56' ' ' LYS . 30.8 m -72.48 -19.75 61.5 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 112.944 -1.935 . . . . 0.0 110.176 174.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -81.22 -22.27 38.92 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.333 166.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.516 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 22.5 mt -90.54 -31.84 5.26 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.787 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 -173.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.654 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.1 OUTLIER -46.14 -32.65 1.81 Allowed Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -175.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.654 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 33.0 Cg_endo -59.54 -31.04 93.9 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.17 1.913 . . . . 0.0 112.99 171.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.515 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.1 mt -102.45 -15.65 16.42 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.621 ' HD3' ' CG2' ' B' ' 5' ' ' THR . 0.1 OUTLIER -51.78 109.88 0.41 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.972 -179.717 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.35 -22.66 35.8 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.162 -177.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -103.77 114.5 28.8 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.413 0.625 . . . . 0.0 110.553 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.435 ' HB ' HG11 ' A' ' 68' ' ' VAL . 7.4 p -123.4 149.99 59.55 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.471 170.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo . . . . . 0 N--CA 1.462 -0.374 0 C-N-CA 121.713 1.609 . . . . 0.0 110.92 164.356 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 p30 . . . . . 0 N--CA 1.44 -0.963 0 CA-C-O 120.166 0.031 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.562 HG13 ' CD ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -81.05 -28.98 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 C-N-CA 117.609 -1.637 . . . . 0.0 108.606 173.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.77 ' O ' HG12 ' A' ' 73' ' ' VAL . 10.0 mm -59.34 -48.04 88.42 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.18 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.627 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.3 t -50.44 -33.96 22.93 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.355 0.598 . . . . 0.0 111.155 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -85.28 -33.64 22.1 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 123.323 0.649 . . . . 0.0 110.507 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.56 ' OH ' ' HA ' ' A' ' 59' ' ' LYS . 4.7 m-30 -75.85 -34.05 60.04 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.754 -176.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.871 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 2.2 m -68.41 -35.67 71.66 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 173.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.528 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 21.7 ttmt -70.71 -27.7 64.18 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 113.894 -1.503 . . . . 0.0 111.188 176.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.477 ' HB1' ' O ' ' A' ' 72' ' ' TYR . . . -61.62 -44.34 97.17 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 171.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.996 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 16.6 t -85.78 3.12 42.83 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.292 176.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.528 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 29.6 t70 . . . . . 0 CA--C 1.538 0.492 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 163.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 1' ' ' PRO . . . . . 0.424 ' HB2' ' H ' ' B' ' 2' ' ' SER . 94.4 Cg_endo . . . . . 0 CA--C 1.517 -0.368 0 N-CA-C 109.156 -1.132 . . . . 0.0 109.156 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' SER . . . . . 0.441 ' HB2' HG21 ' B' ' 5' ' ' THR . 43.3 m -65.13 171.07 3.93 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 162.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.501 ' HE1' ' CD1' ' B' ' 38' ' ' ILE . 0.1 OUTLIER -69.61 -52.54 25.06 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.155 175.349 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . 0.484 ' ND2' ' HG3' ' B' ' 42' ' ' MET . 2.2 p-10 -86.9 6.51 31.6 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.584 -1.189 . . . . 0.0 113.717 -163.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' THR . . . . . 0.621 ' CG2' ' HD3' ' A' ' 59' ' ' LYS . 1.1 p -63.54 -5.75 4.25 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 118.57 0.623 . . . . 0.0 111.865 -176.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.616 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.1 m -75.2 131.98 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 175.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . 0.702 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.1 OUTLIER -155.51 159.37 39.7 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -178.702 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' GLN . . . . . 0.417 ' HG2' ' HB3' ' B' ' 12' ' ' GLU . 2.3 tt0 -44.2 115.0 0.76 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 112.939 -1.937 . . . . 0.0 113.035 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.79 -150.06 24.04 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.162 171.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' SER . . . . . 0.477 ' C ' ' HD3' ' B' ' 11' ' ' LYS . 7.8 p -50.84 100.25 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.604 0.362 . . . . 0.0 111.677 -178.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' B' ' 11' ' ' LYS . 0.0 OUTLIER 30.37 48.19 0.05 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.673 1.189 . . . . 0.0 112.122 -171.575 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.417 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 51.9 tt0 -60.51 140.35 92.28 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.688 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . 0.557 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 31.9 Cg_exo -53.97 121.6 9.91 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 121.861 1.707 . . . . 0.0 109.602 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' TYR . . . . . 0.868 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 13.7 t80 -72.85 -53.35 5.36 Favored Pre-proline 0 N--CA 1.438 -1.049 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -167.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.509 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 32.9 Cg_exo -55.37 -17.33 15.86 Favored 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 121.57 1.514 . . . . 0.0 110.775 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.557 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.7 m-20 -90.62 -43.42 10.18 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 113.935 -1.484 . . . . 0.0 111.024 177.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' PHE . . . . . 0.469 ' CD2' ' HA ' ' B' ' 7' ' ' ARG . 0.0 OUTLIER -53.38 -46.49 69.66 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.662 0.744 . . . . 0.0 109.039 175.525 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.78 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 1.8 p -79.16 -34.83 16.79 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.334 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.298 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' B' ' 15' ' ' PRO . . . -57.91 -32.76 68.06 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 121.366 -0.834 . . . . 0.0 111.773 177.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.692 ' O ' HG11 ' B' ' 24' ' ' VAL . 14.3 ptt180 -84.61 -24.63 29.05 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.549 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 6.1 tp -60.3 -46.47 89.75 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.842 172.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' GLN . . . . . 0.78 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 24.8 mt-30 -70.2 -48.1 58.58 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.004 177.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.723 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 15.2 t70 -47.49 -54.67 10.88 Favored 'General case' 0 C--N 1.313 -1.002 0 O-C-N 124.301 1.001 . . . . 0.0 111.462 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' VAL . . . . . 0.692 HG11 ' O ' ' B' ' 20' ' ' ARG . 7.7 p -79.28 -24.78 12.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.96 -173.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.636 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -67.96 -29.51 68.57 Favored 'General case' 0 C--O 1.205 -1.272 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 174.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . 0.452 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -78.89 -36.26 42.33 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.125 -1.398 . . . . 0.0 109.786 -178.252 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.723 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 39.1 mmtt -65.89 -34.26 77.72 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.496 177.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 15.9 m -105.63 -9.66 17.24 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.884 -170.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.636 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 87.9 mt -118.2 129.28 74.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.983 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.64 -1.32 53.39 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.347 0.594 . . . . 0.0 110.585 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.535 ' H ' HG22 ' B' ' 29' ' ' ILE . 0.6 OUTLIER -113.71 111.81 22.41 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.977 -177.554 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.17 -31.71 32.65 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.092 177.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.487 ' O ' HG12 ' B' ' 37' ' ' VAL . 14.1 mttm -58.66 -61.21 2.77 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -178.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.494 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -66.21 -22.98 66.36 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.483 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.84 ' O ' HG12 ' B' ' 39' ' ' VAL . 5.2 tmm_? -72.15 -54.63 9.13 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.436 ' O ' HG21 ' B' ' 39' ' ' VAL . 16.5 mtpt -59.47 -56.48 21.43 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.461 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.792 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 21.0 m -54.18 -36.57 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.051 -171.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.501 ' CD1' ' HE1' ' B' ' 3' ' ' PHE . 1.2 tt -85.6 -30.55 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.757 -176.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.84 HG12 ' O ' ' B' ' 35' ' ' ARG . 3.3 m -69.39 -48.0 69.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 C-N-CA 118.927 -1.109 . . . . 0.0 109.17 174.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.628 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 58.7 mt-10 -64.63 -23.35 67.23 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.571 0.748 . . . . 0.0 112.268 176.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.792 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.29 -57.16 3.19 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.555 177.331 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' MET . . . . . 0.484 ' HG3' ' ND2' ' B' ' 4' ' ' ASN . 20.0 mmt -63.63 -20.96 66.1 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.521 0.677 . . . . 0.0 109.714 -177.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.665 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . . . -49.13 -27.76 3.75 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.305 170.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' TYR . . . . . 0.465 ' CG ' ' HD2' ' B' ' 59' ' ' LYS . 11.4 t80 -106.09 -67.99 0.9 Allowed 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.602 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 7.2 mm-40 -47.85 -33.48 7.46 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 124.301 1.001 . . . . 0.0 112.491 -173.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.702 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.9 m-20 -103.67 -21.04 13.78 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 116.808 -0.178 . . . . 0.0 110.903 -175.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' B' ' 43' ' ' ALA . . . -57.48 178.07 0.08 Allowed 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 121.864 0.84 . . . . 0.0 112.55 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -56.42 137.53 75.91 Favored Pre-proline 0 N--CA 1.441 -0.917 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.819 174.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.32 -21.63 30.04 Favored 'Trans proline' 0 C--O 1.221 -0.373 0 C-N-CA 123.177 2.585 . . . . 0.0 111.911 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . 0.504 ' O ' ' HB2' ' B' ' 53' ' ' SER . 0.7 OUTLIER -87.8 -37.47 16.56 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 124.303 1.041 . . . . 0.0 111.13 173.044 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.996 ' SG ' ' HB2' ' B' ' 76' ' ' CYS . 41.7 t -75.34 -36.0 61.09 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-O 121.046 0.451 . . . . 0.0 111.315 -172.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . 0.489 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.9 pt20 -69.54 -29.92 67.62 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 175.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' SER . . . . . 0.601 ' HA ' ' CD ' ' B' ' 56' ' ' LYS . 32.4 m -72.26 -19.99 61.6 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 112.92 -1.945 . . . . 0.0 110.29 174.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -81.04 -22.38 39.36 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.216 -0.593 . . . . 0.0 110.388 166.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.51 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 22.5 mt -90.53 -31.95 5.29 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.798 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -173.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . 0.643 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.1 OUTLIER -46.04 -32.76 1.8 Allowed Pre-proline 0 N--CA 1.488 1.466 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -175.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.643 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 32.7 Cg_endo -59.24 -31.44 95.22 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.219 1.946 . . . . 0.0 112.939 171.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . 0.512 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.1 mt -102.15 -15.91 16.54 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -177.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . 0.626 ' HD3' ' CG2' ' A' ' 5' ' ' THR . 0.1 OUTLIER -51.61 109.88 0.4 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.112 -179.713 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.0 -22.09 38.26 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.329 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -103.96 114.76 29.24 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.355 0.597 . . . . 0.0 110.48 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.438 ' HB ' HG11 ' B' ' 68' ' ' VAL . 7.5 p -123.46 150.34 60.65 Favored Pre-proline 0 C--N 1.309 -1.166 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.374 170.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo . . . . . 0 C--N 1.344 0.313 0 C-N-CA 121.753 1.636 . . . . 0.0 110.915 164.108 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 p30 . . . . . 0 N--CA 1.44 -0.958 0 CA-C-O 120.279 0.085 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . 0.566 HG13 ' CD ' ' B' ' 40' ' ' GLU . 0.9 OUTLIER -80.97 -28.79 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 C-N-CA 117.548 -1.661 . . . . 0.0 108.609 173.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . 0.779 ' O ' HG12 ' B' ' 73' ' ' VAL . 9.8 mm -59.75 -47.71 90.27 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.232 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.68 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 42.8 t -50.52 -34.04 23.79 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.397 0.617 . . . . 0.0 111.118 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -85.18 -33.87 22.2 Favored 'General case' 0 C--O 1.213 -0.835 0 C-N-CA 123.298 0.639 . . . . 0.0 110.394 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' TYR . . . . . 0.563 ' OH ' ' HA ' ' B' ' 59' ' ' LYS . 4.7 m-30 -75.56 -33.9 60.66 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.719 -176.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . 0.868 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 2.2 m -68.56 -35.61 71.03 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' LYS . . . . . 0.518 ' O ' ' HB3' ' B' ' 77' ' ' ASP . 22.0 ttmt -70.71 -27.52 64.04 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.253 176.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' B' ' 72' ' ' TYR . . . -61.81 -44.17 97.39 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.996 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 16.5 t -86.02 3.29 42.96 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.336 176.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . 0.518 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 28.5 t70 . . . . . 0 CA--C 1.538 0.512 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 163.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.415 ' HB2' ' H ' ' A' ' 2' ' ' SER . 98.1 Cg_endo . . . . . 0 CA--C 1.517 -0.341 0 N-CA-C 109.052 -1.172 . . . . 0.0 109.052 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.444 ' HB2' HG22 ' A' ' 5' ' ' THR . 50.0 m -66.37 176.82 1.68 Allowed 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 162.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.628 ' CE1' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -77.09 -53.99 7.09 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.589 -0.845 . . . . 0.0 109.743 174.338 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.554 ' ND2' ' HG3' ' A' ' 42' ' ' MET . 2.0 p-10 -82.67 6.19 18.71 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.367 -1.288 . . . . 0.0 112.548 -167.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.642 ' CG2' ' HD3' ' B' ' 59' ' ' LYS . 0.7 OUTLIER -65.12 -4.08 4.5 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.547 -176.75 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.613 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.2 m -79.37 132.78 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 174.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.685 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -155.95 160.07 39.78 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 118.937 -1.105 . . . . 0.0 113.422 -177.798 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.486 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.4 mt-30 -40.67 112.68 0.31 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 113.568 -1.651 . . . . 0.0 112.776 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.08 -161.58 32.74 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 170.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.7 m -50.83 104.09 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 117.292 0.546 . . . . 0.0 111.029 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.4 pttt 44.12 39.11 2.65 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.587 1.155 . . . . 0.0 112.756 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.4 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 48.2 tt0 -62.36 137.97 96.2 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 177.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.512 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 39.0 Cg_exo -53.74 124.72 16.53 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.11 1.874 . . . . 0.0 109.921 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.736 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 6.7 t80 -69.26 -55.32 10.11 Favored Pre-proline 0 N--CA 1.44 -0.958 0 CA-C-O 118.38 -0.819 . . . . 0.0 113.134 -166.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.551 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 30.3 Cg_exo -57.04 -17.57 25.15 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 121.456 1.437 . . . . 0.0 111.211 -178.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 2.1 m-20 -89.52 -42.31 11.52 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.891 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.632 ' HE2' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -55.48 -44.7 76.72 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.307 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.691 HG12 ' O ' ' A' ' 14' ' ' TYR . 1.7 p -80.99 -31.47 12.11 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.937 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.826 -177.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.76 -33.69 70.56 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 121.284 -0.885 . . . . 0.0 111.608 176.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.696 ' O ' HG11 ' A' ' 24' ' ' VAL . 14.6 ptt180 -84.56 -25.48 28.66 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 175.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.593 HD23 ' CE1' ' A' ' 17' ' ' PHE . 9.7 tp -57.98 -45.09 87.31 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.972 172.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.694 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 36.1 mt-30 -73.31 -44.42 59.04 Favored 'General case' 0 CA--C 1.494 -1.196 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.688 177.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.754 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 14.3 t70 -52.08 -50.93 60.58 Favored 'General case' 0 C--N 1.314 -0.945 0 O-C-N 124.087 0.867 . . . . 0.0 111.427 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.696 HG11 ' O ' ' A' ' 20' ' ' ARG . 7.1 p -82.02 -23.96 9.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.249 0.547 . . . . 0.0 109.793 -174.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.848 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -71.69 -18.29 62.18 Favored 'General case' 0 C--O 1.206 -1.223 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 174.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.414 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -87.43 -38.92 15.7 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.958 176.746 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.754 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 40.2 mmtt -65.28 -43.32 91.6 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.321 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.504 ' HB2' ' HB3' ' A' ' 3' ' ' PHE . 24.9 m -98.6 -8.47 26.36 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.243 0.544 . . . . 0.0 110.419 -172.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.848 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 87.2 mt -114.91 125.48 72.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.725 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.84 -4.33 57.65 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.18 0.514 . . . . 0.0 110.01 175.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.662 ' OD1' ' HB2' ' A' ' 33' ' ' LYS . 12.4 t70 -102.59 115.71 31.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.409 -177.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 36' ' ' LYS . 12.5 pt-20 -61.59 -24.71 66.86 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.831 176.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.662 ' HB2' ' OD1' ' A' ' 31' ' ' ASP . 4.5 mptt -75.12 -52.17 11.65 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -177.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.29 -26.94 68.29 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.89 176.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.821 ' O ' HG11 ' A' ' 39' ' ' VAL . 3.9 tmm_? -62.59 -65.19 0.72 Allowed 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.546 ' O ' HG23 ' A' ' 39' ' ' VAL . 7.9 ptmm? -53.11 -58.38 7.2 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.314 0.578 . . . . 0.0 112.259 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.773 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 5.4 m -56.63 -30.39 31.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.928 -172.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.491 ' O ' ' HG2' ' A' ' 42' ' ' MET . 0.1 OUTLIER -85.07 -31.43 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.407 178.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.821 HG11 ' O ' ' A' ' 35' ' ' ARG . 2.4 m -68.33 -47.84 75.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 119.257 -0.977 . . . . 0.0 108.97 175.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.611 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 45.3 mt-10 -68.03 -22.89 64.94 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.335 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.773 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -85.42 -55.2 4.13 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.166 175.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.554 ' HG3' ' ND2' ' A' ' 4' ' ' ASN . 17.8 mmt -63.77 -20.42 65.75 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.567 0.698 . . . . 0.0 109.765 -176.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.634 ' HB1' ' CD1' ' A' ' 69' ' ' ILE . . . -47.9 -30.2 3.96 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.736 171.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.536 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 8.0 t80 -105.66 -66.99 0.95 Allowed 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.629 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 3.9 mm-40 -47.02 -33.79 5.09 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 124.47 1.106 . . . . 0.0 112.107 -173.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.685 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 5.3 m-20 -102.7 -21.0 14.17 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.214 -174.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.617 ' HB1' ' O ' ' A' ' 43' ' ' ALA . . . -60.65 -179.62 0.13 Allowed 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 122.093 0.949 . . . . 0.0 112.966 -173.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.601 ' HB3' ' OE1' ' A' ' 50' ' ' GLU . 15.1 m-20 -61.35 141.61 94.21 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.175 174.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.21 -22.61 33.21 Favored 'Trans proline' 0 C--O 1.22 -0.425 0 C-N-CA 123.413 2.742 . . . . 0.0 112.722 -178.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.712 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 12.2 pm0 -89.37 -31.13 17.91 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 123.5 0.72 . . . . 0.0 110.599 175.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.712 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 92.7 m -82.9 -37.44 24.25 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.57 -170.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.536 ' HB2' ' CG ' ' A' ' 44' ' ' TYR . 3.6 pt20 -70.21 -29.94 66.91 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 172.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.417 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 11.2 m -70.91 -19.87 62.55 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 113.672 -1.604 . . . . 0.0 110.331 174.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 51' ' ' CYS . . . -78.6 -25.43 45.19 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.504 -0.748 . . . . 0.0 109.686 167.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.602 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 22.7 mt -89.8 -32.57 5.65 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.816 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -171.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.59 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -39.92 -37.95 0.88 Allowed Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -174.361 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.602 ' HD2' ' C ' ' A' ' 55' ' ' ILE . 52.3 Cg_endo -63.86 -29.23 67.65 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.217 1.945 . . . . 0.0 113.006 175.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.533 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.5 mt -99.09 -15.61 18.94 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.644 ' HD3' ' CG2' ' B' ' 5' ' ' THR . 0.1 OUTLIER -50.96 109.65 0.35 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.24 -178.371 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.406 ' HA3' ' C ' ' B' ' 1' ' ' PRO . . . 90.2 -20.65 35.75 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.032 -178.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -103.47 113.14 26.41 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.274 0.559 . . . . 0.0 109.785 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.414 ' HB ' HG13 ' A' ' 68' ' ' VAL . 7.5 p -123.72 148.88 57.6 Favored Pre-proline 0 C--N 1.31 -1.146 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.624 172.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo . . . . . 0 N--CA 1.459 -0.51 0 C-N-CA 122.059 1.839 . . . . 0.0 110.788 164.576 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.61 ' OD2' ' HB3' ' A' ' 70' ' ' SER . 0.4 OUTLIER . . . . . 0 N--CA 1.441 -0.887 0 CA-C-O 120.249 0.071 . . . . 0.0 111.117 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.527 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -81.7 -32.98 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 C-N-CA 118.623 -1.231 . . . . 0.0 108.662 173.815 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.779 ' O ' HG11 ' A' ' 73' ' ' VAL . 10.7 mm -56.3 -49.98 73.92 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.349 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.495 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.61 ' HB3' ' OD2' ' A' ' 67' ' ' ASP . 32.5 t -54.66 -29.01 51.3 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.059 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -85.79 -33.27 21.42 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.394 0.616 . . . . 0.0 110.162 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.624 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.2 m-30 -75.31 -35.13 61.3 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.518 -177.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.779 HG11 ' O ' ' A' ' 69' ' ' ILE . 1.4 m -70.78 -32.05 47.79 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 172.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.533 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -67.63 -30.92 70.62 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.27 175.248 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -63.58 -46.02 87.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.056 176.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.608 ' SG ' ' HB2' ' A' ' 14' ' ' TYR . 27.5 t -93.02 9.91 33.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.141 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.533 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 3.8 t70 . . . . . 0 C--N 1.323 -0.578 0 CA-C-O 121.092 0.472 . . . . 0.0 110.854 174.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 1' ' ' PRO . . . . . 0.447 ' HB2' ' H ' ' B' ' 2' ' ' SER . 93.2 Cg_endo . . . . . 0 CA--C 1.516 -0.384 0 N-CA-C 109.135 -1.14 . . . . 0.0 109.135 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' SER . . . . . 0.464 ' HB2' HG22 ' B' ' 5' ' ' THR . 50.1 m -66.91 176.97 1.84 Allowed 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 162.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.629 ' CE1' HD11 ' B' ' 29' ' ' ILE . 0.1 OUTLIER -77.03 -54.14 6.92 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.663 174.296 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . 0.546 ' ND2' ' HG3' ' B' ' 42' ' ' MET . 2.0 p-10 -82.59 6.01 19.08 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.392 -1.276 . . . . 0.0 112.475 -166.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' THR . . . . . 0.644 ' CG2' ' HD3' ' A' ' 59' ' ' LYS . 0.7 OUTLIER -65.1 -3.95 4.31 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.58 -176.698 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.614 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.2 m -79.41 132.9 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . 0.674 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.1 OUTLIER -155.94 160.24 39.94 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.123 -1.031 . . . . 0.0 113.403 -177.79 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' GLN . . . . . 0.495 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.3 mt-30 -41.03 112.16 0.27 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 113.591 -1.64 . . . . 0.0 112.814 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.41 -161.44 31.43 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 170.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 43.5 m -50.92 104.05 0.07 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-N 117.241 0.52 . . . . 0.0 111.093 -178.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 63.7 pttt 44.22 38.88 2.61 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.59 1.156 . . . . 0.0 112.714 -176.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.405 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 48.2 tt0 -62.09 137.71 95.71 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 177.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . 0.523 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 39.4 Cg_exo -53.5 124.89 16.84 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.25 1.967 . . . . 0.0 109.979 178.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' TYR . . . . . 0.743 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 6.7 t80 -69.58 -55.28 9.53 Favored Pre-proline 0 N--CA 1.44 -0.943 0 CA-C-O 118.369 -0.824 . . . . 0.0 113.074 -166.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.554 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 31.1 Cg_exo -57.05 -17.62 25.39 Favored 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 121.437 1.425 . . . . 0.0 111.176 -178.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.523 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 2.3 m-20 -89.44 -42.64 11.38 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 113.872 -1.513 . . . . 0.0 110.804 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' PHE . . . . . 0.633 ' HE2' ' CE2' ' B' ' 14' ' ' TYR . 0.0 OUTLIER -55.22 -44.73 75.68 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 177.351 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.698 HG12 ' O ' ' B' ' 14' ' ' TYR . 1.7 p -80.99 -31.38 12.07 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.927 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.791 -177.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.69 -34.04 70.84 Favored 'General case' 0 C--N 1.315 -0.931 0 O-C-N 121.344 -0.847 . . . . 0.0 111.596 176.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.698 ' O ' HG11 ' B' ' 24' ' ' VAL . 14.7 ptt180 -84.37 -25.48 29.11 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 176.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.592 HD23 ' CE1' ' B' ' 17' ' ' PHE . 9.9 tp -58.09 -45.19 87.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.981 172.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' GLN . . . . . 0.706 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 35.5 mt-30 -73.26 -44.39 59.46 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.701 177.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.745 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 12.8 t70 -51.96 -50.8 60.52 Favored 'General case' 0 C--N 1.314 -0.941 0 O-C-N 123.956 0.785 . . . . 0.0 111.578 -178.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' VAL . . . . . 0.698 HG11 ' O ' ' B' ' 20' ' ' ARG . 7.1 p -82.1 -24.0 9.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.218 0.532 . . . . 0.0 109.766 -174.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.844 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -71.77 -18.16 62.13 Favored 'General case' 0 C--O 1.206 -1.219 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 174.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . 0.424 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -87.59 -38.89 15.55 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.991 176.774 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.745 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 40.4 mmtt -65.09 -43.92 90.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.233 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' SER . . . . . 0.519 ' HB2' ' HB3' ' B' ' 3' ' ' PHE . 36.0 m -98.15 -8.31 27.79 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.116 0.484 . . . . 0.0 110.495 -171.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.844 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 87.4 mt -114.99 125.24 72.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.813 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.59 -4.46 57.82 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.259 0.552 . . . . 0.0 110.143 175.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.642 ' OD1' ' HB2' ' B' ' 33' ' ' LYS . 12.3 t70 -102.79 115.67 31.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.445 -177.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 0.471 ' O ' ' HG2' ' B' ' 36' ' ' LYS . 12.4 pt-20 -61.79 -24.49 66.88 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.857 177.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.642 ' HB2' ' OD1' ' B' ' 31' ' ' ASP . 4.5 mptt -75.1 -52.34 11.26 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -177.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.25 -26.94 68.32 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.848 176.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.822 ' O ' HG11 ' B' ' 39' ' ' VAL . 4.0 tmm_? -62.68 -65.09 0.74 Allowed 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.552 ' O ' HG23 ' B' ' 39' ' ' VAL . 7.8 ptmm? -53.17 -58.33 7.42 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.308 0.575 . . . . 0.0 112.318 -178.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.768 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 5.6 m -56.83 -30.28 32.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.863 -171.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.489 HD12 ' HG ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -85.02 -31.49 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 119.891 -0.723 . . . . 0.0 111.438 178.795 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.822 HG11 ' O ' ' B' ' 35' ' ' ARG . 2.4 m -68.33 -47.93 75.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.931 175.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.615 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 42.6 mt-10 -67.94 -22.92 65.03 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.392 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.768 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -85.42 -55.3 4.08 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.127 175.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' MET . . . . . 0.546 ' HG3' ' ND2' ' B' ' 4' ' ' ASN . 17.9 mmt -63.7 -20.46 65.74 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.585 0.707 . . . . 0.0 109.844 -176.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.63 ' HB1' ' CD1' ' B' ' 69' ' ' ILE . . . -47.74 -30.27 3.76 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.744 171.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' TYR . . . . . 0.533 ' CG ' ' HB2' ' B' ' 52' ' ' GLN . 7.8 t80 -105.66 -66.92 0.95 Allowed 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 176.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.626 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 3.8 mm-40 -47.0 -34.11 5.31 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 124.504 1.128 . . . . 0.0 111.997 -173.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.674 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 5.2 m-20 -102.53 -20.83 14.34 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.256 -174.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.609 ' HB1' ' O ' ' B' ' 43' ' ' ALA . . . -60.54 -179.28 0.11 Allowed 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 122.058 0.932 . . . . 0.0 113.035 -173.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' ASN . . . . . 0.606 ' HB3' ' OE1' ' B' ' 50' ' ' GLU . 14.6 m-20 -61.62 141.77 94.69 Favored Pre-proline 0 N--CA 1.442 -0.847 0 CA-C-N 114.366 -1.288 . . . . 0.0 109.144 174.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -55.33 -22.46 33.51 Favored 'Trans proline' 0 C--O 1.218 -0.512 0 C-N-CA 123.408 2.739 . . . . 0.0 112.757 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . 0.722 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 12.5 pm0 -89.45 -31.24 17.8 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 123.576 0.75 . . . . 0.0 110.648 175.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.722 ' N ' ' HG2' ' B' ' 50' ' ' GLU . 91.7 m -82.82 -37.5 24.36 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.503 -170.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . 0.533 ' HB2' ' CG ' ' B' ' 44' ' ' TYR . 3.7 pt20 -70.3 -29.74 66.55 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 172.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' SER . . . . . 0.429 ' O ' ' HE2' ' B' ' 56' ' ' LYS . 11.3 m -71.24 -19.76 62.33 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 113.749 -1.568 . . . . 0.0 110.248 174.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' B' ' 51' ' ' CYS . . . -78.62 -25.37 45.11 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.484 -0.76 . . . . 0.0 109.756 167.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.599 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 22.6 mt -89.81 -32.63 5.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -171.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . 0.586 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -39.74 -38.29 0.9 Allowed Pre-proline 0 N--CA 1.491 1.609 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -174.423 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.599 ' HD2' ' C ' ' B' ' 55' ' ' ILE . 51.6 Cg_endo -63.51 -29.74 71.01 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.169 1.913 . . . . 0.0 112.704 175.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . 0.531 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.5 mt -98.65 -15.81 19.28 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . 0.642 ' HD3' ' CG2' ' A' ' 5' ' ' THR . 0.1 OUTLIER -51.01 109.57 0.34 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.244 -178.257 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . 0.404 ' HA3' ' C ' ' A' ' 1' ' ' PRO . . . 90.47 -21.13 33.84 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.971 -178.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -103.12 113.19 26.46 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.191 0.52 . . . . 0.0 109.893 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.419 ' HB ' HG13 ' B' ' 68' ' ' VAL . 7.3 p -123.71 149.11 58.22 Favored Pre-proline 0 C--N 1.308 -1.208 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.564 172.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo . . . . . 0 N--CA 1.46 -0.472 0 C-N-CA 122.066 1.844 . . . . 0.0 110.774 164.546 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' ASP . . . . . 0.593 ' OD2' ' HB3' ' B' ' 70' ' ' SER . 0.4 OUTLIER . . . . . 0 N--CA 1.441 -0.917 0 N-CA-C 111.216 0.08 . . . . 0.0 111.216 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . 0.532 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.9 OUTLIER -81.76 -33.04 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.505 0 C-N-CA 118.612 -1.235 . . . . 0.0 108.641 173.818 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . 0.78 ' O ' HG11 ' B' ' 73' ' ' VAL . 10.9 mm -56.12 -50.04 72.53 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.366 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.528 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' SER . . . . . 0.593 ' HB3' ' OD2' ' B' ' 67' ' ' ASP . 32.6 t -54.79 -28.82 51.89 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.124 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -85.79 -33.3 21.42 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.455 0.645 . . . . 0.0 110.134 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' TYR . . . . . 0.615 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.1 m-30 -75.46 -35.1 60.96 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.48 -177.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . 0.78 HG11 ' O ' ' B' ' 69' ' ' ILE . 1.4 m -70.81 -32.0 47.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 172.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' LYS . . . . . 0.546 ' O ' ' HB3' ' B' ' 77' ' ' ASP . 0.0 OUTLIER -67.75 -30.98 70.59 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.34 175.223 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -63.1 -46.74 85.9 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.975 176.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.613 ' SG ' ' HB2' ' B' ' 14' ' ' TYR . 28.0 t -92.39 9.61 33.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.075 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . 0.546 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 3.1 t70 . . . . . 0 C--N 1.32 -0.69 0 CA-C-O 121.072 0.463 . . . . 0.0 110.8 174.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.406 ' HB2' ' H ' ' A' ' 2' ' ' SER . 71.9 Cg_endo . . . . . 0 CA--C 1.517 -0.365 0 N-CA-C 109.219 -1.108 . . . . 0.0 109.219 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.449 ' HB2' HG21 ' A' ' 5' ' ' THR . 42.6 m -69.79 169.37 13.13 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 161.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.497 ' HE1' ' CD1' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -65.55 -53.29 44.14 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 122.391 1.091 . . . . 0.0 109.633 175.496 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.511 ' CG ' ' HG3' ' A' ' 42' ' ' MET . 3.2 p-10 -87.57 4.74 42.49 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 113.418 -1.719 . . . . 0.0 113.569 -161.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.672 ' CG2' ' HD3' ' B' ' 59' ' ' LYS . 0.9 OUTLIER -62.63 0.6 0.48 Allowed 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.066 0.46 . . . . 0.0 112.134 -175.322 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.555 ' HB ' ' CZ ' ' A' ' 20' ' ' ARG . 3.0 m -72.05 115.33 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 CA-C-O 121.908 0.861 . . . . 0.0 109.317 168.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.606 ' HG3' ' HB3' ' A' ' 46' ' ' ASN . 1.1 mpp_? -114.23 158.66 21.09 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 121.517 0.675 . . . . 0.0 110.989 177.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.428 ' HG2' ' HB3' ' A' ' 12' ' ' GLU . 2.2 tt0 -59.8 116.04 3.81 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.735 171.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.9 -156.75 26.28 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.378 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.464 ' C ' ' HD3' ' A' ' 11' ' ' LYS . 21.5 m -50.45 99.72 0.02 OUTLIER 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.774 0.287 . . . . 0.0 111.198 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.464 ' HD3' ' C ' ' A' ' 10' ' ' SER . 0.0 OUTLIER 35.66 48.89 0.49 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.583 1.153 . . . . 0.0 111.988 -171.629 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.428 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 36.4 tt0 -62.4 136.86 95.96 Favored Pre-proline 0 C--O 1.233 0.227 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.576 178.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.532 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 38.9 Cg_exo -52.15 122.08 10.0 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.043 1.829 . . . . 0.0 109.735 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.842 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 27.4 t80 -72.7 -53.18 5.73 Favored Pre-proline 0 N--CA 1.437 -1.117 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -166.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.533 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 31.7 Cg_exo -55.07 -17.63 15.15 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 121.4 1.4 . . . . 0.0 110.692 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.532 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.0 OUTLIER -90.29 -44.11 9.92 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 113.98 -1.464 . . . . 0.0 111.089 178.178 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.424 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -53.71 -43.36 68.95 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 175.139 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.772 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 2.2 p -82.84 -35.47 12.39 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.325 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.867 -177.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . -58.58 -33.78 70.35 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 121.316 -0.865 . . . . 0.0 111.819 177.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.698 ' O ' HG12 ' A' ' 24' ' ' VAL . 16.3 ptt180 -83.7 -27.54 28.94 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 176.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.536 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 7.4 tp -55.87 -47.57 77.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.605 -1.18 . . . . 0.0 108.87 171.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.772 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 25.4 mt-30 -70.13 -46.85 63.93 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.179 176.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.719 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 16.8 t70 -47.12 -54.33 10.76 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 124.289 0.993 . . . . 0.0 111.692 -178.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.698 HG12 ' O ' ' A' ' 20' ' ' ARG . 6.8 p -82.0 -23.54 9.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.197 0.522 . . . . 0.0 109.94 -174.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.789 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -71.32 -18.99 62.37 Favored 'General case' 0 C--O 1.204 -1.295 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 173.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.4 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -87.23 -38.88 15.94 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.955 177.559 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.719 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.4 mmtt -67.02 -39.46 87.05 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.752 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.6 m -98.01 -10.52 24.27 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.027 0.441 . . . . 0.0 110.63 -172.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.789 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 79.5 mt -116.11 129.91 71.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.795 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.01 -5.83 49.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.526 0.679 . . . . 0.0 110.136 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.537 ' H ' HG22 ' A' ' 29' ' ' ILE . 2.3 m-20 -102.51 107.33 18.25 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.067 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -53.6 -29.24 36.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.775 0.322 . . . . 0.0 110.446 175.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.525 ' O ' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -68.36 -52.81 29.13 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.478 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.496 ' O ' ' HB ' ' A' ' 38' ' ' ILE . . . -66.76 -23.57 66.1 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.246 178.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.821 ' O ' HG11 ' A' ' 39' ' ' VAL . 2.1 tmm_? -68.77 -58.55 4.04 Favored 'General case' 0 C--O 1.219 -0.503 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -53.38 -60.54 3.16 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.803 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 21.0 m -52.31 -34.57 18.58 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.952 -171.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.518 ' CD1' ' HG ' ' B' ' 41' ' ' LEU . 0.0 OUTLIER -84.8 -33.85 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -177.218 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.821 HG11 ' O ' ' A' ' 35' ' ' ARG . 2.7 m -72.36 -47.4 52.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 119.65 -0.82 . . . . 0.0 108.999 177.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.554 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 65.8 mt-10 -60.28 -26.07 66.2 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.971 0.908 . . . . 0.0 111.457 172.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.803 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -81.8 -61.68 1.85 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 178.654 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.573 ' HE1' ' HG ' ' B' ' 41' ' ' LEU . 20.1 mmt -62.79 -20.56 65.13 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.484 -177.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.717 ' O ' ' HB3' ' A' ' 47' ' ' ALA . . . -49.29 -25.38 2.34 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.394 169.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.492 ' CD1' ' HB2' ' A' ' 52' ' ' GLN . 16.1 t80 -108.31 -66.44 1.04 Allowed 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 175.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.461 ' CG ' HD12 ' A' ' 41' ' ' LEU . 8.4 mm-40 -48.25 -32.47 7.28 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 123.799 0.687 . . . . 0.0 112.492 -175.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.606 ' HB3' ' HG3' ' A' ' 7' ' ' ARG . 4.9 m-20 -106.33 -11.5 15.97 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.534 0.683 . . . . 0.0 111.226 -176.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 43' ' ' ALA . . . -62.53 168.53 3.59 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.496 0.665 . . . . 0.0 110.768 177.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.567 ' HB3' ' OE1' ' A' ' 50' ' ' GLU . 8.9 m-20 -57.38 144.45 71.17 Favored Pre-proline 0 C--N 1.31 -1.144 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.482 175.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.46 -19.29 28.48 Favored 'Trans proline' 0 C--O 1.219 -0.434 0 C-N-CA 122.92 2.413 . . . . 0.0 112.055 -179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.711 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 10.1 pm0 -90.87 -32.34 16.08 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.214 0.606 . . . . 0.0 110.531 174.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.91 ' SG ' ' HB2' ' A' ' 76' ' ' CYS . 37.3 t -85.1 -37.28 20.45 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.873 -171.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.494 ' HA ' HD13 ' A' ' 55' ' ' ILE . 3.5 pt20 -67.18 -26.72 66.78 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 172.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.58 ' O ' ' HD2' ' A' ' 56' ' ' LYS . 9.3 m -72.47 -22.55 61.06 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 113.141 -1.845 . . . . 0.0 110.916 174.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 51' ' ' CYS . . . -78.37 -23.75 46.74 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.411 0.624 . . . . 0.0 109.527 168.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.525 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 24.7 mt -91.24 -33.22 5.6 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.151 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -172.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.605 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.57 -39.87 2.71 Favored Pre-proline 0 N--CA 1.493 1.688 0 CA-C-N 119.909 1.232 . . . . 0.0 113.757 -175.389 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 51.2 Cg_endo -62.6 -25.32 75.41 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 122.328 2.018 . . . . 0.0 113.045 175.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.498 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.1 mt -104.02 -15.86 15.47 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.65 ' HD3' ' CG2' ' B' ' 5' ' ' THR . 0.1 OUTLIER -50.47 109.09 0.27 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.192 -179.099 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.69 -19.01 43.43 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.31 -178.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.0 mmmt -103.7 114.65 29.07 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.162 0.506 . . . . 0.0 110.167 -178.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.41 ' HB ' HG11 ' A' ' 68' ' ' VAL . 7.6 p -123.38 143.97 42.69 Favored Pre-proline 0 C--N 1.312 -1.03 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.113 173.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo . . . . . 0 C--N 1.343 0.269 0 C-N-CA 122.538 2.158 . . . . 0.0 111.669 168.342 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.403 ' OD1' ' HB ' ' A' ' 69' ' ' ILE . 0.8 OUTLIER . . . . . 0 CA--C 1.517 -0.294 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.532 HG21 ' HB3' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -78.63 -28.51 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 C-N-CA 118.934 -1.106 . . . . 0.0 108.622 178.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.753 ' O ' HG13 ' A' ' 73' ' ' VAL . 6.8 mm -60.4 -45.95 95.9 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.133 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.277 -178.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 41.7 t -48.24 -36.18 13.44 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.143 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.428 ' O ' ' HB3' ' A' ' 74' ' ' LYS . 2.0 mm-40 -86.27 -31.53 21.59 Favored 'General case' 0 C--O 1.216 -0.672 0 C-N-CA 123.31 0.644 . . . . 0.0 111.074 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.508 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.0 m-30 -76.27 -33.79 59.14 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.626 0.727 . . . . 0.0 109.285 -177.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.842 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 2.1 m -73.01 -32.63 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 173.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 70' ' ' SER . 1.8 ttmm -66.45 -30.71 71.12 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.13 -1.395 . . . . 0.0 110.0 175.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' A' ' 72' ' ' TYR . . . -62.52 -45.44 92.95 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.784 175.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.91 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 42.2 t -93.34 9.17 37.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.044 177.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 21.8 t70 . . . . . 0 C--N 1.321 -0.671 0 CA-C-O 121.442 0.639 . . . . 0.0 109.699 173.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 1' ' ' PRO . . . . . 0.422 ' HB2' ' H ' ' B' ' 2' ' ' SER . 72.0 Cg_endo . . . . . 0 CA--C 1.515 -0.43 0 N-CA-C 109.148 -1.135 . . . . 0.0 109.148 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 2' ' ' SER . . . . . 0.447 ' HB2' HG21 ' B' ' 5' ' ' THR . 43.0 m -69.79 169.71 12.47 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 161.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.504 ' HE1' ' CD1' ' B' ' 38' ' ' ILE . 0.0 OUTLIER -65.65 -53.11 45.88 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 122.351 1.072 . . . . 0.0 109.683 175.316 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . 0.518 ' CG ' ' HG3' ' B' ' 42' ' ' MET . 3.2 p-10 -87.75 4.9 42.49 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.51 -1.677 . . . . 0.0 113.58 -161.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' THR . . . . . 0.65 ' CG2' ' HD3' ' A' ' 59' ' ' LYS . 0.9 OUTLIER -62.9 0.71 0.5 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.123 0.487 . . . . 0.0 112.036 -175.165 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.549 ' HB ' ' CZ ' ' B' ' 20' ' ' ARG . 3.0 m -72.18 115.06 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 CA-C-O 121.904 0.859 . . . . 0.0 109.284 168.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . 0.604 ' HG3' ' HB3' ' B' ' 46' ' ' ASN . 1.1 mpp_? -114.0 158.52 21.06 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 121.593 0.711 . . . . 0.0 110.949 177.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' GLN . . . . . 0.429 ' N ' ' CD2' ' B' ' 17' ' ' PHE . 2.2 tt0 -59.64 116.1 3.79 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.702 171.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.99 -156.95 26.88 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.483 174.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' SER . . . . . 0.479 ' C ' ' HD3' ' B' ' 11' ' ' LYS . 23.4 m -50.29 100.05 0.02 OUTLIER 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.71 0.255 . . . . 0.0 111.086 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.479 ' HD3' ' C ' ' B' ' 10' ' ' SER . 0.0 OUTLIER 35.17 49.57 0.45 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.545 1.138 . . . . 0.0 111.865 -171.59 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.427 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 36.1 tt0 -62.78 136.87 96.55 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.555 177.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . 0.531 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 37.8 Cg_exo -52.09 121.99 9.8 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 121.991 1.794 . . . . 0.0 109.703 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' TYR . . . . . 0.845 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 27.4 t80 -72.64 -53.32 5.75 Favored Pre-proline 0 N--CA 1.437 -1.105 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -166.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.541 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 31.8 Cg_exo -54.97 -17.84 15.23 Favored 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 121.382 1.388 . . . . 0.0 110.573 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.531 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 0.9 OUTLIER -90.2 -43.74 10.22 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.111 -1.404 . . . . 0.0 111.196 178.146 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' PHE . . . . . 0.429 ' CD2' ' N ' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -53.93 -43.41 69.76 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 175.069 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.772 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 2.2 p -82.68 -35.61 12.68 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.378 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.761 -177.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' B' ' 15' ' ' PRO . . . -58.46 -33.76 70.1 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 121.308 -0.87 . . . . 0.0 111.871 177.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.684 ' O ' HG12 ' B' ' 24' ' ' VAL . 16.4 ptt180 -83.73 -27.52 28.9 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 176.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.549 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 7.4 tp -56.0 -47.24 78.13 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.882 171.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' GLN . . . . . 0.772 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 25.6 mt-30 -70.49 -46.87 62.91 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.163 176.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.733 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 17.2 t70 -47.09 -54.29 10.77 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 124.304 1.002 . . . . 0.0 111.761 -178.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' VAL . . . . . 0.684 HG12 ' O ' ' B' ' 20' ' ' ARG . 6.8 p -82.1 -23.3 9.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.157 0.503 . . . . 0.0 109.869 -174.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.786 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -71.44 -18.91 62.3 Favored 'General case' 0 C--O 1.205 -1.284 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.18 -39.03 15.85 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.015 177.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.733 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.3 mmtt -66.85 -39.44 87.58 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.736 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 58.3 m -98.02 -10.48 24.33 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.106 0.479 . . . . 0.0 110.517 -172.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.786 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 79.5 mt -116.24 130.49 70.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.775 -178.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.95 -5.08 48.56 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.637 0.732 . . . . 0.0 110.014 176.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.539 ' H ' HG22 ' B' ' 29' ' ' ILE . 2.4 m-20 -102.64 106.95 17.71 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.253 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -53.42 -29.1 33.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.68 0.276 . . . . 0.0 110.449 175.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.536 ' O ' HG12 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -68.39 -52.81 28.91 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.447 -179.569 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.501 ' O ' ' HB ' ' B' ' 38' ' ' ILE . . . -66.77 -23.59 66.1 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.248 178.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.852 ' O ' HG11 ' B' ' 39' ' ' VAL . 2.1 tmm_? -68.78 -58.42 4.22 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 29.7 mtpt -53.55 -60.39 3.37 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.879 177.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.812 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 20.9 m -52.42 -34.38 18.72 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 O-C-N 124.324 1.015 . . . . 0.0 110.978 -171.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.543 ' CD1' ' HG ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -84.78 -34.08 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -177.309 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.852 HG11 ' O ' ' B' ' 35' ' ' ARG . 2.7 m -72.2 -47.5 53.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.012 177.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.555 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 66.2 mt-10 -60.33 -25.9 66.15 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.907 0.883 . . . . 0.0 111.472 172.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.812 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -82.03 -61.59 1.87 Allowed 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.992 178.734 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' MET . . . . . 0.536 ' HE1' ' HG ' ' A' ' 41' ' ' LEU . 20.1 mmt -62.83 -20.56 65.18 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.482 -177.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.7 ' O ' ' HB3' ' B' ' 47' ' ' ALA . . . -49.31 -25.4 2.38 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.406 169.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' TYR . . . . . 0.497 ' CD1' ' HB2' ' B' ' 52' ' ' GLN . 16.1 t80 -108.22 -66.44 1.04 Allowed 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 175.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.446 ' CG ' HD12 ' B' ' 41' ' ' LEU . 8.6 mm-40 -48.26 -32.83 7.78 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 123.856 0.723 . . . . 0.0 112.381 -175.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.604 ' HB3' ' HG3' ' B' ' 7' ' ' ARG . 4.9 m-20 -105.93 -11.46 16.18 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.472 0.653 . . . . 0.0 111.284 -176.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.7 ' HB3' ' O ' ' B' ' 43' ' ' ALA . . . -62.57 168.6 3.56 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.391 0.615 . . . . 0.0 110.779 177.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' ASN . . . . . 0.548 ' HB3' ' OE1' ' B' ' 50' ' ' GLU . 8.5 m-20 -57.39 144.47 71.17 Favored Pre-proline 0 C--N 1.31 -1.139 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.466 175.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -56.62 -19.2 29.06 Favored 'Trans proline' 0 C--O 1.218 -0.48 0 C-N-CA 122.963 2.442 . . . . 0.0 112.029 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . 0.704 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 10.1 pm0 -90.83 -32.29 16.13 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 123.205 0.602 . . . . 0.0 110.644 174.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.915 ' SG ' ' HB2' ' B' ' 76' ' ' CYS . 37.5 t -85.16 -37.4 20.23 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.885 -171.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . 0.497 ' HB2' ' CD1' ' B' ' 44' ' ' TYR . 3.5 pt20 -66.95 -26.71 66.97 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 172.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' SER . . . . . 0.591 ' O ' ' HD2' ' B' ' 56' ' ' LYS . 8.9 m -72.61 -22.53 60.95 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 113.247 -1.797 . . . . 0.0 110.902 174.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.22 -23.81 47.31 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.493 0.663 . . . . 0.0 109.586 168.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.522 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 25.0 mt -91.09 -33.37 5.73 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.137 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -172.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . 0.608 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.5 -39.76 2.56 Favored Pre-proline 0 N--CA 1.492 1.649 0 CA-C-N 119.925 1.239 . . . . 0.0 113.749 -175.34 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 51.0 Cg_endo -62.71 -25.32 74.98 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.245 1.964 . . . . 0.0 113.002 175.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . 0.513 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.2 mt -104.02 -15.81 15.49 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . 0.672 ' HD3' ' CG2' ' A' ' 5' ' ' THR . 0.1 OUTLIER -50.46 109.12 0.27 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.702 -1.135 . . . . 0.0 111.281 -179.207 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . 0.405 ' HA3' ' C ' ' A' ' 1' ' ' PRO . . . 89.99 -19.7 40.58 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.276 -178.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -103.21 114.81 29.4 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.099 0.476 . . . . 0.0 110.027 -178.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.417 ' HB ' HG11 ' B' ' 68' ' ' VAL . 7.8 p -123.25 144.35 43.43 Favored Pre-proline 0 C--N 1.31 -1.125 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.94 172.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo . . . . . 0 C--N 1.345 0.371 0 C-N-CA 122.521 2.148 . . . . 0.0 111.667 168.217 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' ASP . . . . . 0.43 ' OD1' ' HB ' ' B' ' 69' ' ' ILE . 0.8 OUTLIER . . . . . 0 CA--C 1.517 -0.321 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . 0.517 HG23 ' HG2' ' B' ' 40' ' ' GLU . 0.8 OUTLIER -78.48 -28.28 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 C-N-CA 119.006 -1.078 . . . . 0.0 108.568 179.08 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . 0.757 ' O ' HG13 ' B' ' 73' ' ' VAL . 6.8 mm -60.44 -45.81 96.2 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.084 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.391 -178.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 70' ' ' SER . . . . . 0.489 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 43.2 t -48.54 -36.16 14.82 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.077 176.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' B' ' 74' ' ' LYS . 2.3 mm-40 -86.28 -31.38 21.65 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 123.211 0.604 . . . . 0.0 110.998 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 72' ' ' TYR . . . . . 0.513 ' CE1' ' HB2' ' B' ' 58' ' ' LEU . 5.0 m-30 -76.23 -34.13 59.21 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.654 0.74 . . . . 0.0 109.298 -177.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . 0.845 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 2.1 m -72.67 -33.1 43.47 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 173.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' B' ' 70' ' ' SER . 1.8 ttmm -65.87 -30.89 71.57 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.052 175.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' B' ' 72' ' ' TYR . . . -62.36 -45.52 92.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.754 175.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.915 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 41.9 t -93.5 9.14 37.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.089 177.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . 0.465 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 19.9 t70 . . . . . 0 C--N 1.322 -0.622 0 CA-C-O 121.388 0.613 . . . . 0.0 109.515 174.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo . . . . . 0 CA--C 1.517 -0.326 0 N-CA-C 109.005 -1.19 . . . . 0.0 109.005 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.479 ' HB2' HG21 ' A' ' 5' ' ' THR . 70.7 m -72.13 178.9 3.56 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 162.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.471 ' CE1' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -76.13 -52.45 10.09 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.8 0.809 . . . . 0.0 110.125 174.445 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.506 ' OD1' ' HG ' ' B' ' 41' ' ' LEU . 2.5 p-10 -87.61 2.93 49.57 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.403 -163.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.561 ' O ' ' HG3' ' A' ' 7' ' ' ARG . 3.1 p -63.51 -3.12 1.9 Allowed 'General case' 0 C--N 1.311 -1.078 0 O-C-N 122.059 -0.4 . . . . 0.0 111.832 -175.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.541 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 3.3 m -76.49 119.03 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-O 121.677 0.751 . . . . 0.0 109.924 176.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.76 ' HB3' ' O ' ' A' ' 46' ' ' ASN . 32.2 mtm180 -137.58 147.2 44.87 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -170.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.586 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.6 mt-30 -42.02 120.66 1.62 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 112.633 -2.076 . . . . 0.0 113.745 177.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.53 -159.04 35.01 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 169.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.8 t -48.44 101.46 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 117.086 0.443 . . . . 0.0 111.231 -178.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.4 pttt 37.71 42.1 0.37 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.251 1.02 . . . . 0.0 112.084 -173.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.448 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 39.5 tt0 -57.16 137.5 80.54 Favored Pre-proline 0 C--O 1.233 0.226 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.575 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 52.1 Cg_exo -49.31 121.22 6.66 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.056 1.837 . . . . 0.0 109.947 -178.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.789 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 11.3 t80 -71.89 -52.85 7.44 Favored Pre-proline 0 N--CA 1.438 -1.047 0 CA-C-O 118.512 -0.756 . . . . 0.0 113.028 -166.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.536 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 36.4 Cg_exo -55.79 -18.39 21.27 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 121.346 1.364 . . . . 0.0 110.728 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.575 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 0.9 OUTLIER -90.34 -42.35 10.99 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.317 179.66 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.586 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -54.82 -43.64 73.16 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 175.647 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.684 HG12 ' O ' ' A' ' 14' ' ' TYR . 2.7 p -82.78 -32.35 9.89 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.941 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.845 -177.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.446 ' HB1' ' O ' ' A' ' 15' ' ' PRO . . . -58.99 -35.46 73.25 Favored 'General case' 0 C--N 1.317 -0.84 0 O-C-N 121.285 -0.885 . . . . 0.0 111.839 175.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.7 ' O ' HG13 ' A' ' 24' ' ' VAL . 16.7 ptt180 -81.9 -27.26 33.51 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 176.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.557 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 6.7 tp -57.1 -48.14 79.33 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.215 172.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.66 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 40.7 mt-30 -70.91 -44.66 65.77 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.191 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.717 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -48.89 -64.06 0.91 Allowed 'General case' 0 C--N 1.314 -0.961 0 O-C-N 124.426 1.079 . . . . 0.0 110.206 -178.622 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.7 HG13 ' O ' ' A' ' 20' ' ' ARG . 4.2 p -74.0 -20.34 17.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -171.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.614 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -64.33 -35.82 82.11 Favored 'General case' 0 C--O 1.206 -1.195 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 172.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.429 ' HB3' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -75.1 -34.99 61.79 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 113.631 -1.622 . . . . 0.0 109.896 -176.641 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.717 ' HD2' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -65.04 -44.81 87.87 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 121.972 0.891 . . . . 0.0 112.0 177.09 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.416 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 24.7 m -95.97 -9.17 31.8 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.515 -168.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.614 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 84.8 mt -116.91 128.27 74.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.919 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.11 -2.2 56.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.42 0.628 . . . . 0.0 110.141 175.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.526 ' H ' HG22 ' A' ' 29' ' ' ILE . 2.7 m-20 -106.92 104.16 13.77 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.105 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -53.36 -27.59 24.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.664 0.268 . . . . 0.0 110.466 176.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.543 ' O ' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -67.93 -54.38 19.14 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.675 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.503 ' HA ' HG23 ' A' ' 37' ' ' VAL . . . -65.28 -22.7 66.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.44 178.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.856 ' O ' HG11 ' A' ' 39' ' ' VAL . 5.3 tmm_? -69.82 -55.81 8.79 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.453 ' O ' HG23 ' A' ' 39' ' ' VAL . 21.7 mtpt -56.97 -57.55 12.03 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.98 177.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.72 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 19.8 m -54.48 -34.2 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.736 -169.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.491 ' O ' ' HG2' ' A' ' 42' ' ' MET . 1.5 tt -86.97 -28.84 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 119.649 -0.821 . . . . 0.0 111.568 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.856 HG11 ' O ' ' A' ' 35' ' ' ARG . 2.7 m -69.61 -49.07 61.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 119.031 -1.067 . . . . 0.0 109.508 173.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.621 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 60.4 mt-10 -61.81 -28.34 69.4 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 123.556 0.742 . . . . 0.0 112.233 176.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.72 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -85.58 -52.55 5.74 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.72 178.574 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.606 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 19.6 mmt -65.57 -20.72 66.44 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.667 0.746 . . . . 0.0 109.602 -177.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.665 ' O ' ' HB1' ' A' ' 47' ' ' ALA . . . -50.46 -28.11 7.74 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.463 170.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.515 ' CD1' ' HB2' ' A' ' 52' ' ' GLN . 23.1 t80 -105.15 -68.4 0.86 Allowed 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 175.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.462 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 10.9 mm-40 -48.88 -29.82 5.12 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.829 -176.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.76 ' O ' ' HB3' ' A' ' 7' ' ' ARG . 4.2 m-20 -106.53 -16.12 14.61 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 120.718 0.295 . . . . 0.0 111.659 -176.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.665 ' HB1' ' O ' ' A' ' 43' ' ' ALA . . . -65.45 179.25 0.81 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.588 0.708 . . . . 0.0 111.539 -177.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.732 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 24.2 m-20 -58.63 145.67 76.47 Favored Pre-proline 0 C--N 1.31 -1.148 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.21 171.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.781 ' O ' ' HB3' ' A' ' 53' ' ' SER . 11.1 Cg_endo -55.53 -28.96 67.29 Favored 'Trans proline' 0 C--N 1.331 -0.345 0 C-N-CA 122.987 2.458 . . . . 0.0 111.897 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.687 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 8.4 pm0 -87.4 -26.57 23.24 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.398 1.079 . . . . 0.0 111.066 175.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.732 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 86.8 m -80.21 -38.24 31.56 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -177.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.515 ' HB2' ' CD1' ' A' ' 44' ' ' TYR . 4.1 pt20 -73.17 -27.35 61.6 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 172.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.781 ' HB3' ' O ' ' A' ' 49' ' ' PRO . 0.9 OUTLIER -67.91 -23.73 65.13 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.437 174.33 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -83.83 -23.47 31.36 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.862 172.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.526 HD13 ' CE2' ' A' ' 14' ' ' TYR . 22.7 mt -90.83 -32.56 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -173.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.659 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -45.92 -34.11 2.67 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -175.06 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 37.4 Cg_endo -60.61 -29.89 89.4 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.323 2.015 . . . . 0.0 112.946 172.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.523 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.1 mt -102.05 -15.34 16.79 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -178.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.581 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -52.84 109.83 0.45 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.899 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.09 -23.81 31.59 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.407 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.0 mmmt -103.38 111.94 24.6 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.373 0.606 . . . . 0.0 109.914 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.81 146.22 49.97 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 170.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo . . . . . 0 C--N 1.344 0.314 0 C-N-CA 122.194 1.929 . . . . 0.0 111.245 168.299 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.709 ' OD1' ' HB ' ' A' ' 69' ' ' ILE . 26.7 t70 . . . . . 0 CA--C 1.518 -0.281 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.549 HG21 ' HG2' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -81.44 -30.09 10.87 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 C-N-CA 119.035 -1.066 . . . . 0.0 109.089 176.447 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.757 ' O ' HG13 ' A' ' 73' ' ' VAL . 8.5 mm -58.09 -47.37 87.13 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.168 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.825 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 43.6 t -45.58 -37.54 5.62 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.394 175.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -85.36 -32.83 22.21 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.262 0.553 . . . . 0.0 110.629 -178.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.591 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.0 m-30 -76.06 -34.42 59.6 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.488 -175.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.789 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.6 m -72.57 -31.87 39.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.526 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -66.25 -31.65 72.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.075 175.46 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 72' ' ' TYR . . . -62.93 -47.53 82.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.447 176.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.619 ' SG ' ' HB2' ' A' ' 14' ' ' TYR . 14.4 t -91.07 5.43 48.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.469 0.652 . . . . 0.0 111.059 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.526 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 9.6 t70 . . . . . 0 C--N 1.319 -0.751 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.318 175.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 1' ' ' PRO . . . . . 0.434 ' HB2' ' H ' ' B' ' 2' ' ' SER . 90.1 Cg_endo . . . . . 0 CA--C 1.515 -0.426 0 N-CA-C 108.937 -1.217 . . . . 0.0 108.937 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 2' ' ' SER . . . . . 0.491 ' HB2' HG21 ' B' ' 5' ' ' THR . 71.2 m -71.52 178.72 3.34 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 162.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.479 ' CE1' HD11 ' B' ' 29' ' ' ILE . 0.1 OUTLIER -76.13 -52.43 10.12 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.857 0.837 . . . . 0.0 110.079 174.444 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . 0.486 ' ND2' ' HE1' ' B' ' 42' ' ' MET . 2.5 p-10 -87.42 2.64 49.89 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.646 -1.161 . . . . 0.0 113.364 -163.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' THR . . . . . 0.563 ' O ' ' HG3' ' B' ' 7' ' ' ARG . 3.6 p -63.31 -3.06 1.69 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 118.057 0.389 . . . . 0.0 111.779 -175.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.549 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 3.3 m -76.48 118.96 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-O 121.678 0.751 . . . . 0.0 110.008 176.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . 0.752 ' HB3' ' O ' ' B' ' 46' ' ' ASN . 32.1 mtm180 -137.32 147.58 45.71 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -170.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' GLN . . . . . 0.588 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.6 mt-30 -42.62 121.1 1.89 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 112.616 -2.084 . . . . 0.0 113.494 177.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.67 -158.39 34.29 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 169.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 22.9 t -49.24 101.58 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 117.115 0.457 . . . . 0.0 110.988 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 49.1 pttt 37.56 42.3 0.35 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.419 1.088 . . . . 0.0 112.109 -173.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.466 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 38.1 tt0 -57.2 137.36 80.75 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . 0.568 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 52.1 Cg_exo -49.07 121.09 6.27 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.134 1.889 . . . . 0.0 109.992 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' TYR . . . . . 0.792 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 11.3 t80 -72.09 -52.66 7.24 Favored Pre-proline 0 N--CA 1.437 -1.1 0 CA-C-O 118.507 -0.758 . . . . 0.0 112.891 -166.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.543 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 36.0 Cg_exo -55.9 -18.37 21.79 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 121.42 1.413 . . . . 0.0 110.764 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.568 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 0.9 OUTLIER -90.61 -41.84 11.11 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.035 -1.439 . . . . 0.0 111.367 179.708 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' PHE . . . . . 0.588 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -55.34 -43.52 75.08 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 175.581 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.692 HG12 ' O ' ' B' ' 14' ' ' TYR . 2.7 p -82.89 -32.27 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.907 -177.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . 0.429 ' HB1' ' O ' ' B' ' 15' ' ' PRO . . . -59.42 -34.75 72.87 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 121.303 -0.873 . . . . 0.0 111.861 175.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.695 ' O ' HG13 ' B' ' 24' ' ' VAL . 16.7 ptt180 -82.09 -27.43 32.89 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 176.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.567 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 6.7 tp -57.03 -48.38 78.65 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.208 173.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' GLN . . . . . 0.667 ' HA ' ' CG1' ' B' ' 39' ' ' VAL . 40.7 mt-30 -70.79 -44.68 66.13 Favored 'General case' 0 CA--C 1.488 -1.435 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.089 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.705 ' O ' ' HD2' ' B' ' 27' ' ' LYS . 0.9 OUTLIER -48.8 -64.19 0.87 Allowed 'General case' 0 C--N 1.314 -0.943 0 O-C-N 124.39 1.056 . . . . 0.0 110.325 -178.7 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' VAL . . . . . 0.695 HG13 ' O ' ' B' ' 20' ' ' ARG . 4.1 p -73.82 -20.42 17.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -171.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.594 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -64.15 -36.0 82.62 Favored 'General case' 0 C--O 1.208 -1.12 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 172.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . 0.438 ' HB3' ' O ' ' B' ' 23' ' ' ASP . 0.0 OUTLIER -74.9 -35.18 62.25 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 113.62 -1.627 . . . . 0.0 109.903 -176.608 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.705 ' HD2' ' O ' ' B' ' 23' ' ' ASP . 0.0 OUTLIER -64.85 -45.03 87.81 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.898 177.177 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' SER . . . . . 0.407 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 26.4 m -96.15 -8.68 32.55 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.602 -168.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.594 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 84.6 mt -116.94 128.68 74.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.837 -178.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.69 -1.87 56.51 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.499 0.666 . . . . 0.0 110.128 175.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.509 ' H ' HG22 ' B' ' 29' ' ' ILE . 2.8 m-20 -106.91 104.58 14.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.092 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -53.91 -27.36 30.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.715 0.293 . . . . 0.0 110.396 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.552 ' O ' HG12 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -67.93 -54.32 19.57 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.707 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.511 ' HA ' HG23 ' B' ' 37' ' ' VAL . . . -65.46 -22.71 66.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.385 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.843 ' O ' HG11 ' B' ' 39' ' ' VAL . 5.4 tmm_? -69.69 -55.89 8.72 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.44 ' O ' HG23 ' B' ' 39' ' ' VAL . 21.8 mtpt -56.98 -57.37 12.84 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 120.826 0.346 . . . . 0.0 110.936 177.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.704 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 20.0 m -54.71 -34.13 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.661 -169.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.489 ' O ' ' HG2' ' B' ' 42' ' ' MET . 1.4 tt -86.99 -29.11 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.51 -179.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.843 HG11 ' O ' ' B' ' 35' ' ' ARG . 2.7 m -69.31 -49.19 62.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 119.089 -1.045 . . . . 0.0 109.574 173.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.627 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 61.8 mt-10 -61.72 -28.26 69.29 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 123.506 0.722 . . . . 0.0 112.26 176.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.704 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.67 -52.55 5.72 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.713 178.685 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' MET . . . . . 0.603 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 19.5 mmt -65.6 -20.68 66.41 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.574 0.702 . . . . 0.0 109.491 -177.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.667 ' HB2' ' OH ' ' B' ' 14' ' ' TYR . . . -50.53 -28.17 8.03 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.415 170.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' TYR . . . . . 0.505 ' CD1' ' HB2' ' B' ' 52' ' ' GLN . 23.0 t80 -105.06 -68.38 0.86 Allowed 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.478 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 11.8 mm-40 -48.85 -29.8 5.06 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.925 -176.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.752 ' O ' ' HB3' ' B' ' 7' ' ' ARG . 4.1 m-20 -106.53 -16.06 14.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 120.702 0.287 . . . . 0.0 111.568 -176.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.652 ' HB1' ' O ' ' B' ' 43' ' ' ALA . . . -65.29 179.61 0.73 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.819 0.818 . . . . 0.0 111.602 -177.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' ASN . . . . . 0.725 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 24.7 m-20 -58.99 145.54 79.7 Favored Pre-proline 0 C--N 1.309 -1.169 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.242 171.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . 0.796 ' O ' ' HB3' ' B' ' 53' ' ' SER . 11.1 Cg_endo -55.57 -28.92 67.46 Favored 'Trans proline' 0 C--N 1.332 -0.325 0 C-N-CA 123.026 2.484 . . . . 0.0 111.917 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . 0.702 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 8.4 pm0 -87.26 -26.7 23.34 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.429 1.091 . . . . 0.0 111.133 175.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.725 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 86.2 m -80.18 -38.17 31.82 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -177.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . 0.505 ' HB2' ' CD1' ' B' ' 44' ' ' TYR . 4.0 pt20 -73.14 -27.36 61.63 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 172.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' SER . . . . . 0.796 ' HB3' ' O ' ' B' ' 49' ' ' PRO . 0.9 OUTLIER -68.12 -23.5 64.91 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.429 174.54 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.12 -23.31 30.77 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.863 172.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.522 HD13 ' CE2' ' B' ' 14' ' ' TYR . 22.6 mt -90.79 -32.73 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -174.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . 0.649 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -45.93 -34.06 2.64 Favored Pre-proline 0 N--CA 1.487 1.388 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 -175.02 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 37.3 Cg_endo -60.24 -30.95 92.32 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 122.303 2.002 . . . . 0.0 112.902 172.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . 0.53 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.1 mt -101.17 -15.59 17.31 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -178.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . 0.576 ' HA ' ' OH ' ' B' ' 72' ' ' TYR . 0.0 OUTLIER -52.64 109.8 0.44 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.948 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.16 -23.55 32.87 Favored Glycine 0 N--CA 1.44 -1.05 0 C-N-CA 120.768 -0.73 . . . . 0.0 111.575 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -103.59 111.91 24.59 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.411 0.624 . . . . 0.0 109.927 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 7.5 p -123.91 146.06 49.74 Favored Pre-proline 0 C--N 1.311 -1.104 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 170.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo . . . . . 0 N--CA 1.463 -0.308 0 C-N-CA 122.24 1.96 . . . . 0.0 111.248 168.491 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' ASP . . . . . 0.697 ' OD1' ' HB ' ' B' ' 69' ' ' ILE . 26.9 t70 . . . . . 0 CA--C 1.518 -0.252 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . 0.542 HG21 ' HG2' ' B' ' 40' ' ' GLU . 0.9 OUTLIER -81.3 -30.12 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 C-N-CA 118.891 -1.123 . . . . 0.0 109.119 176.508 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . 0.748 ' O ' HG13 ' B' ' 73' ' ' VAL . 8.5 mm -58.01 -47.31 87.02 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.179 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.814 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 70' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 42.7 t -45.84 -37.42 6.16 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.423 175.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -85.4 -32.7 22.23 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.085 0.469 . . . . 0.0 110.649 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 72' ' ' TYR . . . . . 0.586 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.0 m-30 -76.09 -34.49 59.53 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.502 -175.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . 0.792 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.6 m -72.55 -32.03 39.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 173.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 74' ' ' LYS . . . . . 0.515 ' O ' ' HB3' ' B' ' 77' ' ' ASP . 0.0 OUTLIER -66.17 -31.36 72.15 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.029 175.422 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' B' ' 72' ' ' TYR . . . -63.07 -47.77 81.5 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.362 176.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.633 ' SG ' ' HB2' ' B' ' 14' ' ' TYR . 13.7 t -90.89 5.7 47.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.573 0.701 . . . . 0.0 111.179 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . 0.515 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 10.9 t70 . . . . . 0 C--N 1.318 -0.778 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.382 175.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo . . . . . 0 CA--C 1.517 -0.357 0 N-CA-C 109.414 -1.033 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.0 m -66.61 169.0 8.34 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 162.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.467 ' HB2' ' HA ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -72.7 -55.58 6.59 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.847 177.509 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.704 ' CG ' ' HG3' ' A' ' 42' ' ' MET . 11.7 p30 -87.69 -4.75 58.91 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.442 -164.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.7 t -63.15 -1.43 1.0 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.43 0.633 . . . . 0.0 110.945 -173.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.639 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.4 m -74.26 133.55 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 168.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.722 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -155.55 159.8 39.99 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 115.219 1.562 . . . . 0.0 115.219 -175.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.436 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.1 tt0 -40.34 110.52 0.15 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 112.835 -1.984 . . . . 0.0 112.714 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.33 -151.5 11.13 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.558 174.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.4 t -54.38 98.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.757 0.278 . . . . 0.0 110.58 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.9 pttt 40.07 44.3 1.46 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.321 1.048 . . . . 0.0 112.527 -175.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -60.58 141.17 92.25 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 176.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.502 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 27.2 Cg_exo -55.37 123.36 13.62 Favored 'Trans proline' 0 CA--C 1.512 -0.615 0 C-N-CA 121.939 1.759 . . . . 0.0 109.694 177.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.874 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 7.2 t80 -68.98 -53.95 13.25 Favored Pre-proline 0 N--CA 1.44 -0.969 0 CA-C-O 118.421 -0.799 . . . . 0.0 113.025 -168.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.561 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 37.2 Cg_exo -56.01 -18.15 21.69 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 121.476 1.45 . . . . 0.0 111.197 -178.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.502 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 2.6 m-20 -89.97 -42.83 10.95 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.799 179.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.436 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -55.26 -45.78 76.1 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.332 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.771 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 2.1 p -78.05 -34.49 19.23 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.229 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.142 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' A' ' 15' ' ' PRO . . . -55.83 -39.36 71.29 Favored 'General case' 0 C--N 1.316 -0.887 0 O-C-N 121.663 -0.648 . . . . 0.0 111.078 176.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.751 ' O ' HG11 ' A' ' 24' ' ' VAL . 14.5 ptt180 -79.84 -27.74 40.17 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.575 ' HB3' ' O ' ' A' ' 18' ' ' VAL . 13.3 tp -54.98 -48.87 72.7 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 114.563 -1.198 . . . . 0.0 109.268 172.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.771 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 28.5 mt-30 -67.75 -55.66 12.24 Favored 'General case' 0 CA--C 1.486 -1.51 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.356 178.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.718 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 82.8 m-20 -45.71 -50.55 13.57 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 124.824 1.327 . . . . 0.0 111.258 -177.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.751 HG11 ' O ' ' A' ' 20' ' ' ARG . 7.1 p -78.89 -26.19 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.834 -174.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.627 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -67.3 -31.45 71.76 Favored 'General case' 0 C--O 1.206 -1.196 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.22 -34.82 63.8 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.114 -1.403 . . . . 0.0 109.525 -178.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.718 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 39.0 mmtt -67.45 -40.33 85.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.823 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.424 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 35.4 m -100.45 -9.9 21.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.241 0.543 . . . . 0.0 110.547 -171.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.627 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 83.4 mt -111.23 130.15 65.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.522 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.55 -3.07 58.48 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.906 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.543 ' H ' HG22 ' A' ' 29' ' ' ILE . 4.9 t0 -117.81 139.66 50.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.786 0.803 . . . . 0.0 111.918 -177.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -68.76 -31.39 70.4 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.334 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.559 ' O ' HG11 ' A' ' 37' ' ' VAL . 12.0 mttp -68.37 -53.37 24.41 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -176.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.472 ' HA ' HG23 ' A' ' 37' ' ' VAL . . . -64.22 -26.06 68.34 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.504 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.832 ' O ' HG12 ' A' ' 39' ' ' VAL . 4.7 tmm_? -68.15 -58.02 5.13 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.486 ' HB3' ' OE1' ' A' ' 40' ' ' GLU . 32.5 mtpt -53.45 -60.19 3.62 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.237 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.693 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 19.8 m -52.12 -33.9 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.374 -170.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.522 ' O ' ' HG2' ' A' ' 42' ' ' MET . 0.7 OUTLIER -88.35 -35.05 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.391 -179.782 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.832 HG12 ' O ' ' A' ' 35' ' ' ARG . 2.9 m -66.18 -46.8 86.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 119.117 -1.033 . . . . 0.0 109.414 177.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.661 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 42.7 mt-10 -61.17 -31.63 71.36 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 123.953 0.901 . . . . 0.0 112.544 176.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.693 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -83.78 -52.88 6.03 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.378 -179.152 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.704 ' HG3' ' CG ' ' A' ' 4' ' ' ASN . 20.1 mmt -65.71 -20.84 66.43 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.642 0.734 . . . . 0.0 109.632 -176.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.697 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . . . -50.47 -29.01 9.39 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.23 171.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.872 ' CG ' ' HE3' ' A' ' 59' ' ' LYS . 6.2 t80 -103.34 -66.7 0.92 Allowed 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 174.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.587 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 31.4 mm-40 -49.72 -29.76 8.11 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.992 -171.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.722 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.8 m-20 -104.37 -21.44 13.49 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.441 -176.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.6 ' HB3' ' O ' ' A' ' 43' ' ' ALA . . . -61.36 179.75 0.2 Allowed 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.827 0.822 . . . . 0.0 112.923 -174.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.612 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 17.2 m-20 -62.31 141.67 96.22 Favored Pre-proline 0 N--CA 1.444 -0.742 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.587 173.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -41.71 -50.48 4.88 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 123.093 2.529 . . . . 0.0 112.274 -178.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.55 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 0.0 OUTLIER -74.32 -26.54 60.23 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.769 0.828 . . . . 0.0 111.429 -179.268 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.612 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 72.1 m -79.89 -40.19 28.82 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -174.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.55 ' HB2' ' CG ' ' A' ' 44' ' ' TYR . 3.4 pt20 -69.42 -31.13 69.29 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 172.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.8 ' O ' ' HD2' ' A' ' 56' ' ' LYS . 4.2 m -67.71 -27.89 67.2 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 113.996 -1.456 . . . . 0.0 111.305 174.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 51' ' ' CYS . . . -70.96 -23.31 62.2 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 170.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.531 HD11 ' HA ' ' A' ' 52' ' ' GLN . 25.0 mt -89.82 -27.52 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -175.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.8 ' HD2' ' O ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -37.53 -48.53 2.52 Favored Pre-proline 0 N--CA 1.506 2.368 0 CA-C-N 120.628 1.558 . . . . 0.0 112.675 -178.39 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.664 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 48.5 Cg_endo -61.45 -24.89 79.06 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.826 2.351 . . . . 0.0 112.796 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.496 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.6 mt -104.86 -15.45 15.17 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.872 ' HE3' ' CG ' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -50.7 109.96 0.37 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.812 -179.072 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.28 -19.23 44.48 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.075 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.9 mmmt -104.2 115.03 29.69 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -176.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.86 137.11 27.54 Favored Pre-proline 0 C--N 1.315 -0.899 0 C-N-CA 121.168 -0.213 . . . . 0.0 110.48 172.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo . . . . . 0 C--N 1.344 0.321 0 C-N-CA 122.849 2.366 . . . . 0.0 112.227 171.608 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.408 ' OD2' ' HB ' ' A' ' 69' ' ' ILE . 2.6 t70 . . . . . 0 CA--C 1.512 -0.509 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.522 HG21 ' HG2' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -78.49 -29.18 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 C-N-CA 118.792 -1.163 . . . . 0.0 108.879 179.83 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.777 ' O ' HG12 ' A' ' 73' ' ' VAL . 8.5 mm -61.12 -47.01 95.51 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.184 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.09 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.6 t -47.24 -37.83 11.17 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.98 177.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -86.08 -32.62 21.28 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 123.287 0.635 . . . . 0.0 111.094 -177.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.6 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.3 m-30 -74.88 -35.83 62.28 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.314 -177.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.874 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 2.3 m -70.41 -34.11 56.61 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 174.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.437 ' HA ' ' HB2' ' A' ' 77' ' ' ASP . 13.0 ttpp -70.47 -27.86 64.56 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.788 177.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -62.18 -44.65 96.13 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.047 -0.978 . . . . 0.0 109.398 173.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.51 ' SG ' ' HB2' ' A' ' 14' ' ' TYR . 39.3 t -96.04 9.31 41.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.332 178.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.437 ' HB2' ' HA ' ' A' ' 74' ' ' LYS . 10.7 t70 . . . . . 0 C--N 1.324 -0.528 0 CA-C-O 121.057 0.456 . . . . 0.0 110.507 175.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 1' ' ' PRO . . . . . 0.426 ' HB2' ' H ' ' B' ' 2' ' ' SER . 96.3 Cg_endo . . . . . 0 CA--C 1.517 -0.366 0 N-CA-C 109.163 -1.13 . . . . 0.0 109.163 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 2' ' ' SER . . . . . 0.426 ' H ' ' HB2' ' B' ' 1' ' ' PRO . 41.7 m -66.91 168.79 9.21 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 162.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.474 ' HB2' ' HA ' ' B' ' 25' ' ' ALA . 0.1 OUTLIER -72.23 -55.72 6.74 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.812 177.632 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . 0.709 ' CG ' ' HG3' ' B' ' 42' ' ' MET . 11.7 p30 -87.81 -4.67 58.86 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.332 -164.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 7.0 t -63.3 -1.42 1.08 Allowed 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.314 0.578 . . . . 0.0 110.87 -173.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.646 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.5 m -74.38 133.54 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 169.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . 0.719 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -155.48 159.82 40.09 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 -175.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' GLN . . . . . 0.436 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.1 tt0 -40.27 110.38 0.15 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 112.921 -1.945 . . . . 0.0 112.786 -178.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.15 -151.5 10.76 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.631 174.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 22.7 t -54.27 99.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.837 0.319 . . . . 0.0 110.513 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 58.0 pttt 39.75 44.23 1.27 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.365 1.066 . . . . 0.0 112.485 -175.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -60.78 140.94 93.11 Favored Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . 0.509 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 27.5 Cg_exo -55.33 123.43 13.8 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 121.855 1.703 . . . . 0.0 109.751 177.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' TYR . . . . . 0.887 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 7.2 t80 -68.94 -53.87 13.59 Favored Pre-proline 0 N--CA 1.44 -0.926 0 CA-C-O 118.458 -0.782 . . . . 0.0 113.01 -168.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.549 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 36.9 Cg_exo -55.93 -18.46 22.3 Favored 'Trans proline' 0 C--N 1.359 1.103 0 C-N-CA 121.523 1.482 . . . . 0.0 110.991 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.509 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.9 m-20 -89.82 -42.56 11.2 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 113.907 -1.497 . . . . 0.0 110.841 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' PHE . . . . . 0.436 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -55.43 -45.76 76.77 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.458 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.769 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 2.1 p -78.09 -34.38 19.03 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.18 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.172 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . 0.401 ' HB1' ' O ' ' B' ' 15' ' ' PRO . . . -55.59 -39.6 70.93 Favored 'General case' 0 C--N 1.316 -0.882 0 O-C-N 121.674 -0.641 . . . . 0.0 111.077 176.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.75 ' O ' HG11 ' B' ' 24' ' ' VAL . 14.7 ptt180 -79.82 -27.72 40.22 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.58 ' HB3' ' O ' ' B' ' 18' ' ' VAL . 13.2 tp -55.05 -48.68 73.14 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.191 172.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' GLN . . . . . 0.769 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 28.4 mt-30 -68.24 -55.23 12.95 Favored 'General case' 0 CA--C 1.485 -1.529 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.447 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.718 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 78.8 m-20 -45.79 -50.87 13.58 Favored 'General case' 0 C--N 1.312 -1.023 0 O-C-N 124.735 1.272 . . . . 0.0 111.264 -177.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' VAL . . . . . 0.75 HG11 ' O ' ' B' ' 20' ' ' ARG . 7.1 p -78.66 -26.24 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.925 -174.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.633 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -67.22 -31.37 71.7 Favored 'General case' 0 C--O 1.208 -1.131 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 176.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.08 -35.15 64.21 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.174 -1.375 . . . . 0.0 109.474 -178.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.718 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 39.1 mmtt -67.31 -39.96 85.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.628 -1.169 . . . . 0.0 112.015 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' SER . . . . . 0.415 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 38.9 m -100.45 -10.47 21.09 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.247 0.546 . . . . 0.0 110.511 -172.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.633 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 83.9 mt -110.96 129.9 65.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.651 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.48 -3.03 58.54 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.937 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.566 ' H ' HG22 ' B' ' 29' ' ' ILE . 4.7 t0 -117.92 139.63 50.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.715 0.769 . . . . 0.0 111.912 -177.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -68.66 -31.55 70.75 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.43 175.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.568 ' O ' HG11 ' B' ' 37' ' ' VAL . 12.1 mttp -68.16 -53.62 23.77 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -176.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.457 ' HA ' HG23 ' B' ' 37' ' ' VAL . . . -63.89 -26.22 68.5 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.481 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.861 ' O ' HG12 ' B' ' 39' ' ' VAL . 4.8 tmm_? -68.27 -57.91 5.24 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.472 ' HB3' ' OE1' ' B' ' 40' ' ' GLU . 32.8 mtpt -53.53 -60.29 3.49 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.223 178.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.696 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 19.7 m -52.08 -33.85 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.366 -170.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.515 ' O ' ' HG2' ' B' ' 42' ' ' MET . 0.7 OUTLIER -88.36 -35.12 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 C-N-CA 119.769 -0.772 . . . . 0.0 112.355 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.861 HG12 ' O ' ' B' ' 35' ' ' ARG . 2.9 m -66.05 -46.88 86.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 119.124 -1.03 . . . . 0.0 109.44 177.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.648 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 42.9 mt-10 -61.19 -31.59 71.34 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.943 0.897 . . . . 0.0 112.55 176.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.696 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -83.67 -52.98 5.98 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 121.039 -0.265 . . . . 0.0 111.446 -179.152 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' MET . . . . . 0.709 ' HG3' ' CG ' ' B' ' 4' ' ' ASN . 19.9 mmt -65.69 -20.73 66.4 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.712 0.768 . . . . 0.0 109.685 -176.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.687 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . . . -50.51 -29.05 9.61 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.144 171.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' TYR . . . . . 0.871 ' CG ' ' HE3' ' B' ' 59' ' ' LYS . 6.1 t80 -103.4 -66.66 0.93 Allowed 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 174.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.595 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 31.0 mm-40 -49.78 -29.6 8.08 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 124.415 1.072 . . . . 0.0 112.006 -171.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.719 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.9 m-20 -104.42 -21.46 13.47 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.497 -176.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' B' ' 43' ' ' ALA . . . -61.49 179.89 0.21 Allowed 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.873 0.844 . . . . 0.0 113.058 -174.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' ASN . . . . . 0.621 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 17.5 m-20 -62.28 141.87 96.1 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.545 173.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . 0.402 ' O ' ' HG2' ' B' ' 52' ' ' GLN . 75.5 Cg_exo -42.14 -50.36 5.39 Favored 'Trans proline' 0 C--N 1.332 -0.308 0 C-N-CA 122.959 2.44 . . . . 0.0 112.309 -178.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . 0.57 ' HA ' ' HB2' ' B' ' 53' ' ' SER . 0.0 OUTLIER -74.07 -26.72 60.54 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.954 0.901 . . . . 0.0 111.349 -179.42 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.621 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 72.4 m -79.92 -40.15 28.8 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -174.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . 0.547 ' HB2' ' CG ' ' B' ' 44' ' ' TYR . 3.3 pt20 -69.44 -30.86 68.87 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 172.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' SER . . . . . 0.801 ' O ' ' HD2' ' B' ' 56' ' ' LYS . 4.3 m -67.89 -27.54 66.75 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 113.907 -1.497 . . . . 0.0 111.423 174.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' B' ' 51' ' ' CYS . . . -71.4 -23.09 61.81 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.005 0.907 . . . . 0.0 108.566 170.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.543 HD11 ' HA ' ' B' ' 52' ' ' GLN . 25.4 mt -89.91 -27.5 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -175.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . 0.801 ' HD2' ' O ' ' B' ' 53' ' ' SER . 0.0 OUTLIER -37.47 -49.08 2.55 Favored Pre-proline 0 N--CA 1.507 2.404 0 CA-C-N 120.624 1.557 . . . . 0.0 112.525 -178.398 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.658 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 49.9 Cg_endo -61.27 -24.38 78.73 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.836 2.358 . . . . 0.0 112.789 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . 0.516 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.6 mt -105.28 -15.47 15.04 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . 0.871 ' HE3' ' CG ' ' B' ' 44' ' ' TYR . 0.0 OUTLIER -50.62 109.83 0.35 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.684 -179.015 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.67 -19.63 43.58 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.11 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -103.9 115.2 30.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.911 0.386 . . . . 0.0 110.12 -176.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.73 137.67 28.3 Favored Pre-proline 0 C--N 1.315 -0.915 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.406 171.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_exo . . . . . 0 C--N 1.343 0.285 0 C-N-CA 122.888 2.392 . . . . 0.0 112.212 171.321 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' ASP . . . . . 0.407 ' OD2' ' HB ' ' B' ' 69' ' ' ILE . 2.9 t70 . . . . . 0 CA--C 1.511 -0.528 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . 0.502 HG21 ' HG2' ' B' ' 40' ' ' GLU . 1.0 OUTLIER -78.3 -29.4 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 C-N-CA 118.769 -1.172 . . . . 0.0 108.885 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . 0.788 ' O ' HG12 ' B' ' 73' ' ' VAL . 8.6 mm -60.93 -47.12 94.93 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.164 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.091 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 43.0 t -47.13 -37.79 10.5 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.974 177.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -86.22 -32.52 21.13 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 123.282 0.633 . . . . 0.0 111.144 -177.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 72' ' ' TYR . . . . . 0.591 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.3 m-30 -74.97 -35.61 62.07 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.705 0.764 . . . . 0.0 109.348 -177.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . 0.887 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 2.3 m -70.64 -34.16 55.91 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 74' ' ' LYS . . . . . 0.434 ' HE3' ' HB3' ' B' ' 74' ' ' LYS . 13.1 ttpp -70.37 -28.0 64.76 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.684 177.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -62.1 -44.56 96.38 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.431 173.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.513 ' SG ' ' HB2' ' B' ' 14' ' ' TYR . 37.7 t -96.01 9.22 41.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.182 178.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . 0.429 ' HB2' ' HA ' ' B' ' 74' ' ' LYS . 11.2 t70 . . . . . 0 C--N 1.323 -0.569 0 CA-C-O 121.034 0.445 . . . . 0.0 110.6 175.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo . . . . . 0 CA--C 1.518 -0.3 0 N-CA-C 108.984 -1.199 . . . . 0.0 108.984 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.433 ' HG ' ' HD3' ' B' ' 59' ' ' LYS . 16.5 m -66.88 174.17 3.15 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 163.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.462 ' HE1' ' CD1' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -70.83 -51.79 24.47 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 166.029 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.509 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 2.4 p-10 -88.18 5.64 40.47 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 113.944 -1.48 . . . . 0.0 113.781 -165.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.09 -8.47 7.71 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 118.52 0.6 . . . . 0.0 111.305 -177.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.606 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.1 m -74.48 129.4 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 176.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.677 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -155.51 158.73 38.97 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 118.053 -1.459 . . . . 0.0 114.61 -177.556 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.416 ' OE1' ' HB1' ' A' ' 47' ' ' ALA . 2.2 tt0 -47.14 106.66 0.09 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 112.865 -1.97 . . . . 0.0 112.031 -177.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.27 -135.68 1.18 Allowed Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.825 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.5 ' C ' ' HD3' ' A' ' 11' ' ' LYS . 9.1 t -65.37 99.41 0.4 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.5 ' HD3' ' C ' ' A' ' 10' ' ' SER . 0.0 OUTLIER 37.2 44.24 0.41 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.233 1.013 . . . . 0.0 112.017 -175.333 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.414 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 54.8 tt0 -60.55 144.29 89.05 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.735 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.55 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 37.9 Cg_exo -54.48 122.83 12.24 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.356 2.037 . . . . 0.0 110.114 176.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.757 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 21.9 t80 -73.19 -55.87 3.57 Favored Pre-proline 0 N--CA 1.439 -0.984 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -166.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.564 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 27.4 Cg_exo -56.98 -16.13 19.6 Favored 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 121.279 1.32 . . . . 0.0 110.627 -178.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.55 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.3 m-20 -89.16 -44.48 10.28 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 113.606 -1.634 . . . . 0.0 110.837 178.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.517 ' CE2' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -54.62 -44.76 73.43 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.515 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.76 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 1.7 p -79.63 -34.8 16.06 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.277 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.536 -178.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.33 -30.58 68.47 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 121.45 -0.781 . . . . 0.0 111.752 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.719 ' O ' HG13 ' A' ' 24' ' ' VAL . 16.5 ptt180 -84.45 -28.36 26.89 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.526 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 5.6 tp -57.26 -48.29 79.25 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.019 173.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.76 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 24.7 mt-30 -68.78 -47.9 65.02 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.085 177.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.732 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 11.4 t70 -47.19 -54.58 10.37 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 124.332 1.02 . . . . 0.0 111.656 -177.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.719 HG13 ' O ' ' A' ' 20' ' ' ARG . 6.6 p -81.84 -21.95 10.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.038 -174.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.735 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -73.07 -19.39 61.18 Favored 'General case' 0 C--O 1.205 -1.243 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 174.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.49 -38.06 17.64 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.582 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.732 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 39.8 mmtt -66.45 -35.75 81.05 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.753 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.7 m -104.72 -7.32 19.62 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.201 0.524 . . . . 0.0 110.657 -170.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.735 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 88.5 mt -117.8 130.12 73.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.885 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.21 -7.64 47.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.331 0.586 . . . . 0.0 110.332 175.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.517 ' H ' HG23 ' A' ' 29' ' ' ILE . 1.0 OUTLIER -100.31 106.29 17.91 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.735 -179.278 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -56.47 -25.98 52.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.679 0.276 . . . . 0.0 110.271 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.545 ' O ' HG11 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -69.32 -53.57 18.96 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.172 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.492 ' HA ' HG23 ' A' ' 37' ' ' VAL . . . -64.6 -24.07 67.47 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.349 177.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.847 ' O ' HG11 ' A' ' 39' ' ' VAL . 4.7 tmm_? -68.4 -58.61 4.08 Favored 'General case' 0 C--O 1.219 -0.535 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.48 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 27.4 mtpt -52.45 -60.68 2.94 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 120.791 0.329 . . . . 0.0 110.535 177.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.781 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 21.6 m -52.16 -36.15 20.21 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.768 -168.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.462 ' CD1' ' HE1' ' A' ' 3' ' ' PHE . 1.5 tt -87.17 -27.69 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 119.641 -0.823 . . . . 0.0 112.111 -177.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.847 HG11 ' O ' ' A' ' 35' ' ' ARG . 2.1 m -73.35 -47.47 46.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 119.148 -1.021 . . . . 0.0 109.267 175.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.678 ' HB3' ' CG2' ' A' ' 68' ' ' VAL . 0.7 OUTLIER -63.98 -24.47 67.73 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.796 0.838 . . . . 0.0 111.292 176.162 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.781 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -85.45 -57.9 2.88 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 176.667 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.531 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 23.2 mmt -61.49 -20.58 63.33 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.569 0.699 . . . . 0.0 109.703 -177.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.672 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . . . -48.94 -27.89 3.45 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.928 170.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.538 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 10.2 t80 -107.13 -66.77 0.99 Allowed 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 176.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.629 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 17.1 mm-40 -48.1 -32.59 7.02 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.998 -174.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.677 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 5.2 m-20 -105.14 -19.32 13.86 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -175.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 43' ' ' ALA . . . -61.01 -172.15 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -174.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.549 ' HB2' ' CB ' ' A' ' 51' ' ' CYS . 11.5 m120 -52.78 141.49 36.51 Favored Pre-proline 0 C--N 1.342 0.239 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 170.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.92 -19.66 56.14 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 121.618 1.545 . . . . 0.0 110.452 174.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.526 ' O ' ' HB2' ' A' ' 53' ' ' SER . 0.3 OUTLIER -87.11 -34.98 18.92 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.465 174.055 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.951 ' SG ' ' HB2' ' A' ' 76' ' ' CYS . 40.8 t -80.24 -33.92 37.55 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.242 -172.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.511 ' HB2' ' CD1' ' A' ' 44' ' ' TYR . 4.2 pt20 -68.68 -29.32 67.75 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 172.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.544 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 20.0 m -71.58 -19.3 62.16 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.284 -1.78 . . . . 0.0 110.017 173.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.401 ' HB1' ' O ' ' A' ' 51' ' ' CYS . . . -81.06 -27.17 35.81 Favored 'General case' 0 C--N 1.311 -1.107 0 O-C-N 121.431 -0.793 . . . . 0.0 110.158 167.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.576 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 23.7 mt -90.34 -30.18 4.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 114.83 1.418 . . . . 0.0 114.83 -170.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.604 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.57 -38.81 1.99 Allowed Pre-proline 0 N--CA 1.487 1.414 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -174.034 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 54.4 Cg_endo -63.62 -30.96 70.58 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.154 1.903 . . . . 0.0 112.628 176.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.52 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.8 mt -95.08 -16.87 22.33 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.573 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 0.1 OUTLIER -54.87 109.07 0.46 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.698 -179.523 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.38 -23.04 37.58 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.403 -177.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -104.22 113.22 26.61 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.312 0.577 . . . . 0.0 110.232 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.09 142.53 38.52 Favored Pre-proline 0 C--N 1.309 -1.177 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 169.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo . . . . . 0 N--CA 1.463 -0.276 0 C-N-CA 122.19 1.927 . . . . 0.0 111.443 170.958 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.518 -0.271 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.678 ' CG2' ' HB3' ' A' ' 40' ' ' GLU . 0.7 OUTLIER -72.45 -32.53 42.3 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.419 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.757 ' O ' HG12 ' A' ' 73' ' ' VAL . 10.1 mm -55.57 -46.59 79.16 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.071 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.742 -178.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 33.6 t -46.34 -38.11 8.36 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.322 0.582 . . . . 0.0 111.012 176.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -85.63 -31.96 22.29 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.749 -177.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.573 ' OH ' ' HA ' ' A' ' 59' ' ' LYS . 4.9 m-30 -76.59 -34.04 58.42 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.534 -176.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.757 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.5 m -71.41 -31.64 43.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 172.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.562 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -67.89 -29.83 69.02 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.372 175.731 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.477 ' HB1' ' O ' ' A' ' 72' ' ' TYR . . . -64.77 -44.93 88.46 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.109 176.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.951 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 39.5 t -92.52 9.08 36.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.636 177.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.562 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 8.3 t70 . . . . . 0 C--N 1.322 -0.622 0 CA-C-O 121.321 0.581 . . . . 0.0 110.238 172.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 1' ' ' PRO . . . . . 0.448 ' HB2' ' H ' ' B' ' 2' ' ' SER . 98.7 Cg_endo . . . . . 0 CA--C 1.518 -0.324 0 N-CA-C 108.911 -1.226 . . . . 0.0 108.911 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 2' ' ' SER . . . . . 0.448 ' H ' ' HB2' ' B' ' 1' ' ' PRO . 16.4 m -66.9 174.56 2.92 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 162.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.457 ' HE1' ' CD1' ' B' ' 38' ' ' ILE . 0.1 OUTLIER -71.18 -51.76 23.03 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 165.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . 0.509 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.4 p-10 -88.19 5.62 40.61 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 113.904 -1.498 . . . . 0.0 113.731 -165.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' THR . . . . . 0.409 HG22 ' HG2' ' A' ' 59' ' ' LYS . 0.6 OUTLIER -63.36 -7.72 7.13 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 118.554 0.616 . . . . 0.0 111.438 -177.13 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.597 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.1 m -75.0 129.27 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . 0.694 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.2 OUTLIER -155.48 158.77 39.07 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 118.18 -1.408 . . . . 0.0 114.626 -177.652 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' GLN . . . . . 0.425 ' OE1' ' HB1' ' B' ' 47' ' ' ALA . 2.2 tt0 -47.01 106.72 0.09 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 112.766 -2.016 . . . . 0.0 111.944 -177.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.56 -136.48 1.38 Allowed Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.631 177.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' SER . . . . . 0.51 ' C ' ' HD3' ' B' ' 11' ' ' LYS . 8.9 t -64.81 99.38 0.33 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.51 ' HD3' ' C ' ' B' ' 10' ' ' SER . 0.0 OUTLIER 37.35 43.94 0.42 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.19 0.996 . . . . 0.0 112.095 -175.354 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.423 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 52.6 tt0 -60.28 144.27 87.91 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.855 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . 0.532 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 40.4 Cg_exo -54.56 122.78 12.17 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 122.235 1.957 . . . . 0.0 110.139 176.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' TYR . . . . . 0.752 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 21.6 t80 -73.13 -55.92 3.59 Favored Pre-proline 0 N--CA 1.44 -0.939 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -166.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.575 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 27.7 Cg_exo -57.22 -16.02 20.55 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 121.318 1.345 . . . . 0.0 110.609 -178.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.532 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.4 m-20 -89.33 -44.2 10.39 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 113.487 -1.688 . . . . 0.0 110.762 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' PHE . . . . . 0.515 ' CE2' HD23 ' B' ' 21' ' ' LEU . 0.0 OUTLIER -54.89 -44.59 74.24 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 176.744 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.751 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 1.7 p -79.58 -34.91 16.21 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.307 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.496 -178.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.39 -30.29 68.34 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 121.356 -0.84 . . . . 0.0 111.913 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.703 ' O ' HG13 ' B' ' 24' ' ' VAL . 16.6 ptt180 -84.53 -28.44 26.66 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 175.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.54 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 5.6 tp -57.24 -48.23 79.36 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.079 173.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' GLN . . . . . 0.751 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 24.3 mt-30 -69.09 -47.41 65.31 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.075 177.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.737 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 11.8 t70 -47.44 -54.74 10.58 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 124.416 1.072 . . . . 0.0 111.6 -177.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' VAL . . . . . 0.703 HG13 ' O ' ' B' ' 20' ' ' ARG . 6.5 p -81.7 -22.05 10.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.033 -174.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.751 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -72.95 -19.39 61.25 Favored 'General case' 0 C--O 1.204 -1.302 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.49 -38.25 17.45 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.555 177.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.737 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 40.1 mmtt -66.13 -35.95 81.85 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.717 178.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 15.7 m -104.52 -7.64 19.62 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.24 0.543 . . . . 0.0 110.68 -170.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.751 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 88.3 mt -117.74 129.74 73.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.91 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.15 -7.29 48.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.328 0.585 . . . . 0.0 110.314 175.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.492 ' H ' HG23 ' B' ' 29' ' ' ILE . 1.1 m-20 -100.46 106.25 17.79 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.776 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -56.29 -26.04 50.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.666 0.27 . . . . 0.0 110.388 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.554 ' O ' HG11 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -69.24 -53.73 18.39 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.14 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.503 ' HA ' HG23 ' B' ' 37' ' ' VAL . . . -64.33 -24.11 67.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.402 177.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.828 ' O ' HG11 ' B' ' 39' ' ' VAL . 4.6 tmm_? -68.41 -58.75 3.87 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.47 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 27.2 mtpt -52.17 -60.7 2.9 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 120.796 0.332 . . . . 0.0 110.638 177.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.773 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 21.8 m -52.27 -35.96 20.4 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.465 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.716 -168.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.457 ' CD1' ' HE1' ' B' ' 3' ' ' PHE . 1.5 tt -87.24 -27.72 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 119.599 -0.84 . . . . 0.0 112.067 -177.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.828 HG11 ' O ' ' B' ' 35' ' ' ARG . 2.1 m -73.51 -47.14 46.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.332 175.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.678 ' HB3' ' CG2' ' B' ' 68' ' ' VAL . 0.7 OUTLIER -64.19 -24.36 67.65 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.757 0.823 . . . . 0.0 111.348 176.084 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.773 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.46 -57.86 2.9 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 176.534 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' MET . . . . . 0.534 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 23.2 mmt -61.45 -20.75 63.47 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.591 0.71 . . . . 0.0 109.717 -177.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.677 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . . . -48.71 -27.93 3.24 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.991 170.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' TYR . . . . . 0.528 ' CG ' ' HD2' ' B' ' 59' ' ' LYS . 10.4 t80 -107.22 -66.66 1.0 Allowed 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.629 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 17.6 mm-40 -48.21 -32.46 7.14 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.817 -1.083 . . . . 0.0 112.005 -174.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.694 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 5.1 m-20 -105.07 -19.68 13.75 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -175.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.658 ' HB3' ' O ' ' B' ' 43' ' ' ALA . . . -60.71 -172.0 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -174.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' ASN . . . . . 0.55 ' HB2' ' CB ' ' B' ' 51' ' ' CYS . 11.5 m120 -52.86 141.55 37.05 Favored Pre-proline 0 C--O 1.235 0.298 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 170.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.04 -19.7 57.2 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 121.642 1.561 . . . . 0.0 110.471 174.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . 0.521 ' O ' ' HB2' ' B' ' 53' ' ' SER . 0.3 OUTLIER -87.02 -34.89 19.07 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.542 173.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.952 ' SG ' ' HB2' ' B' ' 76' ' ' CYS . 40.7 t -80.33 -33.89 37.07 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.265 -172.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . 0.501 ' HB2' ' CD1' ' B' ' 44' ' ' TYR . 4.1 pt20 -68.6 -29.42 67.93 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 172.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' SER . . . . . 0.542 ' O ' ' HE2' ' B' ' 56' ' ' LYS . 19.6 m -71.55 -19.41 62.17 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 113.264 -1.789 . . . . 0.0 109.986 173.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' B' ' 51' ' ' CYS . . . -80.86 -27.38 36.43 Favored 'General case' 0 C--N 1.311 -1.07 0 O-C-N 121.443 -0.786 . . . . 0.0 110.225 167.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.577 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 24.0 mt -90.11 -30.0 5.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 -170.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . 0.601 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.68 -38.78 2.07 Favored Pre-proline 0 N--CA 1.487 1.377 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -174.043 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 55.6 Cg_endo -63.79 -30.78 68.83 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.196 1.931 . . . . 0.0 112.649 176.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . 0.533 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.7 mt -95.11 -16.74 22.4 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . 0.565 ' HA ' ' OH ' ' B' ' 72' ' ' TYR . 0.1 OUTLIER -55.01 109.09 0.47 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.661 -179.483 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.65 -23.41 36.05 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.419 -177.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -104.07 113.36 26.85 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.351 0.596 . . . . 0.0 110.162 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.16 142.13 37.62 Favored Pre-proline 0 C--N 1.308 -1.201 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.352 169.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo . . . . . 0 C--O 1.234 0.32 0 C-N-CA 122.201 1.934 . . . . 0.0 111.416 171.222 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.519 -0.229 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . 0.678 ' CG2' ' HB3' ' B' ' 40' ' ' GLU . 0.7 OUTLIER -72.3 -32.52 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.495 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . 0.754 ' O ' HG12 ' B' ' 73' ' ' VAL . 9.9 mm -55.65 -46.6 79.42 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.093 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.675 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 70' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 29.4 t -46.49 -37.92 8.52 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.105 176.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -85.67 -32.0 22.22 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.677 -177.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 72' ' ' TYR . . . . . 0.565 ' OH ' ' HA ' ' B' ' 59' ' ' LYS . 4.9 m-30 -76.46 -34.29 58.7 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.572 -176.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . 0.754 HG12 ' O ' ' B' ' 69' ' ' ILE . 1.5 m -71.33 -31.51 43.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 172.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 74' ' ' LYS . . . . . 0.562 ' O ' ' HB3' ' B' ' 77' ' ' ASP . 0.0 OUTLIER -68.08 -29.61 68.61 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.431 175.653 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' B' ' 72' ' ' TYR . . . -65.09 -44.59 88.34 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.175 176.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.952 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 39.1 t -92.5 9.04 36.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.729 177.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . 0.562 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 9.1 t70 . . . . . 0 C--N 1.321 -0.641 0 CA-C-O 121.173 0.511 . . . . 0.0 110.163 172.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.482 ' HB2' ' H ' ' A' ' 2' ' ' SER . 72.3 Cg_endo . . . . . 0 CA--C 1.515 -0.451 0 N-CA-C 108.784 -1.275 . . . . 0.0 108.784 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.482 ' H ' ' HB2' ' A' ' 1' ' ' PRO . 13.7 m -67.11 171.42 5.64 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 162.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.471 ' CE1' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -69.9 -52.02 28.14 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 167.248 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.494 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 2.5 p-10 -82.34 5.37 20.48 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 113.996 -1.456 . . . . 0.0 113.423 -166.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.28 -3.03 5.02 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 118.521 0.6 . . . . 0.0 111.946 -175.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.568 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.1 m -78.57 132.72 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 174.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.708 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -155.08 160.15 40.78 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -178.881 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.411 ' N ' ' CD2' ' A' ' 17' ' ' PHE . 2.0 tt0 -44.33 109.07 0.13 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 112.902 -1.954 . . . . 0.0 112.29 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.69 -151.95 15.13 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.397 174.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.1 t -52.32 98.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 122.421 0.288 . . . . 0.0 110.692 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.7 pttm 40.52 42.14 1.25 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.511 1.124 . . . . 0.0 112.598 -175.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -60.1 141.34 90.35 Favored Pre-proline 0 C--O 1.236 0.386 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.149 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.484 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 27.4 Cg_exo -56.35 122.96 12.7 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.039 1.826 . . . . 0.0 109.712 176.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.825 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 20.2 t80 -72.38 -53.27 6.24 Favored Pre-proline 0 N--CA 1.439 -1.004 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -166.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.536 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 34.3 Cg_exo -55.36 -19.53 22.48 Favored 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 121.361 1.374 . . . . 0.0 110.749 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.484 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 3.4 m-20 -89.9 -41.19 11.93 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 113.737 -1.574 . . . . 0.0 110.948 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -54.96 -46.82 75.08 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 175.73 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.688 HG12 ' O ' ' A' ' 14' ' ' TYR . 2.4 p -79.03 -32.12 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.218 -177.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . -58.0 -36.3 72.45 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 121.639 -0.663 . . . . 0.0 111.768 175.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.692 ' O ' HG12 ' A' ' 24' ' ' VAL . 14.1 ptt180 -83.27 -23.52 32.64 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.53 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 6.6 tp -60.49 -45.63 93.06 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.767 172.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.688 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 37.2 mt-30 -73.14 -44.51 60.04 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.735 178.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.74 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 26.0 t70 -49.16 -53.72 19.67 Favored 'General case' 0 C--N 1.315 -0.893 0 O-C-N 124.155 0.909 . . . . 0.0 111.667 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.692 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.7 p -80.85 -23.19 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-O 121.09 0.472 . . . . 0.0 109.882 -174.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.762 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -71.79 -20.54 61.84 Favored 'General case' 0 C--O 1.204 -1.326 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 174.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.44 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -86.54 -37.14 18.47 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.744 178.602 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.74 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.0 mmtt -65.49 -35.51 81.09 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.459 178.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.5 m -104.47 -9.96 18.02 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.648 -171.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.762 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 91.1 mt -119.27 128.03 75.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.95 -178.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.99 -1.29 56.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.382 0.611 . . . . 0.0 110.488 176.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.537 ' H ' HG21 ' A' ' 29' ' ' ILE . 13.6 t70 -107.95 116.6 32.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.467 -177.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.561 ' OE2' ' HG3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -57.16 -34.05 68.06 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.272 178.332 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.561 ' HG3' ' OE2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -70.88 -54.71 10.48 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -172.543 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.444 ' HA ' HG21 ' A' ' 37' ' ' VAL . . . -60.05 -28.92 68.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.8 176.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.859 ' O ' HG13 ' A' ' 39' ' ' VAL . 6.0 tmm_? -67.38 -58.09 5.41 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.44 ' O ' HG21 ' A' ' 39' ' ' VAL . 16.0 mtpt -56.96 -56.58 19.85 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.008 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.698 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 20.1 m -53.73 -35.03 25.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.399 -171.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.467 ' O ' ' HG2' ' A' ' 42' ' ' MET . 1.3 tt -86.6 -28.24 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 C-N-CA 119.631 -0.828 . . . . 0.0 111.732 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.5 m -70.78 -49.87 47.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 119.088 -1.045 . . . . 0.0 109.561 173.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.715 ' CD ' HG11 ' A' ' 68' ' ' VAL . 0.9 OUTLIER -62.08 -24.85 67.36 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.354 0.662 . . . . 0.0 111.653 176.654 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.698 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -86.23 -55.28 3.99 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 176.381 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.494 ' HG3' ' HB2' ' A' ' 4' ' ' ASN . 16.4 mmt -63.89 -20.35 65.77 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 121.458 0.646 . . . . 0.0 109.861 -176.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.676 ' HB2' ' OH ' ' A' ' 14' ' ' TYR . . . -48.78 -27.81 3.23 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.277 169.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.529 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 16.5 t80 -105.95 -66.23 1.01 Allowed 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 174.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.444 ' OE1' ' HA ' ' A' ' 45' ' ' GLU . 15.3 mm-40 -50.22 -26.85 5.1 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 124.228 0.955 . . . . 0.0 112.699 -172.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.708 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.8 m-20 -109.49 -20.35 12.92 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.625 -177.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.65 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -59.15 -177.52 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.183 0.992 . . . . 0.0 113.633 -174.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -62.98 140.89 97.64 Favored Pre-proline 0 N--CA 1.445 -0.713 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.639 174.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -43.65 -48.04 9.07 Favored 'Trans proline' 0 C--N 1.334 -0.226 0 C-N-CA 122.83 2.353 . . . . 0.0 112.473 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.599 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -76.23 -23.73 54.55 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.31 0.644 . . . . 0.0 110.657 -179.488 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.953 ' SG ' ' HB2' ' A' ' 76' ' ' CYS . 52.9 t -84.26 -40.0 18.57 Favored 'General case' 0 N--CA 1.417 -2.105 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.915 -173.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.49 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.7 pt20 -66.34 -31.18 71.81 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 172.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.755 ' O ' ' HD2' ' A' ' 56' ' ' LYS . 5.1 m -65.81 -30.05 70.62 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.88 172.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.33 -23.71 61.2 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.87 0.843 . . . . 0.0 109.276 172.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.53 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 25.1 mt -90.94 -31.33 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -173.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.755 ' HD2' ' O ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -44.03 -38.18 4.43 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-N 119.805 1.184 . . . . 0.0 113.477 -173.451 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 52.7 Cg_endo -63.06 -29.6 75.12 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 122.296 1.997 . . . . 0.0 112.85 175.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.534 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.5 mt -97.37 -16.45 20.24 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.529 ' HD2' ' CG ' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -52.76 109.68 0.43 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.376 -178.538 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.453 ' N ' ' HZ1' ' A' ' 59' ' ' LYS . . . 94.86 -21.77 41.79 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.177 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.5 mmmt -103.51 114.5 28.81 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -177.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.7 p -122.14 137.1 27.01 Favored Pre-proline 0 C--N 1.309 -1.163 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 170.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo . . . . . 0 C--O 1.234 0.303 0 C-N-CA 122.649 2.233 . . . . 0.0 111.702 172.621 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.436 ' OD2' ' HB ' ' A' ' 69' ' ' ILE . 3.0 t70 . . . . . 0 CA--C 1.519 -0.237 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.715 HG11 ' CD ' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -71.87 -33.36 47.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 C-N-CA 118.055 -1.458 . . . . 0.0 108.937 -179.391 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.758 ' O ' HG12 ' A' ' 73' ' ' VAL . 7.6 mm -57.61 -47.5 85.29 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.112 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.802 -178.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.566 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 41.2 t -48.33 -36.09 13.67 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.202 0.525 . . . . 0.0 111.168 178.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -86.56 -31.21 21.34 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.27 0.628 . . . . 0.0 110.75 -176.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.534 ' CE1' ' HB2' ' A' ' 58' ' ' LEU . 4.9 m-30 -76.28 -35.98 58.62 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.494 -178.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.825 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.7 m -69.87 -33.15 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 173.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.566 ' HB2' ' O ' ' A' ' 70' ' ' SER . 1.6 ttmm -67.9 -30.62 70.0 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.086 -1.415 . . . . 0.0 109.666 176.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 72' ' ' TYR . . . -62.1 -42.81 99.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.653 174.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.953 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 41.9 t -94.86 8.59 42.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.052 178.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.463 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 12.7 t70 . . . . . 0 C--N 1.323 -0.587 0 CA-C-O 121.279 0.561 . . . . 0.0 110.024 173.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 1' ' ' PRO . . . . . 0.419 ' HB2' ' H ' ' B' ' 2' ' ' SER . 72.4 Cg_endo . . . . . 0 CA--C 1.515 -0.449 0 N-CA-C 108.791 -1.273 . . . . 0.0 108.791 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 2' ' ' SER . . . . . 0.427 ' HG ' ' HD3' ' A' ' 59' ' ' LYS . 14.4 m -67.04 171.58 5.39 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 162.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.468 ' CE1' HD11 ' B' ' 29' ' ' ILE . 0.1 OUTLIER -70.03 -52.08 26.97 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 167.184 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . 0.493 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.6 p-10 -82.05 5.25 20.01 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 113.95 -1.477 . . . . 0.0 113.478 -166.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.26 -2.87 4.81 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 121.671 -0.643 . . . . 0.0 111.939 -175.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.581 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.1 m -78.57 133.18 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 174.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . 0.701 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.1 OUTLIER -155.17 160.26 40.77 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -178.825 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' GLN . . . . . 0.426 ' N ' ' CD2' ' B' ' 17' ' ' PHE . 2.0 tt0 -44.58 108.87 0.13 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 112.922 -1.944 . . . . 0.0 112.313 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.27 -152.07 14.38 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.406 174.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 9.9 t -52.44 98.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.753 0.311 . . . . 0.0 110.803 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 23.8 pttm 40.8 41.55 1.22 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.549 1.14 . . . . 0.0 112.635 -175.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -59.73 141.17 89.17 Favored Pre-proline 0 C--O 1.236 0.388 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.217 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . 0.498 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 27.6 Cg_exo -56.24 123.04 12.87 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.031 1.82 . . . . 0.0 109.644 177.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' TYR . . . . . 0.825 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 20.3 t80 -72.36 -53.37 6.19 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -166.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.536 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 35.1 Cg_exo -55.45 -19.34 22.31 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 121.305 1.337 . . . . 0.0 110.696 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.498 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 3.5 m-20 -90.1 -41.15 11.83 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.722 -1.581 . . . . 0.0 110.92 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' PHE . . . . . 0.487 ' CD2' ' HA ' ' B' ' 7' ' ' ARG . 0.0 OUTLIER -54.79 -46.71 74.5 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.569 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.696 HG12 ' O ' ' B' ' 14' ' ' TYR . 2.4 p -79.16 -32.09 14.94 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.21 -177.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' B' ' 15' ' ' PRO . . . -58.06 -36.12 72.34 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 121.634 -0.666 . . . . 0.0 111.765 175.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.685 ' O ' HG12 ' B' ' 24' ' ' VAL . 14.1 ptt180 -83.22 -23.99 32.56 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 177.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.543 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 6.5 tp -60.1 -45.64 92.26 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.802 172.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' GLN . . . . . 0.69 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 36.9 mt-30 -73.21 -44.19 60.09 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.832 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.741 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 25.9 t70 -49.43 -53.83 20.72 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.557 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' VAL . . . . . 0.685 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.7 p -80.96 -23.07 10.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.137 0.494 . . . . 0.0 109.878 -174.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.759 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -71.77 -20.5 61.86 Favored 'General case' 0 C--O 1.203 -1.37 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 174.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . 0.438 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -86.56 -37.29 18.29 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.704 178.597 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.741 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.4 mmtt -65.51 -35.58 81.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.488 178.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 19.6 m -104.34 -9.44 18.51 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.666 -171.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.759 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 91.6 mt -119.76 128.0 75.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.993 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.06 -1.43 56.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.285 0.564 . . . . 0.0 110.286 177.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.546 ' H ' HG21 ' B' ' 29' ' ' ILE . 13.8 t70 -107.62 116.84 32.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.352 -177.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 0.553 ' OE2' ' HG3' ' B' ' 33' ' ' LYS . 0.0 OUTLIER -57.34 -33.87 68.2 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.356 178.267 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.553 ' HG3' ' OE2' ' B' ' 32' ' ' GLU . 0.0 OUTLIER -70.82 -54.57 11.09 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -172.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.467 ' HA ' HG21 ' B' ' 37' ' ' VAL . . . -60.16 -28.89 68.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.784 176.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.839 ' O ' HG13 ' B' ' 39' ' ' VAL . 6.0 tmm_? -67.38 -58.28 5.07 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.438 ' O ' HG21 ' B' ' 39' ' ' VAL . 16.1 mtpt -56.84 -56.52 20.52 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.097 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.686 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 20.2 m -53.83 -34.92 26.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.386 -171.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.461 ' O ' ' HG2' ' B' ' 42' ' ' MET . 1.3 tt -86.64 -28.18 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 C-N-CA 119.649 -0.82 . . . . 0.0 111.668 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.839 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.5 m -70.91 -49.85 47.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 119.152 -1.019 . . . . 0.0 109.58 173.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.711 ' CD ' HG11 ' B' ' 68' ' ' VAL . 0.9 OUTLIER -62.12 -24.87 67.4 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.398 0.679 . . . . 0.0 111.561 176.69 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.686 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -86.22 -55.22 4.02 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 176.293 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' MET . . . . . 0.493 ' HG3' ' HB2' ' B' ' 4' ' ' ASN . 16.4 mmt -64.08 -20.17 65.76 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 121.537 0.684 . . . . 0.0 109.974 -176.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.681 ' HB2' ' OH ' ' B' ' 14' ' ' TYR . . . -48.78 -27.76 3.19 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.194 169.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' TYR . . . . . 0.511 ' CG ' ' HD2' ' B' ' 59' ' ' LYS . 16.5 t80 -106.06 -66.41 1.0 Allowed 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 174.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.447 ' HA ' ' OE1' ' B' ' 45' ' ' GLU . 16.4 mm-40 -50.05 -27.22 5.25 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.627 -172.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.701 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.7 m-20 -109.28 -20.22 13.02 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.602 -176.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -59.06 -177.35 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -174.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -63.26 140.93 97.77 Favored Pre-proline 0 N--CA 1.446 -0.647 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.531 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -43.76 -48.04 9.26 Favored 'Trans proline' 0 C--N 1.334 -0.235 0 C-N-CA 122.773 2.315 . . . . 0.0 112.386 -178.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . 0.609 ' HG3' ' O ' ' B' ' 50' ' ' GLU . 0.0 OUTLIER -76.03 -23.83 55.17 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 123.43 0.692 . . . . 0.0 110.707 -179.467 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.949 ' SG ' ' HB2' ' B' ' 76' ' ' CYS . 52.8 t -84.18 -39.99 18.69 Favored 'General case' 0 N--CA 1.418 -2.038 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.94 -173.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . 0.49 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.8 pt20 -66.5 -31.08 71.59 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 172.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' SER . . . . . 0.755 ' O ' ' HD2' ' B' ' 56' ' ' LYS . 5.7 m -65.93 -30.14 70.67 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 113.783 -1.553 . . . . 0.0 110.809 173.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.09 -23.89 61.41 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 122.026 0.917 . . . . 0.0 109.374 172.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.535 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 25.0 mt -90.89 -31.53 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -173.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . 0.755 ' HD2' ' O ' ' B' ' 53' ' ' SER . 0.0 OUTLIER -43.79 -38.12 3.96 Favored Pre-proline 0 N--CA 1.488 1.45 0 CA-C-N 119.801 1.182 . . . . 0.0 113.653 -173.543 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 54.3 Cg_endo -63.48 -28.84 70.85 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.391 2.061 . . . . 0.0 112.942 175.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . 0.545 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.5 mt -97.84 -16.55 19.75 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . 0.511 ' HD2' ' CG ' ' B' ' 44' ' ' TYR . 0.0 OUTLIER -52.82 109.73 0.44 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.421 -178.501 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . 0.458 ' N ' ' HZ1' ' B' ' 59' ' ' LYS . . . 95.04 -22.02 40.73 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.255 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 11.5 mmmt -103.55 114.3 28.46 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -177.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.15 136.85 26.74 Favored Pre-proline 0 C--N 1.309 -1.184 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 171.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo . . . . . 0 N--CA 1.462 -0.347 0 C-N-CA 122.52 2.147 . . . . 0.0 111.841 172.84 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' ASP . . . . . 0.436 ' OD2' ' HB ' ' B' ' 69' ' ' ILE . 3.1 t70 . . . . . 0 CA--C 1.52 -0.206 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . 0.711 HG11 ' CD ' ' B' ' 40' ' ' GLU . 0.8 OUTLIER -71.66 -33.4 48.77 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 C-N-CA 118.085 -1.446 . . . . 0.0 108.856 -179.214 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . 0.755 ' O ' HG12 ' B' ' 73' ' ' VAL . 7.6 mm -57.45 -47.51 84.76 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.118 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.801 -178.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 70' ' ' SER . . . . . 0.559 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 40.3 t -48.34 -36.2 13.92 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.301 0.572 . . . . 0.0 111.182 178.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.413 ' H ' ' HG2' ' B' ' 71' ' ' GLU . 2.3 mm-40 -86.51 -31.28 21.38 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.592 -176.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 72' ' ' TYR . . . . . 0.545 ' CE1' ' HB2' ' B' ' 58' ' ' LEU . 5.0 m-30 -76.39 -35.82 58.42 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.443 -178.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . 0.825 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.7 m -69.94 -33.13 54.21 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 173.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 74' ' ' LYS . . . . . 0.559 ' HB2' ' O ' ' B' ' 70' ' ' SER . 1.6 ttmm -68.04 -30.56 69.81 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.698 176.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' B' ' 72' ' ' TYR . . . -61.93 -42.89 99.62 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.624 174.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.949 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 43.2 t -94.99 8.66 42.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.12 177.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . 0.467 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 12.0 t70 . . . . . 0 C--N 1.321 -0.654 0 CA-C-O 121.354 0.597 . . . . 0.0 109.971 173.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo . . . . . 0 CA--C 1.52 -0.209 0 N-CA-C 109.064 -1.168 . . . . 0.0 109.064 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.438 ' HB3' HD23 ' B' ' 41' ' ' LEU . 66.6 m -68.62 -176.85 0.85 Allowed 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 162.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.501 ' HE1' ' CD1' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -77.27 -55.47 5.38 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.107 172.675 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.588 ' OD1' ' HG3' ' A' ' 42' ' ' MET . 1.1 p30 -76.22 -8.3 56.76 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.599 -1.182 . . . . 0.0 112.467 -167.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.519 ' CG2' ' HD3' ' B' ' 59' ' ' LYS . 0.3 OUTLIER -57.95 0.61 0.06 Allowed 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -172.197 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.561 ' HB ' ' CZ ' ' A' ' 20' ' ' ARG . 4.0 m -72.96 117.65 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 167.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.677 ' HG3' ' CB ' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -115.91 158.25 23.29 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 121.505 -0.747 . . . . 0.0 110.216 176.765 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.494 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 1.9 tt0 -56.16 113.08 1.4 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.444 173.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.35 -159.99 11.73 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 173.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.7 p -52.16 100.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.942 0.371 . . . . 0.0 111.141 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 11' ' ' LYS . 18.2 pttp 43.01 42.58 3.23 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.305 1.042 . . . . 0.0 112.041 -175.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.44 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 42.7 tt0 -60.26 137.0 91.63 Favored Pre-proline 0 C--O 1.232 0.182 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 177.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.518 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 28.1 Cg_exo -54.06 123.62 13.95 Favored 'Trans proline' 0 CA--C 1.511 -0.672 0 C-N-CA 122.075 1.85 . . . . 0.0 109.936 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.814 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 14.5 t80 -70.19 -53.43 10.79 Favored Pre-proline 0 N--CA 1.44 -0.954 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -166.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.5 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 31.8 Cg_exo -55.69 -18.51 21.06 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 121.414 1.409 . . . . 0.0 110.979 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.518 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 4.1 m-20 -89.96 -41.69 11.6 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.198 -1.365 . . . . 0.0 111.169 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.494 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -56.96 -41.54 78.51 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.533 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.68 HG11 ' O ' ' A' ' 14' ' ' TYR . 2.4 p -82.57 -33.6 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.519 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' A' ' 15' ' ' PRO . . . -57.88 -34.05 69.36 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 121.495 -0.753 . . . . 0.0 111.946 176.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.736 ' O ' HG11 ' A' ' 24' ' ' VAL . 17.5 ptt180 -84.79 -27.72 26.66 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.567 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 9.3 tp -54.96 -46.19 75.0 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.759 171.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.711 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 36.6 mt-30 -73.21 -45.72 54.53 Favored 'General case' 0 CA--C 1.497 -1.073 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.168 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.7 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 11.4 t70 -51.79 -52.42 49.09 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 124.05 0.844 . . . . 0.0 111.812 -177.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.736 HG11 ' O ' ' A' ' 20' ' ' ARG . 7.3 p -82.06 -23.25 9.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -173.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.777 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -72.06 -18.86 61.9 Favored 'General case' 0 C--O 1.203 -1.357 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 173.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.41 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -86.55 -37.75 17.86 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.634 -1.167 . . . . 0.0 109.812 177.842 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.7 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 41.0 mmtt -67.62 -37.84 83.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.013 178.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.8 t -102.67 -7.7 21.52 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.227 0.537 . . . . 0.0 110.044 -171.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.777 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 86.8 mt -116.7 127.49 74.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.435 178.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.55 -9.54 54.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.263 0.554 . . . . 0.0 110.148 177.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.522 ' H ' HG21 ' A' ' 29' ' ' ILE . 13.8 t70 -98.75 136.04 39.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.233 -177.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -75.42 -29.55 59.78 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.761 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.532 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -77.44 -51.41 10.82 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -174.932 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.441 ' HA ' HG21 ' A' ' 37' ' ' VAL . . . -58.57 -27.88 65.01 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.436 175.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.877 ' O ' HG13 ' A' ' 39' ' ' VAL . 1.7 tmm_? -66.31 -60.74 2.49 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.498 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 26.0 mtpt -55.12 -56.1 23.61 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.373 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.71 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 19.7 m -54.8 -32.6 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.16 -170.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.574 ' O ' ' HG2' ' A' ' 42' ' ' MET . 1.2 tt -86.82 -34.0 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.416 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.877 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.0 m -66.14 -47.66 83.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 119.214 -0.995 . . . . 0.0 109.466 176.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.678 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 54.4 mt-10 -67.25 -23.75 65.74 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 123.875 0.87 . . . . 0.0 112.64 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.71 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -86.22 -55.71 3.79 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.375 176.854 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.678 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 14.6 mmt -62.27 -20.67 64.52 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-O 121.76 0.791 . . . . 0.0 109.509 -176.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.762 ' O ' ' HB3' ' A' ' 47' ' ' ALA . . . -48.61 -27.02 2.53 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.766 170.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.481 ' CG ' ' HB2' ' A' ' 52' ' ' GLN . 9.2 t80 -105.4 -66.39 0.98 Allowed 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.473 ' CG ' HD11 ' A' ' 41' ' ' LEU . 14.0 mm-40 -48.25 -33.41 8.64 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 123.646 0.592 . . . . 0.0 112.44 -176.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.678 ' HB2' ' O ' ' A' ' 42' ' ' MET . 5.2 m-20 -99.84 -15.34 18.43 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.349 0.595 . . . . 0.0 111.643 -177.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.762 ' HB3' ' O ' ' A' ' 43' ' ' ALA . . . -63.04 168.48 4.04 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.426 0.632 . . . . 0.0 111.501 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.534 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 11.1 m-20 -58.31 145.46 74.73 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.338 173.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -41.65 -49.1 5.45 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.688 2.258 . . . . 0.0 111.894 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.483 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 0.3 OUTLIER -71.23 -33.56 69.97 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.238 1.015 . . . . 0.0 111.854 177.79 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.534 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 69.8 m -73.94 -39.22 63.93 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 121.118 0.485 . . . . 0.0 110.014 -174.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.481 ' HB2' ' CG ' ' A' ' 44' ' ' TYR . 4.0 pt20 -73.39 -30.75 63.48 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 175.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.559 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 4.0 m -67.72 -21.02 65.32 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.306 172.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.449 ' HB1' ' O ' ' A' ' 51' ' ' CYS . . . -77.1 -27.77 54.26 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.382 -0.824 . . . . 0.0 109.865 169.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.598 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 20.8 mt -89.74 -31.72 5.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -171.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.593 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -40.68 -37.76 1.05 Allowed Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -173.883 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.598 ' HD2' ' C ' ' A' ' 55' ' ' ILE . 55.2 Cg_endo -64.26 -28.89 64.0 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.358 2.039 . . . . 0.0 113.104 175.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.534 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 2.0 mt -98.63 -15.79 19.31 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.568 ' HD3' ' CG2' ' B' ' 5' ' ' THR . 0.3 OUTLIER -52.56 109.35 0.39 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.348 -1.296 . . . . 0.0 110.422 179.6 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.88 -30.09 10.44 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.939 -175.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 35.0 mmtt -103.83 115.17 29.98 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-O 122.423 1.106 . . . . 0.0 111.612 -175.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.461 ' HB ' HG13 ' A' ' 68' ' ' VAL . 7.5 p -122.46 145.04 43.61 Favored Pre-proline 0 C--N 1.296 -1.754 0 CA-C-N 113.555 -1.657 . . . . 0.0 109.52 170.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo . . . . . 0 C--O 1.233 0.265 0 C-N-CA 122.282 1.988 . . . . 0.0 111.198 167.811 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.436 -1.153 0 N-CA-C 110.89 -0.041 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.57 HG12 ' CD ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -79.08 -31.27 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 C-N-CA 118.523 -1.271 . . . . 0.0 108.463 176.248 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.756 ' O ' HG13 ' A' ' 73' ' ' VAL . 6.9 mm -57.77 -49.16 81.77 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.147 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.564 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.6 t -49.07 -36.18 17.75 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.077 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.58 ' O ' ' HE3' ' A' ' 74' ' ' LYS . 1.3 mm-40 -84.88 -33.83 22.72 Favored 'General case' 0 C--O 1.216 -0.666 0 C-N-CA 123.349 0.66 . . . . 0.0 110.458 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.552 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 4.9 m-30 -74.5 -37.91 63.01 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.691 -176.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.814 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.7 m -70.64 -32.65 50.17 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 175.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.58 ' HE3' ' O ' ' A' ' 71' ' ' GLU . 2.4 ttpp -72.39 -27.68 62.52 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.816 177.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 72' ' ' TYR . . . -66.21 -41.72 89.73 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.313 174.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 4.2 m -101.07 10.5 40.93 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.533 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 t70 . . . . . 0 C--N 1.325 -0.487 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.132 178.548 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo . . . . . 0 CA--C 1.518 -0.319 0 N-CA-C 109.113 -1.149 . . . . 0.0 109.113 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 2' ' ' SER . . . . . 0.42 ' HB3' HD23 ' A' ' 41' ' ' LEU . 71.2 m -68.78 -176.55 0.84 Allowed 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 162.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.511 ' HE1' ' CD1' ' B' ' 38' ' ' ILE . 0.1 OUTLIER -77.24 -55.57 5.31 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.509 -0.877 . . . . 0.0 110.173 172.362 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . 0.585 ' OD1' ' HG3' ' B' ' 42' ' ' MET . 1.1 p30 -76.21 -8.32 56.78 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.557 -1.201 . . . . 0.0 112.413 -167.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' THR . . . . . 0.568 ' CG2' ' HD3' ' A' ' 59' ' ' LYS . 0.2 OUTLIER -57.85 0.5 0.06 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -172.182 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.561 ' HB ' ' CZ ' ' B' ' 20' ' ' ARG . 4.0 m -72.88 117.92 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 167.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . 0.67 ' HG3' ' CB ' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -115.86 158.42 22.98 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 121.568 -0.708 . . . . 0.0 110.189 176.621 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' GLN . . . . . 0.497 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 1.9 tt0 -56.44 112.9 1.38 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.372 173.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.2 -159.75 10.94 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 173.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 12.3 p -52.32 100.88 0.03 OUTLIER 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.932 0.366 . . . . 0.0 111.152 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 18.3 pttp 42.89 42.17 2.92 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.383 1.073 . . . . 0.0 112.255 -175.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.448 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 43.1 tt0 -59.84 136.87 90.32 Favored Pre-proline 0 C--O 1.232 0.17 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . 0.533 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 27.6 Cg_exo -54.05 123.6 13.89 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.129 1.886 . . . . 0.0 109.907 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' TYR . . . . . 0.819 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 14.8 t80 -70.07 -53.61 10.85 Favored Pre-proline 0 N--CA 1.44 -0.96 0 CA-C-O 118.335 -0.841 . . . . 0.0 113.23 -166.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.511 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 32.0 Cg_exo -55.6 -18.56 20.71 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 121.55 1.5 . . . . 0.0 110.999 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.533 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 4.4 m-20 -89.92 -41.85 11.54 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.068 -1.424 . . . . 0.0 111.071 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' PHE . . . . . 0.497 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -56.9 -41.54 78.27 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.614 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.687 HG11 ' O ' ' B' ' 14' ' ' TYR . 2.4 p -82.52 -33.61 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.521 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' B' ' 15' ' ' PRO . . . -58.28 -33.33 69.31 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.457 -0.777 . . . . 0.0 112.012 176.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.743 ' O ' HG11 ' B' ' 24' ' ' VAL . 17.5 ptt180 -85.11 -27.85 25.98 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.571 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 9.3 tp -54.84 -46.2 74.6 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.814 171.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' GLN . . . . . 0.713 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 36.3 mt-30 -73.19 -45.88 53.78 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.157 178.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.713 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 11.3 t70 -51.89 -52.24 51.14 Favored 'General case' 0 C--N 1.314 -0.96 0 O-C-N 124.067 0.854 . . . . 0.0 111.841 -177.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' VAL . . . . . 0.743 HG11 ' O ' ' B' ' 20' ' ' ARG . 7.4 p -82.02 -23.27 9.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.302 0.572 . . . . 0.0 109.56 -174.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.794 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -72.06 -18.87 61.91 Favored 'General case' 0 C--O 1.204 -1.307 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . 0.414 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -86.7 -37.54 17.86 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.814 177.799 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.713 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 40.9 mmtt -67.96 -37.23 81.32 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.999 178.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 33.4 t -103.08 -7.49 21.31 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.403 0.621 . . . . 0.0 110.189 -171.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.794 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 86.6 mt -116.98 127.18 74.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.428 178.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.44 -9.47 54.55 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.276 0.56 . . . . 0.0 110.199 177.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.534 ' H ' HG21 ' B' ' 29' ' ' ILE . 13.7 t70 -98.68 136.13 39.19 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.258 -177.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -75.55 -29.56 59.42 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.67 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.528 ' O ' HG13 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -77.36 -51.49 10.74 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -174.944 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.464 ' HA ' HG21 ' B' ' 37' ' ' VAL . . . -58.61 -27.86 65.08 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.378 176.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.86 ' O ' HG13 ' B' ' 39' ' ' VAL . 1.7 tmm_? -66.34 -60.86 2.38 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 178.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.488 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 25.9 mtpt -55.03 -56.1 23.58 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.382 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.699 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 19.6 m -54.8 -32.37 25.96 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.258 -170.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.563 ' O ' ' HG2' ' B' ' 42' ' ' MET . 1.2 tt -86.97 -34.07 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.525 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.86 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.0 m -65.97 -47.69 84.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.438 176.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.673 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 54.6 mt-10 -67.48 -23.43 65.49 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.711 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.699 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -86.33 -55.94 3.67 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.258 176.648 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' MET . . . . . 0.678 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 14.7 mmt -62.2 -20.66 64.41 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-O 121.768 0.794 . . . . 0.0 109.578 -176.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.758 ' O ' ' HB3' ' B' ' 47' ' ' ALA . . . -48.59 -27.1 2.56 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.779 170.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' TYR . . . . . 0.49 ' CD1' ' HB2' ' B' ' 52' ' ' GLN . 9.1 t80 -105.36 -66.7 0.96 Allowed 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.472 ' CG ' HD11 ' B' ' 41' ' ' LEU . 13.1 mm-40 -47.97 -33.65 8.09 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 123.636 0.585 . . . . 0.0 112.405 -176.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.678 ' HB2' ' O ' ' B' ' 42' ' ' MET . 5.3 m-20 -99.55 -15.3 18.68 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.297 0.57 . . . . 0.0 111.724 -177.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.758 ' HB3' ' O ' ' B' ' 43' ' ' ALA . . . -63.11 168.53 4.08 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.39 0.614 . . . . 0.0 111.483 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' ASN . . . . . 0.539 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 11.2 m-20 -58.09 145.41 73.22 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.387 173.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -41.58 -49.49 5.18 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 122.741 2.294 . . . . 0.0 111.875 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . 0.465 ' HA ' ' HB2' ' B' ' 53' ' ' SER . 0.3 OUTLIER -70.78 -33.69 71.01 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.372 1.069 . . . . 0.0 111.801 177.737 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.539 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 70.2 m -73.9 -39.16 64.06 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.29 0.566 . . . . 0.0 110.151 -174.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . 0.49 ' HB2' ' CD1' ' B' ' 44' ' ' TYR . 3.9 pt20 -73.42 -30.65 63.37 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 175.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' SER . . . . . 0.56 ' O ' ' HE2' ' B' ' 56' ' ' LYS . 3.7 m -68.03 -20.87 65.03 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.26 172.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' B' ' 51' ' ' CYS . . . -76.97 -27.86 54.92 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.359 -0.838 . . . . 0.0 109.877 168.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.596 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 20.9 mt -89.66 -31.78 5.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -171.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . 0.596 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -40.62 -37.92 1.08 Allowed Pre-proline 0 N--CA 1.49 1.525 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -173.82 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 53.9 Cg_endo -64.17 -28.97 64.83 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.178 1.919 . . . . 0.0 113.022 175.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . 0.529 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 2.0 mt -98.54 -15.65 19.45 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . 0.55 ' NZ ' HD13 ' B' ' 41' ' ' LEU . 0.3 OUTLIER -52.77 109.31 0.39 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.385 179.459 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.86 -30.24 10.15 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.944 -175.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 34.9 mmtt -103.68 115.31 30.26 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 122.244 1.021 . . . . 0.0 111.688 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.476 ' HB ' HG13 ' B' ' 68' ' ' VAL . 7.6 p -122.53 145.22 44.25 Favored Pre-proline 0 C--N 1.297 -1.681 0 CA-C-N 113.64 -1.618 . . . . 0.0 109.559 170.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo . . . . . 0 C--N 1.345 0.369 0 C-N-CA 122.182 1.921 . . . . 0.0 111.21 168.02 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.436 -1.157 0 CA-C-O 120.222 0.058 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . 0.582 HG12 ' CD ' ' B' ' 40' ' ' GLU . 0.9 OUTLIER -79.24 -31.36 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 C-N-CA 118.567 -1.253 . . . . 0.0 108.547 176.175 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . 0.766 ' O ' HG13 ' B' ' 73' ' ' VAL . 7.0 mm -57.73 -49.28 81.32 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.139 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.522 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 42.8 t -48.81 -36.4 16.63 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.011 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.575 ' O ' ' HE3' ' B' ' 74' ' ' LYS . 1.4 mm-40 -84.81 -33.76 22.87 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 123.442 0.697 . . . . 0.0 110.591 -178.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 72' ' ' TYR . . . . . 0.544 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.0 m-30 -74.79 -37.8 62.29 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.671 -176.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . 0.819 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.7 m -70.47 -32.76 51.07 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.676 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 174.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 74' ' ' LYS . . . . . 0.575 ' HE3' ' O ' ' B' ' 71' ' ' GLU . 2.4 ttpp -72.58 -27.3 62.1 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.866 178.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' B' ' 72' ' ' TYR . . . -66.39 -41.82 88.81 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.3 174.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.402 ' SG ' ' HB3' ' B' ' 51' ' ' CYS . 4.2 m -101.12 10.52 40.83 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.496 -177.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 6.5 t70 . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.059 178.486 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.403 ' HB2' ' H ' ' A' ' 2' ' ' SER . 92.8 Cg_endo . . . . . 0 CA--C 1.518 -0.303 0 N-CA-C 109.1 -1.154 . . . . 0.0 109.1 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.481 ' HB2' HG22 ' A' ' 5' ' ' THR . 73.6 m -68.83 -177.23 0.96 Allowed 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 162.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.668 ' CB ' ' HA ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -78.14 -53.92 6.83 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.649 172.549 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.57 ' OD1' ' HG ' ' B' ' 41' ' ' LEU . 2.2 p-10 -87.58 5.7 38.09 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.133 -0.939 . . . . 0.0 112.994 -164.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.481 HG22 ' HB2' ' A' ' 2' ' ' SER . 2.2 p -64.8 -3.83 3.73 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.069 0.462 . . . . 0.0 111.391 -176.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.507 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.6 m -75.38 131.9 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 175.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.696 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -153.18 158.91 42.47 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.425 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.3 tt0 -42.24 115.16 0.65 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 112.758 -2.019 . . . . 0.0 112.831 -178.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.16 -148.54 11.85 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.44 172.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.8 m -55.89 97.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.106 0.453 . . . . 0.0 110.937 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.0 pttt 40.61 40.28 0.89 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.332 1.053 . . . . 0.0 112.085 -174.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.407 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 42.3 tt0 -55.96 139.57 70.64 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.932 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.555 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 52.1 Cg_exo -51.29 122.67 10.51 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.158 1.905 . . . . 0.0 110.058 178.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.757 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 9.3 t80 -72.22 -52.88 6.8 Favored Pre-proline 0 N--CA 1.442 -0.842 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -166.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.558 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 36.7 Cg_exo -56.2 -20.01 29.73 Favored 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 121.665 1.577 . . . . 0.0 110.968 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.555 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.1 m-20 -89.76 -40.21 12.64 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 113.845 -1.525 . . . . 0.0 110.754 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.425 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -56.01 -43.79 78.04 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 175.512 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.663 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 2.4 p -80.58 -33.24 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.379 -179.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.72 -34.88 67.92 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 121.594 -0.691 . . . . 0.0 111.937 175.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.715 ' O ' HG13 ' A' ' 24' ' ' VAL . 16.7 ptt180 -84.93 -26.87 26.95 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.605 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 4.5 tp -54.35 -49.2 70.34 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 171.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.663 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 30.6 mt-30 -67.21 -52.29 43.01 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.338 177.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.783 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 23.8 t70 -47.53 -53.53 14.17 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 -175.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.715 HG13 ' O ' ' A' ' 20' ' ' ARG . 5.0 p -81.59 -28.3 10.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.452 0.644 . . . . 0.0 110.381 -168.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 1.014 ' HB1' ' CZ ' ' A' ' 35' ' ' ARG . . . -78.91 -17.69 55.11 Favored 'General case' 0 C--O 1.198 -1.623 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 175.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.545 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -76.21 -37.74 57.37 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 172.803 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.783 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 39.7 mmtt -64.23 -36.16 83.17 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.508 177.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.0 t -104.26 -12.93 16.37 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.086 0.469 . . . . 0.0 110.27 -172.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.625 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 91.7 mt -111.8 117.11 54.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.296 177.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.49 -1.78 56.27 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.225 0.536 . . . . 0.0 110.076 175.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.537 ' H ' HG22 ' A' ' 29' ' ' ILE . 10.8 t70 -99.52 131.67 45.37 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.29 -177.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -75.23 -25.48 58.14 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.841 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.55 ' O ' HG11 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -81.08 -52.8 7.0 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -175.18 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.444 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -59.79 -24.68 64.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.54 177.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 1.014 ' CZ ' ' HB1' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -72.73 -57.41 4.12 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.463 ' O ' HG22 ' A' ' 39' ' ' VAL . 22.4 mtpt -52.85 -55.6 21.9 Favored 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.706 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.698 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 13.9 m -55.82 -33.08 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.195 -171.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.599 HG23 HH12 ' A' ' 35' ' ' ARG . 0.2 OUTLIER -87.35 -31.4 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 119.642 -0.823 . . . . 0.0 111.687 177.761 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.796 HG12 ' NH2' ' A' ' 35' ' ' ARG . 1.3 m -57.41 -57.05 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 118.666 -1.213 . . . . 0.0 109.168 168.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.572 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 46.2 mt-10 -63.19 -29.74 71.03 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 124.252 1.021 . . . . 0.0 112.611 -175.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.698 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -85.43 -49.98 7.67 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.937 179.602 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.594 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 19.7 mmt -67.5 -20.5 65.45 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.56 0.695 . . . . 0.0 109.517 -177.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.64 ' HB2' ' OH ' ' A' ' 14' ' ' TYR . . . -52.36 -26.74 13.18 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.655 172.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.543 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 17.2 t80 -105.98 -68.12 0.89 Allowed 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 174.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.432 ' OE2' ' HA ' ' B' ' 5' ' ' THR . 8.8 mm-40 -48.47 -26.6 2.22 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 124.323 1.014 . . . . 0.0 113.024 -175.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.696 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.1 m-20 -108.15 -21.92 12.59 Favored 'General case' 0 N--CA 1.435 -1.212 0 O-C-N 122.083 -0.386 . . . . 0.0 111.567 -178.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.611 ' HB1' ' O ' ' A' ' 43' ' ' ALA . . . -59.49 178.95 0.13 Allowed 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.932 0.872 . . . . 0.0 112.925 -174.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.573 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 8.7 m-20 -60.2 140.45 91.17 Favored Pre-proline 0 N--CA 1.442 -0.83 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.452 174.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.401 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 79.5 Cg_exo -42.6 -47.73 7.51 Favored 'Trans proline' 0 C--N 1.33 -0.447 0 C-N-CA 122.877 2.385 . . . . 0.0 112.091 -178.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.506 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 0.3 OUTLIER -72.85 -33.4 66.11 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.119 0.967 . . . . 0.0 111.627 178.368 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.573 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 99.1 m -74.85 -37.28 62.26 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -173.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.513 ' HA ' HD13 ' A' ' 55' ' ' ILE . 3.8 pt20 -72.54 -31.4 65.27 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 174.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.52 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 12.0 m -68.49 -21.76 64.59 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.178 -1.373 . . . . 0.0 110.409 174.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.22 -25.18 46.86 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.756 0.789 . . . . 0.0 109.617 169.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.553 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 25.4 mt -89.56 -32.02 5.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -173.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.62 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -42.4 -38.94 2.81 Favored Pre-proline 0 N--CA 1.487 1.423 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -173.492 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 56.0 Cg_endo -63.57 -28.96 70.1 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 122.346 2.031 . . . . 0.0 112.958 175.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.517 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.6 mt -96.92 -16.53 20.63 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.579 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -53.36 109.41 0.43 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.189 -178.768 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.79 -20.38 47.47 Favored Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.525 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -104.11 114.19 28.26 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.432 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.3 p -123.02 140.28 33.18 Favored Pre-proline 0 C--N 1.311 -1.096 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 171.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo . . . . . 0 N--CA 1.462 -0.336 0 C-N-CA 122.429 2.086 . . . . 0.0 111.513 170.894 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.732 ' OD1' ' HB ' ' A' ' 69' ' ' ILE . 32.8 t70 . . . . . 0 CA--C 1.516 -0.358 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.536 HG23 ' HB3' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -79.48 -30.58 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 C-N-CA 118.049 -1.46 . . . . 0.0 108.832 178.448 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.76 ' O ' HG12 ' A' ' 73' ' ' VAL . 6.2 mm -59.09 -47.9 88.52 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.978 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.789 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 43.2 t -44.83 -39.37 5.27 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.253 175.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -86.54 -28.8 23.14 Favored 'General case' 0 CA--C 1.512 -0.505 0 C-N-CA 122.771 0.428 . . . . 0.0 111.086 -177.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.58 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.3 m-30 -76.55 -35.6 58.15 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.716 0.77 . . . . 0.0 109.462 -178.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.76 HG12 ' O ' ' A' ' 69' ' ' ILE . 1.5 m -71.39 -30.29 38.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 172.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -68.05 -32.43 72.77 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.292 175.143 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -63.03 -43.65 98.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.916 177.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.408 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 23.7 t -94.96 4.47 53.77 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.033 178.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 10.9 t70 . . . . . 0 C--N 1.324 -0.506 0 CA-C-O 121.233 0.54 . . . . 0.0 110.271 176.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo . . . . . 0 CA--C 1.519 -0.271 0 N-CA-C 109.115 -1.148 . . . . 0.0 109.115 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 2' ' ' SER . . . . . 0.46 ' HB2' HG22 ' B' ' 5' ' ' THR . 74.3 m -68.69 -177.77 1.04 Allowed 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 162.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.647 ' CB ' ' HA ' ' B' ' 25' ' ' ALA . 0.1 OUTLIER -77.85 -53.82 7.05 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.64 172.827 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . 0.551 ' OD1' ' HG ' ' A' ' 41' ' ' LEU . 2.1 p-10 -87.61 5.71 38.11 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.973 -164.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' THR . . . . . 0.46 HG22 ' HB2' ' B' ' 2' ' ' SER . 2.2 p -64.85 -3.75 3.71 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.038 0.447 . . . . 0.0 111.418 -176.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.515 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.6 m -75.5 132.15 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 175.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . 0.715 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -153.32 158.76 42.05 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -179.724 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' GLN . . . . . 0.432 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.3 tt0 -42.32 115.14 0.65 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 112.95 -1.932 . . . . 0.0 112.845 -178.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.4 -148.58 12.29 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.424 173.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 21.6 m -55.45 97.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 117.187 0.493 . . . . 0.0 111.096 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 60.9 pttt 40.5 40.73 0.93 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.275 1.03 . . . . 0.0 111.974 -174.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.414 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 41.1 tt0 -56.4 139.53 74.02 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.891 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . 0.547 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 52.0 Cg_exo -51.19 122.45 10.07 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.25 1.967 . . . . 0.0 110.019 178.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' TYR . . . . . 0.755 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 9.3 t80 -72.19 -52.91 6.84 Favored Pre-proline 0 N--CA 1.44 -0.935 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -166.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.549 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 36.6 Cg_exo -55.94 -20.11 28.4 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 121.589 1.526 . . . . 0.0 110.979 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.547 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 0.9 OUTLIER -89.77 -39.96 12.79 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.869 -1.514 . . . . 0.0 110.826 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' PHE . . . . . 0.432 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -56.28 -43.66 79.04 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 175.575 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.658 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 2.4 p -80.61 -33.23 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.344 -178.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.78 -34.71 67.89 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 121.627 -0.671 . . . . 0.0 111.967 175.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.721 ' O ' HG13 ' B' ' 24' ' ' VAL . 16.6 ptt180 -85.04 -26.96 26.69 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.608 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 4.5 tp -54.33 -49.24 70.18 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 171.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' GLN . . . . . 0.663 ' HA ' ' HE ' ' B' ' 35' ' ' ARG . 30.9 mt-30 -67.16 -52.39 42.07 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.203 177.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.799 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 24.5 t70 -47.38 -53.67 13.24 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -175.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' VAL . . . . . 0.721 HG13 ' O ' ' B' ' 20' ' ' ARG . 4.9 p -81.55 -28.27 10.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.289 0.566 . . . . 0.0 110.405 -168.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 1.029 ' HB1' ' CZ ' ' B' ' 35' ' ' ARG . . . -78.86 -17.6 55.36 Favored 'General case' 0 C--O 1.198 -1.646 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 175.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . 0.535 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -76.6 -37.36 56.57 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 172.83 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.799 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 39.1 mmtt -64.79 -35.32 80.72 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.539 177.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 32.7 t -105.0 -12.38 16.2 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.026 0.441 . . . . 0.0 110.426 -172.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.634 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 91.6 mt -112.43 116.8 53.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.359 177.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.03 -1.49 54.89 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.227 0.537 . . . . 0.0 110.153 175.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.535 ' H ' HG22 ' B' ' 29' ' ' ILE . 10.5 t70 -99.61 131.59 45.51 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.164 -177.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -75.12 -25.78 58.72 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.858 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.542 ' O ' HG11 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -80.93 -53.02 6.82 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -174.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.457 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -59.6 -24.61 63.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.641 177.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 1.029 ' CZ ' ' HB1' ' B' ' 25' ' ' ALA . 0.0 OUTLIER -72.87 -57.29 4.18 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.964 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.461 ' O ' HG22 ' B' ' 39' ' ' VAL . 22.5 mtpt -52.91 -55.58 22.27 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.754 177.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.71 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 13.7 m -55.88 -32.91 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.402 -171.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.593 HG23 HH12 ' B' ' 35' ' ' ARG . 0.2 OUTLIER -87.35 -31.45 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.632 177.687 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.799 HG12 ' NH2' ' B' ' 35' ' ' ARG . 1.3 m -57.35 -57.02 11.8 Favored 'Isoleucine or valine' 0 C--N 1.343 0.308 0 C-N-CA 118.663 -1.215 . . . . 0.0 109.242 168.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.57 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 46.3 mt-10 -63.25 -29.74 71.02 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 124.282 1.033 . . . . 0.0 112.572 -175.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.71 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -85.42 -50.08 7.59 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.983 179.52 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' MET . . . . . 0.586 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 19.8 mmt -67.4 -20.29 65.51 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.618 0.723 . . . . 0.0 109.672 -177.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.633 ' HB2' ' OH ' ' B' ' 14' ' ' TYR . . . -52.54 -26.76 14.12 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.668 172.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' TYR . . . . . 0.542 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 16.9 t80 -105.93 -68.03 0.9 Allowed 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.454 ' OE2' ' HA ' ' A' ' 5' ' ' THR . 9.5 mm-40 -48.57 -26.69 2.33 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 124.259 0.975 . . . . 0.0 112.979 -175.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.715 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.2 m-20 -108.18 -21.9 12.59 Favored 'General case' 0 N--CA 1.435 -1.205 0 O-C-N 122.191 -0.318 . . . . 0.0 111.514 -178.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.597 ' HB1' ' O ' ' B' ' 43' ' ' ALA . . . -59.41 179.27 0.11 Allowed 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 122.018 0.913 . . . . 0.0 112.99 -174.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' ASN . . . . . 0.574 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 7.9 m-20 -60.43 140.42 91.98 Favored Pre-proline 0 N--CA 1.442 -0.846 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.436 174.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -42.41 -47.62 7.25 Favored 'Trans proline' 0 C--N 1.33 -0.411 0 C-N-CA 122.832 2.355 . . . . 0.0 112.251 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . 0.503 ' HA ' ' HB2' ' B' ' 53' ' ' SER . 0.3 OUTLIER -73.09 -33.51 65.64 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 124.226 1.01 . . . . 0.0 111.654 178.435 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.574 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 98.0 m -74.72 -37.18 62.62 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 120.911 0.386 . . . . 0.0 110.024 -173.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . 0.494 ' HA ' HD13 ' B' ' 55' ' ' ILE . 3.8 pt20 -72.52 -31.52 65.39 Favored 'General case' 0 C--O 1.211 -0.925 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 174.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' SER . . . . . 0.512 ' O ' ' HE2' ' B' ' 56' ' ' LYS . 13.2 m -68.42 -21.91 64.64 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.389 174.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.17 -25.0 47.0 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.756 0.789 . . . . 0.0 109.668 169.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.561 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 25.2 mt -89.62 -31.88 5.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -173.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . 0.615 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -42.51 -38.79 2.82 Favored Pre-proline 0 N--CA 1.488 1.425 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -173.477 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 56.0 Cg_endo -63.74 -29.1 68.66 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 122.261 1.974 . . . . 0.0 112.912 175.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . 0.535 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.6 mt -96.65 -16.41 20.99 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . 0.563 ' HA ' ' OH ' ' B' ' 72' ' ' TYR . 0.0 OUTLIER -53.42 109.37 0.43 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.161 -178.801 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.76 -20.08 49.14 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.493 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -104.15 114.27 28.39 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.427 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.3 p -122.96 140.4 33.33 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 171.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo . . . . . 0 C--N 1.345 0.368 0 C-N-CA 122.347 2.031 . . . . 0.0 111.537 170.72 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 67' ' ' ASP . . . . . 0.716 ' OD1' ' HB ' ' B' ' 69' ' ' ILE . 29.8 t70 . . . . . 0 CA--C 1.515 -0.368 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . 0.532 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.9 OUTLIER -79.6 -30.69 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 C-N-CA 118.072 -1.451 . . . . 0.0 108.765 178.417 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . 0.753 ' O ' HG12 ' B' ' 73' ' ' VAL . 6.1 mm -59.01 -47.92 88.33 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.079 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.832 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 70' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 41.0 t -44.9 -39.3 5.31 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.273 175.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -86.45 -29.03 23.13 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 121.101 0.477 . . . . 0.0 111.015 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 72' ' ' TYR . . . . . 0.572 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.3 m-30 -76.48 -35.54 58.35 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.675 0.75 . . . . 0.0 109.402 -178.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . 0.755 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.5 m -71.46 -30.5 39.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 172.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 74' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' B' ' 70' ' ' SER . 0.4 OUTLIER -67.92 -32.31 72.68 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.235 175.134 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -63.08 -43.76 97.64 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.888 177.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.41 ' O ' ' SG ' ' B' ' 76' ' ' CYS . 26.3 t -95.08 4.4 53.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.037 178.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . 0.455 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 8.9 t70 . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.141 176.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.443 ' C ' ' HA3' ' B' ' 60' ' ' GLY . 93.5 Cg_endo . . . . . 0 CA--C 1.517 -0.344 0 N-CA-C 109.114 -1.148 . . . . 0.0 109.114 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.9 m -65.31 177.78 1.04 Allowed 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 162.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.707 ' CB ' ' HA ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -77.27 -54.08 6.92 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.566 174.541 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.5 ' CG ' ' HG3' ' A' ' 42' ' ' MET . 1.8 p-10 -86.58 6.62 29.95 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.792 -165.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.623 ' CG2' ' HD3' ' B' ' 59' ' ' LYS . 0.7 OUTLIER -62.21 -4.94 1.97 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.025 0.441 . . . . 0.0 111.613 -177.507 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.647 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.4 m -75.93 130.3 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 174.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.699 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -154.79 159.64 40.75 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 118.6 -1.24 . . . . 0.0 113.643 -179.752 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.465 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.4 mt-30 -41.39 113.75 0.44 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.125 -1.852 . . . . 0.0 112.809 -178.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.98 -141.75 6.24 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.56 174.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.6 m -62.01 96.81 0.07 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 117.011 0.406 . . . . 0.0 110.528 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.2 pttt 41.54 41.94 1.8 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.423 1.089 . . . . 0.0 112.093 -176.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -58.77 140.0 86.12 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.114 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.509 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 31.5 Cg_exo -54.25 123.55 13.85 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.23 1.953 . . . . 0.0 110.041 178.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.739 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 10.4 t80 -71.13 -52.4 9.35 Favored Pre-proline 0 N--CA 1.439 -0.991 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -166.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.567 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 37.5 Cg_exo -56.47 -19.38 28.91 Favored 'Trans proline' 0 C--N 1.36 1.134 0 C-N-CA 121.478 1.452 . . . . 0.0 111.116 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.509 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.4 m-20 -90.71 -39.32 12.51 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 113.952 -1.476 . . . . 0.0 110.766 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.465 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -56.78 -44.05 81.46 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.532 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.674 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 2.4 p -78.72 -32.99 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.12 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.71 -35.11 68.14 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 121.967 -0.458 . . . . 0.0 111.91 175.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.722 ' O ' HG11 ' A' ' 24' ' ' VAL . 15.3 ptt180 -85.18 -25.38 27.44 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.602 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 3.9 tp -55.57 -48.73 74.31 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.313 171.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.674 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 36.4 mt-30 -66.78 -52.05 48.59 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.658 177.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.737 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 11.4 t70 -47.79 -53.75 14.43 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -175.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.722 HG11 ' O ' ' A' ' 20' ' ' ARG . 4.3 p -82.53 -26.6 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 CA-C-O 122.04 0.924 . . . . 0.0 109.56 -169.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.865 ' HB1' ' CZ ' ' A' ' 35' ' ' ARG . . . -78.51 -16.88 57.01 Favored 'General case' 0 C--O 1.197 -1.699 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 176.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.466 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -80.04 -37.14 34.62 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.821 0.82 . . . . 0.0 108.88 172.875 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.737 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 44.5 mmtt -63.69 -32.73 74.31 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.429 176.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.7 m -106.06 -11.39 16.14 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.06 0.457 . . . . 0.0 110.622 -174.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.657 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 96.3 mt -117.58 119.43 61.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.57 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.28 -1.87 58.27 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.346 0.593 . . . . 0.0 110.08 175.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.53 ' H ' HG23 ' A' ' 29' ' ' ILE . 9.6 t70 -96.65 121.83 38.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.385 -176.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -68.06 -23.02 64.91 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.999 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.518 ' HE3' ' OD2' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -82.42 -54.04 5.52 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -177.42 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.444 ' HA ' HG23 ' A' ' 37' ' ' VAL . . . -57.91 -24.96 60.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.84 178.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.899 ' NH1' ' HA ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -69.14 -62.2 1.48 Allowed 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 176.92 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.458 ' HB3' ' OE2' ' A' ' 40' ' ' GLU . 18.0 mtpt -52.43 -53.93 38.85 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 120.809 0.338 . . . . 0.0 111.119 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.693 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 14.2 m -55.27 -35.65 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.308 -172.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.66 HG23 HH22 ' A' ' 35' ' ' ARG . 0.1 OUTLIER -87.36 -26.95 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 178.088 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.687 HG12 ' O ' ' A' ' 35' ' ' ARG . 1.1 m -59.73 -55.97 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 119.091 -1.044 . . . . 0.0 108.316 169.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.554 ' HB3' HG22 ' A' ' 68' ' ' VAL . 41.7 mt-10 -61.52 -34.33 75.34 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.713 -178.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.693 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -74.87 -58.87 3.02 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.613 179.642 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.5 ' HG3' ' CG ' ' A' ' 4' ' ' ASN . 22.8 mmt -66.96 -20.13 65.84 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.418 0.628 . . . . 0.0 110.022 -174.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.648 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -51.75 -27.07 10.88 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.43 171.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.51 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 18.1 t80 -106.18 -67.6 0.92 Allowed 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.614 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 8.0 mm-40 -47.49 -32.91 5.66 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 124.377 1.048 . . . . 0.0 112.284 -173.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.699 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.4 m-20 -104.47 -21.06 13.51 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.413 -174.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 43' ' ' ALA . . . -59.46 179.43 0.11 Allowed 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.797 0.808 . . . . 0.0 112.86 -174.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.626 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 8.6 m-20 -60.1 141.05 90.58 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.346 175.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -43.1 -44.65 9.67 Favored 'Trans proline' 0 C--N 1.331 -0.368 0 C-N-CA 122.819 2.346 . . . . 0.0 112.025 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.46 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 0.2 OUTLIER -76.79 -31.74 57.19 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.314 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.626 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 81.4 m -76.96 -36.33 56.58 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 120.901 0.382 . . . . 0.0 110.238 -173.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.484 ' HA ' HD13 ' A' ' 55' ' ' ILE . 3.6 pt20 -73.25 -30.92 63.79 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 173.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.587 ' O ' ' HE3' ' A' ' 56' ' ' LYS . 3.9 m -68.91 -19.8 64.21 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.052 -1.431 . . . . 0.0 110.446 173.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 51' ' ' CYS . . . -78.75 -27.1 44.68 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.646 0.736 . . . . 0.0 109.93 167.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.571 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 22.7 mt -89.23 -32.48 5.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -172.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.593 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -40.57 -38.72 1.29 Allowed Pre-proline 0 N--CA 1.488 1.428 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -174.461 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 53.3 Cg_endo -64.06 -28.53 65.75 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 122.233 1.956 . . . . 0.0 112.828 175.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.521 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.0 OUTLIER -99.51 -14.6 18.99 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.722 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.628 ' HD3' ' CG2' ' B' ' 5' ' ' THR . 0.1 OUTLIER -50.0 109.78 0.32 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.404 -178.844 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.443 ' HA3' ' C ' ' B' ' 1' ' ' PRO . . . 87.18 -17.94 39.49 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.358 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt -103.59 114.9 29.52 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.473 ' HB ' HG13 ' A' ' 68' ' ' VAL . 7.3 p -123.57 142.33 38.74 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.352 174.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo . . . . . 0 N--CA 1.463 -0.289 0 C-N-CA 122.349 2.033 . . . . 0.0 111.295 169.09 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.6 t70 . . . . . 0 CA--C 1.511 -0.532 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.554 HG22 ' HB3' ' A' ' 40' ' ' GLU . 1.1 m -81.38 -29.63 10.81 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 C-N-CA 118.33 -1.348 . . . . 0.0 108.787 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.778 ' O ' HG13 ' A' ' 73' ' ' VAL . 5.3 mm -60.14 -47.24 92.79 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.133 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.71 -178.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 40.7 t -47.68 -36.58 11.4 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.14 177.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -85.89 -31.52 22.16 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-O 121.046 0.45 . . . . 0.0 111.018 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.597 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.2 m-30 -74.49 -36.51 63.27 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.672 0.749 . . . . 0.0 109.516 -178.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.778 HG13 ' O ' ' A' ' 69' ' ' ILE . 1.4 m -71.14 -30.72 41.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 173.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.476 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -69.7 -28.58 65.95 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.536 175.477 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 72' ' ' TYR . . . -65.69 -45.81 81.38 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.766 176.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.474 ' SG ' ' HB2' ' A' ' 14' ' ' TYR . 32.0 t -93.17 9.46 35.91 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.826 177.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.476 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 5.1 t70 . . . . . 0 C--N 1.323 -0.552 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.572 175.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 1' ' ' PRO . . . . . 0.443 ' C ' ' HA3' ' A' ' 60' ' ' GLY . 95.6 Cg_endo . . . . . 0 CA--C 1.518 -0.294 0 N-CA-C 109.191 -1.119 . . . . 0.0 109.191 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 2' ' ' SER . . . . . 0.44 ' H ' ' HB2' ' B' ' 1' ' ' PRO . 67.7 m -65.66 177.78 1.16 Allowed 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 162.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.705 ' CB ' ' HA ' ' B' ' 25' ' ' ALA . 0.1 OUTLIER -77.17 -54.28 6.7 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.524 174.583 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . 0.495 ' CG ' ' HG3' ' B' ' 42' ' ' MET . 1.8 p-10 -86.48 6.56 29.88 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.726 -1.125 . . . . 0.0 112.673 -165.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' THR . . . . . 0.628 ' CG2' ' HD3' ' A' ' 59' ' ' LYS . 0.7 OUTLIER -62.28 -4.86 1.98 Allowed 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.98 0.419 . . . . 0.0 111.591 -177.425 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.657 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.4 m -75.92 130.44 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 174.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . 0.688 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -154.99 159.46 40.38 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 118.648 -1.221 . . . . 0.0 113.717 -179.678 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' GLN . . . . . 0.467 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.4 mt-30 -41.12 114.01 0.45 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.276 -1.783 . . . . 0.0 112.832 -178.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.13 -141.94 6.43 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.623 174.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 20.0 m -61.66 96.82 0.07 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.93 0.365 . . . . 0.0 110.572 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 62.3 pttt 41.24 42.24 1.67 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.36 1.064 . . . . 0.0 112.209 -176.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -58.98 139.88 87.11 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.971 178.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . 0.516 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 31.4 Cg_exo -54.25 123.5 13.71 Favored 'Trans proline' 0 CA--C 1.511 -0.665 0 C-N-CA 122.219 1.946 . . . . 0.0 110.145 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' TYR . . . . . 0.732 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 10.2 t80 -70.94 -52.39 9.84 Favored Pre-proline 0 N--CA 1.44 -0.97 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -166.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.559 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 38.3 Cg_exo -56.47 -19.45 29.24 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 121.495 1.463 . . . . 0.0 111.127 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.516 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.3 m-20 -90.69 -38.93 12.75 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 113.933 -1.485 . . . . 0.0 110.895 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' PHE . . . . . 0.467 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -57.23 -43.94 83.34 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.562 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.655 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 2.4 p -78.72 -33.15 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.072 -179.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.65 -35.05 67.93 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 121.846 -0.534 . . . . 0.0 111.939 175.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.723 ' O ' HG11 ' B' ' 24' ' ' VAL . 15.3 ptt180 -85.13 -25.6 27.38 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.605 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 3.9 tp -55.26 -48.89 73.34 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 171.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' GLN . . . . . 0.655 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 36.1 mt-30 -66.65 -52.19 47.72 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.661 177.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.735 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 11.6 t70 -47.54 -54.01 12.84 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -176.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' VAL . . . . . 0.723 HG11 ' O ' ' B' ' 20' ' ' ARG . 4.2 p -82.46 -26.45 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 CA-C-O 121.975 0.893 . . . . 0.0 109.569 -169.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.862 ' HB1' ' CZ ' ' B' ' 35' ' ' ARG . . . -78.57 -16.81 56.99 Favored 'General case' 0 C--O 1.198 -1.638 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 176.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . 0.452 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -80.15 -37.29 33.77 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.025 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.735 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 45.0 mmtt -63.67 -32.83 74.44 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.333 177.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 29.2 m -106.02 -11.18 16.23 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.087 0.47 . . . . 0.0 110.578 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.678 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 95.9 mt -117.79 119.34 61.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.554 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.42 -1.63 58.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.309 0.576 . . . . 0.0 110.114 175.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.528 ' H ' HG23 ' B' ' 29' ' ' ILE . 9.3 t70 -96.84 121.96 39.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.457 -177.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -68.4 -22.68 64.62 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.95 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.509 ' HE3' ' OD2' ' B' ' 31' ' ' ASP . 0.0 OUTLIER -82.54 -53.94 5.56 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -177.555 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.461 ' HA ' HG23 ' B' ' 37' ' ' VAL . . . -57.95 -24.95 60.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.881 178.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.915 ' NH1' ' HA ' ' B' ' 35' ' ' ARG . 0.0 OUTLIER -69.11 -62.21 1.47 Allowed 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.843 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.441 ' HB3' ' OE2' ' B' ' 40' ' ' GLU . 18.0 mtpt -52.45 -54.06 37.22 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 120.715 0.293 . . . . 0.0 111.087 -178.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.689 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 14.1 m -55.1 -35.77 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.321 -172.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.652 HG23 HH22 ' B' ' 35' ' ' ARG . 0.1 OUTLIER -87.38 -26.94 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 178.142 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.675 HG12 ' O ' ' B' ' 35' ' ' ARG . 1.1 m -59.62 -56.05 19.8 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 C-N-CA 118.987 -1.085 . . . . 0.0 108.318 168.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.54 ' HB3' HG22 ' B' ' 68' ' ' VAL . 43.7 mt-10 -61.34 -34.66 75.63 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 114.46 -1.245 . . . . 0.0 111.672 -177.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.689 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -74.53 -58.86 3.02 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.7 179.716 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' MET . . . . . 0.495 ' HG3' ' CG ' ' B' ' 4' ' ' ASN . 22.9 mmt -66.86 -20.2 65.88 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.343 0.592 . . . . 0.0 109.964 -174.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.643 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -51.77 -27.22 11.47 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.313 171.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' TYR . . . . . 0.506 ' CG ' ' HD2' ' B' ' 59' ' ' LYS . 18.1 t80 -106.08 -67.57 0.92 Allowed 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 175.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.615 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 7.8 mm-40 -47.54 -33.04 5.94 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 124.378 1.049 . . . . 0.0 112.196 -173.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.688 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.4 m-20 -104.39 -20.93 13.57 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.419 -174.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' B' ' 43' ' ' ALA . . . -59.62 179.43 0.12 Allowed 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.8 0.809 . . . . 0.0 112.864 -174.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' ASN . . . . . 0.626 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 8.8 m-20 -59.99 140.98 90.24 Favored Pre-proline 0 N--CA 1.443 -0.796 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.488 175.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -43.4 -44.32 10.53 Favored 'Trans proline' 0 C--N 1.332 -0.337 0 C-N-CA 122.792 2.328 . . . . 0.0 112.016 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . 0.46 ' HA ' ' HB2' ' B' ' 53' ' ' SER . 0.2 OUTLIER -76.94 -31.55 56.7 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.326 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.626 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 83.4 m -77.26 -36.45 54.39 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -173.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . 0.467 ' HA ' HD13 ' B' ' 55' ' ' ILE . 3.6 pt20 -73.16 -30.94 63.93 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 173.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' SER . . . . . 0.592 ' O ' ' HE3' ' B' ' 56' ' ' LYS . 3.7 m -68.9 -19.84 64.23 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.183 -1.371 . . . . 0.0 110.498 173.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' B' ' 51' ' ' CYS . . . -78.67 -27.08 45.11 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.612 0.72 . . . . 0.0 110.006 167.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.572 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 22.6 mt -89.39 -32.24 5.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 -171.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . 0.592 ' HE3' ' O ' ' B' ' 53' ' ' SER . 0.0 OUTLIER -40.7 -38.71 1.34 Allowed Pre-proline 0 N--CA 1.487 1.384 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -174.601 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 51.7 Cg_endo -63.72 -29.0 68.81 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.193 1.928 . . . . 0.0 112.809 175.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . 0.538 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.0 OUTLIER -99.29 -14.6 19.17 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 -179.5 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . 0.623 ' HD3' ' CG2' ' A' ' 5' ' ' THR . 0.1 OUTLIER -49.87 109.78 0.32 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.448 -178.903 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . 0.443 ' HA3' ' C ' ' A' ' 1' ' ' PRO . . . 87.09 -18.32 36.89 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.357 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -103.36 114.85 29.46 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -178.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.47 ' HB ' HG13 ' B' ' 68' ' ' VAL . 7.4 p -123.55 142.41 38.91 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.353 174.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo . . . . . 0 C--O 1.235 0.351 0 C-N-CA 122.41 2.073 . . . . 0.0 111.419 168.941 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 2.7 t70 . . . . . 0 CA--C 1.512 -0.516 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . 0.54 HG22 ' HB3' ' B' ' 40' ' ' GLU . 1.1 m -81.37 -29.54 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 C-N-CA 118.371 -1.331 . . . . 0.0 108.856 178.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . 0.778 ' O ' HG13 ' B' ' 73' ' ' VAL . 5.3 mm -60.18 -47.14 93.27 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.093 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.695 -178.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 70' ' ' SER . . . . . 0.432 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 40.8 t -48.01 -36.51 12.89 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.078 177.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -85.79 -31.25 22.44 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 122.862 0.465 . . . . 0.0 111.079 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 72' ' ' TYR . . . . . 0.585 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.2 m-30 -74.77 -36.72 62.55 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 121.671 0.748 . . . . 0.0 109.489 -178.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . 0.778 HG13 ' O ' ' B' ' 69' ' ' ILE . 1.4 m -70.9 -30.82 43.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 173.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 74' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' B' ' 77' ' ' ASP . 0.0 OUTLIER -69.66 -28.54 65.97 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.552 175.495 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' B' ' 72' ' ' TYR . . . -65.51 -46.12 80.89 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.752 176.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.473 ' SG ' ' HB2' ' B' ' 14' ' ' TYR . 32.1 t -93.02 9.78 34.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.84 178.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . 0.487 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 4.4 t70 . . . . . 0 C--N 1.322 -0.605 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.637 175.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.415 ' HB2' ' H ' ' A' ' 2' ' ' SER . 90.6 Cg_endo . . . . . 0 N--CA 1.464 -0.227 0 N-CA-C 108.601 -1.346 . . . . 0.0 108.601 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.415 ' H ' ' HB2' ' A' ' 1' ' ' PRO . 51.2 m -70.44 -176.12 1.17 Allowed 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 163.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.474 ' CD2' ' HB2' ' A' ' 28' ' ' SER . 0.0 OUTLIER -77.14 -54.42 6.54 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 122.406 1.098 . . . . 0.0 109.062 171.681 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.53 ' HA ' HD11 ' A' ' 21' ' ' LEU . 2.4 p-10 -85.6 5.91 29.66 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 113.533 -1.667 . . . . 0.0 113.332 -160.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.4 ' O ' ' HG2' ' A' ' 7' ' ' ARG . 0.7 OUTLIER -69.24 -1.05 7.02 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -174.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.718 HG22 ' O ' ' A' ' 6' ' ' VAL . 24.0 m -81.41 92.84 2.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 122.259 1.028 . . . . 0.0 112.162 -174.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 1.112 ' NE ' ' HB3' ' A' ' 46' ' ' ASN . 13.8 mmm180 -107.19 150.6 26.44 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.506 -1.371 . . . . 0.0 112.978 -159.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.579 ' HG3' ' CG ' ' A' ' 17' ' ' PHE . 2.1 tt0 -44.41 109.12 0.14 Allowed 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 112.53 -2.123 . . . . 0.0 111.572 173.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.39 -152.56 9.42 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.742 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.8 m -55.81 97.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.911 0.355 . . . . 0.0 110.733 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.7 pttt 40.24 46.1 1.88 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.267 1.027 . . . . 0.0 111.935 -172.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -60.34 136.49 91.71 Favored Pre-proline 0 C--O 1.236 0.381 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.445 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 38.4 Cg_exo -53.46 120.52 7.92 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.198 1.932 . . . . 0.0 110.943 -177.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.798 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 5.4 t80 -64.94 -56.05 23.54 Favored Pre-proline 0 C--N 1.313 -0.986 0 C-N-CA 119.73 -0.788 . . . . 0.0 112.737 -161.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.553 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 35.2 Cg_exo -55.89 -19.69 26.46 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.009 1.806 . . . . 0.0 111.508 -176.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.445 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.2 m-20 -89.46 -38.41 14.08 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.233 -178.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.911 ' HE1' ' NH2' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -61.74 -42.12 98.55 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.09 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 14' ' ' TYR . 1.7 p -80.63 -31.69 12.71 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.9 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.841 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 15' ' ' PRO . . . -55.67 -36.74 67.43 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 121.762 -0.586 . . . . 0.0 110.975 175.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.724 ' O ' HG11 ' A' ' 24' ' ' VAL . 15.4 ptt180 -82.29 -27.08 32.56 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.644 HD13 ' NH1' ' A' ' 7' ' ' ARG . 9.7 tp -55.24 -44.3 75.38 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.175 172.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.655 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 26.1 mt-30 -73.97 -51.57 15.57 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.309 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.738 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 45.3 m-20 -47.02 -51.28 17.67 Favored 'General case' 0 C--N 1.313 -1.006 0 O-C-N 124.532 1.145 . . . . 0.0 110.917 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.724 HG11 ' O ' ' A' ' 20' ' ' ARG . 9.9 p -79.64 -27.15 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 C-N-CA 119.936 -0.705 . . . . 0.0 109.833 -171.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.638 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -66.69 -31.57 72.33 Favored 'General case' 0 C--O 1.204 -1.301 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 175.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.409 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -74.69 -35.96 62.75 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.042 -1.435 . . . . 0.0 109.932 -178.19 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.738 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 37.3 mmtt -67.41 -36.38 81.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.466 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.474 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 21.6 m -104.89 -10.23 17.45 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.193 0.521 . . . . 0.0 110.656 -171.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.638 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 78.1 mt -113.94 124.85 70.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.198 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.95 -1.87 57.73 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.947 0.403 . . . . 0.0 110.863 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.562 ' H ' HG22 ' A' ' 29' ' ' ILE . 4.1 t0 -114.13 140.12 48.77 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-O 121.618 0.723 . . . . 0.0 111.528 -177.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -71.02 -32.17 68.86 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.36 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.494 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 12.0 mttp -67.07 -56.1 11.5 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -176.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.465 ' HA ' HG21 ' A' ' 37' ' ' VAL . . . -61.92 -25.49 67.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.57 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.828 ' O ' HG12 ' A' ' 39' ' ' VAL . 1.8 tmm_? -68.67 -58.62 3.97 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.417 ' HB3' ' OE2' ' A' ' 40' ' ' GLU . 15.8 mtpt -55.91 -57.0 13.96 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.205 179.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.783 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 23.9 m -52.25 -36.91 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.048 -170.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.411 ' CD1' ' HE1' ' A' ' 3' ' ' PHE . 1.3 tt -88.31 -30.83 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 C-N-CA 119.823 -0.751 . . . . 0.0 112.161 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.828 HG12 ' O ' ' A' ' 35' ' ' ARG . 3.2 m -67.01 -50.16 66.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 119.24 -0.984 . . . . 0.0 109.242 174.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.634 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 54.7 mt-10 -66.51 -23.58 66.27 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 123.816 0.846 . . . . 0.0 112.406 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.783 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -85.84 -56.97 3.23 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.325 176.338 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.507 ' HG3' ' HB2' ' A' ' 4' ' ' ASN . 25.0 mmt -59.82 -24.95 64.59 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 121.348 0.594 . . . . 0.0 109.996 -175.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.703 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -46.66 -28.3 1.44 Allowed 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.149 174.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.576 ' CG ' ' HB2' ' A' ' 52' ' ' GLN . 7.7 t80 -103.99 -68.02 0.87 Allowed 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 174.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.722 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 5.5 mm-40 -45.23 -35.45 3.34 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.25 -1.341 . . . . 0.0 112.834 -171.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 1.112 ' HB3' ' NE ' ' A' ' 7' ' ' ARG . 1.4 m-20 -111.76 -7.34 14.22 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.873 -172.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -68.01 -169.9 0.15 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.601 0.715 . . . . 0.0 112.425 -175.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.578 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 11.2 m-20 -66.03 140.42 97.04 Favored Pre-proline 0 N--CA 1.442 -0.836 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.939 171.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.445 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 3.0 Cg_endo -46.74 -46.75 17.43 Favored 'Trans proline' 0 CA--C 1.53 0.308 0 C-N-CA 122.642 2.228 . . . . 0.0 111.928 -176.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.52 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 0.3 OUTLIER -72.15 -31.31 65.84 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 124.185 0.994 . . . . 0.0 111.62 177.8 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.578 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 96.0 m -75.25 -36.36 61.29 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 120.889 0.376 . . . . 0.0 110.03 -173.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.576 ' HB2' ' CG ' ' A' ' 44' ' ' TYR . 4.3 pt20 -73.38 -32.21 64.36 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 174.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.601 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 27.0 m -66.87 -21.46 66.01 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 114.033 -1.439 . . . . 0.0 110.064 173.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 51' ' ' CYS . . . -77.85 -27.43 49.84 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.431 -0.793 . . . . 0.0 110.036 169.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.578 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 23.4 mt -89.11 -31.16 5.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -171.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.614 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.93 -39.27 2.64 Favored Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -173.347 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 57.3 Cg_endo -64.33 -25.98 63.9 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.457 2.104 . . . . 0.0 112.925 176.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.497 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.3 mt -99.96 -16.31 18.01 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.569 ' HE3' ' HB3' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -53.01 109.64 0.44 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.988 -178.947 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.29 -21.57 41.75 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.548 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -103.82 113.51 27.09 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 121.147 0.498 . . . . 0.0 110.032 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.12 143.78 43.51 Favored Pre-proline 0 C--N 1.312 -1.051 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 170.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo . . . . . 0 C--N 1.346 0.431 0 C-N-CA 122.767 2.311 . . . . 0.0 111.836 168.71 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.757 ' OD1' ' HB ' ' A' ' 69' ' ' ILE . 19.3 t70 . . . . . 0 C--O 1.232 0.163 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.551 HG13 ' CD ' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -80.96 -30.89 11.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 C-N-CA 118.647 -1.221 . . . . 0.0 109.472 178.259 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.79 ' O ' HG12 ' A' ' 73' ' ' VAL . 14.5 mm -57.63 -46.78 86.46 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.223 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 178.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.4 t -43.24 -39.34 2.94 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.478 174.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -85.45 -33.59 21.85 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 123.413 0.685 . . . . 0.0 110.831 -177.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.634 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.2 m-30 -75.38 -35.04 61.14 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.467 -176.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.798 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.6 m -70.64 -31.92 47.73 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.459 ' HA ' ' HB2' ' A' ' 77' ' ' ASP . 23.1 ttpt -71.79 -27.53 63.01 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.616 -1.174 . . . . 0.0 109.865 176.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -64.8 -44.54 89.61 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.59 175.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 14' ' ' TYR . 31.0 t -92.95 9.14 36.82 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.648 177.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.459 ' HB2' ' HA ' ' A' ' 74' ' ' LYS . 25.2 t70 . . . . . 0 C--N 1.325 -0.471 0 CA-C-O 121.507 0.67 . . . . 0.0 109.914 174.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo . . . . . 0 N--CA 1.464 -0.23 0 N-CA-C 108.679 -1.316 . . . . 0.0 108.679 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 49.7 m -70.13 -176.13 1.09 Allowed 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 163.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.458 ' CD2' ' HB2' ' B' ' 28' ' ' SER . 0.0 OUTLIER -77.23 -54.36 6.59 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 122.398 1.095 . . . . 0.0 109.021 171.852 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . 0.544 ' HA ' HD11 ' B' ' 21' ' ' LEU . 2.4 p-10 -85.49 5.97 28.95 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 113.446 -1.706 . . . . 0.0 113.366 -160.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.44 -1.09 7.57 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -174.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.735 HG22 ' O ' ' B' ' 6' ' ' VAL . 23.3 m -81.38 92.78 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-O 122.264 1.03 . . . . 0.0 112.08 -174.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . 1.119 ' NE ' ' HB3' ' B' ' 46' ' ' ASN . 13.8 mmm180 -107.17 150.71 26.31 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.512 -1.368 . . . . 0.0 113.007 -159.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' GLN . . . . . 0.573 ' HG3' ' CG ' ' B' ' 17' ' ' PHE . 2.1 tt0 -44.43 109.23 0.14 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 112.626 -2.079 . . . . 0.0 111.617 172.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.45 -152.61 9.56 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.708 176.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 19.6 m -56.15 98.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.822 0.311 . . . . 0.0 110.709 -177.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 52.7 pttt 39.86 46.79 1.74 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.054 0.942 . . . . 0.0 111.909 -172.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.413 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 46.9 tt0 -60.81 136.33 93.05 Favored Pre-proline 0 C--O 1.234 0.278 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . 0.449 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 39.8 Cg_exo -53.34 120.55 7.94 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.079 1.852 . . . . 0.0 111.012 -177.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' TYR . . . . . 0.796 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 5.5 t80 -65.07 -56.04 22.98 Favored Pre-proline 0 C--N 1.314 -0.972 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.709 -161.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.554 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 32.1 Cg_exo -55.87 -19.62 26.01 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 121.987 1.792 . . . . 0.0 111.521 -176.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.449 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.2 m-20 -89.45 -38.62 13.93 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.145 -178.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' PHE . . . . . 0.903 ' HE1' ' NH2' ' B' ' 7' ' ' ARG . 0.1 OUTLIER -61.62 -42.15 98.47 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.273 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.653 HG12 ' O ' ' B' ' 14' ' ' TYR . 1.7 p -80.69 -31.48 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.947 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' B' ' 15' ' ' PRO . . . -55.96 -36.54 67.93 Favored 'General case' 0 C--N 1.315 -0.902 0 O-C-N 121.653 -0.654 . . . . 0.0 110.922 175.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.724 ' O ' HG11 ' B' ' 24' ' ' VAL . 15.5 ptt180 -82.37 -27.14 32.3 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.654 HD13 ' NH1' ' B' ' 7' ' ' ARG . 9.7 tp -55.14 -44.44 75.09 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.11 172.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' GLN . . . . . 0.645 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 25.5 mt-30 -73.97 -51.58 15.54 Favored 'General case' 0 CA--C 1.486 -1.494 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.24 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.724 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 41.7 m-20 -46.96 -51.38 17.17 Favored 'General case' 0 C--N 1.311 -1.08 0 O-C-N 124.34 1.025 . . . . 0.0 110.874 178.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' VAL . . . . . 0.724 HG11 ' O ' ' B' ' 20' ' ' ARG . 9.8 p -79.51 -27.29 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.789 -171.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.637 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -66.61 -31.66 72.5 Favored 'General case' 0 C--O 1.205 -1.288 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 175.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . 0.401 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -74.52 -36.26 63.18 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 114.0 -1.455 . . . . 0.0 109.81 -178.225 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.724 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.1 mmtt -67.17 -36.42 81.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.394 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' SER . . . . . 0.458 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 25.2 m -104.69 -10.46 17.47 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.364 0.602 . . . . 0.0 110.609 -171.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.637 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 78.3 mt -113.65 124.86 70.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.313 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.21 -1.94 57.91 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.972 0.415 . . . . 0.0 110.732 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.554 ' H ' HG22 ' B' ' 29' ' ' ILE . 4.0 t0 -113.48 140.59 47.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.58 0.705 . . . . 0.0 111.481 -177.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -71.55 -32.26 67.91 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.469 175.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.489 ' HD2' ' OD1' ' B' ' 31' ' ' ASP . 11.8 mttp -67.08 -55.92 12.24 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -176.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.471 ' HA ' HG21 ' B' ' 37' ' ' VAL . . . -61.97 -25.52 67.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.559 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.845 ' O ' HG12 ' B' ' 39' ' ' VAL . 1.8 tmm_? -68.7 -58.66 3.91 Favored 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.427 ' HB3' ' OE2' ' B' ' 40' ' ' GLU . 15.7 mtpt -55.86 -57.04 13.73 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.227 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.796 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 23.6 m -52.25 -36.91 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.094 -170.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.417 ' CD1' ' HE1' ' B' ' 3' ' ' PHE . 1.3 tt -88.16 -30.85 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.218 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.845 HG12 ' O ' ' B' ' 35' ' ' ARG . 3.2 m -66.96 -50.19 66.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.309 174.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.631 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 52.1 mt-10 -66.4 -23.76 66.37 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 123.891 0.877 . . . . 0.0 112.351 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.796 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.77 -57.12 3.17 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.238 176.447 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' MET . . . . . 0.505 ' HG3' ' HB2' ' B' ' 4' ' ' ASN . 25.1 mmt -59.63 -25.0 64.32 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.358 0.599 . . . . 0.0 109.993 -175.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.693 ' O ' ' HB2' ' B' ' 47' ' ' ALA . . . -46.63 -28.45 1.47 Allowed 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.133 174.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' TYR . . . . . 0.574 ' CG ' ' HB2' ' B' ' 52' ' ' GLN . 7.8 t80 -103.74 -68.02 0.86 Allowed 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 174.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.742 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 5.6 mm-40 -45.22 -35.74 3.5 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.186 -1.37 . . . . 0.0 112.778 -171.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 1.119 ' HB3' ' NE ' ' B' ' 7' ' ' ARG . 1.4 m-20 -111.7 -7.21 14.26 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.846 -172.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.693 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -68.03 -169.74 0.15 Allowed 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.62 0.724 . . . . 0.0 112.498 -175.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' ASN . . . . . 0.588 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 11.2 m-20 -66.21 140.38 96.85 Favored Pre-proline 0 N--CA 1.442 -0.843 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.083 171.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . 0.447 ' O ' ' HG2' ' B' ' 52' ' ' GLN . 2.9 Cg_endo -46.83 -46.63 17.92 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.685 2.257 . . . . 0.0 111.866 -176.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . 0.514 ' HA ' ' HB2' ' B' ' 53' ' ' SER . 0.3 OUTLIER -72.31 -31.14 65.44 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 124.199 1.0 . . . . 0.0 111.591 177.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 94.6 m -75.3 -36.43 61.12 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 120.996 0.427 . . . . 0.0 109.993 -173.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . 0.574 ' HB2' ' CG ' ' B' ' 44' ' ' TYR . 4.4 pt20 -73.43 -32.07 64.18 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 174.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' SER . . . . . 0.613 ' O ' ' HE2' ' B' ' 56' ' ' LYS . 26.4 m -66.97 -21.45 65.97 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 114.014 -1.448 . . . . 0.0 109.999 173.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' B' ' 51' ' ' CYS . . . -78.0 -27.29 48.98 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.398 -0.814 . . . . 0.0 109.985 169.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.582 HD13 ' HH ' ' B' ' 14' ' ' TYR . 23.3 mt -89.17 -31.28 5.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 -171.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . 0.613 ' HE2' ' O ' ' B' ' 53' ' ' SER . 0.0 OUTLIER -41.8 -39.37 2.59 Favored Pre-proline 0 N--CA 1.488 1.435 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -173.263 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 57.5 Cg_endo -64.17 -26.25 64.99 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.383 2.055 . . . . 0.0 112.925 176.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . 0.507 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.4 mt -99.78 -16.54 18.06 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . 0.566 ' HA ' ' OH ' ' B' ' 72' ' ' TYR . 0.0 OUTLIER -52.66 109.77 0.44 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.131 -179.093 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.97 -21.63 40.75 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.696 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -103.92 113.48 27.05 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.21 0.528 . . . . 0.0 110.051 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.18 143.41 42.59 Favored Pre-proline 0 C--N 1.312 -1.05 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.765 170.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo . . . . . 0 C--N 1.347 0.475 0 C-N-CA 122.686 2.257 . . . . 0.0 111.944 168.807 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 67' ' ' ASP . . . . . 0.749 ' OD1' ' HB ' ' B' ' 69' ' ' ILE . 19.5 t70 . . . . . 0 CA--C 1.52 -0.208 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . 0.553 HG13 ' CD ' ' B' ' 40' ' ' GLU . 0.8 OUTLIER -80.93 -30.95 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 C-N-CA 118.588 -1.245 . . . . 0.0 109.517 178.193 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . 0.793 ' O ' HG12 ' B' ' 73' ' ' VAL . 14.3 mm -57.57 -47.04 86.14 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.181 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 30.8 t -43.38 -39.22 3.08 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.45 174.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -85.34 -33.48 22.04 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 123.503 0.721 . . . . 0.0 110.807 -177.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 72' ' ' TYR . . . . . 0.623 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.1 m-30 -75.44 -35.04 61.0 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.449 -176.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . 0.796 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.6 m -70.86 -31.79 46.68 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 173.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 74' ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' B' ' 77' ' ' ASP . 23.0 ttpt -71.84 -27.53 62.96 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.81 176.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -64.9 -44.18 90.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.651 175.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.548 ' SG ' ' HB2' ' B' ' 14' ' ' TYR . 30.7 t -93.45 9.22 37.46 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.612 177.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' B' ' 74' ' ' LYS . 24.7 t70 . . . . . 0 C--N 1.326 -0.435 0 CA-C-O 121.576 0.703 . . . . 0.0 110.068 173.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.464 ' HB2' ' H ' ' A' ' 2' ' ' SER . 95.0 Cg_endo . . . . . 0 CA--C 1.517 -0.337 0 N-CA-C 109.293 -1.08 . . . . 0.0 109.293 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.464 ' H ' ' HB2' ' A' ' 1' ' ' PRO . 67.1 m -68.73 167.95 14.28 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 163.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.483 ' CE1' HD13 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -70.96 -54.38 11.52 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.992 0.901 . . . . 0.0 109.864 172.79 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.561 ' ND2' ' HE1' ' A' ' 42' ' ' MET . 3.0 p-10 -86.76 -4.04 59.13 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.419 -1.264 . . . . 0.0 113.181 -164.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.456 ' HA ' ' OE1' ' B' ' 45' ' ' GLU . 9.9 t -65.47 -2.97 3.72 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.29 0.567 . . . . 0.0 111.075 -173.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.579 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.7 m -73.05 135.26 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 172.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.717 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -154.59 159.43 40.86 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 -178.789 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.534 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.4 mt-30 -42.83 118.98 1.36 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 112.585 -2.098 . . . . 0.0 113.318 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.9 -161.66 37.68 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.843 169.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.5 m -48.05 102.44 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 117.097 0.448 . . . . 0.0 111.592 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.3 pttt 38.91 44.28 0.84 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.533 1.133 . . . . 0.0 112.498 -173.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.453 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 37.8 tt0 -61.96 138.04 95.59 Favored Pre-proline 0 C--O 1.234 0.26 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 177.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.558 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 50.4 Cg_exo -50.68 122.55 9.88 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.244 1.963 . . . . 0.0 110.173 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.765 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 11.3 t80 -71.28 -54.17 7.29 Favored Pre-proline 0 N--CA 1.44 -0.934 0 CA-C-O 118.471 -0.776 . . . . 0.0 113.08 -167.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.535 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 34.5 Cg_exo -55.69 -18.79 21.94 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 121.459 1.44 . . . . 0.0 111.122 -179.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.558 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 2.0 m-20 -90.13 -42.2 11.21 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.881 -1.509 . . . . 0.0 111.001 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.534 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -54.6 -44.17 72.8 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.16 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.771 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 2.0 p -80.84 -34.15 13.77 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.362 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.692 -178.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 15' ' ' PRO . . . -58.16 -31.64 67.43 Favored 'General case' 0 C--N 1.317 -0.841 0 O-C-N 121.276 -0.89 . . . . 0.0 111.881 177.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.708 ' O ' HG13 ' A' ' 24' ' ' VAL . 16.0 ptt180 -84.03 -29.9 26.54 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 175.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.549 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 8.3 tp -53.61 -49.61 67.45 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.992 172.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.771 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 24.6 mt-30 -69.43 -48.22 61.64 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.187 177.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.723 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 18.1 t70 -47.53 -53.31 14.8 Favored 'General case' 0 C--N 1.315 -0.933 0 O-C-N 124.267 0.979 . . . . 0.0 111.532 -177.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.708 HG13 ' O ' ' A' ' 20' ' ' ARG . 7.4 p -82.1 -22.51 9.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.151 0.5 . . . . 0.0 109.79 -173.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.785 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -72.42 -19.44 61.59 Favored 'General case' 0 C--O 1.202 -1.422 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 173.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.06 -37.44 17.44 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.707 178.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.723 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 37.0 mmtt -66.94 -34.48 77.87 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.694 178.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.6 m -103.58 -11.07 17.96 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.195 0.521 . . . . 0.0 110.582 -172.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.785 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 88.7 mt -118.15 129.76 74.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.67 -178.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.99 -1.44 52.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.441 0.639 . . . . 0.0 110.367 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.558 ' OD2' ' HB2' ' A' ' 33' ' ' LYS . 11.1 t70 -106.81 115.7 30.65 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.458 -177.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.649 ' OE2' ' HG3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -57.12 -33.33 67.24 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.149 178.262 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.649 ' HG3' ' OE2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -70.78 -54.72 10.62 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -173.354 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.457 ' HA ' HG21 ' A' ' 37' ' ' VAL . . . -60.68 -28.82 68.9 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.826 177.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.845 ' O ' HG13 ' A' ' 39' ' ' VAL . 2.1 tmm_? -65.4 -60.39 3.01 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 15.5 mtpt -55.41 -56.65 17.7 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.239 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.708 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 17.6 m -55.18 -33.68 30.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.112 -170.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.508 ' O ' ' HG2' ' A' ' 42' ' ' MET . 1.5 tt -87.25 -31.87 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.635 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.845 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.5 m -68.56 -48.14 73.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 119.015 -1.074 . . . . 0.0 109.178 175.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.663 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 73.0 mt-10 -63.18 -27.93 69.7 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 123.634 0.774 . . . . 0.0 112.749 176.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.708 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -86.04 -50.65 6.88 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.838 178.173 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.561 ' HE1' ' ND2' ' A' ' 4' ' ' ASN . 17.8 mmt -64.85 -20.87 66.64 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.632 0.729 . . . . 0.0 109.764 -178.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.673 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -50.62 -28.63 9.16 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.542 171.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.537 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 19.9 t80 -103.9 -67.61 0.89 Allowed 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 174.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.444 ' OE1' ' HA ' ' B' ' 5' ' ' THR . 27.2 mm-40 -50.54 -28.08 7.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.703 -1.135 . . . . 0.0 113.076 -173.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.717 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.1 m-20 -105.73 -22.24 13.0 Favored 'General case' 0 N--CA 1.435 -1.19 0 O-C-N 122.325 -0.234 . . . . 0.0 110.809 -177.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.616 ' HB3' ' O ' ' A' ' 43' ' ' ALA . . . -60.36 178.76 0.18 Allowed 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 122.059 0.933 . . . . 0.0 112.818 -174.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.658 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 17.1 m-20 -58.2 141.63 81.93 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 114.155 -1.384 . . . . 0.0 109.245 174.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -55.02 -23.41 35.08 Favored 'Trans proline' 0 C--O 1.218 -0.515 0 C-N-CA 123.26 2.64 . . . . 0.0 112.407 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.717 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 13.4 pm0 -88.93 -32.12 17.85 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 123.765 0.826 . . . . 0.0 110.85 175.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.717 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 85.8 m -80.5 -38.15 30.36 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.328 -171.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.506 ' HA ' HD13 ' A' ' 55' ' ' ILE . 4.3 pt20 -70.0 -29.72 66.86 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 172.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.472 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 4.8 m -71.36 -20.82 62.11 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.119 175.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.407 ' HB1' ' O ' ' A' ' 51' ' ' CYS . . . -78.55 -25.15 45.38 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.689 0.757 . . . . 0.0 109.821 168.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.567 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 22.6 mt -89.97 -32.53 5.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -172.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.623 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.99 -39.5 2.9 Favored Pre-proline 0 N--CA 1.486 1.344 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -172.799 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 50.6 Cg_endo -62.18 -28.81 79.88 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.187 1.924 . . . . 0.0 112.646 176.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.515 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.3 mt -98.35 -15.7 19.62 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.569 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -52.39 109.17 0.36 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.078 -179.454 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.54 -22.36 39.42 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.462 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.9 mmmt -103.55 113.0 26.17 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.17 0.509 . . . . 0.0 109.831 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.4 p -124.84 146.45 53.19 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.802 172.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo . . . . . 0 C--N 1.344 0.306 0 C-N-CA 122.288 1.992 . . . . 0.0 111.62 166.343 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.656 ' OD2' ' HB ' ' A' ' 69' ' ' ILE . 0.4 OUTLIER . . . . . 0 CA--C 1.517 -0.318 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.575 HG12 ' CD ' ' A' ' 40' ' ' GLU . 0.7 OUTLIER -78.53 -27.65 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 C-N-CA 118.863 -1.135 . . . . 0.0 108.991 177.373 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.755 ' O ' HG11 ' A' ' 73' ' ' VAL . 12.3 mm -58.12 -46.23 88.38 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.184 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.058 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 29.4 t -46.16 -37.54 7.14 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.157 176.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -85.63 -32.34 22.09 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.149 0.5 . . . . 0.0 110.705 -177.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.58 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.1 m-30 -75.93 -35.18 59.82 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.526 -176.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.765 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.5 m -71.79 -31.77 42.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 172.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -67.08 -31.77 72.48 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.339 175.459 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 72' ' ' TYR . . . -63.65 -46.98 83.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.109 177.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.611 ' SG ' ' HB2' ' A' ' 14' ' ' TYR . 24.4 t -92.44 9.35 34.67 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.902 178.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.435 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 12.1 t70 . . . . . 0 C--N 1.323 -0.554 0 CA-C-O 121.302 0.573 . . . . 0.0 110.261 175.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 1' ' ' PRO . . . . . 0.407 ' HB2' ' H ' ' B' ' 2' ' ' SER . 93.5 Cg_endo . . . . . 0 CA--C 1.515 -0.463 0 N-CA-C 109.364 -1.052 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 2' ' ' SER . . . . . 0.407 ' H ' ' HB2' ' B' ' 1' ' ' PRO . 68.7 m -68.92 168.08 14.4 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 163.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.477 ' CE1' HD13 ' B' ' 29' ' ' ILE . 0.1 OUTLIER -71.11 -54.41 11.2 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.843 0.83 . . . . 0.0 109.788 173.057 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . 0.548 ' ND2' ' HE1' ' B' ' 42' ' ' MET . 3.1 p-10 -86.84 -4.06 59.13 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.492 -1.231 . . . . 0.0 113.13 -164.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' THR . . . . . 0.444 ' HA ' ' OE1' ' A' ' 45' ' ' GLU . 9.9 t -65.39 -2.97 3.6 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.185 0.517 . . . . 0.0 111.083 -173.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.594 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.7 m -73.1 134.96 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 172.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . 0.704 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -154.28 159.5 41.3 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -178.753 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' GLN . . . . . 0.525 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.4 mt-30 -42.94 119.08 1.4 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 112.684 -2.053 . . . . 0.0 113.303 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.99 -161.45 37.53 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 169.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 23.3 m -48.31 102.72 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 117.21 0.505 . . . . 0.0 111.498 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 39.2 pttt 38.83 44.42 0.83 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.611 1.164 . . . . 0.0 112.482 -173.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.444 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 37.7 tt0 -62.05 137.96 95.71 Favored Pre-proline 0 C--N 1.332 -0.182 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . 0.564 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 51.1 Cg_exo -50.71 122.46 9.74 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.227 1.951 . . . . 0.0 110.218 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' TYR . . . . . 0.769 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 11.3 t80 -71.21 -54.13 7.45 Favored Pre-proline 0 N--CA 1.438 -1.034 0 CA-C-O 118.425 -0.798 . . . . 0.0 113.048 -167.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.541 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 34.5 Cg_exo -55.77 -18.87 22.65 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 121.458 1.438 . . . . 0.0 111.072 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.564 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.7 m-20 -90.08 -41.98 11.37 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.037 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' PHE . . . . . 0.525 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -54.82 -44.18 73.62 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 176.254 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.76 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 2.0 p -80.77 -34.29 13.97 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.283 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.626 -178.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.19 -31.51 67.36 Favored 'General case' 0 C--N 1.315 -0.893 0 O-C-N 121.321 -0.862 . . . . 0.0 111.848 177.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.7 ' O ' HG13 ' B' ' 24' ' ' VAL . 16.1 ptt180 -84.03 -29.9 26.54 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 175.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.559 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 8.3 tp -53.56 -49.78 66.95 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.055 172.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' GLN . . . . . 0.76 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 25.2 mt-30 -69.41 -48.24 61.68 Favored 'General case' 0 CA--C 1.493 -1.236 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.191 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.741 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 18.4 t70 -47.25 -53.48 13.27 Favored 'General case' 0 C--N 1.315 -0.898 0 O-C-N 124.187 0.929 . . . . 0.0 111.489 -177.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' VAL . . . . . 0.7 HG13 ' O ' ' B' ' 20' ' ' ARG . 7.4 p -82.13 -22.46 9.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.105 0.479 . . . . 0.0 109.746 -173.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.804 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -72.44 -19.46 61.57 Favored 'General case' 0 C--O 1.201 -1.462 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 173.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.03 -37.55 17.37 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.671 178.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.741 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 36.7 mmtt -66.59 -35.1 79.39 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.6 178.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 44.4 m -103.14 -11.15 18.27 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.327 0.584 . . . . 0.0 110.62 -172.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.804 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 88.9 mt -118.13 129.4 74.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.714 -178.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.53 -1.68 52.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.518 0.675 . . . . 0.0 110.375 176.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.568 ' OD2' ' HB2' ' B' ' 33' ' ' LYS . 11.3 t70 -106.39 115.67 30.6 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.418 -177.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 0.66 ' OE2' ' HG3' ' B' ' 33' ' ' LYS . 0.0 OUTLIER -57.17 -33.14 67.14 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.232 178.184 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.66 ' HG3' ' OE2' ' B' ' 32' ' ' GLU . 0.0 OUTLIER -70.96 -54.58 10.79 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -173.369 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.464 ' HA ' HG21 ' B' ' 37' ' ' VAL . . . -60.71 -28.91 69.0 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.821 177.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.85 ' O ' HG13 ' B' ' 39' ' ' VAL . 2.1 tmm_? -65.27 -60.44 2.99 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 15.6 mtpt -55.58 -56.52 19.32 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.193 -179.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.716 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 17.6 m -55.26 -33.59 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.119 -170.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.501 ' O ' ' HG2' ' B' ' 42' ' ' MET . 1.5 tt -87.36 -31.71 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.596 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.85 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.5 m -68.67 -48.02 73.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 118.944 -1.103 . . . . 0.0 109.193 175.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.663 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 73.2 mt-10 -63.25 -28.02 69.74 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 123.695 0.798 . . . . 0.0 112.668 176.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.716 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.99 -50.63 6.92 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.819 178.295 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' MET . . . . . 0.548 ' HE1' ' ND2' ' B' ' 4' ' ' ASN . 18.0 mmt -64.92 -20.85 66.67 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.683 0.754 . . . . 0.0 109.707 -178.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.666 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -50.65 -28.62 9.26 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.533 171.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' TYR . . . . . 0.539 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 20.1 t80 -103.98 -67.57 0.89 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 174.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.456 ' OE1' ' HA ' ' A' ' 5' ' ' THR . 26.8 mm-40 -50.66 -27.67 7.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.75 -1.114 . . . . 0.0 113.064 -173.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.704 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.2 m-20 -106.06 -22.07 12.97 Favored 'General case' 0 N--CA 1.435 -1.219 0 O-C-N 122.283 -0.261 . . . . 0.0 110.845 -178.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' B' ' 43' ' ' ALA . . . -60.45 178.72 0.19 Allowed 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 122.055 0.931 . . . . 0.0 112.827 -174.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' ASN . . . . . 0.653 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 17.8 m-20 -58.11 141.62 81.44 Favored Pre-proline 0 N--CA 1.44 -0.932 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.187 174.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -55.16 -23.25 35.58 Favored 'Trans proline' 0 C--O 1.22 -0.422 0 C-N-CA 123.21 2.606 . . . . 0.0 112.286 -178.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . 0.688 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 13.5 pm0 -88.84 -32.26 17.89 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.863 0.865 . . . . 0.0 110.906 175.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.688 ' N ' ' HG2' ' B' ' 50' ' ' GLU . 83.9 m -80.43 -38.18 30.61 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.272 -171.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . 0.493 ' HA ' HD13 ' B' ' 55' ' ' ILE . 4.4 pt20 -70.02 -29.81 66.96 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 172.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' SER . . . . . 0.473 ' O ' ' HE2' ' B' ' 56' ' ' LYS . 4.9 m -71.31 -20.82 62.14 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 113.897 -1.501 . . . . 0.0 110.261 175.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.409 ' HB1' ' O ' ' B' ' 51' ' ' CYS . . . -78.45 -25.25 45.85 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.672 0.749 . . . . 0.0 109.824 168.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.576 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 22.7 mt -90.02 -32.63 5.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 -172.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . 0.618 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.82 -39.41 2.64 Favored Pre-proline 0 N--CA 1.487 1.388 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -172.853 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 50.9 Cg_endo -62.39 -28.4 78.29 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.308 2.005 . . . . 0.0 112.824 176.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . 0.52 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.3 mt -98.68 -15.78 19.27 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . 0.567 ' HA ' ' OH ' ' B' ' 72' ' ' TYR . 0.0 OUTLIER -52.37 109.36 0.38 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.16 -179.545 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.25 -22.59 37.75 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.63 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 10.9 mmmt -103.43 112.79 25.85 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.146 0.498 . . . . 0.0 110.0 -178.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 7.4 p -124.73 146.21 52.13 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.076 172.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo . . . . . 0 C--O 1.234 0.312 0 C-N-CA 122.22 1.947 . . . . 0.0 111.537 166.675 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 67' ' ' ASP . . . . . 0.658 ' OD2' ' HB ' ' B' ' 69' ' ' ILE . 0.5 OUTLIER . . . . . 0 CA--C 1.517 -0.291 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . 0.58 HG12 ' CD ' ' B' ' 40' ' ' GLU . 0.7 OUTLIER -78.5 -27.73 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 C-N-CA 118.912 -1.115 . . . . 0.0 109.017 177.293 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . 0.753 ' O ' HG11 ' B' ' 73' ' ' VAL . 12.6 mm -58.08 -46.33 88.18 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.116 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.107 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 70' ' ' SER . . . . . 0.446 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 29.1 t -46.06 -37.51 6.83 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.275 175.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -85.53 -32.51 22.14 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.148 0.499 . . . . 0.0 110.689 -177.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 72' ' ' TYR . . . . . 0.571 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.1 m-30 -75.85 -34.95 60.07 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.611 -176.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . 0.769 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.5 m -72.01 -31.47 40.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 172.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 74' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' B' ' 70' ' ' SER . 0.0 OUTLIER -67.25 -31.82 72.43 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.309 175.504 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' B' ' 72' ' ' TYR . . . -63.8 -46.58 84.53 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.11 177.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.601 ' SG ' ' HB2' ' B' ' 14' ' ' TYR . 27.4 t -92.81 9.53 34.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.848 178.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . 0.434 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 11.7 t70 . . . . . 0 C--N 1.322 -0.611 0 CA-C-O 121.254 0.55 . . . . 0.0 110.235 175.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo . . . . . 0 CA--C 1.519 -0.251 0 N-CA-C 109.045 -1.175 . . . . 0.0 109.045 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.425 ' HB2' HG22 ' A' ' 5' ' ' THR . 15.6 m -68.12 179.84 1.43 Allowed 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 162.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.523 ' CE1' HD12 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -76.76 -52.2 9.99 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.245 -0.982 . . . . 0.0 108.536 166.41 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.472 ' OD1' ' HG ' ' B' ' 41' ' ' LEU . 2.4 p-10 -86.33 4.48 38.99 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.256 -1.338 . . . . 0.0 113.677 -164.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.569 ' O ' ' HG3' ' A' ' 7' ' ' ARG . 0.9 OUTLIER -63.73 -3.12 2.09 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 118.602 0.637 . . . . 0.0 111.532 -176.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.575 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 3.0 m -77.9 119.36 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-O 121.914 0.864 . . . . 0.0 109.824 177.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.777 ' HB3' ' O ' ' A' ' 46' ' ' ASN . 27.1 mtm180 -138.68 150.73 46.51 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 119.078 -1.049 . . . . 0.0 113.292 -170.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.568 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.4 mt-30 -41.99 114.35 0.53 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 112.882 -1.963 . . . . 0.0 113.019 176.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.81 -156.66 27.7 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.065 171.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.0 p -52.26 100.46 0.03 OUTLIER 'General case' 0 C--O 1.233 0.228 0 CA-C-N 117.092 0.446 . . . . 0.0 111.204 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.59 ' HD2' ' O ' ' A' ' 80' ' ' GLY . 20.7 pttp 42.47 40.87 2.05 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.396 1.078 . . . . 0.0 112.297 -175.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.431 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 59.4 tt0 -59.21 136.44 88.32 Favored Pre-proline 0 C--O 1.235 0.3 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 177.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.513 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 36.8 Cg_exo -51.77 122.83 11.08 Favored 'Trans proline' 0 CA--C 1.508 -0.784 0 C-N-CA 122.121 1.88 . . . . 0.0 109.689 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.788 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 9.3 t80 -69.46 -53.86 12.09 Favored Pre-proline 0 N--CA 1.437 -1.119 0 CA-C-O 118.316 -0.849 . . . . 0.0 112.937 -166.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.55 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 31.3 Cg_exo -55.38 -20.43 25.84 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.435 1.424 . . . . 0.0 111.06 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.513 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 2.7 m-20 -89.87 -39.17 13.22 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.011 -1.45 . . . . 0.0 111.036 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.568 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -55.94 -45.38 78.83 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 175.451 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 14' ' ' TYR . 1.5 p -81.54 -31.79 11.41 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.031 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.57 -177.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . -58.08 -33.8 69.46 Favored 'General case' 0 C--N 1.317 -0.833 0 O-C-N 121.386 -0.821 . . . . 0.0 111.752 176.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.709 ' O ' HG12 ' A' ' 24' ' ' VAL . 15.3 ptt180 -84.36 -26.9 28.08 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 176.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.565 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 6.7 tp -56.52 -46.55 80.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.002 172.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.66 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 32.8 mt-30 -73.39 -44.15 59.12 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.83 178.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.699 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 21.8 t70 -49.55 -56.06 11.23 Favored 'General case' 0 C--N 1.314 -0.942 0 O-C-N 124.239 0.962 . . . . 0.0 111.612 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.709 HG12 ' O ' ' A' ' 20' ' ' ARG . 6.4 p -80.36 -22.29 11.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 C-N-CA 120.538 -0.465 . . . . 0.0 109.923 -173.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.648 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -68.18 -29.09 67.88 Favored 'General case' 0 C--O 1.204 -1.341 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 173.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.456 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -80.04 -36.9 35.07 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.931 -178.406 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.699 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.5 mmtt -66.65 -32.51 73.87 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.483 178.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.8 m -105.34 -11.77 16.33 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.825 -171.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.648 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 88.7 mt -116.83 133.93 61.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.109 -177.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.26 -4.25 35.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.285 0.564 . . . . 0.0 110.521 176.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.515 ' H ' HG21 ' A' ' 29' ' ' ILE . 11.1 t70 -105.48 107.46 18.47 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.752 -178.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.584 ' OE2' ' HG3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -52.86 -32.22 43.53 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.229 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.584 ' HG3' ' OE2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -73.53 -50.47 21.23 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -173.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.473 ' HA ' HG21 ' A' ' 37' ' ' VAL . . . -61.92 -27.84 69.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.525 175.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.839 ' O ' HG12 ' A' ' 39' ' ' VAL . 3.5 tmm_? -67.4 -57.12 7.17 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.485 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 19.4 mtpt -59.11 -54.82 42.7 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.273 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.747 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 19.4 m -54.69 -33.84 28.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.023 -173.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.489 ' O ' ' HG2' ' A' ' 42' ' ' MET . 1.2 tt -86.3 -31.87 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 119.904 -0.719 . . . . 0.0 111.428 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.839 HG12 ' O ' ' A' ' 35' ' ' ARG . 3.0 m -67.4 -49.8 68.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.779 173.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.624 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 63.9 mt-10 -63.76 -26.34 68.6 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.5 0.72 . . . . 0.0 112.62 177.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.747 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -85.63 -52.1 6.03 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.576 177.348 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.601 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 18.7 mmt -64.52 -20.42 66.2 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.809 0.814 . . . . 0.0 109.37 -178.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.668 ' O ' ' HB1' ' A' ' 47' ' ' ALA . . . -50.75 -28.98 10.28 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.539 171.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.516 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 25.0 t80 -104.08 -68.78 0.83 Allowed 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.478 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 10.3 mm-40 -48.21 -32.41 7.09 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 124.13 0.894 . . . . 0.0 112.546 -175.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.777 ' O ' ' HB3' ' A' ' 7' ' ' ARG . 4.5 m-20 -103.28 -17.39 15.33 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.492 -175.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.668 ' HB1' ' O ' ' A' ' 43' ' ' ALA . . . -62.98 178.27 0.49 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.744 0.783 . . . . 0.0 111.911 -177.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.646 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 17.7 m-20 -59.93 142.92 88.41 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.094 172.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -56.25 -21.46 36.23 Favored 'Trans proline' 0 C--O 1.219 -0.463 0 C-N-CA 123.182 2.588 . . . . 0.0 112.557 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.716 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 12.0 pm0 -88.99 -33.01 17.34 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 123.598 0.759 . . . . 0.0 110.727 174.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.716 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 72.2 m -81.21 -38.02 27.7 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.394 -171.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.501 ' HA ' HD13 ' A' ' 55' ' ' ILE . 3.3 pt20 -69.0 -29.89 68.18 Favored 'General case' 0 C--O 1.211 -0.94 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 172.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.615 ' HB3' ' C ' ' A' ' 91' ' ' GLN . 5.9 m -72.23 -21.26 61.42 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 113.9 -1.5 . . . . 0.0 110.304 176.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.433 ' HB1' HD12 ' A' ' 79' ' ' ILE . . . -76.03 -25.91 56.12 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.783 0.801 . . . . 0.0 109.495 168.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.558 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 22.7 mt -90.33 -33.46 5.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -172.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.611 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.39 -39.08 1.96 Allowed Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -172.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 52.5 Cg_endo -63.13 -31.12 75.53 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.164 1.91 . . . . 0.0 112.568 175.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.493 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 2.4 mt -93.92 -17.08 23.36 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.595 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -54.64 108.95 0.44 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.44 179.67 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.09 -23.84 34.41 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.568 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -104.46 113.88 27.74 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.096 0.474 . . . . 0.0 110.418 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.406 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.1 p -123.58 141.6 36.87 Favored Pre-proline 0 C--N 1.308 -1.21 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 168.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.544 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 77.1 Cg_exo -51.55 139.62 46.74 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.333 2.022 . . . . 0.0 111.52 170.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.28 103.52 0.5 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.015 -176.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.8 -14.16 41.6 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.889 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.544 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 24.1 m -93.31 170.36 9.68 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.187 0.518 . . . . 0.0 111.346 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.29 141.98 28.86 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 176.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.591 HG11 ' CD ' ' A' ' 40' ' ' GLU . 0.7 OUTLIER -77.69 -28.1 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 C-N-CA 118.227 -1.389 . . . . 0.0 108.95 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.779 ' O ' HG13 ' A' ' 73' ' ' VAL . 11.3 mm -58.14 -46.54 88.35 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.075 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.124 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 30.7 t -45.95 -38.33 7.5 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.188 176.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -86.2 -32.31 21.27 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 121.254 0.55 . . . . 0.0 111.046 -177.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.595 ' OH ' ' HA ' ' A' ' 59' ' ' LYS . 5.1 m-30 -75.27 -34.38 61.35 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.369 -176.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.788 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.6 m -72.09 -31.7 40.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -68.0 -30.87 70.23 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.25 176.461 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -63.74 -48.94 75.0 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.891 177.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.748 ' SG ' ' HB ' ' A' ' 79' ' ' ILE . 32.3 t -89.89 9.09 28.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.773 177.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.464 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 18.7 t70 -66.05 -20.74 66.27 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.349 0.595 . . . . 0.0 109.566 173.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.94 -8.08 58.24 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.831 172.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.748 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 99.0 mt -97.92 128.05 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 121.055 0.455 . . . . 0.0 111.433 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.59 ' O ' ' HD2' ' A' ' 11' ' ' LYS . . . 158.75 -25.61 0.37 Allowed Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 174.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.06 137.47 4.72 Favored Glycine 0 CA--C 1.504 -0.618 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.277 172.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 66.33 -74.35 0.06 Allowed 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.273 0.629 . . . . 0.0 111.727 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 75.1 mtm -59.59 -33.97 72.14 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 120.692 0.282 . . . . 0.0 110.61 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.535 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 4.7 t-160 -49.68 -46.45 49.9 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.836 172.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.52 ' HA ' ' HB2' ' A' ' 88' ' ' LEU . 93.8 mttt -87.01 -19.68 28.32 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.881 -172.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.64 -45.29 59.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.765 0.793 . . . . 0.0 109.399 169.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 66.6 mtt -77.59 -13.26 59.96 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.267 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.52 ' HB2' ' HA ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -57.93 -37.78 74.71 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.068 0.461 . . . . 0.0 110.988 -179.042 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 46.5 ttm -83.5 -21.92 32.65 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.936 0.398 . . . . 0.0 110.718 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -90.5 -49.76 6.32 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.013 0.435 . . . . 0.0 111.883 -175.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.615 ' C ' ' HB3' ' A' ' 53' ' ' SER . 24.4 mt-30 -88.71 -54.29 4.22 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.423 -172.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.417 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -50.74 -37.97 44.91 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 175.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.606 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 5.1 pt-20 . . . . . 0 C--O 1.249 1.063 0 CA-C-N 112.991 -1.913 . . . . 0.0 113.186 -176.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' PRO . . . . . 0.489 ' HB2' ' H ' ' B' ' 2' ' ' SER . 84.0 Cg_endo . . . . . 0 CA--C 1.518 -0.306 0 N-CA-C 108.863 -1.245 . . . . 0.0 108.863 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.489 ' H ' ' HB2' ' B' ' 1' ' ' PRO . 15.8 m -68.48 -179.74 1.43 Allowed 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 162.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.516 ' CE1' HD12 ' B' ' 29' ' ' ILE . 0.1 OUTLIER -77.01 -52.24 9.69 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.29 -0.964 . . . . 0.0 108.522 166.261 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.46 ' OD1' ' HG ' ' A' ' 41' ' ' LEU . 2.4 p-10 -86.31 4.69 37.98 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.708 -164.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.566 ' O ' ' HG3' ' B' ' 7' ' ' ARG . 0.9 OUTLIER -63.98 -2.88 2.15 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 118.6 0.636 . . . . 0.0 111.557 -176.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.562 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 3.0 m -78.04 119.25 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 121.823 0.82 . . . . 0.0 109.845 176.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.792 ' HB3' ' O ' ' B' ' 46' ' ' ASN . 27.3 mtm180 -138.63 150.72 46.56 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 119.18 -1.008 . . . . 0.0 113.247 -170.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' GLN . . . . . 0.572 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.4 mt-30 -42.15 114.51 0.56 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 112.755 -2.02 . . . . 0.0 112.887 176.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.11 -156.96 28.73 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.13 171.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 15.6 p -51.67 100.35 0.03 OUTLIER 'General case' 0 C--O 1.235 0.306 0 CA-C-N 117.016 0.408 . . . . 0.0 111.274 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.605 ' HD2' ' O ' ' B' ' 80' ' ' GLY . 20.8 pttp 42.28 41.06 1.99 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.462 1.105 . . . . 0.0 112.225 -175.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.406 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 58.9 tt0 -59.23 136.43 88.38 Favored Pre-proline 0 C--O 1.234 0.283 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . 0.533 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 37.6 Cg_exo -51.69 123.05 11.43 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.13 1.887 . . . . 0.0 109.652 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . 0.788 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 9.5 t80 -69.6 -53.93 11.61 Favored Pre-proline 0 N--CA 1.437 -1.089 0 CA-C-O 118.313 -0.851 . . . . 0.0 112.958 -166.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.558 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 31.2 Cg_exo -55.4 -20.29 25.43 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 121.483 1.455 . . . . 0.0 111.066 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.533 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 3.1 m-20 -89.93 -39.17 13.18 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.019 -1.446 . . . . 0.0 111.023 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' PHE . . . . . 0.572 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -55.81 -45.59 78.26 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.307 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.734 HG12 ' O ' ' B' ' 14' ' ' TYR . 1.5 p -81.46 -31.69 11.48 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.063 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.576 -177.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' B' ' 15' ' ' PRO . . . -58.2 -33.83 69.71 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 121.402 -0.811 . . . . 0.0 111.737 176.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.704 ' O ' HG12 ' B' ' 24' ' ' VAL . 15.2 ptt180 -84.43 -26.47 28.24 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.574 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 6.7 tp -56.86 -46.77 81.57 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.912 172.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . 0.672 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 32.5 mt-30 -73.18 -44.31 60.05 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.835 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.72 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 20.5 t70 -49.15 -56.15 10.1 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 124.192 0.932 . . . . 0.0 111.649 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' VAL . . . . . 0.704 HG12 ' O ' ' B' ' 20' ' ' ARG . 6.5 p -80.31 -22.52 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.922 -173.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.66 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -68.15 -28.97 67.76 Favored 'General case' 0 C--O 1.203 -1.342 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 173.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . 0.451 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -80.23 -36.59 34.52 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.359 -1.291 . . . . 0.0 109.962 -178.498 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.72 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.9 mmtt -66.97 -32.35 73.53 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.502 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 16.9 m -105.5 -12.05 16.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.123 0.487 . . . . 0.0 110.765 -171.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.66 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 88.3 mt -116.44 134.24 60.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.083 -177.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.45 -4.27 34.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.382 0.611 . . . . 0.0 110.436 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.497 ' H ' HG21 ' B' ' 29' ' ' ILE . 11.3 t70 -105.43 107.68 18.79 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.722 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 0.572 ' OE2' ' HG3' ' B' ' 33' ' ' LYS . 0.0 OUTLIER -53.01 -32.22 45.45 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.213 179.487 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.572 ' HG3' ' OE2' ' B' ' 32' ' ' GLU . 0.0 OUTLIER -73.58 -50.23 22.32 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -173.593 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.492 ' HA ' HG21 ' B' ' 37' ' ' VAL . . . -62.16 -27.83 69.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.466 175.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.843 ' O ' HG12 ' B' ' 39' ' ' VAL . 3.5 tmm_? -67.43 -57.12 7.13 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.478 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 19.0 mtpt -59.11 -54.76 43.35 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.314 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.745 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 19.6 m -54.73 -33.82 28.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.073 -173.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.497 ' O ' ' HG2' ' B' ' 42' ' ' MET . 1.2 tt -86.41 -31.64 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.462 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.843 HG12 ' O ' ' B' ' 35' ' ' ARG . 3.0 m -67.43 -49.95 66.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 119.039 -1.065 . . . . 0.0 109.809 173.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.635 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 60.8 mt-10 -63.6 -26.5 68.72 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.506 0.722 . . . . 0.0 112.599 177.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.745 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.61 -52.0 6.1 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.436 -0.505 . . . . 0.0 111.469 177.487 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' MET . . . . . 0.594 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 18.7 mmt -64.66 -20.39 66.27 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.75 0.786 . . . . 0.0 109.256 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.658 ' O ' ' HB1' ' B' ' 47' ' ' ALA . . . -50.82 -28.92 10.4 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.563 171.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' TYR . . . . . 0.503 ' CG ' ' HD2' ' B' ' 59' ' ' LYS . 25.1 t80 -104.09 -68.71 0.83 Allowed 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.477 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 10.5 mm-40 -48.39 -31.92 6.86 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.091 0.87 . . . . 0.0 112.687 -175.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.792 ' O ' ' HB3' ' B' ' 7' ' ' ARG . 4.5 m-20 -103.88 -16.91 15.23 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 120.659 0.266 . . . . 0.0 111.533 -175.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.658 ' HB1' ' O ' ' B' ' 43' ' ' ALA . . . -63.24 178.67 0.49 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.909 0.862 . . . . 0.0 111.978 -177.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . 0.644 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 17.6 m-20 -60.25 142.74 89.79 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.077 172.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.08 -21.54 35.31 Favored 'Trans proline' 0 C--O 1.218 -0.518 0 C-N-CA 123.19 2.593 . . . . 0.0 112.516 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.699 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 11.7 pm0 -88.95 -32.9 17.44 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 123.557 0.743 . . . . 0.0 110.743 174.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.699 ' N ' ' HG2' ' B' ' 50' ' ' GLU . 72.1 m -81.31 -38.06 27.38 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.41 -171.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . 0.495 ' HA ' HD13 ' B' ' 55' ' ' ILE . 3.3 pt20 -68.89 -30.01 68.41 Favored 'General case' 0 C--O 1.211 -0.927 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 172.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' SER . . . . . 0.616 ' HB3' ' C ' ' B' ' 91' ' ' GLN . 6.2 m -72.18 -21.16 61.47 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 113.941 -1.481 . . . . 0.0 110.478 176.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.431 ' HB1' HD12 ' B' ' 79' ' ' ILE . . . -76.21 -25.8 55.48 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.767 0.794 . . . . 0.0 109.466 168.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.564 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 22.7 mt -90.28 -33.5 5.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -172.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.608 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.41 -39.17 2.04 Favored Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -172.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 52.5 Cg_endo -62.95 -31.31 77.14 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.115 1.876 . . . . 0.0 112.554 175.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . 0.508 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 2.5 mt -93.92 -17.07 23.37 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.598 ' HA ' ' OH ' ' B' ' 72' ' ' TYR . 0.0 OUTLIER -54.7 108.96 0.44 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.47 179.71 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.03 -23.86 34.36 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.626 -177.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -104.47 113.89 27.76 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.098 0.475 . . . . 0.0 110.295 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.404 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.2 p -123.48 141.81 37.27 Favored Pre-proline 0 C--N 1.309 -1.162 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 168.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.526 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 73.0 Cg_exo -51.67 139.33 48.47 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.296 1.997 . . . . 0.0 111.631 170.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.93 103.45 0.45 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.03 -177.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.18 -14.52 40.07 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.892 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.526 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 24.0 m -93.07 170.8 9.37 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.09 0.471 . . . . 0.0 111.36 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.86 141.78 28.54 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.571 HG11 ' CD ' ' B' ' 40' ' ' GLU . 0.7 OUTLIER -77.29 -28.5 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 C-N-CA 118.201 -1.399 . . . . 0.0 108.921 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . 0.775 ' O ' HG13 ' B' ' 73' ' ' VAL . 11.2 mm -57.91 -46.56 87.51 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.112 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.169 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 30.2 t -45.93 -38.38 7.49 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.184 176.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -86.17 -32.25 21.35 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.245 0.545 . . . . 0.0 111.001 -177.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' TYR . . . . . 0.598 ' OH ' ' HA ' ' B' ' 59' ' ' LYS . 5.1 m-30 -75.36 -34.21 61.13 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.374 -176.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . 0.788 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.6 m -72.26 -31.64 39.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 172.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' LYS . . . . . 0.451 ' O ' ' HB3' ' B' ' 77' ' ' ASP . 0.0 OUTLIER -68.08 -30.84 70.12 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.274 176.474 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -63.72 -49.15 74.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.843 -1.072 . . . . 0.0 109.833 177.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.742 ' SG ' ' HB ' ' B' ' 79' ' ' ILE . 32.1 t -89.58 9.14 27.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.78 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . 0.451 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 21.1 t70 -66.5 -19.83 65.88 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.344 0.592 . . . . 0.0 109.681 174.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -96.5 -8.13 57.58 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.856 172.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.742 ' HB ' ' SG ' ' B' ' 76' ' ' CYS . 99.2 mt -97.95 127.87 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-O 121.192 0.52 . . . . 0.0 111.452 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . 0.605 ' O ' ' HD2' ' B' ' 11' ' ' LYS . . . 159.09 -25.63 0.35 Allowed Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.283 174.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.28 138.15 5.08 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.139 172.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 66.08 -74.79 0.06 Allowed 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 123.255 0.622 . . . . 0.0 111.807 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' MET . . . . . . . . . . . . . 75.6 mtm -59.25 -34.24 71.99 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 120.715 0.293 . . . . 0.0 110.596 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' HIS . . . . . 0.539 ' HB2' ' H ' ' B' ' 80' ' ' GLY . 4.7 t-160 -49.61 -46.29 49.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.848 172.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.513 ' HA ' ' HB2' ' B' ' 88' ' ' LEU . 93.9 mttt -87.09 -19.53 28.43 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.987 -172.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.99 -45.09 59.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.622 0.725 . . . . 0.0 109.522 169.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 66.6 mtt -77.85 -13.32 59.93 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.222 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.513 ' HB2' ' HA ' ' B' ' 85' ' ' LYS . 0.1 OUTLIER -57.89 -37.94 74.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.943 -179.055 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 47.0 ttm -83.66 -21.27 32.49 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.151 0.501 . . . . 0.0 110.707 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -90.71 -50.14 6.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.952 -175.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' GLN . . . . . 0.618 ' O ' ' HG2' ' B' ' 93' ' ' GLU . 24.3 mt-30 -88.39 -54.54 4.14 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.379 -172.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.436 ' HB2' HD12 ' B' ' 88' ' ' LEU . 0.0 OUTLIER -50.72 -37.84 43.88 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 175.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.618 ' HG2' ' O ' ' B' ' 91' ' ' GLN . 5.2 pt-20 . . . . . 0 C--O 1.248 1.005 0 CA-C-N 113.14 -1.845 . . . . 0.0 113.358 -176.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo . . . . . 0 CA--C 1.518 -0.301 0 N-CA-C 108.856 -1.248 . . . . 0.0 108.856 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.435 ' HG ' ' HD3' ' B' ' 59' ' ' LYS . 15.0 m -67.26 176.33 2.29 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 162.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.465 ' HE1' ' CD1' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -73.66 -52.69 12.49 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 166.099 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.497 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 2.4 p-10 -85.63 5.78 30.35 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.858 -1.519 . . . . 0.0 113.489 -165.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.07 -4.19 3.3 Favored 'General case' 0 C--N 1.315 -0.904 0 O-C-N 121.94 -0.475 . . . . 0.0 111.615 -176.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.596 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.0 m -77.86 133.01 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.72 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -154.63 159.42 40.8 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -179.671 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.401 ' N ' ' CD2' ' A' ' 17' ' ' PHE . 2.1 tt0 -45.31 112.75 0.48 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 113.268 -1.787 . . . . 0.0 112.57 -177.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.13 -150.59 18.56 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.507 173.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 27.2 m -51.98 95.45 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.95 0.375 . . . . 0.0 111.407 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.1 pttp 37.76 43.47 0.48 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.385 1.074 . . . . 0.0 112.254 -172.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -56.46 138.14 75.8 Favored Pre-proline 0 C--O 1.234 0.241 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.528 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 33.8 Cg_exo -53.68 121.87 10.31 Favored 'Trans proline' 0 CA--C 1.51 -0.722 0 C-N-CA 121.806 1.671 . . . . 0.0 109.476 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.778 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 14.5 t80 -71.91 -52.21 7.98 Favored Pre-proline 0 N--CA 1.438 -1.046 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -165.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.543 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 38.7 Cg_exo -56.52 -18.2 24.73 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 121.447 1.431 . . . . 0.0 110.691 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.528 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.5 m-20 -90.21 -42.34 11.08 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 113.754 -1.566 . . . . 0.0 110.874 178.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.489 ' CE2' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -55.02 -45.55 75.16 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 176.537 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.766 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 1.8 p -78.97 -34.41 16.81 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.402 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . -58.6 -31.82 68.41 Favored 'General case' 0 C--N 1.318 -0.761 0 O-C-N 121.529 -0.732 . . . . 0.0 111.807 177.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.673 ' O ' HG11 ' A' ' 24' ' ' VAL . 15.7 ptt180 -84.3 -26.78 28.28 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 175.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.537 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 5.9 tp -58.27 -46.49 85.92 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.918 173.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.766 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 26.2 mt-30 -70.69 -47.28 60.67 Favored 'General case' 0 CA--C 1.493 -1.247 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.3 177.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.72 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 8.9 t70 -49.77 -51.96 35.37 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.531 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.673 HG11 ' O ' ' A' ' 20' ' ' ARG . 7.2 p -81.08 -23.78 10.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.181 0.515 . . . . 0.0 109.719 -174.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.775 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -72.01 -19.15 61.9 Favored 'General case' 0 C--O 1.204 -1.335 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 174.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.59 -36.36 18.91 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.574 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.72 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.6 mmtt -67.26 -37.86 84.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.95 -1.023 . . . . 0.0 112.015 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.5 m -101.76 -10.38 20.0 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.163 0.506 . . . . 0.0 110.645 -172.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.775 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 85.5 mt -112.38 130.24 66.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.819 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.23 -0.93 57.39 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.068 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.661 ' OD1' ' HD2' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -121.55 127.74 51.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.347 0.594 . . . . 0.0 111.901 -178.09 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -56.49 -31.98 64.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.86 175.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.661 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 26.1 mttt -62.29 -61.12 2.67 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -177.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.444 ' HA ' HG23 ' A' ' 37' ' ' VAL . . . -61.94 -24.55 67.05 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.348 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.846 ' O ' HG12 ' A' ' 39' ' ' VAL . 1.7 tmm_? -69.7 -57.92 4.55 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.408 ' O ' HG23 ' A' ' 39' ' ' VAL . 20.9 mtpt -57.21 -55.65 31.94 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.943 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.723 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 19.7 m -53.93 -36.02 29.7 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.312 -170.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.465 ' CD1' ' HE1' ' A' ' 3' ' ' PHE . 1.2 tt -87.5 -28.97 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.96 -178.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.846 HG12 ' O ' ' A' ' 35' ' ' ARG . 3.0 m -70.1 -49.22 57.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 119.11 -1.036 . . . . 0.0 109.326 175.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.649 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 66.1 mt-10 -63.49 -24.22 67.73 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.805 0.842 . . . . 0.0 112.259 176.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.723 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -86.09 -56.99 3.2 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 177.147 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.497 ' HG3' ' HB2' ' A' ' 4' ' ' ASN . 20.7 mmt -62.44 -20.74 64.82 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.585 0.707 . . . . 0.0 109.792 -177.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.657 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . . . -49.18 -28.23 4.26 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.539 170.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.537 ' CG ' ' HB2' ' A' ' 52' ' ' GLN . 5.7 t80 -108.22 -67.92 0.94 Allowed 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 175.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.663 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 5.2 mm-40 -46.9 -31.89 3.42 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 124.421 1.075 . . . . 0.0 112.179 -173.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.72 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.9 m-20 -104.8 -21.17 13.39 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -176.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.631 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -60.4 -179.13 0.1 Allowed 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.954 0.883 . . . . 0.0 112.974 -173.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -57.01 139.72 78.41 Favored Pre-proline 0 N--CA 1.443 -0.786 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.011 175.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.95 -23.31 42.42 Favored 'Trans proline' 0 C--O 1.222 -0.304 0 C-N-CA 123.209 2.606 . . . . 0.0 112.082 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.469 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -88.12 -30.18 20.04 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.702 0.801 . . . . 0.0 110.505 174.194 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.927 ' SG ' ' HB2' ' A' ' 76' ' ' CYS . 43.8 t -83.24 -36.76 24.32 Favored 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.548 -170.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.537 ' HB2' ' CG ' ' A' ' 44' ' ' TYR . 4.1 pt20 -67.37 -30.35 70.12 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 171.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.672 ' HB3' ' C ' ' A' ' 91' ' ' GLN . 17.1 m -69.95 -20.3 63.34 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 113.377 -1.738 . . . . 0.0 110.852 173.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.514 ' HB3' HD13 ' A' ' 79' ' ' ILE . . . -81.16 -24.75 37.36 Favored 'General case' 0 C--N 1.312 -1.039 0 O-C-N 121.399 -0.813 . . . . 0.0 110.014 167.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.556 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 25.4 mt -90.3 -30.81 5.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -171.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.609 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.37 -40.03 2.58 Favored Pre-proline 0 N--CA 1.487 1.38 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -174.458 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 49.9 Cg_endo -62.42 -27.5 77.34 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.313 2.009 . . . . 0.0 112.794 176.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.506 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.0 OUTLIER -100.52 -15.86 17.71 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.539 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 0.1 OUTLIER -53.45 109.22 0.42 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.252 -177.924 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.446 ' N ' ' HZ3' ' A' ' 59' ' ' LYS . . . 92.43 -20.64 42.79 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.34 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -103.87 113.63 27.29 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.92 144.15 42.26 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 173.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.543 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 97.3 Cg_exo -46.6 139.11 13.79 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.153 1.902 . . . . 0.0 111.329 168.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.71 96.63 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.963 -173.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.54 -3.7 46.61 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.954 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.543 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 13.1 m -95.28 179.35 5.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.214 0.531 . . . . 0.0 111.227 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.759 ' OD1' ' HB ' ' A' ' 69' ' ' ILE . 5.4 t70 -87.65 137.28 32.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.378 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.575 HG23 ' HG2' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -79.81 -28.84 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 C-N-CA 118.224 -1.39 . . . . 0.0 109.173 179.218 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.778 ' O ' HG12 ' A' ' 73' ' ' VAL . 11.7 mm -60.57 -46.2 95.97 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.016 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.94 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.3 t -44.58 -38.93 4.56 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.146 175.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.474 ' O ' ' HE2' ' A' ' 74' ' ' LYS . 7.0 mm-40 -85.84 -32.04 21.95 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 123.55 0.74 . . . . 0.0 111.419 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.561 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.0 m-30 -75.41 -34.6 61.04 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.513 0.673 . . . . 0.0 109.421 -176.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.778 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.4 m -71.81 -32.09 43.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 172.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.474 ' HE2' ' O ' ' A' ' 71' ' ' GLU . 13.3 ttpt -71.66 -25.94 62.33 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.406 177.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -65.21 -46.6 80.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.806 174.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.927 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 40.5 t -87.46 0.8 55.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.158 178.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -66.01 -14.14 61.13 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.64 0.733 . . . . 0.0 109.579 175.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.45 -13.29 28.7 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.417 172.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.668 ' CD1' ' HA ' ' A' ' 51' ' ' CYS . 77.3 mt -79.78 -88.91 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 117.296 0.548 . . . . 0.0 111.377 -178.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.41 ' N ' HG23 ' A' ' 79' ' ' ILE . . . 41.29 -109.47 0.16 Allowed Glycine 0 C--N 1.338 0.676 0 O-C-N 123.525 0.515 . . . . 0.0 113.317 -175.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.37 166.29 15.85 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 111.659 -0.576 . . . . 0.0 111.659 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 68.25 -71.13 0.12 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.085 0.554 . . . . 0.0 111.756 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 79.5 mtp -66.01 -30.77 71.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.015 0.436 . . . . 0.0 110.038 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.53 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 6.8 t-160 -57.95 -31.6 67.01 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.765 173.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -82.6 -16.48 48.29 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.259 0.552 . . . . 0.0 110.148 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.26 -47.23 10.27 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.364 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 8.0 mtt -82.99 -14.17 54.54 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.629 -172.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.53 ' HB2' ' O ' ' A' ' 84' ' ' HIS . 0.5 OUTLIER -51.07 -35.43 34.79 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 123.563 0.539 . . . . 0.0 111.849 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 55.3 ttm -83.51 -18.33 38.86 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.947 0.403 . . . . 0.0 110.94 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -95.97 -54.73 3.22 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -174.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.672 ' C ' ' HB3' ' A' ' 53' ' ' SER . 22.4 mt-30 -80.93 -55.01 5.08 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.277 -174.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -49.55 -34.56 17.86 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 175.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.633 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 8.9 pt-20 . . . . . 0 C--O 1.252 1.235 0 CA-C-N 113.415 -1.721 . . . . 0.0 113.586 -174.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' PRO . . . . . 0.472 ' HB2' ' H ' ' B' ' 2' ' ' SER . 88.6 Cg_endo . . . . . 0 CA--C 1.518 -0.297 0 N-CA-C 108.762 -1.284 . . . . 0.0 108.762 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.472 ' H ' ' HB2' ' B' ' 1' ' ' PRO . 14.7 m -67.56 176.01 2.59 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 162.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.461 ' HE1' ' CD1' ' B' ' 38' ' ' ILE . 0.1 OUTLIER -73.37 -52.65 13.06 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.085 -1.046 . . . . 0.0 108.286 166.265 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.496 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.4 p-10 -85.77 5.84 30.65 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 113.936 -1.483 . . . . 0.0 113.429 -165.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.92 -4.42 3.31 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 118.256 0.48 . . . . 0.0 111.707 -176.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.597 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 1.9 m -77.62 133.16 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.698 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.1 OUTLIER -155.0 159.08 40.08 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -179.65 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -45.01 112.65 0.46 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 113.211 -1.813 . . . . 0.0 112.584 -177.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.08 -150.52 18.3 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.411 173.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 33.3 m -52.07 95.17 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 117.023 0.411 . . . . 0.0 111.49 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 21.0 pttp 37.9 43.93 0.56 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.438 1.095 . . . . 0.0 111.99 -172.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -56.75 138.1 77.84 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.411 177.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . 0.531 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 33.6 Cg_exo -53.67 122.12 10.75 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 121.737 1.625 . . . . 0.0 109.477 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . 0.778 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 14.6 t80 -72.17 -52.22 7.44 Favored Pre-proline 0 N--CA 1.438 -1.04 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -165.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.543 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 37.7 Cg_exo -56.52 -18.01 24.06 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 121.547 1.498 . . . . 0.0 110.685 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.531 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.6 m-20 -90.39 -42.52 10.87 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.846 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' PHE . . . . . 0.49 ' CE2' HD23 ' B' ' 21' ' ' LEU . 0.0 OUTLIER -54.91 -45.8 74.78 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.554 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.769 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 1.7 p -78.77 -34.52 17.4 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.289 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.281 -178.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' B' ' 15' ' ' PRO . . . -58.94 -31.23 68.51 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 121.485 -0.76 . . . . 0.0 111.843 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.671 ' O ' HG11 ' B' ' 24' ' ' VAL . 15.6 ptt180 -84.67 -26.41 27.78 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 175.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.547 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 5.9 tp -58.54 -46.53 86.63 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.933 172.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . 0.769 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 26.5 mt-30 -70.58 -47.29 60.99 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.256 177.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.726 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 8.3 t70 -49.85 -51.8 37.4 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 124.202 0.938 . . . . 0.0 111.576 -177.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' VAL . . . . . 0.671 HG11 ' O ' ' B' ' 20' ' ' ARG . 7.2 p -81.17 -23.83 10.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -174.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.784 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -71.77 -19.3 62.04 Favored 'General case' 0 C--O 1.204 -1.294 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 174.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.6 -36.31 18.93 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.531 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.726 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.9 mmtt -67.36 -37.61 83.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.142 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 46.5 m -101.85 -10.63 19.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.194 0.521 . . . . 0.0 110.712 -172.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.784 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 85.4 mt -112.36 130.24 66.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.748 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.23 -0.67 57.4 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.001 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.653 ' OD1' ' HD2' ' B' ' 33' ' ' LYS . 0.9 OUTLIER -121.82 127.85 51.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.326 0.584 . . . . 0.0 112.069 -178.172 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -56.66 -31.8 64.76 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.825 176.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.653 ' HD2' ' OD1' ' B' ' 31' ' ' ASP . 25.9 mttt -62.48 -61.0 2.74 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -177.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.468 ' HA ' HG23 ' B' ' 37' ' ' VAL . . . -62.0 -24.51 67.08 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.413 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.85 ' O ' HG12 ' B' ' 39' ' ' VAL . 1.7 tmm_? -69.83 -57.81 4.64 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 20.6 mtpt -57.28 -55.52 33.75 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.948 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.733 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 19.8 m -54.07 -35.92 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.325 -170.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.461 ' CD1' ' HE1' ' B' ' 3' ' ' PHE . 1.2 tt -87.52 -29.13 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 C-N-CA 119.744 -0.783 . . . . 0.0 111.932 -178.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.85 HG12 ' O ' ' B' ' 35' ' ' ARG . 3.0 m -69.88 -49.4 57.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 119.156 -1.018 . . . . 0.0 109.318 175.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.645 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 66.4 mt-10 -63.41 -24.11 67.69 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.812 0.845 . . . . 0.0 112.377 176.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.733 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -86.21 -56.98 3.19 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 177.114 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' MET . . . . . 0.496 ' HG3' ' HB2' ' B' ' 4' ' ' ASN . 20.8 mmt -62.5 -20.76 64.92 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-O 121.524 0.678 . . . . 0.0 109.812 -177.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.667 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . . . -48.88 -28.4 3.75 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.673 -1.148 . . . . 0.0 110.603 170.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' TYR . . . . . 0.544 ' CG ' ' HB2' ' B' ' 52' ' ' GLN . 5.6 t80 -108.17 -67.68 0.95 Allowed 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 175.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.673 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 5.0 mm-40 -46.94 -32.19 3.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 124.433 1.083 . . . . 0.0 112.109 -173.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.698 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 5.0 m-20 -104.59 -21.21 13.45 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -176.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.637 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -60.44 -179.27 0.11 Allowed 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.928 0.87 . . . . 0.0 112.95 -173.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -56.95 139.67 78.09 Favored Pre-proline 0 N--CA 1.444 -0.758 0 CA-C-N 114.403 -1.272 . . . . 0.0 108.892 175.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.78 -23.31 41.07 Favored 'Trans proline' 0 C--O 1.222 -0.321 0 C-N-CA 123.288 2.659 . . . . 0.0 112.12 -177.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.497 ' O ' ' HG3' ' B' ' 50' ' ' GLU . 0.0 OUTLIER -88.16 -30.27 19.92 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.482 174.181 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.92 ' SG ' ' HB2' ' B' ' 76' ' ' CYS . 43.7 t -83.19 -36.53 24.61 Favored 'General case' 0 N--CA 1.426 -1.662 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.614 -170.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . 0.544 ' HB2' ' CG ' ' B' ' 44' ' ' TYR . 4.2 pt20 -67.66 -30.24 69.74 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 171.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' SER . . . . . 0.663 ' HB3' ' C ' ' B' ' 91' ' ' GLN . 14.7 m -69.94 -20.27 63.34 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 113.343 -1.753 . . . . 0.0 110.727 173.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.499 ' HB3' HD13 ' B' ' 79' ' ' ILE . . . -81.3 -24.73 37.0 Favored 'General case' 0 C--N 1.313 -1.018 0 O-C-N 121.448 -0.782 . . . . 0.0 109.973 167.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.56 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 25.3 mt -90.22 -30.93 5.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -171.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.603 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.29 -40.07 2.51 Favored Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -174.477 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 49.4 Cg_endo -62.39 -27.39 77.4 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.32 2.013 . . . . 0.0 112.801 176.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . 0.518 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.0 OUTLIER -100.87 -15.76 17.46 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.537 ' HE3' ' HB3' ' B' ' 44' ' ' TYR . 0.1 OUTLIER -53.41 109.34 0.43 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.172 -178.098 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . 0.45 ' N ' ' HZ3' ' B' ' 59' ' ' LYS . . . 92.09 -20.54 42.39 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.319 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 10.4 mmmt -103.79 113.54 27.13 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.75 144.19 42.06 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 173.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.569 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 96.7 Cg_exo -46.79 139.25 14.24 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.14 1.893 . . . . 0.0 111.392 168.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.19 96.34 0.05 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.958 -173.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.62 -3.47 46.18 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.888 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.569 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 14.6 m -95.42 179.13 5.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.178 0.513 . . . . 0.0 111.198 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' ASP . . . . . 0.76 ' OD1' ' HB ' ' B' ' 69' ' ' ILE . 5.0 t70 -87.36 137.52 32.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.459 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.573 HG23 ' HG2' ' B' ' 40' ' ' GLU . 0.8 OUTLIER -79.87 -28.96 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 C-N-CA 118.306 -1.357 . . . . 0.0 109.178 179.302 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . 0.772 ' O ' HG12 ' B' ' 73' ' ' VAL . 11.4 mm -60.47 -46.37 95.43 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.988 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.878 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 29.6 t -44.27 -39.09 4.26 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.034 175.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.483 ' O ' ' HE2' ' B' ' 74' ' ' LYS . 6.3 mm-40 -86.16 -31.78 21.61 Favored 'General case' 0 C--O 1.216 -0.694 0 C-N-CA 123.445 0.698 . . . . 0.0 111.364 -177.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' TYR . . . . . 0.556 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.0 m-30 -75.51 -34.65 60.82 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.574 0.702 . . . . 0.0 109.328 -177.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . 0.778 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.4 m -71.79 -31.82 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 173.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' LYS . . . . . 0.483 ' HE2' ' O ' ' B' ' 71' ' ' GLU . 13.4 ttpt -71.76 -26.18 62.34 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.458 -1.247 . . . . 0.0 109.437 177.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -65.28 -46.46 80.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.741 174.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.92 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 39.6 t -87.43 0.55 55.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.167 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.83 -14.36 61.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.632 0.73 . . . . 0.0 109.551 174.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.13 -13.42 29.01 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.463 172.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.661 ' CD1' ' HA ' ' B' ' 51' ' ' CYS . 78.0 mt -79.55 -89.37 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 117.203 0.501 . . . . 0.0 111.328 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . 0.4 ' N ' HG23 ' B' ' 79' ' ' ILE . . . 41.78 -109.57 0.18 Allowed Glycine 0 C--N 1.339 0.724 0 O-C-N 123.653 0.595 . . . . 0.0 113.191 -175.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.37 166.72 15.74 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.692 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 67.87 -71.05 0.11 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.16 0.584 . . . . 0.0 111.63 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' MET . . . . . . . . . . . . . 79.5 mtp -65.81 -31.01 71.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.006 0.431 . . . . 0.0 110.036 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' HIS . . . . . 0.536 ' O ' ' HB2' ' B' ' 88' ' ' LEU . 6.9 t-80 -57.84 -31.71 66.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.844 173.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -82.47 -16.46 48.75 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.174 0.511 . . . . 0.0 110.08 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.54 -46.64 10.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.431 175.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 8.1 mtt -83.36 -14.06 53.65 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.578 -173.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.536 ' HB2' ' O ' ' B' ' 84' ' ' HIS . 0.5 OUTLIER -51.02 -35.48 34.4 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 123.588 0.555 . . . . 0.0 111.815 179.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 54.2 ttm -83.55 -18.43 38.38 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.903 0.382 . . . . 0.0 110.872 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -95.87 -54.53 3.3 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -174.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' GLN . . . . . 0.663 ' C ' ' HB3' ' B' ' 53' ' ' SER . 22.2 mt-30 -81.0 -55.31 4.87 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.135 -174.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -49.61 -34.34 17.71 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 175.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.646 ' HG2' ' O ' ' B' ' 91' ' ' GLN . 8.9 pt-20 . . . . . 0 C--O 1.253 1.257 0 CA-C-N 113.415 -1.721 . . . . 0.0 113.514 -175.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo . . . . . 0 CA--C 1.518 -0.313 0 N-CA-C 108.666 -1.321 . . . . 0.0 108.666 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.407 ' HG ' ' HD3' ' B' ' 59' ' ' LYS . 16.4 m -67.57 -178.9 0.97 Allowed 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 162.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.452 ' HE1' ' CD1' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -77.11 -51.84 10.33 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 164.713 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.488 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 2.3 p-10 -87.28 5.93 35.88 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 113.913 -1.494 . . . . 0.0 113.896 -164.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.403 HG23 ' HB2' ' A' ' 2' ' ' SER . 0.8 OUTLIER -63.77 -5.65 4.53 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 118.784 0.72 . . . . 0.0 111.52 -176.743 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.456 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.0 m -78.16 130.31 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 176.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.673 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -155.72 158.74 38.73 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -178.37 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.454 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.6 mt-30 -39.07 116.65 0.6 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.624 -1.626 . . . . 0.0 113.551 176.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.29 -155.84 32.23 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.573 169.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.6 m -48.25 100.51 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 117.481 0.64 . . . . 0.0 111.678 -177.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.3 pttt 38.24 42.67 0.52 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.295 1.038 . . . . 0.0 112.335 -173.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -57.46 138.26 81.43 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.267 176.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.517 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 37.0 Cg_exo -53.8 122.4 11.28 Favored 'Trans proline' 0 CA--C 1.505 -0.944 0 C-N-CA 121.84 1.693 . . . . 0.0 109.265 177.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.723 ' O ' HG13 ' A' ' 18' ' ' VAL . 11.6 t80 -70.66 -53.92 8.89 Favored Pre-proline 0 N--CA 1.434 -1.241 0 CA-C-O 118.454 -0.784 . . . . 0.0 112.908 -166.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.547 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 36.3 Cg_exo -56.18 -18.2 22.86 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 121.453 1.435 . . . . 0.0 110.825 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.517 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 2.8 m-20 -89.53 -42.79 11.24 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.977 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.678 ' HE2' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -53.78 -46.55 71.06 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 176.63 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.747 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 1.3 p -79.27 -34.52 16.41 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.369 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.615 -177.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . -57.5 -32.61 67.19 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 121.335 -0.853 . . . . 0.0 111.674 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.716 ' O ' HG11 ' A' ' 24' ' ' VAL . 16.6 ptt180 -84.36 -27.12 27.92 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 176.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.617 HD21 ' CE1' ' A' ' 17' ' ' PHE . 6.7 tp -56.56 -47.26 79.88 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.996 172.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.747 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 20.2 mt-30 -71.3 -47.1 58.85 Favored 'General case' 0 CA--C 1.493 -1.236 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.995 177.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.722 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 17.6 t70 -47.22 -54.83 9.82 Favored 'General case' 0 C--N 1.313 -1.015 0 O-C-N 124.297 0.998 . . . . 0.0 111.502 -178.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.716 HG11 ' O ' ' A' ' 20' ' ' ARG . 7.5 p -81.23 -23.31 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.162 0.506 . . . . 0.0 109.983 -174.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.749 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -72.07 -19.5 61.81 Favored 'General case' 0 C--O 1.204 -1.318 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 174.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.421 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -86.25 -36.65 19.25 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.616 178.047 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.722 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 37.8 mmtt -66.9 -38.12 85.66 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.956 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.2 m -101.83 -8.85 21.29 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.166 0.508 . . . . 0.0 110.658 -171.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.749 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 88.7 mt -114.59 135.68 53.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.717 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.56 -2.25 42.14 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.003 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.572 ' H ' HG23 ' A' ' 29' ' ' ILE . 4.8 t0 -117.63 132.38 56.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.11 0.481 . . . . 0.0 111.048 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.581 ' OE1' ' HG3' ' A' ' 33' ' ' LYS . 1.6 pp20? -59.95 -35.39 74.85 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.285 174.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.581 ' HG3' ' OE1' ' A' ' 32' ' ' GLU . 13.2 mttp -61.53 -58.74 6.91 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -175.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.435 ' HA ' HG21 ' A' ' 37' ' ' VAL . . . -61.9 -27.03 68.52 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.494 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.807 ' O ' HG11 ' A' ' 39' ' ' VAL . 5.0 tmm_? -70.4 -58.38 3.79 Favored 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.455 ' HD2' ' OE2' ' A' ' 32' ' ' GLU . 18.4 mtpt -56.14 -55.85 28.09 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.867 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.768 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 22.5 m -53.79 -36.49 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.228 -171.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.46 ' O ' ' HG2' ' A' ' 42' ' ' MET . 1.3 tt -87.0 -29.73 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.826 -177.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.807 HG11 ' O ' ' A' ' 35' ' ' ARG . 3.0 m -69.95 -48.95 60.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 119.089 -1.044 . . . . 0.0 109.488 175.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.589 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 54.1 mt-10 -64.93 -23.33 67.19 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.533 0.733 . . . . 0.0 112.545 176.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.768 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -85.78 -55.45 3.96 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.63 176.391 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.503 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 22.5 mmt -62.65 -20.42 64.79 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.698 0.761 . . . . 0.0 109.372 -178.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.659 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -48.28 -29.48 3.89 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.794 170.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.553 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 10.3 t80 -108.15 -66.39 1.04 Allowed 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.637 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 13.9 mm-40 -48.08 -32.66 7.05 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 124.266 0.979 . . . . 0.0 112.1 -174.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.673 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.9 m-20 -103.75 -20.6 13.89 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.326 -175.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.659 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -59.77 -179.94 0.11 Allowed 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 122.023 0.915 . . . . 0.0 112.681 -174.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.541 ' HB3' ' OE2' ' A' ' 50' ' ' GLU . 13.0 m-20 -58.6 140.52 85.0 Favored Pre-proline 0 N--CA 1.439 -1.016 0 CA-C-N 114.213 -1.358 . . . . 0.0 109.335 174.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -57.73 -20.83 44.78 Favored 'Trans proline' 0 C--O 1.222 -0.321 0 C-N-CA 123.228 2.619 . . . . 0.0 112.166 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.725 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 8.9 pm0 -88.58 -30.92 18.91 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 123.521 0.728 . . . . 0.0 110.255 173.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.97 ' SG ' ' HB2' ' A' ' 76' ' ' CYS . 49.5 t -85.46 -37.08 20.15 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.952 -168.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.499 ' HB2' ' CG ' ' A' ' 44' ' ' TYR . 3.7 pt20 -67.52 -28.94 68.24 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 171.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.636 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 32.8 m -71.88 -20.97 61.72 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 113.166 -1.834 . . . . 0.0 110.318 174.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.439 ' HB1' HD13 ' A' ' 79' ' ' ILE . . . -78.8 -24.32 44.64 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.41 0.624 . . . . 0.0 110.184 167.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.557 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 21.4 mt -90.89 -32.95 5.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -171.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.616 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.28 -38.95 1.79 Allowed Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -173.652 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 43.0 Cg_endo -61.61 -29.72 84.64 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 122.164 1.91 . . . . 0.0 112.636 175.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.509 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.5 mt -98.13 -16.51 19.49 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -179.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.569 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 0.1 OUTLIER -54.73 108.64 0.41 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.597 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.85 -25.37 28.55 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.56 -177.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.3 mmmt -103.99 113.49 27.06 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.046 0.45 . . . . 0.0 110.355 -178.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.42 145.53 49.22 Favored Pre-proline 0 C--N 1.313 -1.016 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 170.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.56 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 85.0 Cg_exo -50.4 138.82 38.04 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.395 2.063 . . . . 0.0 111.443 167.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.11 102.13 0.6 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.482 -175.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.17 -8.57 41.86 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.609 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.56 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 12.4 m -98.38 170.24 8.99 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.09 0.471 . . . . 0.0 111.163 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.28 136.64 35.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.345 176.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.545 HG23 ' HG2' ' A' ' 40' ' ' GLU . 0.7 OUTLIER -75.17 -27.64 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 C-N-CA 119.018 -1.073 . . . . 0.0 108.606 178.736 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.797 ' O ' HG12 ' A' ' 73' ' ' VAL . 17.7 mm -57.15 -47.02 84.7 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.211 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.332 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.9 t -46.77 -36.41 7.25 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.161 0.505 . . . . 0.0 111.237 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.64 ' O ' ' HE3' ' A' ' 74' ' ' LYS . 1.7 mm-40 -85.85 -32.91 21.46 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.45 -177.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.625 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 4.9 m-30 -75.31 -33.46 61.17 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.374 -177.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.797 HG12 ' O ' ' A' ' 69' ' ' ILE . 1.2 m -71.66 -31.15 41.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 171.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.64 ' HE3' ' O ' ' A' ' 71' ' ' GLU . 0.7 OUTLIER -72.0 -24.15 61.52 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.654 176.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -66.33 -47.34 73.84 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.404 173.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.97 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 43.9 t -88.97 7.76 33.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.051 178.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -63.31 -18.62 63.81 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.271 0.558 . . . . 0.0 109.894 172.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -98.82 -11.77 45.7 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.179 172.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.834 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 91.7 mt -92.44 143.77 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 121.071 0.462 . . . . 0.0 110.804 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.501 ' H ' ' HB2' ' A' ' 84' ' ' HIS . . . 142.7 -19.71 2.38 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 173.81 164.53 29.08 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 173.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 56.46 -85.01 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.132 0.573 . . . . 0.0 112.259 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 83.8 mtp -59.83 -39.13 84.08 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.734 -178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.501 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 5.2 t-80 -51.73 -33.92 36.77 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.37 177.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -80.09 -32.97 39.19 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.962 0.411 . . . . 0.0 110.524 -177.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.96 -43.81 51.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.57 0.7 . . . . 0.0 110.43 175.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 81.4 mtp -77.04 -13.79 59.91 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.647 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.411 HD13 ' HB2' ' A' ' 92' ' ' LEU . 0.1 OUTLIER -54.45 -58.16 8.53 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.704 176.16 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.9 ttt -70.49 -23.01 62.6 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.344 0.592 . . . . 0.0 110.712 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -87.14 -27.14 23.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.24 -173.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.636 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 24.1 mt-30 -111.77 -49.04 3.01 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.831 -175.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.411 ' HB2' HD13 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -51.07 -29.13 12.1 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.27 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.454 ' HG3' ' OXT' ' A' ' 93' ' ' GLU . 5.0 pt-20 . . . . . 0 C--O 1.25 1.08 0 CA-C-N 113.423 -1.717 . . . . 0.0 113.759 -174.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' PRO . . . . . 0.485 ' HB2' ' H ' ' B' ' 2' ' ' SER . 83.6 Cg_endo . . . . . 0 CA--C 1.517 -0.336 0 N-CA-C 108.725 -1.298 . . . . 0.0 108.725 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.485 ' H ' ' HB2' ' B' ' 1' ' ' PRO . 16.8 m -67.88 -179.24 1.13 Allowed 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 162.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.453 ' HE1' ' CD1' ' B' ' 38' ' ' ILE . 0.1 OUTLIER -76.7 -51.95 10.53 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 164.761 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.49 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.3 p-10 -87.28 6.09 35.1 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.929 -1.487 . . . . 0.0 113.869 -164.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.411 HG23 ' HB2' ' B' ' 2' ' ' SER . 0.8 OUTLIER -63.82 -5.89 5.0 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 118.806 0.73 . . . . 0.0 111.467 -176.699 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.458 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 1.9 m -77.89 130.23 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 176.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.669 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.1 OUTLIER -155.71 158.66 38.6 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.11 -1.036 . . . . 0.0 113.765 -178.426 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' GLN . . . . . 0.458 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.6 mt-30 -38.7 116.77 0.59 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 113.612 -1.631 . . . . 0.0 113.597 176.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.27 -155.94 32.32 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 169.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 18.4 m -48.19 100.6 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 117.437 0.619 . . . . 0.0 111.615 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 22.2 pttt 38.46 42.04 0.51 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.411 1.084 . . . . 0.0 112.401 -174.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -56.99 138.23 79.49 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.221 176.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . 0.527 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 37.2 Cg_exo -53.87 122.51 11.49 Favored 'Trans proline' 0 CA--C 1.508 -0.823 0 C-N-CA 121.88 1.72 . . . . 0.0 109.292 177.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . 0.716 ' O ' HG13 ' B' ' 18' ' ' VAL . 11.7 t80 -70.82 -54.09 8.28 Favored Pre-proline 0 N--CA 1.435 -1.217 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.833 -166.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.537 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 36.4 Cg_exo -56.05 -18.2 22.09 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 121.432 1.422 . . . . 0.0 110.841 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.527 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 2.3 m-20 -89.62 -42.48 11.36 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.146 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' PHE . . . . . 0.687 ' HE2' ' CE2' ' B' ' 14' ' ' TYR . 0.0 OUTLIER -54.23 -46.48 72.55 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 176.471 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.75 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 1.2 p -79.29 -34.55 16.4 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.366 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.563 -177.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' B' ' 15' ' ' PRO . . . -57.38 -32.71 67.07 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 121.374 -0.829 . . . . 0.0 111.702 178.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.702 ' O ' HG11 ' B' ' 24' ' ' VAL . 16.7 ptt180 -84.36 -27.2 27.86 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.619 HD21 ' CE1' ' B' ' 17' ' ' PHE . 6.8 tp -56.58 -47.27 79.92 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.886 172.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . 0.75 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 20.2 mt-30 -71.28 -46.86 59.86 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.028 177.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.732 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 17.4 t70 -47.54 -54.73 10.85 Favored 'General case' 0 C--N 1.315 -0.922 0 O-C-N 124.254 0.971 . . . . 0.0 111.607 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' VAL . . . . . 0.702 HG11 ' O ' ' B' ' 20' ' ' ARG . 7.5 p -81.14 -23.27 10.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.085 0.469 . . . . 0.0 109.921 -174.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.749 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -72.15 -19.47 61.76 Favored 'General case' 0 C--O 1.204 -1.297 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 174.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . 0.415 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -86.4 -36.4 19.19 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.583 -1.189 . . . . 0.0 109.499 178.105 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.732 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.1 mmtt -66.99 -38.09 85.39 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.98 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 50.1 m -101.63 -9.57 20.82 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.269 0.557 . . . . 0.0 110.768 -171.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.749 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 88.2 mt -113.91 135.95 51.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.677 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.03 -1.84 41.66 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.916 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.569 ' H ' HG23 ' B' ' 29' ' ' ILE . 4.5 t0 -118.04 132.31 56.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.205 0.526 . . . . 0.0 111.147 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 0.551 ' OE1' ' HG3' ' B' ' 33' ' ' LYS . 1.5 pp20? -59.82 -35.58 75.01 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.312 174.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.551 ' HG3' ' OE1' ' B' ' 32' ' ' GLU . 13.2 mttp -61.37 -58.75 6.95 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -175.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.435 ' HA ' HG21 ' B' ' 37' ' ' VAL . . . -61.95 -26.88 68.46 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.531 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.828 ' O ' HG11 ' B' ' 39' ' ' VAL . 5.0 tmm_? -70.54 -58.25 3.89 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.446 ' HD2' ' OE2' ' B' ' 32' ' ' GLU . 17.8 mtpt -56.3 -55.49 32.71 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.992 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.747 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 22.8 m -54.0 -36.58 31.67 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.103 -172.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.453 ' CD1' ' HE1' ' B' ' 3' ' ' PHE . 1.3 tt -87.06 -29.62 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.845 -177.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.828 HG11 ' O ' ' B' ' 35' ' ' ARG . 3.0 m -70.02 -49.03 59.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 119.131 -1.028 . . . . 0.0 109.488 175.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.597 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 58.8 mt-10 -64.91 -23.28 67.18 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.514 0.725 . . . . 0.0 112.604 176.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.747 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -85.92 -55.37 3.98 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.555 176.385 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' MET . . . . . 0.504 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 22.5 mmt -62.58 -20.48 64.74 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.614 0.721 . . . . 0.0 109.318 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.669 ' O ' ' HB2' ' B' ' 47' ' ' ALA . . . -48.26 -29.6 3.98 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.832 170.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' TYR . . . . . 0.547 ' CG ' ' HD2' ' B' ' 59' ' ' LYS . 10.4 t80 -108.06 -66.39 1.04 Allowed 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.633 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 14.6 mm-40 -47.97 -33.24 7.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 124.292 0.995 . . . . 0.0 111.905 -174.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.669 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.9 m-20 -103.2 -20.77 14.01 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.366 -175.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -59.72 179.76 0.11 Allowed 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 122.028 0.918 . . . . 0.0 112.683 -174.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . 0.53 ' HB3' ' OE2' ' B' ' 50' ' ' GLU . 12.5 m-20 -58.24 140.45 83.37 Favored Pre-proline 0 N--CA 1.438 -1.032 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.362 175.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -57.8 -20.65 44.51 Favored 'Trans proline' 0 C--O 1.221 -0.355 0 C-N-CA 123.211 2.607 . . . . 0.0 112.182 -178.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.721 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 9.1 pm0 -88.66 -30.9 18.81 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 123.541 0.737 . . . . 0.0 110.287 173.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.971 ' SG ' ' HB2' ' B' ' 76' ' ' CYS . 49.5 t -85.52 -37.12 20.02 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.97 -168.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . 0.496 ' HB2' ' CG ' ' B' ' 44' ' ' TYR . 3.9 pt20 -67.46 -29.04 68.4 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 171.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' SER . . . . . 0.627 ' HB3' ' HB3' ' B' ' 91' ' ' GLN . 34.8 m -71.8 -21.1 61.75 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 113.176 -1.829 . . . . 0.0 110.379 174.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.422 ' HB1' HD13 ' B' ' 79' ' ' ILE . . . -78.53 -24.56 45.66 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.501 0.667 . . . . 0.0 110.159 167.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.565 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 21.5 mt -90.8 -32.98 5.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -171.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.606 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.19 -39.24 1.86 Allowed Pre-proline 0 N--CA 1.486 1.365 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -173.612 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 42.9 Cg_endo -61.44 -29.55 85.38 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.216 1.944 . . . . 0.0 112.728 175.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . 0.509 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.4 mt -98.23 -16.54 19.39 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.584 ' HA ' ' OH ' ' B' ' 72' ' ' TYR . 0.1 OUTLIER -54.65 108.81 0.43 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.578 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.72 -25.43 28.3 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.59 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 12.3 mmmt -103.99 113.49 27.06 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.114 0.483 . . . . 0.0 110.322 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.22 145.53 48.8 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.844 170.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.549 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 87.7 Cg_exo -50.44 139.41 37.39 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.277 1.985 . . . . 0.0 111.528 167.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.78 102.18 0.73 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.965 0.412 . . . . 0.0 111.466 -175.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.15 -8.37 41.72 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.668 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.549 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 13.1 m -98.35 170.22 9.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.176 0.512 . . . . 0.0 111.242 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.17 136.51 35.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.269 176.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.548 HG11 ' CD ' ' B' ' 40' ' ' GLU . 0.7 OUTLIER -75.14 -27.49 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 C-N-CA 118.795 -1.162 . . . . 0.0 108.64 178.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . 0.797 ' O ' HG12 ' B' ' 73' ' ' VAL . 17.9 mm -57.21 -46.98 84.95 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.194 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.366 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 30.6 t -46.87 -36.14 7.17 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.32 0.581 . . . . 0.0 111.349 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.635 ' O ' ' HE3' ' B' ' 74' ' ' LYS . 1.7 mm-40 -85.98 -32.83 21.32 Favored 'General case' 0 C--O 1.213 -0.817 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.499 -177.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' TYR . . . . . 0.629 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 4.9 m-30 -75.54 -33.27 60.66 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.376 -177.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . 0.797 HG12 ' O ' ' B' ' 69' ' ' ILE . 1.2 m -71.66 -31.3 41.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 171.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' LYS . . . . . 0.635 ' HE3' ' O ' ' B' ' 71' ' ' GLU . 0.7 OUTLIER -71.89 -24.45 61.66 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.539 177.021 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -66.24 -47.14 74.75 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.438 173.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.971 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 44.2 t -89.12 7.64 34.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.831 178.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 12.3 t70 -63.16 -18.69 63.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.192 0.52 . . . . 0.0 109.896 172.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -98.57 -12.39 44.57 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.206 172.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.823 ' HB ' ' SG ' ' B' ' 76' ' ' CYS . 91.7 mt -91.73 144.17 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 O-C-N 122.483 -0.421 . . . . 0.0 110.816 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . 0.5 ' H ' ' HB2' ' B' ' 84' ' ' HIS . . . 141.98 -18.93 2.53 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 173.09 164.19 28.05 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 173.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 56.68 -85.19 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.08 0.552 . . . . 0.0 112.141 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' MET . . . . . . . . . . . . . 83.7 mtp -59.86 -39.07 83.99 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.739 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' HIS . . . . . 0.5 ' HB2' ' H ' ' B' ' 80' ' ' GLY . 5.2 t-80 -51.68 -34.14 36.99 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.786 -0.188 . . . . 0.0 111.375 177.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -79.74 -33.56 40.67 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.944 0.402 . . . . 0.0 110.38 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.15 -44.39 53.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.718 0.771 . . . . 0.0 110.297 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 81.0 mtp -76.63 -13.75 60.04 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.748 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' B' ' 84' ' ' HIS . 0.1 OUTLIER -54.19 -58.34 7.73 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.716 175.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 26.3 ttt -70.48 -23.5 62.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.628 -175.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -86.93 -26.9 23.66 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.345 -173.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' GLN . . . . . 0.627 ' HB3' ' HB3' ' B' ' 53' ' ' SER . 24.1 mt-30 -111.75 -48.83 3.03 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -175.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.402 ' HB2' HD13 ' B' ' 88' ' ' LEU . 0.1 OUTLIER -51.25 -29.19 13.73 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.354 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.423 ' HG3' ' OXT' ' B' ' 93' ' ' GLU . 5.1 pt-20 . . . . . 0 C--O 1.249 1.069 0 CA-C-N 113.273 -1.785 . . . . 0.0 113.756 -173.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.4 ' HB2' ' H ' ' A' ' 2' ' ' SER . 97.8 Cg_endo . . . . . 0 N--CA 1.465 -0.202 0 N-CA-C 108.91 -1.227 . . . . 0.0 108.91 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.404 ' HB2' HG23 ' A' ' 5' ' ' THR . 72.0 m -71.34 -178.86 2.23 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 161.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.479 ' CE1' HD13 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -77.02 -53.48 7.75 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 122.096 0.95 . . . . 0.0 109.716 172.77 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.535 ' ND2' ' HE3' ' A' ' 42' ' ' MET . 2.5 p-10 -85.69 5.85 30.26 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.141 -1.39 . . . . 0.0 113.249 -163.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.449 ' CG2' ' HD3' ' B' ' 59' ' ' LYS . 1.1 p -66.83 -3.38 6.72 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 121.935 -0.478 . . . . 0.0 111.428 -176.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.553 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 1.9 m -78.2 133.89 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 173.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.681 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -156.54 160.84 39.86 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -177.863 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -41.94 115.53 0.68 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 113.704 -1.589 . . . . 0.0 113.056 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.58 -151.72 23.78 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 172.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.481 ' C ' ' HD3' ' A' ' 11' ' ' LYS . 22.8 m -54.25 99.13 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 117.319 0.559 . . . . 0.0 111.133 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.481 ' HD3' ' C ' ' A' ' 10' ' ' SER . 0.0 OUTLIER 34.56 46.52 0.18 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.642 1.177 . . . . 0.0 112.269 -171.333 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -59.54 139.54 89.2 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.23 175.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.538 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 52.1 Cg_exo -51.0 122.47 9.99 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 121.942 1.761 . . . . 0.0 109.651 177.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.847 ' HE2' ' SG ' ' A' ' 51' ' ' CYS . 6.1 t80 -70.4 -55.34 7.8 Favored Pre-proline 0 N--CA 1.439 -1.001 0 CA-C-O 118.569 -0.729 . . . . 0.0 112.651 -167.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.509 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 35.0 Cg_exo -55.57 -19.41 23.37 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 121.535 1.49 . . . . 0.0 111.217 -178.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.538 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 0.8 OUTLIER -90.04 -39.39 12.96 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.176 179.505 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.688 ' HE2' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -56.64 -45.68 81.43 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 175.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.726 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 1.3 p -79.01 -33.97 16.38 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.329 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.275 -178.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.64 -32.0 66.84 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 121.386 -0.821 . . . . 0.0 111.624 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.699 ' O ' HG11 ' A' ' 24' ' ' VAL . 14.5 ptt180 -84.96 -26.32 27.24 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 176.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.58 HD22 ' CE1' ' A' ' 17' ' ' PHE . 7.5 tp -56.99 -47.74 80.09 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.639 171.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.726 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 18.2 mt-30 -70.15 -46.62 64.33 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.753 176.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.719 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 18.6 t70 -46.82 -57.13 5.21 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.288 0.992 . . . . 0.0 111.67 -179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.699 HG11 ' O ' ' A' ' 20' ' ' ARG . 7.7 p -79.22 -23.85 12.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.134 0.492 . . . . 0.0 109.816 -173.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.745 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -72.14 -19.69 61.73 Favored 'General case' 0 C--O 1.205 -1.243 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 174.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.467 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -86.66 -36.98 18.45 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.481 178.522 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.719 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.7 mmtt -66.82 -35.27 79.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.8 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.9 t -105.07 -9.11 18.04 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.166 0.508 . . . . 0.0 110.583 -171.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.745 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 88.7 mt -115.11 129.1 71.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.769 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.26 -4.65 59.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.171 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.553 ' H ' HG22 ' A' ' 29' ' ' ILE . 2.8 t0 -116.16 140.57 49.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.233 0.54 . . . . 0.0 111.276 -177.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.528 ' OE2' ' HG3' ' A' ' 33' ' ' LYS . 1.4 pp20? -66.41 -36.14 82.08 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.256 173.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.528 ' HG3' ' OE2' ' A' ' 32' ' ' GLU . 13.0 mttp -60.45 -61.02 2.9 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -174.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.425 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -59.71 -27.04 66.11 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.623 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.805 ' O ' HG12 ' A' ' 39' ' ' VAL . 4.8 tmm_? -69.65 -59.42 2.97 Favored 'General case' 0 C--O 1.221 -0.43 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -56.73 -55.78 29.84 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.217 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.695 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 18.9 m -53.19 -35.36 23.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 O-C-N 123.98 0.8 . . . . 0.0 111.253 -172.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.5 HD13 ' OD1' ' A' ' 4' ' ' ASN . 1.3 tt -87.46 -31.12 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 119.756 -0.778 . . . . 0.0 112.097 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.805 HG12 ' O ' ' A' ' 35' ' ' ARG . 3.0 m -69.19 -48.57 67.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 119.181 -1.008 . . . . 0.0 109.392 175.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.607 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 58.2 mt-10 -63.73 -23.7 67.47 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 123.624 0.77 . . . . 0.0 112.264 176.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.695 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -86.47 -54.74 4.24 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.803 176.343 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.535 ' HE3' ' ND2' ' A' ' 4' ' ' ASN . 18.7 mmt -62.68 -20.46 64.87 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.504 0.669 . . . . 0.0 109.919 -177.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.617 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . . . -48.23 -29.08 3.45 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.024 171.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.619 ' CG ' ' HB2' ' A' ' 52' ' ' GLN . 2.5 t80 -109.05 -65.68 1.12 Allowed 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 175.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.502 ' CG ' HD13 ' A' ' 41' ' ' LEU . 3.3 mm-40 -46.89 -30.39 2.49 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 124.116 0.885 . . . . 0.0 112.713 -175.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.681 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.8 m-20 -106.55 -20.77 13.26 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -175.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.811 ' HB3' ' SG ' ' A' ' 51' ' ' CYS . . . -64.33 -175.96 0.2 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -172.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 51' ' ' CYS . 18.7 m-20 -61.79 141.7 95.1 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 114.526 -1.216 . . . . 0.0 109.447 175.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -55.27 -26.6 52.9 Favored 'Trans proline' 0 C--O 1.219 -0.458 0 C-N-CA 123.592 2.861 . . . . 0.0 112.968 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.518 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -87.31 -29.29 21.7 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.381 0.672 . . . . 0.0 110.247 174.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.847 ' SG ' ' HE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -76.15 -43.67 41.78 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.547 -172.229 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.619 ' HB2' ' CG ' ' A' ' 44' ' ' TYR . 4.3 pt20 -67.75 -29.46 68.69 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 175.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.562 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 4.0 m -69.42 -20.89 63.79 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 113.703 -1.589 . . . . 0.0 110.729 173.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.504 ' HB1' HD11 ' A' ' 79' ' ' ILE . . . -80.41 -24.87 39.36 Favored 'General case' 0 C--N 1.309 -1.176 0 O-C-N 121.412 -0.805 . . . . 0.0 109.853 168.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.558 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 25.8 mt -90.73 -31.22 5.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 115.008 1.485 . . . . 0.0 115.008 -172.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.624 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.71 -39.75 2.79 Favored Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -172.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 49.6 Cg_endo -62.69 -29.76 77.83 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.327 2.018 . . . . 0.0 112.799 176.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.519 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.6 mt -97.35 -16.37 20.3 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.595 ' HE3' ' HB3' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -52.94 108.4 0.31 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.02 -178.141 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.9 -22.71 36.6 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.74 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -103.39 114.85 29.45 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.55 138.74 29.76 Favored Pre-proline 0 C--N 1.313 -1.015 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.42 173.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.528 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 95.7 Cg_exo -47.85 139.61 19.18 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.661 2.241 . . . . 0.0 111.891 169.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.77 101.33 0.19 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.55 -175.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.34 -13.24 43.83 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.645 177.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.528 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 47.5 m -88.41 166.0 14.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.225 0.536 . . . . 0.0 111.07 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.25 138.94 32.67 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 173.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.566 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.7 OUTLIER -74.33 -28.54 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 C-N-CA 118.462 -1.295 . . . . 0.0 108.669 -177.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.781 ' O ' HG12 ' A' ' 73' ' ' VAL . 14.3 mm -58.49 -46.82 89.56 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.278 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.327 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.526 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 40.3 t -48.77 -36.63 16.96 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.249 0.547 . . . . 0.0 111.098 178.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -86.53 -31.34 21.31 Favored 'General case' 0 CA--C 1.506 -0.719 0 C-N-CA 123.137 0.575 . . . . 0.0 110.517 -176.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.595 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.3 m-30 -75.22 -36.64 61.33 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.285 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.781 HG12 ' O ' ' A' ' 69' ' ' ILE . 1.7 m -69.45 -32.89 54.81 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 173.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 70' ' ' SER . 0.1 OUTLIER -70.23 -32.43 70.3 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.406 178.683 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.411 ' HB3' HD13 ' A' ' 58' ' ' LEU . . . -63.43 -42.76 98.71 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.645 -1.161 . . . . 0.0 108.972 178.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.58 ' SG ' ' SG ' ' A' ' 51' ' ' CYS . 5.0 m -102.21 9.49 40.02 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.34 -175.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -58.54 -15.41 11.18 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.069 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.564 ' O ' ' HB2' ' A' ' 83' ' ' MET . . . -117.71 13.59 13.17 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.823 175.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.636 ' CD1' ' HA ' ' A' ' 51' ' ' CYS . 53.2 mt -94.32 -15.26 7.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.307 0.575 . . . . 0.0 111.632 -176.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.16 -12.09 42.41 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.286 -0.959 . . . . 0.0 112.943 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 176.0 154.32 11.43 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.693 174.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 68.37 -75.67 0.06 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 173.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.564 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 78.0 mtp -61.18 -30.27 70.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.235 0.541 . . . . 0.0 110.111 -177.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.518 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 8.9 t-160 -55.63 -34.59 65.06 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.918 173.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -82.51 -18.14 42.62 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.093 0.473 . . . . 0.0 110.236 -176.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.02 -44.57 12.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.629 175.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 59.0 mtm -81.4 -14.0 57.64 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.346 -176.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.518 ' HB2' ' O ' ' A' ' 84' ' ' HIS . 0.2 OUTLIER -53.16 -33.65 53.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.749 -178.121 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.7 tpt -83.39 -23.06 32.55 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.085 0.469 . . . . 0.0 110.79 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -92.5 -49.33 6.18 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -172.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.549 ' C ' ' HB3' ' A' ' 53' ' ' SER . 23.5 mt-30 -91.47 -52.12 4.94 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.774 -171.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -48.2 -35.93 12.74 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 175.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 6.1 pt-20 . . . . . 0 C--O 1.25 1.08 0 O-C-N 125.558 1.786 . . . . 0.0 113.941 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' PRO . . . . . 0.453 ' HB2' ' H ' ' B' ' 2' ' ' SER . 98.9 Cg_endo . . . . . 0 CA--C 1.518 -0.285 0 N-CA-C 108.811 -1.265 . . . . 0.0 108.811 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.453 ' H ' ' HB2' ' B' ' 1' ' ' PRO . 74.7 m -71.04 -178.75 2.06 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 161.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.474 ' CE1' HD13 ' B' ' 29' ' ' ILE . 0.1 OUTLIER -77.12 -53.5 7.69 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 122.093 0.949 . . . . 0.0 109.646 172.831 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.521 ' ND2' ' HE3' ' B' ' 42' ' ' MET . 2.5 p-10 -85.61 5.77 30.33 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.095 -1.411 . . . . 0.0 113.224 -163.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.454 ' CG2' ' HD3' ' A' ' 59' ' ' LYS . 1.1 p -66.72 -3.75 7.37 Favored 'General case' 0 C--N 1.312 -1.045 0 O-C-N 121.953 -0.467 . . . . 0.0 111.36 -176.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.556 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.0 m -77.99 133.75 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 173.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.678 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.2 OUTLIER -156.41 160.95 40.09 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -177.925 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -41.98 115.22 0.64 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 113.732 -1.576 . . . . 0.0 113.16 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.44 -151.5 23.12 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 171.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' SER . . . . . 0.49 ' C ' ' HD3' ' B' ' 11' ' ' LYS . 24.0 m -54.73 98.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.369 0.585 . . . . 0.0 111.187 -178.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.49 ' HD3' ' C ' ' B' ' 10' ' ' SER . 0.0 OUTLIER 34.99 46.6 0.21 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.799 1.24 . . . . 0.0 112.129 -171.508 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -59.64 139.51 89.55 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.197 175.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . 0.546 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 51.2 Cg_exo -50.98 122.32 9.72 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 121.955 1.77 . . . . 0.0 109.615 177.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . 0.833 ' HE2' ' SG ' ' B' ' 51' ' ' CYS . 6.3 t80 -70.35 -55.22 8.02 Favored Pre-proline 0 N--CA 1.439 -0.98 0 CA-C-O 118.494 -0.765 . . . . 0.0 112.664 -167.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.51 ' HD3' ' HB3' ' B' ' 14' ' ' TYR . 35.2 Cg_exo -55.79 -19.21 24.0 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 121.526 1.484 . . . . 0.0 111.124 -178.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.546 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 0.8 OUTLIER -89.92 -39.79 12.79 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.226 -1.352 . . . . 0.0 111.082 179.579 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' PHE . . . . . 0.686 ' HE2' ' CE2' ' B' ' 14' ' ' TYR . 0.0 OUTLIER -56.59 -45.67 81.24 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.128 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.734 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 1.3 p -78.94 -33.97 16.53 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.354 0 CA-C-N 115.184 -0.917 . . . . 0.0 111.271 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.71 -31.8 66.77 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 121.346 -0.846 . . . . 0.0 111.701 177.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.695 ' O ' HG11 ' B' ' 24' ' ' VAL . 14.7 ptt180 -84.88 -26.61 27.22 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 175.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.581 HD22 ' CE1' ' B' ' 17' ' ' PHE . 7.6 tp -56.84 -47.73 79.67 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.603 172.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . 0.734 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 18.5 mt-30 -70.04 -47.09 63.44 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.817 176.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.737 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 19.4 t70 -46.4 -57.06 5.0 Favored 'General case' 0 C--N 1.314 -0.947 0 O-C-N 124.312 1.008 . . . . 0.0 111.721 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' VAL . . . . . 0.695 HG11 ' O ' ' B' ' 20' ' ' ARG . 7.7 p -79.44 -23.65 12.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.169 0.509 . . . . 0.0 109.849 -173.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.759 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -72.25 -19.69 61.66 Favored 'General case' 0 C--O 1.205 -1.274 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 174.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . 0.46 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -86.73 -36.99 18.33 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.494 178.589 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.737 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.9 mmtt -66.77 -35.36 79.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.699 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 36.2 t -105.08 -8.88 18.18 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 120.946 0.403 . . . . 0.0 110.744 -171.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.759 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 88.9 mt -115.38 129.4 71.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.711 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.55 -5.02 58.95 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.102 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.565 ' H ' HG22 ' B' ' 29' ' ' ILE . 2.5 t0 -115.98 140.58 49.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.305 0.574 . . . . 0.0 111.125 -176.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 0.551 ' OE2' ' HG3' ' B' ' 33' ' ' LYS . 1.5 pp20? -66.48 -35.91 81.44 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.183 174.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.551 ' HG3' ' OE2' ' B' ' 32' ' ' GLU . 12.9 mttp -60.49 -61.04 2.88 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -174.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.43 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -59.93 -26.86 66.29 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.582 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.807 ' O ' HG12 ' B' ' 39' ' ' VAL . 4.7 tmm_? -69.69 -59.39 2.98 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -178.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.409 ' HD2' ' OE1' ' B' ' 32' ' ' GLU . 23.8 mtpt -56.84 -55.44 34.4 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.246 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.687 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 19.2 m -53.52 -35.29 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.192 -172.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.494 HD13 ' OD1' ' B' ' 4' ' ' ASN . 1.3 tt -87.42 -31.12 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.159 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.807 HG12 ' O ' ' B' ' 35' ' ' ARG . 3.0 m -69.15 -48.57 68.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 119.078 -1.049 . . . . 0.0 109.418 175.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.612 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 61.9 mt-10 -63.59 -23.94 67.59 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 123.634 0.774 . . . . 0.0 112.229 176.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.687 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -86.27 -54.73 4.28 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.871 176.328 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' MET . . . . . 0.521 ' HE3' ' ND2' ' B' ' 4' ' ' ASN . 18.8 mmt -62.65 -20.41 64.78 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 121.553 0.692 . . . . 0.0 109.971 -177.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.622 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . . . -48.33 -29.03 3.53 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.48 -1.237 . . . . 0.0 110.992 171.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' TYR . . . . . 0.631 ' CG ' ' HB2' ' B' ' 52' ' ' GLN . 2.4 t80 -109.05 -65.63 1.12 Allowed 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 176.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.496 ' CG ' HD13 ' B' ' 41' ' ' LEU . 3.3 mm-40 -46.89 -30.76 2.69 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 124.145 0.903 . . . . 0.0 112.678 -175.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.678 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.8 m-20 -106.13 -20.97 13.25 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -175.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.812 ' HB3' ' SG ' ' B' ' 51' ' ' CYS . . . -64.23 -175.9 0.19 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -172.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . 0.48 ' HB2' ' HB3' ' B' ' 51' ' ' CYS . 19.4 m-20 -61.75 141.72 95.01 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.473 175.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -55.27 -26.75 53.65 Favored 'Trans proline' 0 C--O 1.219 -0.446 0 C-N-CA 123.518 2.812 . . . . 0.0 112.948 -176.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.557 ' O ' ' HG3' ' B' ' 50' ' ' GLU . 0.0 OUTLIER -87.17 -29.16 21.98 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.327 0.651 . . . . 0.0 110.351 174.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.833 ' SG ' ' HE2' ' B' ' 14' ' ' TYR . 0.0 OUTLIER -76.04 -43.78 42.27 Favored 'General case' 0 N--CA 1.42 -1.942 0 CA-C-O 121.446 0.641 . . . . 0.0 110.547 -172.229 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . 0.631 ' HB2' ' CG ' ' B' ' 44' ' ' TYR . 4.4 pt20 -67.77 -29.47 68.69 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 175.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' SER . . . . . 0.556 ' HB3' ' C ' ' B' ' 91' ' ' GLN . 4.0 m -69.42 -20.87 63.79 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 113.685 -1.598 . . . . 0.0 110.716 173.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.512 ' HB1' HD11 ' B' ' 79' ' ' ILE . . . -80.22 -25.26 39.69 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.289 -0.882 . . . . 0.0 109.821 168.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.566 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 25.7 mt -90.67 -31.28 5.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 -172.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.623 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.64 -39.62 2.6 Favored Pre-proline 0 N--CA 1.487 1.399 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -172.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 50.7 Cg_endo -62.81 -29.67 76.98 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.323 2.015 . . . . 0.0 112.828 176.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . 0.533 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.7 mt -97.42 -16.42 20.2 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.596 ' HE3' ' HB3' ' B' ' 44' ' ' TYR . 0.1 OUTLIER -52.92 108.73 0.34 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.955 -178.104 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.55 -22.47 37.24 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.745 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -103.53 115.11 29.9 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -178.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.92 139.0 30.51 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.429 173.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.537 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 97.0 Cg_exo -47.96 139.43 20.09 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.708 2.272 . . . . 0.0 111.833 169.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.06 101.12 0.19 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.413 -175.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.62 -13.09 42.73 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.757 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.537 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 48.2 m -88.68 166.03 14.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.05 0.453 . . . . 0.0 110.937 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.37 139.2 32.42 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 173.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.557 HG13 ' CD ' ' B' ' 40' ' ' GLU . 0.7 OUTLIER -74.32 -28.33 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 C-N-CA 118.432 -1.307 . . . . 0.0 108.696 -177.462 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . 0.779 ' O ' HG12 ' B' ' 73' ' ' VAL . 14.4 mm -58.61 -46.83 90.01 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.179 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.319 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.534 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 37.6 t -48.62 -36.74 16.45 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.165 0.507 . . . . 0.0 111.081 178.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -86.56 -31.23 21.33 Favored 'General case' 0 CA--C 1.506 -0.73 0 C-N-CA 123.206 0.602 . . . . 0.0 110.545 -176.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' TYR . . . . . 0.585 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.3 m-30 -75.36 -36.6 60.95 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.32 -178.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . 0.779 HG12 ' O ' ' B' ' 69' ' ' ILE . 1.7 m -69.36 -33.23 56.65 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 173.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' B' ' 70' ' ' SER . 0.1 OUTLIER -69.94 -32.31 70.51 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.517 178.473 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . 0.415 ' HB3' HD13 ' B' ' 58' ' ' LEU . . . -63.76 -42.07 97.88 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.208 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.58 ' SG ' ' SG ' ' B' ' 51' ' ' CYS . 5.1 m -102.7 9.53 39.13 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 114.101 -1.409 . . . . 0.0 111.318 -175.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -58.26 -16.19 13.04 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.046 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . 0.551 ' O ' ' HB2' ' B' ' 83' ' ' MET . . . -116.99 13.48 14.24 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.981 175.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.631 ' CD1' ' HA ' ' B' ' 51' ' ' CYS . 53.4 mt -94.22 -15.25 7.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.21 0.529 . . . . 0.0 111.705 -176.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.11 -11.9 41.13 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.961 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 175.77 154.17 11.18 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.678 174.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 68.46 -75.3 0.07 Allowed 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 173.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' MET . . . . . 0.551 ' HB2' ' O ' ' B' ' 78' ' ' GLY . 77.8 mtp -61.27 -30.43 70.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.152 0.501 . . . . 0.0 110.059 -177.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' HIS . . . . . 0.51 ' O ' ' HB2' ' B' ' 88' ' ' LEU . 8.8 t-160 -55.79 -34.62 65.46 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.836 173.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -82.5 -17.72 44.13 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.925 0.393 . . . . 0.0 110.26 -176.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.17 -44.88 11.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.678 175.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 58.5 mtm -81.32 -13.89 57.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.428 -176.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.51 ' HB2' ' O ' ' B' ' 84' ' ' HIS . 0.2 OUTLIER -52.79 -34.43 53.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.615 -178.322 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 15.7 tpt -83.09 -22.83 33.32 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.091 0.472 . . . . 0.0 110.736 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -92.69 -48.91 6.35 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -172.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' GLN . . . . . 0.556 ' C ' ' HB3' ' B' ' 53' ' ' SER . 23.7 mt-30 -91.65 -52.17 4.89 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.855 -171.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.405 ' HB2' HD13 ' B' ' 88' ' ' LEU . 0.0 OUTLIER -48.19 -35.84 12.54 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 174.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' B' ' 91' ' ' GLN . 6.1 pt-20 . . . . . 0 C--O 1.248 1.025 0 O-C-N 125.563 1.789 . . . . 0.0 113.864 -175.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.406 ' HB2' ' H ' ' A' ' 2' ' ' SER . 86.3 Cg_endo . . . . . 0 CA--C 1.517 -0.35 0 N-CA-C 109.024 -1.183 . . . . 0.0 109.024 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.427 ' HB2' HG23 ' A' ' 5' ' ' THR . 21.2 m -68.41 175.2 3.5 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 161.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.595 ' CE1' HD13 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -71.0 -52.2 21.03 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 164.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.495 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 2.3 p-10 -87.41 5.52 38.39 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.875 -1.512 . . . . 0.0 113.692 -165.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.427 HG23 ' HB2' ' A' ' 2' ' ' SER . 0.7 OUTLIER -64.35 -5.76 5.78 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 118.537 0.608 . . . . 0.0 111.116 -177.37 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.627 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.1 m -76.16 130.94 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.691 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -154.31 158.69 40.52 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.538 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 3.3 mt-30 -42.04 116.61 0.84 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 112.997 -1.91 . . . . 0.0 113.465 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.56 -153.67 21.55 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 170.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.647 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 20.8 t -57.19 99.34 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.166 0.483 . . . . 0.0 110.926 -177.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.647 ' HG2' ' O ' ' A' ' 10' ' ' SER . 4.1 ptpp? 49.18 32.71 4.38 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.602 1.161 . . . . 0.0 112.433 -177.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.405 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 38.7 tt0 -56.06 135.39 74.14 Favored Pre-proline 0 C--O 1.233 0.224 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.533 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 52.0 Cg_exo -51.05 123.08 11.09 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.46 2.107 . . . . 0.0 110.169 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.863 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 15.0 t80 -71.13 -53.51 8.18 Favored Pre-proline 0 N--CA 1.438 -1.061 0 CA-C-O 118.277 -0.868 . . . . 0.0 113.183 -167.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.545 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 33.6 Cg_exo -55.9 -18.43 22.05 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 121.425 1.416 . . . . 0.0 111.041 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.533 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.8 m-20 -89.92 -43.49 10.55 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.93 -1.486 . . . . 0.0 110.829 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.538 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -54.31 -44.43 72.0 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.931 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.697 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 3.0 p -82.19 -31.77 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.386 -177.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 15' ' ' PRO . . . -57.89 -35.86 71.61 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 121.763 -0.585 . . . . 0.0 111.853 175.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.709 ' O ' HG13 ' A' ' 24' ' ' VAL . 15.6 ptt180 -82.97 -27.3 30.56 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 177.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.545 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 6.5 tp -56.89 -45.46 82.57 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.858 173.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.697 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 40.5 mt-30 -74.12 -43.71 56.52 Favored 'General case' 0 CA--C 1.496 -1.112 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.999 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.742 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 8.8 t70 -51.17 -51.68 51.41 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 124.137 0.898 . . . . 0.0 111.47 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 20' ' ' ARG . 7.5 p -82.64 -23.15 8.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -174.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.815 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -71.66 -18.67 62.17 Favored 'General case' 0 C--O 1.206 -1.224 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 174.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.0 -39.11 15.98 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.471 -1.24 . . . . 0.0 109.766 176.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.742 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 36.5 mmtt -66.59 -40.61 88.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.065 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.9 m -98.81 -9.7 24.01 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.153 0.501 . . . . 0.0 110.437 -171.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.815 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 87.5 mt -115.18 125.3 72.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.759 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.56 -4.96 59.25 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.004 0.431 . . . . 0.0 110.529 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.677 ' OD1' ' HD2' ' A' ' 33' ' ' LYS . 3.9 t0 -110.62 122.43 47.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.534 -176.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' A' ' 36' ' ' LYS . 12.6 pt-20 -61.85 -25.11 67.33 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.765 176.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.677 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 24.4 mttt -73.81 -46.74 43.43 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 120.901 0.381 . . . . 0.0 110.146 -176.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.08 -25.11 60.78 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.731 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.823 ' O ' HG12 ' A' ' 39' ' ' VAL . 5.0 tmm_? -64.53 -63.14 1.21 Allowed 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.506 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 6.5 ptmm? -51.9 -60.15 3.51 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.198 0.523 . . . . 0.0 112.224 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.607 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 10.4 m -56.32 -30.87 31.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.353 -170.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.497 ' O ' ' HG2' ' A' ' 42' ' ' MET . 1.2 tt -86.08 -30.45 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.247 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.823 HG12 ' O ' ' A' ' 35' ' ' ARG . 2.3 m -70.13 -47.91 65.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 119.481 -0.887 . . . . 0.0 109.348 175.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.66 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 55.3 mt-10 -60.21 -30.27 69.27 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.665 0.786 . . . . 0.0 112.119 176.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.607 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -86.16 -53.15 5.22 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.484 -0.487 . . . . 0.0 112.189 179.198 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.547 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 22.0 mmt -61.95 -22.08 65.33 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.592 0.71 . . . . 0.0 109.84 -178.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.699 ' HB2' ' OH ' ' A' ' 14' ' ' TYR . . . -48.54 -29.02 3.78 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.043 171.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.579 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 8.4 t80 -107.02 -66.58 1.01 Allowed 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.535 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 15.5 mm-40 -48.23 -31.96 6.55 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 124.141 0.901 . . . . 0.0 112.109 -174.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.691 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.9 m-20 -103.03 -21.49 13.92 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.182 -175.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.597 ' HB1' ' O ' ' A' ' 43' ' ' ALA . . . -62.42 -178.98 0.21 Allowed 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.988 0.899 . . . . 0.0 112.986 -173.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.537 ' HB3' ' OE1' ' A' ' 50' ' ' GLU . 12.2 m-20 -61.34 143.24 93.11 Favored Pre-proline 0 C--N 1.317 -0.811 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.003 175.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -50.83 -28.53 23.66 Favored 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 123.666 2.911 . . . . 0.0 112.996 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.708 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 15.9 pm0 -88.42 -30.99 19.04 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.758 0.823 . . . . 0.0 111.015 176.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.708 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 96.9 m -81.79 -38.99 24.73 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.242 -170.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.48 ' HA ' HD12 ' A' ' 55' ' ' ILE . 4.1 pt20 -69.93 -29.76 66.98 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 172.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.589 ' HB3' ' C ' ' A' ' 91' ' ' GLN . 6.7 m -71.12 -20.32 62.34 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.859 -1.518 . . . . 0.0 110.755 174.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.49 ' HB1' HD11 ' A' ' 79' ' ' ILE . . . -77.88 -25.27 48.48 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.691 0.758 . . . . 0.0 109.57 167.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.573 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 24.1 mt -89.76 -33.05 5.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -172.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.605 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.3 -38.71 1.71 Allowed Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -173.363 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 51.5 Cg_endo -63.13 -28.69 73.86 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.188 1.925 . . . . 0.0 112.625 175.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.507 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 2.2 mt -97.58 -16.65 19.95 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.579 ' HD2' ' CG ' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -55.95 108.98 0.51 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.443 -179.146 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.72 -24.9 30.36 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.328 -177.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.0 mmmt -104.54 115.63 30.68 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.853 0.358 . . . . 0.0 110.466 -178.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.77 134.75 24.75 Favored Pre-proline 0 C--N 1.313 -1.0 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 168.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -51.66 136.2 49.6 Favored 'Trans proline' 0 CA--C 1.518 -0.278 0 C-N-CA 122.545 2.163 . . . . 0.0 111.79 172.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.09 109.05 1.38 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.769 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.36 -17.71 39.82 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.623 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.8 t -91.39 -174.59 3.97 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 122.09 0.948 . . . . 0.0 110.719 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -108.03 143.09 37.21 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 113.781 -1.554 . . . . 0.0 108.308 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.516 HG23 ' HG2' ' A' ' 40' ' ' GLU . 1.2 m -76.16 -30.29 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 C-N-CA 118.553 -1.259 . . . . 0.0 108.709 -177.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.764 ' O ' HG13 ' A' ' 73' ' ' VAL . 7.0 mm -60.85 -47.88 91.38 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.158 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.413 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.495 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 34.1 t -50.51 -35.22 28.37 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.892 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -86.58 -32.07 20.85 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.081 0.467 . . . . 0.0 110.414 -177.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.526 ' OH ' ' HA ' ' A' ' 59' ' ' LYS . 5.5 m-30 -74.1 -36.18 64.22 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.318 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.863 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 2.2 m -71.21 -32.88 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -68.51 -31.91 71.51 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.516 177.479 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.38 -44.49 94.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.265 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.536 ' SG ' ' HB3' ' A' ' 51' ' ' CYS . 3.8 m -97.77 9.46 42.56 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.11 -177.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -64.19 -29.74 70.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.653 177.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.95 6.5 76.55 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.932 174.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.565 HG21 ' SG ' ' A' ' 51' ' ' CYS . 80.0 mt -102.34 129.42 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 121.617 0.722 . . . . 0.0 111.715 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.548 ' O ' ' HD3' ' A' ' 11' ' ' LYS . . . 173.22 -50.25 0.16 Allowed Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 108.921 -1.671 . . . . 0.0 108.921 170.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.12 156.86 27.1 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 114.558 -0.821 . . . . 0.0 111.165 177.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 62.85 -78.43 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 122.987 0.515 . . . . 0.0 112.041 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.554 ' O ' ' HG3' ' A' ' 87' ' ' MET . 63.0 mtt -60.77 -38.63 85.93 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 121.118 0.485 . . . . 0.0 109.848 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.525 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 3.8 t-160 -53.6 -33.41 54.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.435 173.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -83.56 -36.6 23.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.729 0.299 . . . . 0.0 110.734 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.54 -52.89 59.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.968 0.889 . . . . 0.0 110.0 174.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.554 ' HG3' ' O ' ' A' ' 83' ' ' MET . 27.7 mtm -73.97 -12.74 60.73 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.987 -176.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.43 HD13 ' HB2' ' A' ' 92' ' ' LEU . 0.1 OUTLIER -57.19 -42.17 80.71 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.554 177.267 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 51.8 ttm -80.81 -20.03 43.39 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.355 0.598 . . . . 0.0 110.803 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -92.52 -46.49 7.61 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.981 -175.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.65 ' O ' ' HG2' ' A' ' 93' ' ' GLU . 22.1 mt-30 -92.64 -52.02 4.83 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.565 -172.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.43 ' HB2' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -51.46 -35.84 41.5 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 175.613 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.65 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 7.8 pt-20 . . . . . 0 C--O 1.249 1.033 0 CA-C-N 112.992 -1.913 . . . . 0.0 113.868 -177.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' PRO . . . . . 0.484 ' HB2' ' H ' ' B' ' 2' ' ' SER . 88.4 Cg_endo . . . . . 0 CA--C 1.519 -0.245 0 N-CA-C 108.797 -1.27 . . . . 0.0 108.797 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.484 ' H ' ' HB2' ' B' ' 1' ' ' PRO . 19.8 m -68.1 175.08 3.37 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 161.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.589 ' CE1' HD13 ' B' ' 29' ' ' ILE . 0.1 OUTLIER -71.08 -52.19 20.83 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 164.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.482 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.2 p-10 -87.5 5.48 38.91 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 113.869 -1.514 . . . . 0.0 113.667 -165.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.421 HG23 ' HB2' ' B' ' 2' ' ' SER . 0.7 OUTLIER -63.88 -6.52 6.09 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 118.542 0.61 . . . . 0.0 111.086 -177.668 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.627 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.2 m -75.61 131.09 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.704 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -154.32 158.59 40.38 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' GLN . . . . . 0.53 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 3.4 mt-30 -41.82 116.88 0.85 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 113.119 -1.855 . . . . 0.0 113.369 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.77 -153.98 22.63 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.732 170.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' SER . . . . . 0.657 ' O ' ' HG2' ' B' ' 11' ' ' LYS . 19.8 t -56.94 98.8 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 117.116 0.458 . . . . 0.0 110.952 -177.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.657 ' HG2' ' O ' ' B' ' 10' ' ' SER . 4.1 ptpp? 49.41 32.86 4.92 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.688 1.195 . . . . 0.0 112.504 -177.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.404 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 38.4 tt0 -56.12 135.41 74.49 Favored Pre-proline 0 C--O 1.234 0.251 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . 0.551 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 52.2 Cg_exo -50.97 123.0 10.88 Favored 'Trans proline' 0 CA--C 1.509 -0.77 0 C-N-CA 122.343 2.029 . . . . 0.0 110.206 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . 0.865 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 14.7 t80 -71.01 -53.53 8.37 Favored Pre-proline 0 N--CA 1.439 -1.019 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -167.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.534 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 34.2 Cg_exo -55.92 -18.48 22.3 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 121.535 1.49 . . . . 0.0 110.999 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.551 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.6 m-20 -89.96 -43.18 10.73 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 113.917 -1.492 . . . . 0.0 110.933 178.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' PHE . . . . . 0.53 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -54.6 -44.43 73.07 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 176.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.704 HG12 ' O ' ' B' ' 14' ' ' TYR . 3.0 p -82.16 -31.86 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.514 -177.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' B' ' 15' ' ' PRO . . . -57.44 -36.39 71.33 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 121.793 -0.567 . . . . 0.0 111.878 175.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.704 ' O ' HG13 ' B' ' 24' ' ' VAL . 15.5 ptt180 -82.72 -27.18 31.32 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.542 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 6.6 tp -57.05 -45.21 83.36 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.87 173.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . 0.696 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 40.6 mt-30 -74.36 -44.06 53.87 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.019 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.739 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 9.5 t70 -50.9 -51.44 51.94 Favored 'General case' 0 C--N 1.314 -0.955 0 O-C-N 124.097 0.873 . . . . 0.0 111.495 -178.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' VAL . . . . . 0.704 HG13 ' O ' ' B' ' 20' ' ' ARG . 7.4 p -82.71 -23.41 8.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.201 0.524 . . . . 0.0 109.707 -174.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.808 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -71.37 -18.76 62.35 Favored 'General case' 0 C--O 1.206 -1.206 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 173.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.1 -38.63 16.3 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.845 176.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.739 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 36.2 mmtt -66.89 -40.64 87.82 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.98 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' SER . . . . . 0.414 ' HB2' ' HB3' ' B' ' 3' ' ' PHE . 45.2 m -98.86 -9.27 24.49 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.039 0.447 . . . . 0.0 110.552 -171.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.808 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 87.2 mt -115.33 125.68 72.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.651 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.05 -4.2 59.14 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.977 0.418 . . . . 0.0 110.468 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.666 ' OD1' ' HD2' ' B' ' 33' ' ' LYS . 3.6 t0 -111.45 122.65 48.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.51 -176.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' B' ' 36' ' ' LYS . 12.7 pt-20 -62.03 -25.25 67.55 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.665 176.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.666 ' HD2' ' OD1' ' B' ' 31' ' ' ASP . 24.0 mttt -73.71 -46.54 45.46 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 120.834 0.349 . . . . 0.0 110.082 -176.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.32 -25.04 60.47 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.5 -0.48 . . . . 0.0 109.77 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.82 ' O ' HG12 ' B' ' 39' ' ' VAL . 5.0 tmm_? -64.44 -63.32 1.16 Allowed 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' B' ' 32' ' ' GLU . 6.5 ptmm? -51.71 -60.08 3.56 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.257 0.551 . . . . 0.0 112.31 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.627 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 10.4 m -56.58 -30.57 32.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.713 -1.131 . . . . 0.0 112.496 -170.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.484 ' O ' ' HG2' ' B' ' 42' ' ' MET . 1.2 tt -86.26 -30.45 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 C-N-CA 119.241 -0.984 . . . . 0.0 111.175 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.82 HG12 ' O ' ' B' ' 35' ' ' ARG . 2.3 m -70.04 -47.87 65.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.411 175.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.645 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 56.6 mt-10 -60.31 -29.96 69.19 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 123.69 0.796 . . . . 0.0 112.193 176.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.627 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -86.25 -53.25 5.14 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.367 -0.533 . . . . 0.0 112.16 179.044 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' MET . . . . . 0.556 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 22.0 mmt -61.9 -22.18 65.36 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.594 0.711 . . . . 0.0 109.831 -177.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.689 ' HB2' ' OH ' ' B' ' 14' ' ' TYR . . . -48.5 -29.03 3.73 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.924 171.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' TYR . . . . . 0.577 ' CG ' ' HD2' ' B' ' 59' ' ' LYS . 8.3 t80 -107.24 -66.65 1.01 Allowed 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 176.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.519 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 14.9 mm-40 -48.1 -31.84 6.07 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 124.168 0.917 . . . . 0.0 112.243 -174.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.704 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.9 m-20 -103.21 -21.47 13.86 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 116.754 -0.203 . . . . 0.0 111.265 -175.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.595 ' HB1' ' O ' ' B' ' 43' ' ' ALA . . . -62.38 -179.16 0.22 Allowed 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.982 0.896 . . . . 0.0 112.865 -173.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . 0.561 ' HB3' ' OE1' ' B' ' 50' ' ' GLU . 12.4 m-20 -61.16 143.31 92.54 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.037 175.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -50.7 -28.75 23.59 Favored 'Trans proline' 0 C--O 1.218 -0.494 0 C-N-CA 123.54 2.827 . . . . 0.0 113.022 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.718 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 15.9 pm0 -88.26 -30.97 19.27 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.739 0.816 . . . . 0.0 111.015 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.718 ' N ' ' HG2' ' B' ' 50' ' ' GLU . 96.7 m -81.83 -39.06 24.53 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.145 -170.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . 0.479 ' HB2' ' CD1' ' B' ' 44' ' ' TYR . 4.1 pt20 -69.95 -29.64 66.82 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 172.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' SER . . . . . 0.6 ' HB3' ' C ' ' B' ' 91' ' ' GLN . 7.0 m -71.18 -20.28 62.3 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 113.847 -1.524 . . . . 0.0 110.704 174.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.469 ' HB1' HD11 ' B' ' 79' ' ' ILE . . . -77.72 -25.38 49.26 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.604 0.716 . . . . 0.0 109.683 167.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.567 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 24.3 mt -89.77 -32.87 5.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 -172.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.604 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.22 -38.91 1.71 Allowed Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -173.523 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 51.5 Cg_endo -63.07 -28.85 74.51 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 122.175 1.916 . . . . 0.0 112.716 175.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . 0.503 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 2.2 mt -97.44 -16.4 20.19 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.577 ' HD2' ' CG ' ' B' ' 44' ' ' TYR . 0.1 OUTLIER -56.13 108.91 0.51 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.523 -179.254 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.0 -25.12 29.48 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.265 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 9.9 mmmt -104.52 115.52 30.49 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.961 0.41 . . . . 0.0 110.381 -177.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.8 134.68 24.74 Favored Pre-proline 0 C--N 1.312 -1.055 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 168.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -52.0 135.85 51.87 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.502 2.135 . . . . 0.0 111.846 172.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.24 108.78 1.15 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.761 -177.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.53 -17.96 38.89 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.592 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.6 t -91.21 -174.85 4.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.831 0.824 . . . . 0.0 110.569 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -107.95 143.09 37.08 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.308 177.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.509 HG23 ' HG2' ' B' ' 40' ' ' GLU . 1.2 m -75.99 -30.25 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 C-N-CA 118.556 -1.258 . . . . 0.0 108.709 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . 0.777 ' O ' HG13 ' B' ' 73' ' ' VAL . 6.9 mm -60.87 -47.94 91.14 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.208 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.306 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 35.1 t -50.41 -35.25 27.59 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.745 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -86.55 -32.21 20.82 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.459 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' TYR . . . . . 0.512 ' OH ' ' HA ' ' B' ' 59' ' ' LYS . 5.5 m-30 -74.09 -36.23 64.27 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.325 -178.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . 0.865 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 2.2 m -71.15 -33.04 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' B' ' 70' ' ' SER . 0.0 OUTLIER -68.31 -32.2 72.16 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.459 177.474 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -63.05 -44.67 95.19 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.194 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.525 ' SG ' ' HB3' ' B' ' 51' ' ' CYS . 3.8 m -97.54 9.28 42.86 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 114.22 -1.355 . . . . 0.0 111.052 -177.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -64.08 -29.67 70.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.649 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.75 6.52 77.1 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.063 174.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.573 HG21 ' SG ' ' B' ' 51' ' ' CYS . 80.0 mt -102.6 128.97 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 121.781 0.8 . . . . 0.0 111.812 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . 0.55 ' O ' ' HD3' ' B' ' 11' ' ' LYS . . . 173.88 -49.76 0.15 Allowed Glycine 0 N--CA 1.436 -1.35 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 169.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.79 156.46 26.85 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.16 -78.51 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 122.899 0.48 . . . . 0.0 112.042 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' MET . . . . . 0.548 ' O ' ' HG3' ' B' ' 87' ' ' MET . 63.6 mtt -60.94 -38.86 87.32 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' HIS . . . . . 0.526 ' HB2' ' H ' ' B' ' 80' ' ' GLY . 3.8 t-160 -53.25 -33.61 53.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.499 173.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -83.24 -36.86 24.25 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.691 0.281 . . . . 0.0 110.736 -177.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.55 -52.16 62.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 122.01 0.91 . . . . 0.0 110.192 174.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' MET . . . . . 0.548 ' HG3' ' O ' ' B' ' 83' ' ' MET . 27.5 mtm -74.56 -12.66 60.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.127 -1.397 . . . . 0.0 110.909 -176.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.442 HD13 ' HB2' ' B' ' 92' ' ' LEU . 0.1 OUTLIER -57.11 -42.34 80.62 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.501 177.145 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 51.9 ttm -80.61 -20.18 43.78 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.179 0.514 . . . . 0.0 110.831 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -92.72 -46.31 7.63 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.862 -175.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' GLN . . . . . 0.67 ' O ' ' HG2' ' B' ' 93' ' ' GLU . 22.2 mt-30 -92.64 -52.23 4.73 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.525 -172.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.442 ' HB2' HD13 ' B' ' 88' ' ' LEU . 0.0 OUTLIER -51.32 -36.07 41.01 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 175.645 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.67 ' HG2' ' O ' ' B' ' 91' ' ' GLN . 7.8 pt-20 . . . . . 0 C--O 1.25 1.126 0 CA-C-N 112.946 -1.934 . . . . 0.0 113.941 -177.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 CA--C 1.519 -0.263 0 N-CA-C 108.721 -1.3 . . . . 0.0 108.721 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.447 ' HG ' ' HD3' ' B' ' 59' ' ' LYS . 16.4 m -67.52 -179.76 1.14 Allowed 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 163.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.47 ' HB2' ' HA ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -75.56 -53.38 8.71 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 118.956 -1.098 . . . . 0.0 108.625 166.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.483 ' ND2' ' HE3' ' A' ' 42' ' ' MET . 2.4 p-10 -86.91 5.04 39.02 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.247 -1.342 . . . . 0.0 113.201 -165.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.404 HG21 ' HG ' ' A' ' 2' ' ' SER . 0.5 OUTLIER -63.96 -5.97 5.39 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 118.166 0.439 . . . . 0.0 111.441 -176.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.578 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.4 m -75.62 131.77 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 176.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.708 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -154.63 159.48 40.84 Favored 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 118.693 -1.203 . . . . 0.0 114.228 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.478 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.5 mt-30 -42.32 116.38 0.83 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 112.965 -1.925 . . . . 0.0 112.829 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.46 -139.87 8.15 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.635 173.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.4 p -58.67 95.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.765 0.282 . . . . 0.0 111.133 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.459 ' HD2' ' O ' ' A' ' 80' ' ' GLY . 56.5 pttt 40.75 39.54 0.8 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.238 1.015 . . . . 0.0 111.986 -175.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.411 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 48.5 tt0 -56.86 139.65 77.36 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.234 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.512 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 36.9 Cg_exo -54.33 122.73 12.03 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.988 1.792 . . . . 0.0 109.781 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.787 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 13.2 t80 -70.36 -52.53 11.57 Favored Pre-proline 0 N--CA 1.438 -1.046 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 -166.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.533 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 27.6 Cg_exo -57.18 -17.32 25.11 Favored 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 121.444 1.429 . . . . 0.0 111.062 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.5 m-20 -90.04 -42.11 11.32 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.04 -1.437 . . . . 0.0 110.698 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.478 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -55.5 -44.84 76.96 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.663 HG12 ' O ' ' A' ' 14' ' ' TYR . 2.1 p -78.99 -34.06 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.274 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 15' ' ' PRO . . . -55.88 -38.15 69.79 Favored 'General case' 0 C--N 1.319 -0.744 0 O-C-N 121.833 -0.542 . . . . 0.0 111.488 176.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.709 ' O ' HG13 ' A' ' 24' ' ' VAL . 15.5 ptt180 -80.78 -28.32 36.38 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 6.2 tp -55.87 -43.78 77.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.976 173.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.669 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 24.0 mt-30 -72.72 -52.71 14.02 Favored 'General case' 0 CA--C 1.486 -1.483 0 CA-C-N 114.702 -1.135 . . . . 0.0 111.493 178.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.723 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 38.3 m-20 -46.86 -50.75 18.08 Favored 'General case' 0 C--N 1.313 -0.996 0 O-C-N 124.375 1.047 . . . . 0.0 111.24 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 20' ' ' ARG . 8.3 p -79.58 -26.23 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.77 -172.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.607 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -67.45 -30.54 70.29 Favored 'General case' 0 C--O 1.207 -1.171 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 175.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.96 -34.98 59.83 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.647 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.723 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 40.7 mmtt -67.9 -36.0 79.46 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.774 178.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.448 ' HB2' ' HB3' ' A' ' 3' ' ' PHE . 16.2 m -105.52 -6.33 19.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.362 0.601 . . . . 0.0 110.564 -171.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.607 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 89.0 mt -118.2 124.15 72.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.334 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.21 -4.07 58.58 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.219 0.533 . . . . 0.0 110.582 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.558 ' O ' ' HB2' ' A' ' 35' ' ' ARG . 26.0 t0 -106.59 140.48 39.41 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.565 -177.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -76.23 -32.05 58.71 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.001 174.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.538 ' O ' HG11 ' A' ' 37' ' ' VAL . 6.9 mttp -70.87 -55.51 8.3 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -176.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.467 ' HA ' HG23 ' A' ' 37' ' ' VAL . . . -57.99 -27.87 63.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.976 175.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.843 ' O ' HG11 ' A' ' 39' ' ' VAL . 1.9 tmm_? -67.22 -56.53 9.49 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.487 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 20.8 mtpt -56.22 -57.93 10.13 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.957 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.722 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 20.1 m -53.08 -34.72 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.414 -169.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.467 HD13 ' OD1' ' A' ' 4' ' ' ASN . 1.1 tt -87.97 -30.75 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 C-N-CA 119.765 -0.774 . . . . 0.0 112.316 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.843 HG11 ' O ' ' A' ' 35' ' ' ARG . 2.9 m -67.89 -50.21 61.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 119.413 -0.915 . . . . 0.0 109.688 174.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.672 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 0.9 OUTLIER -63.73 -25.9 68.4 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.76 0.824 . . . . 0.0 111.622 178.46 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.722 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -85.87 -55.14 4.1 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 177.064 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.513 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 22.2 mmt -62.59 -20.87 65.16 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 121.67 0.747 . . . . 0.0 109.822 -176.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.667 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -48.68 -28.89 3.85 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.81 171.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.541 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 11.5 t80 -106.14 -66.53 0.99 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 175.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.479 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 5.7 mm-40 -48.13 -29.56 3.75 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 124.107 0.88 . . . . 0.0 112.937 -175.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.708 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.7 m-20 -106.87 -21.25 13.08 Favored 'General case' 0 N--CA 1.438 -1.071 0 O-C-N 122.22 -0.3 . . . . 0.0 111.19 -176.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 43' ' ' ALA . . . -60.43 179.22 0.16 Allowed 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.889 0.852 . . . . 0.0 112.905 -174.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.479 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 11.5 m-20 -60.12 139.83 91.07 Favored Pre-proline 0 N--CA 1.443 -0.823 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.228 174.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.463 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 1.8 Cg_endo -44.35 -46.38 11.79 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.906 2.404 . . . . 0.0 112.004 -177.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.487 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 0.4 OUTLIER -71.31 -33.51 69.73 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.335 1.054 . . . . 0.0 111.841 177.173 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.529 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 98.4 m -75.7 -36.37 60.03 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 121.243 0.544 . . . . 0.0 109.967 -173.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.472 ' HB2' ' CG ' ' A' ' 44' ' ' TYR . 3.9 pt20 -73.03 -30.95 64.12 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 174.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.529 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 17.4 m -68.87 -20.51 64.27 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.048 173.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.514 ' HB3' HD12 ' A' ' 79' ' ' ILE . . . -76.38 -28.74 56.88 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.747 0.784 . . . . 0.0 109.958 168.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.592 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 19.2 mt -89.67 -31.85 5.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -171.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.603 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -40.17 -39.78 1.55 Allowed Pre-proline 0 N--CA 1.487 1.41 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -173.075 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 54.2 Cg_endo -63.04 -30.93 76.46 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.141 1.894 . . . . 0.0 112.781 176.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.537 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 2.6 mt -94.48 -17.06 22.8 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.575 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -55.44 108.67 0.45 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.053 179.359 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.29 -31.66 8.47 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.528 -175.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.2 mmtt -104.12 114.85 29.38 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 122.173 0.987 . . . . 0.0 111.147 -177.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.6 p -120.72 131.67 24.39 Favored Pre-proline 0 C--N 1.294 -1.824 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.826 169.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -51.27 137.88 46.33 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.637 2.224 . . . . 0.0 112.078 174.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.06 108.37 1.51 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.591 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.49 -14.86 42.59 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.346 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.7 t -94.43 -175.78 3.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.949 0.88 . . . . 0.0 110.548 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -107.72 143.7 35.87 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 113.723 -1.58 . . . . 0.0 107.96 175.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.672 ' CG2' ' HB3' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -72.25 -34.85 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 118.372 -1.331 . . . . 0.0 108.916 -179.138 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.747 ' O ' HG11 ' A' ' 73' ' ' VAL . 7.2 mm -56.65 -49.77 76.66 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.065 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.676 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 23.0 t -46.14 -38.37 8.09 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.858 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -86.45 -32.27 20.94 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.544 -176.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.575 ' OH ' ' HA ' ' A' ' 59' ' ' LYS . 5.4 m-30 -73.95 -37.53 64.52 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.681 0.753 . . . . 0.0 109.65 -177.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.787 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.7 m -70.1 -32.81 52.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 174.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -68.42 -31.36 70.64 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.567 176.45 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.429 ' HB1' ' O ' ' A' ' 72' ' ' TYR . . . -64.6 -46.35 83.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.492 178.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.529 ' SG ' ' HB3' ' A' ' 51' ' ' CYS . 4.0 m -94.04 9.22 38.51 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.919 -178.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 9.6 t70 -62.35 -27.3 68.96 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.201 177.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.51 -3.52 64.68 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.176 175.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.514 HD12 ' HB3' ' A' ' 54' ' ' ALA . 96.2 mt -96.07 129.11 46.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.787 0.327 . . . . 0.0 110.898 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.459 ' O ' ' HD2' ' A' ' 11' ' ' LYS . . . 162.05 30.48 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.333 175.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.574 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 151.18 -108.3 0.38 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.152 175.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.68 -53.24 59.02 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -173.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 56.7 mtt -67.92 -30.68 70.07 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.516 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 6.6 t-80 -61.57 -35.24 77.23 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.549 175.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.574 ' HG2' ' O ' ' A' ' 81' ' ' GLY . 32.4 mmtp -80.0 -18.26 50.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.115 0.484 . . . . 0.0 110.391 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.21 -50.0 7.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.382 0.611 . . . . 0.0 110.387 176.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -77.98 -13.24 59.95 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.231 -175.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.561 ' O ' ' HB3' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -48.26 -42.93 31.91 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.562 179.134 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 50.7 ttm -83.51 -15.43 49.43 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.019 0.438 . . . . 0.0 111.067 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -95.24 -39.08 10.26 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -174.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.503 ' C ' ' HB3' ' A' ' 53' ' ' SER . 22.8 mt-30 -103.01 -53.31 2.86 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.434 -176.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.595 HD23 ' O ' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -61.69 -5.89 2.22 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.105 0.478 . . . . 0.0 110.319 178.56 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.428 ' H ' ' C ' ' A' ' 91' ' ' GLN . 7.5 pt-20 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.048 -0.977 . . . . 0.0 112.189 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' PRO . . . . . 0.451 ' HB2' ' H ' ' B' ' 2' ' ' SER . 97.7 Cg_endo . . . . . 0 CA--C 1.52 -0.189 0 N-CA-C 108.815 -1.263 . . . . 0.0 108.815 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.475 ' HG ' ' HD3' ' A' ' 59' ' ' LYS . 16.3 m -67.6 179.93 1.24 Allowed 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 163.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.479 ' HB2' ' HA ' ' B' ' 25' ' ' ALA . 0.1 OUTLIER -75.32 -53.6 8.48 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.517 166.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.479 ' ND2' ' HE3' ' B' ' 42' ' ' MET . 2.4 p-10 -86.77 4.98 38.66 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.35 -1.295 . . . . 0.0 113.271 -165.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.417 ' HA ' ' OE1' ' A' ' 45' ' ' GLU . 0.5 OUTLIER -63.7 -5.9 4.76 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 118.099 0.409 . . . . 0.0 111.572 -177.069 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.581 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.4 m -75.67 131.55 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.705 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -154.4 159.6 41.2 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' GLN . . . . . 0.475 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.5 mt-30 -42.37 116.21 0.81 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 112.941 -1.936 . . . . 0.0 112.852 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.17 -139.69 7.88 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.706 173.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 6.4 p -58.94 95.15 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.706 0.253 . . . . 0.0 111.143 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.462 ' HD2' ' O ' ' B' ' 80' ' ' GLY . 56.7 pttt 41.05 39.37 0.85 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.157 0.983 . . . . 0.0 111.976 -175.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.402 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 51.0 tt0 -56.61 139.57 75.61 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.241 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . 0.528 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 35.1 Cg_exo -54.15 122.77 12.04 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.0 1.8 . . . . 0.0 109.743 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . 0.796 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 13.1 t80 -70.45 -52.63 11.14 Favored Pre-proline 0 N--CA 1.438 -1.056 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -166.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.545 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 27.9 Cg_exo -56.97 -17.54 24.63 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 121.474 1.449 . . . . 0.0 111.134 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.528 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.3 m-20 -89.91 -42.42 11.22 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.682 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' PHE . . . . . 0.475 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -55.34 -44.75 76.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.803 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.676 HG12 ' O ' ' B' ' 14' ' ' TYR . 2.1 p -78.97 -34.15 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.27 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.91 -38.04 69.7 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 121.765 -0.585 . . . . 0.0 111.516 176.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.704 ' O ' HG13 ' B' ' 24' ' ' VAL . 15.6 ptt180 -80.78 -28.29 36.41 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.536 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 6.1 tp -55.78 -43.88 77.22 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.005 173.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . 0.658 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 24.1 mt-30 -72.7 -52.64 14.37 Favored 'General case' 0 CA--C 1.487 -1.472 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.48 178.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.728 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 39.5 m-20 -46.8 -50.79 17.77 Favored 'General case' 0 C--N 1.313 -1.011 0 O-C-N 124.417 1.073 . . . . 0.0 111.234 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' VAL . . . . . 0.704 HG13 ' O ' ' B' ' 20' ' ' ARG . 8.3 p -79.71 -26.06 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.836 -172.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.612 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -67.59 -30.46 70.07 Favored 'General case' 0 C--O 1.205 -1.239 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 175.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.78 -35.27 60.17 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.132 -1.395 . . . . 0.0 109.763 -178.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.728 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 40.9 mmtt -67.67 -36.54 80.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.586 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' SER . . . . . 0.453 ' HB2' ' HB3' ' B' ' 3' ' ' PHE . 16.4 m -105.19 -6.22 19.99 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.33 0.586 . . . . 0.0 110.536 -171.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.612 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 89.0 mt -118.21 124.26 72.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.326 178.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.49 -3.65 58.51 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.236 0.541 . . . . 0.0 110.676 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.559 ' O ' ' HB2' ' B' ' 35' ' ' ARG . 25.9 t0 -106.9 140.46 39.68 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.519 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -76.35 -31.97 58.37 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.867 175.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.536 ' O ' HG11 ' B' ' 37' ' ' VAL . 7.1 mttp -70.73 -55.69 8.09 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -176.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.471 ' HA ' HG23 ' B' ' 37' ' ' VAL . . . -58.08 -27.71 63.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.996 176.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.849 ' O ' HG11 ' B' ' 39' ' ' VAL . 1.9 tmm_? -67.47 -56.45 9.55 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.477 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 21.2 mtpt -56.22 -57.93 10.12 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.997 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.733 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 20.1 m -53.06 -34.66 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.53 -169.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.473 HD13 ' OD1' ' B' ' 4' ' ' ASN . 1.1 tt -88.1 -30.72 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 119.727 -0.789 . . . . 0.0 112.25 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.849 HG11 ' O ' ' B' ' 35' ' ' ARG . 3.0 m -67.87 -49.99 63.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.742 174.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.68 ' HB3' ' CG2' ' B' ' 68' ' ' VAL . 0.9 OUTLIER -64.06 -25.66 68.21 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.68 0.792 . . . . 0.0 111.658 178.452 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.733 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.97 -55.03 4.14 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 176.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' MET . . . . . 0.512 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 22.2 mmt -62.81 -20.66 65.25 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.697 0.76 . . . . 0.0 109.818 -176.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.659 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -48.89 -28.77 4.03 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.779 171.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' TYR . . . . . 0.527 ' CG ' ' HD2' ' B' ' 59' ' ' LYS . 11.5 t80 -106.29 -66.66 0.99 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 175.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.471 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 5.7 mm-40 -48.03 -29.49 3.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 124.138 0.899 . . . . 0.0 112.999 -175.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.705 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.6 m-20 -106.9 -21.09 13.13 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 121.031 -0.267 . . . . 0.0 111.19 -176.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' B' ' 43' ' ' ALA . . . -60.61 179.19 0.17 Allowed 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.844 0.831 . . . . 0.0 112.931 -174.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . 0.494 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 11.0 m-20 -60.08 139.69 90.97 Favored Pre-proline 0 N--CA 1.441 -0.888 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.237 174.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . 0.461 ' HB2' ' CD2' ' B' ' 92' ' ' LEU . 1.8 Cg_endo -44.27 -46.35 11.63 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.847 2.365 . . . . 0.0 111.985 -177.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.485 ' HA ' ' HB2' ' B' ' 53' ' ' SER . 0.3 OUTLIER -71.32 -33.39 69.6 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.234 1.013 . . . . 0.0 111.96 177.256 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.533 ' HB3' ' SG ' ' B' ' 76' ' ' CYS . 93.0 m -75.78 -36.38 59.8 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 121.258 0.552 . . . . 0.0 110.026 -174.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . 0.471 ' HB2' ' CG ' ' B' ' 44' ' ' TYR . 3.9 pt20 -72.95 -31.14 64.38 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 106.932 -1.506 . . . . 0.0 106.932 174.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' SER . . . . . 0.528 ' O ' ' HE2' ' B' ' 56' ' ' LYS . 17.9 m -68.64 -20.55 64.47 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.066 -1.424 . . . . 0.0 110.07 173.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.53 ' HB3' HD12 ' B' ' 79' ' ' ILE . . . -76.34 -28.83 57.01 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.813 0.816 . . . . 0.0 109.984 168.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.593 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 19.0 mt -89.76 -31.7 5.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -171.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.599 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -40.33 -39.83 1.66 Allowed Pre-proline 0 N--CA 1.488 1.452 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -173.104 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 52.0 Cg_endo -62.52 -32.19 80.11 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.001 1.801 . . . . 0.0 112.585 176.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . 0.546 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 2.6 mt -93.6 -17.08 23.71 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.565 ' HA ' ' OH ' ' B' ' 72' ' ' TYR . 0.0 OUTLIER -55.49 108.56 0.44 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.966 179.234 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.57 -31.77 8.33 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.41 -175.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 28.4 mmtt -103.84 114.92 29.53 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 122.203 1.001 . . . . 0.0 111.166 -177.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 5.6 p -120.71 131.88 24.33 Favored Pre-proline 0 C--N 1.294 -1.83 0 CA-C-N 113.861 -1.518 . . . . 0.0 109.786 169.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -51.45 138.03 47.77 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.656 2.237 . . . . 0.0 112.103 174.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.12 108.19 1.48 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.556 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.39 -14.64 43.08 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.483 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 4.6 t -94.74 -175.81 3.69 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 122.005 0.907 . . . . 0.0 110.583 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -107.66 143.67 35.81 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 113.811 -1.54 . . . . 0.0 108.002 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.68 ' CG2' ' HB3' ' B' ' 40' ' ' GLU . 0.8 OUTLIER -72.04 -35.12 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 118.41 -1.316 . . . . 0.0 108.908 -179.117 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . 0.762 ' O ' HG11 ' B' ' 73' ' ' VAL . 7.2 mm -56.53 -49.78 76.02 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.992 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.644 -178.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 25.8 t -45.69 -38.82 7.23 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.815 178.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.431 ' H ' ' HG2' ' B' ' 71' ' ' GLU . 2.9 mm-40 -86.4 -32.46 20.89 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.568 -175.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' TYR . . . . . 0.565 ' OH ' ' HA ' ' B' ' 59' ' ' LYS . 5.4 m-30 -73.74 -37.53 65.04 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.6 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . 0.796 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.7 m -70.16 -32.87 52.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 174.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' B' ' 70' ' ' SER . 0.0 OUTLIER -68.3 -31.38 70.78 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.746 -1.116 . . . . 0.0 109.573 176.34 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . 0.435 ' HB1' ' O ' ' B' ' 72' ' ' TYR . . . -64.86 -46.13 83.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.567 178.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.533 ' SG ' ' HB3' ' B' ' 51' ' ' CYS . 4.0 m -94.07 9.18 38.73 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.951 -178.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . 0.401 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 11.3 t70 -62.5 -27.05 68.88 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.249 177.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.48 -3.55 64.7 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.304 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.53 HD12 ' HB3' ' B' ' 54' ' ' ALA . 96.0 mt -95.96 129.31 46.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.985 0.422 . . . . 0.0 110.9 -177.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . 0.462 ' O ' ' HD2' ' B' ' 11' ' ' LYS . . . 161.78 30.48 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.394 174.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.587 ' O ' ' HG2' ' B' ' 85' ' ' LYS . . . 151.43 -108.28 0.37 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.466 -0.873 . . . . 0.0 113.086 175.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.6 -53.3 58.16 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -173.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' MET . . . . . . . . . . . . . 56.9 mtt -68.01 -30.69 70.0 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' HIS . . . . . 0.519 ' O ' ' HB2' ' B' ' 88' ' ' LEU . 6.7 t-80 -61.41 -35.31 77.2 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.599 175.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.587 ' HG2' ' O ' ' B' ' 81' ' ' GLY . 32.3 mmtp -80.11 -17.99 51.1 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 121.978 -0.451 . . . . 0.0 110.306 -178.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.48 -50.11 7.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.453 0.644 . . . . 0.0 110.461 176.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -77.78 -13.21 59.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.183 -175.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.564 ' O ' ' HB3' ' B' ' 92' ' ' LEU . 0.3 OUTLIER -48.37 -42.95 33.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.515 179.153 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 50.3 ttm -83.54 -15.24 50.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.842 0.353 . . . . 0.0 110.991 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -95.41 -38.78 10.33 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -174.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' GLN . . . . . 0.508 ' C ' ' HB3' ' B' ' 53' ' ' SER . 23.0 mt-30 -103.32 -53.31 2.83 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.332 -176.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.597 ' O ' HD23 ' B' ' 92' ' ' LEU . 0.3 OUTLIER -61.95 -5.41 2.11 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.178 0.513 . . . . 0.0 110.324 178.533 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.417 ' H ' ' C ' ' B' ' 91' ' ' GLN . 7.3 pt-20 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.199 -0.905 . . . . 0.0 112.354 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.457 ' HB2' ' H ' ' A' ' 2' ' ' SER . 92.1 Cg_endo . . . . . 0 CA--C 1.517 -0.327 0 N-CA-C 109.171 -1.127 . . . . 0.0 109.171 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.511 ' HG ' ' HD3' ' B' ' 59' ' ' LYS . 12.9 m -64.25 165.94 8.72 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 162.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.488 ' CE1' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -69.86 -54.14 14.85 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.027 -1.069 . . . . 0.0 108.614 167.607 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.551 ' ND2' ' HE2' ' A' ' 42' ' ' MET . 3.2 p-10 -88.31 -3.05 58.91 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 113.947 -1.479 . . . . 0.0 113.403 -164.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.451 ' HB ' ' HB2' ' A' ' 2' ' ' SER . 9.8 t -66.36 -3.58 6.3 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.622 -173.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.525 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 3.0 m -70.7 135.75 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 172.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.721 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -153.86 159.12 41.68 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 -179.781 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.474 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.1 tt0 -41.69 112.1 0.29 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 112.832 -1.986 . . . . 0.0 112.216 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.2 -145.42 6.06 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.756 176.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.7 p -59.79 95.38 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.687 0.279 . . . . 0.0 110.737 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.3 pttt 43.23 41.43 2.97 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.384 1.074 . . . . 0.0 112.3 -176.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -56.58 141.25 72.94 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.801 175.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -51.68 123.1 11.53 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.73 1.62 . . . . 0.0 109.141 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.792 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 11.5 t80 -66.67 -51.47 40.01 Favored Pre-proline 0 N--CA 1.438 -1.052 0 CA-C-O 118.857 -0.592 . . . . 0.0 112.555 -171.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.498 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 20.5 Cg_exo -60.29 -13.77 26.1 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 121.69 1.593 . . . . 0.0 110.413 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -89.45 -46.78 8.46 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 113.903 -1.499 . . . . 0.0 110.282 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.474 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -54.18 -42.88 70.16 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.84 177.682 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.741 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 2.1 p -81.35 -35.22 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.52 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . -56.58 -37.67 70.93 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 121.394 -0.816 . . . . 0.0 111.223 177.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.727 ' O ' HG13 ' A' ' 24' ' ' VAL . 17.4 ptt180 -79.61 -30.05 41.31 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.535 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 7.8 tp -54.2 -46.7 72.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.258 173.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.741 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 28.7 mt-30 -69.94 -53.56 17.31 Favored 'General case' 0 CA--C 1.485 -1.523 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.55 177.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.722 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 56.3 m-20 -45.51 -52.45 10.32 Favored 'General case' 0 C--N 1.314 -0.978 0 O-C-N 124.637 1.21 . . . . 0.0 111.181 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.727 HG13 ' O ' ' A' ' 20' ' ' ARG . 8.2 p -79.67 -26.96 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.745 -171.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.663 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -66.82 -31.2 71.67 Favored 'General case' 0 C--O 1.204 -1.324 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 175.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.61 -35.59 62.95 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.909 -178.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.722 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.6 mmtt -65.86 -40.11 91.38 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.63 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.41 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 40.0 m -101.86 -10.81 19.54 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.32 0.581 . . . . 0.0 110.662 -172.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.663 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 88.4 mt -113.72 122.26 67.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.515 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.85 -1.19 57.82 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.247 0.546 . . . . 0.0 110.317 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.534 ' H ' HG23 ' A' ' 29' ' ' ILE . 11.8 t70 -107.31 119.41 39.33 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.965 -175.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -60.13 -30.35 69.23 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.08 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.561 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -74.31 -53.52 9.53 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -174.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.465 ' HA ' HG23 ' A' ' 37' ' ' VAL . . . -60.56 -27.41 67.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.773 177.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.85 ' O ' HG11 ' A' ' 39' ' ' VAL . 1.9 tmm_? -67.33 -58.47 4.73 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.432 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 32.6 mtpt -54.61 -59.24 4.98 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.123 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.717 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 16.9 m -53.56 -34.14 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.327 -170.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.462 ' O ' ' HG2' ' A' ' 42' ' ' MET . 1.3 tt -87.38 -32.08 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.871 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.85 HG11 ' O ' ' A' ' 35' ' ' ARG . 2.7 m -67.34 -49.14 74.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.156 175.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.635 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 52.0 mt-10 -60.49 -31.72 70.74 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.298 1.039 . . . . 0.0 112.742 175.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.717 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -85.16 -51.29 6.73 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.933 -179.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.566 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 20.5 mmt -64.62 -20.77 66.47 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.553 0.692 . . . . 0.0 109.462 -178.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.663 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -50.26 -30.33 11.52 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.516 171.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.497 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 15.9 t80 -102.91 -66.71 0.92 Allowed 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 174.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.477 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 47.6 mm-40 -50.26 -28.41 7.66 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.725 -1.125 . . . . 0.0 112.713 -172.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.721 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.1 m-20 -106.36 -22.04 12.92 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 121.28 -0.168 . . . . 0.0 111.055 -176.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.62 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -59.56 177.3 0.21 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.8 0.81 . . . . 0.0 112.994 -174.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.589 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 15.2 m-20 -58.89 140.55 86.37 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.93 174.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.64 -23.43 25.81 Favored 'Trans proline' 0 C--O 1.221 -0.35 0 C-N-CA 123.524 2.816 . . . . 0.0 112.731 -176.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.513 ' OE1' ' HB2' ' A' ' 91' ' ' GLN . 0.3 OUTLIER -88.3 -35.37 17.27 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.942 0.897 . . . . 0.0 110.788 175.074 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 72.3 m -76.85 -35.87 57.2 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.207 -171.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.513 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.7 pt20 -72.49 -29.89 64.04 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 174.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.613 ' HB3' ' C ' ' A' ' 91' ' ' GLN . 15.9 m -71.81 -19.01 62.05 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 113.715 -1.584 . . . . 0.0 110.387 174.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.493 ' HB2' HD13 ' A' ' 79' ' ' ILE . . . -77.21 -26.95 53.26 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.813 0.816 . . . . 0.0 109.494 166.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.583 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 25.9 mt -89.27 -31.01 5.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -172.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.598 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.8 -38.77 2.17 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -173.756 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 57.2 Cg_endo -64.49 -30.08 61.87 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.165 1.91 . . . . 0.0 112.765 176.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.497 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 2.2 mt -95.29 -16.35 22.5 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.514 ' HD3' ' HG ' ' B' ' 2' ' ' SER . 0.1 OUTLIER -54.05 108.65 0.38 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.709 -179.522 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.77 -21.98 42.96 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.413 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.9 mmmt -104.17 115.88 31.19 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 120.932 0.396 . . . . 0.0 110.422 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.54 139.72 31.51 Favored Pre-proline 0 C--N 1.311 -1.095 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 169.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.54 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 79.4 Cg_exo -51.7 137.4 50.52 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.338 2.025 . . . . 0.0 111.423 170.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.97 106.71 1.08 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.898 -176.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.03 -14.73 44.5 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.5 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.54 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 25.1 m -94.8 172.23 8.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.319 0.58 . . . . 0.0 111.342 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -90.3 143.21 26.97 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.783 176.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.503 HG23 ' HG2' ' A' ' 40' ' ' GLU . 1.0 OUTLIER -77.38 -29.7 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 C-N-CA 118.651 -1.22 . . . . 0.0 108.813 -179.346 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.787 ' O ' HG13 ' A' ' 73' ' ' VAL . 10.4 mm -60.81 -47.53 92.86 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.117 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.125 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.0 t -46.18 -37.66 7.34 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.017 176.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.453 ' O ' ' HE2' ' A' ' 74' ' ' LYS . 7.2 mm-40 -85.82 -31.85 22.08 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 123.375 0.67 . . . . 0.0 111.014 -177.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.592 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.3 m-30 -75.32 -34.84 61.27 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.555 0.693 . . . . 0.0 109.34 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.792 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.4 m -72.52 -30.17 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 173.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.461 ' HA ' ' HB2' ' A' ' 77' ' ' ASP . 14.8 ttpt -73.52 -25.51 60.45 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.474 177.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -65.89 -46.53 78.03 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.538 174.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.697 ' SG ' ' HB ' ' A' ' 79' ' ' ILE . 26.2 t -93.01 8.77 38.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.871 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.461 ' HB2' ' HA ' ' A' ' 74' ' ' LYS . 17.3 t70 -63.68 -19.93 65.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.302 0.572 . . . . 0.0 110.043 176.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -105.23 2.21 40.43 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.435 173.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.697 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 95.5 mt -101.78 137.54 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 117.411 0.606 . . . . 0.0 112.162 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.588 ' H ' ' HB2' ' A' ' 84' ' ' HIS . . . 157.08 -43.14 0.52 Allowed Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.444 170.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.648 ' O ' ' HB3' ' A' ' 84' ' ' HIS . . . -95.27 -141.58 11.92 Favored Glycine 0 CA--C 1.494 -1.263 0 CA-C-O 122.083 0.824 . . . . 0.0 114.633 -173.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.89 -29.29 70.23 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 113.609 -1.296 . . . . 0.0 110.952 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 68.1 mtm -69.89 -26.86 64.37 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.648 ' HB3' ' O ' ' A' ' 81' ' ' GLY . 8.5 t-160 -64.67 -31.64 72.95 Favored 'General case' 0 C--O 1.219 -0.524 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.457 ' HD2' ' O ' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -82.52 -21.8 35.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.987 0.423 . . . . 0.0 110.424 179.309 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.86 -46.99 14.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.442 0.639 . . . . 0.0 110.592 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -79.43 -14.72 58.74 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.817 -176.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.504 ' HB2' ' O ' ' A' ' 84' ' ' HIS . 0.2 OUTLIER -53.84 -32.04 51.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.29 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.3 ttt -84.43 -21.72 30.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.178 0.513 . . . . 0.0 111.16 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -96.01 -52.59 3.98 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.022 0.439 . . . . 0.0 111.953 -173.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.658 ' O ' ' HG2' ' A' ' 93' ' ' GLU . 26.1 mt-30 -80.72 -62.82 1.56 Allowed 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.726 -173.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.425 ' HB3' ' O ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -45.37 -34.41 3.01 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.625 1.203 . . . . 0.0 108.591 171.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.658 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 6.6 pt-20 . . . . . 0 C--O 1.249 1.076 0 CA-C-N 113.737 -1.574 . . . . 0.0 113.239 -173.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' PRO . . . . . 0.407 ' HB2' ' H ' ' B' ' 2' ' ' SER . 93.8 Cg_endo . . . . . 0 CA--C 1.519 -0.248 0 N-CA-C 109.133 -1.141 . . . . 0.0 109.133 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.514 ' HG ' ' HD3' ' A' ' 59' ' ' LYS . 13.3 m -64.35 166.24 8.47 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 163.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.505 ' CE1' HD11 ' B' ' 29' ' ' ILE . 0.1 OUTLIER -70.12 -54.02 14.81 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.108 -1.037 . . . . 0.0 108.605 167.687 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.541 ' ND2' ' HE2' ' B' ' 42' ' ' MET . 3.2 p-10 -88.5 -2.99 58.9 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.041 -1.436 . . . . 0.0 113.408 -164.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.469 ' HB ' ' HB2' ' B' ' 2' ' ' SER . 9.5 t -66.37 -3.54 6.22 Favored 'General case' 0 C--N 1.315 -0.911 0 O-C-N 121.644 -0.66 . . . . 0.0 110.634 -173.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.512 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 3.0 m -70.63 135.7 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 171.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.731 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -153.9 159.2 41.66 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' GLN . . . . . 0.453 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.1 tt0 -41.77 112.42 0.32 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 112.776 -2.011 . . . . 0.0 112.106 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.35 -145.64 6.3 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.772 175.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 12.4 p -59.51 95.27 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.64 0.257 . . . . 0.0 110.653 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 64.2 pttt 43.17 41.36 2.84 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.44 1.096 . . . . 0.0 112.402 -176.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.404 ' OE2' ' HA ' ' B' ' 17' ' ' PHE . 62.8 tt0 -56.63 141.37 73.11 Favored Pre-proline 0 C--O 1.235 0.301 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.774 175.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . 0.405 ' O ' ' HB3' ' B' ' 16' ' ' ASP . 22.1 Cg_exo -51.66 122.99 11.29 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.742 1.628 . . . . 0.0 109.204 174.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . 0.792 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 11.7 t80 -66.63 -51.64 39.42 Favored Pre-proline 0 N--CA 1.437 -1.078 0 CA-C-O 118.876 -0.583 . . . . 0.0 112.406 -171.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.511 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 20.6 Cg_exo -60.14 -13.79 25.57 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.57 1.513 . . . . 0.0 110.453 -178.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' B' ' 13' ' ' PRO . 18.7 t70 -89.45 -46.74 8.48 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 113.939 -1.482 . . . . 0.0 110.191 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' PHE . . . . . 0.453 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -54.15 -42.85 70.02 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.841 177.675 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.733 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 2.1 p -81.4 -35.27 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.429 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.57 -37.64 70.86 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 121.38 -0.825 . . . . 0.0 111.221 177.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.73 ' O ' HG13 ' B' ' 24' ' ' VAL . 17.4 ptt180 -79.72 -29.72 40.74 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.548 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 7.9 tp -54.47 -46.72 73.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.193 173.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . 0.733 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 28.6 mt-30 -69.81 -53.67 17.15 Favored 'General case' 0 CA--C 1.485 -1.556 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.519 177.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.727 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 48.9 m-20 -45.55 -52.49 10.39 Favored 'General case' 0 C--N 1.314 -0.959 0 O-C-N 124.628 1.205 . . . . 0.0 111.042 -178.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' VAL . . . . . 0.73 HG13 ' O ' ' B' ' 20' ' ' ARG . 8.2 p -79.64 -26.97 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.673 -171.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.648 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -66.86 -31.02 71.35 Favored 'General case' 0 C--O 1.206 -1.211 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 175.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -35.65 62.53 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.802 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.727 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.9 mmtt -65.87 -40.13 91.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.643 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' SER . . . . . 0.421 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 37.4 m -101.66 -11.21 19.36 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.186 0.517 . . . . 0.0 110.546 -172.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.648 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 88.0 mt -113.63 122.33 67.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.569 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.93 -1.11 57.78 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.249 0.547 . . . . 0.0 110.439 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.539 ' H ' HG23 ' B' ' 29' ' ' ILE . 11.4 t70 -107.59 119.36 39.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.959 -175.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.2 -30.15 69.18 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.1 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.576 ' O ' HG13 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -74.42 -53.27 9.91 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -174.867 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.467 ' HA ' HG23 ' B' ' 37' ' ' VAL . . . -60.85 -27.32 68.0 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.87 177.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.857 ' O ' HG11 ' B' ' 39' ' ' VAL . 1.9 tmm_? -67.38 -58.52 4.63 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.438 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 32.3 mtpt -54.6 -59.3 4.89 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.081 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.718 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 17.1 m -53.69 -33.88 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.314 -170.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.461 ' O ' ' HG2' ' B' ' 42' ' ' MET . 1.3 tt -87.53 -32.08 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.808 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.857 HG11 ' O ' ' B' ' 35' ' ' ARG . 2.7 m -67.31 -49.11 75.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.101 174.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.632 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 52.2 mt-10 -60.63 -31.72 70.9 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.259 1.023 . . . . 0.0 112.794 176.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.718 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -85.25 -51.17 6.78 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.393 -0.523 . . . . 0.0 112.02 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' MET . . . . . 0.561 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 20.7 mmt -64.63 -20.7 66.43 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 121.545 0.688 . . . . 0.0 109.524 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.659 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -50.39 -30.33 12.12 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.421 171.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' TYR . . . . . 0.5 ' CG ' ' HD2' ' B' ' 59' ' ' LYS . 16.1 t80 -102.85 -66.61 0.92 Allowed 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 174.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.468 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 46.8 mm-40 -50.49 -27.99 7.61 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.696 -1.138 . . . . 0.0 112.739 -172.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.731 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.2 m-20 -106.76 -21.91 12.89 Favored 'General case' 0 N--CA 1.434 -1.265 0 O-C-N 122.371 -0.206 . . . . 0.0 111.1 -176.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -59.51 177.46 0.2 Allowed 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.81 0.814 . . . . 0.0 113.085 -175.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . 0.593 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 15.1 m-20 -59.09 140.33 87.31 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.864 174.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.75 -23.21 25.78 Favored 'Trans proline' 0 C--O 1.22 -0.407 0 C-N-CA 123.502 2.801 . . . . 0.0 112.628 -176.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.511 ' OE1' ' HB2' ' B' ' 91' ' ' GLN . 0.3 OUTLIER -88.41 -35.27 17.19 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.88 0.872 . . . . 0.0 110.824 174.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.593 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 71.8 m -76.82 -35.83 57.29 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.261 -172.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . 0.493 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.8 pt20 -72.36 -29.99 64.3 Favored 'General case' 0 C--O 1.213 -0.835 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 174.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' SER . . . . . 0.614 ' HB3' ' C ' ' B' ' 91' ' ' GLN . 14.5 m -71.63 -19.26 62.13 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 113.7 -1.591 . . . . 0.0 110.4 174.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.506 ' HB2' HD13 ' B' ' 79' ' ' ILE . . . -77.16 -27.08 53.62 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.692 0.758 . . . . 0.0 109.484 166.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.584 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 25.9 mt -89.23 -30.99 5.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -172.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.596 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.96 -38.67 2.26 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -173.647 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 57.3 Cg_endo -64.7 -29.76 59.89 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 122.055 1.837 . . . . 0.0 112.688 176.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . 0.517 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 2.2 mt -95.36 -16.26 22.48 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.511 ' HD3' ' HG ' ' A' ' 2' ' ' SER . 0.1 OUTLIER -54.18 108.7 0.39 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.746 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.45 -21.5 45.21 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.503 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 15.8 mmmt -104.49 115.84 31.06 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.865 0.365 . . . . 0.0 110.6 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.4 139.72 31.33 Favored Pre-proline 0 C--N 1.312 -1.059 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 169.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.561 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 80.7 Cg_exo -51.59 137.51 49.43 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.368 2.045 . . . . 0.0 111.523 170.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.27 106.45 1.1 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.898 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.31 -14.94 43.28 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.4 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.561 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 27.7 m -94.75 172.34 8.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.355 0.598 . . . . 0.0 111.264 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -90.34 143.47 26.73 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.241 -0.891 . . . . 0.0 108.882 176.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.513 HG23 ' HG2' ' B' ' 40' ' ' GLU . 1.0 OUTLIER -77.54 -29.75 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 C-N-CA 118.691 -1.203 . . . . 0.0 108.813 -179.444 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . 0.783 ' O ' HG13 ' B' ' 73' ' ' VAL . 10.4 mm -60.8 -47.4 93.41 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.155 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.166 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 41.0 t -46.63 -37.29 7.99 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 123.847 0.717 . . . . 0.0 110.998 177.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.449 ' O ' ' HE2' ' B' ' 74' ' ' LYS . 7.5 mm-40 -85.89 -31.67 22.08 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.22 0.608 . . . . 0.0 111.051 -177.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' TYR . . . . . 0.579 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.3 m-30 -75.45 -34.89 60.99 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.599 0.714 . . . . 0.0 109.441 -178.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . 0.792 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.4 m -72.65 -30.03 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 173.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' LYS . . . . . 0.471 ' HA ' ' HB2' ' B' ' 77' ' ' ASP . 14.7 ttpt -73.71 -25.18 60.09 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.581 177.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -65.95 -46.57 77.69 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.646 173.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.704 ' SG ' ' HB ' ' B' ' 79' ' ' ILE . 28.3 t -93.03 8.58 39.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.884 177.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . 0.471 ' HB2' ' HA ' ' B' ' 74' ' ' LYS . 18.0 t70 -63.86 -19.04 64.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.296 0.57 . . . . 0.0 110.056 176.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -105.76 2.08 38.96 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.558 -0.747 . . . . 0.0 112.546 173.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.704 ' HB ' ' SG ' ' B' ' 76' ' ' CYS . 95.1 mt -101.84 137.63 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 117.288 0.544 . . . . 0.0 112.167 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . 0.579 ' H ' ' HB2' ' B' ' 84' ' ' HIS . . . 156.99 -43.22 0.53 Allowed Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.305 -0.862 . . . . 0.0 111.377 170.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.637 ' O ' ' HB3' ' B' ' 84' ' ' HIS . . . -95.2 -141.57 11.89 Favored Glycine 0 CA--C 1.493 -1.307 0 CA-C-O 121.869 0.705 . . . . 0.0 114.64 -173.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.79 -29.84 70.82 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 113.718 -1.241 . . . . 0.0 110.689 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' MET . . . . . . . . . . . . . 68.3 mtm -69.46 -26.67 64.7 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 175.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' HIS . . . . . 0.637 ' HB3' ' O ' ' B' ' 81' ' ' GLY . 8.4 t-160 -64.79 -31.44 72.66 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 121.211 0.529 . . . . 0.0 109.576 173.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.455 ' HD2' ' O ' ' B' ' 81' ' ' GLY . 0.1 OUTLIER -82.88 -21.8 34.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.92 0.39 . . . . 0.0 110.37 179.388 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.84 -46.95 14.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.413 0.625 . . . . 0.0 110.653 177.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -79.21 -14.81 58.83 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.89 -176.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.496 ' HB2' ' O ' ' B' ' 84' ' ' HIS . 0.2 OUTLIER -53.61 -32.21 50.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.229 0.538 . . . . 0.0 111.324 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 25.5 ttt -84.42 -21.52 30.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.049 0.452 . . . . 0.0 111.22 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -96.38 -52.19 4.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.107 0.48 . . . . 0.0 111.958 -173.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' GLN . . . . . 0.665 ' O ' ' HG2' ' B' ' 93' ' ' GLU . 26.2 mt-30 -80.87 -63.17 1.46 Allowed 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.691 -173.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.434 ' HB3' ' O ' ' B' ' 88' ' ' LEU . 0.0 OUTLIER -45.02 -34.9 2.67 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.69 1.244 . . . . 0.0 108.606 171.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.665 ' HG2' ' O ' ' B' ' 91' ' ' GLN . 7.1 pt-20 . . . . . 0 C--O 1.251 1.176 0 CA-C-N 113.828 -1.533 . . . . 0.0 113.134 -173.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.44 ' HB2' ' H ' ' A' ' 2' ' ' SER . 84.1 Cg_endo . . . . . 0 CA--C 1.516 -0.399 0 N-CA-C 109.525 -0.99 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.44 ' H ' ' HB2' ' A' ' 1' ' ' PRO . 49.8 m -65.74 165.14 13.23 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 163.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.46 ' CE1' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -69.9 -55.17 10.43 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 122.058 0.932 . . . . 0.0 109.907 174.142 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.562 ' ND2' ' HG3' ' A' ' 42' ' ' MET . 2.7 p-10 -86.57 -2.38 58.44 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.308 -1.314 . . . . 0.0 112.762 -164.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.405 ' O ' ' HD3' ' A' ' 7' ' ' ARG . 9.9 t -66.1 -3.03 4.75 Favored 'General case' 0 C--N 1.314 -0.942 0 O-C-N 121.708 -0.62 . . . . 0.0 110.445 -176.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.592 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.3 m -73.7 131.98 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 170.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.685 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 1.3 ptt-85 -156.68 160.04 38.97 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 118.38 -1.328 . . . . 0.0 114.375 -176.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.446 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.3 tt0 -39.12 112.33 0.24 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 113.698 -1.592 . . . . 0.0 112.624 178.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.95 -142.36 7.96 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.689 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.5 m -59.33 95.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.973 0.387 . . . . 0.0 110.837 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.4 ' O ' ' HG3' ' A' ' 11' ' ' LYS . 23.3 pttm 40.73 41.75 1.24 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.495 1.118 . . . . 0.0 112.343 -174.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 65.6 tt0 -57.79 139.65 81.95 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.674 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.52 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 34.3 Cg_exo -53.7 125.0 17.19 Favored 'Trans proline' 0 CA--C 1.511 -0.671 0 C-N-CA 122.026 1.817 . . . . 0.0 109.745 177.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.795 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 6.0 t80 -68.22 -55.48 12.62 Favored Pre-proline 0 N--CA 1.44 -0.934 0 CA-C-O 118.482 -0.77 . . . . 0.0 112.924 -167.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.531 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 26.0 Cg_exo -57.62 -17.7 29.63 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 121.456 1.437 . . . . 0.0 111.145 -177.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.52 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 5.7 m-20 -89.8 -40.16 12.64 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.057 -1.428 . . . . 0.0 110.846 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.638 ' HE2' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -56.63 -45.79 81.32 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 176.106 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.777 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 1.4 p -77.82 -33.46 18.74 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.322 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.347 -178.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.04 -31.57 67.15 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 121.179 -0.951 . . . . 0.0 111.834 177.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.73 ' O ' HG12 ' A' ' 24' ' ' VAL . 15.6 ptt180 -84.86 -28.09 26.26 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 175.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.567 HD22 ' CE1' ' A' ' 17' ' ' PHE . 11.8 tp -54.28 -48.9 70.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.962 172.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.777 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 23.0 mt-30 -70.57 -46.65 63.09 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 114.849 -1.068 . . . . 0.0 111.123 177.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.716 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 19.2 t70 -48.41 -54.63 13.34 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.282 0.989 . . . . 0.0 111.479 -178.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.4 p -81.73 -22.18 10.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.13 0.49 . . . . 0.0 109.734 -173.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.791 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -72.93 -18.85 61.35 Favored 'General case' 0 C--O 1.205 -1.259 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 174.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.44 -38.61 17.16 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.568 -1.196 . . . . 0.0 109.553 177.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.716 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.8 mmtt -67.06 -36.29 81.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.014 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.2 m -103.69 -9.1 19.4 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.088 0.47 . . . . 0.0 110.516 -171.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.791 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 84.3 mt -115.07 126.06 72.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.442 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.47 -4.8 59.27 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.242 0.544 . . . . 0.0 110.502 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.557 ' H ' HG22 ' A' ' 29' ' ' ILE . 25.8 t0 -106.28 139.16 41.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.407 -177.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -75.98 -31.45 58.99 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.445 175.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.512 ' O ' HG13 ' A' ' 37' ' ' VAL . 6.4 mttp -71.88 -55.0 8.31 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -175.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.484 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -58.75 -27.31 64.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.022 176.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.864 ' O ' HG13 ' A' ' 39' ' ' VAL . 1.9 tmm_? -66.0 -59.86 3.41 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 178.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 12.6 mtpp -54.94 -57.58 11.07 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.16 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.768 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 20.6 m -52.8 -34.33 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.975 -170.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.484 ' O ' ' HG2' ' A' ' 42' ' ' MET . 1.0 OUTLIER -88.31 -31.37 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 119.87 -0.732 . . . . 0.0 112.217 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.864 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.4 m -68.52 -48.65 71.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 119.067 -1.053 . . . . 0.0 109.513 176.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.679 ' HB3' ' CG2' ' A' ' 68' ' ' VAL . 0.8 OUTLIER -64.59 -28.46 69.64 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.455 0.702 . . . . 0.0 111.573 178.343 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.768 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -81.4 -54.61 5.32 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 122.19 -0.319 . . . . 0.0 111.432 178.014 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.562 ' HG3' ' ND2' ' A' ' 4' ' ' ASN . 22.3 mmt -63.43 -20.41 65.53 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.707 0.765 . . . . 0.0 109.613 -177.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.656 ' HB1' ' CD1' ' A' ' 69' ' ' ILE . . . -49.07 -32.98 10.61 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.86 172.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.425 ' CG ' ' HB2' ' A' ' 52' ' ' GLN . 17.1 t80 -99.75 -64.99 0.99 Allowed 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 175.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.561 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 39.3 mm-40 -50.06 -33.01 17.0 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.468 -1.242 . . . . 0.0 112.413 -171.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.685 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.6 m-20 -103.72 -20.42 13.96 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.087 -174.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 43' ' ' ALA . . . -59.11 175.03 0.32 Allowed 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.691 0.758 . . . . 0.0 112.121 -177.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.583 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 12.3 m-20 -58.77 141.5 85.0 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.503 174.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -48.32 -29.09 12.45 Favored 'Trans proline' 0 C--O 1.22 -0.397 0 C-N-CA 123.761 2.974 . . . . 0.0 112.893 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.493 ' OE1' ' HA ' ' A' ' 84' ' ' HIS . 0.3 OUTLIER -88.15 -33.82 18.08 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 123.86 0.864 . . . . 0.0 111.053 177.033 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.583 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 78.2 m -78.83 -33.8 45.76 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.504 -172.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.49 ' HA ' HD13 ' A' ' 55' ' ' ILE . 3.5 pt20 -73.08 -29.84 63.24 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 172.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.515 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 16.2 m -70.47 -19.12 62.97 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 113.658 -1.61 . . . . 0.0 110.432 173.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.497 ' HB3' HD12 ' A' ' 79' ' ' ILE . . . -76.46 -27.98 56.37 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.169 -0.957 . . . . 0.0 109.458 166.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.61 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 21.8 mt -89.15 -31.5 5.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 115.651 1.722 . . . . 0.0 115.651 -171.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.58 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -40.03 -38.13 0.96 Allowed Pre-proline 0 N--CA 1.492 1.673 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -174.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.61 ' HD2' ' C ' ' A' ' 55' ' ' ILE . 57.7 Cg_endo -65.21 -26.49 56.88 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.139 1.893 . . . . 0.0 113.002 175.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.526 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.8 mt -100.89 -15.61 17.5 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.575 ' NZ ' HD13 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -49.85 109.36 0.28 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.333 -179.215 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.18 -21.4 34.73 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.075 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -103.43 114.04 28.0 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.007 0.432 . . . . 0.0 109.977 -177.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.42 140.67 33.16 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.05 172.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.552 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 80.6 Cg_exo -48.93 140.53 23.55 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.598 2.199 . . . . 0.0 111.848 170.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.24 103.39 0.38 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.417 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.5 -8.73 55.23 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.72 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.552 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 17.6 m -94.51 169.44 10.19 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.496 0.665 . . . . 0.0 111.497 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -84.46 133.95 34.47 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.383 174.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.679 ' CG2' ' HB3' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -71.46 -33.45 49.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.222 -179.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.765 ' O ' HG12 ' A' ' 73' ' ' VAL . 11.9 mm -55.71 -47.95 78.53 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.226 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.524 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.59 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 27.7 t -47.91 -36.65 12.63 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.911 178.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -86.59 -31.85 20.95 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.649 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.601 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.2 m-30 -76.13 -36.24 58.91 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.65 -177.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.795 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.8 m -69.63 -33.43 56.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 173.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.59 ' HB2' ' O ' ' A' ' 70' ' ' SER . 0.8 OUTLIER -68.36 -29.9 68.72 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.73 177.132 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 72' ' ' TYR . . . -63.97 -49.04 74.08 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.741 175.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.748 ' SG ' ' HB ' ' A' ' 79' ' ' ILE . 25.4 t -89.44 7.32 36.6 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.931 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.489 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 10.5 t70 -63.2 -16.28 59.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.487 0.66 . . . . 0.0 110.004 174.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -101.29 -8.92 45.95 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.76 173.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.748 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 90.6 mt -96.04 146.43 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 O-C-N 122.333 -0.51 . . . . 0.0 111.118 -178.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 150.56 71.58 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.6 174.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.559 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 101.47 -110.41 3.85 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.894 -0.669 . . . . 0.0 113.087 177.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.17 -50.32 69.62 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -174.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 77.5 mtp -68.67 -28.44 66.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.884 0.373 . . . . 0.0 110.489 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.506 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 6.0 t-80 -65.94 -31.37 72.25 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.346 176.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.559 ' HG2' ' O ' ' A' ' 81' ' ' GLY . 33.7 mmtp -81.98 -19.3 40.83 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.955 0.407 . . . . 0.0 110.311 -178.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.48 -43.4 13.61 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.786 177.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 1.3 mmt -85.4 -12.78 51.26 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.319 -176.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 84' ' ' HIS . 0.1 OUTLIER -48.6 -43.39 36.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.697 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 26.0 ttt -80.31 -16.96 53.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.989 0.423 . . . . 0.0 110.646 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -91.44 -40.89 11.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.093 -174.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.514 ' C ' ' HB3' ' A' ' 53' ' ' SER . 19.7 mt-30 -105.07 -52.52 2.83 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -170.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.475 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -42.71 -37.05 1.62 Allowed 'General case' 0 N--CA 1.471 0.593 0 O-C-N 123.93 0.769 . . . . 0.0 109.328 -179.806 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 . . . . . 0 C--O 1.248 0.998 0 CA-C-N 114.017 -1.447 . . . . 0.0 113.031 -176.717 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo . . . . . 0 CA--C 1.516 -0.413 0 N-CA-C 109.425 -1.029 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 48.4 m -65.51 164.98 12.96 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 163.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.47 ' CE1' HD11 ' B' ' 29' ' ' ILE . 0.1 OUTLIER -69.79 -55.1 10.78 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.909 174.061 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.554 ' ND2' ' HG3' ' B' ' 42' ' ' MET . 2.7 p-10 -86.69 -2.23 58.35 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.852 -164.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.413 ' O ' ' HD3' ' B' ' 7' ' ' ARG . 9.7 t -66.11 -3.26 5.22 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.439 -176.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.582 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.3 m -73.65 131.97 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 171.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.702 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 1.2 ptt-85 -156.62 160.15 39.14 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -176.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' GLN . . . . . 0.452 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.3 tt0 -39.16 112.28 0.24 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 113.624 -1.626 . . . . 0.0 112.745 178.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.95 -142.72 8.18 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.64 174.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 20.0 m -59.03 95.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.958 0.379 . . . . 0.0 110.85 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 23.2 pttm 41.06 41.38 1.28 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.459 1.103 . . . . 0.0 112.454 -174.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -57.54 139.73 80.75 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.635 176.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . 0.53 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 34.2 Cg_exo -53.73 125.05 17.36 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.053 1.835 . . . . 0.0 109.727 177.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . 0.799 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 6.1 t80 -68.42 -55.37 12.25 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-O 118.504 -0.76 . . . . 0.0 112.877 -167.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.543 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 25.4 Cg_exo -57.57 -17.76 29.59 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 121.375 1.383 . . . . 0.0 111.238 -177.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.53 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 5.8 m-20 -89.71 -40.1 12.74 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.966 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' PHE . . . . . 0.635 ' HE2' ' CE2' ' B' ' 14' ' ' TYR . 0.0 OUTLIER -56.68 -45.79 81.52 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.013 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.775 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 1.4 p -77.75 -33.43 18.86 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.278 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.399 -178.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.27 -31.25 67.28 Favored 'General case' 0 C--N 1.31 -1.119 0 O-C-N 121.271 -0.893 . . . . 0.0 111.83 177.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.721 ' O ' HG12 ' B' ' 24' ' ' VAL . 15.8 ptt180 -84.97 -28.31 25.89 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 174.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.57 HD22 ' CE1' ' B' ' 17' ' ' PHE . 11.8 tp -54.0 -48.84 70.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.97 172.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . 0.775 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 23.1 mt-30 -70.89 -46.38 62.68 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.077 177.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.73 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 19.1 t70 -48.4 -54.72 12.98 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 124.125 0.891 . . . . 0.0 111.574 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' VAL . . . . . 0.721 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.4 p -81.63 -22.38 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-O 121.278 0.561 . . . . 0.0 109.807 -173.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.778 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -72.85 -18.67 61.42 Favored 'General case' 0 C--O 1.205 -1.252 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 173.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . 0.406 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -86.64 -38.39 17.11 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.546 -1.207 . . . . 0.0 109.596 177.133 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.73 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.8 mmtt -67.23 -36.13 81.02 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.033 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 23.8 m -104.02 -8.73 19.35 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.203 0.525 . . . . 0.0 110.628 -171.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.778 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 83.8 mt -115.35 126.13 72.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.394 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.37 -5.55 59.3 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.109 0.48 . . . . 0.0 110.363 178.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.546 ' H ' HG22 ' B' ' 29' ' ' ILE . 26.0 t0 -105.41 139.47 39.99 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.297 -177.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -76.27 -31.5 58.3 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.499 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.52 ' O ' HG13 ' B' ' 37' ' ' VAL . 6.4 mttp -71.68 -55.01 8.51 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.482 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -58.7 -27.56 64.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.289 -0.868 . . . . 0.0 110.967 176.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.843 ' O ' HG13 ' B' ' 39' ' ' VAL . 1.9 tmm_? -65.85 -59.75 3.55 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 12.5 mtpp -55.18 -57.54 11.37 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.1 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.773 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 20.1 m -52.67 -34.5 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.068 -170.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.477 ' O ' ' HG2' ' B' ' 42' ' ' MET . 1.0 OUTLIER -88.26 -31.26 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 119.942 -0.703 . . . . 0.0 112.195 -179.436 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.843 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.4 m -68.63 -48.64 70.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 119.114 -1.035 . . . . 0.0 109.434 176.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.692 ' HB3' ' CG2' ' B' ' 68' ' ' VAL . 0.8 OUTLIER -64.65 -28.44 69.61 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.49 0.716 . . . . 0.0 111.541 178.388 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.773 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -81.4 -54.62 5.31 Favored 'General case' 0 C--N 1.322 -0.602 0 O-C-N 122.141 -0.349 . . . . 0.0 111.5 177.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' MET . . . . . 0.554 ' HG3' ' ND2' ' B' ' 4' ' ' ASN . 22.2 mmt -63.47 -20.45 65.59 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.691 0.758 . . . . 0.0 109.519 -177.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.649 ' O ' ' HB3' ' B' ' 47' ' ' ALA . . . -49.0 -32.99 10.17 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.832 171.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' TYR . . . . . 0.425 ' CG ' ' HB2' ' B' ' 52' ' ' GLN . 17.6 t80 -99.8 -64.79 1.01 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.577 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 39.4 mm-40 -50.2 -32.97 17.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.419 -1.264 . . . . 0.0 112.312 -171.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.702 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.6 m-20 -103.96 -20.21 13.96 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.031 -174.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' B' ' 43' ' ' ALA . . . -59.55 174.91 0.39 Allowed 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.591 0.71 . . . . 0.0 112.119 -177.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . 0.587 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 12.0 m-20 -58.51 141.44 83.73 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 114.755 -1.112 . . . . 0.0 109.496 174.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -48.12 -29.3 12.19 Favored 'Trans proline' 0 C--O 1.221 -0.37 0 C-N-CA 123.715 2.943 . . . . 0.0 112.918 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.496 ' OE1' ' HA ' ' B' ' 84' ' ' HIS . 0.3 OUTLIER -88.05 -33.81 18.19 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 123.823 0.849 . . . . 0.0 111.095 177.213 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 78.8 m -78.8 -33.88 45.88 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.457 -172.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . 0.479 ' HA ' HD13 ' B' ' 55' ' ' ILE . 3.7 pt20 -72.93 -29.99 63.54 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 172.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' SER . . . . . 0.532 ' HB3' ' C ' ' B' ' 91' ' ' GLN . 15.8 m -70.45 -19.06 63.0 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 113.654 -1.612 . . . . 0.0 110.416 173.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.515 ' HB3' HD12 ' B' ' 79' ' ' ILE . . . -76.6 -27.65 55.84 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.271 -0.893 . . . . 0.0 109.545 166.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.602 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 22.0 mt -89.43 -31.41 5.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -171.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.576 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -40.2 -38.15 1.02 Allowed Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -174.756 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.602 ' HD2' ' C ' ' B' ' 55' ' ' ILE . 57.9 Cg_endo -65.21 -26.22 57.08 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.177 1.918 . . . . 0.0 113.069 175.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . 0.544 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.8 mt -100.97 -15.66 17.42 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.561 ' HZ3' HD13 ' B' ' 41' ' ' LEU . 0.2 OUTLIER -49.95 109.36 0.28 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.302 -179.103 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . 0.405 ' HA3' ' C ' ' A' ' 1' ' ' PRO . . . 91.13 -21.23 35.46 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.05 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -103.4 114.01 27.95 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 120.994 0.426 . . . . 0.0 109.972 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.34 140.76 33.22 Favored Pre-proline 0 C--N 1.314 -0.964 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.075 172.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.551 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 82.3 Cg_exo -48.91 140.27 23.88 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.576 2.184 . . . . 0.0 111.906 170.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.77 103.51 0.35 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.195 -176.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.31 -9.02 55.85 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.924 176.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.551 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 18.7 m -94.11 169.75 10.03 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.676 0.751 . . . . 0.0 111.516 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -84.93 134.04 34.27 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.272 174.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.692 ' CG2' ' HB3' ' B' ' 40' ' ' GLU . 0.8 OUTLIER -71.69 -33.35 48.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.198 -179.475 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . 0.773 ' O ' HG12 ' B' ' 73' ' ' VAL . 11.9 mm -55.66 -48.1 78.16 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.215 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.538 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.582 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 27.2 t -47.83 -36.6 12.17 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.943 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -86.42 -32.11 21.07 Favored 'General case' 0 CA--C 1.507 -0.685 0 C-N-CA 123.231 0.613 . . . . 0.0 110.606 -177.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' TYR . . . . . 0.588 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.2 m-30 -75.94 -36.22 59.43 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.616 -177.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . 0.799 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.8 m -69.62 -33.59 57.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.543 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 173.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' LYS . . . . . 0.582 ' HB2' ' O ' ' B' ' 70' ' ' SER . 0.8 OUTLIER -68.11 -30.12 69.2 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.224 -1.353 . . . . 0.0 109.755 177.117 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' B' ' 72' ' ' TYR . . . -63.75 -49.25 73.74 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.676 175.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.75 ' SG ' ' HB ' ' B' ' 79' ' ' ILE . 24.9 t -89.31 7.05 37.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.921 178.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . 0.492 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 8.9 t70 -63.09 -16.63 60.58 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.374 0.607 . . . . 0.0 110.034 174.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -101.1 -8.47 47.54 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.471 173.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.75 ' HB ' ' SG ' ' B' ' 76' ' ' CYS . 90.1 mt -96.15 146.6 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 O-C-N 122.324 -0.515 . . . . 0.0 111.169 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 150.27 71.86 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.566 174.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.567 ' O ' ' HG2' ' B' ' 85' ' ' LYS . . . 101.3 -110.02 3.77 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.892 -0.67 . . . . 0.0 113.054 177.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.52 -50.42 70.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.835 0.35 . . . . 0.0 111.942 -174.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' MET . . . . . . . . . . . . . 75.8 mtp -68.41 -28.81 67.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.892 0.377 . . . . 0.0 110.476 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' HIS . . . . . 0.512 ' O ' ' HB2' ' B' ' 88' ' ' LEU . 6.1 t-80 -65.7 -31.54 72.6 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.312 176.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.567 ' HG2' ' O ' ' B' ' 81' ' ' GLY . 33.6 mmtp -81.76 -19.38 41.45 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.04 0.448 . . . . 0.0 110.337 -178.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.49 -43.36 13.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.79 177.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 1.3 mmt -85.32 -12.78 51.51 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.323 -176.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.512 ' HB2' ' O ' ' B' ' 84' ' ' HIS . 0.1 OUTLIER -48.58 -43.01 35.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.776 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 26.3 ttt -80.81 -17.04 52.13 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.986 0.422 . . . . 0.0 110.753 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -91.21 -41.21 11.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.996 -174.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' GLN . . . . . 0.532 ' C ' ' HB3' ' B' ' 53' ' ' SER . 20.2 mt-30 -104.57 -52.65 2.85 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -170.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.47 ' HB2' HD12 ' B' ' 88' ' ' LEU . 0.1 OUTLIER -42.52 -37.48 1.65 Allowed 'General case' 0 N--CA 1.472 0.661 0 O-C-N 123.854 0.721 . . . . 0.0 109.343 -179.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 . . . . . 0 C--O 1.25 1.103 0 CA-C-N 114.06 -1.427 . . . . 0.0 113.042 -176.627 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo . . . . . 0 CA--C 1.517 -0.345 0 N-CA-C 109.248 -1.097 . . . . 0.0 109.248 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.457 ' HB2' HG21 ' A' ' 5' ' ' THR . 39.4 m -64.93 171.13 3.71 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 162.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.497 ' HE1' ' CD1' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -69.73 -52.53 24.65 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.118 175.299 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.485 ' ND2' ' HG3' ' A' ' 42' ' ' MET . 2.2 p-10 -86.97 6.45 32.16 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.577 -1.192 . . . . 0.0 113.659 -163.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.626 ' CG2' ' HD3' ' B' ' 59' ' ' LYS . 1.1 p -63.32 -5.99 4.14 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 118.513 0.597 . . . . 0.0 111.787 -176.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.616 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.1 m -75.12 132.04 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 175.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.706 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -155.54 159.22 39.54 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -178.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.434 ' HG2' ' HB3' ' A' ' 12' ' ' GLU . 2.3 tt0 -44.29 115.14 0.79 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 112.929 -1.941 . . . . 0.0 113.02 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.73 -149.98 23.81 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.091 -0.958 . . . . 0.0 111.126 171.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.47 ' C ' ' HD3' ' A' ' 11' ' ' LYS . 6.3 p -50.97 100.36 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.61 0.364 . . . . 0.0 111.592 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER 30.25 48.0 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.764 1.226 . . . . 0.0 112.26 -171.507 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.434 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 53.5 tt0 -60.22 140.63 91.17 Favored Pre-proline 0 C--O 1.234 0.283 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.611 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.552 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 32.0 Cg_exo -54.05 121.54 9.82 Favored 'Trans proline' 0 CA--C 1.509 -0.754 0 C-N-CA 121.947 1.765 . . . . 0.0 109.623 178.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.871 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 13.8 t80 -72.75 -53.36 5.52 Favored Pre-proline 0 N--CA 1.439 -1.022 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -167.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.521 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 34.6 Cg_exo -55.66 -17.04 16.42 Favored 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.43 1.42 . . . . 0.0 110.761 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.552 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 2.2 m-20 -90.6 -43.43 10.18 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 113.981 -1.463 . . . . 0.0 111.038 177.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.466 ' CD2' ' HA ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -53.41 -46.51 69.78 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.772 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 1.8 p -79.26 -34.72 16.56 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.363 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.313 -178.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 15' ' ' PRO . . . -57.89 -32.79 68.06 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 121.344 -0.847 . . . . 0.0 111.762 177.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.695 ' O ' HG11 ' A' ' 24' ' ' VAL . 14.3 ptt180 -84.28 -25.04 29.64 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 176.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.547 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 6.2 tp -59.91 -46.72 88.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.821 172.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.772 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 24.7 mt-30 -69.97 -48.28 58.92 Favored 'General case' 0 CA--C 1.492 -1.282 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.933 177.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.724 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 15.5 t70 -47.44 -54.65 10.82 Favored 'General case' 0 C--N 1.313 -1.017 0 O-C-N 124.265 0.978 . . . . 0.0 111.547 -178.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.695 HG11 ' O ' ' A' ' 20' ' ' ARG . 7.7 p -79.18 -24.9 12.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.948 -173.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.634 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -67.89 -29.58 68.71 Favored 'General case' 0 C--O 1.205 -1.263 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.469 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -78.81 -36.32 42.89 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.723 -178.253 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.724 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 39.2 mmtt -65.92 -34.1 77.34 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.469 177.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.1 m -105.6 -9.89 17.14 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.271 0.558 . . . . 0.0 110.823 -170.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.634 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 87.7 mt -118.07 129.07 74.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.062 -178.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.4 -1.47 53.63 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.246 0.546 . . . . 0.0 110.524 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.526 ' H ' HG22 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -113.71 111.76 22.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.015 -177.338 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.86 -32.05 30.47 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 177.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.49 ' O ' HG12 ' A' ' 37' ' ' VAL . 14.2 mttm -58.46 -61.31 2.68 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.488 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -66.36 -22.84 66.27 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.427 -178.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.833 ' O ' HG12 ' A' ' 39' ' ' VAL . 5.3 tmm_? -72.31 -54.6 9.02 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.436 ' O ' HG21 ' A' ' 39' ' ' VAL . 16.6 mtpt -59.44 -56.5 21.26 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.345 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.805 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 20.9 m -54.15 -36.58 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.997 -171.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.497 ' CD1' ' HE1' ' A' ' 3' ' ' PHE . 1.2 tt -85.78 -30.36 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.811 -176.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.833 HG12 ' O ' ' A' ' 35' ' ' ARG . 3.3 m -69.47 -47.94 69.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 C-N-CA 118.915 -1.114 . . . . 0.0 109.245 174.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.625 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 58.6 mt-10 -64.66 -23.13 67.16 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 123.653 0.781 . . . . 0.0 112.383 175.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.805 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -85.48 -57.21 3.16 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.543 177.251 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.485 ' HG3' ' ND2' ' A' ' 4' ' ' ASN . 20.1 mmt -63.6 -20.96 66.09 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 121.462 0.649 . . . . 0.0 109.734 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.654 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . . . -49.18 -27.65 3.78 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.288 170.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.448 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 11.4 t80 -106.12 -68.1 0.89 Allowed 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.597 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 7.2 mm-40 -47.59 -33.85 7.1 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 124.31 1.007 . . . . 0.0 112.414 -173.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.706 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.8 m-20 -103.46 -21.15 13.83 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 120.501 0.191 . . . . 0.0 110.963 -174.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 43' ' ' ALA . . . -57.35 177.61 0.09 Allowed 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 121.817 0.818 . . . . 0.0 112.511 -176.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -56.21 137.64 74.35 Favored Pre-proline 0 N--CA 1.44 -0.958 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.9 174.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.43 -21.75 31.36 Favored 'Trans proline' 0 C--O 1.219 -0.465 0 C-N-CA 123.273 2.649 . . . . 0.0 111.778 -177.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.506 ' O ' ' HB2' ' A' ' 53' ' ' SER . 0.7 OUTLIER -87.86 -37.4 16.54 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 124.157 0.983 . . . . 0.0 111.055 173.325 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.996 ' SG ' ' HB2' ' A' ' 76' ' ' CYS . 42.4 t -75.33 -36.06 61.11 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-O 121.018 0.437 . . . . 0.0 111.328 -172.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.495 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.9 pt20 -69.62 -29.74 67.32 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 175.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.598 ' HA ' ' CD ' ' A' ' 56' ' ' LYS . 30.8 m -72.48 -19.75 61.5 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 112.944 -1.935 . . . . 0.0 110.176 174.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.401 ' CB ' HD11 ' A' ' 79' ' ' ILE . . . -81.22 -22.27 38.92 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.333 166.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.516 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 22.5 mt -90.54 -31.84 5.26 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.787 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 -173.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.654 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.1 OUTLIER -46.14 -32.65 1.81 Allowed Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -175.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.654 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 33.0 Cg_endo -59.54 -31.04 93.9 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.17 1.913 . . . . 0.0 112.99 171.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.515 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.1 mt -102.45 -15.65 16.42 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.621 ' HD3' ' CG2' ' B' ' 5' ' ' THR . 0.1 OUTLIER -51.78 109.88 0.41 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.972 -179.717 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.35 -22.66 35.8 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.162 -177.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -103.77 114.5 28.8 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.413 0.625 . . . . 0.0 110.553 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.435 ' HB ' HG11 ' A' ' 68' ' ' VAL . 7.4 p -123.4 149.99 59.55 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.471 170.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.585 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 92.1 Cg_exo -47.29 139.52 16.23 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 121.713 1.609 . . . . 0.0 110.92 164.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.45 100.81 0.09 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -171.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.16 -2.25 71.31 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.04 176.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.585 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 2.1 m -95.7 -155.33 0.47 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.219 1.009 . . . . 0.0 112.372 -177.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -98.61 124.93 43.69 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 113.568 -1.651 . . . . 0.0 110.93 -172.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.562 HG13 ' CD ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -81.05 -28.98 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 C-N-CA 117.609 -1.637 . . . . 0.0 108.606 173.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.77 ' O ' HG12 ' A' ' 73' ' ' VAL . 10.0 mm -59.34 -48.04 88.42 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.18 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.627 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.3 t -50.44 -33.96 22.93 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.355 0.598 . . . . 0.0 111.155 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -85.28 -33.64 22.1 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 123.323 0.649 . . . . 0.0 110.507 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.56 ' OH ' ' HA ' ' A' ' 59' ' ' LYS . 4.7 m-30 -75.85 -34.05 60.04 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.754 -176.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.871 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 2.2 m -68.41 -35.67 71.66 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 173.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.528 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 21.7 ttmt -70.71 -27.7 64.18 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 113.894 -1.503 . . . . 0.0 111.188 176.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.477 ' HB1' ' O ' ' A' ' 72' ' ' TYR . . . -61.62 -44.34 97.17 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 171.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.996 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 16.6 t -85.78 3.12 42.83 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.292 176.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.528 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 29.6 t70 -65.5 1.19 1.25 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 163.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.514 ' H ' ' C ' ' A' ' 76' ' ' CYS . . . -121.14 -10.09 6.96 Favored Glycine 0 N--CA 1.439 -1.115 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.779 175.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.643 HG12 ' CB ' ' A' ' 76' ' ' CYS . 1.1 mm -68.0 -85.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.046 0.923 . . . . 0.0 110.066 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 42.9 -130.17 5.31 Favored Glycine 0 C--N 1.339 0.719 0 CA-C-N 115.967 -0.56 . . . . 0.0 113.469 -172.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.671 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . -113.76 -66.67 0.47 Allowed Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.353 -176.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.43 -56.87 15.77 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -173.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.522 ' O ' ' HG3' ' A' ' 87' ' ' MET . 54.1 mtt -66.5 -36.6 83.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.948 0.404 . . . . 0.0 110.094 -177.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.63 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 6.2 t-80 -55.4 -34.99 64.87 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.385 176.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.671 ' HG2' ' O ' ' A' ' 81' ' ' GLY . 31.5 mmtp -80.15 -17.41 52.55 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 121.825 -0.547 . . . . 0.0 110.523 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.41 -46.06 10.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.575 0.703 . . . . 0.0 110.682 175.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.522 ' HG3' ' O ' ' A' ' 83' ' ' MET . 25.1 mtm -85.58 -14.05 46.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.38 -172.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.63 ' HB2' ' O ' ' A' ' 84' ' ' HIS . 1.3 tp -48.65 -41.93 32.82 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.619 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 53.0 ttp -82.34 -16.14 50.32 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.033 0.444 . . . . 0.0 111.114 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -97.02 -33.96 11.36 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -174.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.589 ' C ' ' HB3' ' A' ' 53' ' ' SER . 22.0 mt-30 -105.47 -56.27 2.2 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.72 -174.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.432 ' HB2' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -48.03 -31.4 5.36 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.605 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.432 ' HG3' ' OXT' ' A' ' 93' ' ' GLU . 5.3 pt-20 . . . . . 0 C--O 1.249 1.051 0 CA-C-N 113.59 -1.641 . . . . 0.0 113.995 -171.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' PRO . . . . . 0.424 ' HB2' ' H ' ' B' ' 2' ' ' SER . 94.4 Cg_endo . . . . . 0 CA--C 1.517 -0.368 0 N-CA-C 109.156 -1.132 . . . . 0.0 109.156 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.441 ' HB2' HG21 ' B' ' 5' ' ' THR . 43.3 m -65.13 171.07 3.93 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 162.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.501 ' HE1' ' CD1' ' B' ' 38' ' ' ILE . 0.1 OUTLIER -69.61 -52.54 25.06 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.155 175.349 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.484 ' ND2' ' HG3' ' B' ' 42' ' ' MET . 2.2 p-10 -86.9 6.51 31.6 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.584 -1.189 . . . . 0.0 113.717 -163.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.621 ' CG2' ' HD3' ' A' ' 59' ' ' LYS . 1.1 p -63.54 -5.75 4.25 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 118.57 0.623 . . . . 0.0 111.865 -176.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.616 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.1 m -75.2 131.98 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 175.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.702 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.1 OUTLIER -155.51 159.37 39.7 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -178.702 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' GLN . . . . . 0.417 ' HG2' ' HB3' ' B' ' 12' ' ' GLU . 2.3 tt0 -44.2 115.0 0.76 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 112.939 -1.937 . . . . 0.0 113.035 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.79 -150.06 24.04 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.162 171.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' SER . . . . . 0.477 ' C ' ' HD3' ' B' ' 11' ' ' LYS . 7.8 p -50.84 100.25 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.604 0.362 . . . . 0.0 111.677 -178.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' B' ' 11' ' ' LYS . 0.0 OUTLIER 30.37 48.19 0.05 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.673 1.189 . . . . 0.0 112.122 -171.575 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.417 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 51.9 tt0 -60.51 140.35 92.28 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.688 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . 0.557 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 31.9 Cg_exo -53.97 121.6 9.91 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 121.861 1.707 . . . . 0.0 109.602 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . 0.868 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 13.7 t80 -72.85 -53.35 5.36 Favored Pre-proline 0 N--CA 1.438 -1.049 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -167.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.509 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 32.9 Cg_exo -55.37 -17.33 15.86 Favored 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 121.57 1.514 . . . . 0.0 110.775 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.557 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.7 m-20 -90.62 -43.42 10.18 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 113.935 -1.484 . . . . 0.0 111.024 177.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' PHE . . . . . 0.469 ' CD2' ' HA ' ' B' ' 7' ' ' ARG . 0.0 OUTLIER -53.38 -46.49 69.66 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.662 0.744 . . . . 0.0 109.039 175.525 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.78 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 1.8 p -79.16 -34.83 16.79 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.334 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.298 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' B' ' 15' ' ' PRO . . . -57.91 -32.76 68.06 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 121.366 -0.834 . . . . 0.0 111.773 177.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.692 ' O ' HG11 ' B' ' 24' ' ' VAL . 14.3 ptt180 -84.61 -24.63 29.05 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.549 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 6.1 tp -60.3 -46.47 89.75 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.842 172.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . 0.78 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 24.8 mt-30 -70.2 -48.1 58.58 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.004 177.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.723 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 15.2 t70 -47.49 -54.67 10.88 Favored 'General case' 0 C--N 1.313 -1.002 0 O-C-N 124.301 1.001 . . . . 0.0 111.462 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' VAL . . . . . 0.692 HG11 ' O ' ' B' ' 20' ' ' ARG . 7.7 p -79.28 -24.78 12.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.96 -173.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.636 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -67.96 -29.51 68.57 Favored 'General case' 0 C--O 1.205 -1.272 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 174.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . 0.452 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -78.89 -36.26 42.33 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.125 -1.398 . . . . 0.0 109.786 -178.252 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.723 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 39.1 mmtt -65.89 -34.26 77.72 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.496 177.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 15.9 m -105.63 -9.66 17.24 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.884 -170.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.636 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 87.9 mt -118.2 129.28 74.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.983 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.64 -1.32 53.39 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.347 0.594 . . . . 0.0 110.585 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.535 ' H ' HG22 ' B' ' 29' ' ' ILE . 0.6 OUTLIER -113.71 111.81 22.41 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.977 -177.554 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.17 -31.71 32.65 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.092 177.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.487 ' O ' HG12 ' B' ' 37' ' ' VAL . 14.1 mttm -58.66 -61.21 2.77 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -178.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.494 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -66.21 -22.98 66.36 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.483 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.84 ' O ' HG12 ' B' ' 39' ' ' VAL . 5.2 tmm_? -72.15 -54.63 9.13 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.436 ' O ' HG21 ' B' ' 39' ' ' VAL . 16.5 mtpt -59.47 -56.48 21.43 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.461 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.792 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 21.0 m -54.18 -36.57 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.051 -171.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.501 ' CD1' ' HE1' ' B' ' 3' ' ' PHE . 1.2 tt -85.6 -30.55 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.757 -176.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.84 HG12 ' O ' ' B' ' 35' ' ' ARG . 3.3 m -69.39 -48.0 69.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 C-N-CA 118.927 -1.109 . . . . 0.0 109.17 174.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.628 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 58.7 mt-10 -64.63 -23.35 67.23 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.571 0.748 . . . . 0.0 112.268 176.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.792 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.29 -57.16 3.19 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.555 177.331 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' MET . . . . . 0.484 ' HG3' ' ND2' ' B' ' 4' ' ' ASN . 20.0 mmt -63.63 -20.96 66.1 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.521 0.677 . . . . 0.0 109.714 -177.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.665 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . . . -49.13 -27.76 3.75 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.305 170.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' TYR . . . . . 0.465 ' CG ' ' HD2' ' B' ' 59' ' ' LYS . 11.4 t80 -106.09 -67.99 0.9 Allowed 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.602 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 7.2 mm-40 -47.85 -33.48 7.46 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 124.301 1.001 . . . . 0.0 112.491 -173.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.702 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.9 m-20 -103.67 -21.04 13.78 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 116.808 -0.178 . . . . 0.0 110.903 -175.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' B' ' 43' ' ' ALA . . . -57.48 178.07 0.08 Allowed 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 121.864 0.84 . . . . 0.0 112.55 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -56.42 137.53 75.91 Favored Pre-proline 0 N--CA 1.441 -0.917 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.819 174.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.32 -21.63 30.04 Favored 'Trans proline' 0 C--O 1.221 -0.373 0 C-N-CA 123.177 2.585 . . . . 0.0 111.911 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.504 ' O ' ' HB2' ' B' ' 53' ' ' SER . 0.7 OUTLIER -87.8 -37.47 16.56 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 124.303 1.041 . . . . 0.0 111.13 173.044 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.996 ' SG ' ' HB2' ' B' ' 76' ' ' CYS . 41.7 t -75.34 -36.0 61.09 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-O 121.046 0.451 . . . . 0.0 111.315 -172.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . 0.489 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.9 pt20 -69.54 -29.92 67.62 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 175.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' SER . . . . . 0.602 ' HB3' ' C ' ' B' ' 91' ' ' GLN . 32.4 m -72.26 -19.99 61.6 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 112.92 -1.945 . . . . 0.0 110.29 174.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.4 ' CB ' HD11 ' B' ' 79' ' ' ILE . . . -81.04 -22.38 39.36 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.216 -0.593 . . . . 0.0 110.388 166.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.51 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 22.5 mt -90.53 -31.95 5.29 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.798 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -173.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.643 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.1 OUTLIER -46.04 -32.76 1.8 Allowed Pre-proline 0 N--CA 1.488 1.466 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -175.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.643 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 32.7 Cg_endo -59.24 -31.44 95.22 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.219 1.946 . . . . 0.0 112.939 171.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . 0.512 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.1 mt -102.15 -15.91 16.54 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -177.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.626 ' HD3' ' CG2' ' A' ' 5' ' ' THR . 0.1 OUTLIER -51.61 109.88 0.4 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.112 -179.713 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.0 -22.09 38.26 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.329 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -103.96 114.76 29.24 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.355 0.597 . . . . 0.0 110.48 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.438 ' HB ' HG11 ' B' ' 68' ' ' VAL . 7.5 p -123.46 150.34 60.65 Favored Pre-proline 0 C--N 1.309 -1.166 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.374 170.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.592 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 93.4 Cg_exo -47.45 139.52 17.1 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 121.753 1.636 . . . . 0.0 110.915 164.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.58 100.96 0.09 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -171.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.26 -3.19 72.29 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.899 -0.591 . . . . 0.0 113.135 176.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.592 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 2.3 m -95.06 -155.21 0.46 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 122.145 0.974 . . . . 0.0 112.281 -177.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -98.67 124.75 43.67 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 113.513 -1.676 . . . . 0.0 110.898 -172.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.566 HG13 ' CD ' ' B' ' 40' ' ' GLU . 0.9 OUTLIER -80.97 -28.79 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 C-N-CA 117.548 -1.661 . . . . 0.0 108.609 173.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . 0.779 ' O ' HG12 ' B' ' 73' ' ' VAL . 9.8 mm -59.75 -47.71 90.27 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.232 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.68 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 42.8 t -50.52 -34.04 23.79 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.397 0.617 . . . . 0.0 111.118 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -85.18 -33.87 22.2 Favored 'General case' 0 C--O 1.213 -0.835 0 C-N-CA 123.298 0.639 . . . . 0.0 110.394 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' TYR . . . . . 0.563 ' OH ' ' HA ' ' B' ' 59' ' ' LYS . 4.7 m-30 -75.56 -33.9 60.66 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.719 -176.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . 0.868 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 2.2 m -68.56 -35.61 71.03 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' LYS . . . . . 0.518 ' O ' ' HB3' ' B' ' 77' ' ' ASP . 22.0 ttmt -70.71 -27.52 64.04 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.253 176.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' B' ' 72' ' ' TYR . . . -61.81 -44.17 97.39 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.996 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 16.5 t -86.02 3.29 42.96 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.336 176.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . 0.518 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 28.5 t70 -65.55 1.2 1.27 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 163.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' B' ' 76' ' ' CYS . . . -121.26 -9.7 7.11 Favored Glycine 0 N--CA 1.439 -1.122 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.7 175.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.653 HG12 ' CB ' ' B' ' 76' ' ' CYS . 1.1 mm -68.19 -84.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 118.06 0.93 . . . . 0.0 110.042 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 42.5 -130.32 4.91 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-N 115.969 -0.559 . . . . 0.0 113.511 -172.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.679 ' O ' ' HG2' ' B' ' 85' ' ' LYS . . . -113.81 -66.23 0.46 Allowed Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.386 -177.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.89 -56.48 21.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -173.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' MET . . . . . 0.523 ' O ' ' HG3' ' B' ' 87' ' ' MET . 53.8 mtt -66.64 -36.64 83.05 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -177.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' HIS . . . . . 0.631 ' O ' ' HB2' ' B' ' 88' ' ' LEU . 6.2 t-80 -55.48 -34.98 65.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.304 176.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.679 ' HG2' ' O ' ' B' ' 81' ' ' GLY . 31.6 mmtp -80.27 -17.27 52.65 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 121.819 -0.551 . . . . 0.0 110.533 -178.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.53 -45.98 10.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.571 0.7 . . . . 0.0 110.691 175.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' MET . . . . . 0.523 ' HG3' ' O ' ' B' ' 83' ' ' MET . 24.4 mtm -85.66 -14.02 46.78 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.381 -172.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.631 ' HB2' ' O ' ' B' ' 84' ' ' HIS . 1.3 tp -48.73 -41.9 33.53 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.592 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 53.7 ttp -82.34 -16.25 49.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.944 0.402 . . . . 0.0 111.013 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -96.89 -33.76 11.5 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -174.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' GLN . . . . . 0.602 ' C ' ' HB3' ' B' ' 53' ' ' SER . 22.0 mt-30 -105.77 -56.41 2.18 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.653 -174.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.448 ' HB2' HD13 ' B' ' 88' ' ' LEU . 0.0 OUTLIER -48.05 -31.24 5.21 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 177.568 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.421 ' HG3' ' OXT' ' B' ' 93' ' ' GLU . 5.2 pt-20 . . . . . 0 C--O 1.252 1.19 0 CA-C-N 113.809 -1.541 . . . . 0.0 113.843 -171.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.415 ' HB2' ' H ' ' A' ' 2' ' ' SER . 98.1 Cg_endo . . . . . 0 CA--C 1.517 -0.341 0 N-CA-C 109.052 -1.172 . . . . 0.0 109.052 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.444 ' HB2' HG22 ' A' ' 5' ' ' THR . 50.0 m -66.37 176.82 1.68 Allowed 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 162.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.628 ' CE1' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -77.09 -53.99 7.09 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.589 -0.845 . . . . 0.0 109.743 174.338 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.554 ' ND2' ' HG3' ' A' ' 42' ' ' MET . 2.0 p-10 -82.67 6.19 18.71 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.367 -1.288 . . . . 0.0 112.548 -167.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.642 ' CG2' ' HD3' ' B' ' 59' ' ' LYS . 0.7 OUTLIER -65.12 -4.08 4.5 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.547 -176.75 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.613 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.2 m -79.37 132.78 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 174.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.685 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -155.95 160.07 39.78 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 118.937 -1.105 . . . . 0.0 113.422 -177.798 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.486 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.4 mt-30 -40.67 112.68 0.31 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 113.568 -1.651 . . . . 0.0 112.776 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.08 -161.58 32.74 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 170.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.7 m -50.83 104.09 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 117.292 0.546 . . . . 0.0 111.029 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.612 ' HD2' ' O ' ' A' ' 80' ' ' GLY . 63.4 pttt 44.12 39.11 2.65 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.587 1.155 . . . . 0.0 112.756 -176.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.4 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 48.2 tt0 -62.36 137.97 96.2 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 177.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.512 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 39.0 Cg_exo -53.74 124.72 16.53 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.11 1.874 . . . . 0.0 109.921 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.736 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 6.7 t80 -69.26 -55.32 10.11 Favored Pre-proline 0 N--CA 1.44 -0.958 0 CA-C-O 118.38 -0.819 . . . . 0.0 113.134 -166.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.551 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 30.3 Cg_exo -57.04 -17.57 25.15 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 121.456 1.437 . . . . 0.0 111.211 -178.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 2.1 m-20 -89.52 -42.31 11.52 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.891 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.632 ' HE2' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -55.48 -44.7 76.72 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.307 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.691 HG12 ' O ' ' A' ' 14' ' ' TYR . 1.7 p -80.99 -31.47 12.11 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.937 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.826 -177.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.76 -33.69 70.56 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 121.284 -0.885 . . . . 0.0 111.608 176.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.696 ' O ' HG11 ' A' ' 24' ' ' VAL . 14.6 ptt180 -84.56 -25.48 28.66 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 175.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.593 HD23 ' CE1' ' A' ' 17' ' ' PHE . 9.7 tp -57.98 -45.09 87.31 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.972 172.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.694 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 36.1 mt-30 -73.31 -44.42 59.04 Favored 'General case' 0 CA--C 1.494 -1.196 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.688 177.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.754 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 14.3 t70 -52.08 -50.93 60.58 Favored 'General case' 0 C--N 1.314 -0.945 0 O-C-N 124.087 0.867 . . . . 0.0 111.427 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.696 HG11 ' O ' ' A' ' 20' ' ' ARG . 7.1 p -82.02 -23.96 9.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.249 0.547 . . . . 0.0 109.793 -174.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.848 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -71.69 -18.29 62.18 Favored 'General case' 0 C--O 1.206 -1.223 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 174.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.414 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -87.43 -38.92 15.7 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.958 176.746 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.754 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 40.2 mmtt -65.28 -43.32 91.6 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.321 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.504 ' HB2' ' HB3' ' A' ' 3' ' ' PHE . 24.9 m -98.6 -8.47 26.36 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.243 0.544 . . . . 0.0 110.419 -172.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.848 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 87.2 mt -114.91 125.48 72.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.725 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.84 -4.33 57.65 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.18 0.514 . . . . 0.0 110.01 175.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.662 ' OD1' ' HB2' ' A' ' 33' ' ' LYS . 12.4 t70 -102.59 115.71 31.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.409 -177.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 36' ' ' LYS . 12.5 pt-20 -61.59 -24.71 66.86 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.831 176.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.662 ' HB2' ' OD1' ' A' ' 31' ' ' ASP . 4.5 mptt -75.12 -52.17 11.65 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -177.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.29 -26.94 68.29 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.89 176.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.821 ' O ' HG11 ' A' ' 39' ' ' VAL . 3.9 tmm_? -62.59 -65.19 0.72 Allowed 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.546 ' O ' HG23 ' A' ' 39' ' ' VAL . 7.9 ptmm? -53.11 -58.38 7.2 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.314 0.578 . . . . 0.0 112.259 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.773 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 5.4 m -56.63 -30.39 31.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.928 -172.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.491 ' O ' ' HG2' ' A' ' 42' ' ' MET . 0.1 OUTLIER -85.07 -31.43 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.407 178.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.821 HG11 ' O ' ' A' ' 35' ' ' ARG . 2.4 m -68.33 -47.84 75.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 119.257 -0.977 . . . . 0.0 108.97 175.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.611 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 45.3 mt-10 -68.03 -22.89 64.94 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.335 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.773 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -85.42 -55.2 4.13 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.166 175.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.554 ' HG3' ' ND2' ' A' ' 4' ' ' ASN . 17.8 mmt -63.77 -20.42 65.75 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.567 0.698 . . . . 0.0 109.765 -176.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.634 ' HB1' ' CD1' ' A' ' 69' ' ' ILE . . . -47.9 -30.2 3.96 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.736 171.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.536 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 8.0 t80 -105.66 -66.99 0.95 Allowed 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.629 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 3.9 mm-40 -47.02 -33.79 5.09 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 124.47 1.106 . . . . 0.0 112.107 -173.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.685 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 5.3 m-20 -102.7 -21.0 14.17 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.214 -174.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.617 ' HB1' ' O ' ' A' ' 43' ' ' ALA . . . -60.65 -179.62 0.13 Allowed 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 122.093 0.949 . . . . 0.0 112.966 -173.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.601 ' HB3' ' OE1' ' A' ' 50' ' ' GLU . 15.1 m-20 -61.35 141.61 94.21 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.175 174.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.21 -22.61 33.21 Favored 'Trans proline' 0 C--O 1.22 -0.425 0 C-N-CA 123.413 2.742 . . . . 0.0 112.722 -178.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.712 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 12.2 pm0 -89.37 -31.13 17.91 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 123.5 0.72 . . . . 0.0 110.599 175.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.712 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 92.7 m -82.9 -37.44 24.25 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.57 -170.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.536 ' HB2' ' CG ' ' A' ' 44' ' ' TYR . 3.6 pt20 -70.21 -29.94 66.91 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 172.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.55 ' HB3' ' C ' ' A' ' 91' ' ' GLN . 11.2 m -70.91 -19.87 62.55 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 113.672 -1.604 . . . . 0.0 110.331 174.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.48 ' HB3' HD13 ' A' ' 79' ' ' ILE . . . -78.6 -25.43 45.19 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.504 -0.748 . . . . 0.0 109.686 167.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.602 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 22.7 mt -89.8 -32.57 5.65 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.816 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -171.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.59 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -39.92 -37.95 0.88 Allowed Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -174.361 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.602 ' HD2' ' C ' ' A' ' 55' ' ' ILE . 52.3 Cg_endo -63.86 -29.23 67.65 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.217 1.945 . . . . 0.0 113.006 175.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.533 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.5 mt -99.09 -15.61 18.94 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.644 ' HD3' ' CG2' ' B' ' 5' ' ' THR . 0.1 OUTLIER -50.96 109.65 0.35 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.24 -178.371 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.406 ' HA3' ' C ' ' B' ' 1' ' ' PRO . . . 90.2 -20.65 35.75 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.032 -178.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -103.47 113.14 26.41 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.274 0.559 . . . . 0.0 109.785 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.414 ' HB ' HG13 ' A' ' 68' ' ' VAL . 7.5 p -123.72 148.88 57.6 Favored Pre-proline 0 C--N 1.31 -1.146 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.624 172.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.546 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 83.5 Cg_exo -47.5 137.84 19.3 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.059 1.839 . . . . 0.0 110.788 164.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.92 102.06 0.14 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.049 -171.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.78 -9.88 64.2 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.993 176.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.546 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 4.8 m -91.86 -167.88 1.88 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 122.398 1.094 . . . . 0.0 112.309 -177.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.61 ' OD2' ' HB3' ' A' ' 70' ' ' SER . 0.4 OUTLIER -88.16 126.0 34.9 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 112.862 -1.972 . . . . 0.0 111.117 -175.05 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.527 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -81.7 -32.98 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 C-N-CA 118.623 -1.231 . . . . 0.0 108.662 173.815 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.779 ' O ' HG11 ' A' ' 73' ' ' VAL . 10.7 mm -56.3 -49.98 73.92 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.349 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.495 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.61 ' HB3' ' OD2' ' A' ' 67' ' ' ASP . 32.5 t -54.66 -29.01 51.3 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.059 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -85.79 -33.27 21.42 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.394 0.616 . . . . 0.0 110.162 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.624 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.2 m-30 -75.31 -35.13 61.3 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.518 -177.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.779 HG11 ' O ' ' A' ' 69' ' ' ILE . 1.4 m -70.78 -32.05 47.79 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 172.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.533 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -67.63 -30.92 70.62 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.27 175.248 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -63.58 -46.02 87.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.056 176.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.818 ' SG ' ' HB ' ' A' ' 79' ' ' ILE . 27.5 t -93.02 9.91 33.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.141 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.533 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 3.8 t70 -58.49 -26.3 63.27 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.092 0.472 . . . . 0.0 110.854 174.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 83' ' ' MET . . . -92.12 -23.13 28.09 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.226 173.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.818 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 76.7 mt -81.25 149.57 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.1 0.476 . . . . 0.0 111.015 -177.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.612 ' O ' ' HD2' ' A' ' 11' ' ' LYS . . . 140.78 -34.63 1.93 Allowed Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.38 149.28 12.55 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 174.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 65.17 -75.06 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.014 0.526 . . . . 0.0 111.722 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.422 ' HB3' ' SD ' ' A' ' 87' ' ' MET . 59.4 mtt -59.29 -39.03 81.71 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.554 -178.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.45 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 5.1 t-160 -49.96 -36.86 29.73 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.621 174.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -81.48 -32.48 32.46 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.817 0.341 . . . . 0.0 110.939 -174.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.29 -44.1 47.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.595 0.712 . . . . 0.0 110.532 176.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.422 ' SD ' ' HB3' ' A' ' 83' ' ' MET . 67.9 mtp -78.28 -12.55 60.01 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.931 -1.032 . . . . 0.0 110.772 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.434 HD12 ' HB2' ' A' ' 92' ' ' LEU . 0.1 OUTLIER -50.76 -54.69 21.33 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.878 178.075 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 16.1 tpt -76.49 -15.47 59.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.098 0.475 . . . . 0.0 110.661 -176.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -88.41 -26.32 22.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.953 -176.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.55 ' C ' ' HB3' ' A' ' 53' ' ' SER . 16.6 mt-30 -121.35 -50.09 2.13 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -170.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.434 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -42.73 -38.55 2.12 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.902 0.751 . . . . 0.0 109.345 -177.529 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 . . . . . 0 C--O 1.251 1.154 0 CA-C-N 113.353 -1.749 . . . . 0.0 113.665 -177.498 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' PRO . . . . . 0.447 ' HB2' ' H ' ' B' ' 2' ' ' SER . 93.2 Cg_endo . . . . . 0 CA--C 1.516 -0.384 0 N-CA-C 109.135 -1.14 . . . . 0.0 109.135 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.464 ' HB2' HG22 ' B' ' 5' ' ' THR . 50.1 m -66.91 176.97 1.84 Allowed 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 162.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.629 ' CE1' HD11 ' B' ' 29' ' ' ILE . 0.1 OUTLIER -77.03 -54.14 6.92 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.663 174.296 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.546 ' ND2' ' HG3' ' B' ' 42' ' ' MET . 2.0 p-10 -82.59 6.01 19.08 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.392 -1.276 . . . . 0.0 112.475 -166.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.644 ' CG2' ' HD3' ' A' ' 59' ' ' LYS . 0.7 OUTLIER -65.1 -3.95 4.31 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.58 -176.698 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.614 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.2 m -79.41 132.9 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.674 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.1 OUTLIER -155.94 160.24 39.94 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.123 -1.031 . . . . 0.0 113.403 -177.79 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' GLN . . . . . 0.495 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.3 mt-30 -41.03 112.16 0.27 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 113.591 -1.64 . . . . 0.0 112.814 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.41 -161.44 31.43 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 170.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 43.5 m -50.92 104.05 0.07 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-N 117.241 0.52 . . . . 0.0 111.093 -178.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.59 ' HD2' ' O ' ' B' ' 80' ' ' GLY . 63.7 pttt 44.22 38.88 2.61 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.59 1.156 . . . . 0.0 112.714 -176.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.405 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 48.2 tt0 -62.09 137.71 95.71 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 177.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . 0.523 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 39.4 Cg_exo -53.5 124.89 16.84 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.25 1.967 . . . . 0.0 109.979 178.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . 0.743 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 6.7 t80 -69.58 -55.28 9.53 Favored Pre-proline 0 N--CA 1.44 -0.943 0 CA-C-O 118.369 -0.824 . . . . 0.0 113.074 -166.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.554 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 31.1 Cg_exo -57.05 -17.62 25.39 Favored 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 121.437 1.425 . . . . 0.0 111.176 -178.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.523 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 2.3 m-20 -89.44 -42.64 11.38 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 113.872 -1.513 . . . . 0.0 110.804 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' PHE . . . . . 0.633 ' HE2' ' CE2' ' B' ' 14' ' ' TYR . 0.0 OUTLIER -55.22 -44.73 75.68 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 177.351 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.698 HG12 ' O ' ' B' ' 14' ' ' TYR . 1.7 p -80.99 -31.38 12.07 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.927 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.791 -177.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.69 -34.04 70.84 Favored 'General case' 0 C--N 1.315 -0.931 0 O-C-N 121.344 -0.847 . . . . 0.0 111.596 176.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.698 ' O ' HG11 ' B' ' 24' ' ' VAL . 14.7 ptt180 -84.37 -25.48 29.11 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 176.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.592 HD23 ' CE1' ' B' ' 17' ' ' PHE . 9.9 tp -58.09 -45.19 87.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.981 172.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . 0.706 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 35.5 mt-30 -73.26 -44.39 59.46 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.701 177.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.745 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 12.8 t70 -51.96 -50.8 60.52 Favored 'General case' 0 C--N 1.314 -0.941 0 O-C-N 123.956 0.785 . . . . 0.0 111.578 -178.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' VAL . . . . . 0.698 HG11 ' O ' ' B' ' 20' ' ' ARG . 7.1 p -82.1 -24.0 9.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.218 0.532 . . . . 0.0 109.766 -174.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.844 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -71.77 -18.16 62.13 Favored 'General case' 0 C--O 1.206 -1.219 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 174.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . 0.424 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -87.59 -38.89 15.55 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.991 176.774 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.745 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 40.4 mmtt -65.09 -43.92 90.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.233 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' SER . . . . . 0.519 ' HB2' ' HB3' ' B' ' 3' ' ' PHE . 36.0 m -98.15 -8.31 27.79 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.116 0.484 . . . . 0.0 110.495 -171.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.844 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 87.4 mt -114.99 125.24 72.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.813 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.59 -4.46 57.82 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.259 0.552 . . . . 0.0 110.143 175.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.642 ' OD1' ' HB2' ' B' ' 33' ' ' LYS . 12.3 t70 -102.79 115.67 31.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.445 -177.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 0.471 ' O ' ' HG2' ' B' ' 36' ' ' LYS . 12.4 pt-20 -61.79 -24.49 66.88 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.857 177.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.642 ' HB2' ' OD1' ' B' ' 31' ' ' ASP . 4.5 mptt -75.1 -52.34 11.26 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -177.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.25 -26.94 68.32 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.848 176.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.822 ' O ' HG11 ' B' ' 39' ' ' VAL . 4.0 tmm_? -62.68 -65.09 0.74 Allowed 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.552 ' O ' HG23 ' B' ' 39' ' ' VAL . 7.8 ptmm? -53.17 -58.33 7.42 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.308 0.575 . . . . 0.0 112.318 -178.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.768 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 5.6 m -56.83 -30.28 32.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.863 -171.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.489 HD12 ' HG ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -85.02 -31.49 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 119.891 -0.723 . . . . 0.0 111.438 178.795 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.822 HG11 ' O ' ' B' ' 35' ' ' ARG . 2.4 m -68.33 -47.93 75.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.931 175.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.615 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 42.6 mt-10 -67.94 -22.92 65.03 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.392 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.768 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -85.42 -55.3 4.08 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.127 175.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' MET . . . . . 0.546 ' HG3' ' ND2' ' B' ' 4' ' ' ASN . 17.9 mmt -63.7 -20.46 65.74 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.585 0.707 . . . . 0.0 109.844 -176.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.63 ' HB1' ' CD1' ' B' ' 69' ' ' ILE . . . -47.74 -30.27 3.76 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.744 171.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' TYR . . . . . 0.533 ' CG ' ' HB2' ' B' ' 52' ' ' GLN . 7.8 t80 -105.66 -66.92 0.95 Allowed 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 176.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.626 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 3.8 mm-40 -47.0 -34.11 5.31 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 124.504 1.128 . . . . 0.0 111.997 -173.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.674 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 5.2 m-20 -102.53 -20.83 14.34 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.256 -174.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.609 ' HB1' ' O ' ' B' ' 43' ' ' ALA . . . -60.54 -179.28 0.11 Allowed 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 122.058 0.932 . . . . 0.0 113.035 -173.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . 0.606 ' HB3' ' OE1' ' B' ' 50' ' ' GLU . 14.6 m-20 -61.62 141.77 94.69 Favored Pre-proline 0 N--CA 1.442 -0.847 0 CA-C-N 114.366 -1.288 . . . . 0.0 109.144 174.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -55.33 -22.46 33.51 Favored 'Trans proline' 0 C--O 1.218 -0.512 0 C-N-CA 123.408 2.739 . . . . 0.0 112.757 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.722 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 12.5 pm0 -89.45 -31.24 17.8 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 123.576 0.75 . . . . 0.0 110.648 175.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.722 ' N ' ' HG2' ' B' ' 50' ' ' GLU . 91.7 m -82.82 -37.5 24.36 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.503 -170.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . 0.533 ' HB2' ' CG ' ' B' ' 44' ' ' TYR . 3.7 pt20 -70.3 -29.74 66.55 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 172.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' SER . . . . . 0.55 ' HB3' ' C ' ' B' ' 91' ' ' GLN . 11.3 m -71.24 -19.76 62.33 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 113.749 -1.568 . . . . 0.0 110.248 174.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.46 ' HB3' HD13 ' B' ' 79' ' ' ILE . . . -78.62 -25.37 45.11 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.484 -0.76 . . . . 0.0 109.756 167.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.599 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 22.6 mt -89.81 -32.63 5.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -171.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.586 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -39.74 -38.29 0.9 Allowed Pre-proline 0 N--CA 1.491 1.609 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -174.423 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.599 ' HD2' ' C ' ' B' ' 55' ' ' ILE . 51.6 Cg_endo -63.51 -29.74 71.01 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.169 1.913 . . . . 0.0 112.704 175.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . 0.531 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.5 mt -98.65 -15.81 19.28 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.642 ' HD3' ' CG2' ' A' ' 5' ' ' THR . 0.1 OUTLIER -51.01 109.57 0.34 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.244 -178.257 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . 0.404 ' HA3' ' C ' ' A' ' 1' ' ' PRO . . . 90.47 -21.13 33.84 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.971 -178.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -103.12 113.19 26.46 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.191 0.52 . . . . 0.0 109.893 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.419 ' HB ' HG13 ' B' ' 68' ' ' VAL . 7.3 p -123.71 149.11 58.22 Favored Pre-proline 0 C--N 1.308 -1.208 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.564 172.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.561 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 82.6 Cg_exo -47.56 137.94 19.59 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.066 1.844 . . . . 0.0 110.774 164.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.79 101.86 0.13 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -171.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.79 -9.98 64.21 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.933 -0.576 . . . . 0.0 113.028 176.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.561 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 4.7 m -91.76 -167.73 1.85 Allowed 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 122.357 1.075 . . . . 0.0 112.261 -176.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' ASP . . . . . 0.593 ' OD2' ' HB3' ' B' ' 70' ' ' SER . 0.4 OUTLIER -88.18 126.01 34.91 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 112.971 -1.922 . . . . 0.0 111.216 -175.206 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.532 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.9 OUTLIER -81.76 -33.04 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.505 0 C-N-CA 118.612 -1.235 . . . . 0.0 108.641 173.818 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . 0.78 ' O ' HG11 ' B' ' 73' ' ' VAL . 10.9 mm -56.12 -50.04 72.53 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.366 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.528 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.593 ' HB3' ' OD2' ' B' ' 67' ' ' ASP . 32.6 t -54.79 -28.82 51.89 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.124 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -85.79 -33.3 21.42 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.455 0.645 . . . . 0.0 110.134 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' TYR . . . . . 0.615 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.1 m-30 -75.46 -35.1 60.96 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.48 -177.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . 0.78 HG11 ' O ' ' B' ' 69' ' ' ILE . 1.4 m -70.81 -32.0 47.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 172.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' LYS . . . . . 0.546 ' O ' ' HB3' ' B' ' 77' ' ' ASP . 0.0 OUTLIER -67.75 -30.98 70.59 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.34 175.223 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -63.1 -46.74 85.9 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.975 176.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.814 ' SG ' ' HB ' ' B' ' 79' ' ' ILE . 28.0 t -92.39 9.61 33.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.075 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . 0.546 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 3.1 t70 -58.43 -26.22 63.07 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.072 0.463 . . . . 0.0 110.8 174.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' B' ' 83' ' ' MET . . . -92.24 -23.06 28.0 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.194 173.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.814 ' HB ' ' SG ' ' B' ' 76' ' ' CYS . 77.6 mt -81.32 149.78 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-O 121.047 0.451 . . . . 0.0 110.948 -177.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . 0.59 ' O ' ' HD2' ' B' ' 11' ' ' LYS . . . 140.32 -34.29 2.0 Allowed Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.5 149.32 12.53 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 173.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 65.14 -74.9 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 122.966 0.506 . . . . 0.0 111.7 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' MET . . . . . 0.43 ' HB2' ' O ' ' B' ' 78' ' ' GLY . 59.5 mtt -59.53 -38.92 82.3 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.558 -178.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' HIS . . . . . 0.443 ' HB2' ' H ' ' B' ' 80' ' ' GLY . 5.1 t-160 -49.98 -36.69 29.29 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.639 175.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -81.65 -32.37 31.91 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.722 0.296 . . . . 0.0 110.83 -174.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.57 -43.76 46.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.652 0.739 . . . . 0.0 110.625 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' MET . . . . . 0.428 ' SD ' ' HB3' ' B' ' 83' ' ' MET . 68.0 mtp -78.6 -12.46 60.02 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.778 -178.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.443 HD12 ' HB2' ' B' ' 92' ' ' LEU . 0.1 OUTLIER -50.62 -55.41 16.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.677 177.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 16.1 tpt -75.92 -15.41 60.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.035 0.445 . . . . 0.0 110.618 -176.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -88.42 -26.53 22.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.79 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' GLN . . . . . 0.55 ' C ' ' HB3' ' B' ' 53' ' ' SER . 16.5 mt-30 -121.14 -50.03 2.16 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -170.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.443 ' HB2' HD12 ' B' ' 88' ' ' LEU . 0.2 OUTLIER -42.97 -38.18 2.15 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 123.927 0.767 . . . . 0.0 109.337 -177.354 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 . . . . . 0 C--O 1.248 0.992 0 CA-C-N 113.426 -1.716 . . . . 0.0 113.651 -177.736 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.406 ' HB2' ' H ' ' A' ' 2' ' ' SER . 71.9 Cg_endo . . . . . 0 CA--C 1.517 -0.365 0 N-CA-C 109.219 -1.108 . . . . 0.0 109.219 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.449 ' HB2' HG21 ' A' ' 5' ' ' THR . 42.6 m -69.79 169.37 13.13 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 161.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.497 ' HE1' ' CD1' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -65.55 -53.29 44.14 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 122.391 1.091 . . . . 0.0 109.633 175.496 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.511 ' CG ' ' HG3' ' A' ' 42' ' ' MET . 3.2 p-10 -87.57 4.74 42.49 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 113.418 -1.719 . . . . 0.0 113.569 -161.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.672 ' CG2' ' HD3' ' B' ' 59' ' ' LYS . 0.9 OUTLIER -62.63 0.6 0.48 Allowed 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.066 0.46 . . . . 0.0 112.134 -175.322 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.555 ' HB ' ' CZ ' ' A' ' 20' ' ' ARG . 3.0 m -72.05 115.33 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 CA-C-O 121.908 0.861 . . . . 0.0 109.317 168.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.606 ' HG3' ' HB3' ' A' ' 46' ' ' ASN . 1.1 mpp_? -114.23 158.66 21.09 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 121.517 0.675 . . . . 0.0 110.989 177.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.428 ' HG2' ' HB3' ' A' ' 12' ' ' GLU . 2.2 tt0 -59.8 116.04 3.81 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.735 171.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.9 -156.75 26.28 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.378 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.464 ' C ' ' HD3' ' A' ' 11' ' ' LYS . 21.5 m -50.45 99.72 0.02 OUTLIER 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.774 0.287 . . . . 0.0 111.198 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.464 ' HD3' ' C ' ' A' ' 10' ' ' SER . 0.0 OUTLIER 35.66 48.89 0.49 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.583 1.153 . . . . 0.0 111.988 -171.629 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.428 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 36.4 tt0 -62.4 136.86 95.96 Favored Pre-proline 0 C--O 1.233 0.227 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.576 178.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.532 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 38.9 Cg_exo -52.15 122.08 10.0 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.043 1.829 . . . . 0.0 109.735 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.842 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 27.4 t80 -72.7 -53.18 5.73 Favored Pre-proline 0 N--CA 1.437 -1.117 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -166.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.533 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 31.7 Cg_exo -55.07 -17.63 15.15 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 121.4 1.4 . . . . 0.0 110.692 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.532 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.0 OUTLIER -90.29 -44.11 9.92 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 113.98 -1.464 . . . . 0.0 111.089 178.178 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.424 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -53.71 -43.36 68.95 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 175.139 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.772 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 2.2 p -82.84 -35.47 12.39 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.325 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.867 -177.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . -58.58 -33.78 70.35 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 121.316 -0.865 . . . . 0.0 111.819 177.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.698 ' O ' HG12 ' A' ' 24' ' ' VAL . 16.3 ptt180 -83.7 -27.54 28.94 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 176.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.536 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 7.4 tp -55.87 -47.57 77.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.605 -1.18 . . . . 0.0 108.87 171.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.772 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 25.4 mt-30 -70.13 -46.85 63.93 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.179 176.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.719 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 16.8 t70 -47.12 -54.33 10.76 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 124.289 0.993 . . . . 0.0 111.692 -178.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.698 HG12 ' O ' ' A' ' 20' ' ' ARG . 6.8 p -82.0 -23.54 9.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.197 0.522 . . . . 0.0 109.94 -174.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.789 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -71.32 -18.99 62.37 Favored 'General case' 0 C--O 1.204 -1.295 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 173.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.4 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -87.23 -38.88 15.94 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.955 177.559 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.719 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.4 mmtt -67.02 -39.46 87.05 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.752 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.6 m -98.01 -10.52 24.27 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.027 0.441 . . . . 0.0 110.63 -172.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.789 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 79.5 mt -116.11 129.91 71.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.795 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.01 -5.83 49.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.526 0.679 . . . . 0.0 110.136 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.537 ' H ' HG22 ' A' ' 29' ' ' ILE . 2.3 m-20 -102.51 107.33 18.25 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.067 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -53.6 -29.24 36.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.775 0.322 . . . . 0.0 110.446 175.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.525 ' O ' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -68.36 -52.81 29.13 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.478 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.496 ' O ' ' HB ' ' A' ' 38' ' ' ILE . . . -66.76 -23.57 66.1 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.246 178.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.821 ' O ' HG11 ' A' ' 39' ' ' VAL . 2.1 tmm_? -68.77 -58.55 4.04 Favored 'General case' 0 C--O 1.219 -0.503 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -53.38 -60.54 3.16 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.803 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 21.0 m -52.31 -34.57 18.58 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.952 -171.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.518 ' CD1' ' HG ' ' B' ' 41' ' ' LEU . 0.0 OUTLIER -84.8 -33.85 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -177.218 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.821 HG11 ' O ' ' A' ' 35' ' ' ARG . 2.7 m -72.36 -47.4 52.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 119.65 -0.82 . . . . 0.0 108.999 177.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.554 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 65.8 mt-10 -60.28 -26.07 66.2 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.971 0.908 . . . . 0.0 111.457 172.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.803 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -81.8 -61.68 1.85 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 178.654 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.573 ' HE1' ' HG ' ' B' ' 41' ' ' LEU . 20.1 mmt -62.79 -20.56 65.13 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.484 -177.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.717 ' O ' ' HB3' ' A' ' 47' ' ' ALA . . . -49.29 -25.38 2.34 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.394 169.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.492 ' CD1' ' HB2' ' A' ' 52' ' ' GLN . 16.1 t80 -108.31 -66.44 1.04 Allowed 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 175.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.461 ' CG ' HD12 ' A' ' 41' ' ' LEU . 8.4 mm-40 -48.25 -32.47 7.28 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 123.799 0.687 . . . . 0.0 112.492 -175.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.606 ' HB3' ' HG3' ' A' ' 7' ' ' ARG . 4.9 m-20 -106.33 -11.5 15.97 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.534 0.683 . . . . 0.0 111.226 -176.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 43' ' ' ALA . . . -62.53 168.53 3.59 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.496 0.665 . . . . 0.0 110.768 177.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.567 ' HB3' ' OE1' ' A' ' 50' ' ' GLU . 8.9 m-20 -57.38 144.45 71.17 Favored Pre-proline 0 C--N 1.31 -1.144 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.482 175.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.46 -19.29 28.48 Favored 'Trans proline' 0 C--O 1.219 -0.434 0 C-N-CA 122.92 2.413 . . . . 0.0 112.055 -179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.711 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 10.1 pm0 -90.87 -32.34 16.08 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.214 0.606 . . . . 0.0 110.531 174.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.91 ' SG ' ' HB2' ' A' ' 76' ' ' CYS . 37.3 t -85.1 -37.28 20.45 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.873 -171.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.494 ' HA ' HD13 ' A' ' 55' ' ' ILE . 3.5 pt20 -67.18 -26.72 66.78 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 172.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.672 ' HB3' ' C ' ' A' ' 91' ' ' GLN . 9.3 m -72.47 -22.55 61.06 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 113.141 -1.845 . . . . 0.0 110.916 174.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.455 ' HB3' HD12 ' A' ' 79' ' ' ILE . . . -78.37 -23.75 46.74 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.411 0.624 . . . . 0.0 109.527 168.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.525 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 24.7 mt -91.24 -33.22 5.6 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.151 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -172.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.605 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.57 -39.87 2.71 Favored Pre-proline 0 N--CA 1.493 1.688 0 CA-C-N 119.909 1.232 . . . . 0.0 113.757 -175.389 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 51.2 Cg_endo -62.6 -25.32 75.41 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 122.328 2.018 . . . . 0.0 113.045 175.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.498 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.1 mt -104.02 -15.86 15.47 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.65 ' HD3' ' CG2' ' B' ' 5' ' ' THR . 0.1 OUTLIER -50.47 109.09 0.27 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.192 -179.099 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.69 -19.01 43.43 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.31 -178.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.0 mmmt -103.7 114.65 29.07 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.162 0.506 . . . . 0.0 110.167 -178.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.41 ' HB ' HG11 ' A' ' 68' ' ' VAL . 7.6 p -123.38 143.97 42.69 Favored Pre-proline 0 C--N 1.312 -1.03 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.113 173.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.527 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 86.1 Cg_exo -50.18 140.02 34.07 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.538 2.158 . . . . 0.0 111.669 168.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.04 101.92 0.32 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.044 0.449 . . . . 0.0 111.724 -175.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.26 -17.01 41.26 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.668 178.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.527 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 14.0 m -88.71 172.7 9.05 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.902 0.382 . . . . 0.0 111.18 -178.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.403 ' OD1' ' HB ' ' A' ' 69' ' ' ILE . 0.8 OUTLIER -86.28 142.36 28.59 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 176.929 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.532 HG21 ' HB3' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -78.63 -28.51 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 C-N-CA 118.934 -1.106 . . . . 0.0 108.622 178.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.753 ' O ' HG13 ' A' ' 73' ' ' VAL . 6.8 mm -60.4 -45.95 95.9 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.133 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.277 -178.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 41.7 t -48.24 -36.18 13.44 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.143 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.428 ' O ' ' HB3' ' A' ' 74' ' ' LYS . 2.0 mm-40 -86.27 -31.53 21.59 Favored 'General case' 0 C--O 1.216 -0.672 0 C-N-CA 123.31 0.644 . . . . 0.0 111.074 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.508 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.0 m-30 -76.27 -33.79 59.14 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.626 0.727 . . . . 0.0 109.285 -177.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.842 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 2.1 m -73.01 -32.63 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 173.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 70' ' ' SER . 1.8 ttmm -66.45 -30.71 71.12 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.13 -1.395 . . . . 0.0 110.0 175.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' A' ' 72' ' ' TYR . . . -62.52 -45.44 92.95 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.784 175.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.91 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 42.2 t -93.34 9.17 37.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.044 177.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 21.8 t70 -65.03 -17.17 64.22 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.442 0.639 . . . . 0.0 109.699 173.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -108.51 4.32 32.86 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.366 -0.833 . . . . 0.0 112.422 172.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.744 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 94.6 mt -106.89 128.7 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 121.492 0.663 . . . . 0.0 111.797 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.495 ' H ' ' HB2' ' A' ' 84' ' ' HIS . . . 176.12 -49.13 0.12 Allowed Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 171.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.48 156.48 27.01 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 62.9 -80.15 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.912 0.419 . . . . 0.0 111.341 -177.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 80.9 mtp -60.8 -38.13 84.32 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-O 120.722 0.296 . . . . 0.0 110.46 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.495 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 5.4 t-160 -49.49 -45.89 47.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.676 174.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.402 ' HA ' ' HB2' ' A' ' 88' ' ' LEU . 78.6 mttt -87.33 -14.78 39.84 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -174.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.43 -38.3 26.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.015 0.912 . . . . 0.0 109.662 171.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 3.2 mmt -85.94 -11.07 54.07 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.437 -178.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.634 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 0.1 OUTLIER -56.29 -30.75 62.91 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.228 -179.614 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.5 tmm? -83.8 -42.21 16.72 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.213 0.53 . . . . 0.0 109.811 174.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.36 -60.3 3.34 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.47 -173.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.672 ' C ' ' HB3' ' A' ' 53' ' ' SER . 7.2 mt-30 -84.48 -41.91 16.11 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 118.506 -0.759 . . . . 0.0 111.988 -169.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.634 ' HB2' ' O ' ' A' ' 88' ' ' LEU . 1.2 tt -37.17 -38.75 0.22 Allowed 'General case' 0 C--N 1.349 0.573 0 O-C-N 124.908 1.38 . . . . 0.0 109.313 -174.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 92' ' ' LEU . 12.3 mt-10 . . . . . 0 C--O 1.25 1.121 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.996 170.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' PRO . . . . . 0.422 ' HB2' ' H ' ' B' ' 2' ' ' SER . 72.0 Cg_endo . . . . . 0 CA--C 1.515 -0.43 0 N-CA-C 109.148 -1.135 . . . . 0.0 109.148 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.447 ' HB2' HG21 ' B' ' 5' ' ' THR . 43.0 m -69.79 169.71 12.47 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 161.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.504 ' HE1' ' CD1' ' B' ' 38' ' ' ILE . 0.0 OUTLIER -65.65 -53.11 45.88 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 122.351 1.072 . . . . 0.0 109.683 175.316 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.518 ' CG ' ' HG3' ' B' ' 42' ' ' MET . 3.2 p-10 -87.75 4.9 42.49 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.51 -1.677 . . . . 0.0 113.58 -161.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.65 ' CG2' ' HD3' ' A' ' 59' ' ' LYS . 0.9 OUTLIER -62.9 0.71 0.5 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.123 0.487 . . . . 0.0 112.036 -175.165 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.549 ' HB ' ' CZ ' ' B' ' 20' ' ' ARG . 3.0 m -72.18 115.06 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 CA-C-O 121.904 0.859 . . . . 0.0 109.284 168.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.604 ' HG3' ' HB3' ' B' ' 46' ' ' ASN . 1.1 mpp_? -114.0 158.52 21.06 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 121.593 0.711 . . . . 0.0 110.949 177.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' GLN . . . . . 0.429 ' N ' ' CD2' ' B' ' 17' ' ' PHE . 2.2 tt0 -59.64 116.1 3.79 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.702 171.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.99 -156.95 26.88 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.483 174.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' SER . . . . . 0.479 ' C ' ' HD3' ' B' ' 11' ' ' LYS . 23.4 m -50.29 100.05 0.02 OUTLIER 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.71 0.255 . . . . 0.0 111.086 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.479 ' HD3' ' C ' ' B' ' 10' ' ' SER . 0.0 OUTLIER 35.17 49.57 0.45 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.545 1.138 . . . . 0.0 111.865 -171.59 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.427 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 36.1 tt0 -62.78 136.87 96.55 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.555 177.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . 0.531 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 37.8 Cg_exo -52.09 121.99 9.8 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 121.991 1.794 . . . . 0.0 109.703 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . 0.845 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 27.4 t80 -72.64 -53.32 5.75 Favored Pre-proline 0 N--CA 1.437 -1.105 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -166.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.541 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 31.8 Cg_exo -54.97 -17.84 15.23 Favored 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 121.382 1.388 . . . . 0.0 110.573 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.531 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 0.9 OUTLIER -90.2 -43.74 10.22 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.111 -1.404 . . . . 0.0 111.196 178.146 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' PHE . . . . . 0.429 ' CD2' ' N ' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -53.93 -43.41 69.76 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 175.069 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.772 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 2.2 p -82.68 -35.61 12.68 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.378 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.761 -177.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' B' ' 15' ' ' PRO . . . -58.46 -33.76 70.1 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 121.308 -0.87 . . . . 0.0 111.871 177.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.684 ' O ' HG12 ' B' ' 24' ' ' VAL . 16.4 ptt180 -83.73 -27.52 28.9 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 176.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.549 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 7.4 tp -56.0 -47.24 78.13 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.882 171.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . 0.772 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 25.6 mt-30 -70.49 -46.87 62.91 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.163 176.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.733 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 17.2 t70 -47.09 -54.29 10.77 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 124.304 1.002 . . . . 0.0 111.761 -178.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' VAL . . . . . 0.684 HG12 ' O ' ' B' ' 20' ' ' ARG . 6.8 p -82.1 -23.3 9.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.157 0.503 . . . . 0.0 109.869 -174.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.786 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -71.44 -18.91 62.3 Favored 'General case' 0 C--O 1.205 -1.284 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.18 -39.03 15.85 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.015 177.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.733 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.3 mmtt -66.85 -39.44 87.58 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.736 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 58.3 m -98.02 -10.48 24.33 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.106 0.479 . . . . 0.0 110.517 -172.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.786 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 79.5 mt -116.24 130.49 70.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.775 -178.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.95 -5.08 48.56 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.637 0.732 . . . . 0.0 110.014 176.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.539 ' H ' HG22 ' B' ' 29' ' ' ILE . 2.4 m-20 -102.64 106.95 17.71 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.253 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -53.42 -29.1 33.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.68 0.276 . . . . 0.0 110.449 175.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.536 ' O ' HG12 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -68.39 -52.81 28.91 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.447 -179.569 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.501 ' O ' ' HB ' ' B' ' 38' ' ' ILE . . . -66.77 -23.59 66.1 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.248 178.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.852 ' O ' HG11 ' B' ' 39' ' ' VAL . 2.1 tmm_? -68.78 -58.42 4.22 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 29.7 mtpt -53.55 -60.39 3.37 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.879 177.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.812 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 20.9 m -52.42 -34.38 18.72 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 O-C-N 124.324 1.015 . . . . 0.0 110.978 -171.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.543 ' CD1' ' HG ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -84.78 -34.08 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -177.309 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.852 HG11 ' O ' ' B' ' 35' ' ' ARG . 2.7 m -72.2 -47.5 53.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.012 177.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.555 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 66.2 mt-10 -60.33 -25.9 66.15 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.907 0.883 . . . . 0.0 111.472 172.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.812 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -82.03 -61.59 1.87 Allowed 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.992 178.734 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' MET . . . . . 0.536 ' HE1' ' HG ' ' A' ' 41' ' ' LEU . 20.1 mmt -62.83 -20.56 65.18 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.482 -177.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.7 ' O ' ' HB3' ' B' ' 47' ' ' ALA . . . -49.31 -25.4 2.38 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.406 169.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' TYR . . . . . 0.497 ' CD1' ' HB2' ' B' ' 52' ' ' GLN . 16.1 t80 -108.22 -66.44 1.04 Allowed 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 175.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.446 ' CG ' HD12 ' B' ' 41' ' ' LEU . 8.6 mm-40 -48.26 -32.83 7.78 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 123.856 0.723 . . . . 0.0 112.381 -175.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.604 ' HB3' ' HG3' ' B' ' 7' ' ' ARG . 4.9 m-20 -105.93 -11.46 16.18 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.472 0.653 . . . . 0.0 111.284 -176.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.7 ' HB3' ' O ' ' B' ' 43' ' ' ALA . . . -62.57 168.6 3.56 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.391 0.615 . . . . 0.0 110.779 177.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . 0.548 ' HB3' ' OE1' ' B' ' 50' ' ' GLU . 8.5 m-20 -57.39 144.47 71.17 Favored Pre-proline 0 C--N 1.31 -1.139 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.466 175.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -56.62 -19.2 29.06 Favored 'Trans proline' 0 C--O 1.218 -0.48 0 C-N-CA 122.963 2.442 . . . . 0.0 112.029 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.704 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 10.1 pm0 -90.83 -32.29 16.13 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 123.205 0.602 . . . . 0.0 110.644 174.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.915 ' SG ' ' HB2' ' B' ' 76' ' ' CYS . 37.5 t -85.16 -37.4 20.23 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.885 -171.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . 0.497 ' HB2' ' CD1' ' B' ' 44' ' ' TYR . 3.5 pt20 -66.95 -26.71 66.97 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 172.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' SER . . . . . 0.658 ' HB3' ' C ' ' B' ' 91' ' ' GLN . 8.9 m -72.61 -22.53 60.95 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 113.247 -1.797 . . . . 0.0 110.902 174.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.467 ' HB3' HD12 ' B' ' 79' ' ' ILE . . . -78.22 -23.81 47.31 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.493 0.663 . . . . 0.0 109.586 168.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.522 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 25.0 mt -91.09 -33.37 5.73 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.137 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -172.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.608 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.5 -39.76 2.56 Favored Pre-proline 0 N--CA 1.492 1.649 0 CA-C-N 119.925 1.239 . . . . 0.0 113.749 -175.34 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 51.0 Cg_endo -62.71 -25.32 74.98 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.245 1.964 . . . . 0.0 113.002 175.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . 0.513 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.2 mt -104.02 -15.81 15.49 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.672 ' HD3' ' CG2' ' A' ' 5' ' ' THR . 0.1 OUTLIER -50.46 109.12 0.27 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.702 -1.135 . . . . 0.0 111.281 -179.207 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . 0.405 ' HA3' ' C ' ' A' ' 1' ' ' PRO . . . 89.99 -19.7 40.58 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.276 -178.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -103.21 114.81 29.4 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.099 0.476 . . . . 0.0 110.027 -178.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.417 ' HB ' HG11 ' B' ' 68' ' ' VAL . 7.8 p -123.25 144.35 43.43 Favored Pre-proline 0 C--N 1.31 -1.125 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.94 172.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.551 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 86.7 Cg_exo -50.67 140.27 37.34 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.521 2.148 . . . . 0.0 111.667 168.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.03 102.0 0.33 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.708 -175.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.02 -16.84 42.31 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.644 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.551 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 15.9 m -88.65 173.2 8.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.053 0.454 . . . . 0.0 111.15 -178.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' ASP . . . . . 0.43 ' OD1' ' HB ' ' B' ' 69' ' ' ILE . 0.8 OUTLIER -86.63 142.14 28.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.066 176.735 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.517 HG23 ' HG2' ' B' ' 40' ' ' GLU . 0.8 OUTLIER -78.48 -28.28 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 C-N-CA 119.006 -1.078 . . . . 0.0 108.568 179.08 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . 0.757 ' O ' HG13 ' B' ' 73' ' ' VAL . 6.8 mm -60.44 -45.81 96.2 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.084 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.391 -178.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.489 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 43.2 t -48.54 -36.16 14.82 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.077 176.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' B' ' 74' ' ' LYS . 2.3 mm-40 -86.28 -31.38 21.65 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 123.211 0.604 . . . . 0.0 110.998 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' TYR . . . . . 0.513 ' CE1' ' HB2' ' B' ' 58' ' ' LEU . 5.0 m-30 -76.23 -34.13 59.21 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.654 0.74 . . . . 0.0 109.298 -177.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . 0.845 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 2.1 m -72.67 -33.1 43.47 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 173.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' B' ' 70' ' ' SER . 1.8 ttmm -65.87 -30.89 71.57 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.052 175.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' B' ' 72' ' ' TYR . . . -62.36 -45.52 92.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.754 175.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.915 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 41.9 t -93.5 9.14 37.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.089 177.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . 0.465 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 19.9 t70 -65.27 -17.09 64.22 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.388 0.613 . . . . 0.0 109.515 174.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -109.12 5.4 31.98 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.409 172.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.73 ' HB ' ' SG ' ' B' ' 76' ' ' CYS . 94.3 mt -107.69 128.78 62.61 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 CA-C-N 117.348 0.574 . . . . 0.0 111.836 178.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . 0.488 ' H ' ' HB2' ' B' ' 84' ' ' HIS . . . 176.1 -48.38 0.12 Allowed Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 171.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -156.89 155.13 26.11 Favored Glycine 0 C--N 1.318 -0.452 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.99 -80.58 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 122.617 0.367 . . . . 0.0 111.204 -176.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' MET . . . . . . . . . . . . . 81.7 mtp -60.73 -38.17 84.23 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-O 120.775 0.321 . . . . 0.0 110.465 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' HIS . . . . . 0.488 ' HB2' ' H ' ' B' ' 80' ' ' GLY . 5.5 t-160 -49.42 -45.94 46.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.722 173.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.403 ' HA ' ' HB2' ' B' ' 88' ' ' LEU . 78.5 mttt -87.23 -14.93 39.65 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -174.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.52 -37.93 27.05 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 122.002 0.906 . . . . 0.0 109.807 171.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 3.2 mmt -86.06 -10.99 53.99 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.215 -1.357 . . . . 0.0 111.459 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.625 ' O ' ' HB2' ' B' ' 92' ' ' LEU . 0.1 OUTLIER -56.44 -30.71 63.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.147 -179.605 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 15.5 tmm? -83.75 -42.24 16.76 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.167 0.508 . . . . 0.0 109.754 174.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.21 -60.52 3.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.471 -173.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' GLN . . . . . 0.658 ' C ' ' HB3' ' B' ' 53' ' ' SER . 7.1 mt-30 -84.22 -42.12 16.24 Favored 'General case' 0 CA--C 1.491 -1.31 0 CA-C-O 118.557 -0.735 . . . . 0.0 111.899 -169.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.625 ' HB2' ' O ' ' B' ' 88' ' ' LEU . 1.2 tt -37.02 -38.97 0.21 Allowed 'General case' 0 C--N 1.349 0.563 0 O-C-N 124.859 1.35 . . . . 0.0 109.216 -174.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' B' ' 92' ' ' LEU . 12.2 mt-10 . . . . . 0 C--O 1.25 1.118 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.074 170.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo . . . . . 0 CA--C 1.517 -0.326 0 N-CA-C 109.005 -1.19 . . . . 0.0 109.005 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.479 ' HB2' HG21 ' A' ' 5' ' ' THR . 70.7 m -72.13 178.9 3.56 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 162.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.471 ' CE1' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -76.13 -52.45 10.09 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.8 0.809 . . . . 0.0 110.125 174.445 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.506 ' OD1' ' HG ' ' B' ' 41' ' ' LEU . 2.5 p-10 -87.61 2.93 49.57 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.403 -163.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.561 ' O ' ' HG3' ' A' ' 7' ' ' ARG . 3.1 p -63.51 -3.12 1.9 Allowed 'General case' 0 C--N 1.311 -1.078 0 O-C-N 122.059 -0.4 . . . . 0.0 111.832 -175.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.541 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 3.3 m -76.49 119.03 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-O 121.677 0.751 . . . . 0.0 109.924 176.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.76 ' HB3' ' O ' ' A' ' 46' ' ' ASN . 32.2 mtm180 -137.58 147.2 44.87 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -170.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.586 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.6 mt-30 -42.02 120.66 1.62 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 112.633 -2.076 . . . . 0.0 113.745 177.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.53 -159.04 35.01 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 169.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.8 t -48.44 101.46 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 117.086 0.443 . . . . 0.0 111.231 -178.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.4 pttt 37.71 42.1 0.37 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.251 1.02 . . . . 0.0 112.084 -173.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.448 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 39.5 tt0 -57.16 137.5 80.54 Favored Pre-proline 0 C--O 1.233 0.226 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.575 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 52.1 Cg_exo -49.31 121.22 6.66 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.056 1.837 . . . . 0.0 109.947 -178.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.789 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 11.3 t80 -71.89 -52.85 7.44 Favored Pre-proline 0 N--CA 1.438 -1.047 0 CA-C-O 118.512 -0.756 . . . . 0.0 113.028 -166.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.536 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 36.4 Cg_exo -55.79 -18.39 21.27 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 121.346 1.364 . . . . 0.0 110.728 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.575 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 0.9 OUTLIER -90.34 -42.35 10.99 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.317 179.66 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.586 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -54.82 -43.64 73.16 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 175.647 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.684 HG12 ' O ' ' A' ' 14' ' ' TYR . 2.7 p -82.78 -32.35 9.89 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.941 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.845 -177.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.446 ' HB1' ' O ' ' A' ' 15' ' ' PRO . . . -58.99 -35.46 73.25 Favored 'General case' 0 C--N 1.317 -0.84 0 O-C-N 121.285 -0.885 . . . . 0.0 111.839 175.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.7 ' O ' HG13 ' A' ' 24' ' ' VAL . 16.7 ptt180 -81.9 -27.26 33.51 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 176.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.557 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 6.7 tp -57.1 -48.14 79.33 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.215 172.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.66 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 40.7 mt-30 -70.91 -44.66 65.77 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.191 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.717 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -48.89 -64.06 0.91 Allowed 'General case' 0 C--N 1.314 -0.961 0 O-C-N 124.426 1.079 . . . . 0.0 110.206 -178.622 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.7 HG13 ' O ' ' A' ' 20' ' ' ARG . 4.2 p -74.0 -20.34 17.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -171.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.614 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -64.33 -35.82 82.11 Favored 'General case' 0 C--O 1.206 -1.195 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 172.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.429 ' HB3' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -75.1 -34.99 61.79 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 113.631 -1.622 . . . . 0.0 109.896 -176.641 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.717 ' HD2' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -65.04 -44.81 87.87 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 121.972 0.891 . . . . 0.0 112.0 177.09 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.416 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 24.7 m -95.97 -9.17 31.8 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.515 -168.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.614 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 84.8 mt -116.91 128.27 74.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.919 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.11 -2.2 56.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.42 0.628 . . . . 0.0 110.141 175.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.526 ' H ' HG22 ' A' ' 29' ' ' ILE . 2.7 m-20 -106.92 104.16 13.77 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.105 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -53.36 -27.59 24.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.664 0.268 . . . . 0.0 110.466 176.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.543 ' O ' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -67.93 -54.38 19.14 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.675 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.503 ' HA ' HG23 ' A' ' 37' ' ' VAL . . . -65.28 -22.7 66.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.44 178.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.856 ' O ' HG11 ' A' ' 39' ' ' VAL . 5.3 tmm_? -69.82 -55.81 8.79 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.453 ' O ' HG23 ' A' ' 39' ' ' VAL . 21.7 mtpt -56.97 -57.55 12.03 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.98 177.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.72 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 19.8 m -54.48 -34.2 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.736 -169.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.491 ' O ' ' HG2' ' A' ' 42' ' ' MET . 1.5 tt -86.97 -28.84 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 119.649 -0.821 . . . . 0.0 111.568 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.856 HG11 ' O ' ' A' ' 35' ' ' ARG . 2.7 m -69.61 -49.07 61.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 119.031 -1.067 . . . . 0.0 109.508 173.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.621 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 60.4 mt-10 -61.81 -28.34 69.4 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 123.556 0.742 . . . . 0.0 112.233 176.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.72 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -85.58 -52.55 5.74 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.72 178.574 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.606 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 19.6 mmt -65.57 -20.72 66.44 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.667 0.746 . . . . 0.0 109.602 -177.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.665 ' O ' ' HB1' ' A' ' 47' ' ' ALA . . . -50.46 -28.11 7.74 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.463 170.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.515 ' CD1' ' HB2' ' A' ' 52' ' ' GLN . 23.1 t80 -105.15 -68.4 0.86 Allowed 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 175.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.462 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 10.9 mm-40 -48.88 -29.82 5.12 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.829 -176.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.76 ' O ' ' HB3' ' A' ' 7' ' ' ARG . 4.2 m-20 -106.53 -16.12 14.61 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 120.718 0.295 . . . . 0.0 111.659 -176.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.665 ' HB1' ' O ' ' A' ' 43' ' ' ALA . . . -65.45 179.25 0.81 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.588 0.708 . . . . 0.0 111.539 -177.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.732 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 24.2 m-20 -58.63 145.67 76.47 Favored Pre-proline 0 C--N 1.31 -1.148 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.21 171.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.781 ' O ' ' HB3' ' A' ' 53' ' ' SER . 11.1 Cg_endo -55.53 -28.96 67.29 Favored 'Trans proline' 0 C--N 1.331 -0.345 0 C-N-CA 122.987 2.458 . . . . 0.0 111.897 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.687 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 8.4 pm0 -87.4 -26.57 23.24 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.398 1.079 . . . . 0.0 111.066 175.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.732 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 86.8 m -80.21 -38.24 31.56 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -177.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.515 ' HB2' ' CD1' ' A' ' 44' ' ' TYR . 4.1 pt20 -73.17 -27.35 61.6 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 172.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.8 ' OG ' ' HB2' ' A' ' 91' ' ' GLN . 0.9 OUTLIER -67.91 -23.73 65.13 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.437 174.33 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.489 ' HB3' HD13 ' A' ' 79' ' ' ILE . . . -83.83 -23.47 31.36 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.862 172.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.526 HD13 ' CE2' ' A' ' 14' ' ' TYR . 22.7 mt -90.83 -32.56 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -173.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.659 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -45.92 -34.11 2.67 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -175.06 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 37.4 Cg_endo -60.61 -29.89 89.4 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.323 2.015 . . . . 0.0 112.946 172.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.523 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.1 mt -102.05 -15.34 16.79 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -178.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.581 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -52.84 109.83 0.45 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.899 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.09 -23.81 31.59 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.407 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.0 mmmt -103.38 111.94 24.6 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.373 0.606 . . . . 0.0 109.914 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.81 146.22 49.97 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 170.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.556 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 92.0 Cg_exo -47.29 141.81 13.17 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.194 1.929 . . . . 0.0 111.245 168.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.82 98.58 0.07 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.976 0.417 . . . . 0.0 111.849 -173.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.57 -7.51 57.93 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.072 176.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.556 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 10.6 m -91.59 -177.81 4.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.656 0.741 . . . . 0.0 111.905 -177.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.709 ' OD1' ' HB ' ' A' ' 69' ' ' ILE . 26.7 t70 -84.51 133.59 34.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.913 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.549 HG21 ' HG2' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -81.44 -30.09 10.87 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 C-N-CA 119.035 -1.066 . . . . 0.0 109.089 176.447 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.757 ' O ' HG13 ' A' ' 73' ' ' VAL . 8.5 mm -58.09 -47.37 87.13 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.168 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.825 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 43.6 t -45.58 -37.54 5.62 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.394 175.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -85.36 -32.83 22.21 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.262 0.553 . . . . 0.0 110.629 -178.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.591 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.0 m-30 -76.06 -34.42 59.6 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.488 -175.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.789 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.6 m -72.57 -31.87 39.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.526 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -66.25 -31.65 72.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.075 175.46 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 72' ' ' TYR . . . -62.93 -47.53 82.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.447 176.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.68 ' SG ' ' HB ' ' A' ' 79' ' ' ILE . 14.4 t -91.07 5.43 48.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.469 0.652 . . . . 0.0 111.059 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.526 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 9.6 t70 -60.27 -16.47 34.38 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.318 175.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -120.32 21.58 8.66 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.921 174.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.68 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 41.4 mt -101.94 -11.54 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 117.667 0.733 . . . . 0.0 112.974 177.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.4 14.31 1.83 Allowed Glycine 0 CA--C 1.532 1.132 0 C-N-CA 120.353 -0.927 . . . . 0.0 115.377 -168.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.82 72.93 0.11 Allowed Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.114 -1.041 . . . . 0.0 114.423 168.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -177.92 -91.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 122.981 0.512 . . . . 0.0 110.118 174.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 65.1 mtm -65.96 -17.64 64.81 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 121.006 0.431 . . . . 0.0 110.082 177.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.517 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 6.5 t-160 -49.57 -34.63 18.19 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.474 174.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -83.22 -22.48 33.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.816 0.341 . . . . 0.0 110.908 -176.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.8 -40.57 15.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.706 0.765 . . . . 0.0 110.358 176.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.448 ' O ' ' HG3' ' A' ' 91' ' ' GLN . 81.9 mtp -85.27 -13.73 48.87 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.562 -175.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.551 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 0.1 OUTLIER -50.48 -58.79 4.93 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.444 0.465 . . . . 0.0 110.289 179.305 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 52.9 ttm -71.72 -23.07 61.56 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.258 -173.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -88.06 -8.54 55.39 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -170.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.8 ' HB2' ' OG ' ' A' ' 53' ' ' SER . 4.2 mt-30 -132.67 -37.05 1.05 Allowed 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.886 -0.725 . . . . 0.0 111.145 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.551 ' HB2' ' O ' ' A' ' 88' ' ' LEU . 0.2 OUTLIER -50.4 -34.3 23.85 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 171.658 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 93' ' ' GLU . 6.4 pt-20 . . . . . 0 C--O 1.251 1.166 0 CA-C-N 112.632 -2.076 . . . . 0.0 113.597 -173.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' PRO . . . . . 0.434 ' HB2' ' H ' ' B' ' 2' ' ' SER . 90.1 Cg_endo . . . . . 0 CA--C 1.515 -0.426 0 N-CA-C 108.937 -1.217 . . . . 0.0 108.937 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.491 ' HB2' HG21 ' B' ' 5' ' ' THR . 71.2 m -71.52 178.72 3.34 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 162.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.479 ' CE1' HD11 ' B' ' 29' ' ' ILE . 0.1 OUTLIER -76.13 -52.43 10.12 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.857 0.837 . . . . 0.0 110.079 174.444 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.486 ' ND2' ' HE1' ' B' ' 42' ' ' MET . 2.5 p-10 -87.42 2.64 49.89 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.646 -1.161 . . . . 0.0 113.364 -163.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.563 ' O ' ' HG3' ' B' ' 7' ' ' ARG . 3.6 p -63.31 -3.06 1.69 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 118.057 0.389 . . . . 0.0 111.779 -175.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.549 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 3.3 m -76.48 118.96 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-O 121.678 0.751 . . . . 0.0 110.008 176.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.752 ' HB3' ' O ' ' B' ' 46' ' ' ASN . 32.1 mtm180 -137.32 147.58 45.71 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -170.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' GLN . . . . . 0.588 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.6 mt-30 -42.62 121.1 1.89 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 112.616 -2.084 . . . . 0.0 113.494 177.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.67 -158.39 34.29 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 169.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 22.9 t -49.24 101.58 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 117.115 0.457 . . . . 0.0 110.988 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 49.1 pttt 37.56 42.3 0.35 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.419 1.088 . . . . 0.0 112.109 -173.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.466 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 38.1 tt0 -57.2 137.36 80.75 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . 0.568 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 52.1 Cg_exo -49.07 121.09 6.27 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.134 1.889 . . . . 0.0 109.992 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . 0.792 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 11.3 t80 -72.09 -52.66 7.24 Favored Pre-proline 0 N--CA 1.437 -1.1 0 CA-C-O 118.507 -0.758 . . . . 0.0 112.891 -166.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.543 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 36.0 Cg_exo -55.9 -18.37 21.79 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 121.42 1.413 . . . . 0.0 110.764 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.568 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 0.9 OUTLIER -90.61 -41.84 11.11 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.035 -1.439 . . . . 0.0 111.367 179.708 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' PHE . . . . . 0.588 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -55.34 -43.52 75.08 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 175.581 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.692 HG12 ' O ' ' B' ' 14' ' ' TYR . 2.7 p -82.89 -32.27 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.907 -177.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . 0.429 ' HB1' ' O ' ' B' ' 15' ' ' PRO . . . -59.42 -34.75 72.87 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 121.303 -0.873 . . . . 0.0 111.861 175.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.695 ' O ' HG13 ' B' ' 24' ' ' VAL . 16.7 ptt180 -82.09 -27.43 32.89 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 176.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.567 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 6.7 tp -57.03 -48.38 78.65 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.208 173.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . 0.667 ' HA ' ' CG1' ' B' ' 39' ' ' VAL . 40.7 mt-30 -70.79 -44.68 66.13 Favored 'General case' 0 CA--C 1.488 -1.435 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.089 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.705 ' O ' ' HD2' ' B' ' 27' ' ' LYS . 0.9 OUTLIER -48.8 -64.19 0.87 Allowed 'General case' 0 C--N 1.314 -0.943 0 O-C-N 124.39 1.056 . . . . 0.0 110.325 -178.7 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' VAL . . . . . 0.695 HG13 ' O ' ' B' ' 20' ' ' ARG . 4.1 p -73.82 -20.42 17.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -171.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.594 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -64.15 -36.0 82.62 Favored 'General case' 0 C--O 1.208 -1.12 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 172.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . 0.438 ' HB3' ' O ' ' B' ' 23' ' ' ASP . 0.0 OUTLIER -74.9 -35.18 62.25 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 113.62 -1.627 . . . . 0.0 109.903 -176.608 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.705 ' HD2' ' O ' ' B' ' 23' ' ' ASP . 0.0 OUTLIER -64.85 -45.03 87.81 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.898 177.177 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' SER . . . . . 0.407 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 26.4 m -96.15 -8.68 32.55 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.602 -168.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.594 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 84.6 mt -116.94 128.68 74.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.837 -178.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.69 -1.87 56.51 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.499 0.666 . . . . 0.0 110.128 175.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.509 ' H ' HG22 ' B' ' 29' ' ' ILE . 2.8 m-20 -106.91 104.58 14.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.092 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -53.91 -27.36 30.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.715 0.293 . . . . 0.0 110.396 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.552 ' O ' HG12 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -67.93 -54.32 19.57 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.707 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.511 ' HA ' HG23 ' B' ' 37' ' ' VAL . . . -65.46 -22.71 66.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.385 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.843 ' O ' HG11 ' B' ' 39' ' ' VAL . 5.4 tmm_? -69.69 -55.89 8.72 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.44 ' O ' HG23 ' B' ' 39' ' ' VAL . 21.8 mtpt -56.98 -57.37 12.84 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 120.826 0.346 . . . . 0.0 110.936 177.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.704 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 20.0 m -54.71 -34.13 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.661 -169.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.489 ' O ' ' HG2' ' B' ' 42' ' ' MET . 1.4 tt -86.99 -29.11 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.51 -179.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.843 HG11 ' O ' ' B' ' 35' ' ' ARG . 2.7 m -69.31 -49.19 62.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 119.089 -1.045 . . . . 0.0 109.574 173.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.627 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 61.8 mt-10 -61.72 -28.26 69.29 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 123.506 0.722 . . . . 0.0 112.26 176.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.704 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.67 -52.55 5.72 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.713 178.685 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' MET . . . . . 0.603 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 19.5 mmt -65.6 -20.68 66.41 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.574 0.702 . . . . 0.0 109.491 -177.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.667 ' HB2' ' OH ' ' B' ' 14' ' ' TYR . . . -50.53 -28.17 8.03 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.415 170.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' TYR . . . . . 0.505 ' CD1' ' HB2' ' B' ' 52' ' ' GLN . 23.0 t80 -105.06 -68.38 0.86 Allowed 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.478 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 11.8 mm-40 -48.85 -29.8 5.06 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.925 -176.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.752 ' O ' ' HB3' ' B' ' 7' ' ' ARG . 4.1 m-20 -106.53 -16.06 14.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 120.702 0.287 . . . . 0.0 111.568 -176.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.652 ' HB1' ' O ' ' B' ' 43' ' ' ALA . . . -65.29 179.61 0.73 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.819 0.818 . . . . 0.0 111.602 -177.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . 0.725 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 24.7 m-20 -58.99 145.54 79.7 Favored Pre-proline 0 C--N 1.309 -1.169 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.242 171.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . 0.796 ' O ' ' HB3' ' B' ' 53' ' ' SER . 11.1 Cg_endo -55.57 -28.92 67.46 Favored 'Trans proline' 0 C--N 1.332 -0.325 0 C-N-CA 123.026 2.484 . . . . 0.0 111.917 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.702 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 8.4 pm0 -87.26 -26.7 23.34 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.429 1.091 . . . . 0.0 111.133 175.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.725 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 86.2 m -80.18 -38.17 31.82 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -177.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . 0.505 ' HB2' ' CD1' ' B' ' 44' ' ' TYR . 4.0 pt20 -73.14 -27.36 61.63 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 172.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' SER . . . . . 0.796 ' HB3' ' O ' ' B' ' 49' ' ' PRO . 0.9 OUTLIER -68.12 -23.5 64.91 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.429 174.54 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.489 ' HB3' HD13 ' B' ' 79' ' ' ILE . . . -84.12 -23.31 30.77 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.863 172.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.522 HD13 ' CE2' ' B' ' 14' ' ' TYR . 22.6 mt -90.79 -32.73 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -174.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.649 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -45.93 -34.06 2.64 Favored Pre-proline 0 N--CA 1.487 1.388 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 -175.02 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 37.3 Cg_endo -60.24 -30.95 92.32 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 122.303 2.002 . . . . 0.0 112.902 172.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . 0.53 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.1 mt -101.17 -15.59 17.31 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -178.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.576 ' HA ' ' OH ' ' B' ' 72' ' ' TYR . 0.0 OUTLIER -52.64 109.8 0.44 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.948 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.16 -23.55 32.87 Favored Glycine 0 N--CA 1.44 -1.05 0 C-N-CA 120.768 -0.73 . . . . 0.0 111.575 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -103.59 111.91 24.59 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.411 0.624 . . . . 0.0 109.927 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 7.5 p -123.91 146.06 49.74 Favored Pre-proline 0 C--N 1.311 -1.104 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 170.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.578 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 91.3 Cg_exo -47.28 141.48 13.56 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.24 1.96 . . . . 0.0 111.248 168.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.53 98.78 0.07 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.024 0.44 . . . . 0.0 111.941 -173.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.71 -7.86 57.85 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.956 176.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.578 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 9.6 m -91.75 -177.61 4.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.383 0.611 . . . . 0.0 111.985 -176.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' ASP . . . . . 0.697 ' OD1' ' HB ' ' B' ' 69' ' ' ILE . 26.9 t70 -84.69 133.42 34.39 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.992 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.542 HG21 ' HG2' ' B' ' 40' ' ' GLU . 0.9 OUTLIER -81.3 -30.12 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 C-N-CA 118.891 -1.123 . . . . 0.0 109.119 176.508 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . 0.748 ' O ' HG13 ' B' ' 73' ' ' VAL . 8.5 mm -58.01 -47.31 87.02 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.179 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.814 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 42.7 t -45.84 -37.42 6.16 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.423 175.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -85.4 -32.7 22.23 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.085 0.469 . . . . 0.0 110.649 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' TYR . . . . . 0.586 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.0 m-30 -76.09 -34.49 59.53 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.502 -175.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . 0.792 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.6 m -72.55 -32.03 39.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 173.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' LYS . . . . . 0.515 ' O ' ' HB3' ' B' ' 77' ' ' ASP . 0.0 OUTLIER -66.17 -31.36 72.15 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.029 175.422 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' B' ' 72' ' ' TYR . . . -63.07 -47.77 81.5 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.362 176.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.68 ' SG ' ' HB ' ' B' ' 79' ' ' ILE . 13.7 t -90.89 5.7 47.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.573 0.701 . . . . 0.0 111.179 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . 0.515 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 10.9 t70 -60.51 -16.42 36.99 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.382 175.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -120.57 21.69 8.48 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.96 174.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.68 ' HB ' ' SG ' ' B' ' 76' ' ' CYS . 40.5 mt -101.94 -11.47 8.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 117.695 0.748 . . . . 0.0 112.934 177.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.29 14.16 1.81 Allowed Glycine 0 CA--C 1.533 1.169 0 N-CA-C 115.378 0.911 . . . . 0.0 115.378 -168.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.77 72.65 0.11 Allowed Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.255 -0.974 . . . . 0.0 114.643 168.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -177.57 -91.67 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.047 0.539 . . . . 0.0 110.03 174.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' MET . . . . . . . . . . . . . 64.8 mtm -65.95 -17.51 64.72 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 120.983 0.42 . . . . 0.0 110.096 177.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' HIS . . . . . 0.524 ' O ' ' HB2' ' B' ' 88' ' ' LEU . 6.4 t-160 -49.66 -34.88 19.59 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.32 174.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -82.78 -22.77 34.17 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.852 0.358 . . . . 0.0 110.927 -176.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.54 -40.68 16.04 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.666 0.746 . . . . 0.0 110.33 176.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' MET . . . . . 0.454 ' HB3' ' NE2' ' B' ' 91' ' ' GLN . 81.8 mtp -85.22 -13.84 48.66 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.587 -175.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.539 ' O ' ' HB2' ' B' ' 92' ' ' LEU . 0.1 OUTLIER -50.22 -58.85 4.71 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.295 179.327 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 52.8 ttm -71.76 -23.19 61.56 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.158 -172.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -88.05 -8.5 55.47 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -170.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' GLN . . . . . 0.788 ' HB2' ' OG ' ' B' ' 53' ' ' SER . 4.0 mt-30 -132.73 -36.9 1.05 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.121 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.539 ' HB2' ' O ' ' B' ' 88' ' ' LEU . 0.2 OUTLIER -50.76 -33.77 24.54 Favored 'General case' 0 C--N 1.344 0.35 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 171.689 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' B' ' 93' ' ' GLU . 6.5 pt-20 . . . . . 0 C--O 1.248 1.006 0 CA-C-N 112.734 -2.03 . . . . 0.0 113.47 -174.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo . . . . . 0 CA--C 1.517 -0.357 0 N-CA-C 109.414 -1.033 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.0 m -66.61 169.0 8.34 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 162.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.467 ' HB2' ' HA ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -72.7 -55.58 6.59 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.847 177.509 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.704 ' CG ' ' HG3' ' A' ' 42' ' ' MET . 11.7 p30 -87.69 -4.75 58.91 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.442 -164.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.7 t -63.15 -1.43 1.0 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.43 0.633 . . . . 0.0 110.945 -173.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.639 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.4 m -74.26 133.55 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 168.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.722 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -155.55 159.8 39.99 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 115.219 1.562 . . . . 0.0 115.219 -175.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.436 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.1 tt0 -40.34 110.52 0.15 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 112.835 -1.984 . . . . 0.0 112.714 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.33 -151.5 11.13 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.558 174.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.4 t -54.38 98.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.757 0.278 . . . . 0.0 110.58 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.9 pttt 40.07 44.3 1.46 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.321 1.048 . . . . 0.0 112.527 -175.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -60.58 141.17 92.25 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 176.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.502 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 27.2 Cg_exo -55.37 123.36 13.62 Favored 'Trans proline' 0 CA--C 1.512 -0.615 0 C-N-CA 121.939 1.759 . . . . 0.0 109.694 177.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.874 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 7.2 t80 -68.98 -53.95 13.25 Favored Pre-proline 0 N--CA 1.44 -0.969 0 CA-C-O 118.421 -0.799 . . . . 0.0 113.025 -168.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.561 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 37.2 Cg_exo -56.01 -18.15 21.69 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 121.476 1.45 . . . . 0.0 111.197 -178.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.502 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 2.6 m-20 -89.97 -42.83 10.95 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.799 179.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.436 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -55.26 -45.78 76.1 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.332 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.771 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 2.1 p -78.05 -34.49 19.23 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.229 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.142 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' A' ' 15' ' ' PRO . . . -55.83 -39.36 71.29 Favored 'General case' 0 C--N 1.316 -0.887 0 O-C-N 121.663 -0.648 . . . . 0.0 111.078 176.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.751 ' O ' HG11 ' A' ' 24' ' ' VAL . 14.5 ptt180 -79.84 -27.74 40.17 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.575 ' HB3' ' O ' ' A' ' 18' ' ' VAL . 13.3 tp -54.98 -48.87 72.7 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 114.563 -1.198 . . . . 0.0 109.268 172.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.771 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 28.5 mt-30 -67.75 -55.66 12.24 Favored 'General case' 0 CA--C 1.486 -1.51 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.356 178.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.718 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 82.8 m-20 -45.71 -50.55 13.57 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 124.824 1.327 . . . . 0.0 111.258 -177.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.751 HG11 ' O ' ' A' ' 20' ' ' ARG . 7.1 p -78.89 -26.19 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.834 -174.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.627 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -67.3 -31.45 71.76 Favored 'General case' 0 C--O 1.206 -1.196 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.22 -34.82 63.8 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.114 -1.403 . . . . 0.0 109.525 -178.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.718 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 39.0 mmtt -67.45 -40.33 85.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.823 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.424 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 35.4 m -100.45 -9.9 21.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.241 0.543 . . . . 0.0 110.547 -171.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.627 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 83.4 mt -111.23 130.15 65.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.522 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.55 -3.07 58.48 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.906 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.543 ' H ' HG22 ' A' ' 29' ' ' ILE . 4.9 t0 -117.81 139.66 50.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.786 0.803 . . . . 0.0 111.918 -177.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -68.76 -31.39 70.4 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.334 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.559 ' O ' HG11 ' A' ' 37' ' ' VAL . 12.0 mttp -68.37 -53.37 24.41 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -176.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.472 ' HA ' HG23 ' A' ' 37' ' ' VAL . . . -64.22 -26.06 68.34 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.504 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.832 ' O ' HG12 ' A' ' 39' ' ' VAL . 4.7 tmm_? -68.15 -58.02 5.13 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.486 ' HB3' ' OE1' ' A' ' 40' ' ' GLU . 32.5 mtpt -53.45 -60.19 3.62 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.237 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.693 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 19.8 m -52.12 -33.9 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.374 -170.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.522 ' O ' ' HG2' ' A' ' 42' ' ' MET . 0.7 OUTLIER -88.35 -35.05 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.391 -179.782 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.832 HG12 ' O ' ' A' ' 35' ' ' ARG . 2.9 m -66.18 -46.8 86.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 119.117 -1.033 . . . . 0.0 109.414 177.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.661 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 42.7 mt-10 -61.17 -31.63 71.36 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 123.953 0.901 . . . . 0.0 112.544 176.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.693 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -83.78 -52.88 6.03 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.378 -179.152 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.704 ' HG3' ' CG ' ' A' ' 4' ' ' ASN . 20.1 mmt -65.71 -20.84 66.43 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.642 0.734 . . . . 0.0 109.632 -176.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.697 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . . . -50.47 -29.01 9.39 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.23 171.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.872 ' CG ' ' HE3' ' A' ' 59' ' ' LYS . 6.2 t80 -103.34 -66.7 0.92 Allowed 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 174.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.587 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 31.4 mm-40 -49.72 -29.76 8.11 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.992 -171.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.722 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.8 m-20 -104.37 -21.44 13.49 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.441 -176.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.6 ' HB3' ' O ' ' A' ' 43' ' ' ALA . . . -61.36 179.75 0.2 Allowed 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.827 0.822 . . . . 0.0 112.923 -174.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.612 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 17.2 m-20 -62.31 141.67 96.22 Favored Pre-proline 0 N--CA 1.444 -0.742 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.587 173.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -41.71 -50.48 4.88 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 123.093 2.529 . . . . 0.0 112.274 -178.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.55 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 0.0 OUTLIER -74.32 -26.54 60.23 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.769 0.828 . . . . 0.0 111.429 -179.268 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.612 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 72.1 m -79.89 -40.19 28.82 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -174.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.55 ' HB2' ' CG ' ' A' ' 44' ' ' TYR . 3.4 pt20 -69.42 -31.13 69.29 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 172.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.8 ' O ' ' HD2' ' A' ' 56' ' ' LYS . 4.2 m -67.71 -27.89 67.2 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 113.996 -1.456 . . . . 0.0 111.305 174.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.515 ' HB1' HD13 ' A' ' 79' ' ' ILE . . . -70.96 -23.31 62.2 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 170.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.531 HD11 ' HA ' ' A' ' 52' ' ' GLN . 25.0 mt -89.82 -27.52 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -175.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.8 ' HD2' ' O ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -37.53 -48.53 2.52 Favored Pre-proline 0 N--CA 1.506 2.368 0 CA-C-N 120.628 1.558 . . . . 0.0 112.675 -178.39 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.664 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 48.5 Cg_endo -61.45 -24.89 79.06 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.826 2.351 . . . . 0.0 112.796 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.496 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.6 mt -104.86 -15.45 15.17 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.872 ' HE3' ' CG ' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -50.7 109.96 0.37 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.812 -179.072 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.28 -19.23 44.48 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.075 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.9 mmmt -104.2 115.03 29.69 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -176.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.86 137.11 27.54 Favored Pre-proline 0 C--N 1.315 -0.899 0 C-N-CA 121.168 -0.213 . . . . 0.0 110.48 172.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.522 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 97.5 Cg_exo -49.21 142.89 20.43 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.849 2.366 . . . . 0.0 112.227 171.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.44 104.33 0.62 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.18 -177.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.32 -16.74 44.89 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.688 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.522 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 45.6 m -89.19 170.04 10.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.261 0.553 . . . . 0.0 111.212 -179.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.408 ' OD2' ' HB ' ' A' ' 69' ' ' ILE . 2.6 t70 -88.38 145.8 25.6 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.634 174.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.522 HG21 ' HG2' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -78.49 -29.18 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 C-N-CA 118.792 -1.163 . . . . 0.0 108.879 179.83 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.777 ' O ' HG12 ' A' ' 73' ' ' VAL . 8.5 mm -61.12 -47.01 95.51 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.184 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.09 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.6 t -47.24 -37.83 11.17 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.98 177.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -86.08 -32.62 21.28 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 123.287 0.635 . . . . 0.0 111.094 -177.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.6 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.3 m-30 -74.88 -35.83 62.28 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.314 -177.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.874 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 2.3 m -70.41 -34.11 56.61 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 174.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.437 ' HA ' ' HB2' ' A' ' 77' ' ' ASP . 13.0 ttpp -70.47 -27.86 64.56 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.788 177.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -62.18 -44.65 96.13 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.047 -0.978 . . . . 0.0 109.398 173.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.74 ' SG ' ' HB ' ' A' ' 79' ' ' ILE . 39.3 t -96.04 9.31 41.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.332 178.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.437 ' HB2' ' HA ' ' A' ' 74' ' ' LYS . 10.7 t70 -61.72 -21.12 64.22 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.057 0.456 . . . . 0.0 110.507 175.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -101.96 -11.74 36.35 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.655 175.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.74 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 85.6 mt -86.68 136.75 22.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-N 117.202 0.501 . . . . 0.0 111.163 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 159.13 83.49 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.753 174.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.524 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 95.24 -117.83 5.72 Favored Glycine 0 CA--C 1.51 -0.259 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.824 173.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.81 -48.3 78.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.772 0.32 . . . . 0.0 111.751 -175.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 55.3 mtt -64.79 -30.69 71.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.093 0.473 . . . . 0.0 110.116 178.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.511 ' HB3' ' O ' ' A' ' 81' ' ' GLY . 6.4 t-80 -66.28 -29.51 69.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.574 177.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' A' ' 81' ' ' GLY . 33.5 mmtp -84.23 -19.05 34.6 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.208 0.528 . . . . 0.0 110.461 -178.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.09 -45.84 11.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.746 176.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 61.6 mtm -81.06 -12.14 59.37 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.661 -175.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.491 HD11 ' O ' ' A' ' 88' ' ' LEU . 0.1 OUTLIER -54.33 -22.53 12.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.488 0.661 . . . . 0.0 111.195 176.626 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 41.2 ttp -83.44 -21.71 32.84 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.01 0.433 . . . . 0.0 111.036 176.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -109.1 -63.82 1.31 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -170.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.672 ' O ' ' HB3' ' A' ' 53' ' ' SER . 13.5 mt-30 -67.08 -43.41 82.66 Favored 'General case' 0 CA--C 1.504 -0.821 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.49 -175.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.666 ' HA ' ' CB ' ' A' ' 53' ' ' SER . 2.2 tm? -44.2 -28.94 0.56 Allowed 'General case' 0 C--O 1.232 0.179 0 O-C-N 124.251 0.969 . . . . 0.0 110.093 173.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 . . . . . 0 C--O 1.248 0.992 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -175.914 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' PRO . . . . . 0.426 ' HB2' ' H ' ' B' ' 2' ' ' SER . 96.3 Cg_endo . . . . . 0 CA--C 1.517 -0.366 0 N-CA-C 109.163 -1.13 . . . . 0.0 109.163 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.426 ' H ' ' HB2' ' B' ' 1' ' ' PRO . 41.7 m -66.91 168.79 9.21 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 162.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.474 ' HB2' ' HA ' ' B' ' 25' ' ' ALA . 0.1 OUTLIER -72.23 -55.72 6.74 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.812 177.632 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.709 ' CG ' ' HG3' ' B' ' 42' ' ' MET . 11.7 p30 -87.81 -4.67 58.86 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.332 -164.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 7.0 t -63.3 -1.42 1.08 Allowed 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.314 0.578 . . . . 0.0 110.87 -173.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.646 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.5 m -74.38 133.54 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 169.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.719 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -155.48 159.82 40.09 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 -175.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' GLN . . . . . 0.436 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.1 tt0 -40.27 110.38 0.15 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 112.921 -1.945 . . . . 0.0 112.786 -178.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.15 -151.5 10.76 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.631 174.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 22.7 t -54.27 99.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.837 0.319 . . . . 0.0 110.513 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 58.0 pttt 39.75 44.23 1.27 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.365 1.066 . . . . 0.0 112.485 -175.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -60.78 140.94 93.11 Favored Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . 0.509 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 27.5 Cg_exo -55.33 123.43 13.8 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 121.855 1.703 . . . . 0.0 109.751 177.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . 0.887 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 7.2 t80 -68.94 -53.87 13.59 Favored Pre-proline 0 N--CA 1.44 -0.926 0 CA-C-O 118.458 -0.782 . . . . 0.0 113.01 -168.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.549 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 36.9 Cg_exo -55.93 -18.46 22.3 Favored 'Trans proline' 0 C--N 1.359 1.103 0 C-N-CA 121.523 1.482 . . . . 0.0 110.991 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.509 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.9 m-20 -89.82 -42.56 11.2 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 113.907 -1.497 . . . . 0.0 110.841 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' PHE . . . . . 0.436 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -55.43 -45.76 76.77 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.458 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.769 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 2.1 p -78.09 -34.38 19.03 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.18 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.172 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . 0.401 ' HB1' ' O ' ' B' ' 15' ' ' PRO . . . -55.59 -39.6 70.93 Favored 'General case' 0 C--N 1.316 -0.882 0 O-C-N 121.674 -0.641 . . . . 0.0 111.077 176.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.75 ' O ' HG11 ' B' ' 24' ' ' VAL . 14.7 ptt180 -79.82 -27.72 40.22 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.58 ' HB3' ' O ' ' B' ' 18' ' ' VAL . 13.2 tp -55.05 -48.68 73.14 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.191 172.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . 0.769 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 28.4 mt-30 -68.24 -55.23 12.95 Favored 'General case' 0 CA--C 1.485 -1.529 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.447 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.718 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 78.8 m-20 -45.79 -50.87 13.58 Favored 'General case' 0 C--N 1.312 -1.023 0 O-C-N 124.735 1.272 . . . . 0.0 111.264 -177.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' VAL . . . . . 0.75 HG11 ' O ' ' B' ' 20' ' ' ARG . 7.1 p -78.66 -26.24 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.925 -174.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.633 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -67.22 -31.37 71.7 Favored 'General case' 0 C--O 1.208 -1.131 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 176.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.08 -35.15 64.21 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.174 -1.375 . . . . 0.0 109.474 -178.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.718 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 39.1 mmtt -67.31 -39.96 85.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.628 -1.169 . . . . 0.0 112.015 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' SER . . . . . 0.415 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 38.9 m -100.45 -10.47 21.09 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.247 0.546 . . . . 0.0 110.511 -172.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.633 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 83.9 mt -110.96 129.9 65.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.651 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.48 -3.03 58.54 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.937 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.566 ' H ' HG22 ' B' ' 29' ' ' ILE . 4.7 t0 -117.92 139.63 50.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.715 0.769 . . . . 0.0 111.912 -177.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -68.66 -31.55 70.75 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.43 175.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.568 ' O ' HG11 ' B' ' 37' ' ' VAL . 12.1 mttp -68.16 -53.62 23.77 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -176.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.457 ' HA ' HG23 ' B' ' 37' ' ' VAL . . . -63.89 -26.22 68.5 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.481 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.861 ' O ' HG12 ' B' ' 39' ' ' VAL . 4.8 tmm_? -68.27 -57.91 5.24 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.472 ' HB3' ' OE1' ' B' ' 40' ' ' GLU . 32.8 mtpt -53.53 -60.29 3.49 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.223 178.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.696 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 19.7 m -52.08 -33.85 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.366 -170.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.515 ' O ' ' HG2' ' B' ' 42' ' ' MET . 0.7 OUTLIER -88.36 -35.12 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 C-N-CA 119.769 -0.772 . . . . 0.0 112.355 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.861 HG12 ' O ' ' B' ' 35' ' ' ARG . 2.9 m -66.05 -46.88 86.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 119.124 -1.03 . . . . 0.0 109.44 177.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.648 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 42.9 mt-10 -61.19 -31.59 71.34 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.943 0.897 . . . . 0.0 112.55 176.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.696 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -83.67 -52.98 5.98 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 121.039 -0.265 . . . . 0.0 111.446 -179.152 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' MET . . . . . 0.709 ' HG3' ' CG ' ' B' ' 4' ' ' ASN . 19.9 mmt -65.69 -20.73 66.4 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.712 0.768 . . . . 0.0 109.685 -176.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.687 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . . . -50.51 -29.05 9.61 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.144 171.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' TYR . . . . . 0.871 ' CG ' ' HE3' ' B' ' 59' ' ' LYS . 6.1 t80 -103.4 -66.66 0.93 Allowed 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 174.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.595 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 31.0 mm-40 -49.78 -29.6 8.08 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 124.415 1.072 . . . . 0.0 112.006 -171.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.719 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.9 m-20 -104.42 -21.46 13.47 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.497 -176.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' B' ' 43' ' ' ALA . . . -61.49 179.89 0.21 Allowed 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.873 0.844 . . . . 0.0 113.058 -174.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . 0.621 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 17.5 m-20 -62.28 141.87 96.1 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.545 173.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . 0.402 ' O ' ' HG2' ' B' ' 52' ' ' GLN . 75.5 Cg_exo -42.14 -50.36 5.39 Favored 'Trans proline' 0 C--N 1.332 -0.308 0 C-N-CA 122.959 2.44 . . . . 0.0 112.309 -178.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.57 ' HA ' ' HB2' ' B' ' 53' ' ' SER . 0.0 OUTLIER -74.07 -26.72 60.54 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.954 0.901 . . . . 0.0 111.349 -179.42 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.621 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 72.4 m -79.92 -40.15 28.8 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -174.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . 0.547 ' HB2' ' CG ' ' B' ' 44' ' ' TYR . 3.3 pt20 -69.44 -30.86 68.87 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 172.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' SER . . . . . 0.801 ' O ' ' HD2' ' B' ' 56' ' ' LYS . 4.3 m -67.89 -27.54 66.75 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 113.907 -1.497 . . . . 0.0 111.423 174.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.504 ' HB1' HD13 ' B' ' 79' ' ' ILE . . . -71.4 -23.09 61.81 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.005 0.907 . . . . 0.0 108.566 170.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.543 HD11 ' HA ' ' B' ' 52' ' ' GLN . 25.4 mt -89.91 -27.5 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -175.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.801 ' HD2' ' O ' ' B' ' 53' ' ' SER . 0.0 OUTLIER -37.47 -49.08 2.55 Favored Pre-proline 0 N--CA 1.507 2.404 0 CA-C-N 120.624 1.557 . . . . 0.0 112.525 -178.398 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.658 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 49.9 Cg_endo -61.27 -24.38 78.73 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.836 2.358 . . . . 0.0 112.789 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . 0.516 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.6 mt -105.28 -15.47 15.04 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.871 ' HE3' ' CG ' ' B' ' 44' ' ' TYR . 0.0 OUTLIER -50.62 109.83 0.35 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.684 -179.015 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.67 -19.63 43.58 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.11 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -103.9 115.2 30.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.911 0.386 . . . . 0.0 110.12 -176.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.73 137.67 28.3 Favored Pre-proline 0 C--N 1.315 -0.915 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.406 171.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.532 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 96.9 Cg_exo -49.71 142.77 24.17 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.888 2.392 . . . . 0.0 112.212 171.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.94 104.83 0.59 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.176 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.08 -16.47 50.01 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.791 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.532 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 43.2 m -89.09 170.02 10.99 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.282 0.563 . . . . 0.0 111.039 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' ASP . . . . . 0.407 ' OD2' ' HB ' ' B' ' 69' ' ' ILE . 2.9 t70 -88.61 145.66 25.56 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.621 174.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.502 HG21 ' HG2' ' B' ' 40' ' ' GLU . 1.0 OUTLIER -78.3 -29.4 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 C-N-CA 118.769 -1.172 . . . . 0.0 108.885 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . 0.788 ' O ' HG12 ' B' ' 73' ' ' VAL . 8.6 mm -60.93 -47.12 94.93 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.164 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.091 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 43.0 t -47.13 -37.79 10.5 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.974 177.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -86.22 -32.52 21.13 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 123.282 0.633 . . . . 0.0 111.144 -177.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' TYR . . . . . 0.591 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.3 m-30 -74.97 -35.61 62.07 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.705 0.764 . . . . 0.0 109.348 -177.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . 0.887 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 2.3 m -70.64 -34.16 55.91 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' LYS . . . . . 0.434 ' HE3' ' HB3' ' B' ' 74' ' ' LYS . 13.1 ttpp -70.37 -28.0 64.76 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.684 177.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -62.1 -44.56 96.38 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.431 173.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.749 ' SG ' ' HB ' ' B' ' 79' ' ' ILE . 37.7 t -96.01 9.22 41.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.182 178.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . 0.429 ' HB2' ' HA ' ' B' ' 74' ' ' LYS . 11.2 t70 -61.62 -21.0 63.98 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.034 0.445 . . . . 0.0 110.6 175.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -102.02 -11.73 36.22 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.741 175.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.749 ' HB ' ' SG ' ' B' ' 76' ' ' CYS . 84.9 mt -86.7 136.45 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 117.155 0.477 . . . . 0.0 111.195 -178.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 159.28 84.35 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.6 174.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.523 ' O ' ' HG2' ' B' ' 85' ' ' LYS . . . 94.56 -117.66 5.61 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.723 173.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.11 -48.16 79.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.756 0.312 . . . . 0.0 111.633 -174.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' MET . . . . . . . . . . . . . 54.4 mtt -64.78 -30.83 71.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.034 0.445 . . . . 0.0 110.124 178.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' HIS . . . . . 0.516 ' HB3' ' O ' ' B' ' 81' ' ' GLY . 6.5 t-80 -66.17 -29.73 70.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.544 177.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.523 ' HG2' ' O ' ' B' ' 81' ' ' GLY . 33.3 mmtp -84.12 -18.92 35.23 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.151 0.501 . . . . 0.0 110.432 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.13 -45.9 10.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.679 176.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 61.8 mtm -81.07 -12.16 59.36 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.681 -175.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.495 HD11 ' O ' ' B' ' 88' ' ' LEU . 0.1 OUTLIER -54.19 -22.64 11.93 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.555 0.693 . . . . 0.0 111.251 176.628 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 40.7 ttp -83.49 -21.29 32.85 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.127 0.489 . . . . 0.0 111.011 177.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -109.52 -63.7 1.33 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -170.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' GLN . . . . . 0.683 ' O ' ' HB3' ' B' ' 53' ' ' SER . 13.6 mt-30 -67.13 -43.44 82.4 Favored 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.506 -175.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.675 ' HA ' ' CB ' ' B' ' 53' ' ' SER . 2.2 tm? -44.45 -28.81 0.61 Allowed 'General case' 0 C--O 1.234 0.273 0 O-C-N 124.261 0.975 . . . . 0.0 110.017 173.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 N--CA 1.437 -1.079 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -175.989 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo . . . . . 0 CA--C 1.518 -0.3 0 N-CA-C 108.984 -1.199 . . . . 0.0 108.984 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.433 ' HG ' ' HD3' ' B' ' 59' ' ' LYS . 16.5 m -66.88 174.17 3.15 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 163.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.462 ' HE1' ' CD1' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -70.83 -51.79 24.47 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 166.029 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.509 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 2.4 p-10 -88.18 5.64 40.47 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 113.944 -1.48 . . . . 0.0 113.781 -165.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.09 -8.47 7.71 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 118.52 0.6 . . . . 0.0 111.305 -177.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.606 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.1 m -74.48 129.4 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 176.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.677 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -155.51 158.73 38.97 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 118.053 -1.459 . . . . 0.0 114.61 -177.556 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.416 ' OE1' ' HB1' ' A' ' 47' ' ' ALA . 2.2 tt0 -47.14 106.66 0.09 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 112.865 -1.97 . . . . 0.0 112.031 -177.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.27 -135.68 1.18 Allowed Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.825 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.5 ' C ' ' HD3' ' A' ' 11' ' ' LYS . 9.1 t -65.37 99.41 0.4 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.5 ' HD3' ' C ' ' A' ' 10' ' ' SER . 0.0 OUTLIER 37.2 44.24 0.41 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.233 1.013 . . . . 0.0 112.017 -175.333 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.414 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 54.8 tt0 -60.55 144.29 89.05 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.735 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.55 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 37.9 Cg_exo -54.48 122.83 12.24 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.356 2.037 . . . . 0.0 110.114 176.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.757 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 21.9 t80 -73.19 -55.87 3.57 Favored Pre-proline 0 N--CA 1.439 -0.984 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -166.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.564 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 27.4 Cg_exo -56.98 -16.13 19.6 Favored 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 121.279 1.32 . . . . 0.0 110.627 -178.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.55 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.3 m-20 -89.16 -44.48 10.28 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 113.606 -1.634 . . . . 0.0 110.837 178.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.517 ' CE2' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -54.62 -44.76 73.43 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.515 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.76 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 1.7 p -79.63 -34.8 16.06 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.277 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.536 -178.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.33 -30.58 68.47 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 121.45 -0.781 . . . . 0.0 111.752 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.719 ' O ' HG13 ' A' ' 24' ' ' VAL . 16.5 ptt180 -84.45 -28.36 26.89 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.526 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 5.6 tp -57.26 -48.29 79.25 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.019 173.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.76 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 24.7 mt-30 -68.78 -47.9 65.02 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.085 177.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.732 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 11.4 t70 -47.19 -54.58 10.37 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 124.332 1.02 . . . . 0.0 111.656 -177.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.719 HG13 ' O ' ' A' ' 20' ' ' ARG . 6.6 p -81.84 -21.95 10.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.038 -174.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.735 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -73.07 -19.39 61.18 Favored 'General case' 0 C--O 1.205 -1.243 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 174.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.49 -38.06 17.64 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.582 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.732 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 39.8 mmtt -66.45 -35.75 81.05 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.753 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.7 m -104.72 -7.32 19.62 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.201 0.524 . . . . 0.0 110.657 -170.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.735 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 88.5 mt -117.8 130.12 73.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.885 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.21 -7.64 47.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.331 0.586 . . . . 0.0 110.332 175.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.517 ' H ' HG23 ' A' ' 29' ' ' ILE . 1.0 OUTLIER -100.31 106.29 17.91 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.735 -179.278 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -56.47 -25.98 52.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.679 0.276 . . . . 0.0 110.271 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.545 ' O ' HG11 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -69.32 -53.57 18.96 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.172 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.492 ' HA ' HG23 ' A' ' 37' ' ' VAL . . . -64.6 -24.07 67.47 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.349 177.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.847 ' O ' HG11 ' A' ' 39' ' ' VAL . 4.7 tmm_? -68.4 -58.61 4.08 Favored 'General case' 0 C--O 1.219 -0.535 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.48 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 27.4 mtpt -52.45 -60.68 2.94 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 120.791 0.329 . . . . 0.0 110.535 177.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.781 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 21.6 m -52.16 -36.15 20.21 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.768 -168.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.462 ' CD1' ' HE1' ' A' ' 3' ' ' PHE . 1.5 tt -87.17 -27.69 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 119.641 -0.823 . . . . 0.0 112.111 -177.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.847 HG11 ' O ' ' A' ' 35' ' ' ARG . 2.1 m -73.35 -47.47 46.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 119.148 -1.021 . . . . 0.0 109.267 175.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.678 ' HB3' ' CG2' ' A' ' 68' ' ' VAL . 0.7 OUTLIER -63.98 -24.47 67.73 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.796 0.838 . . . . 0.0 111.292 176.162 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.781 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -85.45 -57.9 2.88 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 176.667 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.531 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 23.2 mmt -61.49 -20.58 63.33 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.569 0.699 . . . . 0.0 109.703 -177.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.672 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . . . -48.94 -27.89 3.45 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.928 170.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.538 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 10.2 t80 -107.13 -66.77 0.99 Allowed 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 176.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.629 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 17.1 mm-40 -48.1 -32.59 7.02 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.998 -174.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.677 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 5.2 m-20 -105.14 -19.32 13.86 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -175.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 43' ' ' ALA . . . -61.01 -172.15 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -174.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.549 ' HB2' ' CB ' ' A' ' 51' ' ' CYS . 11.5 m120 -52.78 141.49 36.51 Favored Pre-proline 0 C--N 1.342 0.239 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 170.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.48 ' O ' HD22 ' A' ' 92' ' ' LEU . 19.8 Cg_endo -59.92 -19.66 56.14 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 121.618 1.545 . . . . 0.0 110.452 174.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.526 ' O ' ' HB2' ' A' ' 53' ' ' SER . 0.3 OUTLIER -87.11 -34.98 18.92 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.465 174.055 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.951 ' SG ' ' HB2' ' A' ' 76' ' ' CYS . 40.8 t -80.24 -33.92 37.55 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.242 -172.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.511 ' HB2' ' CD1' ' A' ' 44' ' ' TYR . 4.2 pt20 -68.68 -29.32 67.75 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 172.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.587 ' HB3' ' C ' ' A' ' 91' ' ' GLN . 20.0 m -71.58 -19.3 62.16 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.284 -1.78 . . . . 0.0 110.017 173.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.494 ' HB2' HD12 ' A' ' 79' ' ' ILE . . . -81.06 -27.17 35.81 Favored 'General case' 0 C--N 1.311 -1.107 0 O-C-N 121.431 -0.793 . . . . 0.0 110.158 167.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.576 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 23.7 mt -90.34 -30.18 4.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 114.83 1.418 . . . . 0.0 114.83 -170.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.604 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.57 -38.81 1.99 Allowed Pre-proline 0 N--CA 1.487 1.414 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -174.034 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 54.4 Cg_endo -63.62 -30.96 70.58 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.154 1.903 . . . . 0.0 112.628 176.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.52 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.8 mt -95.08 -16.87 22.33 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.573 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 0.1 OUTLIER -54.87 109.07 0.46 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.698 -179.523 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.38 -23.04 37.58 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.403 -177.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -104.22 113.22 26.61 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.312 0.577 . . . . 0.0 110.232 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.09 142.53 38.52 Favored Pre-proline 0 C--N 1.309 -1.177 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 169.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.558 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 71.1 Cg_exo -51.1 138.68 44.01 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.19 1.927 . . . . 0.0 111.443 170.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.12 103.52 0.38 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.067 -177.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.12 -12.35 44.63 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.742 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.558 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 20.0 m -94.92 169.56 10.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.591 0.71 . . . . 0.0 111.635 -178.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.82 136.97 34.48 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.706 -1.133 . . . . 0.0 109.378 174.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.678 ' CG2' ' HB3' ' A' ' 40' ' ' GLU . 0.7 OUTLIER -72.45 -32.53 42.3 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.419 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.757 ' O ' HG12 ' A' ' 73' ' ' VAL . 10.1 mm -55.57 -46.59 79.16 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.071 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.742 -178.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 33.6 t -46.34 -38.11 8.36 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.322 0.582 . . . . 0.0 111.012 176.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -85.63 -31.96 22.29 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.749 -177.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.573 ' OH ' ' HA ' ' A' ' 59' ' ' LYS . 4.9 m-30 -76.59 -34.04 58.42 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.534 -176.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.757 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.5 m -71.41 -31.64 43.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 172.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.562 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -67.89 -29.83 69.02 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.372 175.731 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.477 ' HB1' ' O ' ' A' ' 72' ' ' TYR . . . -64.77 -44.93 88.46 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.109 176.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.951 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 39.5 t -92.52 9.08 36.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.636 177.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.562 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 8.3 t70 -60.59 -21.53 62.74 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.321 0.581 . . . . 0.0 110.238 172.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 83' ' ' MET . . . -101.15 -9.89 43.75 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.611 173.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.787 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 85.0 mt -96.18 139.03 20.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 117.307 0.553 . . . . 0.0 111.201 -178.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.524 ' H ' ' HB2' ' A' ' 84' ' ' HIS . . . 164.64 -35.37 0.28 Allowed Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.685 173.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.597 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . -148.12 -103.39 0.31 Allowed Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.386 -0.912 . . . . 0.0 113.198 177.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.43 -46.32 89.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -171.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.496 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 71.5 mtp -68.9 -30.83 69.4 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.524 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 5.8 t-160 -62.39 -29.36 70.43 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.027 173.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.597 ' HG2' ' O ' ' A' ' 81' ' ' GLY . 70.7 mmtt -83.79 -20.49 33.21 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.031 0.443 . . . . 0.0 110.406 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.14 -42.48 14.72 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.591 0.71 . . . . 0.0 110.636 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 1.6 mmt -84.85 -12.72 52.94 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.898 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.595 ' O ' ' HB3' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -49.58 -40.88 40.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.433 0.635 . . . . 0.0 111.367 177.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 28.2 ttt -84.17 -15.48 46.94 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.031 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -96.59 -34.16 11.53 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.122 0.487 . . . . 0.0 112.014 -173.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.587 ' C ' ' HB3' ' A' ' 53' ' ' SER . 20.8 mt-30 -109.65 -56.86 2.25 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.293 -176.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.595 ' HB3' ' O ' ' A' ' 88' ' ' LEU . 0.3 OUTLIER -58.49 -4.69 0.43 Allowed 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.299 0.571 . . . . 0.0 110.256 176.356 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.508 ' H ' ' C ' ' A' ' 91' ' ' GLN . 5.0 pt-20 . . . . . 0 C--O 1.249 1.031 0 C-N-CA 123.967 0.907 . . . . 0.0 112.375 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' PRO . . . . . 0.448 ' HB2' ' H ' ' B' ' 2' ' ' SER . 98.7 Cg_endo . . . . . 0 CA--C 1.518 -0.324 0 N-CA-C 108.911 -1.226 . . . . 0.0 108.911 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.448 ' H ' ' HB2' ' B' ' 1' ' ' PRO . 16.4 m -66.9 174.56 2.92 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 162.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.457 ' HE1' ' CD1' ' B' ' 38' ' ' ILE . 0.1 OUTLIER -71.18 -51.76 23.03 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 165.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.509 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.4 p-10 -88.19 5.62 40.61 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 113.904 -1.498 . . . . 0.0 113.731 -165.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.409 HG22 ' HG2' ' A' ' 59' ' ' LYS . 0.6 OUTLIER -63.36 -7.72 7.13 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 118.554 0.616 . . . . 0.0 111.438 -177.13 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.597 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.1 m -75.0 129.27 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.694 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.2 OUTLIER -155.48 158.77 39.07 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 118.18 -1.408 . . . . 0.0 114.626 -177.652 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' GLN . . . . . 0.425 ' OE1' ' HB1' ' B' ' 47' ' ' ALA . 2.2 tt0 -47.01 106.72 0.09 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 112.766 -2.016 . . . . 0.0 111.944 -177.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.56 -136.48 1.38 Allowed Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.631 177.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' SER . . . . . 0.51 ' C ' ' HD3' ' B' ' 11' ' ' LYS . 8.9 t -64.81 99.38 0.33 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.51 ' HD3' ' C ' ' B' ' 10' ' ' SER . 0.0 OUTLIER 37.35 43.94 0.42 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.19 0.996 . . . . 0.0 112.095 -175.354 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.423 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 52.6 tt0 -60.28 144.27 87.91 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.855 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . 0.532 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 40.4 Cg_exo -54.56 122.78 12.17 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 122.235 1.957 . . . . 0.0 110.139 176.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . 0.752 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 21.6 t80 -73.13 -55.92 3.59 Favored Pre-proline 0 N--CA 1.44 -0.939 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -166.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.575 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 27.7 Cg_exo -57.22 -16.02 20.55 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 121.318 1.345 . . . . 0.0 110.609 -178.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.532 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.4 m-20 -89.33 -44.2 10.39 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 113.487 -1.688 . . . . 0.0 110.762 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' PHE . . . . . 0.515 ' CE2' HD23 ' B' ' 21' ' ' LEU . 0.0 OUTLIER -54.89 -44.59 74.24 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 176.744 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.751 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 1.7 p -79.58 -34.91 16.21 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.307 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.496 -178.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.39 -30.29 68.34 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 121.356 -0.84 . . . . 0.0 111.913 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.703 ' O ' HG13 ' B' ' 24' ' ' VAL . 16.6 ptt180 -84.53 -28.44 26.66 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 175.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.54 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 5.6 tp -57.24 -48.23 79.36 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.079 173.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . 0.751 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 24.3 mt-30 -69.09 -47.41 65.31 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.075 177.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.737 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 11.8 t70 -47.44 -54.74 10.58 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 124.416 1.072 . . . . 0.0 111.6 -177.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' VAL . . . . . 0.703 HG13 ' O ' ' B' ' 20' ' ' ARG . 6.5 p -81.7 -22.05 10.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.033 -174.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.751 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -72.95 -19.39 61.25 Favored 'General case' 0 C--O 1.204 -1.302 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.49 -38.25 17.45 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.555 177.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.737 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 40.1 mmtt -66.13 -35.95 81.85 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.717 178.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 15.7 m -104.52 -7.64 19.62 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.24 0.543 . . . . 0.0 110.68 -170.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.751 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 88.3 mt -117.74 129.74 73.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.91 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.15 -7.29 48.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.328 0.585 . . . . 0.0 110.314 175.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.492 ' H ' HG23 ' B' ' 29' ' ' ILE . 1.1 m-20 -100.46 106.25 17.79 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.776 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -56.29 -26.04 50.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.666 0.27 . . . . 0.0 110.388 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.554 ' O ' HG11 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -69.24 -53.73 18.39 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.14 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.503 ' HA ' HG23 ' B' ' 37' ' ' VAL . . . -64.33 -24.11 67.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.402 177.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.828 ' O ' HG11 ' B' ' 39' ' ' VAL . 4.6 tmm_? -68.41 -58.75 3.87 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.47 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 27.2 mtpt -52.17 -60.7 2.9 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 120.796 0.332 . . . . 0.0 110.638 177.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.773 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 21.8 m -52.27 -35.96 20.4 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.465 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.716 -168.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.457 ' CD1' ' HE1' ' B' ' 3' ' ' PHE . 1.5 tt -87.24 -27.72 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 119.599 -0.84 . . . . 0.0 112.067 -177.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.828 HG11 ' O ' ' B' ' 35' ' ' ARG . 2.1 m -73.51 -47.14 46.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.332 175.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.678 ' HB3' ' CG2' ' B' ' 68' ' ' VAL . 0.7 OUTLIER -64.19 -24.36 67.65 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.757 0.823 . . . . 0.0 111.348 176.084 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.773 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.46 -57.86 2.9 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 176.534 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' MET . . . . . 0.534 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 23.2 mmt -61.45 -20.75 63.47 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.591 0.71 . . . . 0.0 109.717 -177.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.677 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . . . -48.71 -27.93 3.24 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.991 170.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' TYR . . . . . 0.528 ' CG ' ' HD2' ' B' ' 59' ' ' LYS . 10.4 t80 -107.22 -66.66 1.0 Allowed 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.629 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 17.6 mm-40 -48.21 -32.46 7.14 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.817 -1.083 . . . . 0.0 112.005 -174.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.694 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 5.1 m-20 -105.07 -19.68 13.75 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -175.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.658 ' HB3' ' O ' ' B' ' 43' ' ' ALA . . . -60.71 -172.0 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -174.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . 0.55 ' HB2' ' CB ' ' B' ' 51' ' ' CYS . 11.5 m120 -52.86 141.55 37.05 Favored Pre-proline 0 C--O 1.235 0.298 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 170.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . 0.471 ' O ' HD22 ' B' ' 92' ' ' LEU . 19.2 Cg_endo -60.04 -19.7 57.2 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 121.642 1.561 . . . . 0.0 110.471 174.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.521 ' O ' ' HB2' ' B' ' 53' ' ' SER . 0.3 OUTLIER -87.02 -34.89 19.07 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.542 173.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.952 ' SG ' ' HB2' ' B' ' 76' ' ' CYS . 40.7 t -80.33 -33.89 37.07 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.265 -172.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . 0.501 ' HB2' ' CD1' ' B' ' 44' ' ' TYR . 4.1 pt20 -68.6 -29.42 67.93 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 172.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' SER . . . . . 0.591 ' HB3' ' C ' ' B' ' 91' ' ' GLN . 19.6 m -71.55 -19.41 62.17 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 113.264 -1.789 . . . . 0.0 109.986 173.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.51 ' HB2' HD12 ' B' ' 79' ' ' ILE . . . -80.86 -27.38 36.43 Favored 'General case' 0 C--N 1.311 -1.07 0 O-C-N 121.443 -0.786 . . . . 0.0 110.225 167.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.577 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 24.0 mt -90.11 -30.0 5.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 -170.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.601 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.68 -38.78 2.07 Favored Pre-proline 0 N--CA 1.487 1.377 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -174.043 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 55.6 Cg_endo -63.79 -30.78 68.83 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.196 1.931 . . . . 0.0 112.649 176.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . 0.533 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.7 mt -95.11 -16.74 22.4 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.565 ' HA ' ' OH ' ' B' ' 72' ' ' TYR . 0.1 OUTLIER -55.01 109.09 0.47 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.661 -179.483 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.65 -23.41 36.05 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.419 -177.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -104.07 113.36 26.85 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.351 0.596 . . . . 0.0 110.162 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.16 142.13 37.62 Favored Pre-proline 0 C--N 1.308 -1.201 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.352 169.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.549 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 74.0 Cg_exo -50.87 138.8 41.86 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.201 1.934 . . . . 0.0 111.416 171.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.31 103.88 0.44 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.01 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.28 -13.51 43.96 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.618 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.549 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 19.6 m -94.15 169.56 10.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.487 0.661 . . . . 0.0 111.596 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.0 136.97 34.32 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.564 174.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.678 ' CG2' ' HB3' ' B' ' 40' ' ' GLU . 0.7 OUTLIER -72.3 -32.52 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.495 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . 0.754 ' O ' HG12 ' B' ' 73' ' ' VAL . 9.9 mm -55.65 -46.6 79.42 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.093 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.675 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 29.4 t -46.49 -37.92 8.52 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.105 176.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -85.67 -32.0 22.22 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.677 -177.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' TYR . . . . . 0.565 ' OH ' ' HA ' ' B' ' 59' ' ' LYS . 4.9 m-30 -76.46 -34.29 58.7 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.572 -176.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . 0.754 HG12 ' O ' ' B' ' 69' ' ' ILE . 1.5 m -71.33 -31.51 43.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 172.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' LYS . . . . . 0.562 ' O ' ' HB3' ' B' ' 77' ' ' ASP . 0.0 OUTLIER -68.08 -29.61 68.61 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.431 175.653 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' B' ' 72' ' ' TYR . . . -65.09 -44.59 88.34 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.175 176.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.952 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 39.1 t -92.5 9.04 36.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.729 177.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . 0.562 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 9.1 t70 -60.61 -21.73 62.99 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.173 0.511 . . . . 0.0 110.163 172.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' B' ' 83' ' ' MET . . . -101.14 -9.63 44.48 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.653 173.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.785 ' HB ' ' SG ' ' B' ' 76' ' ' CYS . 84.2 mt -96.06 138.98 20.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 117.392 0.596 . . . . 0.0 111.342 -178.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . 0.515 ' H ' ' HB2' ' B' ' 84' ' ' HIS . . . 164.38 -34.94 0.28 Allowed Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.718 173.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.584 ' O ' ' HG2' ' B' ' 85' ' ' LYS . . . -148.41 -103.4 0.31 Allowed Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.133 177.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.15 -46.75 87.63 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -171.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' MET . . . . . 0.497 ' HB2' ' O ' ' B' ' 78' ' ' GLY . 72.4 mtp -68.56 -30.85 69.72 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' HIS . . . . . 0.515 ' HB2' ' H ' ' B' ' 80' ' ' GLY . 5.8 t-160 -62.41 -29.11 70.26 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.137 173.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' B' ' 81' ' ' GLY . 70.5 mmtt -84.05 -20.32 32.9 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.937 0.399 . . . . 0.0 110.421 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.09 -43.02 14.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.558 0.694 . . . . 0.0 110.508 177.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 1.6 mmt -84.48 -12.77 53.67 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.081 -176.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.597 ' O ' ' HB3' ' B' ' 92' ' ' LEU . 0.3 OUTLIER -49.52 -41.01 39.84 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.45 0.643 . . . . 0.0 111.17 177.836 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 28.2 ttt -84.06 -15.55 47.03 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.019 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -96.7 -33.63 11.66 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.983 -173.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' GLN . . . . . 0.591 ' C ' ' HB3' ' B' ' 53' ' ' SER . 20.3 mt-30 -110.21 -56.73 2.3 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.279 -176.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.597 ' HB3' ' O ' ' B' ' 88' ' ' LEU . 0.4 OUTLIER -58.41 -5.1 0.46 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 121.087 0.47 . . . . 0.0 110.186 176.355 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.487 ' H ' ' C ' ' B' ' 91' ' ' GLN . 5.1 pt-20 . . . . . 0 C--O 1.252 1.231 0 C-N-CA 123.981 0.912 . . . . 0.0 112.245 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.482 ' HB2' ' H ' ' A' ' 2' ' ' SER . 72.3 Cg_endo . . . . . 0 CA--C 1.515 -0.451 0 N-CA-C 108.784 -1.275 . . . . 0.0 108.784 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.482 ' H ' ' HB2' ' A' ' 1' ' ' PRO . 13.7 m -67.11 171.42 5.64 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 162.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.471 ' CE1' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -69.9 -52.02 28.14 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 167.248 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.494 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 2.5 p-10 -82.34 5.37 20.48 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 113.996 -1.456 . . . . 0.0 113.423 -166.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.28 -3.03 5.02 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 118.521 0.6 . . . . 0.0 111.946 -175.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.568 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.1 m -78.57 132.72 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 174.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.708 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -155.08 160.15 40.78 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -178.881 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.411 ' N ' ' CD2' ' A' ' 17' ' ' PHE . 2.0 tt0 -44.33 109.07 0.13 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 112.902 -1.954 . . . . 0.0 112.29 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.69 -151.95 15.13 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.397 174.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.1 t -52.32 98.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 122.421 0.288 . . . . 0.0 110.692 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.7 pttm 40.52 42.14 1.25 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.511 1.124 . . . . 0.0 112.598 -175.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -60.1 141.34 90.35 Favored Pre-proline 0 C--O 1.236 0.386 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.149 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.484 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 27.4 Cg_exo -56.35 122.96 12.7 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.039 1.826 . . . . 0.0 109.712 176.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.825 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 20.2 t80 -72.38 -53.27 6.24 Favored Pre-proline 0 N--CA 1.439 -1.004 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -166.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.536 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 34.3 Cg_exo -55.36 -19.53 22.48 Favored 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 121.361 1.374 . . . . 0.0 110.749 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.484 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 3.4 m-20 -89.9 -41.19 11.93 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 113.737 -1.574 . . . . 0.0 110.948 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -54.96 -46.82 75.08 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 175.73 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.688 HG12 ' O ' ' A' ' 14' ' ' TYR . 2.4 p -79.03 -32.12 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.218 -177.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . -58.0 -36.3 72.45 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 121.639 -0.663 . . . . 0.0 111.768 175.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.692 ' O ' HG12 ' A' ' 24' ' ' VAL . 14.1 ptt180 -83.27 -23.52 32.64 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.53 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 6.6 tp -60.49 -45.63 93.06 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.767 172.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.688 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 37.2 mt-30 -73.14 -44.51 60.04 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.735 178.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.74 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 26.0 t70 -49.16 -53.72 19.67 Favored 'General case' 0 C--N 1.315 -0.893 0 O-C-N 124.155 0.909 . . . . 0.0 111.667 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.692 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.7 p -80.85 -23.19 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-O 121.09 0.472 . . . . 0.0 109.882 -174.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.762 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -71.79 -20.54 61.84 Favored 'General case' 0 C--O 1.204 -1.326 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 174.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.44 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -86.54 -37.14 18.47 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.744 178.602 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.74 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.0 mmtt -65.49 -35.51 81.09 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.459 178.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.5 m -104.47 -9.96 18.02 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.648 -171.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.762 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 91.1 mt -119.27 128.03 75.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.95 -178.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.99 -1.29 56.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.382 0.611 . . . . 0.0 110.488 176.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.537 ' H ' HG21 ' A' ' 29' ' ' ILE . 13.6 t70 -107.95 116.6 32.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.467 -177.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.561 ' OE2' ' HG3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -57.16 -34.05 68.06 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.272 178.332 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.561 ' HG3' ' OE2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -70.88 -54.71 10.48 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -172.543 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.444 ' HA ' HG21 ' A' ' 37' ' ' VAL . . . -60.05 -28.92 68.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.8 176.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.859 ' O ' HG13 ' A' ' 39' ' ' VAL . 6.0 tmm_? -67.38 -58.09 5.41 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.44 ' O ' HG21 ' A' ' 39' ' ' VAL . 16.0 mtpt -56.96 -56.58 19.85 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.008 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.698 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 20.1 m -53.73 -35.03 25.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.399 -171.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.467 ' O ' ' HG2' ' A' ' 42' ' ' MET . 1.3 tt -86.6 -28.24 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 C-N-CA 119.631 -0.828 . . . . 0.0 111.732 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.5 m -70.78 -49.87 47.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 119.088 -1.045 . . . . 0.0 109.561 173.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.715 ' CD ' HG11 ' A' ' 68' ' ' VAL . 0.9 OUTLIER -62.08 -24.85 67.36 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.354 0.662 . . . . 0.0 111.653 176.654 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.698 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -86.23 -55.28 3.99 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 176.381 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.494 ' HG3' ' HB2' ' A' ' 4' ' ' ASN . 16.4 mmt -63.89 -20.35 65.77 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 121.458 0.646 . . . . 0.0 109.861 -176.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.676 ' HB2' ' OH ' ' A' ' 14' ' ' TYR . . . -48.78 -27.81 3.23 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.277 169.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.529 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 16.5 t80 -105.95 -66.23 1.01 Allowed 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 174.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.444 ' OE1' ' HA ' ' A' ' 45' ' ' GLU . 15.3 mm-40 -50.22 -26.85 5.1 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 124.228 0.955 . . . . 0.0 112.699 -172.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.708 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.8 m-20 -109.49 -20.35 12.92 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.625 -177.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.65 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -59.15 -177.52 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.183 0.992 . . . . 0.0 113.633 -174.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -62.98 140.89 97.64 Favored Pre-proline 0 N--CA 1.445 -0.713 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.639 174.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -43.65 -48.04 9.07 Favored 'Trans proline' 0 C--N 1.334 -0.226 0 C-N-CA 122.83 2.353 . . . . 0.0 112.473 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.599 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -76.23 -23.73 54.55 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.31 0.644 . . . . 0.0 110.657 -179.488 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.953 ' SG ' ' HB2' ' A' ' 76' ' ' CYS . 52.9 t -84.26 -40.0 18.57 Favored 'General case' 0 N--CA 1.417 -2.105 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.915 -173.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.49 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.7 pt20 -66.34 -31.18 71.81 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 172.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.755 ' O ' ' HD2' ' A' ' 56' ' ' LYS . 5.1 m -65.81 -30.05 70.62 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.88 172.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.535 ' HB3' HD13 ' A' ' 79' ' ' ILE . . . -72.33 -23.71 61.2 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.87 0.843 . . . . 0.0 109.276 172.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.53 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 25.1 mt -90.94 -31.33 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -173.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.755 ' HD2' ' O ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -44.03 -38.18 4.43 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-N 119.805 1.184 . . . . 0.0 113.477 -173.451 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 52.7 Cg_endo -63.06 -29.6 75.12 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 122.296 1.997 . . . . 0.0 112.85 175.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.534 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.5 mt -97.37 -16.45 20.24 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.529 ' HD2' ' CG ' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -52.76 109.68 0.43 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.376 -178.538 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.453 ' N ' ' HZ1' ' A' ' 59' ' ' LYS . . . 94.86 -21.77 41.79 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.177 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.5 mmmt -103.51 114.5 28.81 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -177.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.7 p -122.14 137.1 27.01 Favored Pre-proline 0 C--N 1.309 -1.163 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 170.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.547 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 85.5 Cg_exo -49.46 140.35 27.82 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.649 2.233 . . . . 0.0 111.702 172.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.94 102.14 0.26 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.304 -176.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.26 -13.4 44.08 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.657 178.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.547 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 29.2 m -90.22 174.28 7.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.507 0.67 . . . . 0.0 111.841 -178.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.436 ' OD2' ' HB ' ' A' ' 69' ' ' ILE . 3.0 t70 -91.25 136.18 33.28 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.715 HG11 ' CD ' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -71.87 -33.36 47.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 C-N-CA 118.055 -1.458 . . . . 0.0 108.937 -179.391 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.758 ' O ' HG12 ' A' ' 73' ' ' VAL . 7.6 mm -57.61 -47.5 85.29 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.112 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.802 -178.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.566 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 41.2 t -48.33 -36.09 13.67 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.202 0.525 . . . . 0.0 111.168 178.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -86.56 -31.21 21.34 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.27 0.628 . . . . 0.0 110.75 -176.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.534 ' CE1' ' HB2' ' A' ' 58' ' ' LEU . 4.9 m-30 -76.28 -35.98 58.62 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.494 -178.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.825 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.7 m -69.87 -33.15 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 173.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.566 ' HB2' ' O ' ' A' ' 70' ' ' SER . 1.6 ttmm -67.9 -30.62 70.0 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.086 -1.415 . . . . 0.0 109.666 176.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 72' ' ' TYR . . . -62.1 -42.81 99.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.653 174.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.953 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 41.9 t -94.86 8.59 42.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.052 178.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.463 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 12.7 t70 -61.59 -16.43 48.09 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.279 0.561 . . . . 0.0 110.024 173.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -107.47 -5.07 34.59 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.842 173.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.792 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 57.2 mt -102.11 132.47 48.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 117.321 0.56 . . . . 0.0 111.086 -178.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 161.41 62.27 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.005 174.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.21 172.19 36.79 Favored Glycine 0 CA--C 1.51 -0.245 0 N-CA-C 111.771 -0.531 . . . . 0.0 111.771 -176.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 54.51 -91.0 0.03 OUTLIER 'General case' 0 C--O 1.234 0.26 0 C-N-CA 122.937 0.495 . . . . 0.0 111.823 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 65.4 mtt -62.52 -28.51 69.89 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.452 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.481 ' HD2' ' OE2' ' A' ' 50' ' ' GLU . 8.8 t-160 -50.1 -41.56 48.61 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.347 177.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -87.32 -14.83 39.75 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -174.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.43 -43.34 14.74 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.971 0.891 . . . . 0.0 109.404 172.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 65.7 mtt -80.22 -9.71 59.73 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.249 -1.341 . . . . 0.0 111.034 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.449 HD13 ' O ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -56.83 -17.68 10.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.269 0.557 . . . . 0.0 111.056 177.586 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 49.3 tpp -83.73 -24.04 31.36 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.104 0.478 . . . . 0.0 110.528 174.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.17 -56.26 2.35 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -169.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.542 ' O ' ' HB3' ' A' ' 53' ' ' SER . 19.0 mt-30 -70.49 -40.87 73.34 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -176.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.525 ' HA ' ' CB ' ' A' ' 53' ' ' SER . 1.9 tm? -46.45 -29.73 1.86 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.902 169.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.644 ' O ' ' HE3' ' A' ' 56' ' ' LYS . 43.8 mt-10 . . . . . 0 N--CA 1.438 -1.029 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' PRO . . . . . 0.419 ' HB2' ' H ' ' B' ' 2' ' ' SER . 72.4 Cg_endo . . . . . 0 CA--C 1.515 -0.449 0 N-CA-C 108.791 -1.273 . . . . 0.0 108.791 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.427 ' HG ' ' HD3' ' A' ' 59' ' ' LYS . 14.4 m -67.04 171.58 5.39 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 162.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.468 ' CE1' HD11 ' B' ' 29' ' ' ILE . 0.1 OUTLIER -70.03 -52.08 26.97 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 167.184 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.493 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.6 p-10 -82.05 5.25 20.01 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 113.95 -1.477 . . . . 0.0 113.478 -166.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.26 -2.87 4.81 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 121.671 -0.643 . . . . 0.0 111.939 -175.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.581 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.1 m -78.57 133.18 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 174.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.701 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.1 OUTLIER -155.17 160.26 40.77 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -178.825 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' GLN . . . . . 0.426 ' N ' ' CD2' ' B' ' 17' ' ' PHE . 2.0 tt0 -44.58 108.87 0.13 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 112.922 -1.944 . . . . 0.0 112.313 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.27 -152.07 14.38 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.406 174.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 9.9 t -52.44 98.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.753 0.311 . . . . 0.0 110.803 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 23.8 pttm 40.8 41.55 1.22 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.549 1.14 . . . . 0.0 112.635 -175.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -59.73 141.17 89.17 Favored Pre-proline 0 C--O 1.236 0.388 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.217 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . 0.498 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 27.6 Cg_exo -56.24 123.04 12.87 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.031 1.82 . . . . 0.0 109.644 177.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . 0.825 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 20.3 t80 -72.36 -53.37 6.19 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -166.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.536 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 35.1 Cg_exo -55.45 -19.34 22.31 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 121.305 1.337 . . . . 0.0 110.696 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.498 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 3.5 m-20 -90.1 -41.15 11.83 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.722 -1.581 . . . . 0.0 110.92 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' PHE . . . . . 0.487 ' CD2' ' HA ' ' B' ' 7' ' ' ARG . 0.0 OUTLIER -54.79 -46.71 74.5 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.569 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.696 HG12 ' O ' ' B' ' 14' ' ' TYR . 2.4 p -79.16 -32.09 14.94 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.21 -177.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' B' ' 15' ' ' PRO . . . -58.06 -36.12 72.34 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 121.634 -0.666 . . . . 0.0 111.765 175.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.685 ' O ' HG12 ' B' ' 24' ' ' VAL . 14.1 ptt180 -83.22 -23.99 32.56 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 177.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.543 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 6.5 tp -60.1 -45.64 92.26 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.802 172.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . 0.69 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 36.9 mt-30 -73.21 -44.19 60.09 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.832 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.741 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 25.9 t70 -49.43 -53.83 20.72 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.557 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' VAL . . . . . 0.685 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.7 p -80.96 -23.07 10.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.137 0.494 . . . . 0.0 109.878 -174.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.759 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -71.77 -20.5 61.86 Favored 'General case' 0 C--O 1.203 -1.37 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 174.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . 0.438 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -86.56 -37.29 18.29 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.704 178.597 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.741 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.4 mmtt -65.51 -35.58 81.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.488 178.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 19.6 m -104.34 -9.44 18.51 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.666 -171.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.759 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 91.6 mt -119.76 128.0 75.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.993 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.06 -1.43 56.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.285 0.564 . . . . 0.0 110.286 177.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.546 ' H ' HG21 ' B' ' 29' ' ' ILE . 13.8 t70 -107.62 116.84 32.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.352 -177.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 0.553 ' OE2' ' HG3' ' B' ' 33' ' ' LYS . 0.0 OUTLIER -57.34 -33.87 68.2 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.356 178.267 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.553 ' HG3' ' OE2' ' B' ' 32' ' ' GLU . 0.0 OUTLIER -70.82 -54.57 11.09 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -172.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.467 ' HA ' HG21 ' B' ' 37' ' ' VAL . . . -60.16 -28.89 68.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.784 176.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.839 ' O ' HG13 ' B' ' 39' ' ' VAL . 6.0 tmm_? -67.38 -58.28 5.07 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.438 ' O ' HG21 ' B' ' 39' ' ' VAL . 16.1 mtpt -56.84 -56.52 20.52 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.097 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.686 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 20.2 m -53.83 -34.92 26.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.386 -171.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.461 ' O ' ' HG2' ' B' ' 42' ' ' MET . 1.3 tt -86.64 -28.18 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 C-N-CA 119.649 -0.82 . . . . 0.0 111.668 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.839 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.5 m -70.91 -49.85 47.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 119.152 -1.019 . . . . 0.0 109.58 173.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.711 ' CD ' HG11 ' B' ' 68' ' ' VAL . 0.9 OUTLIER -62.12 -24.87 67.4 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.398 0.679 . . . . 0.0 111.561 176.69 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.686 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -86.22 -55.22 4.02 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 176.293 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' MET . . . . . 0.493 ' HG3' ' HB2' ' B' ' 4' ' ' ASN . 16.4 mmt -64.08 -20.17 65.76 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 121.537 0.684 . . . . 0.0 109.974 -176.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.681 ' HB2' ' OH ' ' B' ' 14' ' ' TYR . . . -48.78 -27.76 3.19 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.194 169.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' TYR . . . . . 0.511 ' CG ' ' HD2' ' B' ' 59' ' ' LYS . 16.5 t80 -106.06 -66.41 1.0 Allowed 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 174.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.447 ' HA ' ' OE1' ' B' ' 45' ' ' GLU . 16.4 mm-40 -50.05 -27.22 5.25 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.627 -172.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.701 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.7 m-20 -109.28 -20.22 13.02 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.602 -176.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -59.06 -177.35 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -174.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -63.26 140.93 97.77 Favored Pre-proline 0 N--CA 1.446 -0.647 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.531 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -43.76 -48.04 9.26 Favored 'Trans proline' 0 C--N 1.334 -0.235 0 C-N-CA 122.773 2.315 . . . . 0.0 112.386 -178.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.609 ' HG3' ' O ' ' B' ' 50' ' ' GLU . 0.0 OUTLIER -76.03 -23.83 55.17 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 123.43 0.692 . . . . 0.0 110.707 -179.467 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.949 ' SG ' ' HB2' ' B' ' 76' ' ' CYS . 52.8 t -84.18 -39.99 18.69 Favored 'General case' 0 N--CA 1.418 -2.038 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.94 -173.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . 0.49 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.8 pt20 -66.5 -31.08 71.59 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 172.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' SER . . . . . 0.755 ' O ' ' HD2' ' B' ' 56' ' ' LYS . 5.7 m -65.93 -30.14 70.67 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 113.783 -1.553 . . . . 0.0 110.809 173.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.541 ' HB3' HD13 ' B' ' 79' ' ' ILE . . . -72.09 -23.89 61.41 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 122.026 0.917 . . . . 0.0 109.374 172.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.535 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 25.0 mt -90.89 -31.53 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -173.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.755 ' HD2' ' O ' ' B' ' 53' ' ' SER . 0.0 OUTLIER -43.79 -38.12 3.96 Favored Pre-proline 0 N--CA 1.488 1.45 0 CA-C-N 119.801 1.182 . . . . 0.0 113.653 -173.543 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 54.3 Cg_endo -63.48 -28.84 70.85 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.391 2.061 . . . . 0.0 112.942 175.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . 0.545 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.5 mt -97.84 -16.55 19.75 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.511 ' HD2' ' CG ' ' B' ' 44' ' ' TYR . 0.0 OUTLIER -52.82 109.73 0.44 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.421 -178.501 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . 0.458 ' N ' ' HZ1' ' B' ' 59' ' ' LYS . . . 95.04 -22.02 40.73 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.255 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 11.5 mmmt -103.55 114.3 28.46 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -177.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.15 136.85 26.74 Favored Pre-proline 0 C--N 1.309 -1.184 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 171.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.559 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 84.8 Cg_exo -49.32 140.29 26.82 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.52 2.147 . . . . 0.0 111.841 172.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.76 102.54 0.27 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.12 -176.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.94 -13.34 45.43 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.618 178.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.559 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 29.6 m -90.71 174.13 7.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.418 0.627 . . . . 0.0 111.742 -178.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' ASP . . . . . 0.436 ' OD2' ' HB ' ' B' ' 69' ' ' ILE . 3.1 t70 -91.36 135.83 33.54 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 176.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.711 HG11 ' CD ' ' B' ' 40' ' ' GLU . 0.8 OUTLIER -71.66 -33.4 48.77 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 C-N-CA 118.085 -1.446 . . . . 0.0 108.856 -179.214 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . 0.755 ' O ' HG12 ' B' ' 73' ' ' VAL . 7.6 mm -57.45 -47.51 84.76 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.118 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.801 -178.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.559 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 40.3 t -48.34 -36.2 13.92 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.301 0.572 . . . . 0.0 111.182 178.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.413 ' H ' ' HG2' ' B' ' 71' ' ' GLU . 2.3 mm-40 -86.51 -31.28 21.38 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.592 -176.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' TYR . . . . . 0.545 ' CE1' ' HB2' ' B' ' 58' ' ' LEU . 5.0 m-30 -76.39 -35.82 58.42 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.443 -178.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . 0.825 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.7 m -69.94 -33.13 54.21 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 173.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' LYS . . . . . 0.559 ' HB2' ' O ' ' B' ' 70' ' ' SER . 1.6 ttmm -68.04 -30.56 69.81 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.698 176.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' B' ' 72' ' ' TYR . . . -61.93 -42.89 99.62 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.624 174.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.949 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 43.2 t -94.99 8.66 42.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.12 177.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . 0.467 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 12.0 t70 -61.4 -17.04 52.26 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.354 0.597 . . . . 0.0 109.971 173.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -107.14 -4.65 35.54 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.887 173.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.802 ' HB ' ' SG ' ' B' ' 76' ' ' CYS . 56.6 mt -102.47 132.8 47.79 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.046 0 CA-C-N 117.391 0.596 . . . . 0.0 111.068 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 161.28 61.85 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.992 174.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.53 171.2 35.92 Favored Glycine 0 C--O 1.224 -0.482 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.95 -176.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 55.47 -91.47 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 122.697 0.399 . . . . 0.0 111.82 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' MET . . . . . . . . . . . . . 65.4 mtt -62.26 -28.95 70.07 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.469 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' HIS . . . . . 0.459 ' HD2' ' OE2' ' B' ' 50' ' ' GLU . 8.9 t-160 -49.72 -41.79 44.47 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.275 177.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -87.32 -14.52 40.59 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -174.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.58 -43.41 14.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.949 0.881 . . . . 0.0 109.333 172.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 66.4 mtt -80.21 -9.72 59.73 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.966 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.459 HD13 ' O ' ' B' ' 88' ' ' LEU . 0.0 OUTLIER -56.71 -17.59 9.46 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.468 0.651 . . . . 0.0 111.042 177.499 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 50.4 tpp -83.92 -24.25 30.83 Favored 'General case' 0 C--N 1.316 -0.883 0 O-C-N 121.924 -0.485 . . . . 0.0 110.499 174.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -109.84 -56.4 2.32 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -169.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' GLN . . . . . 0.527 ' O ' ' HB3' ' B' ' 53' ' ' SER . 19.1 mt-30 -70.56 -40.64 73.23 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.299 -176.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.53 ' HA ' ' CB ' ' B' ' 53' ' ' SER . 1.8 tm? -46.62 -29.6 1.91 Allowed 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.71 0.631 . . . . 0.0 109.923 169.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.663 ' O ' ' HE3' ' B' ' 56' ' ' LYS . 43.6 mt-10 . . . . . 0 N--CA 1.437 -1.084 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 -178.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo . . . . . 0 CA--C 1.52 -0.209 0 N-CA-C 109.064 -1.168 . . . . 0.0 109.064 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.438 ' HB3' HD23 ' B' ' 41' ' ' LEU . 66.6 m -68.62 -176.85 0.85 Allowed 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 162.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.501 ' HE1' ' CD1' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -77.27 -55.47 5.38 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.107 172.675 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.588 ' OD1' ' HG3' ' A' ' 42' ' ' MET . 1.1 p30 -76.22 -8.3 56.76 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.599 -1.182 . . . . 0.0 112.467 -167.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.519 ' CG2' ' HD3' ' B' ' 59' ' ' LYS . 0.3 OUTLIER -57.95 0.61 0.06 Allowed 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -172.197 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.561 ' HB ' ' CZ ' ' A' ' 20' ' ' ARG . 4.0 m -72.96 117.65 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 167.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.677 ' HG3' ' CB ' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -115.91 158.25 23.29 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 121.505 -0.747 . . . . 0.0 110.216 176.765 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.494 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 1.9 tt0 -56.16 113.08 1.4 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.444 173.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.35 -159.99 11.73 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 173.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.7 p -52.16 100.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.942 0.371 . . . . 0.0 111.141 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.423 ' HD2' ' O ' ' A' ' 80' ' ' GLY . 18.2 pttp 43.01 42.58 3.23 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.305 1.042 . . . . 0.0 112.041 -175.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.44 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 42.7 tt0 -60.26 137.0 91.63 Favored Pre-proline 0 C--O 1.232 0.182 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 177.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.518 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 28.1 Cg_exo -54.06 123.62 13.95 Favored 'Trans proline' 0 CA--C 1.511 -0.672 0 C-N-CA 122.075 1.85 . . . . 0.0 109.936 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.814 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 14.5 t80 -70.19 -53.43 10.79 Favored Pre-proline 0 N--CA 1.44 -0.954 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -166.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.5 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 31.8 Cg_exo -55.69 -18.51 21.06 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 121.414 1.409 . . . . 0.0 110.979 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.518 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 4.1 m-20 -89.96 -41.69 11.6 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.198 -1.365 . . . . 0.0 111.169 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.494 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -56.96 -41.54 78.51 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.533 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.68 HG11 ' O ' ' A' ' 14' ' ' TYR . 2.4 p -82.57 -33.6 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.519 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' A' ' 15' ' ' PRO . . . -57.88 -34.05 69.36 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 121.495 -0.753 . . . . 0.0 111.946 176.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.736 ' O ' HG11 ' A' ' 24' ' ' VAL . 17.5 ptt180 -84.79 -27.72 26.66 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.567 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 9.3 tp -54.96 -46.19 75.0 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.759 171.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.711 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 36.6 mt-30 -73.21 -45.72 54.53 Favored 'General case' 0 CA--C 1.497 -1.073 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.168 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.7 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 11.4 t70 -51.79 -52.42 49.09 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 124.05 0.844 . . . . 0.0 111.812 -177.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.736 HG11 ' O ' ' A' ' 20' ' ' ARG . 7.3 p -82.06 -23.25 9.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -173.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.777 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -72.06 -18.86 61.9 Favored 'General case' 0 C--O 1.203 -1.357 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 173.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.41 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -86.55 -37.75 17.86 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.634 -1.167 . . . . 0.0 109.812 177.842 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.7 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 41.0 mmtt -67.62 -37.84 83.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.013 178.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.8 t -102.67 -7.7 21.52 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.227 0.537 . . . . 0.0 110.044 -171.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.777 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 86.8 mt -116.7 127.49 74.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.435 178.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.55 -9.54 54.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.263 0.554 . . . . 0.0 110.148 177.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.522 ' H ' HG21 ' A' ' 29' ' ' ILE . 13.8 t70 -98.75 136.04 39.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.233 -177.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -75.42 -29.55 59.78 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.761 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.532 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -77.44 -51.41 10.82 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -174.932 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.441 ' HA ' HG21 ' A' ' 37' ' ' VAL . . . -58.57 -27.88 65.01 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.436 175.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.877 ' O ' HG13 ' A' ' 39' ' ' VAL . 1.7 tmm_? -66.31 -60.74 2.49 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.498 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 26.0 mtpt -55.12 -56.1 23.61 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.373 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.71 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 19.7 m -54.8 -32.6 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.16 -170.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.574 ' O ' ' HG2' ' A' ' 42' ' ' MET . 1.2 tt -86.82 -34.0 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.416 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.877 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.0 m -66.14 -47.66 83.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 119.214 -0.995 . . . . 0.0 109.466 176.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.678 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 54.4 mt-10 -67.25 -23.75 65.74 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 123.875 0.87 . . . . 0.0 112.64 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.71 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -86.22 -55.71 3.79 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.375 176.854 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.678 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 14.6 mmt -62.27 -20.67 64.52 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-O 121.76 0.791 . . . . 0.0 109.509 -176.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.762 ' O ' ' HB3' ' A' ' 47' ' ' ALA . . . -48.61 -27.02 2.53 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.766 170.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.481 ' CG ' ' HB2' ' A' ' 52' ' ' GLN . 9.2 t80 -105.4 -66.39 0.98 Allowed 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.473 ' CG ' HD11 ' A' ' 41' ' ' LEU . 14.0 mm-40 -48.25 -33.41 8.64 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 123.646 0.592 . . . . 0.0 112.44 -176.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.678 ' HB2' ' O ' ' A' ' 42' ' ' MET . 5.2 m-20 -99.84 -15.34 18.43 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.349 0.595 . . . . 0.0 111.643 -177.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.762 ' HB3' ' O ' ' A' ' 43' ' ' ALA . . . -63.04 168.48 4.04 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.426 0.632 . . . . 0.0 111.501 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.534 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 11.1 m-20 -58.31 145.46 74.73 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.338 173.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -41.65 -49.1 5.45 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.688 2.258 . . . . 0.0 111.894 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.483 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 0.3 OUTLIER -71.23 -33.56 69.97 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.238 1.015 . . . . 0.0 111.854 177.79 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.534 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 69.8 m -73.94 -39.22 63.93 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 121.118 0.485 . . . . 0.0 110.014 -174.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.481 ' HB2' ' CG ' ' A' ' 44' ' ' TYR . 4.0 pt20 -73.39 -30.75 63.48 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 175.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.559 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 4.0 m -67.72 -21.02 65.32 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.306 172.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.53 ' HB2' HD13 ' A' ' 79' ' ' ILE . . . -77.1 -27.77 54.26 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.382 -0.824 . . . . 0.0 109.865 169.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.598 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 20.8 mt -89.74 -31.72 5.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -171.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.593 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -40.68 -37.76 1.05 Allowed Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -173.883 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.598 ' HD2' ' C ' ' A' ' 55' ' ' ILE . 55.2 Cg_endo -64.26 -28.89 64.0 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.358 2.039 . . . . 0.0 113.104 175.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.534 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 2.0 mt -98.63 -15.79 19.31 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.568 ' HD3' ' CG2' ' B' ' 5' ' ' THR . 0.3 OUTLIER -52.56 109.35 0.39 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.348 -1.296 . . . . 0.0 110.422 179.6 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.88 -30.09 10.44 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.939 -175.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 35.0 mmtt -103.83 115.17 29.98 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-O 122.423 1.106 . . . . 0.0 111.612 -175.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.461 ' HB ' HG13 ' A' ' 68' ' ' VAL . 7.5 p -122.46 145.04 43.61 Favored Pre-proline 0 C--N 1.296 -1.754 0 CA-C-N 113.555 -1.657 . . . . 0.0 109.52 170.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.542 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 96.4 Cg_exo -48.55 141.25 20.3 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.282 1.988 . . . . 0.0 111.198 167.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.46 101.73 0.09 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.973 0.416 . . . . 0.0 112.073 -173.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.11 -9.31 70.08 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.137 176.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.542 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 4.6 m -89.56 -162.42 0.88 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 122.275 1.036 . . . . 0.0 112.167 -177.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.97 125.69 46.03 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 113.176 -1.829 . . . . 0.0 110.89 -173.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.57 HG12 ' CD ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -79.08 -31.27 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 C-N-CA 118.523 -1.271 . . . . 0.0 108.463 176.248 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.756 ' O ' HG13 ' A' ' 73' ' ' VAL . 6.9 mm -57.77 -49.16 81.77 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.147 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.564 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.6 t -49.07 -36.18 17.75 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.077 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.58 ' O ' ' HE3' ' A' ' 74' ' ' LYS . 1.3 mm-40 -84.88 -33.83 22.72 Favored 'General case' 0 C--O 1.216 -0.666 0 C-N-CA 123.349 0.66 . . . . 0.0 110.458 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.552 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 4.9 m-30 -74.5 -37.91 63.01 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.691 -176.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.814 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.7 m -70.64 -32.65 50.17 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 175.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.58 ' HE3' ' O ' ' A' ' 71' ' ' GLU . 2.4 ttpp -72.39 -27.68 62.52 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.816 177.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 72' ' ' TYR . . . -66.21 -41.72 89.73 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.313 174.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.458 ' HA ' HD12 ' A' ' 79' ' ' ILE . 4.2 m -101.07 10.5 40.93 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.533 -177.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -64.16 -27.48 69.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.132 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.562 ' O ' ' HB2' ' A' ' 83' ' ' MET . . . -82.18 -21.98 59.84 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.571 171.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.53 HD13 ' HB2' ' A' ' 54' ' ' ALA . 49.3 mt -81.17 163.77 3.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.423 ' O ' ' HD2' ' A' ' 11' ' ' LYS . . . 112.95 -13.24 24.39 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -174.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.86 155.36 8.03 Favored Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 175.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.55 -81.41 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.041 0.536 . . . . 0.0 112.334 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.562 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 63.1 mtt -61.75 -29.51 70.17 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-O 120.663 0.268 . . . . 0.0 110.734 -176.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.535 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 8.2 t-80 -56.78 -32.44 65.64 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.824 175.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -84.58 -19.33 33.25 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.096 0.474 . . . . 0.0 110.356 -176.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.06 -46.15 10.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.583 176.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -80.4 -13.78 58.86 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.067 -175.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.535 ' HB2' ' O ' ' A' ' 84' ' ' HIS . 0.4 OUTLIER -50.79 -37.18 41.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.569 179.74 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 49.5 ttm -83.68 -19.9 34.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.099 0.476 . . . . 0.0 111.002 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.4 ' O ' ' HG2' ' A' ' 93' ' ' GLU . . . -93.41 -43.83 8.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.151 -173.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.495 ' C ' ' HB3' ' A' ' 53' ' ' SER . 19.1 mt-30 -99.51 -51.38 3.79 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.36 -174.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.533 ' HB3' ' O ' ' A' ' 88' ' ' LEU . 0.4 OUTLIER -64.86 1.66 0.86 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.361 177.72 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.484 ' H ' ' C ' ' A' ' 91' ' ' GLN . 3.4 pt-20 . . . . . 0 C--O 1.248 1.006 0 C-N-CA 123.819 0.848 . . . . 0.0 112.196 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo . . . . . 0 CA--C 1.518 -0.319 0 N-CA-C 109.113 -1.149 . . . . 0.0 109.113 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.42 ' HB3' HD23 ' A' ' 41' ' ' LEU . 71.2 m -68.78 -176.55 0.84 Allowed 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 162.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.511 ' HE1' ' CD1' ' B' ' 38' ' ' ILE . 0.1 OUTLIER -77.24 -55.57 5.31 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.509 -0.877 . . . . 0.0 110.173 172.362 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.585 ' OD1' ' HG3' ' B' ' 42' ' ' MET . 1.1 p30 -76.21 -8.32 56.78 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.557 -1.201 . . . . 0.0 112.413 -167.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.568 ' CG2' ' HD3' ' A' ' 59' ' ' LYS . 0.2 OUTLIER -57.85 0.5 0.06 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -172.182 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.561 ' HB ' ' CZ ' ' B' ' 20' ' ' ARG . 4.0 m -72.88 117.92 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 167.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.67 ' HG3' ' CB ' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -115.86 158.42 22.98 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 121.568 -0.708 . . . . 0.0 110.189 176.621 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' GLN . . . . . 0.497 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 1.9 tt0 -56.44 112.9 1.38 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.372 173.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.2 -159.75 10.94 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 173.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 12.3 p -52.32 100.88 0.03 OUTLIER 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.932 0.366 . . . . 0.0 111.152 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.416 ' HD2' ' O ' ' B' ' 80' ' ' GLY . 18.3 pttp 42.89 42.17 2.92 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.383 1.073 . . . . 0.0 112.255 -175.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.448 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 43.1 tt0 -59.84 136.87 90.32 Favored Pre-proline 0 C--O 1.232 0.17 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . 0.533 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 27.6 Cg_exo -54.05 123.6 13.89 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.129 1.886 . . . . 0.0 109.907 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . 0.819 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 14.8 t80 -70.07 -53.61 10.85 Favored Pre-proline 0 N--CA 1.44 -0.96 0 CA-C-O 118.335 -0.841 . . . . 0.0 113.23 -166.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.511 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 32.0 Cg_exo -55.6 -18.56 20.71 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 121.55 1.5 . . . . 0.0 110.999 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.533 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 4.4 m-20 -89.92 -41.85 11.54 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.068 -1.424 . . . . 0.0 111.071 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' PHE . . . . . 0.497 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -56.9 -41.54 78.27 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.614 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.687 HG11 ' O ' ' B' ' 14' ' ' TYR . 2.4 p -82.52 -33.61 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.521 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' B' ' 15' ' ' PRO . . . -58.28 -33.33 69.31 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.457 -0.777 . . . . 0.0 112.012 176.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.743 ' O ' HG11 ' B' ' 24' ' ' VAL . 17.5 ptt180 -85.11 -27.85 25.98 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.571 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 9.3 tp -54.84 -46.2 74.6 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.814 171.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . 0.713 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 36.3 mt-30 -73.19 -45.88 53.78 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.157 178.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.713 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 11.3 t70 -51.89 -52.24 51.14 Favored 'General case' 0 C--N 1.314 -0.96 0 O-C-N 124.067 0.854 . . . . 0.0 111.841 -177.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' VAL . . . . . 0.743 HG11 ' O ' ' B' ' 20' ' ' ARG . 7.4 p -82.02 -23.27 9.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.302 0.572 . . . . 0.0 109.56 -174.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.794 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -72.06 -18.87 61.91 Favored 'General case' 0 C--O 1.204 -1.307 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . 0.414 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -86.7 -37.54 17.86 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.814 177.799 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.713 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 40.9 mmtt -67.96 -37.23 81.32 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.999 178.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 33.4 t -103.08 -7.49 21.31 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.403 0.621 . . . . 0.0 110.189 -171.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.794 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 86.6 mt -116.98 127.18 74.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.428 178.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.44 -9.47 54.55 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.276 0.56 . . . . 0.0 110.199 177.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.534 ' H ' HG21 ' B' ' 29' ' ' ILE . 13.7 t70 -98.68 136.13 39.19 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.258 -177.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -75.55 -29.56 59.42 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.67 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.528 ' O ' HG13 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -77.36 -51.49 10.74 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -174.944 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.464 ' HA ' HG21 ' B' ' 37' ' ' VAL . . . -58.61 -27.86 65.08 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.378 176.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.86 ' O ' HG13 ' B' ' 39' ' ' VAL . 1.7 tmm_? -66.34 -60.86 2.38 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 178.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.488 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 25.9 mtpt -55.03 -56.1 23.58 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.382 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.699 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 19.6 m -54.8 -32.37 25.96 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.258 -170.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.563 ' O ' ' HG2' ' B' ' 42' ' ' MET . 1.2 tt -86.97 -34.07 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.525 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.86 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.0 m -65.97 -47.69 84.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.438 176.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.673 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 54.6 mt-10 -67.48 -23.43 65.49 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.711 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.699 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -86.33 -55.94 3.67 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.258 176.648 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' MET . . . . . 0.678 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 14.7 mmt -62.2 -20.66 64.41 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-O 121.768 0.794 . . . . 0.0 109.578 -176.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.758 ' O ' ' HB3' ' B' ' 47' ' ' ALA . . . -48.59 -27.1 2.56 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.779 170.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' TYR . . . . . 0.49 ' CD1' ' HB2' ' B' ' 52' ' ' GLN . 9.1 t80 -105.36 -66.7 0.96 Allowed 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.472 ' CG ' HD11 ' B' ' 41' ' ' LEU . 13.1 mm-40 -47.97 -33.65 8.09 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 123.636 0.585 . . . . 0.0 112.405 -176.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.678 ' HB2' ' O ' ' B' ' 42' ' ' MET . 5.3 m-20 -99.55 -15.3 18.68 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.297 0.57 . . . . 0.0 111.724 -177.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.758 ' HB3' ' O ' ' B' ' 43' ' ' ALA . . . -63.11 168.53 4.08 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.39 0.614 . . . . 0.0 111.483 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . 0.539 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 11.2 m-20 -58.09 145.41 73.22 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.387 173.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -41.58 -49.49 5.18 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 122.741 2.294 . . . . 0.0 111.875 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.465 ' HA ' ' HB2' ' B' ' 53' ' ' SER . 0.3 OUTLIER -70.78 -33.69 71.01 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.372 1.069 . . . . 0.0 111.801 177.737 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.539 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 70.2 m -73.9 -39.16 64.06 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.29 0.566 . . . . 0.0 110.151 -174.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . 0.49 ' HB2' ' CD1' ' B' ' 44' ' ' TYR . 3.9 pt20 -73.42 -30.65 63.37 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 175.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' SER . . . . . 0.56 ' O ' ' HE2' ' B' ' 56' ' ' LYS . 3.7 m -68.03 -20.87 65.03 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.26 172.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.529 ' HB2' HD13 ' B' ' 79' ' ' ILE . . . -76.97 -27.86 54.92 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.359 -0.838 . . . . 0.0 109.877 168.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.596 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 20.9 mt -89.66 -31.78 5.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -171.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.596 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -40.62 -37.92 1.08 Allowed Pre-proline 0 N--CA 1.49 1.525 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -173.82 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 53.9 Cg_endo -64.17 -28.97 64.83 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.178 1.919 . . . . 0.0 113.022 175.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . 0.529 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 2.0 mt -98.54 -15.65 19.45 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.55 ' NZ ' HD13 ' B' ' 41' ' ' LEU . 0.3 OUTLIER -52.77 109.31 0.39 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.385 179.459 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.86 -30.24 10.15 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.944 -175.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 34.9 mmtt -103.68 115.31 30.26 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 122.244 1.021 . . . . 0.0 111.688 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.476 ' HB ' HG13 ' B' ' 68' ' ' VAL . 7.6 p -122.53 145.22 44.25 Favored Pre-proline 0 C--N 1.297 -1.681 0 CA-C-N 113.64 -1.618 . . . . 0.0 109.559 170.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.562 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 98.6 Cg_exo -48.47 141.45 19.52 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.182 1.921 . . . . 0.0 111.21 168.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.53 101.82 0.1 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.991 -173.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.08 -9.47 70.12 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.034 -0.603 . . . . 0.0 113.157 175.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.562 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 4.2 m -89.56 -162.69 0.9 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 122.349 1.071 . . . . 0.0 111.962 -177.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.8 125.9 45.8 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 113.118 -1.855 . . . . 0.0 110.858 -173.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.582 HG12 ' CD ' ' B' ' 40' ' ' GLU . 0.9 OUTLIER -79.24 -31.36 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 C-N-CA 118.567 -1.253 . . . . 0.0 108.547 176.175 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . 0.766 ' O ' HG13 ' B' ' 73' ' ' VAL . 7.0 mm -57.73 -49.28 81.32 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.139 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.522 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 42.8 t -48.81 -36.4 16.63 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.011 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.575 ' O ' ' HE3' ' B' ' 74' ' ' LYS . 1.4 mm-40 -84.81 -33.76 22.87 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 123.442 0.697 . . . . 0.0 110.591 -178.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' TYR . . . . . 0.544 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.0 m-30 -74.79 -37.8 62.29 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.671 -176.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . 0.819 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.7 m -70.47 -32.76 51.07 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.676 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 174.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' LYS . . . . . 0.575 ' HE3' ' O ' ' B' ' 71' ' ' GLU . 2.4 ttpp -72.58 -27.3 62.1 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.866 178.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' B' ' 72' ' ' TYR . . . -66.39 -41.82 88.81 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.3 174.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.455 ' HA ' HD12 ' B' ' 79' ' ' ILE . 4.2 m -101.12 10.52 40.83 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.496 -177.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -64.02 -27.94 69.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.059 178.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . 0.563 ' O ' ' HB2' ' B' ' 83' ' ' MET . . . -81.64 -22.08 60.69 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.619 171.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.529 HD13 ' HB2' ' B' ' 54' ' ' ALA . 49.9 mt -81.25 163.99 3.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . 0.416 ' O ' ' HD2' ' B' ' 11' ' ' LYS . . . 112.71 -13.12 25.0 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -174.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.86 155.36 8.03 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 175.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.51 -81.67 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.09 0.556 . . . . 0.0 112.339 178.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 83' ' ' MET . . . . . 0.563 ' HB2' ' O ' ' B' ' 78' ' ' GLY . 62.9 mtt -61.5 -29.74 70.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.677 0.275 . . . . 0.0 110.632 -176.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' HIS . . . . . 0.546 ' O ' ' HB2' ' B' ' 88' ' ' LEU . 8.2 t-80 -56.62 -32.53 65.39 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 175.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -84.43 -19.4 33.52 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.132 0.492 . . . . 0.0 110.39 -176.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.74 -46.54 10.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.547 176.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -80.16 -13.89 58.9 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.111 -175.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.552 ' O ' ' HB3' ' B' ' 92' ' ' LEU . 0.4 OUTLIER -50.54 -37.42 39.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.495 179.706 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 49.8 ttm -83.49 -20.09 34.6 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.025 0.44 . . . . 0.0 110.981 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -93.43 -43.55 8.69 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.092 -173.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' GLN . . . . . 0.5 ' C ' ' H ' ' B' ' 93' ' ' GLU . 19.1 mt-30 -99.62 -51.22 3.81 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.347 -174.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.552 ' HB3' ' O ' ' B' ' 88' ' ' LEU . 0.4 OUTLIER -65.11 1.77 0.92 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 121.171 0.51 . . . . 0.0 110.338 177.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.5 ' H ' ' C ' ' B' ' 91' ' ' GLN . 3.4 pt-20 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.182 -0.913 . . . . 0.0 111.944 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.403 ' HB2' ' H ' ' A' ' 2' ' ' SER . 92.8 Cg_endo . . . . . 0 CA--C 1.518 -0.303 0 N-CA-C 109.1 -1.154 . . . . 0.0 109.1 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.481 ' HB2' HG22 ' A' ' 5' ' ' THR . 73.6 m -68.83 -177.23 0.96 Allowed 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 162.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.668 ' CB ' ' HA ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -78.14 -53.92 6.83 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.649 172.549 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.57 ' OD1' ' HG ' ' B' ' 41' ' ' LEU . 2.2 p-10 -87.58 5.7 38.09 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.133 -0.939 . . . . 0.0 112.994 -164.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.481 HG22 ' HB2' ' A' ' 2' ' ' SER . 2.2 p -64.8 -3.83 3.73 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.069 0.462 . . . . 0.0 111.391 -176.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.507 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.6 m -75.38 131.9 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 175.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.696 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -153.18 158.91 42.47 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.425 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.3 tt0 -42.24 115.16 0.65 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 112.758 -2.019 . . . . 0.0 112.831 -178.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.16 -148.54 11.85 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.44 172.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.8 m -55.89 97.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.106 0.453 . . . . 0.0 110.937 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.0 pttt 40.61 40.28 0.89 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.332 1.053 . . . . 0.0 112.085 -174.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.407 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 42.3 tt0 -55.96 139.57 70.64 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.932 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.555 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 52.1 Cg_exo -51.29 122.67 10.51 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.158 1.905 . . . . 0.0 110.058 178.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.757 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 9.3 t80 -72.22 -52.88 6.8 Favored Pre-proline 0 N--CA 1.442 -0.842 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -166.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.558 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 36.7 Cg_exo -56.2 -20.01 29.73 Favored 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 121.665 1.577 . . . . 0.0 110.968 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.555 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.1 m-20 -89.76 -40.21 12.64 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 113.845 -1.525 . . . . 0.0 110.754 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.425 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -56.01 -43.79 78.04 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 175.512 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.663 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 2.4 p -80.58 -33.24 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.379 -179.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.72 -34.88 67.92 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 121.594 -0.691 . . . . 0.0 111.937 175.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.715 ' O ' HG13 ' A' ' 24' ' ' VAL . 16.7 ptt180 -84.93 -26.87 26.95 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.605 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 4.5 tp -54.35 -49.2 70.34 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 171.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.663 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 30.6 mt-30 -67.21 -52.29 43.01 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.338 177.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.783 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 23.8 t70 -47.53 -53.53 14.17 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 -175.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.715 HG13 ' O ' ' A' ' 20' ' ' ARG . 5.0 p -81.59 -28.3 10.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.452 0.644 . . . . 0.0 110.381 -168.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 1.014 ' HB1' ' CZ ' ' A' ' 35' ' ' ARG . . . -78.91 -17.69 55.11 Favored 'General case' 0 C--O 1.198 -1.623 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 175.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.545 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -76.21 -37.74 57.37 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 172.803 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.783 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 39.7 mmtt -64.23 -36.16 83.17 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.508 177.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.0 t -104.26 -12.93 16.37 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.086 0.469 . . . . 0.0 110.27 -172.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.625 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 91.7 mt -111.8 117.11 54.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.296 177.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.49 -1.78 56.27 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.225 0.536 . . . . 0.0 110.076 175.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.537 ' H ' HG22 ' A' ' 29' ' ' ILE . 10.8 t70 -99.52 131.67 45.37 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.29 -177.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -75.23 -25.48 58.14 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.841 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.55 ' O ' HG11 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -81.08 -52.8 7.0 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -175.18 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.444 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -59.79 -24.68 64.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.54 177.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 1.014 ' CZ ' ' HB1' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -72.73 -57.41 4.12 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.463 ' O ' HG22 ' A' ' 39' ' ' VAL . 22.4 mtpt -52.85 -55.6 21.9 Favored 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.706 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.698 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 13.9 m -55.82 -33.08 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.195 -171.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.599 HG23 HH12 ' A' ' 35' ' ' ARG . 0.2 OUTLIER -87.35 -31.4 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 119.642 -0.823 . . . . 0.0 111.687 177.761 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.796 HG12 ' NH2' ' A' ' 35' ' ' ARG . 1.3 m -57.41 -57.05 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 118.666 -1.213 . . . . 0.0 109.168 168.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.572 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 46.2 mt-10 -63.19 -29.74 71.03 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 124.252 1.021 . . . . 0.0 112.611 -175.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.698 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -85.43 -49.98 7.67 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.937 179.602 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.594 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 19.7 mmt -67.5 -20.5 65.45 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.56 0.695 . . . . 0.0 109.517 -177.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.64 ' HB2' ' OH ' ' A' ' 14' ' ' TYR . . . -52.36 -26.74 13.18 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.655 172.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.543 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 17.2 t80 -105.98 -68.12 0.89 Allowed 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 174.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.432 ' OE2' ' HA ' ' B' ' 5' ' ' THR . 8.8 mm-40 -48.47 -26.6 2.22 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 124.323 1.014 . . . . 0.0 113.024 -175.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.696 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.1 m-20 -108.15 -21.92 12.59 Favored 'General case' 0 N--CA 1.435 -1.212 0 O-C-N 122.083 -0.386 . . . . 0.0 111.567 -178.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.611 ' HB1' ' O ' ' A' ' 43' ' ' ALA . . . -59.49 178.95 0.13 Allowed 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.932 0.872 . . . . 0.0 112.925 -174.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.573 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 8.7 m-20 -60.2 140.45 91.17 Favored Pre-proline 0 N--CA 1.442 -0.83 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.452 174.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.401 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 79.5 Cg_exo -42.6 -47.73 7.51 Favored 'Trans proline' 0 C--N 1.33 -0.447 0 C-N-CA 122.877 2.385 . . . . 0.0 112.091 -178.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.506 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 0.3 OUTLIER -72.85 -33.4 66.11 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.119 0.967 . . . . 0.0 111.627 178.368 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.682 ' HA ' ' CD1' ' A' ' 79' ' ' ILE . 99.1 m -74.85 -37.28 62.26 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -173.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.513 ' HA ' HD13 ' A' ' 55' ' ' ILE . 3.8 pt20 -72.54 -31.4 65.27 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 174.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.574 ' HB3' ' C ' ' A' ' 91' ' ' GLN . 12.0 m -68.49 -21.76 64.59 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.178 -1.373 . . . . 0.0 110.409 174.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.495 ' HB3' HD11 ' A' ' 79' ' ' ILE . . . -78.22 -25.18 46.86 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.756 0.789 . . . . 0.0 109.617 169.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.553 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 25.4 mt -89.56 -32.02 5.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -173.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.62 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -42.4 -38.94 2.81 Favored Pre-proline 0 N--CA 1.487 1.423 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -173.492 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 56.0 Cg_endo -63.57 -28.96 70.1 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 122.346 2.031 . . . . 0.0 112.958 175.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.517 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.6 mt -96.92 -16.53 20.63 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.579 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -53.36 109.41 0.43 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.189 -178.768 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.79 -20.38 47.47 Favored Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.525 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -104.11 114.19 28.26 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.432 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.3 p -123.02 140.28 33.18 Favored Pre-proline 0 C--N 1.311 -1.096 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 171.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.534 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 87.6 Cg_exo -48.58 138.73 24.57 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.429 2.086 . . . . 0.0 111.513 170.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.73 101.02 0.12 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.431 -175.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.09 -14.34 44.41 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.723 177.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.534 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 17.9 m -89.96 175.92 7.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.555 0.693 . . . . 0.0 111.673 -178.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.732 ' OD1' ' HB ' ' A' ' 69' ' ' ILE . 32.8 t70 -87.94 139.27 30.69 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.086 177.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.536 HG23 ' HB3' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -79.48 -30.58 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 C-N-CA 118.049 -1.46 . . . . 0.0 108.832 178.448 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.76 ' O ' HG12 ' A' ' 73' ' ' VAL . 6.2 mm -59.09 -47.9 88.52 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.978 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.789 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 43.2 t -44.83 -39.37 5.27 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.253 175.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -86.54 -28.8 23.14 Favored 'General case' 0 CA--C 1.512 -0.505 0 C-N-CA 122.771 0.428 . . . . 0.0 111.086 -177.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.58 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.3 m-30 -76.55 -35.6 58.15 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.716 0.77 . . . . 0.0 109.462 -178.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.76 HG12 ' O ' ' A' ' 69' ' ' ILE . 1.5 m -71.39 -30.29 38.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 172.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -68.05 -32.43 72.77 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.292 175.143 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -63.03 -43.65 98.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.916 177.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.556 ' SG ' ' HB ' ' A' ' 79' ' ' ILE . 23.7 t -94.96 4.47 53.77 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.033 178.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 10.9 t70 -60.33 -26.07 66.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.233 0.54 . . . . 0.0 110.271 176.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 83' ' ' MET . . . -92.67 -28.36 12.66 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 115.452 -0.795 . . . . 0.0 112.501 174.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.682 ' CD1' ' HA ' ' A' ' 51' ' ' CYS . 65.0 mt -61.18 -87.01 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -172.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.448 ' N ' HG23 ' A' ' 79' ' ' ILE . . . 29.98 53.37 0.2 Allowed Glycine 0 C--N 1.339 0.707 0 N-CA-C 115.349 0.9 . . . . 0.0 115.349 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.572 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 80.52 -61.01 4.51 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.856 175.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.26 -69.55 0.14 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.416 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 65.6 mtt -73.94 -15.16 61.13 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.652 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 8.0 t-80 -58.58 -34.31 70.94 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.049 176.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.572 ' HG2' ' O ' ' A' ' 81' ' ' GLY . 31.8 mmtp -82.44 -14.85 54.42 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.229 -178.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.6 -47.13 9.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.782 0.801 . . . . 0.0 110.74 175.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 9.7 mmt -86.77 -13.26 45.69 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.612 -1.176 . . . . 0.0 112.177 -172.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.652 ' HB2' ' O ' ' A' ' 84' ' ' HIS . 0.6 OUTLIER -48.38 -39.43 22.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.194 0.521 . . . . 0.0 112.055 -179.103 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 56.7 ttp -83.23 -19.82 35.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.97 0.414 . . . . 0.0 111.045 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -91.79 -51.7 5.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.944 0.402 . . . . 0.0 111.93 -174.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.574 ' C ' ' HB3' ' A' ' 53' ' ' SER . 21.9 mt-30 -89.86 -57.54 2.83 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.168 -174.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.615 ' HB3' ' O ' ' A' ' 88' ' ' LEU . 1.2 tm? -53.27 -33.73 54.31 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 176.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 3.1 pt-20 . . . . . 0 C--O 1.25 1.116 0 O-C-N 125.147 1.53 . . . . 0.0 113.561 -177.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo . . . . . 0 CA--C 1.519 -0.271 0 N-CA-C 109.115 -1.148 . . . . 0.0 109.115 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.46 ' HB2' HG22 ' B' ' 5' ' ' THR . 74.3 m -68.69 -177.77 1.04 Allowed 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 162.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.647 ' CB ' ' HA ' ' B' ' 25' ' ' ALA . 0.1 OUTLIER -77.85 -53.82 7.05 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.64 172.827 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.551 ' OD1' ' HG ' ' A' ' 41' ' ' LEU . 2.1 p-10 -87.61 5.71 38.11 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.973 -164.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.46 HG22 ' HB2' ' B' ' 2' ' ' SER . 2.2 p -64.85 -3.75 3.71 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.038 0.447 . . . . 0.0 111.418 -176.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.515 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.6 m -75.5 132.15 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 175.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.715 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -153.32 158.76 42.05 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -179.724 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' GLN . . . . . 0.432 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.3 tt0 -42.32 115.14 0.65 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 112.95 -1.932 . . . . 0.0 112.845 -178.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.4 -148.58 12.29 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.424 173.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 21.6 m -55.45 97.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 117.187 0.493 . . . . 0.0 111.096 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 60.9 pttt 40.5 40.73 0.93 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.275 1.03 . . . . 0.0 111.974 -174.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.414 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 41.1 tt0 -56.4 139.53 74.02 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.891 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . 0.547 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 52.0 Cg_exo -51.19 122.45 10.07 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.25 1.967 . . . . 0.0 110.019 178.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . 0.755 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 9.3 t80 -72.19 -52.91 6.84 Favored Pre-proline 0 N--CA 1.44 -0.935 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -166.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.549 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 36.6 Cg_exo -55.94 -20.11 28.4 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 121.589 1.526 . . . . 0.0 110.979 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.547 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 0.9 OUTLIER -89.77 -39.96 12.79 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.869 -1.514 . . . . 0.0 110.826 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' PHE . . . . . 0.432 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -56.28 -43.66 79.04 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 175.575 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.658 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 2.4 p -80.61 -33.23 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.344 -178.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.78 -34.71 67.89 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 121.627 -0.671 . . . . 0.0 111.967 175.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.721 ' O ' HG13 ' B' ' 24' ' ' VAL . 16.6 ptt180 -85.04 -26.96 26.69 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.608 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 4.5 tp -54.33 -49.24 70.18 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 171.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . 0.663 ' HA ' ' HE ' ' B' ' 35' ' ' ARG . 30.9 mt-30 -67.16 -52.39 42.07 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.203 177.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.799 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 24.5 t70 -47.38 -53.67 13.24 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -175.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' VAL . . . . . 0.721 HG13 ' O ' ' B' ' 20' ' ' ARG . 4.9 p -81.55 -28.27 10.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.289 0.566 . . . . 0.0 110.405 -168.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 1.029 ' HB1' ' CZ ' ' B' ' 35' ' ' ARG . . . -78.86 -17.6 55.36 Favored 'General case' 0 C--O 1.198 -1.646 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 175.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . 0.535 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -76.6 -37.36 56.57 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 172.83 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.799 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 39.1 mmtt -64.79 -35.32 80.72 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.539 177.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 32.7 t -105.0 -12.38 16.2 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.026 0.441 . . . . 0.0 110.426 -172.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.634 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 91.6 mt -112.43 116.8 53.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.359 177.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.03 -1.49 54.89 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.227 0.537 . . . . 0.0 110.153 175.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.535 ' H ' HG22 ' B' ' 29' ' ' ILE . 10.5 t70 -99.61 131.59 45.51 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.164 -177.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -75.12 -25.78 58.72 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.858 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.542 ' O ' HG11 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -80.93 -53.02 6.82 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -174.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.457 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -59.6 -24.61 63.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.641 177.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 1.029 ' CZ ' ' HB1' ' B' ' 25' ' ' ALA . 0.0 OUTLIER -72.87 -57.29 4.18 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.964 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.461 ' O ' HG22 ' B' ' 39' ' ' VAL . 22.5 mtpt -52.91 -55.58 22.27 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.754 177.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.71 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 13.7 m -55.88 -32.91 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.402 -171.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.593 HG23 HH12 ' B' ' 35' ' ' ARG . 0.2 OUTLIER -87.35 -31.45 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.632 177.687 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.799 HG12 ' NH2' ' B' ' 35' ' ' ARG . 1.3 m -57.35 -57.02 11.8 Favored 'Isoleucine or valine' 0 C--N 1.343 0.308 0 C-N-CA 118.663 -1.215 . . . . 0.0 109.242 168.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.57 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 46.3 mt-10 -63.25 -29.74 71.02 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 124.282 1.033 . . . . 0.0 112.572 -175.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.71 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -85.42 -50.08 7.59 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.983 179.52 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' MET . . . . . 0.586 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 19.8 mmt -67.4 -20.29 65.51 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.618 0.723 . . . . 0.0 109.672 -177.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.633 ' HB2' ' OH ' ' B' ' 14' ' ' TYR . . . -52.54 -26.76 14.12 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.668 172.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' TYR . . . . . 0.542 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 16.9 t80 -105.93 -68.03 0.9 Allowed 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.454 ' OE2' ' HA ' ' A' ' 5' ' ' THR . 9.5 mm-40 -48.57 -26.69 2.33 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 124.259 0.975 . . . . 0.0 112.979 -175.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.715 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.2 m-20 -108.18 -21.9 12.59 Favored 'General case' 0 N--CA 1.435 -1.205 0 O-C-N 122.191 -0.318 . . . . 0.0 111.514 -178.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.597 ' HB1' ' O ' ' B' ' 43' ' ' ALA . . . -59.41 179.27 0.11 Allowed 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 122.018 0.913 . . . . 0.0 112.99 -174.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . 0.574 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 7.9 m-20 -60.43 140.42 91.98 Favored Pre-proline 0 N--CA 1.442 -0.846 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.436 174.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -42.41 -47.62 7.25 Favored 'Trans proline' 0 C--N 1.33 -0.411 0 C-N-CA 122.832 2.355 . . . . 0.0 112.251 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.51 ' OE1' ' HA ' ' B' ' 84' ' ' HIS . 0.3 OUTLIER -73.09 -33.51 65.64 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 124.226 1.01 . . . . 0.0 111.654 178.435 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.681 ' HA ' ' CD1' ' B' ' 79' ' ' ILE . 98.0 m -74.72 -37.18 62.62 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 120.911 0.386 . . . . 0.0 110.024 -173.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . 0.494 ' HA ' HD13 ' B' ' 55' ' ' ILE . 3.8 pt20 -72.52 -31.52 65.39 Favored 'General case' 0 C--O 1.211 -0.925 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 174.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' SER . . . . . 0.587 ' HB3' ' C ' ' B' ' 91' ' ' GLN . 13.2 m -68.42 -21.91 64.64 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.389 174.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.522 ' HB3' HD11 ' B' ' 79' ' ' ILE . . . -78.17 -25.0 47.0 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.756 0.789 . . . . 0.0 109.668 169.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.561 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 25.2 mt -89.62 -31.88 5.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -173.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.615 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -42.51 -38.79 2.82 Favored Pre-proline 0 N--CA 1.488 1.425 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -173.477 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 56.0 Cg_endo -63.74 -29.1 68.66 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 122.261 1.974 . . . . 0.0 112.912 175.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . 0.535 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.6 mt -96.65 -16.41 20.99 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.563 ' HA ' ' OH ' ' B' ' 72' ' ' TYR . 0.0 OUTLIER -53.42 109.37 0.43 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.161 -178.801 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.76 -20.08 49.14 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.493 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -104.15 114.27 28.39 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.427 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.3 p -122.96 140.4 33.33 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 171.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.541 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 86.5 Cg_exo -48.85 138.68 26.18 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.347 2.031 . . . . 0.0 111.537 170.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.79 101.2 0.13 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.421 -175.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.96 -14.29 44.97 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.817 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.541 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 19.0 m -89.85 176.21 6.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.671 0.748 . . . . 0.0 111.497 -178.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' ASP . . . . . 0.716 ' OD1' ' HB ' ' B' ' 69' ' ' ILE . 29.8 t70 -88.03 139.45 30.49 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.172 176.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.532 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.9 OUTLIER -79.6 -30.69 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 C-N-CA 118.072 -1.451 . . . . 0.0 108.765 178.417 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . 0.753 ' O ' HG12 ' B' ' 73' ' ' VAL . 6.1 mm -59.01 -47.92 88.33 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.079 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.832 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 41.0 t -44.9 -39.3 5.31 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.273 175.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -86.45 -29.03 23.13 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 121.101 0.477 . . . . 0.0 111.015 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' TYR . . . . . 0.572 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.3 m-30 -76.48 -35.54 58.35 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.675 0.75 . . . . 0.0 109.402 -178.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . 0.755 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.5 m -71.46 -30.5 39.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 172.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' B' ' 70' ' ' SER . 0.4 OUTLIER -67.92 -32.31 72.68 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.235 175.134 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -63.08 -43.76 97.64 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.888 177.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.564 ' SG ' ' HB ' ' B' ' 79' ' ' ILE . 26.3 t -95.08 4.4 53.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.037 178.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . 0.455 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 8.9 t70 -60.02 -26.58 66.2 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.141 176.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' B' ' 83' ' ' MET . . . -92.36 -27.82 14.5 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.554 174.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.681 ' CD1' ' HA ' ' B' ' 51' ' ' CYS . 65.2 mt -61.58 -86.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -172.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . 0.442 ' N ' HG23 ' B' ' 79' ' ' ILE . . . 29.87 53.55 0.19 Allowed Glycine 0 C--N 1.339 0.721 0 N-CA-C 115.252 0.861 . . . . 0.0 115.252 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.571 ' O ' ' HG2' ' B' ' 85' ' ' LYS . . . 80.11 -60.66 4.44 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.85 -0.69 . . . . 0.0 113.893 175.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.35 -69.25 0.15 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -173.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 83' ' ' MET . . . . . 0.416 ' HB2' ' O ' ' B' ' 78' ' ' GLY . 65.5 mtt -74.24 -14.93 61.0 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' HIS . . . . . 0.647 ' O ' ' HB2' ' B' ' 88' ' ' LEU . 7.9 t-160 -58.76 -34.35 71.32 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.975 176.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.571 ' HG2' ' O ' ' B' ' 81' ' ' GLY . 31.7 mmtp -82.38 -14.71 54.78 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.179 0.514 . . . . 0.0 110.288 -178.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.48 -47.73 9.02 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.666 0.746 . . . . 0.0 110.559 175.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 9.9 mmt -86.55 -13.05 47.02 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.592 -1.185 . . . . 0.0 112.176 -172.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.647 ' HB2' ' O ' ' B' ' 84' ' ' HIS . 0.6 OUTLIER -48.26 -39.51 21.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.242 0.544 . . . . 0.0 111.968 -179.277 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 56.6 ttp -83.23 -20.16 35.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.917 0.389 . . . . 0.0 110.912 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -91.54 -51.49 5.24 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.898 -174.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' GLN . . . . . 0.587 ' C ' ' HB3' ' B' ' 53' ' ' SER . 22.0 mt-30 -89.91 -57.76 2.75 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.076 -174.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.627 ' HB3' ' O ' ' B' ' 88' ' ' LEU . 1.2 tm? -53.11 -34.03 54.92 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 176.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' B' ' 91' ' ' GLN . 2.9 pt-20 . . . . . 0 C--O 1.249 1.037 0 O-C-N 125.087 1.492 . . . . 0.0 113.606 -177.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.443 ' C ' ' HA3' ' B' ' 60' ' ' GLY . 93.5 Cg_endo . . . . . 0 CA--C 1.517 -0.344 0 N-CA-C 109.114 -1.148 . . . . 0.0 109.114 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.9 m -65.31 177.78 1.04 Allowed 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 162.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.707 ' CB ' ' HA ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -77.27 -54.08 6.92 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.566 174.541 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.5 ' CG ' ' HG3' ' A' ' 42' ' ' MET . 1.8 p-10 -86.58 6.62 29.95 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.792 -165.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.623 ' CG2' ' HD3' ' B' ' 59' ' ' LYS . 0.7 OUTLIER -62.21 -4.94 1.97 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.025 0.441 . . . . 0.0 111.613 -177.507 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.647 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.4 m -75.93 130.3 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 174.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.699 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -154.79 159.64 40.75 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 118.6 -1.24 . . . . 0.0 113.643 -179.752 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.465 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.4 mt-30 -41.39 113.75 0.44 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.125 -1.852 . . . . 0.0 112.809 -178.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.98 -141.75 6.24 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.56 174.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.6 m -62.01 96.81 0.07 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 117.011 0.406 . . . . 0.0 110.528 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.2 pttt 41.54 41.94 1.8 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.423 1.089 . . . . 0.0 112.093 -176.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -58.77 140.0 86.12 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.114 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.509 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 31.5 Cg_exo -54.25 123.55 13.85 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.23 1.953 . . . . 0.0 110.041 178.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.739 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 10.4 t80 -71.13 -52.4 9.35 Favored Pre-proline 0 N--CA 1.439 -0.991 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -166.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.567 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 37.5 Cg_exo -56.47 -19.38 28.91 Favored 'Trans proline' 0 C--N 1.36 1.134 0 C-N-CA 121.478 1.452 . . . . 0.0 111.116 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.509 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.4 m-20 -90.71 -39.32 12.51 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 113.952 -1.476 . . . . 0.0 110.766 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.465 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -56.78 -44.05 81.46 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.532 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.674 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 2.4 p -78.72 -32.99 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.12 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.71 -35.11 68.14 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 121.967 -0.458 . . . . 0.0 111.91 175.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.722 ' O ' HG11 ' A' ' 24' ' ' VAL . 15.3 ptt180 -85.18 -25.38 27.44 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.602 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 3.9 tp -55.57 -48.73 74.31 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.313 171.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.674 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 36.4 mt-30 -66.78 -52.05 48.59 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.658 177.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.737 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 11.4 t70 -47.79 -53.75 14.43 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -175.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.722 HG11 ' O ' ' A' ' 20' ' ' ARG . 4.3 p -82.53 -26.6 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 CA-C-O 122.04 0.924 . . . . 0.0 109.56 -169.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.865 ' HB1' ' CZ ' ' A' ' 35' ' ' ARG . . . -78.51 -16.88 57.01 Favored 'General case' 0 C--O 1.197 -1.699 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 176.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.466 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -80.04 -37.14 34.62 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.821 0.82 . . . . 0.0 108.88 172.875 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.737 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 44.5 mmtt -63.69 -32.73 74.31 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.429 176.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.7 m -106.06 -11.39 16.14 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.06 0.457 . . . . 0.0 110.622 -174.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.657 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 96.3 mt -117.58 119.43 61.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.57 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.28 -1.87 58.27 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.346 0.593 . . . . 0.0 110.08 175.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.53 ' H ' HG23 ' A' ' 29' ' ' ILE . 9.6 t70 -96.65 121.83 38.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.385 -176.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -68.06 -23.02 64.91 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.999 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.518 ' HE3' ' OD2' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -82.42 -54.04 5.52 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -177.42 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.444 ' HA ' HG23 ' A' ' 37' ' ' VAL . . . -57.91 -24.96 60.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.84 178.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.899 ' NH1' ' HA ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -69.14 -62.2 1.48 Allowed 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 176.92 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.458 ' HB3' ' OE2' ' A' ' 40' ' ' GLU . 18.0 mtpt -52.43 -53.93 38.85 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 120.809 0.338 . . . . 0.0 111.119 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.693 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 14.2 m -55.27 -35.65 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.308 -172.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.66 HG23 HH22 ' A' ' 35' ' ' ARG . 0.1 OUTLIER -87.36 -26.95 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 178.088 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.687 HG12 ' O ' ' A' ' 35' ' ' ARG . 1.1 m -59.73 -55.97 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 119.091 -1.044 . . . . 0.0 108.316 169.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.554 ' HB3' HG22 ' A' ' 68' ' ' VAL . 41.7 mt-10 -61.52 -34.33 75.34 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.713 -178.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.693 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -74.87 -58.87 3.02 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.613 179.642 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.5 ' HG3' ' CG ' ' A' ' 4' ' ' ASN . 22.8 mmt -66.96 -20.13 65.84 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.418 0.628 . . . . 0.0 110.022 -174.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.648 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -51.75 -27.07 10.88 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.43 171.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.51 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 18.1 t80 -106.18 -67.6 0.92 Allowed 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.614 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 8.0 mm-40 -47.49 -32.91 5.66 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 124.377 1.048 . . . . 0.0 112.284 -173.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.699 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.4 m-20 -104.47 -21.06 13.51 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.413 -174.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 43' ' ' ALA . . . -59.46 179.43 0.11 Allowed 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.797 0.808 . . . . 0.0 112.86 -174.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.626 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 8.6 m-20 -60.1 141.05 90.58 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.346 175.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -43.1 -44.65 9.67 Favored 'Trans proline' 0 C--N 1.331 -0.368 0 C-N-CA 122.819 2.346 . . . . 0.0 112.025 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.504 ' OE2' ' HA ' ' A' ' 84' ' ' HIS . 0.2 OUTLIER -76.79 -31.74 57.19 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.314 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.626 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 81.4 m -76.96 -36.33 56.58 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 120.901 0.382 . . . . 0.0 110.238 -173.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.484 ' HA ' HD13 ' A' ' 55' ' ' ILE . 3.6 pt20 -73.25 -30.92 63.79 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 173.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.587 ' O ' ' HE3' ' A' ' 56' ' ' LYS . 3.9 m -68.91 -19.8 64.21 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.052 -1.431 . . . . 0.0 110.446 173.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.528 ' HB3' HD11 ' A' ' 79' ' ' ILE . . . -78.75 -27.1 44.68 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.646 0.736 . . . . 0.0 109.93 167.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.571 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 22.7 mt -89.23 -32.48 5.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -172.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.593 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -40.57 -38.72 1.29 Allowed Pre-proline 0 N--CA 1.488 1.428 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -174.461 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 53.3 Cg_endo -64.06 -28.53 65.75 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 122.233 1.956 . . . . 0.0 112.828 175.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.521 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.0 OUTLIER -99.51 -14.6 18.99 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.722 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.628 ' HD3' ' CG2' ' B' ' 5' ' ' THR . 0.1 OUTLIER -50.0 109.78 0.32 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.404 -178.844 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.443 ' HA3' ' C ' ' B' ' 1' ' ' PRO . . . 87.18 -17.94 39.49 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.358 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt -103.59 114.9 29.52 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.473 ' HB ' HG13 ' A' ' 68' ' ' VAL . 7.3 p -123.57 142.33 38.74 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.352 174.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.518 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 72.0 Cg_exo -52.35 137.71 56.13 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.349 2.033 . . . . 0.0 111.295 169.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.8 109.66 2.98 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.969 0.414 . . . . 0.0 110.898 -176.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.23 -16.96 44.9 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.112 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.518 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 14.9 m -94.22 175.0 6.86 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.164 0.507 . . . . 0.0 111.133 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -93.23 147.34 22.98 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.476 -0.784 . . . . 0.0 108.981 176.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.554 HG22 ' HB3' ' A' ' 40' ' ' GLU . 1.1 m -81.38 -29.63 10.81 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 C-N-CA 118.33 -1.348 . . . . 0.0 108.787 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.778 ' O ' HG13 ' A' ' 73' ' ' VAL . 5.3 mm -60.14 -47.24 92.79 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.133 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.71 -178.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 40.7 t -47.68 -36.58 11.4 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.14 177.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -85.89 -31.52 22.16 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-O 121.046 0.45 . . . . 0.0 111.018 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.597 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.2 m-30 -74.49 -36.51 63.27 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.672 0.749 . . . . 0.0 109.516 -178.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.778 HG13 ' O ' ' A' ' 69' ' ' ILE . 1.4 m -71.14 -30.72 41.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 173.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.476 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -69.7 -28.58 65.95 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.536 175.477 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 72' ' ' TYR . . . -65.69 -45.81 81.38 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.766 176.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.736 ' SG ' ' HB ' ' A' ' 79' ' ' ILE . 32.0 t -93.17 9.46 35.91 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.826 177.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.476 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 5.1 t70 -58.84 -26.79 64.5 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.572 175.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.8 -20.47 31.25 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.322 174.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.736 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 83.5 mt -83.93 129.89 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 121.108 0.48 . . . . 0.0 111.45 -176.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 161.28 33.7 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.746 175.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.592 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 141.24 -102.91 0.32 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.82 176.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.92 -54.84 42.01 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -173.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 59.3 mtt -67.34 -32.02 72.69 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.907 0.384 . . . . 0.0 110.22 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.504 ' HA ' ' OE2' ' A' ' 50' ' ' GLU . 7.5 t-80 -59.04 -36.59 75.26 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.747 176.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.592 ' HG2' ' O ' ' A' ' 81' ' ' GLY . 31.7 mmtp -80.07 -17.93 51.38 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 121.872 -0.518 . . . . 0.0 110.507 -177.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.08 -42.5 13.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.401 0.62 . . . . 0.0 110.703 176.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -85.48 -13.58 48.67 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.508 -175.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.49 ' HB2' ' O ' ' A' ' 84' ' ' HIS . 0.2 OUTLIER -49.02 -46.82 44.69 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 123.446 0.466 . . . . 0.0 111.752 -179.391 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 27.9 ttt -79.87 -14.59 58.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.999 0.428 . . . . 0.0 110.516 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -89.69 -47.32 8.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.779 -176.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.506 ' C ' ' HB3' ' A' ' 53' ' ' SER . 22.2 mt-30 -99.24 -50.89 3.98 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -170.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.443 ' HB2' HD11 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -45.83 -35.97 4.87 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.559 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 . . . . . 0 C--O 1.252 1.206 0 CA-C-N 114.074 -1.421 . . . . 0.0 112.705 -176.643 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' PRO . . . . . 0.443 ' C ' ' HA3' ' A' ' 60' ' ' GLY . 95.6 Cg_endo . . . . . 0 CA--C 1.518 -0.294 0 N-CA-C 109.191 -1.119 . . . . 0.0 109.191 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.44 ' H ' ' HB2' ' B' ' 1' ' ' PRO . 67.7 m -65.66 177.78 1.16 Allowed 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 162.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.705 ' CB ' ' HA ' ' B' ' 25' ' ' ALA . 0.1 OUTLIER -77.17 -54.28 6.7 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.524 174.583 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.495 ' CG ' ' HG3' ' B' ' 42' ' ' MET . 1.8 p-10 -86.48 6.56 29.88 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.726 -1.125 . . . . 0.0 112.673 -165.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.628 ' CG2' ' HD3' ' A' ' 59' ' ' LYS . 0.7 OUTLIER -62.28 -4.86 1.98 Allowed 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.98 0.419 . . . . 0.0 111.591 -177.425 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.657 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.4 m -75.92 130.44 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 174.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.688 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -154.99 159.46 40.38 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 118.648 -1.221 . . . . 0.0 113.717 -179.678 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' GLN . . . . . 0.467 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.4 mt-30 -41.12 114.01 0.45 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.276 -1.783 . . . . 0.0 112.832 -178.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.13 -141.94 6.43 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.623 174.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 20.0 m -61.66 96.82 0.07 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.93 0.365 . . . . 0.0 110.572 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 62.3 pttt 41.24 42.24 1.67 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.36 1.064 . . . . 0.0 112.209 -176.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -58.98 139.88 87.11 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.971 178.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . 0.516 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 31.4 Cg_exo -54.25 123.5 13.71 Favored 'Trans proline' 0 CA--C 1.511 -0.665 0 C-N-CA 122.219 1.946 . . . . 0.0 110.145 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . 0.732 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 10.2 t80 -70.94 -52.39 9.84 Favored Pre-proline 0 N--CA 1.44 -0.97 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -166.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.559 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 38.3 Cg_exo -56.47 -19.45 29.24 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 121.495 1.463 . . . . 0.0 111.127 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.516 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.3 m-20 -90.69 -38.93 12.75 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 113.933 -1.485 . . . . 0.0 110.895 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' PHE . . . . . 0.467 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -57.23 -43.94 83.34 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.562 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.655 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 2.4 p -78.72 -33.15 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.072 -179.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.65 -35.05 67.93 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 121.846 -0.534 . . . . 0.0 111.939 175.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.723 ' O ' HG11 ' B' ' 24' ' ' VAL . 15.3 ptt180 -85.13 -25.6 27.38 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.605 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 3.9 tp -55.26 -48.89 73.34 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 171.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . 0.655 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 36.1 mt-30 -66.65 -52.19 47.72 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.661 177.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.735 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 11.6 t70 -47.54 -54.01 12.84 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -176.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' VAL . . . . . 0.723 HG11 ' O ' ' B' ' 20' ' ' ARG . 4.2 p -82.46 -26.45 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 CA-C-O 121.975 0.893 . . . . 0.0 109.569 -169.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.862 ' HB1' ' CZ ' ' B' ' 35' ' ' ARG . . . -78.57 -16.81 56.99 Favored 'General case' 0 C--O 1.198 -1.638 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 176.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . 0.452 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -80.15 -37.29 33.77 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.025 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.735 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 45.0 mmtt -63.67 -32.83 74.44 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.333 177.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 29.2 m -106.02 -11.18 16.23 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.087 0.47 . . . . 0.0 110.578 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.678 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 95.9 mt -117.79 119.34 61.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.554 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.42 -1.63 58.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.309 0.576 . . . . 0.0 110.114 175.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.528 ' H ' HG23 ' B' ' 29' ' ' ILE . 9.3 t70 -96.84 121.96 39.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.457 -177.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -68.4 -22.68 64.62 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.95 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.509 ' HE3' ' OD2' ' B' ' 31' ' ' ASP . 0.0 OUTLIER -82.54 -53.94 5.56 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -177.555 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.461 ' HA ' HG23 ' B' ' 37' ' ' VAL . . . -57.95 -24.95 60.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.881 178.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.915 ' NH1' ' HA ' ' B' ' 35' ' ' ARG . 0.0 OUTLIER -69.11 -62.21 1.47 Allowed 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.843 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.441 ' HB3' ' OE2' ' B' ' 40' ' ' GLU . 18.0 mtpt -52.45 -54.06 37.22 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 120.715 0.293 . . . . 0.0 111.087 -178.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.689 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 14.1 m -55.1 -35.77 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.321 -172.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.652 HG23 HH22 ' B' ' 35' ' ' ARG . 0.1 OUTLIER -87.38 -26.94 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 178.142 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.675 HG12 ' O ' ' B' ' 35' ' ' ARG . 1.1 m -59.62 -56.05 19.8 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 C-N-CA 118.987 -1.085 . . . . 0.0 108.318 168.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.54 ' HB3' HG22 ' B' ' 68' ' ' VAL . 43.7 mt-10 -61.34 -34.66 75.63 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 114.46 -1.245 . . . . 0.0 111.672 -177.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.689 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -74.53 -58.86 3.02 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.7 179.716 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' MET . . . . . 0.495 ' HG3' ' CG ' ' B' ' 4' ' ' ASN . 22.9 mmt -66.86 -20.2 65.88 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.343 0.592 . . . . 0.0 109.964 -174.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.643 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -51.77 -27.22 11.47 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.313 171.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' TYR . . . . . 0.506 ' CG ' ' HD2' ' B' ' 59' ' ' LYS . 18.1 t80 -106.08 -67.57 0.92 Allowed 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 175.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.615 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 7.8 mm-40 -47.54 -33.04 5.94 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 124.378 1.049 . . . . 0.0 112.196 -173.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.688 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.4 m-20 -104.39 -20.93 13.57 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.419 -174.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' B' ' 43' ' ' ALA . . . -59.62 179.43 0.12 Allowed 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.8 0.809 . . . . 0.0 112.864 -174.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . 0.626 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 8.8 m-20 -59.99 140.98 90.24 Favored Pre-proline 0 N--CA 1.443 -0.796 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.488 175.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -43.4 -44.32 10.53 Favored 'Trans proline' 0 C--N 1.332 -0.337 0 C-N-CA 122.792 2.328 . . . . 0.0 112.016 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.503 ' OE2' ' HA ' ' B' ' 84' ' ' HIS . 0.2 OUTLIER -76.94 -31.55 56.7 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.326 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.626 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 83.4 m -77.26 -36.45 54.39 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -173.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . 0.467 ' HA ' HD13 ' B' ' 55' ' ' ILE . 3.6 pt20 -73.16 -30.94 63.93 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 173.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' SER . . . . . 0.592 ' O ' ' HE3' ' B' ' 56' ' ' LYS . 3.7 m -68.9 -19.84 64.23 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.183 -1.371 . . . . 0.0 110.498 173.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.52 ' HB3' HD11 ' B' ' 79' ' ' ILE . . . -78.67 -27.08 45.11 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.612 0.72 . . . . 0.0 110.006 167.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.572 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 22.6 mt -89.39 -32.24 5.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 -171.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.592 ' HE3' ' O ' ' B' ' 53' ' ' SER . 0.0 OUTLIER -40.7 -38.71 1.34 Allowed Pre-proline 0 N--CA 1.487 1.384 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -174.601 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 51.7 Cg_endo -63.72 -29.0 68.81 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.193 1.928 . . . . 0.0 112.809 175.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . 0.538 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.0 OUTLIER -99.29 -14.6 19.17 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 -179.5 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.623 ' HD3' ' CG2' ' A' ' 5' ' ' THR . 0.1 OUTLIER -49.87 109.78 0.32 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.448 -178.903 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . 0.443 ' HA3' ' C ' ' A' ' 1' ' ' PRO . . . 87.09 -18.32 36.89 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.357 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -103.36 114.85 29.46 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -178.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.47 ' HB ' HG13 ' B' ' 68' ' ' VAL . 7.4 p -123.55 142.41 38.91 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.353 174.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.549 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 74.7 Cg_exo -52.22 138.03 54.85 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.41 2.073 . . . . 0.0 111.419 168.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.21 108.53 2.74 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.068 -176.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.09 -17.2 41.56 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.114 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.549 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 16.3 m -94.14 175.28 6.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.177 0.513 . . . . 0.0 111.073 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -93.12 147.35 22.94 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.54 HG22 ' HB3' ' B' ' 40' ' ' GLU . 1.1 m -81.37 -29.54 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 C-N-CA 118.371 -1.331 . . . . 0.0 108.856 178.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . 0.778 ' O ' HG13 ' B' ' 73' ' ' VAL . 5.3 mm -60.18 -47.14 93.27 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.093 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.695 -178.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.432 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 40.8 t -48.01 -36.51 12.89 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.078 177.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -85.79 -31.25 22.44 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 122.862 0.465 . . . . 0.0 111.079 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' TYR . . . . . 0.585 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.2 m-30 -74.77 -36.72 62.55 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 121.671 0.748 . . . . 0.0 109.489 -178.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . 0.778 HG13 ' O ' ' B' ' 69' ' ' ILE . 1.4 m -70.9 -30.82 43.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 173.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' B' ' 77' ' ' ASP . 0.0 OUTLIER -69.66 -28.54 65.97 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.552 175.495 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' B' ' 72' ' ' TYR . . . -65.51 -46.12 80.89 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.752 176.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.731 ' SG ' ' HB ' ' B' ' 79' ' ' ILE . 32.1 t -93.02 9.78 34.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.84 178.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . 0.487 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 4.4 t70 -59.18 -26.5 64.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.637 175.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -94.21 -20.52 30.04 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.286 173.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.731 ' HB ' ' SG ' ' B' ' 76' ' ' CYS . 83.9 mt -83.58 130.03 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-O 121.133 0.492 . . . . 0.0 111.401 -176.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 161.43 33.16 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.888 175.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.613 ' O ' ' HG2' ' B' ' 85' ' ' LYS . . . 142.03 -103.17 0.32 Allowed Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.879 176.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.83 -54.9 41.11 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -173.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 83' ' ' MET . . . . . . . . . . . . . 58.1 mtt -67.45 -32.04 72.63 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.849 0.356 . . . . 0.0 110.174 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 84' ' ' HIS . . . . . 0.503 ' HA ' ' OE2' ' B' ' 50' ' ' GLU . 7.5 t-80 -58.95 -36.68 75.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.755 176.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.613 ' HG2' ' O ' ' B' ' 81' ' ' GLY . 31.7 mmtp -80.27 -17.43 52.18 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.542 -177.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.28 -42.73 13.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.673 176.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -85.27 -13.63 49.18 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.494 -175.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' B' ' 84' ' ' HIS . 0.2 OUTLIER -49.25 -46.26 45.84 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 123.445 0.466 . . . . 0.0 111.833 -179.232 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 28.0 ttt -80.32 -14.68 58.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.116 0.484 . . . . 0.0 110.529 -178.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -89.66 -47.32 8.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.507 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 91' ' ' GLN . . . . . 0.518 ' C ' ' HB3' ' B' ' 53' ' ' SER . 21.8 mt-30 -99.1 -51.15 3.92 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -170.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.447 ' HB2' HD11 ' B' ' 88' ' ' LEU . 0.0 OUTLIER -45.55 -36.24 4.49 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 179.628 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 . . . . . 0 C--O 1.249 1.057 0 CA-C-N 113.976 -1.465 . . . . 0.0 112.578 -176.492 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.415 ' HB2' ' H ' ' A' ' 2' ' ' SER . 90.6 Cg_endo . . . . . 0 N--CA 1.464 -0.227 0 N-CA-C 108.601 -1.346 . . . . 0.0 108.601 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.415 ' H ' ' HB2' ' A' ' 1' ' ' PRO . 51.2 m -70.44 -176.12 1.17 Allowed 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 163.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.474 ' CD2' ' HB2' ' A' ' 28' ' ' SER . 0.0 OUTLIER -77.14 -54.42 6.54 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 122.406 1.098 . . . . 0.0 109.062 171.681 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.53 ' HA ' HD11 ' A' ' 21' ' ' LEU . 2.4 p-10 -85.6 5.91 29.66 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 113.533 -1.667 . . . . 0.0 113.332 -160.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.4 ' O ' ' HG2' ' A' ' 7' ' ' ARG . 0.7 OUTLIER -69.24 -1.05 7.02 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -174.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.718 HG22 ' O ' ' A' ' 6' ' ' VAL . 24.0 m -81.41 92.84 2.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 122.259 1.028 . . . . 0.0 112.162 -174.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 1.112 ' NE ' ' HB3' ' A' ' 46' ' ' ASN . 13.8 mmm180 -107.19 150.6 26.44 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.506 -1.371 . . . . 0.0 112.978 -159.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.579 ' HG3' ' CG ' ' A' ' 17' ' ' PHE . 2.1 tt0 -44.41 109.12 0.14 Allowed 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 112.53 -2.123 . . . . 0.0 111.572 173.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.39 -152.56 9.42 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.742 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.8 m -55.81 97.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.911 0.355 . . . . 0.0 110.733 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.7 pttt 40.24 46.1 1.88 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.267 1.027 . . . . 0.0 111.935 -172.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -60.34 136.49 91.71 Favored Pre-proline 0 C--O 1.236 0.381 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.445 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 38.4 Cg_exo -53.46 120.52 7.92 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.198 1.932 . . . . 0.0 110.943 -177.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.798 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 5.4 t80 -64.94 -56.05 23.54 Favored Pre-proline 0 C--N 1.313 -0.986 0 C-N-CA 119.73 -0.788 . . . . 0.0 112.737 -161.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.553 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 35.2 Cg_exo -55.89 -19.69 26.46 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.009 1.806 . . . . 0.0 111.508 -176.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.445 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.2 m-20 -89.46 -38.41 14.08 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.233 -178.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.911 ' HE1' ' NH2' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -61.74 -42.12 98.55 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.09 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 14' ' ' TYR . 1.7 p -80.63 -31.69 12.71 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.9 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.841 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 15' ' ' PRO . . . -55.67 -36.74 67.43 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 121.762 -0.586 . . . . 0.0 110.975 175.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.724 ' O ' HG11 ' A' ' 24' ' ' VAL . 15.4 ptt180 -82.29 -27.08 32.56 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.644 HD13 ' NH1' ' A' ' 7' ' ' ARG . 9.7 tp -55.24 -44.3 75.38 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.175 172.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.655 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 26.1 mt-30 -73.97 -51.57 15.57 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.309 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.738 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 45.3 m-20 -47.02 -51.28 17.67 Favored 'General case' 0 C--N 1.313 -1.006 0 O-C-N 124.532 1.145 . . . . 0.0 110.917 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.724 HG11 ' O ' ' A' ' 20' ' ' ARG . 9.9 p -79.64 -27.15 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 C-N-CA 119.936 -0.705 . . . . 0.0 109.833 -171.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.638 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -66.69 -31.57 72.33 Favored 'General case' 0 C--O 1.204 -1.301 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 175.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.409 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -74.69 -35.96 62.75 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.042 -1.435 . . . . 0.0 109.932 -178.19 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.738 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 37.3 mmtt -67.41 -36.38 81.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.466 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.474 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 21.6 m -104.89 -10.23 17.45 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.193 0.521 . . . . 0.0 110.656 -171.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.638 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 78.1 mt -113.94 124.85 70.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.198 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.95 -1.87 57.73 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.947 0.403 . . . . 0.0 110.863 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.562 ' H ' HG22 ' A' ' 29' ' ' ILE . 4.1 t0 -114.13 140.12 48.77 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-O 121.618 0.723 . . . . 0.0 111.528 -177.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -71.02 -32.17 68.86 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.36 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.494 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 12.0 mttp -67.07 -56.1 11.5 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -176.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.465 ' HA ' HG21 ' A' ' 37' ' ' VAL . . . -61.92 -25.49 67.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.57 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.828 ' O ' HG12 ' A' ' 39' ' ' VAL . 1.8 tmm_? -68.67 -58.62 3.97 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.417 ' HB3' ' OE2' ' A' ' 40' ' ' GLU . 15.8 mtpt -55.91 -57.0 13.96 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.205 179.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.783 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 23.9 m -52.25 -36.91 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.048 -170.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.411 ' CD1' ' HE1' ' A' ' 3' ' ' PHE . 1.3 tt -88.31 -30.83 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 C-N-CA 119.823 -0.751 . . . . 0.0 112.161 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.828 HG12 ' O ' ' A' ' 35' ' ' ARG . 3.2 m -67.01 -50.16 66.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 119.24 -0.984 . . . . 0.0 109.242 174.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.634 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 54.7 mt-10 -66.51 -23.58 66.27 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 123.816 0.846 . . . . 0.0 112.406 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.783 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -85.84 -56.97 3.23 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.325 176.338 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.507 ' HG3' ' HB2' ' A' ' 4' ' ' ASN . 25.0 mmt -59.82 -24.95 64.59 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 121.348 0.594 . . . . 0.0 109.996 -175.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.703 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -46.66 -28.3 1.44 Allowed 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.149 174.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.576 ' CG ' ' HB2' ' A' ' 52' ' ' GLN . 7.7 t80 -103.99 -68.02 0.87 Allowed 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 174.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.722 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 5.5 mm-40 -45.23 -35.45 3.34 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.25 -1.341 . . . . 0.0 112.834 -171.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 1.112 ' HB3' ' NE ' ' A' ' 7' ' ' ARG . 1.4 m-20 -111.76 -7.34 14.22 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.873 -172.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -68.01 -169.9 0.15 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.601 0.715 . . . . 0.0 112.425 -175.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.578 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 11.2 m-20 -66.03 140.42 97.04 Favored Pre-proline 0 N--CA 1.442 -0.836 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.939 171.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.465 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 3.0 Cg_endo -46.74 -46.75 17.43 Favored 'Trans proline' 0 CA--C 1.53 0.308 0 C-N-CA 122.642 2.228 . . . . 0.0 111.928 -176.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.52 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 0.3 OUTLIER -72.15 -31.31 65.84 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 124.185 0.994 . . . . 0.0 111.62 177.8 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.578 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 96.0 m -75.25 -36.36 61.29 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 120.889 0.376 . . . . 0.0 110.03 -173.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.576 ' HB2' ' CG ' ' A' ' 44' ' ' TYR . 4.3 pt20 -73.38 -32.21 64.36 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 174.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.601 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 27.0 m -66.87 -21.46 66.01 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 114.033 -1.439 . . . . 0.0 110.064 173.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.519 ' HB1' HD11 ' A' ' 79' ' ' ILE . . . -77.85 -27.43 49.84 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.431 -0.793 . . . . 0.0 110.036 169.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.578 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 23.4 mt -89.11 -31.16 5.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -171.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.614 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.93 -39.27 2.64 Favored Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -173.347 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 57.3 Cg_endo -64.33 -25.98 63.9 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.457 2.104 . . . . 0.0 112.925 176.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.497 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.3 mt -99.96 -16.31 18.01 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.569 ' HE3' ' HB3' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -53.01 109.64 0.44 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.988 -178.947 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.29 -21.57 41.75 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.548 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -103.82 113.51 27.09 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 121.147 0.498 . . . . 0.0 110.032 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.12 143.78 43.51 Favored Pre-proline 0 C--N 1.312 -1.051 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 170.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.546 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 74.1 Cg_exo -46.35 142.85 8.73 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.767 2.311 . . . . 0.0 111.836 168.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.11 101.13 0.26 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.443 -174.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.36 -5.2 57.21 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.756 -0.656 . . . . 0.0 113.215 176.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.546 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 14.9 m -95.87 178.81 5.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.465 0.65 . . . . 0.0 111.854 -178.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.757 ' OD1' ' HB ' ' A' ' 69' ' ' ILE . 19.3 t70 -86.39 136.39 33.14 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.613 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.551 HG13 ' CD ' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -80.96 -30.89 11.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 C-N-CA 118.647 -1.221 . . . . 0.0 109.472 178.259 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.79 ' O ' HG12 ' A' ' 73' ' ' VAL . 14.5 mm -57.63 -46.78 86.46 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.223 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 178.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.4 t -43.24 -39.34 2.94 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.478 174.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -85.45 -33.59 21.85 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 123.413 0.685 . . . . 0.0 110.831 -177.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.634 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.2 m-30 -75.38 -35.04 61.14 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.467 -176.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.798 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.6 m -70.64 -31.92 47.73 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.459 ' HA ' ' HB2' ' A' ' 77' ' ' ASP . 23.1 ttpt -71.79 -27.53 63.01 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.616 -1.174 . . . . 0.0 109.865 176.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -64.8 -44.54 89.61 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.59 175.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.791 ' SG ' ' HB ' ' A' ' 79' ' ' ILE . 31.0 t -92.95 9.14 36.82 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.648 177.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.459 ' HB2' ' HA ' ' A' ' 74' ' ' LYS . 25.2 t70 -66.38 -11.42 51.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.507 0.67 . . . . 0.0 109.914 174.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -108.39 0.0 32.94 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.318 171.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.791 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 98.1 mt -103.8 137.72 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.138 0.494 . . . . 0.0 111.518 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 136.41 25.02 0.47 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.635 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.603 ' O ' ' HB3' ' A' ' 84' ' ' HIS . . . -165.83 -153.17 7.54 Favored Glycine 0 CA--C 1.49 -1.498 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.796 -176.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.2 -28.33 69.67 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.089 -1.055 . . . . 0.0 111.045 177.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 49.0 mtt -67.03 -32.2 73.26 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 175.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.603 ' HB3' ' O ' ' A' ' 81' ' ' GLY . 5.4 t-160 -63.22 -34.7 78.21 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-O 121.164 0.507 . . . . 0.0 109.876 173.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.449 ' HD2' ' O ' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -77.18 -19.42 56.79 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.986 0.422 . . . . 0.0 110.389 179.37 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.36 -49.29 8.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.489 176.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 66.7 mtt -73.12 -15.08 61.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.861 -177.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.582 ' O ' ' HB3' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -51.25 -38.9 55.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.025 179.185 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.8 ttp -84.43 -18.91 34.46 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.336 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -95.39 -37.09 11.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.017 0.437 . . . . 0.0 112.049 -172.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.597 ' C ' ' HB3' ' A' ' 53' ' ' SER . 21.7 mt-30 -105.8 -56.17 2.22 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.203 -176.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.582 ' HB3' ' O ' ' A' ' 88' ' ' LEU . 0.4 OUTLIER -61.14 -6.1 1.84 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.383 178.289 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.443 ' H ' ' C ' ' A' ' 91' ' ' GLN . 4.9 pt-20 . . . . . 0 C--O 1.25 1.124 0 C-N-CA 123.849 0.86 . . . . 0.0 112.343 -179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo . . . . . 0 N--CA 1.464 -0.23 0 N-CA-C 108.679 -1.316 . . . . 0.0 108.679 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 49.7 m -70.13 -176.13 1.09 Allowed 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 163.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.458 ' CD2' ' HB2' ' B' ' 28' ' ' SER . 0.0 OUTLIER -77.23 -54.36 6.59 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 122.398 1.095 . . . . 0.0 109.021 171.852 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.544 ' HA ' HD11 ' B' ' 21' ' ' LEU . 2.4 p-10 -85.49 5.97 28.95 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 113.446 -1.706 . . . . 0.0 113.366 -160.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.44 -1.09 7.57 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -174.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.735 HG22 ' O ' ' B' ' 6' ' ' VAL . 23.3 m -81.38 92.78 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-O 122.264 1.03 . . . . 0.0 112.08 -174.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 1.119 ' NE ' ' HB3' ' B' ' 46' ' ' ASN . 13.8 mmm180 -107.17 150.71 26.31 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.512 -1.368 . . . . 0.0 113.007 -159.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' GLN . . . . . 0.573 ' HG3' ' CG ' ' B' ' 17' ' ' PHE . 2.1 tt0 -44.43 109.23 0.14 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 112.626 -2.079 . . . . 0.0 111.617 172.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.45 -152.61 9.56 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.708 176.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 19.6 m -56.15 98.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.822 0.311 . . . . 0.0 110.709 -177.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 52.7 pttt 39.86 46.79 1.74 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.054 0.942 . . . . 0.0 111.909 -172.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.413 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 46.9 tt0 -60.81 136.33 93.05 Favored Pre-proline 0 C--O 1.234 0.278 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . 0.449 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 39.8 Cg_exo -53.34 120.55 7.94 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.079 1.852 . . . . 0.0 111.012 -177.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . 0.796 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 5.5 t80 -65.07 -56.04 22.98 Favored Pre-proline 0 C--N 1.314 -0.972 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.709 -161.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.554 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 32.1 Cg_exo -55.87 -19.62 26.01 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 121.987 1.792 . . . . 0.0 111.521 -176.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.449 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.2 m-20 -89.45 -38.62 13.93 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.145 -178.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' PHE . . . . . 0.903 ' HE1' ' NH2' ' B' ' 7' ' ' ARG . 0.1 OUTLIER -61.62 -42.15 98.47 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.273 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.653 HG12 ' O ' ' B' ' 14' ' ' TYR . 1.7 p -80.69 -31.48 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.947 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' B' ' 15' ' ' PRO . . . -55.96 -36.54 67.93 Favored 'General case' 0 C--N 1.315 -0.902 0 O-C-N 121.653 -0.654 . . . . 0.0 110.922 175.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.724 ' O ' HG11 ' B' ' 24' ' ' VAL . 15.5 ptt180 -82.37 -27.14 32.3 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.654 HD13 ' NH1' ' B' ' 7' ' ' ARG . 9.7 tp -55.14 -44.44 75.09 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.11 172.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . 0.645 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 25.5 mt-30 -73.97 -51.58 15.54 Favored 'General case' 0 CA--C 1.486 -1.494 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.24 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.724 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 41.7 m-20 -46.96 -51.38 17.17 Favored 'General case' 0 C--N 1.311 -1.08 0 O-C-N 124.34 1.025 . . . . 0.0 110.874 178.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' VAL . . . . . 0.724 HG11 ' O ' ' B' ' 20' ' ' ARG . 9.8 p -79.51 -27.29 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.789 -171.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.637 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -66.61 -31.66 72.5 Favored 'General case' 0 C--O 1.205 -1.288 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 175.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . 0.401 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -74.52 -36.26 63.18 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 114.0 -1.455 . . . . 0.0 109.81 -178.225 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.724 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.1 mmtt -67.17 -36.42 81.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.394 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' SER . . . . . 0.458 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 25.2 m -104.69 -10.46 17.47 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.364 0.602 . . . . 0.0 110.609 -171.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.637 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 78.3 mt -113.65 124.86 70.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.313 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.21 -1.94 57.91 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.972 0.415 . . . . 0.0 110.732 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.554 ' H ' HG22 ' B' ' 29' ' ' ILE . 4.0 t0 -113.48 140.59 47.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.58 0.705 . . . . 0.0 111.481 -177.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -71.55 -32.26 67.91 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.469 175.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.489 ' HD2' ' OD1' ' B' ' 31' ' ' ASP . 11.8 mttp -67.08 -55.92 12.24 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -176.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.471 ' HA ' HG21 ' B' ' 37' ' ' VAL . . . -61.97 -25.52 67.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.559 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.845 ' O ' HG12 ' B' ' 39' ' ' VAL . 1.8 tmm_? -68.7 -58.66 3.91 Favored 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.427 ' HB3' ' OE2' ' B' ' 40' ' ' GLU . 15.7 mtpt -55.86 -57.04 13.73 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.227 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.796 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 23.6 m -52.25 -36.91 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.094 -170.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.417 ' CD1' ' HE1' ' B' ' 3' ' ' PHE . 1.3 tt -88.16 -30.85 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.218 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.845 HG12 ' O ' ' B' ' 35' ' ' ARG . 3.2 m -66.96 -50.19 66.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.309 174.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.631 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 52.1 mt-10 -66.4 -23.76 66.37 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 123.891 0.877 . . . . 0.0 112.351 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.796 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.77 -57.12 3.17 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.238 176.447 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' MET . . . . . 0.505 ' HG3' ' HB2' ' B' ' 4' ' ' ASN . 25.1 mmt -59.63 -25.0 64.32 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.358 0.599 . . . . 0.0 109.993 -175.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.693 ' O ' ' HB2' ' B' ' 47' ' ' ALA . . . -46.63 -28.45 1.47 Allowed 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.133 174.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' TYR . . . . . 0.574 ' CG ' ' HB2' ' B' ' 52' ' ' GLN . 7.8 t80 -103.74 -68.02 0.86 Allowed 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 174.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.742 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 5.6 mm-40 -45.22 -35.74 3.5 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.186 -1.37 . . . . 0.0 112.778 -171.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 1.119 ' HB3' ' NE ' ' B' ' 7' ' ' ARG . 1.4 m-20 -111.7 -7.21 14.26 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.846 -172.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.693 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -68.03 -169.74 0.15 Allowed 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.62 0.724 . . . . 0.0 112.498 -175.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . 0.588 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 11.2 m-20 -66.21 140.38 96.85 Favored Pre-proline 0 N--CA 1.442 -0.843 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.083 171.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . 0.453 ' HB2' ' CD2' ' B' ' 92' ' ' LEU . 2.9 Cg_endo -46.83 -46.63 17.92 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.685 2.257 . . . . 0.0 111.866 -176.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.514 ' HA ' ' HB2' ' B' ' 53' ' ' SER . 0.3 OUTLIER -72.31 -31.14 65.44 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 124.199 1.0 . . . . 0.0 111.591 177.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 94.6 m -75.3 -36.43 61.12 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 120.996 0.427 . . . . 0.0 109.993 -173.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . 0.574 ' HB2' ' CG ' ' B' ' 44' ' ' TYR . 4.4 pt20 -73.43 -32.07 64.18 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 174.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' SER . . . . . 0.613 ' O ' ' HE2' ' B' ' 56' ' ' LYS . 26.4 m -66.97 -21.45 65.97 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 114.014 -1.448 . . . . 0.0 109.999 173.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.51 ' HB1' HD11 ' B' ' 79' ' ' ILE . . . -78.0 -27.29 48.98 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.398 -0.814 . . . . 0.0 109.985 169.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.582 HD13 ' HH ' ' B' ' 14' ' ' TYR . 23.3 mt -89.17 -31.28 5.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 -171.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.613 ' HE2' ' O ' ' B' ' 53' ' ' SER . 0.0 OUTLIER -41.8 -39.37 2.59 Favored Pre-proline 0 N--CA 1.488 1.435 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -173.263 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 57.5 Cg_endo -64.17 -26.25 64.99 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.383 2.055 . . . . 0.0 112.925 176.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . 0.507 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.4 mt -99.78 -16.54 18.06 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.566 ' HA ' ' OH ' ' B' ' 72' ' ' TYR . 0.0 OUTLIER -52.66 109.77 0.44 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.131 -179.093 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.97 -21.63 40.75 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.696 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -103.92 113.48 27.05 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.21 0.528 . . . . 0.0 110.051 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.18 143.41 42.59 Favored Pre-proline 0 C--N 1.312 -1.05 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.765 170.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.569 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 74.9 Cg_exo -46.04 142.79 7.95 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.686 2.257 . . . . 0.0 111.944 168.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.1 100.52 0.22 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.573 -174.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.21 -5.32 55.61 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.069 176.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.569 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 14.8 m -96.12 178.93 5.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.505 0.669 . . . . 0.0 111.782 -178.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' ASP . . . . . 0.749 ' OD1' ' HB ' ' B' ' 69' ' ' ILE . 19.5 t70 -86.49 136.42 33.1 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.635 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.553 HG13 ' CD ' ' B' ' 40' ' ' GLU . 0.8 OUTLIER -80.93 -30.95 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 C-N-CA 118.588 -1.245 . . . . 0.0 109.517 178.193 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . 0.793 ' O ' HG12 ' B' ' 73' ' ' VAL . 14.3 mm -57.57 -47.04 86.14 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.181 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 30.8 t -43.38 -39.22 3.08 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.45 174.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -85.34 -33.48 22.04 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 123.503 0.721 . . . . 0.0 110.807 -177.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' TYR . . . . . 0.623 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.1 m-30 -75.44 -35.04 61.0 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.449 -176.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . 0.796 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.6 m -70.86 -31.79 46.68 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 173.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' B' ' 77' ' ' ASP . 23.0 ttpt -71.84 -27.53 62.96 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.81 176.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -64.9 -44.18 90.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.651 175.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.776 ' SG ' ' HB ' ' B' ' 79' ' ' ILE . 30.7 t -93.45 9.22 37.46 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.612 177.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' B' ' 74' ' ' LYS . 24.7 t70 -66.2 -11.79 51.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.576 0.703 . . . . 0.0 110.068 173.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -108.37 0.55 32.88 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.222 171.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.776 ' HB ' ' SG ' ' B' ' 76' ' ' CYS . 98.0 mt -104.06 137.82 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 121.179 0.514 . . . . 0.0 111.401 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 136.43 24.36 0.49 Allowed Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.415 177.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.604 ' O ' ' HB3' ' B' ' 84' ' ' HIS . . . -165.28 -153.09 7.4 Favored Glycine 0 CA--C 1.49 -1.525 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.763 -176.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.89 -28.4 69.81 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.087 -1.057 . . . . 0.0 111.047 177.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 83' ' ' MET . . . . . . . . . . . . . 49.2 mtt -67.04 -32.0 72.9 Favored 'General case' 0 C--O 1.22 -0.491 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 175.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 84' ' ' HIS . . . . . 0.604 ' HB3' ' O ' ' B' ' 81' ' ' GLY . 5.3 t-160 -63.43 -34.94 78.84 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-O 121.207 0.527 . . . . 0.0 109.805 173.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' B' ' 85' ' ' LYS . 0.1 OUTLIER -77.0 -19.21 57.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.045 0.45 . . . . 0.0 110.333 179.42 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.52 -49.4 8.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.482 176.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 66.7 mtt -73.26 -14.8 61.39 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.879 -177.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.58 ' O ' ' HB3' ' B' ' 92' ' ' LEU . 0.2 OUTLIER -51.28 -39.08 56.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.949 179.158 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 58.2 ttp -84.17 -19.32 34.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.215 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -95.3 -36.69 11.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.062 0.458 . . . . 0.0 112.104 -172.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 91' ' ' GLN . . . . . 0.603 ' C ' ' HB3' ' B' ' 53' ' ' SER . 21.3 mt-30 -106.17 -56.14 2.23 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.28 -176.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.58 ' HB3' ' O ' ' B' ' 88' ' ' LEU . 0.4 OUTLIER -61.15 -5.9 1.75 Allowed 'General case' 0 CA--C 1.541 0.632 0 O-C-N 123.62 0.575 . . . . 0.0 110.305 178.135 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.439 ' H ' ' C ' ' B' ' 91' ' ' GLN . 4.7 pt-20 . . . . . 0 C--O 1.25 1.095 0 C-N-CA 123.799 0.84 . . . . 0.0 112.455 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.464 ' HB2' ' H ' ' A' ' 2' ' ' SER . 95.0 Cg_endo . . . . . 0 CA--C 1.517 -0.337 0 N-CA-C 109.293 -1.08 . . . . 0.0 109.293 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.464 ' H ' ' HB2' ' A' ' 1' ' ' PRO . 67.1 m -68.73 167.95 14.28 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 163.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.483 ' CE1' HD13 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -70.96 -54.38 11.52 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.992 0.901 . . . . 0.0 109.864 172.79 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.561 ' ND2' ' HE1' ' A' ' 42' ' ' MET . 3.0 p-10 -86.76 -4.04 59.13 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.419 -1.264 . . . . 0.0 113.181 -164.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.456 ' HA ' ' OE1' ' B' ' 45' ' ' GLU . 9.9 t -65.47 -2.97 3.72 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.29 0.567 . . . . 0.0 111.075 -173.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.579 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.7 m -73.05 135.26 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 172.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.717 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -154.59 159.43 40.86 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 -178.789 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.534 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.4 mt-30 -42.83 118.98 1.36 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 112.585 -2.098 . . . . 0.0 113.318 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.9 -161.66 37.68 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.843 169.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.5 m -48.05 102.44 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 117.097 0.448 . . . . 0.0 111.592 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.3 pttt 38.91 44.28 0.84 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.533 1.133 . . . . 0.0 112.498 -173.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.453 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 37.8 tt0 -61.96 138.04 95.59 Favored Pre-proline 0 C--O 1.234 0.26 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 177.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.558 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 50.4 Cg_exo -50.68 122.55 9.88 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.244 1.963 . . . . 0.0 110.173 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.765 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 11.3 t80 -71.28 -54.17 7.29 Favored Pre-proline 0 N--CA 1.44 -0.934 0 CA-C-O 118.471 -0.776 . . . . 0.0 113.08 -167.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.535 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 34.5 Cg_exo -55.69 -18.79 21.94 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 121.459 1.44 . . . . 0.0 111.122 -179.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.558 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 2.0 m-20 -90.13 -42.2 11.21 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.881 -1.509 . . . . 0.0 111.001 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.534 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -54.6 -44.17 72.8 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.16 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.771 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 2.0 p -80.84 -34.15 13.77 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.362 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.692 -178.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 15' ' ' PRO . . . -58.16 -31.64 67.43 Favored 'General case' 0 C--N 1.317 -0.841 0 O-C-N 121.276 -0.89 . . . . 0.0 111.881 177.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.708 ' O ' HG13 ' A' ' 24' ' ' VAL . 16.0 ptt180 -84.03 -29.9 26.54 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 175.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.549 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 8.3 tp -53.61 -49.61 67.45 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.992 172.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.771 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 24.6 mt-30 -69.43 -48.22 61.64 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.187 177.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.723 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 18.1 t70 -47.53 -53.31 14.8 Favored 'General case' 0 C--N 1.315 -0.933 0 O-C-N 124.267 0.979 . . . . 0.0 111.532 -177.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.708 HG13 ' O ' ' A' ' 20' ' ' ARG . 7.4 p -82.1 -22.51 9.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.151 0.5 . . . . 0.0 109.79 -173.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.785 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -72.42 -19.44 61.59 Favored 'General case' 0 C--O 1.202 -1.422 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 173.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.06 -37.44 17.44 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.707 178.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.723 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 37.0 mmtt -66.94 -34.48 77.87 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.694 178.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.6 m -103.58 -11.07 17.96 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.195 0.521 . . . . 0.0 110.582 -172.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.785 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 88.7 mt -118.15 129.76 74.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.67 -178.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.99 -1.44 52.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.441 0.639 . . . . 0.0 110.367 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.558 ' OD2' ' HB2' ' A' ' 33' ' ' LYS . 11.1 t70 -106.81 115.7 30.65 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.458 -177.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.649 ' OE2' ' HG3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -57.12 -33.33 67.24 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.149 178.262 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.649 ' HG3' ' OE2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -70.78 -54.72 10.62 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -173.354 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.457 ' HA ' HG21 ' A' ' 37' ' ' VAL . . . -60.68 -28.82 68.9 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.826 177.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.845 ' O ' HG13 ' A' ' 39' ' ' VAL . 2.1 tmm_? -65.4 -60.39 3.01 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 15.5 mtpt -55.41 -56.65 17.7 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.239 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.708 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 17.6 m -55.18 -33.68 30.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.112 -170.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.508 ' O ' ' HG2' ' A' ' 42' ' ' MET . 1.5 tt -87.25 -31.87 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.635 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.845 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.5 m -68.56 -48.14 73.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 119.015 -1.074 . . . . 0.0 109.178 175.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.663 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 73.0 mt-10 -63.18 -27.93 69.7 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 123.634 0.774 . . . . 0.0 112.749 176.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.708 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -86.04 -50.65 6.88 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.838 178.173 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.561 ' HE1' ' ND2' ' A' ' 4' ' ' ASN . 17.8 mmt -64.85 -20.87 66.64 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.632 0.729 . . . . 0.0 109.764 -178.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.673 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -50.62 -28.63 9.16 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.542 171.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.537 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 19.9 t80 -103.9 -67.61 0.89 Allowed 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 174.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.444 ' OE1' ' HA ' ' B' ' 5' ' ' THR . 27.2 mm-40 -50.54 -28.08 7.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.703 -1.135 . . . . 0.0 113.076 -173.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.717 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.1 m-20 -105.73 -22.24 13.0 Favored 'General case' 0 N--CA 1.435 -1.19 0 O-C-N 122.325 -0.234 . . . . 0.0 110.809 -177.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.616 ' HB3' ' O ' ' A' ' 43' ' ' ALA . . . -60.36 178.76 0.18 Allowed 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 122.059 0.933 . . . . 0.0 112.818 -174.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.658 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 17.1 m-20 -58.2 141.63 81.93 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 114.155 -1.384 . . . . 0.0 109.245 174.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.409 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 10.0 Cg_endo -55.02 -23.41 35.08 Favored 'Trans proline' 0 C--O 1.218 -0.515 0 C-N-CA 123.26 2.64 . . . . 0.0 112.407 -178.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.717 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 13.4 pm0 -88.93 -32.12 17.85 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 123.765 0.826 . . . . 0.0 110.85 175.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.717 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 85.8 m -80.5 -38.15 30.36 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.328 -171.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.506 ' HA ' HD13 ' A' ' 55' ' ' ILE . 4.3 pt20 -70.0 -29.72 66.86 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 172.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.57 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 4.8 m -71.36 -20.82 62.11 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.119 175.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.442 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -78.55 -25.15 45.38 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.689 0.757 . . . . 0.0 109.821 168.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.567 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 22.6 mt -89.97 -32.53 5.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -172.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.623 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.99 -39.5 2.9 Favored Pre-proline 0 N--CA 1.486 1.344 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -172.799 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 50.6 Cg_endo -62.18 -28.81 79.88 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.187 1.924 . . . . 0.0 112.646 176.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.515 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.3 mt -98.35 -15.7 19.62 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.569 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -52.39 109.17 0.36 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.078 -179.454 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.54 -22.36 39.42 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.462 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.9 mmmt -103.55 113.0 26.17 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.17 0.509 . . . . 0.0 109.831 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.4 p -124.84 146.45 53.19 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.802 172.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.541 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 92.1 Cg_exo -47.7 141.64 15.42 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.288 1.992 . . . . 0.0 111.62 166.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.12 106.17 0.48 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.643 -175.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.1 -9.91 72.19 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.022 -0.609 . . . . 0.0 113.311 175.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.541 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 8.9 m -90.51 175.86 6.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.275 0.538 . . . . 0.0 111.46 -177.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.656 ' OD2' ' HB ' ' A' ' 69' ' ' ILE . 0.4 OUTLIER -81.6 134.95 35.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.615 177.81 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.575 HG12 ' CD ' ' A' ' 40' ' ' GLU . 0.7 OUTLIER -78.53 -27.65 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 C-N-CA 118.863 -1.135 . . . . 0.0 108.991 177.373 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.755 ' O ' HG11 ' A' ' 73' ' ' VAL . 12.3 mm -58.12 -46.23 88.38 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.184 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.058 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 29.4 t -46.16 -37.54 7.14 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.157 176.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -85.63 -32.34 22.09 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.149 0.5 . . . . 0.0 110.705 -177.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.58 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.1 m-30 -75.93 -35.18 59.82 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.526 -176.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.765 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.5 m -71.79 -31.77 42.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 172.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -67.08 -31.77 72.48 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.339 175.459 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 72' ' ' TYR . . . -63.65 -46.98 83.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.109 177.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.789 ' SG ' ' HB ' ' A' ' 79' ' ' ILE . 24.4 t -92.44 9.35 34.67 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.902 178.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.435 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 12.1 t70 -62.56 -18.75 62.72 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.302 0.573 . . . . 0.0 110.261 175.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -101.75 -7.88 46.9 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.432 173.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.789 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 98.3 mt -92.66 115.49 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-O 121.443 0.639 . . . . 0.0 111.866 -178.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 170.7 58.06 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 174.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.35 169.01 38.94 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -171.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.47 -89.37 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 175.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.603 ' O ' ' HG3' ' A' ' 87' ' ' MET . 78.1 mtm -61.52 -35.23 77.12 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-O 120.762 0.315 . . . . 0.0 110.57 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -55.2 -34.7 64.14 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.301 174.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -79.34 -31.42 43.03 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.869 0.366 . . . . 0.0 110.501 -177.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.58 -52.42 26.31 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.935 0.874 . . . . 0.0 110.286 175.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.603 ' HG3' ' O ' ' A' ' 83' ' ' MET . 19.7 mtt -75.12 -12.43 60.31 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.924 -175.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.43 HD12 ' HB2' ' A' ' 92' ' ' LEU . 0.1 OUTLIER -50.39 -57.47 7.9 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.323 177.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 26.3 ttt -74.69 -16.33 60.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.9 0.381 . . . . 0.0 110.918 -176.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -95.39 -23.5 17.13 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -173.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.57 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 20.5 mt-30 -115.17 -52.8 2.66 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.168 -177.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.43 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -49.05 -29.88 5.6 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.022 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 93' ' ' GLU . 6.4 pt-20 . . . . . 0 C--O 1.25 1.111 0 CA-C-N 113.82 -1.537 . . . . 0.0 112.597 -178.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' PRO . . . . . 0.407 ' HB2' ' H ' ' B' ' 2' ' ' SER . 93.5 Cg_endo . . . . . 0 CA--C 1.515 -0.463 0 N-CA-C 109.364 -1.052 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.407 ' H ' ' HB2' ' B' ' 1' ' ' PRO . 68.7 m -68.92 168.08 14.4 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 163.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.477 ' CE1' HD13 ' B' ' 29' ' ' ILE . 0.1 OUTLIER -71.11 -54.41 11.2 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.843 0.83 . . . . 0.0 109.788 173.057 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.548 ' ND2' ' HE1' ' B' ' 42' ' ' MET . 3.1 p-10 -86.84 -4.06 59.13 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.492 -1.231 . . . . 0.0 113.13 -164.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.444 ' HA ' ' OE1' ' A' ' 45' ' ' GLU . 9.9 t -65.39 -2.97 3.6 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.185 0.517 . . . . 0.0 111.083 -173.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.594 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.7 m -73.1 134.96 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 172.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.704 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -154.28 159.5 41.3 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -178.753 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' GLN . . . . . 0.525 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.4 mt-30 -42.94 119.08 1.4 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 112.684 -2.053 . . . . 0.0 113.303 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.99 -161.45 37.53 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 169.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 23.3 m -48.31 102.72 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 117.21 0.505 . . . . 0.0 111.498 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 39.2 pttt 38.83 44.42 0.83 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.611 1.164 . . . . 0.0 112.482 -173.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.444 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 37.7 tt0 -62.05 137.96 95.71 Favored Pre-proline 0 C--N 1.332 -0.182 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . 0.564 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 51.1 Cg_exo -50.71 122.46 9.74 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.227 1.951 . . . . 0.0 110.218 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . 0.769 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 11.3 t80 -71.21 -54.13 7.45 Favored Pre-proline 0 N--CA 1.438 -1.034 0 CA-C-O 118.425 -0.798 . . . . 0.0 113.048 -167.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.541 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 34.5 Cg_exo -55.77 -18.87 22.65 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 121.458 1.438 . . . . 0.0 111.072 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.564 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.7 m-20 -90.08 -41.98 11.37 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.037 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' PHE . . . . . 0.525 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -54.82 -44.18 73.62 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 176.254 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.76 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 2.0 p -80.77 -34.29 13.97 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.283 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.626 -178.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.19 -31.51 67.36 Favored 'General case' 0 C--N 1.315 -0.893 0 O-C-N 121.321 -0.862 . . . . 0.0 111.848 177.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.7 ' O ' HG13 ' B' ' 24' ' ' VAL . 16.1 ptt180 -84.03 -29.9 26.54 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 175.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.559 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 8.3 tp -53.56 -49.78 66.95 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.055 172.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . 0.76 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 25.2 mt-30 -69.41 -48.24 61.68 Favored 'General case' 0 CA--C 1.493 -1.236 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.191 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.741 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 18.4 t70 -47.25 -53.48 13.27 Favored 'General case' 0 C--N 1.315 -0.898 0 O-C-N 124.187 0.929 . . . . 0.0 111.489 -177.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' VAL . . . . . 0.7 HG13 ' O ' ' B' ' 20' ' ' ARG . 7.4 p -82.13 -22.46 9.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.105 0.479 . . . . 0.0 109.746 -173.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.804 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -72.44 -19.46 61.57 Favored 'General case' 0 C--O 1.201 -1.462 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 173.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.03 -37.55 17.37 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.671 178.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.741 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 36.7 mmtt -66.59 -35.1 79.39 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.6 178.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 44.4 m -103.14 -11.15 18.27 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.327 0.584 . . . . 0.0 110.62 -172.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.804 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 88.9 mt -118.13 129.4 74.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.714 -178.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.53 -1.68 52.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.518 0.675 . . . . 0.0 110.375 176.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.568 ' OD2' ' HB2' ' B' ' 33' ' ' LYS . 11.3 t70 -106.39 115.67 30.6 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.418 -177.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 0.66 ' OE2' ' HG3' ' B' ' 33' ' ' LYS . 0.0 OUTLIER -57.17 -33.14 67.14 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.232 178.184 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.66 ' HG3' ' OE2' ' B' ' 32' ' ' GLU . 0.0 OUTLIER -70.96 -54.58 10.79 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -173.369 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.464 ' HA ' HG21 ' B' ' 37' ' ' VAL . . . -60.71 -28.91 69.0 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.821 177.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.85 ' O ' HG13 ' B' ' 39' ' ' VAL . 2.1 tmm_? -65.27 -60.44 2.99 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 15.6 mtpt -55.58 -56.52 19.32 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.193 -179.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.716 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 17.6 m -55.26 -33.59 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.119 -170.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.501 ' O ' ' HG2' ' B' ' 42' ' ' MET . 1.5 tt -87.36 -31.71 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.596 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.85 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.5 m -68.67 -48.02 73.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 118.944 -1.103 . . . . 0.0 109.193 175.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.663 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 73.2 mt-10 -63.25 -28.02 69.74 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 123.695 0.798 . . . . 0.0 112.668 176.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.716 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.99 -50.63 6.92 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.819 178.295 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' MET . . . . . 0.548 ' HE1' ' ND2' ' B' ' 4' ' ' ASN . 18.0 mmt -64.92 -20.85 66.67 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.683 0.754 . . . . 0.0 109.707 -178.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.666 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -50.65 -28.62 9.26 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.533 171.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' TYR . . . . . 0.539 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 20.1 t80 -103.98 -67.57 0.89 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 174.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.456 ' OE1' ' HA ' ' A' ' 5' ' ' THR . 26.8 mm-40 -50.66 -27.67 7.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.75 -1.114 . . . . 0.0 113.064 -173.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.704 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.2 m-20 -106.06 -22.07 12.97 Favored 'General case' 0 N--CA 1.435 -1.219 0 O-C-N 122.283 -0.261 . . . . 0.0 110.845 -178.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' B' ' 43' ' ' ALA . . . -60.45 178.72 0.19 Allowed 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 122.055 0.931 . . . . 0.0 112.827 -174.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . 0.653 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 17.8 m-20 -58.11 141.62 81.44 Favored Pre-proline 0 N--CA 1.44 -0.932 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.187 174.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . 0.409 ' HB2' ' CD2' ' B' ' 92' ' ' LEU . 10.0 Cg_endo -55.16 -23.25 35.58 Favored 'Trans proline' 0 C--O 1.22 -0.422 0 C-N-CA 123.21 2.606 . . . . 0.0 112.286 -178.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.688 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 13.5 pm0 -88.84 -32.26 17.89 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.863 0.865 . . . . 0.0 110.906 175.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.688 ' N ' ' HG2' ' B' ' 50' ' ' GLU . 83.9 m -80.43 -38.18 30.61 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.272 -171.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . 0.493 ' HA ' HD13 ' B' ' 55' ' ' ILE . 4.4 pt20 -70.02 -29.81 66.96 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 172.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' SER . . . . . 0.581 ' HB3' ' C ' ' B' ' 91' ' ' GLN . 4.9 m -71.31 -20.82 62.14 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 113.897 -1.501 . . . . 0.0 110.261 175.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.435 ' HB2' HD11 ' B' ' 79' ' ' ILE . . . -78.45 -25.25 45.85 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.672 0.749 . . . . 0.0 109.824 168.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.576 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 22.7 mt -90.02 -32.63 5.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 -172.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.618 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.82 -39.41 2.64 Favored Pre-proline 0 N--CA 1.487 1.388 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -172.853 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 50.9 Cg_endo -62.39 -28.4 78.29 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.308 2.005 . . . . 0.0 112.824 176.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . 0.52 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.3 mt -98.68 -15.78 19.27 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.567 ' HA ' ' OH ' ' B' ' 72' ' ' TYR . 0.0 OUTLIER -52.37 109.36 0.38 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.16 -179.545 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.25 -22.59 37.75 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.63 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 10.9 mmmt -103.43 112.79 25.85 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.146 0.498 . . . . 0.0 110.0 -178.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 7.4 p -124.73 146.21 52.13 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.076 172.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.567 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 93.3 Cg_exo -47.71 141.47 15.72 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.22 1.947 . . . . 0.0 111.537 166.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.07 105.67 0.43 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.662 -175.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.67 -9.86 70.95 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.334 175.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.567 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 9.7 m -90.83 175.21 7.08 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 117.192 0.496 . . . . 0.0 111.494 -177.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' ASP . . . . . 0.658 ' OD2' ' HB ' ' B' ' 69' ' ' ILE . 0.5 OUTLIER -80.85 134.83 35.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.591 177.834 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.58 HG12 ' CD ' ' B' ' 40' ' ' GLU . 0.7 OUTLIER -78.5 -27.73 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 C-N-CA 118.912 -1.115 . . . . 0.0 109.017 177.293 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . 0.753 ' O ' HG11 ' B' ' 73' ' ' VAL . 12.6 mm -58.08 -46.33 88.18 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.116 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.107 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.446 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 29.1 t -46.06 -37.51 6.83 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.275 175.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -85.53 -32.51 22.14 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.148 0.499 . . . . 0.0 110.689 -177.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' TYR . . . . . 0.571 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.1 m-30 -75.85 -34.95 60.07 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.611 -176.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . 0.769 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.5 m -72.01 -31.47 40.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 172.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' B' ' 70' ' ' SER . 0.0 OUTLIER -67.25 -31.82 72.43 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.309 175.504 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' B' ' 72' ' ' TYR . . . -63.8 -46.58 84.53 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.11 177.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.806 ' SG ' ' HB ' ' B' ' 79' ' ' ILE . 27.4 t -92.81 9.53 34.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.848 178.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . 0.434 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 11.7 t70 -62.97 -18.53 63.32 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.254 0.55 . . . . 0.0 110.235 175.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -101.58 -8.25 46.59 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.283 173.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.806 ' HB ' ' SG ' ' B' ' 76' ' ' CYS . 98.5 mt -92.39 115.56 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-O 121.412 0.625 . . . . 0.0 112.006 -178.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 170.36 58.29 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 174.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.25 168.87 39.05 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 -172.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.47 -89.42 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 175.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 83' ' ' MET . . . . . 0.597 ' O ' ' HG3' ' B' ' 87' ' ' MET . 78.3 mtm -61.56 -35.05 76.68 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 120.696 0.284 . . . . 0.0 110.599 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 84' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -55.46 -34.37 64.46 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.3 174.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -79.53 -31.27 42.08 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.807 0.337 . . . . 0.0 110.489 -177.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.72 -52.74 22.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.91 0.862 . . . . 0.0 110.078 175.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 87' ' ' MET . . . . . 0.597 ' HG3' ' O ' ' B' ' 83' ' ' MET . 20.0 mtt -74.87 -12.43 60.37 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.028 -175.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.422 HD12 ' HB2' ' B' ' 92' ' ' LEU . 0.1 OUTLIER -50.39 -57.53 7.77 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.452 177.87 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 26.5 ttt -74.46 -16.76 60.85 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.852 0.358 . . . . 0.0 110.923 -176.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -95.11 -23.32 17.37 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -173.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 91' ' ' GLN . . . . . 0.581 ' C ' ' HB3' ' B' ' 53' ' ' SER . 20.6 mt-30 -115.23 -52.53 2.67 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.207 -177.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.422 ' HB2' HD12 ' B' ' 88' ' ' LEU . 0.0 OUTLIER -49.25 -29.89 6.41 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.187 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.517 ' O ' ' HG3' ' B' ' 93' ' ' GLU . 6.5 pt-20 . . . . . 0 C--O 1.248 1.019 0 CA-C-N 113.826 -1.534 . . . . 0.0 112.458 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.454 ' HB2' ' H ' ' A' ' 2' ' ' SER . 92.5 Cg_endo . . . . . 0 CA--C 1.519 -0.251 0 N-CA-C 109.045 -1.175 . . . . 0.0 109.045 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.54 ' HB2' HG23 ' A' ' 5' ' ' THR . 15.6 m -68.12 179.84 1.43 Allowed 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 162.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.78 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -76.76 -52.2 9.99 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.245 -0.982 . . . . 0.0 108.536 166.41 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.509 ' HB2' HD11 ' A' ' 21' ' ' LEU . 2.4 p-10 -86.33 4.48 38.99 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.256 -1.338 . . . . 0.0 113.677 -164.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.582 ' O ' ' HG3' ' A' ' 7' ' ' ARG . 0.9 OUTLIER -63.73 -3.12 2.09 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 118.602 0.637 . . . . 0.0 111.532 -176.906 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.587 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 3.0 m -77.9 119.36 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-O 121.914 0.864 . . . . 0.0 109.824 177.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.783 ' HB3' ' O ' ' A' ' 46' ' ' ASN . 27.1 mtm180 -138.68 150.73 46.51 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 119.078 -1.049 . . . . 0.0 113.292 -170.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.579 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.4 mt-30 -41.99 114.35 0.53 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 112.882 -1.963 . . . . 0.0 113.019 176.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.81 -156.66 27.7 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.065 171.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.0 p -52.26 100.46 0.03 OUTLIER 'General case' 0 C--O 1.233 0.228 0 CA-C-N 117.092 0.446 . . . . 0.0 111.204 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 pttp 42.47 40.87 2.05 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.396 1.078 . . . . 0.0 112.297 -175.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.47 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 59.4 tt0 -59.21 136.44 88.32 Favored Pre-proline 0 C--O 1.235 0.3 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 177.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.537 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 36.8 Cg_exo -51.77 122.83 11.08 Favored 'Trans proline' 0 CA--C 1.508 -0.784 0 C-N-CA 122.121 1.88 . . . . 0.0 109.689 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.829 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 9.3 t80 -69.46 -53.86 12.09 Favored Pre-proline 0 N--CA 1.437 -1.119 0 CA-C-O 118.316 -0.849 . . . . 0.0 112.937 -166.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.547 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 31.3 Cg_exo -55.38 -20.43 25.84 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.435 1.424 . . . . 0.0 111.06 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.537 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 2.7 m-20 -89.87 -39.17 13.22 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.011 -1.45 . . . . 0.0 111.036 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.579 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -55.94 -45.38 78.83 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 175.451 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.743 HG12 ' O ' ' A' ' 14' ' ' TYR . 1.5 p -81.54 -31.79 11.41 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.031 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.57 -177.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.08 -33.8 69.46 Favored 'General case' 0 C--N 1.317 -0.833 0 O-C-N 121.386 -0.821 . . . . 0.0 111.752 176.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.716 ' O ' HG12 ' A' ' 24' ' ' VAL . 15.3 ptt180 -84.36 -26.9 28.08 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 176.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.596 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 6.7 tp -56.52 -46.55 80.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.002 172.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.689 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 6.3 mt-30 -73.39 -44.15 59.12 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.83 178.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.708 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 21.8 t70 -49.55 -56.06 11.23 Favored 'General case' 0 C--N 1.314 -0.942 0 O-C-N 124.239 0.962 . . . . 0.0 111.612 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 20' ' ' ARG . 6.4 p -80.36 -22.29 11.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 C-N-CA 120.538 -0.465 . . . . 0.0 109.923 -173.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.664 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -68.18 -29.09 67.88 Favored 'General case' 0 C--O 1.204 -1.341 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 173.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.464 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -80.04 -36.9 35.07 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.931 -178.406 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.708 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.5 mmtt -66.65 -32.51 73.87 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.483 178.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.8 m -105.34 -11.77 16.33 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.825 -171.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.664 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 88.7 mt -116.83 133.93 61.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.109 -177.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.26 -4.25 35.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.285 0.564 . . . . 0.0 110.521 176.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.571 ' H ' HG22 ' A' ' 29' ' ' ILE . 11.1 t70 -105.48 107.46 18.47 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.752 -178.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.578 ' OE2' ' HG3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -52.86 -32.22 43.53 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.229 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.615 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -73.53 -50.47 21.23 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -173.672 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.591 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -61.92 -27.84 69.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.525 175.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.846 ' O ' HG13 ' A' ' 39' ' ' VAL . 3.5 tmm_? -67.4 -57.12 7.17 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.476 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 19.4 mtpt -59.11 -54.82 42.7 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.273 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.754 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 19.4 m -54.69 -33.84 28.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.023 -173.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.78 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.2 tt -86.3 -31.87 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 119.904 -0.719 . . . . 0.0 111.428 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.846 HG13 ' O ' ' A' ' 35' ' ' ARG . 3.0 m -67.4 -49.8 68.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.779 173.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.62 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 63.9 mt-10 -63.76 -26.34 68.6 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.5 0.72 . . . . 0.0 112.62 177.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.754 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -85.63 -52.1 6.03 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.576 177.348 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.603 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 18.7 mmt -64.52 -20.42 66.2 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.809 0.814 . . . . 0.0 109.37 -178.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.664 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -50.75 -28.98 10.28 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.539 171.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.532 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 25.0 t80 -104.08 -68.78 0.83 Allowed 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.482 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 10.3 mm-40 -48.21 -32.41 7.09 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 124.13 0.894 . . . . 0.0 112.546 -175.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.783 ' O ' ' HB3' ' A' ' 7' ' ' ARG . 4.5 m-20 -103.28 -17.39 15.33 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.492 -175.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.664 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -62.98 178.27 0.49 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.744 0.783 . . . . 0.0 111.911 -177.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.666 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 17.7 m-20 -59.93 142.92 88.41 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.094 172.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -56.25 -21.46 36.23 Favored 'Trans proline' 0 C--O 1.219 -0.463 0 C-N-CA 123.182 2.588 . . . . 0.0 112.557 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.709 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 12.0 pm0 -88.99 -33.01 17.34 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 123.598 0.759 . . . . 0.0 110.727 174.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.709 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 72.2 m -81.21 -38.02 27.7 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.394 -171.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.605 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.3 pt20 -69.0 -29.89 68.18 Favored 'General case' 0 C--O 1.211 -0.94 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 172.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.475 ' CA ' ' HE2' ' A' ' 56' ' ' LYS . 5.9 m -72.23 -21.26 61.42 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 113.9 -1.5 . . . . 0.0 110.304 176.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 51' ' ' CYS . . . -76.03 -25.91 56.12 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.783 0.801 . . . . 0.0 109.495 168.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.605 HD12 ' HA ' ' A' ' 52' ' ' GLN . 22.7 mt -90.33 -33.46 5.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -172.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.617 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.39 -39.08 1.96 Allowed Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -172.863 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 52.5 Cg_endo -63.13 -31.12 75.53 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.164 1.91 . . . . 0.0 112.568 175.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.526 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 2.4 mt -93.92 -17.08 23.36 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.599 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -54.64 108.95 0.44 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.44 179.67 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.09 -23.84 34.41 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.568 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -104.46 113.88 27.74 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.096 0.474 . . . . 0.0 110.418 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.479 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.1 p -123.58 141.6 36.87 Favored Pre-proline 0 C--N 1.308 -1.21 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 168.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo . . . . . 0 C--N 1.343 0.255 0 C-N-CA 122.333 2.022 . . . . 0.0 111.52 170.905 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.515 -0.372 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.578 HG13 ' CD ' ' A' ' 40' ' ' GLU . 0.7 OUTLIER -77.69 -28.1 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 C-N-CA 118.227 -1.389 . . . . 0.0 108.95 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.783 ' O ' HG13 ' A' ' 73' ' ' VAL . 11.3 mm -58.14 -46.54 88.35 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.075 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.124 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 30.7 t -45.95 -38.33 7.5 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.188 176.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -86.2 -32.31 21.27 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 121.254 0.55 . . . . 0.0 111.046 -177.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.613 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.1 m-30 -75.27 -34.38 61.35 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.369 -176.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.829 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.6 m -72.09 -31.7 40.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.47 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -68.0 -30.87 70.23 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.25 176.461 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -63.74 -48.94 75.0 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.891 177.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.628 ' SG ' ' HB2' ' A' ' 14' ' ' TYR . 32.3 t -89.89 9.09 28.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.773 177.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.47 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 18.7 t70 . . . . . 0 C--N 1.318 -0.786 0 CA-C-O 121.349 0.595 . . . . 0.0 109.566 173.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 1' ' ' PRO . . . . . 0.416 ' HB2' ' H ' ' B' ' 2' ' ' SER . 84.0 Cg_endo . . . . . 0 CA--C 1.518 -0.306 0 N-CA-C 108.863 -1.245 . . . . 0.0 108.863 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 2' ' ' SER . . . . . 0.55 ' HB2' HG23 ' B' ' 5' ' ' THR . 15.8 m -68.48 -179.74 1.43 Allowed 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 162.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.776 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -77.01 -52.24 9.69 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.29 -0.964 . . . . 0.0 108.522 166.261 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.509 ' HB2' HD11 ' B' ' 21' ' ' LEU . 2.4 p-10 -86.31 4.69 37.98 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.708 -164.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.58 ' O ' ' HG3' ' B' ' 7' ' ' ARG . 0.9 OUTLIER -63.98 -2.88 2.15 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 118.6 0.636 . . . . 0.0 111.557 -176.932 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.571 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 3.0 m -78.04 119.25 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 121.823 0.82 . . . . 0.0 109.845 176.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.802 ' HB3' ' O ' ' B' ' 46' ' ' ASN . 27.3 mtm180 -138.63 150.72 46.56 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 119.18 -1.008 . . . . 0.0 113.247 -170.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 8' ' ' GLN . . . . . 0.583 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.4 mt-30 -42.15 114.51 0.56 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 112.755 -2.02 . . . . 0.0 112.887 176.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.11 -156.96 28.73 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.13 171.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 15.6 p -51.67 100.35 0.03 OUTLIER 'General case' 0 C--O 1.235 0.306 0 CA-C-N 117.016 0.408 . . . . 0.0 111.274 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 20.8 pttp 42.28 41.06 1.99 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.462 1.105 . . . . 0.0 112.225 -175.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.448 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 58.9 tt0 -59.23 136.43 88.38 Favored Pre-proline 0 C--O 1.234 0.283 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' PRO . . . . . 0.552 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 37.6 Cg_exo -51.69 123.05 11.43 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.13 1.887 . . . . 0.0 109.652 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' TYR . . . . . 0.836 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 9.5 t80 -69.6 -53.93 11.61 Favored Pre-proline 0 N--CA 1.437 -1.089 0 CA-C-O 118.313 -0.851 . . . . 0.0 112.958 -166.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.556 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 31.2 Cg_exo -55.4 -20.29 25.43 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 121.483 1.455 . . . . 0.0 111.066 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.552 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 3.1 m-20 -89.93 -39.17 13.18 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.019 -1.446 . . . . 0.0 111.023 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 17' ' ' PHE . . . . . 0.583 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -55.81 -45.59 78.26 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.307 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.745 HG12 ' O ' ' B' ' 14' ' ' TYR . 1.5 p -81.46 -31.69 11.48 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.063 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.576 -177.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.2 -33.83 69.71 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 121.402 -0.811 . . . . 0.0 111.737 176.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.71 ' O ' HG12 ' B' ' 24' ' ' VAL . 15.2 ptt180 -84.43 -26.47 28.24 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.604 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 6.7 tp -56.86 -46.77 81.57 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.912 172.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' GLN . . . . . 0.69 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 32.5 mt-30 -73.18 -44.31 60.05 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.835 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.725 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 20.5 t70 -49.15 -56.15 10.1 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 124.192 0.932 . . . . 0.0 111.649 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' VAL . . . . . 0.71 HG12 ' O ' ' B' ' 20' ' ' ARG . 6.5 p -80.31 -22.52 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.922 -173.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.673 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -68.15 -28.97 67.76 Favored 'General case' 0 C--O 1.203 -1.342 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 173.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' GLN . . . . . 0.463 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -80.23 -36.59 34.52 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.359 -1.291 . . . . 0.0 109.962 -178.498 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.725 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.9 mmtt -66.97 -32.35 73.53 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.502 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 16.9 m -105.5 -12.05 16.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.123 0.487 . . . . 0.0 110.765 -171.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.673 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 88.3 mt -116.44 134.24 60.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.083 -177.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.45 -4.27 34.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.382 0.611 . . . . 0.0 110.436 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.558 ' H ' HG22 ' B' ' 29' ' ' ILE . 11.3 t70 -105.43 107.68 18.79 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.722 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.568 ' OE2' ' HG3' ' B' ' 33' ' ' LYS . 0.0 OUTLIER -53.01 -32.22 45.45 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.213 179.487 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.614 ' O ' HG13 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -73.58 -50.23 22.32 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -173.593 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.587 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -62.16 -27.83 69.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.466 175.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.852 ' O ' HG13 ' B' ' 39' ' ' VAL . 3.5 tmm_? -67.43 -57.12 7.13 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.466 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 19.0 mtpt -59.11 -54.76 43.35 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.314 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.751 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 19.6 m -54.73 -33.82 28.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.073 -173.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.776 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.2 tt -86.41 -31.64 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.462 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.852 HG13 ' O ' ' B' ' 35' ' ' ARG . 3.0 m -67.43 -49.95 66.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 119.039 -1.065 . . . . 0.0 109.809 173.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.624 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 60.8 mt-10 -63.6 -26.5 68.72 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.506 0.722 . . . . 0.0 112.599 177.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.751 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.61 -52.0 6.1 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.436 -0.505 . . . . 0.0 111.469 177.487 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 42' ' ' MET . . . . . 0.597 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 18.7 mmt -64.66 -20.39 66.27 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.75 0.786 . . . . 0.0 109.256 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.656 ' O ' ' HB2' ' B' ' 47' ' ' ALA . . . -50.82 -28.92 10.4 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.563 171.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' TYR . . . . . 0.519 ' CG ' ' HD2' ' B' ' 59' ' ' LYS . 25.1 t80 -104.09 -68.71 0.83 Allowed 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.48 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 10.5 mm-40 -48.39 -31.92 6.86 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.091 0.87 . . . . 0.0 112.687 -175.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.802 ' O ' ' HB3' ' B' ' 7' ' ' ARG . 4.5 m-20 -103.88 -16.91 15.23 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 120.659 0.266 . . . . 0.0 111.533 -175.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -63.24 178.67 0.49 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.909 0.862 . . . . 0.0 111.978 -177.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 48' ' ' ASN . . . . . 0.664 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 17.6 m-20 -60.25 142.74 89.79 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.077 172.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.08 -21.54 35.31 Favored 'Trans proline' 0 C--O 1.218 -0.518 0 C-N-CA 123.19 2.593 . . . . 0.0 112.516 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' GLU . . . . . 0.688 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 11.7 pm0 -88.95 -32.9 17.44 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 123.557 0.743 . . . . 0.0 110.743 174.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.688 ' N ' ' HG2' ' B' ' 50' ' ' GLU . 72.1 m -81.31 -38.06 27.38 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.41 -171.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 52' ' ' GLN . . . . . 0.6 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.3 pt20 -68.89 -30.01 68.41 Favored 'General case' 0 C--O 1.211 -0.927 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 172.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 53' ' ' SER . . . . . 0.49 ' CA ' ' HE2' ' B' ' 56' ' ' LYS . 6.2 m -72.18 -21.16 61.47 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 113.941 -1.481 . . . . 0.0 110.478 176.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' B' ' 51' ' ' CYS . . . -76.21 -25.8 55.48 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.767 0.794 . . . . 0.0 109.466 168.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.6 HD12 ' HA ' ' B' ' 52' ' ' GLN . 22.7 mt -90.28 -33.5 5.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -172.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.619 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.41 -39.17 2.04 Favored Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -172.908 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 52.5 Cg_endo -62.95 -31.31 77.14 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.115 1.876 . . . . 0.0 112.554 175.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 58' ' ' LEU . . . . . 0.536 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 2.5 mt -93.92 -17.07 23.37 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 59' ' ' LYS . . . . . 0.601 ' HA ' ' OH ' ' B' ' 72' ' ' TYR . 0.0 OUTLIER -54.7 108.96 0.44 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.47 179.71 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.03 -23.86 34.36 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.626 -177.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -104.47 113.89 27.76 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.098 0.475 . . . . 0.0 110.295 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.471 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.2 p -123.48 141.81 37.27 Favored Pre-proline 0 C--N 1.309 -1.162 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 168.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo . . . . . 0 C--O 1.234 0.304 0 C-N-CA 122.296 1.997 . . . . 0.0 111.631 170.836 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.514 -0.406 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.568 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.7 OUTLIER -77.29 -28.5 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 C-N-CA 118.201 -1.399 . . . . 0.0 108.921 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.774 ' O ' HG13 ' B' ' 73' ' ' VAL . 11.2 mm -57.91 -46.56 87.51 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.112 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.169 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 30.2 t -45.93 -38.38 7.49 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.184 176.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -86.17 -32.25 21.35 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.245 0.545 . . . . 0.0 111.001 -177.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 72' ' ' TYR . . . . . 0.611 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.1 m-30 -75.36 -34.21 61.13 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.374 -176.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.836 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.6 m -72.26 -31.64 39.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 172.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 74' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' B' ' 77' ' ' ASP . 0.0 OUTLIER -68.08 -30.84 70.12 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.274 176.474 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 75' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -63.72 -49.15 74.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.843 -1.072 . . . . 0.0 109.833 177.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.621 ' SG ' ' HB2' ' B' ' 14' ' ' TYR . 32.1 t -89.58 9.14 27.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.78 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 77' ' ' ASP . . . . . 0.457 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 21.1 t70 . . . . . 0 C--N 1.32 -0.694 0 CA-C-O 121.344 0.592 . . . . 0.0 109.681 174.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.443 ' HB2' ' H ' ' A' ' 2' ' ' SER . 87.6 Cg_endo . . . . . 0 CA--C 1.518 -0.301 0 N-CA-C 108.856 -1.248 . . . . 0.0 108.856 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.443 ' H ' ' HB2' ' A' ' 1' ' ' PRO . 15.0 m -67.26 176.33 2.29 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 162.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.79 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -73.66 -52.69 12.49 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 166.099 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.515 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 2.4 p-10 -85.63 5.78 30.35 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.858 -1.519 . . . . 0.0 113.489 -165.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.07 -4.19 3.3 Favored 'General case' 0 C--N 1.315 -0.904 0 O-C-N 121.94 -0.475 . . . . 0.0 111.615 -176.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.608 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.0 m -77.86 133.01 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.797 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -154.63 159.42 40.8 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -179.671 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.427 ' HG2' ' HB3' ' A' ' 12' ' ' GLU . 2.1 tt0 -45.31 112.75 0.48 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 113.268 -1.787 . . . . 0.0 112.57 -177.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.13 -150.59 18.56 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.507 173.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 27.2 m -51.98 95.45 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.95 0.375 . . . . 0.0 111.407 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.1 pttp 37.76 43.47 0.48 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.385 1.074 . . . . 0.0 112.254 -172.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.427 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 50.3 tt0 -56.46 138.14 75.8 Favored Pre-proline 0 C--O 1.234 0.241 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.55 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 33.8 Cg_exo -53.68 121.87 10.31 Favored 'Trans proline' 0 CA--C 1.51 -0.722 0 C-N-CA 121.806 1.671 . . . . 0.0 109.476 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.824 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 14.5 t80 -71.91 -52.21 7.98 Favored Pre-proline 0 N--CA 1.438 -1.046 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -165.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.539 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 38.7 Cg_exo -56.52 -18.2 24.73 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 121.447 1.431 . . . . 0.0 110.691 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.55 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.5 m-20 -90.21 -42.34 11.08 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 113.754 -1.566 . . . . 0.0 110.874 178.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.517 ' CE2' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -55.02 -45.55 75.16 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 176.537 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.785 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 1.8 p -78.97 -34.41 16.81 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.402 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.6 -31.82 68.41 Favored 'General case' 0 C--N 1.318 -0.761 0 O-C-N 121.529 -0.732 . . . . 0.0 111.807 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.684 ' O ' HG12 ' A' ' 24' ' ' VAL . 15.7 ptt180 -84.3 -26.78 28.28 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 175.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.553 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 5.9 tp -58.27 -46.49 85.92 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.918 173.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.785 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 5.0 mt-30 -70.69 -47.28 60.67 Favored 'General case' 0 CA--C 1.493 -1.247 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.3 177.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.729 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 8.9 t70 -49.77 -51.96 35.37 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.531 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.684 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.2 p -81.08 -23.78 10.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.181 0.515 . . . . 0.0 109.719 -174.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.785 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -72.01 -19.15 61.9 Favored 'General case' 0 C--O 1.204 -1.335 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 174.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.412 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -86.59 -36.36 18.91 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.574 178.192 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.729 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.6 mmtt -67.26 -37.86 84.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.95 -1.023 . . . . 0.0 112.015 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.405 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 44.5 m -101.76 -10.38 20.0 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.163 0.506 . . . . 0.0 110.645 -172.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.785 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 85.5 mt -112.38 130.24 66.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.819 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.23 -0.93 57.39 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.068 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.674 ' H ' HG22 ' A' ' 29' ' ' ILE . 0.9 OUTLIER -121.55 127.74 51.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.347 0.594 . . . . 0.0 111.901 -178.09 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -56.49 -31.98 64.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.86 175.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.652 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 26.1 mttt -62.29 -61.12 2.67 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -177.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.584 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -61.94 -24.55 67.05 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.348 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.862 ' O ' HG13 ' A' ' 39' ' ' VAL . 1.7 tmm_? -69.7 -57.92 4.55 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.419 ' O ' HG22 ' A' ' 39' ' ' VAL . 20.9 mtpt -57.21 -55.65 31.94 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.943 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.725 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 19.7 m -53.93 -36.02 29.7 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.312 -170.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.79 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.2 tt -87.5 -28.97 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.96 -178.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.862 HG13 ' O ' ' A' ' 35' ' ' ARG . 3.0 m -70.1 -49.22 57.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 119.11 -1.036 . . . . 0.0 109.326 175.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.639 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 66.1 mt-10 -63.49 -24.22 67.73 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.805 0.842 . . . . 0.0 112.259 176.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.725 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -86.09 -56.99 3.2 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 177.147 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.515 ' HG3' ' HB2' ' A' ' 4' ' ' ASN . 20.7 mmt -62.44 -20.74 64.82 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.585 0.707 . . . . 0.0 109.792 -177.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.67 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -49.18 -28.23 4.26 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.539 170.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.567 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 5.7 t80 -108.22 -67.92 0.94 Allowed 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 175.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.673 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 5.2 mm-40 -46.9 -31.89 3.42 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 124.421 1.075 . . . . 0.0 112.179 -173.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.797 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.9 m-20 -104.8 -21.17 13.39 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -176.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -60.4 -179.13 0.1 Allowed 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.954 0.883 . . . . 0.0 112.974 -173.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -57.01 139.72 78.41 Favored Pre-proline 0 N--CA 1.443 -0.786 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.011 175.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.95 -23.31 42.42 Favored 'Trans proline' 0 C--O 1.222 -0.304 0 C-N-CA 123.209 2.606 . . . . 0.0 112.082 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 53' ' ' SER . 0.0 OUTLIER -88.12 -30.18 20.04 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.702 0.801 . . . . 0.0 110.505 174.194 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.947 ' SG ' ' HB2' ' A' ' 76' ' ' CYS . 43.8 t -83.24 -36.76 24.32 Favored 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.548 -170.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.555 ' HB2' ' CG ' ' A' ' 44' ' ' TYR . 4.1 pt20 -67.37 -30.35 70.12 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 171.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.479 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 17.1 m -69.95 -20.3 63.34 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 113.377 -1.738 . . . . 0.0 110.852 173.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -81.16 -24.75 37.36 Favored 'General case' 0 C--N 1.312 -1.039 0 O-C-N 121.399 -0.813 . . . . 0.0 110.014 167.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.536 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 25.4 mt -90.3 -30.81 5.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -171.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.615 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.37 -40.03 2.58 Favored Pre-proline 0 N--CA 1.487 1.38 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -174.458 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 49.9 Cg_endo -62.42 -27.5 77.34 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.313 2.009 . . . . 0.0 112.794 176.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.536 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.0 OUTLIER -100.52 -15.86 17.71 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.567 ' HE3' ' HB3' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -53.45 109.22 0.42 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.252 -177.924 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.468 ' N ' ' HZ3' ' A' ' 59' ' ' LYS . . . 92.43 -20.64 42.79 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.34 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -103.87 113.63 27.29 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.403 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.3 p -122.92 144.15 42.26 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 173.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo . . . . . 0 N--CA 1.463 -0.305 0 C-N-CA 122.153 1.902 . . . . 0.0 111.329 168.944 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.759 ' OD1' ' HB ' ' A' ' 69' ' ' ILE . 5.4 t70 . . . . . 0 CA--C 1.518 -0.269 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.604 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -79.81 -28.84 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 C-N-CA 118.224 -1.39 . . . . 0.0 109.173 179.218 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.784 ' O ' HG13 ' A' ' 73' ' ' VAL . 11.7 mm -60.57 -46.2 95.97 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.016 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.94 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.3 t -44.58 -38.93 4.56 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.146 175.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.482 ' O ' ' HE2' ' A' ' 74' ' ' LYS . 7.0 mm-40 -85.84 -32.04 21.95 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 123.55 0.74 . . . . 0.0 111.419 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.583 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.0 m-30 -75.41 -34.6 61.04 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.513 0.673 . . . . 0.0 109.421 -176.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.824 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.4 m -71.81 -32.09 43.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 172.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.482 ' HE2' ' O ' ' A' ' 71' ' ' GLU . 13.3 ttpt -71.66 -25.94 62.33 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.406 177.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -65.21 -46.6 80.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.806 174.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.947 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 40.5 t -87.46 0.8 55.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.158 178.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.4 t70 . . . . . 0 C--N 1.323 -0.56 0 CA-C-O 121.64 0.733 . . . . 0.0 109.579 175.066 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 1' ' ' PRO . . . . . 0.403 ' HB2' ' H ' ' B' ' 2' ' ' SER . 88.6 Cg_endo . . . . . 0 CA--C 1.518 -0.297 0 N-CA-C 108.762 -1.284 . . . . 0.0 108.762 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 2' ' ' SER . . . . . 0.403 ' H ' ' HB2' ' B' ' 1' ' ' PRO . 14.7 m -67.56 176.01 2.59 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 162.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.762 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -73.37 -52.65 13.06 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.085 -1.046 . . . . 0.0 108.286 166.265 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.524 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.4 p-10 -85.77 5.84 30.65 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 113.936 -1.483 . . . . 0.0 113.429 -165.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.92 -4.42 3.31 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 118.256 0.48 . . . . 0.0 111.707 -176.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.608 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 1.9 m -77.62 133.16 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.78 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.1 OUTLIER -155.0 159.08 40.08 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -179.65 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 8' ' ' GLN . . . . . 0.432 ' HG2' ' HB3' ' B' ' 12' ' ' GLU . 2.1 tt0 -45.01 112.65 0.46 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 113.211 -1.813 . . . . 0.0 112.584 -177.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.08 -150.52 18.3 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.411 173.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 33.3 m -52.07 95.17 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 117.023 0.411 . . . . 0.0 111.49 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 21.0 pttp 37.9 43.93 0.56 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.438 1.095 . . . . 0.0 111.99 -172.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.432 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 52.0 tt0 -56.75 138.1 77.84 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.411 177.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 13' ' ' PRO . . . . . 0.55 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 33.6 Cg_exo -53.67 122.12 10.75 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 121.737 1.625 . . . . 0.0 109.477 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' TYR . . . . . 0.826 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 14.6 t80 -72.17 -52.22 7.44 Favored Pre-proline 0 N--CA 1.438 -1.04 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -165.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.534 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 37.7 Cg_exo -56.52 -18.01 24.06 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 121.547 1.498 . . . . 0.0 110.685 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.55 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.6 m-20 -90.39 -42.52 10.87 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.846 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 17' ' ' PHE . . . . . 0.511 ' CE2' HD22 ' B' ' 21' ' ' LEU . 0.0 OUTLIER -54.91 -45.8 74.78 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.554 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.785 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 1.7 p -78.77 -34.52 17.4 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.289 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.281 -178.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.94 -31.23 68.51 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 121.485 -0.76 . . . . 0.0 111.843 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.681 ' O ' HG12 ' B' ' 24' ' ' VAL . 15.6 ptt180 -84.67 -26.41 27.78 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 175.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.562 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 5.9 tp -58.54 -46.53 86.63 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.933 172.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' GLN . . . . . 0.785 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 5.0 mt-30 -70.58 -47.29 60.99 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.256 177.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.727 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 8.3 t70 -49.85 -51.8 37.4 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 124.202 0.938 . . . . 0.0 111.576 -177.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' VAL . . . . . 0.681 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.2 p -81.17 -23.83 10.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -174.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.788 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -71.77 -19.3 62.04 Favored 'General case' 0 C--O 1.204 -1.294 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 174.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.6 -36.31 18.93 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.531 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.727 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.9 mmtt -67.36 -37.61 83.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.142 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 46.5 m -101.85 -10.63 19.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.194 0.521 . . . . 0.0 110.712 -172.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.788 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 85.4 mt -112.36 130.24 66.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.748 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.23 -0.67 57.4 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.001 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.677 ' H ' HG22 ' B' ' 29' ' ' ILE . 0.9 OUTLIER -121.82 127.85 51.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.326 0.584 . . . . 0.0 112.069 -178.172 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -56.66 -31.8 64.76 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.825 176.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.644 ' HD2' ' OD1' ' B' ' 31' ' ' ASP . 25.9 mttt -62.48 -61.0 2.74 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -177.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.562 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -62.0 -24.51 67.08 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.413 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.861 ' O ' HG13 ' B' ' 39' ' ' VAL . 1.7 tmm_? -69.83 -57.81 4.64 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.401 ' O ' HG22 ' B' ' 39' ' ' VAL . 20.6 mtpt -57.28 -55.52 33.75 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.948 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.736 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 19.8 m -54.07 -35.92 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.325 -170.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.762 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.2 tt -87.52 -29.13 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 C-N-CA 119.744 -0.783 . . . . 0.0 111.932 -178.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.861 HG13 ' O ' ' B' ' 35' ' ' ARG . 3.0 m -69.88 -49.4 57.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 119.156 -1.018 . . . . 0.0 109.318 175.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.64 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 66.4 mt-10 -63.41 -24.11 67.69 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.812 0.845 . . . . 0.0 112.377 176.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.736 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -86.21 -56.98 3.19 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 177.114 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 42' ' ' MET . . . . . 0.524 ' HG3' ' HB2' ' B' ' 4' ' ' ASN . 20.8 mmt -62.5 -20.76 64.92 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-O 121.524 0.678 . . . . 0.0 109.812 -177.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.67 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -48.88 -28.4 3.75 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.673 -1.148 . . . . 0.0 110.603 170.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' TYR . . . . . 0.589 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 5.6 t80 -108.17 -67.68 0.95 Allowed 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 175.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.682 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 5.0 mm-40 -46.94 -32.19 3.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 124.433 1.083 . . . . 0.0 112.109 -173.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.78 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 5.0 m-20 -104.59 -21.21 13.45 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -176.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.607 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -60.44 -179.27 0.11 Allowed 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.928 0.87 . . . . 0.0 112.95 -173.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -56.95 139.67 78.09 Favored Pre-proline 0 N--CA 1.444 -0.758 0 CA-C-N 114.403 -1.272 . . . . 0.0 108.892 175.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.78 -23.31 41.07 Favored 'Trans proline' 0 C--O 1.222 -0.321 0 C-N-CA 123.288 2.659 . . . . 0.0 112.12 -177.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' B' ' 50' ' ' GLU . 0.0 OUTLIER -88.16 -30.27 19.92 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.482 174.181 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.946 ' SG ' ' HB2' ' B' ' 76' ' ' CYS . 43.7 t -83.19 -36.53 24.61 Favored 'General case' 0 N--CA 1.426 -1.662 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.614 -170.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 52' ' ' GLN . . . . . 0.562 ' HB2' ' CG ' ' B' ' 44' ' ' TYR . 4.2 pt20 -67.66 -30.24 69.74 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 171.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 53' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' B' ' 50' ' ' GLU . 14.7 m -69.94 -20.27 63.34 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 113.343 -1.753 . . . . 0.0 110.727 173.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -81.3 -24.73 37.0 Favored 'General case' 0 C--N 1.313 -1.018 0 O-C-N 121.448 -0.782 . . . . 0.0 109.973 167.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.541 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 25.3 mt -90.22 -30.93 5.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -171.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.615 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.29 -40.07 2.51 Favored Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -174.477 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 49.4 Cg_endo -62.39 -27.39 77.4 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.32 2.013 . . . . 0.0 112.801 176.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 58' ' ' LEU . . . . . 0.543 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.0 OUTLIER -100.87 -15.76 17.46 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 59' ' ' LYS . . . . . 0.589 ' HE3' ' HB3' ' B' ' 44' ' ' TYR . 0.1 OUTLIER -53.41 109.34 0.43 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.172 -178.098 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 60' ' ' GLY . . . . . 0.424 ' N ' ' HZ3' ' B' ' 59' ' ' LYS . . . 92.09 -20.54 42.39 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.319 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 10.4 mmmt -103.79 113.54 27.13 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.412 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.3 p -122.75 144.19 42.06 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 173.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo . . . . . 0 N--CA 1.462 -0.376 0 C-N-CA 122.14 1.893 . . . . 0.0 111.392 168.84 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 67' ' ' ASP . . . . . 0.757 ' OD1' ' HB ' ' B' ' 69' ' ' ILE . 5.0 t70 . . . . . 0 CA--C 1.518 -0.266 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.583 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.8 OUTLIER -79.87 -28.96 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 C-N-CA 118.306 -1.357 . . . . 0.0 109.178 179.302 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.779 ' O ' HG13 ' B' ' 73' ' ' VAL . 11.4 mm -60.47 -46.37 95.43 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.988 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.878 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 29.6 t -44.27 -39.09 4.26 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.034 175.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.493 ' O ' ' HE2' ' B' ' 74' ' ' LYS . 6.3 mm-40 -86.16 -31.78 21.61 Favored 'General case' 0 C--O 1.216 -0.694 0 C-N-CA 123.445 0.698 . . . . 0.0 111.364 -177.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 72' ' ' TYR . . . . . 0.579 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.0 m-30 -75.51 -34.65 60.82 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.574 0.702 . . . . 0.0 109.328 -177.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.826 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.4 m -71.79 -31.82 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 173.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 74' ' ' LYS . . . . . 0.493 ' HE2' ' O ' ' B' ' 71' ' ' GLU . 13.4 ttpt -71.76 -26.18 62.34 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.458 -1.247 . . . . 0.0 109.437 177.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 75' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -65.28 -46.46 80.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.741 174.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.946 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 39.6 t -87.43 0.55 55.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.167 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 29.8 t70 . . . . . 0 C--N 1.322 -0.593 0 CA-C-O 121.632 0.73 . . . . 0.0 109.551 174.997 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.466 ' HB2' ' H ' ' A' ' 2' ' ' SER . 81.8 Cg_endo . . . . . 0 CA--C 1.518 -0.313 0 N-CA-C 108.666 -1.321 . . . . 0.0 108.666 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.466 ' H ' ' HB2' ' A' ' 1' ' ' PRO . 16.4 m -67.57 -178.9 0.97 Allowed 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 162.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.776 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -77.11 -51.84 10.33 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 164.713 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.514 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 2.3 p-10 -87.28 5.93 35.88 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 113.913 -1.494 . . . . 0.0 113.896 -164.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.458 HG23 ' HB2' ' A' ' 2' ' ' SER . 0.8 OUTLIER -63.77 -5.65 4.53 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 118.784 0.72 . . . . 0.0 111.52 -176.743 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.488 ' O ' HD13 ' A' ' 21' ' ' LEU . 2.0 m -78.16 130.31 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 176.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.746 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -155.72 158.74 38.73 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -178.37 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.463 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.6 mt-30 -39.07 116.65 0.6 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.624 -1.626 . . . . 0.0 113.551 176.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.29 -155.84 32.23 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.573 169.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.6 m -48.25 100.51 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 117.481 0.64 . . . . 0.0 111.678 -177.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.3 pttt 38.24 42.67 0.52 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.295 1.038 . . . . 0.0 112.335 -173.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.412 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 26.5 tt0 -57.46 138.26 81.43 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.267 176.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.527 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 37.0 Cg_exo -53.8 122.4 11.28 Favored 'Trans proline' 0 CA--C 1.505 -0.944 0 C-N-CA 121.84 1.693 . . . . 0.0 109.265 177.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.74 ' O ' HG12 ' A' ' 18' ' ' VAL . 11.6 t80 -70.66 -53.92 8.89 Favored Pre-proline 0 N--CA 1.434 -1.241 0 CA-C-O 118.454 -0.784 . . . . 0.0 112.908 -166.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.546 ' HD3' ' HB3' ' A' ' 14' ' ' TYR . 36.3 Cg_exo -56.18 -18.2 22.86 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 121.453 1.435 . . . . 0.0 110.825 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.527 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 2.8 m-20 -89.53 -42.79 11.24 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.977 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.68 ' HE2' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -53.78 -46.55 71.06 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 176.63 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.768 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 1.3 p -79.27 -34.52 16.41 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.369 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.615 -177.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.5 -32.61 67.19 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 121.335 -0.853 . . . . 0.0 111.674 178.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.723 ' O ' HG12 ' A' ' 24' ' ' VAL . 16.6 ptt180 -84.36 -27.12 27.92 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 176.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.655 HD22 ' CE1' ' A' ' 17' ' ' PHE . 6.7 tp -56.56 -47.26 79.88 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.996 172.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.768 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 3.7 mt-30 -71.3 -47.1 58.85 Favored 'General case' 0 CA--C 1.493 -1.236 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.995 177.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.733 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 17.6 t70 -47.22 -54.83 9.82 Favored 'General case' 0 C--N 1.313 -1.015 0 O-C-N 124.297 0.998 . . . . 0.0 111.502 -178.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.723 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.5 p -81.23 -23.31 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.162 0.506 . . . . 0.0 109.983 -174.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.76 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -72.07 -19.5 61.81 Favored 'General case' 0 C--O 1.204 -1.318 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 174.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.431 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -86.25 -36.65 19.25 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.616 178.047 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.733 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 37.8 mmtt -66.9 -38.12 85.66 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.956 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.407 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 50.2 m -101.83 -8.85 21.29 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.166 0.508 . . . . 0.0 110.658 -171.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.76 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 88.7 mt -114.59 135.68 53.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.717 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.56 -2.25 42.14 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.003 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.687 ' H ' HG22 ' A' ' 29' ' ' ILE . 4.8 t0 -117.63 132.38 56.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.11 0.481 . . . . 0.0 111.048 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.603 ' OE1' ' HG3' ' A' ' 33' ' ' LYS . 1.6 pp20? -59.95 -35.39 74.85 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.285 174.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.606 ' O ' HG13 ' A' ' 37' ' ' VAL . 13.2 mttp -61.53 -58.74 6.91 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -175.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.524 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -61.9 -27.03 68.52 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.494 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.844 ' O ' HG13 ' A' ' 39' ' ' VAL . 5.0 tmm_? -70.4 -58.38 3.79 Favored 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.465 ' HD2' ' OE2' ' A' ' 32' ' ' GLU . 18.4 mtpt -56.14 -55.85 28.09 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.867 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.775 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 22.5 m -53.79 -36.49 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.228 -171.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.776 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.3 tt -87.0 -29.73 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.826 -177.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.844 HG13 ' O ' ' A' ' 35' ' ' ARG . 3.0 m -69.95 -48.95 60.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 119.089 -1.044 . . . . 0.0 109.488 175.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.582 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 54.1 mt-10 -64.93 -23.33 67.19 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.533 0.733 . . . . 0.0 112.545 176.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.775 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -85.78 -55.45 3.96 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.63 176.391 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.583 ' HB2' HD21 ' A' ' 21' ' ' LEU . 22.5 mmt -62.65 -20.42 64.79 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.698 0.761 . . . . 0.0 109.372 -178.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.653 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -48.28 -29.48 3.89 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.794 170.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.567 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 10.3 t80 -108.15 -66.39 1.04 Allowed 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.648 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 13.9 mm-40 -48.08 -32.66 7.05 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 124.266 0.979 . . . . 0.0 112.1 -174.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.746 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.9 m-20 -103.75 -20.6 13.89 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.326 -175.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.653 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -59.77 -179.94 0.11 Allowed 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 122.023 0.915 . . . . 0.0 112.681 -174.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.541 ' HB3' ' OE2' ' A' ' 50' ' ' GLU . 13.0 m-20 -58.6 140.52 85.0 Favored Pre-proline 0 N--CA 1.439 -1.016 0 CA-C-N 114.213 -1.358 . . . . 0.0 109.335 174.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -57.73 -20.83 44.78 Favored 'Trans proline' 0 C--O 1.222 -0.321 0 C-N-CA 123.228 2.619 . . . . 0.0 112.166 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.708 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 8.9 pm0 -88.58 -30.92 18.91 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 123.521 0.728 . . . . 0.0 110.255 173.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.986 ' SG ' ' HB2' ' A' ' 76' ' ' CYS . 49.5 t -85.46 -37.08 20.15 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.952 -168.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.567 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.7 pt20 -67.52 -28.94 68.24 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 171.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.508 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 32.8 m -71.88 -20.97 61.72 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 113.166 -1.834 . . . . 0.0 110.318 174.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.8 -24.32 44.64 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.41 0.624 . . . . 0.0 110.184 167.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.567 HD12 ' HA ' ' A' ' 52' ' ' GLN . 21.4 mt -90.89 -32.95 5.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -171.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.621 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.28 -38.95 1.79 Allowed Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -173.652 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 43.0 Cg_endo -61.61 -29.72 84.64 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 122.164 1.91 . . . . 0.0 112.636 175.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.539 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.5 mt -98.13 -16.51 19.49 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -179.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.575 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 0.1 OUTLIER -54.73 108.64 0.41 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.597 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.85 -25.37 28.55 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.56 -177.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.3 mmmt -103.99 113.49 27.06 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.046 0.45 . . . . 0.0 110.355 -178.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.448 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.2 p -124.42 145.53 49.22 Favored Pre-proline 0 C--N 1.313 -1.016 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 170.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo . . . . . 0 C--O 1.233 0.262 0 C-N-CA 122.395 2.063 . . . . 0.0 111.443 167.746 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.514 -0.411 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.538 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.7 OUTLIER -75.17 -27.64 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 C-N-CA 119.018 -1.073 . . . . 0.0 108.606 178.736 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.813 ' O ' HG13 ' A' ' 73' ' ' VAL . 17.7 mm -57.15 -47.02 84.7 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.211 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.332 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.9 t -46.77 -36.41 7.25 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.161 0.505 . . . . 0.0 111.237 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.652 ' O ' ' HE3' ' A' ' 74' ' ' LYS . 1.7 mm-40 -85.85 -32.91 21.46 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.45 -177.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.647 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 4.9 m-30 -75.31 -33.46 61.17 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.374 -177.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.813 HG13 ' O ' ' A' ' 69' ' ' ILE . 1.2 m -71.66 -31.15 41.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 171.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.652 ' HE3' ' O ' ' A' ' 71' ' ' GLU . 0.7 OUTLIER -72.0 -24.15 61.52 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.654 176.876 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -66.33 -47.34 73.84 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.404 173.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.986 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 43.9 t -88.97 7.76 33.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.051 178.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 C--N 1.323 -0.551 0 CA-C-O 121.271 0.558 . . . . 0.0 109.894 172.376 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 1' ' ' PRO . . . . . 0.416 ' HB2' ' H ' ' B' ' 2' ' ' SER . 83.6 Cg_endo . . . . . 0 CA--C 1.517 -0.336 0 N-CA-C 108.725 -1.298 . . . . 0.0 108.725 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 2' ' ' SER . . . . . 0.469 ' HB2' HG23 ' B' ' 5' ' ' THR . 16.8 m -67.88 -179.24 1.13 Allowed 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 162.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.768 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -76.7 -51.95 10.53 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 164.761 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.507 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.3 p-10 -87.28 6.09 35.1 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.929 -1.487 . . . . 0.0 113.869 -164.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.469 HG23 ' HB2' ' B' ' 2' ' ' SER . 0.8 OUTLIER -63.82 -5.89 5.0 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 118.806 0.73 . . . . 0.0 111.467 -176.699 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.479 ' O ' HD13 ' B' ' 21' ' ' LEU . 1.9 m -77.89 130.23 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 176.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.732 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.1 OUTLIER -155.71 158.66 38.6 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.11 -1.036 . . . . 0.0 113.765 -178.426 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 8' ' ' GLN . . . . . 0.47 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.6 mt-30 -38.7 116.77 0.59 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 113.612 -1.631 . . . . 0.0 113.597 176.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.27 -155.94 32.32 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 169.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 18.4 m -48.19 100.6 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 117.437 0.619 . . . . 0.0 111.615 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 22.2 pttt 38.46 42.04 0.51 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.411 1.084 . . . . 0.0 112.401 -174.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -56.99 138.23 79.49 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.221 176.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' PRO . . . . . 0.551 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 37.2 Cg_exo -53.87 122.51 11.49 Favored 'Trans proline' 0 CA--C 1.508 -0.823 0 C-N-CA 121.88 1.72 . . . . 0.0 109.292 177.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 14' ' ' TYR . . . . . 0.738 ' O ' HG12 ' B' ' 18' ' ' VAL . 11.7 t80 -70.82 -54.09 8.28 Favored Pre-proline 0 N--CA 1.435 -1.217 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.833 -166.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.538 ' HD3' ' HB3' ' B' ' 14' ' ' TYR . 36.4 Cg_exo -56.05 -18.2 22.09 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 121.432 1.422 . . . . 0.0 110.841 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.551 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 2.3 m-20 -89.62 -42.48 11.36 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.146 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 17' ' ' PHE . . . . . 0.689 ' HE2' ' CE2' ' B' ' 14' ' ' TYR . 0.0 OUTLIER -54.23 -46.48 72.55 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 176.471 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.771 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 1.2 p -79.29 -34.55 16.4 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.366 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.563 -177.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.38 -32.71 67.07 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 121.374 -0.829 . . . . 0.0 111.702 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.708 ' O ' HG12 ' B' ' 24' ' ' VAL . 16.7 ptt180 -84.36 -27.2 27.86 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.665 HD22 ' CE1' ' B' ' 17' ' ' PHE . 6.8 tp -56.58 -47.27 79.92 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.886 172.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' GLN . . . . . 0.771 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 3.7 mt-30 -71.28 -46.86 59.86 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.028 177.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.734 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 17.4 t70 -47.54 -54.73 10.85 Favored 'General case' 0 C--N 1.315 -0.922 0 O-C-N 124.254 0.971 . . . . 0.0 111.607 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' VAL . . . . . 0.708 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.5 p -81.14 -23.27 10.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.085 0.469 . . . . 0.0 109.921 -174.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.752 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -72.15 -19.47 61.76 Favored 'General case' 0 C--O 1.204 -1.297 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 174.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' GLN . . . . . 0.428 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -86.4 -36.4 19.19 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.583 -1.189 . . . . 0.0 109.499 178.105 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.734 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.1 mmtt -66.99 -38.09 85.39 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.98 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 50.1 m -101.63 -9.57 20.82 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.269 0.557 . . . . 0.0 110.768 -171.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.752 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 88.2 mt -113.91 135.95 51.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.677 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.03 -1.84 41.66 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.916 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.665 ' H ' HG22 ' B' ' 29' ' ' ILE . 4.5 t0 -118.04 132.31 56.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.205 0.526 . . . . 0.0 111.147 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.572 ' OE1' ' HG3' ' B' ' 33' ' ' LYS . 1.5 pp20? -59.82 -35.58 75.01 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.312 174.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.6 ' O ' HG13 ' B' ' 37' ' ' VAL . 13.2 mttp -61.37 -58.75 6.95 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -175.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.511 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -61.95 -26.88 68.46 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.531 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.855 ' O ' HG13 ' B' ' 39' ' ' VAL . 5.0 tmm_? -70.54 -58.25 3.89 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.457 ' HD2' ' OE2' ' B' ' 32' ' ' GLU . 17.8 mtpt -56.3 -55.49 32.71 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.992 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.75 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 22.8 m -54.0 -36.58 31.67 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.103 -172.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.768 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.3 tt -87.06 -29.62 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.845 -177.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.855 HG13 ' O ' ' B' ' 35' ' ' ARG . 3.0 m -70.02 -49.03 59.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 119.131 -1.028 . . . . 0.0 109.488 175.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.594 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 58.8 mt-10 -64.91 -23.28 67.18 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.514 0.725 . . . . 0.0 112.604 176.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.75 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -85.92 -55.37 3.98 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.555 176.385 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 42' ' ' MET . . . . . 0.579 ' HB2' HD21 ' B' ' 21' ' ' LEU . 22.5 mmt -62.58 -20.48 64.74 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.614 0.721 . . . . 0.0 109.318 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.659 ' O ' ' HB2' ' B' ' 47' ' ' ALA . . . -48.26 -29.6 3.98 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.832 170.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' TYR . . . . . 0.564 ' CG ' ' HD2' ' B' ' 59' ' ' LYS . 10.4 t80 -108.06 -66.39 1.04 Allowed 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.643 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 14.6 mm-40 -47.97 -33.24 7.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 124.292 0.995 . . . . 0.0 111.905 -174.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.732 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.9 m-20 -103.2 -20.77 14.01 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.366 -175.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.659 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -59.72 179.76 0.11 Allowed 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 122.028 0.918 . . . . 0.0 112.683 -174.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 48' ' ' ASN . . . . . 0.529 ' HB3' ' CD ' ' B' ' 50' ' ' GLU . 12.5 m-20 -58.24 140.45 83.37 Favored Pre-proline 0 N--CA 1.438 -1.032 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.362 175.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -57.8 -20.65 44.51 Favored 'Trans proline' 0 C--O 1.221 -0.355 0 C-N-CA 123.211 2.607 . . . . 0.0 112.182 -178.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 50' ' ' GLU . . . . . 0.712 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 9.1 pm0 -88.66 -30.9 18.81 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 123.541 0.737 . . . . 0.0 110.287 173.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.99 ' SG ' ' HB2' ' B' ' 76' ' ' CYS . 49.5 t -85.52 -37.12 20.02 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.97 -168.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 52' ' ' GLN . . . . . 0.555 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.9 pt20 -67.46 -29.04 68.4 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 171.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 53' ' ' SER . . . . . 0.495 ' HA ' ' HE2' ' B' ' 56' ' ' LYS . 34.8 m -71.8 -21.1 61.75 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 113.176 -1.829 . . . . 0.0 110.379 174.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.53 -24.56 45.66 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.501 0.667 . . . . 0.0 110.159 167.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.555 HD12 ' HA ' ' B' ' 52' ' ' GLN . 21.5 mt -90.8 -32.98 5.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -171.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.619 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.19 -39.24 1.86 Allowed Pre-proline 0 N--CA 1.486 1.365 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -173.612 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 42.9 Cg_endo -61.44 -29.55 85.38 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.216 1.944 . . . . 0.0 112.728 175.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 58' ' ' LEU . . . . . 0.541 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.4 mt -98.23 -16.54 19.39 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 59' ' ' LYS . . . . . 0.59 ' HA ' ' OH ' ' B' ' 72' ' ' TYR . 0.1 OUTLIER -54.65 108.81 0.43 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.578 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.72 -25.43 28.3 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.59 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 12.3 mmmt -103.99 113.49 27.06 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.114 0.483 . . . . 0.0 110.322 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.452 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.1 p -124.22 145.53 48.8 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.844 170.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo . . . . . 0 C--N 1.345 0.37 0 C-N-CA 122.277 1.985 . . . . 0.0 111.528 167.679 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.515 -0.393 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.545 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.7 OUTLIER -75.14 -27.49 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 C-N-CA 118.795 -1.162 . . . . 0.0 108.64 178.721 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.817 ' O ' HG13 ' B' ' 73' ' ' VAL . 17.9 mm -57.21 -46.98 84.95 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.194 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.366 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.403 ' O ' HG22 ' B' ' 73' ' ' VAL . 30.6 t -46.87 -36.14 7.17 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.32 0.581 . . . . 0.0 111.349 177.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.648 ' O ' ' HE3' ' B' ' 74' ' ' LYS . 1.7 mm-40 -85.98 -32.83 21.32 Favored 'General case' 0 C--O 1.213 -0.817 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.499 -177.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 72' ' ' TYR . . . . . 0.652 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 4.9 m-30 -75.54 -33.27 60.66 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.376 -177.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.817 HG13 ' O ' ' B' ' 69' ' ' ILE . 1.2 m -71.66 -31.3 41.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 171.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 74' ' ' LYS . . . . . 0.648 ' HE3' ' O ' ' B' ' 71' ' ' GLU . 0.7 OUTLIER -71.89 -24.45 61.66 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.539 177.021 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 75' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -66.24 -47.14 74.75 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.438 173.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.99 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 44.2 t -89.12 7.64 34.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.831 178.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 77' ' ' ASP . . . . . 0.42 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 12.3 t70 . . . . . 0 C--N 1.324 -0.53 0 CA-C-O 121.192 0.52 . . . . 0.0 109.896 172.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.407 ' C ' ' HA3' ' B' ' 60' ' ' GLY . 97.8 Cg_endo . . . . . 0 N--CA 1.465 -0.202 0 N-CA-C 108.91 -1.227 . . . . 0.0 108.91 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.558 ' HB2' HG23 ' A' ' 5' ' ' THR . 72.0 m -71.34 -178.86 2.23 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 161.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.719 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -77.02 -53.48 7.75 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 122.096 0.95 . . . . 0.0 109.716 172.77 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.539 ' ND2' ' HE3' ' A' ' 42' ' ' MET . 2.5 p-10 -85.69 5.85 30.26 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.141 -1.39 . . . . 0.0 113.249 -163.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.558 HG23 ' HB2' ' A' ' 2' ' ' SER . 1.1 p -66.83 -3.38 6.72 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 121.935 -0.478 . . . . 0.0 111.428 -176.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.566 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 1.9 m -78.2 133.89 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 173.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.759 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -156.54 160.84 39.86 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -177.863 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.421 ' HG2' ' HB3' ' A' ' 12' ' ' GLU . 2.3 tt0 -41.94 115.53 0.68 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 113.704 -1.589 . . . . 0.0 113.056 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.58 -151.72 23.78 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 172.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.479 ' C ' ' HD3' ' A' ' 11' ' ' LYS . 22.8 m -54.25 99.13 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 117.319 0.559 . . . . 0.0 111.133 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.479 ' HD3' ' C ' ' A' ' 10' ' ' SER . 0.0 OUTLIER 34.56 46.52 0.18 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.642 1.177 . . . . 0.0 112.269 -171.333 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.421 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 36.5 tt0 -59.54 139.54 89.2 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.23 175.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.568 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 52.1 Cg_exo -51.0 122.47 9.99 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 121.942 1.761 . . . . 0.0 109.651 177.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.834 ' HE2' ' SG ' ' A' ' 51' ' ' CYS . 6.1 t80 -70.4 -55.34 7.8 Favored Pre-proline 0 N--CA 1.439 -1.001 0 CA-C-O 118.569 -0.729 . . . . 0.0 112.651 -167.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.517 ' HD3' ' HB3' ' A' ' 14' ' ' TYR . 35.0 Cg_exo -55.57 -19.41 23.37 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 121.535 1.49 . . . . 0.0 111.217 -178.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.568 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 0.8 OUTLIER -90.04 -39.39 12.96 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.176 179.505 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.689 ' HE2' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -56.64 -45.68 81.43 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 175.926 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.75 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 1.3 p -79.01 -33.97 16.38 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.329 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.275 -178.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.64 -32.0 66.84 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 121.386 -0.821 . . . . 0.0 111.624 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.709 ' O ' HG12 ' A' ' 24' ' ' VAL . 14.5 ptt180 -84.96 -26.32 27.24 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 176.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.599 HD22 ' CE1' ' A' ' 17' ' ' PHE . 7.5 tp -56.99 -47.74 80.09 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.639 171.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.75 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 3.7 mt-30 -70.15 -46.62 64.33 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.753 176.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.73 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 18.6 t70 -46.82 -57.13 5.21 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.288 0.992 . . . . 0.0 111.67 -179.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.709 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.7 p -79.22 -23.85 12.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.134 0.492 . . . . 0.0 109.816 -173.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.76 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -72.14 -19.69 61.73 Favored 'General case' 0 C--O 1.205 -1.243 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 174.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.476 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -86.66 -36.98 18.45 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.481 178.522 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.73 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.7 mmtt -66.82 -35.27 79.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.8 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.9 t -105.07 -9.11 18.04 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.166 0.508 . . . . 0.0 110.583 -171.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.76 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 88.7 mt -115.11 129.1 71.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.769 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.26 -4.65 59.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.171 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.699 ' H ' HG22 ' A' ' 29' ' ' ILE . 2.8 t0 -116.16 140.57 49.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.233 0.54 . . . . 0.0 111.276 -177.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.549 ' OE2' ' HG3' ' A' ' 33' ' ' LYS . 1.4 pp20? -66.41 -36.14 82.08 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.256 173.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.621 ' O ' HG13 ' A' ' 37' ' ' VAL . 13.0 mttp -60.45 -61.02 2.9 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -174.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.526 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -59.71 -27.04 66.11 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.623 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.859 ' O ' HG13 ' A' ' 39' ' ' VAL . 4.8 tmm_? -69.65 -59.42 2.97 Favored 'General case' 0 C--O 1.221 -0.43 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.403 ' HD2' ' OE1' ' A' ' 32' ' ' GLU . 23.6 mtpt -56.73 -55.78 29.84 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.217 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.7 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 18.9 m -53.19 -35.36 23.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 O-C-N 123.98 0.8 . . . . 0.0 111.253 -172.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.719 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.3 tt -87.46 -31.12 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 119.756 -0.778 . . . . 0.0 112.097 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 35' ' ' ARG . 3.0 m -69.19 -48.57 67.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 119.181 -1.008 . . . . 0.0 109.392 175.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.598 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 58.2 mt-10 -63.73 -23.7 67.47 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 123.624 0.77 . . . . 0.0 112.264 176.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.7 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -86.47 -54.74 4.24 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.803 176.343 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.555 ' HB2' HD21 ' A' ' 21' ' ' LEU . 18.7 mmt -62.68 -20.46 64.87 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.504 0.669 . . . . 0.0 109.919 -177.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.638 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -48.23 -29.08 3.45 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.024 171.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.662 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 2.5 t80 -109.05 -65.68 1.12 Allowed 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 175.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.553 ' CG ' HD12 ' A' ' 41' ' ' LEU . 3.3 mm-40 -46.89 -30.39 2.49 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 124.116 0.885 . . . . 0.0 112.713 -175.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.759 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.8 m-20 -106.55 -20.77 13.26 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -175.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.811 ' HB1' ' SG ' ' A' ' 51' ' ' CYS . . . -64.33 -175.96 0.2 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -172.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.525 ' HB2' ' HB3' ' A' ' 51' ' ' CYS . 18.7 m-20 -61.79 141.7 95.1 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 114.526 -1.216 . . . . 0.0 109.447 175.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -55.27 -26.6 52.9 Favored 'Trans proline' 0 C--O 1.219 -0.458 0 C-N-CA 123.592 2.861 . . . . 0.0 112.968 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.514 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -87.31 -29.29 21.7 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.381 0.672 . . . . 0.0 110.247 174.963 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.834 ' SG ' ' HE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -76.15 -43.67 41.78 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.547 -172.229 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.638 ' HB2' ' CG ' ' A' ' 44' ' ' TYR . 4.3 pt20 -67.75 -29.46 68.69 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 175.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.56 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 4.0 m -69.42 -20.89 63.79 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 113.703 -1.589 . . . . 0.0 110.729 173.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -80.41 -24.87 39.36 Favored 'General case' 0 C--N 1.309 -1.176 0 O-C-N 121.412 -0.805 . . . . 0.0 109.853 168.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.538 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 25.8 mt -90.73 -31.22 5.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 115.008 1.485 . . . . 0.0 115.008 -172.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.633 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.71 -39.75 2.79 Favored Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -172.991 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 49.6 Cg_endo -62.69 -29.76 77.83 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.327 2.018 . . . . 0.0 112.799 176.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.548 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.6 mt -97.35 -16.37 20.3 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.662 ' HE3' ' HB3' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -52.94 108.4 0.31 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.02 -178.141 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.9 -22.71 36.6 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.74 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -103.39 114.85 29.45 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.452 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.2 p -122.55 138.74 29.76 Favored Pre-proline 0 C--N 1.313 -1.015 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.42 173.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_exo . . . . . 0 C--N 1.344 0.291 0 C-N-CA 122.661 2.241 . . . . 0.0 111.891 169.604 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.513 -0.45 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.561 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.7 OUTLIER -74.33 -28.54 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 C-N-CA 118.462 -1.295 . . . . 0.0 108.669 -177.635 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.794 ' O ' HG13 ' A' ' 73' ' ' VAL . 14.3 mm -58.49 -46.82 89.56 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.278 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.327 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.533 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 40.3 t -48.77 -36.63 16.96 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.249 0.547 . . . . 0.0 111.098 178.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -86.53 -31.34 21.31 Favored 'General case' 0 CA--C 1.506 -0.719 0 C-N-CA 123.137 0.575 . . . . 0.0 110.517 -176.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.616 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.3 m-30 -75.22 -36.64 61.33 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.285 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.812 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.7 m -69.45 -32.89 54.81 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 173.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 70' ' ' SER . 0.1 OUTLIER -70.23 -32.43 70.3 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.406 178.683 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.528 ' HB2' HD11 ' A' ' 58' ' ' LEU . . . -63.43 -42.76 98.71 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.645 -1.161 . . . . 0.0 108.972 178.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 5.0 m -102.21 9.49 40.02 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.34 -175.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.3 t70 . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.069 178.793 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 1' ' ' PRO . . . . . 0.444 ' HB2' ' H ' ' B' ' 2' ' ' SER . 98.9 Cg_endo . . . . . 0 CA--C 1.518 -0.285 0 N-CA-C 108.811 -1.265 . . . . 0.0 108.811 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 2' ' ' SER . . . . . 0.571 ' HB2' HG23 ' B' ' 5' ' ' THR . 74.7 m -71.04 -178.75 2.06 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 161.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.727 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -77.12 -53.5 7.69 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 122.093 0.949 . . . . 0.0 109.646 172.831 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.519 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.5 p-10 -85.61 5.77 30.33 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.095 -1.411 . . . . 0.0 113.224 -163.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.571 HG23 ' HB2' ' B' ' 2' ' ' SER . 1.1 p -66.72 -3.75 7.37 Favored 'General case' 0 C--N 1.312 -1.045 0 O-C-N 121.953 -0.467 . . . . 0.0 111.36 -176.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.57 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.0 m -77.99 133.75 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 173.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.759 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.2 OUTLIER -156.41 160.95 40.09 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -177.925 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 8' ' ' GLN . . . . . 0.426 ' HG2' ' HB3' ' B' ' 12' ' ' GLU . 2.3 tt0 -41.98 115.22 0.64 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 113.732 -1.576 . . . . 0.0 113.16 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.44 -151.5 23.12 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 171.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' SER . . . . . 0.487 ' C ' ' HD3' ' B' ' 11' ' ' LYS . 24.0 m -54.73 98.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.369 0.585 . . . . 0.0 111.187 -178.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' LYS . . . . . 0.487 ' HD3' ' C ' ' B' ' 10' ' ' SER . 0.0 OUTLIER 34.99 46.6 0.21 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.799 1.24 . . . . 0.0 112.129 -171.508 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.426 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 36.6 tt0 -59.64 139.51 89.55 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.197 175.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' PRO . . . . . 0.575 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 51.2 Cg_exo -50.98 122.32 9.72 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 121.955 1.77 . . . . 0.0 109.615 177.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' TYR . . . . . 0.82 ' HE2' ' SG ' ' B' ' 51' ' ' CYS . 6.3 t80 -70.35 -55.22 8.02 Favored Pre-proline 0 N--CA 1.439 -0.98 0 CA-C-O 118.494 -0.765 . . . . 0.0 112.664 -167.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.532 ' HD3' ' HB3' ' B' ' 14' ' ' TYR . 35.2 Cg_exo -55.79 -19.21 24.0 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 121.526 1.484 . . . . 0.0 111.124 -178.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.575 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 0.8 OUTLIER -89.92 -39.79 12.79 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.226 -1.352 . . . . 0.0 111.082 179.579 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 17' ' ' PHE . . . . . 0.687 ' HE2' ' CE2' ' B' ' 14' ' ' TYR . 0.0 OUTLIER -56.59 -45.67 81.24 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.128 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.755 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 1.3 p -78.94 -33.97 16.53 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.354 0 CA-C-N 115.184 -0.917 . . . . 0.0 111.271 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.71 -31.8 66.77 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 121.346 -0.846 . . . . 0.0 111.701 177.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.702 ' O ' HG12 ' B' ' 24' ' ' VAL . 14.7 ptt180 -84.88 -26.61 27.22 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 175.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.607 HD22 ' CE1' ' B' ' 17' ' ' PHE . 7.6 tp -56.84 -47.73 79.67 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.603 172.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' GLN . . . . . 0.755 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 3.7 mt-30 -70.04 -47.09 63.44 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.817 176.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.741 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 19.4 t70 -46.4 -57.06 5.0 Favored 'General case' 0 C--N 1.314 -0.947 0 O-C-N 124.312 1.008 . . . . 0.0 111.721 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' VAL . . . . . 0.702 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.7 p -79.44 -23.65 12.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.169 0.509 . . . . 0.0 109.849 -173.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.764 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -72.25 -19.69 61.66 Favored 'General case' 0 C--O 1.205 -1.274 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 174.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' GLN . . . . . 0.47 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -86.73 -36.99 18.33 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.494 178.589 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.741 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.9 mmtt -66.77 -35.36 79.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.699 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 36.2 t -105.08 -8.88 18.18 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 120.946 0.403 . . . . 0.0 110.744 -171.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.764 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 88.9 mt -115.38 129.4 71.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.711 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.55 -5.02 58.95 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.102 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.681 ' H ' HG22 ' B' ' 29' ' ' ILE . 2.5 t0 -115.98 140.58 49.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.305 0.574 . . . . 0.0 111.125 -176.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.572 ' OE2' ' HG3' ' B' ' 33' ' ' LYS . 1.5 pp20? -66.48 -35.91 81.44 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.183 174.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.618 ' O ' HG13 ' B' ' 37' ' ' VAL . 12.9 mttp -60.49 -61.04 2.88 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -174.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.513 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -59.93 -26.86 66.29 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.582 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.848 ' O ' HG13 ' B' ' 39' ' ' VAL . 4.7 tmm_? -69.69 -59.39 2.98 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -178.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.42 ' HD2' ' OE1' ' B' ' 32' ' ' GLU . 23.8 mtpt -56.84 -55.44 34.4 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.246 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.691 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 19.2 m -53.52 -35.29 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.192 -172.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.727 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.3 tt -87.42 -31.12 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.159 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.848 HG13 ' O ' ' B' ' 35' ' ' ARG . 3.0 m -69.15 -48.57 68.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 119.078 -1.049 . . . . 0.0 109.418 175.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.611 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 61.9 mt-10 -63.59 -23.94 67.59 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 123.634 0.774 . . . . 0.0 112.229 176.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.691 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -86.27 -54.73 4.28 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.871 176.328 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 42' ' ' MET . . . . . 0.564 ' HB2' HD21 ' B' ' 21' ' ' LEU . 18.8 mmt -62.65 -20.41 64.78 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 121.553 0.692 . . . . 0.0 109.971 -177.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.627 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -48.33 -29.03 3.53 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.48 -1.237 . . . . 0.0 110.992 171.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' TYR . . . . . 0.663 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 2.4 t80 -109.05 -65.63 1.12 Allowed 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 176.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.547 ' CG ' HD12 ' B' ' 41' ' ' LEU . 3.3 mm-40 -46.89 -30.76 2.69 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 124.145 0.903 . . . . 0.0 112.678 -175.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.759 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.8 m-20 -106.13 -20.97 13.25 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -175.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.815 ' HB1' ' SG ' ' B' ' 51' ' ' CYS . . . -64.23 -175.9 0.19 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -172.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 48' ' ' ASN . . . . . 0.514 ' HB2' ' HB3' ' B' ' 51' ' ' CYS . 19.4 m-20 -61.75 141.72 95.01 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.473 175.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -55.27 -26.75 53.65 Favored 'Trans proline' 0 C--O 1.219 -0.446 0 C-N-CA 123.518 2.812 . . . . 0.0 112.948 -176.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' GLU . . . . . 0.538 ' O ' ' HG3' ' B' ' 50' ' ' GLU . 0.0 OUTLIER -87.17 -29.16 21.98 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.327 0.651 . . . . 0.0 110.351 174.915 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.82 ' SG ' ' HE2' ' B' ' 14' ' ' TYR . 0.0 OUTLIER -76.04 -43.78 42.27 Favored 'General case' 0 N--CA 1.42 -1.942 0 CA-C-O 121.446 0.641 . . . . 0.0 110.547 -172.229 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 52' ' ' GLN . . . . . 0.648 ' HB2' ' CG ' ' B' ' 44' ' ' TYR . 4.4 pt20 -67.77 -29.47 68.69 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 175.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 53' ' ' SER . . . . . 0.552 ' O ' ' HE2' ' B' ' 56' ' ' LYS . 4.0 m -69.42 -20.87 63.79 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 113.685 -1.598 . . . . 0.0 110.716 173.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -80.22 -25.26 39.69 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.289 -0.882 . . . . 0.0 109.821 168.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.546 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 25.7 mt -90.67 -31.28 5.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 -172.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.627 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.64 -39.62 2.6 Favored Pre-proline 0 N--CA 1.487 1.399 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -172.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 50.7 Cg_endo -62.81 -29.67 76.98 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.323 2.015 . . . . 0.0 112.828 176.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 58' ' ' LEU . . . . . 0.56 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.7 mt -97.42 -16.42 20.2 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 59' ' ' LYS . . . . . 0.663 ' HE3' ' HB3' ' B' ' 44' ' ' TYR . 0.1 OUTLIER -52.92 108.73 0.34 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.955 -178.104 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 60' ' ' GLY . . . . . 0.407 ' HA3' ' C ' ' A' ' 1' ' ' PRO . . . 94.55 -22.47 37.24 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.745 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -103.53 115.11 29.9 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -178.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.45 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.1 p -122.92 139.0 30.51 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.429 173.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo . . . . . 0 C--N 1.346 0.396 0 C-N-CA 122.708 2.272 . . . . 0.0 111.833 169.77 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.513 -0.444 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.57 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.7 OUTLIER -74.32 -28.33 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 C-N-CA 118.432 -1.307 . . . . 0.0 108.696 -177.462 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.799 ' O ' HG13 ' B' ' 73' ' ' VAL . 14.4 mm -58.61 -46.83 90.01 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.179 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.319 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.541 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 37.6 t -48.62 -36.74 16.45 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.165 0.507 . . . . 0.0 111.081 178.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -86.56 -31.23 21.33 Favored 'General case' 0 CA--C 1.506 -0.73 0 C-N-CA 123.206 0.602 . . . . 0.0 110.545 -176.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 72' ' ' TYR . . . . . 0.605 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.3 m-30 -75.36 -36.6 60.95 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.32 -178.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.815 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.7 m -69.36 -33.23 56.65 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 173.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 74' ' ' LYS . . . . . 0.541 ' HB2' ' O ' ' B' ' 70' ' ' SER . 0.1 OUTLIER -69.94 -32.31 70.51 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.517 178.473 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 75' ' ' ALA . . . . . 0.515 ' HB2' HD11 ' B' ' 58' ' ' LEU . . . -63.76 -42.07 97.88 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.208 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 5.1 m -102.7 9.53 39.13 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 114.101 -1.409 . . . . 0.0 111.318 -175.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 CA--C 1.536 0.437 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.046 178.832 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.453 ' HB2' ' H ' ' A' ' 2' ' ' SER . 86.3 Cg_endo . . . . . 0 CA--C 1.517 -0.35 0 N-CA-C 109.024 -1.183 . . . . 0.0 109.024 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.49 ' HB2' HG23 ' A' ' 5' ' ' THR . 21.2 m -68.41 175.2 3.5 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 161.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.833 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -71.0 -52.2 21.03 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 164.827 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.518 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 2.3 p-10 -87.41 5.52 38.39 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.875 -1.512 . . . . 0.0 113.692 -165.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.49 HG23 ' HB2' ' A' ' 2' ' ' SER . 0.7 OUTLIER -64.35 -5.76 5.78 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 118.537 0.608 . . . . 0.0 111.116 -177.37 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.642 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.1 m -76.16 130.94 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.743 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -154.31 158.69 40.52 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.552 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 3.3 mt-30 -42.04 116.61 0.84 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 112.997 -1.91 . . . . 0.0 113.465 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.56 -153.67 21.55 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 170.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.662 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 20.8 t -57.19 99.34 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.166 0.483 . . . . 0.0 110.926 -177.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.662 ' HG2' ' O ' ' A' ' 10' ' ' SER . 4.1 ptpp? 49.18 32.71 4.38 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.602 1.161 . . . . 0.0 112.433 -177.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.431 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 38.7 tt0 -56.06 135.39 74.14 Favored Pre-proline 0 C--O 1.233 0.224 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.558 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 52.0 Cg_exo -51.05 123.08 11.09 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.46 2.107 . . . . 0.0 110.169 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.906 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 15.0 t80 -71.13 -53.51 8.18 Favored Pre-proline 0 N--CA 1.438 -1.061 0 CA-C-O 118.277 -0.868 . . . . 0.0 113.183 -167.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.541 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 33.6 Cg_exo -55.9 -18.43 22.05 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 121.425 1.416 . . . . 0.0 111.041 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.558 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.8 m-20 -89.92 -43.49 10.55 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.93 -1.486 . . . . 0.0 110.829 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.552 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -54.31 -44.43 72.0 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.931 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.727 HG12 ' O ' ' A' ' 14' ' ' TYR . 3.0 p -82.19 -31.77 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.386 -177.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . -57.89 -35.86 71.61 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 121.763 -0.585 . . . . 0.0 111.853 175.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.72 ' O ' HG12 ' A' ' 24' ' ' VAL . 15.6 ptt180 -82.97 -27.3 30.56 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 177.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.572 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 6.5 tp -56.89 -45.46 82.57 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.858 173.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.733 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 8.7 mt-30 -74.12 -43.71 56.52 Favored 'General case' 0 CA--C 1.496 -1.112 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.999 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.754 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 8.8 t70 -51.17 -51.68 51.41 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 124.137 0.898 . . . . 0.0 111.47 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.72 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.5 p -82.64 -23.15 8.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -174.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.825 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -71.66 -18.67 62.17 Favored 'General case' 0 C--O 1.206 -1.224 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 174.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.0 -39.11 15.98 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.471 -1.24 . . . . 0.0 109.766 176.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.754 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 36.5 mmtt -66.59 -40.61 88.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.065 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.403 ' HB2' ' HB3' ' A' ' 3' ' ' PHE . 43.9 m -98.81 -9.7 24.01 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.153 0.501 . . . . 0.0 110.437 -171.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.825 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 87.5 mt -115.18 125.3 72.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.759 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.56 -4.96 59.25 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.004 0.431 . . . . 0.0 110.529 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.678 ' OD1' ' HD2' ' A' ' 33' ' ' LYS . 3.9 t0 -110.62 122.43 47.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.534 -176.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.484 ' O ' ' HG2' ' A' ' 36' ' ' LYS . 12.6 pt-20 -61.85 -25.11 67.33 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.765 176.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.678 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 24.4 mttt -73.81 -46.74 43.43 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 120.901 0.381 . . . . 0.0 110.146 -176.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.08 -25.11 60.78 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.731 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.84 ' O ' HG13 ' A' ' 39' ' ' VAL . 5.0 tmm_? -64.53 -63.14 1.21 Allowed 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.642 ' HG3' HG13 ' A' ' 37' ' ' VAL . 6.5 ptmm? -51.9 -60.15 3.51 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.198 0.523 . . . . 0.0 112.224 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.642 HG13 ' HG3' ' A' ' 36' ' ' LYS . 10.4 m -56.32 -30.87 31.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.353 -170.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.833 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.2 tt -86.08 -30.45 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.247 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.84 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.3 m -70.13 -47.91 65.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 119.481 -0.887 . . . . 0.0 109.348 175.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.658 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 55.3 mt-10 -60.21 -30.27 69.27 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.665 0.786 . . . . 0.0 112.119 176.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.619 ' HG ' HD11 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -86.16 -53.15 5.22 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.484 -0.487 . . . . 0.0 112.189 179.198 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.559 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 22.0 mmt -61.95 -22.08 65.33 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.592 0.71 . . . . 0.0 109.84 -178.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.697 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -48.54 -29.02 3.78 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.043 171.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.598 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 8.4 t80 -107.02 -66.58 1.01 Allowed 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.548 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 15.5 mm-40 -48.23 -31.96 6.55 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 124.141 0.901 . . . . 0.0 112.109 -174.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.743 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.9 m-20 -103.03 -21.49 13.92 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.182 -175.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.605 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -62.42 -178.98 0.21 Allowed 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.988 0.899 . . . . 0.0 112.986 -173.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.542 ' HB3' ' OE1' ' A' ' 50' ' ' GLU . 12.2 m-20 -61.34 143.24 93.11 Favored Pre-proline 0 C--N 1.317 -0.811 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.003 175.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 48' ' ' ASN . 55.5 Cg_exo -50.83 -28.53 23.66 Favored 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 123.666 2.911 . . . . 0.0 112.996 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.689 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 15.9 pm0 -88.42 -30.99 19.04 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.758 0.823 . . . . 0.0 111.015 176.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.689 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 96.9 m -81.79 -38.99 24.73 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.242 -170.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.626 ' HA ' HD12 ' A' ' 55' ' ' ILE . 4.1 pt20 -69.93 -29.76 66.98 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 172.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.467 ' O ' ' HD2' ' A' ' 56' ' ' LYS . 6.7 m -71.12 -20.32 62.34 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.859 -1.518 . . . . 0.0 110.755 174.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.88 -25.27 48.48 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.691 0.758 . . . . 0.0 109.57 167.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.626 HD12 ' HA ' ' A' ' 52' ' ' GLN . 24.1 mt -89.76 -33.05 5.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -172.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.613 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.3 -38.71 1.71 Allowed Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -173.363 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 51.5 Cg_endo -63.13 -28.69 73.86 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.188 1.925 . . . . 0.0 112.625 175.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.537 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 2.2 mt -97.58 -16.65 19.95 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.598 ' HD2' ' CG ' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -55.95 108.98 0.51 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.443 -179.146 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.72 -24.9 30.36 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.328 -177.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.0 mmmt -104.54 115.63 30.68 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.853 0.358 . . . . 0.0 110.466 -178.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.43 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.7 p -121.77 134.75 24.75 Favored Pre-proline 0 C--N 1.313 -1.0 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 168.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo . . . . . 0 CA--C 1.518 -0.278 0 C-N-CA 122.545 2.163 . . . . 0.0 111.79 172.77 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.8 t70 . . . . . 0 N--CA 1.444 -0.769 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.58 HG22 ' HG2' ' A' ' 40' ' ' GLU . 1.2 m -76.16 -30.29 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 C-N-CA 118.553 -1.259 . . . . 0.0 108.709 -177.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.778 ' O ' HG13 ' A' ' 73' ' ' VAL . 7.0 mm -60.85 -47.88 91.38 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.158 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.413 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.498 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 34.1 t -50.51 -35.22 28.37 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.892 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.45 ' H ' ' HG2' ' A' ' 71' ' ' GLU . 3.1 mm-40 -86.58 -32.07 20.85 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.081 0.467 . . . . 0.0 110.414 -177.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.537 ' CE1' ' HB2' ' A' ' 58' ' ' LEU . 5.5 m-30 -74.1 -36.18 64.22 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.318 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.906 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 2.2 m -71.21 -32.88 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -68.51 -31.91 71.51 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.516 177.479 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.5 ' HB2' HD11 ' A' ' 58' ' ' LEU . . . -63.38 -44.49 94.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.265 178.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.532 ' SG ' ' HB3' ' A' ' 51' ' ' CYS . 3.8 m -97.77 9.46 42.56 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.11 -177.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.2 t70 . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.653 177.825 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 1' ' ' PRO . . . . . 0.415 ' HB2' ' H ' ' B' ' 2' ' ' SER . 88.4 Cg_endo . . . . . 0 CA--C 1.519 -0.245 0 N-CA-C 108.797 -1.27 . . . . 0.0 108.797 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 2' ' ' SER . . . . . 0.493 ' HB2' HG23 ' B' ' 5' ' ' THR . 19.8 m -68.1 175.08 3.37 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 161.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.813 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -71.08 -52.19 20.83 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 164.92 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.494 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.2 p-10 -87.5 5.48 38.91 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 113.869 -1.514 . . . . 0.0 113.667 -165.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.493 HG23 ' HB2' ' B' ' 2' ' ' SER . 0.7 OUTLIER -63.88 -6.52 6.09 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 118.542 0.61 . . . . 0.0 111.086 -177.668 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.642 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.2 m -75.61 131.09 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.766 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -154.32 158.59 40.38 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 8' ' ' GLN . . . . . 0.543 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 3.4 mt-30 -41.82 116.88 0.85 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 113.119 -1.855 . . . . 0.0 113.369 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.77 -153.98 22.63 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.732 170.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' SER . . . . . 0.668 ' O ' ' HG2' ' B' ' 11' ' ' LYS . 19.8 t -56.94 98.8 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 117.116 0.458 . . . . 0.0 110.952 -177.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' LYS . . . . . 0.668 ' HG2' ' O ' ' B' ' 10' ' ' SER . 4.1 ptpp? 49.41 32.86 4.92 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.688 1.195 . . . . 0.0 112.504 -177.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.434 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 38.4 tt0 -56.12 135.41 74.49 Favored Pre-proline 0 C--O 1.234 0.251 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' PRO . . . . . 0.575 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 52.2 Cg_exo -50.97 123.0 10.88 Favored 'Trans proline' 0 CA--C 1.509 -0.77 0 C-N-CA 122.343 2.029 . . . . 0.0 110.206 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 14' ' ' TYR . . . . . 0.896 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 14.7 t80 -71.01 -53.53 8.37 Favored Pre-proline 0 N--CA 1.439 -1.019 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -167.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.534 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 34.2 Cg_exo -55.92 -18.48 22.3 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 121.535 1.49 . . . . 0.0 110.999 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.575 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.6 m-20 -89.96 -43.18 10.73 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 113.917 -1.492 . . . . 0.0 110.933 178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 17' ' ' PHE . . . . . 0.543 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -54.6 -44.43 73.07 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 176.932 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.714 HG12 ' O ' ' B' ' 14' ' ' TYR . 3.0 p -82.16 -31.86 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.514 -177.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.44 -36.39 71.33 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 121.793 -0.567 . . . . 0.0 111.878 175.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.713 ' O ' HG12 ' B' ' 24' ' ' VAL . 15.5 ptt180 -82.72 -27.18 31.32 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.565 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 6.6 tp -57.05 -45.21 83.36 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.87 173.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' GLN . . . . . 0.736 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 8.7 mt-30 -74.36 -44.06 53.87 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.019 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.74 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 9.5 t70 -50.9 -51.44 51.94 Favored 'General case' 0 C--N 1.314 -0.955 0 O-C-N 124.097 0.873 . . . . 0.0 111.495 -178.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' VAL . . . . . 0.713 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.4 p -82.71 -23.41 8.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.201 0.524 . . . . 0.0 109.707 -174.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.819 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -71.37 -18.76 62.35 Favored 'General case' 0 C--O 1.206 -1.206 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 173.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.1 -38.63 16.3 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.845 176.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.74 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 36.2 mmtt -66.89 -40.64 87.82 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.98 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 28' ' ' SER . . . . . 0.415 ' HB2' ' HB3' ' B' ' 3' ' ' PHE . 45.2 m -98.86 -9.27 24.49 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.039 0.447 . . . . 0.0 110.552 -171.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.819 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 87.2 mt -115.33 125.68 72.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.651 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.05 -4.2 59.14 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.977 0.418 . . . . 0.0 110.468 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.676 ' H ' HG22 ' B' ' 29' ' ' ILE . 3.6 t0 -111.45 122.65 48.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.51 -176.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' B' ' 36' ' ' LYS . 12.7 pt-20 -62.03 -25.25 67.55 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.665 176.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.666 ' HD2' ' OD1' ' B' ' 31' ' ' ASP . 24.0 mttt -73.71 -46.54 45.46 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 120.834 0.349 . . . . 0.0 110.082 -176.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.32 -25.04 60.47 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.5 -0.48 . . . . 0.0 109.77 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.836 ' O ' HG13 ' B' ' 39' ' ' VAL . 5.0 tmm_? -64.44 -63.32 1.16 Allowed 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.647 ' HG3' HG13 ' B' ' 37' ' ' VAL . 6.5 ptmm? -51.71 -60.08 3.56 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.257 0.551 . . . . 0.0 112.31 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.647 HG13 ' HG3' ' B' ' 36' ' ' LYS . 10.4 m -56.58 -30.57 32.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.713 -1.131 . . . . 0.0 112.496 -170.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.813 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.2 tt -86.26 -30.45 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 C-N-CA 119.241 -0.984 . . . . 0.0 111.175 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.836 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.3 m -70.04 -47.87 65.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.411 175.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.651 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 56.6 mt-10 -60.31 -29.96 69.19 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 123.69 0.796 . . . . 0.0 112.193 176.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.635 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -86.25 -53.25 5.14 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.367 -0.533 . . . . 0.0 112.16 179.044 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 42' ' ' MET . . . . . 0.565 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 22.0 mmt -61.9 -22.18 65.36 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.594 0.711 . . . . 0.0 109.831 -177.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.698 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -48.5 -29.03 3.73 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.924 171.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' TYR . . . . . 0.594 ' CG ' ' HD2' ' B' ' 59' ' ' LYS . 8.3 t80 -107.24 -66.65 1.01 Allowed 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 176.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.529 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 14.9 mm-40 -48.1 -31.84 6.07 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 124.168 0.917 . . . . 0.0 112.243 -174.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.766 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.9 m-20 -103.21 -21.47 13.86 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 116.754 -0.203 . . . . 0.0 111.265 -175.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.602 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -62.38 -179.16 0.22 Allowed 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.982 0.896 . . . . 0.0 112.865 -173.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 48' ' ' ASN . . . . . 0.564 ' HB3' ' OE1' ' B' ' 50' ' ' GLU . 12.4 m-20 -61.16 143.31 92.54 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.037 175.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -50.7 -28.75 23.59 Favored 'Trans proline' 0 C--O 1.218 -0.494 0 C-N-CA 123.54 2.827 . . . . 0.0 113.022 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' GLU . . . . . 0.696 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 15.9 pm0 -88.26 -30.97 19.27 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.739 0.816 . . . . 0.0 111.015 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.696 ' N ' ' HG2' ' B' ' 50' ' ' GLU . 96.7 m -81.83 -39.06 24.53 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.145 -170.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 52' ' ' GLN . . . . . 0.634 ' HA ' HD12 ' B' ' 55' ' ' ILE . 4.1 pt20 -69.95 -29.64 66.82 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 172.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 53' ' ' SER . . . . . 0.469 ' O ' ' HD2' ' B' ' 56' ' ' LYS . 7.0 m -71.18 -20.28 62.3 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 113.847 -1.524 . . . . 0.0 110.704 174.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.72 -25.38 49.26 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.604 0.716 . . . . 0.0 109.683 167.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.634 HD12 ' HA ' ' B' ' 52' ' ' GLN . 24.3 mt -89.77 -32.87 5.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 -172.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.611 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.22 -38.91 1.71 Allowed Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -173.523 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 51.5 Cg_endo -63.07 -28.85 74.51 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 122.175 1.916 . . . . 0.0 112.716 175.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 58' ' ' LEU . . . . . 0.535 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 2.2 mt -97.44 -16.4 20.19 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 59' ' ' LYS . . . . . 0.594 ' HD2' ' CG ' ' B' ' 44' ' ' TYR . 0.1 OUTLIER -56.13 108.91 0.51 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.523 -179.254 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.0 -25.12 29.48 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.265 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 9.9 mmmt -104.52 115.52 30.49 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.961 0.41 . . . . 0.0 110.381 -177.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.427 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.7 p -121.8 134.68 24.74 Favored Pre-proline 0 C--N 1.312 -1.055 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 168.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo . . . . . 0 C--O 1.234 0.287 0 C-N-CA 122.502 2.135 . . . . 0.0 111.846 172.958 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 t70 . . . . . 0 N--CA 1.444 -0.728 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.584 HG22 ' HG2' ' B' ' 40' ' ' GLU . 1.2 m -75.99 -30.25 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 C-N-CA 118.556 -1.258 . . . . 0.0 108.709 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.78 ' O ' HG13 ' B' ' 73' ' ' VAL . 6.9 mm -60.87 -47.94 91.14 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.208 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.306 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 35.1 t -50.41 -35.25 27.59 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.745 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.413 ' H ' ' HG2' ' B' ' 71' ' ' GLU . 3.0 mm-40 -86.55 -32.21 20.82 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.459 -177.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 72' ' ' TYR . . . . . 0.535 ' CE1' ' HB2' ' B' ' 58' ' ' LEU . 5.5 m-30 -74.09 -36.23 64.27 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.325 -178.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.896 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 2.2 m -71.15 -33.04 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 74' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' B' ' 70' ' ' SER . 0.0 OUTLIER -68.31 -32.2 72.16 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.459 177.474 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 75' ' ' ALA . . . . . 0.516 ' HB2' HD11 ' B' ' 58' ' ' LEU . . . -63.05 -44.67 95.19 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.194 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.52 ' SG ' ' HB3' ' B' ' 51' ' ' CYS . 3.8 m -97.54 9.28 42.86 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 114.22 -1.355 . . . . 0.0 111.052 -177.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 8.3 t70 . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.649 177.888 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 CA--C 1.519 -0.263 0 N-CA-C 108.721 -1.3 . . . . 0.0 108.721 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 m -67.52 -179.76 1.14 Allowed 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 163.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.747 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -75.56 -53.38 8.71 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 118.956 -1.098 . . . . 0.0 108.625 166.791 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.493 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 2.4 p-10 -86.91 5.04 39.02 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.247 -1.342 . . . . 0.0 113.201 -165.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.96 -5.97 5.39 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 118.166 0.439 . . . . 0.0 111.441 -176.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.592 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.4 m -75.62 131.77 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 176.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.77 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -154.63 159.48 40.84 Favored 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 118.693 -1.203 . . . . 0.0 114.228 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.487 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.5 mt-30 -42.32 116.38 0.83 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 112.965 -1.925 . . . . 0.0 112.829 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.46 -139.87 8.15 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.635 173.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.4 p -58.67 95.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.765 0.282 . . . . 0.0 111.133 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.5 pttt 40.75 39.54 0.8 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.238 1.015 . . . . 0.0 111.986 -175.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.447 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 48.5 tt0 -56.86 139.65 77.36 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.234 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.525 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 36.9 Cg_exo -54.33 122.73 12.03 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.988 1.792 . . . . 0.0 109.781 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.825 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 13.2 t80 -70.36 -52.53 11.57 Favored Pre-proline 0 N--CA 1.438 -1.046 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 -166.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.531 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 27.6 Cg_exo -57.18 -17.32 25.11 Favored 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 121.444 1.429 . . . . 0.0 111.062 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.525 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.5 m-20 -90.04 -42.11 11.32 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.04 -1.437 . . . . 0.0 110.698 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.487 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -55.5 -44.84 76.96 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.776 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.674 HG12 ' O ' ' A' ' 14' ' ' TYR . 2.1 p -78.99 -34.06 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.274 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.88 -38.15 69.79 Favored 'General case' 0 C--N 1.319 -0.744 0 O-C-N 121.833 -0.542 . . . . 0.0 111.488 176.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.721 ' O ' HG12 ' A' ' 24' ' ' VAL . 15.5 ptt180 -80.78 -28.32 36.38 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.537 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 6.2 tp -55.87 -43.78 77.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.976 173.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.69 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 24.0 mt-30 -72.72 -52.71 14.02 Favored 'General case' 0 CA--C 1.486 -1.483 0 CA-C-N 114.702 -1.135 . . . . 0.0 111.493 178.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.732 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 38.3 m-20 -46.86 -50.75 18.08 Favored 'General case' 0 C--N 1.313 -0.996 0 O-C-N 124.375 1.047 . . . . 0.0 111.24 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.721 HG12 ' O ' ' A' ' 20' ' ' ARG . 8.3 p -79.58 -26.23 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.77 -172.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.617 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -67.45 -30.54 70.29 Favored 'General case' 0 C--O 1.207 -1.171 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 175.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.96 -34.98 59.83 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.647 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.732 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 40.7 mmtt -67.9 -36.0 79.46 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.774 178.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.46 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 16.2 m -105.52 -6.33 19.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.362 0.601 . . . . 0.0 110.564 -171.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.656 HG22 ' H ' ' A' ' 31' ' ' ASP . 89.0 mt -118.2 124.15 72.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.334 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.21 -4.07 58.58 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.219 0.533 . . . . 0.0 110.582 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.656 ' H ' HG22 ' A' ' 29' ' ' ILE . 26.0 t0 -106.59 140.48 39.41 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.565 -177.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -76.23 -32.05 58.71 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.001 174.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.571 ' O ' HG13 ' A' ' 37' ' ' VAL . 6.9 mttp -70.87 -55.51 8.3 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -176.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.605 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -57.99 -27.87 63.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.976 175.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.853 ' O ' HG13 ' A' ' 39' ' ' VAL . 1.9 tmm_? -67.22 -56.53 9.49 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.497 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 20.8 mtpt -56.22 -57.93 10.13 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.957 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.732 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 20.1 m -53.08 -34.72 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.414 -169.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.747 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.1 tt -87.97 -30.75 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 C-N-CA 119.765 -0.774 . . . . 0.0 112.316 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.853 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.9 m -67.89 -50.21 61.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 119.413 -0.915 . . . . 0.0 109.688 174.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.769 ' OE1' HG13 ' A' ' 68' ' ' VAL . 0.9 OUTLIER -63.73 -25.9 68.4 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.76 0.824 . . . . 0.0 111.622 178.46 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.732 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -85.87 -55.14 4.1 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 177.064 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.518 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 22.2 mmt -62.59 -20.87 65.16 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 121.67 0.747 . . . . 0.0 109.822 -176.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.678 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -48.68 -28.89 3.85 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.81 171.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.557 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 11.5 t80 -106.14 -66.53 0.99 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 175.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.484 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 5.7 mm-40 -48.13 -29.56 3.75 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 124.107 0.88 . . . . 0.0 112.937 -175.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.77 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.7 m-20 -106.87 -21.25 13.08 Favored 'General case' 0 N--CA 1.438 -1.071 0 O-C-N 122.22 -0.3 . . . . 0.0 111.19 -176.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -60.43 179.22 0.16 Allowed 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.889 0.852 . . . . 0.0 112.905 -174.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.498 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 11.5 m-20 -60.12 139.83 91.07 Favored Pre-proline 0 N--CA 1.443 -0.823 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.228 174.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.428 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 1.8 Cg_endo -44.35 -46.38 11.79 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.906 2.404 . . . . 0.0 112.004 -177.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.543 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 0.4 OUTLIER -71.31 -33.51 69.73 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.335 1.054 . . . . 0.0 111.841 177.173 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.525 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 98.4 m -75.7 -36.37 60.03 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 121.243 0.544 . . . . 0.0 109.967 -173.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.553 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.9 pt20 -73.03 -30.95 64.12 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 174.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.543 ' HB2' ' HA ' ' A' ' 50' ' ' GLU . 17.4 m -68.87 -20.51 64.27 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.048 173.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 51' ' ' CYS . . . -76.38 -28.74 56.88 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.747 0.784 . . . . 0.0 109.958 168.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.574 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 19.2 mt -89.67 -31.85 5.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -171.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.612 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -40.17 -39.78 1.55 Allowed Pre-proline 0 N--CA 1.487 1.41 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -173.075 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 54.2 Cg_endo -63.04 -30.93 76.46 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.141 1.894 . . . . 0.0 112.781 176.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.563 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 2.6 mt -94.48 -17.06 22.8 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.576 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -55.44 108.67 0.45 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.053 179.359 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.29 -31.66 8.47 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.528 -175.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.2 mmtt -104.12 114.85 29.38 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 122.173 0.987 . . . . 0.0 111.147 -177.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.535 ' HB ' HG12 ' A' ' 68' ' ' VAL . 5.6 p -120.72 131.67 24.39 Favored Pre-proline 0 C--N 1.294 -1.824 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.826 169.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo . . . . . 0 C--O 1.235 0.326 0 C-N-CA 122.637 2.224 . . . . 0.0 112.078 174.554 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 N--CA 1.446 -0.656 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.769 HG13 ' OE1' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -72.25 -34.85 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 118.372 -1.331 . . . . 0.0 108.916 -179.138 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.766 ' O ' HG13 ' A' ' 73' ' ' VAL . 7.2 mm -56.65 -49.77 76.66 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.065 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.676 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 23.0 t -46.14 -38.37 8.09 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.858 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.445 ' H ' ' HG2' ' A' ' 71' ' ' GLU . 2.8 mm-40 -86.45 -32.27 20.94 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.544 -176.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.576 ' OH ' ' HA ' ' A' ' 59' ' ' LYS . 5.4 m-30 -73.95 -37.53 64.52 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.681 0.753 . . . . 0.0 109.65 -177.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.825 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.7 m -70.1 -32.81 52.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 174.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -68.42 -31.36 70.64 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.567 176.45 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.471 ' HB2' HD11 ' A' ' 58' ' ' LEU . . . -64.6 -46.35 83.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.492 178.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.525 ' SG ' ' HB3' ' A' ' 51' ' ' CYS . 4.0 m -94.04 9.22 38.51 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.919 -178.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 9.6 t70 . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.201 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 1' ' ' PRO . . . . . 0.451 ' HB2' ' H ' ' B' ' 2' ' ' SER . 97.7 Cg_endo . . . . . 0 CA--C 1.52 -0.189 0 N-CA-C 108.815 -1.263 . . . . 0.0 108.815 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 2' ' ' SER . . . . . 0.559 ' HG ' ' HZ2' ' A' ' 59' ' ' LYS . 16.3 m -67.6 179.93 1.24 Allowed 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 163.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.752 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -75.32 -53.6 8.48 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.517 166.921 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.493 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.4 p-10 -86.77 4.98 38.66 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.35 -1.295 . . . . 0.0 113.271 -165.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.431 HG21 ' HG2' ' A' ' 59' ' ' LYS . 0.5 OUTLIER -63.7 -5.9 4.76 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 118.099 0.409 . . . . 0.0 111.572 -177.069 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.597 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.4 m -75.67 131.55 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.777 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -154.4 159.6 41.2 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 8' ' ' GLN . . . . . 0.488 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.5 mt-30 -42.37 116.21 0.81 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 112.941 -1.936 . . . . 0.0 112.852 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.17 -139.69 7.88 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.706 173.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 6.4 p -58.94 95.15 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.706 0.253 . . . . 0.0 111.143 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 56.7 pttt 41.05 39.37 0.85 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.157 0.983 . . . . 0.0 111.976 -175.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.436 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 51.0 tt0 -56.61 139.57 75.61 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.241 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 13' ' ' PRO . . . . . 0.537 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 35.1 Cg_exo -54.15 122.77 12.04 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.0 1.8 . . . . 0.0 109.743 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 14' ' ' TYR . . . . . 0.839 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 13.1 t80 -70.45 -52.63 11.14 Favored Pre-proline 0 N--CA 1.438 -1.056 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -166.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.544 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 27.9 Cg_exo -56.97 -17.54 24.63 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 121.474 1.449 . . . . 0.0 111.134 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.537 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.3 m-20 -89.91 -42.42 11.22 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.682 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' PHE . . . . . 0.488 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -55.34 -44.75 76.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.803 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.688 HG12 ' O ' ' B' ' 14' ' ' TYR . 2.1 p -78.97 -34.15 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.27 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.91 -38.04 69.7 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 121.765 -0.585 . . . . 0.0 111.516 176.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.715 ' O ' HG12 ' B' ' 24' ' ' VAL . 15.6 ptt180 -80.78 -28.29 36.41 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.551 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 6.1 tp -55.78 -43.88 77.22 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.005 173.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' GLN . . . . . 0.677 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 24.1 mt-30 -72.7 -52.64 14.37 Favored 'General case' 0 CA--C 1.487 -1.472 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.48 178.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.731 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 39.5 m-20 -46.8 -50.79 17.77 Favored 'General case' 0 C--N 1.313 -1.011 0 O-C-N 124.417 1.073 . . . . 0.0 111.234 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' VAL . . . . . 0.715 HG12 ' O ' ' B' ' 20' ' ' ARG . 8.3 p -79.71 -26.06 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.836 -172.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.625 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -67.59 -30.46 70.07 Favored 'General case' 0 C--O 1.205 -1.239 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 175.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.78 -35.27 60.17 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.132 -1.395 . . . . 0.0 109.763 -178.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.731 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 40.9 mmtt -67.67 -36.54 80.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.586 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' SER . . . . . 0.461 ' HB2' ' HB3' ' B' ' 3' ' ' PHE . 16.4 m -105.19 -6.22 19.99 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.33 0.586 . . . . 0.0 110.536 -171.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.682 HG22 ' H ' ' B' ' 31' ' ' ASP . 89.0 mt -118.21 124.26 72.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.326 178.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.49 -3.65 58.51 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.236 0.541 . . . . 0.0 110.676 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.682 ' H ' HG22 ' B' ' 29' ' ' ILE . 25.9 t0 -106.9 140.46 39.68 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.519 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -76.35 -31.97 58.37 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.867 175.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.568 ' O ' HG13 ' B' ' 37' ' ' VAL . 7.1 mttp -70.73 -55.69 8.09 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -176.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.589 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -58.08 -27.71 63.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.996 176.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.858 ' O ' HG13 ' B' ' 39' ' ' VAL . 1.9 tmm_? -67.47 -56.45 9.55 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.485 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 21.2 mtpt -56.22 -57.93 10.12 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.997 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.742 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 20.1 m -53.06 -34.66 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.53 -169.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.752 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.1 tt -88.1 -30.72 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 119.727 -0.789 . . . . 0.0 112.25 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.858 HG13 ' O ' ' B' ' 35' ' ' ARG . 3.0 m -67.87 -49.99 63.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.742 174.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.775 ' OE1' HG13 ' B' ' 68' ' ' VAL . 0.9 OUTLIER -64.06 -25.66 68.21 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.68 0.792 . . . . 0.0 111.658 178.452 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.742 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.97 -55.03 4.14 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 176.924 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 42' ' ' MET . . . . . 0.516 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 22.2 mmt -62.81 -20.66 65.25 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.697 0.76 . . . . 0.0 109.818 -176.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.667 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -48.89 -28.77 4.03 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.779 171.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' TYR . . . . . 0.562 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 11.5 t80 -106.29 -66.66 0.99 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 175.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.476 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 5.7 mm-40 -48.03 -29.49 3.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 124.138 0.899 . . . . 0.0 112.999 -175.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.777 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.6 m-20 -106.9 -21.09 13.13 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 121.031 -0.267 . . . . 0.0 111.19 -176.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -60.61 179.19 0.17 Allowed 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.844 0.831 . . . . 0.0 112.931 -174.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 48' ' ' ASN . . . . . 0.512 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 11.0 m-20 -60.08 139.69 90.97 Favored Pre-proline 0 N--CA 1.441 -0.888 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.237 174.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 49' ' ' PRO . . . . . 0.427 ' O ' ' HG2' ' B' ' 52' ' ' GLN . 1.8 Cg_endo -44.27 -46.35 11.63 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.847 2.365 . . . . 0.0 111.985 -177.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 50' ' ' GLU . . . . . 0.548 ' HA ' ' HB2' ' B' ' 53' ' ' SER . 0.3 OUTLIER -71.32 -33.39 69.6 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.234 1.013 . . . . 0.0 111.96 177.256 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.528 ' HB3' ' SG ' ' B' ' 76' ' ' CYS . 93.0 m -75.78 -36.38 59.8 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 121.258 0.552 . . . . 0.0 110.026 -174.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 52' ' ' GLN . . . . . 0.569 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.9 pt20 -72.95 -31.14 64.38 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 106.932 -1.506 . . . . 0.0 106.932 174.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 53' ' ' SER . . . . . 0.548 ' HB2' ' HA ' ' B' ' 50' ' ' GLU . 17.9 m -68.64 -20.55 64.47 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.066 -1.424 . . . . 0.0 110.07 173.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' B' ' 51' ' ' CYS . . . -76.34 -28.83 57.01 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.813 0.816 . . . . 0.0 109.984 168.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.577 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 19.0 mt -89.76 -31.7 5.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -171.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.606 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -40.33 -39.83 1.66 Allowed Pre-proline 0 N--CA 1.488 1.452 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -173.104 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 52.0 Cg_endo -62.52 -32.19 80.11 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.001 1.801 . . . . 0.0 112.585 176.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 58' ' ' LEU . . . . . 0.568 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 2.6 mt -93.6 -17.08 23.71 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 59' ' ' LYS . . . . . 0.565 ' HA ' ' OH ' ' B' ' 72' ' ' TYR . 0.0 OUTLIER -55.49 108.56 0.44 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.966 179.234 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.57 -31.77 8.33 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.41 -175.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 28.4 mmtt -103.84 114.92 29.53 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 122.203 1.001 . . . . 0.0 111.166 -177.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.542 ' HB ' HG12 ' B' ' 68' ' ' VAL . 5.6 p -120.71 131.88 24.33 Favored Pre-proline 0 C--N 1.294 -1.83 0 CA-C-N 113.861 -1.518 . . . . 0.0 109.786 169.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo . . . . . 0 C--O 1.235 0.374 0 C-N-CA 122.656 2.237 . . . . 0.0 112.103 174.555 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.445 -0.694 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.775 HG13 ' OE1' ' B' ' 40' ' ' GLU . 0.8 OUTLIER -72.04 -35.12 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 118.41 -1.316 . . . . 0.0 108.908 -179.117 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.772 ' O ' HG13 ' B' ' 73' ' ' VAL . 7.2 mm -56.53 -49.78 76.02 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.992 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.644 -178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 25.8 t -45.69 -38.82 7.23 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.815 178.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.403 ' H ' ' HG2' ' B' ' 71' ' ' GLU . 2.9 mm-40 -86.4 -32.46 20.89 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.568 -175.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 72' ' ' TYR . . . . . 0.568 ' CE1' ' HB2' ' B' ' 58' ' ' LEU . 5.4 m-30 -73.74 -37.53 65.04 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.6 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.839 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.7 m -70.16 -32.87 52.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 174.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 74' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' B' ' 70' ' ' SER . 0.0 OUTLIER -68.3 -31.38 70.78 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.746 -1.116 . . . . 0.0 109.573 176.34 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 75' ' ' ALA . . . . . 0.485 ' HB2' HD11 ' B' ' 58' ' ' LEU . . . -64.86 -46.13 83.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.567 178.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.528 ' SG ' ' HB3' ' B' ' 51' ' ' CYS . 4.0 m -94.07 9.18 38.73 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.951 -178.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 77' ' ' ASP . . . . . 0.401 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 11.3 t70 . . . . . 0 C--N 1.324 -0.542 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.249 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.417 ' HB2' HG21 ' A' ' 5' ' ' THR . 92.1 Cg_endo . . . . . 0 CA--C 1.517 -0.327 0 N-CA-C 109.171 -1.127 . . . . 0.0 109.171 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.414 ' HB2' ' HB ' ' A' ' 5' ' ' THR . 12.9 m -64.25 165.94 8.72 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 162.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.722 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -69.86 -54.14 14.85 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.027 -1.069 . . . . 0.0 108.614 167.607 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.519 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 3.2 p-10 -88.31 -3.05 58.91 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 113.947 -1.479 . . . . 0.0 113.403 -164.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.45 ' O ' ' HD3' ' A' ' 7' ' ' ARG . 9.8 t -66.36 -3.58 6.3 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.622 -173.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.539 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 3.0 m -70.7 135.75 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 172.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.803 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -153.86 159.12 41.68 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 -179.781 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.482 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.1 tt0 -41.69 112.1 0.29 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 112.832 -1.986 . . . . 0.0 112.216 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.2 -145.42 6.06 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.756 176.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.7 p -59.79 95.38 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.687 0.279 . . . . 0.0 110.737 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.3 pttt 43.23 41.43 2.97 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.384 1.074 . . . . 0.0 112.3 -176.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.429 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 62.9 tt0 -56.58 141.25 72.94 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.801 175.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.401 ' O ' ' HB3' ' A' ' 16' ' ' ASP . 22.5 Cg_exo -51.68 123.1 11.53 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.73 1.62 . . . . 0.0 109.141 174.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.835 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 11.5 t80 -66.67 -51.47 40.01 Favored Pre-proline 0 N--CA 1.438 -1.052 0 CA-C-O 118.857 -0.592 . . . . 0.0 112.555 -171.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.494 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 20.5 Cg_exo -60.29 -13.77 26.1 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 121.69 1.593 . . . . 0.0 110.413 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.401 ' HB3' ' O ' ' A' ' 13' ' ' PRO . 17.1 t70 -89.45 -46.78 8.46 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 113.903 -1.499 . . . . 0.0 110.282 178.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.482 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -54.18 -42.88 70.16 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.84 177.682 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.757 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 2.1 p -81.35 -35.22 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.52 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.58 -37.67 70.93 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 121.394 -0.816 . . . . 0.0 111.223 177.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.738 ' O ' HG12 ' A' ' 24' ' ' VAL . 17.4 ptt180 -79.61 -30.05 41.31 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.548 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 7.8 tp -54.2 -46.7 72.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.258 173.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.757 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 6.1 mt-30 -69.94 -53.56 17.31 Favored 'General case' 0 CA--C 1.485 -1.523 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.55 177.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.732 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 56.3 m-20 -45.51 -52.45 10.32 Favored 'General case' 0 C--N 1.314 -0.978 0 O-C-N 124.637 1.21 . . . . 0.0 111.181 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.738 HG12 ' O ' ' A' ' 20' ' ' ARG . 8.2 p -79.67 -26.96 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.745 -171.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.679 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -66.82 -31.2 71.67 Favored 'General case' 0 C--O 1.204 -1.324 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 175.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.61 -35.59 62.95 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.909 -178.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.732 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.6 mmtt -65.86 -40.11 91.38 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.63 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.444 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 40.0 m -101.86 -10.81 19.54 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.32 0.581 . . . . 0.0 110.662 -172.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.679 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 88.4 mt -113.72 122.26 67.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.515 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.85 -1.19 57.82 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.247 0.546 . . . . 0.0 110.317 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.637 ' H ' HG22 ' A' ' 29' ' ' ILE . 11.8 t70 -107.31 119.41 39.33 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.965 -175.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -60.13 -30.35 69.23 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.08 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.588 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -74.31 -53.52 9.53 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -174.864 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.575 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -60.56 -27.41 67.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.773 177.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.859 ' O ' HG13 ' A' ' 39' ' ' VAL . 1.9 tmm_? -67.33 -58.47 4.73 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 32.6 mtpt -54.61 -59.24 4.98 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.123 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.725 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 16.9 m -53.56 -34.14 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.327 -170.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.722 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.3 tt -87.38 -32.08 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.871 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.7 m -67.34 -49.14 74.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.156 175.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.633 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 52.0 mt-10 -60.49 -31.72 70.74 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.298 1.039 . . . . 0.0 112.742 175.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.725 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -85.16 -51.29 6.73 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.933 -179.841 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.707 ' HE2' ' HE2' ' B' ' 42' ' ' MET . 20.5 mmt -64.62 -20.77 66.47 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.553 0.692 . . . . 0.0 109.462 -178.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.681 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -50.26 -30.33 11.52 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.516 171.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.529 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 15.9 t80 -102.91 -66.71 0.92 Allowed 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 174.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.478 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 47.6 mm-40 -50.26 -28.41 7.66 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.725 -1.125 . . . . 0.0 112.713 -172.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.803 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.1 m-20 -106.36 -22.04 12.92 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 121.28 -0.168 . . . . 0.0 111.055 -176.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -59.56 177.3 0.21 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.8 0.81 . . . . 0.0 112.994 -174.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.607 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 15.2 m-20 -58.89 140.55 86.37 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.93 174.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.64 -23.43 25.81 Favored 'Trans proline' 0 C--O 1.221 -0.35 0 C-N-CA 123.524 2.816 . . . . 0.0 112.731 -176.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -88.3 -35.37 17.27 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.942 0.897 . . . . 0.0 110.788 175.074 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.607 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 72.3 m -76.85 -35.87 57.2 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.207 -171.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.628 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.7 pt20 -72.49 -29.89 64.04 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 174.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.489 ' O ' ' HD2' ' A' ' 56' ' ' LYS . 15.9 m -71.81 -19.01 62.05 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 113.715 -1.584 . . . . 0.0 110.387 174.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 51' ' ' CYS . . . -77.21 -26.95 53.26 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.813 0.816 . . . . 0.0 109.494 166.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.628 HD12 ' HA ' ' A' ' 52' ' ' GLN . 25.9 mt -89.27 -31.01 5.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -172.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.607 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.8 -38.77 2.17 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -173.756 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 57.2 Cg_endo -64.49 -30.08 61.87 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.165 1.91 . . . . 0.0 112.765 176.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.527 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 2.2 mt -95.29 -16.35 22.5 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.529 ' HE3' ' HB3' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -54.05 108.65 0.38 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.709 -179.522 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.77 -21.98 42.96 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.413 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.9 mmmt -104.17 115.88 31.19 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 120.932 0.396 . . . . 0.0 110.422 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.54 139.72 31.51 Favored Pre-proline 0 C--N 1.311 -1.095 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 169.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo . . . . . 0 N--CA 1.463 -0.306 0 C-N-CA 122.338 2.025 . . . . 0.0 111.423 170.39 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 t70 . . . . . 0 CA--C 1.514 -0.425 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.602 HG22 ' HG2' ' A' ' 40' ' ' GLU . 1.0 OUTLIER -77.38 -29.7 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 C-N-CA 118.651 -1.22 . . . . 0.0 108.813 -179.346 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.777 ' O ' HG13 ' A' ' 73' ' ' VAL . 10.4 mm -60.81 -47.53 92.86 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.117 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.125 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.0 t -46.18 -37.66 7.34 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.017 176.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.472 ' HA ' ' HB3' ' A' ' 74' ' ' LYS . 7.2 mm-40 -85.82 -31.85 22.08 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 123.375 0.67 . . . . 0.0 111.014 -177.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.612 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.3 m-30 -75.32 -34.84 61.27 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.555 0.693 . . . . 0.0 109.34 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.835 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.4 m -72.52 -30.17 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 173.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.509 ' HA ' ' HB2' ' A' ' 77' ' ' ASP . 14.8 ttpt -73.52 -25.51 60.45 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.474 177.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -65.89 -46.53 78.03 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.538 174.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.503 ' SG ' ' HB2' ' A' ' 14' ' ' TYR . 26.2 t -93.01 8.77 38.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.871 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.509 ' HB2' ' HA ' ' A' ' 74' ' ' LYS . 17.3 t70 . . . . . 0 C--N 1.323 -0.55 0 CA-C-O 121.302 0.572 . . . . 0.0 110.043 176.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 1' ' ' PRO . . . . . 0.414 ' HB2' ' H ' ' B' ' 2' ' ' SER . 93.8 Cg_endo . . . . . 0 CA--C 1.519 -0.248 0 N-CA-C 109.133 -1.141 . . . . 0.0 109.133 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 2' ' ' SER . . . . . 0.429 ' HB2' ' HB ' ' B' ' 5' ' ' THR . 13.3 m -64.35 166.24 8.47 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 163.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.746 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -70.12 -54.02 14.81 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.108 -1.037 . . . . 0.0 108.605 167.687 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.524 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 3.2 p-10 -88.5 -2.99 58.9 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.041 -1.436 . . . . 0.0 113.408 -164.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.436 ' O ' ' HD3' ' B' ' 7' ' ' ARG . 9.5 t -66.37 -3.54 6.22 Favored 'General case' 0 C--N 1.315 -0.911 0 O-C-N 121.644 -0.66 . . . . 0.0 110.634 -173.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.526 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 3.0 m -70.63 135.7 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 171.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.799 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -153.9 159.2 41.66 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 8' ' ' GLN . . . . . 0.458 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.1 tt0 -41.77 112.42 0.32 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 112.776 -2.011 . . . . 0.0 112.106 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.35 -145.64 6.3 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.772 175.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 12.4 p -59.51 95.27 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.64 0.257 . . . . 0.0 110.653 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 64.2 pttt 43.17 41.36 2.84 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.44 1.096 . . . . 0.0 112.402 -176.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.424 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 62.8 tt0 -56.63 141.37 73.11 Favored Pre-proline 0 C--O 1.235 0.301 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.774 175.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' B' ' 16' ' ' ASP . 22.1 Cg_exo -51.66 122.99 11.29 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.742 1.628 . . . . 0.0 109.204 174.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 14' ' ' TYR . . . . . 0.839 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 11.7 t80 -66.63 -51.64 39.42 Favored Pre-proline 0 N--CA 1.437 -1.078 0 CA-C-O 118.876 -0.583 . . . . 0.0 112.406 -171.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.504 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 20.6 Cg_exo -60.14 -13.79 25.57 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.57 1.513 . . . . 0.0 110.453 -178.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.417 ' HB3' ' O ' ' B' ' 13' ' ' PRO . 18.7 t70 -89.45 -46.74 8.48 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 113.939 -1.482 . . . . 0.0 110.191 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 17' ' ' PHE . . . . . 0.458 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -54.15 -42.85 70.02 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.841 177.675 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.752 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 2.1 p -81.4 -35.27 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.429 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.57 -37.64 70.86 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 121.38 -0.825 . . . . 0.0 111.221 177.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.74 ' O ' HG12 ' B' ' 24' ' ' VAL . 17.4 ptt180 -79.72 -29.72 40.74 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.558 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 7.9 tp -54.47 -46.72 73.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.193 173.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 22' ' ' GLN . . . . . 0.752 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 6.1 mt-30 -69.81 -53.67 17.15 Favored 'General case' 0 CA--C 1.485 -1.556 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.519 177.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.728 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 48.9 m-20 -45.55 -52.49 10.39 Favored 'General case' 0 C--N 1.314 -0.959 0 O-C-N 124.628 1.205 . . . . 0.0 111.042 -178.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' VAL . . . . . 0.74 HG12 ' O ' ' B' ' 20' ' ' ARG . 8.2 p -79.64 -26.97 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.673 -171.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.667 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -66.86 -31.02 71.35 Favored 'General case' 0 C--O 1.206 -1.211 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 175.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -35.65 62.53 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.802 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.728 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.9 mmtt -65.87 -40.13 91.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.643 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 28' ' ' SER . . . . . 0.454 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 37.4 m -101.66 -11.21 19.36 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.186 0.517 . . . . 0.0 110.546 -172.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.667 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 88.0 mt -113.63 122.33 67.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.569 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.93 -1.11 57.78 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.249 0.547 . . . . 0.0 110.439 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.658 ' H ' HG22 ' B' ' 29' ' ' ILE . 11.4 t70 -107.59 119.36 39.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.959 -175.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.2 -30.15 69.18 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.1 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.599 ' O ' HG13 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -74.42 -53.27 9.91 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -174.867 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.571 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -60.85 -27.32 68.0 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.87 177.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.87 ' O ' HG13 ' B' ' 39' ' ' VAL . 1.9 tmm_? -67.38 -58.52 4.63 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.431 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 32.3 mtpt -54.6 -59.3 4.89 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.081 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.722 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 17.1 m -53.69 -33.88 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.314 -170.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.746 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.3 tt -87.53 -32.08 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.808 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.87 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.7 m -67.31 -49.11 75.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.101 174.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.637 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 52.2 mt-10 -60.63 -31.72 70.9 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.259 1.023 . . . . 0.0 112.794 176.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.722 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -85.25 -51.17 6.78 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.393 -0.523 . . . . 0.0 112.02 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 42' ' ' MET . . . . . 0.707 ' HE2' ' HE2' ' A' ' 42' ' ' MET . 20.7 mmt -64.63 -20.7 66.43 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 121.545 0.688 . . . . 0.0 109.524 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.675 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -50.39 -30.33 12.12 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.421 171.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' TYR . . . . . 0.536 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 16.1 t80 -102.85 -66.61 0.92 Allowed 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 174.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.47 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 46.8 mm-40 -50.49 -27.99 7.61 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.696 -1.138 . . . . 0.0 112.739 -172.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.799 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.2 m-20 -106.76 -21.91 12.89 Favored 'General case' 0 N--CA 1.434 -1.265 0 O-C-N 122.371 -0.206 . . . . 0.0 111.1 -176.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -59.51 177.46 0.2 Allowed 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.81 0.814 . . . . 0.0 113.085 -175.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' ASN . . . . . 0.61 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 15.1 m-20 -59.09 140.33 87.31 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.864 174.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.75 -23.21 25.78 Favored 'Trans proline' 0 C--O 1.22 -0.407 0 C-N-CA 123.502 2.801 . . . . 0.0 112.628 -176.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -88.41 -35.27 17.19 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.88 0.872 . . . . 0.0 110.824 174.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.61 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 71.8 m -76.82 -35.83 57.29 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.261 -172.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 52' ' ' GLN . . . . . 0.646 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.8 pt20 -72.36 -29.99 64.3 Favored 'General case' 0 C--O 1.213 -0.835 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 174.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 53' ' ' SER . . . . . 0.482 ' O ' ' HD2' ' B' ' 56' ' ' LYS . 14.5 m -71.63 -19.26 62.13 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 113.7 -1.591 . . . . 0.0 110.4 174.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' B' ' 51' ' ' CYS . . . -77.16 -27.08 53.62 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.692 0.758 . . . . 0.0 109.484 166.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.646 HD12 ' HA ' ' B' ' 52' ' ' GLN . 25.9 mt -89.23 -30.99 5.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -172.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.604 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.96 -38.67 2.26 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -173.647 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 57.3 Cg_endo -64.7 -29.76 59.89 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 122.055 1.837 . . . . 0.0 112.688 176.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 58' ' ' LEU . . . . . 0.545 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 2.2 mt -95.36 -16.26 22.48 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 59' ' ' LYS . . . . . 0.536 ' HE3' ' HB3' ' B' ' 44' ' ' TYR . 0.1 OUTLIER -54.18 108.7 0.39 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.746 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.45 -21.5 45.21 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.503 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 15.8 mmmt -104.49 115.84 31.06 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.865 0.365 . . . . 0.0 110.6 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.4 139.72 31.33 Favored Pre-proline 0 C--N 1.312 -1.059 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 169.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo . . . . . 0 N--CA 1.463 -0.281 0 C-N-CA 122.368 2.045 . . . . 0.0 111.523 170.204 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 1.3 t70 . . . . . 0 CA--C 1.513 -0.446 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.583 HG22 ' HG2' ' B' ' 40' ' ' GLU . 1.0 OUTLIER -77.54 -29.75 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 C-N-CA 118.691 -1.203 . . . . 0.0 108.813 -179.444 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.774 ' O ' HG13 ' B' ' 73' ' ' VAL . 10.4 mm -60.8 -47.4 93.41 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.155 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.166 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 41.0 t -46.63 -37.29 7.99 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 123.847 0.717 . . . . 0.0 110.998 177.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.491 ' HA ' ' HB3' ' B' ' 74' ' ' LYS . 7.5 mm-40 -85.89 -31.67 22.08 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.22 0.608 . . . . 0.0 111.051 -177.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 72' ' ' TYR . . . . . 0.6 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.3 m-30 -75.45 -34.89 60.99 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.599 0.714 . . . . 0.0 109.441 -178.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.839 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.4 m -72.65 -30.03 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 173.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 74' ' ' LYS . . . . . 0.528 ' HA ' ' HB2' ' B' ' 77' ' ' ASP . 14.7 ttpt -73.71 -25.18 60.09 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.581 177.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 75' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -65.95 -46.57 77.69 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.646 173.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' B' ' 14' ' ' TYR . 28.3 t -93.03 8.58 39.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.884 177.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 77' ' ' ASP . . . . . 0.528 ' HB2' ' HA ' ' B' ' 74' ' ' LYS . 18.0 t70 . . . . . 0 C--N 1.324 -0.537 0 CA-C-O 121.296 0.57 . . . . 0.0 110.056 176.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.42 ' C ' ' HA3' ' B' ' 60' ' ' GLY . 84.1 Cg_endo . . . . . 0 CA--C 1.516 -0.399 0 N-CA-C 109.525 -0.99 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.8 m -65.74 165.14 13.23 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 163.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.764 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -69.9 -55.17 10.43 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 122.058 0.932 . . . . 0.0 109.907 174.142 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.566 ' ND2' ' HG3' ' A' ' 42' ' ' MET . 2.7 p-10 -86.57 -2.38 58.44 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.308 -1.314 . . . . 0.0 112.762 -164.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.417 ' O ' ' HD3' ' A' ' 7' ' ' ARG . 9.9 t -66.1 -3.03 4.75 Favored 'General case' 0 C--N 1.314 -0.942 0 O-C-N 121.708 -0.62 . . . . 0.0 110.445 -176.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.607 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.3 m -73.7 131.98 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 170.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.759 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 1.3 ptt-85 -156.68 160.04 38.97 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 118.38 -1.328 . . . . 0.0 114.375 -176.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.457 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.3 tt0 -39.12 112.33 0.24 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 113.698 -1.592 . . . . 0.0 112.624 178.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.95 -142.36 7.96 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.689 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.5 m -59.33 95.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.973 0.387 . . . . 0.0 110.837 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.401 ' O ' ' HG3' ' A' ' 11' ' ' LYS . 23.3 pttm 40.73 41.75 1.24 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.495 1.118 . . . . 0.0 112.343 -174.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 65.6 tt0 -57.79 139.65 81.95 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.674 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.518 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 34.3 Cg_exo -53.7 125.0 17.19 Favored 'Trans proline' 0 CA--C 1.511 -0.671 0 C-N-CA 122.026 1.817 . . . . 0.0 109.745 177.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.841 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 6.0 t80 -68.22 -55.48 12.62 Favored Pre-proline 0 N--CA 1.44 -0.934 0 CA-C-O 118.482 -0.77 . . . . 0.0 112.924 -167.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.528 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 26.0 Cg_exo -57.62 -17.7 29.63 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 121.456 1.437 . . . . 0.0 111.145 -177.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.518 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 5.7 m-20 -89.8 -40.16 12.64 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.057 -1.428 . . . . 0.0 110.846 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.639 ' HE2' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -56.63 -45.79 81.32 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 176.106 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.796 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 1.4 p -77.82 -33.46 18.74 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.322 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.347 -178.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.04 -31.57 67.15 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 121.179 -0.951 . . . . 0.0 111.834 177.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.738 ' O ' HG12 ' A' ' 24' ' ' VAL . 15.6 ptt180 -84.86 -28.09 26.26 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 175.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.601 HD22 ' CE1' ' A' ' 17' ' ' PHE . 11.8 tp -54.28 -48.9 70.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.962 172.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.796 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 4.3 mt-30 -70.57 -46.65 63.09 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 114.849 -1.068 . . . . 0.0 111.123 177.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.729 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 19.2 t70 -48.41 -54.63 13.34 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.282 0.989 . . . . 0.0 111.479 -178.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.738 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.4 p -81.73 -22.18 10.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.13 0.49 . . . . 0.0 109.734 -173.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.801 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -72.93 -18.85 61.35 Favored 'General case' 0 C--O 1.205 -1.259 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 174.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.401 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -86.44 -38.61 17.16 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.568 -1.196 . . . . 0.0 109.553 177.22 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.729 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.8 mmtt -67.06 -36.29 81.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.014 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.2 m -103.69 -9.1 19.4 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.088 0.47 . . . . 0.0 110.516 -171.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.801 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 84.3 mt -115.07 126.06 72.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.442 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.47 -4.8 59.27 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.242 0.544 . . . . 0.0 110.502 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.65 ' H ' HG22 ' A' ' 29' ' ' ILE . 25.8 t0 -106.28 139.16 41.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.407 -177.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -75.98 -31.45 58.99 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.445 175.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.567 ' O ' HG13 ' A' ' 37' ' ' VAL . 6.4 mttp -71.88 -55.0 8.31 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -175.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.631 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -58.75 -27.31 64.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.022 176.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.873 ' O ' HG13 ' A' ' 39' ' ' VAL . 1.9 tmm_? -66.0 -59.86 3.41 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 178.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.423 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 12.6 mtpp -54.94 -57.58 11.07 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.16 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.779 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 20.6 m -52.8 -34.33 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.975 -170.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.764 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.0 OUTLIER -88.31 -31.37 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 119.87 -0.732 . . . . 0.0 112.217 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.873 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.4 m -68.52 -48.65 71.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 119.067 -1.053 . . . . 0.0 109.513 176.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.785 ' OE1' HG13 ' A' ' 68' ' ' VAL . 0.8 OUTLIER -64.59 -28.46 69.64 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.455 0.702 . . . . 0.0 111.573 178.343 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.779 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -81.4 -54.61 5.32 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 122.19 -0.319 . . . . 0.0 111.432 178.014 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.566 ' HG3' ' ND2' ' A' ' 4' ' ' ASN . 22.3 mmt -63.43 -20.41 65.53 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.707 0.765 . . . . 0.0 109.613 -177.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.648 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -49.07 -32.98 10.61 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.86 172.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.488 ' HB2' HG21 ' A' ' 55' ' ' ILE . 17.1 t80 -99.75 -64.99 0.99 Allowed 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 175.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.566 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 39.3 mm-40 -50.06 -33.01 17.0 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.468 -1.242 . . . . 0.0 112.413 -171.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.759 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.6 m-20 -103.72 -20.42 13.96 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.087 -174.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.648 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -59.11 175.03 0.32 Allowed 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.691 0.758 . . . . 0.0 112.121 -177.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.603 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 12.3 m-20 -58.77 141.5 85.0 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.503 174.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -48.32 -29.09 12.45 Favored 'Trans proline' 0 C--O 1.22 -0.397 0 C-N-CA 123.761 2.974 . . . . 0.0 112.893 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -88.15 -33.82 18.08 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 123.86 0.864 . . . . 0.0 111.053 177.033 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.603 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 78.2 m -78.83 -33.8 45.76 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.504 -172.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.579 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.5 pt20 -73.08 -29.84 63.24 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 172.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.511 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 16.2 m -70.47 -19.12 62.97 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 113.658 -1.61 . . . . 0.0 110.432 173.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 51' ' ' CYS . . . -76.46 -27.98 56.37 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.169 -0.957 . . . . 0.0 109.458 166.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.593 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 21.8 mt -89.15 -31.5 5.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 115.651 1.722 . . . . 0.0 115.651 -171.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.587 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -40.03 -38.13 0.96 Allowed Pre-proline 0 N--CA 1.492 1.673 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -174.798 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.593 ' HD2' ' C ' ' A' ' 55' ' ' ILE . 57.7 Cg_endo -65.21 -26.49 56.88 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.139 1.893 . . . . 0.0 113.002 175.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.554 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.8 mt -100.89 -15.61 17.5 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.575 ' NZ ' HD13 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -49.85 109.36 0.28 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.333 -179.215 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.18 -21.4 34.73 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.075 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -103.43 114.04 28.0 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.007 0.432 . . . . 0.0 109.977 -177.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.453 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.1 p -122.42 140.67 33.16 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.05 172.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo . . . . . 0 C--O 1.235 0.338 0 C-N-CA 122.598 2.199 . . . . 0.0 111.848 170.119 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.785 HG13 ' OE1' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -71.46 -33.45 49.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.222 -179.626 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.771 ' O ' HG13 ' A' ' 73' ' ' VAL . 11.9 mm -55.71 -47.95 78.53 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.226 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.524 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.601 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 27.7 t -47.91 -36.65 12.63 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.911 178.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -86.59 -31.85 20.95 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.649 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.624 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.2 m-30 -76.13 -36.24 58.91 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.65 -177.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.841 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.8 m -69.63 -33.43 56.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 173.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.601 ' HB2' ' O ' ' A' ' 70' ' ' SER . 0.8 OUTLIER -68.36 -29.9 68.72 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.73 177.132 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -63.97 -49.04 74.08 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.741 175.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 14' ' ' TYR . 25.4 t -89.44 7.32 36.6 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.931 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.492 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 10.5 t70 . . . . . 0 C--N 1.323 -0.544 0 CA-C-O 121.487 0.66 . . . . 0.0 110.004 174.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 1' ' ' PRO . . . . . 0.409 ' HB2' HG21 ' B' ' 5' ' ' THR . 84.5 Cg_endo . . . . . 0 CA--C 1.516 -0.413 0 N-CA-C 109.425 -1.029 . . . . 0.0 109.425 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 48.4 m -65.51 164.98 12.96 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 163.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.767 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -69.79 -55.1 10.78 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.909 174.061 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.56 ' ND2' ' HG3' ' B' ' 42' ' ' MET . 2.7 p-10 -86.69 -2.23 58.35 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.852 -164.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.426 ' O ' ' HD3' ' B' ' 7' ' ' ARG . 9.7 t -66.11 -3.26 5.22 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.439 -176.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.597 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.3 m -73.65 131.97 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 171.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.779 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 1.2 ptt-85 -156.62 160.15 39.14 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -176.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 8' ' ' GLN . . . . . 0.462 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.3 tt0 -39.16 112.28 0.24 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 113.624 -1.626 . . . . 0.0 112.745 178.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.95 -142.72 8.18 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.64 174.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 20.0 m -59.03 95.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.958 0.379 . . . . 0.0 110.85 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 23.2 pttm 41.06 41.38 1.28 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.459 1.103 . . . . 0.0 112.454 -174.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -57.54 139.73 80.75 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.635 176.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 13' ' ' PRO . . . . . 0.538 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 34.2 Cg_exo -53.73 125.05 17.36 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.053 1.835 . . . . 0.0 109.727 177.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 14' ' ' TYR . . . . . 0.849 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 6.1 t80 -68.42 -55.37 12.25 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-O 118.504 -0.76 . . . . 0.0 112.877 -167.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.539 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 25.4 Cg_exo -57.57 -17.76 29.59 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 121.375 1.383 . . . . 0.0 111.238 -177.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.538 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 5.8 m-20 -89.71 -40.1 12.74 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.966 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 17' ' ' PHE . . . . . 0.637 ' HE2' ' CE2' ' B' ' 14' ' ' TYR . 0.0 OUTLIER -56.68 -45.79 81.52 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.013 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.792 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 1.4 p -77.75 -33.43 18.86 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.278 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.399 -178.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.27 -31.25 67.28 Favored 'General case' 0 C--N 1.31 -1.119 0 O-C-N 121.271 -0.893 . . . . 0.0 111.83 177.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.728 ' O ' HG12 ' B' ' 24' ' ' VAL . 15.8 ptt180 -84.97 -28.31 25.89 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 174.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.593 HD22 ' CE1' ' B' ' 17' ' ' PHE . 11.8 tp -54.0 -48.84 70.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.97 172.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' GLN . . . . . 0.792 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 4.4 mt-30 -70.89 -46.38 62.68 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.077 177.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.734 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 19.1 t70 -48.4 -54.72 12.98 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 124.125 0.891 . . . . 0.0 111.574 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 24' ' ' VAL . . . . . 0.728 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.4 p -81.63 -22.38 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-O 121.278 0.561 . . . . 0.0 109.807 -173.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.779 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -72.85 -18.67 61.42 Favored 'General case' 0 C--O 1.205 -1.252 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 173.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 26' ' ' GLN . . . . . 0.419 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -86.64 -38.39 17.11 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.546 -1.207 . . . . 0.0 109.596 177.133 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.734 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.8 mmtt -67.23 -36.13 81.02 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.033 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 23.8 m -104.02 -8.73 19.35 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.203 0.525 . . . . 0.0 110.628 -171.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.779 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 83.8 mt -115.35 126.13 72.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.394 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.37 -5.55 59.3 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.109 0.48 . . . . 0.0 110.363 178.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.669 ' H ' HG22 ' B' ' 29' ' ' ILE . 26.0 t0 -105.41 139.47 39.99 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.297 -177.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -76.27 -31.5 58.3 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.499 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.581 ' O ' HG13 ' B' ' 37' ' ' VAL . 6.4 mttp -71.68 -55.01 8.51 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.624 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -58.7 -27.56 64.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.289 -0.868 . . . . 0.0 110.967 176.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.859 ' O ' HG13 ' B' ' 39' ' ' VAL . 1.9 tmm_? -65.85 -59.75 3.55 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 12.5 mtpp -55.18 -57.54 11.37 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.1 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.781 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 20.1 m -52.67 -34.5 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.068 -170.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.767 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.0 OUTLIER -88.26 -31.26 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 119.942 -0.703 . . . . 0.0 112.195 -179.436 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.859 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.4 m -68.63 -48.64 70.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 119.114 -1.035 . . . . 0.0 109.434 176.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.771 ' OE1' HG13 ' B' ' 68' ' ' VAL . 0.8 OUTLIER -64.65 -28.44 69.61 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.49 0.716 . . . . 0.0 111.541 178.388 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.781 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -81.4 -54.62 5.31 Favored 'General case' 0 C--N 1.322 -0.602 0 O-C-N 122.141 -0.349 . . . . 0.0 111.5 177.97 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 42' ' ' MET . . . . . 0.56 ' HG3' ' ND2' ' B' ' 4' ' ' ASN . 22.2 mmt -63.47 -20.45 65.59 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.691 0.758 . . . . 0.0 109.519 -177.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.659 ' O ' ' HB2' ' B' ' 47' ' ' ALA . . . -49.0 -32.99 10.17 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.832 171.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' TYR . . . . . 0.492 ' HB2' HG21 ' B' ' 55' ' ' ILE . 17.6 t80 -99.8 -64.79 1.01 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.582 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 39.4 mm-40 -50.2 -32.97 17.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.419 -1.264 . . . . 0.0 112.312 -171.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.779 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.6 m-20 -103.96 -20.21 13.96 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.031 -174.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.659 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -59.55 174.91 0.39 Allowed 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.591 0.71 . . . . 0.0 112.119 -177.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' ASN . . . . . 0.606 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 12.0 m-20 -58.51 141.44 83.73 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 114.755 -1.112 . . . . 0.0 109.496 174.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -48.12 -29.3 12.19 Favored 'Trans proline' 0 C--O 1.221 -0.37 0 C-N-CA 123.715 2.943 . . . . 0.0 112.918 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' B' ' 50' ' ' GLU . 0.3 OUTLIER -88.05 -33.81 18.19 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 123.823 0.849 . . . . 0.0 111.095 177.213 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.606 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 78.8 m -78.8 -33.88 45.88 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.457 -172.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 52' ' ' GLN . . . . . 0.596 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.7 pt20 -72.93 -29.99 63.54 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 172.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 53' ' ' SER . . . . . 0.517 ' O ' ' HE2' ' B' ' 56' ' ' LYS . 15.8 m -70.45 -19.06 63.0 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 113.654 -1.612 . . . . 0.0 110.416 173.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' B' ' 51' ' ' CYS . . . -76.6 -27.65 55.84 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.271 -0.893 . . . . 0.0 109.545 166.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' B' ' 52' ' ' GLN . 22.0 mt -89.43 -31.41 5.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -171.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.585 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -40.2 -38.15 1.02 Allowed Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -174.756 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.589 ' HD2' ' C ' ' B' ' 55' ' ' ILE . 57.9 Cg_endo -65.21 -26.22 57.08 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.177 1.918 . . . . 0.0 113.069 175.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 58' ' ' LEU . . . . . 0.57 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.8 mt -100.97 -15.66 17.42 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 59' ' ' LYS . . . . . 0.568 ' NZ ' HD13 ' B' ' 41' ' ' LEU . 0.2 OUTLIER -49.95 109.36 0.28 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.302 -179.103 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 60' ' ' GLY . . . . . 0.42 ' HA3' ' C ' ' A' ' 1' ' ' PRO . . . 91.13 -21.23 35.46 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.05 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -103.4 114.01 27.95 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 120.994 0.426 . . . . 0.0 109.972 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.462 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.1 p -122.34 140.76 33.22 Favored Pre-proline 0 C--N 1.314 -0.964 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.075 172.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo . . . . . 0 C--N 1.343 0.283 0 C-N-CA 122.576 2.184 . . . . 0.0 111.906 170.029 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 . . . . . 0 N--CA 1.454 -0.261 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.771 HG13 ' OE1' ' B' ' 40' ' ' GLU . 0.8 OUTLIER -71.69 -33.35 48.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.198 -179.475 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.772 ' O ' HG13 ' B' ' 73' ' ' VAL . 11.9 mm -55.66 -48.1 78.16 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.215 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.538 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.594 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 27.2 t -47.83 -36.6 12.17 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.943 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -86.42 -32.11 21.07 Favored 'General case' 0 CA--C 1.507 -0.685 0 C-N-CA 123.231 0.613 . . . . 0.0 110.606 -177.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 72' ' ' TYR . . . . . 0.613 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.2 m-30 -75.94 -36.22 59.43 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.616 -177.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.849 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.8 m -69.62 -33.59 57.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.543 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 173.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 74' ' ' LYS . . . . . 0.594 ' HB2' ' O ' ' B' ' 70' ' ' SER . 0.8 OUTLIER -68.11 -30.12 69.2 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.224 -1.353 . . . . 0.0 109.755 177.117 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 75' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -63.75 -49.25 73.74 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.676 175.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' B' ' 14' ' ' TYR . 24.9 t -89.31 7.05 37.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.921 178.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 77' ' ' ASP . . . . . 0.498 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 8.9 t70 . . . . . 0 C--N 1.323 -0.56 0 CA-C-O 121.374 0.607 . . . . 0.0 110.034 174.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.4 ' HB2' ' H ' ' A' ' 2' ' ' SER . 96.0 Cg_endo . . . . . 0 CA--C 1.517 -0.345 0 N-CA-C 109.248 -1.097 . . . . 0.0 109.248 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.554 ' HB2' HG23 ' A' ' 5' ' ' THR . 39.4 m -64.93 171.13 3.71 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 162.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.837 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -69.73 -52.53 24.65 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.118 175.299 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.488 ' ND2' ' HG3' ' A' ' 42' ' ' MET . 2.2 p-10 -86.97 6.45 32.16 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.577 -1.192 . . . . 0.0 113.659 -163.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.628 ' CG2' ' HD3' ' B' ' 59' ' ' LYS . 1.1 p -63.32 -5.99 4.14 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 118.513 0.597 . . . . 0.0 111.787 -176.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.629 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.1 m -75.12 132.04 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 175.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.772 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -155.54 159.22 39.54 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -178.594 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.474 ' HG2' ' HB3' ' A' ' 12' ' ' GLU . 2.3 tt0 -44.29 115.14 0.79 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 112.929 -1.941 . . . . 0.0 113.02 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.73 -149.98 23.81 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.091 -0.958 . . . . 0.0 111.126 171.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.478 ' C ' ' HD3' ' A' ' 11' ' ' LYS . 6.3 p -50.97 100.36 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.61 0.364 . . . . 0.0 111.592 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER 30.25 48.0 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.764 1.226 . . . . 0.0 112.26 -171.507 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.474 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 53.5 tt0 -60.22 140.63 91.17 Favored Pre-proline 0 C--O 1.234 0.283 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.611 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.574 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 32.0 Cg_exo -54.05 121.54 9.82 Favored 'Trans proline' 0 CA--C 1.509 -0.754 0 C-N-CA 121.947 1.765 . . . . 0.0 109.623 178.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.917 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 13.8 t80 -72.75 -53.36 5.52 Favored Pre-proline 0 N--CA 1.439 -1.022 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -167.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' A' ' 14' ' ' TYR . 34.6 Cg_exo -55.66 -17.04 16.42 Favored 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.43 1.42 . . . . 0.0 110.761 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.574 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 2.2 m-20 -90.6 -43.43 10.18 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 113.981 -1.463 . . . . 0.0 111.038 177.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.491 ' CD2' ' HA ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -53.41 -46.51 69.78 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.594 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.791 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 1.8 p -79.26 -34.72 16.56 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.363 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.313 -178.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.89 -32.79 68.06 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 121.344 -0.847 . . . . 0.0 111.762 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.697 ' O ' HG12 ' A' ' 24' ' ' VAL . 14.3 ptt180 -84.28 -25.04 29.64 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 176.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.56 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 6.2 tp -59.91 -46.72 88.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.821 172.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.791 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 4.6 mt-30 -69.97 -48.28 58.92 Favored 'General case' 0 CA--C 1.492 -1.282 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.933 177.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.73 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 15.5 t70 -47.44 -54.65 10.82 Favored 'General case' 0 C--N 1.313 -1.017 0 O-C-N 124.265 0.978 . . . . 0.0 111.547 -178.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.697 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.7 p -79.18 -24.9 12.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.948 -173.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.641 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -67.89 -29.58 68.71 Favored 'General case' 0 C--O 1.205 -1.263 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.474 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -78.81 -36.32 42.89 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.723 -178.253 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.73 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 39.2 mmtt -65.92 -34.1 77.34 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.469 177.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.431 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 16.1 m -105.6 -9.89 17.14 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.271 0.558 . . . . 0.0 110.823 -170.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.641 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 87.7 mt -118.07 129.07 74.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.062 -178.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.4 -1.47 53.63 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.246 0.546 . . . . 0.0 110.524 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.615 ' H ' HG22 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -113.71 111.76 22.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.015 -177.338 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.86 -32.05 30.47 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 177.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.595 ' O ' HG13 ' A' ' 37' ' ' VAL . 14.2 mttm -58.46 -61.31 2.68 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.634 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -66.36 -22.84 66.27 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.427 -178.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.85 ' O ' HG13 ' A' ' 39' ' ' VAL . 5.3 tmm_? -72.31 -54.6 9.02 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.447 ' O ' HG22 ' A' ' 39' ' ' VAL . 16.6 mtpt -59.44 -56.5 21.26 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.345 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.81 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 20.9 m -54.15 -36.58 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.997 -171.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.837 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.2 tt -85.78 -30.36 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.811 -176.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.85 HG13 ' O ' ' A' ' 35' ' ' ARG . 3.3 m -69.47 -47.94 69.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 C-N-CA 118.915 -1.114 . . . . 0.0 109.245 174.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.619 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 58.6 mt-10 -64.66 -23.13 67.16 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 123.653 0.781 . . . . 0.0 112.383 175.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.81 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -85.48 -57.21 3.16 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.543 177.251 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.498 ' HB2' HD21 ' A' ' 21' ' ' LEU . 20.1 mmt -63.6 -20.96 66.09 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 121.462 0.649 . . . . 0.0 109.734 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.671 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -49.18 -27.65 3.78 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.288 170.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.466 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 11.4 t80 -106.12 -68.1 0.89 Allowed 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.603 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 7.2 mm-40 -47.59 -33.85 7.1 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 124.31 1.007 . . . . 0.0 112.414 -173.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.772 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.8 m-20 -103.46 -21.15 13.83 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 120.501 0.191 . . . . 0.0 110.963 -174.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.654 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -57.35 177.61 0.09 Allowed 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 121.817 0.818 . . . . 0.0 112.511 -176.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -56.21 137.64 74.35 Favored Pre-proline 0 N--CA 1.44 -0.958 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.9 174.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.43 -21.75 31.36 Favored 'Trans proline' 0 C--O 1.219 -0.465 0 C-N-CA 123.273 2.649 . . . . 0.0 111.778 -177.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.516 ' O ' ' HB2' ' A' ' 53' ' ' SER . 0.7 OUTLIER -87.86 -37.4 16.54 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 124.157 0.983 . . . . 0.0 111.055 173.325 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 1.015 ' SG ' ' HB2' ' A' ' 76' ' ' CYS . 42.4 t -75.33 -36.06 61.11 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-O 121.018 0.437 . . . . 0.0 111.328 -172.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.554 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.9 pt20 -69.62 -29.74 67.32 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 175.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.636 ' HA ' ' CD ' ' A' ' 56' ' ' LYS . 30.8 m -72.48 -19.75 61.5 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 112.944 -1.935 . . . . 0.0 110.176 174.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -81.22 -22.27 38.92 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.333 166.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.554 HD12 ' HA ' ' A' ' 52' ' ' GLN . 22.5 mt -90.54 -31.84 5.26 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.787 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 -173.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.651 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.1 OUTLIER -46.14 -32.65 1.81 Allowed Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -175.903 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.651 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 33.0 Cg_endo -59.54 -31.04 93.9 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.17 1.913 . . . . 0.0 112.99 171.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.546 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.1 mt -102.45 -15.65 16.42 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.624 ' HD3' ' CG2' ' B' ' 5' ' ' THR . 0.1 OUTLIER -51.78 109.88 0.41 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.972 -179.717 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.35 -22.66 35.8 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.162 -177.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -103.77 114.5 28.8 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.413 0.625 . . . . 0.0 110.553 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.527 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.4 p -123.4 149.99 59.55 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.471 170.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.43 ' HD2' HG23 ' A' ' 62' ' ' VAL . 92.1 Cg_exo . . . . . 0 N--CA 1.462 -0.374 0 C-N-CA 121.713 1.609 . . . . 0.0 110.92 164.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 p30 . . . . . 0 N--CA 1.44 -0.963 0 CA-C-O 120.166 0.031 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.559 HG13 ' CD ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -81.05 -28.98 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 C-N-CA 117.609 -1.637 . . . . 0.0 108.606 173.971 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.78 ' O ' HG13 ' A' ' 73' ' ' VAL . 10.0 mm -59.34 -48.04 88.42 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.18 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.627 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.402 ' O ' HG22 ' A' ' 73' ' ' VAL . 45.3 t -50.44 -33.96 22.93 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.355 0.598 . . . . 0.0 111.155 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -85.28 -33.64 22.1 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 123.323 0.649 . . . . 0.0 110.507 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.576 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 4.7 m-30 -75.85 -34.05 60.04 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.754 -176.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.917 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 2.2 m -68.41 -35.67 71.66 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 173.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.54 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 21.7 ttmt -70.71 -27.7 64.18 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 113.894 -1.503 . . . . 0.0 111.188 176.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -61.62 -44.34 97.17 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 171.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 1.015 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 16.6 t -85.78 3.12 42.83 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.292 176.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.54 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 29.6 t70 . . . . . 0 CA--C 1.538 0.492 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 163.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo . . . . . 0 CA--C 1.517 -0.368 0 N-CA-C 109.156 -1.132 . . . . 0.0 109.156 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 2' ' ' SER . . . . . 0.561 ' HB2' HG23 ' B' ' 5' ' ' THR . 43.3 m -65.13 171.07 3.93 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 162.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.825 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -69.61 -52.54 25.06 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.155 175.349 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.488 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.2 p-10 -86.9 6.51 31.6 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.584 -1.189 . . . . 0.0 113.717 -163.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.624 ' CG2' ' HD3' ' A' ' 59' ' ' LYS . 1.1 p -63.54 -5.75 4.25 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 118.57 0.623 . . . . 0.0 111.865 -176.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.63 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.1 m -75.2 131.98 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 175.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.773 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.1 OUTLIER -155.51 159.37 39.7 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -178.702 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 8' ' ' GLN . . . . . 0.46 ' HG2' ' HB3' ' B' ' 12' ' ' GLU . 2.3 tt0 -44.2 115.0 0.76 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 112.939 -1.937 . . . . 0.0 113.035 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.79 -150.06 24.04 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.162 171.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' SER . . . . . 0.488 ' C ' ' HD3' ' B' ' 11' ' ' LYS . 7.8 p -50.84 100.25 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.604 0.362 . . . . 0.0 111.677 -178.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 11' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' B' ' 11' ' ' LYS . 0.0 OUTLIER 30.37 48.19 0.05 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.673 1.189 . . . . 0.0 112.122 -171.575 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.46 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 51.9 tt0 -60.51 140.35 92.28 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.688 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 13' ' ' PRO . . . . . 0.577 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 31.9 Cg_exo -53.97 121.6 9.91 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 121.861 1.707 . . . . 0.0 109.602 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 14' ' ' TYR . . . . . 0.912 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 13.7 t80 -72.85 -53.35 5.36 Favored Pre-proline 0 N--CA 1.438 -1.049 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -167.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.521 ' HD3' ' HB3' ' B' ' 14' ' ' TYR . 32.9 Cg_exo -55.37 -17.33 15.86 Favored 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 121.57 1.514 . . . . 0.0 110.775 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.577 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.7 m-20 -90.62 -43.42 10.18 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 113.935 -1.484 . . . . 0.0 111.024 177.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 17' ' ' PHE . . . . . 0.502 ' CD2' ' HA ' ' B' ' 7' ' ' ARG . 0.0 OUTLIER -53.38 -46.49 69.66 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.662 0.744 . . . . 0.0 109.039 175.525 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.797 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 1.8 p -79.16 -34.83 16.79 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.334 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.298 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.91 -32.76 68.06 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 121.366 -0.834 . . . . 0.0 111.773 177.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.693 ' O ' HG12 ' B' ' 24' ' ' VAL . 14.3 ptt180 -84.61 -24.63 29.05 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.563 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 6.1 tp -60.3 -46.47 89.75 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.842 172.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 22' ' ' GLN . . . . . 0.797 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 4.6 mt-30 -70.2 -48.1 58.58 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.004 177.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.724 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 15.2 t70 -47.49 -54.67 10.88 Favored 'General case' 0 C--N 1.313 -1.002 0 O-C-N 124.301 1.001 . . . . 0.0 111.462 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' VAL . . . . . 0.693 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.7 p -79.28 -24.78 12.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.96 -173.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.649 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -67.96 -29.51 68.57 Favored 'General case' 0 C--O 1.205 -1.272 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 174.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' GLN . . . . . 0.463 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -78.89 -36.26 42.33 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.125 -1.398 . . . . 0.0 109.786 -178.252 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.724 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 39.1 mmtt -65.89 -34.26 77.72 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.496 177.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 28' ' ' SER . . . . . 0.421 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 15.9 m -105.63 -9.66 17.24 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.884 -170.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.649 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 87.9 mt -118.2 129.28 74.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.983 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.64 -1.32 53.39 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.347 0.594 . . . . 0.0 110.585 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.607 ' H ' HG22 ' B' ' 29' ' ' ILE . 0.6 OUTLIER -113.71 111.81 22.41 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.977 -177.554 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.17 -31.71 32.65 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.092 177.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.586 ' O ' HG13 ' B' ' 37' ' ' VAL . 14.1 mttm -58.66 -61.21 2.77 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -178.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.621 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -66.21 -22.98 66.36 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.483 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.868 ' O ' HG13 ' B' ' 39' ' ' VAL . 5.2 tmm_? -72.15 -54.63 9.13 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.446 ' O ' HG22 ' B' ' 39' ' ' VAL . 16.5 mtpt -59.47 -56.48 21.43 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.461 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.8 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 21.0 m -54.18 -36.57 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.051 -171.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.825 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.2 tt -85.6 -30.55 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.757 -176.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.868 HG13 ' O ' ' B' ' 35' ' ' ARG . 3.3 m -69.39 -48.0 69.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 C-N-CA 118.927 -1.109 . . . . 0.0 109.17 174.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.621 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 58.7 mt-10 -64.63 -23.35 67.23 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.571 0.748 . . . . 0.0 112.268 176.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.8 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.29 -57.16 3.19 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.555 177.331 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 42' ' ' MET . . . . . 0.497 ' HB2' HD21 ' B' ' 21' ' ' LEU . 20.0 mmt -63.63 -20.96 66.1 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.521 0.677 . . . . 0.0 109.714 -177.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.681 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -49.13 -27.76 3.75 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.305 170.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' TYR . . . . . 0.478 ' CG ' ' HD2' ' B' ' 59' ' ' LYS . 11.4 t80 -106.09 -67.99 0.9 Allowed 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.608 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 7.2 mm-40 -47.85 -33.48 7.46 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 124.301 1.001 . . . . 0.0 112.491 -173.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.773 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.9 m-20 -103.67 -21.04 13.78 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 116.808 -0.178 . . . . 0.0 110.903 -175.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.644 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -57.48 178.07 0.08 Allowed 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 121.864 0.84 . . . . 0.0 112.55 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 48' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -56.42 137.53 75.91 Favored Pre-proline 0 N--CA 1.441 -0.917 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.819 174.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.32 -21.63 30.04 Favored 'Trans proline' 0 C--O 1.221 -0.373 0 C-N-CA 123.177 2.585 . . . . 0.0 111.911 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' GLU . . . . . 0.509 ' O ' ' HB2' ' B' ' 53' ' ' SER . 0.7 OUTLIER -87.8 -37.47 16.56 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 124.303 1.041 . . . . 0.0 111.13 173.044 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 1.015 ' SG ' ' HB2' ' B' ' 76' ' ' CYS . 41.7 t -75.34 -36.0 61.09 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-O 121.046 0.451 . . . . 0.0 111.315 -172.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 52' ' ' GLN . . . . . 0.543 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.9 pt20 -69.54 -29.92 67.62 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 175.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 53' ' ' SER . . . . . 0.644 ' HA ' ' CD ' ' B' ' 56' ' ' LYS . 32.4 m -72.26 -19.99 61.6 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 112.92 -1.945 . . . . 0.0 110.29 174.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -81.04 -22.38 39.36 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.216 -0.593 . . . . 0.0 110.388 166.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' B' ' 52' ' ' GLN . 22.5 mt -90.53 -31.95 5.29 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.798 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -173.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.644 ' CD ' ' HA ' ' B' ' 53' ' ' SER . 0.1 OUTLIER -46.04 -32.76 1.8 Allowed Pre-proline 0 N--CA 1.488 1.466 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -175.906 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 32.7 Cg_endo -59.24 -31.44 95.22 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.219 1.946 . . . . 0.0 112.939 171.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 58' ' ' LEU . . . . . 0.542 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.1 mt -102.15 -15.91 16.54 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -177.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 59' ' ' LYS . . . . . 0.628 ' HD3' ' CG2' ' A' ' 5' ' ' THR . 0.1 OUTLIER -51.61 109.88 0.4 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.112 -179.713 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.0 -22.09 38.26 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.329 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -103.96 114.76 29.24 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.355 0.597 . . . . 0.0 110.48 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.511 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.5 p -123.46 150.34 60.65 Favored Pre-proline 0 C--N 1.309 -1.166 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.374 170.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 63' ' ' PRO . . . . . 0.435 ' HD2' HG23 ' B' ' 62' ' ' VAL . 93.4 Cg_exo . . . . . 0 C--N 1.344 0.313 0 C-N-CA 121.753 1.636 . . . . 0.0 110.915 164.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 p30 . . . . . 0 N--CA 1.44 -0.958 0 CA-C-O 120.279 0.085 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.551 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.9 OUTLIER -80.97 -28.79 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 C-N-CA 117.548 -1.661 . . . . 0.0 108.609 173.913 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.789 ' O ' HG13 ' B' ' 73' ' ' VAL . 9.8 mm -59.75 -47.71 90.27 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.232 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.68 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.401 ' O ' HG22 ' B' ' 73' ' ' VAL . 42.8 t -50.52 -34.04 23.79 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.397 0.617 . . . . 0.0 111.118 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -85.18 -33.87 22.2 Favored 'General case' 0 C--O 1.213 -0.835 0 C-N-CA 123.298 0.639 . . . . 0.0 110.394 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 72' ' ' TYR . . . . . 0.575 ' OH ' ' HA ' ' B' ' 59' ' ' LYS . 4.7 m-30 -75.56 -33.9 60.66 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.719 -176.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.912 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 2.2 m -68.56 -35.61 71.03 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 74' ' ' LYS . . . . . 0.53 ' O ' ' HB3' ' B' ' 77' ' ' ASP . 22.0 ttmt -70.71 -27.52 64.04 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.253 176.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 75' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -61.81 -44.17 97.39 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 1.015 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 16.5 t -86.02 3.29 42.96 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.336 176.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 77' ' ' ASP . . . . . 0.53 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 28.5 t70 . . . . . 0 CA--C 1.538 0.512 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 163.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.427 ' HB2' ' H ' ' A' ' 2' ' ' SER . 98.1 Cg_endo . . . . . 0 CA--C 1.517 -0.341 0 N-CA-C 109.052 -1.172 . . . . 0.0 109.052 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.65 ' HB2' HG23 ' A' ' 5' ' ' THR . 50.0 m -66.37 176.82 1.68 Allowed 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 162.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.661 ' CE1' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -77.09 -53.99 7.09 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.589 -0.845 . . . . 0.0 109.743 174.338 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.56 ' ND2' ' HG3' ' A' ' 42' ' ' MET . 2.0 p-10 -82.67 6.19 18.71 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.367 -1.288 . . . . 0.0 112.548 -167.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.65 HG23 ' HB2' ' A' ' 2' ' ' SER . 0.7 OUTLIER -65.12 -4.08 4.5 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.547 -176.75 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.627 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.2 m -79.37 132.78 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 174.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.768 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -155.95 160.07 39.78 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 118.937 -1.105 . . . . 0.0 113.422 -177.798 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.497 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.4 mt-30 -40.67 112.68 0.31 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 113.568 -1.651 . . . . 0.0 112.776 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.08 -161.58 32.74 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 170.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.7 m -50.83 104.09 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 117.292 0.546 . . . . 0.0 111.029 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.4 pttt 44.12 39.11 2.65 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.587 1.155 . . . . 0.0 112.756 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.434 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 48.2 tt0 -62.36 137.97 96.2 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 177.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.512 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 39.0 Cg_exo -53.74 124.72 16.53 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.11 1.874 . . . . 0.0 109.921 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.78 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 6.7 t80 -69.26 -55.32 10.11 Favored Pre-proline 0 N--CA 1.44 -0.958 0 CA-C-O 118.38 -0.819 . . . . 0.0 113.134 -166.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.548 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 30.3 Cg_exo -57.04 -17.57 25.15 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 121.456 1.437 . . . . 0.0 111.211 -178.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 2.1 m-20 -89.52 -42.31 11.52 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.891 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.64 ' CE1' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -55.48 -44.7 76.72 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.307 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.745 HG21 HD12 ' A' ' 69' ' ' ILE . 1.7 p -80.99 -31.47 12.11 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.937 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.826 -177.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.76 -33.69 70.56 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 121.284 -0.885 . . . . 0.0 111.608 176.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.706 ' O ' HG12 ' A' ' 24' ' ' VAL . 14.6 ptt180 -84.56 -25.48 28.66 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 175.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.64 HD22 ' CE1' ' A' ' 17' ' ' PHE . 9.7 tp -57.98 -45.09 87.31 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.972 172.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.723 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 7.1 mt-30 -73.31 -44.42 59.04 Favored 'General case' 0 CA--C 1.494 -1.196 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.688 177.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.759 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 14.3 t70 -52.08 -50.93 60.58 Favored 'General case' 0 C--N 1.314 -0.945 0 O-C-N 124.087 0.867 . . . . 0.0 111.427 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.706 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.1 p -82.02 -23.96 9.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.249 0.547 . . . . 0.0 109.793 -174.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.855 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -71.69 -18.29 62.18 Favored 'General case' 0 C--O 1.206 -1.223 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 174.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.426 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -87.43 -38.92 15.7 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.958 176.746 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.759 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 40.2 mmtt -65.28 -43.32 91.6 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.321 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.515 ' HB2' ' HB3' ' A' ' 3' ' ' PHE . 24.9 m -98.6 -8.47 26.36 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.243 0.544 . . . . 0.0 110.419 -172.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.855 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 87.2 mt -114.91 125.48 72.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.725 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.84 -4.33 57.65 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.18 0.514 . . . . 0.0 110.01 175.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.669 ' OD1' ' HB2' ' A' ' 33' ' ' LYS . 12.4 t70 -102.59 115.71 31.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.409 -177.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.466 ' O ' ' HG2' ' A' ' 36' ' ' LYS . 12.5 pt-20 -61.59 -24.71 66.86 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.831 176.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.669 ' HB2' ' OD1' ' A' ' 31' ' ' ASP . 4.5 mptt -75.12 -52.17 11.65 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -177.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.409 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -65.29 -26.94 68.29 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.89 176.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.827 ' O ' HG13 ' A' ' 39' ' ' VAL . 3.9 tmm_? -62.59 -65.19 0.72 Allowed 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.589 ' HG3' HG13 ' A' ' 37' ' ' VAL . 7.9 ptmm? -53.11 -58.38 7.2 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.314 0.578 . . . . 0.0 112.259 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.779 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 5.4 m -56.63 -30.39 31.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.928 -172.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.497 ' O ' ' HG2' ' A' ' 42' ' ' MET . 0.1 OUTLIER -85.07 -31.43 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.407 178.842 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.827 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.4 m -68.33 -47.84 75.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 119.257 -0.977 . . . . 0.0 108.97 175.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.594 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 45.3 mt-10 -68.03 -22.89 64.94 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.335 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.779 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -85.42 -55.2 4.13 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.166 175.941 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.574 ' HB2' HD21 ' A' ' 21' ' ' LEU . 17.8 mmt -63.77 -20.42 65.75 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.567 0.698 . . . . 0.0 109.765 -176.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.627 ' HB2' ' CD1' ' A' ' 69' ' ' ILE . . . -47.9 -30.2 3.96 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.736 171.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.553 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 8.0 t80 -105.66 -66.99 0.95 Allowed 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.637 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 3.9 mm-40 -47.02 -33.79 5.09 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 124.47 1.106 . . . . 0.0 112.107 -173.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.768 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 5.3 m-20 -102.7 -21.0 14.17 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.214 -174.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.62 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -60.65 -179.62 0.13 Allowed 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 122.093 0.949 . . . . 0.0 112.966 -173.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.604 ' HB3' ' OE1' ' A' ' 50' ' ' GLU . 15.1 m-20 -61.35 141.61 94.21 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.175 174.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.21 -22.61 33.21 Favored 'Trans proline' 0 C--O 1.22 -0.425 0 C-N-CA 123.413 2.742 . . . . 0.0 112.722 -178.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.694 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 12.2 pm0 -89.37 -31.13 17.91 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 123.5 0.72 . . . . 0.0 110.599 175.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.694 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 92.7 m -82.9 -37.44 24.25 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.57 -170.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.611 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.6 pt20 -70.21 -29.94 66.91 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 172.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.413 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 11.2 m -70.91 -19.87 62.55 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 113.672 -1.604 . . . . 0.0 110.331 174.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 51' ' ' CYS . . . -78.6 -25.43 45.19 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.504 -0.748 . . . . 0.0 109.686 167.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.613 HD11 ' CE2' ' A' ' 14' ' ' TYR . 22.7 mt -89.8 -32.57 5.65 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.816 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -171.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.599 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -39.92 -37.95 0.88 Allowed Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -174.361 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 52.3 Cg_endo -63.86 -29.23 67.65 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.217 1.945 . . . . 0.0 113.006 175.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.566 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.5 mt -99.09 -15.61 18.94 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.645 ' HD3' ' CG2' ' B' ' 5' ' ' THR . 0.1 OUTLIER -50.96 109.65 0.35 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.24 -178.371 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.419 ' HA3' ' C ' ' B' ' 1' ' ' PRO . . . 90.2 -20.65 35.75 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.032 -178.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -103.47 113.14 26.41 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.274 0.559 . . . . 0.0 109.785 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.474 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.5 p -123.72 148.88 57.6 Favored Pre-proline 0 C--N 1.31 -1.146 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.624 172.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo . . . . . 0 N--CA 1.459 -0.51 0 C-N-CA 122.059 1.839 . . . . 0.0 110.788 164.576 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.62 ' OD2' ' HB3' ' A' ' 70' ' ' SER . 0.4 OUTLIER . . . . . 0 N--CA 1.441 -0.887 0 CA-C-O 120.249 0.071 . . . . 0.0 111.117 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.534 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -81.7 -32.98 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 C-N-CA 118.623 -1.231 . . . . 0.0 108.662 173.815 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.789 ' O ' HG13 ' A' ' 73' ' ' VAL . 10.7 mm -56.3 -49.98 73.92 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.349 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.495 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.62 ' HB3' ' OD2' ' A' ' 67' ' ' ASP . 32.5 t -54.66 -29.01 51.3 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.059 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -85.79 -33.27 21.42 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.394 0.616 . . . . 0.0 110.162 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.64 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.2 m-30 -75.31 -35.13 61.3 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.518 -177.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.789 HG13 ' O ' ' A' ' 69' ' ' ILE . 1.4 m -70.78 -32.05 47.79 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 172.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.538 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -67.63 -30.92 70.62 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.27 175.248 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -63.58 -46.02 87.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.056 176.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.626 ' SG ' ' HB2' ' A' ' 14' ' ' TYR . 27.5 t -93.02 9.91 33.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.141 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.538 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 3.8 t70 . . . . . 0 C--N 1.323 -0.578 0 CA-C-O 121.092 0.472 . . . . 0.0 110.854 174.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 1' ' ' PRO . . . . . 0.419 ' C ' ' HA3' ' A' ' 60' ' ' GLY . 93.2 Cg_endo . . . . . 0 CA--C 1.516 -0.384 0 N-CA-C 109.135 -1.14 . . . . 0.0 109.135 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 2' ' ' SER . . . . . 0.649 ' HB2' HG23 ' B' ' 5' ' ' THR . 50.1 m -66.91 176.97 1.84 Allowed 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 162.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.659 ' CE1' HD11 ' B' ' 29' ' ' ILE . 0.1 OUTLIER -77.03 -54.14 6.92 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.663 174.296 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.554 ' ND2' ' HG3' ' B' ' 42' ' ' MET . 2.0 p-10 -82.59 6.01 19.08 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.392 -1.276 . . . . 0.0 112.475 -166.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.649 HG23 ' HB2' ' B' ' 2' ' ' SER . 0.7 OUTLIER -65.1 -3.95 4.31 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.58 -176.698 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.629 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.2 m -79.41 132.9 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.746 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.1 OUTLIER -155.94 160.24 39.94 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.123 -1.031 . . . . 0.0 113.403 -177.79 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 8' ' ' GLN . . . . . 0.505 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.3 mt-30 -41.03 112.16 0.27 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 113.591 -1.64 . . . . 0.0 112.814 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.41 -161.44 31.43 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 170.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 43.5 m -50.92 104.05 0.07 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-N 117.241 0.52 . . . . 0.0 111.093 -178.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 63.7 pttt 44.22 38.88 2.61 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.59 1.156 . . . . 0.0 112.714 -176.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.44 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 48.2 tt0 -62.09 137.71 95.71 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 177.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' PRO . . . . . 0.536 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 39.4 Cg_exo -53.5 124.89 16.84 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.25 1.967 . . . . 0.0 109.979 178.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 14' ' ' TYR . . . . . 0.791 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 6.7 t80 -69.58 -55.28 9.53 Favored Pre-proline 0 N--CA 1.44 -0.943 0 CA-C-O 118.369 -0.824 . . . . 0.0 113.074 -166.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.547 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 31.1 Cg_exo -57.05 -17.62 25.39 Favored 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 121.437 1.425 . . . . 0.0 111.176 -178.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.536 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 2.3 m-20 -89.44 -42.64 11.38 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 113.872 -1.513 . . . . 0.0 110.804 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 17' ' ' PHE . . . . . 0.638 ' CE1' HD22 ' B' ' 21' ' ' LEU . 0.0 OUTLIER -55.22 -44.73 75.68 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 177.351 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.728 HG21 HD12 ' B' ' 69' ' ' ILE . 1.7 p -80.99 -31.38 12.07 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.927 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.791 -177.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.69 -34.04 70.84 Favored 'General case' 0 C--N 1.315 -0.931 0 O-C-N 121.344 -0.847 . . . . 0.0 111.596 176.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.707 ' O ' HG12 ' B' ' 24' ' ' VAL . 14.7 ptt180 -84.37 -25.48 29.11 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 176.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.638 HD22 ' CE1' ' B' ' 17' ' ' PHE . 9.9 tp -58.09 -45.19 87.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.981 172.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 22' ' ' GLN . . . . . 0.738 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 6.9 mt-30 -73.26 -44.39 59.46 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.701 177.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.753 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 12.8 t70 -51.96 -50.8 60.52 Favored 'General case' 0 C--N 1.314 -0.941 0 O-C-N 123.956 0.785 . . . . 0.0 111.578 -178.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' VAL . . . . . 0.707 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.1 p -82.1 -24.0 9.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.218 0.532 . . . . 0.0 109.766 -174.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.855 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -71.77 -18.16 62.13 Favored 'General case' 0 C--O 1.206 -1.219 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 174.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' GLN . . . . . 0.433 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -87.59 -38.89 15.55 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.991 176.774 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.753 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 40.4 mmtt -65.09 -43.92 90.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.233 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 28' ' ' SER . . . . . 0.537 ' HB2' ' HB3' ' B' ' 3' ' ' PHE . 36.0 m -98.15 -8.31 27.79 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.116 0.484 . . . . 0.0 110.495 -171.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.855 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 87.4 mt -114.99 125.24 72.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.813 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.59 -4.46 57.82 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.259 0.552 . . . . 0.0 110.143 175.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.644 ' OD1' ' HB2' ' B' ' 33' ' ' LYS . 12.3 t70 -102.79 115.67 31.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.445 -177.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' B' ' 36' ' ' LYS . 12.4 pt-20 -61.79 -24.49 66.88 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.857 177.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.644 ' HB2' ' OD1' ' B' ' 31' ' ' ASP . 4.5 mptt -75.1 -52.34 11.26 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -177.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.416 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -65.25 -26.94 68.32 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.848 176.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.828 ' O ' HG13 ' B' ' 39' ' ' VAL . 4.0 tmm_? -62.68 -65.09 0.74 Allowed 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.581 ' HG3' HG13 ' B' ' 37' ' ' VAL . 7.8 ptmm? -53.17 -58.33 7.42 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.308 0.575 . . . . 0.0 112.318 -178.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.776 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 5.6 m -56.83 -30.28 32.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.863 -171.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.494 ' O ' ' HG2' ' B' ' 42' ' ' MET . 0.1 OUTLIER -85.02 -31.49 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 119.891 -0.723 . . . . 0.0 111.438 178.795 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.828 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.4 m -68.33 -47.93 75.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.931 175.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.609 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 42.6 mt-10 -67.94 -22.92 65.03 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.392 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.776 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -85.42 -55.3 4.08 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.127 175.903 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 42' ' ' MET . . . . . 0.573 ' HB2' HD21 ' B' ' 21' ' ' LEU . 17.9 mmt -63.7 -20.46 65.74 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.585 0.707 . . . . 0.0 109.844 -176.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.616 ' HB2' ' CD1' ' B' ' 69' ' ' ILE . . . -47.74 -30.27 3.76 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.744 171.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' TYR . . . . . 0.548 ' CG ' ' HB2' ' B' ' 52' ' ' GLN . 7.8 t80 -105.66 -66.92 0.95 Allowed 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 176.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.634 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 3.8 mm-40 -47.0 -34.11 5.31 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 124.504 1.128 . . . . 0.0 111.997 -173.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.746 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 5.2 m-20 -102.53 -20.83 14.34 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.256 -174.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -60.54 -179.28 0.11 Allowed 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 122.058 0.932 . . . . 0.0 113.035 -173.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 48' ' ' ASN . . . . . 0.608 ' HB3' ' OE1' ' B' ' 50' ' ' GLU . 14.6 m-20 -61.62 141.77 94.69 Favored Pre-proline 0 N--CA 1.442 -0.847 0 CA-C-N 114.366 -1.288 . . . . 0.0 109.144 174.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -55.33 -22.46 33.51 Favored 'Trans proline' 0 C--O 1.218 -0.512 0 C-N-CA 123.408 2.739 . . . . 0.0 112.757 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' GLU . . . . . 0.714 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 12.5 pm0 -89.45 -31.24 17.8 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 123.576 0.75 . . . . 0.0 110.648 175.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.714 ' N ' ' HG2' ' B' ' 50' ' ' GLU . 91.7 m -82.82 -37.5 24.36 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.503 -170.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 52' ' ' GLN . . . . . 0.601 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.7 pt20 -70.3 -29.74 66.55 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 172.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 53' ' ' SER . . . . . 0.429 ' O ' ' HE2' ' B' ' 56' ' ' LYS . 11.3 m -71.24 -19.76 62.33 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 113.749 -1.568 . . . . 0.0 110.248 174.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' B' ' 51' ' ' CYS . . . -78.62 -25.37 45.11 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.484 -0.76 . . . . 0.0 109.756 167.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.602 HD11 ' CE2' ' B' ' 14' ' ' TYR . 22.6 mt -89.81 -32.63 5.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -171.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.595 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -39.74 -38.29 0.9 Allowed Pre-proline 0 N--CA 1.491 1.609 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -174.423 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 51.6 Cg_endo -63.51 -29.74 71.01 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.169 1.913 . . . . 0.0 112.704 175.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 58' ' ' LEU . . . . . 0.561 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.5 mt -98.65 -15.81 19.28 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 59' ' ' LYS . . . . . 0.646 ' HD3' ' CG2' ' A' ' 5' ' ' THR . 0.1 OUTLIER -51.01 109.57 0.34 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.244 -178.257 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 60' ' ' GLY . . . . . 0.42 ' HA3' ' C ' ' A' ' 1' ' ' PRO . . . 90.47 -21.13 33.84 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.971 -178.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -103.12 113.19 26.46 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.191 0.52 . . . . 0.0 109.893 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.476 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.3 p -123.71 149.11 58.22 Favored Pre-proline 0 C--N 1.308 -1.208 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.564 172.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo . . . . . 0 N--CA 1.46 -0.472 0 C-N-CA 122.066 1.844 . . . . 0.0 110.774 164.546 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 67' ' ' ASP . . . . . 0.603 ' OD2' ' HB3' ' B' ' 70' ' ' SER . 0.4 OUTLIER . . . . . 0 N--CA 1.441 -0.917 0 N-CA-C 111.216 0.08 . . . . 0.0 111.216 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.542 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.9 OUTLIER -81.76 -33.04 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.505 0 C-N-CA 118.612 -1.235 . . . . 0.0 108.641 173.818 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.788 ' O ' HG13 ' B' ' 73' ' ' VAL . 10.9 mm -56.12 -50.04 72.53 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.366 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.528 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.603 ' HB3' ' OD2' ' B' ' 67' ' ' ASP . 32.6 t -54.79 -28.82 51.89 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.124 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -85.79 -33.3 21.42 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.455 0.645 . . . . 0.0 110.134 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 72' ' ' TYR . . . . . 0.634 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.1 m-30 -75.46 -35.1 60.96 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.48 -177.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.791 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.4 m -70.81 -32.0 47.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 172.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 74' ' ' LYS . . . . . 0.553 ' O ' ' HB3' ' B' ' 77' ' ' ASP . 0.0 OUTLIER -67.75 -30.98 70.59 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.34 175.223 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 75' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -63.1 -46.74 85.9 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.975 176.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.627 ' SG ' ' HB2' ' B' ' 14' ' ' TYR . 28.0 t -92.39 9.61 33.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.075 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 77' ' ' ASP . . . . . 0.553 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 3.1 t70 . . . . . 0 C--N 1.32 -0.69 0 CA-C-O 121.072 0.463 . . . . 0.0 110.8 174.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.424 ' C ' ' HA3' ' B' ' 60' ' ' GLY . 71.9 Cg_endo . . . . . 0 CA--C 1.517 -0.365 0 N-CA-C 109.219 -1.108 . . . . 0.0 109.219 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.55 ' HB2' HG23 ' A' ' 5' ' ' THR . 42.6 m -69.79 169.37 13.13 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 161.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.825 ' HE1' HD12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -65.55 -53.29 44.14 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 122.391 1.091 . . . . 0.0 109.633 175.496 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.553 ' HB2' HD11 ' A' ' 21' ' ' LEU . 3.2 p-10 -87.57 4.74 42.49 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 113.418 -1.719 . . . . 0.0 113.569 -161.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.675 ' CG2' ' HD3' ' B' ' 59' ' ' LYS . 0.9 OUTLIER -62.63 0.6 0.48 Allowed 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.066 0.46 . . . . 0.0 112.134 -175.322 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.571 ' HB ' ' CZ ' ' A' ' 20' ' ' ARG . 3.0 m -72.05 115.33 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 CA-C-O 121.908 0.861 . . . . 0.0 109.317 168.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.621 ' HG3' ' HB3' ' A' ' 46' ' ' ASN . 1.1 mpp_? -114.23 158.66 21.09 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 121.517 0.675 . . . . 0.0 110.989 177.107 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.468 ' HG2' ' HB3' ' A' ' 12' ' ' GLU . 2.2 tt0 -59.8 116.04 3.81 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.735 171.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.9 -156.75 26.28 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.378 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.46 ' C ' ' HD3' ' A' ' 11' ' ' LYS . 21.5 m -50.45 99.72 0.02 OUTLIER 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.774 0.287 . . . . 0.0 111.198 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.46 ' HD3' ' C ' ' A' ' 10' ' ' SER . 0.0 OUTLIER 35.66 48.89 0.49 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.583 1.153 . . . . 0.0 111.988 -171.629 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.468 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 36.4 tt0 -62.4 136.86 95.96 Favored Pre-proline 0 C--O 1.233 0.227 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.576 178.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.553 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 38.9 Cg_exo -52.15 122.08 10.0 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.043 1.829 . . . . 0.0 109.735 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.886 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 27.4 t80 -72.7 -53.18 5.73 Favored Pre-proline 0 N--CA 1.437 -1.117 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -166.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.527 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 31.7 Cg_exo -55.07 -17.63 15.15 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 121.4 1.4 . . . . 0.0 110.692 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.553 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.0 OUTLIER -90.29 -44.11 9.92 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 113.98 -1.464 . . . . 0.0 111.089 178.178 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.436 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -53.71 -43.36 68.95 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 175.139 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.795 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 2.2 p -82.84 -35.47 12.39 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.325 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.867 -177.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.58 -33.78 70.35 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 121.316 -0.865 . . . . 0.0 111.819 177.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.706 ' O ' HG12 ' A' ' 24' ' ' VAL . 16.3 ptt180 -83.7 -27.54 28.94 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 176.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.558 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 7.4 tp -55.87 -47.57 77.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.605 -1.18 . . . . 0.0 108.87 171.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.795 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 4.9 mt-30 -70.13 -46.85 63.93 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.179 176.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.719 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 16.8 t70 -47.12 -54.33 10.76 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 124.289 0.993 . . . . 0.0 111.692 -178.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.706 HG12 ' O ' ' A' ' 20' ' ' ARG . 6.8 p -82.0 -23.54 9.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.197 0.522 . . . . 0.0 109.94 -174.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.801 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -71.32 -18.99 62.37 Favored 'General case' 0 C--O 1.204 -1.295 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 173.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.41 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -87.23 -38.88 15.94 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.955 177.559 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.719 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.4 mmtt -67.02 -39.46 87.05 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.752 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.6 m -98.01 -10.52 24.27 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.027 0.441 . . . . 0.0 110.63 -172.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.801 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 79.5 mt -116.11 129.91 71.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.795 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.01 -5.83 49.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.526 0.679 . . . . 0.0 110.136 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.601 ' H ' HG22 ' A' ' 29' ' ' ILE . 2.3 m-20 -102.51 107.33 18.25 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.067 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -53.6 -29.24 36.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.775 0.322 . . . . 0.0 110.446 175.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.552 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -68.36 -52.81 29.13 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.478 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.597 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -66.76 -23.57 66.1 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.246 178.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.836 ' O ' HG13 ' A' ' 39' ' ' VAL . 2.1 tmm_? -68.77 -58.55 4.04 Favored 'General case' 0 C--O 1.219 -0.503 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -53.38 -60.54 3.16 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.81 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 21.0 m -52.31 -34.57 18.58 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.952 -171.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.825 HD12 ' HE1' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -84.8 -33.85 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -177.218 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.836 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.7 m -72.36 -47.4 52.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 119.65 -0.82 . . . . 0.0 108.999 177.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.655 ' HG2' HG22 ' A' ' 68' ' ' VAL . 65.8 mt-10 -60.28 -26.07 66.2 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.971 0.908 . . . . 0.0 111.457 172.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.81 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -81.8 -61.68 1.85 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 178.654 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.598 ' HE3' ' HG ' ' B' ' 41' ' ' LEU . 20.1 mmt -62.79 -20.56 65.13 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.484 -177.002 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.728 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -49.29 -25.38 2.34 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.394 169.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.493 ' CD1' ' HB2' ' A' ' 52' ' ' GLN . 16.1 t80 -108.31 -66.44 1.04 Allowed 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 175.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.5 ' CG ' HD12 ' A' ' 41' ' ' LEU . 8.4 mm-40 -48.25 -32.47 7.28 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 123.799 0.687 . . . . 0.0 112.492 -175.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.621 ' HB3' ' HG3' ' A' ' 7' ' ' ARG . 4.9 m-20 -106.33 -11.5 15.97 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.534 0.683 . . . . 0.0 111.226 -176.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.728 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -62.53 168.53 3.59 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.496 0.665 . . . . 0.0 110.768 177.256 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.565 ' HB3' ' OE1' ' A' ' 50' ' ' GLU . 8.9 m-20 -57.38 144.45 71.17 Favored Pre-proline 0 C--N 1.31 -1.144 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.482 175.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.46 -19.29 28.48 Favored 'Trans proline' 0 C--O 1.219 -0.434 0 C-N-CA 122.92 2.413 . . . . 0.0 112.055 -179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.693 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 10.1 pm0 -90.87 -32.34 16.08 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.214 0.606 . . . . 0.0 110.531 174.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.935 ' SG ' ' HB2' ' A' ' 76' ' ' CYS . 37.3 t -85.1 -37.28 20.45 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.873 -171.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.549 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.5 pt20 -67.18 -26.72 66.78 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 172.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.598 ' O ' ' HD2' ' A' ' 56' ' ' LYS . 9.3 m -72.47 -22.55 61.06 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 113.141 -1.845 . . . . 0.0 110.916 174.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.37 -23.75 46.74 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.411 0.624 . . . . 0.0 109.527 168.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.549 HD12 ' HA ' ' A' ' 52' ' ' GLN . 24.7 mt -91.24 -33.22 5.6 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.151 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -172.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.616 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.57 -39.87 2.71 Favored Pre-proline 0 N--CA 1.493 1.688 0 CA-C-N 119.909 1.232 . . . . 0.0 113.757 -175.389 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 51.2 Cg_endo -62.6 -25.32 75.41 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 122.328 2.018 . . . . 0.0 113.045 175.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.528 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.1 mt -104.02 -15.86 15.47 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.652 ' HD3' ' CG2' ' B' ' 5' ' ' THR . 0.1 OUTLIER -50.47 109.09 0.27 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.192 -179.099 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.405 ' HA3' ' C ' ' B' ' 1' ' ' PRO . . . 89.69 -19.01 43.43 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.31 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.0 mmmt -103.7 114.65 29.07 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.162 0.506 . . . . 0.0 110.167 -178.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.463 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.6 p -123.38 143.97 42.69 Favored Pre-proline 0 C--N 1.312 -1.03 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.113 173.062 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo . . . . . 0 C--N 1.343 0.269 0 C-N-CA 122.538 2.158 . . . . 0.0 111.669 168.342 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.517 -0.294 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.655 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -78.63 -28.51 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 C-N-CA 118.934 -1.106 . . . . 0.0 108.622 178.954 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.757 ' O ' HG13 ' A' ' 73' ' ' VAL . 6.8 mm -60.4 -45.95 95.9 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.133 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.277 -178.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 41.7 t -48.24 -36.18 13.44 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.143 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 74' ' ' LYS . 2.0 mm-40 -86.27 -31.53 21.59 Favored 'General case' 0 C--O 1.216 -0.672 0 C-N-CA 123.31 0.644 . . . . 0.0 111.074 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.532 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.0 m-30 -76.27 -33.79 59.14 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.626 0.727 . . . . 0.0 109.285 -177.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.886 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 2.1 m -73.01 -32.63 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 173.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 70' ' ' SER . 1.8 ttmm -66.45 -30.71 71.12 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.13 -1.395 . . . . 0.0 110.0 175.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -62.52 -45.44 92.95 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.784 175.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.935 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 42.2 t -93.34 9.17 37.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.044 177.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.484 ' HB2' ' HA ' ' A' ' 74' ' ' LYS . 21.8 t70 . . . . . 0 C--N 1.321 -0.671 0 CA-C-O 121.442 0.639 . . . . 0.0 109.699 173.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 1' ' ' PRO . . . . . 0.405 ' C ' ' HA3' ' A' ' 60' ' ' GLY . 72.0 Cg_endo . . . . . 0 CA--C 1.515 -0.43 0 N-CA-C 109.148 -1.135 . . . . 0.0 109.148 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 2' ' ' SER . . . . . 0.57 ' HB2' HG23 ' B' ' 5' ' ' THR . 43.0 m -69.79 169.71 12.47 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 161.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.863 ' HE1' HD12 ' B' ' 38' ' ' ILE . 0.0 OUTLIER -65.65 -53.11 45.88 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 122.351 1.072 . . . . 0.0 109.683 175.316 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.55 ' HB2' HD11 ' B' ' 21' ' ' LEU . 3.2 p-10 -87.75 4.9 42.49 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.51 -1.677 . . . . 0.0 113.58 -161.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.652 ' CG2' ' HD3' ' A' ' 59' ' ' LYS . 0.9 OUTLIER -62.9 0.71 0.5 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.123 0.487 . . . . 0.0 112.036 -175.165 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.566 ' HB ' ' CZ ' ' B' ' 20' ' ' ARG . 3.0 m -72.18 115.06 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 CA-C-O 121.904 0.859 . . . . 0.0 109.284 168.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.608 ' HG3' ' CB ' ' B' ' 46' ' ' ASN . 1.1 mpp_? -114.0 158.52 21.06 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 121.593 0.711 . . . . 0.0 110.949 177.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 8' ' ' GLN . . . . . 0.462 ' HG2' ' HB3' ' B' ' 12' ' ' GLU . 2.2 tt0 -59.64 116.1 3.79 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.702 171.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.99 -156.95 26.88 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.483 174.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 10' ' ' SER . . . . . 0.477 ' C ' ' HD3' ' B' ' 11' ' ' LYS . 23.4 m -50.29 100.05 0.02 OUTLIER 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.71 0.255 . . . . 0.0 111.086 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 11' ' ' LYS . . . . . 0.477 ' HD3' ' C ' ' B' ' 10' ' ' SER . 0.0 OUTLIER 35.17 49.57 0.45 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.545 1.138 . . . . 0.0 111.865 -171.59 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.462 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 36.1 tt0 -62.78 136.87 96.55 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.555 177.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 13' ' ' PRO . . . . . 0.551 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 37.8 Cg_exo -52.09 121.99 9.8 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 121.991 1.794 . . . . 0.0 109.703 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 14' ' ' TYR . . . . . 0.893 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 27.4 t80 -72.64 -53.32 5.75 Favored Pre-proline 0 N--CA 1.437 -1.105 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -166.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.534 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 31.8 Cg_exo -54.97 -17.84 15.23 Favored 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 121.382 1.388 . . . . 0.0 110.573 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.551 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 0.9 OUTLIER -90.2 -43.74 10.22 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.111 -1.404 . . . . 0.0 111.196 178.146 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 17' ' ' PHE . . . . . 0.429 ' CD2' ' N ' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -53.93 -43.41 69.76 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 175.069 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.791 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 2.2 p -82.68 -35.61 12.68 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.378 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.761 -177.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.46 -33.76 70.1 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 121.308 -0.87 . . . . 0.0 111.871 177.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.692 ' O ' HG12 ' B' ' 24' ' ' VAL . 16.4 ptt180 -83.73 -27.52 28.9 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 176.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.573 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 7.4 tp -56.0 -47.24 78.13 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.882 171.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 22' ' ' GLN . . . . . 0.791 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 4.9 mt-30 -70.49 -46.87 62.91 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.163 176.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.736 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 17.2 t70 -47.09 -54.29 10.77 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 124.304 1.002 . . . . 0.0 111.761 -178.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 24' ' ' VAL . . . . . 0.692 HG12 ' O ' ' B' ' 20' ' ' ARG . 6.8 p -82.1 -23.3 9.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.157 0.503 . . . . 0.0 109.869 -174.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.791 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -71.44 -18.91 62.3 Favored 'General case' 0 C--O 1.205 -1.284 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 26' ' ' GLN . . . . . 0.407 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -87.18 -39.03 15.85 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.015 177.497 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.736 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.3 mmtt -66.85 -39.44 87.58 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.736 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 58.3 m -98.02 -10.48 24.33 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.106 0.479 . . . . 0.0 110.517 -172.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.791 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 79.5 mt -116.24 130.49 70.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.775 -178.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.95 -5.08 48.56 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.637 0.732 . . . . 0.0 110.014 176.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.594 ' H ' HG22 ' B' ' 29' ' ' ILE . 2.4 m-20 -102.64 106.95 17.71 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.253 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -53.42 -29.1 33.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.68 0.276 . . . . 0.0 110.449 175.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.562 ' O ' HG13 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -68.39 -52.81 28.91 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.447 -179.569 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.596 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -66.77 -23.59 66.1 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.248 178.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.865 ' O ' HG13 ' B' ' 39' ' ' VAL . 2.1 tmm_? -68.78 -58.42 4.22 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 29.7 mtpt -53.55 -60.39 3.37 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.879 177.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.812 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 20.9 m -52.42 -34.38 18.72 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 O-C-N 124.324 1.015 . . . . 0.0 110.978 -171.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.863 HD12 ' HE1' ' B' ' 3' ' ' PHE . 0.0 OUTLIER -84.78 -34.08 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -177.309 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.865 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.7 m -72.2 -47.5 53.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.012 177.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.642 ' HG2' HG22 ' B' ' 68' ' ' VAL . 66.2 mt-10 -60.33 -25.9 66.15 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.907 0.883 . . . . 0.0 111.472 172.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.812 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -82.03 -61.59 1.87 Allowed 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.992 178.734 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 42' ' ' MET . . . . . 0.537 ' HE3' ' HG ' ' A' ' 41' ' ' LEU . 20.1 mmt -62.83 -20.56 65.18 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.482 -177.063 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.71 ' O ' ' HB2' ' B' ' 47' ' ' ALA . . . -49.31 -25.4 2.38 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.406 169.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 44' ' ' TYR . . . . . 0.498 ' CD1' ' HB2' ' B' ' 52' ' ' GLN . 16.1 t80 -108.22 -66.44 1.04 Allowed 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 175.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.498 ' CG ' HD12 ' B' ' 41' ' ' LEU . 8.6 mm-40 -48.26 -32.83 7.78 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 123.856 0.723 . . . . 0.0 112.381 -175.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.608 ' CB ' ' HG3' ' B' ' 7' ' ' ARG . 4.9 m-20 -105.93 -11.46 16.18 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.472 0.653 . . . . 0.0 111.284 -176.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.71 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -62.57 168.6 3.56 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.391 0.615 . . . . 0.0 110.779 177.197 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 48' ' ' ASN . . . . . 0.55 ' HB3' ' OE1' ' B' ' 50' ' ' GLU . 8.5 m-20 -57.39 144.47 71.17 Favored Pre-proline 0 C--N 1.31 -1.139 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.466 175.117 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 49' ' ' PRO . . . . . 0.429 ' HA ' HE21 ' B' ' 52' ' ' GLN . 11.2 Cg_endo -56.62 -19.2 29.06 Favored 'Trans proline' 0 C--O 1.218 -0.48 0 C-N-CA 122.963 2.442 . . . . 0.0 112.029 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 50' ' ' GLU . . . . . 0.697 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 10.1 pm0 -90.83 -32.29 16.13 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 123.205 0.602 . . . . 0.0 110.644 174.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.94 ' SG ' ' HB2' ' B' ' 76' ' ' CYS . 37.5 t -85.16 -37.4 20.23 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.885 -171.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 52' ' ' GLN . . . . . 0.534 ' HA ' HD12 ' B' ' 55' ' ' ILE . 28.7 pt20 -66.95 -26.71 66.97 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 172.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 53' ' ' SER . . . . . 0.6 ' O ' ' HD2' ' B' ' 56' ' ' LYS . 8.9 m -72.61 -22.53 60.95 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 113.247 -1.797 . . . . 0.0 110.902 174.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.22 -23.81 47.31 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.493 0.663 . . . . 0.0 109.586 168.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.534 HD12 ' HA ' ' B' ' 52' ' ' GLN . 25.0 mt -91.09 -33.37 5.73 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.137 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -172.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.615 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.5 -39.76 2.56 Favored Pre-proline 0 N--CA 1.492 1.649 0 CA-C-N 119.925 1.239 . . . . 0.0 113.749 -175.34 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 51.0 Cg_endo -62.71 -25.32 74.98 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.245 1.964 . . . . 0.0 113.002 175.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 58' ' ' LEU . . . . . 0.541 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.2 mt -104.02 -15.81 15.49 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 59' ' ' LYS . . . . . 0.675 ' HD3' ' CG2' ' A' ' 5' ' ' THR . 0.1 OUTLIER -50.46 109.12 0.27 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.702 -1.135 . . . . 0.0 111.281 -179.207 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 60' ' ' GLY . . . . . 0.424 ' HA3' ' C ' ' A' ' 1' ' ' PRO . . . 89.99 -19.7 40.58 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.276 -178.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -103.21 114.81 29.4 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.099 0.476 . . . . 0.0 110.027 -178.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.465 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.8 p -123.25 144.35 43.43 Favored Pre-proline 0 C--N 1.31 -1.125 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.94 172.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo . . . . . 0 C--N 1.345 0.371 0 C-N-CA 122.521 2.148 . . . . 0.0 111.667 168.217 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 67' ' ' ASP . . . . . 0.43 ' OD1' ' HB ' ' B' ' 69' ' ' ILE . 0.8 OUTLIER . . . . . 0 CA--C 1.517 -0.321 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.642 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.8 OUTLIER -78.48 -28.28 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 C-N-CA 119.006 -1.078 . . . . 0.0 108.568 179.08 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.756 ' O ' HG13 ' B' ' 73' ' ' VAL . 6.8 mm -60.44 -45.81 96.2 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.084 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.391 -178.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.501 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 43.2 t -48.54 -36.16 14.82 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.077 176.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' B' ' 74' ' ' LYS . 2.3 mm-40 -86.28 -31.38 21.65 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 123.211 0.604 . . . . 0.0 110.998 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 72' ' ' TYR . . . . . 0.541 ' CE1' ' HB2' ' B' ' 58' ' ' LEU . 5.0 m-30 -76.23 -34.13 59.21 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.654 0.74 . . . . 0.0 109.298 -177.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.893 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 2.1 m -72.67 -33.1 43.47 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 173.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 74' ' ' LYS . . . . . 0.501 ' HB2' ' O ' ' B' ' 70' ' ' SER . 1.8 ttmm -65.87 -30.89 71.57 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.052 175.221 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 75' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -62.36 -45.52 92.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.754 175.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.94 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 41.9 t -93.5 9.14 37.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.089 177.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 77' ' ' ASP . . . . . 0.488 ' HB2' ' HA ' ' B' ' 74' ' ' LYS . 19.9 t70 . . . . . 0 C--N 1.322 -0.622 0 CA-C-O 121.388 0.613 . . . . 0.0 109.515 174.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.44 ' HB2' ' H ' ' A' ' 2' ' ' SER . 92.3 Cg_endo . . . . . 0 CA--C 1.517 -0.326 0 N-CA-C 109.005 -1.19 . . . . 0.0 109.005 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.756 ' HB2' HG23 ' A' ' 5' ' ' THR . 70.7 m -72.13 178.9 3.56 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 162.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.773 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -76.13 -52.45 10.09 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.8 0.809 . . . . 0.0 110.125 174.445 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.503 ' OD1' ' HG ' ' B' ' 41' ' ' LEU . 2.5 p-10 -87.61 2.93 49.57 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.403 -163.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.756 HG23 ' HB2' ' A' ' 2' ' ' SER . 3.1 p -63.51 -3.12 1.9 Allowed 'General case' 0 C--N 1.311 -1.078 0 O-C-N 122.059 -0.4 . . . . 0.0 111.832 -175.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.555 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 3.3 m -76.49 119.03 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-O 121.677 0.751 . . . . 0.0 109.924 176.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.767 ' HB3' ' O ' ' A' ' 46' ' ' ASN . 32.2 mtm180 -137.58 147.2 44.87 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -170.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.6 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.6 mt-30 -42.02 120.66 1.62 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 112.633 -2.076 . . . . 0.0 113.745 177.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.53 -159.04 35.01 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 169.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.8 t -48.44 101.46 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 117.086 0.443 . . . . 0.0 111.231 -178.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.4 pttt 37.71 42.1 0.37 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.251 1.02 . . . . 0.0 112.084 -173.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.479 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 39.5 tt0 -57.16 137.5 80.54 Favored Pre-proline 0 C--O 1.233 0.226 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.602 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 52.1 Cg_exo -49.31 121.22 6.66 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.056 1.837 . . . . 0.0 109.947 -178.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.834 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 11.3 t80 -71.89 -52.85 7.44 Favored Pre-proline 0 N--CA 1.438 -1.047 0 CA-C-O 118.512 -0.756 . . . . 0.0 113.028 -166.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.538 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 36.4 Cg_exo -55.79 -18.39 21.27 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 121.346 1.364 . . . . 0.0 110.728 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.602 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 0.9 OUTLIER -90.34 -42.35 10.99 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.317 179.66 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.6 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -54.82 -43.64 73.16 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 175.647 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.686 HG12 ' O ' ' A' ' 14' ' ' TYR . 2.7 p -82.78 -32.35 9.89 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.941 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.845 -177.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.99 -35.46 73.25 Favored 'General case' 0 C--N 1.317 -0.84 0 O-C-N 121.285 -0.885 . . . . 0.0 111.839 175.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.709 ' O ' HG12 ' A' ' 24' ' ' VAL . 16.7 ptt180 -81.9 -27.26 33.51 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 176.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.588 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 6.7 tp -57.1 -48.14 79.33 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.215 172.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.679 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 8.6 mt-30 -70.91 -44.66 65.77 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.191 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.762 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -48.89 -64.06 0.91 Allowed 'General case' 0 C--N 1.314 -0.961 0 O-C-N 124.426 1.079 . . . . 0.0 110.206 -178.622 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.709 HG12 ' O ' ' A' ' 20' ' ' ARG . 4.2 p -74.0 -20.34 17.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -171.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.622 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -64.33 -35.82 82.11 Favored 'General case' 0 C--O 1.206 -1.195 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 172.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.405 ' HB3' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -75.1 -34.99 61.79 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 113.631 -1.622 . . . . 0.0 109.896 -176.641 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.762 ' HD2' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -65.04 -44.81 87.87 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 121.972 0.891 . . . . 0.0 112.0 177.09 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.456 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 24.7 m -95.97 -9.17 31.8 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.515 -168.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.626 HG22 ' H ' ' A' ' 31' ' ' ASP . 84.8 mt -116.91 128.27 74.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.919 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.11 -2.2 56.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.42 0.628 . . . . 0.0 110.141 175.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.626 ' H ' HG22 ' A' ' 29' ' ' ILE . 2.7 m-20 -106.92 104.16 13.77 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.105 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -53.36 -27.59 24.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.664 0.268 . . . . 0.0 110.466 176.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.569 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -67.93 -54.38 19.14 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.675 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.644 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -65.28 -22.7 66.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.44 178.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.886 ' O ' HG13 ' A' ' 39' ' ' VAL . 5.3 tmm_? -69.82 -55.81 8.79 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.491 ' O ' HG22 ' A' ' 39' ' ' VAL . 21.7 mtpt -56.97 -57.55 12.03 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.98 177.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.728 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 19.8 m -54.48 -34.2 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.736 -169.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.773 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.5 tt -86.97 -28.84 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 119.649 -0.821 . . . . 0.0 111.568 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.886 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.7 m -69.61 -49.07 61.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 119.031 -1.067 . . . . 0.0 109.508 173.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.622 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 60.4 mt-10 -61.81 -28.34 69.4 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 123.556 0.742 . . . . 0.0 112.233 176.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.728 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -85.58 -52.55 5.74 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.72 178.574 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.666 ' HE2' ' HE2' ' B' ' 42' ' ' MET . 19.6 mmt -65.57 -20.72 66.44 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.667 0.746 . . . . 0.0 109.602 -177.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.687 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -50.46 -28.11 7.74 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.463 170.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.524 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 23.1 t80 -105.15 -68.4 0.86 Allowed 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 175.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.469 ' CG ' HD12 ' A' ' 41' ' ' LEU . 10.9 mm-40 -48.88 -29.82 5.12 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.829 -176.198 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.767 ' O ' ' HB3' ' A' ' 7' ' ' ARG . 4.2 m-20 -106.53 -16.12 14.61 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 120.718 0.295 . . . . 0.0 111.659 -176.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -65.45 179.25 0.81 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.588 0.708 . . . . 0.0 111.539 -177.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.748 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 24.2 m-20 -58.63 145.67 76.47 Favored Pre-proline 0 C--N 1.31 -1.148 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.21 171.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.795 ' O ' ' HB3' ' A' ' 53' ' ' SER . 11.1 Cg_endo -55.53 -28.96 67.29 Favored 'Trans proline' 0 C--N 1.331 -0.345 0 C-N-CA 122.987 2.458 . . . . 0.0 111.897 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.672 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 8.4 pm0 -87.4 -26.57 23.24 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.398 1.079 . . . . 0.0 111.066 175.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.748 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 86.8 m -80.21 -38.24 31.56 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -177.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.523 ' HB2' ' CD1' ' A' ' 44' ' ' TYR . 4.1 pt20 -73.17 -27.35 61.6 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 172.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.795 ' HB3' ' O ' ' A' ' 49' ' ' PRO . 0.9 OUTLIER -67.91 -23.73 65.13 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.437 174.33 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -83.83 -23.47 31.36 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.862 172.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.54 HD11 ' CE2' ' A' ' 14' ' ' TYR . 22.7 mt -90.83 -32.56 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -173.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.655 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -45.92 -34.11 2.67 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -175.06 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.655 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 37.4 Cg_endo -60.61 -29.89 89.4 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.323 2.015 . . . . 0.0 112.946 172.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.552 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.1 mt -102.05 -15.34 16.79 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -178.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.589 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -52.84 109.83 0.45 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.899 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.09 -23.81 31.59 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.407 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.0 mmmt -103.38 111.94 24.6 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.373 0.606 . . . . 0.0 109.914 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.427 HG23 ' HD2' ' A' ' 63' ' ' PRO . 7.4 p -123.81 146.22 49.97 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 170.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.427 ' HD2' HG23 ' A' ' 62' ' ' VAL . 92.0 Cg_exo . . . . . 0 C--N 1.344 0.314 0 C-N-CA 122.194 1.929 . . . . 0.0 111.245 168.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.706 ' OD1' ' HB ' ' A' ' 69' ' ' ILE . 26.7 t70 . . . . . 0 CA--C 1.518 -0.281 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.605 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -81.44 -30.09 10.87 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 C-N-CA 119.035 -1.066 . . . . 0.0 109.089 176.447 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.76 ' O ' HG13 ' A' ' 73' ' ' VAL . 8.5 mm -58.09 -47.37 87.13 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.168 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.825 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 43.6 t -45.58 -37.54 5.62 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.394 175.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -85.36 -32.83 22.21 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.262 0.553 . . . . 0.0 110.629 -178.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.614 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.0 m-30 -76.06 -34.42 59.6 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.488 -175.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.834 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.6 m -72.57 -31.87 39.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.033 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.533 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -66.25 -31.65 72.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.075 175.46 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -62.93 -47.53 82.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.447 176.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.637 ' SG ' ' HB2' ' A' ' 14' ' ' TYR . 14.4 t -91.07 5.43 48.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.469 0.652 . . . . 0.0 111.059 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.533 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 9.6 t70 . . . . . 0 C--N 1.319 -0.751 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.318 175.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 1' ' ' PRO . . . . . 0.41 ' HB2' ' H ' ' B' ' 2' ' ' SER . 90.1 Cg_endo . . . . . 0 CA--C 1.515 -0.426 0 N-CA-C 108.937 -1.217 . . . . 0.0 108.937 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 2' ' ' SER . . . . . 0.752 ' HB2' HG23 ' B' ' 5' ' ' THR . 71.2 m -71.52 178.72 3.34 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 162.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.752 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -76.13 -52.43 10.12 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.857 0.837 . . . . 0.0 110.079 174.444 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.483 ' OD1' ' HG ' ' A' ' 41' ' ' LEU . 2.5 p-10 -87.42 2.64 49.89 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.646 -1.161 . . . . 0.0 113.364 -163.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.752 HG23 ' HB2' ' B' ' 2' ' ' SER . 3.6 p -63.31 -3.06 1.69 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 118.057 0.389 . . . . 0.0 111.779 -175.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.561 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 3.3 m -76.48 118.96 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-O 121.678 0.751 . . . . 0.0 110.008 176.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.76 ' HB3' ' O ' ' B' ' 46' ' ' ASN . 32.1 mtm180 -137.32 147.58 45.71 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -170.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 8' ' ' GLN . . . . . 0.601 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.6 mt-30 -42.62 121.1 1.89 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 112.616 -2.084 . . . . 0.0 113.494 177.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.67 -158.39 34.29 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 169.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 22.9 t -49.24 101.58 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 117.115 0.457 . . . . 0.0 110.988 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 49.1 pttt 37.56 42.3 0.35 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.419 1.088 . . . . 0.0 112.109 -173.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.505 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 38.1 tt0 -57.2 137.36 80.75 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 13' ' ' PRO . . . . . 0.594 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 52.1 Cg_exo -49.07 121.09 6.27 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.134 1.889 . . . . 0.0 109.992 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 14' ' ' TYR . . . . . 0.84 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 11.3 t80 -72.09 -52.66 7.24 Favored Pre-proline 0 N--CA 1.437 -1.1 0 CA-C-O 118.507 -0.758 . . . . 0.0 112.891 -166.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.541 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 36.0 Cg_exo -55.9 -18.37 21.79 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 121.42 1.413 . . . . 0.0 110.764 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.594 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 0.9 OUTLIER -90.61 -41.84 11.11 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.035 -1.439 . . . . 0.0 111.367 179.708 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 17' ' ' PHE . . . . . 0.601 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -55.34 -43.52 75.08 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 175.581 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.702 HG12 ' O ' ' B' ' 14' ' ' TYR . 2.7 p -82.89 -32.27 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.907 -177.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.42 -34.75 72.87 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 121.303 -0.873 . . . . 0.0 111.861 175.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.704 ' O ' HG12 ' B' ' 24' ' ' VAL . 16.7 ptt180 -82.09 -27.43 32.89 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 176.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.599 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 6.7 tp -57.03 -48.38 78.65 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.208 173.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 22' ' ' GLN . . . . . 0.693 ' HA ' ' CG1' ' B' ' 39' ' ' VAL . 8.6 mt-30 -70.79 -44.68 66.13 Favored 'General case' 0 CA--C 1.488 -1.435 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.089 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.751 ' O ' ' HD2' ' B' ' 27' ' ' LYS . 0.9 OUTLIER -48.8 -64.19 0.87 Allowed 'General case' 0 C--N 1.314 -0.943 0 O-C-N 124.39 1.056 . . . . 0.0 110.325 -178.7 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 24' ' ' VAL . . . . . 0.704 HG12 ' O ' ' B' ' 20' ' ' ARG . 4.1 p -73.82 -20.42 17.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -171.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.609 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -64.15 -36.0 82.62 Favored 'General case' 0 C--O 1.208 -1.12 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 172.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 26' ' ' GLN . . . . . 0.417 ' HB3' ' O ' ' B' ' 23' ' ' ASP . 0.0 OUTLIER -74.9 -35.18 62.25 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 113.62 -1.627 . . . . 0.0 109.903 -176.608 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.751 ' HD2' ' O ' ' B' ' 23' ' ' ASP . 0.0 OUTLIER -64.85 -45.03 87.81 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.898 177.177 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 28' ' ' SER . . . . . 0.444 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 26.4 m -96.15 -8.68 32.55 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.602 -168.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.609 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 84.6 mt -116.94 128.68 74.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.837 -178.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.69 -1.87 56.51 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.499 0.666 . . . . 0.0 110.128 175.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.603 ' H ' HG22 ' B' ' 29' ' ' ILE . 2.8 m-20 -106.91 104.58 14.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.092 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -53.91 -27.36 30.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.715 0.293 . . . . 0.0 110.396 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.58 ' O ' HG13 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -67.93 -54.32 19.57 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.707 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.647 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -65.46 -22.71 66.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.385 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.866 ' O ' HG13 ' B' ' 39' ' ' VAL . 5.4 tmm_? -69.69 -55.89 8.72 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.483 ' O ' HG22 ' B' ' 39' ' ' VAL . 21.8 mtpt -56.98 -57.37 12.84 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 120.826 0.346 . . . . 0.0 110.936 177.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.714 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 20.0 m -54.71 -34.13 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.661 -169.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.752 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.4 tt -86.99 -29.11 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.51 -179.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.866 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.7 m -69.31 -49.19 62.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 119.089 -1.045 . . . . 0.0 109.574 173.289 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.623 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 61.8 mt-10 -61.72 -28.26 69.29 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 123.506 0.722 . . . . 0.0 112.26 176.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.714 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.67 -52.55 5.72 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.713 178.685 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 42' ' ' MET . . . . . 0.666 ' HE2' ' HE2' ' A' ' 42' ' ' MET . 19.5 mmt -65.6 -20.68 66.41 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.574 0.702 . . . . 0.0 109.491 -177.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.679 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -50.53 -28.17 8.03 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.415 170.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 44' ' ' TYR . . . . . 0.537 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 23.0 t80 -105.06 -68.38 0.86 Allowed 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.479 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 11.8 mm-40 -48.85 -29.8 5.06 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.925 -176.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.76 ' O ' ' HB3' ' B' ' 7' ' ' ARG . 4.1 m-20 -106.53 -16.06 14.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 120.702 0.287 . . . . 0.0 111.568 -176.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.637 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -65.29 179.61 0.73 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.819 0.818 . . . . 0.0 111.602 -177.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 48' ' ' ASN . . . . . 0.74 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 24.7 m-20 -58.99 145.54 79.7 Favored Pre-proline 0 C--N 1.309 -1.169 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.242 171.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 49' ' ' PRO . . . . . 0.808 ' O ' ' HB3' ' B' ' 53' ' ' SER . 11.1 Cg_endo -55.57 -28.92 67.46 Favored 'Trans proline' 0 C--N 1.332 -0.325 0 C-N-CA 123.026 2.484 . . . . 0.0 111.917 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 50' ' ' GLU . . . . . 0.669 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 8.4 pm0 -87.26 -26.7 23.34 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.429 1.091 . . . . 0.0 111.133 175.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.74 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 86.2 m -80.18 -38.17 31.82 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -177.144 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 52' ' ' GLN . . . . . 0.513 ' HB2' ' CD1' ' B' ' 44' ' ' TYR . 4.0 pt20 -73.14 -27.36 61.63 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 172.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 53' ' ' SER . . . . . 0.808 ' HB3' ' O ' ' B' ' 49' ' ' PRO . 0.9 OUTLIER -68.12 -23.5 64.91 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.429 174.54 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.12 -23.31 30.77 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.863 172.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.544 HD11 ' CE2' ' B' ' 14' ' ' TYR . 22.6 mt -90.79 -32.73 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -174.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.646 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -45.93 -34.06 2.64 Favored Pre-proline 0 N--CA 1.487 1.388 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 -175.02 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 37.3 Cg_endo -60.24 -30.95 92.32 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 122.303 2.002 . . . . 0.0 112.902 172.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 58' ' ' LEU . . . . . 0.556 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.1 mt -101.17 -15.59 17.31 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -178.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 59' ' ' LYS . . . . . 0.584 ' HA ' ' OH ' ' B' ' 72' ' ' TYR . 0.0 OUTLIER -52.64 109.8 0.44 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.948 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.16 -23.55 32.87 Favored Glycine 0 N--CA 1.44 -1.05 0 C-N-CA 120.768 -0.73 . . . . 0.0 111.575 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -103.59 111.91 24.59 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.411 0.624 . . . . 0.0 109.927 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.426 HG23 ' HD2' ' B' ' 63' ' ' PRO . 7.5 p -123.91 146.06 49.74 Favored Pre-proline 0 C--N 1.311 -1.104 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 170.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 63' ' ' PRO . . . . . 0.426 ' HD2' HG23 ' B' ' 62' ' ' VAL . 91.3 Cg_exo . . . . . 0 N--CA 1.463 -0.308 0 C-N-CA 122.24 1.96 . . . . 0.0 111.248 168.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 67' ' ' ASP . . . . . 0.698 ' OD1' ' HB ' ' B' ' 69' ' ' ILE . 26.9 t70 . . . . . 0 CA--C 1.518 -0.252 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.615 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.9 OUTLIER -81.3 -30.12 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 C-N-CA 118.891 -1.123 . . . . 0.0 109.119 176.508 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.747 ' O ' HG13 ' B' ' 73' ' ' VAL . 8.5 mm -58.01 -47.31 87.02 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.179 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.814 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 42.7 t -45.84 -37.42 6.16 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.423 175.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -85.4 -32.7 22.23 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.085 0.469 . . . . 0.0 110.649 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 72' ' ' TYR . . . . . 0.61 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.0 m-30 -76.09 -34.49 59.53 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.502 -175.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.84 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.6 m -72.55 -32.03 39.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 173.057 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 74' ' ' LYS . . . . . 0.521 ' O ' ' HB3' ' B' ' 77' ' ' ASP . 0.0 OUTLIER -66.17 -31.36 72.15 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.029 175.422 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 75' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -63.07 -47.77 81.5 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.362 176.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.653 ' SG ' ' HB2' ' B' ' 14' ' ' TYR . 13.7 t -90.89 5.7 47.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.573 0.701 . . . . 0.0 111.179 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 77' ' ' ASP . . . . . 0.521 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 10.9 t70 . . . . . 0 C--N 1.318 -0.778 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.382 175.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.402 ' HB2' ' H ' ' A' ' 2' ' ' SER . 92.3 Cg_endo . . . . . 0 CA--C 1.517 -0.357 0 N-CA-C 109.414 -1.033 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.402 ' H ' ' HB2' ' A' ' 1' ' ' PRO . 48.0 m -66.61 169.0 8.34 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 162.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.881 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -72.7 -55.58 6.59 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.847 177.509 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.719 ' CG ' ' HG3' ' A' ' 42' ' ' MET . 11.7 p30 -87.69 -4.75 58.91 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.442 -164.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.402 ' H ' HG22 ' A' ' 5' ' ' THR . 6.7 t -63.15 -1.43 1.0 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.43 0.633 . . . . 0.0 110.945 -173.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.655 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.4 m -74.26 133.55 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 168.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.795 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -155.55 159.8 39.99 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 115.219 1.562 . . . . 0.0 115.219 -175.889 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.444 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.1 tt0 -40.34 110.52 0.15 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 112.835 -1.984 . . . . 0.0 112.714 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.33 -151.5 11.13 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.558 174.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.4 t -54.38 98.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.757 0.278 . . . . 0.0 110.58 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.9 pttt 40.07 44.3 1.46 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.321 1.048 . . . . 0.0 112.527 -175.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.429 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 67.2 tt0 -60.58 141.17 92.25 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 176.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.517 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 27.2 Cg_exo -55.37 123.36 13.62 Favored 'Trans proline' 0 CA--C 1.512 -0.615 0 C-N-CA 121.939 1.759 . . . . 0.0 109.694 177.118 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.915 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 7.2 t80 -68.98 -53.95 13.25 Favored Pre-proline 0 N--CA 1.44 -0.969 0 CA-C-O 118.421 -0.799 . . . . 0.0 113.025 -168.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.566 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 37.2 Cg_exo -56.01 -18.15 21.69 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 121.476 1.45 . . . . 0.0 111.197 -178.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.517 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 2.6 m-20 -89.97 -42.83 10.95 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.799 179.084 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.444 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -55.26 -45.78 76.1 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.332 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.795 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 2.1 p -78.05 -34.49 19.23 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.229 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.142 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.83 -39.36 71.29 Favored 'General case' 0 C--N 1.316 -0.887 0 O-C-N 121.663 -0.648 . . . . 0.0 111.078 176.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.754 ' O ' HG12 ' A' ' 24' ' ' VAL . 14.5 ptt180 -79.84 -27.74 40.17 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.592 ' HB3' ' O ' ' A' ' 18' ' ' VAL . 13.3 tp -54.98 -48.87 72.7 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 114.563 -1.198 . . . . 0.0 109.268 172.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.795 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 6.0 mt-30 -67.75 -55.66 12.24 Favored 'General case' 0 CA--C 1.486 -1.51 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.356 178.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.725 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 82.8 m-20 -45.71 -50.55 13.57 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 124.824 1.327 . . . . 0.0 111.258 -177.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.754 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.1 p -78.89 -26.19 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.834 -174.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.638 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -67.3 -31.45 71.76 Favored 'General case' 0 C--O 1.206 -1.196 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.22 -34.82 63.8 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.114 -1.403 . . . . 0.0 109.525 -178.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.725 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 39.0 mmtt -67.45 -40.33 85.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.823 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.457 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 35.4 m -100.45 -9.9 21.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.241 0.543 . . . . 0.0 110.547 -171.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.692 HG22 ' H ' ' A' ' 31' ' ' ASP . 83.4 mt -111.23 130.15 65.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.522 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.55 -3.07 58.48 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.906 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.692 ' H ' HG22 ' A' ' 29' ' ' ILE . 4.9 t0 -117.81 139.66 50.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.786 0.803 . . . . 0.0 111.918 -177.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -68.76 -31.39 70.4 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.334 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.588 ' O ' HG13 ' A' ' 37' ' ' VAL . 12.0 mttp -68.37 -53.37 24.41 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -176.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.578 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -64.22 -26.06 68.34 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.504 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.842 ' O ' HG13 ' A' ' 39' ' ' VAL . 4.7 tmm_? -68.15 -58.02 5.13 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.488 ' HB3' ' OE1' ' A' ' 40' ' ' GLU . 32.5 mtpt -53.45 -60.19 3.62 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.237 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.702 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 19.8 m -52.12 -33.9 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.374 -170.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.881 HD13 ' HE1' ' A' ' 3' ' ' PHE . 0.7 OUTLIER -88.35 -35.05 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.391 -179.782 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.842 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.9 m -66.18 -46.8 86.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 119.117 -1.033 . . . . 0.0 109.414 177.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.662 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 42.7 mt-10 -61.17 -31.63 71.36 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 123.953 0.901 . . . . 0.0 112.544 176.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.714 ' HG ' HD11 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -83.78 -52.88 6.03 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.378 -179.152 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.719 ' HG3' ' CG ' ' A' ' 4' ' ' ASN . 20.1 mmt -65.71 -20.84 66.43 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.642 0.734 . . . . 0.0 109.632 -176.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.693 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -50.47 -29.01 9.39 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.23 171.144 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.876 ' CG ' ' HE3' ' A' ' 59' ' ' LYS . 6.2 t80 -103.34 -66.7 0.92 Allowed 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 174.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.592 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 31.4 mm-40 -49.72 -29.76 8.11 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.992 -171.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.795 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.8 m-20 -104.37 -21.44 13.49 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.441 -176.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -61.36 179.75 0.2 Allowed 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.827 0.822 . . . . 0.0 112.923 -174.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.631 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 17.2 m-20 -62.31 141.67 96.22 Favored Pre-proline 0 N--CA 1.444 -0.742 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.587 173.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.426 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 80.0 Cg_exo -41.71 -50.48 4.88 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 123.093 2.529 . . . . 0.0 112.274 -178.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.617 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 0.0 OUTLIER -74.32 -26.54 60.23 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.769 0.828 . . . . 0.0 111.429 -179.268 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.631 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 72.1 m -79.89 -40.19 28.82 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -174.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.723 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.4 pt20 -69.42 -31.13 69.29 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 172.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.826 ' O ' ' HD2' ' A' ' 56' ' ' LYS . 4.2 m -67.71 -27.89 67.2 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 113.996 -1.456 . . . . 0.0 111.305 174.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.96 -23.31 62.2 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 170.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.723 HD12 ' HA ' ' A' ' 52' ' ' GLN . 25.0 mt -89.82 -27.52 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -175.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.826 ' HD2' ' O ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -37.53 -48.53 2.52 Favored Pre-proline 0 N--CA 1.506 2.368 0 CA-C-N 120.628 1.558 . . . . 0.0 112.675 -178.39 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 48.5 Cg_endo -61.45 -24.89 79.06 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.826 2.351 . . . . 0.0 112.796 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.527 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.6 mt -104.86 -15.45 15.17 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.876 ' HE3' ' CG ' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -50.7 109.96 0.37 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.812 -179.072 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.28 -19.23 44.48 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.075 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.9 mmmt -104.2 115.03 29.69 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -176.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.43 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.6 p -122.86 137.11 27.54 Favored Pre-proline 0 C--N 1.315 -0.899 0 C-N-CA 121.168 -0.213 . . . . 0.0 110.48 172.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo . . . . . 0 C--N 1.344 0.321 0 C-N-CA 122.849 2.366 . . . . 0.0 112.227 171.608 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.404 ' OD2' ' HB ' ' A' ' 69' ' ' ILE . 2.6 t70 . . . . . 0 CA--C 1.512 -0.509 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.583 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -78.49 -29.18 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 C-N-CA 118.792 -1.163 . . . . 0.0 108.879 179.83 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.791 ' O ' HG13 ' A' ' 73' ' ' VAL . 8.5 mm -61.12 -47.01 95.51 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.184 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.09 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.6 t -47.24 -37.83 11.17 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.98 177.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.422 ' HA ' ' HB3' ' A' ' 74' ' ' LYS . 3.3 mm-40 -86.08 -32.62 21.28 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 123.287 0.635 . . . . 0.0 111.094 -177.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.619 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.3 m-30 -74.88 -35.83 62.28 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.314 -177.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.915 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 2.3 m -70.41 -34.11 56.61 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 174.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.491 ' HA ' ' HB2' ' A' ' 77' ' ' ASP . 13.0 ttpp -70.47 -27.86 64.56 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.788 177.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -62.18 -44.65 96.13 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.047 -0.978 . . . . 0.0 109.398 173.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.528 ' SG ' ' HB2' ' A' ' 14' ' ' TYR . 39.3 t -96.04 9.31 41.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.332 178.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.491 ' HB2' ' HA ' ' A' ' 74' ' ' LYS . 10.7 t70 . . . . . 0 C--N 1.324 -0.528 0 CA-C-O 121.057 0.456 . . . . 0.0 110.507 175.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 1' ' ' PRO . . . . . 0.408 ' HB2' HG21 ' B' ' 5' ' ' THR . 96.3 Cg_endo . . . . . 0 CA--C 1.517 -0.366 0 N-CA-C 109.163 -1.13 . . . . 0.0 109.163 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 41.7 m -66.91 168.79 9.21 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 162.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.882 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -72.23 -55.72 6.74 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.812 177.632 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.718 ' CG ' ' HG3' ' B' ' 42' ' ' MET . 11.7 p30 -87.81 -4.67 58.86 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.332 -164.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.408 HG21 ' HB2' ' B' ' 1' ' ' PRO . 7.0 t -63.3 -1.42 1.08 Allowed 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.314 0.578 . . . . 0.0 110.87 -173.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.663 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.5 m -74.38 133.54 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 169.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.799 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -155.48 159.82 40.09 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 -175.945 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 8' ' ' GLN . . . . . 0.444 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.1 tt0 -40.27 110.38 0.15 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 112.921 -1.945 . . . . 0.0 112.786 -178.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.15 -151.5 10.76 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.631 174.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 22.7 t -54.27 99.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.837 0.319 . . . . 0.0 110.513 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 58.0 pttt 39.75 44.23 1.27 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.365 1.066 . . . . 0.0 112.485 -175.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.429 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 68.9 tt0 -60.78 140.94 93.11 Favored Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 13' ' ' PRO . . . . . 0.52 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 27.5 Cg_exo -55.33 123.43 13.8 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 121.855 1.703 . . . . 0.0 109.751 177.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 14' ' ' TYR . . . . . 0.924 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 7.2 t80 -68.94 -53.87 13.59 Favored Pre-proline 0 N--CA 1.44 -0.926 0 CA-C-O 118.458 -0.782 . . . . 0.0 113.01 -168.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.546 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 36.9 Cg_exo -55.93 -18.46 22.3 Favored 'Trans proline' 0 C--N 1.359 1.103 0 C-N-CA 121.523 1.482 . . . . 0.0 110.991 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.52 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.9 m-20 -89.82 -42.56 11.2 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 113.907 -1.497 . . . . 0.0 110.841 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 17' ' ' PHE . . . . . 0.444 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -55.43 -45.76 76.77 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.458 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.787 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 2.1 p -78.09 -34.38 19.03 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.18 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.172 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.59 -39.6 70.93 Favored 'General case' 0 C--N 1.316 -0.882 0 O-C-N 121.674 -0.641 . . . . 0.0 111.077 176.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.754 ' O ' HG12 ' B' ' 24' ' ' VAL . 14.7 ptt180 -79.82 -27.72 40.22 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.594 ' HB3' ' O ' ' B' ' 18' ' ' VAL . 13.2 tp -55.05 -48.68 73.14 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.191 172.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 22' ' ' GLN . . . . . 0.787 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 6.0 mt-30 -68.24 -55.23 12.95 Favored 'General case' 0 CA--C 1.485 -1.529 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.447 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.723 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 78.8 m-20 -45.79 -50.87 13.58 Favored 'General case' 0 C--N 1.312 -1.023 0 O-C-N 124.735 1.272 . . . . 0.0 111.264 -177.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 24' ' ' VAL . . . . . 0.754 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.1 p -78.66 -26.24 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.925 -174.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.641 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -67.22 -31.37 71.7 Favored 'General case' 0 C--O 1.208 -1.131 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 176.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.08 -35.15 64.21 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.174 -1.375 . . . . 0.0 109.474 -178.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.723 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 39.1 mmtt -67.31 -39.96 85.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.628 -1.169 . . . . 0.0 112.015 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 28' ' ' SER . . . . . 0.449 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 38.9 m -100.45 -10.47 21.09 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.247 0.546 . . . . 0.0 110.511 -172.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.691 HG22 ' H ' ' B' ' 31' ' ' ASP . 83.9 mt -110.96 129.9 65.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.651 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.48 -3.03 58.54 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.937 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.691 ' H ' HG22 ' B' ' 29' ' ' ILE . 4.7 t0 -117.92 139.63 50.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.715 0.769 . . . . 0.0 111.912 -177.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -68.66 -31.55 70.75 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.43 175.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.597 ' O ' HG13 ' B' ' 37' ' ' VAL . 12.1 mttp -68.16 -53.62 23.77 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -176.137 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.578 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -63.89 -26.22 68.5 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.481 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.869 ' O ' HG13 ' B' ' 39' ' ' VAL . 4.8 tmm_? -68.27 -57.91 5.24 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.473 ' HB3' ' OE1' ' B' ' 40' ' ' GLU . 32.8 mtpt -53.53 -60.29 3.49 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.223 178.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.703 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 19.7 m -52.08 -33.85 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.366 -170.264 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.882 HD13 ' HE1' ' B' ' 3' ' ' PHE . 0.7 OUTLIER -88.36 -35.12 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 C-N-CA 119.769 -0.772 . . . . 0.0 112.355 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.869 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.9 m -66.05 -46.88 86.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 119.124 -1.03 . . . . 0.0 109.44 177.04 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.654 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 42.9 mt-10 -61.19 -31.59 71.34 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.943 0.897 . . . . 0.0 112.55 176.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.703 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -83.67 -52.98 5.98 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 121.039 -0.265 . . . . 0.0 111.446 -179.152 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 42' ' ' MET . . . . . 0.718 ' HG3' ' CG ' ' B' ' 4' ' ' ASN . 19.9 mmt -65.69 -20.73 66.4 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.712 0.768 . . . . 0.0 109.685 -176.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.692 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -50.51 -29.05 9.61 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.144 171.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 44' ' ' TYR . . . . . 0.871 ' CG ' ' HE3' ' B' ' 59' ' ' LYS . 6.1 t80 -103.4 -66.66 0.93 Allowed 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 174.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.601 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 31.0 mm-40 -49.78 -29.6 8.08 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 124.415 1.072 . . . . 0.0 112.006 -171.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.799 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.9 m-20 -104.42 -21.46 13.47 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.497 -176.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -61.49 179.89 0.21 Allowed 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.873 0.844 . . . . 0.0 113.058 -174.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 48' ' ' ASN . . . . . 0.641 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 17.5 m-20 -62.28 141.87 96.1 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.545 173.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 49' ' ' PRO . . . . . 0.43 ' O ' ' HG2' ' B' ' 52' ' ' GLN . 75.5 Cg_exo -42.14 -50.36 5.39 Favored 'Trans proline' 0 C--N 1.332 -0.308 0 C-N-CA 122.959 2.44 . . . . 0.0 112.309 -178.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 50' ' ' GLU . . . . . 0.632 ' HA ' ' HB2' ' B' ' 53' ' ' SER . 0.0 OUTLIER -74.07 -26.72 60.54 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.954 0.901 . . . . 0.0 111.349 -179.42 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.641 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 72.4 m -79.92 -40.15 28.8 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -174.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 52' ' ' GLN . . . . . 0.735 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.3 pt20 -69.44 -30.86 68.87 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 172.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 53' ' ' SER . . . . . 0.825 ' O ' ' HD2' ' B' ' 56' ' ' LYS . 4.3 m -67.89 -27.54 66.75 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 113.907 -1.497 . . . . 0.0 111.423 174.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.4 -23.09 61.81 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.005 0.907 . . . . 0.0 108.566 170.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.735 HD12 ' HA ' ' B' ' 52' ' ' GLN . 25.4 mt -89.91 -27.5 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -175.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.825 ' HD2' ' O ' ' B' ' 53' ' ' SER . 0.0 OUTLIER -37.47 -49.08 2.55 Favored Pre-proline 0 N--CA 1.507 2.404 0 CA-C-N 120.624 1.557 . . . . 0.0 112.525 -178.398 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 49.9 Cg_endo -61.27 -24.38 78.73 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.836 2.358 . . . . 0.0 112.789 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 58' ' ' LEU . . . . . 0.544 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.6 mt -105.28 -15.47 15.04 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.096 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 59' ' ' LYS . . . . . 0.871 ' HE3' ' CG ' ' B' ' 44' ' ' TYR . 0.0 OUTLIER -50.62 109.83 0.35 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.684 -179.015 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.67 -19.63 43.58 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.11 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -103.9 115.2 30.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.911 0.386 . . . . 0.0 110.12 -176.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.436 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.6 p -122.73 137.67 28.3 Favored Pre-proline 0 C--N 1.315 -0.915 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.406 171.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_exo . . . . . 0 C--N 1.343 0.285 0 C-N-CA 122.888 2.392 . . . . 0.0 112.212 171.321 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 67' ' ' ASP . . . . . 0.4 ' OD2' ' HB ' ' B' ' 69' ' ' ILE . 2.9 t70 . . . . . 0 CA--C 1.511 -0.528 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.578 HG22 ' HG2' ' B' ' 40' ' ' GLU . 1.0 OUTLIER -78.3 -29.4 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 C-N-CA 118.769 -1.172 . . . . 0.0 108.885 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.796 ' O ' HG13 ' B' ' 73' ' ' VAL . 8.6 mm -60.93 -47.12 94.93 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.164 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.091 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 43.0 t -47.13 -37.79 10.5 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.974 177.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.433 ' HA ' ' HB3' ' B' ' 74' ' ' LYS . 3.2 mm-40 -86.22 -32.52 21.13 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 123.282 0.633 . . . . 0.0 111.144 -177.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 72' ' ' TYR . . . . . 0.61 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.3 m-30 -74.97 -35.61 62.07 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.705 0.764 . . . . 0.0 109.348 -177.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.924 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 2.3 m -70.64 -34.16 55.91 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 74' ' ' LYS . . . . . 0.494 ' HA ' ' HB2' ' B' ' 77' ' ' ASP . 13.1 ttpp -70.37 -28.0 64.76 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.684 177.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 75' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -62.1 -44.56 96.38 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.431 173.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' B' ' 14' ' ' TYR . 37.7 t -96.01 9.22 41.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.182 178.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 77' ' ' ASP . . . . . 0.494 ' HB2' ' HA ' ' B' ' 74' ' ' LYS . 11.2 t70 . . . . . 0 C--N 1.323 -0.569 0 CA-C-O 121.034 0.445 . . . . 0.0 110.6 175.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.422 ' HB2' ' H ' ' A' ' 2' ' ' SER . 97.3 Cg_endo . . . . . 0 CA--C 1.518 -0.3 0 N-CA-C 108.984 -1.199 . . . . 0.0 108.984 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.458 ' HB2' HG23 ' A' ' 5' ' ' THR . 16.5 m -66.88 174.17 3.15 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 163.043 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.731 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -70.83 -51.79 24.47 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 166.029 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.533 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 2.4 p-10 -88.18 5.64 40.47 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 113.944 -1.48 . . . . 0.0 113.781 -165.156 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.458 HG23 ' HB2' ' A' ' 2' ' ' SER . 0.6 OUTLIER -63.09 -8.47 7.71 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 118.52 0.6 . . . . 0.0 111.305 -177.096 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.62 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.1 m -74.48 129.4 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 176.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.741 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -155.51 158.73 38.97 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 118.053 -1.459 . . . . 0.0 114.61 -177.556 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.45 ' HG2' ' HB3' ' A' ' 12' ' ' GLU . 2.2 tt0 -47.14 106.66 0.09 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 112.865 -1.97 . . . . 0.0 112.031 -177.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.27 -135.68 1.18 Allowed Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.825 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.497 ' C ' ' HD3' ' A' ' 11' ' ' LYS . 9.1 t -65.37 99.41 0.4 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.497 ' HD3' ' C ' ' A' ' 10' ' ' SER . 0.0 OUTLIER 37.2 44.24 0.41 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.233 1.013 . . . . 0.0 112.017 -175.333 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.45 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 54.8 tt0 -60.55 144.29 89.05 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.735 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.576 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 37.9 Cg_exo -54.48 122.83 12.24 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.356 2.037 . . . . 0.0 110.114 176.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.805 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 21.9 t80 -73.19 -55.87 3.57 Favored Pre-proline 0 N--CA 1.439 -0.984 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -166.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.557 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 27.4 Cg_exo -56.98 -16.13 19.6 Favored 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 121.279 1.32 . . . . 0.0 110.627 -178.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.576 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.3 m-20 -89.16 -44.48 10.28 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 113.606 -1.634 . . . . 0.0 110.837 178.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.54 ' CE2' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -54.62 -44.76 73.43 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.515 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.78 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 1.7 p -79.63 -34.8 16.06 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.277 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.536 -178.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.33 -30.58 68.47 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 121.45 -0.781 . . . . 0.0 111.752 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.728 ' O ' HG12 ' A' ' 24' ' ' VAL . 16.5 ptt180 -84.45 -28.36 26.89 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.543 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 5.6 tp -57.26 -48.29 79.25 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.019 173.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.78 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 4.6 mt-30 -68.78 -47.9 65.02 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.085 177.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.732 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 11.4 t70 -47.19 -54.58 10.37 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 124.332 1.02 . . . . 0.0 111.656 -177.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.728 HG12 ' O ' ' A' ' 20' ' ' ARG . 6.6 p -81.84 -21.95 10.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.038 -174.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.753 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -73.07 -19.39 61.18 Favored 'General case' 0 C--O 1.205 -1.243 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 174.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.49 -38.06 17.64 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.582 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.732 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 39.8 mmtt -66.45 -35.75 81.05 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.753 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.418 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 15.7 m -104.72 -7.32 19.62 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.201 0.524 . . . . 0.0 110.657 -170.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.753 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 88.5 mt -117.8 130.12 73.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.885 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.21 -7.64 47.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.331 0.586 . . . . 0.0 110.332 175.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.54 ' H ' HG22 ' A' ' 29' ' ' ILE . 1.0 OUTLIER -100.31 106.29 17.91 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.735 -179.278 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -56.47 -25.98 52.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.679 0.276 . . . . 0.0 110.271 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.566 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -69.32 -53.57 18.96 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.172 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.622 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -64.6 -24.07 67.47 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.349 177.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.871 ' O ' HG13 ' A' ' 39' ' ' VAL . 4.7 tmm_? -68.4 -58.61 4.08 Favored 'General case' 0 C--O 1.219 -0.535 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.485 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 27.4 mtpt -52.45 -60.68 2.94 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 120.791 0.329 . . . . 0.0 110.535 177.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.785 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 21.6 m -52.16 -36.15 20.21 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.768 -168.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.731 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.5 tt -87.17 -27.69 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 119.641 -0.823 . . . . 0.0 112.111 -177.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.871 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.1 m -73.35 -47.47 46.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 119.148 -1.021 . . . . 0.0 109.267 175.24 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.773 ' OE2' HG13 ' A' ' 68' ' ' VAL . 0.7 OUTLIER -63.98 -24.47 67.73 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.796 0.838 . . . . 0.0 111.292 176.162 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.785 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -85.45 -57.9 2.88 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 176.667 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.539 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 23.2 mmt -61.49 -20.58 63.33 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.569 0.699 . . . . 0.0 109.703 -177.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.685 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -48.94 -27.89 3.45 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.928 170.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.554 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 10.2 t80 -107.13 -66.77 0.99 Allowed 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 176.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.637 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 17.1 mm-40 -48.1 -32.59 7.02 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.998 -174.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.741 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 5.2 m-20 -105.14 -19.32 13.86 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -175.175 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.626 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -61.01 -172.15 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -174.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.556 ' HB2' ' H ' ' A' ' 51' ' ' CYS . 84.9 m-20 -52.78 141.49 36.51 Favored Pre-proline 0 C--N 1.342 0.239 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 170.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.92 -19.66 56.14 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 121.618 1.545 . . . . 0.0 110.452 174.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.537 ' O ' ' HB2' ' A' ' 53' ' ' SER . 0.3 OUTLIER -87.11 -34.98 18.92 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.465 174.055 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.975 ' SG ' ' HB2' ' A' ' 76' ' ' CYS . 40.8 t -80.24 -33.92 37.55 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.242 -172.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.517 ' HB2' ' CD1' ' A' ' 44' ' ' TYR . 4.2 pt20 -68.68 -29.32 67.75 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 172.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.537 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 20.0 m -71.58 -19.3 62.16 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.284 -1.78 . . . . 0.0 110.017 173.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -81.06 -27.17 35.81 Favored 'General case' 0 C--N 1.311 -1.107 0 O-C-N 121.431 -0.793 . . . . 0.0 110.158 167.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.557 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 23.7 mt -90.34 -30.18 4.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 114.83 1.418 . . . . 0.0 114.83 -170.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.613 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.57 -38.81 1.99 Allowed Pre-proline 0 N--CA 1.487 1.414 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -174.034 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 54.4 Cg_endo -63.62 -30.96 70.58 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.154 1.903 . . . . 0.0 112.628 176.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.543 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.8 mt -95.08 -16.87 22.33 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.578 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 0.1 OUTLIER -54.87 109.07 0.46 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.698 -179.523 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.38 -23.04 37.58 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.403 -177.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -104.22 113.22 26.61 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.312 0.577 . . . . 0.0 110.232 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.464 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.7 p -123.09 142.53 38.52 Favored Pre-proline 0 C--N 1.309 -1.177 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 169.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo . . . . . 0 N--CA 1.463 -0.276 0 C-N-CA 122.19 1.927 . . . . 0.0 111.443 170.958 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.518 -0.271 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.773 HG13 ' OE2' ' A' ' 40' ' ' GLU . 0.7 OUTLIER -72.45 -32.53 42.3 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.419 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.755 ' O ' HG13 ' A' ' 73' ' ' VAL . 10.1 mm -55.57 -46.59 79.16 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.071 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.742 -178.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 33.6 t -46.34 -38.11 8.36 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.322 0.582 . . . . 0.0 111.012 176.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -85.63 -31.96 22.29 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.749 -177.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.578 ' OH ' ' HA ' ' A' ' 59' ' ' LYS . 4.9 m-30 -76.59 -34.04 58.42 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.534 -176.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.805 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.5 m -71.41 -31.64 43.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 172.037 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.569 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -67.89 -29.83 69.02 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.372 175.731 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -64.77 -44.93 88.46 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.109 176.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.975 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 39.5 t -92.52 9.08 36.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.636 177.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.569 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 8.3 t70 . . . . . 0 C--N 1.322 -0.622 0 CA-C-O 121.321 0.581 . . . . 0.0 110.238 172.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo . . . . . 0 CA--C 1.518 -0.324 0 N-CA-C 108.911 -1.226 . . . . 0.0 108.911 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 2' ' ' SER . . . . . 0.462 ' HB2' HG23 ' B' ' 5' ' ' THR . 16.4 m -66.9 174.56 2.92 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 162.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.729 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -71.18 -51.76 23.03 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 165.997 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.525 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.4 p-10 -88.19 5.62 40.61 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 113.904 -1.498 . . . . 0.0 113.731 -165.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.462 HG23 ' HB2' ' B' ' 2' ' ' SER . 0.6 OUTLIER -63.36 -7.72 7.13 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 118.554 0.616 . . . . 0.0 111.438 -177.13 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.611 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.1 m -75.0 129.27 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.764 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.2 OUTLIER -155.48 158.77 39.07 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 118.18 -1.408 . . . . 0.0 114.626 -177.652 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 8' ' ' GLN . . . . . 0.459 ' HG2' ' HB3' ' B' ' 12' ' ' GLU . 2.2 tt0 -47.01 106.72 0.09 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 112.766 -2.016 . . . . 0.0 111.944 -177.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.56 -136.48 1.38 Allowed Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.631 177.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 10' ' ' SER . . . . . 0.506 ' C ' ' HD3' ' B' ' 11' ' ' LYS . 8.9 t -64.81 99.38 0.33 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 11' ' ' LYS . . . . . 0.506 ' HD3' ' C ' ' B' ' 10' ' ' SER . 0.0 OUTLIER 37.35 43.94 0.42 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.19 0.996 . . . . 0.0 112.095 -175.354 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.459 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 52.6 tt0 -60.28 144.27 87.91 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.855 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 13' ' ' PRO . . . . . 0.552 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 40.4 Cg_exo -54.56 122.78 12.17 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 122.235 1.957 . . . . 0.0 110.139 176.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 14' ' ' TYR . . . . . 0.802 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 21.6 t80 -73.13 -55.92 3.59 Favored Pre-proline 0 N--CA 1.44 -0.939 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -166.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.569 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 27.7 Cg_exo -57.22 -16.02 20.55 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 121.318 1.345 . . . . 0.0 110.609 -178.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.552 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.4 m-20 -89.33 -44.2 10.39 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 113.487 -1.688 . . . . 0.0 110.762 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 17' ' ' PHE . . . . . 0.535 ' CE2' HD22 ' B' ' 21' ' ' LEU . 0.0 OUTLIER -54.89 -44.59 74.24 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 176.744 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.767 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 1.7 p -79.58 -34.91 16.21 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.307 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.496 -178.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.39 -30.29 68.34 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 121.356 -0.84 . . . . 0.0 111.913 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.712 ' O ' HG12 ' B' ' 24' ' ' VAL . 16.6 ptt180 -84.53 -28.44 26.66 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 175.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.558 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 5.6 tp -57.24 -48.23 79.36 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.079 173.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 22' ' ' GLN . . . . . 0.767 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 4.6 mt-30 -69.09 -47.41 65.31 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.075 177.329 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.743 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 11.8 t70 -47.44 -54.74 10.58 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 124.416 1.072 . . . . 0.0 111.6 -177.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 24' ' ' VAL . . . . . 0.712 HG12 ' O ' ' B' ' 20' ' ' ARG . 6.5 p -81.7 -22.05 10.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.033 -174.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.759 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -72.95 -19.39 61.25 Favored 'General case' 0 C--O 1.204 -1.302 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.49 -38.25 17.45 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.555 177.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.743 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 40.1 mmtt -66.13 -35.95 81.85 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.717 178.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 28' ' ' SER . . . . . 0.409 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 15.7 m -104.52 -7.64 19.62 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.24 0.543 . . . . 0.0 110.68 -170.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.759 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 88.3 mt -117.74 129.74 73.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.91 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.15 -7.29 48.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.328 0.585 . . . . 0.0 110.314 175.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.514 ' H ' HG22 ' B' ' 29' ' ' ILE . 1.1 m-20 -100.46 106.25 17.79 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.776 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -56.29 -26.04 50.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.666 0.27 . . . . 0.0 110.388 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.57 ' O ' HG13 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -69.24 -53.73 18.39 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.14 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.633 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -64.33 -24.11 67.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.402 177.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.867 ' O ' HG13 ' B' ' 39' ' ' VAL . 4.6 tmm_? -68.41 -58.75 3.87 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.479 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 27.2 mtpt -52.17 -60.7 2.9 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 120.796 0.332 . . . . 0.0 110.638 177.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.779 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 21.8 m -52.27 -35.96 20.4 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.465 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.716 -168.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.729 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.5 tt -87.24 -27.72 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 119.599 -0.84 . . . . 0.0 112.067 -177.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.867 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.1 m -73.51 -47.14 46.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.332 175.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.769 ' OE2' HG13 ' B' ' 68' ' ' VAL . 0.7 OUTLIER -64.19 -24.36 67.65 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.757 0.823 . . . . 0.0 111.348 176.084 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.779 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.46 -57.86 2.9 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 176.534 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 42' ' ' MET . . . . . 0.541 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 23.2 mmt -61.45 -20.75 63.47 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.591 0.71 . . . . 0.0 109.717 -177.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.68 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -48.71 -27.93 3.24 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.991 170.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 44' ' ' TYR . . . . . 0.554 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 10.4 t80 -107.22 -66.66 1.0 Allowed 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.638 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 17.6 mm-40 -48.21 -32.46 7.14 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.817 -1.083 . . . . 0.0 112.005 -174.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.764 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 5.1 m-20 -105.07 -19.68 13.75 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -175.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -60.71 -172.0 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -174.471 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 48' ' ' ASN . . . . . 0.552 ' HB2' ' CB ' ' B' ' 51' ' ' CYS . 84.7 m-20 -52.86 141.55 37.05 Favored Pre-proline 0 C--O 1.235 0.298 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 170.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.04 -19.7 57.2 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 121.642 1.561 . . . . 0.0 110.471 174.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 50' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' B' ' 53' ' ' SER . 0.3 OUTLIER -87.02 -34.89 19.07 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.542 173.991 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.975 ' SG ' ' HB2' ' B' ' 76' ' ' CYS . 40.7 t -80.33 -33.89 37.07 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.265 -172.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 52' ' ' GLN . . . . . 0.51 ' HB2' ' CD1' ' B' ' 44' ' ' TYR . 4.1 pt20 -68.6 -29.42 67.93 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 172.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 53' ' ' SER . . . . . 0.534 ' O ' ' HE2' ' B' ' 56' ' ' LYS . 19.6 m -71.55 -19.41 62.17 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 113.264 -1.789 . . . . 0.0 109.986 173.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -80.86 -27.38 36.43 Favored 'General case' 0 C--N 1.311 -1.07 0 O-C-N 121.443 -0.786 . . . . 0.0 110.225 167.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.561 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 24.0 mt -90.11 -30.0 5.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 -170.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.607 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.68 -38.78 2.07 Favored Pre-proline 0 N--CA 1.487 1.377 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -174.043 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 55.6 Cg_endo -63.79 -30.78 68.83 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.196 1.931 . . . . 0.0 112.649 176.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 58' ' ' LEU . . . . . 0.557 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.7 mt -95.11 -16.74 22.4 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 59' ' ' LYS . . . . . 0.57 ' HA ' ' OH ' ' B' ' 72' ' ' TYR . 0.1 OUTLIER -55.01 109.09 0.47 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.661 -179.483 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.65 -23.41 36.05 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.419 -177.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -104.07 113.36 26.85 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.351 0.596 . . . . 0.0 110.162 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.48 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.7 p -123.16 142.13 37.62 Favored Pre-proline 0 C--N 1.308 -1.201 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.352 169.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo . . . . . 0 C--O 1.234 0.32 0 C-N-CA 122.201 1.934 . . . . 0.0 111.416 171.222 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.519 -0.229 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.769 HG13 ' OE2' ' B' ' 40' ' ' GLU . 0.7 OUTLIER -72.3 -32.52 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.495 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.754 ' O ' HG13 ' B' ' 73' ' ' VAL . 9.9 mm -55.65 -46.6 79.42 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.093 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.675 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 29.4 t -46.49 -37.92 8.52 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.105 176.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -85.67 -32.0 22.22 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.677 -177.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 72' ' ' TYR . . . . . 0.579 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 4.9 m-30 -76.46 -34.29 58.7 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.572 -176.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.802 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.5 m -71.33 -31.51 43.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 172.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 74' ' ' LYS . . . . . 0.569 ' O ' ' HB3' ' B' ' 77' ' ' ASP . 0.0 OUTLIER -68.08 -29.61 68.61 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.431 175.653 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 75' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -65.09 -44.59 88.34 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.175 176.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.975 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 39.1 t -92.5 9.04 36.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.729 177.299 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 77' ' ' ASP . . . . . 0.569 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 9.1 t70 . . . . . 0 C--N 1.321 -0.641 0 CA-C-O 121.173 0.511 . . . . 0.0 110.163 172.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.413 ' C ' ' HA3' ' B' ' 60' ' ' GLY . 72.3 Cg_endo . . . . . 0 CA--C 1.515 -0.451 0 N-CA-C 108.784 -1.275 . . . . 0.0 108.784 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.723 ' HG ' ' HZ2' ' B' ' 59' ' ' LYS . 13.7 m -67.11 171.42 5.64 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 162.178 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.812 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -69.9 -52.02 28.14 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 167.248 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.521 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 2.5 p-10 -82.34 5.37 20.48 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 113.996 -1.456 . . . . 0.0 113.423 -166.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.409 HG23 ' HB2' ' A' ' 2' ' ' SER . 0.4 OUTLIER -66.28 -3.03 5.02 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 118.521 0.6 . . . . 0.0 111.946 -175.158 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.582 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.1 m -78.57 132.72 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 174.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.783 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -155.08 160.15 40.78 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -178.881 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.411 ' N ' ' CD2' ' A' ' 17' ' ' PHE . 2.0 tt0 -44.33 109.07 0.13 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 112.902 -1.954 . . . . 0.0 112.29 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.69 -151.95 15.13 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.397 174.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.1 t -52.32 98.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 122.421 0.288 . . . . 0.0 110.692 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.7 pttm 40.52 42.14 1.25 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.511 1.124 . . . . 0.0 112.598 -175.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -60.1 141.34 90.35 Favored Pre-proline 0 C--O 1.236 0.386 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.149 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.506 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 27.4 Cg_exo -56.35 122.96 12.7 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.039 1.826 . . . . 0.0 109.712 176.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.871 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 20.2 t80 -72.38 -53.27 6.24 Favored Pre-proline 0 N--CA 1.439 -1.004 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -166.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.529 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 34.3 Cg_exo -55.36 -19.53 22.48 Favored 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 121.361 1.374 . . . . 0.0 110.749 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.506 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 3.4 m-20 -89.9 -41.19 11.93 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 113.737 -1.574 . . . . 0.0 110.948 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.506 ' CD2' ' HA ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -54.96 -46.82 75.08 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 175.73 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.7 HG12 ' O ' ' A' ' 14' ' ' TYR . 2.4 p -79.03 -32.12 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.218 -177.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.0 -36.3 72.45 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 121.639 -0.663 . . . . 0.0 111.768 175.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.705 ' O ' HG12 ' A' ' 24' ' ' VAL . 14.1 ptt180 -83.27 -23.52 32.64 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.547 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 6.6 tp -60.49 -45.63 93.06 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.767 172.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.716 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 7.6 mt-30 -73.14 -44.51 60.04 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.735 178.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.751 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 26.0 t70 -49.16 -53.72 19.67 Favored 'General case' 0 C--N 1.315 -0.893 0 O-C-N 124.155 0.909 . . . . 0.0 111.667 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.705 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.7 p -80.85 -23.19 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-O 121.09 0.472 . . . . 0.0 109.882 -174.134 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.774 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -71.79 -20.54 61.84 Favored 'General case' 0 C--O 1.204 -1.326 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 174.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.451 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -86.54 -37.14 18.47 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.744 178.602 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.751 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.0 mmtt -65.49 -35.51 81.09 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.459 178.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.5 m -104.47 -9.96 18.02 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.648 -171.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.774 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 91.1 mt -119.27 128.03 75.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.95 -178.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.99 -1.29 56.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.382 0.611 . . . . 0.0 110.488 176.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.66 ' H ' HG22 ' A' ' 29' ' ' ILE . 13.6 t70 -107.95 116.6 32.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.467 -177.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.558 ' OE2' ' HG3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -57.16 -34.05 68.06 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.272 178.332 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.612 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -70.88 -54.71 10.48 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -172.543 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.563 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -60.05 -28.92 68.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.8 176.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.878 ' O ' HG13 ' A' ' 39' ' ' VAL . 6.0 tmm_? -67.38 -58.09 5.41 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.441 ' O ' HG22 ' A' ' 39' ' ' VAL . 16.0 mtpt -56.96 -56.58 19.85 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.008 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.704 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 20.1 m -53.73 -35.03 25.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.399 -171.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.812 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.3 tt -86.6 -28.24 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 C-N-CA 119.631 -0.828 . . . . 0.0 111.732 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.878 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.5 m -70.78 -49.87 47.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 119.088 -1.045 . . . . 0.0 109.561 173.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.774 ' OE1' HG13 ' A' ' 68' ' ' VAL . 0.9 OUTLIER -62.08 -24.85 67.36 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.354 0.662 . . . . 0.0 111.653 176.654 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.704 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -86.23 -55.28 3.99 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 176.381 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.521 ' HG3' ' HB2' ' A' ' 4' ' ' ASN . 16.4 mmt -63.89 -20.35 65.77 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 121.458 0.646 . . . . 0.0 109.861 -176.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.689 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -48.78 -27.81 3.23 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.277 169.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.558 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 16.5 t80 -105.95 -66.23 1.01 Allowed 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 174.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.45 ' CG ' HD12 ' A' ' 41' ' ' LEU . 15.3 mm-40 -50.22 -26.85 5.1 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 124.228 0.955 . . . . 0.0 112.699 -172.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.783 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.8 m-20 -109.49 -20.35 12.92 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.625 -177.052 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -59.15 -177.52 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.183 0.992 . . . . 0.0 113.633 -174.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -62.98 140.89 97.64 Favored Pre-proline 0 N--CA 1.445 -0.713 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.639 174.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -43.65 -48.04 9.07 Favored 'Trans proline' 0 C--N 1.334 -0.226 0 C-N-CA 122.83 2.353 . . . . 0.0 112.473 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.602 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -76.23 -23.73 54.55 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.31 0.644 . . . . 0.0 110.657 -179.488 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.969 ' SG ' ' HB2' ' A' ' 76' ' ' CYS . 52.9 t -84.26 -40.0 18.57 Favored 'General case' 0 N--CA 1.417 -2.105 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.915 -173.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.57 ' HA ' HD12 ' A' ' 55' ' ' ILE . 29.8 pt20 -66.34 -31.18 71.81 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 172.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.757 ' O ' ' HD2' ' A' ' 56' ' ' LYS . 5.1 m -65.81 -30.05 70.62 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.88 172.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.33 -23.71 61.2 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.87 0.843 . . . . 0.0 109.276 172.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.57 HD12 ' HA ' ' A' ' 52' ' ' GLN . 25.1 mt -90.94 -31.33 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -173.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.757 ' HD2' ' O ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -44.03 -38.18 4.43 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-N 119.805 1.184 . . . . 0.0 113.477 -173.451 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 52.7 Cg_endo -63.06 -29.6 75.12 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 122.296 1.997 . . . . 0.0 112.85 175.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.559 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.5 mt -97.37 -16.45 20.24 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.558 ' HE3' ' HB3' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -52.76 109.68 0.43 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.376 -178.538 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.525 ' N ' ' HZ3' ' A' ' 59' ' ' LYS . . . 94.86 -21.77 41.79 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.177 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.5 mmmt -103.51 114.5 28.81 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -177.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.528 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.7 p -122.14 137.1 27.01 Favored Pre-proline 0 C--N 1.309 -1.163 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 170.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo . . . . . 0 C--O 1.234 0.303 0 C-N-CA 122.649 2.233 . . . . 0.0 111.702 172.621 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.444 ' OD2' ' HB ' ' A' ' 69' ' ' ILE . 3.0 t70 . . . . . 0 CA--C 1.519 -0.237 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.774 HG13 ' OE1' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -71.87 -33.36 47.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 C-N-CA 118.055 -1.458 . . . . 0.0 108.937 -179.391 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.774 ' O ' HG13 ' A' ' 73' ' ' VAL . 7.6 mm -57.61 -47.5 85.29 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.112 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.802 -178.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.577 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 41.2 t -48.33 -36.09 13.67 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.202 0.525 . . . . 0.0 111.168 178.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.411 ' H ' ' HG2' ' A' ' 71' ' ' GLU . 2.3 mm-40 -86.56 -31.21 21.34 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.27 0.628 . . . . 0.0 110.75 -176.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.559 ' CE1' ' HB2' ' A' ' 58' ' ' LEU . 4.9 m-30 -76.28 -35.98 58.62 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.494 -178.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.871 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.7 m -69.87 -33.15 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 173.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.577 ' HB2' ' O ' ' A' ' 70' ' ' SER . 1.6 ttmm -67.9 -30.62 70.0 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.086 -1.415 . . . . 0.0 109.666 176.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -62.1 -42.81 99.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.653 174.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.969 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 41.9 t -94.86 8.59 42.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.052 178.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 12.7 t70 . . . . . 0 C--N 1.323 -0.587 0 CA-C-O 121.279 0.561 . . . . 0.0 110.024 173.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 1' ' ' PRO . . . . . 0.43 ' HB2' ' H ' ' B' ' 2' ' ' SER . 72.4 Cg_endo . . . . . 0 CA--C 1.515 -0.449 0 N-CA-C 108.791 -1.273 . . . . 0.0 108.791 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 2' ' ' SER . . . . . 0.43 ' H ' ' HB2' ' B' ' 1' ' ' PRO . 14.4 m -67.04 171.58 5.39 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 162.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.783 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -70.03 -52.08 26.97 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 167.184 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.521 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.6 p-10 -82.05 5.25 20.01 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 113.95 -1.477 . . . . 0.0 113.478 -166.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.411 HG23 ' HB2' ' B' ' 2' ' ' SER . 0.4 OUTLIER -66.26 -2.87 4.81 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 121.671 -0.643 . . . . 0.0 111.939 -175.16 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.596 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.1 m -78.57 133.18 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 174.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.773 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.1 OUTLIER -155.17 160.26 40.77 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -178.825 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 8' ' ' GLN . . . . . 0.426 ' N ' ' CD2' ' B' ' 17' ' ' PHE . 2.0 tt0 -44.58 108.87 0.13 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 112.922 -1.944 . . . . 0.0 112.313 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.27 -152.07 14.38 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.406 174.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 9.9 t -52.44 98.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.753 0.311 . . . . 0.0 110.803 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 23.8 pttm 40.8 41.55 1.22 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.549 1.14 . . . . 0.0 112.635 -175.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -59.73 141.17 89.17 Favored Pre-proline 0 C--O 1.236 0.388 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.217 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 13' ' ' PRO . . . . . 0.516 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 27.6 Cg_exo -56.24 123.04 12.87 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.031 1.82 . . . . 0.0 109.644 177.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 14' ' ' TYR . . . . . 0.877 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 20.3 t80 -72.36 -53.37 6.19 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -166.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.527 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 35.1 Cg_exo -55.45 -19.34 22.31 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 121.305 1.337 . . . . 0.0 110.696 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.516 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 3.5 m-20 -90.1 -41.15 11.83 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.722 -1.581 . . . . 0.0 110.92 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 17' ' ' PHE . . . . . 0.516 ' CD2' ' HA ' ' B' ' 7' ' ' ARG . 0.0 OUTLIER -54.79 -46.71 74.5 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.569 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.699 HG12 ' O ' ' B' ' 14' ' ' TYR . 2.4 p -79.16 -32.09 14.94 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.21 -177.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.06 -36.12 72.34 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 121.634 -0.666 . . . . 0.0 111.765 175.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.697 ' O ' HG12 ' B' ' 24' ' ' VAL . 14.1 ptt180 -83.22 -23.99 32.56 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 177.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.556 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 6.5 tp -60.1 -45.64 92.26 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.802 172.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 22' ' ' GLN . . . . . 0.721 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 7.5 mt-30 -73.21 -44.19 60.09 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.832 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.74 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 25.9 t70 -49.43 -53.83 20.72 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.557 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 24' ' ' VAL . . . . . 0.697 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.7 p -80.96 -23.07 10.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.137 0.494 . . . . 0.0 109.878 -174.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.778 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -71.77 -20.5 61.86 Favored 'General case' 0 C--O 1.203 -1.37 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 174.174 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 26' ' ' GLN . . . . . 0.451 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -86.56 -37.29 18.29 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.704 178.597 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.74 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.4 mmtt -65.51 -35.58 81.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.488 178.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 19.6 m -104.34 -9.44 18.51 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.666 -171.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.778 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 91.6 mt -119.76 128.0 75.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.993 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.06 -1.43 56.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.285 0.564 . . . . 0.0 110.286 177.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.675 ' H ' HG22 ' B' ' 29' ' ' ILE . 13.8 t70 -107.62 116.84 32.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.352 -177.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.549 ' OE2' ' HG3' ' B' ' 33' ' ' LYS . 0.0 OUTLIER -57.34 -33.87 68.2 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.356 178.267 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.616 ' O ' HG13 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -70.82 -54.57 11.09 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -172.707 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.545 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -60.16 -28.89 68.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.784 176.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.854 ' O ' HG13 ' B' ' 39' ' ' VAL . 6.0 tmm_? -67.38 -58.28 5.07 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.438 ' O ' HG22 ' B' ' 39' ' ' VAL . 16.1 mtpt -56.84 -56.52 20.52 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.097 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.689 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 20.2 m -53.83 -34.92 26.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.386 -171.12 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.783 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.3 tt -86.64 -28.18 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 C-N-CA 119.649 -0.82 . . . . 0.0 111.668 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.854 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.5 m -70.91 -49.85 47.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 119.152 -1.019 . . . . 0.0 109.58 173.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.782 ' OE1' HG13 ' B' ' 68' ' ' VAL . 0.9 OUTLIER -62.12 -24.87 67.4 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.398 0.679 . . . . 0.0 111.561 176.69 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.689 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -86.22 -55.22 4.02 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 176.293 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 42' ' ' MET . . . . . 0.521 ' HG3' ' HB2' ' B' ' 4' ' ' ASN . 16.4 mmt -64.08 -20.17 65.76 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 121.537 0.684 . . . . 0.0 109.974 -176.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.68 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -48.78 -27.76 3.19 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.194 169.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 44' ' ' TYR . . . . . 0.561 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 16.5 t80 -106.06 -66.41 1.0 Allowed 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 174.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.46 ' CG ' HD12 ' B' ' 41' ' ' LEU . 16.4 mm-40 -50.05 -27.22 5.25 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.627 -172.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.773 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.7 m-20 -109.28 -20.22 13.02 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.602 -176.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -59.06 -177.35 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -174.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 48' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -63.26 140.93 97.77 Favored Pre-proline 0 N--CA 1.446 -0.647 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.531 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -43.76 -48.04 9.26 Favored 'Trans proline' 0 C--N 1.334 -0.235 0 C-N-CA 122.773 2.315 . . . . 0.0 112.386 -178.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 50' ' ' GLU . . . . . 0.604 ' HG3' ' O ' ' B' ' 50' ' ' GLU . 0.0 OUTLIER -76.03 -23.83 55.17 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 123.43 0.692 . . . . 0.0 110.707 -179.467 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.97 ' SG ' ' HB2' ' B' ' 76' ' ' CYS . 52.8 t -84.18 -39.99 18.69 Favored 'General case' 0 N--CA 1.418 -2.038 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.94 -173.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 52' ' ' GLN . . . . . 0.574 ' HA ' HD12 ' B' ' 55' ' ' ILE . 29.8 pt20 -66.5 -31.08 71.59 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 172.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 53' ' ' SER . . . . . 0.745 ' O ' ' HD2' ' B' ' 56' ' ' LYS . 5.7 m -65.93 -30.14 70.67 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 113.783 -1.553 . . . . 0.0 110.809 173.012 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.09 -23.89 61.41 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 122.026 0.917 . . . . 0.0 109.374 172.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.574 HD12 ' HA ' ' B' ' 52' ' ' GLN . 25.0 mt -90.89 -31.53 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -173.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.745 ' HD2' ' O ' ' B' ' 53' ' ' SER . 0.0 OUTLIER -43.79 -38.12 3.96 Favored Pre-proline 0 N--CA 1.488 1.45 0 CA-C-N 119.801 1.182 . . . . 0.0 113.653 -173.543 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 54.3 Cg_endo -63.48 -28.84 70.85 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.391 2.061 . . . . 0.0 112.942 175.086 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 58' ' ' LEU . . . . . 0.572 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.5 mt -97.84 -16.55 19.75 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 59' ' ' LYS . . . . . 0.723 ' HZ2' ' HG ' ' A' ' 2' ' ' SER . 0.0 OUTLIER -52.82 109.73 0.44 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.421 -178.501 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 60' ' ' GLY . . . . . 0.413 ' HA3' ' C ' ' A' ' 1' ' ' PRO . . . 95.04 -22.02 40.73 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.255 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 11.5 mmmt -103.55 114.3 28.46 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -177.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.519 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.6 p -122.15 136.85 26.74 Favored Pre-proline 0 C--N 1.309 -1.184 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 171.112 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo . . . . . 0 N--CA 1.462 -0.347 0 C-N-CA 122.52 2.147 . . . . 0.0 111.841 172.84 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 67' ' ' ASP . . . . . 0.442 ' OD2' ' HB ' ' B' ' 69' ' ' ILE . 3.1 t70 . . . . . 0 CA--C 1.52 -0.206 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.782 HG13 ' OE1' ' B' ' 40' ' ' GLU . 0.8 OUTLIER -71.66 -33.4 48.77 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 C-N-CA 118.085 -1.446 . . . . 0.0 108.856 -179.214 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.778 ' O ' HG13 ' B' ' 73' ' ' VAL . 7.6 mm -57.45 -47.51 84.76 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.118 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.801 -178.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.571 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 40.3 t -48.34 -36.2 13.92 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.301 0.572 . . . . 0.0 111.182 178.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -86.51 -31.28 21.38 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.592 -176.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 72' ' ' TYR . . . . . 0.572 ' CE1' ' HB2' ' B' ' 58' ' ' LEU . 5.0 m-30 -76.39 -35.82 58.42 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.443 -178.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.877 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.7 m -69.94 -33.13 54.21 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 173.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 74' ' ' LYS . . . . . 0.571 ' HB2' ' O ' ' B' ' 70' ' ' SER . 1.6 ttmm -68.04 -30.56 69.81 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.698 176.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 75' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -61.93 -42.89 99.62 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.624 174.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.97 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 43.2 t -94.99 8.66 42.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.12 177.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 77' ' ' ASP . . . . . 0.467 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 12.0 t70 . . . . . 0 C--N 1.321 -0.654 0 CA-C-O 121.354 0.597 . . . . 0.0 109.971 173.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo . . . . . 0 CA--C 1.52 -0.209 0 N-CA-C 109.064 -1.168 . . . . 0.0 109.064 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.488 ' HB3' HD21 ' B' ' 41' ' ' LEU . 66.6 m -68.62 -176.85 0.85 Allowed 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 162.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.862 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -77.27 -55.47 5.38 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.107 172.675 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.812 HD21 HD11 ' B' ' 41' ' ' LEU . 1.1 p30 -76.22 -8.3 56.76 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.599 -1.182 . . . . 0.0 112.467 -167.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.532 ' CG2' ' HD3' ' B' ' 59' ' ' LYS . 0.3 OUTLIER -57.95 0.61 0.06 Allowed 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -172.197 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.58 ' HB ' ' CZ ' ' A' ' 20' ' ' ARG . 4.0 m -72.96 117.65 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 167.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.715 ' HG3' ' CB ' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -115.91 158.25 23.29 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 121.505 -0.747 . . . . 0.0 110.216 176.765 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.502 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 1.9 tt0 -56.16 113.08 1.4 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.444 173.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.35 -159.99 11.73 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 173.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.7 p -52.16 100.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.942 0.371 . . . . 0.0 111.141 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 11' ' ' LYS . 18.2 pttp 43.01 42.58 3.23 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.305 1.042 . . . . 0.0 112.041 -175.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.486 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 42.7 tt0 -60.26 137.0 91.63 Favored Pre-proline 0 C--O 1.232 0.182 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 177.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.531 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 28.1 Cg_exo -54.06 123.62 13.95 Favored 'Trans proline' 0 CA--C 1.511 -0.672 0 C-N-CA 122.075 1.85 . . . . 0.0 109.936 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.862 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 14.5 t80 -70.19 -53.43 10.79 Favored Pre-proline 0 N--CA 1.44 -0.954 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -166.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.501 ' HD3' ' HB3' ' A' ' 14' ' ' TYR . 31.8 Cg_exo -55.69 -18.51 21.06 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 121.414 1.409 . . . . 0.0 110.979 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.531 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 4.1 m-20 -89.96 -41.69 11.6 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.198 -1.365 . . . . 0.0 111.169 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.502 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -56.96 -41.54 78.51 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.533 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.703 HG12 ' O ' ' A' ' 14' ' ' TYR . 2.4 p -82.57 -33.6 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.519 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.88 -34.05 69.36 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 121.495 -0.753 . . . . 0.0 111.946 176.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.748 ' O ' HG12 ' A' ' 24' ' ' VAL . 17.5 ptt180 -84.79 -27.72 26.66 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.08 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.604 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 9.3 tp -54.96 -46.19 75.0 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.759 171.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.747 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 7.3 mt-30 -73.21 -45.72 54.53 Favored 'General case' 0 CA--C 1.497 -1.073 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.168 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.71 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 11.4 t70 -51.79 -52.42 49.09 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 124.05 0.844 . . . . 0.0 111.812 -177.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.748 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.3 p -82.06 -23.25 9.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -173.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.793 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -72.06 -18.86 61.9 Favored 'General case' 0 C--O 1.203 -1.357 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 173.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.422 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -86.55 -37.75 17.86 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.634 -1.167 . . . . 0.0 109.812 177.842 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.71 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 41.0 mmtt -67.62 -37.84 83.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.013 178.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.8 t -102.67 -7.7 21.52 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.227 0.537 . . . . 0.0 110.044 -171.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.793 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 86.8 mt -116.7 127.49 74.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.435 178.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.55 -9.54 54.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.263 0.554 . . . . 0.0 110.148 177.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.583 ' H ' HG22 ' A' ' 29' ' ' ILE . 13.8 t70 -98.75 136.04 39.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.233 -177.015 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -75.42 -29.55 59.78 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.761 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.592 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -77.44 -51.41 10.82 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -174.932 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.574 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -58.57 -27.88 65.01 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.436 175.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.884 ' O ' HG13 ' A' ' 39' ' ' VAL . 1.7 tmm_? -66.31 -60.74 2.49 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.5 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 26.0 mtpt -55.12 -56.1 23.61 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.373 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.719 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 19.7 m -54.8 -32.6 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.16 -170.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.862 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.2 tt -86.82 -34.0 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.416 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.884 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.0 m -66.14 -47.66 83.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 119.214 -0.995 . . . . 0.0 109.466 176.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.672 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 54.4 mt-10 -67.25 -23.75 65.74 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 123.875 0.87 . . . . 0.0 112.64 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.838 HD11 HD21 ' B' ' 4' ' ' ASN . 0.0 OUTLIER -86.22 -55.71 3.79 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.375 176.854 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.668 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 14.6 mmt -62.27 -20.67 64.52 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-O 121.76 0.791 . . . . 0.0 109.509 -176.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.754 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -48.61 -27.02 2.53 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.766 170.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.499 ' HB3' ' NZ ' ' A' ' 59' ' ' LYS . 9.2 t80 -105.4 -66.39 0.98 Allowed 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.485 ' HG2' HD12 ' A' ' 41' ' ' LEU . 14.0 mm-40 -48.25 -33.41 8.64 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 123.646 0.592 . . . . 0.0 112.44 -176.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.715 ' CB ' ' HG3' ' A' ' 7' ' ' ARG . 0.9 OUTLIER -99.84 -15.34 18.43 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.349 0.595 . . . . 0.0 111.643 -177.66 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.754 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -63.04 168.48 4.04 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.426 0.632 . . . . 0.0 111.501 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.554 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 11.1 m-20 -58.31 145.46 74.73 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.338 173.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -41.65 -49.1 5.45 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.688 2.258 . . . . 0.0 111.894 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.552 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 0.3 OUTLIER -71.23 -33.56 69.97 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.238 1.015 . . . . 0.0 111.854 177.79 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.554 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 69.8 m -73.94 -39.22 63.93 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 121.118 0.485 . . . . 0.0 110.014 -174.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.522 ' HA ' HD12 ' A' ' 55' ' ' ILE . 4.0 pt20 -73.39 -30.75 63.48 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 175.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.553 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 4.0 m -67.72 -21.02 65.32 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.306 172.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 51' ' ' CYS . . . -77.1 -27.77 54.26 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.382 -0.824 . . . . 0.0 109.865 169.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.581 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 20.8 mt -89.74 -31.72 5.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -171.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.606 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -40.68 -37.76 1.05 Allowed Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -173.883 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 55.2 Cg_endo -64.26 -28.89 64.0 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.358 2.039 . . . . 0.0 113.104 175.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.564 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 2.0 mt -98.63 -15.79 19.31 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.665 ' NZ ' HD13 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -52.56 109.35 0.39 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.348 -1.296 . . . . 0.0 110.422 179.6 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.88 -30.09 10.44 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.939 -175.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 35.0 mmtt -103.83 115.17 29.98 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-O 122.423 1.106 . . . . 0.0 111.612 -175.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.587 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.5 p -122.46 145.04 43.61 Favored Pre-proline 0 C--N 1.296 -1.754 0 CA-C-N 113.555 -1.657 . . . . 0.0 109.52 170.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo . . . . . 0 C--O 1.233 0.265 0 C-N-CA 122.282 1.988 . . . . 0.0 111.198 167.811 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.436 -1.153 0 N-CA-C 110.89 -0.041 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.587 HG12 ' HB ' ' A' ' 62' ' ' VAL . 0.9 OUTLIER -79.08 -31.27 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 C-N-CA 118.523 -1.271 . . . . 0.0 108.463 176.248 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.773 ' O ' HG13 ' A' ' 73' ' ' VAL . 6.9 mm -57.77 -49.16 81.77 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.147 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.564 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.6 t -49.07 -36.18 17.75 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.077 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.589 ' O ' ' HE3' ' A' ' 74' ' ' LYS . 1.3 mm-40 -84.88 -33.83 22.72 Favored 'General case' 0 C--O 1.216 -0.666 0 C-N-CA 123.349 0.66 . . . . 0.0 110.458 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.568 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 4.9 m-30 -74.5 -37.91 63.01 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.691 -176.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.862 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.7 m -70.64 -32.65 50.17 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 175.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.589 ' HE3' ' O ' ' A' ' 71' ' ' GLU . 2.4 ttpp -72.39 -27.68 62.52 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.816 177.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.491 ' HB2' HD11 ' A' ' 58' ' ' LEU . . . -66.21 -41.72 89.73 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.313 174.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 4.2 m -101.07 10.5 40.93 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.533 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 t70 . . . . . 0 C--N 1.325 -0.487 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.132 178.548 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 1' ' ' PRO . . . . . 0.422 ' HB2' ' H ' ' B' ' 2' ' ' SER . 96.2 Cg_endo . . . . . 0 CA--C 1.518 -0.319 0 N-CA-C 109.113 -1.149 . . . . 0.0 109.113 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 2' ' ' SER . . . . . 0.468 ' HB3' HD21 ' A' ' 41' ' ' LEU . 71.2 m -68.78 -176.55 0.84 Allowed 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 162.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.859 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -77.24 -55.57 5.31 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.509 -0.877 . . . . 0.0 110.173 172.362 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.838 HD21 HD11 ' A' ' 41' ' ' LEU . 1.1 p30 -76.21 -8.32 56.78 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.557 -1.201 . . . . 0.0 112.413 -167.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.579 ' CG2' ' HD3' ' A' ' 59' ' ' LYS . 0.2 OUTLIER -57.85 0.5 0.06 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -172.182 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.578 ' HB ' ' CZ ' ' B' ' 20' ' ' ARG . 4.0 m -72.88 117.92 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 167.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.705 ' HG3' ' CB ' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -115.86 158.42 22.98 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 121.568 -0.708 . . . . 0.0 110.189 176.621 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 8' ' ' GLN . . . . . 0.509 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 1.9 tt0 -56.44 112.9 1.38 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.372 173.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.2 -159.75 10.94 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 173.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 12.3 p -52.32 100.88 0.03 OUTLIER 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.932 0.366 . . . . 0.0 111.152 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 18.3 pttp 42.89 42.17 2.92 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.383 1.073 . . . . 0.0 112.255 -175.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.49 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 43.1 tt0 -59.84 136.87 90.32 Favored Pre-proline 0 C--O 1.232 0.17 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 13' ' ' PRO . . . . . 0.543 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 27.6 Cg_exo -54.05 123.6 13.89 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.129 1.886 . . . . 0.0 109.907 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 14' ' ' TYR . . . . . 0.864 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 14.8 t80 -70.07 -53.61 10.85 Favored Pre-proline 0 N--CA 1.44 -0.96 0 CA-C-O 118.335 -0.841 . . . . 0.0 113.23 -166.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.512 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 32.0 Cg_exo -55.6 -18.56 20.71 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 121.55 1.5 . . . . 0.0 110.999 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.543 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 4.4 m-20 -89.92 -41.85 11.54 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.068 -1.424 . . . . 0.0 111.071 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 17' ' ' PHE . . . . . 0.509 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -56.9 -41.54 78.27 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.614 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.699 HG12 ' O ' ' B' ' 14' ' ' TYR . 2.4 p -82.52 -33.61 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.521 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.28 -33.33 69.31 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.457 -0.777 . . . . 0.0 112.012 176.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.753 ' O ' HG12 ' B' ' 24' ' ' VAL . 17.5 ptt180 -85.11 -27.85 25.98 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.609 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 9.3 tp -54.84 -46.2 74.6 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.814 171.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 22' ' ' GLN . . . . . 0.751 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 7.3 mt-30 -73.19 -45.88 53.78 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.157 178.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.714 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 11.3 t70 -51.89 -52.24 51.14 Favored 'General case' 0 C--N 1.314 -0.96 0 O-C-N 124.067 0.854 . . . . 0.0 111.841 -177.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 24' ' ' VAL . . . . . 0.753 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.4 p -82.02 -23.27 9.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.302 0.572 . . . . 0.0 109.56 -174.109 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.801 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -72.06 -18.87 61.91 Favored 'General case' 0 C--O 1.204 -1.307 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 26' ' ' GLN . . . . . 0.426 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -86.7 -37.54 17.86 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.814 177.799 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.714 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 40.9 mmtt -67.96 -37.23 81.32 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.999 178.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 33.4 t -103.08 -7.49 21.31 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.403 0.621 . . . . 0.0 110.189 -171.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.801 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 86.6 mt -116.98 127.18 74.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.428 178.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.44 -9.47 54.55 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.276 0.56 . . . . 0.0 110.199 177.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.58 ' H ' HG22 ' B' ' 29' ' ' ILE . 13.7 t70 -98.68 136.13 39.19 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.258 -177.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -75.55 -29.56 59.42 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.67 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.592 ' O ' HG13 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -77.36 -51.49 10.74 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -174.944 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.55 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -58.61 -27.86 65.08 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.378 176.089 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.867 ' O ' HG13 ' B' ' 39' ' ' VAL . 1.7 tmm_? -66.34 -60.86 2.38 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 178.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.488 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 25.9 mtpt -55.03 -56.1 23.58 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.382 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.713 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 19.6 m -54.8 -32.37 25.96 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.258 -170.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.859 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.2 tt -86.97 -34.07 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.525 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.867 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.0 m -65.97 -47.69 84.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.438 176.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.671 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 54.6 mt-10 -67.48 -23.43 65.49 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.711 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.812 HD11 HD21 ' A' ' 4' ' ' ASN . 0.0 OUTLIER -86.33 -55.94 3.67 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.258 176.648 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 42' ' ' MET . . . . . 0.675 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 14.7 mmt -62.2 -20.66 64.41 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-O 121.768 0.794 . . . . 0.0 109.578 -176.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.745 ' O ' ' HB2' ' B' ' 47' ' ' ALA . . . -48.59 -27.1 2.56 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.779 170.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 44' ' ' TYR . . . . . 0.503 ' CG ' ' HB2' ' B' ' 52' ' ' GLN . 9.1 t80 -105.36 -66.7 0.96 Allowed 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.491 ' HG2' HD12 ' B' ' 41' ' ' LEU . 13.1 mm-40 -47.97 -33.65 8.09 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 123.636 0.585 . . . . 0.0 112.405 -176.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.705 ' CB ' ' HG3' ' B' ' 7' ' ' ARG . 0.9 OUTLIER -99.55 -15.3 18.68 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.297 0.57 . . . . 0.0 111.724 -177.753 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.745 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -63.11 168.53 4.08 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.39 0.614 . . . . 0.0 111.483 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 48' ' ' ASN . . . . . 0.558 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 11.2 m-20 -58.09 145.41 73.22 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.387 173.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -41.58 -49.49 5.18 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 122.741 2.294 . . . . 0.0 111.875 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 50' ' ' GLU . . . . . 0.544 ' HA ' ' HB2' ' B' ' 53' ' ' SER . 0.3 OUTLIER -70.78 -33.69 71.01 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.372 1.069 . . . . 0.0 111.801 177.737 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.558 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 70.2 m -73.9 -39.16 64.06 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.29 0.566 . . . . 0.0 110.151 -174.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 52' ' ' GLN . . . . . 0.541 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.9 pt20 -73.42 -30.65 63.37 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 175.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 53' ' ' SER . . . . . 0.554 ' O ' ' HE2' ' B' ' 56' ' ' LYS . 3.7 m -68.03 -20.87 65.03 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.26 172.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' B' ' 51' ' ' CYS . . . -76.97 -27.86 54.92 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.359 -0.838 . . . . 0.0 109.877 168.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.577 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 20.9 mt -89.66 -31.78 5.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -171.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.603 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -40.62 -37.92 1.08 Allowed Pre-proline 0 N--CA 1.49 1.525 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -173.82 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 53.9 Cg_endo -64.17 -28.97 64.83 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.178 1.919 . . . . 0.0 113.022 175.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 58' ' ' LEU . . . . . 0.56 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 2.0 mt -98.54 -15.65 19.45 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 59' ' ' LYS . . . . . 0.668 ' NZ ' HD13 ' B' ' 41' ' ' LEU . 0.3 OUTLIER -52.77 109.31 0.39 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.385 179.459 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.86 -30.24 10.15 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.944 -175.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 34.9 mmtt -103.68 115.31 30.26 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 122.244 1.021 . . . . 0.0 111.688 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.595 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.6 p -122.53 145.22 44.25 Favored Pre-proline 0 C--N 1.297 -1.681 0 CA-C-N 113.64 -1.618 . . . . 0.0 109.559 170.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 63' ' ' PRO . . . . . 0.41 ' HD2' HG23 ' B' ' 62' ' ' VAL . 98.6 Cg_exo . . . . . 0 C--N 1.345 0.369 0 C-N-CA 122.182 1.921 . . . . 0.0 111.21 168.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.436 -1.157 0 CA-C-O 120.222 0.058 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.595 HG12 ' HB ' ' B' ' 62' ' ' VAL . 0.9 OUTLIER -79.24 -31.36 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 C-N-CA 118.567 -1.253 . . . . 0.0 108.547 176.175 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.772 ' O ' HG13 ' B' ' 73' ' ' VAL . 7.0 mm -57.73 -49.28 81.32 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.139 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.522 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 42.8 t -48.81 -36.4 16.63 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.011 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.584 ' O ' ' HE3' ' B' ' 74' ' ' LYS . 1.4 mm-40 -84.81 -33.76 22.87 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 123.442 0.697 . . . . 0.0 110.591 -178.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 72' ' ' TYR . . . . . 0.56 ' CE1' ' HB2' ' B' ' 58' ' ' LEU . 5.0 m-30 -74.79 -37.8 62.29 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.671 -176.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.864 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.7 m -70.47 -32.76 51.07 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.676 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 174.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 74' ' ' LYS . . . . . 0.584 ' HE3' ' O ' ' B' ' 71' ' ' GLU . 2.4 ttpp -72.58 -27.3 62.1 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.866 178.022 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 75' ' ' ALA . . . . . 0.486 ' HB2' HD11 ' B' ' 58' ' ' LEU . . . -66.39 -41.82 88.81 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.3 174.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 4.2 m -101.12 10.52 40.83 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.496 -177.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 6.5 t70 . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.059 178.486 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo . . . . . 0 CA--C 1.518 -0.303 0 N-CA-C 109.1 -1.154 . . . . 0.0 109.1 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.735 ' HB2' HG23 ' A' ' 5' ' ' THR . 73.6 m -68.83 -177.23 0.96 Allowed 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 162.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.769 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -78.14 -53.92 6.83 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.649 172.549 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.574 ' OD1' ' HG ' ' B' ' 41' ' ' LEU . 2.2 p-10 -87.58 5.7 38.09 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.133 -0.939 . . . . 0.0 112.994 -164.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.735 HG23 ' HB2' ' A' ' 2' ' ' SER . 2.2 p -64.8 -3.83 3.73 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.069 0.462 . . . . 0.0 111.391 -176.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.52 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.6 m -75.38 131.9 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 175.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.768 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -153.18 158.91 42.47 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.443 ' HG2' ' HB3' ' A' ' 12' ' ' GLU . 2.3 tt0 -42.24 115.16 0.65 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 112.758 -2.019 . . . . 0.0 112.831 -178.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.16 -148.54 11.85 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.44 172.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.8 m -55.89 97.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.106 0.453 . . . . 0.0 110.937 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.0 pttt 40.61 40.28 0.89 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.332 1.053 . . . . 0.0 112.085 -174.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.443 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 42.3 tt0 -55.96 139.57 70.64 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.932 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.583 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 52.1 Cg_exo -51.29 122.67 10.51 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.158 1.905 . . . . 0.0 110.058 178.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.801 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 9.3 t80 -72.22 -52.88 6.8 Favored Pre-proline 0 N--CA 1.442 -0.842 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -166.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.544 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 36.7 Cg_exo -56.2 -20.01 29.73 Favored 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 121.665 1.577 . . . . 0.0 110.968 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.583 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.1 m-20 -89.76 -40.21 12.64 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 113.845 -1.525 . . . . 0.0 110.754 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.436 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -56.01 -43.79 78.04 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 175.512 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.678 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 2.4 p -80.58 -33.24 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.379 -179.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.72 -34.88 67.92 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 121.594 -0.691 . . . . 0.0 111.937 175.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.727 ' O ' HG12 ' A' ' 24' ' ' VAL . 16.7 ptt180 -84.93 -26.87 26.95 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.649 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 4.5 tp -54.35 -49.2 70.34 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 171.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.678 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 5.5 mt-30 -67.21 -52.29 43.01 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.338 177.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.779 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 23.8 t70 -47.53 -53.53 14.17 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 -175.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.727 HG12 ' O ' ' A' ' 20' ' ' ARG . 5.0 p -81.59 -28.3 10.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.452 0.644 . . . . 0.0 110.381 -168.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.918 ' HB3' ' CZ ' ' A' ' 35' ' ' ARG . . . -78.91 -17.69 55.11 Favored 'General case' 0 C--O 1.198 -1.623 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 175.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.555 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -76.21 -37.74 57.37 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 172.803 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.779 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 39.7 mmtt -64.23 -36.16 83.17 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.508 177.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.0 t -104.26 -12.93 16.37 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.086 0.469 . . . . 0.0 110.27 -172.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.633 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 91.7 mt -111.8 117.11 54.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.296 177.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.49 -1.78 56.27 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.225 0.536 . . . . 0.0 110.076 175.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.596 ' H ' HG22 ' A' ' 29' ' ' ILE . 10.8 t70 -99.52 131.67 45.37 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.29 -177.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -75.23 -25.48 58.14 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.841 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.597 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -81.08 -52.8 7.0 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -175.18 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.537 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -59.79 -24.68 64.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.54 177.104 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.918 ' CZ ' ' HB3' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -72.73 -57.41 4.12 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.998 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.513 ' O ' HG22 ' A' ' 39' ' ' VAL . 22.4 mtpt -52.85 -55.6 21.9 Favored 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.706 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.708 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 13.9 m -55.82 -33.08 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.195 -171.577 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.892 HG22 HH12 ' A' ' 35' ' ' ARG . 0.2 OUTLIER -87.35 -31.4 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 119.642 -0.823 . . . . 0.0 111.687 177.761 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.765 HG12 ' NH2' ' A' ' 35' ' ' ARG . 1.3 m -57.41 -57.05 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 118.666 -1.213 . . . . 0.0 109.168 168.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.61 ' HG2' HG22 ' A' ' 68' ' ' VAL . 46.2 mt-10 -63.19 -29.74 71.03 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 124.252 1.021 . . . . 0.0 112.611 -175.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.708 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -85.43 -49.98 7.67 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.937 179.602 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.598 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 19.7 mmt -67.5 -20.5 65.45 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.56 0.695 . . . . 0.0 109.517 -177.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.651 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -52.36 -26.74 13.18 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.655 172.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.596 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 17.2 t80 -105.98 -68.12 0.89 Allowed 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 174.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.477 ' CG ' HD12 ' A' ' 41' ' ' LEU . 8.8 mm-40 -48.47 -26.6 2.22 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 124.323 1.014 . . . . 0.0 113.024 -175.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.768 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.1 m-20 -108.15 -21.92 12.59 Favored 'General case' 0 N--CA 1.435 -1.212 0 O-C-N 122.083 -0.386 . . . . 0.0 111.567 -178.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.632 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -59.49 178.95 0.13 Allowed 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.932 0.872 . . . . 0.0 112.925 -174.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.594 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 8.7 m-20 -60.2 140.45 91.17 Favored Pre-proline 0 N--CA 1.442 -0.83 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.452 174.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.424 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 79.5 Cg_exo -42.6 -47.73 7.51 Favored 'Trans proline' 0 C--N 1.33 -0.447 0 C-N-CA 122.877 2.385 . . . . 0.0 112.091 -178.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.56 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 0.3 OUTLIER -72.85 -33.4 66.11 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.119 0.967 . . . . 0.0 111.627 178.368 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.594 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 99.1 m -74.85 -37.28 62.26 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -173.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.615 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.8 pt20 -72.54 -31.4 65.27 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 174.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.56 ' HB2' ' HA ' ' A' ' 50' ' ' GLU . 12.0 m -68.49 -21.76 64.59 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.178 -1.373 . . . . 0.0 110.409 174.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.22 -25.18 46.86 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.756 0.789 . . . . 0.0 109.617 169.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.615 HD12 ' HA ' ' A' ' 52' ' ' GLN . 25.4 mt -89.56 -32.02 5.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -173.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.626 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -42.4 -38.94 2.81 Favored Pre-proline 0 N--CA 1.487 1.423 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -173.492 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 56.0 Cg_endo -63.57 -28.96 70.1 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 122.346 2.031 . . . . 0.0 112.958 175.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.547 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.6 mt -96.92 -16.53 20.63 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.596 ' HE3' ' HB3' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -53.36 109.41 0.43 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.189 -178.768 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.79 -20.38 47.47 Favored Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.525 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -104.11 114.19 28.26 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.477 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.3 p -123.02 140.28 33.18 Favored Pre-proline 0 C--N 1.311 -1.096 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 171.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo . . . . . 0 N--CA 1.462 -0.336 0 C-N-CA 122.429 2.086 . . . . 0.0 111.513 170.894 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.732 ' OD1' ' HB ' ' A' ' 69' ' ' ILE . 32.8 t70 . . . . . 0 CA--C 1.516 -0.358 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.61 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -79.48 -30.58 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 C-N-CA 118.049 -1.46 . . . . 0.0 108.832 178.448 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.763 ' O ' HG13 ' A' ' 73' ' ' VAL . 6.2 mm -59.09 -47.9 88.52 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.978 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.789 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 43.2 t -44.83 -39.37 5.27 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.253 175.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -86.54 -28.8 23.14 Favored 'General case' 0 CA--C 1.512 -0.505 0 C-N-CA 122.771 0.428 . . . . 0.0 111.086 -177.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.601 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.3 m-30 -76.55 -35.6 58.15 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.716 0.77 . . . . 0.0 109.462 -178.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.801 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.5 m -71.39 -30.29 38.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 172.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.465 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -68.05 -32.43 72.77 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.292 175.143 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -63.03 -43.65 98.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.916 177.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.421 ' SG ' ' HB2' ' A' ' 14' ' ' TYR . 23.7 t -94.96 4.47 53.77 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.033 178.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.465 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 10.9 t70 . . . . . 0 C--N 1.324 -0.506 0 CA-C-O 121.233 0.54 . . . . 0.0 110.271 176.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 1' ' ' PRO . . . . . 0.437 ' HB2' ' H ' ' B' ' 2' ' ' SER . 94.2 Cg_endo . . . . . 0 CA--C 1.519 -0.271 0 N-CA-C 109.115 -1.148 . . . . 0.0 109.115 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 2' ' ' SER . . . . . 0.761 ' HB2' HG23 ' B' ' 5' ' ' THR . 74.3 m -68.69 -177.77 1.04 Allowed 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 162.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.782 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -77.85 -53.82 7.05 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.64 172.827 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.55 ' OD1' ' HG ' ' A' ' 41' ' ' LEU . 2.1 p-10 -87.61 5.71 38.11 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.973 -164.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.761 HG23 ' HB2' ' B' ' 2' ' ' SER . 2.2 p -64.85 -3.75 3.71 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.038 0.447 . . . . 0.0 111.418 -176.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.529 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.6 m -75.5 132.15 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 175.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.775 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -153.32 158.76 42.05 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -179.724 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 8' ' ' GLN . . . . . 0.451 ' HG2' ' HB3' ' B' ' 12' ' ' GLU . 2.3 tt0 -42.32 115.14 0.65 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 112.95 -1.932 . . . . 0.0 112.845 -178.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.4 -148.58 12.29 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.424 173.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 21.6 m -55.45 97.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 117.187 0.493 . . . . 0.0 111.096 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 60.9 pttt 40.5 40.73 0.93 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.275 1.03 . . . . 0.0 111.974 -174.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.451 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 41.1 tt0 -56.4 139.53 74.02 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.891 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 13' ' ' PRO . . . . . 0.574 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 52.0 Cg_exo -51.19 122.45 10.07 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.25 1.967 . . . . 0.0 110.019 178.249 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 14' ' ' TYR . . . . . 0.803 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 9.3 t80 -72.19 -52.91 6.84 Favored Pre-proline 0 N--CA 1.44 -0.935 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -166.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.533 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 36.6 Cg_exo -55.94 -20.11 28.4 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 121.589 1.526 . . . . 0.0 110.979 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.574 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 0.9 OUTLIER -89.77 -39.96 12.79 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.869 -1.514 . . . . 0.0 110.826 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 17' ' ' PHE . . . . . 0.441 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -56.28 -43.66 79.04 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 175.575 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.672 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 2.4 p -80.61 -33.23 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.344 -178.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.78 -34.71 67.89 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 121.627 -0.671 . . . . 0.0 111.967 175.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.731 ' O ' HG12 ' B' ' 24' ' ' VAL . 16.6 ptt180 -85.04 -26.96 26.69 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.652 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 4.5 tp -54.33 -49.24 70.18 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 171.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 22' ' ' GLN . . . . . 0.672 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 5.6 mt-30 -67.16 -52.39 42.07 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.203 177.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.801 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 24.5 t70 -47.38 -53.67 13.24 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -175.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 24' ' ' VAL . . . . . 0.731 HG12 ' O ' ' B' ' 20' ' ' ARG . 4.9 p -81.55 -28.27 10.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.289 0.566 . . . . 0.0 110.405 -168.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.91 ' HB3' ' CZ ' ' B' ' 35' ' ' ARG . . . -78.86 -17.6 55.36 Favored 'General case' 0 C--O 1.198 -1.646 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 175.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 26' ' ' GLN . . . . . 0.548 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -76.6 -37.36 56.57 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 172.83 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.801 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 39.1 mmtt -64.79 -35.32 80.72 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.539 177.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 32.7 t -105.0 -12.38 16.2 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.026 0.441 . . . . 0.0 110.426 -172.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.647 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 91.6 mt -112.43 116.8 53.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.359 177.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.03 -1.49 54.89 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.227 0.537 . . . . 0.0 110.153 175.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.592 ' H ' HG22 ' B' ' 29' ' ' ILE . 10.5 t70 -99.61 131.59 45.51 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.164 -177.308 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -75.12 -25.78 58.72 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.858 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.596 ' O ' HG13 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -80.93 -53.02 6.82 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -174.981 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.553 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -59.6 -24.61 63.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.641 177.069 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.91 ' CZ ' ' HB3' ' B' ' 25' ' ' ALA . 0.0 OUTLIER -72.87 -57.29 4.18 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.964 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.517 ' O ' HG22 ' B' ' 39' ' ' VAL . 22.5 mtpt -52.91 -55.58 22.27 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.754 177.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.714 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 13.7 m -55.88 -32.91 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.402 -171.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.867 HG22 HH12 ' B' ' 35' ' ' ARG . 0.2 OUTLIER -87.35 -31.45 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.632 177.687 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.757 HG12 ' NH2' ' B' ' 35' ' ' ARG . 1.3 m -57.35 -57.02 11.8 Favored 'Isoleucine or valine' 0 C--N 1.343 0.308 0 C-N-CA 118.663 -1.215 . . . . 0.0 109.242 168.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.6 ' HG2' HG22 ' B' ' 68' ' ' VAL . 46.3 mt-10 -63.25 -29.74 71.02 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 124.282 1.033 . . . . 0.0 112.572 -175.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.714 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -85.42 -50.08 7.59 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.983 179.52 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 42' ' ' MET . . . . . 0.588 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 19.8 mmt -67.4 -20.29 65.51 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.618 0.723 . . . . 0.0 109.672 -177.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.643 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -52.54 -26.76 14.12 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.668 172.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 44' ' ' TYR . . . . . 0.599 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 16.9 t80 -105.93 -68.03 0.9 Allowed 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.041 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.467 ' CG ' HD12 ' B' ' 41' ' ' LEU . 9.5 mm-40 -48.57 -26.69 2.33 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 124.259 0.975 . . . . 0.0 112.979 -175.312 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.775 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.2 m-20 -108.18 -21.9 12.59 Favored 'General case' 0 N--CA 1.435 -1.205 0 O-C-N 122.191 -0.318 . . . . 0.0 111.514 -178.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -59.41 179.27 0.11 Allowed 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 122.018 0.913 . . . . 0.0 112.99 -174.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 48' ' ' ASN . . . . . 0.596 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 7.9 m-20 -60.43 140.42 91.98 Favored Pre-proline 0 N--CA 1.442 -0.846 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.436 174.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 49' ' ' PRO . . . . . 0.422 ' O ' ' HG2' ' B' ' 52' ' ' GLN . 78.3 Cg_exo -42.41 -47.62 7.25 Favored 'Trans proline' 0 C--N 1.33 -0.411 0 C-N-CA 122.832 2.355 . . . . 0.0 112.251 -178.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 50' ' ' GLU . . . . . 0.564 ' HA ' ' HB2' ' B' ' 53' ' ' SER . 0.3 OUTLIER -73.09 -33.51 65.64 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 124.226 1.01 . . . . 0.0 111.654 178.435 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 98.0 m -74.72 -37.18 62.62 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 120.911 0.386 . . . . 0.0 110.024 -173.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 52' ' ' GLN . . . . . 0.617 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.8 pt20 -72.52 -31.52 65.39 Favored 'General case' 0 C--O 1.211 -0.925 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 174.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 53' ' ' SER . . . . . 0.564 ' HB2' ' HA ' ' B' ' 50' ' ' GLU . 13.2 m -68.42 -21.91 64.64 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.389 174.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.17 -25.0 47.0 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.756 0.789 . . . . 0.0 109.668 169.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.617 HD12 ' HA ' ' B' ' 52' ' ' GLN . 25.2 mt -89.62 -31.88 5.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -173.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.629 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -42.51 -38.79 2.82 Favored Pre-proline 0 N--CA 1.488 1.425 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -173.477 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 56.0 Cg_endo -63.74 -29.1 68.66 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 122.261 1.974 . . . . 0.0 112.912 175.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 58' ' ' LEU . . . . . 0.565 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.6 mt -96.65 -16.41 20.99 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 59' ' ' LYS . . . . . 0.599 ' HE3' ' HB3' ' B' ' 44' ' ' TYR . 0.0 OUTLIER -53.42 109.37 0.43 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.161 -178.801 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.76 -20.08 49.14 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.493 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -104.15 114.27 28.39 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.474 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.3 p -122.96 140.4 33.33 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 171.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo . . . . . 0 C--N 1.345 0.368 0 C-N-CA 122.347 2.031 . . . . 0.0 111.537 170.72 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 67' ' ' ASP . . . . . 0.716 ' OD1' ' HB ' ' B' ' 69' ' ' ILE . 29.8 t70 . . . . . 0 CA--C 1.515 -0.368 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.6 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.9 OUTLIER -79.6 -30.69 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 C-N-CA 118.072 -1.451 . . . . 0.0 108.765 178.417 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.754 ' O ' HG13 ' B' ' 73' ' ' VAL . 6.1 mm -59.01 -47.92 88.33 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.079 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.832 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 41.0 t -44.9 -39.3 5.31 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.273 175.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -86.45 -29.03 23.13 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 121.101 0.477 . . . . 0.0 111.015 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 72' ' ' TYR . . . . . 0.593 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.3 m-30 -76.48 -35.54 58.35 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.675 0.75 . . . . 0.0 109.402 -178.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.803 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.5 m -71.46 -30.5 39.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 172.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 74' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' B' ' 70' ' ' SER . 0.4 OUTLIER -67.92 -32.31 72.68 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.235 175.134 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 75' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -63.08 -43.76 97.64 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.888 177.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.412 ' SG ' ' HB2' ' B' ' 14' ' ' TYR . 26.3 t -95.08 4.4 53.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.037 178.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 77' ' ' ASP . . . . . 0.46 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 8.9 t70 . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.141 176.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.456 ' C ' ' HA3' ' B' ' 60' ' ' GLY . 93.5 Cg_endo . . . . . 0 CA--C 1.517 -0.344 0 N-CA-C 109.114 -1.148 . . . . 0.0 109.114 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.544 ' HB2' HG23 ' A' ' 5' ' ' THR . 58.9 m -65.31 177.78 1.04 Allowed 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 162.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.702 ' CB ' ' HA ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -77.27 -54.08 6.92 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.566 174.541 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.52 ' CG ' ' HG3' ' A' ' 42' ' ' MET . 1.8 p-10 -86.58 6.62 29.95 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.792 -165.284 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.627 ' CG2' ' HD3' ' B' ' 59' ' ' LYS . 0.7 OUTLIER -62.21 -4.94 1.97 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.025 0.441 . . . . 0.0 111.613 -177.507 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.662 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.4 m -75.93 130.3 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 174.135 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.76 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -154.79 159.64 40.75 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 118.6 -1.24 . . . . 0.0 113.643 -179.752 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.472 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.4 mt-30 -41.39 113.75 0.44 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.125 -1.852 . . . . 0.0 112.809 -178.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.98 -141.75 6.24 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.56 174.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.6 m -62.01 96.81 0.07 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 117.011 0.406 . . . . 0.0 110.528 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.2 pttt 41.54 41.94 1.8 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.423 1.089 . . . . 0.0 112.093 -176.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.413 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 71.8 tt0 -58.77 140.0 86.12 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.114 178.145 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.531 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 31.5 Cg_exo -54.25 123.55 13.85 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.23 1.953 . . . . 0.0 110.041 178.072 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.783 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 10.4 t80 -71.13 -52.4 9.35 Favored Pre-proline 0 N--CA 1.439 -0.991 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -166.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.55 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 37.5 Cg_exo -56.47 -19.38 28.91 Favored 'Trans proline' 0 C--N 1.36 1.134 0 C-N-CA 121.478 1.452 . . . . 0.0 111.116 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.531 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.4 m-20 -90.71 -39.32 12.51 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 113.952 -1.476 . . . . 0.0 110.766 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.472 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -56.78 -44.05 81.46 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.532 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.687 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 2.4 p -78.72 -32.99 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.12 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.71 -35.11 68.14 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 121.967 -0.458 . . . . 0.0 111.91 175.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.733 ' O ' HG12 ' A' ' 24' ' ' VAL . 15.3 ptt180 -85.18 -25.38 27.44 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.65 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 3.9 tp -55.57 -48.73 74.31 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.313 171.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.687 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 36.4 mt-30 -66.78 -52.05 48.59 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.658 177.21 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.739 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 11.4 t70 -47.79 -53.75 14.43 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -175.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 20' ' ' ARG . 4.3 p -82.53 -26.6 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 CA-C-O 122.04 0.924 . . . . 0.0 109.56 -169.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.709 ' HB3' ' CZ ' ' A' ' 35' ' ' ARG . . . -78.51 -16.88 57.01 Favored 'General case' 0 C--O 1.197 -1.699 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 176.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.471 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -80.04 -37.14 34.62 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.821 0.82 . . . . 0.0 108.88 172.875 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.739 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 44.5 mmtt -63.69 -32.73 74.31 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.429 176.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.433 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 34.7 m -106.06 -11.39 16.14 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.06 0.457 . . . . 0.0 110.622 -174.289 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.675 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 96.3 mt -117.58 119.43 61.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.57 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.28 -1.87 58.27 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.346 0.593 . . . . 0.0 110.08 175.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.536 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 9.6 t70 -96.65 121.83 38.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.385 -176.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -68.06 -23.02 64.91 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.999 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.563 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -82.42 -54.04 5.52 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -177.42 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.551 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -57.91 -24.96 60.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.84 178.3 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.917 ' NH1' ' HA ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -69.14 -62.2 1.48 Allowed 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 176.92 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.492 ' O ' HG22 ' A' ' 39' ' ' VAL . 18.0 mtpt -52.43 -53.93 38.85 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 120.809 0.338 . . . . 0.0 111.119 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.693 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 14.2 m -55.27 -35.65 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.308 -172.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.773 HG22 HH22 ' A' ' 35' ' ' ARG . 0.1 OUTLIER -87.36 -26.95 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 178.088 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.706 HG12 ' NH2' ' A' ' 35' ' ' ARG . 1.1 m -59.73 -55.97 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 119.091 -1.044 . . . . 0.0 108.316 169.016 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.613 ' HG2' HG22 ' A' ' 68' ' ' VAL . 41.7 mt-10 -61.52 -34.33 75.34 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.713 -178.044 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.693 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -74.87 -58.87 3.02 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.613 179.642 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.52 ' HG3' ' CG ' ' A' ' 4' ' ' ASN . 22.8 mmt -66.96 -20.13 65.84 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.418 0.628 . . . . 0.0 110.022 -174.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.66 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -51.75 -27.07 10.88 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.43 171.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.525 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 18.1 t80 -106.18 -67.6 0.92 Allowed 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.243 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.622 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 8.0 mm-40 -47.49 -32.91 5.66 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 124.377 1.048 . . . . 0.0 112.284 -173.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.76 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.4 m-20 -104.47 -21.06 13.51 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.413 -174.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.591 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -59.46 179.43 0.11 Allowed 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.797 0.808 . . . . 0.0 112.86 -174.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.645 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 8.6 m-20 -60.1 141.05 90.58 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.346 175.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.419 ' HA ' HE21 ' A' ' 52' ' ' GLN . 70.9 Cg_exo -43.1 -44.65 9.67 Favored 'Trans proline' 0 C--N 1.331 -0.368 0 C-N-CA 122.819 2.346 . . . . 0.0 112.025 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.52 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 0.2 OUTLIER -76.79 -31.74 57.19 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.314 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.645 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 81.4 m -76.96 -36.33 56.58 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 120.901 0.382 . . . . 0.0 110.238 -173.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.561 ' HA ' HD12 ' A' ' 55' ' ' ILE . 29.4 pt20 -73.25 -30.92 63.79 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 173.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.554 ' O ' ' HE3' ' A' ' 56' ' ' LYS . 3.9 m -68.91 -19.8 64.21 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.052 -1.431 . . . . 0.0 110.446 173.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 51' ' ' CYS . . . -78.75 -27.1 44.68 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.646 0.736 . . . . 0.0 109.93 167.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.561 HD12 ' HA ' ' A' ' 52' ' ' GLN . 22.7 mt -89.23 -32.48 5.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -172.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.599 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -40.57 -38.72 1.29 Allowed Pre-proline 0 N--CA 1.488 1.428 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -174.461 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 53.3 Cg_endo -64.06 -28.53 65.75 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 122.233 1.956 . . . . 0.0 112.828 175.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.549 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.0 OUTLIER -99.51 -14.6 18.99 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.722 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.63 ' HD3' ' CG2' ' B' ' 5' ' ' THR . 0.1 OUTLIER -50.0 109.78 0.32 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.404 -178.844 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.456 ' HA3' ' C ' ' B' ' 1' ' ' PRO . . . 87.18 -17.94 39.49 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.358 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt -103.59 114.9 29.52 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.504 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.3 p -123.57 142.33 38.74 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.352 174.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo . . . . . 0 N--CA 1.463 -0.289 0 C-N-CA 122.349 2.033 . . . . 0.0 111.295 169.09 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.6 t70 . . . . . 0 CA--C 1.511 -0.532 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.613 HG22 ' HG2' ' A' ' 40' ' ' GLU . 1.1 m -81.38 -29.63 10.81 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 C-N-CA 118.33 -1.348 . . . . 0.0 108.787 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.781 ' O ' HG13 ' A' ' 73' ' ' VAL . 5.3 mm -60.14 -47.24 92.79 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.133 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.71 -178.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 40.7 t -47.68 -36.58 11.4 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.14 177.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -85.89 -31.52 22.16 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-O 121.046 0.45 . . . . 0.0 111.018 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.617 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.2 m-30 -74.49 -36.51 63.27 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.672 0.749 . . . . 0.0 109.516 -178.015 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.783 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.4 m -71.14 -30.72 41.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 173.144 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -69.7 -28.58 65.95 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.536 175.477 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -65.69 -45.81 81.38 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.766 176.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 14' ' ' TYR . 32.0 t -93.17 9.46 35.91 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.826 177.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.478 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 5.1 t70 . . . . . 0 C--N 1.323 -0.552 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.572 175.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 1' ' ' PRO . . . . . 0.456 ' C ' ' HA3' ' A' ' 60' ' ' GLY . 95.6 Cg_endo . . . . . 0 CA--C 1.518 -0.294 0 N-CA-C 109.191 -1.119 . . . . 0.0 109.191 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 2' ' ' SER . . . . . 0.551 ' HB2' HG23 ' B' ' 5' ' ' THR . 67.7 m -65.66 177.78 1.16 Allowed 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 162.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.694 ' CB ' ' HA ' ' B' ' 25' ' ' ALA . 0.1 OUTLIER -77.17 -54.28 6.7 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.524 174.583 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.513 ' CG ' ' HG3' ' B' ' 42' ' ' MET . 1.8 p-10 -86.48 6.56 29.88 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.726 -1.125 . . . . 0.0 112.673 -165.222 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.63 ' CG2' ' HD3' ' A' ' 59' ' ' LYS . 0.7 OUTLIER -62.28 -4.86 1.98 Allowed 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.98 0.419 . . . . 0.0 111.591 -177.425 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.672 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.4 m -75.92 130.44 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 174.019 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.754 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -154.99 159.46 40.38 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 118.648 -1.221 . . . . 0.0 113.717 -179.678 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 8' ' ' GLN . . . . . 0.479 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.4 mt-30 -41.12 114.01 0.45 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.276 -1.783 . . . . 0.0 112.832 -178.265 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.13 -141.94 6.43 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.623 174.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 20.0 m -61.66 96.82 0.07 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.93 0.365 . . . . 0.0 110.572 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 62.3 pttt 41.24 42.24 1.67 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.36 1.064 . . . . 0.0 112.209 -176.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.415 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 73.2 tt0 -58.98 139.88 87.11 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.971 178.109 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 13' ' ' PRO . . . . . 0.534 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 31.4 Cg_exo -54.25 123.5 13.71 Favored 'Trans proline' 0 CA--C 1.511 -0.665 0 C-N-CA 122.219 1.946 . . . . 0.0 110.145 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 14' ' ' TYR . . . . . 0.781 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 10.2 t80 -70.94 -52.39 9.84 Favored Pre-proline 0 N--CA 1.44 -0.97 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -166.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.544 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 38.3 Cg_exo -56.47 -19.45 29.24 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 121.495 1.463 . . . . 0.0 111.127 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.534 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.3 m-20 -90.69 -38.93 12.75 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 113.933 -1.485 . . . . 0.0 110.895 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 17' ' ' PHE . . . . . 0.479 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -57.23 -43.94 83.34 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.562 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.667 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 2.4 p -78.72 -33.15 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.072 -179.071 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.65 -35.05 67.93 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 121.846 -0.534 . . . . 0.0 111.939 175.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.733 ' O ' HG12 ' B' ' 24' ' ' VAL . 15.3 ptt180 -85.13 -25.6 27.38 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.65 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 3.9 tp -55.26 -48.89 73.34 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 171.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 22' ' ' GLN . . . . . 0.667 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 36.1 mt-30 -66.65 -52.19 47.72 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.661 177.238 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.737 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 11.6 t70 -47.54 -54.01 12.84 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -176.008 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 24' ' ' VAL . . . . . 0.733 HG12 ' O ' ' B' ' 20' ' ' ARG . 4.2 p -82.46 -26.45 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 CA-C-O 121.975 0.893 . . . . 0.0 109.569 -169.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.715 ' HB3' ' CZ ' ' B' ' 35' ' ' ARG . . . -78.57 -16.81 56.99 Favored 'General case' 0 C--O 1.198 -1.638 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 176.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 26' ' ' GLN . . . . . 0.462 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -80.15 -37.29 33.77 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.025 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.737 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 45.0 mmtt -63.67 -32.83 74.44 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.333 177.101 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 28' ' ' SER . . . . . 0.429 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 29.2 m -106.02 -11.18 16.23 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.087 0.47 . . . . 0.0 110.578 -174.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.689 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 95.9 mt -117.79 119.34 61.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.554 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.42 -1.63 58.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.309 0.576 . . . . 0.0 110.114 175.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.549 ' H ' HG22 ' B' ' 29' ' ' ILE . 9.3 t70 -96.84 121.96 39.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.457 -177.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -68.4 -22.68 64.62 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.95 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.58 ' O ' HG13 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -82.54 -53.94 5.56 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -177.555 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.561 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -57.95 -24.95 60.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.881 178.227 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.94 ' NH1' ' HA ' ' B' ' 35' ' ' ARG . 0.0 OUTLIER -69.11 -62.21 1.47 Allowed 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.843 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.501 ' O ' HG22 ' B' ' 39' ' ' VAL . 18.0 mtpt -52.45 -54.06 37.22 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 120.715 0.293 . . . . 0.0 111.087 -178.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.689 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 14.1 m -55.1 -35.77 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.321 -172.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.755 HG22 HH22 ' B' ' 35' ' ' ARG . 0.1 OUTLIER -87.38 -26.94 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 178.142 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.706 HG12 ' NH2' ' B' ' 35' ' ' ARG . 1.1 m -59.62 -56.05 19.8 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 C-N-CA 118.987 -1.085 . . . . 0.0 108.318 168.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.628 ' HG2' HG22 ' B' ' 68' ' ' VAL . 43.7 mt-10 -61.34 -34.66 75.63 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 114.46 -1.245 . . . . 0.0 111.672 -177.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.689 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -74.53 -58.86 3.02 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.7 179.716 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 42' ' ' MET . . . . . 0.513 ' HG3' ' CG ' ' B' ' 4' ' ' ASN . 22.9 mmt -66.86 -20.2 65.88 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.343 0.592 . . . . 0.0 109.964 -174.203 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.654 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -51.77 -27.22 11.47 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.313 171.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 44' ' ' TYR . . . . . 0.516 ' CG ' ' HD2' ' B' ' 59' ' ' LYS . 18.1 t80 -106.08 -67.57 0.92 Allowed 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 175.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.624 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 7.8 mm-40 -47.54 -33.04 5.94 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 124.378 1.049 . . . . 0.0 112.196 -173.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.754 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.4 m-20 -104.39 -20.93 13.57 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.419 -174.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.577 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -59.62 179.43 0.12 Allowed 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.8 0.809 . . . . 0.0 112.864 -174.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 48' ' ' ASN . . . . . 0.646 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 8.8 m-20 -59.99 140.98 90.24 Favored Pre-proline 0 N--CA 1.443 -0.796 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.488 175.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 49' ' ' PRO . . . . . 0.412 ' HA ' HE21 ' B' ' 52' ' ' GLN . 71.5 Cg_exo -43.4 -44.32 10.53 Favored 'Trans proline' 0 C--N 1.332 -0.337 0 C-N-CA 122.792 2.328 . . . . 0.0 112.016 -178.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 50' ' ' GLU . . . . . 0.526 ' HA ' ' HB2' ' B' ' 53' ' ' SER . 0.2 OUTLIER -76.94 -31.55 56.7 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.326 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.646 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 83.4 m -77.26 -36.45 54.39 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -173.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 52' ' ' GLN . . . . . 0.557 ' HA ' HD12 ' B' ' 55' ' ' ILE . 29.4 pt20 -73.16 -30.94 63.93 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 173.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 53' ' ' SER . . . . . 0.568 ' O ' ' HE3' ' B' ' 56' ' ' LYS . 3.7 m -68.9 -19.84 64.23 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.183 -1.371 . . . . 0.0 110.498 173.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' B' ' 51' ' ' CYS . . . -78.67 -27.08 45.11 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.612 0.72 . . . . 0.0 110.006 167.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.557 HD12 ' HA ' ' B' ' 52' ' ' GLN . 22.6 mt -89.39 -32.24 5.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 -171.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.598 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -40.7 -38.71 1.34 Allowed Pre-proline 0 N--CA 1.487 1.384 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -174.601 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 51.7 Cg_endo -63.72 -29.0 68.81 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.193 1.928 . . . . 0.0 112.809 175.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 58' ' ' LEU . . . . . 0.563 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.0 OUTLIER -99.29 -14.6 19.17 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 -179.5 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 59' ' ' LYS . . . . . 0.627 ' HD3' ' CG2' ' A' ' 5' ' ' THR . 0.1 OUTLIER -49.87 109.78 0.32 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.448 -178.903 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 60' ' ' GLY . . . . . 0.456 ' HA3' ' C ' ' A' ' 1' ' ' PRO . . . 87.09 -18.32 36.89 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.357 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -103.36 114.85 29.46 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -178.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.497 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.4 p -123.55 142.41 38.91 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.353 174.3 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo . . . . . 0 C--O 1.235 0.351 0 C-N-CA 122.41 2.073 . . . . 0.0 111.419 168.941 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 2.7 t70 . . . . . 0 CA--C 1.512 -0.516 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.628 HG22 ' HG2' ' B' ' 40' ' ' GLU . 1.1 m -81.37 -29.54 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 C-N-CA 118.371 -1.331 . . . . 0.0 108.856 178.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.777 ' O ' HG13 ' B' ' 73' ' ' VAL . 5.3 mm -60.18 -47.14 93.27 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.093 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.695 -178.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 40.8 t -48.01 -36.51 12.89 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.078 177.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -85.79 -31.25 22.44 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 122.862 0.465 . . . . 0.0 111.079 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 72' ' ' TYR . . . . . 0.607 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.2 m-30 -74.77 -36.72 62.55 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 121.671 0.748 . . . . 0.0 109.489 -178.137 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.781 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.4 m -70.9 -30.82 43.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 173.094 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 74' ' ' LYS . . . . . 0.493 ' O ' ' HB3' ' B' ' 77' ' ' ASP . 0.0 OUTLIER -69.66 -28.54 65.97 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.552 175.495 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 75' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -65.51 -46.12 80.89 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.752 176.404 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' B' ' 14' ' ' TYR . 32.1 t -93.02 9.78 34.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.84 178.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 77' ' ' ASP . . . . . 0.493 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 4.4 t70 . . . . . 0 C--N 1.322 -0.605 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.637 175.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo . . . . . 0 N--CA 1.464 -0.227 0 N-CA-C 108.601 -1.346 . . . . 0.0 108.601 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.2 m -70.44 -176.12 1.17 Allowed 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 163.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.618 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -77.14 -54.42 6.54 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 122.406 1.098 . . . . 0.0 109.062 171.681 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.679 ' HB2' HD11 ' A' ' 21' ' ' LEU . 2.4 p-10 -85.6 5.91 29.66 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 113.533 -1.667 . . . . 0.0 113.332 -160.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.24 -1.05 7.02 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -174.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.687 ' O ' HG23 ' A' ' 6' ' ' VAL . 24.0 m -81.41 92.84 2.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 122.259 1.028 . . . . 0.0 112.162 -174.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 1.096 ' NE ' ' HB3' ' A' ' 46' ' ' ASN . 13.8 mmm180 -107.19 150.6 26.44 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.506 -1.371 . . . . 0.0 112.978 -159.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.582 ' HG3' ' CG ' ' A' ' 17' ' ' PHE . 2.1 tt0 -44.41 109.12 0.14 Allowed 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 112.53 -2.123 . . . . 0.0 111.572 173.152 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.39 -152.56 9.42 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.742 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.8 m -55.81 97.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.911 0.355 . . . . 0.0 110.733 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.7 pttt 40.24 46.1 1.88 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.267 1.027 . . . . 0.0 111.935 -172.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.434 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 46.3 tt0 -60.34 136.49 91.71 Favored Pre-proline 0 C--O 1.236 0.381 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.139 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.452 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 38.4 Cg_exo -53.46 120.52 7.92 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.198 1.932 . . . . 0.0 110.943 -177.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.841 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 5.4 t80 -64.94 -56.05 23.54 Favored Pre-proline 0 C--N 1.313 -0.986 0 C-N-CA 119.73 -0.788 . . . . 0.0 112.737 -161.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.55 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 35.2 Cg_exo -55.89 -19.69 26.46 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.009 1.806 . . . . 0.0 111.508 -176.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.452 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.2 m-20 -89.46 -38.41 14.08 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.233 -178.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.916 ' HE1' ' NH2' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -61.74 -42.12 98.55 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.09 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.748 HG21 HD12 ' A' ' 69' ' ' ILE . 1.7 p -80.63 -31.69 12.71 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.9 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.841 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.67 -36.74 67.43 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 121.762 -0.586 . . . . 0.0 110.975 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.736 ' O ' HG12 ' A' ' 24' ' ' VAL . 15.4 ptt180 -82.29 -27.08 32.56 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.053 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.907 HD13 ' NH1' ' A' ' 7' ' ' ARG . 9.7 tp -55.24 -44.3 75.38 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.175 172.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.67 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 4.7 mt-30 -73.97 -51.57 15.57 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.309 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.744 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 45.3 m-20 -47.02 -51.28 17.67 Favored 'General case' 0 C--N 1.313 -1.006 0 O-C-N 124.532 1.145 . . . . 0.0 110.917 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.736 HG12 ' O ' ' A' ' 20' ' ' ARG . 9.9 p -79.64 -27.15 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 C-N-CA 119.936 -0.705 . . . . 0.0 109.833 -171.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.646 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -66.69 -31.57 72.33 Favored 'General case' 0 C--O 1.204 -1.301 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 175.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.418 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -74.69 -35.96 62.75 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.042 -1.435 . . . . 0.0 109.932 -178.19 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.744 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 37.3 mmtt -67.41 -36.38 81.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.466 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.506 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 21.6 m -104.89 -10.23 17.45 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.193 0.521 . . . . 0.0 110.656 -171.111 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.654 HG22 ' H ' ' A' ' 31' ' ' ASP . 78.1 mt -113.94 124.85 70.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.198 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.95 -1.87 57.73 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.947 0.403 . . . . 0.0 110.863 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.654 ' H ' HG22 ' A' ' 29' ' ' ILE . 4.1 t0 -114.13 140.12 48.77 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-O 121.618 0.723 . . . . 0.0 111.528 -177.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -71.02 -32.17 68.86 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.36 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.563 ' O ' HG13 ' A' ' 37' ' ' VAL . 12.0 mttp -67.07 -56.1 11.5 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -176.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.584 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -61.92 -25.49 67.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.57 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.842 ' O ' HG13 ' A' ' 39' ' ' VAL . 1.8 tmm_? -68.67 -58.62 3.97 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.43 ' HB3' ' OE2' ' A' ' 40' ' ' GLU . 15.8 mtpt -55.91 -57.0 13.96 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.205 179.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.793 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 23.9 m -52.25 -36.91 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.048 -170.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.618 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.3 tt -88.31 -30.83 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 C-N-CA 119.823 -0.751 . . . . 0.0 112.161 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.842 HG13 ' O ' ' A' ' 35' ' ' ARG . 3.2 m -67.01 -50.16 66.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 119.24 -0.984 . . . . 0.0 109.242 174.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.632 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 54.7 mt-10 -66.51 -23.58 66.27 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 123.816 0.846 . . . . 0.0 112.406 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.793 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -85.84 -56.97 3.23 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.325 176.338 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.58 ' HB2' HD21 ' A' ' 21' ' ' LEU . 25.0 mmt -59.82 -24.95 64.59 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 121.348 0.594 . . . . 0.0 109.996 -175.086 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.66 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -46.66 -28.3 1.44 Allowed 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.149 174.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.628 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 7.7 t80 -103.99 -68.02 0.87 Allowed 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 174.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.73 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 5.5 mm-40 -45.23 -35.45 3.34 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.25 -1.341 . . . . 0.0 112.834 -171.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 1.096 ' HB3' ' NE ' ' A' ' 7' ' ' ARG . 1.4 m-20 -111.76 -7.34 14.22 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.873 -172.221 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.66 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -68.01 -169.9 0.15 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.601 0.715 . . . . 0.0 112.425 -175.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.598 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 11.2 m-20 -66.03 140.42 97.04 Favored Pre-proline 0 N--CA 1.442 -0.836 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.939 171.443 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.464 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 3.0 Cg_endo -46.74 -46.75 17.43 Favored 'Trans proline' 0 CA--C 1.53 0.308 0 C-N-CA 122.642 2.228 . . . . 0.0 111.928 -176.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.584 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 0.3 OUTLIER -72.15 -31.31 65.84 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 124.185 0.994 . . . . 0.0 111.62 177.8 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.598 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 96.0 m -75.25 -36.36 61.29 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 120.889 0.376 . . . . 0.0 110.03 -173.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.61 ' HA ' HD12 ' A' ' 55' ' ' ILE . 4.3 pt20 -73.38 -32.21 64.36 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 174.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.597 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 27.0 m -66.87 -21.46 66.01 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 114.033 -1.439 . . . . 0.0 110.064 173.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 51' ' ' CYS . . . -77.85 -27.43 49.84 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.431 -0.793 . . . . 0.0 110.036 169.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.61 HD12 ' HA ' ' A' ' 52' ' ' GLN . 23.4 mt -89.11 -31.16 5.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -171.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.622 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.93 -39.27 2.64 Favored Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -173.347 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 57.3 Cg_endo -64.33 -25.98 63.9 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.457 2.104 . . . . 0.0 112.925 176.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.529 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.3 mt -99.96 -16.31 18.01 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.628 ' HE3' ' HB3' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -53.01 109.64 0.44 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.988 -178.947 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.29 -21.57 41.75 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.548 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -103.82 113.51 27.09 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 121.147 0.498 . . . . 0.0 110.032 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.12 143.78 43.51 Favored Pre-proline 0 C--N 1.312 -1.051 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 170.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo . . . . . 0 C--N 1.346 0.431 0 C-N-CA 122.767 2.311 . . . . 0.0 111.836 168.71 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.747 ' OD1' ' HB ' ' A' ' 69' ' ' ILE . 19.3 t70 . . . . . 0 C--O 1.232 0.163 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.554 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -80.96 -30.89 11.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 C-N-CA 118.647 -1.221 . . . . 0.0 109.472 178.259 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.789 ' O ' HG13 ' A' ' 73' ' ' VAL . 14.5 mm -57.63 -46.78 86.46 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.223 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 178.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.4 t -43.24 -39.34 2.94 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.478 174.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -85.45 -33.59 21.85 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 123.413 0.685 . . . . 0.0 110.831 -177.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.656 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.2 m-30 -75.38 -35.04 61.14 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.467 -176.092 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.841 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.6 m -70.64 -31.92 47.73 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.066 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.518 ' HA ' ' HB2' ' A' ' 77' ' ' ASP . 23.1 ttpt -71.79 -27.53 63.01 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.616 -1.174 . . . . 0.0 109.865 176.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.463 ' HB2' HD11 ' A' ' 58' ' ' LEU . . . -64.8 -44.54 89.61 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.59 175.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.556 ' SG ' ' HB2' ' A' ' 14' ' ' TYR . 31.0 t -92.95 9.14 36.82 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.648 177.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.518 ' HB2' ' HA ' ' A' ' 74' ' ' LYS . 25.2 t70 . . . . . 0 C--N 1.325 -0.471 0 CA-C-O 121.507 0.67 . . . . 0.0 109.914 174.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 1' ' ' PRO . . . . . 0.461 ' HB2' ' H ' ' B' ' 2' ' ' SER . 86.2 Cg_endo . . . . . 0 N--CA 1.464 -0.23 0 N-CA-C 108.679 -1.316 . . . . 0.0 108.679 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 2' ' ' SER . . . . . 0.461 ' H ' ' HB2' ' B' ' 1' ' ' PRO . 49.7 m -70.13 -176.13 1.09 Allowed 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 163.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.63 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.0 OUTLIER -77.23 -54.36 6.59 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 122.398 1.095 . . . . 0.0 109.021 171.852 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.663 ' HB2' HD11 ' B' ' 21' ' ' LEU . 2.4 p-10 -85.49 5.97 28.95 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 113.446 -1.706 . . . . 0.0 113.366 -160.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.44 -1.09 7.57 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -174.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.674 ' O ' HG23 ' B' ' 6' ' ' VAL . 23.3 m -81.38 92.78 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-O 122.264 1.03 . . . . 0.0 112.08 -174.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 1.102 ' NE ' ' HB3' ' B' ' 46' ' ' ASN . 13.8 mmm180 -107.17 150.71 26.31 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.512 -1.368 . . . . 0.0 113.007 -159.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 8' ' ' GLN . . . . . 0.572 ' HG3' ' CG ' ' B' ' 17' ' ' PHE . 2.1 tt0 -44.43 109.23 0.14 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 112.626 -2.079 . . . . 0.0 111.617 172.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.45 -152.61 9.56 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.708 176.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 19.6 m -56.15 98.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.822 0.311 . . . . 0.0 110.709 -177.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 52.7 pttt 39.86 46.79 1.74 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.054 0.942 . . . . 0.0 111.909 -172.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.453 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 46.9 tt0 -60.81 136.33 93.05 Favored Pre-proline 0 C--O 1.234 0.278 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 13' ' ' PRO . . . . . 0.459 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 39.8 Cg_exo -53.34 120.55 7.94 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.079 1.852 . . . . 0.0 111.012 -177.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 14' ' ' TYR . . . . . 0.843 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 5.5 t80 -65.07 -56.04 22.98 Favored Pre-proline 0 C--N 1.314 -0.972 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.709 -161.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.551 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 32.1 Cg_exo -55.87 -19.62 26.01 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 121.987 1.792 . . . . 0.0 111.521 -176.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.459 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.2 m-20 -89.45 -38.62 13.93 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.145 -178.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 17' ' ' PHE . . . . . 0.908 ' HE1' ' NH2' ' B' ' 7' ' ' ARG . 0.1 OUTLIER -61.62 -42.15 98.47 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.273 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.726 HG21 HD12 ' B' ' 69' ' ' ILE . 1.7 p -80.69 -31.48 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.947 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.96 -36.54 67.93 Favored 'General case' 0 C--N 1.315 -0.902 0 O-C-N 121.653 -0.654 . . . . 0.0 110.922 175.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.736 ' O ' HG12 ' B' ' 24' ' ' VAL . 15.5 ptt180 -82.37 -27.14 32.3 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.898 HD13 ' NH1' ' B' ' 7' ' ' ARG . 9.7 tp -55.14 -44.44 75.09 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.11 172.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 22' ' ' GLN . . . . . 0.658 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 4.5 mt-30 -73.97 -51.58 15.54 Favored 'General case' 0 CA--C 1.486 -1.494 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.24 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.733 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 41.7 m-20 -46.96 -51.38 17.17 Favored 'General case' 0 C--N 1.311 -1.08 0 O-C-N 124.34 1.025 . . . . 0.0 110.874 178.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 24' ' ' VAL . . . . . 0.736 HG12 ' O ' ' B' ' 20' ' ' ARG . 9.8 p -79.51 -27.29 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.789 -171.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.649 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -66.61 -31.66 72.5 Favored 'General case' 0 C--O 1.205 -1.288 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 175.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 26' ' ' GLN . . . . . 0.414 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -74.52 -36.26 63.18 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 114.0 -1.455 . . . . 0.0 109.81 -178.225 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.733 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.1 mmtt -67.17 -36.42 81.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.394 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 28' ' ' SER . . . . . 0.491 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 25.2 m -104.69 -10.46 17.47 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.364 0.602 . . . . 0.0 110.609 -171.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.675 HG22 ' H ' ' B' ' 31' ' ' ASP . 78.3 mt -113.65 124.86 70.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.313 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.21 -1.94 57.91 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.972 0.415 . . . . 0.0 110.732 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.675 ' H ' HG22 ' B' ' 29' ' ' ILE . 4.0 t0 -113.48 140.59 47.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.58 0.705 . . . . 0.0 111.481 -177.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -71.55 -32.26 67.91 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.469 175.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.575 ' O ' HG13 ' B' ' 37' ' ' VAL . 11.8 mttp -67.08 -55.92 12.24 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -176.139 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.574 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -61.97 -25.52 67.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.559 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.854 ' O ' HG13 ' B' ' 39' ' ' VAL . 1.8 tmm_? -68.7 -58.66 3.91 Favored 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.44 ' HB3' ' OE2' ' B' ' 40' ' ' GLU . 15.7 mtpt -55.86 -57.04 13.73 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.227 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.802 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 23.6 m -52.25 -36.91 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.094 -170.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.63 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.3 tt -88.16 -30.85 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.218 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.854 HG13 ' O ' ' B' ' 35' ' ' ARG . 3.2 m -66.96 -50.19 66.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.309 174.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.633 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 52.1 mt-10 -66.4 -23.76 66.37 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 123.891 0.877 . . . . 0.0 112.351 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.802 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.77 -57.12 3.17 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.238 176.447 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 42' ' ' MET . . . . . 0.584 ' HB2' HD21 ' B' ' 21' ' ' LEU . 25.1 mmt -59.63 -25.0 64.32 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.358 0.599 . . . . 0.0 109.993 -175.05 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.665 ' O ' ' HB2' ' B' ' 47' ' ' ALA . . . -46.63 -28.45 1.47 Allowed 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.133 174.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 44' ' ' TYR . . . . . 0.62 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 7.8 t80 -103.74 -68.02 0.86 Allowed 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 174.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.75 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 5.6 mm-40 -45.22 -35.74 3.5 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.186 -1.37 . . . . 0.0 112.778 -171.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 1.102 ' HB3' ' NE ' ' B' ' 7' ' ' ARG . 1.4 m-20 -111.7 -7.21 14.26 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.846 -172.157 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.665 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -68.03 -169.74 0.15 Allowed 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.62 0.724 . . . . 0.0 112.498 -175.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 48' ' ' ASN . . . . . 0.609 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 11.2 m-20 -66.21 140.38 96.85 Favored Pre-proline 0 N--CA 1.442 -0.843 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.083 171.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 49' ' ' PRO . . . . . 0.467 ' O ' ' HG2' ' B' ' 52' ' ' GLN . 2.9 Cg_endo -46.83 -46.63 17.92 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.685 2.257 . . . . 0.0 111.866 -176.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 50' ' ' GLU . . . . . 0.589 ' HA ' ' HB2' ' B' ' 53' ' ' SER . 0.3 OUTLIER -72.31 -31.14 65.44 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 124.199 1.0 . . . . 0.0 111.591 177.839 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.609 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 94.6 m -75.3 -36.43 61.12 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 120.996 0.427 . . . . 0.0 109.993 -173.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 52' ' ' GLN . . . . . 0.59 ' HB2' ' CG ' ' B' ' 44' ' ' TYR . 4.4 pt20 -73.43 -32.07 64.18 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 174.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 53' ' ' SER . . . . . 0.609 ' O ' ' HE2' ' B' ' 56' ' ' LYS . 26.4 m -66.97 -21.45 65.97 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 114.014 -1.448 . . . . 0.0 109.999 173.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' B' ' 51' ' ' CYS . . . -78.0 -27.29 48.98 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.398 -0.814 . . . . 0.0 109.985 169.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.589 HD12 ' HA ' ' B' ' 52' ' ' GLN . 23.3 mt -89.17 -31.28 5.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 -171.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.617 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.8 -39.37 2.59 Favored Pre-proline 0 N--CA 1.488 1.435 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -173.263 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 57.5 Cg_endo -64.17 -26.25 64.99 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.383 2.055 . . . . 0.0 112.925 176.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 58' ' ' LEU . . . . . 0.532 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.4 mt -99.78 -16.54 18.06 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 59' ' ' LYS . . . . . 0.62 ' HE3' ' HB3' ' B' ' 44' ' ' TYR . 0.0 OUTLIER -52.66 109.77 0.44 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.131 -179.093 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.97 -21.63 40.75 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.696 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -103.92 113.48 27.05 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.21 0.528 . . . . 0.0 110.051 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.411 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.6 p -124.18 143.41 42.59 Favored Pre-proline 0 C--N 1.312 -1.05 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.765 170.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo . . . . . 0 C--N 1.347 0.475 0 C-N-CA 122.686 2.257 . . . . 0.0 111.944 168.807 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 67' ' ' ASP . . . . . 0.748 ' OD1' ' HB ' ' B' ' 69' ' ' ILE . 19.5 t70 . . . . . 0 CA--C 1.52 -0.208 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.564 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.8 OUTLIER -80.93 -30.95 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 C-N-CA 118.588 -1.245 . . . . 0.0 109.517 178.193 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.789 ' O ' HG13 ' B' ' 73' ' ' VAL . 14.3 mm -57.57 -47.04 86.14 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.181 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 30.8 t -43.38 -39.22 3.08 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.45 174.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -85.34 -33.48 22.04 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 123.503 0.721 . . . . 0.0 110.807 -177.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 72' ' ' TYR . . . . . 0.645 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.1 m-30 -75.44 -35.04 61.0 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.449 -176.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.843 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.6 m -70.86 -31.79 46.68 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 173.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 74' ' ' LYS . . . . . 0.501 ' HA ' ' HB2' ' B' ' 77' ' ' ASP . 23.0 ttpt -71.84 -27.53 62.96 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.81 176.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 75' ' ' ALA . . . . . 0.456 ' HB2' HD11 ' B' ' 58' ' ' LEU . . . -64.9 -44.18 90.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.651 175.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.568 ' SG ' ' HB2' ' B' ' 14' ' ' TYR . 30.7 t -93.45 9.22 37.46 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.612 177.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 77' ' ' ASP . . . . . 0.501 ' HB2' ' HA ' ' B' ' 74' ' ' LYS . 24.7 t70 . . . . . 0 C--N 1.326 -0.435 0 CA-C-O 121.576 0.703 . . . . 0.0 110.068 173.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo . . . . . 0 CA--C 1.517 -0.337 0 N-CA-C 109.293 -1.08 . . . . 0.0 109.293 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.1 m -68.73 167.95 14.28 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 163.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.768 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -70.96 -54.38 11.52 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.992 0.901 . . . . 0.0 109.864 172.79 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.545 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 3.0 p-10 -86.76 -4.04 59.13 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.419 -1.264 . . . . 0.0 113.181 -164.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.453 ' HA ' ' OE1' ' B' ' 45' ' ' GLU . 9.9 t -65.47 -2.97 3.72 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.29 0.567 . . . . 0.0 111.075 -173.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.596 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.7 m -73.05 135.26 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 172.107 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.791 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -154.59 159.43 40.86 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 -178.789 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.542 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.4 mt-30 -42.83 118.98 1.36 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 112.585 -2.098 . . . . 0.0 113.318 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.9 -161.66 37.68 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.843 169.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.5 m -48.05 102.44 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 117.097 0.448 . . . . 0.0 111.592 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.3 pttt 38.91 44.28 0.84 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.533 1.133 . . . . 0.0 112.498 -173.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.494 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 37.8 tt0 -61.96 138.04 95.59 Favored Pre-proline 0 C--O 1.234 0.26 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 177.109 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.59 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 50.4 Cg_exo -50.68 122.55 9.88 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.244 1.963 . . . . 0.0 110.173 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.81 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 11.3 t80 -71.28 -54.17 7.29 Favored Pre-proline 0 N--CA 1.44 -0.934 0 CA-C-O 118.471 -0.776 . . . . 0.0 113.08 -167.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.533 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 34.5 Cg_exo -55.69 -18.79 21.94 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 121.459 1.44 . . . . 0.0 111.122 -179.191 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.59 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 2.0 m-20 -90.13 -42.2 11.21 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.881 -1.509 . . . . 0.0 111.001 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.542 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -54.6 -44.17 72.8 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.16 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.788 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 2.0 p -80.84 -34.15 13.77 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.362 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.692 -178.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.16 -31.64 67.43 Favored 'General case' 0 C--N 1.317 -0.841 0 O-C-N 121.276 -0.89 . . . . 0.0 111.881 177.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.718 ' O ' HG12 ' A' ' 24' ' ' VAL . 16.0 ptt180 -84.03 -29.9 26.54 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 175.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.562 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 8.3 tp -53.61 -49.61 67.45 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.992 172.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.788 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 4.5 mt-30 -69.43 -48.22 61.64 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.187 177.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.734 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 18.1 t70 -47.53 -53.31 14.8 Favored 'General case' 0 C--N 1.315 -0.933 0 O-C-N 124.267 0.979 . . . . 0.0 111.532 -177.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.718 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.4 p -82.1 -22.51 9.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.151 0.5 . . . . 0.0 109.79 -173.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.804 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -72.42 -19.44 61.59 Favored 'General case' 0 C--O 1.202 -1.422 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 173.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.41 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -87.06 -37.44 17.44 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.707 178.18 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.734 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 37.0 mmtt -66.94 -34.48 77.87 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.694 178.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.6 m -103.58 -11.07 17.96 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.195 0.521 . . . . 0.0 110.582 -172.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.804 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 88.7 mt -118.15 129.76 74.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.67 -178.21 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.99 -1.44 52.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.441 0.639 . . . . 0.0 110.367 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.638 ' H ' HG22 ' A' ' 29' ' ' ILE . 11.1 t70 -106.81 115.7 30.65 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.458 -177.017 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.646 ' OE2' ' HG3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -57.12 -33.33 67.24 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.149 178.262 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.646 ' HG3' ' OE2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -70.78 -54.72 10.62 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -173.354 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.564 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -60.68 -28.82 68.9 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.826 177.034 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.855 ' O ' HG13 ' A' ' 39' ' ' VAL . 2.1 tmm_? -65.4 -60.39 3.01 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.41 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 15.5 mtpt -55.41 -56.65 17.7 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.239 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.719 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 17.6 m -55.18 -33.68 30.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.112 -170.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.768 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.5 tt -87.25 -31.87 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.635 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.855 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.5 m -68.56 -48.14 73.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 119.015 -1.074 . . . . 0.0 109.178 175.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.657 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 73.0 mt-10 -63.18 -27.93 69.7 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 123.634 0.774 . . . . 0.0 112.749 176.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.719 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -86.04 -50.65 6.88 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.838 178.173 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.716 ' HE2' ' HE2' ' B' ' 42' ' ' MET . 17.8 mmt -64.85 -20.87 66.64 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.632 0.729 . . . . 0.0 109.764 -178.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.685 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -50.62 -28.63 9.16 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.542 171.215 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.593 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 19.9 t80 -103.9 -67.61 0.89 Allowed 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 174.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.453 ' CG ' HD12 ' A' ' 41' ' ' LEU . 27.2 mm-40 -50.54 -28.08 7.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.703 -1.135 . . . . 0.0 113.076 -173.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.791 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.1 m-20 -105.73 -22.24 13.0 Favored 'General case' 0 N--CA 1.435 -1.19 0 O-C-N 122.325 -0.234 . . . . 0.0 110.809 -177.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -60.36 178.76 0.18 Allowed 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 122.059 0.933 . . . . 0.0 112.818 -174.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.677 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 17.1 m-20 -58.2 141.63 81.93 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 114.155 -1.384 . . . . 0.0 109.245 174.177 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -55.02 -23.41 35.08 Favored 'Trans proline' 0 C--O 1.218 -0.515 0 C-N-CA 123.26 2.64 . . . . 0.0 112.407 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.705 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 13.4 pm0 -88.93 -32.12 17.85 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 123.765 0.826 . . . . 0.0 110.85 175.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.705 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 85.8 m -80.5 -38.15 30.36 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.328 -171.324 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.601 ' HA ' HD12 ' A' ' 55' ' ' ILE . 4.3 pt20 -70.0 -29.72 66.86 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 172.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.471 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 4.8 m -71.36 -20.82 62.11 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.119 175.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.55 -25.15 45.38 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.689 0.757 . . . . 0.0 109.821 168.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.601 HD12 ' HA ' ' A' ' 52' ' ' GLN . 22.6 mt -89.97 -32.53 5.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -172.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.63 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.99 -39.5 2.9 Favored Pre-proline 0 N--CA 1.486 1.344 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -172.799 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.63 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 50.6 Cg_endo -62.18 -28.81 79.88 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.187 1.924 . . . . 0.0 112.646 176.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.547 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.3 mt -98.35 -15.7 19.62 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.593 ' HE3' ' HB3' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -52.39 109.17 0.36 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.078 -179.454 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.54 -22.36 39.42 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.462 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.9 mmmt -103.55 113.0 26.17 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.17 0.509 . . . . 0.0 109.831 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.443 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.4 p -124.84 146.45 53.19 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.802 172.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo . . . . . 0 C--N 1.344 0.306 0 C-N-CA 122.288 1.992 . . . . 0.0 111.62 166.343 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.658 ' OD2' ' HB ' ' A' ' 69' ' ' ILE . 0.4 OUTLIER . . . . . 0 CA--C 1.517 -0.318 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.574 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.7 OUTLIER -78.53 -27.65 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 C-N-CA 118.863 -1.135 . . . . 0.0 108.991 177.373 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.758 ' O ' HG13 ' A' ' 73' ' ' VAL . 12.3 mm -58.12 -46.23 88.38 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.184 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.058 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 29.4 t -46.16 -37.54 7.14 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.157 176.116 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -85.63 -32.34 22.09 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.149 0.5 . . . . 0.0 110.705 -177.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.6 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.1 m-30 -75.93 -35.18 59.82 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.526 -176.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.81 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.5 m -71.79 -31.77 42.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 172.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -67.08 -31.77 72.48 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.339 175.459 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -63.65 -46.98 83.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.109 177.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.628 ' SG ' ' HB2' ' A' ' 14' ' ' TYR . 24.4 t -92.44 9.35 34.67 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.902 178.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 12.1 t70 . . . . . 0 C--N 1.323 -0.554 0 CA-C-O 121.302 0.573 . . . . 0.0 110.261 175.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo . . . . . 0 CA--C 1.515 -0.463 0 N-CA-C 109.364 -1.052 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 68.7 m -68.92 168.08 14.4 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 163.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.773 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -71.11 -54.41 11.2 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.843 0.83 . . . . 0.0 109.788 173.057 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.546 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 3.1 p-10 -86.84 -4.06 59.13 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.492 -1.231 . . . . 0.0 113.13 -164.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.443 ' HA ' ' OE1' ' A' ' 45' ' ' GLU . 9.9 t -65.39 -2.97 3.6 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.185 0.517 . . . . 0.0 111.083 -173.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.609 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.7 m -73.1 134.96 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 172.087 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.772 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -154.28 159.5 41.3 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -178.753 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 8' ' ' GLN . . . . . 0.533 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.4 mt-30 -42.94 119.08 1.4 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 112.684 -2.053 . . . . 0.0 113.303 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.99 -161.45 37.53 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 169.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 23.3 m -48.31 102.72 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 117.21 0.505 . . . . 0.0 111.498 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 39.2 pttt 38.83 44.42 0.83 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.611 1.164 . . . . 0.0 112.482 -173.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.488 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 37.7 tt0 -62.05 137.96 95.71 Favored Pre-proline 0 C--N 1.332 -0.182 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 13' ' ' PRO . . . . . 0.589 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 51.1 Cg_exo -50.71 122.46 9.74 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.227 1.951 . . . . 0.0 110.218 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 14' ' ' TYR . . . . . 0.817 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 11.3 t80 -71.21 -54.13 7.45 Favored Pre-proline 0 N--CA 1.438 -1.034 0 CA-C-O 118.425 -0.798 . . . . 0.0 113.048 -167.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.537 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 34.5 Cg_exo -55.77 -18.87 22.65 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 121.458 1.438 . . . . 0.0 111.072 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.589 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.7 m-20 -90.08 -41.98 11.37 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.037 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 17' ' ' PHE . . . . . 0.533 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -54.82 -44.18 73.62 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 176.254 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.776 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 2.0 p -80.77 -34.29 13.97 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.283 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.626 -178.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.19 -31.51 67.36 Favored 'General case' 0 C--N 1.315 -0.893 0 O-C-N 121.321 -0.862 . . . . 0.0 111.848 177.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.708 ' O ' HG12 ' B' ' 24' ' ' VAL . 16.1 ptt180 -84.03 -29.9 26.54 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 175.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.57 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 8.3 tp -53.56 -49.78 66.95 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.055 172.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 22' ' ' GLN . . . . . 0.776 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 4.6 mt-30 -69.41 -48.24 61.68 Favored 'General case' 0 CA--C 1.493 -1.236 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.191 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.741 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 18.4 t70 -47.25 -53.48 13.27 Favored 'General case' 0 C--N 1.315 -0.898 0 O-C-N 124.187 0.929 . . . . 0.0 111.489 -177.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 24' ' ' VAL . . . . . 0.708 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.4 p -82.13 -22.46 9.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.105 0.479 . . . . 0.0 109.746 -173.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.815 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -72.44 -19.46 61.57 Favored 'General case' 0 C--O 1.201 -1.462 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 173.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 26' ' ' GLN . . . . . 0.406 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -87.03 -37.55 17.37 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.671 178.331 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.741 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 36.7 mmtt -66.59 -35.1 79.39 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.6 178.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 44.4 m -103.14 -11.15 18.27 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.327 0.584 . . . . 0.0 110.62 -172.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.815 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 88.9 mt -118.13 129.4 74.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.714 -178.27 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.53 -1.68 52.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.518 0.675 . . . . 0.0 110.375 176.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.653 ' H ' HG22 ' B' ' 29' ' ' ILE . 11.3 t70 -106.39 115.67 30.6 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.418 -177.011 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.656 ' OE2' ' HG3' ' B' ' 33' ' ' LYS . 0.0 OUTLIER -57.17 -33.14 67.14 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.232 178.184 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.656 ' HG3' ' OE2' ' B' ' 32' ' ' GLU . 0.0 OUTLIER -70.96 -54.58 10.79 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -173.369 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.551 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -60.71 -28.91 69.0 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.821 177.026 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.868 ' O ' HG13 ' B' ' 39' ' ' VAL . 2.1 tmm_? -65.27 -60.44 2.99 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.119 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 15.6 mtpt -55.58 -56.52 19.32 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.193 -179.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.724 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 17.6 m -55.26 -33.59 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.119 -170.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.773 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.5 tt -87.36 -31.71 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.596 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.868 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.5 m -68.67 -48.02 73.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 118.944 -1.103 . . . . 0.0 109.193 175.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.66 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 73.2 mt-10 -63.25 -28.02 69.74 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 123.695 0.798 . . . . 0.0 112.668 176.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.724 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.99 -50.63 6.92 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.819 178.295 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 42' ' ' MET . . . . . 0.716 ' HE2' ' HE2' ' A' ' 42' ' ' MET . 18.0 mmt -64.92 -20.85 66.67 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.683 0.754 . . . . 0.0 109.707 -178.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.675 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -50.65 -28.62 9.26 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.533 171.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 44' ' ' TYR . . . . . 0.594 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 20.1 t80 -103.98 -67.57 0.89 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 174.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.453 ' OE1' ' HA ' ' A' ' 5' ' ' THR . 26.8 mm-40 -50.66 -27.67 7.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.75 -1.114 . . . . 0.0 113.064 -173.278 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.772 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.2 m-20 -106.06 -22.07 12.97 Favored 'General case' 0 N--CA 1.435 -1.219 0 O-C-N 122.283 -0.261 . . . . 0.0 110.845 -178.082 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.597 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -60.45 178.72 0.19 Allowed 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 122.055 0.931 . . . . 0.0 112.827 -174.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 48' ' ' ASN . . . . . 0.674 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 17.8 m-20 -58.11 141.62 81.44 Favored Pre-proline 0 N--CA 1.44 -0.932 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.187 174.099 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -55.16 -23.25 35.58 Favored 'Trans proline' 0 C--O 1.22 -0.422 0 C-N-CA 123.21 2.606 . . . . 0.0 112.286 -178.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 50' ' ' GLU . . . . . 0.686 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 13.5 pm0 -88.84 -32.26 17.89 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.863 0.865 . . . . 0.0 110.906 175.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.686 ' N ' ' HG2' ' B' ' 50' ' ' GLU . 83.9 m -80.43 -38.18 30.61 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.272 -171.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 52' ' ' GLN . . . . . 0.577 ' HA ' HD12 ' B' ' 55' ' ' ILE . 4.4 pt20 -70.02 -29.81 66.96 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 172.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 53' ' ' SER . . . . . 0.474 ' O ' ' HE2' ' B' ' 56' ' ' LYS . 4.9 m -71.31 -20.82 62.14 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 113.897 -1.501 . . . . 0.0 110.261 175.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.45 -25.25 45.85 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.672 0.749 . . . . 0.0 109.824 168.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.577 HD12 ' HA ' ' B' ' 52' ' ' GLN . 22.7 mt -90.02 -32.63 5.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 -172.369 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.628 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.82 -39.41 2.64 Favored Pre-proline 0 N--CA 1.487 1.388 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -172.853 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 50.9 Cg_endo -62.39 -28.4 78.29 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.308 2.005 . . . . 0.0 112.824 176.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 58' ' ' LEU . . . . . 0.546 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.3 mt -98.68 -15.78 19.27 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 59' ' ' LYS . . . . . 0.594 ' HE3' ' HB3' ' B' ' 44' ' ' TYR . 0.0 OUTLIER -52.37 109.36 0.38 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.16 -179.545 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.25 -22.59 37.75 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.63 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 10.9 mmmt -103.43 112.79 25.85 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.146 0.498 . . . . 0.0 110.0 -178.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.455 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.4 p -124.73 146.21 52.13 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.076 172.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo . . . . . 0 C--O 1.234 0.312 0 C-N-CA 122.22 1.947 . . . . 0.0 111.537 166.675 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 67' ' ' ASP . . . . . 0.655 ' OD2' ' HB ' ' B' ' 69' ' ' ILE . 0.5 OUTLIER . . . . . 0 CA--C 1.517 -0.291 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.562 HG13 ' CD ' ' B' ' 40' ' ' GLU . 0.7 OUTLIER -78.5 -27.73 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 C-N-CA 118.912 -1.115 . . . . 0.0 109.017 177.293 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.749 ' O ' HG13 ' B' ' 73' ' ' VAL . 12.6 mm -58.08 -46.33 88.18 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.116 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.107 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 29.1 t -46.06 -37.51 6.83 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.275 175.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -85.53 -32.51 22.14 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.148 0.499 . . . . 0.0 110.689 -177.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 72' ' ' TYR . . . . . 0.594 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.1 m-30 -75.85 -34.95 60.07 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.611 -176.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.817 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.5 m -72.01 -31.47 40.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 172.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 74' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' B' ' 70' ' ' SER . 0.0 OUTLIER -67.25 -31.82 72.43 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.309 175.504 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 75' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -63.8 -46.58 84.53 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.11 177.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.616 ' SG ' ' HB2' ' B' ' 14' ' ' TYR . 27.4 t -92.81 9.53 34.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.848 178.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 77' ' ' ASP . . . . . 0.436 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 11.7 t70 . . . . . 0 C--N 1.322 -0.611 0 CA-C-O 121.254 0.55 . . . . 0.0 110.235 175.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.454 ' HB2' ' H ' ' A' ' 2' ' ' SER . 92.5 Cg_endo . . . . . 0 CA--C 1.519 -0.251 0 N-CA-C 109.045 -1.175 . . . . 0.0 109.045 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.54 ' HB2' HG23 ' A' ' 5' ' ' THR . 15.6 m -68.12 179.84 1.43 Allowed 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 162.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.78 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -76.76 -52.2 9.99 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.245 -0.982 . . . . 0.0 108.536 166.41 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.509 ' HB2' HD11 ' A' ' 21' ' ' LEU . 2.4 p-10 -86.33 4.48 38.99 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.256 -1.338 . . . . 0.0 113.677 -164.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.582 ' O ' ' HG3' ' A' ' 7' ' ' ARG . 0.9 OUTLIER -63.73 -3.12 2.09 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 118.602 0.637 . . . . 0.0 111.532 -176.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.587 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 3.0 m -77.9 119.36 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-O 121.914 0.864 . . . . 0.0 109.824 177.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.783 ' HB3' ' O ' ' A' ' 46' ' ' ASN . 27.1 mtm180 -138.68 150.73 46.51 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 119.078 -1.049 . . . . 0.0 113.292 -170.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.579 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.4 mt-30 -41.99 114.35 0.53 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 112.882 -1.963 . . . . 0.0 113.019 176.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.81 -156.66 27.7 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.065 171.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.0 p -52.26 100.46 0.03 OUTLIER 'General case' 0 C--O 1.233 0.228 0 CA-C-N 117.092 0.446 . . . . 0.0 111.204 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.608 ' HD2' ' O ' ' A' ' 80' ' ' GLY . 20.7 pttp 42.47 40.87 2.05 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.396 1.078 . . . . 0.0 112.297 -175.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.47 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 59.4 tt0 -59.21 136.44 88.32 Favored Pre-proline 0 C--O 1.235 0.3 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 177.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.537 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 36.8 Cg_exo -51.77 122.83 11.08 Favored 'Trans proline' 0 CA--C 1.508 -0.784 0 C-N-CA 122.121 1.88 . . . . 0.0 109.689 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.829 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 9.3 t80 -69.46 -53.86 12.09 Favored Pre-proline 0 N--CA 1.437 -1.119 0 CA-C-O 118.316 -0.849 . . . . 0.0 112.937 -166.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.547 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 31.3 Cg_exo -55.38 -20.43 25.84 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.435 1.424 . . . . 0.0 111.06 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.537 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 2.7 m-20 -89.87 -39.17 13.22 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.011 -1.45 . . . . 0.0 111.036 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.579 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -55.94 -45.38 78.83 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 175.451 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.743 HG12 ' O ' ' A' ' 14' ' ' TYR . 1.5 p -81.54 -31.79 11.41 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.031 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.57 -177.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.08 -33.8 69.46 Favored 'General case' 0 C--N 1.317 -0.833 0 O-C-N 121.386 -0.821 . . . . 0.0 111.752 176.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.716 ' O ' HG12 ' A' ' 24' ' ' VAL . 15.3 ptt180 -84.36 -26.9 28.08 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 176.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.596 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 6.7 tp -56.52 -46.55 80.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.002 172.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.689 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 6.3 mt-30 -73.39 -44.15 59.12 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.83 178.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.708 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 21.8 t70 -49.55 -56.06 11.23 Favored 'General case' 0 C--N 1.314 -0.942 0 O-C-N 124.239 0.962 . . . . 0.0 111.612 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 20' ' ' ARG . 6.4 p -80.36 -22.29 11.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 C-N-CA 120.538 -0.465 . . . . 0.0 109.923 -173.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.664 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -68.18 -29.09 67.88 Favored 'General case' 0 C--O 1.204 -1.341 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 173.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.464 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -80.04 -36.9 35.07 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.931 -178.406 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.708 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.5 mmtt -66.65 -32.51 73.87 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.483 178.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.8 m -105.34 -11.77 16.33 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.825 -171.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.664 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 88.7 mt -116.83 133.93 61.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.109 -177.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.26 -4.25 35.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.285 0.564 . . . . 0.0 110.521 176.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.571 ' H ' HG22 ' A' ' 29' ' ' ILE . 11.1 t70 -105.48 107.46 18.47 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.752 -178.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.578 ' OE2' ' HG3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -52.86 -32.22 43.53 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.229 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.615 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -73.53 -50.47 21.23 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -173.672 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.591 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -61.92 -27.84 69.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.525 175.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.846 ' O ' HG13 ' A' ' 39' ' ' VAL . 3.5 tmm_? -67.4 -57.12 7.17 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.476 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 19.4 mtpt -59.11 -54.82 42.7 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.273 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.754 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 19.4 m -54.69 -33.84 28.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.023 -173.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.78 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.2 tt -86.3 -31.87 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 119.904 -0.719 . . . . 0.0 111.428 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.846 HG13 ' O ' ' A' ' 35' ' ' ARG . 3.0 m -67.4 -49.8 68.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.779 173.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.62 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 63.9 mt-10 -63.76 -26.34 68.6 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.5 0.72 . . . . 0.0 112.62 177.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.754 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -85.63 -52.1 6.03 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.576 177.348 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.603 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 18.7 mmt -64.52 -20.42 66.2 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.809 0.814 . . . . 0.0 109.37 -178.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.664 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -50.75 -28.98 10.28 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.539 171.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.532 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 25.0 t80 -104.08 -68.78 0.83 Allowed 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.482 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 10.3 mm-40 -48.21 -32.41 7.09 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 124.13 0.894 . . . . 0.0 112.546 -175.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.783 ' O ' ' HB3' ' A' ' 7' ' ' ARG . 4.5 m-20 -103.28 -17.39 15.33 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.492 -175.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.664 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -62.98 178.27 0.49 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.744 0.783 . . . . 0.0 111.911 -177.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.666 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 17.7 m-20 -59.93 142.92 88.41 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.094 172.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.405 ' HB2' HD21 ' A' ' 92' ' ' LEU . 11.0 Cg_endo -56.25 -21.46 36.23 Favored 'Trans proline' 0 C--O 1.219 -0.463 0 C-N-CA 123.182 2.588 . . . . 0.0 112.557 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.709 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 12.0 pm0 -88.99 -33.01 17.34 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 123.598 0.759 . . . . 0.0 110.727 174.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.709 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 72.2 m -81.21 -38.02 27.7 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.394 -171.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.605 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.3 pt20 -69.0 -29.89 68.18 Favored 'General case' 0 C--O 1.211 -0.94 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 172.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.647 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 5.9 m -72.23 -21.26 61.42 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 113.9 -1.5 . . . . 0.0 110.304 176.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.619 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -76.03 -25.91 56.12 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.783 0.801 . . . . 0.0 109.495 168.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.605 HD12 ' HA ' ' A' ' 52' ' ' GLN . 22.7 mt -90.33 -33.46 5.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -172.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.617 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.39 -39.08 1.96 Allowed Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -172.863 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 52.5 Cg_endo -63.13 -31.12 75.53 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.164 1.91 . . . . 0.0 112.568 175.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.526 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 2.4 mt -93.92 -17.08 23.36 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.599 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -54.64 108.95 0.44 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.44 179.67 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.09 -23.84 34.41 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.568 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -104.46 113.88 27.74 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.096 0.474 . . . . 0.0 110.418 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.479 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.1 p -123.58 141.6 36.87 Favored Pre-proline 0 C--N 1.308 -1.21 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 168.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.535 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 77.1 Cg_exo -51.55 139.62 46.74 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.333 2.022 . . . . 0.0 111.52 170.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.28 103.52 0.5 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.015 -176.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.8 -14.16 41.6 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.889 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.535 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 24.1 m -93.31 170.36 9.68 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.187 0.518 . . . . 0.0 111.346 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.29 141.98 28.86 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 176.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.578 HG13 ' CD ' ' A' ' 40' ' ' GLU . 0.7 OUTLIER -77.69 -28.1 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 C-N-CA 118.227 -1.389 . . . . 0.0 108.95 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.783 ' O ' HG13 ' A' ' 73' ' ' VAL . 11.3 mm -58.14 -46.54 88.35 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.075 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.124 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 30.7 t -45.95 -38.33 7.5 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.188 176.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -86.2 -32.31 21.27 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 121.254 0.55 . . . . 0.0 111.046 -177.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.613 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.1 m-30 -75.27 -34.38 61.35 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.369 -176.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.829 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.6 m -72.09 -31.7 40.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.47 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -68.0 -30.87 70.23 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.25 176.461 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -63.74 -48.94 75.0 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.891 177.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.763 ' SG ' ' HB ' ' A' ' 79' ' ' ILE . 32.3 t -89.89 9.09 28.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.773 177.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.47 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 18.7 t70 -66.05 -20.74 66.27 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.349 0.595 . . . . 0.0 109.566 173.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.94 -8.08 58.24 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.831 172.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.763 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 99.0 mt -97.92 128.05 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 121.055 0.455 . . . . 0.0 111.433 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.608 ' O ' ' HD2' ' A' ' 11' ' ' LYS . . . 158.75 -25.61 0.37 Allowed Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 174.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.06 137.47 4.72 Favored Glycine 0 CA--C 1.504 -0.618 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.277 172.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 66.33 -74.35 0.06 Allowed 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.273 0.629 . . . . 0.0 111.727 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 75.1 mtm -59.59 -33.97 72.14 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 120.692 0.282 . . . . 0.0 110.61 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.588 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 4.7 t-160 -49.68 -46.45 49.9 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.836 172.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.579 ' HA ' ' HB2' ' A' ' 88' ' ' LEU . 93.8 mttt -87.01 -19.68 28.32 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.881 -172.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.64 -45.29 59.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.765 0.793 . . . . 0.0 109.399 169.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 66.6 mtt -77.59 -13.26 59.96 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.267 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.579 ' HB2' ' HA ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -57.93 -37.78 74.71 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.068 0.461 . . . . 0.0 110.988 -179.042 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 46.5 ttm -83.5 -21.92 32.65 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.936 0.398 . . . . 0.0 110.718 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -90.5 -49.76 6.32 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.013 0.435 . . . . 0.0 111.883 -175.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.647 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 94.9 mt-30 -88.71 -54.29 4.22 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.423 -172.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.442 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -50.74 -37.97 44.91 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 175.848 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.635 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 5.1 pt-20 . . . . . 0 C--O 1.249 1.063 0 CA-C-N 112.991 -1.913 . . . . 0.0 113.186 -176.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 1' ' ' PRO . . . . . 0.416 ' HB2' ' H ' ' B' ' 2' ' ' SER . 84.0 Cg_endo . . . . . 0 CA--C 1.518 -0.306 0 N-CA-C 108.863 -1.245 . . . . 0.0 108.863 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.55 ' HB2' HG23 ' B' ' 5' ' ' THR . 15.8 m -68.48 -179.74 1.43 Allowed 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 162.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.776 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -77.01 -52.24 9.69 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.29 -0.964 . . . . 0.0 108.522 166.261 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.509 ' HB2' HD11 ' B' ' 21' ' ' LEU . 2.4 p-10 -86.31 4.69 37.98 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.708 -164.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.58 ' O ' ' HG3' ' B' ' 7' ' ' ARG . 0.9 OUTLIER -63.98 -2.88 2.15 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 118.6 0.636 . . . . 0.0 111.557 -176.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.571 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 3.0 m -78.04 119.25 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 121.823 0.82 . . . . 0.0 109.845 176.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.802 ' HB3' ' O ' ' B' ' 46' ' ' ASN . 27.3 mtm180 -138.63 150.72 46.56 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 119.18 -1.008 . . . . 0.0 113.247 -170.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' GLN . . . . . 0.583 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.4 mt-30 -42.15 114.51 0.56 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 112.755 -2.02 . . . . 0.0 112.887 176.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.11 -156.96 28.73 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.13 171.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 15.6 p -51.67 100.35 0.03 OUTLIER 'General case' 0 C--O 1.235 0.306 0 CA-C-N 117.016 0.408 . . . . 0.0 111.274 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.621 ' HD2' ' O ' ' B' ' 80' ' ' GLY . 20.8 pttp 42.28 41.06 1.99 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.462 1.105 . . . . 0.0 112.225 -175.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.448 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 58.9 tt0 -59.23 136.43 88.38 Favored Pre-proline 0 C--O 1.234 0.283 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' PRO . . . . . 0.552 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 37.6 Cg_exo -51.69 123.05 11.43 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.13 1.887 . . . . 0.0 109.652 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' TYR . . . . . 0.836 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 9.5 t80 -69.6 -53.93 11.61 Favored Pre-proline 0 N--CA 1.437 -1.089 0 CA-C-O 118.313 -0.851 . . . . 0.0 112.958 -166.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.556 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 31.2 Cg_exo -55.4 -20.29 25.43 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 121.483 1.455 . . . . 0.0 111.066 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.552 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 3.1 m-20 -89.93 -39.17 13.18 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.019 -1.446 . . . . 0.0 111.023 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' PHE . . . . . 0.583 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -55.81 -45.59 78.26 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.307 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.745 HG12 ' O ' ' B' ' 14' ' ' TYR . 1.5 p -81.46 -31.69 11.48 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.063 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.576 -177.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.2 -33.83 69.71 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 121.402 -0.811 . . . . 0.0 111.737 176.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.71 ' O ' HG12 ' B' ' 24' ' ' VAL . 15.2 ptt180 -84.43 -26.47 28.24 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.604 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 6.7 tp -56.86 -46.77 81.57 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.912 172.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' GLN . . . . . 0.69 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 32.5 mt-30 -73.18 -44.31 60.05 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.835 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.725 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 20.5 t70 -49.15 -56.15 10.1 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 124.192 0.932 . . . . 0.0 111.649 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' VAL . . . . . 0.71 HG12 ' O ' ' B' ' 20' ' ' ARG . 6.5 p -80.31 -22.52 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.922 -173.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.673 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -68.15 -28.97 67.76 Favored 'General case' 0 C--O 1.203 -1.342 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 173.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' GLN . . . . . 0.463 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -80.23 -36.59 34.52 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.359 -1.291 . . . . 0.0 109.962 -178.498 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.725 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.9 mmtt -66.97 -32.35 73.53 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.502 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 16.9 m -105.5 -12.05 16.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.123 0.487 . . . . 0.0 110.765 -171.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.673 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 88.3 mt -116.44 134.24 60.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.083 -177.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.45 -4.27 34.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.382 0.611 . . . . 0.0 110.436 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.558 ' H ' HG22 ' B' ' 29' ' ' ILE . 11.3 t70 -105.43 107.68 18.79 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.722 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.568 ' OE2' ' HG3' ' B' ' 33' ' ' LYS . 0.0 OUTLIER -53.01 -32.22 45.45 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.213 179.487 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.614 ' O ' HG13 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -73.58 -50.23 22.32 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -173.593 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.587 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -62.16 -27.83 69.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.466 175.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.852 ' O ' HG13 ' B' ' 39' ' ' VAL . 3.5 tmm_? -67.43 -57.12 7.13 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.466 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 19.0 mtpt -59.11 -54.76 43.35 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.314 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.751 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 19.6 m -54.73 -33.82 28.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.073 -173.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.776 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.2 tt -86.41 -31.64 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.462 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.852 HG13 ' O ' ' B' ' 35' ' ' ARG . 3.0 m -67.43 -49.95 66.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 119.039 -1.065 . . . . 0.0 109.809 173.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.624 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 60.8 mt-10 -63.6 -26.5 68.72 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.506 0.722 . . . . 0.0 112.599 177.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.751 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.61 -52.0 6.1 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.436 -0.505 . . . . 0.0 111.469 177.487 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 42' ' ' MET . . . . . 0.597 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 18.7 mmt -64.66 -20.39 66.27 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.75 0.786 . . . . 0.0 109.256 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.656 ' O ' ' HB2' ' B' ' 47' ' ' ALA . . . -50.82 -28.92 10.4 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.563 171.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' TYR . . . . . 0.519 ' CG ' ' HD2' ' B' ' 59' ' ' LYS . 25.1 t80 -104.09 -68.71 0.83 Allowed 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.48 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 10.5 mm-40 -48.39 -31.92 6.86 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.091 0.87 . . . . 0.0 112.687 -175.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.802 ' O ' ' HB3' ' B' ' 7' ' ' ARG . 4.5 m-20 -103.88 -16.91 15.23 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 120.659 0.266 . . . . 0.0 111.533 -175.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -63.24 178.67 0.49 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.909 0.862 . . . . 0.0 111.978 -177.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.664 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 17.6 m-20 -60.25 142.74 89.79 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.077 172.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' PRO . . . . . 0.421 ' HB2' HD21 ' B' ' 92' ' ' LEU . 10.9 Cg_endo -56.08 -21.54 35.31 Favored 'Trans proline' 0 C--O 1.218 -0.518 0 C-N-CA 123.19 2.593 . . . . 0.0 112.516 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.688 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 11.7 pm0 -88.95 -32.9 17.44 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 123.557 0.743 . . . . 0.0 110.743 174.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.688 ' N ' ' HG2' ' B' ' 50' ' ' GLU . 72.1 m -81.31 -38.06 27.38 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.41 -171.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.6 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.3 pt20 -68.89 -30.01 68.41 Favored 'General case' 0 C--O 1.211 -0.927 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 172.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' SER . . . . . 0.637 ' HB3' ' HB3' ' B' ' 91' ' ' GLN . 6.2 m -72.18 -21.16 61.47 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 113.941 -1.481 . . . . 0.0 110.478 176.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.595 ' HB2' HD11 ' B' ' 79' ' ' ILE . . . -76.21 -25.8 55.48 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.767 0.794 . . . . 0.0 109.466 168.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.6 HD12 ' HA ' ' B' ' 52' ' ' GLN . 22.7 mt -90.28 -33.5 5.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -172.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.619 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.41 -39.17 2.04 Favored Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -172.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 52.5 Cg_endo -62.95 -31.31 77.14 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.115 1.876 . . . . 0.0 112.554 175.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' LEU . . . . . 0.536 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 2.5 mt -93.92 -17.07 23.37 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.601 ' HA ' ' OH ' ' B' ' 72' ' ' TYR . 0.0 OUTLIER -54.7 108.96 0.44 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.47 179.71 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.03 -23.86 34.36 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.626 -177.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -104.47 113.89 27.76 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.098 0.475 . . . . 0.0 110.295 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.471 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.2 p -123.48 141.81 37.27 Favored Pre-proline 0 C--N 1.309 -1.162 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 168.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.517 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 73.0 Cg_exo -51.67 139.33 48.47 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.296 1.997 . . . . 0.0 111.631 170.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.93 103.45 0.45 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.03 -177.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.18 -14.52 40.07 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.892 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.517 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 24.0 m -93.07 170.8 9.37 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.09 0.471 . . . . 0.0 111.36 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.86 141.78 28.54 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.568 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.7 OUTLIER -77.29 -28.5 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 C-N-CA 118.201 -1.399 . . . . 0.0 108.921 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.774 ' O ' HG13 ' B' ' 73' ' ' VAL . 11.2 mm -57.91 -46.56 87.51 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.112 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.169 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 30.2 t -45.93 -38.38 7.49 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.184 176.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -86.17 -32.25 21.35 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.245 0.545 . . . . 0.0 111.001 -177.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' TYR . . . . . 0.611 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.1 m-30 -75.36 -34.21 61.13 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.374 -176.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.836 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.6 m -72.26 -31.64 39.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 172.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 74' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' B' ' 77' ' ' ASP . 0.0 OUTLIER -68.08 -30.84 70.12 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.274 176.474 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 75' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -63.72 -49.15 74.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.843 -1.072 . . . . 0.0 109.833 177.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.756 ' SG ' ' HB ' ' B' ' 79' ' ' ILE . 32.1 t -89.58 9.14 27.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.78 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 77' ' ' ASP . . . . . 0.457 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 21.1 t70 -66.5 -19.83 65.88 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.344 0.592 . . . . 0.0 109.681 174.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -96.5 -8.13 57.58 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.856 172.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.756 ' HB ' ' SG ' ' B' ' 76' ' ' CYS . 99.2 mt -97.95 127.87 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-O 121.192 0.52 . . . . 0.0 111.452 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 80' ' ' GLY . . . . . 0.621 ' O ' ' HD2' ' B' ' 11' ' ' LYS . . . 159.09 -25.63 0.35 Allowed Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.283 174.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.28 138.15 5.08 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.139 172.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 66.08 -74.79 0.06 Allowed 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 123.255 0.622 . . . . 0.0 111.807 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' MET . . . . . . . . . . . . . 75.6 mtm -59.25 -34.24 71.99 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 120.715 0.293 . . . . 0.0 110.596 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 84' ' ' HIS . . . . . 0.605 ' HB2' ' H ' ' B' ' 80' ' ' GLY . 4.7 t-160 -49.61 -46.29 49.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.848 172.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.577 ' HA ' ' HB2' ' B' ' 88' ' ' LEU . 93.9 mttt -87.09 -19.53 28.43 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.987 -172.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.99 -45.09 59.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.622 0.725 . . . . 0.0 109.522 169.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 66.6 mtt -77.85 -13.32 59.93 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.222 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.577 ' HB2' ' HA ' ' B' ' 85' ' ' LYS . 0.1 OUTLIER -57.89 -37.94 74.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.943 -179.055 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 47.0 ttm -83.66 -21.27 32.49 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.151 0.501 . . . . 0.0 110.707 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -90.71 -50.14 6.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.952 -175.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 91' ' ' GLN . . . . . 0.647 ' O ' ' HG2' ' B' ' 93' ' ' GLU . 94.8 mt-30 -88.39 -54.54 4.14 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.379 -172.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.461 ' HB2' HD12 ' B' ' 88' ' ' LEU . 0.0 OUTLIER -50.72 -37.84 43.88 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 175.895 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.647 ' HG2' ' O ' ' B' ' 91' ' ' GLN . 5.2 pt-20 . . . . . 0 C--O 1.248 1.005 0 CA-C-N 113.14 -1.845 . . . . 0.0 113.358 -176.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.443 ' HB2' ' H ' ' A' ' 2' ' ' SER . 87.6 Cg_endo . . . . . 0 CA--C 1.518 -0.301 0 N-CA-C 108.856 -1.248 . . . . 0.0 108.856 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.443 ' H ' ' HB2' ' A' ' 1' ' ' PRO . 15.0 m -67.26 176.33 2.29 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 162.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.79 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -73.66 -52.69 12.49 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 166.099 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.515 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 2.4 p-10 -85.63 5.78 30.35 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.858 -1.519 . . . . 0.0 113.489 -165.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.07 -4.19 3.3 Favored 'General case' 0 C--N 1.315 -0.904 0 O-C-N 121.94 -0.475 . . . . 0.0 111.615 -176.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.608 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.0 m -77.86 133.01 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.797 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -154.63 159.42 40.8 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -179.671 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.427 ' HG2' ' HB3' ' A' ' 12' ' ' GLU . 2.1 tt0 -45.31 112.75 0.48 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 113.268 -1.787 . . . . 0.0 112.57 -177.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.13 -150.59 18.56 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.507 173.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 27.2 m -51.98 95.45 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.95 0.375 . . . . 0.0 111.407 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.1 pttp 37.76 43.47 0.48 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.385 1.074 . . . . 0.0 112.254 -172.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.427 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 50.3 tt0 -56.46 138.14 75.8 Favored Pre-proline 0 C--O 1.234 0.241 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.55 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 33.8 Cg_exo -53.68 121.87 10.31 Favored 'Trans proline' 0 CA--C 1.51 -0.722 0 C-N-CA 121.806 1.671 . . . . 0.0 109.476 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.824 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 14.5 t80 -71.91 -52.21 7.98 Favored Pre-proline 0 N--CA 1.438 -1.046 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -165.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.539 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 38.7 Cg_exo -56.52 -18.2 24.73 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 121.447 1.431 . . . . 0.0 110.691 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.55 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.5 m-20 -90.21 -42.34 11.08 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 113.754 -1.566 . . . . 0.0 110.874 178.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.517 ' CE2' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -55.02 -45.55 75.16 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 176.537 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.785 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 1.8 p -78.97 -34.41 16.81 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.402 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.6 -31.82 68.41 Favored 'General case' 0 C--N 1.318 -0.761 0 O-C-N 121.529 -0.732 . . . . 0.0 111.807 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.684 ' O ' HG12 ' A' ' 24' ' ' VAL . 15.7 ptt180 -84.3 -26.78 28.28 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 175.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.553 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 5.9 tp -58.27 -46.49 85.92 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.918 173.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.785 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 5.0 mt-30 -70.69 -47.28 60.67 Favored 'General case' 0 CA--C 1.493 -1.247 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.3 177.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.729 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 8.9 t70 -49.77 -51.96 35.37 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.531 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.684 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.2 p -81.08 -23.78 10.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.181 0.515 . . . . 0.0 109.719 -174.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.785 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -72.01 -19.15 61.9 Favored 'General case' 0 C--O 1.204 -1.335 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 174.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.412 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -86.59 -36.36 18.91 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.574 178.192 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.729 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.6 mmtt -67.26 -37.86 84.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.95 -1.023 . . . . 0.0 112.015 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.405 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 44.5 m -101.76 -10.38 20.0 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.163 0.506 . . . . 0.0 110.645 -172.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.785 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 85.5 mt -112.38 130.24 66.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.819 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.23 -0.93 57.39 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.068 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.674 ' H ' HG22 ' A' ' 29' ' ' ILE . 0.9 OUTLIER -121.55 127.74 51.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.347 0.594 . . . . 0.0 111.901 -178.09 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -56.49 -31.98 64.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.86 175.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.652 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 26.1 mttt -62.29 -61.12 2.67 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -177.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.584 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -61.94 -24.55 67.05 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.348 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.862 ' O ' HG13 ' A' ' 39' ' ' VAL . 1.7 tmm_? -69.7 -57.92 4.55 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.419 ' O ' HG22 ' A' ' 39' ' ' VAL . 20.9 mtpt -57.21 -55.65 31.94 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.943 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.725 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 19.7 m -53.93 -36.02 29.7 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.312 -170.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.79 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.2 tt -87.5 -28.97 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.96 -178.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.862 HG13 ' O ' ' A' ' 35' ' ' ARG . 3.0 m -70.1 -49.22 57.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 119.11 -1.036 . . . . 0.0 109.326 175.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.639 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 66.1 mt-10 -63.49 -24.22 67.73 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.805 0.842 . . . . 0.0 112.259 176.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.725 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -86.09 -56.99 3.2 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 177.147 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.515 ' HG3' ' HB2' ' A' ' 4' ' ' ASN . 20.7 mmt -62.44 -20.74 64.82 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.585 0.707 . . . . 0.0 109.792 -177.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.67 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -49.18 -28.23 4.26 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.539 170.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.567 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 5.7 t80 -108.22 -67.92 0.94 Allowed 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 175.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.673 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 5.2 mm-40 -46.9 -31.89 3.42 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 124.421 1.075 . . . . 0.0 112.179 -173.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.797 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.9 m-20 -104.8 -21.17 13.39 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -176.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -60.4 -179.13 0.1 Allowed 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.954 0.883 . . . . 0.0 112.974 -173.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -57.01 139.72 78.41 Favored Pre-proline 0 N--CA 1.443 -0.786 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.011 175.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.95 -23.31 42.42 Favored 'Trans proline' 0 C--O 1.222 -0.304 0 C-N-CA 123.209 2.606 . . . . 0.0 112.082 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 53' ' ' SER . 0.0 OUTLIER -88.12 -30.18 20.04 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.702 0.801 . . . . 0.0 110.505 174.194 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.947 ' SG ' ' HB2' ' A' ' 76' ' ' CYS . 43.8 t -83.24 -36.76 24.32 Favored 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.548 -170.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.555 ' HB2' ' CG ' ' A' ' 44' ' ' TYR . 4.1 pt20 -67.37 -30.35 70.12 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 171.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.677 ' HB3' ' C ' ' A' ' 91' ' ' GLN . 17.1 m -69.95 -20.3 63.34 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 113.377 -1.738 . . . . 0.0 110.852 173.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.77 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -81.16 -24.75 37.36 Favored 'General case' 0 C--N 1.312 -1.039 0 O-C-N 121.399 -0.813 . . . . 0.0 110.014 167.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.536 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 25.4 mt -90.3 -30.81 5.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -171.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.615 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.37 -40.03 2.58 Favored Pre-proline 0 N--CA 1.487 1.38 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -174.458 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 49.9 Cg_endo -62.42 -27.5 77.34 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.313 2.009 . . . . 0.0 112.794 176.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.536 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.0 OUTLIER -100.52 -15.86 17.71 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.567 ' HE3' ' HB3' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -53.45 109.22 0.42 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.252 -177.924 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.468 ' N ' ' HZ3' ' A' ' 59' ' ' LYS . . . 92.43 -20.64 42.79 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.34 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -103.87 113.63 27.29 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.403 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.3 p -122.92 144.15 42.26 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 173.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.551 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 97.3 Cg_exo -46.6 139.11 13.79 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.153 1.902 . . . . 0.0 111.329 168.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.71 96.63 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.963 -173.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.54 -3.7 46.61 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.954 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.551 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 13.1 m -95.28 179.35 5.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.214 0.531 . . . . 0.0 111.227 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.759 ' OD1' ' HB ' ' A' ' 69' ' ' ILE . 5.4 t70 -87.65 137.28 32.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.378 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.604 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -79.81 -28.84 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 C-N-CA 118.224 -1.39 . . . . 0.0 109.173 179.218 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.784 ' O ' HG13 ' A' ' 73' ' ' VAL . 11.7 mm -60.57 -46.2 95.97 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.016 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.94 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.3 t -44.58 -38.93 4.56 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.146 175.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.482 ' O ' ' HE2' ' A' ' 74' ' ' LYS . 7.0 mm-40 -85.84 -32.04 21.95 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 123.55 0.74 . . . . 0.0 111.419 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.583 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.0 m-30 -75.41 -34.6 61.04 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.513 0.673 . . . . 0.0 109.421 -176.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.824 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.4 m -71.81 -32.09 43.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 172.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.482 ' HE2' ' O ' ' A' ' 71' ' ' GLU . 13.3 ttpt -71.66 -25.94 62.33 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.406 177.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -65.21 -46.6 80.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.806 174.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.947 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 40.5 t -87.46 0.8 55.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.158 178.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -66.01 -14.14 61.13 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.64 0.733 . . . . 0.0 109.579 175.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.45 -13.29 28.7 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.417 172.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.77 HD11 ' HB2' ' A' ' 54' ' ' ALA . 77.3 mt -79.78 -88.91 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 117.296 0.548 . . . . 0.0 111.377 -178.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.404 ' N ' HG22 ' A' ' 79' ' ' ILE . . . 41.29 -109.47 0.16 Allowed Glycine 0 C--N 1.338 0.676 0 O-C-N 123.525 0.515 . . . . 0.0 113.317 -175.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.37 166.29 15.85 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 111.659 -0.576 . . . . 0.0 111.659 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 68.25 -71.13 0.12 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.085 0.554 . . . . 0.0 111.756 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 79.5 mtp -66.01 -30.77 71.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.015 0.436 . . . . 0.0 110.038 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.536 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 8.6 t60 -57.95 -31.6 67.01 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.765 173.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -82.6 -16.48 48.29 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.259 0.552 . . . . 0.0 110.148 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.26 -47.23 10.27 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.364 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 8.0 mtt -82.99 -14.17 54.54 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.629 -172.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.536 ' HB2' ' O ' ' A' ' 84' ' ' HIS . 0.5 OUTLIER -51.07 -35.43 34.79 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 123.563 0.539 . . . . 0.0 111.849 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 55.3 ttm -83.51 -18.33 38.86 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.947 0.403 . . . . 0.0 110.94 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -95.97 -54.73 3.22 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -174.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.677 ' C ' ' HB3' ' A' ' 53' ' ' SER . 97.4 mt-30 -80.93 -55.01 5.08 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.277 -174.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.408 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -49.55 -34.56 17.86 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 175.189 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.655 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 8.9 pt-20 . . . . . 0 C--O 1.252 1.235 0 CA-C-N 113.415 -1.721 . . . . 0.0 113.586 -174.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 1' ' ' PRO . . . . . 0.403 ' HB2' ' H ' ' B' ' 2' ' ' SER . 88.6 Cg_endo . . . . . 0 CA--C 1.518 -0.297 0 N-CA-C 108.762 -1.284 . . . . 0.0 108.762 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.403 ' H ' ' HB2' ' B' ' 1' ' ' PRO . 14.7 m -67.56 176.01 2.59 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 162.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.762 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -73.37 -52.65 13.06 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.085 -1.046 . . . . 0.0 108.286 166.265 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.524 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.4 p-10 -85.77 5.84 30.65 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 113.936 -1.483 . . . . 0.0 113.429 -165.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.92 -4.42 3.31 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 118.256 0.48 . . . . 0.0 111.707 -176.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.608 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 1.9 m -77.62 133.16 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.78 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.1 OUTLIER -155.0 159.08 40.08 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -179.65 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 8' ' ' GLN . . . . . 0.432 ' HG2' ' HB3' ' B' ' 12' ' ' GLU . 2.1 tt0 -45.01 112.65 0.46 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 113.211 -1.813 . . . . 0.0 112.584 -177.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.08 -150.52 18.3 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.411 173.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 33.3 m -52.07 95.17 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 117.023 0.411 . . . . 0.0 111.49 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 21.0 pttp 37.9 43.93 0.56 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.438 1.095 . . . . 0.0 111.99 -172.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.432 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 52.0 tt0 -56.75 138.1 77.84 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.411 177.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' PRO . . . . . 0.55 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 33.6 Cg_exo -53.67 122.12 10.75 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 121.737 1.625 . . . . 0.0 109.477 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' TYR . . . . . 0.826 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 14.6 t80 -72.17 -52.22 7.44 Favored Pre-proline 0 N--CA 1.438 -1.04 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -165.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.534 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 37.7 Cg_exo -56.52 -18.01 24.06 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 121.547 1.498 . . . . 0.0 110.685 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.55 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.6 m-20 -90.39 -42.52 10.87 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.846 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' PHE . . . . . 0.511 ' CE2' HD22 ' B' ' 21' ' ' LEU . 0.0 OUTLIER -54.91 -45.8 74.78 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.554 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.785 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 1.7 p -78.77 -34.52 17.4 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.289 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.281 -178.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.94 -31.23 68.51 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 121.485 -0.76 . . . . 0.0 111.843 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.681 ' O ' HG12 ' B' ' 24' ' ' VAL . 15.6 ptt180 -84.67 -26.41 27.78 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 175.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.562 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 5.9 tp -58.54 -46.53 86.63 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.933 172.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' GLN . . . . . 0.785 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 5.0 mt-30 -70.58 -47.29 60.99 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.256 177.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.727 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 8.3 t70 -49.85 -51.8 37.4 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 124.202 0.938 . . . . 0.0 111.576 -177.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' VAL . . . . . 0.681 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.2 p -81.17 -23.83 10.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -174.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.788 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -71.77 -19.3 62.04 Favored 'General case' 0 C--O 1.204 -1.294 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 174.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.6 -36.31 18.93 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.531 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.727 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.9 mmtt -67.36 -37.61 83.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.142 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 46.5 m -101.85 -10.63 19.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.194 0.521 . . . . 0.0 110.712 -172.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.788 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 85.4 mt -112.36 130.24 66.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.748 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.23 -0.67 57.4 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.001 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.677 ' H ' HG22 ' B' ' 29' ' ' ILE . 0.9 OUTLIER -121.82 127.85 51.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.326 0.584 . . . . 0.0 112.069 -178.172 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -56.66 -31.8 64.76 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.825 176.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.644 ' HD2' ' OD1' ' B' ' 31' ' ' ASP . 25.9 mttt -62.48 -61.0 2.74 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -177.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.562 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -62.0 -24.51 67.08 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.413 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.861 ' O ' HG13 ' B' ' 39' ' ' VAL . 1.7 tmm_? -69.83 -57.81 4.64 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.401 ' O ' HG22 ' B' ' 39' ' ' VAL . 20.6 mtpt -57.28 -55.52 33.75 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.948 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.736 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 19.8 m -54.07 -35.92 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.325 -170.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.762 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.2 tt -87.52 -29.13 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 C-N-CA 119.744 -0.783 . . . . 0.0 111.932 -178.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.861 HG13 ' O ' ' B' ' 35' ' ' ARG . 3.0 m -69.88 -49.4 57.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 119.156 -1.018 . . . . 0.0 109.318 175.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.64 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 66.4 mt-10 -63.41 -24.11 67.69 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.812 0.845 . . . . 0.0 112.377 176.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.736 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -86.21 -56.98 3.19 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 177.114 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 42' ' ' MET . . . . . 0.524 ' HG3' ' HB2' ' B' ' 4' ' ' ASN . 20.8 mmt -62.5 -20.76 64.92 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-O 121.524 0.678 . . . . 0.0 109.812 -177.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.67 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -48.88 -28.4 3.75 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.673 -1.148 . . . . 0.0 110.603 170.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' TYR . . . . . 0.589 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 5.6 t80 -108.17 -67.68 0.95 Allowed 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 175.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.682 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 5.0 mm-40 -46.94 -32.19 3.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 124.433 1.083 . . . . 0.0 112.109 -173.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.78 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 5.0 m-20 -104.59 -21.21 13.45 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -176.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.607 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -60.44 -179.27 0.11 Allowed 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.928 0.87 . . . . 0.0 112.95 -173.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -56.95 139.67 78.09 Favored Pre-proline 0 N--CA 1.444 -0.758 0 CA-C-N 114.403 -1.272 . . . . 0.0 108.892 175.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.78 -23.31 41.07 Favored 'Trans proline' 0 C--O 1.222 -0.321 0 C-N-CA 123.288 2.659 . . . . 0.0 112.12 -177.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' B' ' 50' ' ' GLU . 0.0 OUTLIER -88.16 -30.27 19.92 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.482 174.181 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.946 ' SG ' ' HB2' ' B' ' 76' ' ' CYS . 43.7 t -83.19 -36.53 24.61 Favored 'General case' 0 N--CA 1.426 -1.662 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.614 -170.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.562 ' HB2' ' CG ' ' B' ' 44' ' ' TYR . 4.2 pt20 -67.66 -30.24 69.74 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 171.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' SER . . . . . 0.669 ' HB3' ' C ' ' B' ' 91' ' ' GLN . 14.7 m -69.94 -20.27 63.34 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 113.343 -1.753 . . . . 0.0 110.727 173.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.796 ' HB2' HD11 ' B' ' 79' ' ' ILE . . . -81.3 -24.73 37.0 Favored 'General case' 0 C--N 1.313 -1.018 0 O-C-N 121.448 -0.782 . . . . 0.0 109.973 167.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.541 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 25.3 mt -90.22 -30.93 5.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -171.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.615 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.29 -40.07 2.51 Favored Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -174.477 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 49.4 Cg_endo -62.39 -27.39 77.4 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.32 2.013 . . . . 0.0 112.801 176.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' LEU . . . . . 0.543 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.0 OUTLIER -100.87 -15.76 17.46 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.589 ' HE3' ' HB3' ' B' ' 44' ' ' TYR . 0.1 OUTLIER -53.41 109.34 0.43 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.172 -178.098 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.47 ' N ' ' HZ3' ' B' ' 59' ' ' LYS . . . 92.09 -20.54 42.39 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.319 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 10.4 mmmt -103.79 113.54 27.13 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.412 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.3 p -122.75 144.19 42.06 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 173.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.57 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 96.7 Cg_exo -46.79 139.25 14.24 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.14 1.893 . . . . 0.0 111.392 168.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.19 96.34 0.05 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.958 -173.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.62 -3.47 46.18 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.888 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.57 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 14.6 m -95.42 179.13 5.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.178 0.513 . . . . 0.0 111.198 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 67' ' ' ASP . . . . . 0.757 ' OD1' ' HB ' ' B' ' 69' ' ' ILE . 5.0 t70 -87.36 137.52 32.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.459 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.583 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.8 OUTLIER -79.87 -28.96 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 C-N-CA 118.306 -1.357 . . . . 0.0 109.178 179.302 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.779 ' O ' HG13 ' B' ' 73' ' ' VAL . 11.4 mm -60.47 -46.37 95.43 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.988 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.878 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 29.6 t -44.27 -39.09 4.26 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.034 175.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.493 ' O ' ' HE2' ' B' ' 74' ' ' LYS . 6.3 mm-40 -86.16 -31.78 21.61 Favored 'General case' 0 C--O 1.216 -0.694 0 C-N-CA 123.445 0.698 . . . . 0.0 111.364 -177.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 72' ' ' TYR . . . . . 0.579 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.0 m-30 -75.51 -34.65 60.82 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.574 0.702 . . . . 0.0 109.328 -177.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.826 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.4 m -71.79 -31.82 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 173.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 74' ' ' LYS . . . . . 0.493 ' HE2' ' O ' ' B' ' 71' ' ' GLU . 13.4 ttpt -71.76 -26.18 62.34 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.458 -1.247 . . . . 0.0 109.437 177.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 75' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -65.28 -46.46 80.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.741 174.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.946 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 39.6 t -87.43 0.55 55.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.167 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.83 -14.36 61.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.632 0.73 . . . . 0.0 109.551 174.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.13 -13.42 29.01 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.463 172.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.796 HD11 ' HB2' ' B' ' 54' ' ' ALA . 78.0 mt -79.55 -89.37 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 117.203 0.501 . . . . 0.0 111.328 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 80' ' ' GLY . . . . . 0.407 ' N ' HG22 ' B' ' 79' ' ' ILE . . . 41.78 -109.57 0.18 Allowed Glycine 0 C--N 1.339 0.724 0 O-C-N 123.653 0.595 . . . . 0.0 113.191 -175.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.37 166.72 15.74 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.692 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 67.87 -71.05 0.11 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.16 0.584 . . . . 0.0 111.63 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 83' ' ' MET . . . . . . . . . . . . . 79.5 mtp -65.81 -31.01 71.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.006 0.431 . . . . 0.0 110.036 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 84' ' ' HIS . . . . . 0.54 ' O ' ' HB2' ' B' ' 88' ' ' LEU . 8.8 t60 -57.84 -31.71 66.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.844 173.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -82.47 -16.46 48.75 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.174 0.511 . . . . 0.0 110.08 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.54 -46.64 10.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.431 175.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 8.1 mtt -83.36 -14.06 53.65 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.578 -173.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.54 ' HB2' ' O ' ' B' ' 84' ' ' HIS . 0.5 OUTLIER -51.02 -35.48 34.4 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 123.588 0.555 . . . . 0.0 111.815 179.853 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 54.2 ttm -83.55 -18.43 38.38 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.903 0.382 . . . . 0.0 110.872 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -95.87 -54.53 3.3 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -174.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 91' ' ' GLN . . . . . 0.669 ' C ' ' HB3' ' B' ' 53' ' ' SER . 97.3 mt-30 -81.0 -55.31 4.87 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.135 -174.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.414 ' HB2' HD12 ' B' ' 88' ' ' LEU . 0.0 OUTLIER -49.61 -34.34 17.71 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 175.367 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.66 ' HG2' ' O ' ' B' ' 91' ' ' GLN . 8.9 pt-20 . . . . . 0 C--O 1.253 1.257 0 CA-C-N 113.415 -1.721 . . . . 0.0 113.514 -175.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.466 ' HB2' ' H ' ' A' ' 2' ' ' SER . 81.8 Cg_endo . . . . . 0 CA--C 1.518 -0.313 0 N-CA-C 108.666 -1.321 . . . . 0.0 108.666 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.466 ' H ' ' HB2' ' A' ' 1' ' ' PRO . 16.4 m -67.57 -178.9 0.97 Allowed 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 162.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.776 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -77.11 -51.84 10.33 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 164.713 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.514 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 2.3 p-10 -87.28 5.93 35.88 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 113.913 -1.494 . . . . 0.0 113.896 -164.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.458 HG23 ' HB2' ' A' ' 2' ' ' SER . 0.8 OUTLIER -63.77 -5.65 4.53 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 118.784 0.72 . . . . 0.0 111.52 -176.743 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.488 ' O ' HD13 ' A' ' 21' ' ' LEU . 2.0 m -78.16 130.31 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 176.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.746 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -155.72 158.74 38.73 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -178.37 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.463 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.6 mt-30 -39.07 116.65 0.6 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.624 -1.626 . . . . 0.0 113.551 176.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.29 -155.84 32.23 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.573 169.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.6 m -48.25 100.51 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 117.481 0.64 . . . . 0.0 111.678 -177.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.3 pttt 38.24 42.67 0.52 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.295 1.038 . . . . 0.0 112.335 -173.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.412 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 26.5 tt0 -57.46 138.26 81.43 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.267 176.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.527 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 37.0 Cg_exo -53.8 122.4 11.28 Favored 'Trans proline' 0 CA--C 1.505 -0.944 0 C-N-CA 121.84 1.693 . . . . 0.0 109.265 177.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.74 ' O ' HG12 ' A' ' 18' ' ' VAL . 11.6 t80 -70.66 -53.92 8.89 Favored Pre-proline 0 N--CA 1.434 -1.241 0 CA-C-O 118.454 -0.784 . . . . 0.0 112.908 -166.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.546 ' HD3' ' HB3' ' A' ' 14' ' ' TYR . 36.3 Cg_exo -56.18 -18.2 22.86 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 121.453 1.435 . . . . 0.0 110.825 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.527 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 2.8 m-20 -89.53 -42.79 11.24 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.977 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.68 ' HE2' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -53.78 -46.55 71.06 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 176.63 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.768 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 1.3 p -79.27 -34.52 16.41 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.369 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.615 -177.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.5 -32.61 67.19 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 121.335 -0.853 . . . . 0.0 111.674 178.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.723 ' O ' HG12 ' A' ' 24' ' ' VAL . 16.6 ptt180 -84.36 -27.12 27.92 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 176.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.655 HD22 ' CE1' ' A' ' 17' ' ' PHE . 6.7 tp -56.56 -47.26 79.88 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.996 172.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.768 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 3.7 mt-30 -71.3 -47.1 58.85 Favored 'General case' 0 CA--C 1.493 -1.236 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.995 177.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.733 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 17.6 t70 -47.22 -54.83 9.82 Favored 'General case' 0 C--N 1.313 -1.015 0 O-C-N 124.297 0.998 . . . . 0.0 111.502 -178.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.723 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.5 p -81.23 -23.31 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.162 0.506 . . . . 0.0 109.983 -174.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.76 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -72.07 -19.5 61.81 Favored 'General case' 0 C--O 1.204 -1.318 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 174.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.431 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -86.25 -36.65 19.25 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.616 178.047 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.733 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 37.8 mmtt -66.9 -38.12 85.66 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.956 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.407 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 50.2 m -101.83 -8.85 21.29 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.166 0.508 . . . . 0.0 110.658 -171.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.76 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 88.7 mt -114.59 135.68 53.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.717 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.56 -2.25 42.14 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.003 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.687 ' H ' HG22 ' A' ' 29' ' ' ILE . 4.8 t0 -117.63 132.38 56.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.11 0.481 . . . . 0.0 111.048 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.603 ' OE1' ' HG3' ' A' ' 33' ' ' LYS . 1.6 pp20? -59.95 -35.39 74.85 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.285 174.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.606 ' O ' HG13 ' A' ' 37' ' ' VAL . 13.2 mttp -61.53 -58.74 6.91 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -175.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.524 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -61.9 -27.03 68.52 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.494 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.844 ' O ' HG13 ' A' ' 39' ' ' VAL . 5.0 tmm_? -70.4 -58.38 3.79 Favored 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.465 ' HD2' ' OE2' ' A' ' 32' ' ' GLU . 18.4 mtpt -56.14 -55.85 28.09 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.867 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.775 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 22.5 m -53.79 -36.49 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.228 -171.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.776 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.3 tt -87.0 -29.73 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.826 -177.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.844 HG13 ' O ' ' A' ' 35' ' ' ARG . 3.0 m -69.95 -48.95 60.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 119.089 -1.044 . . . . 0.0 109.488 175.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.582 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 54.1 mt-10 -64.93 -23.33 67.19 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.533 0.733 . . . . 0.0 112.545 176.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.775 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -85.78 -55.45 3.96 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.63 176.391 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.583 ' HB2' HD21 ' A' ' 21' ' ' LEU . 22.5 mmt -62.65 -20.42 64.79 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.698 0.761 . . . . 0.0 109.372 -178.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.653 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -48.28 -29.48 3.89 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.794 170.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.567 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 10.3 t80 -108.15 -66.39 1.04 Allowed 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.648 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 13.9 mm-40 -48.08 -32.66 7.05 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 124.266 0.979 . . . . 0.0 112.1 -174.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.746 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.9 m-20 -103.75 -20.6 13.89 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.326 -175.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.653 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -59.77 -179.94 0.11 Allowed 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 122.023 0.915 . . . . 0.0 112.681 -174.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.541 ' HB3' ' OE2' ' A' ' 50' ' ' GLU . 13.0 m-20 -58.6 140.52 85.0 Favored Pre-proline 0 N--CA 1.439 -1.016 0 CA-C-N 114.213 -1.358 . . . . 0.0 109.335 174.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -57.73 -20.83 44.78 Favored 'Trans proline' 0 C--O 1.222 -0.321 0 C-N-CA 123.228 2.619 . . . . 0.0 112.166 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.708 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 8.9 pm0 -88.58 -30.92 18.91 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 123.521 0.728 . . . . 0.0 110.255 173.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.986 ' SG ' ' HB2' ' A' ' 76' ' ' CYS . 49.5 t -85.46 -37.08 20.15 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.952 -168.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.567 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.7 pt20 -67.52 -28.94 68.24 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 171.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.685 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 32.8 m -71.88 -20.97 61.72 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 113.166 -1.834 . . . . 0.0 110.318 174.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.562 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -78.8 -24.32 44.64 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.41 0.624 . . . . 0.0 110.184 167.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.567 HD12 ' HA ' ' A' ' 52' ' ' GLN . 21.4 mt -90.89 -32.95 5.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -171.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.621 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.28 -38.95 1.79 Allowed Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -173.652 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 43.0 Cg_endo -61.61 -29.72 84.64 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 122.164 1.91 . . . . 0.0 112.636 175.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.539 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.5 mt -98.13 -16.51 19.49 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -179.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.575 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 0.1 OUTLIER -54.73 108.64 0.41 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.597 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.85 -25.37 28.55 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.56 -177.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.3 mmmt -103.99 113.49 27.06 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.046 0.45 . . . . 0.0 110.355 -178.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.448 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.2 p -124.42 145.53 49.22 Favored Pre-proline 0 C--N 1.313 -1.016 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 170.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.561 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 85.0 Cg_exo -50.4 138.82 38.04 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.395 2.063 . . . . 0.0 111.443 167.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.11 102.13 0.6 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.482 -175.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.17 -8.57 41.86 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.609 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.561 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 12.4 m -98.38 170.24 8.99 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.09 0.471 . . . . 0.0 111.163 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.28 136.64 35.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.345 176.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.538 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.7 OUTLIER -75.17 -27.64 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 C-N-CA 119.018 -1.073 . . . . 0.0 108.606 178.736 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.813 ' O ' HG13 ' A' ' 73' ' ' VAL . 17.7 mm -57.15 -47.02 84.7 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.211 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.332 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.9 t -46.77 -36.41 7.25 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.161 0.505 . . . . 0.0 111.237 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.652 ' O ' ' HE3' ' A' ' 74' ' ' LYS . 1.7 mm-40 -85.85 -32.91 21.46 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.45 -177.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.647 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 4.9 m-30 -75.31 -33.46 61.17 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.374 -177.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.813 HG13 ' O ' ' A' ' 69' ' ' ILE . 1.2 m -71.66 -31.15 41.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 171.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.652 ' HE3' ' O ' ' A' ' 71' ' ' GLU . 0.7 OUTLIER -72.0 -24.15 61.52 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.654 176.876 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -66.33 -47.34 73.84 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.404 173.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.986 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 43.9 t -88.97 7.76 33.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.051 178.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -63.31 -18.62 63.81 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.271 0.558 . . . . 0.0 109.894 172.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -98.82 -11.77 45.7 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.179 172.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.846 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 91.7 mt -92.44 143.77 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 121.071 0.462 . . . . 0.0 110.804 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.511 ' H ' ' HB2' ' A' ' 84' ' ' HIS . . . 142.7 -19.71 2.38 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 173.81 164.53 29.08 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 173.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 56.46 -85.01 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.132 0.573 . . . . 0.0 112.259 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 83.8 mtp -59.83 -39.13 84.08 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.734 -178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.511 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 5.2 t-80 -51.73 -33.92 36.77 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.37 177.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -80.09 -32.97 39.19 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.962 0.411 . . . . 0.0 110.524 -177.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.96 -43.81 51.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.57 0.7 . . . . 0.0 110.43 175.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 81.4 mtp -77.04 -13.79 59.91 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.647 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.415 HD12 ' HB2' ' A' ' 92' ' ' LEU . 0.1 OUTLIER -54.45 -58.16 8.53 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.704 176.16 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.9 ttt -70.49 -23.01 62.6 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.344 0.592 . . . . 0.0 110.712 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -87.14 -27.14 23.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.24 -173.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.685 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 24.1 mt-30 -111.77 -49.04 3.01 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.831 -175.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.415 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -51.07 -29.13 12.1 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.27 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.453 ' HG3' ' OXT' ' A' ' 93' ' ' GLU . 5.0 pt-20 . . . . . 0 C--O 1.25 1.08 0 CA-C-N 113.423 -1.717 . . . . 0.0 113.759 -174.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 1' ' ' PRO . . . . . 0.416 ' HB2' ' H ' ' B' ' 2' ' ' SER . 83.6 Cg_endo . . . . . 0 CA--C 1.517 -0.336 0 N-CA-C 108.725 -1.298 . . . . 0.0 108.725 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.469 ' HB2' HG23 ' B' ' 5' ' ' THR . 16.8 m -67.88 -179.24 1.13 Allowed 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 162.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.768 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -76.7 -51.95 10.53 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 164.761 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.507 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.3 p-10 -87.28 6.09 35.1 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.929 -1.487 . . . . 0.0 113.869 -164.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.469 HG23 ' HB2' ' B' ' 2' ' ' SER . 0.8 OUTLIER -63.82 -5.89 5.0 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 118.806 0.73 . . . . 0.0 111.467 -176.699 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.479 ' O ' HD13 ' B' ' 21' ' ' LEU . 1.9 m -77.89 130.23 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 176.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.732 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.1 OUTLIER -155.71 158.66 38.6 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.11 -1.036 . . . . 0.0 113.765 -178.426 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 8' ' ' GLN . . . . . 0.47 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.6 mt-30 -38.7 116.77 0.59 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 113.612 -1.631 . . . . 0.0 113.597 176.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.27 -155.94 32.32 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 169.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 18.4 m -48.19 100.6 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 117.437 0.619 . . . . 0.0 111.615 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 22.2 pttt 38.46 42.04 0.51 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.411 1.084 . . . . 0.0 112.401 -174.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -56.99 138.23 79.49 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.221 176.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' PRO . . . . . 0.551 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 37.2 Cg_exo -53.87 122.51 11.49 Favored 'Trans proline' 0 CA--C 1.508 -0.823 0 C-N-CA 121.88 1.72 . . . . 0.0 109.292 177.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' TYR . . . . . 0.738 ' O ' HG12 ' B' ' 18' ' ' VAL . 11.7 t80 -70.82 -54.09 8.28 Favored Pre-proline 0 N--CA 1.435 -1.217 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.833 -166.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.538 ' HD3' ' HB3' ' B' ' 14' ' ' TYR . 36.4 Cg_exo -56.05 -18.2 22.09 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 121.432 1.422 . . . . 0.0 110.841 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.551 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 2.3 m-20 -89.62 -42.48 11.36 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.146 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' PHE . . . . . 0.689 ' HE2' ' CE2' ' B' ' 14' ' ' TYR . 0.0 OUTLIER -54.23 -46.48 72.55 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 176.471 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.771 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 1.2 p -79.29 -34.55 16.4 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.366 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.563 -177.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.38 -32.71 67.07 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 121.374 -0.829 . . . . 0.0 111.702 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.708 ' O ' HG12 ' B' ' 24' ' ' VAL . 16.7 ptt180 -84.36 -27.2 27.86 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.665 HD22 ' CE1' ' B' ' 17' ' ' PHE . 6.8 tp -56.58 -47.27 79.92 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.886 172.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' GLN . . . . . 0.771 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 3.7 mt-30 -71.28 -46.86 59.86 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.028 177.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.734 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 17.4 t70 -47.54 -54.73 10.85 Favored 'General case' 0 C--N 1.315 -0.922 0 O-C-N 124.254 0.971 . . . . 0.0 111.607 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' VAL . . . . . 0.708 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.5 p -81.14 -23.27 10.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.085 0.469 . . . . 0.0 109.921 -174.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.752 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -72.15 -19.47 61.76 Favored 'General case' 0 C--O 1.204 -1.297 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 174.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' GLN . . . . . 0.428 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -86.4 -36.4 19.19 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.583 -1.189 . . . . 0.0 109.499 178.105 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.734 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.1 mmtt -66.99 -38.09 85.39 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.98 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 50.1 m -101.63 -9.57 20.82 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.269 0.557 . . . . 0.0 110.768 -171.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.752 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 88.2 mt -113.91 135.95 51.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.677 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.03 -1.84 41.66 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.916 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.665 ' H ' HG22 ' B' ' 29' ' ' ILE . 4.5 t0 -118.04 132.31 56.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.205 0.526 . . . . 0.0 111.147 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.572 ' OE1' ' HG3' ' B' ' 33' ' ' LYS . 1.5 pp20? -59.82 -35.58 75.01 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.312 174.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.6 ' O ' HG13 ' B' ' 37' ' ' VAL . 13.2 mttp -61.37 -58.75 6.95 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -175.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.511 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -61.95 -26.88 68.46 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.531 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.855 ' O ' HG13 ' B' ' 39' ' ' VAL . 5.0 tmm_? -70.54 -58.25 3.89 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.457 ' HD2' ' OE2' ' B' ' 32' ' ' GLU . 17.8 mtpt -56.3 -55.49 32.71 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.992 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.75 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 22.8 m -54.0 -36.58 31.67 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.103 -172.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.768 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.3 tt -87.06 -29.62 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.845 -177.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.855 HG13 ' O ' ' B' ' 35' ' ' ARG . 3.0 m -70.02 -49.03 59.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 119.131 -1.028 . . . . 0.0 109.488 175.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.594 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 58.8 mt-10 -64.91 -23.28 67.18 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.514 0.725 . . . . 0.0 112.604 176.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.75 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -85.92 -55.37 3.98 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.555 176.385 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 42' ' ' MET . . . . . 0.579 ' HB2' HD21 ' B' ' 21' ' ' LEU . 22.5 mmt -62.58 -20.48 64.74 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.614 0.721 . . . . 0.0 109.318 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.659 ' O ' ' HB2' ' B' ' 47' ' ' ALA . . . -48.26 -29.6 3.98 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.832 170.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' TYR . . . . . 0.564 ' CG ' ' HD2' ' B' ' 59' ' ' LYS . 10.4 t80 -108.06 -66.39 1.04 Allowed 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.643 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 14.6 mm-40 -47.97 -33.24 7.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 124.292 0.995 . . . . 0.0 111.905 -174.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.732 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.9 m-20 -103.2 -20.77 14.01 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.366 -175.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.659 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -59.72 179.76 0.11 Allowed 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 122.028 0.918 . . . . 0.0 112.683 -174.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.529 ' HB3' ' CD ' ' B' ' 50' ' ' GLU . 12.5 m-20 -58.24 140.45 83.37 Favored Pre-proline 0 N--CA 1.438 -1.032 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.362 175.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -57.8 -20.65 44.51 Favored 'Trans proline' 0 C--O 1.221 -0.355 0 C-N-CA 123.211 2.607 . . . . 0.0 112.182 -178.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.712 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 9.1 pm0 -88.66 -30.9 18.81 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 123.541 0.737 . . . . 0.0 110.287 173.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.99 ' SG ' ' HB2' ' B' ' 76' ' ' CYS . 49.5 t -85.52 -37.12 20.02 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.97 -168.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.555 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.9 pt20 -67.46 -29.04 68.4 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 171.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 53' ' ' SER . . . . . 0.676 ' HB3' ' HB3' ' B' ' 91' ' ' GLN . 34.8 m -71.8 -21.1 61.75 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 113.176 -1.829 . . . . 0.0 110.379 174.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.558 ' HB2' HD11 ' B' ' 79' ' ' ILE . . . -78.53 -24.56 45.66 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.501 0.667 . . . . 0.0 110.159 167.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.555 HD12 ' HA ' ' B' ' 52' ' ' GLN . 21.5 mt -90.8 -32.98 5.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -171.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.619 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.19 -39.24 1.86 Allowed Pre-proline 0 N--CA 1.486 1.365 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -173.612 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 42.9 Cg_endo -61.44 -29.55 85.38 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.216 1.944 . . . . 0.0 112.728 175.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 58' ' ' LEU . . . . . 0.541 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.4 mt -98.23 -16.54 19.39 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.59 ' HA ' ' OH ' ' B' ' 72' ' ' TYR . 0.1 OUTLIER -54.65 108.81 0.43 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.578 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.72 -25.43 28.3 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.59 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 12.3 mmmt -103.99 113.49 27.06 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.114 0.483 . . . . 0.0 110.322 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.452 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.1 p -124.22 145.53 48.8 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.844 170.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.556 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 87.7 Cg_exo -50.44 139.41 37.39 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.277 1.985 . . . . 0.0 111.528 167.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.78 102.18 0.73 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.965 0.412 . . . . 0.0 111.466 -175.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.15 -8.37 41.72 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.668 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.556 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 13.1 m -98.35 170.22 9.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.176 0.512 . . . . 0.0 111.242 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.17 136.51 35.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.269 176.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.545 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.7 OUTLIER -75.14 -27.49 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 C-N-CA 118.795 -1.162 . . . . 0.0 108.64 178.721 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.817 ' O ' HG13 ' B' ' 73' ' ' VAL . 17.9 mm -57.21 -46.98 84.95 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.194 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.366 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.403 ' O ' HG22 ' B' ' 73' ' ' VAL . 30.6 t -46.87 -36.14 7.17 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.32 0.581 . . . . 0.0 111.349 177.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.648 ' O ' ' HE3' ' B' ' 74' ' ' LYS . 1.7 mm-40 -85.98 -32.83 21.32 Favored 'General case' 0 C--O 1.213 -0.817 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.499 -177.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 72' ' ' TYR . . . . . 0.652 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 4.9 m-30 -75.54 -33.27 60.66 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.376 -177.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.817 HG13 ' O ' ' B' ' 69' ' ' ILE . 1.2 m -71.66 -31.3 41.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 171.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 74' ' ' LYS . . . . . 0.648 ' HE3' ' O ' ' B' ' 71' ' ' GLU . 0.7 OUTLIER -71.89 -24.45 61.66 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.539 177.021 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 75' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -66.24 -47.14 74.75 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.438 173.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.99 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 44.2 t -89.12 7.64 34.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.831 178.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 77' ' ' ASP . . . . . 0.42 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 12.3 t70 -63.16 -18.69 63.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.192 0.52 . . . . 0.0 109.896 172.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -98.57 -12.39 44.57 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.206 172.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.833 ' HB ' ' SG ' ' B' ' 76' ' ' CYS . 91.7 mt -91.73 144.17 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 O-C-N 122.483 -0.421 . . . . 0.0 110.816 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 80' ' ' GLY . . . . . 0.519 ' H ' ' HB2' ' B' ' 84' ' ' HIS . . . 141.98 -18.93 2.53 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 173.09 164.19 28.05 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 173.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 56.68 -85.19 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.08 0.552 . . . . 0.0 112.141 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 83' ' ' MET . . . . . . . . . . . . . 83.7 mtp -59.86 -39.07 83.99 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.739 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 84' ' ' HIS . . . . . 0.519 ' HB2' ' H ' ' B' ' 80' ' ' GLY . 5.2 t-80 -51.68 -34.14 36.99 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.786 -0.188 . . . . 0.0 111.375 177.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -79.74 -33.56 40.67 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.944 0.402 . . . . 0.0 110.38 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.15 -44.39 53.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.718 0.771 . . . . 0.0 110.297 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 81.0 mtp -76.63 -13.75 60.04 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.748 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.421 HD12 ' HB2' ' B' ' 92' ' ' LEU . 0.1 OUTLIER -54.19 -58.34 7.73 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.716 175.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 26.3 ttt -70.48 -23.5 62.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.628 -175.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -86.93 -26.9 23.66 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.345 -173.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 91' ' ' GLN . . . . . 0.676 ' HB3' ' HB3' ' B' ' 53' ' ' SER . 24.1 mt-30 -111.75 -48.83 3.03 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -175.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.421 ' HB2' HD12 ' B' ' 88' ' ' LEU . 0.1 OUTLIER -51.25 -29.19 13.73 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.354 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.427 ' HG3' ' OXT' ' B' ' 93' ' ' GLU . 5.1 pt-20 . . . . . 0 C--O 1.249 1.069 0 CA-C-N 113.273 -1.785 . . . . 0.0 113.756 -173.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.407 ' C ' ' HA3' ' B' ' 60' ' ' GLY . 97.8 Cg_endo . . . . . 0 N--CA 1.465 -0.202 0 N-CA-C 108.91 -1.227 . . . . 0.0 108.91 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.558 ' HB2' HG23 ' A' ' 5' ' ' THR . 72.0 m -71.34 -178.86 2.23 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 161.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.719 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -77.02 -53.48 7.75 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 122.096 0.95 . . . . 0.0 109.716 172.77 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.539 ' ND2' ' HE3' ' A' ' 42' ' ' MET . 2.5 p-10 -85.69 5.85 30.26 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.141 -1.39 . . . . 0.0 113.249 -163.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.558 HG23 ' HB2' ' A' ' 2' ' ' SER . 1.1 p -66.83 -3.38 6.72 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 121.935 -0.478 . . . . 0.0 111.428 -176.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.566 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 1.9 m -78.2 133.89 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 173.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.759 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -156.54 160.84 39.86 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -177.863 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.421 ' HG2' ' HB3' ' A' ' 12' ' ' GLU . 2.3 tt0 -41.94 115.53 0.68 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 113.704 -1.589 . . . . 0.0 113.056 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.58 -151.72 23.78 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 172.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.479 ' C ' ' HD3' ' A' ' 11' ' ' LYS . 22.8 m -54.25 99.13 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 117.319 0.559 . . . . 0.0 111.133 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.479 ' HD3' ' C ' ' A' ' 10' ' ' SER . 0.0 OUTLIER 34.56 46.52 0.18 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.642 1.177 . . . . 0.0 112.269 -171.333 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.421 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 36.5 tt0 -59.54 139.54 89.2 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.23 175.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.568 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 52.1 Cg_exo -51.0 122.47 9.99 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 121.942 1.761 . . . . 0.0 109.651 177.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.834 ' HE2' ' SG ' ' A' ' 51' ' ' CYS . 6.1 t80 -70.4 -55.34 7.8 Favored Pre-proline 0 N--CA 1.439 -1.001 0 CA-C-O 118.569 -0.729 . . . . 0.0 112.651 -167.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.517 ' HD3' ' HB3' ' A' ' 14' ' ' TYR . 35.0 Cg_exo -55.57 -19.41 23.37 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 121.535 1.49 . . . . 0.0 111.217 -178.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.568 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 0.8 OUTLIER -90.04 -39.39 12.96 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.176 179.505 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.689 ' HE2' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -56.64 -45.68 81.43 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 175.926 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.75 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 1.3 p -79.01 -33.97 16.38 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.329 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.275 -178.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.64 -32.0 66.84 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 121.386 -0.821 . . . . 0.0 111.624 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.709 ' O ' HG12 ' A' ' 24' ' ' VAL . 14.5 ptt180 -84.96 -26.32 27.24 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 176.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.599 HD22 ' CE1' ' A' ' 17' ' ' PHE . 7.5 tp -56.99 -47.74 80.09 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.639 171.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.75 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 3.7 mt-30 -70.15 -46.62 64.33 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.753 176.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.73 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 18.6 t70 -46.82 -57.13 5.21 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.288 0.992 . . . . 0.0 111.67 -179.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.709 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.7 p -79.22 -23.85 12.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.134 0.492 . . . . 0.0 109.816 -173.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.76 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -72.14 -19.69 61.73 Favored 'General case' 0 C--O 1.205 -1.243 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 174.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.476 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -86.66 -36.98 18.45 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.481 178.522 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.73 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.7 mmtt -66.82 -35.27 79.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.8 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.9 t -105.07 -9.11 18.04 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.166 0.508 . . . . 0.0 110.583 -171.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.76 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 88.7 mt -115.11 129.1 71.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.769 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.26 -4.65 59.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.171 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.699 ' H ' HG22 ' A' ' 29' ' ' ILE . 2.8 t0 -116.16 140.57 49.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.233 0.54 . . . . 0.0 111.276 -177.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.549 ' OE2' ' HG3' ' A' ' 33' ' ' LYS . 1.4 pp20? -66.41 -36.14 82.08 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.256 173.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.621 ' O ' HG13 ' A' ' 37' ' ' VAL . 13.0 mttp -60.45 -61.02 2.9 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -174.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.526 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -59.71 -27.04 66.11 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.623 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.859 ' O ' HG13 ' A' ' 39' ' ' VAL . 4.8 tmm_? -69.65 -59.42 2.97 Favored 'General case' 0 C--O 1.221 -0.43 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.403 ' HD2' ' OE1' ' A' ' 32' ' ' GLU . 23.6 mtpt -56.73 -55.78 29.84 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.217 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.7 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 18.9 m -53.19 -35.36 23.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 O-C-N 123.98 0.8 . . . . 0.0 111.253 -172.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.719 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.3 tt -87.46 -31.12 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 119.756 -0.778 . . . . 0.0 112.097 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 35' ' ' ARG . 3.0 m -69.19 -48.57 67.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 119.181 -1.008 . . . . 0.0 109.392 175.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.598 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 58.2 mt-10 -63.73 -23.7 67.47 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 123.624 0.77 . . . . 0.0 112.264 176.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.7 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -86.47 -54.74 4.24 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.803 176.343 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.555 ' HB2' HD21 ' A' ' 21' ' ' LEU . 18.7 mmt -62.68 -20.46 64.87 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.504 0.669 . . . . 0.0 109.919 -177.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.638 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -48.23 -29.08 3.45 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.024 171.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.662 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 2.5 t80 -109.05 -65.68 1.12 Allowed 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 175.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.553 ' CG ' HD12 ' A' ' 41' ' ' LEU . 3.3 mm-40 -46.89 -30.39 2.49 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 124.116 0.885 . . . . 0.0 112.713 -175.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.759 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.8 m-20 -106.55 -20.77 13.26 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -175.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.811 ' HB1' ' SG ' ' A' ' 51' ' ' CYS . . . -64.33 -175.96 0.2 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -172.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.525 ' HB2' ' HB3' ' A' ' 51' ' ' CYS . 18.7 m-20 -61.79 141.7 95.1 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 114.526 -1.216 . . . . 0.0 109.447 175.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -55.27 -26.6 52.9 Favored 'Trans proline' 0 C--O 1.219 -0.458 0 C-N-CA 123.592 2.861 . . . . 0.0 112.968 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.514 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -87.31 -29.29 21.7 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.381 0.672 . . . . 0.0 110.247 174.963 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.834 ' SG ' ' HE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -76.15 -43.67 41.78 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.547 -172.229 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.638 ' HB2' ' CG ' ' A' ' 44' ' ' TYR . 4.3 pt20 -67.75 -29.46 68.69 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 175.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.56 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 4.0 m -69.42 -20.89 63.79 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 113.703 -1.589 . . . . 0.0 110.729 173.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.697 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -80.41 -24.87 39.36 Favored 'General case' 0 C--N 1.309 -1.176 0 O-C-N 121.412 -0.805 . . . . 0.0 109.853 168.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.538 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 25.8 mt -90.73 -31.22 5.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 115.008 1.485 . . . . 0.0 115.008 -172.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.633 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.71 -39.75 2.79 Favored Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -172.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 49.6 Cg_endo -62.69 -29.76 77.83 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.327 2.018 . . . . 0.0 112.799 176.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.548 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.6 mt -97.35 -16.37 20.3 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.662 ' HE3' ' HB3' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -52.94 108.4 0.31 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.02 -178.141 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.9 -22.71 36.6 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.74 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -103.39 114.85 29.45 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.452 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.2 p -122.55 138.74 29.76 Favored Pre-proline 0 C--N 1.313 -1.015 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.42 173.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.521 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 95.7 Cg_exo -47.85 139.61 19.18 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.661 2.241 . . . . 0.0 111.891 169.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.77 101.33 0.19 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.55 -175.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.34 -13.24 43.83 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.645 177.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.521 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 47.5 m -88.41 166.0 14.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.225 0.536 . . . . 0.0 111.07 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.25 138.94 32.67 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 173.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.561 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.7 OUTLIER -74.33 -28.54 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 C-N-CA 118.462 -1.295 . . . . 0.0 108.669 -177.635 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.794 ' O ' HG13 ' A' ' 73' ' ' VAL . 14.3 mm -58.49 -46.82 89.56 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.278 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.327 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.533 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 40.3 t -48.77 -36.63 16.96 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.249 0.547 . . . . 0.0 111.098 178.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -86.53 -31.34 21.31 Favored 'General case' 0 CA--C 1.506 -0.719 0 C-N-CA 123.137 0.575 . . . . 0.0 110.517 -176.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.616 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.3 m-30 -75.22 -36.64 61.33 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.285 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.812 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.7 m -69.45 -32.89 54.81 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 173.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 70' ' ' SER . 0.1 OUTLIER -70.23 -32.43 70.3 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.406 178.683 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.528 ' HB2' HD11 ' A' ' 58' ' ' LEU . . . -63.43 -42.76 98.71 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.645 -1.161 . . . . 0.0 108.972 178.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 5.0 m -102.21 9.49 40.02 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.34 -175.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -58.54 -15.41 11.18 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.069 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.57 ' O ' ' HB2' ' A' ' 83' ' ' MET . . . -117.71 13.59 13.17 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.823 175.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.697 HD11 ' HB2' ' A' ' 54' ' ' ALA . 53.2 mt -94.32 -15.26 7.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.307 0.575 . . . . 0.0 111.632 -176.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.16 -12.09 42.41 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.286 -0.959 . . . . 0.0 112.943 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 176.0 154.32 11.43 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.693 174.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 68.37 -75.67 0.06 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 173.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.57 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 78.0 mtp -61.18 -30.27 70.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.235 0.541 . . . . 0.0 110.111 -177.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.521 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 4.3 t60 -55.63 -34.59 65.06 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.918 173.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -82.51 -18.14 42.62 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.093 0.473 . . . . 0.0 110.236 -176.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.02 -44.57 12.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.629 175.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 59.0 mtm -81.4 -14.0 57.64 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.346 -176.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.521 ' HB2' ' O ' ' A' ' 84' ' ' HIS . 0.2 OUTLIER -53.16 -33.65 53.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.749 -178.121 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.7 tpt -83.39 -23.06 32.55 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.085 0.469 . . . . 0.0 110.79 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -92.5 -49.33 6.18 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -172.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.551 ' C ' ' HB3' ' A' ' 53' ' ' SER . 95.3 mt-30 -91.47 -52.12 4.94 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.774 -171.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.414 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -48.2 -35.93 12.74 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 175.047 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 6.1 pt-20 . . . . . 0 C--O 1.25 1.08 0 O-C-N 125.558 1.786 . . . . 0.0 113.941 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 1' ' ' PRO . . . . . 0.444 ' HB2' ' H ' ' B' ' 2' ' ' SER . 98.9 Cg_endo . . . . . 0 CA--C 1.518 -0.285 0 N-CA-C 108.811 -1.265 . . . . 0.0 108.811 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.571 ' HB2' HG23 ' B' ' 5' ' ' THR . 74.7 m -71.04 -178.75 2.06 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 161.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.727 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -77.12 -53.5 7.69 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 122.093 0.949 . . . . 0.0 109.646 172.831 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.519 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.5 p-10 -85.61 5.77 30.33 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.095 -1.411 . . . . 0.0 113.224 -163.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.571 HG23 ' HB2' ' B' ' 2' ' ' SER . 1.1 p -66.72 -3.75 7.37 Favored 'General case' 0 C--N 1.312 -1.045 0 O-C-N 121.953 -0.467 . . . . 0.0 111.36 -176.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.57 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.0 m -77.99 133.75 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 173.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.759 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.2 OUTLIER -156.41 160.95 40.09 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -177.925 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 8' ' ' GLN . . . . . 0.426 ' HG2' ' HB3' ' B' ' 12' ' ' GLU . 2.3 tt0 -41.98 115.22 0.64 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 113.732 -1.576 . . . . 0.0 113.16 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.44 -151.5 23.12 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 171.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' SER . . . . . 0.487 ' C ' ' HD3' ' B' ' 11' ' ' LYS . 24.0 m -54.73 98.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.369 0.585 . . . . 0.0 111.187 -178.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.487 ' HD3' ' C ' ' B' ' 10' ' ' SER . 0.0 OUTLIER 34.99 46.6 0.21 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.799 1.24 . . . . 0.0 112.129 -171.508 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.426 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 36.6 tt0 -59.64 139.51 89.55 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.197 175.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' PRO . . . . . 0.575 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 51.2 Cg_exo -50.98 122.32 9.72 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 121.955 1.77 . . . . 0.0 109.615 177.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' TYR . . . . . 0.82 ' HE2' ' SG ' ' B' ' 51' ' ' CYS . 6.3 t80 -70.35 -55.22 8.02 Favored Pre-proline 0 N--CA 1.439 -0.98 0 CA-C-O 118.494 -0.765 . . . . 0.0 112.664 -167.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.532 ' HD3' ' HB3' ' B' ' 14' ' ' TYR . 35.2 Cg_exo -55.79 -19.21 24.0 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 121.526 1.484 . . . . 0.0 111.124 -178.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.575 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 0.8 OUTLIER -89.92 -39.79 12.79 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.226 -1.352 . . . . 0.0 111.082 179.579 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 17' ' ' PHE . . . . . 0.687 ' HE2' ' CE2' ' B' ' 14' ' ' TYR . 0.0 OUTLIER -56.59 -45.67 81.24 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.128 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.755 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 1.3 p -78.94 -33.97 16.53 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.354 0 CA-C-N 115.184 -0.917 . . . . 0.0 111.271 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.71 -31.8 66.77 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 121.346 -0.846 . . . . 0.0 111.701 177.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.702 ' O ' HG12 ' B' ' 24' ' ' VAL . 14.7 ptt180 -84.88 -26.61 27.22 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 175.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.607 HD22 ' CE1' ' B' ' 17' ' ' PHE . 7.6 tp -56.84 -47.73 79.67 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.603 172.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' GLN . . . . . 0.755 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 3.7 mt-30 -70.04 -47.09 63.44 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.817 176.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.741 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 19.4 t70 -46.4 -57.06 5.0 Favored 'General case' 0 C--N 1.314 -0.947 0 O-C-N 124.312 1.008 . . . . 0.0 111.721 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' VAL . . . . . 0.702 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.7 p -79.44 -23.65 12.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.169 0.509 . . . . 0.0 109.849 -173.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.764 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -72.25 -19.69 61.66 Favored 'General case' 0 C--O 1.205 -1.274 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 174.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' GLN . . . . . 0.47 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -86.73 -36.99 18.33 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.494 178.589 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.741 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.9 mmtt -66.77 -35.36 79.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.699 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 36.2 t -105.08 -8.88 18.18 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 120.946 0.403 . . . . 0.0 110.744 -171.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.764 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 88.9 mt -115.38 129.4 71.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.711 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.55 -5.02 58.95 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.102 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.681 ' H ' HG22 ' B' ' 29' ' ' ILE . 2.5 t0 -115.98 140.58 49.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.305 0.574 . . . . 0.0 111.125 -176.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.572 ' OE2' ' HG3' ' B' ' 33' ' ' LYS . 1.5 pp20? -66.48 -35.91 81.44 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.183 174.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.618 ' O ' HG13 ' B' ' 37' ' ' VAL . 12.9 mttp -60.49 -61.04 2.88 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -174.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.513 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -59.93 -26.86 66.29 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.582 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.848 ' O ' HG13 ' B' ' 39' ' ' VAL . 4.7 tmm_? -69.69 -59.39 2.98 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -178.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.42 ' HD2' ' OE1' ' B' ' 32' ' ' GLU . 23.8 mtpt -56.84 -55.44 34.4 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.246 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.691 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 19.2 m -53.52 -35.29 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.192 -172.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.727 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.3 tt -87.42 -31.12 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.159 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.848 HG13 ' O ' ' B' ' 35' ' ' ARG . 3.0 m -69.15 -48.57 68.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 119.078 -1.049 . . . . 0.0 109.418 175.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.611 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 61.9 mt-10 -63.59 -23.94 67.59 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 123.634 0.774 . . . . 0.0 112.229 176.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.691 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -86.27 -54.73 4.28 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.871 176.328 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 42' ' ' MET . . . . . 0.564 ' HB2' HD21 ' B' ' 21' ' ' LEU . 18.8 mmt -62.65 -20.41 64.78 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 121.553 0.692 . . . . 0.0 109.971 -177.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.627 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -48.33 -29.03 3.53 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.48 -1.237 . . . . 0.0 110.992 171.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' TYR . . . . . 0.663 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 2.4 t80 -109.05 -65.63 1.12 Allowed 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 176.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.547 ' CG ' HD12 ' B' ' 41' ' ' LEU . 3.3 mm-40 -46.89 -30.76 2.69 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 124.145 0.903 . . . . 0.0 112.678 -175.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.759 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.8 m-20 -106.13 -20.97 13.25 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -175.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.815 ' HB1' ' SG ' ' B' ' 51' ' ' CYS . . . -64.23 -175.9 0.19 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -172.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.514 ' HB2' ' HB3' ' B' ' 51' ' ' CYS . 19.4 m-20 -61.75 141.72 95.01 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.473 175.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -55.27 -26.75 53.65 Favored 'Trans proline' 0 C--O 1.219 -0.446 0 C-N-CA 123.518 2.812 . . . . 0.0 112.948 -176.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.538 ' O ' ' HG3' ' B' ' 50' ' ' GLU . 0.0 OUTLIER -87.17 -29.16 21.98 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.327 0.651 . . . . 0.0 110.351 174.915 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.82 ' SG ' ' HE2' ' B' ' 14' ' ' TYR . 0.0 OUTLIER -76.04 -43.78 42.27 Favored 'General case' 0 N--CA 1.42 -1.942 0 CA-C-O 121.446 0.641 . . . . 0.0 110.547 -172.229 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.648 ' HB2' ' CG ' ' B' ' 44' ' ' TYR . 4.4 pt20 -67.77 -29.47 68.69 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 175.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 53' ' ' SER . . . . . 0.558 ' HB3' ' C ' ' B' ' 91' ' ' GLN . 4.0 m -69.42 -20.87 63.79 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 113.685 -1.598 . . . . 0.0 110.716 173.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.713 ' HB2' HD11 ' B' ' 79' ' ' ILE . . . -80.22 -25.26 39.69 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.289 -0.882 . . . . 0.0 109.821 168.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.546 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 25.7 mt -90.67 -31.28 5.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 -172.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.627 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.64 -39.62 2.6 Favored Pre-proline 0 N--CA 1.487 1.399 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -172.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 50.7 Cg_endo -62.81 -29.67 76.98 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.323 2.015 . . . . 0.0 112.828 176.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 58' ' ' LEU . . . . . 0.56 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.7 mt -97.42 -16.42 20.2 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.663 ' HE3' ' HB3' ' B' ' 44' ' ' TYR . 0.1 OUTLIER -52.92 108.73 0.34 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.955 -178.104 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.407 ' HA3' ' C ' ' A' ' 1' ' ' PRO . . . 94.55 -22.47 37.24 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.745 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -103.53 115.11 29.9 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -178.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.45 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.1 p -122.92 139.0 30.51 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.429 173.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.521 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 97.0 Cg_exo -47.96 139.43 20.09 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.708 2.272 . . . . 0.0 111.833 169.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.06 101.12 0.19 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.413 -175.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.62 -13.09 42.73 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.757 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.521 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 48.2 m -88.68 166.03 14.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.05 0.453 . . . . 0.0 110.937 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.37 139.2 32.42 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 173.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.57 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.7 OUTLIER -74.32 -28.33 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 C-N-CA 118.432 -1.307 . . . . 0.0 108.696 -177.462 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.799 ' O ' HG13 ' B' ' 73' ' ' VAL . 14.4 mm -58.61 -46.83 90.01 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.179 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.319 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.541 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 37.6 t -48.62 -36.74 16.45 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.165 0.507 . . . . 0.0 111.081 178.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -86.56 -31.23 21.33 Favored 'General case' 0 CA--C 1.506 -0.73 0 C-N-CA 123.206 0.602 . . . . 0.0 110.545 -176.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' TYR . . . . . 0.605 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.3 m-30 -75.36 -36.6 60.95 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.32 -178.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.815 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.7 m -69.36 -33.23 56.65 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 173.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 74' ' ' LYS . . . . . 0.541 ' HB2' ' O ' ' B' ' 70' ' ' SER . 0.1 OUTLIER -69.94 -32.31 70.51 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.517 178.473 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 75' ' ' ALA . . . . . 0.515 ' HB2' HD11 ' B' ' 58' ' ' LEU . . . -63.76 -42.07 97.88 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.208 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 5.1 m -102.7 9.53 39.13 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 114.101 -1.409 . . . . 0.0 111.318 -175.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -58.26 -16.19 13.04 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.046 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 78' ' ' GLY . . . . . 0.56 ' O ' ' HB2' ' B' ' 83' ' ' MET . . . -116.99 13.48 14.24 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.981 175.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.713 HD11 ' HB2' ' B' ' 54' ' ' ALA . 53.4 mt -94.22 -15.25 7.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.21 0.529 . . . . 0.0 111.705 -176.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.11 -11.9 41.13 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.961 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 175.77 154.17 11.18 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.678 174.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 68.46 -75.3 0.07 Allowed 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 173.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 83' ' ' MET . . . . . 0.56 ' HB2' ' O ' ' B' ' 78' ' ' GLY . 77.8 mtp -61.27 -30.43 70.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.152 0.501 . . . . 0.0 110.059 -177.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 84' ' ' HIS . . . . . 0.51 ' O ' ' HB2' ' B' ' 88' ' ' LEU . 4.3 t60 -55.79 -34.62 65.46 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.836 173.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -82.5 -17.72 44.13 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.925 0.393 . . . . 0.0 110.26 -176.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.17 -44.88 11.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.678 175.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 58.5 mtm -81.32 -13.89 57.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.428 -176.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.51 ' HB2' ' O ' ' B' ' 84' ' ' HIS . 0.2 OUTLIER -52.79 -34.43 53.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.615 -178.322 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 15.7 tpt -83.09 -22.83 33.32 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.091 0.472 . . . . 0.0 110.736 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -92.69 -48.91 6.35 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -172.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 91' ' ' GLN . . . . . 0.558 ' C ' ' HB3' ' B' ' 53' ' ' SER . 95.0 mt-30 -91.65 -52.17 4.89 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.855 -171.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.426 ' HB2' HD12 ' B' ' 88' ' ' LEU . 0.0 OUTLIER -48.19 -35.84 12.54 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 174.95 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' B' ' 91' ' ' GLN . 6.1 pt-20 . . . . . 0 C--O 1.248 1.025 0 O-C-N 125.563 1.789 . . . . 0.0 113.864 -175.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.453 ' HB2' ' H ' ' A' ' 2' ' ' SER . 86.3 Cg_endo . . . . . 0 CA--C 1.517 -0.35 0 N-CA-C 109.024 -1.183 . . . . 0.0 109.024 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.49 ' HB2' HG23 ' A' ' 5' ' ' THR . 21.2 m -68.41 175.2 3.5 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 161.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.833 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -71.0 -52.2 21.03 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 164.827 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.518 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 2.3 p-10 -87.41 5.52 38.39 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.875 -1.512 . . . . 0.0 113.692 -165.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.49 HG23 ' HB2' ' A' ' 2' ' ' SER . 0.7 OUTLIER -64.35 -5.76 5.78 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 118.537 0.608 . . . . 0.0 111.116 -177.37 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.642 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.1 m -76.16 130.94 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.743 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -154.31 158.69 40.52 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.552 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 3.3 mt-30 -42.04 116.61 0.84 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 112.997 -1.91 . . . . 0.0 113.465 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.56 -153.67 21.55 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 170.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.662 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 20.8 t -57.19 99.34 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.166 0.483 . . . . 0.0 110.926 -177.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.662 ' HG2' ' O ' ' A' ' 10' ' ' SER . 4.1 ptpp? 49.18 32.71 4.38 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.602 1.161 . . . . 0.0 112.433 -177.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.431 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 38.7 tt0 -56.06 135.39 74.14 Favored Pre-proline 0 C--O 1.233 0.224 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.558 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 52.0 Cg_exo -51.05 123.08 11.09 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.46 2.107 . . . . 0.0 110.169 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.906 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 15.0 t80 -71.13 -53.51 8.18 Favored Pre-proline 0 N--CA 1.438 -1.061 0 CA-C-O 118.277 -0.868 . . . . 0.0 113.183 -167.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.541 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 33.6 Cg_exo -55.9 -18.43 22.05 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 121.425 1.416 . . . . 0.0 111.041 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.558 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.8 m-20 -89.92 -43.49 10.55 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.93 -1.486 . . . . 0.0 110.829 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.552 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -54.31 -44.43 72.0 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.931 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.727 HG12 ' O ' ' A' ' 14' ' ' TYR . 3.0 p -82.19 -31.77 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.386 -177.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . -57.89 -35.86 71.61 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 121.763 -0.585 . . . . 0.0 111.853 175.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.72 ' O ' HG12 ' A' ' 24' ' ' VAL . 15.6 ptt180 -82.97 -27.3 30.56 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 177.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.572 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 6.5 tp -56.89 -45.46 82.57 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.858 173.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.733 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 8.7 mt-30 -74.12 -43.71 56.52 Favored 'General case' 0 CA--C 1.496 -1.112 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.999 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.754 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 8.8 t70 -51.17 -51.68 51.41 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 124.137 0.898 . . . . 0.0 111.47 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.72 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.5 p -82.64 -23.15 8.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -174.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.825 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -71.66 -18.67 62.17 Favored 'General case' 0 C--O 1.206 -1.224 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 174.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.0 -39.11 15.98 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.471 -1.24 . . . . 0.0 109.766 176.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.754 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 36.5 mmtt -66.59 -40.61 88.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.065 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.403 ' HB2' ' HB3' ' A' ' 3' ' ' PHE . 43.9 m -98.81 -9.7 24.01 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.153 0.501 . . . . 0.0 110.437 -171.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.825 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 87.5 mt -115.18 125.3 72.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.759 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.56 -4.96 59.25 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.004 0.431 . . . . 0.0 110.529 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.678 ' OD1' ' HD2' ' A' ' 33' ' ' LYS . 3.9 t0 -110.62 122.43 47.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.534 -176.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.484 ' O ' ' HG2' ' A' ' 36' ' ' LYS . 12.6 pt-20 -61.85 -25.11 67.33 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.765 176.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.678 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 24.4 mttt -73.81 -46.74 43.43 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 120.901 0.381 . . . . 0.0 110.146 -176.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.08 -25.11 60.78 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.731 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.84 ' O ' HG13 ' A' ' 39' ' ' VAL . 5.0 tmm_? -64.53 -63.14 1.21 Allowed 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.642 ' HG3' HG13 ' A' ' 37' ' ' VAL . 6.5 ptmm? -51.9 -60.15 3.51 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.198 0.523 . . . . 0.0 112.224 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.642 HG13 ' HG3' ' A' ' 36' ' ' LYS . 10.4 m -56.32 -30.87 31.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.353 -170.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.833 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.2 tt -86.08 -30.45 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.247 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.84 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.3 m -70.13 -47.91 65.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 119.481 -0.887 . . . . 0.0 109.348 175.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.658 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 55.3 mt-10 -60.21 -30.27 69.27 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.665 0.786 . . . . 0.0 112.119 176.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.619 ' HG ' HD11 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -86.16 -53.15 5.22 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.484 -0.487 . . . . 0.0 112.189 179.198 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.559 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 22.0 mmt -61.95 -22.08 65.33 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.592 0.71 . . . . 0.0 109.84 -178.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.697 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -48.54 -29.02 3.78 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.043 171.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.598 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 8.4 t80 -107.02 -66.58 1.01 Allowed 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.548 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 15.5 mm-40 -48.23 -31.96 6.55 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 124.141 0.901 . . . . 0.0 112.109 -174.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.743 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.9 m-20 -103.03 -21.49 13.92 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.182 -175.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.605 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -62.42 -178.98 0.21 Allowed 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.988 0.899 . . . . 0.0 112.986 -173.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.542 ' HB3' ' OE1' ' A' ' 50' ' ' GLU . 12.2 m-20 -61.34 143.24 93.11 Favored Pre-proline 0 C--N 1.317 -0.811 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.003 175.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 48' ' ' ASN . 55.5 Cg_exo -50.83 -28.53 23.66 Favored 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 123.666 2.911 . . . . 0.0 112.996 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.689 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 15.9 pm0 -88.42 -30.99 19.04 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.758 0.823 . . . . 0.0 111.015 176.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.689 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 96.9 m -81.79 -38.99 24.73 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.242 -170.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.626 ' HA ' HD12 ' A' ' 55' ' ' ILE . 4.1 pt20 -69.93 -29.76 66.98 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 172.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.628 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 6.7 m -71.12 -20.32 62.34 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.859 -1.518 . . . . 0.0 110.755 174.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.684 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -77.88 -25.27 48.48 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.691 0.758 . . . . 0.0 109.57 167.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.626 HD12 ' HA ' ' A' ' 52' ' ' GLN . 24.1 mt -89.76 -33.05 5.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -172.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.613 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.3 -38.71 1.71 Allowed Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -173.363 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 51.5 Cg_endo -63.13 -28.69 73.86 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.188 1.925 . . . . 0.0 112.625 175.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.537 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 2.2 mt -97.58 -16.65 19.95 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.598 ' HD2' ' CG ' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -55.95 108.98 0.51 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.443 -179.146 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.72 -24.9 30.36 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.328 -177.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.0 mmmt -104.54 115.63 30.68 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.853 0.358 . . . . 0.0 110.466 -178.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.43 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.7 p -121.77 134.75 24.75 Favored Pre-proline 0 C--N 1.313 -1.0 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 168.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.411 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 85.4 Cg_exo -51.66 136.2 49.6 Favored 'Trans proline' 0 CA--C 1.518 -0.278 0 C-N-CA 122.545 2.163 . . . . 0.0 111.79 172.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.09 109.05 1.38 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.769 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.36 -17.71 39.82 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.623 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.411 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 1.8 t -91.39 -174.59 3.97 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 122.09 0.948 . . . . 0.0 110.719 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -108.03 143.09 37.21 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 113.781 -1.554 . . . . 0.0 108.308 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.58 HG22 ' HG2' ' A' ' 40' ' ' GLU . 1.2 m -76.16 -30.29 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 C-N-CA 118.553 -1.259 . . . . 0.0 108.709 -177.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.778 ' O ' HG13 ' A' ' 73' ' ' VAL . 7.0 mm -60.85 -47.88 91.38 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.158 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.413 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.498 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 34.1 t -50.51 -35.22 28.37 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.892 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.45 ' H ' ' HG2' ' A' ' 71' ' ' GLU . 3.1 mm-40 -86.58 -32.07 20.85 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.081 0.467 . . . . 0.0 110.414 -177.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.537 ' CE1' ' HB2' ' A' ' 58' ' ' LEU . 5.5 m-30 -74.1 -36.18 64.22 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.318 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.906 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 2.2 m -71.21 -32.88 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -68.51 -31.91 71.51 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.516 177.479 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.5 ' HB2' HD11 ' A' ' 58' ' ' LEU . . . -63.38 -44.49 94.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.265 178.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.532 ' SG ' ' HB3' ' A' ' 51' ' ' CYS . 3.8 m -97.77 9.46 42.56 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.11 -177.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -64.19 -29.74 70.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.653 177.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.95 6.5 76.55 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.932 174.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.684 HD11 ' HB2' ' A' ' 54' ' ' ALA . 80.0 mt -102.34 129.42 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 121.617 0.722 . . . . 0.0 111.715 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.604 ' H ' ' HB2' ' A' ' 84' ' ' HIS . . . 173.22 -50.25 0.16 Allowed Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 108.921 -1.671 . . . . 0.0 108.921 170.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.12 156.86 27.1 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 114.558 -0.821 . . . . 0.0 111.165 177.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 62.85 -78.43 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 122.987 0.515 . . . . 0.0 112.041 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.552 ' O ' ' HG3' ' A' ' 87' ' ' MET . 63.0 mtt -60.77 -38.63 85.93 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 121.118 0.485 . . . . 0.0 109.848 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.604 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 3.8 t-160 -53.6 -33.41 54.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.435 173.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -83.56 -36.6 23.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.729 0.299 . . . . 0.0 110.734 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.54 -52.89 59.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.968 0.889 . . . . 0.0 110.0 174.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.552 ' HG3' ' O ' ' A' ' 83' ' ' MET . 27.7 mtm -73.97 -12.74 60.73 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.987 -176.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.45 HD12 ' HB2' ' A' ' 92' ' ' LEU . 0.1 OUTLIER -57.19 -42.17 80.71 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.554 177.267 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 51.8 ttm -80.81 -20.03 43.39 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.355 0.598 . . . . 0.0 110.803 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -92.52 -46.49 7.61 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.981 -175.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.672 ' O ' ' HG2' ' A' ' 93' ' ' GLU . 92.2 mt-30 -92.64 -52.02 4.83 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.565 -172.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.45 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -51.46 -35.84 41.5 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 175.613 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.672 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 7.8 pt-20 . . . . . 0 C--O 1.249 1.033 0 CA-C-N 112.992 -1.913 . . . . 0.0 113.868 -177.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 1' ' ' PRO . . . . . 0.415 ' HB2' ' H ' ' B' ' 2' ' ' SER . 88.4 Cg_endo . . . . . 0 CA--C 1.519 -0.245 0 N-CA-C 108.797 -1.27 . . . . 0.0 108.797 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.493 ' HB2' HG23 ' B' ' 5' ' ' THR . 19.8 m -68.1 175.08 3.37 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 161.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.813 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -71.08 -52.19 20.83 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 164.92 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.494 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.2 p-10 -87.5 5.48 38.91 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 113.869 -1.514 . . . . 0.0 113.667 -165.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.493 HG23 ' HB2' ' B' ' 2' ' ' SER . 0.7 OUTLIER -63.88 -6.52 6.09 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 118.542 0.61 . . . . 0.0 111.086 -177.668 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.642 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.2 m -75.61 131.09 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.766 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -154.32 158.59 40.38 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 8' ' ' GLN . . . . . 0.543 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 3.4 mt-30 -41.82 116.88 0.85 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 113.119 -1.855 . . . . 0.0 113.369 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.77 -153.98 22.63 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.732 170.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' SER . . . . . 0.668 ' O ' ' HG2' ' B' ' 11' ' ' LYS . 19.8 t -56.94 98.8 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 117.116 0.458 . . . . 0.0 110.952 -177.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.668 ' HG2' ' O ' ' B' ' 10' ' ' SER . 4.1 ptpp? 49.41 32.86 4.92 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.688 1.195 . . . . 0.0 112.504 -177.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.434 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 38.4 tt0 -56.12 135.41 74.49 Favored Pre-proline 0 C--O 1.234 0.251 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' PRO . . . . . 0.575 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 52.2 Cg_exo -50.97 123.0 10.88 Favored 'Trans proline' 0 CA--C 1.509 -0.77 0 C-N-CA 122.343 2.029 . . . . 0.0 110.206 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 14' ' ' TYR . . . . . 0.896 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 14.7 t80 -71.01 -53.53 8.37 Favored Pre-proline 0 N--CA 1.439 -1.019 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -167.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.534 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 34.2 Cg_exo -55.92 -18.48 22.3 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 121.535 1.49 . . . . 0.0 110.999 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.575 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.6 m-20 -89.96 -43.18 10.73 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 113.917 -1.492 . . . . 0.0 110.933 178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' PHE . . . . . 0.543 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -54.6 -44.43 73.07 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 176.932 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.714 HG12 ' O ' ' B' ' 14' ' ' TYR . 3.0 p -82.16 -31.86 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.514 -177.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.44 -36.39 71.33 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 121.793 -0.567 . . . . 0.0 111.878 175.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.713 ' O ' HG12 ' B' ' 24' ' ' VAL . 15.5 ptt180 -82.72 -27.18 31.32 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.565 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 6.6 tp -57.05 -45.21 83.36 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.87 173.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' GLN . . . . . 0.736 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 8.7 mt-30 -74.36 -44.06 53.87 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.019 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.74 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 9.5 t70 -50.9 -51.44 51.94 Favored 'General case' 0 C--N 1.314 -0.955 0 O-C-N 124.097 0.873 . . . . 0.0 111.495 -178.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' VAL . . . . . 0.713 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.4 p -82.71 -23.41 8.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.201 0.524 . . . . 0.0 109.707 -174.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.819 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -71.37 -18.76 62.35 Favored 'General case' 0 C--O 1.206 -1.206 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 173.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.1 -38.63 16.3 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.845 176.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.74 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 36.2 mmtt -66.89 -40.64 87.82 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.98 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' SER . . . . . 0.415 ' HB2' ' HB3' ' B' ' 3' ' ' PHE . 45.2 m -98.86 -9.27 24.49 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.039 0.447 . . . . 0.0 110.552 -171.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.819 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 87.2 mt -115.33 125.68 72.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.651 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.05 -4.2 59.14 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.977 0.418 . . . . 0.0 110.468 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.676 ' H ' HG22 ' B' ' 29' ' ' ILE . 3.6 t0 -111.45 122.65 48.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.51 -176.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' B' ' 36' ' ' LYS . 12.7 pt-20 -62.03 -25.25 67.55 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.665 176.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.666 ' HD2' ' OD1' ' B' ' 31' ' ' ASP . 24.0 mttt -73.71 -46.54 45.46 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 120.834 0.349 . . . . 0.0 110.082 -176.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.32 -25.04 60.47 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.5 -0.48 . . . . 0.0 109.77 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.836 ' O ' HG13 ' B' ' 39' ' ' VAL . 5.0 tmm_? -64.44 -63.32 1.16 Allowed 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.647 ' HG3' HG13 ' B' ' 37' ' ' VAL . 6.5 ptmm? -51.71 -60.08 3.56 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.257 0.551 . . . . 0.0 112.31 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.647 HG13 ' HG3' ' B' ' 36' ' ' LYS . 10.4 m -56.58 -30.57 32.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.713 -1.131 . . . . 0.0 112.496 -170.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.813 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.2 tt -86.26 -30.45 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 C-N-CA 119.241 -0.984 . . . . 0.0 111.175 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.836 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.3 m -70.04 -47.87 65.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.411 175.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.651 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 56.6 mt-10 -60.31 -29.96 69.19 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 123.69 0.796 . . . . 0.0 112.193 176.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.635 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -86.25 -53.25 5.14 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.367 -0.533 . . . . 0.0 112.16 179.044 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 42' ' ' MET . . . . . 0.565 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 22.0 mmt -61.9 -22.18 65.36 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.594 0.711 . . . . 0.0 109.831 -177.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.698 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -48.5 -29.03 3.73 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.924 171.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' TYR . . . . . 0.594 ' CG ' ' HD2' ' B' ' 59' ' ' LYS . 8.3 t80 -107.24 -66.65 1.01 Allowed 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 176.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.529 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 14.9 mm-40 -48.1 -31.84 6.07 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 124.168 0.917 . . . . 0.0 112.243 -174.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.766 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.9 m-20 -103.21 -21.47 13.86 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 116.754 -0.203 . . . . 0.0 111.265 -175.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.602 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -62.38 -179.16 0.22 Allowed 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.982 0.896 . . . . 0.0 112.865 -173.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.564 ' HB3' ' OE1' ' B' ' 50' ' ' GLU . 12.4 m-20 -61.16 143.31 92.54 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.037 175.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -50.7 -28.75 23.59 Favored 'Trans proline' 0 C--O 1.218 -0.494 0 C-N-CA 123.54 2.827 . . . . 0.0 113.022 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.696 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 15.9 pm0 -88.26 -30.97 19.27 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.739 0.816 . . . . 0.0 111.015 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.696 ' N ' ' HG2' ' B' ' 50' ' ' GLU . 96.7 m -81.83 -39.06 24.53 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.145 -170.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.634 ' HA ' HD12 ' B' ' 55' ' ' ILE . 4.1 pt20 -69.95 -29.64 66.82 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 172.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 53' ' ' SER . . . . . 0.63 ' HB3' ' HB3' ' B' ' 91' ' ' GLN . 7.0 m -71.18 -20.28 62.3 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 113.847 -1.524 . . . . 0.0 110.704 174.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.684 ' HB2' HD11 ' B' ' 79' ' ' ILE . . . -77.72 -25.38 49.26 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.604 0.716 . . . . 0.0 109.683 167.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.634 HD12 ' HA ' ' B' ' 52' ' ' GLN . 24.3 mt -89.77 -32.87 5.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 -172.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.611 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.22 -38.91 1.71 Allowed Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -173.523 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 51.5 Cg_endo -63.07 -28.85 74.51 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 122.175 1.916 . . . . 0.0 112.716 175.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 58' ' ' LEU . . . . . 0.535 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 2.2 mt -97.44 -16.4 20.19 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.594 ' HD2' ' CG ' ' B' ' 44' ' ' TYR . 0.1 OUTLIER -56.13 108.91 0.51 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.523 -179.254 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.0 -25.12 29.48 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.265 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 9.9 mmmt -104.52 115.52 30.49 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.961 0.41 . . . . 0.0 110.381 -177.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.427 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.7 p -121.8 134.68 24.74 Favored Pre-proline 0 C--N 1.312 -1.055 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 168.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.4 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 86.0 Cg_exo -52.0 135.85 51.87 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.502 2.135 . . . . 0.0 111.846 172.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.24 108.78 1.15 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.761 -177.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.53 -17.96 38.89 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.592 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.4 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 1.6 t -91.21 -174.85 4.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.831 0.824 . . . . 0.0 110.569 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -107.95 143.09 37.08 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.308 177.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.584 HG22 ' HG2' ' B' ' 40' ' ' GLU . 1.2 m -75.99 -30.25 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 C-N-CA 118.556 -1.258 . . . . 0.0 108.709 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.78 ' O ' HG13 ' B' ' 73' ' ' VAL . 6.9 mm -60.87 -47.94 91.14 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.208 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.306 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 35.1 t -50.41 -35.25 27.59 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.745 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.413 ' H ' ' HG2' ' B' ' 71' ' ' GLU . 3.0 mm-40 -86.55 -32.21 20.82 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.459 -177.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 72' ' ' TYR . . . . . 0.535 ' CE1' ' HB2' ' B' ' 58' ' ' LEU . 5.5 m-30 -74.09 -36.23 64.27 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.325 -178.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.896 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 2.2 m -71.15 -33.04 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 74' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' B' ' 70' ' ' SER . 0.0 OUTLIER -68.31 -32.2 72.16 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.459 177.474 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 75' ' ' ALA . . . . . 0.516 ' HB2' HD11 ' B' ' 58' ' ' LEU . . . -63.05 -44.67 95.19 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.194 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.52 ' SG ' ' HB3' ' B' ' 51' ' ' CYS . 3.8 m -97.54 9.28 42.86 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 114.22 -1.355 . . . . 0.0 111.052 -177.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -64.08 -29.67 70.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.649 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.75 6.52 77.1 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.063 174.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.684 HD11 ' HB2' ' B' ' 54' ' ' ALA . 80.0 mt -102.6 128.97 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 121.781 0.8 . . . . 0.0 111.812 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 80' ' ' GLY . . . . . 0.583 ' H ' ' HB2' ' B' ' 84' ' ' HIS . . . 173.88 -49.76 0.15 Allowed Glycine 0 N--CA 1.436 -1.35 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 169.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.79 156.46 26.85 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.16 -78.51 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 122.899 0.48 . . . . 0.0 112.042 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 83' ' ' MET . . . . . 0.547 ' O ' ' HG3' ' B' ' 87' ' ' MET . 63.6 mtt -60.94 -38.86 87.32 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 84' ' ' HIS . . . . . 0.583 ' HB2' ' H ' ' B' ' 80' ' ' GLY . 3.8 t-160 -53.25 -33.61 53.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.499 173.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -83.24 -36.86 24.25 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.691 0.281 . . . . 0.0 110.736 -177.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.55 -52.16 62.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 122.01 0.91 . . . . 0.0 110.192 174.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 87' ' ' MET . . . . . 0.547 ' HG3' ' O ' ' B' ' 83' ' ' MET . 27.5 mtm -74.56 -12.66 60.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.127 -1.397 . . . . 0.0 110.909 -176.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.462 HD12 ' HB2' ' B' ' 92' ' ' LEU . 0.1 OUTLIER -57.11 -42.34 80.62 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.501 177.145 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 51.9 ttm -80.61 -20.18 43.78 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.179 0.514 . . . . 0.0 110.831 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -92.72 -46.31 7.63 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.862 -175.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 91' ' ' GLN . . . . . 0.689 ' O ' ' HG2' ' B' ' 93' ' ' GLU . 92.4 mt-30 -92.64 -52.23 4.73 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.525 -172.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.462 ' HB2' HD12 ' B' ' 88' ' ' LEU . 0.0 OUTLIER -51.32 -36.07 41.01 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 175.645 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.689 ' HG2' ' O ' ' B' ' 91' ' ' GLN . 7.8 pt-20 . . . . . 0 C--O 1.25 1.126 0 CA-C-N 112.946 -1.934 . . . . 0.0 113.941 -177.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 CA--C 1.519 -0.263 0 N-CA-C 108.721 -1.3 . . . . 0.0 108.721 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 m -67.52 -179.76 1.14 Allowed 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 163.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.747 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -75.56 -53.38 8.71 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 118.956 -1.098 . . . . 0.0 108.625 166.791 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.493 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 2.4 p-10 -86.91 5.04 39.02 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.247 -1.342 . . . . 0.0 113.201 -165.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.96 -5.97 5.39 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 118.166 0.439 . . . . 0.0 111.441 -176.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.592 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.4 m -75.62 131.77 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 176.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.77 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -154.63 159.48 40.84 Favored 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 118.693 -1.203 . . . . 0.0 114.228 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.487 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.5 mt-30 -42.32 116.38 0.83 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 112.965 -1.925 . . . . 0.0 112.829 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.46 -139.87 8.15 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.635 173.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.4 p -58.67 95.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.765 0.282 . . . . 0.0 111.133 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.471 ' HD2' ' O ' ' A' ' 80' ' ' GLY . 56.5 pttt 40.75 39.54 0.8 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.238 1.015 . . . . 0.0 111.986 -175.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.447 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 48.5 tt0 -56.86 139.65 77.36 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.234 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.525 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 36.9 Cg_exo -54.33 122.73 12.03 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.988 1.792 . . . . 0.0 109.781 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.825 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 13.2 t80 -70.36 -52.53 11.57 Favored Pre-proline 0 N--CA 1.438 -1.046 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 -166.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.531 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 27.6 Cg_exo -57.18 -17.32 25.11 Favored 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 121.444 1.429 . . . . 0.0 111.062 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.525 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.5 m-20 -90.04 -42.11 11.32 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.04 -1.437 . . . . 0.0 110.698 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.487 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -55.5 -44.84 76.96 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.776 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.674 HG12 ' O ' ' A' ' 14' ' ' TYR . 2.1 p -78.99 -34.06 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.274 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.88 -38.15 69.79 Favored 'General case' 0 C--N 1.319 -0.744 0 O-C-N 121.833 -0.542 . . . . 0.0 111.488 176.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.721 ' O ' HG12 ' A' ' 24' ' ' VAL . 15.5 ptt180 -80.78 -28.32 36.38 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.537 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 6.2 tp -55.87 -43.78 77.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.976 173.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.69 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 24.0 mt-30 -72.72 -52.71 14.02 Favored 'General case' 0 CA--C 1.486 -1.483 0 CA-C-N 114.702 -1.135 . . . . 0.0 111.493 178.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.732 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 38.3 m-20 -46.86 -50.75 18.08 Favored 'General case' 0 C--N 1.313 -0.996 0 O-C-N 124.375 1.047 . . . . 0.0 111.24 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.721 HG12 ' O ' ' A' ' 20' ' ' ARG . 8.3 p -79.58 -26.23 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.77 -172.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.617 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -67.45 -30.54 70.29 Favored 'General case' 0 C--O 1.207 -1.171 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 175.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.96 -34.98 59.83 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.647 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.732 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 40.7 mmtt -67.9 -36.0 79.46 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.774 178.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.46 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 16.2 m -105.52 -6.33 19.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.362 0.601 . . . . 0.0 110.564 -171.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.656 HG22 ' H ' ' A' ' 31' ' ' ASP . 89.0 mt -118.2 124.15 72.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.334 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.21 -4.07 58.58 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.219 0.533 . . . . 0.0 110.582 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.656 ' H ' HG22 ' A' ' 29' ' ' ILE . 26.0 t0 -106.59 140.48 39.41 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.565 -177.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -76.23 -32.05 58.71 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.001 174.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.571 ' O ' HG13 ' A' ' 37' ' ' VAL . 6.9 mttp -70.87 -55.51 8.3 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -176.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.605 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -57.99 -27.87 63.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.976 175.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.853 ' O ' HG13 ' A' ' 39' ' ' VAL . 1.9 tmm_? -67.22 -56.53 9.49 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.497 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 20.8 mtpt -56.22 -57.93 10.13 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.957 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.732 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 20.1 m -53.08 -34.72 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.414 -169.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.747 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.1 tt -87.97 -30.75 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 C-N-CA 119.765 -0.774 . . . . 0.0 112.316 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.853 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.9 m -67.89 -50.21 61.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 119.413 -0.915 . . . . 0.0 109.688 174.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.769 ' OE1' HG13 ' A' ' 68' ' ' VAL . 0.9 OUTLIER -63.73 -25.9 68.4 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.76 0.824 . . . . 0.0 111.622 178.46 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.732 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -85.87 -55.14 4.1 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 177.064 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.518 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 22.2 mmt -62.59 -20.87 65.16 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 121.67 0.747 . . . . 0.0 109.822 -176.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.678 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -48.68 -28.89 3.85 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.81 171.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.557 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 11.5 t80 -106.14 -66.53 0.99 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 175.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.484 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 5.7 mm-40 -48.13 -29.56 3.75 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 124.107 0.88 . . . . 0.0 112.937 -175.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.77 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.7 m-20 -106.87 -21.25 13.08 Favored 'General case' 0 N--CA 1.438 -1.071 0 O-C-N 122.22 -0.3 . . . . 0.0 111.19 -176.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -60.43 179.22 0.16 Allowed 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.889 0.852 . . . . 0.0 112.905 -174.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.498 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 11.5 m-20 -60.12 139.83 91.07 Favored Pre-proline 0 N--CA 1.443 -0.823 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.228 174.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.473 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 1.8 Cg_endo -44.35 -46.38 11.79 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.906 2.404 . . . . 0.0 112.004 -177.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.543 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 0.4 OUTLIER -71.31 -33.51 69.73 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.335 1.054 . . . . 0.0 111.841 177.173 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.525 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 98.4 m -75.7 -36.37 60.03 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 121.243 0.544 . . . . 0.0 109.967 -173.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.553 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.9 pt20 -73.03 -30.95 64.12 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 174.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.543 ' HB2' ' HA ' ' A' ' 50' ' ' GLU . 17.4 m -68.87 -20.51 64.27 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.048 173.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.715 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -76.38 -28.74 56.88 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.747 0.784 . . . . 0.0 109.958 168.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.574 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 19.2 mt -89.67 -31.85 5.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -171.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.612 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -40.17 -39.78 1.55 Allowed Pre-proline 0 N--CA 1.487 1.41 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -173.075 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 54.2 Cg_endo -63.04 -30.93 76.46 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.141 1.894 . . . . 0.0 112.781 176.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.563 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 2.6 mt -94.48 -17.06 22.8 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.576 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -55.44 108.67 0.45 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.053 179.359 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.29 -31.66 8.47 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.528 -175.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.2 mmtt -104.12 114.85 29.38 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 122.173 0.987 . . . . 0.0 111.147 -177.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.535 ' HB ' HG12 ' A' ' 68' ' ' VAL . 5.6 p -120.72 131.67 24.39 Favored Pre-proline 0 C--N 1.294 -1.824 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.826 169.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.406 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 79.4 Cg_exo -51.27 137.88 46.33 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.637 2.224 . . . . 0.0 112.078 174.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.06 108.37 1.51 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.591 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.49 -14.86 42.59 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.346 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.406 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 4.7 t -94.43 -175.78 3.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.949 0.88 . . . . 0.0 110.548 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -107.72 143.7 35.87 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 113.723 -1.58 . . . . 0.0 107.96 175.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.769 HG13 ' OE1' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -72.25 -34.85 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 118.372 -1.331 . . . . 0.0 108.916 -179.138 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.766 ' O ' HG13 ' A' ' 73' ' ' VAL . 7.2 mm -56.65 -49.77 76.66 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.065 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.676 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 23.0 t -46.14 -38.37 8.09 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.858 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.445 ' H ' ' HG2' ' A' ' 71' ' ' GLU . 2.8 mm-40 -86.45 -32.27 20.94 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.544 -176.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.576 ' OH ' ' HA ' ' A' ' 59' ' ' LYS . 5.4 m-30 -73.95 -37.53 64.52 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.681 0.753 . . . . 0.0 109.65 -177.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.825 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.7 m -70.1 -32.81 52.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 174.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -68.42 -31.36 70.64 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.567 176.45 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.471 ' HB2' HD11 ' A' ' 58' ' ' LEU . . . -64.6 -46.35 83.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.492 178.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.525 ' SG ' ' HB3' ' A' ' 51' ' ' CYS . 4.0 m -94.04 9.22 38.51 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.919 -178.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 9.6 t70 -62.35 -27.3 68.96 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.201 177.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.51 -3.52 64.68 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.176 175.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.715 HD11 ' HB2' ' A' ' 54' ' ' ALA . 96.2 mt -96.07 129.11 46.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.787 0.327 . . . . 0.0 110.898 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.471 ' O ' ' HD2' ' A' ' 11' ' ' LYS . . . 162.05 30.48 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.333 175.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.576 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 151.18 -108.3 0.38 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.152 175.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.68 -53.24 59.02 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -173.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 56.7 mtt -67.92 -30.68 70.07 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.515 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 7.9 t60 -61.57 -35.24 77.23 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.549 175.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.576 ' HG2' ' O ' ' A' ' 81' ' ' GLY . 32.4 mmtp -80.0 -18.26 50.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.115 0.484 . . . . 0.0 110.391 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.21 -50.0 7.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.382 0.611 . . . . 0.0 110.387 176.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -77.98 -13.24 59.95 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.231 -175.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.575 ' O ' ' HB3' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -48.26 -42.93 31.91 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.562 179.134 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 50.7 ttm -83.51 -15.43 49.43 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.019 0.438 . . . . 0.0 111.067 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -95.24 -39.08 10.26 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -174.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.507 ' C ' ' HB3' ' A' ' 53' ' ' SER . 92.1 mt-30 -103.01 -53.31 2.86 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.434 -176.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.592 HD22 ' O ' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -61.69 -5.89 2.22 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.105 0.478 . . . . 0.0 110.319 178.56 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.048 -0.977 . . . . 0.0 112.189 178.991 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' PRO . . . . . 0.451 ' HB2' ' H ' ' B' ' 2' ' ' SER . 97.7 Cg_endo . . . . . 0 CA--C 1.52 -0.189 0 N-CA-C 108.815 -1.263 . . . . 0.0 108.815 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.559 ' HG ' ' HZ2' ' A' ' 59' ' ' LYS . 16.3 m -67.6 179.93 1.24 Allowed 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 163.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.752 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -75.32 -53.6 8.48 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.517 166.921 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.493 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.4 p-10 -86.77 4.98 38.66 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.35 -1.295 . . . . 0.0 113.271 -165.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.431 HG21 ' HG2' ' A' ' 59' ' ' LYS . 0.5 OUTLIER -63.7 -5.9 4.76 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 118.099 0.409 . . . . 0.0 111.572 -177.069 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.597 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.4 m -75.67 131.55 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.777 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -154.4 159.6 41.2 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 8' ' ' GLN . . . . . 0.488 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.5 mt-30 -42.37 116.21 0.81 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 112.941 -1.936 . . . . 0.0 112.852 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.17 -139.69 7.88 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.706 173.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 6.4 p -58.94 95.15 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.706 0.253 . . . . 0.0 111.143 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.475 ' HD2' ' O ' ' B' ' 80' ' ' GLY . 56.7 pttt 41.05 39.37 0.85 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.157 0.983 . . . . 0.0 111.976 -175.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.436 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 51.0 tt0 -56.61 139.57 75.61 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.241 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' PRO . . . . . 0.537 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 35.1 Cg_exo -54.15 122.77 12.04 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.0 1.8 . . . . 0.0 109.743 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' TYR . . . . . 0.839 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 13.1 t80 -70.45 -52.63 11.14 Favored Pre-proline 0 N--CA 1.438 -1.056 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -166.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.544 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 27.9 Cg_exo -56.97 -17.54 24.63 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 121.474 1.449 . . . . 0.0 111.134 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.537 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.3 m-20 -89.91 -42.42 11.22 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.682 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' PHE . . . . . 0.488 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -55.34 -44.75 76.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.803 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.688 HG12 ' O ' ' B' ' 14' ' ' TYR . 2.1 p -78.97 -34.15 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.27 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.91 -38.04 69.7 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 121.765 -0.585 . . . . 0.0 111.516 176.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.715 ' O ' HG12 ' B' ' 24' ' ' VAL . 15.6 ptt180 -80.78 -28.29 36.41 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.551 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 6.1 tp -55.78 -43.88 77.22 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.005 173.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' GLN . . . . . 0.677 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 24.1 mt-30 -72.7 -52.64 14.37 Favored 'General case' 0 CA--C 1.487 -1.472 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.48 178.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.731 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 39.5 m-20 -46.8 -50.79 17.77 Favored 'General case' 0 C--N 1.313 -1.011 0 O-C-N 124.417 1.073 . . . . 0.0 111.234 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' VAL . . . . . 0.715 HG12 ' O ' ' B' ' 20' ' ' ARG . 8.3 p -79.71 -26.06 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.836 -172.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.625 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -67.59 -30.46 70.07 Favored 'General case' 0 C--O 1.205 -1.239 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 175.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.78 -35.27 60.17 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.132 -1.395 . . . . 0.0 109.763 -178.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.731 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 40.9 mmtt -67.67 -36.54 80.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.586 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' SER . . . . . 0.461 ' HB2' ' HB3' ' B' ' 3' ' ' PHE . 16.4 m -105.19 -6.22 19.99 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.33 0.586 . . . . 0.0 110.536 -171.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.682 HG22 ' H ' ' B' ' 31' ' ' ASP . 89.0 mt -118.21 124.26 72.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.326 178.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.49 -3.65 58.51 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.236 0.541 . . . . 0.0 110.676 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.682 ' H ' HG22 ' B' ' 29' ' ' ILE . 25.9 t0 -106.9 140.46 39.68 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.519 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -76.35 -31.97 58.37 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.867 175.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.568 ' O ' HG13 ' B' ' 37' ' ' VAL . 7.1 mttp -70.73 -55.69 8.09 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -176.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.589 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -58.08 -27.71 63.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.996 176.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.858 ' O ' HG13 ' B' ' 39' ' ' VAL . 1.9 tmm_? -67.47 -56.45 9.55 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.485 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 21.2 mtpt -56.22 -57.93 10.12 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.997 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.742 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 20.1 m -53.06 -34.66 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.53 -169.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.752 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.1 tt -88.1 -30.72 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 119.727 -0.789 . . . . 0.0 112.25 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.858 HG13 ' O ' ' B' ' 35' ' ' ARG . 3.0 m -67.87 -49.99 63.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.742 174.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.775 ' OE1' HG13 ' B' ' 68' ' ' VAL . 0.9 OUTLIER -64.06 -25.66 68.21 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.68 0.792 . . . . 0.0 111.658 178.452 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.742 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.97 -55.03 4.14 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 176.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 42' ' ' MET . . . . . 0.516 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 22.2 mmt -62.81 -20.66 65.25 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.697 0.76 . . . . 0.0 109.818 -176.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.667 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -48.89 -28.77 4.03 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.779 171.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' TYR . . . . . 0.562 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 11.5 t80 -106.29 -66.66 0.99 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 175.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.476 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 5.7 mm-40 -48.03 -29.49 3.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 124.138 0.899 . . . . 0.0 112.999 -175.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.777 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.6 m-20 -106.9 -21.09 13.13 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 121.031 -0.267 . . . . 0.0 111.19 -176.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -60.61 179.19 0.17 Allowed 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.844 0.831 . . . . 0.0 112.931 -174.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.512 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 11.0 m-20 -60.08 139.69 90.97 Favored Pre-proline 0 N--CA 1.441 -0.888 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.237 174.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' PRO . . . . . 0.471 ' HB2' ' CD2' ' B' ' 92' ' ' LEU . 1.8 Cg_endo -44.27 -46.35 11.63 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.847 2.365 . . . . 0.0 111.985 -177.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.548 ' HA ' ' HB2' ' B' ' 53' ' ' SER . 0.3 OUTLIER -71.32 -33.39 69.6 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.234 1.013 . . . . 0.0 111.96 177.256 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.528 ' HB3' ' SG ' ' B' ' 76' ' ' CYS . 93.0 m -75.78 -36.38 59.8 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 121.258 0.552 . . . . 0.0 110.026 -174.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.569 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.9 pt20 -72.95 -31.14 64.38 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 106.932 -1.506 . . . . 0.0 106.932 174.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 53' ' ' SER . . . . . 0.548 ' HB2' ' HA ' ' B' ' 50' ' ' GLU . 17.9 m -68.64 -20.55 64.47 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.066 -1.424 . . . . 0.0 110.07 173.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.723 ' HB2' HD11 ' B' ' 79' ' ' ILE . . . -76.34 -28.83 57.01 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.813 0.816 . . . . 0.0 109.984 168.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.577 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 19.0 mt -89.76 -31.7 5.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -171.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.606 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -40.33 -39.83 1.66 Allowed Pre-proline 0 N--CA 1.488 1.452 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -173.104 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 52.0 Cg_endo -62.52 -32.19 80.11 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.001 1.801 . . . . 0.0 112.585 176.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 58' ' ' LEU . . . . . 0.568 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 2.6 mt -93.6 -17.08 23.71 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.565 ' HA ' ' OH ' ' B' ' 72' ' ' TYR . 0.0 OUTLIER -55.49 108.56 0.44 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.966 179.234 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.57 -31.77 8.33 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.41 -175.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 28.4 mmtt -103.84 114.92 29.53 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 122.203 1.001 . . . . 0.0 111.166 -177.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.542 ' HB ' HG12 ' B' ' 68' ' ' VAL . 5.6 p -120.71 131.88 24.33 Favored Pre-proline 0 C--N 1.294 -1.83 0 CA-C-N 113.861 -1.518 . . . . 0.0 109.786 169.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.401 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 84.1 Cg_exo -51.45 138.03 47.77 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.656 2.237 . . . . 0.0 112.103 174.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.12 108.19 1.48 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.556 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.39 -14.64 43.08 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.483 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.401 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 4.6 t -94.74 -175.81 3.69 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 122.005 0.907 . . . . 0.0 110.583 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -107.66 143.67 35.81 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 113.811 -1.54 . . . . 0.0 108.002 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.775 HG13 ' OE1' ' B' ' 40' ' ' GLU . 0.8 OUTLIER -72.04 -35.12 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 118.41 -1.316 . . . . 0.0 108.908 -179.117 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.772 ' O ' HG13 ' B' ' 73' ' ' VAL . 7.2 mm -56.53 -49.78 76.02 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.992 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.644 -178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 25.8 t -45.69 -38.82 7.23 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.815 178.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.403 ' H ' ' HG2' ' B' ' 71' ' ' GLU . 2.9 mm-40 -86.4 -32.46 20.89 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.568 -175.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 72' ' ' TYR . . . . . 0.568 ' CE1' ' HB2' ' B' ' 58' ' ' LEU . 5.4 m-30 -73.74 -37.53 65.04 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.6 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.839 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.7 m -70.16 -32.87 52.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 174.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 74' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' B' ' 70' ' ' SER . 0.0 OUTLIER -68.3 -31.38 70.78 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.746 -1.116 . . . . 0.0 109.573 176.34 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 75' ' ' ALA . . . . . 0.485 ' HB2' HD11 ' B' ' 58' ' ' LEU . . . -64.86 -46.13 83.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.567 178.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.528 ' SG ' ' HB3' ' B' ' 51' ' ' CYS . 4.0 m -94.07 9.18 38.73 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.951 -178.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 77' ' ' ASP . . . . . 0.401 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 11.3 t70 -62.5 -27.05 68.88 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.249 177.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.48 -3.55 64.7 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.304 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.723 HD11 ' HB2' ' B' ' 54' ' ' ALA . 96.0 mt -95.96 129.31 46.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.985 0.422 . . . . 0.0 110.9 -177.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 80' ' ' GLY . . . . . 0.475 ' O ' ' HD2' ' B' ' 11' ' ' LYS . . . 161.78 30.48 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.394 174.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.592 ' O ' ' HG2' ' B' ' 85' ' ' LYS . . . 151.43 -108.28 0.37 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.466 -0.873 . . . . 0.0 113.086 175.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.6 -53.3 58.16 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -173.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 83' ' ' MET . . . . . . . . . . . . . 56.9 mtt -68.01 -30.69 70.0 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 84' ' ' HIS . . . . . 0.519 ' O ' ' HB2' ' B' ' 88' ' ' LEU . 7.9 t60 -61.41 -35.31 77.2 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.599 175.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.592 ' HG2' ' O ' ' B' ' 81' ' ' GLY . 32.3 mmtp -80.11 -17.99 51.1 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 121.978 -0.451 . . . . 0.0 110.306 -178.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.48 -50.11 7.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.453 0.644 . . . . 0.0 110.461 176.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -77.78 -13.21 59.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.183 -175.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.577 ' O ' ' HB3' ' B' ' 92' ' ' LEU . 0.3 OUTLIER -48.37 -42.95 33.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.515 179.153 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 50.3 ttm -83.54 -15.24 50.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.842 0.353 . . . . 0.0 110.991 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -95.41 -38.78 10.33 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -174.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 91' ' ' GLN . . . . . 0.513 ' C ' ' HB3' ' B' ' 53' ' ' SER . 92.1 mt-30 -103.32 -53.31 2.83 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.332 -176.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.598 HD22 ' O ' ' B' ' 92' ' ' LEU . 0.3 OUTLIER -61.95 -5.41 2.11 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.178 0.513 . . . . 0.0 110.324 178.533 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.199 -0.905 . . . . 0.0 112.354 179.068 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.417 ' HB2' HG21 ' A' ' 5' ' ' THR . 92.1 Cg_endo . . . . . 0 CA--C 1.517 -0.327 0 N-CA-C 109.171 -1.127 . . . . 0.0 109.171 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.414 ' HB2' ' HB ' ' A' ' 5' ' ' THR . 12.9 m -64.25 165.94 8.72 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 162.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.722 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -69.86 -54.14 14.85 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.027 -1.069 . . . . 0.0 108.614 167.607 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.519 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 3.2 p-10 -88.31 -3.05 58.91 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 113.947 -1.479 . . . . 0.0 113.403 -164.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.45 ' O ' ' HD3' ' A' ' 7' ' ' ARG . 9.8 t -66.36 -3.58 6.3 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.622 -173.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.539 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 3.0 m -70.7 135.75 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 172.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.803 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -153.86 159.12 41.68 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 -179.781 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.482 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.1 tt0 -41.69 112.1 0.29 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 112.832 -1.986 . . . . 0.0 112.216 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.2 -145.42 6.06 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.756 176.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.7 p -59.79 95.38 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.687 0.279 . . . . 0.0 110.737 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.403 ' HD2' ' O ' ' A' ' 80' ' ' GLY . 64.3 pttt 43.23 41.43 2.97 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.384 1.074 . . . . 0.0 112.3 -176.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.429 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 62.9 tt0 -56.58 141.25 72.94 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.801 175.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.401 ' O ' ' HB3' ' A' ' 16' ' ' ASP . 22.5 Cg_exo -51.68 123.1 11.53 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.73 1.62 . . . . 0.0 109.141 174.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.835 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 11.5 t80 -66.67 -51.47 40.01 Favored Pre-proline 0 N--CA 1.438 -1.052 0 CA-C-O 118.857 -0.592 . . . . 0.0 112.555 -171.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.494 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 20.5 Cg_exo -60.29 -13.77 26.1 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 121.69 1.593 . . . . 0.0 110.413 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.401 ' HB3' ' O ' ' A' ' 13' ' ' PRO . 17.1 t70 -89.45 -46.78 8.46 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 113.903 -1.499 . . . . 0.0 110.282 178.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.482 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -54.18 -42.88 70.16 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.84 177.682 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.757 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 2.1 p -81.35 -35.22 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.52 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.58 -37.67 70.93 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 121.394 -0.816 . . . . 0.0 111.223 177.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.738 ' O ' HG12 ' A' ' 24' ' ' VAL . 17.4 ptt180 -79.61 -30.05 41.31 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.548 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 7.8 tp -54.2 -46.7 72.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.258 173.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.757 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 6.1 mt-30 -69.94 -53.56 17.31 Favored 'General case' 0 CA--C 1.485 -1.523 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.55 177.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.732 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 56.3 m-20 -45.51 -52.45 10.32 Favored 'General case' 0 C--N 1.314 -0.978 0 O-C-N 124.637 1.21 . . . . 0.0 111.181 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.738 HG12 ' O ' ' A' ' 20' ' ' ARG . 8.2 p -79.67 -26.96 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.745 -171.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.679 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -66.82 -31.2 71.67 Favored 'General case' 0 C--O 1.204 -1.324 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 175.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.61 -35.59 62.95 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.909 -178.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.732 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.6 mmtt -65.86 -40.11 91.38 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.63 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.444 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 40.0 m -101.86 -10.81 19.54 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.32 0.581 . . . . 0.0 110.662 -172.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.679 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 88.4 mt -113.72 122.26 67.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.515 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.85 -1.19 57.82 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.247 0.546 . . . . 0.0 110.317 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.637 ' H ' HG22 ' A' ' 29' ' ' ILE . 11.8 t70 -107.31 119.41 39.33 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.965 -175.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -60.13 -30.35 69.23 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.08 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.588 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -74.31 -53.52 9.53 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -174.864 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.575 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -60.56 -27.41 67.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.773 177.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.859 ' O ' HG13 ' A' ' 39' ' ' VAL . 1.9 tmm_? -67.33 -58.47 4.73 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 32.6 mtpt -54.61 -59.24 4.98 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.123 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.725 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 16.9 m -53.56 -34.14 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.327 -170.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.722 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.3 tt -87.38 -32.08 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.871 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.7 m -67.34 -49.14 74.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.156 175.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.633 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 52.0 mt-10 -60.49 -31.72 70.74 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.298 1.039 . . . . 0.0 112.742 175.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.725 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -85.16 -51.29 6.73 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.933 -179.841 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.707 ' HE2' ' HE2' ' B' ' 42' ' ' MET . 20.5 mmt -64.62 -20.77 66.47 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.553 0.692 . . . . 0.0 109.462 -178.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.681 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -50.26 -30.33 11.52 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.516 171.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.529 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 15.9 t80 -102.91 -66.71 0.92 Allowed 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 174.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.478 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 47.6 mm-40 -50.26 -28.41 7.66 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.725 -1.125 . . . . 0.0 112.713 -172.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.803 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.1 m-20 -106.36 -22.04 12.92 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 121.28 -0.168 . . . . 0.0 111.055 -176.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -59.56 177.3 0.21 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.8 0.81 . . . . 0.0 112.994 -174.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.607 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 15.2 m-20 -58.89 140.55 86.37 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.93 174.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.411 ' HB2' HD21 ' A' ' 92' ' ' LEU . 9.2 Cg_endo -53.64 -23.43 25.81 Favored 'Trans proline' 0 C--O 1.221 -0.35 0 C-N-CA 123.524 2.816 . . . . 0.0 112.731 -176.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.564 ' OE1' ' HB2' ' A' ' 91' ' ' GLN . 0.3 OUTLIER -88.3 -35.37 17.27 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.942 0.897 . . . . 0.0 110.788 175.074 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.607 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 72.3 m -76.85 -35.87 57.2 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.207 -171.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.628 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.7 pt20 -72.49 -29.89 64.04 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 174.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.62 ' HB3' ' C ' ' A' ' 91' ' ' GLN . 15.9 m -71.81 -19.01 62.05 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 113.715 -1.584 . . . . 0.0 110.387 174.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.775 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -77.21 -26.95 53.26 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.813 0.816 . . . . 0.0 109.494 166.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.628 HD12 ' HA ' ' A' ' 52' ' ' GLN . 25.9 mt -89.27 -31.01 5.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -172.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.607 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.8 -38.77 2.17 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -173.756 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 57.2 Cg_endo -64.49 -30.08 61.87 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.165 1.91 . . . . 0.0 112.765 176.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.527 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 2.2 mt -95.29 -16.35 22.5 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.529 ' HE3' ' HB3' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -54.05 108.65 0.38 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.709 -179.522 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.77 -21.98 42.96 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.413 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.9 mmmt -104.17 115.88 31.19 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 120.932 0.396 . . . . 0.0 110.422 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.54 139.72 31.51 Favored Pre-proline 0 C--N 1.311 -1.095 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 169.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.541 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 79.4 Cg_exo -51.7 137.4 50.52 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.338 2.025 . . . . 0.0 111.423 170.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.97 106.71 1.08 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.898 -176.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.03 -14.73 44.5 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.5 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.541 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 25.1 m -94.8 172.23 8.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.319 0.58 . . . . 0.0 111.342 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -90.3 143.21 26.97 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.783 176.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.602 HG22 ' HG2' ' A' ' 40' ' ' GLU . 1.0 OUTLIER -77.38 -29.7 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 C-N-CA 118.651 -1.22 . . . . 0.0 108.813 -179.346 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.777 ' O ' HG13 ' A' ' 73' ' ' VAL . 10.4 mm -60.81 -47.53 92.86 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.117 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.125 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.0 t -46.18 -37.66 7.34 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.017 176.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.472 ' HA ' ' HB3' ' A' ' 74' ' ' LYS . 7.2 mm-40 -85.82 -31.85 22.08 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 123.375 0.67 . . . . 0.0 111.014 -177.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.612 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.3 m-30 -75.32 -34.84 61.27 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.555 0.693 . . . . 0.0 109.34 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.835 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.4 m -72.52 -30.17 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 173.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.509 ' HA ' ' HB2' ' A' ' 77' ' ' ASP . 14.8 ttpt -73.52 -25.51 60.45 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.474 177.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -65.89 -46.53 78.03 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.538 174.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.707 ' SG ' ' HB ' ' A' ' 79' ' ' ILE . 26.2 t -93.01 8.77 38.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.871 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.509 ' HB2' ' HA ' ' A' ' 74' ' ' LYS . 17.3 t70 -63.68 -19.93 65.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.302 0.572 . . . . 0.0 110.043 176.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -105.23 2.21 40.43 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.435 173.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.775 HD11 ' HB2' ' A' ' 54' ' ' ALA . 95.5 mt -101.78 137.54 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 117.411 0.606 . . . . 0.0 112.162 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.693 ' H ' ' HB2' ' A' ' 84' ' ' HIS . . . 157.08 -43.14 0.52 Allowed Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.444 170.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.663 ' O ' ' HB3' ' A' ' 84' ' ' HIS . . . -95.27 -141.58 11.92 Favored Glycine 0 CA--C 1.494 -1.263 0 CA-C-O 122.083 0.824 . . . . 0.0 114.633 -173.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.89 -29.29 70.23 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 113.609 -1.296 . . . . 0.0 110.952 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 68.1 mtm -69.89 -26.86 64.37 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.693 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 4.8 t60 -64.67 -31.64 72.95 Favored 'General case' 0 C--O 1.219 -0.524 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -82.52 -21.8 35.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.987 0.423 . . . . 0.0 110.424 179.309 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.86 -46.99 14.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.442 0.639 . . . . 0.0 110.592 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -79.43 -14.72 58.74 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.817 -176.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 84' ' ' HIS . 0.2 OUTLIER -53.84 -32.04 51.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.29 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.3 ttt -84.43 -21.72 30.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.178 0.513 . . . . 0.0 111.16 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -96.01 -52.59 3.98 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.022 0.439 . . . . 0.0 111.953 -173.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.678 ' O ' ' HG2' ' A' ' 93' ' ' GLU . 93.0 mt-30 -80.72 -62.82 1.56 Allowed 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.726 -173.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.437 ' HB3' ' O ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -45.37 -34.41 3.01 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.625 1.203 . . . . 0.0 108.591 171.838 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.678 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 6.6 pt-20 . . . . . 0 C--O 1.249 1.076 0 CA-C-N 113.737 -1.574 . . . . 0.0 113.239 -173.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 1' ' ' PRO . . . . . 0.414 ' HB2' ' H ' ' B' ' 2' ' ' SER . 93.8 Cg_endo . . . . . 0 CA--C 1.519 -0.248 0 N-CA-C 109.133 -1.141 . . . . 0.0 109.133 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.429 ' HB2' ' HB ' ' B' ' 5' ' ' THR . 13.3 m -64.35 166.24 8.47 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 163.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.746 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -70.12 -54.02 14.81 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.108 -1.037 . . . . 0.0 108.605 167.687 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.524 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 3.2 p-10 -88.5 -2.99 58.9 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.041 -1.436 . . . . 0.0 113.408 -164.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.436 ' O ' ' HD3' ' B' ' 7' ' ' ARG . 9.5 t -66.37 -3.54 6.22 Favored 'General case' 0 C--N 1.315 -0.911 0 O-C-N 121.644 -0.66 . . . . 0.0 110.634 -173.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.526 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 3.0 m -70.63 135.7 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 171.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.799 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -153.9 159.2 41.66 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 8' ' ' GLN . . . . . 0.458 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.1 tt0 -41.77 112.42 0.32 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 112.776 -2.011 . . . . 0.0 112.106 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.35 -145.64 6.3 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.772 175.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 12.4 p -59.51 95.27 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.64 0.257 . . . . 0.0 110.653 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 64.2 pttt 43.17 41.36 2.84 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.44 1.096 . . . . 0.0 112.402 -176.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.424 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 62.8 tt0 -56.63 141.37 73.11 Favored Pre-proline 0 C--O 1.235 0.301 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.774 175.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' B' ' 16' ' ' ASP . 22.1 Cg_exo -51.66 122.99 11.29 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.742 1.628 . . . . 0.0 109.204 174.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' TYR . . . . . 0.839 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 11.7 t80 -66.63 -51.64 39.42 Favored Pre-proline 0 N--CA 1.437 -1.078 0 CA-C-O 118.876 -0.583 . . . . 0.0 112.406 -171.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.504 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 20.6 Cg_exo -60.14 -13.79 25.57 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.57 1.513 . . . . 0.0 110.453 -178.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.417 ' HB3' ' O ' ' B' ' 13' ' ' PRO . 18.7 t70 -89.45 -46.74 8.48 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 113.939 -1.482 . . . . 0.0 110.191 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 17' ' ' PHE . . . . . 0.458 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -54.15 -42.85 70.02 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.841 177.675 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.752 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 2.1 p -81.4 -35.27 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.429 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.57 -37.64 70.86 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 121.38 -0.825 . . . . 0.0 111.221 177.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.74 ' O ' HG12 ' B' ' 24' ' ' VAL . 17.4 ptt180 -79.72 -29.72 40.74 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.558 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 7.9 tp -54.47 -46.72 73.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.193 173.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 22' ' ' GLN . . . . . 0.752 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 6.1 mt-30 -69.81 -53.67 17.15 Favored 'General case' 0 CA--C 1.485 -1.556 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.519 177.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.728 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 48.9 m-20 -45.55 -52.49 10.39 Favored 'General case' 0 C--N 1.314 -0.959 0 O-C-N 124.628 1.205 . . . . 0.0 111.042 -178.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' VAL . . . . . 0.74 HG12 ' O ' ' B' ' 20' ' ' ARG . 8.2 p -79.64 -26.97 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.673 -171.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.667 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -66.86 -31.02 71.35 Favored 'General case' 0 C--O 1.206 -1.211 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 175.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -35.65 62.53 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.802 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.728 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.9 mmtt -65.87 -40.13 91.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.643 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' SER . . . . . 0.454 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 37.4 m -101.66 -11.21 19.36 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.186 0.517 . . . . 0.0 110.546 -172.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.667 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 88.0 mt -113.63 122.33 67.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.569 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.93 -1.11 57.78 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.249 0.547 . . . . 0.0 110.439 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.658 ' H ' HG22 ' B' ' 29' ' ' ILE . 11.4 t70 -107.59 119.36 39.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.959 -175.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.2 -30.15 69.18 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.1 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.599 ' O ' HG13 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -74.42 -53.27 9.91 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -174.867 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.571 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -60.85 -27.32 68.0 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.87 177.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.87 ' O ' HG13 ' B' ' 39' ' ' VAL . 1.9 tmm_? -67.38 -58.52 4.63 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.431 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 32.3 mtpt -54.6 -59.3 4.89 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.081 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.722 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 17.1 m -53.69 -33.88 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.314 -170.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.746 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.3 tt -87.53 -32.08 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.808 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.87 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.7 m -67.31 -49.11 75.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.101 174.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.637 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 52.2 mt-10 -60.63 -31.72 70.9 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.259 1.023 . . . . 0.0 112.794 176.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.722 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -85.25 -51.17 6.78 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.393 -0.523 . . . . 0.0 112.02 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 42' ' ' MET . . . . . 0.707 ' HE2' ' HE2' ' A' ' 42' ' ' MET . 20.7 mmt -64.63 -20.7 66.43 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 121.545 0.688 . . . . 0.0 109.524 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.675 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -50.39 -30.33 12.12 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.421 171.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' TYR . . . . . 0.536 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 16.1 t80 -102.85 -66.61 0.92 Allowed 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 174.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.47 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 46.8 mm-40 -50.49 -27.99 7.61 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.696 -1.138 . . . . 0.0 112.739 -172.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.799 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.2 m-20 -106.76 -21.91 12.89 Favored 'General case' 0 N--CA 1.434 -1.265 0 O-C-N 122.371 -0.206 . . . . 0.0 111.1 -176.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -59.51 177.46 0.2 Allowed 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.81 0.814 . . . . 0.0 113.085 -175.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.61 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 15.1 m-20 -59.09 140.33 87.31 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.864 174.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 49' ' ' PRO . . . . . 0.404 ' HB2' HD21 ' B' ' 92' ' ' LEU . 9.2 Cg_endo -53.75 -23.21 25.78 Favored 'Trans proline' 0 C--O 1.22 -0.407 0 C-N-CA 123.502 2.801 . . . . 0.0 112.628 -176.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.562 ' OE1' ' HB2' ' B' ' 91' ' ' GLN . 0.3 OUTLIER -88.41 -35.27 17.19 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.88 0.872 . . . . 0.0 110.824 174.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.61 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 71.8 m -76.82 -35.83 57.29 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.261 -172.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.646 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.8 pt20 -72.36 -29.99 64.3 Favored 'General case' 0 C--O 1.213 -0.835 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 174.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 53' ' ' SER . . . . . 0.619 ' HB3' ' C ' ' B' ' 91' ' ' GLN . 14.5 m -71.63 -19.26 62.13 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 113.7 -1.591 . . . . 0.0 110.4 174.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.797 ' HB2' HD11 ' B' ' 79' ' ' ILE . . . -77.16 -27.08 53.62 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.692 0.758 . . . . 0.0 109.484 166.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.646 HD12 ' HA ' ' B' ' 52' ' ' GLN . 25.9 mt -89.23 -30.99 5.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -172.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.604 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.96 -38.67 2.26 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -173.647 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 57.3 Cg_endo -64.7 -29.76 59.89 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 122.055 1.837 . . . . 0.0 112.688 176.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 58' ' ' LEU . . . . . 0.545 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 2.2 mt -95.36 -16.26 22.48 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.536 ' HE3' ' HB3' ' B' ' 44' ' ' TYR . 0.1 OUTLIER -54.18 108.7 0.39 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.746 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.45 -21.5 45.21 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.503 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 15.8 mmmt -104.49 115.84 31.06 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.865 0.365 . . . . 0.0 110.6 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.4 139.72 31.33 Favored Pre-proline 0 C--N 1.312 -1.059 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 169.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.559 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 80.7 Cg_exo -51.59 137.51 49.43 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.368 2.045 . . . . 0.0 111.523 170.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.27 106.45 1.1 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.898 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.31 -14.94 43.28 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.4 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.559 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 27.7 m -94.75 172.34 8.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.355 0.598 . . . . 0.0 111.264 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -90.34 143.47 26.73 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.241 -0.891 . . . . 0.0 108.882 176.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.583 HG22 ' HG2' ' B' ' 40' ' ' GLU . 1.0 OUTLIER -77.54 -29.75 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 C-N-CA 118.691 -1.203 . . . . 0.0 108.813 -179.444 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.774 ' O ' HG13 ' B' ' 73' ' ' VAL . 10.4 mm -60.8 -47.4 93.41 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.155 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.166 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 41.0 t -46.63 -37.29 7.99 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 123.847 0.717 . . . . 0.0 110.998 177.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.491 ' HA ' ' HB3' ' B' ' 74' ' ' LYS . 7.5 mm-40 -85.89 -31.67 22.08 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.22 0.608 . . . . 0.0 111.051 -177.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 72' ' ' TYR . . . . . 0.6 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.3 m-30 -75.45 -34.89 60.99 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.599 0.714 . . . . 0.0 109.441 -178.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.839 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.4 m -72.65 -30.03 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 173.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 74' ' ' LYS . . . . . 0.528 ' HA ' ' HB2' ' B' ' 77' ' ' ASP . 14.7 ttpt -73.71 -25.18 60.09 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.581 177.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 75' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -65.95 -46.57 77.69 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.646 173.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.716 ' SG ' ' HB ' ' B' ' 79' ' ' ILE . 28.3 t -93.03 8.58 39.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.884 177.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 77' ' ' ASP . . . . . 0.528 ' HB2' ' HA ' ' B' ' 74' ' ' LYS . 18.0 t70 -63.86 -19.04 64.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.296 0.57 . . . . 0.0 110.056 176.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -105.76 2.08 38.96 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.558 -0.747 . . . . 0.0 112.546 173.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.797 HD11 ' HB2' ' B' ' 54' ' ' ALA . 95.1 mt -101.84 137.63 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 117.288 0.544 . . . . 0.0 112.167 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 80' ' ' GLY . . . . . 0.691 ' H ' ' HB2' ' B' ' 84' ' ' HIS . . . 156.99 -43.22 0.53 Allowed Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.305 -0.862 . . . . 0.0 111.377 170.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.652 ' O ' ' HB3' ' B' ' 84' ' ' HIS . . . -95.2 -141.57 11.89 Favored Glycine 0 CA--C 1.493 -1.307 0 CA-C-O 121.869 0.705 . . . . 0.0 114.64 -173.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.79 -29.84 70.82 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 113.718 -1.241 . . . . 0.0 110.689 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 83' ' ' MET . . . . . . . . . . . . . 68.3 mtm -69.46 -26.67 64.7 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 175.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 84' ' ' HIS . . . . . 0.691 ' HB2' ' H ' ' B' ' 80' ' ' GLY . 4.8 t60 -64.79 -31.44 72.66 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 121.211 0.529 . . . . 0.0 109.576 173.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.469 ' HD2' ' O ' ' B' ' 81' ' ' GLY . 0.1 OUTLIER -82.88 -21.8 34.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.92 0.39 . . . . 0.0 110.37 179.388 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.84 -46.95 14.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.413 0.625 . . . . 0.0 110.653 177.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -79.21 -14.81 58.83 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.89 -176.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.496 ' HB2' ' O ' ' B' ' 84' ' ' HIS . 0.2 OUTLIER -53.61 -32.21 50.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.229 0.538 . . . . 0.0 111.324 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 25.5 ttt -84.42 -21.52 30.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.049 0.452 . . . . 0.0 111.22 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -96.38 -52.19 4.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.107 0.48 . . . . 0.0 111.958 -173.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 91' ' ' GLN . . . . . 0.684 ' O ' ' HG2' ' B' ' 93' ' ' GLU . 92.8 mt-30 -80.87 -63.17 1.46 Allowed 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.691 -173.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.446 ' HB3' ' O ' ' B' ' 88' ' ' LEU . 0.0 OUTLIER -45.02 -34.9 2.67 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.69 1.244 . . . . 0.0 108.606 171.81 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.684 ' HG2' ' O ' ' B' ' 91' ' ' GLN . 7.1 pt-20 . . . . . 0 C--O 1.251 1.176 0 CA-C-N 113.828 -1.533 . . . . 0.0 113.134 -173.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.42 ' C ' ' HA3' ' B' ' 60' ' ' GLY . 84.1 Cg_endo . . . . . 0 CA--C 1.516 -0.399 0 N-CA-C 109.525 -0.99 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.8 m -65.74 165.14 13.23 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 163.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.764 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -69.9 -55.17 10.43 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 122.058 0.932 . . . . 0.0 109.907 174.142 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.566 ' ND2' ' HG3' ' A' ' 42' ' ' MET . 2.7 p-10 -86.57 -2.38 58.44 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.308 -1.314 . . . . 0.0 112.762 -164.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.417 ' O ' ' HD3' ' A' ' 7' ' ' ARG . 9.9 t -66.1 -3.03 4.75 Favored 'General case' 0 C--N 1.314 -0.942 0 O-C-N 121.708 -0.62 . . . . 0.0 110.445 -176.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.607 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.3 m -73.7 131.98 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 170.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.759 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 1.3 ptt-85 -156.68 160.04 38.97 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 118.38 -1.328 . . . . 0.0 114.375 -176.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.457 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.3 tt0 -39.12 112.33 0.24 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 113.698 -1.592 . . . . 0.0 112.624 178.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.95 -142.36 7.96 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.689 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.5 m -59.33 95.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.973 0.387 . . . . 0.0 110.837 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.401 ' O ' ' HG3' ' A' ' 11' ' ' LYS . 23.3 pttm 40.73 41.75 1.24 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.495 1.118 . . . . 0.0 112.343 -174.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 65.6 tt0 -57.79 139.65 81.95 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.674 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.518 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 34.3 Cg_exo -53.7 125.0 17.19 Favored 'Trans proline' 0 CA--C 1.511 -0.671 0 C-N-CA 122.026 1.817 . . . . 0.0 109.745 177.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.841 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 6.0 t80 -68.22 -55.48 12.62 Favored Pre-proline 0 N--CA 1.44 -0.934 0 CA-C-O 118.482 -0.77 . . . . 0.0 112.924 -167.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.528 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 26.0 Cg_exo -57.62 -17.7 29.63 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 121.456 1.437 . . . . 0.0 111.145 -177.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.518 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 5.7 m-20 -89.8 -40.16 12.64 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.057 -1.428 . . . . 0.0 110.846 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.639 ' HE2' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -56.63 -45.79 81.32 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 176.106 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.796 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 1.4 p -77.82 -33.46 18.74 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.322 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.347 -178.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.04 -31.57 67.15 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 121.179 -0.951 . . . . 0.0 111.834 177.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.738 ' O ' HG12 ' A' ' 24' ' ' VAL . 15.6 ptt180 -84.86 -28.09 26.26 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 175.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.601 HD22 ' CE1' ' A' ' 17' ' ' PHE . 11.8 tp -54.28 -48.9 70.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.962 172.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.796 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 4.3 mt-30 -70.57 -46.65 63.09 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 114.849 -1.068 . . . . 0.0 111.123 177.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.729 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 19.2 t70 -48.41 -54.63 13.34 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.282 0.989 . . . . 0.0 111.479 -178.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.738 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.4 p -81.73 -22.18 10.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.13 0.49 . . . . 0.0 109.734 -173.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.801 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -72.93 -18.85 61.35 Favored 'General case' 0 C--O 1.205 -1.259 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 174.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.401 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -86.44 -38.61 17.16 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.568 -1.196 . . . . 0.0 109.553 177.22 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.729 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.8 mmtt -67.06 -36.29 81.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.014 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.2 m -103.69 -9.1 19.4 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.088 0.47 . . . . 0.0 110.516 -171.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.801 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 84.3 mt -115.07 126.06 72.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.442 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.47 -4.8 59.27 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.242 0.544 . . . . 0.0 110.502 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.65 ' H ' HG22 ' A' ' 29' ' ' ILE . 25.8 t0 -106.28 139.16 41.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.407 -177.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -75.98 -31.45 58.99 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.445 175.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.567 ' O ' HG13 ' A' ' 37' ' ' VAL . 6.4 mttp -71.88 -55.0 8.31 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -175.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.631 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -58.75 -27.31 64.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.022 176.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.873 ' O ' HG13 ' A' ' 39' ' ' VAL . 1.9 tmm_? -66.0 -59.86 3.41 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 178.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.423 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 12.6 mtpp -54.94 -57.58 11.07 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.16 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.779 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 20.6 m -52.8 -34.33 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.975 -170.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.764 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.0 OUTLIER -88.31 -31.37 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 119.87 -0.732 . . . . 0.0 112.217 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.873 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.4 m -68.52 -48.65 71.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 119.067 -1.053 . . . . 0.0 109.513 176.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.785 ' OE1' HG13 ' A' ' 68' ' ' VAL . 0.8 OUTLIER -64.59 -28.46 69.64 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.455 0.702 . . . . 0.0 111.573 178.343 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.779 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -81.4 -54.61 5.32 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 122.19 -0.319 . . . . 0.0 111.432 178.014 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.566 ' HG3' ' ND2' ' A' ' 4' ' ' ASN . 22.3 mmt -63.43 -20.41 65.53 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.707 0.765 . . . . 0.0 109.613 -177.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.648 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -49.07 -32.98 10.61 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.86 172.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.488 ' HB2' HG21 ' A' ' 55' ' ' ILE . 17.1 t80 -99.75 -64.99 0.99 Allowed 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 175.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.566 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 39.3 mm-40 -50.06 -33.01 17.0 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.468 -1.242 . . . . 0.0 112.413 -171.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.759 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.6 m-20 -103.72 -20.42 13.96 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.087 -174.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.648 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -59.11 175.03 0.32 Allowed 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.691 0.758 . . . . 0.0 112.121 -177.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.603 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 12.3 m-20 -58.77 141.5 85.0 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.503 174.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -48.32 -29.09 12.45 Favored 'Trans proline' 0 C--O 1.22 -0.397 0 C-N-CA 123.761 2.974 . . . . 0.0 112.893 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.507 ' HG3' HD13 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -88.15 -33.82 18.08 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 123.86 0.864 . . . . 0.0 111.053 177.033 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.603 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 78.2 m -78.83 -33.8 45.76 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.504 -172.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.579 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.5 pt20 -73.08 -29.84 63.24 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 172.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.518 ' HB3' ' C ' ' A' ' 91' ' ' GLN . 16.2 m -70.47 -19.12 62.97 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 113.658 -1.61 . . . . 0.0 110.432 173.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.805 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -76.46 -27.98 56.37 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.169 -0.957 . . . . 0.0 109.458 166.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.593 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 21.8 mt -89.15 -31.5 5.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 115.651 1.722 . . . . 0.0 115.651 -171.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.587 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -40.03 -38.13 0.96 Allowed Pre-proline 0 N--CA 1.492 1.673 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -174.798 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.593 ' HD2' ' C ' ' A' ' 55' ' ' ILE . 57.7 Cg_endo -65.21 -26.49 56.88 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.139 1.893 . . . . 0.0 113.002 175.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.554 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.8 mt -100.89 -15.61 17.5 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.575 ' NZ ' HD13 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -49.85 109.36 0.28 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.333 -179.215 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.18 -21.4 34.73 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.075 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -103.43 114.04 28.0 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.007 0.432 . . . . 0.0 109.977 -177.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.453 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.1 p -122.42 140.67 33.16 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.05 172.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.554 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 80.6 Cg_exo -48.93 140.53 23.55 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.598 2.199 . . . . 0.0 111.848 170.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.24 103.39 0.38 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.417 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.5 -8.73 55.23 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.72 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.554 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 17.6 m -94.51 169.44 10.19 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.496 0.665 . . . . 0.0 111.497 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -84.46 133.95 34.47 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.383 174.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.785 HG13 ' OE1' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -71.46 -33.45 49.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.222 -179.626 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.771 ' O ' HG13 ' A' ' 73' ' ' VAL . 11.9 mm -55.71 -47.95 78.53 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.226 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.524 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.601 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 27.7 t -47.91 -36.65 12.63 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.911 178.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -86.59 -31.85 20.95 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.649 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.624 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.2 m-30 -76.13 -36.24 58.91 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.65 -177.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.841 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.8 m -69.63 -33.43 56.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 173.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.601 ' HB2' ' O ' ' A' ' 70' ' ' SER . 0.8 OUTLIER -68.36 -29.9 68.72 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.73 177.132 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -63.97 -49.04 74.08 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.741 175.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.763 ' SG ' ' HB ' ' A' ' 79' ' ' ILE . 25.4 t -89.44 7.32 36.6 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.931 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.492 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 10.5 t70 -63.2 -16.28 59.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.487 0.66 . . . . 0.0 110.004 174.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -101.29 -8.92 45.95 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.76 173.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.805 HD11 ' HB2' ' A' ' 54' ' ' ALA . 90.6 mt -96.04 146.43 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 O-C-N 122.333 -0.51 . . . . 0.0 111.118 -178.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 150.56 71.58 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.6 174.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.569 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 101.47 -110.41 3.85 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.894 -0.669 . . . . 0.0 113.087 177.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.17 -50.32 69.62 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -174.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 77.5 mtp -68.67 -28.44 66.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.884 0.373 . . . . 0.0 110.489 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.507 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 9.4 t60 -65.94 -31.37 72.25 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.346 176.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' A' ' 81' ' ' GLY . 33.7 mmtp -81.98 -19.3 40.83 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.955 0.407 . . . . 0.0 110.311 -178.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.48 -43.4 13.61 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.786 177.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 1.3 mmt -85.4 -12.78 51.26 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.319 -176.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.507 ' HB2' ' O ' ' A' ' 84' ' ' HIS . 0.1 OUTLIER -48.6 -43.39 36.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.697 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 26.0 ttt -80.31 -16.96 53.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.989 0.423 . . . . 0.0 110.646 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -91.44 -40.89 11.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.093 -174.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.518 ' C ' ' HB3' ' A' ' 53' ' ' SER . 85.1 mt-30 -105.07 -52.52 2.83 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -170.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.507 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -42.71 -37.05 1.62 Allowed 'General case' 0 N--CA 1.471 0.593 0 O-C-N 123.93 0.769 . . . . 0.0 109.328 -179.806 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 . . . . . 0 C--O 1.248 0.998 0 CA-C-N 114.017 -1.447 . . . . 0.0 113.031 -176.717 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' PRO . . . . . 0.409 ' HB2' HG21 ' B' ' 5' ' ' THR . 84.5 Cg_endo . . . . . 0 CA--C 1.516 -0.413 0 N-CA-C 109.425 -1.029 . . . . 0.0 109.425 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 48.4 m -65.51 164.98 12.96 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 163.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.767 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -69.79 -55.1 10.78 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.909 174.061 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.56 ' ND2' ' HG3' ' B' ' 42' ' ' MET . 2.7 p-10 -86.69 -2.23 58.35 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.852 -164.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.426 ' O ' ' HD3' ' B' ' 7' ' ' ARG . 9.7 t -66.11 -3.26 5.22 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.439 -176.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.597 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.3 m -73.65 131.97 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 171.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.779 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 1.2 ptt-85 -156.62 160.15 39.14 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -176.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' GLN . . . . . 0.462 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.3 tt0 -39.16 112.28 0.24 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 113.624 -1.626 . . . . 0.0 112.745 178.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.95 -142.72 8.18 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.64 174.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 20.0 m -59.03 95.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.958 0.379 . . . . 0.0 110.85 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 23.2 pttm 41.06 41.38 1.28 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.459 1.103 . . . . 0.0 112.454 -174.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -57.54 139.73 80.75 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.635 176.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' PRO . . . . . 0.538 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 34.2 Cg_exo -53.73 125.05 17.36 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.053 1.835 . . . . 0.0 109.727 177.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 14' ' ' TYR . . . . . 0.849 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 6.1 t80 -68.42 -55.37 12.25 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-O 118.504 -0.76 . . . . 0.0 112.877 -167.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.539 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 25.4 Cg_exo -57.57 -17.76 29.59 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 121.375 1.383 . . . . 0.0 111.238 -177.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.538 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 5.8 m-20 -89.71 -40.1 12.74 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.966 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 17' ' ' PHE . . . . . 0.637 ' HE2' ' CE2' ' B' ' 14' ' ' TYR . 0.0 OUTLIER -56.68 -45.79 81.52 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.013 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.792 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 1.4 p -77.75 -33.43 18.86 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.278 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.399 -178.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.27 -31.25 67.28 Favored 'General case' 0 C--N 1.31 -1.119 0 O-C-N 121.271 -0.893 . . . . 0.0 111.83 177.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.728 ' O ' HG12 ' B' ' 24' ' ' VAL . 15.8 ptt180 -84.97 -28.31 25.89 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 174.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.593 HD22 ' CE1' ' B' ' 17' ' ' PHE . 11.8 tp -54.0 -48.84 70.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.97 172.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' GLN . . . . . 0.792 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 4.4 mt-30 -70.89 -46.38 62.68 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.077 177.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.734 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 19.1 t70 -48.4 -54.72 12.98 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 124.125 0.891 . . . . 0.0 111.574 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 24' ' ' VAL . . . . . 0.728 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.4 p -81.63 -22.38 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-O 121.278 0.561 . . . . 0.0 109.807 -173.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.779 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -72.85 -18.67 61.42 Favored 'General case' 0 C--O 1.205 -1.252 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 173.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' GLN . . . . . 0.419 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -86.64 -38.39 17.11 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.546 -1.207 . . . . 0.0 109.596 177.133 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.734 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.8 mmtt -67.23 -36.13 81.02 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.033 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 23.8 m -104.02 -8.73 19.35 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.203 0.525 . . . . 0.0 110.628 -171.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.779 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 83.8 mt -115.35 126.13 72.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.394 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.37 -5.55 59.3 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.109 0.48 . . . . 0.0 110.363 178.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.669 ' H ' HG22 ' B' ' 29' ' ' ILE . 26.0 t0 -105.41 139.47 39.99 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.297 -177.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -76.27 -31.5 58.3 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.499 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.581 ' O ' HG13 ' B' ' 37' ' ' VAL . 6.4 mttp -71.68 -55.01 8.51 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.624 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -58.7 -27.56 64.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.289 -0.868 . . . . 0.0 110.967 176.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.859 ' O ' HG13 ' B' ' 39' ' ' VAL . 1.9 tmm_? -65.85 -59.75 3.55 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 12.5 mtpp -55.18 -57.54 11.37 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.1 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.781 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 20.1 m -52.67 -34.5 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.068 -170.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.767 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.0 OUTLIER -88.26 -31.26 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 119.942 -0.703 . . . . 0.0 112.195 -179.436 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.859 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.4 m -68.63 -48.64 70.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 119.114 -1.035 . . . . 0.0 109.434 176.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.771 ' OE1' HG13 ' B' ' 68' ' ' VAL . 0.8 OUTLIER -64.65 -28.44 69.61 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.49 0.716 . . . . 0.0 111.541 178.388 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.781 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -81.4 -54.62 5.31 Favored 'General case' 0 C--N 1.322 -0.602 0 O-C-N 122.141 -0.349 . . . . 0.0 111.5 177.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 42' ' ' MET . . . . . 0.56 ' HG3' ' ND2' ' B' ' 4' ' ' ASN . 22.2 mmt -63.47 -20.45 65.59 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.691 0.758 . . . . 0.0 109.519 -177.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.659 ' O ' ' HB2' ' B' ' 47' ' ' ALA . . . -49.0 -32.99 10.17 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.832 171.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' TYR . . . . . 0.492 ' HB2' HG21 ' B' ' 55' ' ' ILE . 17.6 t80 -99.8 -64.79 1.01 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.582 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 39.4 mm-40 -50.2 -32.97 17.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.419 -1.264 . . . . 0.0 112.312 -171.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.779 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.6 m-20 -103.96 -20.21 13.96 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.031 -174.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.659 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -59.55 174.91 0.39 Allowed 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.591 0.71 . . . . 0.0 112.119 -177.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.606 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 12.0 m-20 -58.51 141.44 83.73 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 114.755 -1.112 . . . . 0.0 109.496 174.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -48.12 -29.3 12.19 Favored 'Trans proline' 0 C--O 1.221 -0.37 0 C-N-CA 123.715 2.943 . . . . 0.0 112.918 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.514 ' OE1' ' HA ' ' B' ' 84' ' ' HIS . 0.3 OUTLIER -88.05 -33.81 18.19 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 123.823 0.849 . . . . 0.0 111.095 177.213 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.606 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 78.8 m -78.8 -33.88 45.88 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.457 -172.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.596 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.7 pt20 -72.93 -29.99 63.54 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 172.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 53' ' ' SER . . . . . 0.535 ' HB3' ' C ' ' B' ' 91' ' ' GLN . 15.8 m -70.45 -19.06 63.0 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 113.654 -1.612 . . . . 0.0 110.416 173.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.815 ' HB2' HD11 ' B' ' 79' ' ' ILE . . . -76.6 -27.65 55.84 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.271 -0.893 . . . . 0.0 109.545 166.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' B' ' 52' ' ' GLN . 22.0 mt -89.43 -31.41 5.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -171.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.585 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -40.2 -38.15 1.02 Allowed Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -174.756 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.589 ' HD2' ' C ' ' B' ' 55' ' ' ILE . 57.9 Cg_endo -65.21 -26.22 57.08 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.177 1.918 . . . . 0.0 113.069 175.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 58' ' ' LEU . . . . . 0.57 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.8 mt -100.97 -15.66 17.42 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.568 ' NZ ' HD13 ' B' ' 41' ' ' LEU . 0.2 OUTLIER -49.95 109.36 0.28 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.302 -179.103 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.42 ' HA3' ' C ' ' A' ' 1' ' ' PRO . . . 91.13 -21.23 35.46 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.05 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -103.4 114.01 27.95 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 120.994 0.426 . . . . 0.0 109.972 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.462 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.1 p -122.34 140.76 33.22 Favored Pre-proline 0 C--N 1.314 -0.964 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.075 172.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.543 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 82.3 Cg_exo -48.91 140.27 23.88 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.576 2.184 . . . . 0.0 111.906 170.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.77 103.51 0.35 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.195 -176.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.31 -9.02 55.85 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.924 176.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.543 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 18.7 m -94.11 169.75 10.03 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.676 0.751 . . . . 0.0 111.516 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -84.93 134.04 34.27 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.272 174.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.771 HG13 ' OE1' ' B' ' 40' ' ' GLU . 0.8 OUTLIER -71.69 -33.35 48.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.198 -179.475 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.772 ' O ' HG13 ' B' ' 73' ' ' VAL . 11.9 mm -55.66 -48.1 78.16 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.215 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.538 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.594 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 27.2 t -47.83 -36.6 12.17 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.943 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -86.42 -32.11 21.07 Favored 'General case' 0 CA--C 1.507 -0.685 0 C-N-CA 123.231 0.613 . . . . 0.0 110.606 -177.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 72' ' ' TYR . . . . . 0.613 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.2 m-30 -75.94 -36.22 59.43 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.616 -177.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.849 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.8 m -69.62 -33.59 57.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.543 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 173.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 74' ' ' LYS . . . . . 0.594 ' HB2' ' O ' ' B' ' 70' ' ' SER . 0.8 OUTLIER -68.11 -30.12 69.2 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.224 -1.353 . . . . 0.0 109.755 177.117 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 75' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -63.75 -49.25 73.74 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.676 175.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.766 ' SG ' ' HB ' ' B' ' 79' ' ' ILE . 24.9 t -89.31 7.05 37.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.921 178.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 77' ' ' ASP . . . . . 0.498 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 8.9 t70 -63.09 -16.63 60.58 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.374 0.607 . . . . 0.0 110.034 174.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -101.1 -8.47 47.54 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.471 173.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.815 HD11 ' HB2' ' B' ' 54' ' ' ALA . 90.1 mt -96.15 146.6 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 O-C-N 122.324 -0.515 . . . . 0.0 111.169 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 150.27 71.86 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.566 174.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.574 ' O ' ' HG2' ' B' ' 85' ' ' LYS . . . 101.3 -110.02 3.77 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.892 -0.67 . . . . 0.0 113.054 177.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.52 -50.42 70.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.835 0.35 . . . . 0.0 111.942 -174.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' MET . . . . . . . . . . . . . 75.8 mtp -68.41 -28.81 67.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.892 0.377 . . . . 0.0 110.476 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 84' ' ' HIS . . . . . 0.514 ' HA ' ' OE1' ' B' ' 50' ' ' GLU . 9.4 t60 -65.7 -31.54 72.6 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.312 176.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.574 ' HG2' ' O ' ' B' ' 81' ' ' GLY . 33.6 mmtp -81.76 -19.38 41.45 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.04 0.448 . . . . 0.0 110.337 -178.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.49 -43.36 13.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.79 177.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 1.3 mmt -85.32 -12.78 51.51 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.323 -176.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' B' ' 84' ' ' HIS . 0.1 OUTLIER -48.58 -43.01 35.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.776 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 26.3 ttt -80.81 -17.04 52.13 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.986 0.422 . . . . 0.0 110.753 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -91.21 -41.21 11.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.996 -174.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 91' ' ' GLN . . . . . 0.535 ' C ' ' HB3' ' B' ' 53' ' ' SER . 85.4 mt-30 -104.57 -52.65 2.85 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -170.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.496 ' HB2' HD12 ' B' ' 88' ' ' LEU . 0.1 OUTLIER -42.52 -37.48 1.65 Allowed 'General case' 0 N--CA 1.472 0.661 0 O-C-N 123.854 0.721 . . . . 0.0 109.343 -179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 . . . . . 0 C--O 1.25 1.103 0 CA-C-N 114.06 -1.427 . . . . 0.0 113.042 -176.627 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.4 ' HB2' ' H ' ' A' ' 2' ' ' SER . 96.0 Cg_endo . . . . . 0 CA--C 1.517 -0.345 0 N-CA-C 109.248 -1.097 . . . . 0.0 109.248 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.554 ' HB2' HG23 ' A' ' 5' ' ' THR . 39.4 m -64.93 171.13 3.71 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 162.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.837 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -69.73 -52.53 24.65 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.118 175.299 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.488 ' ND2' ' HG3' ' A' ' 42' ' ' MET . 2.2 p-10 -86.97 6.45 32.16 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.577 -1.192 . . . . 0.0 113.659 -163.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.628 ' CG2' ' HD3' ' B' ' 59' ' ' LYS . 1.1 p -63.32 -5.99 4.14 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 118.513 0.597 . . . . 0.0 111.787 -176.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.629 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.1 m -75.12 132.04 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 175.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.772 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -155.54 159.22 39.54 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -178.594 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.474 ' HG2' ' HB3' ' A' ' 12' ' ' GLU . 2.3 tt0 -44.29 115.14 0.79 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 112.929 -1.941 . . . . 0.0 113.02 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.73 -149.98 23.81 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.091 -0.958 . . . . 0.0 111.126 171.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.478 ' C ' ' HD3' ' A' ' 11' ' ' LYS . 6.3 p -50.97 100.36 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.61 0.364 . . . . 0.0 111.592 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER 30.25 48.0 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.764 1.226 . . . . 0.0 112.26 -171.507 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.474 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 53.5 tt0 -60.22 140.63 91.17 Favored Pre-proline 0 C--O 1.234 0.283 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.611 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.574 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 32.0 Cg_exo -54.05 121.54 9.82 Favored 'Trans proline' 0 CA--C 1.509 -0.754 0 C-N-CA 121.947 1.765 . . . . 0.0 109.623 178.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.917 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 13.8 t80 -72.75 -53.36 5.52 Favored Pre-proline 0 N--CA 1.439 -1.022 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -167.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' A' ' 14' ' ' TYR . 34.6 Cg_exo -55.66 -17.04 16.42 Favored 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.43 1.42 . . . . 0.0 110.761 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.574 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 2.2 m-20 -90.6 -43.43 10.18 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 113.981 -1.463 . . . . 0.0 111.038 177.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.491 ' CD2' ' HA ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -53.41 -46.51 69.78 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.594 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.791 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 1.8 p -79.26 -34.72 16.56 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.363 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.313 -178.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.89 -32.79 68.06 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 121.344 -0.847 . . . . 0.0 111.762 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.697 ' O ' HG12 ' A' ' 24' ' ' VAL . 14.3 ptt180 -84.28 -25.04 29.64 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 176.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.56 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 6.2 tp -59.91 -46.72 88.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.821 172.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.791 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 4.6 mt-30 -69.97 -48.28 58.92 Favored 'General case' 0 CA--C 1.492 -1.282 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.933 177.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.73 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 15.5 t70 -47.44 -54.65 10.82 Favored 'General case' 0 C--N 1.313 -1.017 0 O-C-N 124.265 0.978 . . . . 0.0 111.547 -178.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.697 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.7 p -79.18 -24.9 12.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.948 -173.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.641 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -67.89 -29.58 68.71 Favored 'General case' 0 C--O 1.205 -1.263 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.474 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -78.81 -36.32 42.89 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.723 -178.253 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.73 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 39.2 mmtt -65.92 -34.1 77.34 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.469 177.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.431 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 16.1 m -105.6 -9.89 17.14 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.271 0.558 . . . . 0.0 110.823 -170.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.641 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 87.7 mt -118.07 129.07 74.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.062 -178.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.4 -1.47 53.63 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.246 0.546 . . . . 0.0 110.524 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.615 ' H ' HG22 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -113.71 111.76 22.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.015 -177.338 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.86 -32.05 30.47 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 177.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.595 ' O ' HG13 ' A' ' 37' ' ' VAL . 14.2 mttm -58.46 -61.31 2.68 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.634 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -66.36 -22.84 66.27 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.427 -178.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.85 ' O ' HG13 ' A' ' 39' ' ' VAL . 5.3 tmm_? -72.31 -54.6 9.02 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.447 ' O ' HG22 ' A' ' 39' ' ' VAL . 16.6 mtpt -59.44 -56.5 21.26 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.345 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.81 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 20.9 m -54.15 -36.58 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.997 -171.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.837 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.2 tt -85.78 -30.36 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.811 -176.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.85 HG13 ' O ' ' A' ' 35' ' ' ARG . 3.3 m -69.47 -47.94 69.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 C-N-CA 118.915 -1.114 . . . . 0.0 109.245 174.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.619 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 58.6 mt-10 -64.66 -23.13 67.16 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 123.653 0.781 . . . . 0.0 112.383 175.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.81 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -85.48 -57.21 3.16 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.543 177.251 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.498 ' HB2' HD21 ' A' ' 21' ' ' LEU . 20.1 mmt -63.6 -20.96 66.09 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 121.462 0.649 . . . . 0.0 109.734 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.671 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -49.18 -27.65 3.78 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.288 170.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.466 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 11.4 t80 -106.12 -68.1 0.89 Allowed 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.603 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 7.2 mm-40 -47.59 -33.85 7.1 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 124.31 1.007 . . . . 0.0 112.414 -173.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.772 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.8 m-20 -103.46 -21.15 13.83 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 120.501 0.191 . . . . 0.0 110.963 -174.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.654 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -57.35 177.61 0.09 Allowed 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 121.817 0.818 . . . . 0.0 112.511 -176.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -56.21 137.64 74.35 Favored Pre-proline 0 N--CA 1.44 -0.958 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.9 174.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.432 ' HB2' HD21 ' A' ' 92' ' ' LEU . 9.7 Cg_endo -55.43 -21.75 31.36 Favored 'Trans proline' 0 C--O 1.219 -0.465 0 C-N-CA 123.273 2.649 . . . . 0.0 111.778 -177.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.516 ' O ' ' HB2' ' A' ' 53' ' ' SER . 0.7 OUTLIER -87.86 -37.4 16.54 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 124.157 0.983 . . . . 0.0 111.055 173.325 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 1.015 ' SG ' ' HB2' ' A' ' 76' ' ' CYS . 42.4 t -75.33 -36.06 61.11 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-O 121.018 0.437 . . . . 0.0 111.328 -172.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.554 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.9 pt20 -69.62 -29.74 67.32 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 175.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.636 ' HA ' ' CD ' ' A' ' 56' ' ' LYS . 30.8 m -72.48 -19.75 61.5 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 112.944 -1.935 . . . . 0.0 110.176 174.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -81.22 -22.27 38.92 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.333 166.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.554 HD12 ' HA ' ' A' ' 52' ' ' GLN . 22.5 mt -90.54 -31.84 5.26 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.787 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 -173.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.651 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.1 OUTLIER -46.14 -32.65 1.81 Allowed Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -175.903 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.651 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 33.0 Cg_endo -59.54 -31.04 93.9 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.17 1.913 . . . . 0.0 112.99 171.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.546 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.1 mt -102.45 -15.65 16.42 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.624 ' HD3' ' CG2' ' B' ' 5' ' ' THR . 0.1 OUTLIER -51.78 109.88 0.41 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.972 -179.717 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.35 -22.66 35.8 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.162 -177.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -103.77 114.5 28.8 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.413 0.625 . . . . 0.0 110.553 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.527 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.4 p -123.4 149.99 59.55 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.471 170.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.6 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 92.1 Cg_exo -47.29 139.52 16.23 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 121.713 1.609 . . . . 0.0 110.92 164.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.45 100.81 0.09 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -171.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.16 -2.25 71.31 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.04 176.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.6 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 2.1 m -95.7 -155.33 0.47 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.219 1.009 . . . . 0.0 112.372 -177.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -98.61 124.93 43.69 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 113.568 -1.651 . . . . 0.0 110.93 -172.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.559 HG13 ' CD ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -81.05 -28.98 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 C-N-CA 117.609 -1.637 . . . . 0.0 108.606 173.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.78 ' O ' HG13 ' A' ' 73' ' ' VAL . 10.0 mm -59.34 -48.04 88.42 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.18 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.627 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.402 ' O ' HG22 ' A' ' 73' ' ' VAL . 45.3 t -50.44 -33.96 22.93 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.355 0.598 . . . . 0.0 111.155 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -85.28 -33.64 22.1 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 123.323 0.649 . . . . 0.0 110.507 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.576 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 4.7 m-30 -75.85 -34.05 60.04 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.754 -176.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.917 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 2.2 m -68.41 -35.67 71.66 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 173.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.54 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 21.7 ttmt -70.71 -27.7 64.18 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 113.894 -1.503 . . . . 0.0 111.188 176.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -61.62 -44.34 97.17 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 171.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 1.015 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 16.6 t -85.78 3.12 42.83 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.292 176.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.54 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 29.6 t70 -65.5 1.19 1.25 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 163.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 76' ' ' CYS . . . -121.14 -10.09 6.96 Favored Glycine 0 N--CA 1.439 -1.115 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.779 175.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.66 HG12 ' CB ' ' A' ' 76' ' ' CYS . 1.1 mm -68.0 -85.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.046 0.923 . . . . 0.0 110.066 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 42.9 -130.17 5.31 Favored Glycine 0 C--N 1.339 0.719 0 CA-C-N 115.967 -0.56 . . . . 0.0 113.469 -172.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.681 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . -113.76 -66.67 0.47 Allowed Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.353 -176.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.43 -56.87 15.77 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -173.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.529 ' O ' ' HG3' ' A' ' 87' ' ' MET . 54.1 mtt -66.5 -36.6 83.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.948 0.404 . . . . 0.0 110.094 -177.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.63 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 7.5 t60 -55.4 -34.99 64.87 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.385 176.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.681 ' HG2' ' O ' ' A' ' 81' ' ' GLY . 31.5 mmtp -80.15 -17.41 52.55 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 121.825 -0.547 . . . . 0.0 110.523 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.41 -46.06 10.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.575 0.703 . . . . 0.0 110.682 175.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.529 ' HG3' ' O ' ' A' ' 83' ' ' MET . 25.1 mtm -85.58 -14.05 46.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.38 -172.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.63 ' HB2' ' O ' ' A' ' 84' ' ' HIS . 1.3 tp -48.65 -41.93 32.82 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.619 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 53.0 ttp -82.34 -16.14 50.32 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.033 0.444 . . . . 0.0 111.114 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -97.02 -33.96 11.36 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -174.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.591 ' C ' ' HB3' ' A' ' 53' ' ' SER . 22.0 mt-30 -105.47 -56.27 2.2 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.72 -174.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.445 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -48.03 -31.4 5.36 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.605 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.428 ' HG3' ' OXT' ' A' ' 93' ' ' GLU . 5.3 pt-20 . . . . . 0 C--O 1.249 1.051 0 CA-C-N 113.59 -1.641 . . . . 0.0 113.995 -171.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo . . . . . 0 CA--C 1.517 -0.368 0 N-CA-C 109.156 -1.132 . . . . 0.0 109.156 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.561 ' HB2' HG23 ' B' ' 5' ' ' THR . 43.3 m -65.13 171.07 3.93 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 162.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.825 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -69.61 -52.54 25.06 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.155 175.349 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.488 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.2 p-10 -86.9 6.51 31.6 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.584 -1.189 . . . . 0.0 113.717 -163.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.624 ' CG2' ' HD3' ' A' ' 59' ' ' LYS . 1.1 p -63.54 -5.75 4.25 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 118.57 0.623 . . . . 0.0 111.865 -176.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.63 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.1 m -75.2 131.98 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 175.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.773 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.1 OUTLIER -155.51 159.37 39.7 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -178.702 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 8' ' ' GLN . . . . . 0.46 ' HG2' ' HB3' ' B' ' 12' ' ' GLU . 2.3 tt0 -44.2 115.0 0.76 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 112.939 -1.937 . . . . 0.0 113.035 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.79 -150.06 24.04 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.162 171.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' SER . . . . . 0.488 ' C ' ' HD3' ' B' ' 11' ' ' LYS . 7.8 p -50.84 100.25 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.604 0.362 . . . . 0.0 111.677 -178.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' B' ' 11' ' ' LYS . 0.0 OUTLIER 30.37 48.19 0.05 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.673 1.189 . . . . 0.0 112.122 -171.575 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.46 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 51.9 tt0 -60.51 140.35 92.28 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.688 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' PRO . . . . . 0.577 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 31.9 Cg_exo -53.97 121.6 9.91 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 121.861 1.707 . . . . 0.0 109.602 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 14' ' ' TYR . . . . . 0.912 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 13.7 t80 -72.85 -53.35 5.36 Favored Pre-proline 0 N--CA 1.438 -1.049 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -167.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.521 ' HD3' ' HB3' ' B' ' 14' ' ' TYR . 32.9 Cg_exo -55.37 -17.33 15.86 Favored 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 121.57 1.514 . . . . 0.0 110.775 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.577 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.7 m-20 -90.62 -43.42 10.18 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 113.935 -1.484 . . . . 0.0 111.024 177.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 17' ' ' PHE . . . . . 0.502 ' CD2' ' HA ' ' B' ' 7' ' ' ARG . 0.0 OUTLIER -53.38 -46.49 69.66 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.662 0.744 . . . . 0.0 109.039 175.525 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.797 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 1.8 p -79.16 -34.83 16.79 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.334 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.298 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.91 -32.76 68.06 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 121.366 -0.834 . . . . 0.0 111.773 177.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.693 ' O ' HG12 ' B' ' 24' ' ' VAL . 14.3 ptt180 -84.61 -24.63 29.05 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.563 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 6.1 tp -60.3 -46.47 89.75 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.842 172.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' GLN . . . . . 0.797 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 4.6 mt-30 -70.2 -48.1 58.58 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.004 177.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.724 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 15.2 t70 -47.49 -54.67 10.88 Favored 'General case' 0 C--N 1.313 -1.002 0 O-C-N 124.301 1.001 . . . . 0.0 111.462 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' VAL . . . . . 0.693 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.7 p -79.28 -24.78 12.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.96 -173.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.649 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -67.96 -29.51 68.57 Favored 'General case' 0 C--O 1.205 -1.272 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 174.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' GLN . . . . . 0.463 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -78.89 -36.26 42.33 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.125 -1.398 . . . . 0.0 109.786 -178.252 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.724 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 39.1 mmtt -65.89 -34.26 77.72 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.496 177.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' SER . . . . . 0.421 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 15.9 m -105.63 -9.66 17.24 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.884 -170.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.649 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 87.9 mt -118.2 129.28 74.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.983 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.64 -1.32 53.39 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.347 0.594 . . . . 0.0 110.585 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.607 ' H ' HG22 ' B' ' 29' ' ' ILE . 0.6 OUTLIER -113.71 111.81 22.41 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.977 -177.554 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.17 -31.71 32.65 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.092 177.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.586 ' O ' HG13 ' B' ' 37' ' ' VAL . 14.1 mttm -58.66 -61.21 2.77 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -178.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.621 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -66.21 -22.98 66.36 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.483 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.868 ' O ' HG13 ' B' ' 39' ' ' VAL . 5.2 tmm_? -72.15 -54.63 9.13 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.446 ' O ' HG22 ' B' ' 39' ' ' VAL . 16.5 mtpt -59.47 -56.48 21.43 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.461 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.8 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 21.0 m -54.18 -36.57 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.051 -171.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.825 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.2 tt -85.6 -30.55 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.757 -176.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.868 HG13 ' O ' ' B' ' 35' ' ' ARG . 3.3 m -69.39 -48.0 69.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 C-N-CA 118.927 -1.109 . . . . 0.0 109.17 174.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.621 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 58.7 mt-10 -64.63 -23.35 67.23 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.571 0.748 . . . . 0.0 112.268 176.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.8 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.29 -57.16 3.19 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.555 177.331 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 42' ' ' MET . . . . . 0.497 ' HB2' HD21 ' B' ' 21' ' ' LEU . 20.0 mmt -63.63 -20.96 66.1 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.521 0.677 . . . . 0.0 109.714 -177.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.681 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -49.13 -27.76 3.75 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.305 170.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' TYR . . . . . 0.478 ' CG ' ' HD2' ' B' ' 59' ' ' LYS . 11.4 t80 -106.09 -67.99 0.9 Allowed 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.608 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 7.2 mm-40 -47.85 -33.48 7.46 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 124.301 1.001 . . . . 0.0 112.491 -173.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.773 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.9 m-20 -103.67 -21.04 13.78 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 116.808 -0.178 . . . . 0.0 110.903 -175.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.644 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -57.48 178.07 0.08 Allowed 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 121.864 0.84 . . . . 0.0 112.55 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 48' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -56.42 137.53 75.91 Favored Pre-proline 0 N--CA 1.441 -0.917 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.819 174.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' PRO . . . . . 0.427 ' HB2' HD21 ' B' ' 92' ' ' LEU . 9.7 Cg_endo -55.32 -21.63 30.04 Favored 'Trans proline' 0 C--O 1.221 -0.373 0 C-N-CA 123.177 2.585 . . . . 0.0 111.911 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.509 ' O ' ' HB2' ' B' ' 53' ' ' SER . 0.7 OUTLIER -87.8 -37.47 16.56 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 124.303 1.041 . . . . 0.0 111.13 173.044 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 1.015 ' SG ' ' HB2' ' B' ' 76' ' ' CYS . 41.7 t -75.34 -36.0 61.09 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-O 121.046 0.451 . . . . 0.0 111.315 -172.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.543 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.9 pt20 -69.54 -29.92 67.62 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 175.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 53' ' ' SER . . . . . 0.644 ' HA ' ' CD ' ' B' ' 56' ' ' LYS . 32.4 m -72.26 -19.99 61.6 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 112.92 -1.945 . . . . 0.0 110.29 174.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -81.04 -22.38 39.36 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.216 -0.593 . . . . 0.0 110.388 166.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' B' ' 52' ' ' GLN . 22.5 mt -90.53 -31.95 5.29 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.798 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -173.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.644 ' CD ' ' HA ' ' B' ' 53' ' ' SER . 0.1 OUTLIER -46.04 -32.76 1.8 Allowed Pre-proline 0 N--CA 1.488 1.466 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -175.906 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 32.7 Cg_endo -59.24 -31.44 95.22 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.219 1.946 . . . . 0.0 112.939 171.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 58' ' ' LEU . . . . . 0.542 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.1 mt -102.15 -15.91 16.54 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -177.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.628 ' HD3' ' CG2' ' A' ' 5' ' ' THR . 0.1 OUTLIER -51.61 109.88 0.4 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.112 -179.713 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.0 -22.09 38.26 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.329 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -103.96 114.76 29.24 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.355 0.597 . . . . 0.0 110.48 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.511 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.5 p -123.46 150.34 60.65 Favored Pre-proline 0 C--N 1.309 -1.166 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.374 170.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.612 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 93.4 Cg_exo -47.45 139.52 17.1 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 121.753 1.636 . . . . 0.0 110.915 164.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.58 100.96 0.09 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -171.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.26 -3.19 72.29 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.899 -0.591 . . . . 0.0 113.135 176.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.612 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 2.3 m -95.06 -155.21 0.46 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 122.145 0.974 . . . . 0.0 112.281 -177.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -98.67 124.75 43.67 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 113.513 -1.676 . . . . 0.0 110.898 -172.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.551 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.9 OUTLIER -80.97 -28.79 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 C-N-CA 117.548 -1.661 . . . . 0.0 108.609 173.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.789 ' O ' HG13 ' B' ' 73' ' ' VAL . 9.8 mm -59.75 -47.71 90.27 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.232 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.68 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.401 ' O ' HG22 ' B' ' 73' ' ' VAL . 42.8 t -50.52 -34.04 23.79 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.397 0.617 . . . . 0.0 111.118 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -85.18 -33.87 22.2 Favored 'General case' 0 C--O 1.213 -0.835 0 C-N-CA 123.298 0.639 . . . . 0.0 110.394 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 72' ' ' TYR . . . . . 0.575 ' OH ' ' HA ' ' B' ' 59' ' ' LYS . 4.7 m-30 -75.56 -33.9 60.66 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.719 -176.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.912 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 2.2 m -68.56 -35.61 71.03 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 74' ' ' LYS . . . . . 0.53 ' O ' ' HB3' ' B' ' 77' ' ' ASP . 22.0 ttmt -70.71 -27.52 64.04 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.253 176.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 75' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -61.81 -44.17 97.39 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 1.015 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 16.5 t -86.02 3.29 42.96 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.336 176.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 77' ' ' ASP . . . . . 0.53 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 28.5 t70 -65.55 1.2 1.27 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 163.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 78' ' ' GLY . . . . . 0.448 ' H ' ' C ' ' B' ' 76' ' ' CYS . . . -121.26 -9.7 7.11 Favored Glycine 0 N--CA 1.439 -1.122 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.7 175.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.67 HG12 ' CB ' ' B' ' 76' ' ' CYS . 1.1 mm -68.19 -84.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 118.06 0.93 . . . . 0.0 110.042 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 42.5 -130.32 4.91 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-N 115.969 -0.559 . . . . 0.0 113.511 -172.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.688 ' O ' ' HG2' ' B' ' 85' ' ' LYS . . . -113.81 -66.23 0.46 Allowed Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.386 -177.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.89 -56.48 21.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -173.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' MET . . . . . 0.531 ' O ' ' HG3' ' B' ' 87' ' ' MET . 53.8 mtt -66.64 -36.64 83.05 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -177.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 84' ' ' HIS . . . . . 0.632 ' O ' ' HB2' ' B' ' 88' ' ' LEU . 7.4 t60 -55.48 -34.98 65.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.304 176.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.688 ' HG2' ' O ' ' B' ' 81' ' ' GLY . 31.6 mmtp -80.27 -17.27 52.65 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 121.819 -0.551 . . . . 0.0 110.533 -178.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.53 -45.98 10.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.571 0.7 . . . . 0.0 110.691 175.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 87' ' ' MET . . . . . 0.531 ' HG3' ' O ' ' B' ' 83' ' ' MET . 24.4 mtm -85.66 -14.02 46.78 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.381 -172.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.632 ' HB2' ' O ' ' B' ' 84' ' ' HIS . 1.3 tp -48.73 -41.9 33.53 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.592 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 53.7 ttp -82.34 -16.25 49.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.944 0.402 . . . . 0.0 111.013 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -96.89 -33.76 11.5 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -174.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 91' ' ' GLN . . . . . 0.605 ' C ' ' HB3' ' B' ' 53' ' ' SER . 22.0 mt-30 -105.77 -56.41 2.18 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.653 -174.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.463 ' HB2' HD12 ' B' ' 88' ' ' LEU . 0.0 OUTLIER -48.05 -31.24 5.21 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 177.568 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.416 ' HG3' ' OXT' ' B' ' 93' ' ' GLU . 5.2 pt-20 . . . . . 0 C--O 1.252 1.19 0 CA-C-N 113.809 -1.541 . . . . 0.0 113.843 -171.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.427 ' HB2' ' H ' ' A' ' 2' ' ' SER . 98.1 Cg_endo . . . . . 0 CA--C 1.517 -0.341 0 N-CA-C 109.052 -1.172 . . . . 0.0 109.052 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.65 ' HB2' HG23 ' A' ' 5' ' ' THR . 50.0 m -66.37 176.82 1.68 Allowed 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 162.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.661 ' CE1' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -77.09 -53.99 7.09 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.589 -0.845 . . . . 0.0 109.743 174.338 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.56 ' ND2' ' HG3' ' A' ' 42' ' ' MET . 2.0 p-10 -82.67 6.19 18.71 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.367 -1.288 . . . . 0.0 112.548 -167.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.65 HG23 ' HB2' ' A' ' 2' ' ' SER . 0.7 OUTLIER -65.12 -4.08 4.5 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.547 -176.75 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.627 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.2 m -79.37 132.78 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 174.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.768 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -155.95 160.07 39.78 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 118.937 -1.105 . . . . 0.0 113.422 -177.798 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.497 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.4 mt-30 -40.67 112.68 0.31 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 113.568 -1.651 . . . . 0.0 112.776 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.08 -161.58 32.74 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 170.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.7 m -50.83 104.09 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 117.292 0.546 . . . . 0.0 111.029 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.624 ' HD2' ' O ' ' A' ' 80' ' ' GLY . 63.4 pttt 44.12 39.11 2.65 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.587 1.155 . . . . 0.0 112.756 -176.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.434 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 48.2 tt0 -62.36 137.97 96.2 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 177.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.512 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 39.0 Cg_exo -53.74 124.72 16.53 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.11 1.874 . . . . 0.0 109.921 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.78 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 6.7 t80 -69.26 -55.32 10.11 Favored Pre-proline 0 N--CA 1.44 -0.958 0 CA-C-O 118.38 -0.819 . . . . 0.0 113.134 -166.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.548 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 30.3 Cg_exo -57.04 -17.57 25.15 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 121.456 1.437 . . . . 0.0 111.211 -178.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 2.1 m-20 -89.52 -42.31 11.52 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.891 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.64 ' CE1' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -55.48 -44.7 76.72 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.307 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.745 HG21 HD12 ' A' ' 69' ' ' ILE . 1.7 p -80.99 -31.47 12.11 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.937 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.826 -177.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.76 -33.69 70.56 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 121.284 -0.885 . . . . 0.0 111.608 176.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.706 ' O ' HG12 ' A' ' 24' ' ' VAL . 14.6 ptt180 -84.56 -25.48 28.66 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 175.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.64 HD22 ' CE1' ' A' ' 17' ' ' PHE . 9.7 tp -57.98 -45.09 87.31 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.972 172.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.723 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 7.1 mt-30 -73.31 -44.42 59.04 Favored 'General case' 0 CA--C 1.494 -1.196 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.688 177.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.759 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 14.3 t70 -52.08 -50.93 60.58 Favored 'General case' 0 C--N 1.314 -0.945 0 O-C-N 124.087 0.867 . . . . 0.0 111.427 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.706 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.1 p -82.02 -23.96 9.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.249 0.547 . . . . 0.0 109.793 -174.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.855 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -71.69 -18.29 62.18 Favored 'General case' 0 C--O 1.206 -1.223 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 174.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.426 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -87.43 -38.92 15.7 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.958 176.746 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.759 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 40.2 mmtt -65.28 -43.32 91.6 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.321 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.515 ' HB2' ' HB3' ' A' ' 3' ' ' PHE . 24.9 m -98.6 -8.47 26.36 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.243 0.544 . . . . 0.0 110.419 -172.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.855 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 87.2 mt -114.91 125.48 72.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.725 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.84 -4.33 57.65 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.18 0.514 . . . . 0.0 110.01 175.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.669 ' OD1' ' HB2' ' A' ' 33' ' ' LYS . 12.4 t70 -102.59 115.71 31.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.409 -177.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.466 ' O ' ' HG2' ' A' ' 36' ' ' LYS . 12.5 pt-20 -61.59 -24.71 66.86 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.831 176.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.669 ' HB2' ' OD1' ' A' ' 31' ' ' ASP . 4.5 mptt -75.12 -52.17 11.65 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -177.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.409 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -65.29 -26.94 68.29 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.89 176.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.827 ' O ' HG13 ' A' ' 39' ' ' VAL . 3.9 tmm_? -62.59 -65.19 0.72 Allowed 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.589 ' HG3' HG13 ' A' ' 37' ' ' VAL . 7.9 ptmm? -53.11 -58.38 7.2 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.314 0.578 . . . . 0.0 112.259 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.779 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 5.4 m -56.63 -30.39 31.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.928 -172.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.497 ' O ' ' HG2' ' A' ' 42' ' ' MET . 0.1 OUTLIER -85.07 -31.43 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.407 178.842 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.827 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.4 m -68.33 -47.84 75.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 119.257 -0.977 . . . . 0.0 108.97 175.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.594 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 45.3 mt-10 -68.03 -22.89 64.94 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.335 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.779 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -85.42 -55.2 4.13 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.166 175.941 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.574 ' HB2' HD21 ' A' ' 21' ' ' LEU . 17.8 mmt -63.77 -20.42 65.75 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.567 0.698 . . . . 0.0 109.765 -176.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.627 ' HB2' ' CD1' ' A' ' 69' ' ' ILE . . . -47.9 -30.2 3.96 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.736 171.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.553 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 8.0 t80 -105.66 -66.99 0.95 Allowed 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.637 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 3.9 mm-40 -47.02 -33.79 5.09 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 124.47 1.106 . . . . 0.0 112.107 -173.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.768 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 5.3 m-20 -102.7 -21.0 14.17 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.214 -174.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.62 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -60.65 -179.62 0.13 Allowed 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 122.093 0.949 . . . . 0.0 112.966 -173.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.604 ' HB3' ' OE1' ' A' ' 50' ' ' GLU . 15.1 m-20 -61.35 141.61 94.21 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.175 174.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.21 -22.61 33.21 Favored 'Trans proline' 0 C--O 1.22 -0.425 0 C-N-CA 123.413 2.742 . . . . 0.0 112.722 -178.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.694 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 12.2 pm0 -89.37 -31.13 17.91 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 123.5 0.72 . . . . 0.0 110.599 175.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.694 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 92.7 m -82.9 -37.44 24.25 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.57 -170.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.611 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.6 pt20 -70.21 -29.94 66.91 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 172.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.574 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 11.2 m -70.91 -19.87 62.55 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 113.672 -1.604 . . . . 0.0 110.331 174.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.705 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -78.6 -25.43 45.19 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.504 -0.748 . . . . 0.0 109.686 167.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.613 HD11 ' CE2' ' A' ' 14' ' ' TYR . 22.7 mt -89.8 -32.57 5.65 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.816 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -171.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.599 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -39.92 -37.95 0.88 Allowed Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -174.361 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 52.3 Cg_endo -63.86 -29.23 67.65 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.217 1.945 . . . . 0.0 113.006 175.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.566 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.5 mt -99.09 -15.61 18.94 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.645 ' HD3' ' CG2' ' B' ' 5' ' ' THR . 0.1 OUTLIER -50.96 109.65 0.35 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.24 -178.371 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.419 ' HA3' ' C ' ' B' ' 1' ' ' PRO . . . 90.2 -20.65 35.75 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.032 -178.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -103.47 113.14 26.41 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.274 0.559 . . . . 0.0 109.785 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.474 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.5 p -123.72 148.88 57.6 Favored Pre-proline 0 C--N 1.31 -1.146 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.624 172.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.558 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 83.5 Cg_exo -47.5 137.84 19.3 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.059 1.839 . . . . 0.0 110.788 164.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.92 102.06 0.14 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.049 -171.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.78 -9.88 64.2 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.993 176.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.558 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 4.8 m -91.86 -167.88 1.88 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 122.398 1.094 . . . . 0.0 112.309 -177.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.62 ' OD2' ' HB3' ' A' ' 70' ' ' SER . 0.4 OUTLIER -88.16 126.0 34.9 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 112.862 -1.972 . . . . 0.0 111.117 -175.05 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.534 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -81.7 -32.98 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 C-N-CA 118.623 -1.231 . . . . 0.0 108.662 173.815 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.789 ' O ' HG13 ' A' ' 73' ' ' VAL . 10.7 mm -56.3 -49.98 73.92 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.349 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.495 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.62 ' HB3' ' OD2' ' A' ' 67' ' ' ASP . 32.5 t -54.66 -29.01 51.3 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.059 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -85.79 -33.27 21.42 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.394 0.616 . . . . 0.0 110.162 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.64 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.2 m-30 -75.31 -35.13 61.3 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.518 -177.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.789 HG13 ' O ' ' A' ' 69' ' ' ILE . 1.4 m -70.78 -32.05 47.79 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 172.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.538 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -67.63 -30.92 70.62 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.27 175.248 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -63.58 -46.02 87.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.056 176.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.829 ' SG ' ' HB ' ' A' ' 79' ' ' ILE . 27.5 t -93.02 9.91 33.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.141 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.538 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 3.8 t70 -58.49 -26.3 63.27 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.092 0.472 . . . . 0.0 110.854 174.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 83' ' ' MET . . . -92.12 -23.13 28.09 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.226 173.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.829 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 76.7 mt -81.25 149.57 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.1 0.476 . . . . 0.0 111.015 -177.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.624 ' O ' ' HD2' ' A' ' 11' ' ' LYS . . . 140.78 -34.63 1.93 Allowed Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.38 149.28 12.55 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 174.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 65.17 -75.06 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.014 0.526 . . . . 0.0 111.722 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.44 ' HB3' ' SD ' ' A' ' 87' ' ' MET . 59.4 mtt -59.29 -39.03 81.71 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.554 -178.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.498 ' HB2' HG23 ' A' ' 79' ' ' ILE . 5.1 t-160 -49.96 -36.86 29.73 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.621 174.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -81.48 -32.48 32.46 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.817 0.341 . . . . 0.0 110.939 -174.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.29 -44.1 47.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.595 0.712 . . . . 0.0 110.532 176.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.44 ' SD ' ' HB3' ' A' ' 83' ' ' MET . 67.9 mtp -78.28 -12.55 60.01 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.931 -1.032 . . . . 0.0 110.772 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.455 HD12 ' HB2' ' A' ' 92' ' ' LEU . 0.1 OUTLIER -50.76 -54.69 21.33 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.878 178.075 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 16.1 tpt -76.49 -15.47 59.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.098 0.475 . . . . 0.0 110.661 -176.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -88.41 -26.32 22.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.953 -176.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.574 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 16.6 mt-30 -121.35 -50.09 2.13 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -170.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.455 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -42.73 -38.55 2.12 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.902 0.751 . . . . 0.0 109.345 -177.529 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 . . . . . 0 C--O 1.251 1.154 0 CA-C-N 113.353 -1.749 . . . . 0.0 113.665 -177.498 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' PRO . . . . . 0.419 ' C ' ' HA3' ' A' ' 60' ' ' GLY . 93.2 Cg_endo . . . . . 0 CA--C 1.516 -0.384 0 N-CA-C 109.135 -1.14 . . . . 0.0 109.135 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.649 ' HB2' HG23 ' B' ' 5' ' ' THR . 50.1 m -66.91 176.97 1.84 Allowed 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 162.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.659 ' CE1' HD11 ' B' ' 29' ' ' ILE . 0.1 OUTLIER -77.03 -54.14 6.92 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.663 174.296 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.554 ' ND2' ' HG3' ' B' ' 42' ' ' MET . 2.0 p-10 -82.59 6.01 19.08 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.392 -1.276 . . . . 0.0 112.475 -166.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.649 HG23 ' HB2' ' B' ' 2' ' ' SER . 0.7 OUTLIER -65.1 -3.95 4.31 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.58 -176.698 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.629 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.2 m -79.41 132.9 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.746 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.1 OUTLIER -155.94 160.24 39.94 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.123 -1.031 . . . . 0.0 113.403 -177.79 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 8' ' ' GLN . . . . . 0.505 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.3 mt-30 -41.03 112.16 0.27 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 113.591 -1.64 . . . . 0.0 112.814 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.41 -161.44 31.43 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 170.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 43.5 m -50.92 104.05 0.07 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-N 117.241 0.52 . . . . 0.0 111.093 -178.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.605 ' HD2' ' O ' ' B' ' 80' ' ' GLY . 63.7 pttt 44.22 38.88 2.61 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.59 1.156 . . . . 0.0 112.714 -176.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.44 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 48.2 tt0 -62.09 137.71 95.71 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 177.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' PRO . . . . . 0.536 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 39.4 Cg_exo -53.5 124.89 16.84 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.25 1.967 . . . . 0.0 109.979 178.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 14' ' ' TYR . . . . . 0.791 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 6.7 t80 -69.58 -55.28 9.53 Favored Pre-proline 0 N--CA 1.44 -0.943 0 CA-C-O 118.369 -0.824 . . . . 0.0 113.074 -166.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.547 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 31.1 Cg_exo -57.05 -17.62 25.39 Favored 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 121.437 1.425 . . . . 0.0 111.176 -178.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.536 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 2.3 m-20 -89.44 -42.64 11.38 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 113.872 -1.513 . . . . 0.0 110.804 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 17' ' ' PHE . . . . . 0.638 ' CE1' HD22 ' B' ' 21' ' ' LEU . 0.0 OUTLIER -55.22 -44.73 75.68 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 177.351 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.728 HG21 HD12 ' B' ' 69' ' ' ILE . 1.7 p -80.99 -31.38 12.07 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.927 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.791 -177.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.69 -34.04 70.84 Favored 'General case' 0 C--N 1.315 -0.931 0 O-C-N 121.344 -0.847 . . . . 0.0 111.596 176.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.707 ' O ' HG12 ' B' ' 24' ' ' VAL . 14.7 ptt180 -84.37 -25.48 29.11 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 176.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.638 HD22 ' CE1' ' B' ' 17' ' ' PHE . 9.9 tp -58.09 -45.19 87.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.981 172.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' GLN . . . . . 0.738 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 6.9 mt-30 -73.26 -44.39 59.46 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.701 177.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.753 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 12.8 t70 -51.96 -50.8 60.52 Favored 'General case' 0 C--N 1.314 -0.941 0 O-C-N 123.956 0.785 . . . . 0.0 111.578 -178.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' VAL . . . . . 0.707 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.1 p -82.1 -24.0 9.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.218 0.532 . . . . 0.0 109.766 -174.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.855 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -71.77 -18.16 62.13 Favored 'General case' 0 C--O 1.206 -1.219 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 174.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' GLN . . . . . 0.433 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -87.59 -38.89 15.55 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.991 176.774 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.753 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 40.4 mmtt -65.09 -43.92 90.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.233 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' SER . . . . . 0.537 ' HB2' ' HB3' ' B' ' 3' ' ' PHE . 36.0 m -98.15 -8.31 27.79 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.116 0.484 . . . . 0.0 110.495 -171.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.855 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 87.4 mt -114.99 125.24 72.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.813 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.59 -4.46 57.82 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.259 0.552 . . . . 0.0 110.143 175.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.644 ' OD1' ' HB2' ' B' ' 33' ' ' LYS . 12.3 t70 -102.79 115.67 31.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.445 -177.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' B' ' 36' ' ' LYS . 12.4 pt-20 -61.79 -24.49 66.88 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.857 177.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.644 ' HB2' ' OD1' ' B' ' 31' ' ' ASP . 4.5 mptt -75.1 -52.34 11.26 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -177.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.416 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -65.25 -26.94 68.32 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.848 176.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.828 ' O ' HG13 ' B' ' 39' ' ' VAL . 4.0 tmm_? -62.68 -65.09 0.74 Allowed 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.581 ' HG3' HG13 ' B' ' 37' ' ' VAL . 7.8 ptmm? -53.17 -58.33 7.42 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.308 0.575 . . . . 0.0 112.318 -178.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.776 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 5.6 m -56.83 -30.28 32.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.863 -171.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.494 ' O ' ' HG2' ' B' ' 42' ' ' MET . 0.1 OUTLIER -85.02 -31.49 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 119.891 -0.723 . . . . 0.0 111.438 178.795 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.828 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.4 m -68.33 -47.93 75.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.931 175.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.609 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 42.6 mt-10 -67.94 -22.92 65.03 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.392 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.776 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -85.42 -55.3 4.08 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.127 175.903 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 42' ' ' MET . . . . . 0.573 ' HB2' HD21 ' B' ' 21' ' ' LEU . 17.9 mmt -63.7 -20.46 65.74 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.585 0.707 . . . . 0.0 109.844 -176.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.616 ' HB2' ' CD1' ' B' ' 69' ' ' ILE . . . -47.74 -30.27 3.76 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.744 171.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' TYR . . . . . 0.548 ' CG ' ' HB2' ' B' ' 52' ' ' GLN . 7.8 t80 -105.66 -66.92 0.95 Allowed 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 176.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.634 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 3.8 mm-40 -47.0 -34.11 5.31 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 124.504 1.128 . . . . 0.0 111.997 -173.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.746 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 5.2 m-20 -102.53 -20.83 14.34 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.256 -174.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -60.54 -179.28 0.11 Allowed 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 122.058 0.932 . . . . 0.0 113.035 -173.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.608 ' HB3' ' OE1' ' B' ' 50' ' ' GLU . 14.6 m-20 -61.62 141.77 94.69 Favored Pre-proline 0 N--CA 1.442 -0.847 0 CA-C-N 114.366 -1.288 . . . . 0.0 109.144 174.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -55.33 -22.46 33.51 Favored 'Trans proline' 0 C--O 1.218 -0.512 0 C-N-CA 123.408 2.739 . . . . 0.0 112.757 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.714 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 12.5 pm0 -89.45 -31.24 17.8 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 123.576 0.75 . . . . 0.0 110.648 175.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.714 ' N ' ' HG2' ' B' ' 50' ' ' GLU . 91.7 m -82.82 -37.5 24.36 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.503 -170.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.601 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.7 pt20 -70.3 -29.74 66.55 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 172.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 53' ' ' SER . . . . . 0.58 ' HB3' ' HB3' ' B' ' 91' ' ' GLN . 11.3 m -71.24 -19.76 62.33 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 113.749 -1.568 . . . . 0.0 110.248 174.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.684 ' HB2' HD11 ' B' ' 79' ' ' ILE . . . -78.62 -25.37 45.11 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.484 -0.76 . . . . 0.0 109.756 167.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.602 HD11 ' CE2' ' B' ' 14' ' ' TYR . 22.6 mt -89.81 -32.63 5.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -171.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.595 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -39.74 -38.29 0.9 Allowed Pre-proline 0 N--CA 1.491 1.609 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -174.423 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 51.6 Cg_endo -63.51 -29.74 71.01 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.169 1.913 . . . . 0.0 112.704 175.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 58' ' ' LEU . . . . . 0.561 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.5 mt -98.65 -15.81 19.28 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.646 ' HD3' ' CG2' ' A' ' 5' ' ' THR . 0.1 OUTLIER -51.01 109.57 0.34 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.244 -178.257 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.42 ' HA3' ' C ' ' A' ' 1' ' ' PRO . . . 90.47 -21.13 33.84 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.971 -178.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -103.12 113.19 26.46 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.191 0.52 . . . . 0.0 109.893 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.476 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.3 p -123.71 149.11 58.22 Favored Pre-proline 0 C--N 1.308 -1.208 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.564 172.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.579 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 82.6 Cg_exo -47.56 137.94 19.59 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.066 1.844 . . . . 0.0 110.774 164.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.79 101.86 0.13 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -171.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.79 -9.98 64.21 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.933 -0.576 . . . . 0.0 113.028 176.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.579 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 4.7 m -91.76 -167.73 1.85 Allowed 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 122.357 1.075 . . . . 0.0 112.261 -176.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 67' ' ' ASP . . . . . 0.603 ' OD2' ' HB3' ' B' ' 70' ' ' SER . 0.4 OUTLIER -88.18 126.01 34.91 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 112.971 -1.922 . . . . 0.0 111.216 -175.206 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.542 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.9 OUTLIER -81.76 -33.04 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.505 0 C-N-CA 118.612 -1.235 . . . . 0.0 108.641 173.818 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.788 ' O ' HG13 ' B' ' 73' ' ' VAL . 10.9 mm -56.12 -50.04 72.53 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.366 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.528 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.603 ' HB3' ' OD2' ' B' ' 67' ' ' ASP . 32.6 t -54.79 -28.82 51.89 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.124 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -85.79 -33.3 21.42 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.455 0.645 . . . . 0.0 110.134 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 72' ' ' TYR . . . . . 0.634 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.1 m-30 -75.46 -35.1 60.96 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.48 -177.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.791 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.4 m -70.81 -32.0 47.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 172.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 74' ' ' LYS . . . . . 0.553 ' O ' ' HB3' ' B' ' 77' ' ' ASP . 0.0 OUTLIER -67.75 -30.98 70.59 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.34 175.223 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 75' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -63.1 -46.74 85.9 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.975 176.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.824 ' SG ' ' HB ' ' B' ' 79' ' ' ILE . 28.0 t -92.39 9.61 33.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.075 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 77' ' ' ASP . . . . . 0.553 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 3.1 t70 -58.43 -26.22 63.07 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.072 0.463 . . . . 0.0 110.8 174.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 78' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' B' ' 83' ' ' MET . . . -92.24 -23.06 28.0 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.194 173.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.824 ' HB ' ' SG ' ' B' ' 76' ' ' CYS . 77.6 mt -81.32 149.78 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-O 121.047 0.451 . . . . 0.0 110.948 -177.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 80' ' ' GLY . . . . . 0.605 ' O ' ' HD2' ' B' ' 11' ' ' LYS . . . 140.32 -34.29 2.0 Allowed Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.5 149.32 12.53 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 173.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 65.14 -74.9 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 122.966 0.506 . . . . 0.0 111.7 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 83' ' ' MET . . . . . 0.443 ' HB3' ' SD ' ' B' ' 87' ' ' MET . 59.5 mtt -59.53 -38.92 82.3 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.558 -178.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 84' ' ' HIS . . . . . 0.513 ' HB2' HG23 ' B' ' 79' ' ' ILE . 5.1 t-160 -49.98 -36.69 29.29 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.639 175.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -81.65 -32.37 31.91 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.722 0.296 . . . . 0.0 110.83 -174.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.57 -43.76 46.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.652 0.739 . . . . 0.0 110.625 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 87' ' ' MET . . . . . 0.443 ' SD ' ' HB3' ' B' ' 83' ' ' MET . 68.0 mtp -78.6 -12.46 60.02 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.778 -178.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.46 HD12 ' HB2' ' B' ' 92' ' ' LEU . 0.1 OUTLIER -50.62 -55.41 16.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.677 177.941 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 16.1 tpt -75.92 -15.41 60.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.035 0.445 . . . . 0.0 110.618 -176.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -88.42 -26.53 22.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.79 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 91' ' ' GLN . . . . . 0.58 ' HB3' ' HB3' ' B' ' 53' ' ' SER . 16.5 mt-30 -121.14 -50.03 2.16 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -170.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.46 ' HB2' HD12 ' B' ' 88' ' ' LEU . 0.2 OUTLIER -42.97 -38.18 2.15 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 123.927 0.767 . . . . 0.0 109.337 -177.354 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 . . . . . 0 C--O 1.248 0.992 0 CA-C-N 113.426 -1.716 . . . . 0.0 113.651 -177.736 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.424 ' C ' ' HA3' ' B' ' 60' ' ' GLY . 71.9 Cg_endo . . . . . 0 CA--C 1.517 -0.365 0 N-CA-C 109.219 -1.108 . . . . 0.0 109.219 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.55 ' HB2' HG23 ' A' ' 5' ' ' THR . 42.6 m -69.79 169.37 13.13 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 161.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.825 ' HE1' HD12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -65.55 -53.29 44.14 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 122.391 1.091 . . . . 0.0 109.633 175.496 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.553 ' HB2' HD11 ' A' ' 21' ' ' LEU . 3.2 p-10 -87.57 4.74 42.49 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 113.418 -1.719 . . . . 0.0 113.569 -161.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.675 ' CG2' ' HD3' ' B' ' 59' ' ' LYS . 0.9 OUTLIER -62.63 0.6 0.48 Allowed 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.066 0.46 . . . . 0.0 112.134 -175.322 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.571 ' HB ' ' CZ ' ' A' ' 20' ' ' ARG . 3.0 m -72.05 115.33 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 CA-C-O 121.908 0.861 . . . . 0.0 109.317 168.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.621 ' HG3' ' HB3' ' A' ' 46' ' ' ASN . 1.1 mpp_? -114.23 158.66 21.09 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 121.517 0.675 . . . . 0.0 110.989 177.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.468 ' HG2' ' HB3' ' A' ' 12' ' ' GLU . 2.2 tt0 -59.8 116.04 3.81 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.735 171.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.9 -156.75 26.28 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.378 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.46 ' C ' ' HD3' ' A' ' 11' ' ' LYS . 21.5 m -50.45 99.72 0.02 OUTLIER 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.774 0.287 . . . . 0.0 111.198 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.467 ' HB2' ' HA2' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 35.66 48.89 0.49 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.583 1.153 . . . . 0.0 111.988 -171.629 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.468 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 36.4 tt0 -62.4 136.86 95.96 Favored Pre-proline 0 C--O 1.233 0.227 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.576 178.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.553 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 38.9 Cg_exo -52.15 122.08 10.0 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.043 1.829 . . . . 0.0 109.735 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.886 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 27.4 t80 -72.7 -53.18 5.73 Favored Pre-proline 0 N--CA 1.437 -1.117 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -166.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.527 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 31.7 Cg_exo -55.07 -17.63 15.15 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 121.4 1.4 . . . . 0.0 110.692 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.553 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.0 OUTLIER -90.29 -44.11 9.92 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 113.98 -1.464 . . . . 0.0 111.089 178.178 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.436 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -53.71 -43.36 68.95 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 175.139 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.795 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 2.2 p -82.84 -35.47 12.39 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.325 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.867 -177.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.58 -33.78 70.35 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 121.316 -0.865 . . . . 0.0 111.819 177.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.706 ' O ' HG12 ' A' ' 24' ' ' VAL . 16.3 ptt180 -83.7 -27.54 28.94 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 176.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.558 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 7.4 tp -55.87 -47.57 77.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.605 -1.18 . . . . 0.0 108.87 171.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.795 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 4.9 mt-30 -70.13 -46.85 63.93 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.179 176.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.719 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 16.8 t70 -47.12 -54.33 10.76 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 124.289 0.993 . . . . 0.0 111.692 -178.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.706 HG12 ' O ' ' A' ' 20' ' ' ARG . 6.8 p -82.0 -23.54 9.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.197 0.522 . . . . 0.0 109.94 -174.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.801 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -71.32 -18.99 62.37 Favored 'General case' 0 C--O 1.204 -1.295 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 173.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.41 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -87.23 -38.88 15.94 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.955 177.559 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.719 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.4 mmtt -67.02 -39.46 87.05 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.752 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.6 m -98.01 -10.52 24.27 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.027 0.441 . . . . 0.0 110.63 -172.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.801 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 79.5 mt -116.11 129.91 71.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.795 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.01 -5.83 49.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.526 0.679 . . . . 0.0 110.136 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.601 ' H ' HG22 ' A' ' 29' ' ' ILE . 2.3 m-20 -102.51 107.33 18.25 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.067 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -53.6 -29.24 36.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.775 0.322 . . . . 0.0 110.446 175.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.552 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -68.36 -52.81 29.13 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.478 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.597 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -66.76 -23.57 66.1 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.246 178.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.836 ' O ' HG13 ' A' ' 39' ' ' VAL . 2.1 tmm_? -68.77 -58.55 4.04 Favored 'General case' 0 C--O 1.219 -0.503 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -53.38 -60.54 3.16 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.81 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 21.0 m -52.31 -34.57 18.58 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.952 -171.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.825 HD12 ' HE1' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -84.8 -33.85 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -177.218 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.836 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.7 m -72.36 -47.4 52.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 119.65 -0.82 . . . . 0.0 108.999 177.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.655 ' HG2' HG22 ' A' ' 68' ' ' VAL . 65.8 mt-10 -60.28 -26.07 66.2 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.971 0.908 . . . . 0.0 111.457 172.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.81 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -81.8 -61.68 1.85 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 178.654 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.598 ' HE3' ' HG ' ' B' ' 41' ' ' LEU . 20.1 mmt -62.79 -20.56 65.13 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.484 -177.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.728 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -49.29 -25.38 2.34 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.394 169.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.493 ' CD1' ' HB2' ' A' ' 52' ' ' GLN . 16.1 t80 -108.31 -66.44 1.04 Allowed 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 175.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.5 ' CG ' HD12 ' A' ' 41' ' ' LEU . 8.4 mm-40 -48.25 -32.47 7.28 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 123.799 0.687 . . . . 0.0 112.492 -175.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.621 ' HB3' ' HG3' ' A' ' 7' ' ' ARG . 4.9 m-20 -106.33 -11.5 15.97 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.534 0.683 . . . . 0.0 111.226 -176.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.728 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -62.53 168.53 3.59 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.496 0.665 . . . . 0.0 110.768 177.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.565 ' HB3' ' OE1' ' A' ' 50' ' ' GLU . 8.9 m-20 -57.38 144.45 71.17 Favored Pre-proline 0 C--N 1.31 -1.144 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.482 175.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.46 -19.29 28.48 Favored 'Trans proline' 0 C--O 1.219 -0.434 0 C-N-CA 122.92 2.413 . . . . 0.0 112.055 -179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.693 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 10.1 pm0 -90.87 -32.34 16.08 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.214 0.606 . . . . 0.0 110.531 174.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.935 ' SG ' ' HB2' ' A' ' 76' ' ' CYS . 37.3 t -85.1 -37.28 20.45 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.873 -171.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.549 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.5 pt20 -67.18 -26.72 66.78 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 172.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.671 ' HB3' ' C ' ' A' ' 91' ' ' GLN . 9.3 m -72.47 -22.55 61.06 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 113.141 -1.845 . . . . 0.0 110.916 174.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.65 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -78.37 -23.75 46.74 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.411 0.624 . . . . 0.0 109.527 168.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.549 HD12 ' HA ' ' A' ' 52' ' ' GLN . 24.7 mt -91.24 -33.22 5.6 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.151 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -172.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.616 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.57 -39.87 2.71 Favored Pre-proline 0 N--CA 1.493 1.688 0 CA-C-N 119.909 1.232 . . . . 0.0 113.757 -175.389 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 51.2 Cg_endo -62.6 -25.32 75.41 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 122.328 2.018 . . . . 0.0 113.045 175.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.528 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.1 mt -104.02 -15.86 15.47 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.652 ' HD3' ' CG2' ' B' ' 5' ' ' THR . 0.1 OUTLIER -50.47 109.09 0.27 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.192 -179.099 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.405 ' HA3' ' C ' ' B' ' 1' ' ' PRO . . . 89.69 -19.01 43.43 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.31 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.0 mmmt -103.7 114.65 29.07 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.162 0.506 . . . . 0.0 110.167 -178.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.463 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.6 p -123.38 143.97 42.69 Favored Pre-proline 0 C--N 1.312 -1.03 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.113 173.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.53 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 86.1 Cg_exo -50.18 140.02 34.07 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.538 2.158 . . . . 0.0 111.669 168.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.04 101.92 0.32 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.044 0.449 . . . . 0.0 111.724 -175.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.26 -17.01 41.26 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.668 178.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.53 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 14.0 m -88.71 172.7 9.05 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.902 0.382 . . . . 0.0 111.18 -178.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.28 142.36 28.59 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 176.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.655 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -78.63 -28.51 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 C-N-CA 118.934 -1.106 . . . . 0.0 108.622 178.954 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.757 ' O ' HG13 ' A' ' 73' ' ' VAL . 6.8 mm -60.4 -45.95 95.9 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.133 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.277 -178.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 41.7 t -48.24 -36.18 13.44 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.143 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 74' ' ' LYS . 2.0 mm-40 -86.27 -31.53 21.59 Favored 'General case' 0 C--O 1.216 -0.672 0 C-N-CA 123.31 0.644 . . . . 0.0 111.074 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.532 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.0 m-30 -76.27 -33.79 59.14 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.626 0.727 . . . . 0.0 109.285 -177.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.886 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 2.1 m -73.01 -32.63 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 173.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 70' ' ' SER . 1.8 ttmm -66.45 -30.71 71.12 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.13 -1.395 . . . . 0.0 110.0 175.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -62.52 -45.44 92.95 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.784 175.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.935 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 42.2 t -93.34 9.17 37.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.044 177.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.484 ' HB2' ' HA ' ' A' ' 74' ' ' LYS . 21.8 t70 -65.03 -17.17 64.22 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.442 0.639 . . . . 0.0 109.699 173.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -108.51 4.32 32.86 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.366 -0.833 . . . . 0.0 112.422 172.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.755 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 94.6 mt -106.89 128.7 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 121.492 0.663 . . . . 0.0 111.797 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.562 ' H ' ' HB2' ' A' ' 84' ' ' HIS . . . 176.12 -49.13 0.12 Allowed Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 171.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.48 156.48 27.01 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 62.9 -80.15 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.912 0.419 . . . . 0.0 111.341 -177.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 80.9 mtp -60.8 -38.13 84.32 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-O 120.722 0.296 . . . . 0.0 110.46 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.562 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 5.4 t-160 -49.49 -45.89 47.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.676 174.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.46 ' HA ' ' HB2' ' A' ' 88' ' ' LEU . 78.6 mttt -87.33 -14.78 39.84 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -174.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.43 -38.3 26.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.015 0.912 . . . . 0.0 109.662 171.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 3.2 mmt -85.94 -11.07 54.07 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.437 -178.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.655 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 0.1 OUTLIER -56.29 -30.75 62.91 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.228 -179.614 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.5 tmm? -83.8 -42.21 16.72 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.213 0.53 . . . . 0.0 109.811 174.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.36 -60.3 3.34 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.47 -173.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.671 ' C ' ' HB3' ' A' ' 53' ' ' SER . 49.2 mt-30 -84.48 -41.91 16.11 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 118.506 -0.759 . . . . 0.0 111.988 -169.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.655 ' HB2' ' O ' ' A' ' 88' ' ' LEU . 1.2 tt -37.17 -38.75 0.22 Allowed 'General case' 0 C--N 1.349 0.573 0 O-C-N 124.908 1.38 . . . . 0.0 109.313 -174.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 92' ' ' LEU . 12.3 mt-10 . . . . . 0 C--O 1.25 1.121 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.996 170.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 1' ' ' PRO . . . . . 0.405 ' C ' ' HA3' ' A' ' 60' ' ' GLY . 72.0 Cg_endo . . . . . 0 CA--C 1.515 -0.43 0 N-CA-C 109.148 -1.135 . . . . 0.0 109.148 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.57 ' HB2' HG23 ' B' ' 5' ' ' THR . 43.0 m -69.79 169.71 12.47 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 161.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.863 ' HE1' HD12 ' B' ' 38' ' ' ILE . 0.0 OUTLIER -65.65 -53.11 45.88 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 122.351 1.072 . . . . 0.0 109.683 175.316 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.55 ' HB2' HD11 ' B' ' 21' ' ' LEU . 3.2 p-10 -87.75 4.9 42.49 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.51 -1.677 . . . . 0.0 113.58 -161.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.652 ' CG2' ' HD3' ' A' ' 59' ' ' LYS . 0.9 OUTLIER -62.9 0.71 0.5 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.123 0.487 . . . . 0.0 112.036 -175.165 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.566 ' HB ' ' CZ ' ' B' ' 20' ' ' ARG . 3.0 m -72.18 115.06 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 CA-C-O 121.904 0.859 . . . . 0.0 109.284 168.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.608 ' HG3' ' CB ' ' B' ' 46' ' ' ASN . 1.1 mpp_? -114.0 158.52 21.06 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 121.593 0.711 . . . . 0.0 110.949 177.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 8' ' ' GLN . . . . . 0.462 ' HG2' ' HB3' ' B' ' 12' ' ' GLU . 2.2 tt0 -59.64 116.1 3.79 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.702 171.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.99 -156.95 26.88 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.483 174.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 10' ' ' SER . . . . . 0.477 ' C ' ' HD3' ' B' ' 11' ' ' LYS . 23.4 m -50.29 100.05 0.02 OUTLIER 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.71 0.255 . . . . 0.0 111.086 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.477 ' HD3' ' C ' ' B' ' 10' ' ' SER . 0.0 OUTLIER 35.17 49.57 0.45 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.545 1.138 . . . . 0.0 111.865 -171.59 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.462 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 36.1 tt0 -62.78 136.87 96.55 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.555 177.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 13' ' ' PRO . . . . . 0.551 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 37.8 Cg_exo -52.09 121.99 9.8 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 121.991 1.794 . . . . 0.0 109.703 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 14' ' ' TYR . . . . . 0.893 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 27.4 t80 -72.64 -53.32 5.75 Favored Pre-proline 0 N--CA 1.437 -1.105 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -166.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.534 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 31.8 Cg_exo -54.97 -17.84 15.23 Favored 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 121.382 1.388 . . . . 0.0 110.573 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.551 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 0.9 OUTLIER -90.2 -43.74 10.22 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.111 -1.404 . . . . 0.0 111.196 178.146 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 17' ' ' PHE . . . . . 0.429 ' CD2' ' N ' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -53.93 -43.41 69.76 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 175.069 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.791 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 2.2 p -82.68 -35.61 12.68 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.378 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.761 -177.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.46 -33.76 70.1 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 121.308 -0.87 . . . . 0.0 111.871 177.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.692 ' O ' HG12 ' B' ' 24' ' ' VAL . 16.4 ptt180 -83.73 -27.52 28.9 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 176.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.573 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 7.4 tp -56.0 -47.24 78.13 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.882 171.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 22' ' ' GLN . . . . . 0.791 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 4.9 mt-30 -70.49 -46.87 62.91 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.163 176.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.736 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 17.2 t70 -47.09 -54.29 10.77 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 124.304 1.002 . . . . 0.0 111.761 -178.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 24' ' ' VAL . . . . . 0.692 HG12 ' O ' ' B' ' 20' ' ' ARG . 6.8 p -82.1 -23.3 9.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.157 0.503 . . . . 0.0 109.869 -174.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.791 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -71.44 -18.91 62.3 Favored 'General case' 0 C--O 1.205 -1.284 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 26' ' ' GLN . . . . . 0.407 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -87.18 -39.03 15.85 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.015 177.497 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.736 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.3 mmtt -66.85 -39.44 87.58 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.736 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 58.3 m -98.02 -10.48 24.33 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.106 0.479 . . . . 0.0 110.517 -172.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.791 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 79.5 mt -116.24 130.49 70.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.775 -178.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.95 -5.08 48.56 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.637 0.732 . . . . 0.0 110.014 176.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.594 ' H ' HG22 ' B' ' 29' ' ' ILE . 2.4 m-20 -102.64 106.95 17.71 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.253 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -53.42 -29.1 33.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.68 0.276 . . . . 0.0 110.449 175.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.562 ' O ' HG13 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -68.39 -52.81 28.91 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.447 -179.569 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.596 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -66.77 -23.59 66.1 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.248 178.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.865 ' O ' HG13 ' B' ' 39' ' ' VAL . 2.1 tmm_? -68.78 -58.42 4.22 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 29.7 mtpt -53.55 -60.39 3.37 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.879 177.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.812 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 20.9 m -52.42 -34.38 18.72 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 O-C-N 124.324 1.015 . . . . 0.0 110.978 -171.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.863 HD12 ' HE1' ' B' ' 3' ' ' PHE . 0.0 OUTLIER -84.78 -34.08 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -177.309 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.865 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.7 m -72.2 -47.5 53.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.012 177.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.642 ' HG2' HG22 ' B' ' 68' ' ' VAL . 66.2 mt-10 -60.33 -25.9 66.15 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.907 0.883 . . . . 0.0 111.472 172.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.812 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -82.03 -61.59 1.87 Allowed 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.992 178.734 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 42' ' ' MET . . . . . 0.537 ' HE3' ' HG ' ' A' ' 41' ' ' LEU . 20.1 mmt -62.83 -20.56 65.18 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.482 -177.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.71 ' O ' ' HB2' ' B' ' 47' ' ' ALA . . . -49.31 -25.4 2.38 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.406 169.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 44' ' ' TYR . . . . . 0.498 ' CD1' ' HB2' ' B' ' 52' ' ' GLN . 16.1 t80 -108.22 -66.44 1.04 Allowed 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 175.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.498 ' CG ' HD12 ' B' ' 41' ' ' LEU . 8.6 mm-40 -48.26 -32.83 7.78 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 123.856 0.723 . . . . 0.0 112.381 -175.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.608 ' CB ' ' HG3' ' B' ' 7' ' ' ARG . 4.9 m-20 -105.93 -11.46 16.18 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.472 0.653 . . . . 0.0 111.284 -176.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.71 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -62.57 168.6 3.56 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.391 0.615 . . . . 0.0 110.779 177.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.55 ' HB3' ' OE1' ' B' ' 50' ' ' GLU . 8.5 m-20 -57.39 144.47 71.17 Favored Pre-proline 0 C--N 1.31 -1.139 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.466 175.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 49' ' ' PRO . . . . . 0.429 ' HA ' HE21 ' B' ' 52' ' ' GLN . 11.2 Cg_endo -56.62 -19.2 29.06 Favored 'Trans proline' 0 C--O 1.218 -0.48 0 C-N-CA 122.963 2.442 . . . . 0.0 112.029 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.697 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 10.1 pm0 -90.83 -32.29 16.13 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 123.205 0.602 . . . . 0.0 110.644 174.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.94 ' SG ' ' HB2' ' B' ' 76' ' ' CYS . 37.5 t -85.16 -37.4 20.23 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.885 -171.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.534 ' HA ' HD12 ' B' ' 55' ' ' ILE . 28.7 pt20 -66.95 -26.71 66.97 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 172.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 53' ' ' SER . . . . . 0.658 ' HB3' ' C ' ' B' ' 91' ' ' GLN . 8.9 m -72.61 -22.53 60.95 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 113.247 -1.797 . . . . 0.0 110.902 174.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.666 ' HB2' HD11 ' B' ' 79' ' ' ILE . . . -78.22 -23.81 47.31 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.493 0.663 . . . . 0.0 109.586 168.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.534 HD12 ' HA ' ' B' ' 52' ' ' GLN . 25.0 mt -91.09 -33.37 5.73 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.137 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -172.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.615 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.5 -39.76 2.56 Favored Pre-proline 0 N--CA 1.492 1.649 0 CA-C-N 119.925 1.239 . . . . 0.0 113.749 -175.34 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 51.0 Cg_endo -62.71 -25.32 74.98 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.245 1.964 . . . . 0.0 113.002 175.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 58' ' ' LEU . . . . . 0.541 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.2 mt -104.02 -15.81 15.49 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.675 ' HD3' ' CG2' ' A' ' 5' ' ' THR . 0.1 OUTLIER -50.46 109.12 0.27 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.702 -1.135 . . . . 0.0 111.281 -179.207 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.424 ' HA3' ' C ' ' A' ' 1' ' ' PRO . . . 89.99 -19.7 40.58 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.276 -178.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -103.21 114.81 29.4 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.099 0.476 . . . . 0.0 110.027 -178.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.465 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.8 p -123.25 144.35 43.43 Favored Pre-proline 0 C--N 1.31 -1.125 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.94 172.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.549 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 86.7 Cg_exo -50.67 140.27 37.34 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.521 2.148 . . . . 0.0 111.667 168.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.03 102.0 0.33 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.708 -175.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.02 -16.84 42.31 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.644 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.549 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 15.9 m -88.65 173.2 8.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.053 0.454 . . . . 0.0 111.15 -178.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 67' ' ' ASP . . . . . 0.43 ' OD1' ' HB ' ' B' ' 69' ' ' ILE . 0.8 OUTLIER -86.63 142.14 28.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.066 176.735 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.642 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.8 OUTLIER -78.48 -28.28 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 C-N-CA 119.006 -1.078 . . . . 0.0 108.568 179.08 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.756 ' O ' HG13 ' B' ' 73' ' ' VAL . 6.8 mm -60.44 -45.81 96.2 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.084 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.391 -178.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.501 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 43.2 t -48.54 -36.16 14.82 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.077 176.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' B' ' 74' ' ' LYS . 2.3 mm-40 -86.28 -31.38 21.65 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 123.211 0.604 . . . . 0.0 110.998 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 72' ' ' TYR . . . . . 0.541 ' CE1' ' HB2' ' B' ' 58' ' ' LEU . 5.0 m-30 -76.23 -34.13 59.21 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.654 0.74 . . . . 0.0 109.298 -177.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.893 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 2.1 m -72.67 -33.1 43.47 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 173.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 74' ' ' LYS . . . . . 0.501 ' HB2' ' O ' ' B' ' 70' ' ' SER . 1.8 ttmm -65.87 -30.89 71.57 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.052 175.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 75' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -62.36 -45.52 92.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.754 175.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.94 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 41.9 t -93.5 9.14 37.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.089 177.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 77' ' ' ASP . . . . . 0.488 ' HB2' ' HA ' ' B' ' 74' ' ' LYS . 19.9 t70 -65.27 -17.09 64.22 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.388 0.613 . . . . 0.0 109.515 174.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -109.12 5.4 31.98 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.409 172.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.743 ' HB ' ' SG ' ' B' ' 76' ' ' CYS . 94.3 mt -107.69 128.78 62.61 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 CA-C-N 117.348 0.574 . . . . 0.0 111.836 178.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 80' ' ' GLY . . . . . 0.566 ' H ' ' HB2' ' B' ' 84' ' ' HIS . . . 176.1 -48.38 0.12 Allowed Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 171.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -156.89 155.13 26.11 Favored Glycine 0 C--N 1.318 -0.452 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.99 -80.58 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 122.617 0.367 . . . . 0.0 111.204 -176.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 83' ' ' MET . . . . . . . . . . . . . 81.7 mtp -60.73 -38.17 84.23 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-O 120.775 0.321 . . . . 0.0 110.465 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 84' ' ' HIS . . . . . 0.566 ' HB2' ' H ' ' B' ' 80' ' ' GLY . 5.5 t-160 -49.42 -45.94 46.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.722 173.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.456 ' HA ' ' HB2' ' B' ' 88' ' ' LEU . 78.5 mttt -87.23 -14.93 39.65 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -174.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.52 -37.93 27.05 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 122.002 0.906 . . . . 0.0 109.807 171.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 3.2 mmt -86.06 -10.99 53.99 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.215 -1.357 . . . . 0.0 111.459 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.646 ' O ' ' HB2' ' B' ' 92' ' ' LEU . 0.1 OUTLIER -56.44 -30.71 63.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.147 -179.605 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 15.5 tmm? -83.75 -42.24 16.76 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.167 0.508 . . . . 0.0 109.754 174.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.21 -60.52 3.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.471 -173.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 91' ' ' GLN . . . . . 0.658 ' C ' ' HB3' ' B' ' 53' ' ' SER . 48.6 mt-30 -84.22 -42.12 16.24 Favored 'General case' 0 CA--C 1.491 -1.31 0 CA-C-O 118.557 -0.735 . . . . 0.0 111.899 -169.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.646 ' HB2' ' O ' ' B' ' 88' ' ' LEU . 1.2 tt -37.02 -38.97 0.21 Allowed 'General case' 0 C--N 1.349 0.563 0 O-C-N 124.859 1.35 . . . . 0.0 109.216 -174.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' B' ' 92' ' ' LEU . 12.2 mt-10 . . . . . 0 C--O 1.25 1.118 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.074 170.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.44 ' HB2' ' H ' ' A' ' 2' ' ' SER . 92.3 Cg_endo . . . . . 0 CA--C 1.517 -0.326 0 N-CA-C 109.005 -1.19 . . . . 0.0 109.005 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.756 ' HB2' HG23 ' A' ' 5' ' ' THR . 70.7 m -72.13 178.9 3.56 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 162.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.773 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -76.13 -52.45 10.09 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.8 0.809 . . . . 0.0 110.125 174.445 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.503 ' OD1' ' HG ' ' B' ' 41' ' ' LEU . 2.5 p-10 -87.61 2.93 49.57 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.403 -163.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.756 HG23 ' HB2' ' A' ' 2' ' ' SER . 3.1 p -63.51 -3.12 1.9 Allowed 'General case' 0 C--N 1.311 -1.078 0 O-C-N 122.059 -0.4 . . . . 0.0 111.832 -175.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.555 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 3.3 m -76.49 119.03 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-O 121.677 0.751 . . . . 0.0 109.924 176.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.767 ' HB3' ' O ' ' A' ' 46' ' ' ASN . 32.2 mtm180 -137.58 147.2 44.87 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -170.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.6 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.6 mt-30 -42.02 120.66 1.62 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 112.633 -2.076 . . . . 0.0 113.745 177.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.53 -159.04 35.01 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 169.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.8 t -48.44 101.46 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 117.086 0.443 . . . . 0.0 111.231 -178.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.4 pttt 37.71 42.1 0.37 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.251 1.02 . . . . 0.0 112.084 -173.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.479 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 39.5 tt0 -57.16 137.5 80.54 Favored Pre-proline 0 C--O 1.233 0.226 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.602 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 52.1 Cg_exo -49.31 121.22 6.66 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.056 1.837 . . . . 0.0 109.947 -178.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.834 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 11.3 t80 -71.89 -52.85 7.44 Favored Pre-proline 0 N--CA 1.438 -1.047 0 CA-C-O 118.512 -0.756 . . . . 0.0 113.028 -166.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.538 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 36.4 Cg_exo -55.79 -18.39 21.27 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 121.346 1.364 . . . . 0.0 110.728 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.602 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 0.9 OUTLIER -90.34 -42.35 10.99 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.317 179.66 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.6 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -54.82 -43.64 73.16 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 175.647 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.686 HG12 ' O ' ' A' ' 14' ' ' TYR . 2.7 p -82.78 -32.35 9.89 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.941 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.845 -177.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.99 -35.46 73.25 Favored 'General case' 0 C--N 1.317 -0.84 0 O-C-N 121.285 -0.885 . . . . 0.0 111.839 175.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.709 ' O ' HG12 ' A' ' 24' ' ' VAL . 16.7 ptt180 -81.9 -27.26 33.51 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 176.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.588 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 6.7 tp -57.1 -48.14 79.33 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.215 172.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.679 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 8.6 mt-30 -70.91 -44.66 65.77 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.191 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.762 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -48.89 -64.06 0.91 Allowed 'General case' 0 C--N 1.314 -0.961 0 O-C-N 124.426 1.079 . . . . 0.0 110.206 -178.622 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.709 HG12 ' O ' ' A' ' 20' ' ' ARG . 4.2 p -74.0 -20.34 17.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -171.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.622 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -64.33 -35.82 82.11 Favored 'General case' 0 C--O 1.206 -1.195 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 172.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.405 ' HB3' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -75.1 -34.99 61.79 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 113.631 -1.622 . . . . 0.0 109.896 -176.641 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.762 ' HD2' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -65.04 -44.81 87.87 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 121.972 0.891 . . . . 0.0 112.0 177.09 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.456 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 24.7 m -95.97 -9.17 31.8 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.515 -168.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.626 HG22 ' H ' ' A' ' 31' ' ' ASP . 84.8 mt -116.91 128.27 74.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.919 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.11 -2.2 56.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.42 0.628 . . . . 0.0 110.141 175.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.626 ' H ' HG22 ' A' ' 29' ' ' ILE . 2.7 m-20 -106.92 104.16 13.77 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.105 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -53.36 -27.59 24.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.664 0.268 . . . . 0.0 110.466 176.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.569 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -67.93 -54.38 19.14 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.675 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.644 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -65.28 -22.7 66.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.44 178.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.886 ' O ' HG13 ' A' ' 39' ' ' VAL . 5.3 tmm_? -69.82 -55.81 8.79 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.491 ' O ' HG22 ' A' ' 39' ' ' VAL . 21.7 mtpt -56.97 -57.55 12.03 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.98 177.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.728 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 19.8 m -54.48 -34.2 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.736 -169.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.773 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.5 tt -86.97 -28.84 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 119.649 -0.821 . . . . 0.0 111.568 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.886 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.7 m -69.61 -49.07 61.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 119.031 -1.067 . . . . 0.0 109.508 173.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.622 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 60.4 mt-10 -61.81 -28.34 69.4 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 123.556 0.742 . . . . 0.0 112.233 176.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.728 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -85.58 -52.55 5.74 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.72 178.574 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.666 ' HE2' ' HE2' ' B' ' 42' ' ' MET . 19.6 mmt -65.57 -20.72 66.44 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.667 0.746 . . . . 0.0 109.602 -177.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.687 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -50.46 -28.11 7.74 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.463 170.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.524 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 23.1 t80 -105.15 -68.4 0.86 Allowed 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 175.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.469 ' CG ' HD12 ' A' ' 41' ' ' LEU . 10.9 mm-40 -48.88 -29.82 5.12 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.829 -176.198 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.767 ' O ' ' HB3' ' A' ' 7' ' ' ARG . 4.2 m-20 -106.53 -16.12 14.61 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 120.718 0.295 . . . . 0.0 111.659 -176.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -65.45 179.25 0.81 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.588 0.708 . . . . 0.0 111.539 -177.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.748 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 24.2 m-20 -58.63 145.67 76.47 Favored Pre-proline 0 C--N 1.31 -1.148 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.21 171.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.795 ' O ' ' HB3' ' A' ' 53' ' ' SER . 11.1 Cg_endo -55.53 -28.96 67.29 Favored 'Trans proline' 0 C--N 1.331 -0.345 0 C-N-CA 122.987 2.458 . . . . 0.0 111.897 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.672 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 8.4 pm0 -87.4 -26.57 23.24 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.398 1.079 . . . . 0.0 111.066 175.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.748 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 86.8 m -80.21 -38.24 31.56 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -177.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.523 ' HB2' ' CD1' ' A' ' 44' ' ' TYR . 4.1 pt20 -73.17 -27.35 61.6 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 172.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.814 ' OG ' ' HB2' ' A' ' 91' ' ' GLN . 0.9 OUTLIER -67.91 -23.73 65.13 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.437 174.33 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.675 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -83.83 -23.47 31.36 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.862 172.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.54 HD11 ' CE2' ' A' ' 14' ' ' TYR . 22.7 mt -90.83 -32.56 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -173.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.655 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -45.92 -34.11 2.67 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -175.06 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.655 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 37.4 Cg_endo -60.61 -29.89 89.4 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.323 2.015 . . . . 0.0 112.946 172.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.552 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.1 mt -102.05 -15.34 16.79 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -178.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.589 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -52.84 109.83 0.45 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.899 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.09 -23.81 31.59 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.407 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.0 mmmt -103.38 111.94 24.6 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.373 0.606 . . . . 0.0 109.914 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.427 HG23 ' HD2' ' A' ' 63' ' ' PRO . 7.4 p -123.81 146.22 49.97 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 170.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.567 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 92.0 Cg_exo -47.29 141.81 13.17 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.194 1.929 . . . . 0.0 111.245 168.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.82 98.58 0.07 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.976 0.417 . . . . 0.0 111.849 -173.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.57 -7.51 57.93 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.072 176.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.567 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 10.6 m -91.59 -177.81 4.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.656 0.741 . . . . 0.0 111.905 -177.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.706 ' OD1' ' HB ' ' A' ' 69' ' ' ILE . 26.7 t70 -84.51 133.59 34.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.913 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.605 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -81.44 -30.09 10.87 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 C-N-CA 119.035 -1.066 . . . . 0.0 109.089 176.447 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.76 ' O ' HG13 ' A' ' 73' ' ' VAL . 8.5 mm -58.09 -47.37 87.13 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.168 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.825 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 43.6 t -45.58 -37.54 5.62 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.394 175.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -85.36 -32.83 22.21 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.262 0.553 . . . . 0.0 110.629 -178.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.614 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.0 m-30 -76.06 -34.42 59.6 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.488 -175.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.834 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.6 m -72.57 -31.87 39.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.533 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -66.25 -31.65 72.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.075 175.46 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -62.93 -47.53 82.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.447 176.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.704 ' SG ' ' HB ' ' A' ' 79' ' ' ILE . 14.4 t -91.07 5.43 48.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.469 0.652 . . . . 0.0 111.059 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.533 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 9.6 t70 -60.27 -16.47 34.38 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.318 175.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -120.32 21.58 8.66 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.921 174.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.704 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 41.4 mt -101.94 -11.54 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 117.667 0.733 . . . . 0.0 112.974 177.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.4 14.31 1.83 Allowed Glycine 0 CA--C 1.532 1.132 0 C-N-CA 120.353 -0.927 . . . . 0.0 115.377 -168.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.82 72.93 0.11 Allowed Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.114 -1.041 . . . . 0.0 114.423 168.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -177.92 -91.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 122.981 0.512 . . . . 0.0 110.118 174.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 65.1 mtm -65.96 -17.64 64.81 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 121.006 0.431 . . . . 0.0 110.082 177.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.517 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 6.5 t-160 -49.57 -34.63 18.19 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.474 174.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -83.22 -22.48 33.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.816 0.341 . . . . 0.0 110.908 -176.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.8 -40.57 15.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.706 0.765 . . . . 0.0 110.358 176.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.444 ' O ' ' HG3' ' A' ' 91' ' ' GLN . 81.9 mtp -85.27 -13.73 48.87 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.562 -175.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.566 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 0.1 OUTLIER -50.48 -58.79 4.93 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.444 0.465 . . . . 0.0 110.289 179.305 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 52.9 ttm -71.72 -23.07 61.56 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.258 -173.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -88.06 -8.54 55.39 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -170.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.814 ' HB2' ' OG ' ' A' ' 53' ' ' SER . 3.2 mt-30 -132.67 -37.05 1.05 Allowed 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.886 -0.725 . . . . 0.0 111.145 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.566 ' HB2' ' O ' ' A' ' 88' ' ' LEU . 0.2 OUTLIER -50.4 -34.3 23.85 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 171.658 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 93' ' ' GLU . 6.4 pt-20 . . . . . 0 C--O 1.251 1.166 0 CA-C-N 112.632 -2.076 . . . . 0.0 113.597 -173.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 1' ' ' PRO . . . . . 0.41 ' HB2' ' H ' ' B' ' 2' ' ' SER . 90.1 Cg_endo . . . . . 0 CA--C 1.515 -0.426 0 N-CA-C 108.937 -1.217 . . . . 0.0 108.937 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.752 ' HB2' HG23 ' B' ' 5' ' ' THR . 71.2 m -71.52 178.72 3.34 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 162.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.752 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -76.13 -52.43 10.12 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.857 0.837 . . . . 0.0 110.079 174.444 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.483 ' OD1' ' HG ' ' A' ' 41' ' ' LEU . 2.5 p-10 -87.42 2.64 49.89 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.646 -1.161 . . . . 0.0 113.364 -163.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.752 HG23 ' HB2' ' B' ' 2' ' ' SER . 3.6 p -63.31 -3.06 1.69 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 118.057 0.389 . . . . 0.0 111.779 -175.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.561 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 3.3 m -76.48 118.96 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-O 121.678 0.751 . . . . 0.0 110.008 176.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.76 ' HB3' ' O ' ' B' ' 46' ' ' ASN . 32.1 mtm180 -137.32 147.58 45.71 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -170.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 8' ' ' GLN . . . . . 0.601 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.6 mt-30 -42.62 121.1 1.89 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 112.616 -2.084 . . . . 0.0 113.494 177.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.67 -158.39 34.29 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 169.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 22.9 t -49.24 101.58 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 117.115 0.457 . . . . 0.0 110.988 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 49.1 pttt 37.56 42.3 0.35 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.419 1.088 . . . . 0.0 112.109 -173.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.505 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 38.1 tt0 -57.2 137.36 80.75 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 13' ' ' PRO . . . . . 0.594 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 52.1 Cg_exo -49.07 121.09 6.27 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.134 1.889 . . . . 0.0 109.992 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 14' ' ' TYR . . . . . 0.84 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 11.3 t80 -72.09 -52.66 7.24 Favored Pre-proline 0 N--CA 1.437 -1.1 0 CA-C-O 118.507 -0.758 . . . . 0.0 112.891 -166.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.541 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 36.0 Cg_exo -55.9 -18.37 21.79 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 121.42 1.413 . . . . 0.0 110.764 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.594 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 0.9 OUTLIER -90.61 -41.84 11.11 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.035 -1.439 . . . . 0.0 111.367 179.708 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 17' ' ' PHE . . . . . 0.601 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -55.34 -43.52 75.08 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 175.581 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.702 HG12 ' O ' ' B' ' 14' ' ' TYR . 2.7 p -82.89 -32.27 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.907 -177.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.42 -34.75 72.87 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 121.303 -0.873 . . . . 0.0 111.861 175.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.704 ' O ' HG12 ' B' ' 24' ' ' VAL . 16.7 ptt180 -82.09 -27.43 32.89 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 176.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.599 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 6.7 tp -57.03 -48.38 78.65 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.208 173.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 22' ' ' GLN . . . . . 0.693 ' HA ' ' CG1' ' B' ' 39' ' ' VAL . 8.6 mt-30 -70.79 -44.68 66.13 Favored 'General case' 0 CA--C 1.488 -1.435 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.089 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.751 ' O ' ' HD2' ' B' ' 27' ' ' LYS . 0.9 OUTLIER -48.8 -64.19 0.87 Allowed 'General case' 0 C--N 1.314 -0.943 0 O-C-N 124.39 1.056 . . . . 0.0 110.325 -178.7 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 24' ' ' VAL . . . . . 0.704 HG12 ' O ' ' B' ' 20' ' ' ARG . 4.1 p -73.82 -20.42 17.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -171.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.609 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -64.15 -36.0 82.62 Favored 'General case' 0 C--O 1.208 -1.12 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 172.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 26' ' ' GLN . . . . . 0.417 ' HB3' ' O ' ' B' ' 23' ' ' ASP . 0.0 OUTLIER -74.9 -35.18 62.25 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 113.62 -1.627 . . . . 0.0 109.903 -176.608 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.751 ' HD2' ' O ' ' B' ' 23' ' ' ASP . 0.0 OUTLIER -64.85 -45.03 87.81 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.898 177.177 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 28' ' ' SER . . . . . 0.444 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 26.4 m -96.15 -8.68 32.55 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.602 -168.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.609 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 84.6 mt -116.94 128.68 74.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.837 -178.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.69 -1.87 56.51 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.499 0.666 . . . . 0.0 110.128 175.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.603 ' H ' HG22 ' B' ' 29' ' ' ILE . 2.8 m-20 -106.91 104.58 14.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.092 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -53.91 -27.36 30.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.715 0.293 . . . . 0.0 110.396 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.58 ' O ' HG13 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -67.93 -54.32 19.57 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.707 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.647 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -65.46 -22.71 66.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.385 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.866 ' O ' HG13 ' B' ' 39' ' ' VAL . 5.4 tmm_? -69.69 -55.89 8.72 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.483 ' O ' HG22 ' B' ' 39' ' ' VAL . 21.8 mtpt -56.98 -57.37 12.84 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 120.826 0.346 . . . . 0.0 110.936 177.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.714 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 20.0 m -54.71 -34.13 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.661 -169.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.752 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.4 tt -86.99 -29.11 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.51 -179.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.866 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.7 m -69.31 -49.19 62.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 119.089 -1.045 . . . . 0.0 109.574 173.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.623 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 61.8 mt-10 -61.72 -28.26 69.29 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 123.506 0.722 . . . . 0.0 112.26 176.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.714 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.67 -52.55 5.72 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.713 178.685 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 42' ' ' MET . . . . . 0.666 ' HE2' ' HE2' ' A' ' 42' ' ' MET . 19.5 mmt -65.6 -20.68 66.41 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.574 0.702 . . . . 0.0 109.491 -177.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.679 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -50.53 -28.17 8.03 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.415 170.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 44' ' ' TYR . . . . . 0.537 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 23.0 t80 -105.06 -68.38 0.86 Allowed 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.479 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 11.8 mm-40 -48.85 -29.8 5.06 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.925 -176.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.76 ' O ' ' HB3' ' B' ' 7' ' ' ARG . 4.1 m-20 -106.53 -16.06 14.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 120.702 0.287 . . . . 0.0 111.568 -176.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.637 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -65.29 179.61 0.73 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.819 0.818 . . . . 0.0 111.602 -177.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.74 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 24.7 m-20 -58.99 145.54 79.7 Favored Pre-proline 0 C--N 1.309 -1.169 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.242 171.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 49' ' ' PRO . . . . . 0.808 ' O ' ' HB3' ' B' ' 53' ' ' SER . 11.1 Cg_endo -55.57 -28.92 67.46 Favored 'Trans proline' 0 C--N 1.332 -0.325 0 C-N-CA 123.026 2.484 . . . . 0.0 111.917 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.669 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 8.4 pm0 -87.26 -26.7 23.34 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.429 1.091 . . . . 0.0 111.133 175.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.74 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 86.2 m -80.18 -38.17 31.82 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -177.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.513 ' HB2' ' CD1' ' B' ' 44' ' ' TYR . 4.0 pt20 -73.14 -27.36 61.63 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 172.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 53' ' ' SER . . . . . 0.808 ' HB3' ' O ' ' B' ' 49' ' ' PRO . 0.9 OUTLIER -68.12 -23.5 64.91 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.429 174.54 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.652 ' HB2' HD11 ' B' ' 79' ' ' ILE . . . -84.12 -23.31 30.77 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.863 172.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.544 HD11 ' CE2' ' B' ' 14' ' ' TYR . 22.6 mt -90.79 -32.73 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -174.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.646 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -45.93 -34.06 2.64 Favored Pre-proline 0 N--CA 1.487 1.388 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 -175.02 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 37.3 Cg_endo -60.24 -30.95 92.32 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 122.303 2.002 . . . . 0.0 112.902 172.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 58' ' ' LEU . . . . . 0.556 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.1 mt -101.17 -15.59 17.31 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -178.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.584 ' HA ' ' OH ' ' B' ' 72' ' ' TYR . 0.0 OUTLIER -52.64 109.8 0.44 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.948 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.16 -23.55 32.87 Favored Glycine 0 N--CA 1.44 -1.05 0 C-N-CA 120.768 -0.73 . . . . 0.0 111.575 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -103.59 111.91 24.59 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.411 0.624 . . . . 0.0 109.927 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.426 HG23 ' HD2' ' B' ' 63' ' ' PRO . 7.5 p -123.91 146.06 49.74 Favored Pre-proline 0 C--N 1.311 -1.104 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 170.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.581 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 91.3 Cg_exo -47.28 141.48 13.56 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.24 1.96 . . . . 0.0 111.248 168.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.53 98.78 0.07 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.024 0.44 . . . . 0.0 111.941 -173.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.71 -7.86 57.85 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.956 176.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.581 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 9.6 m -91.75 -177.61 4.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.383 0.611 . . . . 0.0 111.985 -176.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 67' ' ' ASP . . . . . 0.698 ' OD1' ' HB ' ' B' ' 69' ' ' ILE . 26.9 t70 -84.69 133.42 34.39 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.992 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.615 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.9 OUTLIER -81.3 -30.12 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 C-N-CA 118.891 -1.123 . . . . 0.0 109.119 176.508 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.747 ' O ' HG13 ' B' ' 73' ' ' VAL . 8.5 mm -58.01 -47.31 87.02 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.179 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.814 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 42.7 t -45.84 -37.42 6.16 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.423 175.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -85.4 -32.7 22.23 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.085 0.469 . . . . 0.0 110.649 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 72' ' ' TYR . . . . . 0.61 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.0 m-30 -76.09 -34.49 59.53 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.502 -175.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.84 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.6 m -72.55 -32.03 39.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 173.057 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 74' ' ' LYS . . . . . 0.521 ' O ' ' HB3' ' B' ' 77' ' ' ASP . 0.0 OUTLIER -66.17 -31.36 72.15 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.029 175.422 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 75' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -63.07 -47.77 81.5 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.362 176.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.702 ' SG ' ' HB ' ' B' ' 79' ' ' ILE . 13.7 t -90.89 5.7 47.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.573 0.701 . . . . 0.0 111.179 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 77' ' ' ASP . . . . . 0.521 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 10.9 t70 -60.51 -16.42 36.99 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.382 175.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -120.57 21.69 8.48 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.96 174.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.702 ' HB ' ' SG ' ' B' ' 76' ' ' CYS . 40.5 mt -101.94 -11.47 8.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 117.695 0.748 . . . . 0.0 112.934 177.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.29 14.16 1.81 Allowed Glycine 0 CA--C 1.533 1.169 0 N-CA-C 115.378 0.911 . . . . 0.0 115.378 -168.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.77 72.65 0.11 Allowed Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.255 -0.974 . . . . 0.0 114.643 168.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -177.57 -91.67 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.047 0.539 . . . . 0.0 110.03 174.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 83' ' ' MET . . . . . . . . . . . . . 64.8 mtm -65.95 -17.51 64.72 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 120.983 0.42 . . . . 0.0 110.096 177.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 84' ' ' HIS . . . . . 0.525 ' O ' ' HB2' ' B' ' 88' ' ' LEU . 6.4 t-160 -49.66 -34.88 19.59 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.32 174.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -82.78 -22.77 34.17 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.852 0.358 . . . . 0.0 110.927 -176.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.54 -40.68 16.04 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.666 0.746 . . . . 0.0 110.33 176.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 87' ' ' MET . . . . . 0.445 ' O ' ' HG3' ' B' ' 91' ' ' GLN . 81.8 mtp -85.22 -13.84 48.66 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.587 -175.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.553 ' O ' ' HB2' ' B' ' 92' ' ' LEU . 0.1 OUTLIER -50.22 -58.85 4.71 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.295 179.327 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 52.8 ttm -71.76 -23.19 61.56 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.158 -172.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -88.05 -8.5 55.47 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -170.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 91' ' ' GLN . . . . . 0.803 ' HB2' ' OG ' ' B' ' 53' ' ' SER . 3.1 mt-30 -132.73 -36.9 1.05 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.121 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.553 ' HB2' ' O ' ' B' ' 88' ' ' LEU . 0.2 OUTLIER -50.76 -33.77 24.54 Favored 'General case' 0 C--N 1.344 0.35 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 171.689 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' B' ' 93' ' ' GLU . 6.5 pt-20 . . . . . 0 C--O 1.248 1.006 0 CA-C-N 112.734 -2.03 . . . . 0.0 113.47 -174.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.402 ' HB2' ' H ' ' A' ' 2' ' ' SER . 92.3 Cg_endo . . . . . 0 CA--C 1.517 -0.357 0 N-CA-C 109.414 -1.033 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.402 ' H ' ' HB2' ' A' ' 1' ' ' PRO . 48.0 m -66.61 169.0 8.34 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 162.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.881 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -72.7 -55.58 6.59 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.847 177.509 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.719 ' CG ' ' HG3' ' A' ' 42' ' ' MET . 11.7 p30 -87.69 -4.75 58.91 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.442 -164.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.402 ' H ' HG22 ' A' ' 5' ' ' THR . 6.7 t -63.15 -1.43 1.0 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.43 0.633 . . . . 0.0 110.945 -173.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.655 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.4 m -74.26 133.55 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 168.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.795 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -155.55 159.8 39.99 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 115.219 1.562 . . . . 0.0 115.219 -175.889 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.444 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.1 tt0 -40.34 110.52 0.15 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 112.835 -1.984 . . . . 0.0 112.714 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.33 -151.5 11.13 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.558 174.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.4 t -54.38 98.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.757 0.278 . . . . 0.0 110.58 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.9 pttt 40.07 44.3 1.46 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.321 1.048 . . . . 0.0 112.527 -175.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.429 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 67.2 tt0 -60.58 141.17 92.25 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 176.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.517 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 27.2 Cg_exo -55.37 123.36 13.62 Favored 'Trans proline' 0 CA--C 1.512 -0.615 0 C-N-CA 121.939 1.759 . . . . 0.0 109.694 177.118 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.915 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 7.2 t80 -68.98 -53.95 13.25 Favored Pre-proline 0 N--CA 1.44 -0.969 0 CA-C-O 118.421 -0.799 . . . . 0.0 113.025 -168.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.566 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 37.2 Cg_exo -56.01 -18.15 21.69 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 121.476 1.45 . . . . 0.0 111.197 -178.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.517 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 2.6 m-20 -89.97 -42.83 10.95 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.799 179.084 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.444 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -55.26 -45.78 76.1 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.332 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.795 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 2.1 p -78.05 -34.49 19.23 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.229 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.142 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.83 -39.36 71.29 Favored 'General case' 0 C--N 1.316 -0.887 0 O-C-N 121.663 -0.648 . . . . 0.0 111.078 176.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.754 ' O ' HG12 ' A' ' 24' ' ' VAL . 14.5 ptt180 -79.84 -27.74 40.17 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.592 ' HB3' ' O ' ' A' ' 18' ' ' VAL . 13.3 tp -54.98 -48.87 72.7 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 114.563 -1.198 . . . . 0.0 109.268 172.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.795 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 6.0 mt-30 -67.75 -55.66 12.24 Favored 'General case' 0 CA--C 1.486 -1.51 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.356 178.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.725 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 82.8 m-20 -45.71 -50.55 13.57 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 124.824 1.327 . . . . 0.0 111.258 -177.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.754 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.1 p -78.89 -26.19 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.834 -174.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.638 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -67.3 -31.45 71.76 Favored 'General case' 0 C--O 1.206 -1.196 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.22 -34.82 63.8 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.114 -1.403 . . . . 0.0 109.525 -178.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.725 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 39.0 mmtt -67.45 -40.33 85.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.823 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.457 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 35.4 m -100.45 -9.9 21.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.241 0.543 . . . . 0.0 110.547 -171.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.692 HG22 ' H ' ' A' ' 31' ' ' ASP . 83.4 mt -111.23 130.15 65.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.522 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.55 -3.07 58.48 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.906 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.692 ' H ' HG22 ' A' ' 29' ' ' ILE . 4.9 t0 -117.81 139.66 50.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.786 0.803 . . . . 0.0 111.918 -177.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -68.76 -31.39 70.4 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.334 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.588 ' O ' HG13 ' A' ' 37' ' ' VAL . 12.0 mttp -68.37 -53.37 24.41 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -176.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.578 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -64.22 -26.06 68.34 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.504 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.842 ' O ' HG13 ' A' ' 39' ' ' VAL . 4.7 tmm_? -68.15 -58.02 5.13 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.488 ' HB3' ' OE1' ' A' ' 40' ' ' GLU . 32.5 mtpt -53.45 -60.19 3.62 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.237 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.702 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 19.8 m -52.12 -33.9 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.374 -170.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.881 HD13 ' HE1' ' A' ' 3' ' ' PHE . 0.7 OUTLIER -88.35 -35.05 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.391 -179.782 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.842 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.9 m -66.18 -46.8 86.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 119.117 -1.033 . . . . 0.0 109.414 177.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.662 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 42.7 mt-10 -61.17 -31.63 71.36 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 123.953 0.901 . . . . 0.0 112.544 176.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.714 ' HG ' HD11 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -83.78 -52.88 6.03 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.378 -179.152 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.719 ' HG3' ' CG ' ' A' ' 4' ' ' ASN . 20.1 mmt -65.71 -20.84 66.43 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.642 0.734 . . . . 0.0 109.632 -176.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.693 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -50.47 -29.01 9.39 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.23 171.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.876 ' CG ' ' HE3' ' A' ' 59' ' ' LYS . 6.2 t80 -103.34 -66.7 0.92 Allowed 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 174.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.592 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 31.4 mm-40 -49.72 -29.76 8.11 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.992 -171.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.795 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.8 m-20 -104.37 -21.44 13.49 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.441 -176.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -61.36 179.75 0.2 Allowed 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.827 0.822 . . . . 0.0 112.923 -174.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.631 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 17.2 m-20 -62.31 141.67 96.22 Favored Pre-proline 0 N--CA 1.444 -0.742 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.587 173.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.426 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 80.0 Cg_exo -41.71 -50.48 4.88 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 123.093 2.529 . . . . 0.0 112.274 -178.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.617 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 0.0 OUTLIER -74.32 -26.54 60.23 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.769 0.828 . . . . 0.0 111.429 -179.268 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.631 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 72.1 m -79.89 -40.19 28.82 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -174.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.723 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.4 pt20 -69.42 -31.13 69.29 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 172.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.826 ' O ' ' HD2' ' A' ' 56' ' ' LYS . 4.2 m -67.71 -27.89 67.2 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 113.996 -1.456 . . . . 0.0 111.305 174.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.776 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -70.96 -23.31 62.2 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 170.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.723 HD12 ' HA ' ' A' ' 52' ' ' GLN . 25.0 mt -89.82 -27.52 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -175.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.826 ' HD2' ' O ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -37.53 -48.53 2.52 Favored Pre-proline 0 N--CA 1.506 2.368 0 CA-C-N 120.628 1.558 . . . . 0.0 112.675 -178.39 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 48.5 Cg_endo -61.45 -24.89 79.06 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.826 2.351 . . . . 0.0 112.796 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.527 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.6 mt -104.86 -15.45 15.17 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.876 ' HE3' ' CG ' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -50.7 109.96 0.37 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.812 -179.072 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.28 -19.23 44.48 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.075 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.9 mmmt -104.2 115.03 29.69 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -176.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.43 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.6 p -122.86 137.11 27.54 Favored Pre-proline 0 C--N 1.315 -0.899 0 C-N-CA 121.168 -0.213 . . . . 0.0 110.48 172.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.521 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 97.5 Cg_exo -49.21 142.89 20.43 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.849 2.366 . . . . 0.0 112.227 171.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.44 104.33 0.62 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.18 -177.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.32 -16.74 44.89 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.688 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.521 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 45.6 m -89.19 170.04 10.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.261 0.553 . . . . 0.0 111.212 -179.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.404 ' OD2' ' HB ' ' A' ' 69' ' ' ILE . 2.6 t70 -88.38 145.8 25.6 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.634 174.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.583 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -78.49 -29.18 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 C-N-CA 118.792 -1.163 . . . . 0.0 108.879 179.83 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.791 ' O ' HG13 ' A' ' 73' ' ' VAL . 8.5 mm -61.12 -47.01 95.51 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.184 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.09 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.6 t -47.24 -37.83 11.17 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.98 177.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.422 ' HA ' ' HB3' ' A' ' 74' ' ' LYS . 3.3 mm-40 -86.08 -32.62 21.28 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 123.287 0.635 . . . . 0.0 111.094 -177.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.619 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.3 m-30 -74.88 -35.83 62.28 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.314 -177.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.915 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 2.3 m -70.41 -34.11 56.61 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 174.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.491 ' HA ' ' HB2' ' A' ' 77' ' ' ASP . 13.0 ttpp -70.47 -27.86 64.56 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.788 177.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -62.18 -44.65 96.13 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.047 -0.978 . . . . 0.0 109.398 173.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.757 ' SG ' ' HB ' ' A' ' 79' ' ' ILE . 39.3 t -96.04 9.31 41.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.332 178.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.491 ' HB2' ' HA ' ' A' ' 74' ' ' LYS . 10.7 t70 -61.72 -21.12 64.22 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.057 0.456 . . . . 0.0 110.507 175.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -101.96 -11.74 36.35 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.655 175.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.776 HD11 ' HB2' ' A' ' 54' ' ' ALA . 85.6 mt -86.68 136.75 22.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-N 117.202 0.501 . . . . 0.0 111.163 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 159.13 83.49 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.753 174.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.53 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 95.24 -117.83 5.72 Favored Glycine 0 CA--C 1.51 -0.259 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.824 173.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.81 -48.3 78.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.772 0.32 . . . . 0.0 111.751 -175.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 55.3 mtt -64.79 -30.69 71.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.093 0.473 . . . . 0.0 110.116 178.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.519 ' HB3' ' O ' ' A' ' 81' ' ' GLY . 10.2 t60 -66.28 -29.51 69.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.574 177.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.53 ' HG2' ' O ' ' A' ' 81' ' ' GLY . 33.5 mmtp -84.23 -19.05 34.6 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.208 0.528 . . . . 0.0 110.461 -178.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.09 -45.84 11.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.746 176.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 61.6 mtm -81.06 -12.14 59.37 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.661 -175.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.49 ' HB2' ' O ' ' A' ' 84' ' ' HIS . 0.1 OUTLIER -54.33 -22.53 12.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.488 0.661 . . . . 0.0 111.195 176.626 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 41.2 ttp -83.44 -21.71 32.84 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.01 0.433 . . . . 0.0 111.036 176.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -109.1 -63.82 1.31 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -170.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.682 ' O ' ' HB3' ' A' ' 53' ' ' SER . 84.7 mt-30 -67.08 -43.41 82.66 Favored 'General case' 0 CA--C 1.504 -0.821 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.49 -175.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.685 ' HA ' ' CB ' ' A' ' 53' ' ' SER . 2.2 tm? -44.2 -28.94 0.56 Allowed 'General case' 0 C--O 1.232 0.179 0 O-C-N 124.251 0.969 . . . . 0.0 110.093 173.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 . . . . . 0 C--O 1.248 0.992 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -175.914 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' PRO . . . . . 0.408 ' HB2' HG21 ' B' ' 5' ' ' THR . 96.3 Cg_endo . . . . . 0 CA--C 1.517 -0.366 0 N-CA-C 109.163 -1.13 . . . . 0.0 109.163 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 41.7 m -66.91 168.79 9.21 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 162.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.882 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -72.23 -55.72 6.74 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.812 177.632 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.718 ' CG ' ' HG3' ' B' ' 42' ' ' MET . 11.7 p30 -87.81 -4.67 58.86 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.332 -164.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.408 HG21 ' HB2' ' B' ' 1' ' ' PRO . 7.0 t -63.3 -1.42 1.08 Allowed 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.314 0.578 . . . . 0.0 110.87 -173.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.663 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.5 m -74.38 133.54 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 169.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.799 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -155.48 159.82 40.09 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 -175.945 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 8' ' ' GLN . . . . . 0.444 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.1 tt0 -40.27 110.38 0.15 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 112.921 -1.945 . . . . 0.0 112.786 -178.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.15 -151.5 10.76 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.631 174.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 22.7 t -54.27 99.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.837 0.319 . . . . 0.0 110.513 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 58.0 pttt 39.75 44.23 1.27 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.365 1.066 . . . . 0.0 112.485 -175.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.429 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 68.9 tt0 -60.78 140.94 93.11 Favored Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 13' ' ' PRO . . . . . 0.52 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 27.5 Cg_exo -55.33 123.43 13.8 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 121.855 1.703 . . . . 0.0 109.751 177.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 14' ' ' TYR . . . . . 0.924 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 7.2 t80 -68.94 -53.87 13.59 Favored Pre-proline 0 N--CA 1.44 -0.926 0 CA-C-O 118.458 -0.782 . . . . 0.0 113.01 -168.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.546 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 36.9 Cg_exo -55.93 -18.46 22.3 Favored 'Trans proline' 0 C--N 1.359 1.103 0 C-N-CA 121.523 1.482 . . . . 0.0 110.991 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.52 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.9 m-20 -89.82 -42.56 11.2 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 113.907 -1.497 . . . . 0.0 110.841 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 17' ' ' PHE . . . . . 0.444 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -55.43 -45.76 76.77 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.458 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.787 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 2.1 p -78.09 -34.38 19.03 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.18 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.172 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.59 -39.6 70.93 Favored 'General case' 0 C--N 1.316 -0.882 0 O-C-N 121.674 -0.641 . . . . 0.0 111.077 176.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.754 ' O ' HG12 ' B' ' 24' ' ' VAL . 14.7 ptt180 -79.82 -27.72 40.22 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.594 ' HB3' ' O ' ' B' ' 18' ' ' VAL . 13.2 tp -55.05 -48.68 73.14 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.191 172.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 22' ' ' GLN . . . . . 0.787 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 6.0 mt-30 -68.24 -55.23 12.95 Favored 'General case' 0 CA--C 1.485 -1.529 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.447 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.723 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 78.8 m-20 -45.79 -50.87 13.58 Favored 'General case' 0 C--N 1.312 -1.023 0 O-C-N 124.735 1.272 . . . . 0.0 111.264 -177.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 24' ' ' VAL . . . . . 0.754 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.1 p -78.66 -26.24 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.925 -174.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.641 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -67.22 -31.37 71.7 Favored 'General case' 0 C--O 1.208 -1.131 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 176.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.08 -35.15 64.21 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.174 -1.375 . . . . 0.0 109.474 -178.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.723 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 39.1 mmtt -67.31 -39.96 85.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.628 -1.169 . . . . 0.0 112.015 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 28' ' ' SER . . . . . 0.449 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 38.9 m -100.45 -10.47 21.09 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.247 0.546 . . . . 0.0 110.511 -172.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.691 HG22 ' H ' ' B' ' 31' ' ' ASP . 83.9 mt -110.96 129.9 65.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.651 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.48 -3.03 58.54 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.937 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.691 ' H ' HG22 ' B' ' 29' ' ' ILE . 4.7 t0 -117.92 139.63 50.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.715 0.769 . . . . 0.0 111.912 -177.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -68.66 -31.55 70.75 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.43 175.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.597 ' O ' HG13 ' B' ' 37' ' ' VAL . 12.1 mttp -68.16 -53.62 23.77 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -176.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.578 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -63.89 -26.22 68.5 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.481 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.869 ' O ' HG13 ' B' ' 39' ' ' VAL . 4.8 tmm_? -68.27 -57.91 5.24 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.473 ' HB3' ' OE1' ' B' ' 40' ' ' GLU . 32.8 mtpt -53.53 -60.29 3.49 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.223 178.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.703 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 19.7 m -52.08 -33.85 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.366 -170.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.882 HD13 ' HE1' ' B' ' 3' ' ' PHE . 0.7 OUTLIER -88.36 -35.12 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 C-N-CA 119.769 -0.772 . . . . 0.0 112.355 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.869 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.9 m -66.05 -46.88 86.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 119.124 -1.03 . . . . 0.0 109.44 177.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.654 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 42.9 mt-10 -61.19 -31.59 71.34 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.943 0.897 . . . . 0.0 112.55 176.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.703 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -83.67 -52.98 5.98 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 121.039 -0.265 . . . . 0.0 111.446 -179.152 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 42' ' ' MET . . . . . 0.718 ' HG3' ' CG ' ' B' ' 4' ' ' ASN . 19.9 mmt -65.69 -20.73 66.4 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.712 0.768 . . . . 0.0 109.685 -176.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.692 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -50.51 -29.05 9.61 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.144 171.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 44' ' ' TYR . . . . . 0.871 ' CG ' ' HE3' ' B' ' 59' ' ' LYS . 6.1 t80 -103.4 -66.66 0.93 Allowed 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 174.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.601 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 31.0 mm-40 -49.78 -29.6 8.08 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 124.415 1.072 . . . . 0.0 112.006 -171.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.799 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.9 m-20 -104.42 -21.46 13.47 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.497 -176.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -61.49 179.89 0.21 Allowed 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.873 0.844 . . . . 0.0 113.058 -174.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.641 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 17.5 m-20 -62.28 141.87 96.1 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.545 173.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 49' ' ' PRO . . . . . 0.43 ' O ' ' HG2' ' B' ' 52' ' ' GLN . 75.5 Cg_exo -42.14 -50.36 5.39 Favored 'Trans proline' 0 C--N 1.332 -0.308 0 C-N-CA 122.959 2.44 . . . . 0.0 112.309 -178.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.632 ' HA ' ' HB2' ' B' ' 53' ' ' SER . 0.0 OUTLIER -74.07 -26.72 60.54 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.954 0.901 . . . . 0.0 111.349 -179.42 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.641 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 72.4 m -79.92 -40.15 28.8 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -174.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.735 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.3 pt20 -69.44 -30.86 68.87 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 172.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 53' ' ' SER . . . . . 0.825 ' O ' ' HD2' ' B' ' 56' ' ' LYS . 4.3 m -67.89 -27.54 66.75 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 113.907 -1.497 . . . . 0.0 111.423 174.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.801 ' HB2' HD11 ' B' ' 79' ' ' ILE . . . -71.4 -23.09 61.81 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.005 0.907 . . . . 0.0 108.566 170.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.735 HD12 ' HA ' ' B' ' 52' ' ' GLN . 25.4 mt -89.91 -27.5 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -175.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.825 ' HD2' ' O ' ' B' ' 53' ' ' SER . 0.0 OUTLIER -37.47 -49.08 2.55 Favored Pre-proline 0 N--CA 1.507 2.404 0 CA-C-N 120.624 1.557 . . . . 0.0 112.525 -178.398 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 49.9 Cg_endo -61.27 -24.38 78.73 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.836 2.358 . . . . 0.0 112.789 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 58' ' ' LEU . . . . . 0.544 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.6 mt -105.28 -15.47 15.04 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.871 ' HE3' ' CG ' ' B' ' 44' ' ' TYR . 0.0 OUTLIER -50.62 109.83 0.35 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.684 -179.015 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.67 -19.63 43.58 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.11 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -103.9 115.2 30.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.911 0.386 . . . . 0.0 110.12 -176.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.436 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.6 p -122.73 137.67 28.3 Favored Pre-proline 0 C--N 1.315 -0.915 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.406 171.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.522 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 96.9 Cg_exo -49.71 142.77 24.17 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.888 2.392 . . . . 0.0 112.212 171.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.94 104.83 0.59 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.176 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.08 -16.47 50.01 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.791 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.522 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 43.2 m -89.09 170.02 10.99 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.282 0.563 . . . . 0.0 111.039 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 67' ' ' ASP . . . . . 0.4 ' OD2' ' HB ' ' B' ' 69' ' ' ILE . 2.9 t70 -88.61 145.66 25.56 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.621 174.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.578 HG22 ' HG2' ' B' ' 40' ' ' GLU . 1.0 OUTLIER -78.3 -29.4 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 C-N-CA 118.769 -1.172 . . . . 0.0 108.885 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.796 ' O ' HG13 ' B' ' 73' ' ' VAL . 8.6 mm -60.93 -47.12 94.93 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.164 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.091 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 43.0 t -47.13 -37.79 10.5 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.974 177.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.433 ' HA ' ' HB3' ' B' ' 74' ' ' LYS . 3.2 mm-40 -86.22 -32.52 21.13 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 123.282 0.633 . . . . 0.0 111.144 -177.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 72' ' ' TYR . . . . . 0.61 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.3 m-30 -74.97 -35.61 62.07 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.705 0.764 . . . . 0.0 109.348 -177.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.924 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 2.3 m -70.64 -34.16 55.91 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 74' ' ' LYS . . . . . 0.494 ' HA ' ' HB2' ' B' ' 77' ' ' ASP . 13.1 ttpp -70.37 -28.0 64.76 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.684 177.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 75' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -62.1 -44.56 96.38 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.431 173.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.764 ' SG ' ' HB ' ' B' ' 79' ' ' ILE . 37.7 t -96.01 9.22 41.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.182 178.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 77' ' ' ASP . . . . . 0.494 ' HB2' ' HA ' ' B' ' 74' ' ' LYS . 11.2 t70 -61.62 -21.0 63.98 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.034 0.445 . . . . 0.0 110.6 175.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -102.02 -11.73 36.22 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.741 175.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.801 HD11 ' HB2' ' B' ' 54' ' ' ALA . 84.9 mt -86.7 136.45 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 117.155 0.477 . . . . 0.0 111.195 -178.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 159.28 84.35 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.6 174.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.527 ' O ' ' HG2' ' B' ' 85' ' ' LYS . . . 94.56 -117.66 5.61 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.723 173.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.11 -48.16 79.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.756 0.312 . . . . 0.0 111.633 -174.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 83' ' ' MET . . . . . . . . . . . . . 54.4 mtt -64.78 -30.83 71.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.034 0.445 . . . . 0.0 110.124 178.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 84' ' ' HIS . . . . . 0.523 ' HB3' ' O ' ' B' ' 81' ' ' GLY . 10.7 t60 -66.17 -29.73 70.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.544 177.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.527 ' HG2' ' O ' ' B' ' 81' ' ' GLY . 33.3 mmtp -84.12 -18.92 35.23 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.151 0.501 . . . . 0.0 110.432 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.13 -45.9 10.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.679 176.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 61.8 mtm -81.07 -12.16 59.36 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.681 -175.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.494 ' HB2' ' O ' ' B' ' 84' ' ' HIS . 0.1 OUTLIER -54.19 -22.64 11.93 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.555 0.693 . . . . 0.0 111.251 176.628 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 40.7 ttp -83.49 -21.29 32.85 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.127 0.489 . . . . 0.0 111.011 177.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -109.52 -63.7 1.33 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -170.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 91' ' ' GLN . . . . . 0.694 ' O ' ' HB3' ' B' ' 53' ' ' SER . 84.9 mt-30 -67.13 -43.44 82.4 Favored 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.506 -175.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.691 ' HA ' ' CB ' ' B' ' 53' ' ' SER . 2.2 tm? -44.45 -28.81 0.61 Allowed 'General case' 0 C--O 1.234 0.273 0 O-C-N 124.261 0.975 . . . . 0.0 110.017 173.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 N--CA 1.437 -1.079 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -175.989 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.422 ' HB2' ' H ' ' A' ' 2' ' ' SER . 97.3 Cg_endo . . . . . 0 CA--C 1.518 -0.3 0 N-CA-C 108.984 -1.199 . . . . 0.0 108.984 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.458 ' HB2' HG23 ' A' ' 5' ' ' THR . 16.5 m -66.88 174.17 3.15 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 163.043 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.731 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -70.83 -51.79 24.47 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 166.029 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.533 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 2.4 p-10 -88.18 5.64 40.47 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 113.944 -1.48 . . . . 0.0 113.781 -165.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.458 HG23 ' HB2' ' A' ' 2' ' ' SER . 0.6 OUTLIER -63.09 -8.47 7.71 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 118.52 0.6 . . . . 0.0 111.305 -177.096 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.62 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.1 m -74.48 129.4 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 176.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.741 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -155.51 158.73 38.97 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 118.053 -1.459 . . . . 0.0 114.61 -177.556 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.45 ' HG2' ' HB3' ' A' ' 12' ' ' GLU . 2.2 tt0 -47.14 106.66 0.09 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 112.865 -1.97 . . . . 0.0 112.031 -177.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.27 -135.68 1.18 Allowed Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.825 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.497 ' C ' ' HD3' ' A' ' 11' ' ' LYS . 9.1 t -65.37 99.41 0.4 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.497 ' HD3' ' C ' ' A' ' 10' ' ' SER . 0.0 OUTLIER 37.2 44.24 0.41 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.233 1.013 . . . . 0.0 112.017 -175.333 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.45 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 54.8 tt0 -60.55 144.29 89.05 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.735 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.576 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 37.9 Cg_exo -54.48 122.83 12.24 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.356 2.037 . . . . 0.0 110.114 176.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.805 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 21.9 t80 -73.19 -55.87 3.57 Favored Pre-proline 0 N--CA 1.439 -0.984 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -166.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.557 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 27.4 Cg_exo -56.98 -16.13 19.6 Favored 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 121.279 1.32 . . . . 0.0 110.627 -178.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.576 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.3 m-20 -89.16 -44.48 10.28 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 113.606 -1.634 . . . . 0.0 110.837 178.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.54 ' CE2' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -54.62 -44.76 73.43 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.515 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.78 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 1.7 p -79.63 -34.8 16.06 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.277 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.536 -178.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.33 -30.58 68.47 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 121.45 -0.781 . . . . 0.0 111.752 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.728 ' O ' HG12 ' A' ' 24' ' ' VAL . 16.5 ptt180 -84.45 -28.36 26.89 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.543 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 5.6 tp -57.26 -48.29 79.25 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.019 173.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.78 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 4.6 mt-30 -68.78 -47.9 65.02 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.085 177.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.732 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 11.4 t70 -47.19 -54.58 10.37 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 124.332 1.02 . . . . 0.0 111.656 -177.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.728 HG12 ' O ' ' A' ' 20' ' ' ARG . 6.6 p -81.84 -21.95 10.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.038 -174.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.753 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -73.07 -19.39 61.18 Favored 'General case' 0 C--O 1.205 -1.243 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 174.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.49 -38.06 17.64 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.582 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.732 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 39.8 mmtt -66.45 -35.75 81.05 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.753 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.418 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 15.7 m -104.72 -7.32 19.62 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.201 0.524 . . . . 0.0 110.657 -170.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.753 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 88.5 mt -117.8 130.12 73.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.885 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.21 -7.64 47.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.331 0.586 . . . . 0.0 110.332 175.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.54 ' H ' HG22 ' A' ' 29' ' ' ILE . 1.0 OUTLIER -100.31 106.29 17.91 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.735 -179.278 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -56.47 -25.98 52.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.679 0.276 . . . . 0.0 110.271 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.566 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -69.32 -53.57 18.96 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.172 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.622 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -64.6 -24.07 67.47 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.349 177.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.871 ' O ' HG13 ' A' ' 39' ' ' VAL . 4.7 tmm_? -68.4 -58.61 4.08 Favored 'General case' 0 C--O 1.219 -0.535 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.485 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 27.4 mtpt -52.45 -60.68 2.94 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 120.791 0.329 . . . . 0.0 110.535 177.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.785 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 21.6 m -52.16 -36.15 20.21 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.768 -168.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.731 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.5 tt -87.17 -27.69 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 119.641 -0.823 . . . . 0.0 112.111 -177.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.871 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.1 m -73.35 -47.47 46.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 119.148 -1.021 . . . . 0.0 109.267 175.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.773 ' OE2' HG13 ' A' ' 68' ' ' VAL . 0.7 OUTLIER -63.98 -24.47 67.73 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.796 0.838 . . . . 0.0 111.292 176.162 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.785 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -85.45 -57.9 2.88 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 176.667 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.539 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 23.2 mmt -61.49 -20.58 63.33 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.569 0.699 . . . . 0.0 109.703 -177.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.685 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -48.94 -27.89 3.45 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.928 170.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.554 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 10.2 t80 -107.13 -66.77 0.99 Allowed 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 176.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.637 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 17.1 mm-40 -48.1 -32.59 7.02 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.998 -174.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.741 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 5.2 m-20 -105.14 -19.32 13.86 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -175.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.626 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -61.01 -172.15 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -174.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.556 ' HB2' ' H ' ' A' ' 51' ' ' CYS . 84.9 m-20 -52.78 141.49 36.51 Favored Pre-proline 0 C--N 1.342 0.239 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 170.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.49 ' O ' HD23 ' A' ' 92' ' ' LEU . 19.8 Cg_endo -59.92 -19.66 56.14 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 121.618 1.545 . . . . 0.0 110.452 174.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.537 ' O ' ' HB2' ' A' ' 53' ' ' SER . 0.3 OUTLIER -87.11 -34.98 18.92 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.465 174.055 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.975 ' SG ' ' HB2' ' A' ' 76' ' ' CYS . 40.8 t -80.24 -33.92 37.55 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.242 -172.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.517 ' HB2' ' CD1' ' A' ' 44' ' ' TYR . 4.2 pt20 -68.68 -29.32 67.75 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 172.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.589 ' HB3' ' C ' ' A' ' 91' ' ' GLN . 20.0 m -71.58 -19.3 62.16 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.284 -1.78 . . . . 0.0 110.017 173.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.787 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -81.06 -27.17 35.81 Favored 'General case' 0 C--N 1.311 -1.107 0 O-C-N 121.431 -0.793 . . . . 0.0 110.158 167.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.557 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 23.7 mt -90.34 -30.18 4.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 114.83 1.418 . . . . 0.0 114.83 -170.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.613 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.57 -38.81 1.99 Allowed Pre-proline 0 N--CA 1.487 1.414 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -174.034 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 54.4 Cg_endo -63.62 -30.96 70.58 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.154 1.903 . . . . 0.0 112.628 176.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.543 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.8 mt -95.08 -16.87 22.33 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.578 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 0.1 OUTLIER -54.87 109.07 0.46 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.698 -179.523 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.38 -23.04 37.58 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.403 -177.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -104.22 113.22 26.61 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.312 0.577 . . . . 0.0 110.232 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.464 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.7 p -123.09 142.53 38.52 Favored Pre-proline 0 C--N 1.309 -1.177 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 169.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.553 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 71.1 Cg_exo -51.1 138.68 44.01 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.19 1.927 . . . . 0.0 111.443 170.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.12 103.52 0.38 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.067 -177.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.12 -12.35 44.63 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.742 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.553 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 20.0 m -94.92 169.56 10.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.591 0.71 . . . . 0.0 111.635 -178.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.82 136.97 34.48 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.706 -1.133 . . . . 0.0 109.378 174.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.773 HG13 ' OE2' ' A' ' 40' ' ' GLU . 0.7 OUTLIER -72.45 -32.53 42.3 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.419 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.755 ' O ' HG13 ' A' ' 73' ' ' VAL . 10.1 mm -55.57 -46.59 79.16 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.071 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.742 -178.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 33.6 t -46.34 -38.11 8.36 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.322 0.582 . . . . 0.0 111.012 176.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -85.63 -31.96 22.29 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.749 -177.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.578 ' OH ' ' HA ' ' A' ' 59' ' ' LYS . 4.9 m-30 -76.59 -34.04 58.42 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.534 -176.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.805 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.5 m -71.41 -31.64 43.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 172.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.569 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -67.89 -29.83 69.02 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.372 175.731 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -64.77 -44.93 88.46 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.109 176.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.975 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 39.5 t -92.52 9.08 36.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.636 177.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.569 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 8.3 t70 -60.59 -21.53 62.74 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.321 0.581 . . . . 0.0 110.238 172.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 83' ' ' MET . . . -101.15 -9.89 43.75 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.611 173.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.798 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 85.0 mt -96.18 139.03 20.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 117.307 0.553 . . . . 0.0 111.201 -178.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.576 ' H ' ' HB2' ' A' ' 84' ' ' HIS . . . 164.64 -35.37 0.28 Allowed Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.685 173.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.61 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . -148.12 -103.39 0.31 Allowed Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.386 -0.912 . . . . 0.0 113.198 177.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.43 -46.32 89.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -171.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.513 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 71.5 mtp -68.9 -30.83 69.4 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.576 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 5.4 t60 -62.39 -29.36 70.43 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.027 173.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.61 ' HG2' ' O ' ' A' ' 81' ' ' GLY . 70.7 mmtt -83.79 -20.49 33.21 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.031 0.443 . . . . 0.0 110.406 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.14 -42.48 14.72 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.591 0.71 . . . . 0.0 110.636 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 1.6 mmt -84.85 -12.72 52.94 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.898 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.605 ' O ' ' HB3' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -49.58 -40.88 40.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.433 0.635 . . . . 0.0 111.367 177.906 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 28.2 ttt -84.17 -15.48 46.94 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.031 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -96.59 -34.16 11.53 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.122 0.487 . . . . 0.0 112.014 -173.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.589 ' C ' ' HB3' ' A' ' 53' ' ' SER . 87.3 mt-30 -109.65 -56.86 2.25 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.293 -176.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.605 ' HB3' ' O ' ' A' ' 88' ' ' LEU . 0.3 OUTLIER -58.49 -4.69 0.43 Allowed 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.299 0.571 . . . . 0.0 110.256 176.356 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.467 ' H ' ' C ' ' A' ' 91' ' ' GLN . 5.0 pt-20 . . . . . 0 C--O 1.249 1.031 0 C-N-CA 123.967 0.907 . . . . 0.0 112.375 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo . . . . . 0 CA--C 1.518 -0.324 0 N-CA-C 108.911 -1.226 . . . . 0.0 108.911 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.462 ' HB2' HG23 ' B' ' 5' ' ' THR . 16.4 m -66.9 174.56 2.92 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 162.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.729 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -71.18 -51.76 23.03 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 165.997 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.525 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.4 p-10 -88.19 5.62 40.61 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 113.904 -1.498 . . . . 0.0 113.731 -165.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.462 HG23 ' HB2' ' B' ' 2' ' ' SER . 0.6 OUTLIER -63.36 -7.72 7.13 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 118.554 0.616 . . . . 0.0 111.438 -177.13 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.611 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.1 m -75.0 129.27 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.764 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.2 OUTLIER -155.48 158.77 39.07 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 118.18 -1.408 . . . . 0.0 114.626 -177.652 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 8' ' ' GLN . . . . . 0.459 ' HG2' ' HB3' ' B' ' 12' ' ' GLU . 2.2 tt0 -47.01 106.72 0.09 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 112.766 -2.016 . . . . 0.0 111.944 -177.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.56 -136.48 1.38 Allowed Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.631 177.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 10' ' ' SER . . . . . 0.506 ' C ' ' HD3' ' B' ' 11' ' ' LYS . 8.9 t -64.81 99.38 0.33 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.506 ' HD3' ' C ' ' B' ' 10' ' ' SER . 0.0 OUTLIER 37.35 43.94 0.42 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.19 0.996 . . . . 0.0 112.095 -175.354 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.459 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 52.6 tt0 -60.28 144.27 87.91 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.855 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 13' ' ' PRO . . . . . 0.552 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 40.4 Cg_exo -54.56 122.78 12.17 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 122.235 1.957 . . . . 0.0 110.139 176.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 14' ' ' TYR . . . . . 0.802 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 21.6 t80 -73.13 -55.92 3.59 Favored Pre-proline 0 N--CA 1.44 -0.939 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -166.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.569 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 27.7 Cg_exo -57.22 -16.02 20.55 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 121.318 1.345 . . . . 0.0 110.609 -178.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.552 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.4 m-20 -89.33 -44.2 10.39 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 113.487 -1.688 . . . . 0.0 110.762 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 17' ' ' PHE . . . . . 0.535 ' CE2' HD22 ' B' ' 21' ' ' LEU . 0.0 OUTLIER -54.89 -44.59 74.24 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 176.744 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.767 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 1.7 p -79.58 -34.91 16.21 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.307 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.496 -178.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.39 -30.29 68.34 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 121.356 -0.84 . . . . 0.0 111.913 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.712 ' O ' HG12 ' B' ' 24' ' ' VAL . 16.6 ptt180 -84.53 -28.44 26.66 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 175.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.558 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 5.6 tp -57.24 -48.23 79.36 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.079 173.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 22' ' ' GLN . . . . . 0.767 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 4.6 mt-30 -69.09 -47.41 65.31 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.075 177.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.743 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 11.8 t70 -47.44 -54.74 10.58 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 124.416 1.072 . . . . 0.0 111.6 -177.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 24' ' ' VAL . . . . . 0.712 HG12 ' O ' ' B' ' 20' ' ' ARG . 6.5 p -81.7 -22.05 10.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.033 -174.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.759 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -72.95 -19.39 61.25 Favored 'General case' 0 C--O 1.204 -1.302 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.49 -38.25 17.45 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.555 177.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.743 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 40.1 mmtt -66.13 -35.95 81.85 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.717 178.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 28' ' ' SER . . . . . 0.409 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 15.7 m -104.52 -7.64 19.62 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.24 0.543 . . . . 0.0 110.68 -170.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.759 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 88.3 mt -117.74 129.74 73.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.91 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.15 -7.29 48.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.328 0.585 . . . . 0.0 110.314 175.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.514 ' H ' HG22 ' B' ' 29' ' ' ILE . 1.1 m-20 -100.46 106.25 17.79 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.776 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -56.29 -26.04 50.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.666 0.27 . . . . 0.0 110.388 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.57 ' O ' HG13 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -69.24 -53.73 18.39 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.14 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.633 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -64.33 -24.11 67.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.402 177.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.867 ' O ' HG13 ' B' ' 39' ' ' VAL . 4.6 tmm_? -68.41 -58.75 3.87 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.479 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 27.2 mtpt -52.17 -60.7 2.9 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 120.796 0.332 . . . . 0.0 110.638 177.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.779 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 21.8 m -52.27 -35.96 20.4 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.465 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.716 -168.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.729 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.5 tt -87.24 -27.72 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 119.599 -0.84 . . . . 0.0 112.067 -177.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.867 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.1 m -73.51 -47.14 46.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.332 175.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.769 ' OE2' HG13 ' B' ' 68' ' ' VAL . 0.7 OUTLIER -64.19 -24.36 67.65 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.757 0.823 . . . . 0.0 111.348 176.084 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.779 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.46 -57.86 2.9 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 176.534 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 42' ' ' MET . . . . . 0.541 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 23.2 mmt -61.45 -20.75 63.47 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.591 0.71 . . . . 0.0 109.717 -177.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.68 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -48.71 -27.93 3.24 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.991 170.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 44' ' ' TYR . . . . . 0.554 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 10.4 t80 -107.22 -66.66 1.0 Allowed 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.638 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 17.6 mm-40 -48.21 -32.46 7.14 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.817 -1.083 . . . . 0.0 112.005 -174.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.764 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 5.1 m-20 -105.07 -19.68 13.75 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -175.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -60.71 -172.0 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -174.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.552 ' HB2' ' CB ' ' B' ' 51' ' ' CYS . 84.7 m-20 -52.86 141.55 37.05 Favored Pre-proline 0 C--O 1.235 0.298 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 170.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 49' ' ' PRO . . . . . 0.493 ' O ' HD23 ' B' ' 92' ' ' LEU . 19.2 Cg_endo -60.04 -19.7 57.2 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 121.642 1.561 . . . . 0.0 110.471 174.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' B' ' 53' ' ' SER . 0.3 OUTLIER -87.02 -34.89 19.07 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.542 173.991 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.975 ' SG ' ' HB2' ' B' ' 76' ' ' CYS . 40.7 t -80.33 -33.89 37.07 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.265 -172.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.51 ' HB2' ' CD1' ' B' ' 44' ' ' TYR . 4.1 pt20 -68.6 -29.42 67.93 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 172.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 53' ' ' SER . . . . . 0.591 ' HB3' ' C ' ' B' ' 91' ' ' GLN . 19.6 m -71.55 -19.41 62.17 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 113.264 -1.789 . . . . 0.0 109.986 173.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.783 ' HB2' HD11 ' B' ' 79' ' ' ILE . . . -80.86 -27.38 36.43 Favored 'General case' 0 C--N 1.311 -1.07 0 O-C-N 121.443 -0.786 . . . . 0.0 110.225 167.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.561 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 24.0 mt -90.11 -30.0 5.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 -170.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.607 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.68 -38.78 2.07 Favored Pre-proline 0 N--CA 1.487 1.377 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -174.043 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 55.6 Cg_endo -63.79 -30.78 68.83 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.196 1.931 . . . . 0.0 112.649 176.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 58' ' ' LEU . . . . . 0.557 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.7 mt -95.11 -16.74 22.4 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.57 ' HA ' ' OH ' ' B' ' 72' ' ' TYR . 0.1 OUTLIER -55.01 109.09 0.47 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.661 -179.483 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.65 -23.41 36.05 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.419 -177.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -104.07 113.36 26.85 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.351 0.596 . . . . 0.0 110.162 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.48 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.7 p -123.16 142.13 37.62 Favored Pre-proline 0 C--N 1.308 -1.201 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.352 169.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.546 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 74.0 Cg_exo -50.87 138.8 41.86 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.201 1.934 . . . . 0.0 111.416 171.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.31 103.88 0.44 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.01 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.28 -13.51 43.96 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.618 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.546 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 19.6 m -94.15 169.56 10.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.487 0.661 . . . . 0.0 111.596 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.0 136.97 34.32 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.564 174.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.769 HG13 ' OE2' ' B' ' 40' ' ' GLU . 0.7 OUTLIER -72.3 -32.52 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.495 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.754 ' O ' HG13 ' B' ' 73' ' ' VAL . 9.9 mm -55.65 -46.6 79.42 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.093 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.675 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 29.4 t -46.49 -37.92 8.52 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.105 176.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -85.67 -32.0 22.22 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.677 -177.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 72' ' ' TYR . . . . . 0.579 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 4.9 m-30 -76.46 -34.29 58.7 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.572 -176.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.802 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.5 m -71.33 -31.51 43.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 172.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 74' ' ' LYS . . . . . 0.569 ' O ' ' HB3' ' B' ' 77' ' ' ASP . 0.0 OUTLIER -68.08 -29.61 68.61 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.431 175.653 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 75' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -65.09 -44.59 88.34 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.175 176.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.975 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 39.1 t -92.5 9.04 36.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.729 177.299 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 77' ' ' ASP . . . . . 0.569 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 9.1 t70 -60.61 -21.73 62.99 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.173 0.511 . . . . 0.0 110.163 172.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 78' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' B' ' 83' ' ' MET . . . -101.14 -9.63 44.48 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.653 173.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.792 ' HB ' ' SG ' ' B' ' 76' ' ' CYS . 84.2 mt -96.06 138.98 20.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 117.392 0.596 . . . . 0.0 111.342 -178.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 80' ' ' GLY . . . . . 0.569 ' H ' ' HB2' ' B' ' 84' ' ' HIS . . . 164.38 -34.94 0.28 Allowed Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.718 173.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.6 ' O ' ' HG2' ' B' ' 85' ' ' LYS . . . -148.41 -103.4 0.31 Allowed Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.133 177.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.15 -46.75 87.63 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -171.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 83' ' ' MET . . . . . 0.513 ' HB2' ' O ' ' B' ' 78' ' ' GLY . 72.4 mtp -68.56 -30.85 69.72 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 84' ' ' HIS . . . . . 0.569 ' HB2' ' H ' ' B' ' 80' ' ' GLY . 5.6 t60 -62.41 -29.11 70.26 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.137 173.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.6 ' HG2' ' O ' ' B' ' 81' ' ' GLY . 70.5 mmtt -84.05 -20.32 32.9 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.937 0.399 . . . . 0.0 110.421 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.09 -43.02 14.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.558 0.694 . . . . 0.0 110.508 177.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 1.6 mmt -84.48 -12.77 53.67 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.081 -176.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.61 ' O ' ' HB3' ' B' ' 92' ' ' LEU . 0.3 OUTLIER -49.52 -41.01 39.84 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.45 0.643 . . . . 0.0 111.17 177.836 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 28.2 ttt -84.06 -15.55 47.03 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.019 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -96.7 -33.63 11.66 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.983 -173.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 91' ' ' GLN . . . . . 0.591 ' C ' ' HB3' ' B' ' 53' ' ' SER . 87.0 mt-30 -110.21 -56.73 2.3 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.279 -176.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.61 ' HB3' ' O ' ' B' ' 88' ' ' LEU . 0.4 OUTLIER -58.41 -5.1 0.46 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 121.087 0.47 . . . . 0.0 110.186 176.355 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.452 ' H ' ' C ' ' B' ' 91' ' ' GLN . 5.1 pt-20 . . . . . 0 C--O 1.252 1.231 0 C-N-CA 123.981 0.912 . . . . 0.0 112.245 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.413 ' C ' ' HA3' ' B' ' 60' ' ' GLY . 72.3 Cg_endo . . . . . 0 CA--C 1.515 -0.451 0 N-CA-C 108.784 -1.275 . . . . 0.0 108.784 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.723 ' HG ' ' HZ2' ' B' ' 59' ' ' LYS . 13.7 m -67.11 171.42 5.64 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 162.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.812 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -69.9 -52.02 28.14 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 167.248 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.521 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 2.5 p-10 -82.34 5.37 20.48 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 113.996 -1.456 . . . . 0.0 113.423 -166.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.409 HG23 ' HB2' ' A' ' 2' ' ' SER . 0.4 OUTLIER -66.28 -3.03 5.02 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 118.521 0.6 . . . . 0.0 111.946 -175.158 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.582 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.1 m -78.57 132.72 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 174.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.783 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -155.08 160.15 40.78 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -178.881 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.411 ' N ' ' CD2' ' A' ' 17' ' ' PHE . 2.0 tt0 -44.33 109.07 0.13 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 112.902 -1.954 . . . . 0.0 112.29 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.69 -151.95 15.13 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.397 174.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.1 t -52.32 98.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 122.421 0.288 . . . . 0.0 110.692 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.7 pttm 40.52 42.14 1.25 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.511 1.124 . . . . 0.0 112.598 -175.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -60.1 141.34 90.35 Favored Pre-proline 0 C--O 1.236 0.386 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.149 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.506 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 27.4 Cg_exo -56.35 122.96 12.7 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.039 1.826 . . . . 0.0 109.712 176.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.871 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 20.2 t80 -72.38 -53.27 6.24 Favored Pre-proline 0 N--CA 1.439 -1.004 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -166.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.529 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 34.3 Cg_exo -55.36 -19.53 22.48 Favored 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 121.361 1.374 . . . . 0.0 110.749 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.506 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 3.4 m-20 -89.9 -41.19 11.93 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 113.737 -1.574 . . . . 0.0 110.948 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.506 ' CD2' ' HA ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -54.96 -46.82 75.08 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 175.73 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.7 HG12 ' O ' ' A' ' 14' ' ' TYR . 2.4 p -79.03 -32.12 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.218 -177.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.0 -36.3 72.45 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 121.639 -0.663 . . . . 0.0 111.768 175.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.705 ' O ' HG12 ' A' ' 24' ' ' VAL . 14.1 ptt180 -83.27 -23.52 32.64 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.547 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 6.6 tp -60.49 -45.63 93.06 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.767 172.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.716 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 7.6 mt-30 -73.14 -44.51 60.04 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.735 178.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.751 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 26.0 t70 -49.16 -53.72 19.67 Favored 'General case' 0 C--N 1.315 -0.893 0 O-C-N 124.155 0.909 . . . . 0.0 111.667 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.705 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.7 p -80.85 -23.19 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-O 121.09 0.472 . . . . 0.0 109.882 -174.134 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.774 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -71.79 -20.54 61.84 Favored 'General case' 0 C--O 1.204 -1.326 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 174.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.451 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -86.54 -37.14 18.47 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.744 178.602 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.751 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.0 mmtt -65.49 -35.51 81.09 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.459 178.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.5 m -104.47 -9.96 18.02 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.648 -171.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.774 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 91.1 mt -119.27 128.03 75.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.95 -178.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.99 -1.29 56.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.382 0.611 . . . . 0.0 110.488 176.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.66 ' H ' HG22 ' A' ' 29' ' ' ILE . 13.6 t70 -107.95 116.6 32.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.467 -177.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.558 ' OE2' ' HG3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -57.16 -34.05 68.06 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.272 178.332 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.612 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -70.88 -54.71 10.48 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -172.543 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.563 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -60.05 -28.92 68.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.8 176.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.878 ' O ' HG13 ' A' ' 39' ' ' VAL . 6.0 tmm_? -67.38 -58.09 5.41 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.441 ' O ' HG22 ' A' ' 39' ' ' VAL . 16.0 mtpt -56.96 -56.58 19.85 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.008 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.704 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 20.1 m -53.73 -35.03 25.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.399 -171.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.812 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.3 tt -86.6 -28.24 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 C-N-CA 119.631 -0.828 . . . . 0.0 111.732 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.878 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.5 m -70.78 -49.87 47.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 119.088 -1.045 . . . . 0.0 109.561 173.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.774 ' OE1' HG13 ' A' ' 68' ' ' VAL . 0.9 OUTLIER -62.08 -24.85 67.36 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.354 0.662 . . . . 0.0 111.653 176.654 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.704 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -86.23 -55.28 3.99 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 176.381 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.521 ' HG3' ' HB2' ' A' ' 4' ' ' ASN . 16.4 mmt -63.89 -20.35 65.77 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 121.458 0.646 . . . . 0.0 109.861 -176.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.689 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -48.78 -27.81 3.23 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.277 169.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.558 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 16.5 t80 -105.95 -66.23 1.01 Allowed 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 174.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.45 ' CG ' HD12 ' A' ' 41' ' ' LEU . 15.3 mm-40 -50.22 -26.85 5.1 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 124.228 0.955 . . . . 0.0 112.699 -172.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.783 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.8 m-20 -109.49 -20.35 12.92 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.625 -177.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -59.15 -177.52 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.183 0.992 . . . . 0.0 113.633 -174.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -62.98 140.89 97.64 Favored Pre-proline 0 N--CA 1.445 -0.713 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.639 174.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -43.65 -48.04 9.07 Favored 'Trans proline' 0 C--N 1.334 -0.226 0 C-N-CA 122.83 2.353 . . . . 0.0 112.473 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.602 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -76.23 -23.73 54.55 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.31 0.644 . . . . 0.0 110.657 -179.488 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.969 ' SG ' ' HB2' ' A' ' 76' ' ' CYS . 52.9 t -84.26 -40.0 18.57 Favored 'General case' 0 N--CA 1.417 -2.105 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.915 -173.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.57 ' HA ' HD12 ' A' ' 55' ' ' ILE . 29.8 pt20 -66.34 -31.18 71.81 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 172.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.757 ' O ' ' HD2' ' A' ' 56' ' ' LYS . 5.1 m -65.81 -30.05 70.62 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.88 172.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.762 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -72.33 -23.71 61.2 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.87 0.843 . . . . 0.0 109.276 172.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.57 HD12 ' HA ' ' A' ' 52' ' ' GLN . 25.1 mt -90.94 -31.33 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -173.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.757 ' HD2' ' O ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -44.03 -38.18 4.43 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-N 119.805 1.184 . . . . 0.0 113.477 -173.451 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 52.7 Cg_endo -63.06 -29.6 75.12 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 122.296 1.997 . . . . 0.0 112.85 175.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.559 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.5 mt -97.37 -16.45 20.24 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.558 ' HE3' ' HB3' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -52.76 109.68 0.43 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.376 -178.538 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.525 ' N ' ' HZ3' ' A' ' 59' ' ' LYS . . . 94.86 -21.77 41.79 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.177 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.5 mmmt -103.51 114.5 28.81 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -177.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.528 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.7 p -122.14 137.1 27.01 Favored Pre-proline 0 C--N 1.309 -1.163 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 170.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.537 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 85.5 Cg_exo -49.46 140.35 27.82 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.649 2.233 . . . . 0.0 111.702 172.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.94 102.14 0.26 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.304 -176.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.26 -13.4 44.08 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.657 178.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.537 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 29.2 m -90.22 174.28 7.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.507 0.67 . . . . 0.0 111.841 -178.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.444 ' OD2' ' HB ' ' A' ' 69' ' ' ILE . 3.0 t70 -91.25 136.18 33.28 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.774 HG13 ' OE1' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -71.87 -33.36 47.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 C-N-CA 118.055 -1.458 . . . . 0.0 108.937 -179.391 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.774 ' O ' HG13 ' A' ' 73' ' ' VAL . 7.6 mm -57.61 -47.5 85.29 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.112 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.802 -178.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.577 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 41.2 t -48.33 -36.09 13.67 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.202 0.525 . . . . 0.0 111.168 178.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.411 ' H ' ' HG2' ' A' ' 71' ' ' GLU . 2.3 mm-40 -86.56 -31.21 21.34 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.27 0.628 . . . . 0.0 110.75 -176.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.559 ' CE1' ' HB2' ' A' ' 58' ' ' LEU . 4.9 m-30 -76.28 -35.98 58.62 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.494 -178.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.871 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.7 m -69.87 -33.15 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 173.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.577 ' HB2' ' O ' ' A' ' 70' ' ' SER . 1.6 ttmm -67.9 -30.62 70.0 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.086 -1.415 . . . . 0.0 109.666 176.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -62.1 -42.81 99.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.653 174.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.969 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 41.9 t -94.86 8.59 42.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.052 178.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 12.7 t70 -61.59 -16.43 48.09 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.279 0.561 . . . . 0.0 110.024 173.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -107.47 -5.07 34.59 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.842 173.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.802 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 57.2 mt -102.11 132.47 48.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 117.321 0.56 . . . . 0.0 111.086 -178.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 161.41 62.27 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.005 174.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.21 172.19 36.79 Favored Glycine 0 CA--C 1.51 -0.245 0 N-CA-C 111.771 -0.531 . . . . 0.0 111.771 -176.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 54.51 -91.0 0.03 OUTLIER 'General case' 0 C--O 1.234 0.26 0 C-N-CA 122.937 0.495 . . . . 0.0 111.823 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 65.4 mtt -62.52 -28.51 69.89 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.452 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -50.1 -41.56 48.61 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.347 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.453 ' HA ' ' HB2' ' A' ' 88' ' ' LEU . 75.0 mttt -87.32 -14.83 39.75 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -174.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.43 -43.34 14.74 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.971 0.891 . . . . 0.0 109.404 172.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 65.7 mtt -80.22 -9.71 59.73 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.249 -1.341 . . . . 0.0 111.034 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.453 ' HB2' ' HA ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -56.83 -17.68 10.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.269 0.557 . . . . 0.0 111.056 177.586 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 49.3 tpp -83.73 -24.04 31.36 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.104 0.478 . . . . 0.0 110.528 174.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.17 -56.26 2.35 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -169.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.551 ' O ' ' HB3' ' A' ' 53' ' ' SER . 93.6 mt-30 -70.49 -40.87 73.34 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -176.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.551 ' HA ' ' CB ' ' A' ' 53' ' ' SER . 1.9 tm? -46.45 -29.73 1.86 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.902 169.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.65 ' O ' ' HE3' ' A' ' 56' ' ' LYS . 43.8 mt-10 . . . . . 0 N--CA 1.438 -1.029 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 1' ' ' PRO . . . . . 0.43 ' HB2' ' H ' ' B' ' 2' ' ' SER . 72.4 Cg_endo . . . . . 0 CA--C 1.515 -0.449 0 N-CA-C 108.791 -1.273 . . . . 0.0 108.791 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.43 ' H ' ' HB2' ' B' ' 1' ' ' PRO . 14.4 m -67.04 171.58 5.39 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 162.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.783 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -70.03 -52.08 26.97 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 167.184 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.521 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.6 p-10 -82.05 5.25 20.01 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 113.95 -1.477 . . . . 0.0 113.478 -166.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.411 HG23 ' HB2' ' B' ' 2' ' ' SER . 0.4 OUTLIER -66.26 -2.87 4.81 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 121.671 -0.643 . . . . 0.0 111.939 -175.16 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.596 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.1 m -78.57 133.18 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 174.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.773 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.1 OUTLIER -155.17 160.26 40.77 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -178.825 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 8' ' ' GLN . . . . . 0.426 ' N ' ' CD2' ' B' ' 17' ' ' PHE . 2.0 tt0 -44.58 108.87 0.13 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 112.922 -1.944 . . . . 0.0 112.313 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.27 -152.07 14.38 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.406 174.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 9.9 t -52.44 98.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.753 0.311 . . . . 0.0 110.803 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 23.8 pttm 40.8 41.55 1.22 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.549 1.14 . . . . 0.0 112.635 -175.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -59.73 141.17 89.17 Favored Pre-proline 0 C--O 1.236 0.388 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.217 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 13' ' ' PRO . . . . . 0.516 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 27.6 Cg_exo -56.24 123.04 12.87 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.031 1.82 . . . . 0.0 109.644 177.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 14' ' ' TYR . . . . . 0.877 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 20.3 t80 -72.36 -53.37 6.19 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -166.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.527 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 35.1 Cg_exo -55.45 -19.34 22.31 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 121.305 1.337 . . . . 0.0 110.696 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.516 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 3.5 m-20 -90.1 -41.15 11.83 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.722 -1.581 . . . . 0.0 110.92 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 17' ' ' PHE . . . . . 0.516 ' CD2' ' HA ' ' B' ' 7' ' ' ARG . 0.0 OUTLIER -54.79 -46.71 74.5 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.569 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.699 HG12 ' O ' ' B' ' 14' ' ' TYR . 2.4 p -79.16 -32.09 14.94 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.21 -177.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.06 -36.12 72.34 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 121.634 -0.666 . . . . 0.0 111.765 175.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.697 ' O ' HG12 ' B' ' 24' ' ' VAL . 14.1 ptt180 -83.22 -23.99 32.56 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 177.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.556 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 6.5 tp -60.1 -45.64 92.26 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.802 172.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 22' ' ' GLN . . . . . 0.721 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 7.5 mt-30 -73.21 -44.19 60.09 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.832 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.74 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 25.9 t70 -49.43 -53.83 20.72 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.557 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 24' ' ' VAL . . . . . 0.697 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.7 p -80.96 -23.07 10.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.137 0.494 . . . . 0.0 109.878 -174.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.778 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -71.77 -20.5 61.86 Favored 'General case' 0 C--O 1.203 -1.37 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 174.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 26' ' ' GLN . . . . . 0.451 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -86.56 -37.29 18.29 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.704 178.597 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.74 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.4 mmtt -65.51 -35.58 81.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.488 178.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 19.6 m -104.34 -9.44 18.51 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.666 -171.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.778 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 91.6 mt -119.76 128.0 75.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.993 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.06 -1.43 56.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.285 0.564 . . . . 0.0 110.286 177.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.675 ' H ' HG22 ' B' ' 29' ' ' ILE . 13.8 t70 -107.62 116.84 32.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.352 -177.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.549 ' OE2' ' HG3' ' B' ' 33' ' ' LYS . 0.0 OUTLIER -57.34 -33.87 68.2 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.356 178.267 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.616 ' O ' HG13 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -70.82 -54.57 11.09 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -172.707 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.545 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -60.16 -28.89 68.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.784 176.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.854 ' O ' HG13 ' B' ' 39' ' ' VAL . 6.0 tmm_? -67.38 -58.28 5.07 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.438 ' O ' HG22 ' B' ' 39' ' ' VAL . 16.1 mtpt -56.84 -56.52 20.52 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.097 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.689 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 20.2 m -53.83 -34.92 26.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.386 -171.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.783 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.3 tt -86.64 -28.18 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 C-N-CA 119.649 -0.82 . . . . 0.0 111.668 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.854 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.5 m -70.91 -49.85 47.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 119.152 -1.019 . . . . 0.0 109.58 173.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.782 ' OE1' HG13 ' B' ' 68' ' ' VAL . 0.9 OUTLIER -62.12 -24.87 67.4 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.398 0.679 . . . . 0.0 111.561 176.69 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.689 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -86.22 -55.22 4.02 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 176.293 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 42' ' ' MET . . . . . 0.521 ' HG3' ' HB2' ' B' ' 4' ' ' ASN . 16.4 mmt -64.08 -20.17 65.76 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 121.537 0.684 . . . . 0.0 109.974 -176.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.68 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -48.78 -27.76 3.19 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.194 169.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 44' ' ' TYR . . . . . 0.561 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 16.5 t80 -106.06 -66.41 1.0 Allowed 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 174.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.46 ' CG ' HD12 ' B' ' 41' ' ' LEU . 16.4 mm-40 -50.05 -27.22 5.25 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.627 -172.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.773 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.7 m-20 -109.28 -20.22 13.02 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.602 -176.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -59.06 -177.35 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -174.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 48' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -63.26 140.93 97.77 Favored Pre-proline 0 N--CA 1.446 -0.647 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.531 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -43.76 -48.04 9.26 Favored 'Trans proline' 0 C--N 1.334 -0.235 0 C-N-CA 122.773 2.315 . . . . 0.0 112.386 -178.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.604 ' HG3' ' O ' ' B' ' 50' ' ' GLU . 0.0 OUTLIER -76.03 -23.83 55.17 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 123.43 0.692 . . . . 0.0 110.707 -179.467 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.97 ' SG ' ' HB2' ' B' ' 76' ' ' CYS . 52.8 t -84.18 -39.99 18.69 Favored 'General case' 0 N--CA 1.418 -2.038 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.94 -173.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.574 ' HA ' HD12 ' B' ' 55' ' ' ILE . 29.8 pt20 -66.5 -31.08 71.59 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 172.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 53' ' ' SER . . . . . 0.745 ' O ' ' HD2' ' B' ' 56' ' ' LYS . 5.7 m -65.93 -30.14 70.67 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 113.783 -1.553 . . . . 0.0 110.809 173.012 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.745 ' HB2' HD11 ' B' ' 79' ' ' ILE . . . -72.09 -23.89 61.41 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 122.026 0.917 . . . . 0.0 109.374 172.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.574 HD12 ' HA ' ' B' ' 52' ' ' GLN . 25.0 mt -90.89 -31.53 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -173.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.745 ' HD2' ' O ' ' B' ' 53' ' ' SER . 0.0 OUTLIER -43.79 -38.12 3.96 Favored Pre-proline 0 N--CA 1.488 1.45 0 CA-C-N 119.801 1.182 . . . . 0.0 113.653 -173.543 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 54.3 Cg_endo -63.48 -28.84 70.85 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.391 2.061 . . . . 0.0 112.942 175.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 58' ' ' LEU . . . . . 0.572 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.5 mt -97.84 -16.55 19.75 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.723 ' HZ2' ' HG ' ' A' ' 2' ' ' SER . 0.0 OUTLIER -52.82 109.73 0.44 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.421 -178.501 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.413 ' HA3' ' C ' ' A' ' 1' ' ' PRO . . . 95.04 -22.02 40.73 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.255 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 11.5 mmmt -103.55 114.3 28.46 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -177.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.519 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.6 p -122.15 136.85 26.74 Favored Pre-proline 0 C--N 1.309 -1.184 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 171.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.541 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 84.8 Cg_exo -49.32 140.29 26.82 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.52 2.147 . . . . 0.0 111.841 172.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.76 102.54 0.27 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.12 -176.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.94 -13.34 45.43 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.618 178.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.541 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 29.6 m -90.71 174.13 7.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.418 0.627 . . . . 0.0 111.742 -178.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 67' ' ' ASP . . . . . 0.442 ' OD2' ' HB ' ' B' ' 69' ' ' ILE . 3.1 t70 -91.36 135.83 33.54 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 176.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.782 HG13 ' OE1' ' B' ' 40' ' ' GLU . 0.8 OUTLIER -71.66 -33.4 48.77 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 C-N-CA 118.085 -1.446 . . . . 0.0 108.856 -179.214 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.778 ' O ' HG13 ' B' ' 73' ' ' VAL . 7.6 mm -57.45 -47.51 84.76 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.118 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.801 -178.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.571 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 40.3 t -48.34 -36.2 13.92 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.301 0.572 . . . . 0.0 111.182 178.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -86.51 -31.28 21.38 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.592 -176.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 72' ' ' TYR . . . . . 0.572 ' CE1' ' HB2' ' B' ' 58' ' ' LEU . 5.0 m-30 -76.39 -35.82 58.42 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.443 -178.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.877 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.7 m -69.94 -33.13 54.21 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 173.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 74' ' ' LYS . . . . . 0.571 ' HB2' ' O ' ' B' ' 70' ' ' SER . 1.6 ttmm -68.04 -30.56 69.81 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.698 176.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 75' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -61.93 -42.89 99.62 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.624 174.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.97 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 43.2 t -94.99 8.66 42.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.12 177.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 77' ' ' ASP . . . . . 0.467 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 12.0 t70 -61.4 -17.04 52.26 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.354 0.597 . . . . 0.0 109.971 173.241 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -107.14 -4.65 35.54 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.887 173.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.816 ' HB ' ' SG ' ' B' ' 76' ' ' CYS . 56.6 mt -102.47 132.8 47.79 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.046 0 CA-C-N 117.391 0.596 . . . . 0.0 111.068 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 161.28 61.85 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.992 174.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.53 171.2 35.92 Favored Glycine 0 C--O 1.224 -0.482 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.95 -176.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 55.47 -91.47 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 122.697 0.399 . . . . 0.0 111.82 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 83' ' ' MET . . . . . . . . . . . . . 65.4 mtt -62.26 -28.95 70.07 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.469 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 84' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -49.72 -41.79 44.47 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.275 177.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.443 ' HA ' ' HB2' ' B' ' 88' ' ' LEU . 75.1 mttt -87.32 -14.52 40.59 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -174.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.58 -43.41 14.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.949 0.881 . . . . 0.0 109.333 172.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 66.4 mtt -80.21 -9.72 59.73 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.966 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.443 ' HB2' ' HA ' ' B' ' 85' ' ' LYS . 0.0 OUTLIER -56.71 -17.59 9.46 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.468 0.651 . . . . 0.0 111.042 177.499 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 50.4 tpp -83.92 -24.25 30.83 Favored 'General case' 0 C--N 1.316 -0.883 0 O-C-N 121.924 -0.485 . . . . 0.0 110.499 174.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -109.84 -56.4 2.32 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -169.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 91' ' ' GLN . . . . . 0.536 ' O ' ' HB3' ' B' ' 53' ' ' SER . 93.8 mt-30 -70.56 -40.64 73.23 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.299 -176.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.558 ' HA ' ' CB ' ' B' ' 53' ' ' SER . 1.8 tm? -46.62 -29.6 1.91 Allowed 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.71 0.631 . . . . 0.0 109.923 169.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.666 ' O ' ' HE3' ' B' ' 56' ' ' LYS . 43.6 mt-10 . . . . . 0 N--CA 1.437 -1.084 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 -178.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo . . . . . 0 CA--C 1.52 -0.209 0 N-CA-C 109.064 -1.168 . . . . 0.0 109.064 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.488 ' HB3' HD21 ' B' ' 41' ' ' LEU . 66.6 m -68.62 -176.85 0.85 Allowed 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 162.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.862 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -77.27 -55.47 5.38 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.107 172.675 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.812 HD21 HD11 ' B' ' 41' ' ' LEU . 1.1 p30 -76.22 -8.3 56.76 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.599 -1.182 . . . . 0.0 112.467 -167.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.532 ' CG2' ' HD3' ' B' ' 59' ' ' LYS . 0.3 OUTLIER -57.95 0.61 0.06 Allowed 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -172.197 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.58 ' HB ' ' CZ ' ' A' ' 20' ' ' ARG . 4.0 m -72.96 117.65 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 167.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.715 ' HG3' ' CB ' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -115.91 158.25 23.29 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 121.505 -0.747 . . . . 0.0 110.216 176.765 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.502 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 1.9 tt0 -56.16 113.08 1.4 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.444 173.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.35 -159.99 11.73 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 173.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.7 p -52.16 100.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.942 0.371 . . . . 0.0 111.141 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.418 ' HD2' ' O ' ' A' ' 80' ' ' GLY . 18.2 pttp 43.01 42.58 3.23 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.305 1.042 . . . . 0.0 112.041 -175.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.486 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 42.7 tt0 -60.26 137.0 91.63 Favored Pre-proline 0 C--O 1.232 0.182 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 177.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.531 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 28.1 Cg_exo -54.06 123.62 13.95 Favored 'Trans proline' 0 CA--C 1.511 -0.672 0 C-N-CA 122.075 1.85 . . . . 0.0 109.936 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.862 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 14.5 t80 -70.19 -53.43 10.79 Favored Pre-proline 0 N--CA 1.44 -0.954 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -166.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.501 ' HD3' ' HB3' ' A' ' 14' ' ' TYR . 31.8 Cg_exo -55.69 -18.51 21.06 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 121.414 1.409 . . . . 0.0 110.979 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.531 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 4.1 m-20 -89.96 -41.69 11.6 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.198 -1.365 . . . . 0.0 111.169 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.502 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -56.96 -41.54 78.51 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.533 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.703 HG12 ' O ' ' A' ' 14' ' ' TYR . 2.4 p -82.57 -33.6 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.519 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.88 -34.05 69.36 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 121.495 -0.753 . . . . 0.0 111.946 176.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.748 ' O ' HG12 ' A' ' 24' ' ' VAL . 17.5 ptt180 -84.79 -27.72 26.66 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.08 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.604 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 9.3 tp -54.96 -46.19 75.0 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.759 171.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.747 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 7.3 mt-30 -73.21 -45.72 54.53 Favored 'General case' 0 CA--C 1.497 -1.073 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.168 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.71 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 11.4 t70 -51.79 -52.42 49.09 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 124.05 0.844 . . . . 0.0 111.812 -177.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.748 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.3 p -82.06 -23.25 9.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -173.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.793 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -72.06 -18.86 61.9 Favored 'General case' 0 C--O 1.203 -1.357 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 173.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.422 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -86.55 -37.75 17.86 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.634 -1.167 . . . . 0.0 109.812 177.842 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.71 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 41.0 mmtt -67.62 -37.84 83.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.013 178.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.8 t -102.67 -7.7 21.52 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.227 0.537 . . . . 0.0 110.044 -171.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.793 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 86.8 mt -116.7 127.49 74.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.435 178.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.55 -9.54 54.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.263 0.554 . . . . 0.0 110.148 177.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.583 ' H ' HG22 ' A' ' 29' ' ' ILE . 13.8 t70 -98.75 136.04 39.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.233 -177.015 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -75.42 -29.55 59.78 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.761 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.592 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -77.44 -51.41 10.82 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -174.932 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.574 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -58.57 -27.88 65.01 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.436 175.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.884 ' O ' HG13 ' A' ' 39' ' ' VAL . 1.7 tmm_? -66.31 -60.74 2.49 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.5 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 26.0 mtpt -55.12 -56.1 23.61 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.373 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.719 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 19.7 m -54.8 -32.6 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.16 -170.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.862 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.2 tt -86.82 -34.0 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.416 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.884 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.0 m -66.14 -47.66 83.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 119.214 -0.995 . . . . 0.0 109.466 176.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.672 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 54.4 mt-10 -67.25 -23.75 65.74 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 123.875 0.87 . . . . 0.0 112.64 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.838 HD11 HD21 ' B' ' 4' ' ' ASN . 0.0 OUTLIER -86.22 -55.71 3.79 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.375 176.854 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.668 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 14.6 mmt -62.27 -20.67 64.52 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-O 121.76 0.791 . . . . 0.0 109.509 -176.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.754 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -48.61 -27.02 2.53 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.766 170.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.499 ' HB3' ' NZ ' ' A' ' 59' ' ' LYS . 9.2 t80 -105.4 -66.39 0.98 Allowed 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.485 ' HG2' HD12 ' A' ' 41' ' ' LEU . 14.0 mm-40 -48.25 -33.41 8.64 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 123.646 0.592 . . . . 0.0 112.44 -176.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.715 ' CB ' ' HG3' ' A' ' 7' ' ' ARG . 0.9 OUTLIER -99.84 -15.34 18.43 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.349 0.595 . . . . 0.0 111.643 -177.66 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.754 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -63.04 168.48 4.04 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.426 0.632 . . . . 0.0 111.501 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.554 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 11.1 m-20 -58.31 145.46 74.73 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.338 173.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -41.65 -49.1 5.45 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.688 2.258 . . . . 0.0 111.894 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.552 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 0.3 OUTLIER -71.23 -33.56 69.97 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.238 1.015 . . . . 0.0 111.854 177.79 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.554 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 69.8 m -73.94 -39.22 63.93 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 121.118 0.485 . . . . 0.0 110.014 -174.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.522 ' HA ' HD12 ' A' ' 55' ' ' ILE . 4.0 pt20 -73.39 -30.75 63.48 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 175.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.553 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 4.0 m -67.72 -21.02 65.32 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.306 172.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.698 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -77.1 -27.77 54.26 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.382 -0.824 . . . . 0.0 109.865 169.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.581 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 20.8 mt -89.74 -31.72 5.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -171.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.606 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -40.68 -37.76 1.05 Allowed Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -173.883 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 55.2 Cg_endo -64.26 -28.89 64.0 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.358 2.039 . . . . 0.0 113.104 175.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.564 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 2.0 mt -98.63 -15.79 19.31 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.665 ' NZ ' HD13 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -52.56 109.35 0.39 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.348 -1.296 . . . . 0.0 110.422 179.6 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.88 -30.09 10.44 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.939 -175.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 35.0 mmtt -103.83 115.17 29.98 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-O 122.423 1.106 . . . . 0.0 111.612 -175.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.587 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.5 p -122.46 145.04 43.61 Favored Pre-proline 0 C--N 1.296 -1.754 0 CA-C-N 113.555 -1.657 . . . . 0.0 109.52 170.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.557 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 96.4 Cg_exo -48.55 141.25 20.3 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.282 1.988 . . . . 0.0 111.198 167.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.46 101.73 0.09 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.973 0.416 . . . . 0.0 112.073 -173.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.11 -9.31 70.08 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.137 176.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.557 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 4.6 m -89.56 -162.42 0.88 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 122.275 1.036 . . . . 0.0 112.167 -177.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.97 125.69 46.03 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 113.176 -1.829 . . . . 0.0 110.89 -173.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.587 HG12 ' HB ' ' A' ' 62' ' ' VAL . 0.9 OUTLIER -79.08 -31.27 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 C-N-CA 118.523 -1.271 . . . . 0.0 108.463 176.248 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.773 ' O ' HG13 ' A' ' 73' ' ' VAL . 6.9 mm -57.77 -49.16 81.77 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.147 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.564 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.6 t -49.07 -36.18 17.75 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.077 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.589 ' O ' ' HE3' ' A' ' 74' ' ' LYS . 1.3 mm-40 -84.88 -33.83 22.72 Favored 'General case' 0 C--O 1.216 -0.666 0 C-N-CA 123.349 0.66 . . . . 0.0 110.458 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.568 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 4.9 m-30 -74.5 -37.91 63.01 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.691 -176.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.862 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.7 m -70.64 -32.65 50.17 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 175.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.589 ' HE3' ' O ' ' A' ' 71' ' ' GLU . 2.4 ttpp -72.39 -27.68 62.52 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.816 177.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.491 ' HB2' HD11 ' A' ' 58' ' ' LEU . . . -66.21 -41.72 89.73 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.313 174.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 4.2 m -101.07 10.5 40.93 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.533 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -64.16 -27.48 69.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.132 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.569 ' O ' ' HB2' ' A' ' 83' ' ' MET . . . -82.18 -21.98 59.84 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.571 171.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.698 HD11 ' HB2' ' A' ' 54' ' ' ALA . 49.3 mt -81.17 163.77 3.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.446 ' N ' HG22 ' A' ' 79' ' ' ILE . . . 112.95 -13.24 24.39 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -174.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.86 155.36 8.03 Favored Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 175.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.55 -81.41 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.041 0.536 . . . . 0.0 112.334 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.569 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 63.1 mtt -61.75 -29.51 70.17 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-O 120.663 0.268 . . . . 0.0 110.734 -176.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.534 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 11.4 t60 -56.78 -32.44 65.64 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.824 175.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -84.58 -19.33 33.25 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.096 0.474 . . . . 0.0 110.356 -176.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.06 -46.15 10.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.583 176.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -80.4 -13.78 58.86 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.067 -175.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.547 ' O ' ' HB3' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -50.79 -37.18 41.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.569 179.74 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 49.5 ttm -83.68 -19.9 34.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.099 0.476 . . . . 0.0 111.002 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -93.41 -43.83 8.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.151 -173.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.498 ' C ' ' HB3' ' A' ' 53' ' ' SER . 87.6 mt-30 -99.51 -51.38 3.79 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.36 -174.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.547 ' HB3' ' O ' ' A' ' 88' ' ' LEU . 0.4 OUTLIER -64.86 1.66 0.86 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.361 177.72 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.463 ' H ' ' C ' ' A' ' 91' ' ' GLN . 3.4 pt-20 . . . . . 0 C--O 1.248 1.006 0 C-N-CA 123.819 0.848 . . . . 0.0 112.196 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 1' ' ' PRO . . . . . 0.422 ' HB2' ' H ' ' B' ' 2' ' ' SER . 96.2 Cg_endo . . . . . 0 CA--C 1.518 -0.319 0 N-CA-C 109.113 -1.149 . . . . 0.0 109.113 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.468 ' HB3' HD21 ' A' ' 41' ' ' LEU . 71.2 m -68.78 -176.55 0.84 Allowed 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 162.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.859 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -77.24 -55.57 5.31 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.509 -0.877 . . . . 0.0 110.173 172.362 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.838 HD21 HD11 ' A' ' 41' ' ' LEU . 1.1 p30 -76.21 -8.32 56.78 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.557 -1.201 . . . . 0.0 112.413 -167.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.579 ' CG2' ' HD3' ' A' ' 59' ' ' LYS . 0.2 OUTLIER -57.85 0.5 0.06 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -172.182 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.578 ' HB ' ' CZ ' ' B' ' 20' ' ' ARG . 4.0 m -72.88 117.92 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 167.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.705 ' HG3' ' CB ' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -115.86 158.42 22.98 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 121.568 -0.708 . . . . 0.0 110.189 176.621 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 8' ' ' GLN . . . . . 0.509 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 1.9 tt0 -56.44 112.9 1.38 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.372 173.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.2 -159.75 10.94 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 173.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 12.3 p -52.32 100.88 0.03 OUTLIER 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.932 0.366 . . . . 0.0 111.152 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.407 ' HD2' ' O ' ' B' ' 80' ' ' GLY . 18.3 pttp 42.89 42.17 2.92 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.383 1.073 . . . . 0.0 112.255 -175.015 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.49 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 43.1 tt0 -59.84 136.87 90.32 Favored Pre-proline 0 C--O 1.232 0.17 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 13' ' ' PRO . . . . . 0.543 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 27.6 Cg_exo -54.05 123.6 13.89 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.129 1.886 . . . . 0.0 109.907 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 14' ' ' TYR . . . . . 0.864 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 14.8 t80 -70.07 -53.61 10.85 Favored Pre-proline 0 N--CA 1.44 -0.96 0 CA-C-O 118.335 -0.841 . . . . 0.0 113.23 -166.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.512 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 32.0 Cg_exo -55.6 -18.56 20.71 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 121.55 1.5 . . . . 0.0 110.999 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.543 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 4.4 m-20 -89.92 -41.85 11.54 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.068 -1.424 . . . . 0.0 111.071 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 17' ' ' PHE . . . . . 0.509 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -56.9 -41.54 78.27 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.614 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.699 HG12 ' O ' ' B' ' 14' ' ' TYR . 2.4 p -82.52 -33.61 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.521 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.28 -33.33 69.31 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.457 -0.777 . . . . 0.0 112.012 176.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.753 ' O ' HG12 ' B' ' 24' ' ' VAL . 17.5 ptt180 -85.11 -27.85 25.98 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.609 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 9.3 tp -54.84 -46.2 74.6 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.814 171.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 22' ' ' GLN . . . . . 0.751 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 7.3 mt-30 -73.19 -45.88 53.78 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.157 178.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.714 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 11.3 t70 -51.89 -52.24 51.14 Favored 'General case' 0 C--N 1.314 -0.96 0 O-C-N 124.067 0.854 . . . . 0.0 111.841 -177.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 24' ' ' VAL . . . . . 0.753 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.4 p -82.02 -23.27 9.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.302 0.572 . . . . 0.0 109.56 -174.109 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.801 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -72.06 -18.87 61.91 Favored 'General case' 0 C--O 1.204 -1.307 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 26' ' ' GLN . . . . . 0.426 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -86.7 -37.54 17.86 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.814 177.799 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.714 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 40.9 mmtt -67.96 -37.23 81.32 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.999 178.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 33.4 t -103.08 -7.49 21.31 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.403 0.621 . . . . 0.0 110.189 -171.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.801 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 86.6 mt -116.98 127.18 74.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.428 178.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.44 -9.47 54.55 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.276 0.56 . . . . 0.0 110.199 177.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.58 ' H ' HG22 ' B' ' 29' ' ' ILE . 13.7 t70 -98.68 136.13 39.19 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.258 -177.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -75.55 -29.56 59.42 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.67 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.592 ' O ' HG13 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -77.36 -51.49 10.74 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -174.944 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.55 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -58.61 -27.86 65.08 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.378 176.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.867 ' O ' HG13 ' B' ' 39' ' ' VAL . 1.7 tmm_? -66.34 -60.86 2.38 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 178.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.488 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 25.9 mtpt -55.03 -56.1 23.58 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.382 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.713 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 19.6 m -54.8 -32.37 25.96 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.258 -170.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.859 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.2 tt -86.97 -34.07 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.525 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.867 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.0 m -65.97 -47.69 84.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.438 176.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.671 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 54.6 mt-10 -67.48 -23.43 65.49 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.711 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.812 HD11 HD21 ' A' ' 4' ' ' ASN . 0.0 OUTLIER -86.33 -55.94 3.67 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.258 176.648 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 42' ' ' MET . . . . . 0.675 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 14.7 mmt -62.2 -20.66 64.41 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-O 121.768 0.794 . . . . 0.0 109.578 -176.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.745 ' O ' ' HB2' ' B' ' 47' ' ' ALA . . . -48.59 -27.1 2.56 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.779 170.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 44' ' ' TYR . . . . . 0.503 ' CG ' ' HB2' ' B' ' 52' ' ' GLN . 9.1 t80 -105.36 -66.7 0.96 Allowed 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.491 ' HG2' HD12 ' B' ' 41' ' ' LEU . 13.1 mm-40 -47.97 -33.65 8.09 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 123.636 0.585 . . . . 0.0 112.405 -176.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.705 ' CB ' ' HG3' ' B' ' 7' ' ' ARG . 0.9 OUTLIER -99.55 -15.3 18.68 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.297 0.57 . . . . 0.0 111.724 -177.753 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.745 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -63.11 168.53 4.08 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.39 0.614 . . . . 0.0 111.483 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.558 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 11.2 m-20 -58.09 145.41 73.22 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.387 173.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -41.58 -49.49 5.18 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 122.741 2.294 . . . . 0.0 111.875 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.544 ' HA ' ' HB2' ' B' ' 53' ' ' SER . 0.3 OUTLIER -70.78 -33.69 71.01 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.372 1.069 . . . . 0.0 111.801 177.737 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.558 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 70.2 m -73.9 -39.16 64.06 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.29 0.566 . . . . 0.0 110.151 -174.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.541 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.9 pt20 -73.42 -30.65 63.37 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 175.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 53' ' ' SER . . . . . 0.554 ' O ' ' HE2' ' B' ' 56' ' ' LYS . 3.7 m -68.03 -20.87 65.03 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.26 172.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.709 ' HB2' HD11 ' B' ' 79' ' ' ILE . . . -76.97 -27.86 54.92 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.359 -0.838 . . . . 0.0 109.877 168.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.577 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 20.9 mt -89.66 -31.78 5.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -171.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.603 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -40.62 -37.92 1.08 Allowed Pre-proline 0 N--CA 1.49 1.525 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -173.82 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 53.9 Cg_endo -64.17 -28.97 64.83 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.178 1.919 . . . . 0.0 113.022 175.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 58' ' ' LEU . . . . . 0.56 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 2.0 mt -98.54 -15.65 19.45 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.668 ' NZ ' HD13 ' B' ' 41' ' ' LEU . 0.3 OUTLIER -52.77 109.31 0.39 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.385 179.459 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.86 -30.24 10.15 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.944 -175.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 34.9 mmtt -103.68 115.31 30.26 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 122.244 1.021 . . . . 0.0 111.688 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.595 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.6 p -122.53 145.22 44.25 Favored Pre-proline 0 C--N 1.297 -1.681 0 CA-C-N 113.64 -1.618 . . . . 0.0 109.559 170.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.568 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 98.6 Cg_exo -48.47 141.45 19.52 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.182 1.921 . . . . 0.0 111.21 168.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.53 101.82 0.1 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.991 -173.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.08 -9.47 70.12 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.034 -0.603 . . . . 0.0 113.157 175.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.568 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 4.2 m -89.56 -162.69 0.9 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 122.349 1.071 . . . . 0.0 111.962 -177.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.8 125.9 45.8 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 113.118 -1.855 . . . . 0.0 110.858 -173.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.595 HG12 ' HB ' ' B' ' 62' ' ' VAL . 0.9 OUTLIER -79.24 -31.36 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 C-N-CA 118.567 -1.253 . . . . 0.0 108.547 176.175 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.772 ' O ' HG13 ' B' ' 73' ' ' VAL . 7.0 mm -57.73 -49.28 81.32 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.139 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.522 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 42.8 t -48.81 -36.4 16.63 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.011 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.584 ' O ' ' HE3' ' B' ' 74' ' ' LYS . 1.4 mm-40 -84.81 -33.76 22.87 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 123.442 0.697 . . . . 0.0 110.591 -178.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 72' ' ' TYR . . . . . 0.56 ' CE1' ' HB2' ' B' ' 58' ' ' LEU . 5.0 m-30 -74.79 -37.8 62.29 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.671 -176.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.864 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.7 m -70.47 -32.76 51.07 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.676 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 174.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 74' ' ' LYS . . . . . 0.584 ' HE3' ' O ' ' B' ' 71' ' ' GLU . 2.4 ttpp -72.58 -27.3 62.1 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.866 178.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 75' ' ' ALA . . . . . 0.486 ' HB2' HD11 ' B' ' 58' ' ' LEU . . . -66.39 -41.82 88.81 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.3 174.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 4.2 m -101.12 10.52 40.83 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.496 -177.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -64.02 -27.94 69.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.059 178.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 78' ' ' GLY . . . . . 0.568 ' O ' ' HB2' ' B' ' 83' ' ' MET . . . -81.64 -22.08 60.69 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.619 171.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.709 HD11 ' HB2' ' B' ' 54' ' ' ALA . 49.9 mt -81.25 163.99 3.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 80' ' ' GLY . . . . . 0.437 ' N ' HG22 ' B' ' 79' ' ' ILE . . . 112.71 -13.12 25.0 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -174.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.86 155.36 8.03 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 175.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.51 -81.67 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.09 0.556 . . . . 0.0 112.339 178.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 83' ' ' MET . . . . . 0.568 ' HB2' ' O ' ' B' ' 78' ' ' GLY . 62.9 mtt -61.5 -29.74 70.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.677 0.275 . . . . 0.0 110.632 -176.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 84' ' ' HIS . . . . . 0.546 ' O ' ' HB2' ' B' ' 88' ' ' LEU . 11.7 t60 -56.62 -32.53 65.39 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 175.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -84.43 -19.4 33.52 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.132 0.492 . . . . 0.0 110.39 -176.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.74 -46.54 10.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.547 176.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -80.16 -13.89 58.9 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.111 -175.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.565 ' O ' ' HB3' ' B' ' 92' ' ' LEU . 0.4 OUTLIER -50.54 -37.42 39.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.495 179.706 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 49.8 ttm -83.49 -20.09 34.6 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.025 0.44 . . . . 0.0 110.981 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -93.43 -43.55 8.69 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.092 -173.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 91' ' ' GLN . . . . . 0.504 ' C ' ' HB3' ' B' ' 53' ' ' SER . 87.7 mt-30 -99.62 -51.22 3.81 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.347 -174.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.565 ' HB3' ' O ' ' B' ' 88' ' ' LEU . 0.4 OUTLIER -65.11 1.77 0.92 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 121.171 0.51 . . . . 0.0 110.338 177.934 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.465 ' H ' ' C ' ' B' ' 91' ' ' GLN . 3.4 pt-20 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.182 -0.913 . . . . 0.0 111.944 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo . . . . . 0 CA--C 1.518 -0.303 0 N-CA-C 109.1 -1.154 . . . . 0.0 109.1 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.735 ' HB2' HG23 ' A' ' 5' ' ' THR . 73.6 m -68.83 -177.23 0.96 Allowed 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 162.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.769 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -78.14 -53.92 6.83 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.649 172.549 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.574 ' OD1' ' HG ' ' B' ' 41' ' ' LEU . 2.2 p-10 -87.58 5.7 38.09 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.133 -0.939 . . . . 0.0 112.994 -164.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.735 HG23 ' HB2' ' A' ' 2' ' ' SER . 2.2 p -64.8 -3.83 3.73 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.069 0.462 . . . . 0.0 111.391 -176.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.52 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.6 m -75.38 131.9 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 175.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.768 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -153.18 158.91 42.47 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.443 ' HG2' ' HB3' ' A' ' 12' ' ' GLU . 2.3 tt0 -42.24 115.16 0.65 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 112.758 -2.019 . . . . 0.0 112.831 -178.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.16 -148.54 11.85 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.44 172.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.8 m -55.89 97.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.106 0.453 . . . . 0.0 110.937 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.0 pttt 40.61 40.28 0.89 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.332 1.053 . . . . 0.0 112.085 -174.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.443 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 42.3 tt0 -55.96 139.57 70.64 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.932 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.583 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 52.1 Cg_exo -51.29 122.67 10.51 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.158 1.905 . . . . 0.0 110.058 178.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.801 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 9.3 t80 -72.22 -52.88 6.8 Favored Pre-proline 0 N--CA 1.442 -0.842 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -166.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.544 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 36.7 Cg_exo -56.2 -20.01 29.73 Favored 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 121.665 1.577 . . . . 0.0 110.968 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.583 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.1 m-20 -89.76 -40.21 12.64 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 113.845 -1.525 . . . . 0.0 110.754 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.436 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -56.01 -43.79 78.04 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 175.512 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.678 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 2.4 p -80.58 -33.24 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.379 -179.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.72 -34.88 67.92 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 121.594 -0.691 . . . . 0.0 111.937 175.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.727 ' O ' HG12 ' A' ' 24' ' ' VAL . 16.7 ptt180 -84.93 -26.87 26.95 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.649 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 4.5 tp -54.35 -49.2 70.34 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 171.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.678 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 5.5 mt-30 -67.21 -52.29 43.01 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.338 177.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.779 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 23.8 t70 -47.53 -53.53 14.17 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 -175.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.727 HG12 ' O ' ' A' ' 20' ' ' ARG . 5.0 p -81.59 -28.3 10.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.452 0.644 . . . . 0.0 110.381 -168.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.918 ' HB3' ' CZ ' ' A' ' 35' ' ' ARG . . . -78.91 -17.69 55.11 Favored 'General case' 0 C--O 1.198 -1.623 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 175.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.555 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -76.21 -37.74 57.37 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 172.803 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.779 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 39.7 mmtt -64.23 -36.16 83.17 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.508 177.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.0 t -104.26 -12.93 16.37 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.086 0.469 . . . . 0.0 110.27 -172.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.633 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 91.7 mt -111.8 117.11 54.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.296 177.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.49 -1.78 56.27 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.225 0.536 . . . . 0.0 110.076 175.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.596 ' H ' HG22 ' A' ' 29' ' ' ILE . 10.8 t70 -99.52 131.67 45.37 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.29 -177.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -75.23 -25.48 58.14 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.841 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.597 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -81.08 -52.8 7.0 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -175.18 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.537 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -59.79 -24.68 64.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.54 177.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.918 ' CZ ' ' HB3' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -72.73 -57.41 4.12 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.998 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.513 ' O ' HG22 ' A' ' 39' ' ' VAL . 22.4 mtpt -52.85 -55.6 21.9 Favored 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.706 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.708 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 13.9 m -55.82 -33.08 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.195 -171.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.892 HG22 HH12 ' A' ' 35' ' ' ARG . 0.2 OUTLIER -87.35 -31.4 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 119.642 -0.823 . . . . 0.0 111.687 177.761 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.765 HG12 ' NH2' ' A' ' 35' ' ' ARG . 1.3 m -57.41 -57.05 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 118.666 -1.213 . . . . 0.0 109.168 168.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.61 ' HG2' HG22 ' A' ' 68' ' ' VAL . 46.2 mt-10 -63.19 -29.74 71.03 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 124.252 1.021 . . . . 0.0 112.611 -175.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.708 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -85.43 -49.98 7.67 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.937 179.602 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.598 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 19.7 mmt -67.5 -20.5 65.45 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.56 0.695 . . . . 0.0 109.517 -177.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.651 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -52.36 -26.74 13.18 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.655 172.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.596 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 17.2 t80 -105.98 -68.12 0.89 Allowed 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 174.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.477 ' CG ' HD12 ' A' ' 41' ' ' LEU . 8.8 mm-40 -48.47 -26.6 2.22 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 124.323 1.014 . . . . 0.0 113.024 -175.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.768 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.1 m-20 -108.15 -21.92 12.59 Favored 'General case' 0 N--CA 1.435 -1.212 0 O-C-N 122.083 -0.386 . . . . 0.0 111.567 -178.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.632 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -59.49 178.95 0.13 Allowed 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.932 0.872 . . . . 0.0 112.925 -174.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.594 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 8.7 m-20 -60.2 140.45 91.17 Favored Pre-proline 0 N--CA 1.442 -0.83 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.452 174.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.424 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 79.5 Cg_exo -42.6 -47.73 7.51 Favored 'Trans proline' 0 C--N 1.33 -0.447 0 C-N-CA 122.877 2.385 . . . . 0.0 112.091 -178.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.56 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 0.3 OUTLIER -72.85 -33.4 66.11 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.119 0.967 . . . . 0.0 111.627 178.368 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.684 ' HA ' ' CD1' ' A' ' 79' ' ' ILE . 99.1 m -74.85 -37.28 62.26 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -173.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.615 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.8 pt20 -72.54 -31.4 65.27 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 174.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.576 ' HB3' ' C ' ' A' ' 91' ' ' GLN . 12.0 m -68.49 -21.76 64.59 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.178 -1.373 . . . . 0.0 110.409 174.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.848 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -78.22 -25.18 46.86 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.756 0.789 . . . . 0.0 109.617 169.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.615 HD12 ' HA ' ' A' ' 52' ' ' GLN . 25.4 mt -89.56 -32.02 5.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -173.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.626 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -42.4 -38.94 2.81 Favored Pre-proline 0 N--CA 1.487 1.423 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -173.492 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 56.0 Cg_endo -63.57 -28.96 70.1 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 122.346 2.031 . . . . 0.0 112.958 175.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.547 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.6 mt -96.92 -16.53 20.63 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.596 ' HE3' ' HB3' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -53.36 109.41 0.43 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.189 -178.768 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.79 -20.38 47.47 Favored Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.525 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -104.11 114.19 28.26 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.477 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.3 p -123.02 140.28 33.18 Favored Pre-proline 0 C--N 1.311 -1.096 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 171.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.532 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 87.6 Cg_exo -48.58 138.73 24.57 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.429 2.086 . . . . 0.0 111.513 170.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.73 101.02 0.12 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.431 -175.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.09 -14.34 44.41 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.723 177.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.532 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 17.9 m -89.96 175.92 7.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.555 0.693 . . . . 0.0 111.673 -178.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.732 ' OD1' ' HB ' ' A' ' 69' ' ' ILE . 32.8 t70 -87.94 139.27 30.69 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.086 177.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.61 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -79.48 -30.58 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 C-N-CA 118.049 -1.46 . . . . 0.0 108.832 178.448 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.763 ' O ' HG13 ' A' ' 73' ' ' VAL . 6.2 mm -59.09 -47.9 88.52 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.978 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.789 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 43.2 t -44.83 -39.37 5.27 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.253 175.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -86.54 -28.8 23.14 Favored 'General case' 0 CA--C 1.512 -0.505 0 C-N-CA 122.771 0.428 . . . . 0.0 111.086 -177.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.601 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.3 m-30 -76.55 -35.6 58.15 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.716 0.77 . . . . 0.0 109.462 -178.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.801 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.5 m -71.39 -30.29 38.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 172.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.465 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -68.05 -32.43 72.77 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.292 175.143 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -63.03 -43.65 98.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.916 177.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.57 ' SG ' ' HB ' ' A' ' 79' ' ' ILE . 23.7 t -94.96 4.47 53.77 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.033 178.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.465 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 10.9 t70 -60.33 -26.07 66.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.233 0.54 . . . . 0.0 110.271 176.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 83' ' ' MET . . . -92.67 -28.36 12.66 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 115.452 -0.795 . . . . 0.0 112.501 174.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.848 HD11 ' HB2' ' A' ' 54' ' ' ALA . 65.0 mt -61.18 -87.01 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -172.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.449 ' N ' HG22 ' A' ' 79' ' ' ILE . . . 29.98 53.37 0.2 Allowed Glycine 0 C--N 1.339 0.707 0 N-CA-C 115.349 0.9 . . . . 0.0 115.349 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.583 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 80.52 -61.01 4.51 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.856 175.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.26 -69.55 0.14 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.41 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 65.6 mtt -73.94 -15.16 61.13 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.654 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 12.4 t60 -58.58 -34.31 70.94 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.049 176.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.583 ' HG2' ' O ' ' A' ' 81' ' ' GLY . 31.8 mmtp -82.44 -14.85 54.42 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.229 -178.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.6 -47.13 9.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.782 0.801 . . . . 0.0 110.74 175.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 9.7 mmt -86.77 -13.26 45.69 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.612 -1.176 . . . . 0.0 112.177 -172.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.654 ' HB2' ' O ' ' A' ' 84' ' ' HIS . 0.6 OUTLIER -48.38 -39.43 22.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.194 0.521 . . . . 0.0 112.055 -179.103 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 56.7 ttp -83.23 -19.82 35.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.97 0.414 . . . . 0.0 111.045 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -91.79 -51.7 5.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.944 0.402 . . . . 0.0 111.93 -174.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.576 ' C ' ' HB3' ' A' ' 53' ' ' SER . 94.0 mt-30 -89.86 -57.54 2.83 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.168 -174.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.629 ' HB3' ' O ' ' A' ' 88' ' ' LEU . 1.2 tm? -53.27 -33.73 54.31 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 176.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 3.1 pt-20 . . . . . 0 C--O 1.25 1.116 0 O-C-N 125.147 1.53 . . . . 0.0 113.561 -177.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 1' ' ' PRO . . . . . 0.437 ' HB2' ' H ' ' B' ' 2' ' ' SER . 94.2 Cg_endo . . . . . 0 CA--C 1.519 -0.271 0 N-CA-C 109.115 -1.148 . . . . 0.0 109.115 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.761 ' HB2' HG23 ' B' ' 5' ' ' THR . 74.3 m -68.69 -177.77 1.04 Allowed 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 162.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.782 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -77.85 -53.82 7.05 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.64 172.827 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.55 ' OD1' ' HG ' ' A' ' 41' ' ' LEU . 2.1 p-10 -87.61 5.71 38.11 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.973 -164.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.761 HG23 ' HB2' ' B' ' 2' ' ' SER . 2.2 p -64.85 -3.75 3.71 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.038 0.447 . . . . 0.0 111.418 -176.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.529 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.6 m -75.5 132.15 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 175.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.775 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -153.32 158.76 42.05 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -179.724 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 8' ' ' GLN . . . . . 0.451 ' HG2' ' HB3' ' B' ' 12' ' ' GLU . 2.3 tt0 -42.32 115.14 0.65 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 112.95 -1.932 . . . . 0.0 112.845 -178.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.4 -148.58 12.29 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.424 173.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 21.6 m -55.45 97.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 117.187 0.493 . . . . 0.0 111.096 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 60.9 pttt 40.5 40.73 0.93 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.275 1.03 . . . . 0.0 111.974 -174.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.451 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 41.1 tt0 -56.4 139.53 74.02 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.891 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 13' ' ' PRO . . . . . 0.574 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 52.0 Cg_exo -51.19 122.45 10.07 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.25 1.967 . . . . 0.0 110.019 178.249 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 14' ' ' TYR . . . . . 0.803 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 9.3 t80 -72.19 -52.91 6.84 Favored Pre-proline 0 N--CA 1.44 -0.935 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -166.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.533 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 36.6 Cg_exo -55.94 -20.11 28.4 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 121.589 1.526 . . . . 0.0 110.979 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.574 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 0.9 OUTLIER -89.77 -39.96 12.79 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.869 -1.514 . . . . 0.0 110.826 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 17' ' ' PHE . . . . . 0.441 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -56.28 -43.66 79.04 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 175.575 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.672 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 2.4 p -80.61 -33.23 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.344 -178.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.78 -34.71 67.89 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 121.627 -0.671 . . . . 0.0 111.967 175.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.731 ' O ' HG12 ' B' ' 24' ' ' VAL . 16.6 ptt180 -85.04 -26.96 26.69 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.652 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 4.5 tp -54.33 -49.24 70.18 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 171.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 22' ' ' GLN . . . . . 0.672 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 5.6 mt-30 -67.16 -52.39 42.07 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.203 177.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.801 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 24.5 t70 -47.38 -53.67 13.24 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -175.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 24' ' ' VAL . . . . . 0.731 HG12 ' O ' ' B' ' 20' ' ' ARG . 4.9 p -81.55 -28.27 10.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.289 0.566 . . . . 0.0 110.405 -168.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.91 ' HB3' ' CZ ' ' B' ' 35' ' ' ARG . . . -78.86 -17.6 55.36 Favored 'General case' 0 C--O 1.198 -1.646 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 175.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 26' ' ' GLN . . . . . 0.548 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -76.6 -37.36 56.57 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 172.83 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.801 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 39.1 mmtt -64.79 -35.32 80.72 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.539 177.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 32.7 t -105.0 -12.38 16.2 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.026 0.441 . . . . 0.0 110.426 -172.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.647 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 91.6 mt -112.43 116.8 53.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.359 177.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.03 -1.49 54.89 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.227 0.537 . . . . 0.0 110.153 175.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.592 ' H ' HG22 ' B' ' 29' ' ' ILE . 10.5 t70 -99.61 131.59 45.51 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.164 -177.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -75.12 -25.78 58.72 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.858 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.596 ' O ' HG13 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -80.93 -53.02 6.82 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -174.981 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.553 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -59.6 -24.61 63.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.641 177.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.91 ' CZ ' ' HB3' ' B' ' 25' ' ' ALA . 0.0 OUTLIER -72.87 -57.29 4.18 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.964 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.517 ' O ' HG22 ' B' ' 39' ' ' VAL . 22.5 mtpt -52.91 -55.58 22.27 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.754 177.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.714 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 13.7 m -55.88 -32.91 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.402 -171.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.867 HG22 HH12 ' B' ' 35' ' ' ARG . 0.2 OUTLIER -87.35 -31.45 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.632 177.687 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.757 HG12 ' NH2' ' B' ' 35' ' ' ARG . 1.3 m -57.35 -57.02 11.8 Favored 'Isoleucine or valine' 0 C--N 1.343 0.308 0 C-N-CA 118.663 -1.215 . . . . 0.0 109.242 168.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.6 ' HG2' HG22 ' B' ' 68' ' ' VAL . 46.3 mt-10 -63.25 -29.74 71.02 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 124.282 1.033 . . . . 0.0 112.572 -175.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.714 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -85.42 -50.08 7.59 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.983 179.52 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 42' ' ' MET . . . . . 0.588 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 19.8 mmt -67.4 -20.29 65.51 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.618 0.723 . . . . 0.0 109.672 -177.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.643 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -52.54 -26.76 14.12 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.668 172.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 44' ' ' TYR . . . . . 0.599 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 16.9 t80 -105.93 -68.03 0.9 Allowed 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.467 ' CG ' HD12 ' B' ' 41' ' ' LEU . 9.5 mm-40 -48.57 -26.69 2.33 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 124.259 0.975 . . . . 0.0 112.979 -175.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.775 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.2 m-20 -108.18 -21.9 12.59 Favored 'General case' 0 N--CA 1.435 -1.205 0 O-C-N 122.191 -0.318 . . . . 0.0 111.514 -178.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -59.41 179.27 0.11 Allowed 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 122.018 0.913 . . . . 0.0 112.99 -174.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.596 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 7.9 m-20 -60.43 140.42 91.98 Favored Pre-proline 0 N--CA 1.442 -0.846 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.436 174.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 49' ' ' PRO . . . . . 0.422 ' O ' ' HG2' ' B' ' 52' ' ' GLN . 78.3 Cg_exo -42.41 -47.62 7.25 Favored 'Trans proline' 0 C--N 1.33 -0.411 0 C-N-CA 122.832 2.355 . . . . 0.0 112.251 -178.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.564 ' HA ' ' HB2' ' B' ' 53' ' ' SER . 0.3 OUTLIER -73.09 -33.51 65.64 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 124.226 1.01 . . . . 0.0 111.654 178.435 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.686 ' HA ' ' CD1' ' B' ' 79' ' ' ILE . 98.0 m -74.72 -37.18 62.62 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 120.911 0.386 . . . . 0.0 110.024 -173.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.617 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.8 pt20 -72.52 -31.52 65.39 Favored 'General case' 0 C--O 1.211 -0.925 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 174.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 53' ' ' SER . . . . . 0.591 ' HB3' ' C ' ' B' ' 91' ' ' GLN . 13.2 m -68.42 -21.91 64.64 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.389 174.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.824 ' HB2' HD11 ' B' ' 79' ' ' ILE . . . -78.17 -25.0 47.0 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.756 0.789 . . . . 0.0 109.668 169.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.617 HD12 ' HA ' ' B' ' 52' ' ' GLN . 25.2 mt -89.62 -31.88 5.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -173.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.629 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -42.51 -38.79 2.82 Favored Pre-proline 0 N--CA 1.488 1.425 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -173.477 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 56.0 Cg_endo -63.74 -29.1 68.66 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 122.261 1.974 . . . . 0.0 112.912 175.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 58' ' ' LEU . . . . . 0.565 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.6 mt -96.65 -16.41 20.99 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.599 ' HE3' ' HB3' ' B' ' 44' ' ' TYR . 0.0 OUTLIER -53.42 109.37 0.43 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.161 -178.801 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.76 -20.08 49.14 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.493 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -104.15 114.27 28.39 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.474 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.3 p -122.96 140.4 33.33 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 171.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.531 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 86.5 Cg_exo -48.85 138.68 26.18 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.347 2.031 . . . . 0.0 111.537 170.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.79 101.2 0.13 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.421 -175.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.96 -14.29 44.97 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.817 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.531 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 19.0 m -89.85 176.21 6.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.671 0.748 . . . . 0.0 111.497 -178.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 67' ' ' ASP . . . . . 0.716 ' OD1' ' HB ' ' B' ' 69' ' ' ILE . 29.8 t70 -88.03 139.45 30.49 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.172 176.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.6 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.9 OUTLIER -79.6 -30.69 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 C-N-CA 118.072 -1.451 . . . . 0.0 108.765 178.417 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.754 ' O ' HG13 ' B' ' 73' ' ' VAL . 6.1 mm -59.01 -47.92 88.33 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.079 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.832 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 41.0 t -44.9 -39.3 5.31 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.273 175.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -86.45 -29.03 23.13 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 121.101 0.477 . . . . 0.0 111.015 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 72' ' ' TYR . . . . . 0.593 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.3 m-30 -76.48 -35.54 58.35 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.675 0.75 . . . . 0.0 109.402 -178.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.803 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.5 m -71.46 -30.5 39.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 172.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 74' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' B' ' 70' ' ' SER . 0.4 OUTLIER -67.92 -32.31 72.68 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.235 175.134 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 75' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -63.08 -43.76 97.64 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.888 177.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.579 ' SG ' ' HB ' ' B' ' 79' ' ' ILE . 26.3 t -95.08 4.4 53.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.037 178.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 77' ' ' ASP . . . . . 0.46 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 8.9 t70 -60.02 -26.58 66.2 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.141 176.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 78' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' B' ' 83' ' ' MET . . . -92.36 -27.82 14.5 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.554 174.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.824 HD11 ' HB2' ' B' ' 54' ' ' ALA . 65.2 mt -61.58 -86.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -172.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 80' ' ' GLY . . . . . 0.438 ' N ' HG22 ' B' ' 79' ' ' ILE . . . 29.87 53.55 0.19 Allowed Glycine 0 C--N 1.339 0.721 0 N-CA-C 115.252 0.861 . . . . 0.0 115.252 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.577 ' O ' ' HG2' ' B' ' 85' ' ' LYS . . . 80.11 -60.66 4.44 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.85 -0.69 . . . . 0.0 113.893 175.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.35 -69.25 0.15 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -173.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 83' ' ' MET . . . . . 0.416 ' HB2' ' O ' ' B' ' 78' ' ' GLY . 65.5 mtt -74.24 -14.93 61.0 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 84' ' ' HIS . . . . . 0.649 ' O ' ' HB2' ' B' ' 88' ' ' LEU . 12.1 t60 -58.76 -34.35 71.32 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.975 176.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.577 ' HG2' ' O ' ' B' ' 81' ' ' GLY . 31.7 mmtp -82.38 -14.71 54.78 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.179 0.514 . . . . 0.0 110.288 -178.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.48 -47.73 9.02 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.666 0.746 . . . . 0.0 110.559 175.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 9.9 mmt -86.55 -13.05 47.02 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.592 -1.185 . . . . 0.0 112.176 -172.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.649 ' HB2' ' O ' ' B' ' 84' ' ' HIS . 0.6 OUTLIER -48.26 -39.51 21.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.242 0.544 . . . . 0.0 111.968 -179.277 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 56.6 ttp -83.23 -20.16 35.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.917 0.389 . . . . 0.0 110.912 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -91.54 -51.49 5.24 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.898 -174.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 91' ' ' GLN . . . . . 0.591 ' C ' ' HB3' ' B' ' 53' ' ' SER . 94.3 mt-30 -89.91 -57.76 2.75 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.076 -174.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.641 ' HB3' ' O ' ' B' ' 88' ' ' LEU . 1.2 tm? -53.11 -34.03 54.92 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 176.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' B' ' 91' ' ' GLN . 2.9 pt-20 . . . . . 0 C--O 1.249 1.037 0 O-C-N 125.087 1.492 . . . . 0.0 113.606 -177.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.456 ' C ' ' HA3' ' B' ' 60' ' ' GLY . 93.5 Cg_endo . . . . . 0 CA--C 1.517 -0.344 0 N-CA-C 109.114 -1.148 . . . . 0.0 109.114 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.544 ' HB2' HG23 ' A' ' 5' ' ' THR . 58.9 m -65.31 177.78 1.04 Allowed 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 162.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.702 ' CB ' ' HA ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -77.27 -54.08 6.92 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.566 174.541 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.52 ' CG ' ' HG3' ' A' ' 42' ' ' MET . 1.8 p-10 -86.58 6.62 29.95 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.792 -165.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.627 ' CG2' ' HD3' ' B' ' 59' ' ' LYS . 0.7 OUTLIER -62.21 -4.94 1.97 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.025 0.441 . . . . 0.0 111.613 -177.507 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.662 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.4 m -75.93 130.3 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 174.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.76 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -154.79 159.64 40.75 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 118.6 -1.24 . . . . 0.0 113.643 -179.752 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.472 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.4 mt-30 -41.39 113.75 0.44 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.125 -1.852 . . . . 0.0 112.809 -178.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.98 -141.75 6.24 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.56 174.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.6 m -62.01 96.81 0.07 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 117.011 0.406 . . . . 0.0 110.528 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.2 pttt 41.54 41.94 1.8 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.423 1.089 . . . . 0.0 112.093 -176.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.413 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 71.8 tt0 -58.77 140.0 86.12 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.114 178.145 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.531 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 31.5 Cg_exo -54.25 123.55 13.85 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.23 1.953 . . . . 0.0 110.041 178.072 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.783 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 10.4 t80 -71.13 -52.4 9.35 Favored Pre-proline 0 N--CA 1.439 -0.991 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -166.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.55 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 37.5 Cg_exo -56.47 -19.38 28.91 Favored 'Trans proline' 0 C--N 1.36 1.134 0 C-N-CA 121.478 1.452 . . . . 0.0 111.116 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.531 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.4 m-20 -90.71 -39.32 12.51 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 113.952 -1.476 . . . . 0.0 110.766 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.472 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -56.78 -44.05 81.46 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.532 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.687 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 2.4 p -78.72 -32.99 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.12 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.71 -35.11 68.14 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 121.967 -0.458 . . . . 0.0 111.91 175.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.733 ' O ' HG12 ' A' ' 24' ' ' VAL . 15.3 ptt180 -85.18 -25.38 27.44 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.65 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 3.9 tp -55.57 -48.73 74.31 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.313 171.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.687 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 36.4 mt-30 -66.78 -52.05 48.59 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.658 177.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.739 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 11.4 t70 -47.79 -53.75 14.43 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -175.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 20' ' ' ARG . 4.3 p -82.53 -26.6 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 CA-C-O 122.04 0.924 . . . . 0.0 109.56 -169.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.709 ' HB3' ' CZ ' ' A' ' 35' ' ' ARG . . . -78.51 -16.88 57.01 Favored 'General case' 0 C--O 1.197 -1.699 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 176.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.471 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -80.04 -37.14 34.62 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.821 0.82 . . . . 0.0 108.88 172.875 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.739 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 44.5 mmtt -63.69 -32.73 74.31 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.429 176.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.433 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 34.7 m -106.06 -11.39 16.14 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.06 0.457 . . . . 0.0 110.622 -174.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.675 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 96.3 mt -117.58 119.43 61.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.57 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.28 -1.87 58.27 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.346 0.593 . . . . 0.0 110.08 175.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.536 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 9.6 t70 -96.65 121.83 38.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.385 -176.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -68.06 -23.02 64.91 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.999 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.563 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -82.42 -54.04 5.52 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -177.42 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.551 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -57.91 -24.96 60.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.84 178.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.917 ' NH1' ' HA ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -69.14 -62.2 1.48 Allowed 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 176.92 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.492 ' O ' HG22 ' A' ' 39' ' ' VAL . 18.0 mtpt -52.43 -53.93 38.85 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 120.809 0.338 . . . . 0.0 111.119 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.693 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 14.2 m -55.27 -35.65 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.308 -172.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.773 HG22 HH22 ' A' ' 35' ' ' ARG . 0.1 OUTLIER -87.36 -26.95 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 178.088 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.706 HG12 ' NH2' ' A' ' 35' ' ' ARG . 1.1 m -59.73 -55.97 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 119.091 -1.044 . . . . 0.0 108.316 169.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.613 ' HG2' HG22 ' A' ' 68' ' ' VAL . 41.7 mt-10 -61.52 -34.33 75.34 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.713 -178.044 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.693 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -74.87 -58.87 3.02 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.613 179.642 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.52 ' HG3' ' CG ' ' A' ' 4' ' ' ASN . 22.8 mmt -66.96 -20.13 65.84 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.418 0.628 . . . . 0.0 110.022 -174.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.66 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -51.75 -27.07 10.88 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.43 171.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.525 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 18.1 t80 -106.18 -67.6 0.92 Allowed 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.622 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 8.0 mm-40 -47.49 -32.91 5.66 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 124.377 1.048 . . . . 0.0 112.284 -173.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.76 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.4 m-20 -104.47 -21.06 13.51 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.413 -174.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.591 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -59.46 179.43 0.11 Allowed 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.797 0.808 . . . . 0.0 112.86 -174.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.645 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 8.6 m-20 -60.1 141.05 90.58 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.346 175.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.419 ' HA ' HE21 ' A' ' 52' ' ' GLN . 70.9 Cg_exo -43.1 -44.65 9.67 Favored 'Trans proline' 0 C--N 1.331 -0.368 0 C-N-CA 122.819 2.346 . . . . 0.0 112.025 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.52 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 0.2 OUTLIER -76.79 -31.74 57.19 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.314 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.645 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 81.4 m -76.96 -36.33 56.58 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 120.901 0.382 . . . . 0.0 110.238 -173.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.561 ' HA ' HD12 ' A' ' 55' ' ' ILE . 29.4 pt20 -73.25 -30.92 63.79 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 173.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.554 ' O ' ' HE3' ' A' ' 56' ' ' LYS . 3.9 m -68.91 -19.8 64.21 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.052 -1.431 . . . . 0.0 110.446 173.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.745 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -78.75 -27.1 44.68 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.646 0.736 . . . . 0.0 109.93 167.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.561 HD12 ' HA ' ' A' ' 52' ' ' GLN . 22.7 mt -89.23 -32.48 5.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -172.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.599 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -40.57 -38.72 1.29 Allowed Pre-proline 0 N--CA 1.488 1.428 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -174.461 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 53.3 Cg_endo -64.06 -28.53 65.75 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 122.233 1.956 . . . . 0.0 112.828 175.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.549 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.0 OUTLIER -99.51 -14.6 18.99 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.722 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.63 ' HD3' ' CG2' ' B' ' 5' ' ' THR . 0.1 OUTLIER -50.0 109.78 0.32 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.404 -178.844 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.456 ' HA3' ' C ' ' B' ' 1' ' ' PRO . . . 87.18 -17.94 39.49 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.358 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt -103.59 114.9 29.52 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.504 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.3 p -123.57 142.33 38.74 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.352 174.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.522 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 72.0 Cg_exo -52.35 137.71 56.13 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.349 2.033 . . . . 0.0 111.295 169.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.8 109.66 2.98 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.969 0.414 . . . . 0.0 110.898 -176.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.23 -16.96 44.9 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.112 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.522 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 14.9 m -94.22 175.0 6.86 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.164 0.507 . . . . 0.0 111.133 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -93.23 147.34 22.98 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.476 -0.784 . . . . 0.0 108.981 176.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.613 HG22 ' HG2' ' A' ' 40' ' ' GLU . 1.1 m -81.38 -29.63 10.81 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 C-N-CA 118.33 -1.348 . . . . 0.0 108.787 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.781 ' O ' HG13 ' A' ' 73' ' ' VAL . 5.3 mm -60.14 -47.24 92.79 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.133 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.71 -178.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 40.7 t -47.68 -36.58 11.4 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.14 177.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -85.89 -31.52 22.16 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-O 121.046 0.45 . . . . 0.0 111.018 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.617 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.2 m-30 -74.49 -36.51 63.27 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.672 0.749 . . . . 0.0 109.516 -178.015 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.783 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.4 m -71.14 -30.72 41.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 173.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -69.7 -28.58 65.95 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.536 175.477 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -65.69 -45.81 81.38 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.766 176.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.747 ' SG ' ' HB ' ' A' ' 79' ' ' ILE . 32.0 t -93.17 9.46 35.91 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.826 177.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.478 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 5.1 t70 -58.84 -26.79 64.5 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.572 175.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.8 -20.47 31.25 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.322 174.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.747 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 83.5 mt -83.93 129.89 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 121.108 0.48 . . . . 0.0 111.45 -176.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 161.28 33.7 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.746 175.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.603 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 141.24 -102.91 0.32 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.82 176.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.92 -54.84 42.01 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -173.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 59.3 mtt -67.34 -32.02 72.69 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.907 0.384 . . . . 0.0 110.22 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.515 ' HA ' ' OE2' ' A' ' 50' ' ' GLU . 9.1 t60 -59.04 -36.59 75.26 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.747 176.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' A' ' 81' ' ' GLY . 31.7 mmtp -80.07 -17.93 51.38 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 121.872 -0.518 . . . . 0.0 110.507 -177.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.08 -42.5 13.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.401 0.62 . . . . 0.0 110.703 176.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -85.48 -13.58 48.67 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.508 -175.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' A' ' 84' ' ' HIS . 0.2 OUTLIER -49.02 -46.82 44.69 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 123.446 0.466 . . . . 0.0 111.752 -179.391 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 27.9 ttt -79.87 -14.59 58.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.999 0.428 . . . . 0.0 110.516 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -89.69 -47.32 8.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.779 -176.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.511 ' C ' ' HB3' ' A' ' 53' ' ' SER . 89.7 mt-30 -99.24 -50.89 3.98 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -170.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.468 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -45.83 -35.97 4.87 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.559 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 . . . . . 0 C--O 1.252 1.206 0 CA-C-N 114.074 -1.421 . . . . 0.0 112.705 -176.643 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' PRO . . . . . 0.456 ' C ' ' HA3' ' A' ' 60' ' ' GLY . 95.6 Cg_endo . . . . . 0 CA--C 1.518 -0.294 0 N-CA-C 109.191 -1.119 . . . . 0.0 109.191 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.551 ' HB2' HG23 ' B' ' 5' ' ' THR . 67.7 m -65.66 177.78 1.16 Allowed 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 162.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.694 ' CB ' ' HA ' ' B' ' 25' ' ' ALA . 0.1 OUTLIER -77.17 -54.28 6.7 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.524 174.583 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.513 ' CG ' ' HG3' ' B' ' 42' ' ' MET . 1.8 p-10 -86.48 6.56 29.88 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.726 -1.125 . . . . 0.0 112.673 -165.222 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.63 ' CG2' ' HD3' ' A' ' 59' ' ' LYS . 0.7 OUTLIER -62.28 -4.86 1.98 Allowed 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.98 0.419 . . . . 0.0 111.591 -177.425 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.672 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.4 m -75.92 130.44 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 174.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.754 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -154.99 159.46 40.38 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 118.648 -1.221 . . . . 0.0 113.717 -179.678 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 8' ' ' GLN . . . . . 0.479 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.4 mt-30 -41.12 114.01 0.45 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.276 -1.783 . . . . 0.0 112.832 -178.265 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.13 -141.94 6.43 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.623 174.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 20.0 m -61.66 96.82 0.07 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.93 0.365 . . . . 0.0 110.572 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.402 ' HB2' ' HA2' ' B' ' 80' ' ' GLY . 62.3 pttt 41.24 42.24 1.67 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.36 1.064 . . . . 0.0 112.209 -176.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.415 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 73.2 tt0 -58.98 139.88 87.11 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.971 178.109 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 13' ' ' PRO . . . . . 0.534 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 31.4 Cg_exo -54.25 123.5 13.71 Favored 'Trans proline' 0 CA--C 1.511 -0.665 0 C-N-CA 122.219 1.946 . . . . 0.0 110.145 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 14' ' ' TYR . . . . . 0.781 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 10.2 t80 -70.94 -52.39 9.84 Favored Pre-proline 0 N--CA 1.44 -0.97 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -166.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.544 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 38.3 Cg_exo -56.47 -19.45 29.24 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 121.495 1.463 . . . . 0.0 111.127 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.534 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.3 m-20 -90.69 -38.93 12.75 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 113.933 -1.485 . . . . 0.0 110.895 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 17' ' ' PHE . . . . . 0.479 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -57.23 -43.94 83.34 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.562 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.667 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 2.4 p -78.72 -33.15 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.072 -179.071 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.65 -35.05 67.93 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 121.846 -0.534 . . . . 0.0 111.939 175.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.733 ' O ' HG12 ' B' ' 24' ' ' VAL . 15.3 ptt180 -85.13 -25.6 27.38 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.65 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 3.9 tp -55.26 -48.89 73.34 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 171.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 22' ' ' GLN . . . . . 0.667 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 36.1 mt-30 -66.65 -52.19 47.72 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.661 177.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.737 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 11.6 t70 -47.54 -54.01 12.84 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -176.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 24' ' ' VAL . . . . . 0.733 HG12 ' O ' ' B' ' 20' ' ' ARG . 4.2 p -82.46 -26.45 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 CA-C-O 121.975 0.893 . . . . 0.0 109.569 -169.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.715 ' HB3' ' CZ ' ' B' ' 35' ' ' ARG . . . -78.57 -16.81 56.99 Favored 'General case' 0 C--O 1.198 -1.638 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 176.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 26' ' ' GLN . . . . . 0.462 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -80.15 -37.29 33.77 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.025 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.737 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 45.0 mmtt -63.67 -32.83 74.44 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.333 177.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 28' ' ' SER . . . . . 0.429 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 29.2 m -106.02 -11.18 16.23 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.087 0.47 . . . . 0.0 110.578 -174.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.689 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 95.9 mt -117.79 119.34 61.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.554 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.42 -1.63 58.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.309 0.576 . . . . 0.0 110.114 175.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.549 ' H ' HG22 ' B' ' 29' ' ' ILE . 9.3 t70 -96.84 121.96 39.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.457 -177.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -68.4 -22.68 64.62 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.95 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.58 ' O ' HG13 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -82.54 -53.94 5.56 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -177.555 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.561 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -57.95 -24.95 60.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.881 178.227 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.94 ' NH1' ' HA ' ' B' ' 35' ' ' ARG . 0.0 OUTLIER -69.11 -62.21 1.47 Allowed 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.843 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.501 ' O ' HG22 ' B' ' 39' ' ' VAL . 18.0 mtpt -52.45 -54.06 37.22 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 120.715 0.293 . . . . 0.0 111.087 -178.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.689 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 14.1 m -55.1 -35.77 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.321 -172.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.755 HG22 HH22 ' B' ' 35' ' ' ARG . 0.1 OUTLIER -87.38 -26.94 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 178.142 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.706 HG12 ' NH2' ' B' ' 35' ' ' ARG . 1.1 m -59.62 -56.05 19.8 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 C-N-CA 118.987 -1.085 . . . . 0.0 108.318 168.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.628 ' HG2' HG22 ' B' ' 68' ' ' VAL . 43.7 mt-10 -61.34 -34.66 75.63 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 114.46 -1.245 . . . . 0.0 111.672 -177.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.689 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -74.53 -58.86 3.02 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.7 179.716 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 42' ' ' MET . . . . . 0.513 ' HG3' ' CG ' ' B' ' 4' ' ' ASN . 22.9 mmt -66.86 -20.2 65.88 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.343 0.592 . . . . 0.0 109.964 -174.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.654 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -51.77 -27.22 11.47 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.313 171.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 44' ' ' TYR . . . . . 0.516 ' CG ' ' HD2' ' B' ' 59' ' ' LYS . 18.1 t80 -106.08 -67.57 0.92 Allowed 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 175.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.624 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 7.8 mm-40 -47.54 -33.04 5.94 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 124.378 1.049 . . . . 0.0 112.196 -173.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.754 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.4 m-20 -104.39 -20.93 13.57 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.419 -174.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.577 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -59.62 179.43 0.12 Allowed 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.8 0.809 . . . . 0.0 112.864 -174.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.646 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 8.8 m-20 -59.99 140.98 90.24 Favored Pre-proline 0 N--CA 1.443 -0.796 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.488 175.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 49' ' ' PRO . . . . . 0.412 ' HA ' HE21 ' B' ' 52' ' ' GLN . 71.5 Cg_exo -43.4 -44.32 10.53 Favored 'Trans proline' 0 C--N 1.332 -0.337 0 C-N-CA 122.792 2.328 . . . . 0.0 112.016 -178.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.526 ' HA ' ' HB2' ' B' ' 53' ' ' SER . 0.2 OUTLIER -76.94 -31.55 56.7 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.326 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.646 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 83.4 m -77.26 -36.45 54.39 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -173.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.557 ' HA ' HD12 ' B' ' 55' ' ' ILE . 29.4 pt20 -73.16 -30.94 63.93 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 173.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 53' ' ' SER . . . . . 0.568 ' O ' ' HE3' ' B' ' 56' ' ' LYS . 3.7 m -68.9 -19.84 64.23 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.183 -1.371 . . . . 0.0 110.498 173.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.729 ' HB2' HD11 ' B' ' 79' ' ' ILE . . . -78.67 -27.08 45.11 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.612 0.72 . . . . 0.0 110.006 167.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.557 HD12 ' HA ' ' B' ' 52' ' ' GLN . 22.6 mt -89.39 -32.24 5.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 -171.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.598 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -40.7 -38.71 1.34 Allowed Pre-proline 0 N--CA 1.487 1.384 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -174.601 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 51.7 Cg_endo -63.72 -29.0 68.81 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.193 1.928 . . . . 0.0 112.809 175.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 58' ' ' LEU . . . . . 0.563 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.0 OUTLIER -99.29 -14.6 19.17 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 -179.5 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.627 ' HD3' ' CG2' ' A' ' 5' ' ' THR . 0.1 OUTLIER -49.87 109.78 0.32 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.448 -178.903 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.456 ' HA3' ' C ' ' A' ' 1' ' ' PRO . . . 87.09 -18.32 36.89 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.357 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -103.36 114.85 29.46 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -178.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.497 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.4 p -123.55 142.41 38.91 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.353 174.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.548 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 74.7 Cg_exo -52.22 138.03 54.85 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.41 2.073 . . . . 0.0 111.419 168.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.21 108.53 2.74 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.068 -176.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.09 -17.2 41.56 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.114 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.548 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 16.3 m -94.14 175.28 6.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.177 0.513 . . . . 0.0 111.073 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -93.12 147.35 22.94 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.628 HG22 ' HG2' ' B' ' 40' ' ' GLU . 1.1 m -81.37 -29.54 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 C-N-CA 118.371 -1.331 . . . . 0.0 108.856 178.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.777 ' O ' HG13 ' B' ' 73' ' ' VAL . 5.3 mm -60.18 -47.14 93.27 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.093 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.695 -178.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 40.8 t -48.01 -36.51 12.89 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.078 177.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -85.79 -31.25 22.44 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 122.862 0.465 . . . . 0.0 111.079 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 72' ' ' TYR . . . . . 0.607 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.2 m-30 -74.77 -36.72 62.55 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 121.671 0.748 . . . . 0.0 109.489 -178.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.781 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.4 m -70.9 -30.82 43.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 173.094 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 74' ' ' LYS . . . . . 0.493 ' O ' ' HB3' ' B' ' 77' ' ' ASP . 0.0 OUTLIER -69.66 -28.54 65.97 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.552 175.495 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 75' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -65.51 -46.12 80.89 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.752 176.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.741 ' SG ' ' HB ' ' B' ' 79' ' ' ILE . 32.1 t -93.02 9.78 34.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.84 178.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 77' ' ' ASP . . . . . 0.493 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 4.4 t70 -59.18 -26.5 64.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.637 175.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -94.21 -20.52 30.04 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.286 173.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.741 ' HB ' ' SG ' ' B' ' 76' ' ' CYS . 83.9 mt -83.58 130.03 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-O 121.133 0.492 . . . . 0.0 111.401 -176.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 80' ' ' GLY . . . . . 0.402 ' HA2' ' HB2' ' B' ' 11' ' ' LYS . . . 161.43 33.16 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.888 175.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.621 ' O ' ' HG2' ' B' ' 85' ' ' LYS . . . 142.03 -103.17 0.32 Allowed Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.879 176.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.83 -54.9 41.11 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -173.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 83' ' ' MET . . . . . . . . . . . . . 58.1 mtt -67.45 -32.04 72.63 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.849 0.356 . . . . 0.0 110.174 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 84' ' ' HIS . . . . . 0.513 ' HA ' ' OE2' ' B' ' 50' ' ' GLU . 9.9 t60 -58.95 -36.68 75.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.755 176.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.621 ' HG2' ' O ' ' B' ' 81' ' ' GLY . 31.7 mmtp -80.27 -17.43 52.18 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.542 -177.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.28 -42.73 13.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.673 176.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -85.27 -13.63 49.18 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.494 -175.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' B' ' 84' ' ' HIS . 0.2 OUTLIER -49.25 -46.26 45.84 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 123.445 0.466 . . . . 0.0 111.833 -179.232 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 28.0 ttt -80.32 -14.68 58.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.116 0.484 . . . . 0.0 110.529 -178.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -89.66 -47.32 8.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.507 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 91' ' ' GLN . . . . . 0.52 ' C ' ' HB3' ' B' ' 53' ' ' SER . 89.2 mt-30 -99.1 -51.15 3.92 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -170.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.471 ' HB2' HD12 ' B' ' 88' ' ' LEU . 0.0 OUTLIER -45.55 -36.24 4.49 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 179.628 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 . . . . . 0 C--O 1.249 1.057 0 CA-C-N 113.976 -1.465 . . . . 0.0 112.578 -176.492 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo . . . . . 0 N--CA 1.464 -0.227 0 N-CA-C 108.601 -1.346 . . . . 0.0 108.601 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.2 m -70.44 -176.12 1.17 Allowed 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 163.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.618 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -77.14 -54.42 6.54 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 122.406 1.098 . . . . 0.0 109.062 171.681 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.679 ' HB2' HD11 ' A' ' 21' ' ' LEU . 2.4 p-10 -85.6 5.91 29.66 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 113.533 -1.667 . . . . 0.0 113.332 -160.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.24 -1.05 7.02 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -174.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.687 ' O ' HG23 ' A' ' 6' ' ' VAL . 24.0 m -81.41 92.84 2.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 122.259 1.028 . . . . 0.0 112.162 -174.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 1.096 ' NE ' ' HB3' ' A' ' 46' ' ' ASN . 13.8 mmm180 -107.19 150.6 26.44 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.506 -1.371 . . . . 0.0 112.978 -159.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.582 ' HG3' ' CG ' ' A' ' 17' ' ' PHE . 2.1 tt0 -44.41 109.12 0.14 Allowed 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 112.53 -2.123 . . . . 0.0 111.572 173.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.39 -152.56 9.42 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.742 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.8 m -55.81 97.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.911 0.355 . . . . 0.0 110.733 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.411 ' HB2' ' HA2' ' A' ' 80' ' ' GLY . 52.7 pttt 40.24 46.1 1.88 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.267 1.027 . . . . 0.0 111.935 -172.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.434 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 46.3 tt0 -60.34 136.49 91.71 Favored Pre-proline 0 C--O 1.236 0.381 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.452 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 38.4 Cg_exo -53.46 120.52 7.92 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.198 1.932 . . . . 0.0 110.943 -177.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.841 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 5.4 t80 -64.94 -56.05 23.54 Favored Pre-proline 0 C--N 1.313 -0.986 0 C-N-CA 119.73 -0.788 . . . . 0.0 112.737 -161.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.55 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 35.2 Cg_exo -55.89 -19.69 26.46 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.009 1.806 . . . . 0.0 111.508 -176.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.452 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.2 m-20 -89.46 -38.41 14.08 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.233 -178.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.916 ' HE1' ' NH2' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -61.74 -42.12 98.55 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.09 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.748 HG21 HD12 ' A' ' 69' ' ' ILE . 1.7 p -80.63 -31.69 12.71 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.9 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.841 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.67 -36.74 67.43 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 121.762 -0.586 . . . . 0.0 110.975 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.736 ' O ' HG12 ' A' ' 24' ' ' VAL . 15.4 ptt180 -82.29 -27.08 32.56 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.907 HD13 ' NH1' ' A' ' 7' ' ' ARG . 9.7 tp -55.24 -44.3 75.38 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.175 172.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.67 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 4.7 mt-30 -73.97 -51.57 15.57 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.309 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.744 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 45.3 m-20 -47.02 -51.28 17.67 Favored 'General case' 0 C--N 1.313 -1.006 0 O-C-N 124.532 1.145 . . . . 0.0 110.917 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.736 HG12 ' O ' ' A' ' 20' ' ' ARG . 9.9 p -79.64 -27.15 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 C-N-CA 119.936 -0.705 . . . . 0.0 109.833 -171.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.646 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -66.69 -31.57 72.33 Favored 'General case' 0 C--O 1.204 -1.301 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 175.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.418 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -74.69 -35.96 62.75 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.042 -1.435 . . . . 0.0 109.932 -178.19 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.744 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 37.3 mmtt -67.41 -36.38 81.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.466 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.506 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 21.6 m -104.89 -10.23 17.45 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.193 0.521 . . . . 0.0 110.656 -171.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.654 HG22 ' H ' ' A' ' 31' ' ' ASP . 78.1 mt -113.94 124.85 70.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.198 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.95 -1.87 57.73 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.947 0.403 . . . . 0.0 110.863 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.654 ' H ' HG22 ' A' ' 29' ' ' ILE . 4.1 t0 -114.13 140.12 48.77 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-O 121.618 0.723 . . . . 0.0 111.528 -177.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -71.02 -32.17 68.86 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.36 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.563 ' O ' HG13 ' A' ' 37' ' ' VAL . 12.0 mttp -67.07 -56.1 11.5 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -176.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.584 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -61.92 -25.49 67.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.57 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.842 ' O ' HG13 ' A' ' 39' ' ' VAL . 1.8 tmm_? -68.67 -58.62 3.97 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.43 ' HB3' ' OE2' ' A' ' 40' ' ' GLU . 15.8 mtpt -55.91 -57.0 13.96 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.205 179.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.793 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 23.9 m -52.25 -36.91 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.048 -170.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.618 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.3 tt -88.31 -30.83 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 C-N-CA 119.823 -0.751 . . . . 0.0 112.161 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.842 HG13 ' O ' ' A' ' 35' ' ' ARG . 3.2 m -67.01 -50.16 66.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 119.24 -0.984 . . . . 0.0 109.242 174.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.632 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 54.7 mt-10 -66.51 -23.58 66.27 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 123.816 0.846 . . . . 0.0 112.406 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.793 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -85.84 -56.97 3.23 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.325 176.338 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.58 ' HB2' HD21 ' A' ' 21' ' ' LEU . 25.0 mmt -59.82 -24.95 64.59 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 121.348 0.594 . . . . 0.0 109.996 -175.086 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.66 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -46.66 -28.3 1.44 Allowed 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.149 174.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.628 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 7.7 t80 -103.99 -68.02 0.87 Allowed 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 174.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.73 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 5.5 mm-40 -45.23 -35.45 3.34 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.25 -1.341 . . . . 0.0 112.834 -171.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 1.096 ' HB3' ' NE ' ' A' ' 7' ' ' ARG . 1.4 m-20 -111.76 -7.34 14.22 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.873 -172.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.66 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -68.01 -169.9 0.15 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.601 0.715 . . . . 0.0 112.425 -175.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.598 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 11.2 m-20 -66.03 140.42 97.04 Favored Pre-proline 0 N--CA 1.442 -0.836 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.939 171.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.479 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 3.0 Cg_endo -46.74 -46.75 17.43 Favored 'Trans proline' 0 CA--C 1.53 0.308 0 C-N-CA 122.642 2.228 . . . . 0.0 111.928 -176.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.584 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 0.3 OUTLIER -72.15 -31.31 65.84 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 124.185 0.994 . . . . 0.0 111.62 177.8 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.598 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 96.0 m -75.25 -36.36 61.29 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 120.889 0.376 . . . . 0.0 110.03 -173.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.61 ' HA ' HD12 ' A' ' 55' ' ' ILE . 4.3 pt20 -73.38 -32.21 64.36 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 174.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.6 ' HB3' ' C ' ' A' ' 91' ' ' GLN . 27.0 m -66.87 -21.46 66.01 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 114.033 -1.439 . . . . 0.0 110.064 173.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.805 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -77.85 -27.43 49.84 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.431 -0.793 . . . . 0.0 110.036 169.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.61 HD12 ' HA ' ' A' ' 52' ' ' GLN . 23.4 mt -89.11 -31.16 5.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -171.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.622 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.93 -39.27 2.64 Favored Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -173.347 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 57.3 Cg_endo -64.33 -25.98 63.9 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.457 2.104 . . . . 0.0 112.925 176.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.529 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.3 mt -99.96 -16.31 18.01 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.628 ' HE3' ' HB3' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -53.01 109.64 0.44 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.988 -178.947 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.29 -21.57 41.75 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.548 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -103.82 113.51 27.09 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 121.147 0.498 . . . . 0.0 110.032 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.12 143.78 43.51 Favored Pre-proline 0 C--N 1.312 -1.051 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 170.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.559 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 74.1 Cg_exo -46.35 142.85 8.73 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.767 2.311 . . . . 0.0 111.836 168.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.11 101.13 0.26 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.443 -174.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.36 -5.2 57.21 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.756 -0.656 . . . . 0.0 113.215 176.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.559 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 14.9 m -95.87 178.81 5.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.465 0.65 . . . . 0.0 111.854 -178.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.747 ' OD1' ' HB ' ' A' ' 69' ' ' ILE . 19.3 t70 -86.39 136.39 33.14 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.613 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.554 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -80.96 -30.89 11.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 C-N-CA 118.647 -1.221 . . . . 0.0 109.472 178.259 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.789 ' O ' HG13 ' A' ' 73' ' ' VAL . 14.5 mm -57.63 -46.78 86.46 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.223 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 178.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.4 t -43.24 -39.34 2.94 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.478 174.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -85.45 -33.59 21.85 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 123.413 0.685 . . . . 0.0 110.831 -177.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.656 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.2 m-30 -75.38 -35.04 61.14 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.467 -176.092 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.841 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.6 m -70.64 -31.92 47.73 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.518 ' HA ' ' HB2' ' A' ' 77' ' ' ASP . 23.1 ttpt -71.79 -27.53 63.01 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.616 -1.174 . . . . 0.0 109.865 176.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.463 ' HB2' HD11 ' A' ' 58' ' ' LEU . . . -64.8 -44.54 89.61 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.59 175.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.804 ' SG ' ' HB ' ' A' ' 79' ' ' ILE . 31.0 t -92.95 9.14 36.82 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.648 177.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.518 ' HB2' ' HA ' ' A' ' 74' ' ' LYS . 25.2 t70 -66.38 -11.42 51.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.507 0.67 . . . . 0.0 109.914 174.004 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -108.39 0.0 32.94 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.318 171.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.805 HD11 ' HB2' ' A' ' 54' ' ' ALA . 98.1 mt -103.8 137.72 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.138 0.494 . . . . 0.0 111.518 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' A' ' 11' ' ' LYS . . . 136.41 25.02 0.47 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.635 178.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.612 ' O ' ' HB3' ' A' ' 84' ' ' HIS . . . -165.83 -153.17 7.54 Favored Glycine 0 CA--C 1.49 -1.498 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.796 -176.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.2 -28.33 69.67 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.089 -1.055 . . . . 0.0 111.045 177.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 49.0 mtt -67.03 -32.2 73.26 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 175.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.612 ' HB3' ' O ' ' A' ' 81' ' ' GLY . 3.1 t60 -63.22 -34.7 78.21 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-O 121.164 0.507 . . . . 0.0 109.876 173.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.468 ' HD2' ' O ' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -77.18 -19.42 56.79 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.986 0.422 . . . . 0.0 110.389 179.37 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.36 -49.29 8.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.489 176.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 66.7 mtt -73.12 -15.08 61.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.861 -177.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.595 ' O ' ' HB3' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -51.25 -38.9 55.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.025 179.185 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.8 ttp -84.43 -18.91 34.46 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.336 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -95.39 -37.09 11.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.017 0.437 . . . . 0.0 112.049 -172.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.6 ' C ' ' HB3' ' A' ' 53' ' ' SER . 90.0 mt-30 -105.8 -56.17 2.22 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.203 -176.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.595 ' HB3' ' O ' ' A' ' 88' ' ' LEU . 0.4 OUTLIER -61.14 -6.1 1.84 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.383 178.289 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 . . . . . 0 C--O 1.25 1.124 0 C-N-CA 123.849 0.86 . . . . 0.0 112.343 -179.585 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' PRO . . . . . 0.461 ' HB2' ' H ' ' B' ' 2' ' ' SER . 86.2 Cg_endo . . . . . 0 N--CA 1.464 -0.23 0 N-CA-C 108.679 -1.316 . . . . 0.0 108.679 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.461 ' H ' ' HB2' ' B' ' 1' ' ' PRO . 49.7 m -70.13 -176.13 1.09 Allowed 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 163.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.63 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.0 OUTLIER -77.23 -54.36 6.59 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 122.398 1.095 . . . . 0.0 109.021 171.852 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.663 ' HB2' HD11 ' B' ' 21' ' ' LEU . 2.4 p-10 -85.49 5.97 28.95 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 113.446 -1.706 . . . . 0.0 113.366 -160.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.44 -1.09 7.57 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -174.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.674 ' O ' HG23 ' B' ' 6' ' ' VAL . 23.3 m -81.38 92.78 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-O 122.264 1.03 . . . . 0.0 112.08 -174.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 1.102 ' NE ' ' HB3' ' B' ' 46' ' ' ASN . 13.8 mmm180 -107.17 150.71 26.31 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.512 -1.368 . . . . 0.0 113.007 -159.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 8' ' ' GLN . . . . . 0.572 ' HG3' ' CG ' ' B' ' 17' ' ' PHE . 2.1 tt0 -44.43 109.23 0.14 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 112.626 -2.079 . . . . 0.0 111.617 172.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.45 -152.61 9.56 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.708 176.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 19.6 m -56.15 98.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.822 0.311 . . . . 0.0 110.709 -177.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.409 ' HB2' ' HA2' ' B' ' 80' ' ' GLY . 52.7 pttt 39.86 46.79 1.74 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.054 0.942 . . . . 0.0 111.909 -172.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.453 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 46.9 tt0 -60.81 136.33 93.05 Favored Pre-proline 0 C--O 1.234 0.278 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 13' ' ' PRO . . . . . 0.459 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 39.8 Cg_exo -53.34 120.55 7.94 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.079 1.852 . . . . 0.0 111.012 -177.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 14' ' ' TYR . . . . . 0.843 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 5.5 t80 -65.07 -56.04 22.98 Favored Pre-proline 0 C--N 1.314 -0.972 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.709 -161.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.551 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 32.1 Cg_exo -55.87 -19.62 26.01 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 121.987 1.792 . . . . 0.0 111.521 -176.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.459 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.2 m-20 -89.45 -38.62 13.93 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.145 -178.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 17' ' ' PHE . . . . . 0.908 ' HE1' ' NH2' ' B' ' 7' ' ' ARG . 0.1 OUTLIER -61.62 -42.15 98.47 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.273 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.726 HG21 HD12 ' B' ' 69' ' ' ILE . 1.7 p -80.69 -31.48 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.947 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.96 -36.54 67.93 Favored 'General case' 0 C--N 1.315 -0.902 0 O-C-N 121.653 -0.654 . . . . 0.0 110.922 175.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.736 ' O ' HG12 ' B' ' 24' ' ' VAL . 15.5 ptt180 -82.37 -27.14 32.3 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.898 HD13 ' NH1' ' B' ' 7' ' ' ARG . 9.7 tp -55.14 -44.44 75.09 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.11 172.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 22' ' ' GLN . . . . . 0.658 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 4.5 mt-30 -73.97 -51.58 15.54 Favored 'General case' 0 CA--C 1.486 -1.494 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.24 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.733 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 41.7 m-20 -46.96 -51.38 17.17 Favored 'General case' 0 C--N 1.311 -1.08 0 O-C-N 124.34 1.025 . . . . 0.0 110.874 178.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 24' ' ' VAL . . . . . 0.736 HG12 ' O ' ' B' ' 20' ' ' ARG . 9.8 p -79.51 -27.29 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.789 -171.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.649 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -66.61 -31.66 72.5 Favored 'General case' 0 C--O 1.205 -1.288 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 175.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 26' ' ' GLN . . . . . 0.414 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -74.52 -36.26 63.18 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 114.0 -1.455 . . . . 0.0 109.81 -178.225 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.733 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.1 mmtt -67.17 -36.42 81.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.394 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 28' ' ' SER . . . . . 0.491 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 25.2 m -104.69 -10.46 17.47 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.364 0.602 . . . . 0.0 110.609 -171.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.675 HG22 ' H ' ' B' ' 31' ' ' ASP . 78.3 mt -113.65 124.86 70.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.313 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.21 -1.94 57.91 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.972 0.415 . . . . 0.0 110.732 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.675 ' H ' HG22 ' B' ' 29' ' ' ILE . 4.0 t0 -113.48 140.59 47.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.58 0.705 . . . . 0.0 111.481 -177.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -71.55 -32.26 67.91 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.469 175.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.575 ' O ' HG13 ' B' ' 37' ' ' VAL . 11.8 mttp -67.08 -55.92 12.24 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -176.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.574 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -61.97 -25.52 67.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.559 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.854 ' O ' HG13 ' B' ' 39' ' ' VAL . 1.8 tmm_? -68.7 -58.66 3.91 Favored 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.44 ' HB3' ' OE2' ' B' ' 40' ' ' GLU . 15.7 mtpt -55.86 -57.04 13.73 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.227 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.802 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 23.6 m -52.25 -36.91 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.094 -170.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.63 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.3 tt -88.16 -30.85 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.218 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.854 HG13 ' O ' ' B' ' 35' ' ' ARG . 3.2 m -66.96 -50.19 66.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.309 174.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.633 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 52.1 mt-10 -66.4 -23.76 66.37 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 123.891 0.877 . . . . 0.0 112.351 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.802 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.77 -57.12 3.17 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.238 176.447 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 42' ' ' MET . . . . . 0.584 ' HB2' HD21 ' B' ' 21' ' ' LEU . 25.1 mmt -59.63 -25.0 64.32 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.358 0.599 . . . . 0.0 109.993 -175.05 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.665 ' O ' ' HB2' ' B' ' 47' ' ' ALA . . . -46.63 -28.45 1.47 Allowed 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.133 174.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 44' ' ' TYR . . . . . 0.62 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 7.8 t80 -103.74 -68.02 0.86 Allowed 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 174.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.75 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 5.6 mm-40 -45.22 -35.74 3.5 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.186 -1.37 . . . . 0.0 112.778 -171.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 1.102 ' HB3' ' NE ' ' B' ' 7' ' ' ARG . 1.4 m-20 -111.7 -7.21 14.26 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.846 -172.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.665 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -68.03 -169.74 0.15 Allowed 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.62 0.724 . . . . 0.0 112.498 -175.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.609 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 11.2 m-20 -66.21 140.38 96.85 Favored Pre-proline 0 N--CA 1.442 -0.843 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.083 171.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 49' ' ' PRO . . . . . 0.467 ' O ' ' HG2' ' B' ' 52' ' ' GLN . 2.9 Cg_endo -46.83 -46.63 17.92 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.685 2.257 . . . . 0.0 111.866 -176.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.589 ' HA ' ' HB2' ' B' ' 53' ' ' SER . 0.3 OUTLIER -72.31 -31.14 65.44 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 124.199 1.0 . . . . 0.0 111.591 177.839 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.609 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 94.6 m -75.3 -36.43 61.12 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 120.996 0.427 . . . . 0.0 109.993 -173.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.59 ' HB2' ' CG ' ' B' ' 44' ' ' TYR . 4.4 pt20 -73.43 -32.07 64.18 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 174.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 53' ' ' SER . . . . . 0.609 ' O ' ' HE2' ' B' ' 56' ' ' LYS . 26.4 m -66.97 -21.45 65.97 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 114.014 -1.448 . . . . 0.0 109.999 173.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.781 ' HB2' HD11 ' B' ' 79' ' ' ILE . . . -78.0 -27.29 48.98 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.398 -0.814 . . . . 0.0 109.985 169.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.589 HD12 ' HA ' ' B' ' 52' ' ' GLN . 23.3 mt -89.17 -31.28 5.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 -171.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.617 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.8 -39.37 2.59 Favored Pre-proline 0 N--CA 1.488 1.435 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -173.263 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 57.5 Cg_endo -64.17 -26.25 64.99 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.383 2.055 . . . . 0.0 112.925 176.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 58' ' ' LEU . . . . . 0.532 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.4 mt -99.78 -16.54 18.06 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.62 ' HE3' ' HB3' ' B' ' 44' ' ' TYR . 0.0 OUTLIER -52.66 109.77 0.44 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.131 -179.093 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.97 -21.63 40.75 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.696 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -103.92 113.48 27.05 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.21 0.528 . . . . 0.0 110.051 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.411 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.6 p -124.18 143.41 42.59 Favored Pre-proline 0 C--N 1.312 -1.05 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.765 170.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.57 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 74.9 Cg_exo -46.04 142.79 7.95 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.686 2.257 . . . . 0.0 111.944 168.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.1 100.52 0.22 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.573 -174.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.21 -5.32 55.61 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.069 176.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.57 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 14.8 m -96.12 178.93 5.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.505 0.669 . . . . 0.0 111.782 -178.318 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 67' ' ' ASP . . . . . 0.748 ' OD1' ' HB ' ' B' ' 69' ' ' ILE . 19.5 t70 -86.49 136.42 33.1 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.635 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.564 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.8 OUTLIER -80.93 -30.95 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 C-N-CA 118.588 -1.245 . . . . 0.0 109.517 178.193 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.789 ' O ' HG13 ' B' ' 73' ' ' VAL . 14.3 mm -57.57 -47.04 86.14 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.181 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 30.8 t -43.38 -39.22 3.08 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.45 174.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -85.34 -33.48 22.04 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 123.503 0.721 . . . . 0.0 110.807 -177.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 72' ' ' TYR . . . . . 0.645 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.1 m-30 -75.44 -35.04 61.0 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.449 -176.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.843 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.6 m -70.86 -31.79 46.68 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 173.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 74' ' ' LYS . . . . . 0.501 ' HA ' ' HB2' ' B' ' 77' ' ' ASP . 23.0 ttpt -71.84 -27.53 62.96 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.81 176.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 75' ' ' ALA . . . . . 0.456 ' HB2' HD11 ' B' ' 58' ' ' LEU . . . -64.9 -44.18 90.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.651 175.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.788 ' SG ' ' HB ' ' B' ' 79' ' ' ILE . 30.7 t -93.45 9.22 37.46 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.612 177.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 77' ' ' ASP . . . . . 0.501 ' HB2' ' HA ' ' B' ' 74' ' ' LYS . 24.7 t70 -66.2 -11.79 51.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.576 0.703 . . . . 0.0 110.068 173.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -108.37 0.55 32.88 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.222 171.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.788 ' HB ' ' SG ' ' B' ' 76' ' ' CYS . 98.0 mt -104.06 137.82 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 121.179 0.514 . . . . 0.0 111.401 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 80' ' ' GLY . . . . . 0.409 ' HA2' ' HB2' ' B' ' 11' ' ' LYS . . . 136.43 24.36 0.49 Allowed Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.415 177.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.616 ' O ' ' HB3' ' B' ' 84' ' ' HIS . . . -165.28 -153.09 7.4 Favored Glycine 0 CA--C 1.49 -1.525 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.763 -176.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.89 -28.4 69.81 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.087 -1.057 . . . . 0.0 111.047 177.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 83' ' ' MET . . . . . . . . . . . . . 49.2 mtt -67.04 -32.0 72.9 Favored 'General case' 0 C--O 1.22 -0.491 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 175.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 84' ' ' HIS . . . . . 0.616 ' HB3' ' O ' ' B' ' 81' ' ' GLY . 3.1 t60 -63.43 -34.94 78.84 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-O 121.207 0.527 . . . . 0.0 109.805 173.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.464 ' HD2' ' O ' ' B' ' 81' ' ' GLY . 0.1 OUTLIER -77.0 -19.21 57.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.045 0.45 . . . . 0.0 110.333 179.42 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.52 -49.4 8.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.482 176.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 66.7 mtt -73.26 -14.8 61.39 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.879 -177.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.593 ' O ' ' HB3' ' B' ' 92' ' ' LEU . 0.2 OUTLIER -51.28 -39.08 56.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.949 179.158 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 58.2 ttp -84.17 -19.32 34.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.215 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -95.3 -36.69 11.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.062 0.458 . . . . 0.0 112.104 -172.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 91' ' ' GLN . . . . . 0.606 ' C ' ' HB3' ' B' ' 53' ' ' SER . 89.9 mt-30 -106.17 -56.14 2.23 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.28 -176.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.593 ' HB3' ' O ' ' B' ' 88' ' ' LEU . 0.4 OUTLIER -61.15 -5.9 1.75 Allowed 'General case' 0 CA--C 1.541 0.632 0 O-C-N 123.62 0.575 . . . . 0.0 110.305 178.135 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.401 ' H ' ' C ' ' B' ' 91' ' ' GLN . 4.7 pt-20 . . . . . 0 C--O 1.25 1.095 0 C-N-CA 123.799 0.84 . . . . 0.0 112.455 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo . . . . . 0 CA--C 1.517 -0.337 0 N-CA-C 109.293 -1.08 . . . . 0.0 109.293 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.1 m -68.73 167.95 14.28 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 163.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.768 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -70.96 -54.38 11.52 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.992 0.901 . . . . 0.0 109.864 172.79 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.545 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 3.0 p-10 -86.76 -4.04 59.13 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.419 -1.264 . . . . 0.0 113.181 -164.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.453 ' HA ' ' OE1' ' B' ' 45' ' ' GLU . 9.9 t -65.47 -2.97 3.72 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.29 0.567 . . . . 0.0 111.075 -173.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.596 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.7 m -73.05 135.26 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 172.107 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.791 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -154.59 159.43 40.86 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 -178.789 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.542 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.4 mt-30 -42.83 118.98 1.36 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 112.585 -2.098 . . . . 0.0 113.318 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.9 -161.66 37.68 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.843 169.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.5 m -48.05 102.44 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 117.097 0.448 . . . . 0.0 111.592 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.3 pttt 38.91 44.28 0.84 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.533 1.133 . . . . 0.0 112.498 -173.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.494 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 37.8 tt0 -61.96 138.04 95.59 Favored Pre-proline 0 C--O 1.234 0.26 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 177.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.59 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 50.4 Cg_exo -50.68 122.55 9.88 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.244 1.963 . . . . 0.0 110.173 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.81 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 11.3 t80 -71.28 -54.17 7.29 Favored Pre-proline 0 N--CA 1.44 -0.934 0 CA-C-O 118.471 -0.776 . . . . 0.0 113.08 -167.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.533 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 34.5 Cg_exo -55.69 -18.79 21.94 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 121.459 1.44 . . . . 0.0 111.122 -179.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.59 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 2.0 m-20 -90.13 -42.2 11.21 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.881 -1.509 . . . . 0.0 111.001 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.542 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -54.6 -44.17 72.8 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.16 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.788 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 2.0 p -80.84 -34.15 13.77 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.362 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.692 -178.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.16 -31.64 67.43 Favored 'General case' 0 C--N 1.317 -0.841 0 O-C-N 121.276 -0.89 . . . . 0.0 111.881 177.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.718 ' O ' HG12 ' A' ' 24' ' ' VAL . 16.0 ptt180 -84.03 -29.9 26.54 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 175.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.562 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 8.3 tp -53.61 -49.61 67.45 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.992 172.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.788 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 4.5 mt-30 -69.43 -48.22 61.64 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.187 177.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.734 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 18.1 t70 -47.53 -53.31 14.8 Favored 'General case' 0 C--N 1.315 -0.933 0 O-C-N 124.267 0.979 . . . . 0.0 111.532 -177.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.718 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.4 p -82.1 -22.51 9.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.151 0.5 . . . . 0.0 109.79 -173.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.804 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -72.42 -19.44 61.59 Favored 'General case' 0 C--O 1.202 -1.422 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 173.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.41 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -87.06 -37.44 17.44 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.707 178.18 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.734 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 37.0 mmtt -66.94 -34.48 77.87 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.694 178.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.6 m -103.58 -11.07 17.96 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.195 0.521 . . . . 0.0 110.582 -172.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.804 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 88.7 mt -118.15 129.76 74.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.67 -178.21 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.99 -1.44 52.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.441 0.639 . . . . 0.0 110.367 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.638 ' H ' HG22 ' A' ' 29' ' ' ILE . 11.1 t70 -106.81 115.7 30.65 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.458 -177.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.646 ' OE2' ' HG3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -57.12 -33.33 67.24 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.149 178.262 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.646 ' HG3' ' OE2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -70.78 -54.72 10.62 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -173.354 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.564 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -60.68 -28.82 68.9 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.826 177.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.855 ' O ' HG13 ' A' ' 39' ' ' VAL . 2.1 tmm_? -65.4 -60.39 3.01 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.41 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 15.5 mtpt -55.41 -56.65 17.7 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.239 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.719 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 17.6 m -55.18 -33.68 30.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.112 -170.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.768 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.5 tt -87.25 -31.87 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.635 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.855 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.5 m -68.56 -48.14 73.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 119.015 -1.074 . . . . 0.0 109.178 175.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.657 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 73.0 mt-10 -63.18 -27.93 69.7 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 123.634 0.774 . . . . 0.0 112.749 176.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.719 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -86.04 -50.65 6.88 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.838 178.173 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.716 ' HE2' ' HE2' ' B' ' 42' ' ' MET . 17.8 mmt -64.85 -20.87 66.64 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.632 0.729 . . . . 0.0 109.764 -178.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.685 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -50.62 -28.63 9.16 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.542 171.215 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.593 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 19.9 t80 -103.9 -67.61 0.89 Allowed 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 174.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.453 ' CG ' HD12 ' A' ' 41' ' ' LEU . 27.2 mm-40 -50.54 -28.08 7.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.703 -1.135 . . . . 0.0 113.076 -173.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.791 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.1 m-20 -105.73 -22.24 13.0 Favored 'General case' 0 N--CA 1.435 -1.19 0 O-C-N 122.325 -0.234 . . . . 0.0 110.809 -177.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -60.36 178.76 0.18 Allowed 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 122.059 0.933 . . . . 0.0 112.818 -174.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.677 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 17.1 m-20 -58.2 141.63 81.93 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 114.155 -1.384 . . . . 0.0 109.245 174.177 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.432 ' HB2' HD21 ' A' ' 92' ' ' LEU . 10.0 Cg_endo -55.02 -23.41 35.08 Favored 'Trans proline' 0 C--O 1.218 -0.515 0 C-N-CA 123.26 2.64 . . . . 0.0 112.407 -178.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.705 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 13.4 pm0 -88.93 -32.12 17.85 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 123.765 0.826 . . . . 0.0 110.85 175.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.705 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 85.8 m -80.5 -38.15 30.36 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.328 -171.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.601 ' HA ' HD12 ' A' ' 55' ' ' ILE . 4.3 pt20 -70.0 -29.72 66.86 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 172.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.616 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 4.8 m -71.36 -20.82 62.11 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.119 175.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.611 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -78.55 -25.15 45.38 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.689 0.757 . . . . 0.0 109.821 168.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.601 HD12 ' HA ' ' A' ' 52' ' ' GLN . 22.6 mt -89.97 -32.53 5.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -172.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.63 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.99 -39.5 2.9 Favored Pre-proline 0 N--CA 1.486 1.344 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -172.799 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.63 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 50.6 Cg_endo -62.18 -28.81 79.88 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.187 1.924 . . . . 0.0 112.646 176.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.547 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.3 mt -98.35 -15.7 19.62 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.593 ' HE3' ' HB3' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -52.39 109.17 0.36 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.078 -179.454 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.54 -22.36 39.42 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.462 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.9 mmmt -103.55 113.0 26.17 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.17 0.509 . . . . 0.0 109.831 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.443 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.4 p -124.84 146.45 53.19 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.802 172.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.552 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 92.1 Cg_exo -47.7 141.64 15.42 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.288 1.992 . . . . 0.0 111.62 166.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.12 106.17 0.48 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.643 -175.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.1 -9.91 72.19 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.022 -0.609 . . . . 0.0 113.311 175.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.552 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 8.9 m -90.51 175.86 6.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.275 0.538 . . . . 0.0 111.46 -177.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.658 ' OD2' ' HB ' ' A' ' 69' ' ' ILE . 0.4 OUTLIER -81.6 134.95 35.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.615 177.81 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.574 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.7 OUTLIER -78.53 -27.65 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 C-N-CA 118.863 -1.135 . . . . 0.0 108.991 177.373 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.758 ' O ' HG13 ' A' ' 73' ' ' VAL . 12.3 mm -58.12 -46.23 88.38 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.184 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.058 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 29.4 t -46.16 -37.54 7.14 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.157 176.116 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -85.63 -32.34 22.09 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.149 0.5 . . . . 0.0 110.705 -177.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.6 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.1 m-30 -75.93 -35.18 59.82 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.526 -176.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.81 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.5 m -71.79 -31.77 42.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 172.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -67.08 -31.77 72.48 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.339 175.459 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -63.65 -46.98 83.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.109 177.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.805 ' SG ' ' HB ' ' A' ' 79' ' ' ILE . 24.4 t -92.44 9.35 34.67 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.902 178.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 12.1 t70 -62.56 -18.75 62.72 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.302 0.573 . . . . 0.0 110.261 175.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -101.75 -7.88 46.9 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.432 173.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.805 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 98.3 mt -92.66 115.49 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-O 121.443 0.639 . . . . 0.0 111.866 -178.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 170.7 58.06 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 174.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.35 169.01 38.94 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -171.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.47 -89.37 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 175.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.609 ' O ' ' HG3' ' A' ' 87' ' ' MET . 78.1 mtm -61.52 -35.23 77.12 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-O 120.762 0.315 . . . . 0.0 110.57 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.407 ' HB2' HG23 ' A' ' 79' ' ' ILE . 3.8 t-160 -55.2 -34.7 64.14 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.301 174.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -79.34 -31.42 43.03 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.869 0.366 . . . . 0.0 110.501 -177.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.58 -52.42 26.31 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.935 0.874 . . . . 0.0 110.286 175.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.609 ' HG3' ' O ' ' A' ' 83' ' ' MET . 19.7 mtt -75.12 -12.43 60.31 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.924 -175.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.449 HD12 ' HB2' ' A' ' 92' ' ' LEU . 0.1 OUTLIER -50.39 -57.47 7.9 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.323 177.949 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 26.3 ttt -74.69 -16.33 60.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.9 0.381 . . . . 0.0 110.918 -176.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -95.39 -23.5 17.13 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -173.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.616 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 84.8 mt-30 -115.17 -52.8 2.66 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.168 -177.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.449 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -49.05 -29.88 5.6 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.022 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.512 ' HG3' ' O ' ' A' ' 93' ' ' GLU . 6.4 pt-20 . . . . . 0 C--O 1.25 1.111 0 CA-C-N 113.82 -1.537 . . . . 0.0 112.597 -178.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo . . . . . 0 CA--C 1.515 -0.463 0 N-CA-C 109.364 -1.052 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 68.7 m -68.92 168.08 14.4 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 163.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.773 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -71.11 -54.41 11.2 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.843 0.83 . . . . 0.0 109.788 173.057 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.546 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 3.1 p-10 -86.84 -4.06 59.13 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.492 -1.231 . . . . 0.0 113.13 -164.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.443 ' HA ' ' OE1' ' A' ' 45' ' ' GLU . 9.9 t -65.39 -2.97 3.6 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.185 0.517 . . . . 0.0 111.083 -173.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.609 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.7 m -73.1 134.96 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 172.087 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.772 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -154.28 159.5 41.3 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -178.753 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 8' ' ' GLN . . . . . 0.533 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.4 mt-30 -42.94 119.08 1.4 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 112.684 -2.053 . . . . 0.0 113.303 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.99 -161.45 37.53 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 169.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 23.3 m -48.31 102.72 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 117.21 0.505 . . . . 0.0 111.498 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.401 ' HB2' ' HA2' ' B' ' 80' ' ' GLY . 39.2 pttt 38.83 44.42 0.83 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.611 1.164 . . . . 0.0 112.482 -173.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.488 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 37.7 tt0 -62.05 137.96 95.71 Favored Pre-proline 0 C--N 1.332 -0.182 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 13' ' ' PRO . . . . . 0.589 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 51.1 Cg_exo -50.71 122.46 9.74 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.227 1.951 . . . . 0.0 110.218 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 14' ' ' TYR . . . . . 0.817 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 11.3 t80 -71.21 -54.13 7.45 Favored Pre-proline 0 N--CA 1.438 -1.034 0 CA-C-O 118.425 -0.798 . . . . 0.0 113.048 -167.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.537 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 34.5 Cg_exo -55.77 -18.87 22.65 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 121.458 1.438 . . . . 0.0 111.072 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.589 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.7 m-20 -90.08 -41.98 11.37 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.037 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 17' ' ' PHE . . . . . 0.533 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -54.82 -44.18 73.62 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 176.254 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.776 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 2.0 p -80.77 -34.29 13.97 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.283 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.626 -178.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.19 -31.51 67.36 Favored 'General case' 0 C--N 1.315 -0.893 0 O-C-N 121.321 -0.862 . . . . 0.0 111.848 177.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.708 ' O ' HG12 ' B' ' 24' ' ' VAL . 16.1 ptt180 -84.03 -29.9 26.54 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 175.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.57 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 8.3 tp -53.56 -49.78 66.95 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.055 172.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 22' ' ' GLN . . . . . 0.776 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 4.6 mt-30 -69.41 -48.24 61.68 Favored 'General case' 0 CA--C 1.493 -1.236 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.191 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.741 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 18.4 t70 -47.25 -53.48 13.27 Favored 'General case' 0 C--N 1.315 -0.898 0 O-C-N 124.187 0.929 . . . . 0.0 111.489 -177.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 24' ' ' VAL . . . . . 0.708 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.4 p -82.13 -22.46 9.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.105 0.479 . . . . 0.0 109.746 -173.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.815 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -72.44 -19.46 61.57 Favored 'General case' 0 C--O 1.201 -1.462 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 173.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 26' ' ' GLN . . . . . 0.406 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -87.03 -37.55 17.37 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.671 178.331 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.741 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 36.7 mmtt -66.59 -35.1 79.39 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.6 178.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 44.4 m -103.14 -11.15 18.27 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.327 0.584 . . . . 0.0 110.62 -172.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.815 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 88.9 mt -118.13 129.4 74.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.714 -178.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.53 -1.68 52.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.518 0.675 . . . . 0.0 110.375 176.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.653 ' H ' HG22 ' B' ' 29' ' ' ILE . 11.3 t70 -106.39 115.67 30.6 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.418 -177.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.656 ' OE2' ' HG3' ' B' ' 33' ' ' LYS . 0.0 OUTLIER -57.17 -33.14 67.14 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.232 178.184 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.656 ' HG3' ' OE2' ' B' ' 32' ' ' GLU . 0.0 OUTLIER -70.96 -54.58 10.79 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -173.369 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.551 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -60.71 -28.91 69.0 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.821 177.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.868 ' O ' HG13 ' B' ' 39' ' ' VAL . 2.1 tmm_? -65.27 -60.44 2.99 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 15.6 mtpt -55.58 -56.52 19.32 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.193 -179.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.724 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 17.6 m -55.26 -33.59 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.119 -170.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.773 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.5 tt -87.36 -31.71 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.596 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.868 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.5 m -68.67 -48.02 73.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 118.944 -1.103 . . . . 0.0 109.193 175.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.66 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 73.2 mt-10 -63.25 -28.02 69.74 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 123.695 0.798 . . . . 0.0 112.668 176.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.724 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.99 -50.63 6.92 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.819 178.295 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 42' ' ' MET . . . . . 0.716 ' HE2' ' HE2' ' A' ' 42' ' ' MET . 18.0 mmt -64.92 -20.85 66.67 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.683 0.754 . . . . 0.0 109.707 -178.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.675 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -50.65 -28.62 9.26 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.533 171.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 44' ' ' TYR . . . . . 0.594 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 20.1 t80 -103.98 -67.57 0.89 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 174.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.453 ' OE1' ' HA ' ' A' ' 5' ' ' THR . 26.8 mm-40 -50.66 -27.67 7.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.75 -1.114 . . . . 0.0 113.064 -173.278 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.772 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.2 m-20 -106.06 -22.07 12.97 Favored 'General case' 0 N--CA 1.435 -1.219 0 O-C-N 122.283 -0.261 . . . . 0.0 110.845 -178.082 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.597 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -60.45 178.72 0.19 Allowed 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 122.055 0.931 . . . . 0.0 112.827 -174.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.674 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 17.8 m-20 -58.11 141.62 81.44 Favored Pre-proline 0 N--CA 1.44 -0.932 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.187 174.099 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 49' ' ' PRO . . . . . 0.451 ' HB2' HD21 ' B' ' 92' ' ' LEU . 10.0 Cg_endo -55.16 -23.25 35.58 Favored 'Trans proline' 0 C--O 1.22 -0.422 0 C-N-CA 123.21 2.606 . . . . 0.0 112.286 -178.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.686 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 13.5 pm0 -88.84 -32.26 17.89 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.863 0.865 . . . . 0.0 110.906 175.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.686 ' N ' ' HG2' ' B' ' 50' ' ' GLU . 83.9 m -80.43 -38.18 30.61 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.272 -171.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.577 ' HA ' HD12 ' B' ' 55' ' ' ILE . 4.4 pt20 -70.02 -29.81 66.96 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 172.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 53' ' ' SER . . . . . 0.615 ' HB3' ' HB3' ' B' ' 91' ' ' GLN . 4.9 m -71.31 -20.82 62.14 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 113.897 -1.501 . . . . 0.0 110.261 175.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.627 ' HB2' HD11 ' B' ' 79' ' ' ILE . . . -78.45 -25.25 45.85 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.672 0.749 . . . . 0.0 109.824 168.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.577 HD12 ' HA ' ' B' ' 52' ' ' GLN . 22.7 mt -90.02 -32.63 5.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 -172.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.628 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.82 -39.41 2.64 Favored Pre-proline 0 N--CA 1.487 1.388 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -172.853 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 50.9 Cg_endo -62.39 -28.4 78.29 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.308 2.005 . . . . 0.0 112.824 176.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 58' ' ' LEU . . . . . 0.546 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.3 mt -98.68 -15.78 19.27 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.594 ' HE3' ' HB3' ' B' ' 44' ' ' TYR . 0.0 OUTLIER -52.37 109.36 0.38 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.16 -179.545 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.25 -22.59 37.75 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.63 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 10.9 mmmt -103.43 112.79 25.85 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.146 0.498 . . . . 0.0 110.0 -178.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.455 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.4 p -124.73 146.21 52.13 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.076 172.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.573 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 93.3 Cg_exo -47.71 141.47 15.72 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.22 1.947 . . . . 0.0 111.537 166.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.07 105.67 0.43 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.662 -175.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.67 -9.86 70.95 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.334 175.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.573 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 9.7 m -90.83 175.21 7.08 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 117.192 0.496 . . . . 0.0 111.494 -177.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 67' ' ' ASP . . . . . 0.655 ' OD2' ' HB ' ' B' ' 69' ' ' ILE . 0.5 OUTLIER -80.85 134.83 35.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.591 177.834 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.562 HG13 ' CD ' ' B' ' 40' ' ' GLU . 0.7 OUTLIER -78.5 -27.73 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 C-N-CA 118.912 -1.115 . . . . 0.0 109.017 177.293 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.749 ' O ' HG13 ' B' ' 73' ' ' VAL . 12.6 mm -58.08 -46.33 88.18 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.116 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.107 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 29.1 t -46.06 -37.51 6.83 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.275 175.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -85.53 -32.51 22.14 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.148 0.499 . . . . 0.0 110.689 -177.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 72' ' ' TYR . . . . . 0.594 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.1 m-30 -75.85 -34.95 60.07 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.611 -176.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.817 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.5 m -72.01 -31.47 40.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 172.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 74' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' B' ' 70' ' ' SER . 0.0 OUTLIER -67.25 -31.82 72.43 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.309 175.504 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 75' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -63.8 -46.58 84.53 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.11 177.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.819 ' SG ' ' HB ' ' B' ' 79' ' ' ILE . 27.4 t -92.81 9.53 34.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.848 178.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 77' ' ' ASP . . . . . 0.436 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 11.7 t70 -62.97 -18.53 63.32 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.254 0.55 . . . . 0.0 110.235 175.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -101.58 -8.25 46.59 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.283 173.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.819 ' HB ' ' SG ' ' B' ' 76' ' ' CYS . 98.5 mt -92.39 115.56 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-O 121.412 0.625 . . . . 0.0 112.006 -178.148 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 80' ' ' GLY . . . . . 0.401 ' HA2' ' HB2' ' B' ' 11' ' ' LYS . . . 170.36 58.29 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 174.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.25 168.87 39.05 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 -172.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.47 -89.42 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 175.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 83' ' ' MET . . . . . 0.6 ' O ' ' HG3' ' B' ' 87' ' ' MET . 78.3 mtm -61.56 -35.05 76.68 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 120.696 0.284 . . . . 0.0 110.599 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 84' ' ' HIS . . . . . 0.406 ' HB2' HG23 ' B' ' 79' ' ' ILE . 3.8 t-160 -55.46 -34.37 64.46 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.3 174.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -79.53 -31.27 42.08 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.807 0.337 . . . . 0.0 110.489 -177.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.72 -52.74 22.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.91 0.862 . . . . 0.0 110.078 175.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 87' ' ' MET . . . . . 0.6 ' HG3' ' O ' ' B' ' 83' ' ' MET . 20.0 mtt -74.87 -12.43 60.37 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.028 -175.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.437 HD12 ' HB2' ' B' ' 92' ' ' LEU . 0.1 OUTLIER -50.39 -57.53 7.77 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.452 177.87 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 26.5 ttt -74.46 -16.76 60.85 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.852 0.358 . . . . 0.0 110.923 -176.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -95.11 -23.32 17.37 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -173.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 91' ' ' GLN . . . . . 0.615 ' HB3' ' HB3' ' B' ' 53' ' ' SER . 84.9 mt-30 -115.23 -52.53 2.67 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.207 -177.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.451 HD21 ' HB2' ' B' ' 49' ' ' PRO . 0.0 OUTLIER -49.25 -29.89 6.41 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.187 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.522 ' O ' ' HG3' ' B' ' 93' ' ' GLU . 6.5 pt-20 . . . . . 0 C--O 1.248 1.019 0 CA-C-N 113.826 -1.534 . . . . 0.0 112.458 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.454 ' HB2' ' H ' ' A' ' 2' ' ' SER . 92.5 Cg_endo . . . . . 0 CA--C 1.519 -0.251 0 N-CA-C 109.045 -1.175 . . . . 0.0 109.045 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.54 ' HB2' HG23 ' A' ' 5' ' ' THR . 15.6 m -68.12 179.84 1.43 Allowed 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 162.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.78 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -76.76 -52.2 9.99 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.245 -0.982 . . . . 0.0 108.536 166.41 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.509 ' HB2' HD11 ' A' ' 21' ' ' LEU . 2.4 p-10 -86.33 4.48 38.99 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.256 -1.338 . . . . 0.0 113.677 -164.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.582 ' O ' ' HG3' ' A' ' 7' ' ' ARG . 0.9 OUTLIER -63.73 -3.12 2.09 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 118.602 0.637 . . . . 0.0 111.532 -176.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.587 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 3.0 m -77.9 119.36 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-O 121.914 0.864 . . . . 0.0 109.824 177.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.783 ' HB3' ' O ' ' A' ' 46' ' ' ASN . 27.1 mtm180 -138.68 150.73 46.51 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 119.078 -1.049 . . . . 0.0 113.292 -170.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.579 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.4 mt-30 -41.99 114.35 0.53 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 112.882 -1.963 . . . . 0.0 113.019 176.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.81 -156.66 27.7 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.065 171.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.0 p -52.26 100.46 0.03 OUTLIER 'General case' 0 C--O 1.233 0.228 0 CA-C-N 117.092 0.446 . . . . 0.0 111.204 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 pttp 42.47 40.87 2.05 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.396 1.078 . . . . 0.0 112.297 -175.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.47 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 59.4 tt0 -59.21 136.44 88.32 Favored Pre-proline 0 C--O 1.235 0.3 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 177.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.537 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 36.8 Cg_exo -51.77 122.83 11.08 Favored 'Trans proline' 0 CA--C 1.508 -0.784 0 C-N-CA 122.121 1.88 . . . . 0.0 109.689 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.829 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 9.3 t80 -69.46 -53.86 12.09 Favored Pre-proline 0 N--CA 1.437 -1.119 0 CA-C-O 118.316 -0.849 . . . . 0.0 112.937 -166.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.547 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 31.3 Cg_exo -55.38 -20.43 25.84 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.435 1.424 . . . . 0.0 111.06 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.537 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 2.7 m-20 -89.87 -39.17 13.22 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.011 -1.45 . . . . 0.0 111.036 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.579 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -55.94 -45.38 78.83 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 175.451 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.743 HG12 ' O ' ' A' ' 14' ' ' TYR . 1.5 p -81.54 -31.79 11.41 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.031 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.57 -177.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.08 -33.8 69.46 Favored 'General case' 0 C--N 1.317 -0.833 0 O-C-N 121.386 -0.821 . . . . 0.0 111.752 176.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.716 ' O ' HG12 ' A' ' 24' ' ' VAL . 15.3 ptt180 -84.36 -26.9 28.08 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 176.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.596 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 6.7 tp -56.52 -46.55 80.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.002 172.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.689 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 32.8 mt-30 -73.39 -44.15 59.12 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.83 178.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.708 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 21.8 t70 -49.55 -56.06 11.23 Favored 'General case' 0 C--N 1.314 -0.942 0 O-C-N 124.239 0.962 . . . . 0.0 111.612 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 20' ' ' ARG . 6.4 p -80.36 -22.29 11.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 C-N-CA 120.538 -0.465 . . . . 0.0 109.923 -173.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.664 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -68.18 -29.09 67.88 Favored 'General case' 0 C--O 1.204 -1.341 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 173.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.464 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -80.04 -36.9 35.07 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.931 -178.406 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.708 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.5 mmtt -66.65 -32.51 73.87 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.483 178.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.8 m -105.34 -11.77 16.33 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.825 -171.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.664 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 88.7 mt -116.83 133.93 61.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.109 -177.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.26 -4.25 35.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.285 0.564 . . . . 0.0 110.521 176.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.571 ' H ' HG22 ' A' ' 29' ' ' ILE . 11.1 t70 -105.48 107.46 18.47 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.752 -178.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.578 ' OE2' ' HG3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -52.86 -32.22 43.53 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.229 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.615 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -73.53 -50.47 21.23 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -173.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.591 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -61.92 -27.84 69.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.525 175.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.846 ' O ' HG13 ' A' ' 39' ' ' VAL . 3.5 tmm_? -67.4 -57.12 7.17 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.476 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 19.4 mtpt -59.11 -54.82 42.7 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.273 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.754 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 19.4 m -54.69 -33.84 28.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.023 -173.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.78 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.2 tt -86.3 -31.87 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 119.904 -0.719 . . . . 0.0 111.428 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.846 HG13 ' O ' ' A' ' 35' ' ' ARG . 3.0 m -67.4 -49.8 68.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.779 173.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.62 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 63.9 mt-10 -63.76 -26.34 68.6 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.5 0.72 . . . . 0.0 112.62 177.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.754 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -85.63 -52.1 6.03 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.576 177.348 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.603 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 18.7 mmt -64.52 -20.42 66.2 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.809 0.814 . . . . 0.0 109.37 -178.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.664 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -50.75 -28.98 10.28 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.539 171.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.532 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 25.0 t80 -104.08 -68.78 0.83 Allowed 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.482 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 10.3 mm-40 -48.21 -32.41 7.09 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 124.13 0.894 . . . . 0.0 112.546 -175.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.783 ' O ' ' HB3' ' A' ' 7' ' ' ARG . 4.5 m-20 -103.28 -17.39 15.33 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.492 -175.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.664 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -62.98 178.27 0.49 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.744 0.783 . . . . 0.0 111.911 -177.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.666 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 17.7 m-20 -59.93 142.92 88.41 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.094 172.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -56.25 -21.46 36.23 Favored 'Trans proline' 0 C--O 1.219 -0.463 0 C-N-CA 123.182 2.588 . . . . 0.0 112.557 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.709 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 12.0 pm0 -88.99 -33.01 17.34 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 123.598 0.759 . . . . 0.0 110.727 174.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.709 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 72.2 m -81.21 -38.02 27.7 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.394 -171.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.605 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.3 pt20 -69.0 -29.89 68.18 Favored 'General case' 0 C--O 1.211 -0.94 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 172.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.475 ' CA ' ' HE2' ' A' ' 56' ' ' LYS . 5.9 m -72.23 -21.26 61.42 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 113.9 -1.5 . . . . 0.0 110.304 176.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 51' ' ' CYS . . . -76.03 -25.91 56.12 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.783 0.801 . . . . 0.0 109.495 168.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.605 HD12 ' HA ' ' A' ' 52' ' ' GLN . 22.7 mt -90.33 -33.46 5.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -172.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.617 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.39 -39.08 1.96 Allowed Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -172.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 52.5 Cg_endo -63.13 -31.12 75.53 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.164 1.91 . . . . 0.0 112.568 175.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.526 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 2.4 mt -93.92 -17.08 23.36 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.599 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -54.64 108.95 0.44 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.44 179.67 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.09 -23.84 34.41 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.568 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -104.46 113.88 27.74 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.096 0.474 . . . . 0.0 110.418 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.479 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.1 p -123.58 141.6 36.87 Favored Pre-proline 0 C--N 1.308 -1.21 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 168.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo . . . . . 0 C--N 1.343 0.255 0 C-N-CA 122.333 2.022 . . . . 0.0 111.52 170.905 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.515 -0.372 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.578 HG13 ' CD ' ' A' ' 40' ' ' GLU . 0.7 OUTLIER -77.69 -28.1 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 C-N-CA 118.227 -1.389 . . . . 0.0 108.95 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.783 ' O ' HG13 ' A' ' 73' ' ' VAL . 11.3 mm -58.14 -46.54 88.35 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.075 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.124 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 30.7 t -45.95 -38.33 7.5 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.188 176.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -86.2 -32.31 21.27 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 121.254 0.55 . . . . 0.0 111.046 -177.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.613 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.1 m-30 -75.27 -34.38 61.35 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.369 -176.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.829 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.6 m -72.09 -31.7 40.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.47 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -68.0 -30.87 70.23 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.25 176.461 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -63.74 -48.94 75.0 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.891 177.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.628 ' SG ' ' HB2' ' A' ' 14' ' ' TYR . 32.3 t -89.89 9.09 28.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.773 177.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.47 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 18.7 t70 . . . . . 0 C--N 1.318 -0.786 0 CA-C-O 121.349 0.595 . . . . 0.0 109.566 173.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 1' ' ' PRO . . . . . 0.416 ' HB2' ' H ' ' B' ' 2' ' ' SER . 84.0 Cg_endo . . . . . 0 CA--C 1.518 -0.306 0 N-CA-C 108.863 -1.245 . . . . 0.0 108.863 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . 0.55 ' HB2' HG23 ' B' ' 5' ' ' THR . 15.8 m -68.48 -179.74 1.43 Allowed 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 162.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.776 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -77.01 -52.24 9.69 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.29 -0.964 . . . . 0.0 108.522 166.261 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.509 ' HB2' HD11 ' B' ' 21' ' ' LEU . 2.4 p-10 -86.31 4.69 37.98 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.708 -164.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.58 ' O ' ' HG3' ' B' ' 7' ' ' ARG . 0.9 OUTLIER -63.98 -2.88 2.15 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 118.6 0.636 . . . . 0.0 111.557 -176.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.571 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 3.0 m -78.04 119.25 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 121.823 0.82 . . . . 0.0 109.845 176.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.802 ' HB3' ' O ' ' B' ' 46' ' ' ASN . 27.3 mtm180 -138.63 150.72 46.56 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 119.18 -1.008 . . . . 0.0 113.247 -170.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' GLN . . . . . 0.583 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.4 mt-30 -42.15 114.51 0.56 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 112.755 -2.02 . . . . 0.0 112.887 176.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.11 -156.96 28.73 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.13 171.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 15.6 p -51.67 100.35 0.03 OUTLIER 'General case' 0 C--O 1.235 0.306 0 CA-C-N 117.016 0.408 . . . . 0.0 111.274 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 20.8 pttp 42.28 41.06 1.99 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.462 1.105 . . . . 0.0 112.225 -175.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.448 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 58.9 tt0 -59.23 136.43 88.38 Favored Pre-proline 0 C--O 1.234 0.283 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . 0.552 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 37.6 Cg_exo -51.69 123.05 11.43 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.13 1.887 . . . . 0.0 109.652 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' TYR . . . . . 0.836 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 9.5 t80 -69.6 -53.93 11.61 Favored Pre-proline 0 N--CA 1.437 -1.089 0 CA-C-O 118.313 -0.851 . . . . 0.0 112.958 -166.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.556 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 31.2 Cg_exo -55.4 -20.29 25.43 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 121.483 1.455 . . . . 0.0 111.066 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.552 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 3.1 m-20 -89.93 -39.17 13.18 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.019 -1.446 . . . . 0.0 111.023 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' PHE . . . . . 0.583 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -55.81 -45.59 78.26 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.307 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.745 HG12 ' O ' ' B' ' 14' ' ' TYR . 1.5 p -81.46 -31.69 11.48 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.063 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.576 -177.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.2 -33.83 69.71 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 121.402 -0.811 . . . . 0.0 111.737 176.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.71 ' O ' HG12 ' B' ' 24' ' ' VAL . 15.2 ptt180 -84.43 -26.47 28.24 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.604 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 6.7 tp -56.86 -46.77 81.57 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.912 172.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' GLN . . . . . 0.69 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 32.5 mt-30 -73.18 -44.31 60.05 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.835 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.725 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 20.5 t70 -49.15 -56.15 10.1 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 124.192 0.932 . . . . 0.0 111.649 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' VAL . . . . . 0.71 HG12 ' O ' ' B' ' 20' ' ' ARG . 6.5 p -80.31 -22.52 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.922 -173.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.673 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -68.15 -28.97 67.76 Favored 'General case' 0 C--O 1.203 -1.342 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 173.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . 0.463 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -80.23 -36.59 34.52 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.359 -1.291 . . . . 0.0 109.962 -178.498 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.725 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.9 mmtt -66.97 -32.35 73.53 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.502 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 16.9 m -105.5 -12.05 16.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.123 0.487 . . . . 0.0 110.765 -171.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.673 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 88.3 mt -116.44 134.24 60.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.083 -177.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.45 -4.27 34.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.382 0.611 . . . . 0.0 110.436 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.558 ' H ' HG22 ' B' ' 29' ' ' ILE . 11.3 t70 -105.43 107.68 18.79 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.722 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.568 ' OE2' ' HG3' ' B' ' 33' ' ' LYS . 0.0 OUTLIER -53.01 -32.22 45.45 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.213 179.487 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.614 ' O ' HG13 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -73.58 -50.23 22.32 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -173.593 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.587 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -62.16 -27.83 69.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.466 175.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.852 ' O ' HG13 ' B' ' 39' ' ' VAL . 3.5 tmm_? -67.43 -57.12 7.13 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.466 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 19.0 mtpt -59.11 -54.76 43.35 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.314 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.751 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 19.6 m -54.73 -33.82 28.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.073 -173.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.776 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.2 tt -86.41 -31.64 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.462 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.852 HG13 ' O ' ' B' ' 35' ' ' ARG . 3.0 m -67.43 -49.95 66.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 119.039 -1.065 . . . . 0.0 109.809 173.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.624 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 60.8 mt-10 -63.6 -26.5 68.72 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.506 0.722 . . . . 0.0 112.599 177.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.751 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.61 -52.0 6.1 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.436 -0.505 . . . . 0.0 111.469 177.487 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' MET . . . . . 0.597 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 18.7 mmt -64.66 -20.39 66.27 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.75 0.786 . . . . 0.0 109.256 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.656 ' O ' ' HB2' ' B' ' 47' ' ' ALA . . . -50.82 -28.92 10.4 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.563 171.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' TYR . . . . . 0.519 ' CG ' ' HD2' ' B' ' 59' ' ' LYS . 25.1 t80 -104.09 -68.71 0.83 Allowed 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.48 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 10.5 mm-40 -48.39 -31.92 6.86 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.091 0.87 . . . . 0.0 112.687 -175.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.802 ' O ' ' HB3' ' B' ' 7' ' ' ARG . 4.5 m-20 -103.88 -16.91 15.23 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 120.659 0.266 . . . . 0.0 111.533 -175.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -63.24 178.67 0.49 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.909 0.862 . . . . 0.0 111.978 -177.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' ASN . . . . . 0.664 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 17.6 m-20 -60.25 142.74 89.79 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.077 172.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.08 -21.54 35.31 Favored 'Trans proline' 0 C--O 1.218 -0.518 0 C-N-CA 123.19 2.593 . . . . 0.0 112.516 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . 0.688 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 11.7 pm0 -88.95 -32.9 17.44 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 123.557 0.743 . . . . 0.0 110.743 174.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.688 ' N ' ' HG2' ' B' ' 50' ' ' GLU . 72.1 m -81.31 -38.06 27.38 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.41 -171.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . 0.6 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.3 pt20 -68.89 -30.01 68.41 Favored 'General case' 0 C--O 1.211 -0.927 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 172.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' SER . . . . . 0.49 ' CA ' ' HE2' ' B' ' 56' ' ' LYS . 6.2 m -72.18 -21.16 61.47 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 113.941 -1.481 . . . . 0.0 110.478 176.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' B' ' 51' ' ' CYS . . . -76.21 -25.8 55.48 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.767 0.794 . . . . 0.0 109.466 168.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.6 HD12 ' HA ' ' B' ' 52' ' ' GLN . 22.7 mt -90.28 -33.5 5.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -172.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.619 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.41 -39.17 2.04 Favored Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -172.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 52.5 Cg_endo -62.95 -31.31 77.14 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.115 1.876 . . . . 0.0 112.554 175.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . 0.536 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 2.5 mt -93.92 -17.07 23.37 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . 0.601 ' HA ' ' OH ' ' B' ' 72' ' ' TYR . 0.0 OUTLIER -54.7 108.96 0.44 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.47 179.71 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.03 -23.86 34.36 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.626 -177.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -104.47 113.89 27.76 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.098 0.475 . . . . 0.0 110.295 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.471 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.2 p -123.48 141.81 37.27 Favored Pre-proline 0 C--N 1.309 -1.162 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 168.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo . . . . . 0 C--O 1.234 0.304 0 C-N-CA 122.296 1.997 . . . . 0.0 111.631 170.836 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.514 -0.406 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.568 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.7 OUTLIER -77.29 -28.5 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 C-N-CA 118.201 -1.399 . . . . 0.0 108.921 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.774 ' O ' HG13 ' B' ' 73' ' ' VAL . 11.2 mm -57.91 -46.56 87.51 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.112 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.169 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 30.2 t -45.93 -38.38 7.49 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.184 176.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -86.17 -32.25 21.35 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.245 0.545 . . . . 0.0 111.001 -177.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' TYR . . . . . 0.611 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.1 m-30 -75.36 -34.21 61.13 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.374 -176.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.836 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.6 m -72.26 -31.64 39.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 172.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' B' ' 77' ' ' ASP . 0.0 OUTLIER -68.08 -30.84 70.12 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.274 176.474 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -63.72 -49.15 74.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.843 -1.072 . . . . 0.0 109.833 177.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.621 ' SG ' ' HB2' ' B' ' 14' ' ' TYR . 32.1 t -89.58 9.14 27.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.78 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . 0.457 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 21.1 t70 . . . . . 0 C--N 1.32 -0.694 0 CA-C-O 121.344 0.592 . . . . 0.0 109.681 174.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.443 ' HB2' ' H ' ' A' ' 2' ' ' SER . 87.6 Cg_endo . . . . . 0 CA--C 1.518 -0.301 0 N-CA-C 108.856 -1.248 . . . . 0.0 108.856 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.443 ' H ' ' HB2' ' A' ' 1' ' ' PRO . 15.0 m -67.26 176.33 2.29 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 162.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.79 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -73.66 -52.69 12.49 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 166.099 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.515 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 2.4 p-10 -85.63 5.78 30.35 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.858 -1.519 . . . . 0.0 113.489 -165.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.07 -4.19 3.3 Favored 'General case' 0 C--N 1.315 -0.904 0 O-C-N 121.94 -0.475 . . . . 0.0 111.615 -176.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.608 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.0 m -77.86 133.01 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.797 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -154.63 159.42 40.8 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -179.671 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.427 ' HG2' ' HB3' ' A' ' 12' ' ' GLU . 2.1 tt0 -45.31 112.75 0.48 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 113.268 -1.787 . . . . 0.0 112.57 -177.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.13 -150.59 18.56 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.507 173.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 27.2 m -51.98 95.45 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.95 0.375 . . . . 0.0 111.407 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.1 pttp 37.76 43.47 0.48 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.385 1.074 . . . . 0.0 112.254 -172.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.427 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 50.3 tt0 -56.46 138.14 75.8 Favored Pre-proline 0 C--O 1.234 0.241 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.55 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 33.8 Cg_exo -53.68 121.87 10.31 Favored 'Trans proline' 0 CA--C 1.51 -0.722 0 C-N-CA 121.806 1.671 . . . . 0.0 109.476 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.824 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 14.5 t80 -71.91 -52.21 7.98 Favored Pre-proline 0 N--CA 1.438 -1.046 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -165.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.539 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 38.7 Cg_exo -56.52 -18.2 24.73 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 121.447 1.431 . . . . 0.0 110.691 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.55 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.5 m-20 -90.21 -42.34 11.08 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 113.754 -1.566 . . . . 0.0 110.874 178.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.517 ' CE2' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -55.02 -45.55 75.16 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 176.537 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.785 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 1.8 p -78.97 -34.41 16.81 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.402 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.6 -31.82 68.41 Favored 'General case' 0 C--N 1.318 -0.761 0 O-C-N 121.529 -0.732 . . . . 0.0 111.807 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.684 ' O ' HG12 ' A' ' 24' ' ' VAL . 15.7 ptt180 -84.3 -26.78 28.28 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 175.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.553 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 5.9 tp -58.27 -46.49 85.92 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.918 173.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.785 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 26.2 mt-30 -70.69 -47.28 60.67 Favored 'General case' 0 CA--C 1.493 -1.247 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.3 177.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.729 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 8.9 t70 -49.77 -51.96 35.37 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.531 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.684 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.2 p -81.08 -23.78 10.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.181 0.515 . . . . 0.0 109.719 -174.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.785 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -72.01 -19.15 61.9 Favored 'General case' 0 C--O 1.204 -1.335 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 174.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.412 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -86.59 -36.36 18.91 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.574 178.192 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.729 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.6 mmtt -67.26 -37.86 84.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.95 -1.023 . . . . 0.0 112.015 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.405 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 44.5 m -101.76 -10.38 20.0 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.163 0.506 . . . . 0.0 110.645 -172.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.785 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 85.5 mt -112.38 130.24 66.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.819 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.23 -0.93 57.39 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.068 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.674 ' H ' HG22 ' A' ' 29' ' ' ILE . 0.9 OUTLIER -121.55 127.74 51.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.347 0.594 . . . . 0.0 111.901 -178.09 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -56.49 -31.98 64.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.86 175.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.652 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 26.1 mttt -62.29 -61.12 2.67 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -177.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.584 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -61.94 -24.55 67.05 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.348 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.862 ' O ' HG13 ' A' ' 39' ' ' VAL . 1.7 tmm_? -69.7 -57.92 4.55 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.419 ' O ' HG22 ' A' ' 39' ' ' VAL . 20.9 mtpt -57.21 -55.65 31.94 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.943 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.725 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 19.7 m -53.93 -36.02 29.7 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.312 -170.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.79 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.2 tt -87.5 -28.97 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.96 -178.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.862 HG13 ' O ' ' A' ' 35' ' ' ARG . 3.0 m -70.1 -49.22 57.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 119.11 -1.036 . . . . 0.0 109.326 175.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.639 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 66.1 mt-10 -63.49 -24.22 67.73 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.805 0.842 . . . . 0.0 112.259 176.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.725 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -86.09 -56.99 3.2 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 177.147 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.515 ' HG3' ' HB2' ' A' ' 4' ' ' ASN . 20.7 mmt -62.44 -20.74 64.82 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.585 0.707 . . . . 0.0 109.792 -177.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.67 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -49.18 -28.23 4.26 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.539 170.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.567 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 5.7 t80 -108.22 -67.92 0.94 Allowed 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 175.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.673 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 5.2 mm-40 -46.9 -31.89 3.42 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 124.421 1.075 . . . . 0.0 112.179 -173.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.797 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.9 m-20 -104.8 -21.17 13.39 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -176.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -60.4 -179.13 0.1 Allowed 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.954 0.883 . . . . 0.0 112.974 -173.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -57.01 139.72 78.41 Favored Pre-proline 0 N--CA 1.443 -0.786 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.011 175.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.95 -23.31 42.42 Favored 'Trans proline' 0 C--O 1.222 -0.304 0 C-N-CA 123.209 2.606 . . . . 0.0 112.082 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 53' ' ' SER . 0.0 OUTLIER -88.12 -30.18 20.04 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.702 0.801 . . . . 0.0 110.505 174.194 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.947 ' SG ' ' HB2' ' A' ' 76' ' ' CYS . 43.8 t -83.24 -36.76 24.32 Favored 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.548 -170.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.555 ' HB2' ' CG ' ' A' ' 44' ' ' TYR . 4.1 pt20 -67.37 -30.35 70.12 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 171.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.479 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 17.1 m -69.95 -20.3 63.34 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 113.377 -1.738 . . . . 0.0 110.852 173.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -81.16 -24.75 37.36 Favored 'General case' 0 C--N 1.312 -1.039 0 O-C-N 121.399 -0.813 . . . . 0.0 110.014 167.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.536 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 25.4 mt -90.3 -30.81 5.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -171.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.615 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.37 -40.03 2.58 Favored Pre-proline 0 N--CA 1.487 1.38 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -174.458 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 49.9 Cg_endo -62.42 -27.5 77.34 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.313 2.009 . . . . 0.0 112.794 176.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.536 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.0 OUTLIER -100.52 -15.86 17.71 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.567 ' HE3' ' HB3' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -53.45 109.22 0.42 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.252 -177.924 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.468 ' N ' ' HZ3' ' A' ' 59' ' ' LYS . . . 92.43 -20.64 42.79 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.34 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -103.87 113.63 27.29 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.403 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.3 p -122.92 144.15 42.26 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 173.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo . . . . . 0 N--CA 1.463 -0.305 0 C-N-CA 122.153 1.902 . . . . 0.0 111.329 168.944 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.759 ' OD1' ' HB ' ' A' ' 69' ' ' ILE . 5.4 t70 . . . . . 0 CA--C 1.518 -0.269 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.604 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -79.81 -28.84 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 C-N-CA 118.224 -1.39 . . . . 0.0 109.173 179.218 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.784 ' O ' HG13 ' A' ' 73' ' ' VAL . 11.7 mm -60.57 -46.2 95.97 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.016 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.94 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.3 t -44.58 -38.93 4.56 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.146 175.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.482 ' O ' ' HE2' ' A' ' 74' ' ' LYS . 7.0 mm-40 -85.84 -32.04 21.95 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 123.55 0.74 . . . . 0.0 111.419 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.583 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.0 m-30 -75.41 -34.6 61.04 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.513 0.673 . . . . 0.0 109.421 -176.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.824 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.4 m -71.81 -32.09 43.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 172.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.482 ' HE2' ' O ' ' A' ' 71' ' ' GLU . 13.3 ttpt -71.66 -25.94 62.33 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.406 177.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -65.21 -46.6 80.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.806 174.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.947 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 40.5 t -87.46 0.8 55.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.158 178.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.4 t70 . . . . . 0 C--N 1.323 -0.56 0 CA-C-O 121.64 0.733 . . . . 0.0 109.579 175.066 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 1' ' ' PRO . . . . . 0.403 ' HB2' ' H ' ' B' ' 2' ' ' SER . 88.6 Cg_endo . . . . . 0 CA--C 1.518 -0.297 0 N-CA-C 108.762 -1.284 . . . . 0.0 108.762 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . 0.403 ' H ' ' HB2' ' B' ' 1' ' ' PRO . 14.7 m -67.56 176.01 2.59 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 162.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.762 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -73.37 -52.65 13.06 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.085 -1.046 . . . . 0.0 108.286 166.265 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.524 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.4 p-10 -85.77 5.84 30.65 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 113.936 -1.483 . . . . 0.0 113.429 -165.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.92 -4.42 3.31 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 118.256 0.48 . . . . 0.0 111.707 -176.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.608 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 1.9 m -77.62 133.16 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.78 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.1 OUTLIER -155.0 159.08 40.08 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -179.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' GLN . . . . . 0.432 ' HG2' ' HB3' ' B' ' 12' ' ' GLU . 2.1 tt0 -45.01 112.65 0.46 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 113.211 -1.813 . . . . 0.0 112.584 -177.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.08 -150.52 18.3 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.411 173.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 33.3 m -52.07 95.17 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 117.023 0.411 . . . . 0.0 111.49 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 21.0 pttp 37.9 43.93 0.56 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.438 1.095 . . . . 0.0 111.99 -172.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.432 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 52.0 tt0 -56.75 138.1 77.84 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.411 177.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . 0.55 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 33.6 Cg_exo -53.67 122.12 10.75 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 121.737 1.625 . . . . 0.0 109.477 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' TYR . . . . . 0.826 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 14.6 t80 -72.17 -52.22 7.44 Favored Pre-proline 0 N--CA 1.438 -1.04 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -165.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.534 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 37.7 Cg_exo -56.52 -18.01 24.06 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 121.547 1.498 . . . . 0.0 110.685 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.55 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.6 m-20 -90.39 -42.52 10.87 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.846 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' PHE . . . . . 0.511 ' CE2' HD22 ' B' ' 21' ' ' LEU . 0.0 OUTLIER -54.91 -45.8 74.78 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.554 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.785 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 1.7 p -78.77 -34.52 17.4 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.289 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.281 -178.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.94 -31.23 68.51 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 121.485 -0.76 . . . . 0.0 111.843 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.681 ' O ' HG12 ' B' ' 24' ' ' VAL . 15.6 ptt180 -84.67 -26.41 27.78 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 175.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.562 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 5.9 tp -58.54 -46.53 86.63 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.933 172.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' GLN . . . . . 0.785 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 26.5 mt-30 -70.58 -47.29 60.99 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.256 177.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.727 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 8.3 t70 -49.85 -51.8 37.4 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 124.202 0.938 . . . . 0.0 111.576 -177.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' VAL . . . . . 0.681 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.2 p -81.17 -23.83 10.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -174.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.788 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -71.77 -19.3 62.04 Favored 'General case' 0 C--O 1.204 -1.294 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 174.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.6 -36.31 18.93 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.531 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.727 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.9 mmtt -67.36 -37.61 83.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.142 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 46.5 m -101.85 -10.63 19.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.194 0.521 . . . . 0.0 110.712 -172.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.788 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 85.4 mt -112.36 130.24 66.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.748 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.23 -0.67 57.4 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.001 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.677 ' H ' HG22 ' B' ' 29' ' ' ILE . 0.9 OUTLIER -121.82 127.85 51.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.326 0.584 . . . . 0.0 112.069 -178.172 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -56.66 -31.8 64.76 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.825 176.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.644 ' HD2' ' OD1' ' B' ' 31' ' ' ASP . 25.9 mttt -62.48 -61.0 2.74 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -177.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.562 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -62.0 -24.51 67.08 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.413 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.861 ' O ' HG13 ' B' ' 39' ' ' VAL . 1.7 tmm_? -69.83 -57.81 4.64 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.401 ' O ' HG22 ' B' ' 39' ' ' VAL . 20.6 mtpt -57.28 -55.52 33.75 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.948 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.736 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 19.8 m -54.07 -35.92 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.325 -170.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.762 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.2 tt -87.52 -29.13 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 C-N-CA 119.744 -0.783 . . . . 0.0 111.932 -178.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.861 HG13 ' O ' ' B' ' 35' ' ' ARG . 3.0 m -69.88 -49.4 57.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 119.156 -1.018 . . . . 0.0 109.318 175.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.64 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 66.4 mt-10 -63.41 -24.11 67.69 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.812 0.845 . . . . 0.0 112.377 176.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.736 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -86.21 -56.98 3.19 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 177.114 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' MET . . . . . 0.524 ' HG3' ' HB2' ' B' ' 4' ' ' ASN . 20.8 mmt -62.5 -20.76 64.92 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-O 121.524 0.678 . . . . 0.0 109.812 -177.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.67 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -48.88 -28.4 3.75 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.673 -1.148 . . . . 0.0 110.603 170.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' TYR . . . . . 0.589 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 5.6 t80 -108.17 -67.68 0.95 Allowed 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 175.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.682 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 5.0 mm-40 -46.94 -32.19 3.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 124.433 1.083 . . . . 0.0 112.109 -173.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.78 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 5.0 m-20 -104.59 -21.21 13.45 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -176.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.607 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -60.44 -179.27 0.11 Allowed 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.928 0.87 . . . . 0.0 112.95 -173.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -56.95 139.67 78.09 Favored Pre-proline 0 N--CA 1.444 -0.758 0 CA-C-N 114.403 -1.272 . . . . 0.0 108.892 175.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.78 -23.31 41.07 Favored 'Trans proline' 0 C--O 1.222 -0.321 0 C-N-CA 123.288 2.659 . . . . 0.0 112.12 -177.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' B' ' 50' ' ' GLU . 0.0 OUTLIER -88.16 -30.27 19.92 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.482 174.181 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.946 ' SG ' ' HB2' ' B' ' 76' ' ' CYS . 43.7 t -83.19 -36.53 24.61 Favored 'General case' 0 N--CA 1.426 -1.662 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.614 -170.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . 0.562 ' HB2' ' CG ' ' B' ' 44' ' ' TYR . 4.2 pt20 -67.66 -30.24 69.74 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 171.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' B' ' 50' ' ' GLU . 14.7 m -69.94 -20.27 63.34 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 113.343 -1.753 . . . . 0.0 110.727 173.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -81.3 -24.73 37.0 Favored 'General case' 0 C--N 1.313 -1.018 0 O-C-N 121.448 -0.782 . . . . 0.0 109.973 167.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.541 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 25.3 mt -90.22 -30.93 5.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -171.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.615 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.29 -40.07 2.51 Favored Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -174.477 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 49.4 Cg_endo -62.39 -27.39 77.4 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.32 2.013 . . . . 0.0 112.801 176.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . 0.543 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.0 OUTLIER -100.87 -15.76 17.46 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . 0.589 ' HE3' ' HB3' ' B' ' 44' ' ' TYR . 0.1 OUTLIER -53.41 109.34 0.43 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.172 -178.098 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . 0.424 ' N ' ' HZ3' ' B' ' 59' ' ' LYS . . . 92.09 -20.54 42.39 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.319 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 10.4 mmmt -103.79 113.54 27.13 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.412 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.3 p -122.75 144.19 42.06 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 173.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo . . . . . 0 N--CA 1.462 -0.376 0 C-N-CA 122.14 1.893 . . . . 0.0 111.392 168.84 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' ASP . . . . . 0.757 ' OD1' ' HB ' ' B' ' 69' ' ' ILE . 5.0 t70 . . . . . 0 CA--C 1.518 -0.266 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.583 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.8 OUTLIER -79.87 -28.96 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 C-N-CA 118.306 -1.357 . . . . 0.0 109.178 179.302 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.779 ' O ' HG13 ' B' ' 73' ' ' VAL . 11.4 mm -60.47 -46.37 95.43 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.988 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.878 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 29.6 t -44.27 -39.09 4.26 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.034 175.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.493 ' O ' ' HE2' ' B' ' 74' ' ' LYS . 6.3 mm-40 -86.16 -31.78 21.61 Favored 'General case' 0 C--O 1.216 -0.694 0 C-N-CA 123.445 0.698 . . . . 0.0 111.364 -177.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' TYR . . . . . 0.579 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.0 m-30 -75.51 -34.65 60.82 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.574 0.702 . . . . 0.0 109.328 -177.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.826 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.4 m -71.79 -31.82 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 173.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' LYS . . . . . 0.493 ' HE2' ' O ' ' B' ' 71' ' ' GLU . 13.4 ttpt -71.76 -26.18 62.34 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.458 -1.247 . . . . 0.0 109.437 177.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -65.28 -46.46 80.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.741 174.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.946 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 39.6 t -87.43 0.55 55.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.167 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 29.8 t70 . . . . . 0 C--N 1.322 -0.593 0 CA-C-O 121.632 0.73 . . . . 0.0 109.551 174.997 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.466 ' HB2' ' H ' ' A' ' 2' ' ' SER . 81.8 Cg_endo . . . . . 0 CA--C 1.518 -0.313 0 N-CA-C 108.666 -1.321 . . . . 0.0 108.666 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.466 ' H ' ' HB2' ' A' ' 1' ' ' PRO . 16.4 m -67.57 -178.9 0.97 Allowed 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 162.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.776 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -77.11 -51.84 10.33 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 164.713 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.514 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 2.3 p-10 -87.28 5.93 35.88 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 113.913 -1.494 . . . . 0.0 113.896 -164.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.458 HG23 ' HB2' ' A' ' 2' ' ' SER . 0.8 OUTLIER -63.77 -5.65 4.53 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 118.784 0.72 . . . . 0.0 111.52 -176.743 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.488 ' O ' HD13 ' A' ' 21' ' ' LEU . 2.0 m -78.16 130.31 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 176.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.746 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -155.72 158.74 38.73 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -178.37 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.463 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.6 mt-30 -39.07 116.65 0.6 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.624 -1.626 . . . . 0.0 113.551 176.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.29 -155.84 32.23 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.573 169.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.6 m -48.25 100.51 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 117.481 0.64 . . . . 0.0 111.678 -177.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.3 pttt 38.24 42.67 0.52 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.295 1.038 . . . . 0.0 112.335 -173.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.412 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 26.5 tt0 -57.46 138.26 81.43 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.267 176.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.527 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 37.0 Cg_exo -53.8 122.4 11.28 Favored 'Trans proline' 0 CA--C 1.505 -0.944 0 C-N-CA 121.84 1.693 . . . . 0.0 109.265 177.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.74 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 11.6 t80 -70.66 -53.92 8.89 Favored Pre-proline 0 N--CA 1.434 -1.241 0 CA-C-O 118.454 -0.784 . . . . 0.0 112.908 -166.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.546 ' HD3' ' HB3' ' A' ' 14' ' ' TYR . 36.3 Cg_exo -56.18 -18.2 22.86 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 121.453 1.435 . . . . 0.0 110.825 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.527 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 2.8 m-20 -89.53 -42.79 11.24 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.977 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.68 ' HE2' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -53.78 -46.55 71.06 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 176.63 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.768 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 1.3 p -79.27 -34.52 16.41 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.369 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.615 -177.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.5 -32.61 67.19 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 121.335 -0.853 . . . . 0.0 111.674 178.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.723 ' O ' HG12 ' A' ' 24' ' ' VAL . 16.6 ptt180 -84.36 -27.12 27.92 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 176.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.655 HD22 ' CE1' ' A' ' 17' ' ' PHE . 6.7 tp -56.56 -47.26 79.88 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.996 172.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.768 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 20.2 mt-30 -71.3 -47.1 58.85 Favored 'General case' 0 CA--C 1.493 -1.236 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.995 177.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.733 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 17.6 t70 -47.22 -54.83 9.82 Favored 'General case' 0 C--N 1.313 -1.015 0 O-C-N 124.297 0.998 . . . . 0.0 111.502 -178.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.723 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.5 p -81.23 -23.31 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.162 0.506 . . . . 0.0 109.983 -174.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.76 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -72.07 -19.5 61.81 Favored 'General case' 0 C--O 1.204 -1.318 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 174.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.431 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -86.25 -36.65 19.25 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.616 178.047 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.733 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 37.8 mmtt -66.9 -38.12 85.66 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.956 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.407 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 50.2 m -101.83 -8.85 21.29 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.166 0.508 . . . . 0.0 110.658 -171.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.76 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 88.7 mt -114.59 135.68 53.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.717 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.56 -2.25 42.14 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.003 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.687 ' H ' HG22 ' A' ' 29' ' ' ILE . 4.8 t0 -117.63 132.38 56.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.11 0.481 . . . . 0.0 111.048 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.603 ' OE1' ' HG3' ' A' ' 33' ' ' LYS . 1.6 pp20? -59.95 -35.39 74.85 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.285 174.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.606 ' O ' HG13 ' A' ' 37' ' ' VAL . 13.2 mttp -61.53 -58.74 6.91 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -175.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.524 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -61.9 -27.03 68.52 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.494 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.844 ' O ' HG13 ' A' ' 39' ' ' VAL . 5.0 tmm_? -70.4 -58.38 3.79 Favored 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.465 ' HD2' ' OE2' ' A' ' 32' ' ' GLU . 18.4 mtpt -56.14 -55.85 28.09 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.867 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.775 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 22.5 m -53.79 -36.49 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.228 -171.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.776 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.3 tt -87.0 -29.73 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.826 -177.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.844 HG13 ' O ' ' A' ' 35' ' ' ARG . 3.0 m -69.95 -48.95 60.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 119.089 -1.044 . . . . 0.0 109.488 175.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.582 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 54.1 mt-10 -64.93 -23.33 67.19 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.533 0.733 . . . . 0.0 112.545 176.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.775 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -85.78 -55.45 3.96 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.63 176.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.583 ' HB2' HD21 ' A' ' 21' ' ' LEU . 22.5 mmt -62.65 -20.42 64.79 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.698 0.761 . . . . 0.0 109.372 -178.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.653 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -48.28 -29.48 3.89 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.794 170.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.567 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 10.3 t80 -108.15 -66.39 1.04 Allowed 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.648 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 13.9 mm-40 -48.08 -32.66 7.05 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 124.266 0.979 . . . . 0.0 112.1 -174.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.746 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.9 m-20 -103.75 -20.6 13.89 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.326 -175.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.653 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -59.77 -179.94 0.11 Allowed 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 122.023 0.915 . . . . 0.0 112.681 -174.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.541 ' HB3' ' OE2' ' A' ' 50' ' ' GLU . 13.0 m-20 -58.6 140.52 85.0 Favored Pre-proline 0 N--CA 1.439 -1.016 0 CA-C-N 114.213 -1.358 . . . . 0.0 109.335 174.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -57.73 -20.83 44.78 Favored 'Trans proline' 0 C--O 1.222 -0.321 0 C-N-CA 123.228 2.619 . . . . 0.0 112.166 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.708 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 8.9 pm0 -88.58 -30.92 18.91 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 123.521 0.728 . . . . 0.0 110.255 173.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.986 ' SG ' ' HB2' ' A' ' 76' ' ' CYS . 49.5 t -85.46 -37.08 20.15 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.952 -168.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.567 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.7 pt20 -67.52 -28.94 68.24 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 171.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.508 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 32.8 m -71.88 -20.97 61.72 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 113.166 -1.834 . . . . 0.0 110.318 174.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.8 -24.32 44.64 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.41 0.624 . . . . 0.0 110.184 167.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.567 HD12 ' HA ' ' A' ' 52' ' ' GLN . 21.4 mt -90.89 -32.95 5.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -171.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.621 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.28 -38.95 1.79 Allowed Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -173.652 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 43.0 Cg_endo -61.61 -29.72 84.64 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 122.164 1.91 . . . . 0.0 112.636 175.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.539 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.5 mt -98.13 -16.51 19.49 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -179.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.575 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 0.1 OUTLIER -54.73 108.64 0.41 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.597 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.85 -25.37 28.55 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.56 -177.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.3 mmmt -103.99 113.49 27.06 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.046 0.45 . . . . 0.0 110.355 -178.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.448 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.2 p -124.42 145.53 49.22 Favored Pre-proline 0 C--N 1.313 -1.016 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 170.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo . . . . . 0 C--O 1.233 0.262 0 C-N-CA 122.395 2.063 . . . . 0.0 111.443 167.746 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.514 -0.411 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.538 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.7 OUTLIER -75.17 -27.64 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 C-N-CA 119.018 -1.073 . . . . 0.0 108.606 178.736 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.813 ' O ' HG13 ' A' ' 73' ' ' VAL . 17.7 mm -57.15 -47.02 84.7 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.211 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.332 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.9 t -46.77 -36.41 7.25 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.161 0.505 . . . . 0.0 111.237 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.652 ' O ' ' HE3' ' A' ' 74' ' ' LYS . 1.7 mm-40 -85.85 -32.91 21.46 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.45 -177.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.647 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 4.9 m-30 -75.31 -33.46 61.17 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.374 -177.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.813 HG13 ' O ' ' A' ' 69' ' ' ILE . 1.2 m -71.66 -31.15 41.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 171.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.652 ' HE3' ' O ' ' A' ' 71' ' ' GLU . 0.7 OUTLIER -72.0 -24.15 61.52 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.654 176.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -66.33 -47.34 73.84 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.404 173.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.986 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 43.9 t -88.97 7.76 33.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.051 178.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 C--N 1.323 -0.551 0 CA-C-O 121.271 0.558 . . . . 0.0 109.894 172.376 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 1' ' ' PRO . . . . . 0.416 ' HB2' ' H ' ' B' ' 2' ' ' SER . 83.6 Cg_endo . . . . . 0 CA--C 1.517 -0.336 0 N-CA-C 108.725 -1.298 . . . . 0.0 108.725 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . 0.469 ' HB2' HG23 ' B' ' 5' ' ' THR . 16.8 m -67.88 -179.24 1.13 Allowed 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 162.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.768 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -76.7 -51.95 10.53 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 164.761 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.507 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.3 p-10 -87.28 6.09 35.1 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.929 -1.487 . . . . 0.0 113.869 -164.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.469 HG23 ' HB2' ' B' ' 2' ' ' SER . 0.8 OUTLIER -63.82 -5.89 5.0 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 118.806 0.73 . . . . 0.0 111.467 -176.699 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.479 ' O ' HD13 ' B' ' 21' ' ' LEU . 1.9 m -77.89 130.23 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 176.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.732 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.1 OUTLIER -155.71 158.66 38.6 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.11 -1.036 . . . . 0.0 113.765 -178.426 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' GLN . . . . . 0.47 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.6 mt-30 -38.7 116.77 0.59 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 113.612 -1.631 . . . . 0.0 113.597 176.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.27 -155.94 32.32 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 169.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 18.4 m -48.19 100.6 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 117.437 0.619 . . . . 0.0 111.615 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 22.2 pttt 38.46 42.04 0.51 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.411 1.084 . . . . 0.0 112.401 -174.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -56.99 138.23 79.49 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.221 176.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . 0.551 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 37.2 Cg_exo -53.87 122.51 11.49 Favored 'Trans proline' 0 CA--C 1.508 -0.823 0 C-N-CA 121.88 1.72 . . . . 0.0 109.292 177.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' TYR . . . . . 0.738 ' O ' HG12 ' B' ' 18' ' ' VAL . 11.7 t80 -70.82 -54.09 8.28 Favored Pre-proline 0 N--CA 1.435 -1.217 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.833 -166.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.538 ' HD3' ' HB3' ' B' ' 14' ' ' TYR . 36.4 Cg_exo -56.05 -18.2 22.09 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 121.432 1.422 . . . . 0.0 110.841 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.551 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 2.3 m-20 -89.62 -42.48 11.36 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.146 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' PHE . . . . . 0.689 ' HE2' ' CE2' ' B' ' 14' ' ' TYR . 0.0 OUTLIER -54.23 -46.48 72.55 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 176.471 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.771 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 1.2 p -79.29 -34.55 16.4 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.366 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.563 -177.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.38 -32.71 67.07 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 121.374 -0.829 . . . . 0.0 111.702 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.708 ' O ' HG12 ' B' ' 24' ' ' VAL . 16.7 ptt180 -84.36 -27.2 27.86 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.665 HD22 ' CE1' ' B' ' 17' ' ' PHE . 6.8 tp -56.58 -47.27 79.92 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.886 172.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' GLN . . . . . 0.771 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 20.2 mt-30 -71.28 -46.86 59.86 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.028 177.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.734 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 17.4 t70 -47.54 -54.73 10.85 Favored 'General case' 0 C--N 1.315 -0.922 0 O-C-N 124.254 0.971 . . . . 0.0 111.607 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' VAL . . . . . 0.708 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.5 p -81.14 -23.27 10.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.085 0.469 . . . . 0.0 109.921 -174.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.752 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -72.15 -19.47 61.76 Favored 'General case' 0 C--O 1.204 -1.297 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 174.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . 0.428 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -86.4 -36.4 19.19 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.583 -1.189 . . . . 0.0 109.499 178.105 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.734 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.1 mmtt -66.99 -38.09 85.39 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.98 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 50.1 m -101.63 -9.57 20.82 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.269 0.557 . . . . 0.0 110.768 -171.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.752 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 88.2 mt -113.91 135.95 51.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.677 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.03 -1.84 41.66 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.916 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.665 ' H ' HG22 ' B' ' 29' ' ' ILE . 4.5 t0 -118.04 132.31 56.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.205 0.526 . . . . 0.0 111.147 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.572 ' OE1' ' HG3' ' B' ' 33' ' ' LYS . 1.5 pp20? -59.82 -35.58 75.01 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.312 174.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.6 ' O ' HG13 ' B' ' 37' ' ' VAL . 13.2 mttp -61.37 -58.75 6.95 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -175.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.511 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -61.95 -26.88 68.46 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.531 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.855 ' O ' HG13 ' B' ' 39' ' ' VAL . 5.0 tmm_? -70.54 -58.25 3.89 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.457 ' HD2' ' OE2' ' B' ' 32' ' ' GLU . 17.8 mtpt -56.3 -55.49 32.71 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.992 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.75 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 22.8 m -54.0 -36.58 31.67 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.103 -172.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.768 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.3 tt -87.06 -29.62 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.845 -177.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.855 HG13 ' O ' ' B' ' 35' ' ' ARG . 3.0 m -70.02 -49.03 59.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 119.131 -1.028 . . . . 0.0 109.488 175.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.594 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 58.8 mt-10 -64.91 -23.28 67.18 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.514 0.725 . . . . 0.0 112.604 176.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.75 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -85.92 -55.37 3.98 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.555 176.385 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' MET . . . . . 0.579 ' HB2' HD21 ' B' ' 21' ' ' LEU . 22.5 mmt -62.58 -20.48 64.74 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.614 0.721 . . . . 0.0 109.318 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.659 ' O ' ' HB2' ' B' ' 47' ' ' ALA . . . -48.26 -29.6 3.98 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.832 170.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' TYR . . . . . 0.564 ' CG ' ' HD2' ' B' ' 59' ' ' LYS . 10.4 t80 -108.06 -66.39 1.04 Allowed 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.643 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 14.6 mm-40 -47.97 -33.24 7.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 124.292 0.995 . . . . 0.0 111.905 -174.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.732 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.9 m-20 -103.2 -20.77 14.01 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.366 -175.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.659 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -59.72 179.76 0.11 Allowed 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 122.028 0.918 . . . . 0.0 112.683 -174.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' ASN . . . . . 0.529 ' HB3' ' CD ' ' B' ' 50' ' ' GLU . 12.5 m-20 -58.24 140.45 83.37 Favored Pre-proline 0 N--CA 1.438 -1.032 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.362 175.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -57.8 -20.65 44.51 Favored 'Trans proline' 0 C--O 1.221 -0.355 0 C-N-CA 123.211 2.607 . . . . 0.0 112.182 -178.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . 0.712 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 9.1 pm0 -88.66 -30.9 18.81 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 123.541 0.737 . . . . 0.0 110.287 173.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.99 ' SG ' ' HB2' ' B' ' 76' ' ' CYS . 49.5 t -85.52 -37.12 20.02 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.97 -168.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . 0.555 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.9 pt20 -67.46 -29.04 68.4 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 171.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' SER . . . . . 0.495 ' HA ' ' HE2' ' B' ' 56' ' ' LYS . 34.8 m -71.8 -21.1 61.75 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 113.176 -1.829 . . . . 0.0 110.379 174.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.53 -24.56 45.66 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.501 0.667 . . . . 0.0 110.159 167.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.555 HD12 ' HA ' ' B' ' 52' ' ' GLN . 21.5 mt -90.8 -32.98 5.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -171.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.619 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.19 -39.24 1.86 Allowed Pre-proline 0 N--CA 1.486 1.365 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -173.612 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 42.9 Cg_endo -61.44 -29.55 85.38 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.216 1.944 . . . . 0.0 112.728 175.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . 0.541 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.4 mt -98.23 -16.54 19.39 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . 0.59 ' HA ' ' OH ' ' B' ' 72' ' ' TYR . 0.1 OUTLIER -54.65 108.81 0.43 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.578 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.72 -25.43 28.3 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.59 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 12.3 mmmt -103.99 113.49 27.06 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.114 0.483 . . . . 0.0 110.322 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.452 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.1 p -124.22 145.53 48.8 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.844 170.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo . . . . . 0 C--N 1.345 0.37 0 C-N-CA 122.277 1.985 . . . . 0.0 111.528 167.679 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.515 -0.393 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.545 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.7 OUTLIER -75.14 -27.49 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 C-N-CA 118.795 -1.162 . . . . 0.0 108.64 178.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.817 ' O ' HG13 ' B' ' 73' ' ' VAL . 17.9 mm -57.21 -46.98 84.95 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.194 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.366 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.403 ' O ' HG22 ' B' ' 73' ' ' VAL . 30.6 t -46.87 -36.14 7.17 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.32 0.581 . . . . 0.0 111.349 177.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.648 ' O ' ' HE3' ' B' ' 74' ' ' LYS . 1.7 mm-40 -85.98 -32.83 21.32 Favored 'General case' 0 C--O 1.213 -0.817 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.499 -177.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' TYR . . . . . 0.652 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 4.9 m-30 -75.54 -33.27 60.66 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.376 -177.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.817 HG13 ' O ' ' B' ' 69' ' ' ILE . 1.2 m -71.66 -31.3 41.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 171.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' LYS . . . . . 0.648 ' HE3' ' O ' ' B' ' 71' ' ' GLU . 0.7 OUTLIER -71.89 -24.45 61.66 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.539 177.021 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -66.24 -47.14 74.75 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.438 173.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.99 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 44.2 t -89.12 7.64 34.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.831 178.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . 0.42 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 12.3 t70 . . . . . 0 C--N 1.324 -0.53 0 CA-C-O 121.192 0.52 . . . . 0.0 109.896 172.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.407 ' C ' ' HA3' ' B' ' 60' ' ' GLY . 97.8 Cg_endo . . . . . 0 N--CA 1.465 -0.202 0 N-CA-C 108.91 -1.227 . . . . 0.0 108.91 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.558 ' HB2' HG23 ' A' ' 5' ' ' THR . 72.0 m -71.34 -178.86 2.23 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 161.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.719 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -77.02 -53.48 7.75 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 122.096 0.95 . . . . 0.0 109.716 172.77 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.539 ' ND2' ' HE3' ' A' ' 42' ' ' MET . 2.5 p-10 -85.69 5.85 30.26 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.141 -1.39 . . . . 0.0 113.249 -163.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.558 HG23 ' HB2' ' A' ' 2' ' ' SER . 1.1 p -66.83 -3.38 6.72 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 121.935 -0.478 . . . . 0.0 111.428 -176.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.566 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 1.9 m -78.2 133.89 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 173.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.759 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -156.54 160.84 39.86 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -177.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.421 ' HG2' ' HB3' ' A' ' 12' ' ' GLU . 2.3 tt0 -41.94 115.53 0.68 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 113.704 -1.589 . . . . 0.0 113.056 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.58 -151.72 23.78 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 172.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.479 ' C ' ' HD3' ' A' ' 11' ' ' LYS . 22.8 m -54.25 99.13 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 117.319 0.559 . . . . 0.0 111.133 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.479 ' HD3' ' C ' ' A' ' 10' ' ' SER . 0.0 OUTLIER 34.56 46.52 0.18 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.642 1.177 . . . . 0.0 112.269 -171.333 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.421 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 36.5 tt0 -59.54 139.54 89.2 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.23 175.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.568 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 52.1 Cg_exo -51.0 122.47 9.99 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 121.942 1.761 . . . . 0.0 109.651 177.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.834 ' HE2' ' SG ' ' A' ' 51' ' ' CYS . 6.1 t80 -70.4 -55.34 7.8 Favored Pre-proline 0 N--CA 1.439 -1.001 0 CA-C-O 118.569 -0.729 . . . . 0.0 112.651 -167.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.517 ' HD3' ' HB3' ' A' ' 14' ' ' TYR . 35.0 Cg_exo -55.57 -19.41 23.37 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 121.535 1.49 . . . . 0.0 111.217 -178.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.568 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 0.8 OUTLIER -90.04 -39.39 12.96 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.176 179.505 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.689 ' HE2' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -56.64 -45.68 81.43 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 175.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.75 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 1.3 p -79.01 -33.97 16.38 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.329 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.275 -178.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.64 -32.0 66.84 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 121.386 -0.821 . . . . 0.0 111.624 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.709 ' O ' HG12 ' A' ' 24' ' ' VAL . 14.5 ptt180 -84.96 -26.32 27.24 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 176.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.599 HD22 ' CE1' ' A' ' 17' ' ' PHE . 7.5 tp -56.99 -47.74 80.09 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.639 171.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.75 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 18.2 mt-30 -70.15 -46.62 64.33 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.753 176.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.73 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 18.6 t70 -46.82 -57.13 5.21 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.288 0.992 . . . . 0.0 111.67 -179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.709 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.7 p -79.22 -23.85 12.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.134 0.492 . . . . 0.0 109.816 -173.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.76 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -72.14 -19.69 61.73 Favored 'General case' 0 C--O 1.205 -1.243 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 174.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.476 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -86.66 -36.98 18.45 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.481 178.522 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.73 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.7 mmtt -66.82 -35.27 79.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.8 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.9 t -105.07 -9.11 18.04 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.166 0.508 . . . . 0.0 110.583 -171.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.76 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 88.7 mt -115.11 129.1 71.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.769 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.26 -4.65 59.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.171 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.699 ' H ' HG22 ' A' ' 29' ' ' ILE . 2.8 t0 -116.16 140.57 49.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.233 0.54 . . . . 0.0 111.276 -177.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.549 ' OE2' ' HG3' ' A' ' 33' ' ' LYS . 1.4 pp20? -66.41 -36.14 82.08 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.256 173.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.621 ' O ' HG13 ' A' ' 37' ' ' VAL . 13.0 mttp -60.45 -61.02 2.9 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -174.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.526 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -59.71 -27.04 66.11 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.623 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.859 ' O ' HG13 ' A' ' 39' ' ' VAL . 4.8 tmm_? -69.65 -59.42 2.97 Favored 'General case' 0 C--O 1.221 -0.43 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.403 ' HD2' ' OE1' ' A' ' 32' ' ' GLU . 23.6 mtpt -56.73 -55.78 29.84 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.217 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.7 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 18.9 m -53.19 -35.36 23.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 O-C-N 123.98 0.8 . . . . 0.0 111.253 -172.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.719 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.3 tt -87.46 -31.12 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 119.756 -0.778 . . . . 0.0 112.097 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 35' ' ' ARG . 3.0 m -69.19 -48.57 67.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 119.181 -1.008 . . . . 0.0 109.392 175.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.598 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 58.2 mt-10 -63.73 -23.7 67.47 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 123.624 0.77 . . . . 0.0 112.264 176.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.7 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -86.47 -54.74 4.24 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.803 176.343 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.555 ' HB2' HD21 ' A' ' 21' ' ' LEU . 18.7 mmt -62.68 -20.46 64.87 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.504 0.669 . . . . 0.0 109.919 -177.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.638 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -48.23 -29.08 3.45 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.024 171.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.662 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 2.5 t80 -109.05 -65.68 1.12 Allowed 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 175.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.553 ' CG ' HD12 ' A' ' 41' ' ' LEU . 3.3 mm-40 -46.89 -30.39 2.49 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 124.116 0.885 . . . . 0.0 112.713 -175.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.759 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.8 m-20 -106.55 -20.77 13.26 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -175.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.811 ' HB1' ' SG ' ' A' ' 51' ' ' CYS . . . -64.33 -175.96 0.2 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -172.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.525 ' HB2' ' HB3' ' A' ' 51' ' ' CYS . 18.7 m-20 -61.79 141.7 95.1 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 114.526 -1.216 . . . . 0.0 109.447 175.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -55.27 -26.6 52.9 Favored 'Trans proline' 0 C--O 1.219 -0.458 0 C-N-CA 123.592 2.861 . . . . 0.0 112.968 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.514 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -87.31 -29.29 21.7 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.381 0.672 . . . . 0.0 110.247 174.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.834 ' SG ' ' HE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -76.15 -43.67 41.78 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.547 -172.229 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.638 ' HB2' ' CG ' ' A' ' 44' ' ' TYR . 4.3 pt20 -67.75 -29.46 68.69 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 175.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.56 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 4.0 m -69.42 -20.89 63.79 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 113.703 -1.589 . . . . 0.0 110.729 173.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -80.41 -24.87 39.36 Favored 'General case' 0 C--N 1.309 -1.176 0 O-C-N 121.412 -0.805 . . . . 0.0 109.853 168.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.538 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 25.8 mt -90.73 -31.22 5.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 115.008 1.485 . . . . 0.0 115.008 -172.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.633 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.71 -39.75 2.79 Favored Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -172.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 49.6 Cg_endo -62.69 -29.76 77.83 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.327 2.018 . . . . 0.0 112.799 176.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.548 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.6 mt -97.35 -16.37 20.3 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.662 ' HE3' ' HB3' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -52.94 108.4 0.31 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.02 -178.141 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.9 -22.71 36.6 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.74 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -103.39 114.85 29.45 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.452 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.2 p -122.55 138.74 29.76 Favored Pre-proline 0 C--N 1.313 -1.015 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.42 173.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_exo . . . . . 0 C--N 1.344 0.291 0 C-N-CA 122.661 2.241 . . . . 0.0 111.891 169.604 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.513 -0.45 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.561 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.7 OUTLIER -74.33 -28.54 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 C-N-CA 118.462 -1.295 . . . . 0.0 108.669 -177.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.794 ' O ' HG13 ' A' ' 73' ' ' VAL . 14.3 mm -58.49 -46.82 89.56 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.278 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.327 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.533 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 40.3 t -48.77 -36.63 16.96 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.249 0.547 . . . . 0.0 111.098 178.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -86.53 -31.34 21.31 Favored 'General case' 0 CA--C 1.506 -0.719 0 C-N-CA 123.137 0.575 . . . . 0.0 110.517 -176.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.616 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.3 m-30 -75.22 -36.64 61.33 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.285 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.812 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.7 m -69.45 -32.89 54.81 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 173.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 70' ' ' SER . 0.1 OUTLIER -70.23 -32.43 70.3 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.406 178.683 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.528 ' HB2' HD11 ' A' ' 58' ' ' LEU . . . -63.43 -42.76 98.71 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.645 -1.161 . . . . 0.0 108.972 178.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 5.0 m -102.21 9.49 40.02 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.34 -175.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.3 t70 . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.069 178.793 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 1' ' ' PRO . . . . . 0.444 ' HB2' ' H ' ' B' ' 2' ' ' SER . 98.9 Cg_endo . . . . . 0 CA--C 1.518 -0.285 0 N-CA-C 108.811 -1.265 . . . . 0.0 108.811 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . 0.571 ' HB2' HG23 ' B' ' 5' ' ' THR . 74.7 m -71.04 -178.75 2.06 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 161.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.727 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -77.12 -53.5 7.69 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 122.093 0.949 . . . . 0.0 109.646 172.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.519 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.5 p-10 -85.61 5.77 30.33 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.095 -1.411 . . . . 0.0 113.224 -163.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.571 HG23 ' HB2' ' B' ' 2' ' ' SER . 1.1 p -66.72 -3.75 7.37 Favored 'General case' 0 C--N 1.312 -1.045 0 O-C-N 121.953 -0.467 . . . . 0.0 111.36 -176.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.57 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.0 m -77.99 133.75 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 173.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.759 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.2 OUTLIER -156.41 160.95 40.09 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -177.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' GLN . . . . . 0.426 ' HG2' ' HB3' ' B' ' 12' ' ' GLU . 2.3 tt0 -41.98 115.22 0.64 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 113.732 -1.576 . . . . 0.0 113.16 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.44 -151.5 23.12 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 171.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . 0.487 ' C ' ' HD3' ' B' ' 11' ' ' LYS . 24.0 m -54.73 98.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.369 0.585 . . . . 0.0 111.187 -178.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . 0.487 ' HD3' ' C ' ' B' ' 10' ' ' SER . 0.0 OUTLIER 34.99 46.6 0.21 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.799 1.24 . . . . 0.0 112.129 -171.508 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.426 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 36.6 tt0 -59.64 139.51 89.55 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.197 175.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . 0.575 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 51.2 Cg_exo -50.98 122.32 9.72 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 121.955 1.77 . . . . 0.0 109.615 177.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' TYR . . . . . 0.82 ' HE2' ' SG ' ' B' ' 51' ' ' CYS . 6.3 t80 -70.35 -55.22 8.02 Favored Pre-proline 0 N--CA 1.439 -0.98 0 CA-C-O 118.494 -0.765 . . . . 0.0 112.664 -167.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.532 ' HD3' ' HB3' ' B' ' 14' ' ' TYR . 35.2 Cg_exo -55.79 -19.21 24.0 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 121.526 1.484 . . . . 0.0 111.124 -178.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.575 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 0.8 OUTLIER -89.92 -39.79 12.79 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.226 -1.352 . . . . 0.0 111.082 179.579 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' PHE . . . . . 0.687 ' HE2' ' CE2' ' B' ' 14' ' ' TYR . 0.0 OUTLIER -56.59 -45.67 81.24 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.128 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.755 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 1.3 p -78.94 -33.97 16.53 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.354 0 CA-C-N 115.184 -0.917 . . . . 0.0 111.271 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.71 -31.8 66.77 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 121.346 -0.846 . . . . 0.0 111.701 177.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.702 ' O ' HG12 ' B' ' 24' ' ' VAL . 14.7 ptt180 -84.88 -26.61 27.22 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 175.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.607 HD22 ' CE1' ' B' ' 17' ' ' PHE . 7.6 tp -56.84 -47.73 79.67 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.603 172.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' GLN . . . . . 0.755 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 18.5 mt-30 -70.04 -47.09 63.44 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.817 176.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.741 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 19.4 t70 -46.4 -57.06 5.0 Favored 'General case' 0 C--N 1.314 -0.947 0 O-C-N 124.312 1.008 . . . . 0.0 111.721 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' VAL . . . . . 0.702 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.7 p -79.44 -23.65 12.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.169 0.509 . . . . 0.0 109.849 -173.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.764 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -72.25 -19.69 61.66 Favored 'General case' 0 C--O 1.205 -1.274 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 174.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . 0.47 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -86.73 -36.99 18.33 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.494 178.589 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.741 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.9 mmtt -66.77 -35.36 79.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.699 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 36.2 t -105.08 -8.88 18.18 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 120.946 0.403 . . . . 0.0 110.744 -171.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.764 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 88.9 mt -115.38 129.4 71.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.711 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.55 -5.02 58.95 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.102 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.681 ' H ' HG22 ' B' ' 29' ' ' ILE . 2.5 t0 -115.98 140.58 49.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.305 0.574 . . . . 0.0 111.125 -176.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.572 ' OE2' ' HG3' ' B' ' 33' ' ' LYS . 1.5 pp20? -66.48 -35.91 81.44 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.183 174.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.618 ' O ' HG13 ' B' ' 37' ' ' VAL . 12.9 mttp -60.49 -61.04 2.88 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -174.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.513 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -59.93 -26.86 66.29 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.582 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.848 ' O ' HG13 ' B' ' 39' ' ' VAL . 4.7 tmm_? -69.69 -59.39 2.98 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -178.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.42 ' HD2' ' OE1' ' B' ' 32' ' ' GLU . 23.8 mtpt -56.84 -55.44 34.4 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.246 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.691 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 19.2 m -53.52 -35.29 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.192 -172.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.727 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.3 tt -87.42 -31.12 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.159 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.848 HG13 ' O ' ' B' ' 35' ' ' ARG . 3.0 m -69.15 -48.57 68.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 119.078 -1.049 . . . . 0.0 109.418 175.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.611 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 61.9 mt-10 -63.59 -23.94 67.59 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 123.634 0.774 . . . . 0.0 112.229 176.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.691 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -86.27 -54.73 4.28 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.871 176.328 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' MET . . . . . 0.564 ' HB2' HD21 ' B' ' 21' ' ' LEU . 18.8 mmt -62.65 -20.41 64.78 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 121.553 0.692 . . . . 0.0 109.971 -177.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.627 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -48.33 -29.03 3.53 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.48 -1.237 . . . . 0.0 110.992 171.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' TYR . . . . . 0.663 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 2.4 t80 -109.05 -65.63 1.12 Allowed 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 176.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.547 ' CG ' HD12 ' B' ' 41' ' ' LEU . 3.3 mm-40 -46.89 -30.76 2.69 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 124.145 0.903 . . . . 0.0 112.678 -175.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.759 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.8 m-20 -106.13 -20.97 13.25 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -175.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.815 ' HB1' ' SG ' ' B' ' 51' ' ' CYS . . . -64.23 -175.9 0.19 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -172.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' ASN . . . . . 0.514 ' HB2' ' HB3' ' B' ' 51' ' ' CYS . 19.4 m-20 -61.75 141.72 95.01 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.473 175.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -55.27 -26.75 53.65 Favored 'Trans proline' 0 C--O 1.219 -0.446 0 C-N-CA 123.518 2.812 . . . . 0.0 112.948 -176.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . 0.538 ' O ' ' HG3' ' B' ' 50' ' ' GLU . 0.0 OUTLIER -87.17 -29.16 21.98 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.327 0.651 . . . . 0.0 110.351 174.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.82 ' SG ' ' HE2' ' B' ' 14' ' ' TYR . 0.0 OUTLIER -76.04 -43.78 42.27 Favored 'General case' 0 N--CA 1.42 -1.942 0 CA-C-O 121.446 0.641 . . . . 0.0 110.547 -172.229 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . 0.648 ' HB2' ' CG ' ' B' ' 44' ' ' TYR . 4.4 pt20 -67.77 -29.47 68.69 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 175.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' SER . . . . . 0.552 ' O ' ' HE2' ' B' ' 56' ' ' LYS . 4.0 m -69.42 -20.87 63.79 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 113.685 -1.598 . . . . 0.0 110.716 173.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -80.22 -25.26 39.69 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.289 -0.882 . . . . 0.0 109.821 168.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.546 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 25.7 mt -90.67 -31.28 5.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 -172.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.627 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.64 -39.62 2.6 Favored Pre-proline 0 N--CA 1.487 1.399 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -172.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 50.7 Cg_endo -62.81 -29.67 76.98 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.323 2.015 . . . . 0.0 112.828 176.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . 0.56 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.7 mt -97.42 -16.42 20.2 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . 0.663 ' HE3' ' HB3' ' B' ' 44' ' ' TYR . 0.1 OUTLIER -52.92 108.73 0.34 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.955 -178.104 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . 0.407 ' HA3' ' C ' ' A' ' 1' ' ' PRO . . . 94.55 -22.47 37.24 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.745 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -103.53 115.11 29.9 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -178.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.45 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.1 p -122.92 139.0 30.51 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.429 173.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo . . . . . 0 C--N 1.346 0.396 0 C-N-CA 122.708 2.272 . . . . 0.0 111.833 169.77 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.513 -0.444 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.57 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.7 OUTLIER -74.32 -28.33 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 C-N-CA 118.432 -1.307 . . . . 0.0 108.696 -177.462 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.799 ' O ' HG13 ' B' ' 73' ' ' VAL . 14.4 mm -58.61 -46.83 90.01 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.179 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.319 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.541 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 37.6 t -48.62 -36.74 16.45 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.165 0.507 . . . . 0.0 111.081 178.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -86.56 -31.23 21.33 Favored 'General case' 0 CA--C 1.506 -0.73 0 C-N-CA 123.206 0.602 . . . . 0.0 110.545 -176.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' TYR . . . . . 0.605 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.3 m-30 -75.36 -36.6 60.95 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.32 -178.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.815 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.7 m -69.36 -33.23 56.65 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 173.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' LYS . . . . . 0.541 ' HB2' ' O ' ' B' ' 70' ' ' SER . 0.1 OUTLIER -69.94 -32.31 70.51 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.517 178.473 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . 0.515 ' HB2' HD11 ' B' ' 58' ' ' LEU . . . -63.76 -42.07 97.88 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.208 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 5.1 m -102.7 9.53 39.13 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 114.101 -1.409 . . . . 0.0 111.318 -175.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 CA--C 1.536 0.437 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.046 178.832 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.453 ' HB2' ' H ' ' A' ' 2' ' ' SER . 86.3 Cg_endo . . . . . 0 CA--C 1.517 -0.35 0 N-CA-C 109.024 -1.183 . . . . 0.0 109.024 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.49 ' HB2' HG23 ' A' ' 5' ' ' THR . 21.2 m -68.41 175.2 3.5 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 161.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.833 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -71.0 -52.2 21.03 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 164.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.518 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 2.3 p-10 -87.41 5.52 38.39 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.875 -1.512 . . . . 0.0 113.692 -165.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.49 HG23 ' HB2' ' A' ' 2' ' ' SER . 0.7 OUTLIER -64.35 -5.76 5.78 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 118.537 0.608 . . . . 0.0 111.116 -177.37 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.642 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.1 m -76.16 130.94 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.743 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -154.31 158.69 40.52 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.552 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 3.3 mt-30 -42.04 116.61 0.84 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 112.997 -1.91 . . . . 0.0 113.465 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.56 -153.67 21.55 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 170.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.662 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 20.8 t -57.19 99.34 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.166 0.483 . . . . 0.0 110.926 -177.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.662 ' HG2' ' O ' ' A' ' 10' ' ' SER . 4.1 ptpp? 49.18 32.71 4.38 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.602 1.161 . . . . 0.0 112.433 -177.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.431 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 38.7 tt0 -56.06 135.39 74.14 Favored Pre-proline 0 C--O 1.233 0.224 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.558 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 52.0 Cg_exo -51.05 123.08 11.09 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.46 2.107 . . . . 0.0 110.169 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.906 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 15.0 t80 -71.13 -53.51 8.18 Favored Pre-proline 0 N--CA 1.438 -1.061 0 CA-C-O 118.277 -0.868 . . . . 0.0 113.183 -167.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.541 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 33.6 Cg_exo -55.9 -18.43 22.05 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 121.425 1.416 . . . . 0.0 111.041 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.558 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.8 m-20 -89.92 -43.49 10.55 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.93 -1.486 . . . . 0.0 110.829 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.552 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -54.31 -44.43 72.0 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.727 HG12 ' O ' ' A' ' 14' ' ' TYR . 3.0 p -82.19 -31.77 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.386 -177.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . -57.89 -35.86 71.61 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 121.763 -0.585 . . . . 0.0 111.853 175.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.72 ' O ' HG12 ' A' ' 24' ' ' VAL . 15.6 ptt180 -82.97 -27.3 30.56 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 177.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.572 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 6.5 tp -56.89 -45.46 82.57 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.858 173.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.733 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 40.5 mt-30 -74.12 -43.71 56.52 Favored 'General case' 0 CA--C 1.496 -1.112 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.999 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.754 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 8.8 t70 -51.17 -51.68 51.41 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 124.137 0.898 . . . . 0.0 111.47 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.72 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.5 p -82.64 -23.15 8.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -174.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.825 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -71.66 -18.67 62.17 Favored 'General case' 0 C--O 1.206 -1.224 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 174.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.0 -39.11 15.98 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.471 -1.24 . . . . 0.0 109.766 176.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.754 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 36.5 mmtt -66.59 -40.61 88.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.065 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.403 ' HB2' ' HB3' ' A' ' 3' ' ' PHE . 43.9 m -98.81 -9.7 24.01 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.153 0.501 . . . . 0.0 110.437 -171.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.825 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 87.5 mt -115.18 125.3 72.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.759 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.56 -4.96 59.25 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.004 0.431 . . . . 0.0 110.529 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.678 ' OD1' ' HD2' ' A' ' 33' ' ' LYS . 3.9 t0 -110.62 122.43 47.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.534 -176.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.484 ' O ' ' HG2' ' A' ' 36' ' ' LYS . 12.6 pt-20 -61.85 -25.11 67.33 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.765 176.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.678 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 24.4 mttt -73.81 -46.74 43.43 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 120.901 0.381 . . . . 0.0 110.146 -176.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.08 -25.11 60.78 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.731 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.84 ' O ' HG13 ' A' ' 39' ' ' VAL . 5.0 tmm_? -64.53 -63.14 1.21 Allowed 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.642 ' HG3' HG13 ' A' ' 37' ' ' VAL . 6.5 ptmm? -51.9 -60.15 3.51 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.198 0.523 . . . . 0.0 112.224 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.642 HG13 ' HG3' ' A' ' 36' ' ' LYS . 10.4 m -56.32 -30.87 31.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.353 -170.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.833 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.2 tt -86.08 -30.45 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.247 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.84 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.3 m -70.13 -47.91 65.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 119.481 -0.887 . . . . 0.0 109.348 175.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.658 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 55.3 mt-10 -60.21 -30.27 69.27 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.665 0.786 . . . . 0.0 112.119 176.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.619 ' HG ' HD11 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -86.16 -53.15 5.22 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.484 -0.487 . . . . 0.0 112.189 179.198 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.559 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 22.0 mmt -61.95 -22.08 65.33 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.592 0.71 . . . . 0.0 109.84 -178.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.697 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -48.54 -29.02 3.78 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.043 171.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.598 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 8.4 t80 -107.02 -66.58 1.01 Allowed 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.548 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 15.5 mm-40 -48.23 -31.96 6.55 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 124.141 0.901 . . . . 0.0 112.109 -174.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.743 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.9 m-20 -103.03 -21.49 13.92 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.182 -175.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.605 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -62.42 -178.98 0.21 Allowed 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.988 0.899 . . . . 0.0 112.986 -173.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.542 ' HB3' ' OE1' ' A' ' 50' ' ' GLU . 12.2 m-20 -61.34 143.24 93.11 Favored Pre-proline 0 C--N 1.317 -0.811 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.003 175.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 48' ' ' ASN . 55.5 Cg_exo -50.83 -28.53 23.66 Favored 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 123.666 2.911 . . . . 0.0 112.996 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.689 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 15.9 pm0 -88.42 -30.99 19.04 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.758 0.823 . . . . 0.0 111.015 176.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.689 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 96.9 m -81.79 -38.99 24.73 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.242 -170.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.626 ' HA ' HD12 ' A' ' 55' ' ' ILE . 4.1 pt20 -69.93 -29.76 66.98 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 172.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.467 ' O ' ' HD2' ' A' ' 56' ' ' LYS . 6.7 m -71.12 -20.32 62.34 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.859 -1.518 . . . . 0.0 110.755 174.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.88 -25.27 48.48 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.691 0.758 . . . . 0.0 109.57 167.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.626 HD12 ' HA ' ' A' ' 52' ' ' GLN . 24.1 mt -89.76 -33.05 5.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -172.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.613 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.3 -38.71 1.71 Allowed Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -173.363 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 51.5 Cg_endo -63.13 -28.69 73.86 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.188 1.925 . . . . 0.0 112.625 175.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.537 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 2.2 mt -97.58 -16.65 19.95 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.598 ' HD2' ' CG ' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -55.95 108.98 0.51 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.443 -179.146 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.72 -24.9 30.36 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.328 -177.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.0 mmmt -104.54 115.63 30.68 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.853 0.358 . . . . 0.0 110.466 -178.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.43 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.7 p -121.77 134.75 24.75 Favored Pre-proline 0 C--N 1.313 -1.0 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 168.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo . . . . . 0 CA--C 1.518 -0.278 0 C-N-CA 122.545 2.163 . . . . 0.0 111.79 172.77 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.8 t70 . . . . . 0 N--CA 1.444 -0.769 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.58 HG22 ' HG2' ' A' ' 40' ' ' GLU . 1.2 m -76.16 -30.29 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 C-N-CA 118.553 -1.259 . . . . 0.0 108.709 -177.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.778 ' O ' HG13 ' A' ' 73' ' ' VAL . 7.0 mm -60.85 -47.88 91.38 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.158 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.413 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.498 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 34.1 t -50.51 -35.22 28.37 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.892 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.45 ' H ' ' HG2' ' A' ' 71' ' ' GLU . 3.1 mm-40 -86.58 -32.07 20.85 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.081 0.467 . . . . 0.0 110.414 -177.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.537 ' CE1' ' HB2' ' A' ' 58' ' ' LEU . 5.5 m-30 -74.1 -36.18 64.22 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.318 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.906 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 2.2 m -71.21 -32.88 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -68.51 -31.91 71.51 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.516 177.479 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.5 ' HB2' HD11 ' A' ' 58' ' ' LEU . . . -63.38 -44.49 94.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.265 178.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.532 ' SG ' ' HB3' ' A' ' 51' ' ' CYS . 3.8 m -97.77 9.46 42.56 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.11 -177.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.2 t70 . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.653 177.825 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 1' ' ' PRO . . . . . 0.415 ' HB2' ' H ' ' B' ' 2' ' ' SER . 88.4 Cg_endo . . . . . 0 CA--C 1.519 -0.245 0 N-CA-C 108.797 -1.27 . . . . 0.0 108.797 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . 0.493 ' HB2' HG23 ' B' ' 5' ' ' THR . 19.8 m -68.1 175.08 3.37 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 161.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.813 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -71.08 -52.19 20.83 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 164.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.494 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.2 p-10 -87.5 5.48 38.91 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 113.869 -1.514 . . . . 0.0 113.667 -165.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.493 HG23 ' HB2' ' B' ' 2' ' ' SER . 0.7 OUTLIER -63.88 -6.52 6.09 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 118.542 0.61 . . . . 0.0 111.086 -177.668 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.642 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.2 m -75.61 131.09 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.766 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -154.32 158.59 40.38 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' GLN . . . . . 0.543 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 3.4 mt-30 -41.82 116.88 0.85 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 113.119 -1.855 . . . . 0.0 113.369 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.77 -153.98 22.63 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.732 170.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . 0.668 ' O ' ' HG2' ' B' ' 11' ' ' LYS . 19.8 t -56.94 98.8 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 117.116 0.458 . . . . 0.0 110.952 -177.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . 0.668 ' HG2' ' O ' ' B' ' 10' ' ' SER . 4.1 ptpp? 49.41 32.86 4.92 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.688 1.195 . . . . 0.0 112.504 -177.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.434 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 38.4 tt0 -56.12 135.41 74.49 Favored Pre-proline 0 C--O 1.234 0.251 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . 0.575 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 52.2 Cg_exo -50.97 123.0 10.88 Favored 'Trans proline' 0 CA--C 1.509 -0.77 0 C-N-CA 122.343 2.029 . . . . 0.0 110.206 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' TYR . . . . . 0.896 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 14.7 t80 -71.01 -53.53 8.37 Favored Pre-proline 0 N--CA 1.439 -1.019 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -167.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.534 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 34.2 Cg_exo -55.92 -18.48 22.3 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 121.535 1.49 . . . . 0.0 110.999 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.575 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.6 m-20 -89.96 -43.18 10.73 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 113.917 -1.492 . . . . 0.0 110.933 178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' PHE . . . . . 0.543 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -54.6 -44.43 73.07 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 176.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.714 HG12 ' O ' ' B' ' 14' ' ' TYR . 3.0 p -82.16 -31.86 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.514 -177.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.44 -36.39 71.33 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 121.793 -0.567 . . . . 0.0 111.878 175.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.713 ' O ' HG12 ' B' ' 24' ' ' VAL . 15.5 ptt180 -82.72 -27.18 31.32 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.565 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 6.6 tp -57.05 -45.21 83.36 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.87 173.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' GLN . . . . . 0.736 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 40.6 mt-30 -74.36 -44.06 53.87 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.019 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.74 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 9.5 t70 -50.9 -51.44 51.94 Favored 'General case' 0 C--N 1.314 -0.955 0 O-C-N 124.097 0.873 . . . . 0.0 111.495 -178.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' VAL . . . . . 0.713 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.4 p -82.71 -23.41 8.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.201 0.524 . . . . 0.0 109.707 -174.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.819 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -71.37 -18.76 62.35 Favored 'General case' 0 C--O 1.206 -1.206 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 173.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.1 -38.63 16.3 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.845 176.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.74 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 36.2 mmtt -66.89 -40.64 87.82 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.98 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . 0.415 ' HB2' ' HB3' ' B' ' 3' ' ' PHE . 45.2 m -98.86 -9.27 24.49 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.039 0.447 . . . . 0.0 110.552 -171.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.819 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 87.2 mt -115.33 125.68 72.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.651 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.05 -4.2 59.14 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.977 0.418 . . . . 0.0 110.468 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.676 ' H ' HG22 ' B' ' 29' ' ' ILE . 3.6 t0 -111.45 122.65 48.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.51 -176.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' B' ' 36' ' ' LYS . 12.7 pt-20 -62.03 -25.25 67.55 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.665 176.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.666 ' HD2' ' OD1' ' B' ' 31' ' ' ASP . 24.0 mttt -73.71 -46.54 45.46 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 120.834 0.349 . . . . 0.0 110.082 -176.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.32 -25.04 60.47 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.5 -0.48 . . . . 0.0 109.77 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.836 ' O ' HG13 ' B' ' 39' ' ' VAL . 5.0 tmm_? -64.44 -63.32 1.16 Allowed 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.647 ' HG3' HG13 ' B' ' 37' ' ' VAL . 6.5 ptmm? -51.71 -60.08 3.56 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.257 0.551 . . . . 0.0 112.31 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.647 HG13 ' HG3' ' B' ' 36' ' ' LYS . 10.4 m -56.58 -30.57 32.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.713 -1.131 . . . . 0.0 112.496 -170.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.813 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.2 tt -86.26 -30.45 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 C-N-CA 119.241 -0.984 . . . . 0.0 111.175 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.836 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.3 m -70.04 -47.87 65.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.411 175.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.651 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 56.6 mt-10 -60.31 -29.96 69.19 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 123.69 0.796 . . . . 0.0 112.193 176.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.635 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -86.25 -53.25 5.14 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.367 -0.533 . . . . 0.0 112.16 179.044 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' MET . . . . . 0.565 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 22.0 mmt -61.9 -22.18 65.36 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.594 0.711 . . . . 0.0 109.831 -177.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.698 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -48.5 -29.03 3.73 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.924 171.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' TYR . . . . . 0.594 ' CG ' ' HD2' ' B' ' 59' ' ' LYS . 8.3 t80 -107.24 -66.65 1.01 Allowed 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 176.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.529 ' CG ' HD12 ' B' ' 41' ' ' LEU . 14.9 mm-40 -48.1 -31.84 6.07 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 124.168 0.917 . . . . 0.0 112.243 -174.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.766 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.9 m-20 -103.21 -21.47 13.86 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 116.754 -0.203 . . . . 0.0 111.265 -175.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.602 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -62.38 -179.16 0.22 Allowed 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.982 0.896 . . . . 0.0 112.865 -173.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' ASN . . . . . 0.564 ' HB3' ' OE1' ' B' ' 50' ' ' GLU . 12.4 m-20 -61.16 143.31 92.54 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.037 175.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -50.7 -28.75 23.59 Favored 'Trans proline' 0 C--O 1.218 -0.494 0 C-N-CA 123.54 2.827 . . . . 0.0 113.022 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . 0.696 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 15.9 pm0 -88.26 -30.97 19.27 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.739 0.816 . . . . 0.0 111.015 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.696 ' N ' ' HG2' ' B' ' 50' ' ' GLU . 96.7 m -81.83 -39.06 24.53 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.145 -170.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . 0.634 ' HA ' HD12 ' B' ' 55' ' ' ILE . 4.1 pt20 -69.95 -29.64 66.82 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 172.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' SER . . . . . 0.469 ' O ' ' HD2' ' B' ' 56' ' ' LYS . 7.0 m -71.18 -20.28 62.3 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 113.847 -1.524 . . . . 0.0 110.704 174.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.72 -25.38 49.26 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.604 0.716 . . . . 0.0 109.683 167.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.634 HD12 ' HA ' ' B' ' 52' ' ' GLN . 24.3 mt -89.77 -32.87 5.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 -172.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.611 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.22 -38.91 1.71 Allowed Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -173.523 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 51.5 Cg_endo -63.07 -28.85 74.51 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 122.175 1.916 . . . . 0.0 112.716 175.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . 0.535 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 2.2 mt -97.44 -16.4 20.19 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . 0.594 ' HD2' ' CG ' ' B' ' 44' ' ' TYR . 0.1 OUTLIER -56.13 108.91 0.51 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.523 -179.254 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.0 -25.12 29.48 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.265 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 9.9 mmmt -104.52 115.52 30.49 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.961 0.41 . . . . 0.0 110.381 -177.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.427 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.7 p -121.8 134.68 24.74 Favored Pre-proline 0 C--N 1.312 -1.055 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 168.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo . . . . . 0 C--O 1.234 0.287 0 C-N-CA 122.502 2.135 . . . . 0.0 111.846 172.958 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 t70 . . . . . 0 N--CA 1.444 -0.728 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.584 HG22 ' HG2' ' B' ' 40' ' ' GLU . 1.2 m -75.99 -30.25 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 C-N-CA 118.556 -1.258 . . . . 0.0 108.709 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.78 ' O ' HG13 ' B' ' 73' ' ' VAL . 6.9 mm -60.87 -47.94 91.14 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.208 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.306 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 35.1 t -50.41 -35.25 27.59 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.745 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.413 ' H ' ' HG2' ' B' ' 71' ' ' GLU . 3.0 mm-40 -86.55 -32.21 20.82 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.459 -177.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' TYR . . . . . 0.535 ' CE1' ' HB2' ' B' ' 58' ' ' LEU . 5.5 m-30 -74.09 -36.23 64.27 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.325 -178.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.896 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 2.2 m -71.15 -33.04 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' B' ' 70' ' ' SER . 0.0 OUTLIER -68.31 -32.2 72.16 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.459 177.474 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . 0.516 ' HB2' HD11 ' B' ' 58' ' ' LEU . . . -63.05 -44.67 95.19 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.194 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.52 ' SG ' ' HB3' ' B' ' 51' ' ' CYS . 3.8 m -97.54 9.28 42.86 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 114.22 -1.355 . . . . 0.0 111.052 -177.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 8.3 t70 . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.649 177.888 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 CA--C 1.519 -0.263 0 N-CA-C 108.721 -1.3 . . . . 0.0 108.721 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 m -67.52 -179.76 1.14 Allowed 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 163.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.747 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -75.56 -53.38 8.71 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 118.956 -1.098 . . . . 0.0 108.625 166.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.493 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 2.4 p-10 -86.91 5.04 39.02 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.247 -1.342 . . . . 0.0 113.201 -165.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.96 -5.97 5.39 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 118.166 0.439 . . . . 0.0 111.441 -176.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.592 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.4 m -75.62 131.77 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 176.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.77 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -154.63 159.48 40.84 Favored 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 118.693 -1.203 . . . . 0.0 114.228 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.487 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.5 mt-30 -42.32 116.38 0.83 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 112.965 -1.925 . . . . 0.0 112.829 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.46 -139.87 8.15 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.635 173.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.4 p -58.67 95.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.765 0.282 . . . . 0.0 111.133 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.5 pttt 40.75 39.54 0.8 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.238 1.015 . . . . 0.0 111.986 -175.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.447 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 48.5 tt0 -56.86 139.65 77.36 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.234 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.525 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 36.9 Cg_exo -54.33 122.73 12.03 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.988 1.792 . . . . 0.0 109.781 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.825 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 13.2 t80 -70.36 -52.53 11.57 Favored Pre-proline 0 N--CA 1.438 -1.046 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 -166.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.531 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 27.6 Cg_exo -57.18 -17.32 25.11 Favored 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 121.444 1.429 . . . . 0.0 111.062 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.525 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.5 m-20 -90.04 -42.11 11.32 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.04 -1.437 . . . . 0.0 110.698 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.487 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -55.5 -44.84 76.96 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.674 HG12 ' O ' ' A' ' 14' ' ' TYR . 2.1 p -78.99 -34.06 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.274 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.88 -38.15 69.79 Favored 'General case' 0 C--N 1.319 -0.744 0 O-C-N 121.833 -0.542 . . . . 0.0 111.488 176.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.721 ' O ' HG12 ' A' ' 24' ' ' VAL . 15.5 ptt180 -80.78 -28.32 36.38 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.537 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 6.2 tp -55.87 -43.78 77.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.976 173.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.69 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 24.0 mt-30 -72.72 -52.71 14.02 Favored 'General case' 0 CA--C 1.486 -1.483 0 CA-C-N 114.702 -1.135 . . . . 0.0 111.493 178.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.732 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 38.3 m-20 -46.86 -50.75 18.08 Favored 'General case' 0 C--N 1.313 -0.996 0 O-C-N 124.375 1.047 . . . . 0.0 111.24 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.721 HG12 ' O ' ' A' ' 20' ' ' ARG . 8.3 p -79.58 -26.23 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.77 -172.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.617 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -67.45 -30.54 70.29 Favored 'General case' 0 C--O 1.207 -1.171 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 175.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.96 -34.98 59.83 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.647 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.732 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 40.7 mmtt -67.9 -36.0 79.46 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.774 178.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.46 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 16.2 m -105.52 -6.33 19.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.362 0.601 . . . . 0.0 110.564 -171.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.656 HG22 ' H ' ' A' ' 31' ' ' ASP . 89.0 mt -118.2 124.15 72.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.334 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.21 -4.07 58.58 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.219 0.533 . . . . 0.0 110.582 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.656 ' H ' HG22 ' A' ' 29' ' ' ILE . 26.0 t0 -106.59 140.48 39.41 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.565 -177.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -76.23 -32.05 58.71 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.001 174.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.571 ' O ' HG13 ' A' ' 37' ' ' VAL . 6.9 mttp -70.87 -55.51 8.3 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -176.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.605 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -57.99 -27.87 63.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.976 175.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.853 ' O ' HG13 ' A' ' 39' ' ' VAL . 1.9 tmm_? -67.22 -56.53 9.49 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.497 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 20.8 mtpt -56.22 -57.93 10.13 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.957 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.732 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 20.1 m -53.08 -34.72 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.414 -169.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.747 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.1 tt -87.97 -30.75 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 C-N-CA 119.765 -0.774 . . . . 0.0 112.316 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.853 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.9 m -67.89 -50.21 61.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 119.413 -0.915 . . . . 0.0 109.688 174.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.769 ' OE1' HG13 ' A' ' 68' ' ' VAL . 0.9 OUTLIER -63.73 -25.9 68.4 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.76 0.824 . . . . 0.0 111.622 178.46 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.732 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -85.87 -55.14 4.1 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 177.064 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.518 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 22.2 mmt -62.59 -20.87 65.16 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 121.67 0.747 . . . . 0.0 109.822 -176.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.678 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -48.68 -28.89 3.85 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.81 171.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.557 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 11.5 t80 -106.14 -66.53 0.99 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 175.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.484 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 5.7 mm-40 -48.13 -29.56 3.75 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 124.107 0.88 . . . . 0.0 112.937 -175.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.77 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.7 m-20 -106.87 -21.25 13.08 Favored 'General case' 0 N--CA 1.438 -1.071 0 O-C-N 122.22 -0.3 . . . . 0.0 111.19 -176.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -60.43 179.22 0.16 Allowed 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.889 0.852 . . . . 0.0 112.905 -174.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.498 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 11.5 m-20 -60.12 139.83 91.07 Favored Pre-proline 0 N--CA 1.443 -0.823 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.228 174.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.428 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 1.8 Cg_endo -44.35 -46.38 11.79 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.906 2.404 . . . . 0.0 112.004 -177.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.543 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 0.4 OUTLIER -71.31 -33.51 69.73 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.335 1.054 . . . . 0.0 111.841 177.173 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.525 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 98.4 m -75.7 -36.37 60.03 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 121.243 0.544 . . . . 0.0 109.967 -173.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.553 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.9 pt20 -73.03 -30.95 64.12 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 174.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.543 ' HB2' ' HA ' ' A' ' 50' ' ' GLU . 17.4 m -68.87 -20.51 64.27 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.048 173.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 51' ' ' CYS . . . -76.38 -28.74 56.88 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.747 0.784 . . . . 0.0 109.958 168.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.574 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 19.2 mt -89.67 -31.85 5.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -171.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.612 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -40.17 -39.78 1.55 Allowed Pre-proline 0 N--CA 1.487 1.41 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -173.075 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 54.2 Cg_endo -63.04 -30.93 76.46 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.141 1.894 . . . . 0.0 112.781 176.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.563 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 2.6 mt -94.48 -17.06 22.8 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.576 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -55.44 108.67 0.45 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.053 179.359 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.29 -31.66 8.47 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.528 -175.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.2 mmtt -104.12 114.85 29.38 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 122.173 0.987 . . . . 0.0 111.147 -177.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.535 ' HB ' HG12 ' A' ' 68' ' ' VAL . 5.6 p -120.72 131.67 24.39 Favored Pre-proline 0 C--N 1.294 -1.824 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.826 169.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo . . . . . 0 C--O 1.235 0.326 0 C-N-CA 122.637 2.224 . . . . 0.0 112.078 174.554 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 N--CA 1.446 -0.656 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.769 HG13 ' OE1' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -72.25 -34.85 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 118.372 -1.331 . . . . 0.0 108.916 -179.138 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.766 ' O ' HG13 ' A' ' 73' ' ' VAL . 7.2 mm -56.65 -49.77 76.66 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.065 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.676 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 23.0 t -46.14 -38.37 8.09 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.858 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.445 ' H ' ' HG2' ' A' ' 71' ' ' GLU . 2.8 mm-40 -86.45 -32.27 20.94 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.544 -176.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.576 ' OH ' ' HA ' ' A' ' 59' ' ' LYS . 5.4 m-30 -73.95 -37.53 64.52 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.681 0.753 . . . . 0.0 109.65 -177.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.825 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.7 m -70.1 -32.81 52.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 174.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -68.42 -31.36 70.64 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.567 176.45 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.471 ' HB2' HD11 ' A' ' 58' ' ' LEU . . . -64.6 -46.35 83.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.492 178.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.525 ' SG ' ' HB3' ' A' ' 51' ' ' CYS . 4.0 m -94.04 9.22 38.51 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.919 -178.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 9.6 t70 . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.201 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 1' ' ' PRO . . . . . 0.451 ' HB2' ' H ' ' B' ' 2' ' ' SER . 97.7 Cg_endo . . . . . 0 CA--C 1.52 -0.189 0 N-CA-C 108.815 -1.263 . . . . 0.0 108.815 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . 0.559 ' HG ' ' HZ2' ' A' ' 59' ' ' LYS . 16.3 m -67.6 179.93 1.24 Allowed 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 163.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.752 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -75.32 -53.6 8.48 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.517 166.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.493 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.4 p-10 -86.77 4.98 38.66 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.35 -1.295 . . . . 0.0 113.271 -165.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.431 HG21 ' HG2' ' A' ' 59' ' ' LYS . 0.5 OUTLIER -63.7 -5.9 4.76 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 118.099 0.409 . . . . 0.0 111.572 -177.069 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.597 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.4 m -75.67 131.55 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.777 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -154.4 159.6 41.2 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' GLN . . . . . 0.488 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.5 mt-30 -42.37 116.21 0.81 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 112.941 -1.936 . . . . 0.0 112.852 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.17 -139.69 7.88 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.706 173.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 6.4 p -58.94 95.15 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.706 0.253 . . . . 0.0 111.143 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 56.7 pttt 41.05 39.37 0.85 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.157 0.983 . . . . 0.0 111.976 -175.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.436 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 51.0 tt0 -56.61 139.57 75.61 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.241 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . 0.537 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 35.1 Cg_exo -54.15 122.77 12.04 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.0 1.8 . . . . 0.0 109.743 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' TYR . . . . . 0.839 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 13.1 t80 -70.45 -52.63 11.14 Favored Pre-proline 0 N--CA 1.438 -1.056 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -166.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.544 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 27.9 Cg_exo -56.97 -17.54 24.63 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 121.474 1.449 . . . . 0.0 111.134 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.537 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.3 m-20 -89.91 -42.42 11.22 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.682 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' PHE . . . . . 0.488 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -55.34 -44.75 76.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.803 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.688 HG12 ' O ' ' B' ' 14' ' ' TYR . 2.1 p -78.97 -34.15 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.27 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.91 -38.04 69.7 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 121.765 -0.585 . . . . 0.0 111.516 176.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.715 ' O ' HG12 ' B' ' 24' ' ' VAL . 15.6 ptt180 -80.78 -28.29 36.41 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.551 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 6.1 tp -55.78 -43.88 77.22 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.005 173.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' GLN . . . . . 0.677 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 24.1 mt-30 -72.7 -52.64 14.37 Favored 'General case' 0 CA--C 1.487 -1.472 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.48 178.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.731 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 39.5 m-20 -46.8 -50.79 17.77 Favored 'General case' 0 C--N 1.313 -1.011 0 O-C-N 124.417 1.073 . . . . 0.0 111.234 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' VAL . . . . . 0.715 HG12 ' O ' ' B' ' 20' ' ' ARG . 8.3 p -79.71 -26.06 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.836 -172.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.625 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -67.59 -30.46 70.07 Favored 'General case' 0 C--O 1.205 -1.239 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 175.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.78 -35.27 60.17 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.132 -1.395 . . . . 0.0 109.763 -178.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.731 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 40.9 mmtt -67.67 -36.54 80.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.586 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . 0.461 ' HB2' ' HB3' ' B' ' 3' ' ' PHE . 16.4 m -105.19 -6.22 19.99 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.33 0.586 . . . . 0.0 110.536 -171.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.682 HG22 ' H ' ' B' ' 31' ' ' ASP . 89.0 mt -118.21 124.26 72.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.326 178.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.49 -3.65 58.51 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.236 0.541 . . . . 0.0 110.676 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.682 ' H ' HG22 ' B' ' 29' ' ' ILE . 25.9 t0 -106.9 140.46 39.68 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.519 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -76.35 -31.97 58.37 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.867 175.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.568 ' O ' HG13 ' B' ' 37' ' ' VAL . 7.1 mttp -70.73 -55.69 8.09 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -176.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.589 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -58.08 -27.71 63.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.996 176.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.858 ' O ' HG13 ' B' ' 39' ' ' VAL . 1.9 tmm_? -67.47 -56.45 9.55 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.485 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 21.2 mtpt -56.22 -57.93 10.12 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.997 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.742 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 20.1 m -53.06 -34.66 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.53 -169.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.752 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.1 tt -88.1 -30.72 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 119.727 -0.789 . . . . 0.0 112.25 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.858 HG13 ' O ' ' B' ' 35' ' ' ARG . 3.0 m -67.87 -49.99 63.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.742 174.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.775 ' OE1' HG13 ' B' ' 68' ' ' VAL . 0.9 OUTLIER -64.06 -25.66 68.21 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.68 0.792 . . . . 0.0 111.658 178.452 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.742 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.97 -55.03 4.14 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 176.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' MET . . . . . 0.516 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 22.2 mmt -62.81 -20.66 65.25 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.697 0.76 . . . . 0.0 109.818 -176.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.667 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -48.89 -28.77 4.03 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.779 171.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' TYR . . . . . 0.562 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 11.5 t80 -106.29 -66.66 0.99 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 175.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.476 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 5.7 mm-40 -48.03 -29.49 3.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 124.138 0.899 . . . . 0.0 112.999 -175.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.777 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.6 m-20 -106.9 -21.09 13.13 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 121.031 -0.267 . . . . 0.0 111.19 -176.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -60.61 179.19 0.17 Allowed 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.844 0.831 . . . . 0.0 112.931 -174.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' ASN . . . . . 0.512 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 11.0 m-20 -60.08 139.69 90.97 Favored Pre-proline 0 N--CA 1.441 -0.888 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.237 174.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . 0.427 ' O ' ' HG2' ' B' ' 52' ' ' GLN . 1.8 Cg_endo -44.27 -46.35 11.63 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.847 2.365 . . . . 0.0 111.985 -177.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . 0.548 ' HA ' ' HB2' ' B' ' 53' ' ' SER . 0.3 OUTLIER -71.32 -33.39 69.6 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.234 1.013 . . . . 0.0 111.96 177.256 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.528 ' HB3' ' SG ' ' B' ' 76' ' ' CYS . 93.0 m -75.78 -36.38 59.8 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 121.258 0.552 . . . . 0.0 110.026 -174.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . 0.569 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.9 pt20 -72.95 -31.14 64.38 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 106.932 -1.506 . . . . 0.0 106.932 174.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' SER . . . . . 0.548 ' HB2' ' HA ' ' B' ' 50' ' ' GLU . 17.9 m -68.64 -20.55 64.47 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.066 -1.424 . . . . 0.0 110.07 173.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' B' ' 51' ' ' CYS . . . -76.34 -28.83 57.01 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.813 0.816 . . . . 0.0 109.984 168.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.577 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 19.0 mt -89.76 -31.7 5.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -171.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.606 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -40.33 -39.83 1.66 Allowed Pre-proline 0 N--CA 1.488 1.452 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -173.104 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 52.0 Cg_endo -62.52 -32.19 80.11 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.001 1.801 . . . . 0.0 112.585 176.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . 0.568 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 2.6 mt -93.6 -17.08 23.71 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . 0.565 ' HA ' ' OH ' ' B' ' 72' ' ' TYR . 0.0 OUTLIER -55.49 108.56 0.44 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.966 179.234 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.57 -31.77 8.33 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.41 -175.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 28.4 mmtt -103.84 114.92 29.53 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 122.203 1.001 . . . . 0.0 111.166 -177.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.542 ' HB ' HG12 ' B' ' 68' ' ' VAL . 5.6 p -120.71 131.88 24.33 Favored Pre-proline 0 C--N 1.294 -1.83 0 CA-C-N 113.861 -1.518 . . . . 0.0 109.786 169.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo . . . . . 0 C--O 1.235 0.374 0 C-N-CA 122.656 2.237 . . . . 0.0 112.103 174.555 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.445 -0.694 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.775 HG13 ' OE1' ' B' ' 40' ' ' GLU . 0.8 OUTLIER -72.04 -35.12 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 118.41 -1.316 . . . . 0.0 108.908 -179.117 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.772 ' O ' HG13 ' B' ' 73' ' ' VAL . 7.2 mm -56.53 -49.78 76.02 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.992 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.644 -178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 25.8 t -45.69 -38.82 7.23 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.815 178.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.403 ' H ' ' HG2' ' B' ' 71' ' ' GLU . 2.9 mm-40 -86.4 -32.46 20.89 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.568 -175.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' TYR . . . . . 0.568 ' CE1' ' HB2' ' B' ' 58' ' ' LEU . 5.4 m-30 -73.74 -37.53 65.04 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.6 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.839 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.7 m -70.16 -32.87 52.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 174.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' B' ' 70' ' ' SER . 0.0 OUTLIER -68.3 -31.38 70.78 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.746 -1.116 . . . . 0.0 109.573 176.34 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . 0.485 ' HB2' HD11 ' B' ' 58' ' ' LEU . . . -64.86 -46.13 83.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.567 178.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.528 ' SG ' ' HB3' ' B' ' 51' ' ' CYS . 4.0 m -94.07 9.18 38.73 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.951 -178.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . 0.401 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 11.3 t70 . . . . . 0 C--N 1.324 -0.542 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.249 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.417 ' HB2' HG21 ' A' ' 5' ' ' THR . 92.1 Cg_endo . . . . . 0 CA--C 1.517 -0.327 0 N-CA-C 109.171 -1.127 . . . . 0.0 109.171 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.414 ' HB2' ' HB ' ' A' ' 5' ' ' THR . 12.9 m -64.25 165.94 8.72 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 162.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.722 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -69.86 -54.14 14.85 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.027 -1.069 . . . . 0.0 108.614 167.607 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.519 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 3.2 p-10 -88.31 -3.05 58.91 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 113.947 -1.479 . . . . 0.0 113.403 -164.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.45 ' O ' ' HD3' ' A' ' 7' ' ' ARG . 9.8 t -66.36 -3.58 6.3 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.622 -173.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.539 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 3.0 m -70.7 135.75 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 172.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.803 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -153.86 159.12 41.68 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 -179.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.482 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.1 tt0 -41.69 112.1 0.29 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 112.832 -1.986 . . . . 0.0 112.216 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.2 -145.42 6.06 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.756 176.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.7 p -59.79 95.38 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.687 0.279 . . . . 0.0 110.737 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.3 pttt 43.23 41.43 2.97 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.384 1.074 . . . . 0.0 112.3 -176.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.429 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 62.9 tt0 -56.58 141.25 72.94 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.801 175.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.401 ' O ' ' HB3' ' A' ' 16' ' ' ASP . 22.5 Cg_exo -51.68 123.1 11.53 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.73 1.62 . . . . 0.0 109.141 174.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.835 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 11.5 t80 -66.67 -51.47 40.01 Favored Pre-proline 0 N--CA 1.438 -1.052 0 CA-C-O 118.857 -0.592 . . . . 0.0 112.555 -171.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.494 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 20.5 Cg_exo -60.29 -13.77 26.1 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 121.69 1.593 . . . . 0.0 110.413 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.401 ' HB3' ' O ' ' A' ' 13' ' ' PRO . 17.1 t70 -89.45 -46.78 8.46 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 113.903 -1.499 . . . . 0.0 110.282 178.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.482 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -54.18 -42.88 70.16 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.84 177.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.757 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 2.1 p -81.35 -35.22 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.52 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.58 -37.67 70.93 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 121.394 -0.816 . . . . 0.0 111.223 177.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.738 ' O ' HG12 ' A' ' 24' ' ' VAL . 17.4 ptt180 -79.61 -30.05 41.31 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.548 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 7.8 tp -54.2 -46.7 72.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.258 173.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.757 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 28.7 mt-30 -69.94 -53.56 17.31 Favored 'General case' 0 CA--C 1.485 -1.523 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.55 177.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.732 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 56.3 m-20 -45.51 -52.45 10.32 Favored 'General case' 0 C--N 1.314 -0.978 0 O-C-N 124.637 1.21 . . . . 0.0 111.181 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.738 HG12 ' O ' ' A' ' 20' ' ' ARG . 8.2 p -79.67 -26.96 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.745 -171.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.679 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -66.82 -31.2 71.67 Favored 'General case' 0 C--O 1.204 -1.324 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 175.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.61 -35.59 62.95 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.909 -178.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.732 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.6 mmtt -65.86 -40.11 91.38 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.63 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.444 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 40.0 m -101.86 -10.81 19.54 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.32 0.581 . . . . 0.0 110.662 -172.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.679 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 88.4 mt -113.72 122.26 67.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.515 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.85 -1.19 57.82 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.247 0.546 . . . . 0.0 110.317 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.637 ' H ' HG22 ' A' ' 29' ' ' ILE . 11.8 t70 -107.31 119.41 39.33 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.965 -175.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -60.13 -30.35 69.23 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.08 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.588 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -74.31 -53.52 9.53 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -174.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.575 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -60.56 -27.41 67.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.773 177.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.859 ' O ' HG13 ' A' ' 39' ' ' VAL . 1.9 tmm_? -67.33 -58.47 4.73 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 32.6 mtpt -54.61 -59.24 4.98 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.123 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.725 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 16.9 m -53.56 -34.14 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.327 -170.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.722 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.3 tt -87.38 -32.08 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.871 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.7 m -67.34 -49.14 74.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.156 175.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.633 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 52.0 mt-10 -60.49 -31.72 70.74 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.298 1.039 . . . . 0.0 112.742 175.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.725 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -85.16 -51.29 6.73 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.933 -179.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.707 ' HE2' ' HE2' ' B' ' 42' ' ' MET . 20.5 mmt -64.62 -20.77 66.47 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.553 0.692 . . . . 0.0 109.462 -178.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.681 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -50.26 -30.33 11.52 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.516 171.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.529 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 15.9 t80 -102.91 -66.71 0.92 Allowed 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 174.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.478 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 47.6 mm-40 -50.26 -28.41 7.66 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.725 -1.125 . . . . 0.0 112.713 -172.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.803 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.1 m-20 -106.36 -22.04 12.92 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 121.28 -0.168 . . . . 0.0 111.055 -176.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -59.56 177.3 0.21 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.8 0.81 . . . . 0.0 112.994 -174.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.607 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 15.2 m-20 -58.89 140.55 86.37 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.93 174.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.64 -23.43 25.81 Favored 'Trans proline' 0 C--O 1.221 -0.35 0 C-N-CA 123.524 2.816 . . . . 0.0 112.731 -176.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -88.3 -35.37 17.27 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.942 0.897 . . . . 0.0 110.788 175.074 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.607 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 72.3 m -76.85 -35.87 57.2 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.207 -171.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.628 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.7 pt20 -72.49 -29.89 64.04 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 174.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.489 ' O ' ' HD2' ' A' ' 56' ' ' LYS . 15.9 m -71.81 -19.01 62.05 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 113.715 -1.584 . . . . 0.0 110.387 174.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 51' ' ' CYS . . . -77.21 -26.95 53.26 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.813 0.816 . . . . 0.0 109.494 166.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.628 HD12 ' HA ' ' A' ' 52' ' ' GLN . 25.9 mt -89.27 -31.01 5.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -172.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.607 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.8 -38.77 2.17 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -173.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 57.2 Cg_endo -64.49 -30.08 61.87 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.165 1.91 . . . . 0.0 112.765 176.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.527 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 2.2 mt -95.29 -16.35 22.5 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.529 ' HE3' ' HB3' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -54.05 108.65 0.38 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.709 -179.522 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.77 -21.98 42.96 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.413 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.9 mmmt -104.17 115.88 31.19 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 120.932 0.396 . . . . 0.0 110.422 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.54 139.72 31.51 Favored Pre-proline 0 C--N 1.311 -1.095 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 169.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo . . . . . 0 N--CA 1.463 -0.306 0 C-N-CA 122.338 2.025 . . . . 0.0 111.423 170.39 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 t70 . . . . . 0 CA--C 1.514 -0.425 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.602 HG22 ' HG2' ' A' ' 40' ' ' GLU . 1.0 OUTLIER -77.38 -29.7 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 C-N-CA 118.651 -1.22 . . . . 0.0 108.813 -179.346 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.777 ' O ' HG13 ' A' ' 73' ' ' VAL . 10.4 mm -60.81 -47.53 92.86 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.117 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.125 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.0 t -46.18 -37.66 7.34 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.017 176.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.472 ' HA ' ' HB3' ' A' ' 74' ' ' LYS . 7.2 mm-40 -85.82 -31.85 22.08 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 123.375 0.67 . . . . 0.0 111.014 -177.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.612 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.3 m-30 -75.32 -34.84 61.27 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.555 0.693 . . . . 0.0 109.34 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.835 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.4 m -72.52 -30.17 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 173.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.509 ' HA ' ' HB2' ' A' ' 77' ' ' ASP . 14.8 ttpt -73.52 -25.51 60.45 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.474 177.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -65.89 -46.53 78.03 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.538 174.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.503 ' SG ' ' HB2' ' A' ' 14' ' ' TYR . 26.2 t -93.01 8.77 38.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.871 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.509 ' HB2' ' HA ' ' A' ' 74' ' ' LYS . 17.3 t70 . . . . . 0 C--N 1.323 -0.55 0 CA-C-O 121.302 0.572 . . . . 0.0 110.043 176.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 1' ' ' PRO . . . . . 0.414 ' HB2' ' H ' ' B' ' 2' ' ' SER . 93.8 Cg_endo . . . . . 0 CA--C 1.519 -0.248 0 N-CA-C 109.133 -1.141 . . . . 0.0 109.133 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . 0.429 ' HB2' ' HB ' ' B' ' 5' ' ' THR . 13.3 m -64.35 166.24 8.47 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 163.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.746 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -70.12 -54.02 14.81 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.108 -1.037 . . . . 0.0 108.605 167.687 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.524 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 3.2 p-10 -88.5 -2.99 58.9 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.041 -1.436 . . . . 0.0 113.408 -164.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.436 ' O ' ' HD3' ' B' ' 7' ' ' ARG . 9.5 t -66.37 -3.54 6.22 Favored 'General case' 0 C--N 1.315 -0.911 0 O-C-N 121.644 -0.66 . . . . 0.0 110.634 -173.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.526 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 3.0 m -70.63 135.7 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 171.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.799 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -153.9 159.2 41.66 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' GLN . . . . . 0.458 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.1 tt0 -41.77 112.42 0.32 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 112.776 -2.011 . . . . 0.0 112.106 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.35 -145.64 6.3 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.772 175.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 12.4 p -59.51 95.27 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.64 0.257 . . . . 0.0 110.653 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 64.2 pttt 43.17 41.36 2.84 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.44 1.096 . . . . 0.0 112.402 -176.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.424 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 62.8 tt0 -56.63 141.37 73.11 Favored Pre-proline 0 C--O 1.235 0.301 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.774 175.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' B' ' 16' ' ' ASP . 22.1 Cg_exo -51.66 122.99 11.29 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.742 1.628 . . . . 0.0 109.204 174.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' TYR . . . . . 0.839 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 11.7 t80 -66.63 -51.64 39.42 Favored Pre-proline 0 N--CA 1.437 -1.078 0 CA-C-O 118.876 -0.583 . . . . 0.0 112.406 -171.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.504 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 20.6 Cg_exo -60.14 -13.79 25.57 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.57 1.513 . . . . 0.0 110.453 -178.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.417 ' HB3' ' O ' ' B' ' 13' ' ' PRO . 18.7 t70 -89.45 -46.74 8.48 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 113.939 -1.482 . . . . 0.0 110.191 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' PHE . . . . . 0.458 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -54.15 -42.85 70.02 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.841 177.675 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.752 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 2.1 p -81.4 -35.27 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.429 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.57 -37.64 70.86 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 121.38 -0.825 . . . . 0.0 111.221 177.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.74 ' O ' HG12 ' B' ' 24' ' ' VAL . 17.4 ptt180 -79.72 -29.72 40.74 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.558 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 7.9 tp -54.47 -46.72 73.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.193 173.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' GLN . . . . . 0.752 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 28.6 mt-30 -69.81 -53.67 17.15 Favored 'General case' 0 CA--C 1.485 -1.556 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.519 177.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.728 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 48.9 m-20 -45.55 -52.49 10.39 Favored 'General case' 0 C--N 1.314 -0.959 0 O-C-N 124.628 1.205 . . . . 0.0 111.042 -178.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' VAL . . . . . 0.74 HG12 ' O ' ' B' ' 20' ' ' ARG . 8.2 p -79.64 -26.97 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.673 -171.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.667 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -66.86 -31.02 71.35 Favored 'General case' 0 C--O 1.206 -1.211 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 175.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -35.65 62.53 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.802 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.728 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.9 mmtt -65.87 -40.13 91.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.643 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . 0.454 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 37.4 m -101.66 -11.21 19.36 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.186 0.517 . . . . 0.0 110.546 -172.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.667 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 88.0 mt -113.63 122.33 67.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.569 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.93 -1.11 57.78 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.249 0.547 . . . . 0.0 110.439 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.658 ' H ' HG22 ' B' ' 29' ' ' ILE . 11.4 t70 -107.59 119.36 39.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.959 -175.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.2 -30.15 69.18 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.1 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.599 ' O ' HG13 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -74.42 -53.27 9.91 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -174.867 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.571 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -60.85 -27.32 68.0 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.87 177.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.87 ' O ' HG13 ' B' ' 39' ' ' VAL . 1.9 tmm_? -67.38 -58.52 4.63 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.431 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 32.3 mtpt -54.6 -59.3 4.89 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.081 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.722 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 17.1 m -53.69 -33.88 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.314 -170.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.746 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.3 tt -87.53 -32.08 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.808 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.87 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.7 m -67.31 -49.11 75.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.101 174.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.637 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 52.2 mt-10 -60.63 -31.72 70.9 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.259 1.023 . . . . 0.0 112.794 176.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.722 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -85.25 -51.17 6.78 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.393 -0.523 . . . . 0.0 112.02 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' MET . . . . . 0.707 ' HE2' ' HE2' ' A' ' 42' ' ' MET . 20.7 mmt -64.63 -20.7 66.43 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 121.545 0.688 . . . . 0.0 109.524 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.675 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -50.39 -30.33 12.12 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.421 171.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' TYR . . . . . 0.536 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 16.1 t80 -102.85 -66.61 0.92 Allowed 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 174.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.47 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 46.8 mm-40 -50.49 -27.99 7.61 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.696 -1.138 . . . . 0.0 112.739 -172.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.799 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.2 m-20 -106.76 -21.91 12.89 Favored 'General case' 0 N--CA 1.434 -1.265 0 O-C-N 122.371 -0.206 . . . . 0.0 111.1 -176.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -59.51 177.46 0.2 Allowed 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.81 0.814 . . . . 0.0 113.085 -175.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' ASN . . . . . 0.61 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 15.1 m-20 -59.09 140.33 87.31 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.864 174.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.75 -23.21 25.78 Favored 'Trans proline' 0 C--O 1.22 -0.407 0 C-N-CA 123.502 2.801 . . . . 0.0 112.628 -176.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -88.41 -35.27 17.19 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.88 0.872 . . . . 0.0 110.824 174.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.61 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 71.8 m -76.82 -35.83 57.29 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.261 -172.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . 0.646 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.8 pt20 -72.36 -29.99 64.3 Favored 'General case' 0 C--O 1.213 -0.835 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 174.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' SER . . . . . 0.482 ' O ' ' HD2' ' B' ' 56' ' ' LYS . 14.5 m -71.63 -19.26 62.13 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 113.7 -1.591 . . . . 0.0 110.4 174.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' B' ' 51' ' ' CYS . . . -77.16 -27.08 53.62 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.692 0.758 . . . . 0.0 109.484 166.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.646 HD12 ' HA ' ' B' ' 52' ' ' GLN . 25.9 mt -89.23 -30.99 5.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -172.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.604 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.96 -38.67 2.26 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -173.647 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 57.3 Cg_endo -64.7 -29.76 59.89 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 122.055 1.837 . . . . 0.0 112.688 176.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . 0.545 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 2.2 mt -95.36 -16.26 22.48 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . 0.536 ' HE3' ' HB3' ' B' ' 44' ' ' TYR . 0.1 OUTLIER -54.18 108.7 0.39 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.746 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.45 -21.5 45.21 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.503 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 15.8 mmmt -104.49 115.84 31.06 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.865 0.365 . . . . 0.0 110.6 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.4 139.72 31.33 Favored Pre-proline 0 C--N 1.312 -1.059 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 169.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo . . . . . 0 N--CA 1.463 -0.281 0 C-N-CA 122.368 2.045 . . . . 0.0 111.523 170.204 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 1.3 t70 . . . . . 0 CA--C 1.513 -0.446 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.583 HG22 ' HG2' ' B' ' 40' ' ' GLU . 1.0 OUTLIER -77.54 -29.75 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 C-N-CA 118.691 -1.203 . . . . 0.0 108.813 -179.444 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.774 ' O ' HG13 ' B' ' 73' ' ' VAL . 10.4 mm -60.8 -47.4 93.41 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.155 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.166 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 41.0 t -46.63 -37.29 7.99 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 123.847 0.717 . . . . 0.0 110.998 177.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.491 ' HA ' ' HB3' ' B' ' 74' ' ' LYS . 7.5 mm-40 -85.89 -31.67 22.08 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.22 0.608 . . . . 0.0 111.051 -177.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' TYR . . . . . 0.6 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.3 m-30 -75.45 -34.89 60.99 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.599 0.714 . . . . 0.0 109.441 -178.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.839 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.4 m -72.65 -30.03 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 173.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' LYS . . . . . 0.528 ' HA ' ' HB2' ' B' ' 77' ' ' ASP . 14.7 ttpt -73.71 -25.18 60.09 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.581 177.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -65.95 -46.57 77.69 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.646 173.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' B' ' 14' ' ' TYR . 28.3 t -93.03 8.58 39.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.884 177.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . 0.528 ' HB2' ' HA ' ' B' ' 74' ' ' LYS . 18.0 t70 . . . . . 0 C--N 1.324 -0.537 0 CA-C-O 121.296 0.57 . . . . 0.0 110.056 176.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.42 ' C ' ' HA3' ' B' ' 60' ' ' GLY . 84.1 Cg_endo . . . . . 0 CA--C 1.516 -0.399 0 N-CA-C 109.525 -0.99 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.8 m -65.74 165.14 13.23 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 163.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.764 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -69.9 -55.17 10.43 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 122.058 0.932 . . . . 0.0 109.907 174.142 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.566 ' ND2' ' HG3' ' A' ' 42' ' ' MET . 2.7 p-10 -86.57 -2.38 58.44 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.308 -1.314 . . . . 0.0 112.762 -164.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.417 ' O ' ' HD3' ' A' ' 7' ' ' ARG . 9.9 t -66.1 -3.03 4.75 Favored 'General case' 0 C--N 1.314 -0.942 0 O-C-N 121.708 -0.62 . . . . 0.0 110.445 -176.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.607 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.3 m -73.7 131.98 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 170.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.759 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 1.3 ptt-85 -156.68 160.04 38.97 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 118.38 -1.328 . . . . 0.0 114.375 -176.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.457 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.3 tt0 -39.12 112.33 0.24 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 113.698 -1.592 . . . . 0.0 112.624 178.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.95 -142.36 7.96 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.689 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.5 m -59.33 95.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.973 0.387 . . . . 0.0 110.837 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.401 ' O ' ' HG3' ' A' ' 11' ' ' LYS . 23.3 pttm 40.73 41.75 1.24 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.495 1.118 . . . . 0.0 112.343 -174.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 65.6 tt0 -57.79 139.65 81.95 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.674 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.518 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 34.3 Cg_exo -53.7 125.0 17.19 Favored 'Trans proline' 0 CA--C 1.511 -0.671 0 C-N-CA 122.026 1.817 . . . . 0.0 109.745 177.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.841 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 6.0 t80 -68.22 -55.48 12.62 Favored Pre-proline 0 N--CA 1.44 -0.934 0 CA-C-O 118.482 -0.77 . . . . 0.0 112.924 -167.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.528 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 26.0 Cg_exo -57.62 -17.7 29.63 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 121.456 1.437 . . . . 0.0 111.145 -177.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.518 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 5.7 m-20 -89.8 -40.16 12.64 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.057 -1.428 . . . . 0.0 110.846 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.639 ' HE2' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -56.63 -45.79 81.32 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 176.106 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.796 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 1.4 p -77.82 -33.46 18.74 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.322 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.347 -178.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.04 -31.57 67.15 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 121.179 -0.951 . . . . 0.0 111.834 177.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.738 ' O ' HG12 ' A' ' 24' ' ' VAL . 15.6 ptt180 -84.86 -28.09 26.26 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 175.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.601 HD22 ' CE1' ' A' ' 17' ' ' PHE . 11.8 tp -54.28 -48.9 70.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.962 172.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.796 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 23.0 mt-30 -70.57 -46.65 63.09 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 114.849 -1.068 . . . . 0.0 111.123 177.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.729 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 19.2 t70 -48.41 -54.63 13.34 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.282 0.989 . . . . 0.0 111.479 -178.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.738 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.4 p -81.73 -22.18 10.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.13 0.49 . . . . 0.0 109.734 -173.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.801 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -72.93 -18.85 61.35 Favored 'General case' 0 C--O 1.205 -1.259 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 174.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.401 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -86.44 -38.61 17.16 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.568 -1.196 . . . . 0.0 109.553 177.22 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.729 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.8 mmtt -67.06 -36.29 81.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.014 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.2 m -103.69 -9.1 19.4 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.088 0.47 . . . . 0.0 110.516 -171.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.801 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 84.3 mt -115.07 126.06 72.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.442 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.47 -4.8 59.27 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.242 0.544 . . . . 0.0 110.502 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.65 ' H ' HG22 ' A' ' 29' ' ' ILE . 25.8 t0 -106.28 139.16 41.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.407 -177.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -75.98 -31.45 58.99 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.445 175.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.567 ' O ' HG13 ' A' ' 37' ' ' VAL . 6.4 mttp -71.88 -55.0 8.31 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -175.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.631 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -58.75 -27.31 64.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.022 176.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.873 ' O ' HG13 ' A' ' 39' ' ' VAL . 1.9 tmm_? -66.0 -59.86 3.41 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 178.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.423 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 12.6 mtpp -54.94 -57.58 11.07 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.16 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.779 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 20.6 m -52.8 -34.33 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.975 -170.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.764 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.0 OUTLIER -88.31 -31.37 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 119.87 -0.732 . . . . 0.0 112.217 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.873 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.4 m -68.52 -48.65 71.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 119.067 -1.053 . . . . 0.0 109.513 176.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.785 ' OE1' HG13 ' A' ' 68' ' ' VAL . 0.8 OUTLIER -64.59 -28.46 69.64 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.455 0.702 . . . . 0.0 111.573 178.343 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.779 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -81.4 -54.61 5.32 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 122.19 -0.319 . . . . 0.0 111.432 178.014 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.566 ' HG3' ' ND2' ' A' ' 4' ' ' ASN . 22.3 mmt -63.43 -20.41 65.53 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.707 0.765 . . . . 0.0 109.613 -177.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.648 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -49.07 -32.98 10.61 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.86 172.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.488 ' HB2' HG21 ' A' ' 55' ' ' ILE . 17.1 t80 -99.75 -64.99 0.99 Allowed 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 175.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.566 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 39.3 mm-40 -50.06 -33.01 17.0 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.468 -1.242 . . . . 0.0 112.413 -171.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.759 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.6 m-20 -103.72 -20.42 13.96 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.087 -174.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.648 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -59.11 175.03 0.32 Allowed 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.691 0.758 . . . . 0.0 112.121 -177.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.603 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 12.3 m-20 -58.77 141.5 85.0 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.503 174.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -48.32 -29.09 12.45 Favored 'Trans proline' 0 C--O 1.22 -0.397 0 C-N-CA 123.761 2.974 . . . . 0.0 112.893 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -88.15 -33.82 18.08 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 123.86 0.864 . . . . 0.0 111.053 177.033 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.603 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 78.2 m -78.83 -33.8 45.76 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.504 -172.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.579 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.5 pt20 -73.08 -29.84 63.24 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 172.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.511 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 16.2 m -70.47 -19.12 62.97 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 113.658 -1.61 . . . . 0.0 110.432 173.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 51' ' ' CYS . . . -76.46 -27.98 56.37 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.169 -0.957 . . . . 0.0 109.458 166.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.593 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 21.8 mt -89.15 -31.5 5.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 115.651 1.722 . . . . 0.0 115.651 -171.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.587 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -40.03 -38.13 0.96 Allowed Pre-proline 0 N--CA 1.492 1.673 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -174.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.593 ' HD2' ' C ' ' A' ' 55' ' ' ILE . 57.7 Cg_endo -65.21 -26.49 56.88 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.139 1.893 . . . . 0.0 113.002 175.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.554 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.8 mt -100.89 -15.61 17.5 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.575 ' NZ ' HD13 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -49.85 109.36 0.28 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.333 -179.215 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.18 -21.4 34.73 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.075 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -103.43 114.04 28.0 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.007 0.432 . . . . 0.0 109.977 -177.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.453 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.1 p -122.42 140.67 33.16 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.05 172.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo . . . . . 0 C--O 1.235 0.338 0 C-N-CA 122.598 2.199 . . . . 0.0 111.848 170.119 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.785 HG13 ' OE1' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -71.46 -33.45 49.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.222 -179.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.771 ' O ' HG13 ' A' ' 73' ' ' VAL . 11.9 mm -55.71 -47.95 78.53 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.226 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.524 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.601 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 27.7 t -47.91 -36.65 12.63 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.911 178.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -86.59 -31.85 20.95 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.649 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.624 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.2 m-30 -76.13 -36.24 58.91 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.65 -177.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.841 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.8 m -69.63 -33.43 56.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 173.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.601 ' HB2' ' O ' ' A' ' 70' ' ' SER . 0.8 OUTLIER -68.36 -29.9 68.72 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.73 177.132 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -63.97 -49.04 74.08 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.741 175.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 14' ' ' TYR . 25.4 t -89.44 7.32 36.6 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.931 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.492 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 10.5 t70 . . . . . 0 C--N 1.323 -0.544 0 CA-C-O 121.487 0.66 . . . . 0.0 110.004 174.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 1' ' ' PRO . . . . . 0.409 ' HB2' HG21 ' B' ' 5' ' ' THR . 84.5 Cg_endo . . . . . 0 CA--C 1.516 -0.413 0 N-CA-C 109.425 -1.029 . . . . 0.0 109.425 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 48.4 m -65.51 164.98 12.96 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 163.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.767 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -69.79 -55.1 10.78 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.909 174.061 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.56 ' ND2' ' HG3' ' B' ' 42' ' ' MET . 2.7 p-10 -86.69 -2.23 58.35 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.852 -164.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.426 ' O ' ' HD3' ' B' ' 7' ' ' ARG . 9.7 t -66.11 -3.26 5.22 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.439 -176.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.597 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.3 m -73.65 131.97 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 171.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.779 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 1.2 ptt-85 -156.62 160.15 39.14 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -176.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' GLN . . . . . 0.462 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.3 tt0 -39.16 112.28 0.24 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 113.624 -1.626 . . . . 0.0 112.745 178.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.95 -142.72 8.18 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.64 174.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 20.0 m -59.03 95.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.958 0.379 . . . . 0.0 110.85 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 23.2 pttm 41.06 41.38 1.28 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.459 1.103 . . . . 0.0 112.454 -174.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -57.54 139.73 80.75 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.635 176.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . 0.538 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 34.2 Cg_exo -53.73 125.05 17.36 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.053 1.835 . . . . 0.0 109.727 177.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' TYR . . . . . 0.849 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 6.1 t80 -68.42 -55.37 12.25 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-O 118.504 -0.76 . . . . 0.0 112.877 -167.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.539 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 25.4 Cg_exo -57.57 -17.76 29.59 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 121.375 1.383 . . . . 0.0 111.238 -177.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.538 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 5.8 m-20 -89.71 -40.1 12.74 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.966 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' PHE . . . . . 0.637 ' HE2' ' CE2' ' B' ' 14' ' ' TYR . 0.0 OUTLIER -56.68 -45.79 81.52 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.013 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.792 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 1.4 p -77.75 -33.43 18.86 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.278 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.399 -178.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.27 -31.25 67.28 Favored 'General case' 0 C--N 1.31 -1.119 0 O-C-N 121.271 -0.893 . . . . 0.0 111.83 177.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.728 ' O ' HG12 ' B' ' 24' ' ' VAL . 15.8 ptt180 -84.97 -28.31 25.89 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 174.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.593 HD22 ' CE1' ' B' ' 17' ' ' PHE . 11.8 tp -54.0 -48.84 70.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.97 172.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' GLN . . . . . 0.792 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 23.1 mt-30 -70.89 -46.38 62.68 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.077 177.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.734 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 19.1 t70 -48.4 -54.72 12.98 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 124.125 0.891 . . . . 0.0 111.574 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' VAL . . . . . 0.728 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.4 p -81.63 -22.38 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-O 121.278 0.561 . . . . 0.0 109.807 -173.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.779 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -72.85 -18.67 61.42 Favored 'General case' 0 C--O 1.205 -1.252 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 173.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . 0.419 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -86.64 -38.39 17.11 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.546 -1.207 . . . . 0.0 109.596 177.133 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.734 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.8 mmtt -67.23 -36.13 81.02 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.033 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 23.8 m -104.02 -8.73 19.35 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.203 0.525 . . . . 0.0 110.628 -171.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.779 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 83.8 mt -115.35 126.13 72.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.394 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.37 -5.55 59.3 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.109 0.48 . . . . 0.0 110.363 178.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.669 ' H ' HG22 ' B' ' 29' ' ' ILE . 26.0 t0 -105.41 139.47 39.99 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.297 -177.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -76.27 -31.5 58.3 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.499 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.581 ' O ' HG13 ' B' ' 37' ' ' VAL . 6.4 mttp -71.68 -55.01 8.51 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.624 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -58.7 -27.56 64.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.289 -0.868 . . . . 0.0 110.967 176.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.859 ' O ' HG13 ' B' ' 39' ' ' VAL . 1.9 tmm_? -65.85 -59.75 3.55 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 12.5 mtpp -55.18 -57.54 11.37 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.1 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.781 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 20.1 m -52.67 -34.5 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.068 -170.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.767 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.0 OUTLIER -88.26 -31.26 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 119.942 -0.703 . . . . 0.0 112.195 -179.436 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.859 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.4 m -68.63 -48.64 70.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 119.114 -1.035 . . . . 0.0 109.434 176.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.771 ' OE1' HG13 ' B' ' 68' ' ' VAL . 0.8 OUTLIER -64.65 -28.44 69.61 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.49 0.716 . . . . 0.0 111.541 178.388 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.781 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -81.4 -54.62 5.31 Favored 'General case' 0 C--N 1.322 -0.602 0 O-C-N 122.141 -0.349 . . . . 0.0 111.5 177.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' MET . . . . . 0.56 ' HG3' ' ND2' ' B' ' 4' ' ' ASN . 22.2 mmt -63.47 -20.45 65.59 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.691 0.758 . . . . 0.0 109.519 -177.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.659 ' O ' ' HB2' ' B' ' 47' ' ' ALA . . . -49.0 -32.99 10.17 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.832 171.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' TYR . . . . . 0.492 ' HB2' HG21 ' B' ' 55' ' ' ILE . 17.6 t80 -99.8 -64.79 1.01 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.582 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 39.4 mm-40 -50.2 -32.97 17.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.419 -1.264 . . . . 0.0 112.312 -171.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.779 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.6 m-20 -103.96 -20.21 13.96 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.031 -174.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.659 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -59.55 174.91 0.39 Allowed 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.591 0.71 . . . . 0.0 112.119 -177.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' ASN . . . . . 0.606 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 12.0 m-20 -58.51 141.44 83.73 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 114.755 -1.112 . . . . 0.0 109.496 174.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -48.12 -29.3 12.19 Favored 'Trans proline' 0 C--O 1.221 -0.37 0 C-N-CA 123.715 2.943 . . . . 0.0 112.918 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' B' ' 50' ' ' GLU . 0.3 OUTLIER -88.05 -33.81 18.19 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 123.823 0.849 . . . . 0.0 111.095 177.213 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.606 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 78.8 m -78.8 -33.88 45.88 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.457 -172.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . 0.596 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.7 pt20 -72.93 -29.99 63.54 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 172.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' SER . . . . . 0.517 ' O ' ' HE2' ' B' ' 56' ' ' LYS . 15.8 m -70.45 -19.06 63.0 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 113.654 -1.612 . . . . 0.0 110.416 173.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' B' ' 51' ' ' CYS . . . -76.6 -27.65 55.84 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.271 -0.893 . . . . 0.0 109.545 166.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' B' ' 52' ' ' GLN . 22.0 mt -89.43 -31.41 5.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -171.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.585 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -40.2 -38.15 1.02 Allowed Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -174.756 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.589 ' HD2' ' C ' ' B' ' 55' ' ' ILE . 57.9 Cg_endo -65.21 -26.22 57.08 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.177 1.918 . . . . 0.0 113.069 175.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . 0.57 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.8 mt -100.97 -15.66 17.42 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . 0.568 ' NZ ' HD13 ' B' ' 41' ' ' LEU . 0.2 OUTLIER -49.95 109.36 0.28 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.302 -179.103 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . 0.42 ' HA3' ' C ' ' A' ' 1' ' ' PRO . . . 91.13 -21.23 35.46 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.05 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -103.4 114.01 27.95 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 120.994 0.426 . . . . 0.0 109.972 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.462 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.1 p -122.34 140.76 33.22 Favored Pre-proline 0 C--N 1.314 -0.964 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.075 172.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo . . . . . 0 C--N 1.343 0.283 0 C-N-CA 122.576 2.184 . . . . 0.0 111.906 170.029 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 . . . . . 0 N--CA 1.454 -0.261 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.771 HG13 ' OE1' ' B' ' 40' ' ' GLU . 0.8 OUTLIER -71.69 -33.35 48.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.198 -179.475 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.772 ' O ' HG13 ' B' ' 73' ' ' VAL . 11.9 mm -55.66 -48.1 78.16 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.215 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.538 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.594 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 27.2 t -47.83 -36.6 12.17 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.943 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -86.42 -32.11 21.07 Favored 'General case' 0 CA--C 1.507 -0.685 0 C-N-CA 123.231 0.613 . . . . 0.0 110.606 -177.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' TYR . . . . . 0.613 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.2 m-30 -75.94 -36.22 59.43 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.616 -177.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.849 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.8 m -69.62 -33.59 57.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.543 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 173.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' LYS . . . . . 0.594 ' HB2' ' O ' ' B' ' 70' ' ' SER . 0.8 OUTLIER -68.11 -30.12 69.2 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.224 -1.353 . . . . 0.0 109.755 177.117 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -63.75 -49.25 73.74 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.676 175.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' B' ' 14' ' ' TYR . 24.9 t -89.31 7.05 37.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.921 178.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . 0.498 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 8.9 t70 . . . . . 0 C--N 1.323 -0.56 0 CA-C-O 121.374 0.607 . . . . 0.0 110.034 174.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.4 ' HB2' ' H ' ' A' ' 2' ' ' SER . 96.0 Cg_endo . . . . . 0 CA--C 1.517 -0.345 0 N-CA-C 109.248 -1.097 . . . . 0.0 109.248 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.554 ' HB2' HG23 ' A' ' 5' ' ' THR . 39.4 m -64.93 171.13 3.71 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 162.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.837 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -69.73 -52.53 24.65 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.118 175.299 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.488 ' ND2' ' HG3' ' A' ' 42' ' ' MET . 2.2 p-10 -86.97 6.45 32.16 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.577 -1.192 . . . . 0.0 113.659 -163.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.628 ' CG2' ' HD3' ' B' ' 59' ' ' LYS . 1.1 p -63.32 -5.99 4.14 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 118.513 0.597 . . . . 0.0 111.787 -176.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.629 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.1 m -75.12 132.04 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 175.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.772 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -155.54 159.22 39.54 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -178.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.474 ' HG2' ' HB3' ' A' ' 12' ' ' GLU . 2.3 tt0 -44.29 115.14 0.79 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 112.929 -1.941 . . . . 0.0 113.02 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.73 -149.98 23.81 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.091 -0.958 . . . . 0.0 111.126 171.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.478 ' C ' ' HD3' ' A' ' 11' ' ' LYS . 6.3 p -50.97 100.36 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.61 0.364 . . . . 0.0 111.592 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER 30.25 48.0 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.764 1.226 . . . . 0.0 112.26 -171.507 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.474 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 53.5 tt0 -60.22 140.63 91.17 Favored Pre-proline 0 C--O 1.234 0.283 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.611 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.574 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 32.0 Cg_exo -54.05 121.54 9.82 Favored 'Trans proline' 0 CA--C 1.509 -0.754 0 C-N-CA 121.947 1.765 . . . . 0.0 109.623 178.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.917 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 13.8 t80 -72.75 -53.36 5.52 Favored Pre-proline 0 N--CA 1.439 -1.022 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -167.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' A' ' 14' ' ' TYR . 34.6 Cg_exo -55.66 -17.04 16.42 Favored 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.43 1.42 . . . . 0.0 110.761 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.574 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 2.2 m-20 -90.6 -43.43 10.18 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 113.981 -1.463 . . . . 0.0 111.038 177.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.491 ' CD2' ' HA ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -53.41 -46.51 69.78 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.791 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 1.8 p -79.26 -34.72 16.56 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.363 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.313 -178.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.89 -32.79 68.06 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 121.344 -0.847 . . . . 0.0 111.762 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.697 ' O ' HG12 ' A' ' 24' ' ' VAL . 14.3 ptt180 -84.28 -25.04 29.64 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 176.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.56 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 6.2 tp -59.91 -46.72 88.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.821 172.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.791 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 24.7 mt-30 -69.97 -48.28 58.92 Favored 'General case' 0 CA--C 1.492 -1.282 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.933 177.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.73 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 15.5 t70 -47.44 -54.65 10.82 Favored 'General case' 0 C--N 1.313 -1.017 0 O-C-N 124.265 0.978 . . . . 0.0 111.547 -178.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.697 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.7 p -79.18 -24.9 12.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.948 -173.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.641 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -67.89 -29.58 68.71 Favored 'General case' 0 C--O 1.205 -1.263 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.474 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -78.81 -36.32 42.89 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.723 -178.253 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.73 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 39.2 mmtt -65.92 -34.1 77.34 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.469 177.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.431 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 16.1 m -105.6 -9.89 17.14 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.271 0.558 . . . . 0.0 110.823 -170.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.641 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 87.7 mt -118.07 129.07 74.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.062 -178.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.4 -1.47 53.63 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.246 0.546 . . . . 0.0 110.524 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.615 ' H ' HG22 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -113.71 111.76 22.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.015 -177.338 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.86 -32.05 30.47 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 177.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.595 ' O ' HG13 ' A' ' 37' ' ' VAL . 14.2 mttm -58.46 -61.31 2.68 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.634 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -66.36 -22.84 66.27 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.427 -178.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.85 ' O ' HG13 ' A' ' 39' ' ' VAL . 5.3 tmm_? -72.31 -54.6 9.02 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.447 ' O ' HG22 ' A' ' 39' ' ' VAL . 16.6 mtpt -59.44 -56.5 21.26 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.345 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.81 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 20.9 m -54.15 -36.58 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.997 -171.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.837 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.2 tt -85.78 -30.36 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.811 -176.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.85 HG13 ' O ' ' A' ' 35' ' ' ARG . 3.3 m -69.47 -47.94 69.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 C-N-CA 118.915 -1.114 . . . . 0.0 109.245 174.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.619 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 58.6 mt-10 -64.66 -23.13 67.16 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 123.653 0.781 . . . . 0.0 112.383 175.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.81 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -85.48 -57.21 3.16 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.543 177.251 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.498 ' HB2' HD21 ' A' ' 21' ' ' LEU . 20.1 mmt -63.6 -20.96 66.09 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 121.462 0.649 . . . . 0.0 109.734 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.671 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -49.18 -27.65 3.78 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.288 170.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.466 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 11.4 t80 -106.12 -68.1 0.89 Allowed 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.603 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 7.2 mm-40 -47.59 -33.85 7.1 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 124.31 1.007 . . . . 0.0 112.414 -173.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.772 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.8 m-20 -103.46 -21.15 13.83 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 120.501 0.191 . . . . 0.0 110.963 -174.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.654 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -57.35 177.61 0.09 Allowed 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 121.817 0.818 . . . . 0.0 112.511 -176.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -56.21 137.64 74.35 Favored Pre-proline 0 N--CA 1.44 -0.958 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.9 174.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.43 -21.75 31.36 Favored 'Trans proline' 0 C--O 1.219 -0.465 0 C-N-CA 123.273 2.649 . . . . 0.0 111.778 -177.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.516 ' O ' ' HB2' ' A' ' 53' ' ' SER . 0.7 OUTLIER -87.86 -37.4 16.54 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 124.157 0.983 . . . . 0.0 111.055 173.325 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 1.015 ' SG ' ' HB2' ' A' ' 76' ' ' CYS . 42.4 t -75.33 -36.06 61.11 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-O 121.018 0.437 . . . . 0.0 111.328 -172.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.554 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.9 pt20 -69.62 -29.74 67.32 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 175.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.636 ' HA ' ' CD ' ' A' ' 56' ' ' LYS . 30.8 m -72.48 -19.75 61.5 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 112.944 -1.935 . . . . 0.0 110.176 174.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -81.22 -22.27 38.92 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.333 166.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.554 HD12 ' HA ' ' A' ' 52' ' ' GLN . 22.5 mt -90.54 -31.84 5.26 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.787 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 -173.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.651 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.1 OUTLIER -46.14 -32.65 1.81 Allowed Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -175.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.651 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 33.0 Cg_endo -59.54 -31.04 93.9 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.17 1.913 . . . . 0.0 112.99 171.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.546 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.1 mt -102.45 -15.65 16.42 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.624 ' HD3' ' CG2' ' B' ' 5' ' ' THR . 0.1 OUTLIER -51.78 109.88 0.41 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.972 -179.717 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.35 -22.66 35.8 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.162 -177.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -103.77 114.5 28.8 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.413 0.625 . . . . 0.0 110.553 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.527 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.4 p -123.4 149.99 59.55 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.471 170.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.43 ' HD2' HG23 ' A' ' 62' ' ' VAL . 92.1 Cg_exo . . . . . 0 N--CA 1.462 -0.374 0 C-N-CA 121.713 1.609 . . . . 0.0 110.92 164.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 p30 . . . . . 0 N--CA 1.44 -0.963 0 CA-C-O 120.166 0.031 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.559 HG13 ' CD ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -81.05 -28.98 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 C-N-CA 117.609 -1.637 . . . . 0.0 108.606 173.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.78 ' O ' HG13 ' A' ' 73' ' ' VAL . 10.0 mm -59.34 -48.04 88.42 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.18 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.627 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.402 ' O ' HG22 ' A' ' 73' ' ' VAL . 45.3 t -50.44 -33.96 22.93 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.355 0.598 . . . . 0.0 111.155 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -85.28 -33.64 22.1 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 123.323 0.649 . . . . 0.0 110.507 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.576 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 4.7 m-30 -75.85 -34.05 60.04 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.754 -176.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.917 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 2.2 m -68.41 -35.67 71.66 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 173.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.54 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 21.7 ttmt -70.71 -27.7 64.18 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 113.894 -1.503 . . . . 0.0 111.188 176.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -61.62 -44.34 97.17 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 171.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 1.015 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 16.6 t -85.78 3.12 42.83 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.292 176.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.54 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 29.6 t70 . . . . . 0 CA--C 1.538 0.492 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 163.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo . . . . . 0 CA--C 1.517 -0.368 0 N-CA-C 109.156 -1.132 . . . . 0.0 109.156 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . 0.561 ' HB2' HG23 ' B' ' 5' ' ' THR . 43.3 m -65.13 171.07 3.93 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 162.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.825 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -69.61 -52.54 25.06 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.155 175.349 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.488 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.2 p-10 -86.9 6.51 31.6 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.584 -1.189 . . . . 0.0 113.717 -163.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.624 ' CG2' ' HD3' ' A' ' 59' ' ' LYS . 1.1 p -63.54 -5.75 4.25 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 118.57 0.623 . . . . 0.0 111.865 -176.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.63 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.1 m -75.2 131.98 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 175.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.773 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.1 OUTLIER -155.51 159.37 39.7 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -178.702 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' GLN . . . . . 0.46 ' HG2' ' HB3' ' B' ' 12' ' ' GLU . 2.3 tt0 -44.2 115.0 0.76 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 112.939 -1.937 . . . . 0.0 113.035 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.79 -150.06 24.04 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.162 171.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . 0.488 ' C ' ' HD3' ' B' ' 11' ' ' LYS . 7.8 p -50.84 100.25 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.604 0.362 . . . . 0.0 111.677 -178.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' B' ' 11' ' ' LYS . 0.0 OUTLIER 30.37 48.19 0.05 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.673 1.189 . . . . 0.0 112.122 -171.575 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.46 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 51.9 tt0 -60.51 140.35 92.28 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.688 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . 0.577 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 31.9 Cg_exo -53.97 121.6 9.91 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 121.861 1.707 . . . . 0.0 109.602 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' TYR . . . . . 0.912 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 13.7 t80 -72.85 -53.35 5.36 Favored Pre-proline 0 N--CA 1.438 -1.049 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -167.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.521 ' HD3' ' HB3' ' B' ' 14' ' ' TYR . 32.9 Cg_exo -55.37 -17.33 15.86 Favored 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 121.57 1.514 . . . . 0.0 110.775 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.577 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.7 m-20 -90.62 -43.42 10.18 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 113.935 -1.484 . . . . 0.0 111.024 177.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' PHE . . . . . 0.502 ' CD2' ' HA ' ' B' ' 7' ' ' ARG . 0.0 OUTLIER -53.38 -46.49 69.66 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.662 0.744 . . . . 0.0 109.039 175.525 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.797 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 1.8 p -79.16 -34.83 16.79 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.334 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.298 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.91 -32.76 68.06 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 121.366 -0.834 . . . . 0.0 111.773 177.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.693 ' O ' HG12 ' B' ' 24' ' ' VAL . 14.3 ptt180 -84.61 -24.63 29.05 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.563 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 6.1 tp -60.3 -46.47 89.75 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.842 172.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' GLN . . . . . 0.797 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 24.8 mt-30 -70.2 -48.1 58.58 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.004 177.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.724 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 15.2 t70 -47.49 -54.67 10.88 Favored 'General case' 0 C--N 1.313 -1.002 0 O-C-N 124.301 1.001 . . . . 0.0 111.462 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' VAL . . . . . 0.693 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.7 p -79.28 -24.78 12.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.96 -173.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.649 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -67.96 -29.51 68.57 Favored 'General case' 0 C--O 1.205 -1.272 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 174.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . 0.463 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -78.89 -36.26 42.33 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.125 -1.398 . . . . 0.0 109.786 -178.252 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.724 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 39.1 mmtt -65.89 -34.26 77.72 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.496 177.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . 0.421 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 15.9 m -105.63 -9.66 17.24 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.884 -170.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.649 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 87.9 mt -118.2 129.28 74.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.983 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.64 -1.32 53.39 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.347 0.594 . . . . 0.0 110.585 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.607 ' H ' HG22 ' B' ' 29' ' ' ILE . 0.6 OUTLIER -113.71 111.81 22.41 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.977 -177.554 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.17 -31.71 32.65 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.092 177.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.586 ' O ' HG13 ' B' ' 37' ' ' VAL . 14.1 mttm -58.66 -61.21 2.77 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -178.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.621 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -66.21 -22.98 66.36 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.483 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.868 ' O ' HG13 ' B' ' 39' ' ' VAL . 5.2 tmm_? -72.15 -54.63 9.13 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.446 ' O ' HG22 ' B' ' 39' ' ' VAL . 16.5 mtpt -59.47 -56.48 21.43 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.461 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.8 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 21.0 m -54.18 -36.57 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.051 -171.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.825 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.2 tt -85.6 -30.55 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.757 -176.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.868 HG13 ' O ' ' B' ' 35' ' ' ARG . 3.3 m -69.39 -48.0 69.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 C-N-CA 118.927 -1.109 . . . . 0.0 109.17 174.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.621 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 58.7 mt-10 -64.63 -23.35 67.23 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.571 0.748 . . . . 0.0 112.268 176.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.8 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.29 -57.16 3.19 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.555 177.331 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' MET . . . . . 0.497 ' HB2' HD21 ' B' ' 21' ' ' LEU . 20.0 mmt -63.63 -20.96 66.1 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.521 0.677 . . . . 0.0 109.714 -177.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.681 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -49.13 -27.76 3.75 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.305 170.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' TYR . . . . . 0.478 ' CG ' ' HD2' ' B' ' 59' ' ' LYS . 11.4 t80 -106.09 -67.99 0.9 Allowed 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.608 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 7.2 mm-40 -47.85 -33.48 7.46 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 124.301 1.001 . . . . 0.0 112.491 -173.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.773 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.9 m-20 -103.67 -21.04 13.78 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 116.808 -0.178 . . . . 0.0 110.903 -175.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.644 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -57.48 178.07 0.08 Allowed 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 121.864 0.84 . . . . 0.0 112.55 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -56.42 137.53 75.91 Favored Pre-proline 0 N--CA 1.441 -0.917 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.819 174.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.32 -21.63 30.04 Favored 'Trans proline' 0 C--O 1.221 -0.373 0 C-N-CA 123.177 2.585 . . . . 0.0 111.911 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . 0.509 ' O ' ' HB2' ' B' ' 53' ' ' SER . 0.7 OUTLIER -87.8 -37.47 16.56 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 124.303 1.041 . . . . 0.0 111.13 173.044 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 1.015 ' SG ' ' HB2' ' B' ' 76' ' ' CYS . 41.7 t -75.34 -36.0 61.09 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-O 121.046 0.451 . . . . 0.0 111.315 -172.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . 0.543 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.9 pt20 -69.54 -29.92 67.62 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 175.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' SER . . . . . 0.644 ' HA ' ' CD ' ' B' ' 56' ' ' LYS . 32.4 m -72.26 -19.99 61.6 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 112.92 -1.945 . . . . 0.0 110.29 174.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -81.04 -22.38 39.36 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.216 -0.593 . . . . 0.0 110.388 166.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' B' ' 52' ' ' GLN . 22.5 mt -90.53 -31.95 5.29 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.798 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -173.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.644 ' CD ' ' HA ' ' B' ' 53' ' ' SER . 0.1 OUTLIER -46.04 -32.76 1.8 Allowed Pre-proline 0 N--CA 1.488 1.466 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -175.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 32.7 Cg_endo -59.24 -31.44 95.22 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.219 1.946 . . . . 0.0 112.939 171.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . 0.542 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.1 mt -102.15 -15.91 16.54 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -177.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . 0.628 ' HD3' ' CG2' ' A' ' 5' ' ' THR . 0.1 OUTLIER -51.61 109.88 0.4 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.112 -179.713 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.0 -22.09 38.26 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.329 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -103.96 114.76 29.24 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.355 0.597 . . . . 0.0 110.48 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.511 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.5 p -123.46 150.34 60.65 Favored Pre-proline 0 C--N 1.309 -1.166 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.374 170.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . 0.435 ' HD2' HG23 ' B' ' 62' ' ' VAL . 93.4 Cg_exo . . . . . 0 C--N 1.344 0.313 0 C-N-CA 121.753 1.636 . . . . 0.0 110.915 164.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 p30 . . . . . 0 N--CA 1.44 -0.958 0 CA-C-O 120.279 0.085 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.551 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.9 OUTLIER -80.97 -28.79 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 C-N-CA 117.548 -1.661 . . . . 0.0 108.609 173.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.789 ' O ' HG13 ' B' ' 73' ' ' VAL . 9.8 mm -59.75 -47.71 90.27 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.232 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.68 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.401 ' O ' HG22 ' B' ' 73' ' ' VAL . 42.8 t -50.52 -34.04 23.79 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.397 0.617 . . . . 0.0 111.118 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -85.18 -33.87 22.2 Favored 'General case' 0 C--O 1.213 -0.835 0 C-N-CA 123.298 0.639 . . . . 0.0 110.394 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' TYR . . . . . 0.575 ' OH ' ' HA ' ' B' ' 59' ' ' LYS . 4.7 m-30 -75.56 -33.9 60.66 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.719 -176.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.912 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 2.2 m -68.56 -35.61 71.03 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' LYS . . . . . 0.53 ' O ' ' HB3' ' B' ' 77' ' ' ASP . 22.0 ttmt -70.71 -27.52 64.04 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.253 176.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -61.81 -44.17 97.39 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 1.015 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 16.5 t -86.02 3.29 42.96 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.336 176.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . 0.53 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 28.5 t70 . . . . . 0 CA--C 1.538 0.512 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 163.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.427 ' HB2' ' H ' ' A' ' 2' ' ' SER . 98.1 Cg_endo . . . . . 0 CA--C 1.517 -0.341 0 N-CA-C 109.052 -1.172 . . . . 0.0 109.052 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.65 ' HB2' HG23 ' A' ' 5' ' ' THR . 50.0 m -66.37 176.82 1.68 Allowed 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 162.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.661 ' CE1' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -77.09 -53.99 7.09 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.589 -0.845 . . . . 0.0 109.743 174.338 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.56 ' ND2' ' HG3' ' A' ' 42' ' ' MET . 2.0 p-10 -82.67 6.19 18.71 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.367 -1.288 . . . . 0.0 112.548 -167.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.65 HG23 ' HB2' ' A' ' 2' ' ' SER . 0.7 OUTLIER -65.12 -4.08 4.5 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.547 -176.75 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.627 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.2 m -79.37 132.78 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 174.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.768 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -155.95 160.07 39.78 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 118.937 -1.105 . . . . 0.0 113.422 -177.798 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.497 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.4 mt-30 -40.67 112.68 0.31 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 113.568 -1.651 . . . . 0.0 112.776 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.08 -161.58 32.74 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 170.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.7 m -50.83 104.09 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 117.292 0.546 . . . . 0.0 111.029 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.4 pttt 44.12 39.11 2.65 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.587 1.155 . . . . 0.0 112.756 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.434 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 48.2 tt0 -62.36 137.97 96.2 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 177.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.512 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 39.0 Cg_exo -53.74 124.72 16.53 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.11 1.874 . . . . 0.0 109.921 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.78 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 6.7 t80 -69.26 -55.32 10.11 Favored Pre-proline 0 N--CA 1.44 -0.958 0 CA-C-O 118.38 -0.819 . . . . 0.0 113.134 -166.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.548 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 30.3 Cg_exo -57.04 -17.57 25.15 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 121.456 1.437 . . . . 0.0 111.211 -178.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 2.1 m-20 -89.52 -42.31 11.52 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.891 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.64 ' CE1' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -55.48 -44.7 76.72 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.307 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.745 HG21 HD12 ' A' ' 69' ' ' ILE . 1.7 p -80.99 -31.47 12.11 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.937 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.826 -177.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.76 -33.69 70.56 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 121.284 -0.885 . . . . 0.0 111.608 176.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.706 ' O ' HG12 ' A' ' 24' ' ' VAL . 14.6 ptt180 -84.56 -25.48 28.66 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 175.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.64 HD22 ' CE1' ' A' ' 17' ' ' PHE . 9.7 tp -57.98 -45.09 87.31 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.972 172.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.723 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 36.1 mt-30 -73.31 -44.42 59.04 Favored 'General case' 0 CA--C 1.494 -1.196 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.688 177.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.759 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 14.3 t70 -52.08 -50.93 60.58 Favored 'General case' 0 C--N 1.314 -0.945 0 O-C-N 124.087 0.867 . . . . 0.0 111.427 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.706 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.1 p -82.02 -23.96 9.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.249 0.547 . . . . 0.0 109.793 -174.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.855 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -71.69 -18.29 62.18 Favored 'General case' 0 C--O 1.206 -1.223 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 174.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.426 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -87.43 -38.92 15.7 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.958 176.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.759 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 40.2 mmtt -65.28 -43.32 91.6 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.321 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.515 ' HB2' ' HB3' ' A' ' 3' ' ' PHE . 24.9 m -98.6 -8.47 26.36 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.243 0.544 . . . . 0.0 110.419 -172.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.855 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 87.2 mt -114.91 125.48 72.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.725 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.84 -4.33 57.65 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.18 0.514 . . . . 0.0 110.01 175.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.669 ' OD1' ' HB2' ' A' ' 33' ' ' LYS . 12.4 t70 -102.59 115.71 31.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.409 -177.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.466 ' O ' ' HG2' ' A' ' 36' ' ' LYS . 12.5 pt-20 -61.59 -24.71 66.86 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.831 176.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.669 ' HB2' ' OD1' ' A' ' 31' ' ' ASP . 4.5 mptt -75.12 -52.17 11.65 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -177.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.409 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -65.29 -26.94 68.29 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.89 176.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.827 ' O ' HG13 ' A' ' 39' ' ' VAL . 3.9 tmm_? -62.59 -65.19 0.72 Allowed 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.589 ' HG3' HG13 ' A' ' 37' ' ' VAL . 7.9 ptmm? -53.11 -58.38 7.2 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.314 0.578 . . . . 0.0 112.259 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.779 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 5.4 m -56.63 -30.39 31.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.928 -172.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.497 ' O ' ' HG2' ' A' ' 42' ' ' MET . 0.1 OUTLIER -85.07 -31.43 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.407 178.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.827 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.4 m -68.33 -47.84 75.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 119.257 -0.977 . . . . 0.0 108.97 175.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.594 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 45.3 mt-10 -68.03 -22.89 64.94 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.335 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.779 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -85.42 -55.2 4.13 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.166 175.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.574 ' HB2' HD21 ' A' ' 21' ' ' LEU . 17.8 mmt -63.77 -20.42 65.75 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.567 0.698 . . . . 0.0 109.765 -176.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.627 ' HB2' ' CD1' ' A' ' 69' ' ' ILE . . . -47.9 -30.2 3.96 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.736 171.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.553 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 8.0 t80 -105.66 -66.99 0.95 Allowed 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.637 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 3.9 mm-40 -47.02 -33.79 5.09 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 124.47 1.106 . . . . 0.0 112.107 -173.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.768 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 5.3 m-20 -102.7 -21.0 14.17 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.214 -174.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.62 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -60.65 -179.62 0.13 Allowed 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 122.093 0.949 . . . . 0.0 112.966 -173.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.604 ' HB3' ' OE1' ' A' ' 50' ' ' GLU . 15.1 m-20 -61.35 141.61 94.21 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.175 174.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.21 -22.61 33.21 Favored 'Trans proline' 0 C--O 1.22 -0.425 0 C-N-CA 123.413 2.742 . . . . 0.0 112.722 -178.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.694 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 12.2 pm0 -89.37 -31.13 17.91 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 123.5 0.72 . . . . 0.0 110.599 175.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.694 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 92.7 m -82.9 -37.44 24.25 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.57 -170.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.611 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.6 pt20 -70.21 -29.94 66.91 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 172.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.413 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 11.2 m -70.91 -19.87 62.55 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 113.672 -1.604 . . . . 0.0 110.331 174.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 51' ' ' CYS . . . -78.6 -25.43 45.19 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.504 -0.748 . . . . 0.0 109.686 167.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.613 HD11 ' CE2' ' A' ' 14' ' ' TYR . 22.7 mt -89.8 -32.57 5.65 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.816 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -171.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.599 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -39.92 -37.95 0.88 Allowed Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -174.361 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 52.3 Cg_endo -63.86 -29.23 67.65 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.217 1.945 . . . . 0.0 113.006 175.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.566 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.5 mt -99.09 -15.61 18.94 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.645 ' HD3' ' CG2' ' B' ' 5' ' ' THR . 0.1 OUTLIER -50.96 109.65 0.35 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.24 -178.371 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.419 ' HA3' ' C ' ' B' ' 1' ' ' PRO . . . 90.2 -20.65 35.75 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.032 -178.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -103.47 113.14 26.41 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.274 0.559 . . . . 0.0 109.785 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.474 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.5 p -123.72 148.88 57.6 Favored Pre-proline 0 C--N 1.31 -1.146 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.624 172.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo . . . . . 0 N--CA 1.459 -0.51 0 C-N-CA 122.059 1.839 . . . . 0.0 110.788 164.576 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.62 ' OD2' ' HB3' ' A' ' 70' ' ' SER . 0.4 OUTLIER . . . . . 0 N--CA 1.441 -0.887 0 CA-C-O 120.249 0.071 . . . . 0.0 111.117 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.534 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -81.7 -32.98 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 C-N-CA 118.623 -1.231 . . . . 0.0 108.662 173.815 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.789 ' O ' HG13 ' A' ' 73' ' ' VAL . 10.7 mm -56.3 -49.98 73.92 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.349 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.495 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.62 ' HB3' ' OD2' ' A' ' 67' ' ' ASP . 32.5 t -54.66 -29.01 51.3 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.059 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -85.79 -33.27 21.42 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.394 0.616 . . . . 0.0 110.162 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.64 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.2 m-30 -75.31 -35.13 61.3 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.518 -177.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.789 HG13 ' O ' ' A' ' 69' ' ' ILE . 1.4 m -70.78 -32.05 47.79 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 172.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.538 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -67.63 -30.92 70.62 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.27 175.248 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -63.58 -46.02 87.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.056 176.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.626 ' SG ' ' HB2' ' A' ' 14' ' ' TYR . 27.5 t -93.02 9.91 33.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.141 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.538 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 3.8 t70 . . . . . 0 C--N 1.323 -0.578 0 CA-C-O 121.092 0.472 . . . . 0.0 110.854 174.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 1' ' ' PRO . . . . . 0.419 ' C ' ' HA3' ' A' ' 60' ' ' GLY . 93.2 Cg_endo . . . . . 0 CA--C 1.516 -0.384 0 N-CA-C 109.135 -1.14 . . . . 0.0 109.135 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . 0.649 ' HB2' HG23 ' B' ' 5' ' ' THR . 50.1 m -66.91 176.97 1.84 Allowed 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 162.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.659 ' CE1' HD11 ' B' ' 29' ' ' ILE . 0.1 OUTLIER -77.03 -54.14 6.92 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.663 174.296 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.554 ' ND2' ' HG3' ' B' ' 42' ' ' MET . 2.0 p-10 -82.59 6.01 19.08 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.392 -1.276 . . . . 0.0 112.475 -166.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.649 HG23 ' HB2' ' B' ' 2' ' ' SER . 0.7 OUTLIER -65.1 -3.95 4.31 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.58 -176.698 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.629 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.2 m -79.41 132.9 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.746 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.1 OUTLIER -155.94 160.24 39.94 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.123 -1.031 . . . . 0.0 113.403 -177.79 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' GLN . . . . . 0.505 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.3 mt-30 -41.03 112.16 0.27 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 113.591 -1.64 . . . . 0.0 112.814 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.41 -161.44 31.43 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 170.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 43.5 m -50.92 104.05 0.07 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-N 117.241 0.52 . . . . 0.0 111.093 -178.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 63.7 pttt 44.22 38.88 2.61 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.59 1.156 . . . . 0.0 112.714 -176.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.44 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 48.2 tt0 -62.09 137.71 95.71 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 177.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . 0.536 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 39.4 Cg_exo -53.5 124.89 16.84 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.25 1.967 . . . . 0.0 109.979 178.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' TYR . . . . . 0.791 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 6.7 t80 -69.58 -55.28 9.53 Favored Pre-proline 0 N--CA 1.44 -0.943 0 CA-C-O 118.369 -0.824 . . . . 0.0 113.074 -166.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.547 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 31.1 Cg_exo -57.05 -17.62 25.39 Favored 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 121.437 1.425 . . . . 0.0 111.176 -178.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.536 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 2.3 m-20 -89.44 -42.64 11.38 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 113.872 -1.513 . . . . 0.0 110.804 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' PHE . . . . . 0.638 ' CE1' HD22 ' B' ' 21' ' ' LEU . 0.0 OUTLIER -55.22 -44.73 75.68 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 177.351 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.728 HG21 HD12 ' B' ' 69' ' ' ILE . 1.7 p -80.99 -31.38 12.07 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.927 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.791 -177.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.69 -34.04 70.84 Favored 'General case' 0 C--N 1.315 -0.931 0 O-C-N 121.344 -0.847 . . . . 0.0 111.596 176.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.707 ' O ' HG12 ' B' ' 24' ' ' VAL . 14.7 ptt180 -84.37 -25.48 29.11 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 176.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.638 HD22 ' CE1' ' B' ' 17' ' ' PHE . 9.9 tp -58.09 -45.19 87.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.981 172.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' GLN . . . . . 0.738 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 35.5 mt-30 -73.26 -44.39 59.46 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.701 177.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.753 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 12.8 t70 -51.96 -50.8 60.52 Favored 'General case' 0 C--N 1.314 -0.941 0 O-C-N 123.956 0.785 . . . . 0.0 111.578 -178.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' VAL . . . . . 0.707 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.1 p -82.1 -24.0 9.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.218 0.532 . . . . 0.0 109.766 -174.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.855 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -71.77 -18.16 62.13 Favored 'General case' 0 C--O 1.206 -1.219 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 174.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . 0.433 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -87.59 -38.89 15.55 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.991 176.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.753 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 40.4 mmtt -65.09 -43.92 90.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.233 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . 0.537 ' HB2' ' HB3' ' B' ' 3' ' ' PHE . 36.0 m -98.15 -8.31 27.79 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.116 0.484 . . . . 0.0 110.495 -171.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.855 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 87.4 mt -114.99 125.24 72.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.813 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.59 -4.46 57.82 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.259 0.552 . . . . 0.0 110.143 175.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.644 ' OD1' ' HB2' ' B' ' 33' ' ' LYS . 12.3 t70 -102.79 115.67 31.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.445 -177.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' B' ' 36' ' ' LYS . 12.4 pt-20 -61.79 -24.49 66.88 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.857 177.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.644 ' HB2' ' OD1' ' B' ' 31' ' ' ASP . 4.5 mptt -75.1 -52.34 11.26 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -177.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.416 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -65.25 -26.94 68.32 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.848 176.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.828 ' O ' HG13 ' B' ' 39' ' ' VAL . 4.0 tmm_? -62.68 -65.09 0.74 Allowed 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.581 ' HG3' HG13 ' B' ' 37' ' ' VAL . 7.8 ptmm? -53.17 -58.33 7.42 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.308 0.575 . . . . 0.0 112.318 -178.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.776 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 5.6 m -56.83 -30.28 32.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.863 -171.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.494 ' O ' ' HG2' ' B' ' 42' ' ' MET . 0.1 OUTLIER -85.02 -31.49 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 119.891 -0.723 . . . . 0.0 111.438 178.795 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.828 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.4 m -68.33 -47.93 75.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.931 175.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.609 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 42.6 mt-10 -67.94 -22.92 65.03 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.392 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.776 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -85.42 -55.3 4.08 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.127 175.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' MET . . . . . 0.573 ' HB2' HD21 ' B' ' 21' ' ' LEU . 17.9 mmt -63.7 -20.46 65.74 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.585 0.707 . . . . 0.0 109.844 -176.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.616 ' HB2' ' CD1' ' B' ' 69' ' ' ILE . . . -47.74 -30.27 3.76 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.744 171.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' TYR . . . . . 0.548 ' CG ' ' HB2' ' B' ' 52' ' ' GLN . 7.8 t80 -105.66 -66.92 0.95 Allowed 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 176.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.634 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 3.8 mm-40 -47.0 -34.11 5.31 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 124.504 1.128 . . . . 0.0 111.997 -173.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.746 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 5.2 m-20 -102.53 -20.83 14.34 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.256 -174.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -60.54 -179.28 0.11 Allowed 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 122.058 0.932 . . . . 0.0 113.035 -173.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' ASN . . . . . 0.608 ' HB3' ' OE1' ' B' ' 50' ' ' GLU . 14.6 m-20 -61.62 141.77 94.69 Favored Pre-proline 0 N--CA 1.442 -0.847 0 CA-C-N 114.366 -1.288 . . . . 0.0 109.144 174.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -55.33 -22.46 33.51 Favored 'Trans proline' 0 C--O 1.218 -0.512 0 C-N-CA 123.408 2.739 . . . . 0.0 112.757 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . 0.714 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 12.5 pm0 -89.45 -31.24 17.8 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 123.576 0.75 . . . . 0.0 110.648 175.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.714 ' N ' ' HG2' ' B' ' 50' ' ' GLU . 91.7 m -82.82 -37.5 24.36 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.503 -170.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . 0.601 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.7 pt20 -70.3 -29.74 66.55 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 172.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' SER . . . . . 0.429 ' O ' ' HE2' ' B' ' 56' ' ' LYS . 11.3 m -71.24 -19.76 62.33 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 113.749 -1.568 . . . . 0.0 110.248 174.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' B' ' 51' ' ' CYS . . . -78.62 -25.37 45.11 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.484 -0.76 . . . . 0.0 109.756 167.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.602 HD11 ' CE2' ' B' ' 14' ' ' TYR . 22.6 mt -89.81 -32.63 5.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -171.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.595 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -39.74 -38.29 0.9 Allowed Pre-proline 0 N--CA 1.491 1.609 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -174.423 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 51.6 Cg_endo -63.51 -29.74 71.01 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.169 1.913 . . . . 0.0 112.704 175.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . 0.561 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.5 mt -98.65 -15.81 19.28 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . 0.646 ' HD3' ' CG2' ' A' ' 5' ' ' THR . 0.1 OUTLIER -51.01 109.57 0.34 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.244 -178.257 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . 0.42 ' HA3' ' C ' ' A' ' 1' ' ' PRO . . . 90.47 -21.13 33.84 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.971 -178.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -103.12 113.19 26.46 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.191 0.52 . . . . 0.0 109.893 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.476 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.3 p -123.71 149.11 58.22 Favored Pre-proline 0 C--N 1.308 -1.208 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.564 172.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo . . . . . 0 N--CA 1.46 -0.472 0 C-N-CA 122.066 1.844 . . . . 0.0 110.774 164.546 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' ASP . . . . . 0.603 ' OD2' ' HB3' ' B' ' 70' ' ' SER . 0.4 OUTLIER . . . . . 0 N--CA 1.441 -0.917 0 N-CA-C 111.216 0.08 . . . . 0.0 111.216 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.542 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.9 OUTLIER -81.76 -33.04 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.505 0 C-N-CA 118.612 -1.235 . . . . 0.0 108.641 173.818 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.788 ' O ' HG13 ' B' ' 73' ' ' VAL . 10.9 mm -56.12 -50.04 72.53 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.366 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.528 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.603 ' HB3' ' OD2' ' B' ' 67' ' ' ASP . 32.6 t -54.79 -28.82 51.89 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.124 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -85.79 -33.3 21.42 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.455 0.645 . . . . 0.0 110.134 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' TYR . . . . . 0.634 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.1 m-30 -75.46 -35.1 60.96 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.48 -177.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.791 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.4 m -70.81 -32.0 47.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 172.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' LYS . . . . . 0.553 ' O ' ' HB3' ' B' ' 77' ' ' ASP . 0.0 OUTLIER -67.75 -30.98 70.59 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.34 175.223 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -63.1 -46.74 85.9 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.975 176.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.627 ' SG ' ' HB2' ' B' ' 14' ' ' TYR . 28.0 t -92.39 9.61 33.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.075 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . 0.553 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 3.1 t70 . . . . . 0 C--N 1.32 -0.69 0 CA-C-O 121.072 0.463 . . . . 0.0 110.8 174.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.424 ' C ' ' HA3' ' B' ' 60' ' ' GLY . 71.9 Cg_endo . . . . . 0 CA--C 1.517 -0.365 0 N-CA-C 109.219 -1.108 . . . . 0.0 109.219 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.55 ' HB2' HG23 ' A' ' 5' ' ' THR . 42.6 m -69.79 169.37 13.13 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 161.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.825 ' HE1' HD12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -65.55 -53.29 44.14 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 122.391 1.091 . . . . 0.0 109.633 175.496 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.553 ' HB2' HD11 ' A' ' 21' ' ' LEU . 3.2 p-10 -87.57 4.74 42.49 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 113.418 -1.719 . . . . 0.0 113.569 -161.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.675 ' CG2' ' HD3' ' B' ' 59' ' ' LYS . 0.9 OUTLIER -62.63 0.6 0.48 Allowed 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.066 0.46 . . . . 0.0 112.134 -175.322 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.571 ' HB ' ' CZ ' ' A' ' 20' ' ' ARG . 3.0 m -72.05 115.33 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 CA-C-O 121.908 0.861 . . . . 0.0 109.317 168.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.621 ' HG3' ' HB3' ' A' ' 46' ' ' ASN . 1.1 mpp_? -114.23 158.66 21.09 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 121.517 0.675 . . . . 0.0 110.989 177.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.468 ' HG2' ' HB3' ' A' ' 12' ' ' GLU . 2.2 tt0 -59.8 116.04 3.81 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.735 171.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.9 -156.75 26.28 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.378 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.46 ' C ' ' HD3' ' A' ' 11' ' ' LYS . 21.5 m -50.45 99.72 0.02 OUTLIER 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.774 0.287 . . . . 0.0 111.198 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.46 ' HD3' ' C ' ' A' ' 10' ' ' SER . 0.0 OUTLIER 35.66 48.89 0.49 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.583 1.153 . . . . 0.0 111.988 -171.629 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.468 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 36.4 tt0 -62.4 136.86 95.96 Favored Pre-proline 0 C--O 1.233 0.227 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.576 178.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.553 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 38.9 Cg_exo -52.15 122.08 10.0 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.043 1.829 . . . . 0.0 109.735 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.886 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 27.4 t80 -72.7 -53.18 5.73 Favored Pre-proline 0 N--CA 1.437 -1.117 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -166.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.527 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 31.7 Cg_exo -55.07 -17.63 15.15 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 121.4 1.4 . . . . 0.0 110.692 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.553 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.0 OUTLIER -90.29 -44.11 9.92 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 113.98 -1.464 . . . . 0.0 111.089 178.178 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.436 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -53.71 -43.36 68.95 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 175.139 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.795 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 2.2 p -82.84 -35.47 12.39 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.325 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.867 -177.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.58 -33.78 70.35 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 121.316 -0.865 . . . . 0.0 111.819 177.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.706 ' O ' HG12 ' A' ' 24' ' ' VAL . 16.3 ptt180 -83.7 -27.54 28.94 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 176.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.558 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 7.4 tp -55.87 -47.57 77.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.605 -1.18 . . . . 0.0 108.87 171.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.795 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 25.4 mt-30 -70.13 -46.85 63.93 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.179 176.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.719 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 16.8 t70 -47.12 -54.33 10.76 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 124.289 0.993 . . . . 0.0 111.692 -178.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.706 HG12 ' O ' ' A' ' 20' ' ' ARG . 6.8 p -82.0 -23.54 9.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.197 0.522 . . . . 0.0 109.94 -174.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.801 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -71.32 -18.99 62.37 Favored 'General case' 0 C--O 1.204 -1.295 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 173.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.41 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -87.23 -38.88 15.94 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.955 177.559 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.719 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.4 mmtt -67.02 -39.46 87.05 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.752 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.6 m -98.01 -10.52 24.27 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.027 0.441 . . . . 0.0 110.63 -172.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.801 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 79.5 mt -116.11 129.91 71.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.795 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.01 -5.83 49.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.526 0.679 . . . . 0.0 110.136 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.601 ' H ' HG22 ' A' ' 29' ' ' ILE . 2.3 m-20 -102.51 107.33 18.25 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.067 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -53.6 -29.24 36.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.775 0.322 . . . . 0.0 110.446 175.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.552 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -68.36 -52.81 29.13 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.478 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.597 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -66.76 -23.57 66.1 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.246 178.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.836 ' O ' HG13 ' A' ' 39' ' ' VAL . 2.1 tmm_? -68.77 -58.55 4.04 Favored 'General case' 0 C--O 1.219 -0.503 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -53.38 -60.54 3.16 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.81 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 21.0 m -52.31 -34.57 18.58 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.952 -171.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.825 HD12 ' HE1' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -84.8 -33.85 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -177.218 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.836 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.7 m -72.36 -47.4 52.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 119.65 -0.82 . . . . 0.0 108.999 177.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.655 ' HG2' HG22 ' A' ' 68' ' ' VAL . 65.8 mt-10 -60.28 -26.07 66.2 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.971 0.908 . . . . 0.0 111.457 172.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.81 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -81.8 -61.68 1.85 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 178.654 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.598 ' HE3' ' HG ' ' B' ' 41' ' ' LEU . 20.1 mmt -62.79 -20.56 65.13 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.484 -177.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.728 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -49.29 -25.38 2.34 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.394 169.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.493 ' CD1' ' HB2' ' A' ' 52' ' ' GLN . 16.1 t80 -108.31 -66.44 1.04 Allowed 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 175.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.5 ' CG ' HD12 ' A' ' 41' ' ' LEU . 8.4 mm-40 -48.25 -32.47 7.28 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 123.799 0.687 . . . . 0.0 112.492 -175.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.621 ' HB3' ' HG3' ' A' ' 7' ' ' ARG . 4.9 m-20 -106.33 -11.5 15.97 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.534 0.683 . . . . 0.0 111.226 -176.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.728 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -62.53 168.53 3.59 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.496 0.665 . . . . 0.0 110.768 177.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.565 ' HB3' ' OE1' ' A' ' 50' ' ' GLU . 8.9 m-20 -57.38 144.45 71.17 Favored Pre-proline 0 C--N 1.31 -1.144 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.482 175.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.46 -19.29 28.48 Favored 'Trans proline' 0 C--O 1.219 -0.434 0 C-N-CA 122.92 2.413 . . . . 0.0 112.055 -179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.693 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 10.1 pm0 -90.87 -32.34 16.08 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.214 0.606 . . . . 0.0 110.531 174.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.935 ' SG ' ' HB2' ' A' ' 76' ' ' CYS . 37.3 t -85.1 -37.28 20.45 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.873 -171.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.549 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.5 pt20 -67.18 -26.72 66.78 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 172.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.598 ' O ' ' HD2' ' A' ' 56' ' ' LYS . 9.3 m -72.47 -22.55 61.06 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 113.141 -1.845 . . . . 0.0 110.916 174.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.37 -23.75 46.74 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.411 0.624 . . . . 0.0 109.527 168.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.549 HD12 ' HA ' ' A' ' 52' ' ' GLN . 24.7 mt -91.24 -33.22 5.6 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.151 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -172.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.616 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.57 -39.87 2.71 Favored Pre-proline 0 N--CA 1.493 1.688 0 CA-C-N 119.909 1.232 . . . . 0.0 113.757 -175.389 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 51.2 Cg_endo -62.6 -25.32 75.41 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 122.328 2.018 . . . . 0.0 113.045 175.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.528 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.1 mt -104.02 -15.86 15.47 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.652 ' HD3' ' CG2' ' B' ' 5' ' ' THR . 0.1 OUTLIER -50.47 109.09 0.27 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.192 -179.099 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.405 ' HA3' ' C ' ' B' ' 1' ' ' PRO . . . 89.69 -19.01 43.43 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.31 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.0 mmmt -103.7 114.65 29.07 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.162 0.506 . . . . 0.0 110.167 -178.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.463 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.6 p -123.38 143.97 42.69 Favored Pre-proline 0 C--N 1.312 -1.03 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.113 173.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo . . . . . 0 C--N 1.343 0.269 0 C-N-CA 122.538 2.158 . . . . 0.0 111.669 168.342 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.517 -0.294 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.655 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -78.63 -28.51 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 C-N-CA 118.934 -1.106 . . . . 0.0 108.622 178.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.757 ' O ' HG13 ' A' ' 73' ' ' VAL . 6.8 mm -60.4 -45.95 95.9 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.133 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.277 -178.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 41.7 t -48.24 -36.18 13.44 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.143 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 74' ' ' LYS . 2.0 mm-40 -86.27 -31.53 21.59 Favored 'General case' 0 C--O 1.216 -0.672 0 C-N-CA 123.31 0.644 . . . . 0.0 111.074 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.532 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.0 m-30 -76.27 -33.79 59.14 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.626 0.727 . . . . 0.0 109.285 -177.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.886 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 2.1 m -73.01 -32.63 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 173.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 70' ' ' SER . 1.8 ttmm -66.45 -30.71 71.12 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.13 -1.395 . . . . 0.0 110.0 175.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -62.52 -45.44 92.95 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.784 175.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.935 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 42.2 t -93.34 9.17 37.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.044 177.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.484 ' HB2' ' HA ' ' A' ' 74' ' ' LYS . 21.8 t70 . . . . . 0 C--N 1.321 -0.671 0 CA-C-O 121.442 0.639 . . . . 0.0 109.699 173.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 1' ' ' PRO . . . . . 0.405 ' C ' ' HA3' ' A' ' 60' ' ' GLY . 72.0 Cg_endo . . . . . 0 CA--C 1.515 -0.43 0 N-CA-C 109.148 -1.135 . . . . 0.0 109.148 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . 0.57 ' HB2' HG23 ' B' ' 5' ' ' THR . 43.0 m -69.79 169.71 12.47 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 161.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.863 ' HE1' HD12 ' B' ' 38' ' ' ILE . 0.0 OUTLIER -65.65 -53.11 45.88 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 122.351 1.072 . . . . 0.0 109.683 175.316 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.55 ' HB2' HD11 ' B' ' 21' ' ' LEU . 3.2 p-10 -87.75 4.9 42.49 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.51 -1.677 . . . . 0.0 113.58 -161.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.652 ' CG2' ' HD3' ' A' ' 59' ' ' LYS . 0.9 OUTLIER -62.9 0.71 0.5 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.123 0.487 . . . . 0.0 112.036 -175.165 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.566 ' HB ' ' CZ ' ' B' ' 20' ' ' ARG . 3.0 m -72.18 115.06 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 CA-C-O 121.904 0.859 . . . . 0.0 109.284 168.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.608 ' HG3' ' CB ' ' B' ' 46' ' ' ASN . 1.1 mpp_? -114.0 158.52 21.06 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 121.593 0.711 . . . . 0.0 110.949 177.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' GLN . . . . . 0.462 ' HG2' ' HB3' ' B' ' 12' ' ' GLU . 2.2 tt0 -59.64 116.1 3.79 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.702 171.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.99 -156.95 26.88 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.483 174.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . 0.477 ' C ' ' HD3' ' B' ' 11' ' ' LYS . 23.4 m -50.29 100.05 0.02 OUTLIER 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.71 0.255 . . . . 0.0 111.086 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . 0.477 ' HD3' ' C ' ' B' ' 10' ' ' SER . 0.0 OUTLIER 35.17 49.57 0.45 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.545 1.138 . . . . 0.0 111.865 -171.59 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.462 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 36.1 tt0 -62.78 136.87 96.55 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.555 177.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . 0.551 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 37.8 Cg_exo -52.09 121.99 9.8 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 121.991 1.794 . . . . 0.0 109.703 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' TYR . . . . . 0.893 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 27.4 t80 -72.64 -53.32 5.75 Favored Pre-proline 0 N--CA 1.437 -1.105 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -166.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.534 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 31.8 Cg_exo -54.97 -17.84 15.23 Favored 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 121.382 1.388 . . . . 0.0 110.573 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.551 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 0.9 OUTLIER -90.2 -43.74 10.22 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.111 -1.404 . . . . 0.0 111.196 178.146 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' PHE . . . . . 0.429 ' CD2' ' N ' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -53.93 -43.41 69.76 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 175.069 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.791 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 2.2 p -82.68 -35.61 12.68 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.378 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.761 -177.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.46 -33.76 70.1 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 121.308 -0.87 . . . . 0.0 111.871 177.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.692 ' O ' HG12 ' B' ' 24' ' ' VAL . 16.4 ptt180 -83.73 -27.52 28.9 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 176.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.573 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 7.4 tp -56.0 -47.24 78.13 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.882 171.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' GLN . . . . . 0.791 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 25.6 mt-30 -70.49 -46.87 62.91 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.163 176.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.736 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 17.2 t70 -47.09 -54.29 10.77 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 124.304 1.002 . . . . 0.0 111.761 -178.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' VAL . . . . . 0.692 HG12 ' O ' ' B' ' 20' ' ' ARG . 6.8 p -82.1 -23.3 9.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.157 0.503 . . . . 0.0 109.869 -174.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.791 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -71.44 -18.91 62.3 Favored 'General case' 0 C--O 1.205 -1.284 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . 0.407 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -87.18 -39.03 15.85 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.015 177.497 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.736 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.3 mmtt -66.85 -39.44 87.58 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.736 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 58.3 m -98.02 -10.48 24.33 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.106 0.479 . . . . 0.0 110.517 -172.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.791 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 79.5 mt -116.24 130.49 70.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.775 -178.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.95 -5.08 48.56 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.637 0.732 . . . . 0.0 110.014 176.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.594 ' H ' HG22 ' B' ' 29' ' ' ILE . 2.4 m-20 -102.64 106.95 17.71 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.253 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -53.42 -29.1 33.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.68 0.276 . . . . 0.0 110.449 175.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.562 ' O ' HG13 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -68.39 -52.81 28.91 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.447 -179.569 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.596 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -66.77 -23.59 66.1 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.248 178.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.865 ' O ' HG13 ' B' ' 39' ' ' VAL . 2.1 tmm_? -68.78 -58.42 4.22 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 29.7 mtpt -53.55 -60.39 3.37 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.879 177.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.812 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 20.9 m -52.42 -34.38 18.72 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 O-C-N 124.324 1.015 . . . . 0.0 110.978 -171.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.863 HD12 ' HE1' ' B' ' 3' ' ' PHE . 0.0 OUTLIER -84.78 -34.08 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -177.309 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.865 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.7 m -72.2 -47.5 53.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.012 177.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.642 ' HG2' HG22 ' B' ' 68' ' ' VAL . 66.2 mt-10 -60.33 -25.9 66.15 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.907 0.883 . . . . 0.0 111.472 172.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.812 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -82.03 -61.59 1.87 Allowed 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.992 178.734 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' MET . . . . . 0.537 ' HE3' ' HG ' ' A' ' 41' ' ' LEU . 20.1 mmt -62.83 -20.56 65.18 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.482 -177.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.71 ' O ' ' HB2' ' B' ' 47' ' ' ALA . . . -49.31 -25.4 2.38 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.406 169.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' TYR . . . . . 0.498 ' CD1' ' HB2' ' B' ' 52' ' ' GLN . 16.1 t80 -108.22 -66.44 1.04 Allowed 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 175.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.498 ' CG ' HD12 ' B' ' 41' ' ' LEU . 8.6 mm-40 -48.26 -32.83 7.78 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 123.856 0.723 . . . . 0.0 112.381 -175.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.608 ' CB ' ' HG3' ' B' ' 7' ' ' ARG . 4.9 m-20 -105.93 -11.46 16.18 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.472 0.653 . . . . 0.0 111.284 -176.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.71 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -62.57 168.6 3.56 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.391 0.615 . . . . 0.0 110.779 177.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' ASN . . . . . 0.55 ' HB3' ' OE1' ' B' ' 50' ' ' GLU . 8.5 m-20 -57.39 144.47 71.17 Favored Pre-proline 0 C--N 1.31 -1.139 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.466 175.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -56.62 -19.2 29.06 Favored 'Trans proline' 0 C--O 1.218 -0.48 0 C-N-CA 122.963 2.442 . . . . 0.0 112.029 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . 0.697 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 10.1 pm0 -90.83 -32.29 16.13 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 123.205 0.602 . . . . 0.0 110.644 174.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.94 ' SG ' ' HB2' ' B' ' 76' ' ' CYS . 37.5 t -85.16 -37.4 20.23 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.885 -171.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . 0.534 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.5 pt20 -66.95 -26.71 66.97 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 172.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' SER . . . . . 0.6 ' O ' ' HD2' ' B' ' 56' ' ' LYS . 8.9 m -72.61 -22.53 60.95 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 113.247 -1.797 . . . . 0.0 110.902 174.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.22 -23.81 47.31 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.493 0.663 . . . . 0.0 109.586 168.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.534 HD12 ' HA ' ' B' ' 52' ' ' GLN . 25.0 mt -91.09 -33.37 5.73 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.137 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -172.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.615 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.5 -39.76 2.56 Favored Pre-proline 0 N--CA 1.492 1.649 0 CA-C-N 119.925 1.239 . . . . 0.0 113.749 -175.34 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 51.0 Cg_endo -62.71 -25.32 74.98 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.245 1.964 . . . . 0.0 113.002 175.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . 0.541 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.2 mt -104.02 -15.81 15.49 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . 0.675 ' HD3' ' CG2' ' A' ' 5' ' ' THR . 0.1 OUTLIER -50.46 109.12 0.27 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.702 -1.135 . . . . 0.0 111.281 -179.207 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . 0.424 ' HA3' ' C ' ' A' ' 1' ' ' PRO . . . 89.99 -19.7 40.58 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.276 -178.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -103.21 114.81 29.4 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.099 0.476 . . . . 0.0 110.027 -178.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.465 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.8 p -123.25 144.35 43.43 Favored Pre-proline 0 C--N 1.31 -1.125 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.94 172.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo . . . . . 0 C--N 1.345 0.371 0 C-N-CA 122.521 2.148 . . . . 0.0 111.667 168.217 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' ASP . . . . . 0.43 ' OD1' ' HB ' ' B' ' 69' ' ' ILE . 0.8 OUTLIER . . . . . 0 CA--C 1.517 -0.321 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.642 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.8 OUTLIER -78.48 -28.28 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 C-N-CA 119.006 -1.078 . . . . 0.0 108.568 179.08 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.756 ' O ' HG13 ' B' ' 73' ' ' VAL . 6.8 mm -60.44 -45.81 96.2 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.084 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.391 -178.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.501 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 43.2 t -48.54 -36.16 14.82 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.077 176.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' B' ' 74' ' ' LYS . 2.3 mm-40 -86.28 -31.38 21.65 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 123.211 0.604 . . . . 0.0 110.998 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 72' ' ' TYR . . . . . 0.541 ' CE1' ' HB2' ' B' ' 58' ' ' LEU . 5.0 m-30 -76.23 -34.13 59.21 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.654 0.74 . . . . 0.0 109.298 -177.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.893 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 2.1 m -72.67 -33.1 43.47 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 173.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' LYS . . . . . 0.501 ' HB2' ' O ' ' B' ' 70' ' ' SER . 1.8 ttmm -65.87 -30.89 71.57 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.052 175.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -62.36 -45.52 92.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.754 175.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.94 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 41.9 t -93.5 9.14 37.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.089 177.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . 0.488 ' HB2' ' HA ' ' B' ' 74' ' ' LYS . 19.9 t70 . . . . . 0 C--N 1.322 -0.622 0 CA-C-O 121.388 0.613 . . . . 0.0 109.515 174.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.44 ' HB2' ' H ' ' A' ' 2' ' ' SER . 92.3 Cg_endo . . . . . 0 CA--C 1.517 -0.326 0 N-CA-C 109.005 -1.19 . . . . 0.0 109.005 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.756 ' HB2' HG23 ' A' ' 5' ' ' THR . 70.7 m -72.13 178.9 3.56 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 162.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.773 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -76.13 -52.45 10.09 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.8 0.809 . . . . 0.0 110.125 174.445 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.503 ' OD1' ' HG ' ' B' ' 41' ' ' LEU . 2.5 p-10 -87.61 2.93 49.57 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.403 -163.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.756 HG23 ' HB2' ' A' ' 2' ' ' SER . 3.1 p -63.51 -3.12 1.9 Allowed 'General case' 0 C--N 1.311 -1.078 0 O-C-N 122.059 -0.4 . . . . 0.0 111.832 -175.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.555 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 3.3 m -76.49 119.03 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-O 121.677 0.751 . . . . 0.0 109.924 176.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.767 ' HB3' ' O ' ' A' ' 46' ' ' ASN . 32.2 mtm180 -137.58 147.2 44.87 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -170.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.6 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.6 mt-30 -42.02 120.66 1.62 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 112.633 -2.076 . . . . 0.0 113.745 177.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.53 -159.04 35.01 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 169.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.8 t -48.44 101.46 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 117.086 0.443 . . . . 0.0 111.231 -178.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.4 pttt 37.71 42.1 0.37 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.251 1.02 . . . . 0.0 112.084 -173.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.479 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 39.5 tt0 -57.16 137.5 80.54 Favored Pre-proline 0 C--O 1.233 0.226 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.602 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 52.1 Cg_exo -49.31 121.22 6.66 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.056 1.837 . . . . 0.0 109.947 -178.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.834 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 11.3 t80 -71.89 -52.85 7.44 Favored Pre-proline 0 N--CA 1.438 -1.047 0 CA-C-O 118.512 -0.756 . . . . 0.0 113.028 -166.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.538 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 36.4 Cg_exo -55.79 -18.39 21.27 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 121.346 1.364 . . . . 0.0 110.728 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.602 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 0.9 OUTLIER -90.34 -42.35 10.99 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.317 179.66 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.6 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -54.82 -43.64 73.16 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 175.647 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.686 HG12 ' O ' ' A' ' 14' ' ' TYR . 2.7 p -82.78 -32.35 9.89 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.941 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.845 -177.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.99 -35.46 73.25 Favored 'General case' 0 C--N 1.317 -0.84 0 O-C-N 121.285 -0.885 . . . . 0.0 111.839 175.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.709 ' O ' HG12 ' A' ' 24' ' ' VAL . 16.7 ptt180 -81.9 -27.26 33.51 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 176.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.588 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 6.7 tp -57.1 -48.14 79.33 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.215 172.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.679 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 40.7 mt-30 -70.91 -44.66 65.77 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.191 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.762 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -48.89 -64.06 0.91 Allowed 'General case' 0 C--N 1.314 -0.961 0 O-C-N 124.426 1.079 . . . . 0.0 110.206 -178.622 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.709 HG12 ' O ' ' A' ' 20' ' ' ARG . 4.2 p -74.0 -20.34 17.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -171.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.622 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -64.33 -35.82 82.11 Favored 'General case' 0 C--O 1.206 -1.195 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 172.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.405 ' HB3' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -75.1 -34.99 61.79 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 113.631 -1.622 . . . . 0.0 109.896 -176.641 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.762 ' HD2' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -65.04 -44.81 87.87 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 121.972 0.891 . . . . 0.0 112.0 177.09 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.456 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 24.7 m -95.97 -9.17 31.8 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.515 -168.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.626 HG22 ' H ' ' A' ' 31' ' ' ASP . 84.8 mt -116.91 128.27 74.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.919 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.11 -2.2 56.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.42 0.628 . . . . 0.0 110.141 175.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.626 ' H ' HG22 ' A' ' 29' ' ' ILE . 2.7 m-20 -106.92 104.16 13.77 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.105 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -53.36 -27.59 24.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.664 0.268 . . . . 0.0 110.466 176.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.569 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -67.93 -54.38 19.14 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.675 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.644 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -65.28 -22.7 66.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.44 178.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.886 ' O ' HG13 ' A' ' 39' ' ' VAL . 5.3 tmm_? -69.82 -55.81 8.79 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.491 ' O ' HG22 ' A' ' 39' ' ' VAL . 21.7 mtpt -56.97 -57.55 12.03 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.98 177.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.728 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 19.8 m -54.48 -34.2 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.736 -169.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.773 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.5 tt -86.97 -28.84 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 119.649 -0.821 . . . . 0.0 111.568 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.886 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.7 m -69.61 -49.07 61.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 119.031 -1.067 . . . . 0.0 109.508 173.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.622 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 60.4 mt-10 -61.81 -28.34 69.4 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 123.556 0.742 . . . . 0.0 112.233 176.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.728 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -85.58 -52.55 5.74 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.72 178.574 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.666 ' HE2' ' HE2' ' B' ' 42' ' ' MET . 19.6 mmt -65.57 -20.72 66.44 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.667 0.746 . . . . 0.0 109.602 -177.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.687 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -50.46 -28.11 7.74 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.463 170.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.524 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 23.1 t80 -105.15 -68.4 0.86 Allowed 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 175.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.469 ' CG ' HD12 ' A' ' 41' ' ' LEU . 10.9 mm-40 -48.88 -29.82 5.12 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.829 -176.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.767 ' O ' ' HB3' ' A' ' 7' ' ' ARG . 4.2 m-20 -106.53 -16.12 14.61 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 120.718 0.295 . . . . 0.0 111.659 -176.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -65.45 179.25 0.81 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.588 0.708 . . . . 0.0 111.539 -177.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.748 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 24.2 m-20 -58.63 145.67 76.47 Favored Pre-proline 0 C--N 1.31 -1.148 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.21 171.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.795 ' O ' ' HB3' ' A' ' 53' ' ' SER . 11.1 Cg_endo -55.53 -28.96 67.29 Favored 'Trans proline' 0 C--N 1.331 -0.345 0 C-N-CA 122.987 2.458 . . . . 0.0 111.897 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.672 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 8.4 pm0 -87.4 -26.57 23.24 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.398 1.079 . . . . 0.0 111.066 175.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.748 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 86.8 m -80.21 -38.24 31.56 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -177.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.523 ' HB2' ' CD1' ' A' ' 44' ' ' TYR . 4.1 pt20 -73.17 -27.35 61.6 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 172.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.795 ' HB3' ' O ' ' A' ' 49' ' ' PRO . 0.9 OUTLIER -67.91 -23.73 65.13 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.437 174.33 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -83.83 -23.47 31.36 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.862 172.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.54 HD11 ' CE2' ' A' ' 14' ' ' TYR . 22.7 mt -90.83 -32.56 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -173.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.655 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -45.92 -34.11 2.67 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -175.06 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.655 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 37.4 Cg_endo -60.61 -29.89 89.4 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.323 2.015 . . . . 0.0 112.946 172.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.552 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.1 mt -102.05 -15.34 16.79 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -178.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.589 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -52.84 109.83 0.45 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.899 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.09 -23.81 31.59 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.407 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.0 mmmt -103.38 111.94 24.6 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.373 0.606 . . . . 0.0 109.914 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.427 HG23 ' HD2' ' A' ' 63' ' ' PRO . 7.4 p -123.81 146.22 49.97 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 170.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.427 ' HD2' HG23 ' A' ' 62' ' ' VAL . 92.0 Cg_exo . . . . . 0 C--N 1.344 0.314 0 C-N-CA 122.194 1.929 . . . . 0.0 111.245 168.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.706 ' OD1' ' HB ' ' A' ' 69' ' ' ILE . 26.7 t70 . . . . . 0 CA--C 1.518 -0.281 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.605 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -81.44 -30.09 10.87 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 C-N-CA 119.035 -1.066 . . . . 0.0 109.089 176.447 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.76 ' O ' HG13 ' A' ' 73' ' ' VAL . 8.5 mm -58.09 -47.37 87.13 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.168 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.825 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 43.6 t -45.58 -37.54 5.62 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.394 175.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -85.36 -32.83 22.21 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.262 0.553 . . . . 0.0 110.629 -178.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.614 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.0 m-30 -76.06 -34.42 59.6 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.488 -175.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.834 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.6 m -72.57 -31.87 39.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.533 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -66.25 -31.65 72.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.075 175.46 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -62.93 -47.53 82.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.447 176.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.637 ' SG ' ' HB2' ' A' ' 14' ' ' TYR . 14.4 t -91.07 5.43 48.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.469 0.652 . . . . 0.0 111.059 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.533 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 9.6 t70 . . . . . 0 C--N 1.319 -0.751 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.318 175.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 1' ' ' PRO . . . . . 0.41 ' HB2' ' H ' ' B' ' 2' ' ' SER . 90.1 Cg_endo . . . . . 0 CA--C 1.515 -0.426 0 N-CA-C 108.937 -1.217 . . . . 0.0 108.937 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . 0.752 ' HB2' HG23 ' B' ' 5' ' ' THR . 71.2 m -71.52 178.72 3.34 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 162.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.752 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -76.13 -52.43 10.12 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.857 0.837 . . . . 0.0 110.079 174.444 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.483 ' OD1' ' HG ' ' A' ' 41' ' ' LEU . 2.5 p-10 -87.42 2.64 49.89 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.646 -1.161 . . . . 0.0 113.364 -163.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.752 HG23 ' HB2' ' B' ' 2' ' ' SER . 3.6 p -63.31 -3.06 1.69 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 118.057 0.389 . . . . 0.0 111.779 -175.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.561 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 3.3 m -76.48 118.96 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-O 121.678 0.751 . . . . 0.0 110.008 176.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.76 ' HB3' ' O ' ' B' ' 46' ' ' ASN . 32.1 mtm180 -137.32 147.58 45.71 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -170.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' GLN . . . . . 0.601 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.6 mt-30 -42.62 121.1 1.89 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 112.616 -2.084 . . . . 0.0 113.494 177.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.67 -158.39 34.29 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 169.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 22.9 t -49.24 101.58 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 117.115 0.457 . . . . 0.0 110.988 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 49.1 pttt 37.56 42.3 0.35 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.419 1.088 . . . . 0.0 112.109 -173.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.505 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 38.1 tt0 -57.2 137.36 80.75 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . 0.594 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 52.1 Cg_exo -49.07 121.09 6.27 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.134 1.889 . . . . 0.0 109.992 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' TYR . . . . . 0.84 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 11.3 t80 -72.09 -52.66 7.24 Favored Pre-proline 0 N--CA 1.437 -1.1 0 CA-C-O 118.507 -0.758 . . . . 0.0 112.891 -166.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.541 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 36.0 Cg_exo -55.9 -18.37 21.79 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 121.42 1.413 . . . . 0.0 110.764 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.594 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 0.9 OUTLIER -90.61 -41.84 11.11 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.035 -1.439 . . . . 0.0 111.367 179.708 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' PHE . . . . . 0.601 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -55.34 -43.52 75.08 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 175.581 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.702 HG12 ' O ' ' B' ' 14' ' ' TYR . 2.7 p -82.89 -32.27 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.907 -177.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.42 -34.75 72.87 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 121.303 -0.873 . . . . 0.0 111.861 175.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.704 ' O ' HG12 ' B' ' 24' ' ' VAL . 16.7 ptt180 -82.09 -27.43 32.89 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 176.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.599 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 6.7 tp -57.03 -48.38 78.65 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.208 173.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' GLN . . . . . 0.693 ' HA ' ' CG1' ' B' ' 39' ' ' VAL . 40.7 mt-30 -70.79 -44.68 66.13 Favored 'General case' 0 CA--C 1.488 -1.435 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.089 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.751 ' O ' ' HD2' ' B' ' 27' ' ' LYS . 0.9 OUTLIER -48.8 -64.19 0.87 Allowed 'General case' 0 C--N 1.314 -0.943 0 O-C-N 124.39 1.056 . . . . 0.0 110.325 -178.7 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' VAL . . . . . 0.704 HG12 ' O ' ' B' ' 20' ' ' ARG . 4.1 p -73.82 -20.42 17.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -171.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.609 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -64.15 -36.0 82.62 Favored 'General case' 0 C--O 1.208 -1.12 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 172.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . 0.417 ' HB3' ' O ' ' B' ' 23' ' ' ASP . 0.0 OUTLIER -74.9 -35.18 62.25 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 113.62 -1.627 . . . . 0.0 109.903 -176.608 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.751 ' HD2' ' O ' ' B' ' 23' ' ' ASP . 0.0 OUTLIER -64.85 -45.03 87.81 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.898 177.177 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . 0.444 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 26.4 m -96.15 -8.68 32.55 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.602 -168.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.609 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 84.6 mt -116.94 128.68 74.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.837 -178.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.69 -1.87 56.51 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.499 0.666 . . . . 0.0 110.128 175.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.603 ' H ' HG22 ' B' ' 29' ' ' ILE . 2.8 m-20 -106.91 104.58 14.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.092 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -53.91 -27.36 30.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.715 0.293 . . . . 0.0 110.396 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.58 ' O ' HG13 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -67.93 -54.32 19.57 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.707 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.647 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -65.46 -22.71 66.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.385 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.866 ' O ' HG13 ' B' ' 39' ' ' VAL . 5.4 tmm_? -69.69 -55.89 8.72 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.483 ' O ' HG22 ' B' ' 39' ' ' VAL . 21.8 mtpt -56.98 -57.37 12.84 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 120.826 0.346 . . . . 0.0 110.936 177.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.714 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 20.0 m -54.71 -34.13 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.661 -169.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.752 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.4 tt -86.99 -29.11 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.51 -179.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.866 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.7 m -69.31 -49.19 62.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 119.089 -1.045 . . . . 0.0 109.574 173.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.623 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 61.8 mt-10 -61.72 -28.26 69.29 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 123.506 0.722 . . . . 0.0 112.26 176.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.714 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.67 -52.55 5.72 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.713 178.685 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' MET . . . . . 0.666 ' HE2' ' HE2' ' A' ' 42' ' ' MET . 19.5 mmt -65.6 -20.68 66.41 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.574 0.702 . . . . 0.0 109.491 -177.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.679 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -50.53 -28.17 8.03 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.415 170.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' TYR . . . . . 0.537 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 23.0 t80 -105.06 -68.38 0.86 Allowed 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.479 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 11.8 mm-40 -48.85 -29.8 5.06 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.925 -176.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.76 ' O ' ' HB3' ' B' ' 7' ' ' ARG . 4.1 m-20 -106.53 -16.06 14.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 120.702 0.287 . . . . 0.0 111.568 -176.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.637 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -65.29 179.61 0.73 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.819 0.818 . . . . 0.0 111.602 -177.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' ASN . . . . . 0.74 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 24.7 m-20 -58.99 145.54 79.7 Favored Pre-proline 0 C--N 1.309 -1.169 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.242 171.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . 0.808 ' O ' ' HB3' ' B' ' 53' ' ' SER . 11.1 Cg_endo -55.57 -28.92 67.46 Favored 'Trans proline' 0 C--N 1.332 -0.325 0 C-N-CA 123.026 2.484 . . . . 0.0 111.917 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . 0.669 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 8.4 pm0 -87.26 -26.7 23.34 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.429 1.091 . . . . 0.0 111.133 175.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.74 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 86.2 m -80.18 -38.17 31.82 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -177.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . 0.513 ' HB2' ' CD1' ' B' ' 44' ' ' TYR . 4.0 pt20 -73.14 -27.36 61.63 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 172.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' SER . . . . . 0.808 ' HB3' ' O ' ' B' ' 49' ' ' PRO . 0.9 OUTLIER -68.12 -23.5 64.91 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.429 174.54 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.12 -23.31 30.77 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.863 172.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.544 HD11 ' CE2' ' B' ' 14' ' ' TYR . 22.6 mt -90.79 -32.73 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -174.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.646 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -45.93 -34.06 2.64 Favored Pre-proline 0 N--CA 1.487 1.388 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 -175.02 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 37.3 Cg_endo -60.24 -30.95 92.32 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 122.303 2.002 . . . . 0.0 112.902 172.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . 0.556 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.1 mt -101.17 -15.59 17.31 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -178.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . 0.584 ' HA ' ' OH ' ' B' ' 72' ' ' TYR . 0.0 OUTLIER -52.64 109.8 0.44 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.948 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.16 -23.55 32.87 Favored Glycine 0 N--CA 1.44 -1.05 0 C-N-CA 120.768 -0.73 . . . . 0.0 111.575 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -103.59 111.91 24.59 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.411 0.624 . . . . 0.0 109.927 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.426 HG23 ' HD2' ' B' ' 63' ' ' PRO . 7.5 p -123.91 146.06 49.74 Favored Pre-proline 0 C--N 1.311 -1.104 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 170.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . 0.426 ' HD2' HG23 ' B' ' 62' ' ' VAL . 91.3 Cg_exo . . . . . 0 N--CA 1.463 -0.308 0 C-N-CA 122.24 1.96 . . . . 0.0 111.248 168.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' ASP . . . . . 0.698 ' OD1' ' HB ' ' B' ' 69' ' ' ILE . 26.9 t70 . . . . . 0 CA--C 1.518 -0.252 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.615 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.9 OUTLIER -81.3 -30.12 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 C-N-CA 118.891 -1.123 . . . . 0.0 109.119 176.508 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.747 ' O ' HG13 ' B' ' 73' ' ' VAL . 8.5 mm -58.01 -47.31 87.02 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.179 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.814 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 42.7 t -45.84 -37.42 6.16 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.423 175.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -85.4 -32.7 22.23 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.085 0.469 . . . . 0.0 110.649 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 72' ' ' TYR . . . . . 0.61 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.0 m-30 -76.09 -34.49 59.53 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.502 -175.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.84 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.6 m -72.55 -32.03 39.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 173.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 74' ' ' LYS . . . . . 0.521 ' O ' ' HB3' ' B' ' 77' ' ' ASP . 0.0 OUTLIER -66.17 -31.36 72.15 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.029 175.422 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -63.07 -47.77 81.5 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.362 176.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.653 ' SG ' ' HB2' ' B' ' 14' ' ' TYR . 13.7 t -90.89 5.7 47.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.573 0.701 . . . . 0.0 111.179 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . 0.521 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 10.9 t70 . . . . . 0 C--N 1.318 -0.778 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.382 175.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.402 ' HB2' ' H ' ' A' ' 2' ' ' SER . 92.3 Cg_endo . . . . . 0 CA--C 1.517 -0.357 0 N-CA-C 109.414 -1.033 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.402 ' H ' ' HB2' ' A' ' 1' ' ' PRO . 48.0 m -66.61 169.0 8.34 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 162.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.881 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -72.7 -55.58 6.59 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.847 177.509 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.719 ' CG ' ' HG3' ' A' ' 42' ' ' MET . 11.7 p30 -87.69 -4.75 58.91 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.442 -164.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.402 ' H ' HG22 ' A' ' 5' ' ' THR . 6.7 t -63.15 -1.43 1.0 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.43 0.633 . . . . 0.0 110.945 -173.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.655 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.4 m -74.26 133.55 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 168.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.795 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -155.55 159.8 39.99 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 115.219 1.562 . . . . 0.0 115.219 -175.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.444 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.1 tt0 -40.34 110.52 0.15 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 112.835 -1.984 . . . . 0.0 112.714 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.33 -151.5 11.13 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.558 174.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.4 t -54.38 98.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.757 0.278 . . . . 0.0 110.58 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.9 pttt 40.07 44.3 1.46 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.321 1.048 . . . . 0.0 112.527 -175.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.429 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 67.2 tt0 -60.58 141.17 92.25 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 176.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.517 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 27.2 Cg_exo -55.37 123.36 13.62 Favored 'Trans proline' 0 CA--C 1.512 -0.615 0 C-N-CA 121.939 1.759 . . . . 0.0 109.694 177.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.915 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 7.2 t80 -68.98 -53.95 13.25 Favored Pre-proline 0 N--CA 1.44 -0.969 0 CA-C-O 118.421 -0.799 . . . . 0.0 113.025 -168.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.566 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 37.2 Cg_exo -56.01 -18.15 21.69 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 121.476 1.45 . . . . 0.0 111.197 -178.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.517 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 2.6 m-20 -89.97 -42.83 10.95 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.799 179.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.444 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -55.26 -45.78 76.1 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.332 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.795 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 2.1 p -78.05 -34.49 19.23 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.229 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.142 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.83 -39.36 71.29 Favored 'General case' 0 C--N 1.316 -0.887 0 O-C-N 121.663 -0.648 . . . . 0.0 111.078 176.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.754 ' O ' HG12 ' A' ' 24' ' ' VAL . 14.5 ptt180 -79.84 -27.74 40.17 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.592 ' HB3' ' O ' ' A' ' 18' ' ' VAL . 13.3 tp -54.98 -48.87 72.7 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 114.563 -1.198 . . . . 0.0 109.268 172.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.795 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 28.5 mt-30 -67.75 -55.66 12.24 Favored 'General case' 0 CA--C 1.486 -1.51 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.356 178.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.725 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 82.8 m-20 -45.71 -50.55 13.57 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 124.824 1.327 . . . . 0.0 111.258 -177.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.754 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.1 p -78.89 -26.19 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.834 -174.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.638 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -67.3 -31.45 71.76 Favored 'General case' 0 C--O 1.206 -1.196 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.22 -34.82 63.8 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.114 -1.403 . . . . 0.0 109.525 -178.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.725 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 39.0 mmtt -67.45 -40.33 85.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.823 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.457 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 35.4 m -100.45 -9.9 21.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.241 0.543 . . . . 0.0 110.547 -171.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.692 HG22 ' H ' ' A' ' 31' ' ' ASP . 83.4 mt -111.23 130.15 65.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.522 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.55 -3.07 58.48 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.906 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.692 ' H ' HG22 ' A' ' 29' ' ' ILE . 4.9 t0 -117.81 139.66 50.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.786 0.803 . . . . 0.0 111.918 -177.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -68.76 -31.39 70.4 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.334 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.588 ' O ' HG13 ' A' ' 37' ' ' VAL . 12.0 mttp -68.37 -53.37 24.41 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -176.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.578 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -64.22 -26.06 68.34 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.504 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.842 ' O ' HG13 ' A' ' 39' ' ' VAL . 4.7 tmm_? -68.15 -58.02 5.13 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.488 ' HB3' ' OE1' ' A' ' 40' ' ' GLU . 32.5 mtpt -53.45 -60.19 3.62 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.237 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.702 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 19.8 m -52.12 -33.9 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.374 -170.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.881 HD13 ' HE1' ' A' ' 3' ' ' PHE . 0.7 OUTLIER -88.35 -35.05 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.391 -179.782 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.842 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.9 m -66.18 -46.8 86.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 119.117 -1.033 . . . . 0.0 109.414 177.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.662 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 42.7 mt-10 -61.17 -31.63 71.36 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 123.953 0.901 . . . . 0.0 112.544 176.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.714 ' HG ' HD11 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -83.78 -52.88 6.03 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.378 -179.152 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.719 ' HG3' ' CG ' ' A' ' 4' ' ' ASN . 20.1 mmt -65.71 -20.84 66.43 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.642 0.734 . . . . 0.0 109.632 -176.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.693 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -50.47 -29.01 9.39 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.23 171.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.876 ' CG ' ' HE3' ' A' ' 59' ' ' LYS . 6.2 t80 -103.34 -66.7 0.92 Allowed 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 174.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.592 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 31.4 mm-40 -49.72 -29.76 8.11 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.992 -171.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.795 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.8 m-20 -104.37 -21.44 13.49 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.441 -176.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -61.36 179.75 0.2 Allowed 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.827 0.822 . . . . 0.0 112.923 -174.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.631 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 17.2 m-20 -62.31 141.67 96.22 Favored Pre-proline 0 N--CA 1.444 -0.742 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.587 173.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.426 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 80.0 Cg_exo -41.71 -50.48 4.88 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 123.093 2.529 . . . . 0.0 112.274 -178.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.617 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 0.0 OUTLIER -74.32 -26.54 60.23 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.769 0.828 . . . . 0.0 111.429 -179.268 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.631 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 72.1 m -79.89 -40.19 28.82 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -174.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.723 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.4 pt20 -69.42 -31.13 69.29 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 172.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.826 ' O ' ' HD2' ' A' ' 56' ' ' LYS . 4.2 m -67.71 -27.89 67.2 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 113.996 -1.456 . . . . 0.0 111.305 174.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.96 -23.31 62.2 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 170.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.723 HD12 ' HA ' ' A' ' 52' ' ' GLN . 25.0 mt -89.82 -27.52 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -175.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.826 ' HD2' ' O ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -37.53 -48.53 2.52 Favored Pre-proline 0 N--CA 1.506 2.368 0 CA-C-N 120.628 1.558 . . . . 0.0 112.675 -178.39 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 48.5 Cg_endo -61.45 -24.89 79.06 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.826 2.351 . . . . 0.0 112.796 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.527 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.6 mt -104.86 -15.45 15.17 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.876 ' HE3' ' CG ' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -50.7 109.96 0.37 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.812 -179.072 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.28 -19.23 44.48 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.075 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.9 mmmt -104.2 115.03 29.69 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -176.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.43 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.6 p -122.86 137.11 27.54 Favored Pre-proline 0 C--N 1.315 -0.899 0 C-N-CA 121.168 -0.213 . . . . 0.0 110.48 172.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo . . . . . 0 C--N 1.344 0.321 0 C-N-CA 122.849 2.366 . . . . 0.0 112.227 171.608 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.404 ' OD2' ' HB ' ' A' ' 69' ' ' ILE . 2.6 t70 . . . . . 0 CA--C 1.512 -0.509 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.583 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -78.49 -29.18 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 C-N-CA 118.792 -1.163 . . . . 0.0 108.879 179.83 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.791 ' O ' HG13 ' A' ' 73' ' ' VAL . 8.5 mm -61.12 -47.01 95.51 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.184 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.09 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.6 t -47.24 -37.83 11.17 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.98 177.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.422 ' HA ' ' HB3' ' A' ' 74' ' ' LYS . 3.3 mm-40 -86.08 -32.62 21.28 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 123.287 0.635 . . . . 0.0 111.094 -177.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.619 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.3 m-30 -74.88 -35.83 62.28 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.314 -177.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.915 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 2.3 m -70.41 -34.11 56.61 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 174.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.491 ' HA ' ' HB2' ' A' ' 77' ' ' ASP . 13.0 ttpp -70.47 -27.86 64.56 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.788 177.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -62.18 -44.65 96.13 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.047 -0.978 . . . . 0.0 109.398 173.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.528 ' SG ' ' HB2' ' A' ' 14' ' ' TYR . 39.3 t -96.04 9.31 41.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.332 178.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.491 ' HB2' ' HA ' ' A' ' 74' ' ' LYS . 10.7 t70 . . . . . 0 C--N 1.324 -0.528 0 CA-C-O 121.057 0.456 . . . . 0.0 110.507 175.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 1' ' ' PRO . . . . . 0.408 ' HB2' HG21 ' B' ' 5' ' ' THR . 96.3 Cg_endo . . . . . 0 CA--C 1.517 -0.366 0 N-CA-C 109.163 -1.13 . . . . 0.0 109.163 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 41.7 m -66.91 168.79 9.21 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 162.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.882 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -72.23 -55.72 6.74 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.812 177.632 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.718 ' CG ' ' HG3' ' B' ' 42' ' ' MET . 11.7 p30 -87.81 -4.67 58.86 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.332 -164.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.408 HG21 ' HB2' ' B' ' 1' ' ' PRO . 7.0 t -63.3 -1.42 1.08 Allowed 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.314 0.578 . . . . 0.0 110.87 -173.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.663 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.5 m -74.38 133.54 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 169.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.799 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -155.48 159.82 40.09 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 -175.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' GLN . . . . . 0.444 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.1 tt0 -40.27 110.38 0.15 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 112.921 -1.945 . . . . 0.0 112.786 -178.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.15 -151.5 10.76 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.631 174.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 22.7 t -54.27 99.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.837 0.319 . . . . 0.0 110.513 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 58.0 pttt 39.75 44.23 1.27 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.365 1.066 . . . . 0.0 112.485 -175.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.429 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 68.9 tt0 -60.78 140.94 93.11 Favored Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . 0.52 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 27.5 Cg_exo -55.33 123.43 13.8 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 121.855 1.703 . . . . 0.0 109.751 177.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' TYR . . . . . 0.924 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 7.2 t80 -68.94 -53.87 13.59 Favored Pre-proline 0 N--CA 1.44 -0.926 0 CA-C-O 118.458 -0.782 . . . . 0.0 113.01 -168.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.546 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 36.9 Cg_exo -55.93 -18.46 22.3 Favored 'Trans proline' 0 C--N 1.359 1.103 0 C-N-CA 121.523 1.482 . . . . 0.0 110.991 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.52 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.9 m-20 -89.82 -42.56 11.2 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 113.907 -1.497 . . . . 0.0 110.841 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' PHE . . . . . 0.444 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -55.43 -45.76 76.77 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.458 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.787 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 2.1 p -78.09 -34.38 19.03 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.18 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.172 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.59 -39.6 70.93 Favored 'General case' 0 C--N 1.316 -0.882 0 O-C-N 121.674 -0.641 . . . . 0.0 111.077 176.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.754 ' O ' HG12 ' B' ' 24' ' ' VAL . 14.7 ptt180 -79.82 -27.72 40.22 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.594 ' HB3' ' O ' ' B' ' 18' ' ' VAL . 13.2 tp -55.05 -48.68 73.14 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.191 172.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' GLN . . . . . 0.787 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 28.4 mt-30 -68.24 -55.23 12.95 Favored 'General case' 0 CA--C 1.485 -1.529 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.447 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.723 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 78.8 m-20 -45.79 -50.87 13.58 Favored 'General case' 0 C--N 1.312 -1.023 0 O-C-N 124.735 1.272 . . . . 0.0 111.264 -177.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' VAL . . . . . 0.754 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.1 p -78.66 -26.24 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.925 -174.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.641 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -67.22 -31.37 71.7 Favored 'General case' 0 C--O 1.208 -1.131 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 176.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.08 -35.15 64.21 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.174 -1.375 . . . . 0.0 109.474 -178.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.723 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 39.1 mmtt -67.31 -39.96 85.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.628 -1.169 . . . . 0.0 112.015 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . 0.449 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 38.9 m -100.45 -10.47 21.09 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.247 0.546 . . . . 0.0 110.511 -172.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.691 HG22 ' H ' ' B' ' 31' ' ' ASP . 83.9 mt -110.96 129.9 65.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.651 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.48 -3.03 58.54 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.937 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.691 ' H ' HG22 ' B' ' 29' ' ' ILE . 4.7 t0 -117.92 139.63 50.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.715 0.769 . . . . 0.0 111.912 -177.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -68.66 -31.55 70.75 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.43 175.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.597 ' O ' HG13 ' B' ' 37' ' ' VAL . 12.1 mttp -68.16 -53.62 23.77 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -176.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.578 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -63.89 -26.22 68.5 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.481 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.869 ' O ' HG13 ' B' ' 39' ' ' VAL . 4.8 tmm_? -68.27 -57.91 5.24 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.473 ' HB3' ' OE1' ' B' ' 40' ' ' GLU . 32.8 mtpt -53.53 -60.29 3.49 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.223 178.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.703 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 19.7 m -52.08 -33.85 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.366 -170.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.882 HD13 ' HE1' ' B' ' 3' ' ' PHE . 0.7 OUTLIER -88.36 -35.12 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 C-N-CA 119.769 -0.772 . . . . 0.0 112.355 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.869 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.9 m -66.05 -46.88 86.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 119.124 -1.03 . . . . 0.0 109.44 177.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.654 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 42.9 mt-10 -61.19 -31.59 71.34 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.943 0.897 . . . . 0.0 112.55 176.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.703 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -83.67 -52.98 5.98 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 121.039 -0.265 . . . . 0.0 111.446 -179.152 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' MET . . . . . 0.718 ' HG3' ' CG ' ' B' ' 4' ' ' ASN . 19.9 mmt -65.69 -20.73 66.4 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.712 0.768 . . . . 0.0 109.685 -176.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.692 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -50.51 -29.05 9.61 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.144 171.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' TYR . . . . . 0.871 ' CG ' ' HE3' ' B' ' 59' ' ' LYS . 6.1 t80 -103.4 -66.66 0.93 Allowed 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 174.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.601 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 31.0 mm-40 -49.78 -29.6 8.08 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 124.415 1.072 . . . . 0.0 112.006 -171.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.799 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.9 m-20 -104.42 -21.46 13.47 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.497 -176.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -61.49 179.89 0.21 Allowed 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.873 0.844 . . . . 0.0 113.058 -174.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' ASN . . . . . 0.641 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 17.5 m-20 -62.28 141.87 96.1 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.545 173.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . 0.43 ' O ' ' HG2' ' B' ' 52' ' ' GLN . 75.5 Cg_exo -42.14 -50.36 5.39 Favored 'Trans proline' 0 C--N 1.332 -0.308 0 C-N-CA 122.959 2.44 . . . . 0.0 112.309 -178.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . 0.632 ' HA ' ' HB2' ' B' ' 53' ' ' SER . 0.0 OUTLIER -74.07 -26.72 60.54 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.954 0.901 . . . . 0.0 111.349 -179.42 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.641 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 72.4 m -79.92 -40.15 28.8 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -174.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . 0.735 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.3 pt20 -69.44 -30.86 68.87 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 172.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' SER . . . . . 0.825 ' O ' ' HD2' ' B' ' 56' ' ' LYS . 4.3 m -67.89 -27.54 66.75 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 113.907 -1.497 . . . . 0.0 111.423 174.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.4 -23.09 61.81 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.005 0.907 . . . . 0.0 108.566 170.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.735 HD12 ' HA ' ' B' ' 52' ' ' GLN . 25.4 mt -89.91 -27.5 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -175.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.825 ' HD2' ' O ' ' B' ' 53' ' ' SER . 0.0 OUTLIER -37.47 -49.08 2.55 Favored Pre-proline 0 N--CA 1.507 2.404 0 CA-C-N 120.624 1.557 . . . . 0.0 112.525 -178.398 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 49.9 Cg_endo -61.27 -24.38 78.73 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.836 2.358 . . . . 0.0 112.789 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . 0.544 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.6 mt -105.28 -15.47 15.04 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . 0.871 ' HE3' ' CG ' ' B' ' 44' ' ' TYR . 0.0 OUTLIER -50.62 109.83 0.35 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.684 -179.015 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.67 -19.63 43.58 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.11 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -103.9 115.2 30.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.911 0.386 . . . . 0.0 110.12 -176.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.436 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.6 p -122.73 137.67 28.3 Favored Pre-proline 0 C--N 1.315 -0.915 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.406 171.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_exo . . . . . 0 C--N 1.343 0.285 0 C-N-CA 122.888 2.392 . . . . 0.0 112.212 171.321 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' ASP . . . . . 0.4 ' OD2' ' HB ' ' B' ' 69' ' ' ILE . 2.9 t70 . . . . . 0 CA--C 1.511 -0.528 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.578 HG22 ' HG2' ' B' ' 40' ' ' GLU . 1.0 OUTLIER -78.3 -29.4 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 C-N-CA 118.769 -1.172 . . . . 0.0 108.885 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.796 ' O ' HG13 ' B' ' 73' ' ' VAL . 8.6 mm -60.93 -47.12 94.93 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.164 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.091 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 43.0 t -47.13 -37.79 10.5 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.974 177.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.433 ' HA ' ' HB3' ' B' ' 74' ' ' LYS . 3.2 mm-40 -86.22 -32.52 21.13 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 123.282 0.633 . . . . 0.0 111.144 -177.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 72' ' ' TYR . . . . . 0.61 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.3 m-30 -74.97 -35.61 62.07 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.705 0.764 . . . . 0.0 109.348 -177.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.924 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 2.3 m -70.64 -34.16 55.91 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 74' ' ' LYS . . . . . 0.494 ' HA ' ' HB2' ' B' ' 77' ' ' ASP . 13.1 ttpp -70.37 -28.0 64.76 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.684 177.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -62.1 -44.56 96.38 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.431 173.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' B' ' 14' ' ' TYR . 37.7 t -96.01 9.22 41.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.182 178.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . 0.494 ' HB2' ' HA ' ' B' ' 74' ' ' LYS . 11.2 t70 . . . . . 0 C--N 1.323 -0.569 0 CA-C-O 121.034 0.445 . . . . 0.0 110.6 175.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.422 ' HB2' ' H ' ' A' ' 2' ' ' SER . 97.3 Cg_endo . . . . . 0 CA--C 1.518 -0.3 0 N-CA-C 108.984 -1.199 . . . . 0.0 108.984 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.458 ' HB2' HG23 ' A' ' 5' ' ' THR . 16.5 m -66.88 174.17 3.15 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 163.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.731 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -70.83 -51.79 24.47 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 166.029 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.533 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 2.4 p-10 -88.18 5.64 40.47 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 113.944 -1.48 . . . . 0.0 113.781 -165.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.458 HG23 ' HB2' ' A' ' 2' ' ' SER . 0.6 OUTLIER -63.09 -8.47 7.71 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 118.52 0.6 . . . . 0.0 111.305 -177.096 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.62 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.1 m -74.48 129.4 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 176.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.741 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -155.51 158.73 38.97 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 118.053 -1.459 . . . . 0.0 114.61 -177.556 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.45 ' HG2' ' HB3' ' A' ' 12' ' ' GLU . 2.2 tt0 -47.14 106.66 0.09 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 112.865 -1.97 . . . . 0.0 112.031 -177.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.27 -135.68 1.18 Allowed Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.825 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.497 ' C ' ' HD3' ' A' ' 11' ' ' LYS . 9.1 t -65.37 99.41 0.4 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.497 ' HD3' ' C ' ' A' ' 10' ' ' SER . 0.0 OUTLIER 37.2 44.24 0.41 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.233 1.013 . . . . 0.0 112.017 -175.333 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.45 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 54.8 tt0 -60.55 144.29 89.05 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.735 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.576 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 37.9 Cg_exo -54.48 122.83 12.24 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.356 2.037 . . . . 0.0 110.114 176.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.805 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 21.9 t80 -73.19 -55.87 3.57 Favored Pre-proline 0 N--CA 1.439 -0.984 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -166.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.557 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 27.4 Cg_exo -56.98 -16.13 19.6 Favored 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 121.279 1.32 . . . . 0.0 110.627 -178.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.576 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.3 m-20 -89.16 -44.48 10.28 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 113.606 -1.634 . . . . 0.0 110.837 178.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.54 ' CE2' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -54.62 -44.76 73.43 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.515 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.78 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 1.7 p -79.63 -34.8 16.06 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.277 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.536 -178.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.33 -30.58 68.47 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 121.45 -0.781 . . . . 0.0 111.752 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.728 ' O ' HG12 ' A' ' 24' ' ' VAL . 16.5 ptt180 -84.45 -28.36 26.89 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.543 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 5.6 tp -57.26 -48.29 79.25 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.019 173.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.78 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 24.7 mt-30 -68.78 -47.9 65.02 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.085 177.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.732 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 11.4 t70 -47.19 -54.58 10.37 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 124.332 1.02 . . . . 0.0 111.656 -177.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.728 HG12 ' O ' ' A' ' 20' ' ' ARG . 6.6 p -81.84 -21.95 10.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.038 -174.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.753 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -73.07 -19.39 61.18 Favored 'General case' 0 C--O 1.205 -1.243 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 174.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.49 -38.06 17.64 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.582 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.732 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 39.8 mmtt -66.45 -35.75 81.05 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.753 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.418 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 15.7 m -104.72 -7.32 19.62 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.201 0.524 . . . . 0.0 110.657 -170.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.753 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 88.5 mt -117.8 130.12 73.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.885 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.21 -7.64 47.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.331 0.586 . . . . 0.0 110.332 175.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.54 ' H ' HG22 ' A' ' 29' ' ' ILE . 1.0 OUTLIER -100.31 106.29 17.91 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.735 -179.278 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -56.47 -25.98 52.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.679 0.276 . . . . 0.0 110.271 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.566 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -69.32 -53.57 18.96 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.172 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.622 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -64.6 -24.07 67.47 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.349 177.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.871 ' O ' HG13 ' A' ' 39' ' ' VAL . 4.7 tmm_? -68.4 -58.61 4.08 Favored 'General case' 0 C--O 1.219 -0.535 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.485 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 27.4 mtpt -52.45 -60.68 2.94 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 120.791 0.329 . . . . 0.0 110.535 177.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.785 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 21.6 m -52.16 -36.15 20.21 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.768 -168.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.731 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.5 tt -87.17 -27.69 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 119.641 -0.823 . . . . 0.0 112.111 -177.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.871 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.1 m -73.35 -47.47 46.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 119.148 -1.021 . . . . 0.0 109.267 175.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.773 ' OE2' HG13 ' A' ' 68' ' ' VAL . 0.7 OUTLIER -63.98 -24.47 67.73 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.796 0.838 . . . . 0.0 111.292 176.162 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.785 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -85.45 -57.9 2.88 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 176.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.539 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 23.2 mmt -61.49 -20.58 63.33 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.569 0.699 . . . . 0.0 109.703 -177.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.685 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -48.94 -27.89 3.45 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.928 170.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.554 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 10.2 t80 -107.13 -66.77 0.99 Allowed 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 176.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.637 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 17.1 mm-40 -48.1 -32.59 7.02 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.998 -174.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.741 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 5.2 m-20 -105.14 -19.32 13.86 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -175.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.626 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -61.01 -172.15 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -174.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.556 ' HB2' ' H ' ' A' ' 51' ' ' CYS . 11.5 m120 -52.78 141.49 36.51 Favored Pre-proline 0 C--N 1.342 0.239 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 170.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.92 -19.66 56.14 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 121.618 1.545 . . . . 0.0 110.452 174.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.537 ' O ' ' HB2' ' A' ' 53' ' ' SER . 0.3 OUTLIER -87.11 -34.98 18.92 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.465 174.055 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.975 ' SG ' ' HB2' ' A' ' 76' ' ' CYS . 40.8 t -80.24 -33.92 37.55 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.242 -172.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.517 ' HB2' ' CD1' ' A' ' 44' ' ' TYR . 4.2 pt20 -68.68 -29.32 67.75 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 172.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.537 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 20.0 m -71.58 -19.3 62.16 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.284 -1.78 . . . . 0.0 110.017 173.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -81.06 -27.17 35.81 Favored 'General case' 0 C--N 1.311 -1.107 0 O-C-N 121.431 -0.793 . . . . 0.0 110.158 167.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.557 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 23.7 mt -90.34 -30.18 4.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 114.83 1.418 . . . . 0.0 114.83 -170.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.613 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.57 -38.81 1.99 Allowed Pre-proline 0 N--CA 1.487 1.414 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -174.034 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 54.4 Cg_endo -63.62 -30.96 70.58 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.154 1.903 . . . . 0.0 112.628 176.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.543 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.8 mt -95.08 -16.87 22.33 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.578 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 0.1 OUTLIER -54.87 109.07 0.46 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.698 -179.523 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.38 -23.04 37.58 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.403 -177.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -104.22 113.22 26.61 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.312 0.577 . . . . 0.0 110.232 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.464 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.7 p -123.09 142.53 38.52 Favored Pre-proline 0 C--N 1.309 -1.177 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 169.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo . . . . . 0 N--CA 1.463 -0.276 0 C-N-CA 122.19 1.927 . . . . 0.0 111.443 170.958 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.518 -0.271 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.773 HG13 ' OE2' ' A' ' 40' ' ' GLU . 0.7 OUTLIER -72.45 -32.53 42.3 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.419 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.755 ' O ' HG13 ' A' ' 73' ' ' VAL . 10.1 mm -55.57 -46.59 79.16 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.071 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.742 -178.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 33.6 t -46.34 -38.11 8.36 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.322 0.582 . . . . 0.0 111.012 176.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -85.63 -31.96 22.29 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.749 -177.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.578 ' OH ' ' HA ' ' A' ' 59' ' ' LYS . 4.9 m-30 -76.59 -34.04 58.42 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.534 -176.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.805 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.5 m -71.41 -31.64 43.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 172.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.569 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -67.89 -29.83 69.02 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.372 175.731 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -64.77 -44.93 88.46 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.109 176.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.975 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 39.5 t -92.52 9.08 36.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.636 177.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.569 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 8.3 t70 . . . . . 0 C--N 1.322 -0.622 0 CA-C-O 121.321 0.581 . . . . 0.0 110.238 172.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo . . . . . 0 CA--C 1.518 -0.324 0 N-CA-C 108.911 -1.226 . . . . 0.0 108.911 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . 0.462 ' HB2' HG23 ' B' ' 5' ' ' THR . 16.4 m -66.9 174.56 2.92 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 162.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.729 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -71.18 -51.76 23.03 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 165.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.525 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.4 p-10 -88.19 5.62 40.61 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 113.904 -1.498 . . . . 0.0 113.731 -165.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.462 HG23 ' HB2' ' B' ' 2' ' ' SER . 0.6 OUTLIER -63.36 -7.72 7.13 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 118.554 0.616 . . . . 0.0 111.438 -177.13 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.611 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.1 m -75.0 129.27 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.764 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.2 OUTLIER -155.48 158.77 39.07 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 118.18 -1.408 . . . . 0.0 114.626 -177.652 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' GLN . . . . . 0.459 ' HG2' ' HB3' ' B' ' 12' ' ' GLU . 2.2 tt0 -47.01 106.72 0.09 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 112.766 -2.016 . . . . 0.0 111.944 -177.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.56 -136.48 1.38 Allowed Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.631 177.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . 0.506 ' C ' ' HD3' ' B' ' 11' ' ' LYS . 8.9 t -64.81 99.38 0.33 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . 0.506 ' HD3' ' C ' ' B' ' 10' ' ' SER . 0.0 OUTLIER 37.35 43.94 0.42 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.19 0.996 . . . . 0.0 112.095 -175.354 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.459 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 52.6 tt0 -60.28 144.27 87.91 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.855 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . 0.552 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 40.4 Cg_exo -54.56 122.78 12.17 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 122.235 1.957 . . . . 0.0 110.139 176.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' TYR . . . . . 0.802 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 21.6 t80 -73.13 -55.92 3.59 Favored Pre-proline 0 N--CA 1.44 -0.939 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -166.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.569 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 27.7 Cg_exo -57.22 -16.02 20.55 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 121.318 1.345 . . . . 0.0 110.609 -178.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.552 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.4 m-20 -89.33 -44.2 10.39 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 113.487 -1.688 . . . . 0.0 110.762 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' PHE . . . . . 0.535 ' CE2' HD22 ' B' ' 21' ' ' LEU . 0.0 OUTLIER -54.89 -44.59 74.24 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 176.744 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.767 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 1.7 p -79.58 -34.91 16.21 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.307 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.496 -178.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.39 -30.29 68.34 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 121.356 -0.84 . . . . 0.0 111.913 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.712 ' O ' HG12 ' B' ' 24' ' ' VAL . 16.6 ptt180 -84.53 -28.44 26.66 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 175.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.558 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 5.6 tp -57.24 -48.23 79.36 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.079 173.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' GLN . . . . . 0.767 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 24.3 mt-30 -69.09 -47.41 65.31 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.075 177.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.743 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 11.8 t70 -47.44 -54.74 10.58 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 124.416 1.072 . . . . 0.0 111.6 -177.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' VAL . . . . . 0.712 HG12 ' O ' ' B' ' 20' ' ' ARG . 6.5 p -81.7 -22.05 10.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.033 -174.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.759 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -72.95 -19.39 61.25 Favored 'General case' 0 C--O 1.204 -1.302 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.49 -38.25 17.45 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.555 177.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.743 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 40.1 mmtt -66.13 -35.95 81.85 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.717 178.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . 0.409 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 15.7 m -104.52 -7.64 19.62 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.24 0.543 . . . . 0.0 110.68 -170.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.759 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 88.3 mt -117.74 129.74 73.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.91 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.15 -7.29 48.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.328 0.585 . . . . 0.0 110.314 175.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.514 ' H ' HG22 ' B' ' 29' ' ' ILE . 1.1 m-20 -100.46 106.25 17.79 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.776 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -56.29 -26.04 50.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.666 0.27 . . . . 0.0 110.388 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.57 ' O ' HG13 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -69.24 -53.73 18.39 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.14 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.633 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -64.33 -24.11 67.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.402 177.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.867 ' O ' HG13 ' B' ' 39' ' ' VAL . 4.6 tmm_? -68.41 -58.75 3.87 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.479 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 27.2 mtpt -52.17 -60.7 2.9 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 120.796 0.332 . . . . 0.0 110.638 177.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.779 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 21.8 m -52.27 -35.96 20.4 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.465 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.716 -168.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.729 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.5 tt -87.24 -27.72 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 119.599 -0.84 . . . . 0.0 112.067 -177.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.867 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.1 m -73.51 -47.14 46.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.332 175.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.769 ' OE2' HG13 ' B' ' 68' ' ' VAL . 0.7 OUTLIER -64.19 -24.36 67.65 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.757 0.823 . . . . 0.0 111.348 176.084 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.779 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.46 -57.86 2.9 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 176.534 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' MET . . . . . 0.541 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 23.2 mmt -61.45 -20.75 63.47 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.591 0.71 . . . . 0.0 109.717 -177.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.68 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -48.71 -27.93 3.24 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.991 170.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' TYR . . . . . 0.554 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 10.4 t80 -107.22 -66.66 1.0 Allowed 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.638 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 17.6 mm-40 -48.21 -32.46 7.14 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.817 -1.083 . . . . 0.0 112.005 -174.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.764 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 5.1 m-20 -105.07 -19.68 13.75 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -175.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -60.71 -172.0 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -174.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' ASN . . . . . 0.552 ' HB2' ' CB ' ' B' ' 51' ' ' CYS . 11.5 m120 -52.86 141.55 37.05 Favored Pre-proline 0 C--O 1.235 0.298 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 170.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.04 -19.7 57.2 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 121.642 1.561 . . . . 0.0 110.471 174.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' B' ' 53' ' ' SER . 0.3 OUTLIER -87.02 -34.89 19.07 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.542 173.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.975 ' SG ' ' HB2' ' B' ' 76' ' ' CYS . 40.7 t -80.33 -33.89 37.07 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.265 -172.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . 0.51 ' HB2' ' CD1' ' B' ' 44' ' ' TYR . 4.1 pt20 -68.6 -29.42 67.93 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 172.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' SER . . . . . 0.534 ' O ' ' HE2' ' B' ' 56' ' ' LYS . 19.6 m -71.55 -19.41 62.17 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 113.264 -1.789 . . . . 0.0 109.986 173.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -80.86 -27.38 36.43 Favored 'General case' 0 C--N 1.311 -1.07 0 O-C-N 121.443 -0.786 . . . . 0.0 110.225 167.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.561 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 24.0 mt -90.11 -30.0 5.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 -170.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.607 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.68 -38.78 2.07 Favored Pre-proline 0 N--CA 1.487 1.377 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -174.043 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 55.6 Cg_endo -63.79 -30.78 68.83 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.196 1.931 . . . . 0.0 112.649 176.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . 0.557 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.7 mt -95.11 -16.74 22.4 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . 0.57 ' HA ' ' OH ' ' B' ' 72' ' ' TYR . 0.1 OUTLIER -55.01 109.09 0.47 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.661 -179.483 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.65 -23.41 36.05 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.419 -177.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -104.07 113.36 26.85 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.351 0.596 . . . . 0.0 110.162 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.48 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.7 p -123.16 142.13 37.62 Favored Pre-proline 0 C--N 1.308 -1.201 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.352 169.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo . . . . . 0 C--O 1.234 0.32 0 C-N-CA 122.201 1.934 . . . . 0.0 111.416 171.222 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.519 -0.229 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.769 HG13 ' OE2' ' B' ' 40' ' ' GLU . 0.7 OUTLIER -72.3 -32.52 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.495 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.754 ' O ' HG13 ' B' ' 73' ' ' VAL . 9.9 mm -55.65 -46.6 79.42 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.093 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.675 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 29.4 t -46.49 -37.92 8.52 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.105 176.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -85.67 -32.0 22.22 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.677 -177.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 72' ' ' TYR . . . . . 0.579 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 4.9 m-30 -76.46 -34.29 58.7 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.572 -176.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.802 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.5 m -71.33 -31.51 43.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 172.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 74' ' ' LYS . . . . . 0.569 ' O ' ' HB3' ' B' ' 77' ' ' ASP . 0.0 OUTLIER -68.08 -29.61 68.61 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.431 175.653 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -65.09 -44.59 88.34 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.175 176.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.975 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 39.1 t -92.5 9.04 36.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.729 177.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . 0.569 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 9.1 t70 . . . . . 0 C--N 1.321 -0.641 0 CA-C-O 121.173 0.511 . . . . 0.0 110.163 172.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.413 ' C ' ' HA3' ' B' ' 60' ' ' GLY . 72.3 Cg_endo . . . . . 0 CA--C 1.515 -0.451 0 N-CA-C 108.784 -1.275 . . . . 0.0 108.784 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.723 ' HG ' ' HZ2' ' B' ' 59' ' ' LYS . 13.7 m -67.11 171.42 5.64 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 162.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.812 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -69.9 -52.02 28.14 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 167.248 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.521 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 2.5 p-10 -82.34 5.37 20.48 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 113.996 -1.456 . . . . 0.0 113.423 -166.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.409 HG23 ' HB2' ' A' ' 2' ' ' SER . 0.4 OUTLIER -66.28 -3.03 5.02 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 118.521 0.6 . . . . 0.0 111.946 -175.158 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.582 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.1 m -78.57 132.72 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 174.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.783 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -155.08 160.15 40.78 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -178.881 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.411 ' N ' ' CD2' ' A' ' 17' ' ' PHE . 2.0 tt0 -44.33 109.07 0.13 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 112.902 -1.954 . . . . 0.0 112.29 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.69 -151.95 15.13 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.397 174.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.1 t -52.32 98.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 122.421 0.288 . . . . 0.0 110.692 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.7 pttm 40.52 42.14 1.25 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.511 1.124 . . . . 0.0 112.598 -175.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -60.1 141.34 90.35 Favored Pre-proline 0 C--O 1.236 0.386 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.149 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.506 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 27.4 Cg_exo -56.35 122.96 12.7 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.039 1.826 . . . . 0.0 109.712 176.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.871 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 20.2 t80 -72.38 -53.27 6.24 Favored Pre-proline 0 N--CA 1.439 -1.004 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -166.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.529 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 34.3 Cg_exo -55.36 -19.53 22.48 Favored 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 121.361 1.374 . . . . 0.0 110.749 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.506 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 3.4 m-20 -89.9 -41.19 11.93 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 113.737 -1.574 . . . . 0.0 110.948 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.506 ' CD2' ' HA ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -54.96 -46.82 75.08 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 175.73 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.7 HG12 ' O ' ' A' ' 14' ' ' TYR . 2.4 p -79.03 -32.12 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.218 -177.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.0 -36.3 72.45 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 121.639 -0.663 . . . . 0.0 111.768 175.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.705 ' O ' HG12 ' A' ' 24' ' ' VAL . 14.1 ptt180 -83.27 -23.52 32.64 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.547 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 6.6 tp -60.49 -45.63 93.06 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.767 172.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.716 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 37.2 mt-30 -73.14 -44.51 60.04 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.735 178.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.751 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 26.0 t70 -49.16 -53.72 19.67 Favored 'General case' 0 C--N 1.315 -0.893 0 O-C-N 124.155 0.909 . . . . 0.0 111.667 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.705 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.7 p -80.85 -23.19 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-O 121.09 0.472 . . . . 0.0 109.882 -174.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.774 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -71.79 -20.54 61.84 Favored 'General case' 0 C--O 1.204 -1.326 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 174.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.451 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -86.54 -37.14 18.47 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.744 178.602 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.751 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.0 mmtt -65.49 -35.51 81.09 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.459 178.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.5 m -104.47 -9.96 18.02 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.648 -171.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.774 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 91.1 mt -119.27 128.03 75.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.95 -178.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.99 -1.29 56.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.382 0.611 . . . . 0.0 110.488 176.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.66 ' H ' HG22 ' A' ' 29' ' ' ILE . 13.6 t70 -107.95 116.6 32.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.467 -177.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.558 ' OE2' ' HG3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -57.16 -34.05 68.06 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.272 178.332 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.612 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -70.88 -54.71 10.48 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -172.543 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.563 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -60.05 -28.92 68.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.8 176.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.878 ' O ' HG13 ' A' ' 39' ' ' VAL . 6.0 tmm_? -67.38 -58.09 5.41 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.441 ' O ' HG22 ' A' ' 39' ' ' VAL . 16.0 mtpt -56.96 -56.58 19.85 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.008 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.704 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 20.1 m -53.73 -35.03 25.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.399 -171.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.812 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.3 tt -86.6 -28.24 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 C-N-CA 119.631 -0.828 . . . . 0.0 111.732 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.878 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.5 m -70.78 -49.87 47.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 119.088 -1.045 . . . . 0.0 109.561 173.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.774 ' OE1' HG13 ' A' ' 68' ' ' VAL . 0.9 OUTLIER -62.08 -24.85 67.36 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.354 0.662 . . . . 0.0 111.653 176.654 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.704 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -86.23 -55.28 3.99 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 176.381 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.521 ' HG3' ' HB2' ' A' ' 4' ' ' ASN . 16.4 mmt -63.89 -20.35 65.77 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 121.458 0.646 . . . . 0.0 109.861 -176.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.689 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -48.78 -27.81 3.23 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.277 169.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.558 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 16.5 t80 -105.95 -66.23 1.01 Allowed 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 174.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.45 ' CG ' HD12 ' A' ' 41' ' ' LEU . 15.3 mm-40 -50.22 -26.85 5.1 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 124.228 0.955 . . . . 0.0 112.699 -172.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.783 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.8 m-20 -109.49 -20.35 12.92 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.625 -177.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -59.15 -177.52 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.183 0.992 . . . . 0.0 113.633 -174.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -62.98 140.89 97.64 Favored Pre-proline 0 N--CA 1.445 -0.713 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.639 174.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -43.65 -48.04 9.07 Favored 'Trans proline' 0 C--N 1.334 -0.226 0 C-N-CA 122.83 2.353 . . . . 0.0 112.473 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.602 ' HG3' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -76.23 -23.73 54.55 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.31 0.644 . . . . 0.0 110.657 -179.488 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.969 ' SG ' ' HB2' ' A' ' 76' ' ' CYS . 52.9 t -84.26 -40.0 18.57 Favored 'General case' 0 N--CA 1.417 -2.105 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.915 -173.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.57 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.7 pt20 -66.34 -31.18 71.81 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 172.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.757 ' O ' ' HD2' ' A' ' 56' ' ' LYS . 5.1 m -65.81 -30.05 70.62 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.88 172.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.33 -23.71 61.2 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.87 0.843 . . . . 0.0 109.276 172.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.57 HD12 ' HA ' ' A' ' 52' ' ' GLN . 25.1 mt -90.94 -31.33 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -173.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.757 ' HD2' ' O ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -44.03 -38.18 4.43 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-N 119.805 1.184 . . . . 0.0 113.477 -173.451 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 52.7 Cg_endo -63.06 -29.6 75.12 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 122.296 1.997 . . . . 0.0 112.85 175.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.559 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.5 mt -97.37 -16.45 20.24 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.558 ' HE3' ' HB3' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -52.76 109.68 0.43 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.376 -178.538 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.525 ' N ' ' HZ3' ' A' ' 59' ' ' LYS . . . 94.86 -21.77 41.79 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.177 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.5 mmmt -103.51 114.5 28.81 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -177.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.528 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.7 p -122.14 137.1 27.01 Favored Pre-proline 0 C--N 1.309 -1.163 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 170.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo . . . . . 0 C--O 1.234 0.303 0 C-N-CA 122.649 2.233 . . . . 0.0 111.702 172.621 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.444 ' OD2' ' HB ' ' A' ' 69' ' ' ILE . 3.0 t70 . . . . . 0 CA--C 1.519 -0.237 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.774 HG13 ' OE1' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -71.87 -33.36 47.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 C-N-CA 118.055 -1.458 . . . . 0.0 108.937 -179.391 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.774 ' O ' HG13 ' A' ' 73' ' ' VAL . 7.6 mm -57.61 -47.5 85.29 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.112 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.802 -178.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.577 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 41.2 t -48.33 -36.09 13.67 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.202 0.525 . . . . 0.0 111.168 178.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.411 ' H ' ' HG2' ' A' ' 71' ' ' GLU . 2.3 mm-40 -86.56 -31.21 21.34 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.27 0.628 . . . . 0.0 110.75 -176.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.559 ' CE1' ' HB2' ' A' ' 58' ' ' LEU . 4.9 m-30 -76.28 -35.98 58.62 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.494 -178.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.871 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.7 m -69.87 -33.15 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 173.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.577 ' HB2' ' O ' ' A' ' 70' ' ' SER . 1.6 ttmm -67.9 -30.62 70.0 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.086 -1.415 . . . . 0.0 109.666 176.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -62.1 -42.81 99.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.653 174.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.969 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 41.9 t -94.86 8.59 42.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.052 178.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 12.7 t70 . . . . . 0 C--N 1.323 -0.587 0 CA-C-O 121.279 0.561 . . . . 0.0 110.024 173.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 1' ' ' PRO . . . . . 0.43 ' HB2' ' H ' ' B' ' 2' ' ' SER . 72.4 Cg_endo . . . . . 0 CA--C 1.515 -0.449 0 N-CA-C 108.791 -1.273 . . . . 0.0 108.791 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . 0.43 ' H ' ' HB2' ' B' ' 1' ' ' PRO . 14.4 m -67.04 171.58 5.39 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 162.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.783 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -70.03 -52.08 26.97 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 167.184 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.521 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.6 p-10 -82.05 5.25 20.01 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 113.95 -1.477 . . . . 0.0 113.478 -166.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.411 HG23 ' HB2' ' B' ' 2' ' ' SER . 0.4 OUTLIER -66.26 -2.87 4.81 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 121.671 -0.643 . . . . 0.0 111.939 -175.16 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.596 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.1 m -78.57 133.18 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 174.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.773 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.1 OUTLIER -155.17 160.26 40.77 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -178.825 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' GLN . . . . . 0.426 ' N ' ' CD2' ' B' ' 17' ' ' PHE . 2.0 tt0 -44.58 108.87 0.13 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 112.922 -1.944 . . . . 0.0 112.313 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.27 -152.07 14.38 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.406 174.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 9.9 t -52.44 98.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.753 0.311 . . . . 0.0 110.803 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 23.8 pttm 40.8 41.55 1.22 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.549 1.14 . . . . 0.0 112.635 -175.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -59.73 141.17 89.17 Favored Pre-proline 0 C--O 1.236 0.388 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.217 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . 0.516 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 27.6 Cg_exo -56.24 123.04 12.87 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.031 1.82 . . . . 0.0 109.644 177.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' TYR . . . . . 0.877 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 20.3 t80 -72.36 -53.37 6.19 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -166.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.527 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 35.1 Cg_exo -55.45 -19.34 22.31 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 121.305 1.337 . . . . 0.0 110.696 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.516 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 3.5 m-20 -90.1 -41.15 11.83 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.722 -1.581 . . . . 0.0 110.92 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' PHE . . . . . 0.516 ' CD2' ' HA ' ' B' ' 7' ' ' ARG . 0.0 OUTLIER -54.79 -46.71 74.5 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.569 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.699 HG12 ' O ' ' B' ' 14' ' ' TYR . 2.4 p -79.16 -32.09 14.94 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.21 -177.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.06 -36.12 72.34 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 121.634 -0.666 . . . . 0.0 111.765 175.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.697 ' O ' HG12 ' B' ' 24' ' ' VAL . 14.1 ptt180 -83.22 -23.99 32.56 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 177.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.556 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 6.5 tp -60.1 -45.64 92.26 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.802 172.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' GLN . . . . . 0.721 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 36.9 mt-30 -73.21 -44.19 60.09 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.832 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.74 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 25.9 t70 -49.43 -53.83 20.72 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.557 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' VAL . . . . . 0.697 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.7 p -80.96 -23.07 10.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.137 0.494 . . . . 0.0 109.878 -174.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.778 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -71.77 -20.5 61.86 Favored 'General case' 0 C--O 1.203 -1.37 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 174.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . 0.451 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -86.56 -37.29 18.29 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.704 178.597 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.74 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.4 mmtt -65.51 -35.58 81.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.488 178.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 19.6 m -104.34 -9.44 18.51 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.666 -171.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.778 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 91.6 mt -119.76 128.0 75.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.993 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.06 -1.43 56.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.285 0.564 . . . . 0.0 110.286 177.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.675 ' H ' HG22 ' B' ' 29' ' ' ILE . 13.8 t70 -107.62 116.84 32.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.352 -177.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.549 ' OE2' ' HG3' ' B' ' 33' ' ' LYS . 0.0 OUTLIER -57.34 -33.87 68.2 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.356 178.267 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.616 ' O ' HG13 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -70.82 -54.57 11.09 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -172.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.545 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -60.16 -28.89 68.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.784 176.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.854 ' O ' HG13 ' B' ' 39' ' ' VAL . 6.0 tmm_? -67.38 -58.28 5.07 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.438 ' O ' HG22 ' B' ' 39' ' ' VAL . 16.1 mtpt -56.84 -56.52 20.52 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.097 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.689 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 20.2 m -53.83 -34.92 26.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.386 -171.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.783 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.3 tt -86.64 -28.18 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 C-N-CA 119.649 -0.82 . . . . 0.0 111.668 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.854 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.5 m -70.91 -49.85 47.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 119.152 -1.019 . . . . 0.0 109.58 173.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.782 ' OE1' HG13 ' B' ' 68' ' ' VAL . 0.9 OUTLIER -62.12 -24.87 67.4 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.398 0.679 . . . . 0.0 111.561 176.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.689 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -86.22 -55.22 4.02 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 176.293 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' MET . . . . . 0.521 ' HG3' ' HB2' ' B' ' 4' ' ' ASN . 16.4 mmt -64.08 -20.17 65.76 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 121.537 0.684 . . . . 0.0 109.974 -176.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.68 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -48.78 -27.76 3.19 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.194 169.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' TYR . . . . . 0.561 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 16.5 t80 -106.06 -66.41 1.0 Allowed 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 174.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.46 ' CG ' HD12 ' B' ' 41' ' ' LEU . 16.4 mm-40 -50.05 -27.22 5.25 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.627 -172.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.773 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.7 m-20 -109.28 -20.22 13.02 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.602 -176.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -59.06 -177.35 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -174.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -63.26 140.93 97.77 Favored Pre-proline 0 N--CA 1.446 -0.647 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.531 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -43.76 -48.04 9.26 Favored 'Trans proline' 0 C--N 1.334 -0.235 0 C-N-CA 122.773 2.315 . . . . 0.0 112.386 -178.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . 0.604 ' HG3' ' O ' ' B' ' 50' ' ' GLU . 0.0 OUTLIER -76.03 -23.83 55.17 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 123.43 0.692 . . . . 0.0 110.707 -179.467 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.97 ' SG ' ' HB2' ' B' ' 76' ' ' CYS . 52.8 t -84.18 -39.99 18.69 Favored 'General case' 0 N--CA 1.418 -2.038 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.94 -173.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . 0.574 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.8 pt20 -66.5 -31.08 71.59 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 172.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' SER . . . . . 0.745 ' O ' ' HD2' ' B' ' 56' ' ' LYS . 5.7 m -65.93 -30.14 70.67 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 113.783 -1.553 . . . . 0.0 110.809 173.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.09 -23.89 61.41 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 122.026 0.917 . . . . 0.0 109.374 172.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.574 HD12 ' HA ' ' B' ' 52' ' ' GLN . 25.0 mt -90.89 -31.53 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -173.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.745 ' HD2' ' O ' ' B' ' 53' ' ' SER . 0.0 OUTLIER -43.79 -38.12 3.96 Favored Pre-proline 0 N--CA 1.488 1.45 0 CA-C-N 119.801 1.182 . . . . 0.0 113.653 -173.543 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 54.3 Cg_endo -63.48 -28.84 70.85 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.391 2.061 . . . . 0.0 112.942 175.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . 0.572 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.5 mt -97.84 -16.55 19.75 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . 0.723 ' HZ2' ' HG ' ' A' ' 2' ' ' SER . 0.0 OUTLIER -52.82 109.73 0.44 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.421 -178.501 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . 0.413 ' HA3' ' C ' ' A' ' 1' ' ' PRO . . . 95.04 -22.02 40.73 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.255 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 11.5 mmmt -103.55 114.3 28.46 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -177.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.519 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.6 p -122.15 136.85 26.74 Favored Pre-proline 0 C--N 1.309 -1.184 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 171.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo . . . . . 0 N--CA 1.462 -0.347 0 C-N-CA 122.52 2.147 . . . . 0.0 111.841 172.84 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' ASP . . . . . 0.442 ' OD2' ' HB ' ' B' ' 69' ' ' ILE . 3.1 t70 . . . . . 0 CA--C 1.52 -0.206 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.782 HG13 ' OE1' ' B' ' 40' ' ' GLU . 0.8 OUTLIER -71.66 -33.4 48.77 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 C-N-CA 118.085 -1.446 . . . . 0.0 108.856 -179.214 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.778 ' O ' HG13 ' B' ' 73' ' ' VAL . 7.6 mm -57.45 -47.51 84.76 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.118 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.801 -178.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.571 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 40.3 t -48.34 -36.2 13.92 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.301 0.572 . . . . 0.0 111.182 178.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -86.51 -31.28 21.38 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.592 -176.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 72' ' ' TYR . . . . . 0.572 ' CE1' ' HB2' ' B' ' 58' ' ' LEU . 5.0 m-30 -76.39 -35.82 58.42 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.443 -178.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.877 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.7 m -69.94 -33.13 54.21 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 173.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 74' ' ' LYS . . . . . 0.571 ' HB2' ' O ' ' B' ' 70' ' ' SER . 1.6 ttmm -68.04 -30.56 69.81 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.698 176.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -61.93 -42.89 99.62 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.624 174.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.97 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 43.2 t -94.99 8.66 42.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.12 177.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . 0.467 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 12.0 t70 . . . . . 0 C--N 1.321 -0.654 0 CA-C-O 121.354 0.597 . . . . 0.0 109.971 173.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo . . . . . 0 CA--C 1.52 -0.209 0 N-CA-C 109.064 -1.168 . . . . 0.0 109.064 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.488 ' HB3' HD21 ' B' ' 41' ' ' LEU . 66.6 m -68.62 -176.85 0.85 Allowed 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 162.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.862 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -77.27 -55.47 5.38 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.107 172.675 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.812 HD21 HD11 ' B' ' 41' ' ' LEU . 1.1 p30 -76.22 -8.3 56.76 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.599 -1.182 . . . . 0.0 112.467 -167.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.532 ' CG2' ' HD3' ' B' ' 59' ' ' LYS . 0.3 OUTLIER -57.95 0.61 0.06 Allowed 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -172.197 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.58 ' HB ' ' CZ ' ' A' ' 20' ' ' ARG . 4.0 m -72.96 117.65 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 167.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.715 ' HG3' ' CB ' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -115.91 158.25 23.29 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 121.505 -0.747 . . . . 0.0 110.216 176.765 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.502 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 1.9 tt0 -56.16 113.08 1.4 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.444 173.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.35 -159.99 11.73 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 173.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.7 p -52.16 100.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.942 0.371 . . . . 0.0 111.141 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 11' ' ' LYS . 18.2 pttp 43.01 42.58 3.23 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.305 1.042 . . . . 0.0 112.041 -175.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.486 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 42.7 tt0 -60.26 137.0 91.63 Favored Pre-proline 0 C--O 1.232 0.182 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 177.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.531 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 28.1 Cg_exo -54.06 123.62 13.95 Favored 'Trans proline' 0 CA--C 1.511 -0.672 0 C-N-CA 122.075 1.85 . . . . 0.0 109.936 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.862 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 14.5 t80 -70.19 -53.43 10.79 Favored Pre-proline 0 N--CA 1.44 -0.954 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -166.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.501 ' HD3' ' HB3' ' A' ' 14' ' ' TYR . 31.8 Cg_exo -55.69 -18.51 21.06 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 121.414 1.409 . . . . 0.0 110.979 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.531 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 4.1 m-20 -89.96 -41.69 11.6 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.198 -1.365 . . . . 0.0 111.169 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.502 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -56.96 -41.54 78.51 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.533 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.703 HG12 ' O ' ' A' ' 14' ' ' TYR . 2.4 p -82.57 -33.6 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.519 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.88 -34.05 69.36 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 121.495 -0.753 . . . . 0.0 111.946 176.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.748 ' O ' HG12 ' A' ' 24' ' ' VAL . 17.5 ptt180 -84.79 -27.72 26.66 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.604 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 9.3 tp -54.96 -46.19 75.0 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.759 171.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.747 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 36.6 mt-30 -73.21 -45.72 54.53 Favored 'General case' 0 CA--C 1.497 -1.073 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.168 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.71 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 11.4 t70 -51.79 -52.42 49.09 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 124.05 0.844 . . . . 0.0 111.812 -177.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.748 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.3 p -82.06 -23.25 9.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -173.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.793 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -72.06 -18.86 61.9 Favored 'General case' 0 C--O 1.203 -1.357 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 173.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.422 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -86.55 -37.75 17.86 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.634 -1.167 . . . . 0.0 109.812 177.842 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.71 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 41.0 mmtt -67.62 -37.84 83.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.013 178.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.8 t -102.67 -7.7 21.52 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.227 0.537 . . . . 0.0 110.044 -171.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.793 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 86.8 mt -116.7 127.49 74.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.435 178.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.55 -9.54 54.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.263 0.554 . . . . 0.0 110.148 177.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.583 ' H ' HG22 ' A' ' 29' ' ' ILE . 13.8 t70 -98.75 136.04 39.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.233 -177.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -75.42 -29.55 59.78 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.761 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.592 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -77.44 -51.41 10.82 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -174.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.574 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -58.57 -27.88 65.01 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.436 175.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.884 ' O ' HG13 ' A' ' 39' ' ' VAL . 1.7 tmm_? -66.31 -60.74 2.49 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.5 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 26.0 mtpt -55.12 -56.1 23.61 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.373 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.719 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 19.7 m -54.8 -32.6 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.16 -170.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.862 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.2 tt -86.82 -34.0 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.416 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.884 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.0 m -66.14 -47.66 83.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 119.214 -0.995 . . . . 0.0 109.466 176.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.672 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 54.4 mt-10 -67.25 -23.75 65.74 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 123.875 0.87 . . . . 0.0 112.64 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.838 HD11 HD21 ' B' ' 4' ' ' ASN . 0.0 OUTLIER -86.22 -55.71 3.79 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.375 176.854 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.668 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 14.6 mmt -62.27 -20.67 64.52 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-O 121.76 0.791 . . . . 0.0 109.509 -176.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.754 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -48.61 -27.02 2.53 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.766 170.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.499 ' HB3' ' NZ ' ' A' ' 59' ' ' LYS . 9.2 t80 -105.4 -66.39 0.98 Allowed 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.485 ' HG2' HD12 ' A' ' 41' ' ' LEU . 14.0 mm-40 -48.25 -33.41 8.64 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 123.646 0.592 . . . . 0.0 112.44 -176.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.715 ' CB ' ' HG3' ' A' ' 7' ' ' ARG . 5.2 m-20 -99.84 -15.34 18.43 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.349 0.595 . . . . 0.0 111.643 -177.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.754 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -63.04 168.48 4.04 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.426 0.632 . . . . 0.0 111.501 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.554 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 11.1 m-20 -58.31 145.46 74.73 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.338 173.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -41.65 -49.1 5.45 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.688 2.258 . . . . 0.0 111.894 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.552 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 0.3 OUTLIER -71.23 -33.56 69.97 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.238 1.015 . . . . 0.0 111.854 177.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.554 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 69.8 m -73.94 -39.22 63.93 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 121.118 0.485 . . . . 0.0 110.014 -174.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.522 ' HA ' HD12 ' A' ' 55' ' ' ILE . 4.0 pt20 -73.39 -30.75 63.48 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 175.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.553 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 4.0 m -67.72 -21.02 65.32 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.306 172.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 51' ' ' CYS . . . -77.1 -27.77 54.26 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.382 -0.824 . . . . 0.0 109.865 169.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.581 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 20.8 mt -89.74 -31.72 5.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -171.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.606 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -40.68 -37.76 1.05 Allowed Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -173.883 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 55.2 Cg_endo -64.26 -28.89 64.0 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.358 2.039 . . . . 0.0 113.104 175.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.564 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 2.0 mt -98.63 -15.79 19.31 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.665 ' NZ ' HD13 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -52.56 109.35 0.39 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.348 -1.296 . . . . 0.0 110.422 179.6 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.88 -30.09 10.44 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.939 -175.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 35.0 mmtt -103.83 115.17 29.98 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-O 122.423 1.106 . . . . 0.0 111.612 -175.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.587 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.5 p -122.46 145.04 43.61 Favored Pre-proline 0 C--N 1.296 -1.754 0 CA-C-N 113.555 -1.657 . . . . 0.0 109.52 170.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo . . . . . 0 C--O 1.233 0.265 0 C-N-CA 122.282 1.988 . . . . 0.0 111.198 167.811 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.436 -1.153 0 N-CA-C 110.89 -0.041 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.587 HG12 ' HB ' ' A' ' 62' ' ' VAL . 0.9 OUTLIER -79.08 -31.27 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 C-N-CA 118.523 -1.271 . . . . 0.0 108.463 176.248 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.773 ' O ' HG13 ' A' ' 73' ' ' VAL . 6.9 mm -57.77 -49.16 81.77 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.147 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.564 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.6 t -49.07 -36.18 17.75 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.077 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.589 ' O ' ' HE3' ' A' ' 74' ' ' LYS . 1.3 mm-40 -84.88 -33.83 22.72 Favored 'General case' 0 C--O 1.216 -0.666 0 C-N-CA 123.349 0.66 . . . . 0.0 110.458 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.568 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 4.9 m-30 -74.5 -37.91 63.01 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.691 -176.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.862 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.7 m -70.64 -32.65 50.17 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 175.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.589 ' HE3' ' O ' ' A' ' 71' ' ' GLU . 2.4 ttpp -72.39 -27.68 62.52 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.816 177.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.491 ' HB2' HD11 ' A' ' 58' ' ' LEU . . . -66.21 -41.72 89.73 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.313 174.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 4.2 m -101.07 10.5 40.93 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.533 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 t70 . . . . . 0 C--N 1.325 -0.487 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.132 178.548 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 1' ' ' PRO . . . . . 0.422 ' HB2' ' H ' ' B' ' 2' ' ' SER . 96.2 Cg_endo . . . . . 0 CA--C 1.518 -0.319 0 N-CA-C 109.113 -1.149 . . . . 0.0 109.113 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . 0.468 ' HB3' HD21 ' A' ' 41' ' ' LEU . 71.2 m -68.78 -176.55 0.84 Allowed 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 162.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.859 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -77.24 -55.57 5.31 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.509 -0.877 . . . . 0.0 110.173 172.362 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.838 HD21 HD11 ' A' ' 41' ' ' LEU . 1.1 p30 -76.21 -8.32 56.78 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.557 -1.201 . . . . 0.0 112.413 -167.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.579 ' CG2' ' HD3' ' A' ' 59' ' ' LYS . 0.2 OUTLIER -57.85 0.5 0.06 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -172.182 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.578 ' HB ' ' CZ ' ' B' ' 20' ' ' ARG . 4.0 m -72.88 117.92 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 167.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.705 ' HG3' ' CB ' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -115.86 158.42 22.98 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 121.568 -0.708 . . . . 0.0 110.189 176.621 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' GLN . . . . . 0.509 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 1.9 tt0 -56.44 112.9 1.38 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.372 173.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.2 -159.75 10.94 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 173.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 12.3 p -52.32 100.88 0.03 OUTLIER 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.932 0.366 . . . . 0.0 111.152 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 18.3 pttp 42.89 42.17 2.92 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.383 1.073 . . . . 0.0 112.255 -175.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.49 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 43.1 tt0 -59.84 136.87 90.32 Favored Pre-proline 0 C--O 1.232 0.17 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . 0.543 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 27.6 Cg_exo -54.05 123.6 13.89 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.129 1.886 . . . . 0.0 109.907 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' TYR . . . . . 0.864 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 14.8 t80 -70.07 -53.61 10.85 Favored Pre-proline 0 N--CA 1.44 -0.96 0 CA-C-O 118.335 -0.841 . . . . 0.0 113.23 -166.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.512 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 32.0 Cg_exo -55.6 -18.56 20.71 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 121.55 1.5 . . . . 0.0 110.999 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.543 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 4.4 m-20 -89.92 -41.85 11.54 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.068 -1.424 . . . . 0.0 111.071 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' PHE . . . . . 0.509 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -56.9 -41.54 78.27 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.614 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.699 HG12 ' O ' ' B' ' 14' ' ' TYR . 2.4 p -82.52 -33.61 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.521 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.28 -33.33 69.31 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.457 -0.777 . . . . 0.0 112.012 176.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.753 ' O ' HG12 ' B' ' 24' ' ' VAL . 17.5 ptt180 -85.11 -27.85 25.98 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.609 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 9.3 tp -54.84 -46.2 74.6 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.814 171.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' GLN . . . . . 0.751 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 36.3 mt-30 -73.19 -45.88 53.78 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.157 178.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.714 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 11.3 t70 -51.89 -52.24 51.14 Favored 'General case' 0 C--N 1.314 -0.96 0 O-C-N 124.067 0.854 . . . . 0.0 111.841 -177.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' VAL . . . . . 0.753 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.4 p -82.02 -23.27 9.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.302 0.572 . . . . 0.0 109.56 -174.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.801 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -72.06 -18.87 61.91 Favored 'General case' 0 C--O 1.204 -1.307 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . 0.426 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -86.7 -37.54 17.86 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.814 177.799 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.714 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 40.9 mmtt -67.96 -37.23 81.32 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.999 178.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 33.4 t -103.08 -7.49 21.31 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.403 0.621 . . . . 0.0 110.189 -171.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.801 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 86.6 mt -116.98 127.18 74.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.428 178.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.44 -9.47 54.55 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.276 0.56 . . . . 0.0 110.199 177.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.58 ' H ' HG22 ' B' ' 29' ' ' ILE . 13.7 t70 -98.68 136.13 39.19 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.258 -177.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -75.55 -29.56 59.42 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.67 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.592 ' O ' HG13 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -77.36 -51.49 10.74 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -174.944 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.55 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -58.61 -27.86 65.08 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.378 176.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.867 ' O ' HG13 ' B' ' 39' ' ' VAL . 1.7 tmm_? -66.34 -60.86 2.38 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 178.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.488 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 25.9 mtpt -55.03 -56.1 23.58 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.382 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.713 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 19.6 m -54.8 -32.37 25.96 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.258 -170.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.859 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.2 tt -86.97 -34.07 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.525 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.867 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.0 m -65.97 -47.69 84.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.438 176.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.671 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 54.6 mt-10 -67.48 -23.43 65.49 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.711 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.812 HD11 HD21 ' A' ' 4' ' ' ASN . 0.0 OUTLIER -86.33 -55.94 3.67 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.258 176.648 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' MET . . . . . 0.675 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 14.7 mmt -62.2 -20.66 64.41 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-O 121.768 0.794 . . . . 0.0 109.578 -176.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.745 ' O ' ' HB2' ' B' ' 47' ' ' ALA . . . -48.59 -27.1 2.56 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.779 170.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' TYR . . . . . 0.503 ' CG ' ' HB2' ' B' ' 52' ' ' GLN . 9.1 t80 -105.36 -66.7 0.96 Allowed 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.491 ' HG2' HD12 ' B' ' 41' ' ' LEU . 13.1 mm-40 -47.97 -33.65 8.09 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 123.636 0.585 . . . . 0.0 112.405 -176.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.705 ' CB ' ' HG3' ' B' ' 7' ' ' ARG . 5.3 m-20 -99.55 -15.3 18.68 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.297 0.57 . . . . 0.0 111.724 -177.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.745 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -63.11 168.53 4.08 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.39 0.614 . . . . 0.0 111.483 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' ASN . . . . . 0.558 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 11.2 m-20 -58.09 145.41 73.22 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.387 173.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -41.58 -49.49 5.18 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 122.741 2.294 . . . . 0.0 111.875 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . 0.544 ' HA ' ' HB2' ' B' ' 53' ' ' SER . 0.3 OUTLIER -70.78 -33.69 71.01 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.372 1.069 . . . . 0.0 111.801 177.737 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.558 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 70.2 m -73.9 -39.16 64.06 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.29 0.566 . . . . 0.0 110.151 -174.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . 0.541 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.9 pt20 -73.42 -30.65 63.37 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 175.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' SER . . . . . 0.554 ' O ' ' HE2' ' B' ' 56' ' ' LYS . 3.7 m -68.03 -20.87 65.03 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.26 172.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' B' ' 51' ' ' CYS . . . -76.97 -27.86 54.92 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.359 -0.838 . . . . 0.0 109.877 168.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.577 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 20.9 mt -89.66 -31.78 5.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -171.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.603 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -40.62 -37.92 1.08 Allowed Pre-proline 0 N--CA 1.49 1.525 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -173.82 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 53.9 Cg_endo -64.17 -28.97 64.83 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.178 1.919 . . . . 0.0 113.022 175.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . 0.56 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 2.0 mt -98.54 -15.65 19.45 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . 0.668 ' NZ ' HD13 ' B' ' 41' ' ' LEU . 0.3 OUTLIER -52.77 109.31 0.39 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.385 179.459 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.86 -30.24 10.15 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.944 -175.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 34.9 mmtt -103.68 115.31 30.26 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 122.244 1.021 . . . . 0.0 111.688 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.595 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.6 p -122.53 145.22 44.25 Favored Pre-proline 0 C--N 1.297 -1.681 0 CA-C-N 113.64 -1.618 . . . . 0.0 109.559 170.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . 0.41 ' HD2' HG23 ' B' ' 62' ' ' VAL . 98.6 Cg_exo . . . . . 0 C--N 1.345 0.369 0 C-N-CA 122.182 1.921 . . . . 0.0 111.21 168.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.436 -1.157 0 CA-C-O 120.222 0.058 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.595 HG12 ' HB ' ' B' ' 62' ' ' VAL . 0.9 OUTLIER -79.24 -31.36 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 C-N-CA 118.567 -1.253 . . . . 0.0 108.547 176.175 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.772 ' O ' HG13 ' B' ' 73' ' ' VAL . 7.0 mm -57.73 -49.28 81.32 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.139 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.522 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 42.8 t -48.81 -36.4 16.63 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.011 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.584 ' O ' ' HE3' ' B' ' 74' ' ' LYS . 1.4 mm-40 -84.81 -33.76 22.87 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 123.442 0.697 . . . . 0.0 110.591 -178.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 72' ' ' TYR . . . . . 0.56 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.0 m-30 -74.79 -37.8 62.29 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.671 -176.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.864 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.7 m -70.47 -32.76 51.07 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.676 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 174.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 74' ' ' LYS . . . . . 0.584 ' HE3' ' O ' ' B' ' 71' ' ' GLU . 2.4 ttpp -72.58 -27.3 62.1 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.866 178.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . 0.486 ' HB2' HD11 ' B' ' 58' ' ' LEU . . . -66.39 -41.82 88.81 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.3 174.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 4.2 m -101.12 10.52 40.83 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.496 -177.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 6.5 t70 . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.059 178.486 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo . . . . . 0 CA--C 1.518 -0.303 0 N-CA-C 109.1 -1.154 . . . . 0.0 109.1 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.735 ' HB2' HG23 ' A' ' 5' ' ' THR . 73.6 m -68.83 -177.23 0.96 Allowed 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 162.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.769 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -78.14 -53.92 6.83 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.649 172.549 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.574 ' OD1' ' HG ' ' B' ' 41' ' ' LEU . 2.2 p-10 -87.58 5.7 38.09 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.133 -0.939 . . . . 0.0 112.994 -164.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.735 HG23 ' HB2' ' A' ' 2' ' ' SER . 2.2 p -64.8 -3.83 3.73 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.069 0.462 . . . . 0.0 111.391 -176.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.52 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.6 m -75.38 131.9 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 175.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.768 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -153.18 158.91 42.47 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.443 ' HG2' ' HB3' ' A' ' 12' ' ' GLU . 2.3 tt0 -42.24 115.16 0.65 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 112.758 -2.019 . . . . 0.0 112.831 -178.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.16 -148.54 11.85 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.44 172.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.8 m -55.89 97.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.106 0.453 . . . . 0.0 110.937 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.0 pttt 40.61 40.28 0.89 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.332 1.053 . . . . 0.0 112.085 -174.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.443 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 42.3 tt0 -55.96 139.57 70.64 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.932 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.583 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 52.1 Cg_exo -51.29 122.67 10.51 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.158 1.905 . . . . 0.0 110.058 178.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.801 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 9.3 t80 -72.22 -52.88 6.8 Favored Pre-proline 0 N--CA 1.442 -0.842 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -166.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.544 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 36.7 Cg_exo -56.2 -20.01 29.73 Favored 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 121.665 1.577 . . . . 0.0 110.968 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.583 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.1 m-20 -89.76 -40.21 12.64 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 113.845 -1.525 . . . . 0.0 110.754 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.436 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -56.01 -43.79 78.04 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 175.512 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.678 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 2.4 p -80.58 -33.24 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.379 -179.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.72 -34.88 67.92 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 121.594 -0.691 . . . . 0.0 111.937 175.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.727 ' O ' HG12 ' A' ' 24' ' ' VAL . 16.7 ptt180 -84.93 -26.87 26.95 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.649 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 4.5 tp -54.35 -49.2 70.34 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 171.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.678 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 30.6 mt-30 -67.21 -52.29 43.01 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.338 177.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.779 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 23.8 t70 -47.53 -53.53 14.17 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 -175.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.727 HG12 ' O ' ' A' ' 20' ' ' ARG . 5.0 p -81.59 -28.3 10.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.452 0.644 . . . . 0.0 110.381 -168.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.918 ' HB3' ' CZ ' ' A' ' 35' ' ' ARG . . . -78.91 -17.69 55.11 Favored 'General case' 0 C--O 1.198 -1.623 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 175.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.555 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -76.21 -37.74 57.37 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 172.803 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.779 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 39.7 mmtt -64.23 -36.16 83.17 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.508 177.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.0 t -104.26 -12.93 16.37 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.086 0.469 . . . . 0.0 110.27 -172.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.633 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 91.7 mt -111.8 117.11 54.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.296 177.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.49 -1.78 56.27 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.225 0.536 . . . . 0.0 110.076 175.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.596 ' H ' HG22 ' A' ' 29' ' ' ILE . 10.8 t70 -99.52 131.67 45.37 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.29 -177.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -75.23 -25.48 58.14 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.841 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.597 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -81.08 -52.8 7.0 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -175.18 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.537 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -59.79 -24.68 64.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.54 177.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.918 ' CZ ' ' HB3' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -72.73 -57.41 4.12 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.513 ' O ' HG22 ' A' ' 39' ' ' VAL . 22.4 mtpt -52.85 -55.6 21.9 Favored 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.706 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.708 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 13.9 m -55.82 -33.08 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.195 -171.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.892 HG22 HH12 ' A' ' 35' ' ' ARG . 0.2 OUTLIER -87.35 -31.4 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 119.642 -0.823 . . . . 0.0 111.687 177.761 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.765 HG12 ' NH2' ' A' ' 35' ' ' ARG . 1.3 m -57.41 -57.05 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 118.666 -1.213 . . . . 0.0 109.168 168.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.61 ' HG2' HG22 ' A' ' 68' ' ' VAL . 46.2 mt-10 -63.19 -29.74 71.03 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 124.252 1.021 . . . . 0.0 112.611 -175.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.708 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -85.43 -49.98 7.67 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.937 179.602 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.598 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 19.7 mmt -67.5 -20.5 65.45 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.56 0.695 . . . . 0.0 109.517 -177.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.651 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -52.36 -26.74 13.18 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.655 172.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.596 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 17.2 t80 -105.98 -68.12 0.89 Allowed 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 174.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.477 ' CG ' HD12 ' A' ' 41' ' ' LEU . 8.8 mm-40 -48.47 -26.6 2.22 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 124.323 1.014 . . . . 0.0 113.024 -175.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.768 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.1 m-20 -108.15 -21.92 12.59 Favored 'General case' 0 N--CA 1.435 -1.212 0 O-C-N 122.083 -0.386 . . . . 0.0 111.567 -178.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.632 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -59.49 178.95 0.13 Allowed 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.932 0.872 . . . . 0.0 112.925 -174.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.594 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 8.7 m-20 -60.2 140.45 91.17 Favored Pre-proline 0 N--CA 1.442 -0.83 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.452 174.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.424 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 79.5 Cg_exo -42.6 -47.73 7.51 Favored 'Trans proline' 0 C--N 1.33 -0.447 0 C-N-CA 122.877 2.385 . . . . 0.0 112.091 -178.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.56 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 0.3 OUTLIER -72.85 -33.4 66.11 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.119 0.967 . . . . 0.0 111.627 178.368 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.594 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 99.1 m -74.85 -37.28 62.26 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -173.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.615 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.8 pt20 -72.54 -31.4 65.27 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 174.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.56 ' HB2' ' HA ' ' A' ' 50' ' ' GLU . 12.0 m -68.49 -21.76 64.59 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.178 -1.373 . . . . 0.0 110.409 174.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.22 -25.18 46.86 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.756 0.789 . . . . 0.0 109.617 169.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.615 HD12 ' HA ' ' A' ' 52' ' ' GLN . 25.4 mt -89.56 -32.02 5.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -173.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.626 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -42.4 -38.94 2.81 Favored Pre-proline 0 N--CA 1.487 1.423 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -173.492 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 56.0 Cg_endo -63.57 -28.96 70.1 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 122.346 2.031 . . . . 0.0 112.958 175.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.547 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.6 mt -96.92 -16.53 20.63 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.596 ' HE3' ' HB3' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -53.36 109.41 0.43 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.189 -178.768 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.79 -20.38 47.47 Favored Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.525 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -104.11 114.19 28.26 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.477 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.3 p -123.02 140.28 33.18 Favored Pre-proline 0 C--N 1.311 -1.096 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 171.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo . . . . . 0 N--CA 1.462 -0.336 0 C-N-CA 122.429 2.086 . . . . 0.0 111.513 170.894 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.732 ' OD1' ' HB ' ' A' ' 69' ' ' ILE . 32.8 t70 . . . . . 0 CA--C 1.516 -0.358 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.61 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -79.48 -30.58 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 C-N-CA 118.049 -1.46 . . . . 0.0 108.832 178.448 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.763 ' O ' HG13 ' A' ' 73' ' ' VAL . 6.2 mm -59.09 -47.9 88.52 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.978 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.789 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 43.2 t -44.83 -39.37 5.27 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.253 175.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -86.54 -28.8 23.14 Favored 'General case' 0 CA--C 1.512 -0.505 0 C-N-CA 122.771 0.428 . . . . 0.0 111.086 -177.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.601 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.3 m-30 -76.55 -35.6 58.15 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.716 0.77 . . . . 0.0 109.462 -178.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.801 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.5 m -71.39 -30.29 38.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 172.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.465 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -68.05 -32.43 72.77 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.292 175.143 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -63.03 -43.65 98.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.916 177.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.421 ' SG ' ' HB2' ' A' ' 14' ' ' TYR . 23.7 t -94.96 4.47 53.77 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.033 178.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.465 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 10.9 t70 . . . . . 0 C--N 1.324 -0.506 0 CA-C-O 121.233 0.54 . . . . 0.0 110.271 176.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 1' ' ' PRO . . . . . 0.437 ' HB2' ' H ' ' B' ' 2' ' ' SER . 94.2 Cg_endo . . . . . 0 CA--C 1.519 -0.271 0 N-CA-C 109.115 -1.148 . . . . 0.0 109.115 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . 0.761 ' HB2' HG23 ' B' ' 5' ' ' THR . 74.3 m -68.69 -177.77 1.04 Allowed 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 162.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.782 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -77.85 -53.82 7.05 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.64 172.827 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.55 ' OD1' ' HG ' ' A' ' 41' ' ' LEU . 2.1 p-10 -87.61 5.71 38.11 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.973 -164.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.761 HG23 ' HB2' ' B' ' 2' ' ' SER . 2.2 p -64.85 -3.75 3.71 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.038 0.447 . . . . 0.0 111.418 -176.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.529 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.6 m -75.5 132.15 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 175.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.775 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -153.32 158.76 42.05 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -179.724 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' GLN . . . . . 0.451 ' HG2' ' HB3' ' B' ' 12' ' ' GLU . 2.3 tt0 -42.32 115.14 0.65 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 112.95 -1.932 . . . . 0.0 112.845 -178.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.4 -148.58 12.29 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.424 173.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 21.6 m -55.45 97.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 117.187 0.493 . . . . 0.0 111.096 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 60.9 pttt 40.5 40.73 0.93 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.275 1.03 . . . . 0.0 111.974 -174.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.451 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 41.1 tt0 -56.4 139.53 74.02 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.891 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . 0.574 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 52.0 Cg_exo -51.19 122.45 10.07 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.25 1.967 . . . . 0.0 110.019 178.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' TYR . . . . . 0.803 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 9.3 t80 -72.19 -52.91 6.84 Favored Pre-proline 0 N--CA 1.44 -0.935 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -166.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.533 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 36.6 Cg_exo -55.94 -20.11 28.4 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 121.589 1.526 . . . . 0.0 110.979 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.574 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 0.9 OUTLIER -89.77 -39.96 12.79 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.869 -1.514 . . . . 0.0 110.826 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' PHE . . . . . 0.441 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -56.28 -43.66 79.04 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 175.575 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.672 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 2.4 p -80.61 -33.23 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.344 -178.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.78 -34.71 67.89 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 121.627 -0.671 . . . . 0.0 111.967 175.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.731 ' O ' HG12 ' B' ' 24' ' ' VAL . 16.6 ptt180 -85.04 -26.96 26.69 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.652 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 4.5 tp -54.33 -49.24 70.18 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 171.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' GLN . . . . . 0.672 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 30.9 mt-30 -67.16 -52.39 42.07 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.203 177.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.801 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 24.5 t70 -47.38 -53.67 13.24 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -175.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' VAL . . . . . 0.731 HG12 ' O ' ' B' ' 20' ' ' ARG . 4.9 p -81.55 -28.27 10.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.289 0.566 . . . . 0.0 110.405 -168.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.91 ' HB3' ' CZ ' ' B' ' 35' ' ' ARG . . . -78.86 -17.6 55.36 Favored 'General case' 0 C--O 1.198 -1.646 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 175.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . 0.548 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -76.6 -37.36 56.57 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 172.83 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.801 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 39.1 mmtt -64.79 -35.32 80.72 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.539 177.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 32.7 t -105.0 -12.38 16.2 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.026 0.441 . . . . 0.0 110.426 -172.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.647 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 91.6 mt -112.43 116.8 53.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.359 177.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.03 -1.49 54.89 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.227 0.537 . . . . 0.0 110.153 175.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.592 ' H ' HG22 ' B' ' 29' ' ' ILE . 10.5 t70 -99.61 131.59 45.51 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.164 -177.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -75.12 -25.78 58.72 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.858 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.596 ' O ' HG13 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -80.93 -53.02 6.82 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -174.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.553 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -59.6 -24.61 63.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.641 177.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.91 ' CZ ' ' HB3' ' B' ' 25' ' ' ALA . 0.0 OUTLIER -72.87 -57.29 4.18 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.964 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.517 ' O ' HG22 ' B' ' 39' ' ' VAL . 22.5 mtpt -52.91 -55.58 22.27 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.754 177.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.714 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 13.7 m -55.88 -32.91 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.402 -171.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.867 HG22 HH12 ' B' ' 35' ' ' ARG . 0.2 OUTLIER -87.35 -31.45 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.632 177.687 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.757 HG12 ' NH2' ' B' ' 35' ' ' ARG . 1.3 m -57.35 -57.02 11.8 Favored 'Isoleucine or valine' 0 C--N 1.343 0.308 0 C-N-CA 118.663 -1.215 . . . . 0.0 109.242 168.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.6 ' HG2' HG22 ' B' ' 68' ' ' VAL . 46.3 mt-10 -63.25 -29.74 71.02 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 124.282 1.033 . . . . 0.0 112.572 -175.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.714 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -85.42 -50.08 7.59 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.983 179.52 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' MET . . . . . 0.588 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 19.8 mmt -67.4 -20.29 65.51 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.618 0.723 . . . . 0.0 109.672 -177.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.643 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -52.54 -26.76 14.12 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.668 172.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' TYR . . . . . 0.599 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 16.9 t80 -105.93 -68.03 0.9 Allowed 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.467 ' CG ' HD12 ' B' ' 41' ' ' LEU . 9.5 mm-40 -48.57 -26.69 2.33 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 124.259 0.975 . . . . 0.0 112.979 -175.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.775 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.2 m-20 -108.18 -21.9 12.59 Favored 'General case' 0 N--CA 1.435 -1.205 0 O-C-N 122.191 -0.318 . . . . 0.0 111.514 -178.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -59.41 179.27 0.11 Allowed 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 122.018 0.913 . . . . 0.0 112.99 -174.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' ASN . . . . . 0.596 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 7.9 m-20 -60.43 140.42 91.98 Favored Pre-proline 0 N--CA 1.442 -0.846 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.436 174.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . 0.422 ' O ' ' HG2' ' B' ' 52' ' ' GLN . 78.3 Cg_exo -42.41 -47.62 7.25 Favored 'Trans proline' 0 C--N 1.33 -0.411 0 C-N-CA 122.832 2.355 . . . . 0.0 112.251 -178.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . 0.564 ' HA ' ' HB2' ' B' ' 53' ' ' SER . 0.3 OUTLIER -73.09 -33.51 65.64 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 124.226 1.01 . . . . 0.0 111.654 178.435 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 98.0 m -74.72 -37.18 62.62 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 120.911 0.386 . . . . 0.0 110.024 -173.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . 0.617 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.8 pt20 -72.52 -31.52 65.39 Favored 'General case' 0 C--O 1.211 -0.925 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 174.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' SER . . . . . 0.564 ' HB2' ' HA ' ' B' ' 50' ' ' GLU . 13.2 m -68.42 -21.91 64.64 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.389 174.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.17 -25.0 47.0 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.756 0.789 . . . . 0.0 109.668 169.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.617 HD12 ' HA ' ' B' ' 52' ' ' GLN . 25.2 mt -89.62 -31.88 5.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -173.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.629 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -42.51 -38.79 2.82 Favored Pre-proline 0 N--CA 1.488 1.425 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -173.477 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 56.0 Cg_endo -63.74 -29.1 68.66 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 122.261 1.974 . . . . 0.0 112.912 175.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . 0.565 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.6 mt -96.65 -16.41 20.99 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . 0.599 ' HE3' ' HB3' ' B' ' 44' ' ' TYR . 0.0 OUTLIER -53.42 109.37 0.43 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.161 -178.801 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.76 -20.08 49.14 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.493 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -104.15 114.27 28.39 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.474 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.3 p -122.96 140.4 33.33 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 171.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo . . . . . 0 C--N 1.345 0.368 0 C-N-CA 122.347 2.031 . . . . 0.0 111.537 170.72 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 67' ' ' ASP . . . . . 0.716 ' OD1' ' HB ' ' B' ' 69' ' ' ILE . 29.8 t70 . . . . . 0 CA--C 1.515 -0.368 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.6 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.9 OUTLIER -79.6 -30.69 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 C-N-CA 118.072 -1.451 . . . . 0.0 108.765 178.417 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.754 ' O ' HG13 ' B' ' 73' ' ' VAL . 6.1 mm -59.01 -47.92 88.33 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.079 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.832 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 41.0 t -44.9 -39.3 5.31 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.273 175.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -86.45 -29.03 23.13 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 121.101 0.477 . . . . 0.0 111.015 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 72' ' ' TYR . . . . . 0.593 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.3 m-30 -76.48 -35.54 58.35 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.675 0.75 . . . . 0.0 109.402 -178.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.803 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.5 m -71.46 -30.5 39.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 172.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 74' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' B' ' 70' ' ' SER . 0.4 OUTLIER -67.92 -32.31 72.68 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.235 175.134 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -63.08 -43.76 97.64 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.888 177.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.412 ' SG ' ' HB2' ' B' ' 14' ' ' TYR . 26.3 t -95.08 4.4 53.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.037 178.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . 0.46 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 8.9 t70 . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.141 176.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.456 ' C ' ' HA3' ' B' ' 60' ' ' GLY . 93.5 Cg_endo . . . . . 0 CA--C 1.517 -0.344 0 N-CA-C 109.114 -1.148 . . . . 0.0 109.114 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.544 ' HB2' HG23 ' A' ' 5' ' ' THR . 58.9 m -65.31 177.78 1.04 Allowed 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 162.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.702 ' CB ' ' HA ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -77.27 -54.08 6.92 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.566 174.541 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.52 ' CG ' ' HG3' ' A' ' 42' ' ' MET . 1.8 p-10 -86.58 6.62 29.95 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.792 -165.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.627 ' CG2' ' HD3' ' B' ' 59' ' ' LYS . 0.7 OUTLIER -62.21 -4.94 1.97 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.025 0.441 . . . . 0.0 111.613 -177.507 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.662 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.4 m -75.93 130.3 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 174.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.76 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -154.79 159.64 40.75 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 118.6 -1.24 . . . . 0.0 113.643 -179.752 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.472 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.4 mt-30 -41.39 113.75 0.44 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.125 -1.852 . . . . 0.0 112.809 -178.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.98 -141.75 6.24 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.56 174.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.6 m -62.01 96.81 0.07 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 117.011 0.406 . . . . 0.0 110.528 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.2 pttt 41.54 41.94 1.8 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.423 1.089 . . . . 0.0 112.093 -176.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.413 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 71.8 tt0 -58.77 140.0 86.12 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.114 178.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.531 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 31.5 Cg_exo -54.25 123.55 13.85 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.23 1.953 . . . . 0.0 110.041 178.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.783 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 10.4 t80 -71.13 -52.4 9.35 Favored Pre-proline 0 N--CA 1.439 -0.991 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -166.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.55 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 37.5 Cg_exo -56.47 -19.38 28.91 Favored 'Trans proline' 0 C--N 1.36 1.134 0 C-N-CA 121.478 1.452 . . . . 0.0 111.116 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.531 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.4 m-20 -90.71 -39.32 12.51 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 113.952 -1.476 . . . . 0.0 110.766 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.472 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -56.78 -44.05 81.46 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.532 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.687 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 2.4 p -78.72 -32.99 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.12 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.71 -35.11 68.14 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 121.967 -0.458 . . . . 0.0 111.91 175.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.733 ' O ' HG12 ' A' ' 24' ' ' VAL . 15.3 ptt180 -85.18 -25.38 27.44 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.65 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 3.9 tp -55.57 -48.73 74.31 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.313 171.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.687 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 36.4 mt-30 -66.78 -52.05 48.59 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.658 177.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.739 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 11.4 t70 -47.79 -53.75 14.43 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -175.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 20' ' ' ARG . 4.3 p -82.53 -26.6 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 CA-C-O 122.04 0.924 . . . . 0.0 109.56 -169.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.709 ' HB3' ' CZ ' ' A' ' 35' ' ' ARG . . . -78.51 -16.88 57.01 Favored 'General case' 0 C--O 1.197 -1.699 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 176.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.471 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -80.04 -37.14 34.62 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.821 0.82 . . . . 0.0 108.88 172.875 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.739 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 44.5 mmtt -63.69 -32.73 74.31 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.429 176.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.433 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 34.7 m -106.06 -11.39 16.14 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.06 0.457 . . . . 0.0 110.622 -174.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.675 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 96.3 mt -117.58 119.43 61.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.57 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.28 -1.87 58.27 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.346 0.593 . . . . 0.0 110.08 175.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.536 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 9.6 t70 -96.65 121.83 38.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.385 -176.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -68.06 -23.02 64.91 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.999 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.563 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -82.42 -54.04 5.52 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -177.42 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.551 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -57.91 -24.96 60.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.84 178.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.917 ' NH1' ' HA ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -69.14 -62.2 1.48 Allowed 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 176.92 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.492 ' O ' HG22 ' A' ' 39' ' ' VAL . 18.0 mtpt -52.43 -53.93 38.85 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 120.809 0.338 . . . . 0.0 111.119 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.693 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 14.2 m -55.27 -35.65 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.308 -172.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.773 HG22 HH22 ' A' ' 35' ' ' ARG . 0.1 OUTLIER -87.36 -26.95 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 178.088 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.706 HG12 ' NH2' ' A' ' 35' ' ' ARG . 1.1 m -59.73 -55.97 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 119.091 -1.044 . . . . 0.0 108.316 169.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.613 ' HG2' HG22 ' A' ' 68' ' ' VAL . 41.7 mt-10 -61.52 -34.33 75.34 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.713 -178.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.693 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -74.87 -58.87 3.02 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.613 179.642 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.52 ' HG3' ' CG ' ' A' ' 4' ' ' ASN . 22.8 mmt -66.96 -20.13 65.84 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.418 0.628 . . . . 0.0 110.022 -174.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.66 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -51.75 -27.07 10.88 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.43 171.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.525 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 18.1 t80 -106.18 -67.6 0.92 Allowed 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.622 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 8.0 mm-40 -47.49 -32.91 5.66 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 124.377 1.048 . . . . 0.0 112.284 -173.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.76 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.4 m-20 -104.47 -21.06 13.51 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.413 -174.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.591 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -59.46 179.43 0.11 Allowed 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.797 0.808 . . . . 0.0 112.86 -174.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.645 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 8.6 m-20 -60.1 141.05 90.58 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.346 175.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -43.1 -44.65 9.67 Favored 'Trans proline' 0 C--N 1.331 -0.368 0 C-N-CA 122.819 2.346 . . . . 0.0 112.025 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.52 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 0.2 OUTLIER -76.79 -31.74 57.19 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.314 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.645 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 81.4 m -76.96 -36.33 56.58 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 120.901 0.382 . . . . 0.0 110.238 -173.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.561 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.6 pt20 -73.25 -30.92 63.79 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 173.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.554 ' O ' ' HE3' ' A' ' 56' ' ' LYS . 3.9 m -68.91 -19.8 64.21 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.052 -1.431 . . . . 0.0 110.446 173.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 51' ' ' CYS . . . -78.75 -27.1 44.68 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.646 0.736 . . . . 0.0 109.93 167.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.561 HD12 ' HA ' ' A' ' 52' ' ' GLN . 22.7 mt -89.23 -32.48 5.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -172.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.599 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -40.57 -38.72 1.29 Allowed Pre-proline 0 N--CA 1.488 1.428 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -174.461 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 53.3 Cg_endo -64.06 -28.53 65.75 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 122.233 1.956 . . . . 0.0 112.828 175.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.549 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.0 OUTLIER -99.51 -14.6 18.99 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.722 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.63 ' HD3' ' CG2' ' B' ' 5' ' ' THR . 0.1 OUTLIER -50.0 109.78 0.32 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.404 -178.844 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.456 ' HA3' ' C ' ' B' ' 1' ' ' PRO . . . 87.18 -17.94 39.49 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.358 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt -103.59 114.9 29.52 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.504 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.3 p -123.57 142.33 38.74 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.352 174.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo . . . . . 0 N--CA 1.463 -0.289 0 C-N-CA 122.349 2.033 . . . . 0.0 111.295 169.09 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.6 t70 . . . . . 0 CA--C 1.511 -0.532 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.613 HG22 ' HG2' ' A' ' 40' ' ' GLU . 1.1 m -81.38 -29.63 10.81 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 C-N-CA 118.33 -1.348 . . . . 0.0 108.787 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.781 ' O ' HG13 ' A' ' 73' ' ' VAL . 5.3 mm -60.14 -47.24 92.79 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.133 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.71 -178.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 40.7 t -47.68 -36.58 11.4 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.14 177.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -85.89 -31.52 22.16 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-O 121.046 0.45 . . . . 0.0 111.018 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.617 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.2 m-30 -74.49 -36.51 63.27 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.672 0.749 . . . . 0.0 109.516 -178.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.783 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.4 m -71.14 -30.72 41.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 173.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -69.7 -28.58 65.95 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.536 175.477 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -65.69 -45.81 81.38 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.766 176.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 14' ' ' TYR . 32.0 t -93.17 9.46 35.91 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.826 177.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.478 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 5.1 t70 . . . . . 0 C--N 1.323 -0.552 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.572 175.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 1' ' ' PRO . . . . . 0.456 ' C ' ' HA3' ' A' ' 60' ' ' GLY . 95.6 Cg_endo . . . . . 0 CA--C 1.518 -0.294 0 N-CA-C 109.191 -1.119 . . . . 0.0 109.191 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . 0.551 ' HB2' HG23 ' B' ' 5' ' ' THR . 67.7 m -65.66 177.78 1.16 Allowed 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 162.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.694 ' CB ' ' HA ' ' B' ' 25' ' ' ALA . 0.1 OUTLIER -77.17 -54.28 6.7 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.524 174.583 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.513 ' CG ' ' HG3' ' B' ' 42' ' ' MET . 1.8 p-10 -86.48 6.56 29.88 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.726 -1.125 . . . . 0.0 112.673 -165.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.63 ' CG2' ' HD3' ' A' ' 59' ' ' LYS . 0.7 OUTLIER -62.28 -4.86 1.98 Allowed 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.98 0.419 . . . . 0.0 111.591 -177.425 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.672 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.4 m -75.92 130.44 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 174.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.754 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -154.99 159.46 40.38 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 118.648 -1.221 . . . . 0.0 113.717 -179.678 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' GLN . . . . . 0.479 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.4 mt-30 -41.12 114.01 0.45 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.276 -1.783 . . . . 0.0 112.832 -178.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.13 -141.94 6.43 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.623 174.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 20.0 m -61.66 96.82 0.07 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.93 0.365 . . . . 0.0 110.572 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 62.3 pttt 41.24 42.24 1.67 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.36 1.064 . . . . 0.0 112.209 -176.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.415 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 73.2 tt0 -58.98 139.88 87.11 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.971 178.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . 0.534 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 31.4 Cg_exo -54.25 123.5 13.71 Favored 'Trans proline' 0 CA--C 1.511 -0.665 0 C-N-CA 122.219 1.946 . . . . 0.0 110.145 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' TYR . . . . . 0.781 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 10.2 t80 -70.94 -52.39 9.84 Favored Pre-proline 0 N--CA 1.44 -0.97 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -166.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.544 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 38.3 Cg_exo -56.47 -19.45 29.24 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 121.495 1.463 . . . . 0.0 111.127 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.534 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.3 m-20 -90.69 -38.93 12.75 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 113.933 -1.485 . . . . 0.0 110.895 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' PHE . . . . . 0.479 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -57.23 -43.94 83.34 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.562 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.667 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 2.4 p -78.72 -33.15 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.072 -179.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.65 -35.05 67.93 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 121.846 -0.534 . . . . 0.0 111.939 175.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.733 ' O ' HG12 ' B' ' 24' ' ' VAL . 15.3 ptt180 -85.13 -25.6 27.38 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.65 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 3.9 tp -55.26 -48.89 73.34 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 171.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' GLN . . . . . 0.667 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 36.1 mt-30 -66.65 -52.19 47.72 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.661 177.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.737 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 11.6 t70 -47.54 -54.01 12.84 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -176.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' VAL . . . . . 0.733 HG12 ' O ' ' B' ' 20' ' ' ARG . 4.2 p -82.46 -26.45 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 CA-C-O 121.975 0.893 . . . . 0.0 109.569 -169.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.715 ' HB3' ' CZ ' ' B' ' 35' ' ' ARG . . . -78.57 -16.81 56.99 Favored 'General case' 0 C--O 1.198 -1.638 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 176.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . 0.462 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -80.15 -37.29 33.77 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.025 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.737 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 45.0 mmtt -63.67 -32.83 74.44 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.333 177.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . 0.429 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 29.2 m -106.02 -11.18 16.23 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.087 0.47 . . . . 0.0 110.578 -174.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.689 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 95.9 mt -117.79 119.34 61.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.554 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.42 -1.63 58.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.309 0.576 . . . . 0.0 110.114 175.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.549 ' H ' HG22 ' B' ' 29' ' ' ILE . 9.3 t70 -96.84 121.96 39.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.457 -177.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -68.4 -22.68 64.62 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.95 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.58 ' O ' HG13 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -82.54 -53.94 5.56 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -177.555 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.561 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -57.95 -24.95 60.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.881 178.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.94 ' NH1' ' HA ' ' B' ' 35' ' ' ARG . 0.0 OUTLIER -69.11 -62.21 1.47 Allowed 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.843 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.501 ' O ' HG22 ' B' ' 39' ' ' VAL . 18.0 mtpt -52.45 -54.06 37.22 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 120.715 0.293 . . . . 0.0 111.087 -178.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.689 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 14.1 m -55.1 -35.77 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.321 -172.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.755 HG22 HH22 ' B' ' 35' ' ' ARG . 0.1 OUTLIER -87.38 -26.94 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 178.142 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.706 HG12 ' NH2' ' B' ' 35' ' ' ARG . 1.1 m -59.62 -56.05 19.8 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 C-N-CA 118.987 -1.085 . . . . 0.0 108.318 168.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.628 ' HG2' HG22 ' B' ' 68' ' ' VAL . 43.7 mt-10 -61.34 -34.66 75.63 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 114.46 -1.245 . . . . 0.0 111.672 -177.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.689 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -74.53 -58.86 3.02 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.7 179.716 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' MET . . . . . 0.513 ' HG3' ' CG ' ' B' ' 4' ' ' ASN . 22.9 mmt -66.86 -20.2 65.88 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.343 0.592 . . . . 0.0 109.964 -174.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.654 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -51.77 -27.22 11.47 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.313 171.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' TYR . . . . . 0.516 ' CG ' ' HD2' ' B' ' 59' ' ' LYS . 18.1 t80 -106.08 -67.57 0.92 Allowed 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 175.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.624 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 7.8 mm-40 -47.54 -33.04 5.94 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 124.378 1.049 . . . . 0.0 112.196 -173.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.754 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.4 m-20 -104.39 -20.93 13.57 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.419 -174.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.577 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -59.62 179.43 0.12 Allowed 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.8 0.809 . . . . 0.0 112.864 -174.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' ASN . . . . . 0.646 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 8.8 m-20 -59.99 140.98 90.24 Favored Pre-proline 0 N--CA 1.443 -0.796 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.488 175.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -43.4 -44.32 10.53 Favored 'Trans proline' 0 C--N 1.332 -0.337 0 C-N-CA 122.792 2.328 . . . . 0.0 112.016 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . 0.526 ' HA ' ' HB2' ' B' ' 53' ' ' SER . 0.2 OUTLIER -76.94 -31.55 56.7 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.326 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.646 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 83.4 m -77.26 -36.45 54.39 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -173.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . 0.557 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.6 pt20 -73.16 -30.94 63.93 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 173.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' SER . . . . . 0.568 ' O ' ' HE3' ' B' ' 56' ' ' LYS . 3.7 m -68.9 -19.84 64.23 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.183 -1.371 . . . . 0.0 110.498 173.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' B' ' 51' ' ' CYS . . . -78.67 -27.08 45.11 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.612 0.72 . . . . 0.0 110.006 167.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.557 HD12 ' HA ' ' B' ' 52' ' ' GLN . 22.6 mt -89.39 -32.24 5.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 -171.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.598 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -40.7 -38.71 1.34 Allowed Pre-proline 0 N--CA 1.487 1.384 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -174.601 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 51.7 Cg_endo -63.72 -29.0 68.81 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.193 1.928 . . . . 0.0 112.809 175.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . 0.563 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.0 OUTLIER -99.29 -14.6 19.17 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 -179.5 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . 0.627 ' HD3' ' CG2' ' A' ' 5' ' ' THR . 0.1 OUTLIER -49.87 109.78 0.32 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.448 -178.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . 0.456 ' HA3' ' C ' ' A' ' 1' ' ' PRO . . . 87.09 -18.32 36.89 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.357 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -103.36 114.85 29.46 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -178.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.497 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.4 p -123.55 142.41 38.91 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.353 174.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo . . . . . 0 C--O 1.235 0.351 0 C-N-CA 122.41 2.073 . . . . 0.0 111.419 168.941 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 2.7 t70 . . . . . 0 CA--C 1.512 -0.516 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.628 HG22 ' HG2' ' B' ' 40' ' ' GLU . 1.1 m -81.37 -29.54 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 C-N-CA 118.371 -1.331 . . . . 0.0 108.856 178.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.777 ' O ' HG13 ' B' ' 73' ' ' VAL . 5.3 mm -60.18 -47.14 93.27 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.093 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.695 -178.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 40.8 t -48.01 -36.51 12.89 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.078 177.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -85.79 -31.25 22.44 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 122.862 0.465 . . . . 0.0 111.079 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 72' ' ' TYR . . . . . 0.607 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.2 m-30 -74.77 -36.72 62.55 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 121.671 0.748 . . . . 0.0 109.489 -178.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.781 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.4 m -70.9 -30.82 43.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 173.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 74' ' ' LYS . . . . . 0.493 ' O ' ' HB3' ' B' ' 77' ' ' ASP . 0.0 OUTLIER -69.66 -28.54 65.97 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.552 175.495 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -65.51 -46.12 80.89 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.752 176.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' B' ' 14' ' ' TYR . 32.1 t -93.02 9.78 34.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.84 178.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . 0.493 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 4.4 t70 . . . . . 0 C--N 1.322 -0.605 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.637 175.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo . . . . . 0 N--CA 1.464 -0.227 0 N-CA-C 108.601 -1.346 . . . . 0.0 108.601 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.2 m -70.44 -176.12 1.17 Allowed 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 163.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.618 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -77.14 -54.42 6.54 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 122.406 1.098 . . . . 0.0 109.062 171.681 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.679 ' HB2' HD11 ' A' ' 21' ' ' LEU . 2.4 p-10 -85.6 5.91 29.66 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 113.533 -1.667 . . . . 0.0 113.332 -160.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.24 -1.05 7.02 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -174.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.687 ' O ' HG23 ' A' ' 6' ' ' VAL . 24.0 m -81.41 92.84 2.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 122.259 1.028 . . . . 0.0 112.162 -174.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 1.096 ' NE ' ' HB3' ' A' ' 46' ' ' ASN . 13.8 mmm180 -107.19 150.6 26.44 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.506 -1.371 . . . . 0.0 112.978 -159.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.582 ' HG3' ' CG ' ' A' ' 17' ' ' PHE . 2.1 tt0 -44.41 109.12 0.14 Allowed 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 112.53 -2.123 . . . . 0.0 111.572 173.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.39 -152.56 9.42 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.742 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.8 m -55.81 97.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.911 0.355 . . . . 0.0 110.733 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.7 pttt 40.24 46.1 1.88 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.267 1.027 . . . . 0.0 111.935 -172.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.434 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 46.3 tt0 -60.34 136.49 91.71 Favored Pre-proline 0 C--O 1.236 0.381 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.452 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 38.4 Cg_exo -53.46 120.52 7.92 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.198 1.932 . . . . 0.0 110.943 -177.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.841 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 5.4 t80 -64.94 -56.05 23.54 Favored Pre-proline 0 C--N 1.313 -0.986 0 C-N-CA 119.73 -0.788 . . . . 0.0 112.737 -161.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.55 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 35.2 Cg_exo -55.89 -19.69 26.46 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.009 1.806 . . . . 0.0 111.508 -176.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.452 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.2 m-20 -89.46 -38.41 14.08 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.233 -178.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.916 ' HE1' ' NH2' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -61.74 -42.12 98.55 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.09 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.748 HG21 HD12 ' A' ' 69' ' ' ILE . 1.7 p -80.63 -31.69 12.71 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.9 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.841 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.67 -36.74 67.43 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 121.762 -0.586 . . . . 0.0 110.975 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.736 ' O ' HG12 ' A' ' 24' ' ' VAL . 15.4 ptt180 -82.29 -27.08 32.56 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.907 HD13 ' NH1' ' A' ' 7' ' ' ARG . 9.7 tp -55.24 -44.3 75.38 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.175 172.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.67 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 26.1 mt-30 -73.97 -51.57 15.57 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.309 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.744 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 45.3 m-20 -47.02 -51.28 17.67 Favored 'General case' 0 C--N 1.313 -1.006 0 O-C-N 124.532 1.145 . . . . 0.0 110.917 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.736 HG12 ' O ' ' A' ' 20' ' ' ARG . 9.9 p -79.64 -27.15 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 C-N-CA 119.936 -0.705 . . . . 0.0 109.833 -171.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.646 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -66.69 -31.57 72.33 Favored 'General case' 0 C--O 1.204 -1.301 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 175.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.418 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -74.69 -35.96 62.75 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.042 -1.435 . . . . 0.0 109.932 -178.19 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.744 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 37.3 mmtt -67.41 -36.38 81.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.466 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.506 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 21.6 m -104.89 -10.23 17.45 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.193 0.521 . . . . 0.0 110.656 -171.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.654 HG22 ' H ' ' A' ' 31' ' ' ASP . 78.1 mt -113.94 124.85 70.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.198 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.95 -1.87 57.73 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.947 0.403 . . . . 0.0 110.863 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.654 ' H ' HG22 ' A' ' 29' ' ' ILE . 4.1 t0 -114.13 140.12 48.77 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-O 121.618 0.723 . . . . 0.0 111.528 -177.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -71.02 -32.17 68.86 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.36 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.563 ' O ' HG13 ' A' ' 37' ' ' VAL . 12.0 mttp -67.07 -56.1 11.5 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -176.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.584 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -61.92 -25.49 67.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.57 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.842 ' O ' HG13 ' A' ' 39' ' ' VAL . 1.8 tmm_? -68.67 -58.62 3.97 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.43 ' HB3' ' OE2' ' A' ' 40' ' ' GLU . 15.8 mtpt -55.91 -57.0 13.96 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.205 179.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.793 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 23.9 m -52.25 -36.91 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.048 -170.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.618 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.3 tt -88.31 -30.83 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 C-N-CA 119.823 -0.751 . . . . 0.0 112.161 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.842 HG13 ' O ' ' A' ' 35' ' ' ARG . 3.2 m -67.01 -50.16 66.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 119.24 -0.984 . . . . 0.0 109.242 174.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.632 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 54.7 mt-10 -66.51 -23.58 66.27 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 123.816 0.846 . . . . 0.0 112.406 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.793 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -85.84 -56.97 3.23 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.325 176.338 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.58 ' HB2' HD21 ' A' ' 21' ' ' LEU . 25.0 mmt -59.82 -24.95 64.59 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 121.348 0.594 . . . . 0.0 109.996 -175.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.66 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -46.66 -28.3 1.44 Allowed 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.149 174.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.628 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 7.7 t80 -103.99 -68.02 0.87 Allowed 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 174.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.73 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 5.5 mm-40 -45.23 -35.45 3.34 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.25 -1.341 . . . . 0.0 112.834 -171.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 1.096 ' HB3' ' NE ' ' A' ' 7' ' ' ARG . 1.4 m-20 -111.76 -7.34 14.22 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.873 -172.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.66 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -68.01 -169.9 0.15 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.601 0.715 . . . . 0.0 112.425 -175.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.598 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 11.2 m-20 -66.03 140.42 97.04 Favored Pre-proline 0 N--CA 1.442 -0.836 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.939 171.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.464 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 3.0 Cg_endo -46.74 -46.75 17.43 Favored 'Trans proline' 0 CA--C 1.53 0.308 0 C-N-CA 122.642 2.228 . . . . 0.0 111.928 -176.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.584 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 0.3 OUTLIER -72.15 -31.31 65.84 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 124.185 0.994 . . . . 0.0 111.62 177.8 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.598 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 96.0 m -75.25 -36.36 61.29 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 120.889 0.376 . . . . 0.0 110.03 -173.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.61 ' HA ' HD12 ' A' ' 55' ' ' ILE . 4.3 pt20 -73.38 -32.21 64.36 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 174.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.597 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 27.0 m -66.87 -21.46 66.01 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 114.033 -1.439 . . . . 0.0 110.064 173.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 51' ' ' CYS . . . -77.85 -27.43 49.84 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.431 -0.793 . . . . 0.0 110.036 169.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.61 HD12 ' HA ' ' A' ' 52' ' ' GLN . 23.4 mt -89.11 -31.16 5.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -171.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.622 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.93 -39.27 2.64 Favored Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -173.347 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 57.3 Cg_endo -64.33 -25.98 63.9 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.457 2.104 . . . . 0.0 112.925 176.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.529 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.3 mt -99.96 -16.31 18.01 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.628 ' HE3' ' HB3' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -53.01 109.64 0.44 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.988 -178.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.29 -21.57 41.75 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.548 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -103.82 113.51 27.09 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 121.147 0.498 . . . . 0.0 110.032 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.12 143.78 43.51 Favored Pre-proline 0 C--N 1.312 -1.051 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 170.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo . . . . . 0 C--N 1.346 0.431 0 C-N-CA 122.767 2.311 . . . . 0.0 111.836 168.71 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.747 ' OD1' ' HB ' ' A' ' 69' ' ' ILE . 19.3 t70 . . . . . 0 C--O 1.232 0.163 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.554 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -80.96 -30.89 11.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 C-N-CA 118.647 -1.221 . . . . 0.0 109.472 178.259 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.789 ' O ' HG13 ' A' ' 73' ' ' VAL . 14.5 mm -57.63 -46.78 86.46 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.223 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 178.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.4 t -43.24 -39.34 2.94 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.478 174.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -85.45 -33.59 21.85 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 123.413 0.685 . . . . 0.0 110.831 -177.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.656 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.2 m-30 -75.38 -35.04 61.14 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.467 -176.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.841 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.6 m -70.64 -31.92 47.73 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.518 ' HA ' ' HB2' ' A' ' 77' ' ' ASP . 23.1 ttpt -71.79 -27.53 63.01 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.616 -1.174 . . . . 0.0 109.865 176.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.463 ' HB2' HD11 ' A' ' 58' ' ' LEU . . . -64.8 -44.54 89.61 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.59 175.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.556 ' SG ' ' HB2' ' A' ' 14' ' ' TYR . 31.0 t -92.95 9.14 36.82 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.648 177.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.518 ' HB2' ' HA ' ' A' ' 74' ' ' LYS . 25.2 t70 . . . . . 0 C--N 1.325 -0.471 0 CA-C-O 121.507 0.67 . . . . 0.0 109.914 174.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 1' ' ' PRO . . . . . 0.461 ' HB2' ' H ' ' B' ' 2' ' ' SER . 86.2 Cg_endo . . . . . 0 N--CA 1.464 -0.23 0 N-CA-C 108.679 -1.316 . . . . 0.0 108.679 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . 0.461 ' H ' ' HB2' ' B' ' 1' ' ' PRO . 49.7 m -70.13 -176.13 1.09 Allowed 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 163.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.63 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.0 OUTLIER -77.23 -54.36 6.59 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 122.398 1.095 . . . . 0.0 109.021 171.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.663 ' HB2' HD11 ' B' ' 21' ' ' LEU . 2.4 p-10 -85.49 5.97 28.95 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 113.446 -1.706 . . . . 0.0 113.366 -160.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.44 -1.09 7.57 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -174.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.674 ' O ' HG23 ' B' ' 6' ' ' VAL . 23.3 m -81.38 92.78 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-O 122.264 1.03 . . . . 0.0 112.08 -174.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 1.102 ' NE ' ' HB3' ' B' ' 46' ' ' ASN . 13.8 mmm180 -107.17 150.71 26.31 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.512 -1.368 . . . . 0.0 113.007 -159.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' GLN . . . . . 0.572 ' HG3' ' CG ' ' B' ' 17' ' ' PHE . 2.1 tt0 -44.43 109.23 0.14 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 112.626 -2.079 . . . . 0.0 111.617 172.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.45 -152.61 9.56 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.708 176.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 19.6 m -56.15 98.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.822 0.311 . . . . 0.0 110.709 -177.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 52.7 pttt 39.86 46.79 1.74 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.054 0.942 . . . . 0.0 111.909 -172.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.453 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 46.9 tt0 -60.81 136.33 93.05 Favored Pre-proline 0 C--O 1.234 0.278 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . 0.459 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 39.8 Cg_exo -53.34 120.55 7.94 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.079 1.852 . . . . 0.0 111.012 -177.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' TYR . . . . . 0.843 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 5.5 t80 -65.07 -56.04 22.98 Favored Pre-proline 0 C--N 1.314 -0.972 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.709 -161.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.551 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 32.1 Cg_exo -55.87 -19.62 26.01 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 121.987 1.792 . . . . 0.0 111.521 -176.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.459 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.2 m-20 -89.45 -38.62 13.93 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.145 -178.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' PHE . . . . . 0.908 ' HE1' ' NH2' ' B' ' 7' ' ' ARG . 0.1 OUTLIER -61.62 -42.15 98.47 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.273 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.726 HG21 HD12 ' B' ' 69' ' ' ILE . 1.7 p -80.69 -31.48 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.947 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.96 -36.54 67.93 Favored 'General case' 0 C--N 1.315 -0.902 0 O-C-N 121.653 -0.654 . . . . 0.0 110.922 175.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.736 ' O ' HG12 ' B' ' 24' ' ' VAL . 15.5 ptt180 -82.37 -27.14 32.3 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.898 HD13 ' NH1' ' B' ' 7' ' ' ARG . 9.7 tp -55.14 -44.44 75.09 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.11 172.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' GLN . . . . . 0.658 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 25.5 mt-30 -73.97 -51.58 15.54 Favored 'General case' 0 CA--C 1.486 -1.494 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.24 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.733 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 41.7 m-20 -46.96 -51.38 17.17 Favored 'General case' 0 C--N 1.311 -1.08 0 O-C-N 124.34 1.025 . . . . 0.0 110.874 178.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' VAL . . . . . 0.736 HG12 ' O ' ' B' ' 20' ' ' ARG . 9.8 p -79.51 -27.29 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.789 -171.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.649 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -66.61 -31.66 72.5 Favored 'General case' 0 C--O 1.205 -1.288 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 175.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . 0.414 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -74.52 -36.26 63.18 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 114.0 -1.455 . . . . 0.0 109.81 -178.225 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.733 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.1 mmtt -67.17 -36.42 81.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.394 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . 0.491 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 25.2 m -104.69 -10.46 17.47 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.364 0.602 . . . . 0.0 110.609 -171.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.675 HG22 ' H ' ' B' ' 31' ' ' ASP . 78.3 mt -113.65 124.86 70.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.313 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.21 -1.94 57.91 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.972 0.415 . . . . 0.0 110.732 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.675 ' H ' HG22 ' B' ' 29' ' ' ILE . 4.0 t0 -113.48 140.59 47.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.58 0.705 . . . . 0.0 111.481 -177.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -71.55 -32.26 67.91 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.469 175.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.575 ' O ' HG13 ' B' ' 37' ' ' VAL . 11.8 mttp -67.08 -55.92 12.24 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -176.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.574 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -61.97 -25.52 67.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.559 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.854 ' O ' HG13 ' B' ' 39' ' ' VAL . 1.8 tmm_? -68.7 -58.66 3.91 Favored 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.44 ' HB3' ' OE2' ' B' ' 40' ' ' GLU . 15.7 mtpt -55.86 -57.04 13.73 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.227 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.802 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 23.6 m -52.25 -36.91 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.094 -170.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.63 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.3 tt -88.16 -30.85 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.218 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.854 HG13 ' O ' ' B' ' 35' ' ' ARG . 3.2 m -66.96 -50.19 66.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.309 174.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.633 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 52.1 mt-10 -66.4 -23.76 66.37 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 123.891 0.877 . . . . 0.0 112.351 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.802 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.77 -57.12 3.17 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.238 176.447 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' MET . . . . . 0.584 ' HB2' HD21 ' B' ' 21' ' ' LEU . 25.1 mmt -59.63 -25.0 64.32 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.358 0.599 . . . . 0.0 109.993 -175.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.665 ' O ' ' HB2' ' B' ' 47' ' ' ALA . . . -46.63 -28.45 1.47 Allowed 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.133 174.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' TYR . . . . . 0.62 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 7.8 t80 -103.74 -68.02 0.86 Allowed 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 174.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.75 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 5.6 mm-40 -45.22 -35.74 3.5 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.186 -1.37 . . . . 0.0 112.778 -171.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 1.102 ' HB3' ' NE ' ' B' ' 7' ' ' ARG . 1.4 m-20 -111.7 -7.21 14.26 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.846 -172.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.665 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -68.03 -169.74 0.15 Allowed 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.62 0.724 . . . . 0.0 112.498 -175.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' ASN . . . . . 0.609 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 11.2 m-20 -66.21 140.38 96.85 Favored Pre-proline 0 N--CA 1.442 -0.843 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.083 171.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . 0.467 ' O ' ' HG2' ' B' ' 52' ' ' GLN . 2.9 Cg_endo -46.83 -46.63 17.92 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.685 2.257 . . . . 0.0 111.866 -176.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . 0.589 ' HA ' ' HB2' ' B' ' 53' ' ' SER . 0.3 OUTLIER -72.31 -31.14 65.44 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 124.199 1.0 . . . . 0.0 111.591 177.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.609 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 94.6 m -75.3 -36.43 61.12 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 120.996 0.427 . . . . 0.0 109.993 -173.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . 0.59 ' HB2' ' CG ' ' B' ' 44' ' ' TYR . 4.4 pt20 -73.43 -32.07 64.18 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 174.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' SER . . . . . 0.609 ' O ' ' HE2' ' B' ' 56' ' ' LYS . 26.4 m -66.97 -21.45 65.97 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 114.014 -1.448 . . . . 0.0 109.999 173.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' B' ' 51' ' ' CYS . . . -78.0 -27.29 48.98 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.398 -0.814 . . . . 0.0 109.985 169.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.589 HD12 ' HA ' ' B' ' 52' ' ' GLN . 23.3 mt -89.17 -31.28 5.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 -171.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.617 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.8 -39.37 2.59 Favored Pre-proline 0 N--CA 1.488 1.435 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -173.263 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 57.5 Cg_endo -64.17 -26.25 64.99 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.383 2.055 . . . . 0.0 112.925 176.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . 0.532 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.4 mt -99.78 -16.54 18.06 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . 0.62 ' HE3' ' HB3' ' B' ' 44' ' ' TYR . 0.0 OUTLIER -52.66 109.77 0.44 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.131 -179.093 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.97 -21.63 40.75 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.696 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -103.92 113.48 27.05 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.21 0.528 . . . . 0.0 110.051 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.411 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.6 p -124.18 143.41 42.59 Favored Pre-proline 0 C--N 1.312 -1.05 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.765 170.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo . . . . . 0 C--N 1.347 0.475 0 C-N-CA 122.686 2.257 . . . . 0.0 111.944 168.807 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 67' ' ' ASP . . . . . 0.748 ' OD1' ' HB ' ' B' ' 69' ' ' ILE . 19.5 t70 . . . . . 0 CA--C 1.52 -0.208 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.564 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.8 OUTLIER -80.93 -30.95 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 C-N-CA 118.588 -1.245 . . . . 0.0 109.517 178.193 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.789 ' O ' HG13 ' B' ' 73' ' ' VAL . 14.3 mm -57.57 -47.04 86.14 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.181 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 30.8 t -43.38 -39.22 3.08 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.45 174.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -85.34 -33.48 22.04 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 123.503 0.721 . . . . 0.0 110.807 -177.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 72' ' ' TYR . . . . . 0.645 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.1 m-30 -75.44 -35.04 61.0 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.449 -176.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.843 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.6 m -70.86 -31.79 46.68 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 173.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 74' ' ' LYS . . . . . 0.501 ' HA ' ' HB2' ' B' ' 77' ' ' ASP . 23.0 ttpt -71.84 -27.53 62.96 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.81 176.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . 0.456 ' HB2' HD11 ' B' ' 58' ' ' LEU . . . -64.9 -44.18 90.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.651 175.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.568 ' SG ' ' HB2' ' B' ' 14' ' ' TYR . 30.7 t -93.45 9.22 37.46 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.612 177.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . 0.501 ' HB2' ' HA ' ' B' ' 74' ' ' LYS . 24.7 t70 . . . . . 0 C--N 1.326 -0.435 0 CA-C-O 121.576 0.703 . . . . 0.0 110.068 173.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo . . . . . 0 CA--C 1.517 -0.337 0 N-CA-C 109.293 -1.08 . . . . 0.0 109.293 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.1 m -68.73 167.95 14.28 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 163.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.768 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -70.96 -54.38 11.52 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.992 0.901 . . . . 0.0 109.864 172.79 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.545 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 3.0 p-10 -86.76 -4.04 59.13 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.419 -1.264 . . . . 0.0 113.181 -164.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.453 ' HA ' ' OE1' ' B' ' 45' ' ' GLU . 9.9 t -65.47 -2.97 3.72 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.29 0.567 . . . . 0.0 111.075 -173.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.596 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.7 m -73.05 135.26 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 172.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.791 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -154.59 159.43 40.86 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 -178.789 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.542 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.4 mt-30 -42.83 118.98 1.36 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 112.585 -2.098 . . . . 0.0 113.318 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.9 -161.66 37.68 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.843 169.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.5 m -48.05 102.44 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 117.097 0.448 . . . . 0.0 111.592 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.3 pttt 38.91 44.28 0.84 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.533 1.133 . . . . 0.0 112.498 -173.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.494 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 37.8 tt0 -61.96 138.04 95.59 Favored Pre-proline 0 C--O 1.234 0.26 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 177.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.59 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 50.4 Cg_exo -50.68 122.55 9.88 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.244 1.963 . . . . 0.0 110.173 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.81 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 11.3 t80 -71.28 -54.17 7.29 Favored Pre-proline 0 N--CA 1.44 -0.934 0 CA-C-O 118.471 -0.776 . . . . 0.0 113.08 -167.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.533 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 34.5 Cg_exo -55.69 -18.79 21.94 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 121.459 1.44 . . . . 0.0 111.122 -179.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.59 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 2.0 m-20 -90.13 -42.2 11.21 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.881 -1.509 . . . . 0.0 111.001 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.542 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -54.6 -44.17 72.8 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.16 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.788 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 2.0 p -80.84 -34.15 13.77 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.362 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.692 -178.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.16 -31.64 67.43 Favored 'General case' 0 C--N 1.317 -0.841 0 O-C-N 121.276 -0.89 . . . . 0.0 111.881 177.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.718 ' O ' HG12 ' A' ' 24' ' ' VAL . 16.0 ptt180 -84.03 -29.9 26.54 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 175.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.562 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 8.3 tp -53.61 -49.61 67.45 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.992 172.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.788 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 24.6 mt-30 -69.43 -48.22 61.64 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.187 177.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.734 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 18.1 t70 -47.53 -53.31 14.8 Favored 'General case' 0 C--N 1.315 -0.933 0 O-C-N 124.267 0.979 . . . . 0.0 111.532 -177.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.718 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.4 p -82.1 -22.51 9.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.151 0.5 . . . . 0.0 109.79 -173.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.804 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -72.42 -19.44 61.59 Favored 'General case' 0 C--O 1.202 -1.422 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 173.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.41 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -87.06 -37.44 17.44 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.707 178.18 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.734 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 37.0 mmtt -66.94 -34.48 77.87 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.694 178.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.6 m -103.58 -11.07 17.96 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.195 0.521 . . . . 0.0 110.582 -172.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.804 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 88.7 mt -118.15 129.76 74.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.67 -178.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.99 -1.44 52.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.441 0.639 . . . . 0.0 110.367 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.638 ' H ' HG22 ' A' ' 29' ' ' ILE . 11.1 t70 -106.81 115.7 30.65 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.458 -177.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.646 ' OE2' ' HG3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -57.12 -33.33 67.24 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.149 178.262 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.646 ' HG3' ' OE2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -70.78 -54.72 10.62 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -173.354 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.564 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -60.68 -28.82 68.9 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.826 177.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.855 ' O ' HG13 ' A' ' 39' ' ' VAL . 2.1 tmm_? -65.4 -60.39 3.01 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.41 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 15.5 mtpt -55.41 -56.65 17.7 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.239 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.719 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 17.6 m -55.18 -33.68 30.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.112 -170.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.768 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.5 tt -87.25 -31.87 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.635 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.855 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.5 m -68.56 -48.14 73.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 119.015 -1.074 . . . . 0.0 109.178 175.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.657 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 73.0 mt-10 -63.18 -27.93 69.7 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 123.634 0.774 . . . . 0.0 112.749 176.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.719 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -86.04 -50.65 6.88 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.838 178.173 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.716 ' HE2' ' HE2' ' B' ' 42' ' ' MET . 17.8 mmt -64.85 -20.87 66.64 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.632 0.729 . . . . 0.0 109.764 -178.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.685 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -50.62 -28.63 9.16 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.542 171.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.593 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 19.9 t80 -103.9 -67.61 0.89 Allowed 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 174.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.453 ' CG ' HD12 ' A' ' 41' ' ' LEU . 27.2 mm-40 -50.54 -28.08 7.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.703 -1.135 . . . . 0.0 113.076 -173.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.791 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.1 m-20 -105.73 -22.24 13.0 Favored 'General case' 0 N--CA 1.435 -1.19 0 O-C-N 122.325 -0.234 . . . . 0.0 110.809 -177.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -60.36 178.76 0.18 Allowed 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 122.059 0.933 . . . . 0.0 112.818 -174.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.677 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 17.1 m-20 -58.2 141.63 81.93 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 114.155 -1.384 . . . . 0.0 109.245 174.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -55.02 -23.41 35.08 Favored 'Trans proline' 0 C--O 1.218 -0.515 0 C-N-CA 123.26 2.64 . . . . 0.0 112.407 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.705 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 13.4 pm0 -88.93 -32.12 17.85 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 123.765 0.826 . . . . 0.0 110.85 175.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.705 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 85.8 m -80.5 -38.15 30.36 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.328 -171.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.601 ' HA ' HD12 ' A' ' 55' ' ' ILE . 4.3 pt20 -70.0 -29.72 66.86 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 172.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.471 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 4.8 m -71.36 -20.82 62.11 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.119 175.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.55 -25.15 45.38 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.689 0.757 . . . . 0.0 109.821 168.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.601 HD12 ' HA ' ' A' ' 52' ' ' GLN . 22.6 mt -89.97 -32.53 5.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -172.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.63 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.99 -39.5 2.9 Favored Pre-proline 0 N--CA 1.486 1.344 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -172.799 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.63 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 50.6 Cg_endo -62.18 -28.81 79.88 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.187 1.924 . . . . 0.0 112.646 176.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.547 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.3 mt -98.35 -15.7 19.62 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.593 ' HE3' ' HB3' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -52.39 109.17 0.36 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.078 -179.454 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.54 -22.36 39.42 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.462 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.9 mmmt -103.55 113.0 26.17 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.17 0.509 . . . . 0.0 109.831 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.443 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.4 p -124.84 146.45 53.19 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.802 172.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo . . . . . 0 C--N 1.344 0.306 0 C-N-CA 122.288 1.992 . . . . 0.0 111.62 166.343 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.658 ' OD2' ' HB ' ' A' ' 69' ' ' ILE . 0.4 OUTLIER . . . . . 0 CA--C 1.517 -0.318 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.574 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.7 OUTLIER -78.53 -27.65 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 C-N-CA 118.863 -1.135 . . . . 0.0 108.991 177.373 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.758 ' O ' HG13 ' A' ' 73' ' ' VAL . 12.3 mm -58.12 -46.23 88.38 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.184 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.058 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 29.4 t -46.16 -37.54 7.14 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.157 176.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -85.63 -32.34 22.09 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.149 0.5 . . . . 0.0 110.705 -177.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.6 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.1 m-30 -75.93 -35.18 59.82 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.526 -176.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.81 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.5 m -71.79 -31.77 42.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 172.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -67.08 -31.77 72.48 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.339 175.459 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -63.65 -46.98 83.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.109 177.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.628 ' SG ' ' HB2' ' A' ' 14' ' ' TYR . 24.4 t -92.44 9.35 34.67 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.902 178.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 12.1 t70 . . . . . 0 C--N 1.323 -0.554 0 CA-C-O 121.302 0.573 . . . . 0.0 110.261 175.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo . . . . . 0 CA--C 1.515 -0.463 0 N-CA-C 109.364 -1.052 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 68.7 m -68.92 168.08 14.4 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 163.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.773 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -71.11 -54.41 11.2 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.843 0.83 . . . . 0.0 109.788 173.057 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.546 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 3.1 p-10 -86.84 -4.06 59.13 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.492 -1.231 . . . . 0.0 113.13 -164.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.443 ' HA ' ' OE1' ' A' ' 45' ' ' GLU . 9.9 t -65.39 -2.97 3.6 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.185 0.517 . . . . 0.0 111.083 -173.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.609 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.7 m -73.1 134.96 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 172.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.772 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -154.28 159.5 41.3 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -178.753 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' GLN . . . . . 0.533 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.4 mt-30 -42.94 119.08 1.4 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 112.684 -2.053 . . . . 0.0 113.303 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.99 -161.45 37.53 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 169.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 23.3 m -48.31 102.72 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 117.21 0.505 . . . . 0.0 111.498 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 39.2 pttt 38.83 44.42 0.83 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.611 1.164 . . . . 0.0 112.482 -173.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.488 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 37.7 tt0 -62.05 137.96 95.71 Favored Pre-proline 0 C--N 1.332 -0.182 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . 0.589 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 51.1 Cg_exo -50.71 122.46 9.74 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.227 1.951 . . . . 0.0 110.218 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' TYR . . . . . 0.817 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 11.3 t80 -71.21 -54.13 7.45 Favored Pre-proline 0 N--CA 1.438 -1.034 0 CA-C-O 118.425 -0.798 . . . . 0.0 113.048 -167.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.537 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 34.5 Cg_exo -55.77 -18.87 22.65 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 121.458 1.438 . . . . 0.0 111.072 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.589 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.7 m-20 -90.08 -41.98 11.37 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.037 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' PHE . . . . . 0.533 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -54.82 -44.18 73.62 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 176.254 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.776 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 2.0 p -80.77 -34.29 13.97 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.283 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.626 -178.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.19 -31.51 67.36 Favored 'General case' 0 C--N 1.315 -0.893 0 O-C-N 121.321 -0.862 . . . . 0.0 111.848 177.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.708 ' O ' HG12 ' B' ' 24' ' ' VAL . 16.1 ptt180 -84.03 -29.9 26.54 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 175.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.57 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 8.3 tp -53.56 -49.78 66.95 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.055 172.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' GLN . . . . . 0.776 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 25.2 mt-30 -69.41 -48.24 61.68 Favored 'General case' 0 CA--C 1.493 -1.236 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.191 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.741 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 18.4 t70 -47.25 -53.48 13.27 Favored 'General case' 0 C--N 1.315 -0.898 0 O-C-N 124.187 0.929 . . . . 0.0 111.489 -177.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' VAL . . . . . 0.708 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.4 p -82.13 -22.46 9.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.105 0.479 . . . . 0.0 109.746 -173.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.815 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -72.44 -19.46 61.57 Favored 'General case' 0 C--O 1.201 -1.462 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 173.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . 0.406 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -87.03 -37.55 17.37 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.671 178.331 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.741 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 36.7 mmtt -66.59 -35.1 79.39 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.6 178.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 44.4 m -103.14 -11.15 18.27 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.327 0.584 . . . . 0.0 110.62 -172.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.815 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 88.9 mt -118.13 129.4 74.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.714 -178.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.53 -1.68 52.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.518 0.675 . . . . 0.0 110.375 176.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.653 ' H ' HG22 ' B' ' 29' ' ' ILE . 11.3 t70 -106.39 115.67 30.6 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.418 -177.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.656 ' OE2' ' HG3' ' B' ' 33' ' ' LYS . 0.0 OUTLIER -57.17 -33.14 67.14 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.232 178.184 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.656 ' HG3' ' OE2' ' B' ' 32' ' ' GLU . 0.0 OUTLIER -70.96 -54.58 10.79 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -173.369 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.551 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -60.71 -28.91 69.0 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.821 177.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.868 ' O ' HG13 ' B' ' 39' ' ' VAL . 2.1 tmm_? -65.27 -60.44 2.99 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 15.6 mtpt -55.58 -56.52 19.32 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.193 -179.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.724 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 17.6 m -55.26 -33.59 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.119 -170.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.773 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.5 tt -87.36 -31.71 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.596 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.868 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.5 m -68.67 -48.02 73.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 118.944 -1.103 . . . . 0.0 109.193 175.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.66 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 73.2 mt-10 -63.25 -28.02 69.74 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 123.695 0.798 . . . . 0.0 112.668 176.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.724 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.99 -50.63 6.92 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.819 178.295 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' MET . . . . . 0.716 ' HE2' ' HE2' ' A' ' 42' ' ' MET . 18.0 mmt -64.92 -20.85 66.67 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.683 0.754 . . . . 0.0 109.707 -178.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.675 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -50.65 -28.62 9.26 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.533 171.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' TYR . . . . . 0.594 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 20.1 t80 -103.98 -67.57 0.89 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 174.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.453 ' OE1' ' HA ' ' A' ' 5' ' ' THR . 26.8 mm-40 -50.66 -27.67 7.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.75 -1.114 . . . . 0.0 113.064 -173.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.772 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.2 m-20 -106.06 -22.07 12.97 Favored 'General case' 0 N--CA 1.435 -1.219 0 O-C-N 122.283 -0.261 . . . . 0.0 110.845 -178.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.597 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -60.45 178.72 0.19 Allowed 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 122.055 0.931 . . . . 0.0 112.827 -174.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' ASN . . . . . 0.674 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 17.8 m-20 -58.11 141.62 81.44 Favored Pre-proline 0 N--CA 1.44 -0.932 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.187 174.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -55.16 -23.25 35.58 Favored 'Trans proline' 0 C--O 1.22 -0.422 0 C-N-CA 123.21 2.606 . . . . 0.0 112.286 -178.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . 0.686 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 13.5 pm0 -88.84 -32.26 17.89 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.863 0.865 . . . . 0.0 110.906 175.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.686 ' N ' ' HG2' ' B' ' 50' ' ' GLU . 83.9 m -80.43 -38.18 30.61 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.272 -171.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . 0.577 ' HA ' HD12 ' B' ' 55' ' ' ILE . 4.4 pt20 -70.02 -29.81 66.96 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 172.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' SER . . . . . 0.474 ' O ' ' HE2' ' B' ' 56' ' ' LYS . 4.9 m -71.31 -20.82 62.14 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 113.897 -1.501 . . . . 0.0 110.261 175.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.45 -25.25 45.85 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.672 0.749 . . . . 0.0 109.824 168.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.577 HD12 ' HA ' ' B' ' 52' ' ' GLN . 22.7 mt -90.02 -32.63 5.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 -172.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.628 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.82 -39.41 2.64 Favored Pre-proline 0 N--CA 1.487 1.388 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -172.853 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 50.9 Cg_endo -62.39 -28.4 78.29 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.308 2.005 . . . . 0.0 112.824 176.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . 0.546 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.3 mt -98.68 -15.78 19.27 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . 0.594 ' HE3' ' HB3' ' B' ' 44' ' ' TYR . 0.0 OUTLIER -52.37 109.36 0.38 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.16 -179.545 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.25 -22.59 37.75 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.63 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 10.9 mmmt -103.43 112.79 25.85 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.146 0.498 . . . . 0.0 110.0 -178.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.455 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.4 p -124.73 146.21 52.13 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.076 172.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo . . . . . 0 C--O 1.234 0.312 0 C-N-CA 122.22 1.947 . . . . 0.0 111.537 166.675 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 67' ' ' ASP . . . . . 0.655 ' OD2' ' HB ' ' B' ' 69' ' ' ILE . 0.5 OUTLIER . . . . . 0 CA--C 1.517 -0.291 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.562 HG13 ' CD ' ' B' ' 40' ' ' GLU . 0.7 OUTLIER -78.5 -27.73 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 C-N-CA 118.912 -1.115 . . . . 0.0 109.017 177.293 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.749 ' O ' HG13 ' B' ' 73' ' ' VAL . 12.6 mm -58.08 -46.33 88.18 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.116 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.107 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 29.1 t -46.06 -37.51 6.83 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.275 175.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -85.53 -32.51 22.14 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.148 0.499 . . . . 0.0 110.689 -177.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 72' ' ' TYR . . . . . 0.594 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.1 m-30 -75.85 -34.95 60.07 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.611 -176.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.817 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.5 m -72.01 -31.47 40.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 172.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 74' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' B' ' 70' ' ' SER . 0.0 OUTLIER -67.25 -31.82 72.43 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.309 175.504 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -63.8 -46.58 84.53 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.11 177.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.616 ' SG ' ' HB2' ' B' ' 14' ' ' TYR . 27.4 t -92.81 9.53 34.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.848 178.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . 0.436 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 11.7 t70 . . . . . 0 C--N 1.322 -0.611 0 CA-C-O 121.254 0.55 . . . . 0.0 110.235 175.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.454 ' HB2' ' H ' ' A' ' 2' ' ' SER . 92.5 Cg_endo . . . . . 0 CA--C 1.519 -0.251 0 N-CA-C 109.045 -1.175 . . . . 0.0 109.045 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.54 ' HB2' HG23 ' A' ' 5' ' ' THR . 15.6 m -68.12 179.84 1.43 Allowed 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 162.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.78 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -76.76 -52.2 9.99 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.245 -0.982 . . . . 0.0 108.536 166.41 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.509 ' HB2' HD11 ' A' ' 21' ' ' LEU . 2.4 p-10 -86.33 4.48 38.99 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.256 -1.338 . . . . 0.0 113.677 -164.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.582 ' O ' ' HG3' ' A' ' 7' ' ' ARG . 0.9 OUTLIER -63.73 -3.12 2.09 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 118.602 0.637 . . . . 0.0 111.532 -176.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.587 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 3.0 m -77.9 119.36 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-O 121.914 0.864 . . . . 0.0 109.824 177.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.783 ' HB3' ' O ' ' A' ' 46' ' ' ASN . 27.1 mtm180 -138.68 150.73 46.51 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 119.078 -1.049 . . . . 0.0 113.292 -170.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.579 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.4 mt-30 -41.99 114.35 0.53 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 112.882 -1.963 . . . . 0.0 113.019 176.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.81 -156.66 27.7 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.065 171.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.0 p -52.26 100.46 0.03 OUTLIER 'General case' 0 C--O 1.233 0.228 0 CA-C-N 117.092 0.446 . . . . 0.0 111.204 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.608 ' HD2' ' O ' ' A' ' 80' ' ' GLY . 20.7 pttp 42.47 40.87 2.05 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.396 1.078 . . . . 0.0 112.297 -175.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.47 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 59.4 tt0 -59.21 136.44 88.32 Favored Pre-proline 0 C--O 1.235 0.3 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 177.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.537 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 36.8 Cg_exo -51.77 122.83 11.08 Favored 'Trans proline' 0 CA--C 1.508 -0.784 0 C-N-CA 122.121 1.88 . . . . 0.0 109.689 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.829 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 9.3 t80 -69.46 -53.86 12.09 Favored Pre-proline 0 N--CA 1.437 -1.119 0 CA-C-O 118.316 -0.849 . . . . 0.0 112.937 -166.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.547 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 31.3 Cg_exo -55.38 -20.43 25.84 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.435 1.424 . . . . 0.0 111.06 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.537 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 2.7 m-20 -89.87 -39.17 13.22 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.011 -1.45 . . . . 0.0 111.036 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.579 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -55.94 -45.38 78.83 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 175.451 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.743 HG12 ' O ' ' A' ' 14' ' ' TYR . 1.5 p -81.54 -31.79 11.41 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.031 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.57 -177.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.08 -33.8 69.46 Favored 'General case' 0 C--N 1.317 -0.833 0 O-C-N 121.386 -0.821 . . . . 0.0 111.752 176.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.716 ' O ' HG12 ' A' ' 24' ' ' VAL . 15.3 ptt180 -84.36 -26.9 28.08 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 176.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.596 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 6.7 tp -56.52 -46.55 80.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.002 172.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.689 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 32.8 mt-30 -73.39 -44.15 59.12 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.83 178.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.708 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 21.8 t70 -49.55 -56.06 11.23 Favored 'General case' 0 C--N 1.314 -0.942 0 O-C-N 124.239 0.962 . . . . 0.0 111.612 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 20' ' ' ARG . 6.4 p -80.36 -22.29 11.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 C-N-CA 120.538 -0.465 . . . . 0.0 109.923 -173.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.664 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -68.18 -29.09 67.88 Favored 'General case' 0 C--O 1.204 -1.341 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 173.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.464 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -80.04 -36.9 35.07 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.931 -178.406 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.708 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.5 mmtt -66.65 -32.51 73.87 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.483 178.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.8 m -105.34 -11.77 16.33 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.825 -171.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.664 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 88.7 mt -116.83 133.93 61.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.109 -177.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.26 -4.25 35.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.285 0.564 . . . . 0.0 110.521 176.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.571 ' H ' HG22 ' A' ' 29' ' ' ILE . 11.1 t70 -105.48 107.46 18.47 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.752 -178.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.578 ' OE2' ' HG3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -52.86 -32.22 43.53 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.229 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.615 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -73.53 -50.47 21.23 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -173.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.591 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -61.92 -27.84 69.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.525 175.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.846 ' O ' HG13 ' A' ' 39' ' ' VAL . 3.5 tmm_? -67.4 -57.12 7.17 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.476 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 19.4 mtpt -59.11 -54.82 42.7 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.273 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.754 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 19.4 m -54.69 -33.84 28.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.023 -173.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.78 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.2 tt -86.3 -31.87 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 119.904 -0.719 . . . . 0.0 111.428 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.846 HG13 ' O ' ' A' ' 35' ' ' ARG . 3.0 m -67.4 -49.8 68.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.779 173.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.62 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 63.9 mt-10 -63.76 -26.34 68.6 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.5 0.72 . . . . 0.0 112.62 177.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.754 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -85.63 -52.1 6.03 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.576 177.348 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.603 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 18.7 mmt -64.52 -20.42 66.2 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.809 0.814 . . . . 0.0 109.37 -178.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.664 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -50.75 -28.98 10.28 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.539 171.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.532 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 25.0 t80 -104.08 -68.78 0.83 Allowed 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.482 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 10.3 mm-40 -48.21 -32.41 7.09 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 124.13 0.894 . . . . 0.0 112.546 -175.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.783 ' O ' ' HB3' ' A' ' 7' ' ' ARG . 4.5 m-20 -103.28 -17.39 15.33 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.492 -175.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.664 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -62.98 178.27 0.49 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.744 0.783 . . . . 0.0 111.911 -177.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.666 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 17.7 m-20 -59.93 142.92 88.41 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.094 172.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.405 ' HB2' HD21 ' A' ' 92' ' ' LEU . 11.0 Cg_endo -56.25 -21.46 36.23 Favored 'Trans proline' 0 C--O 1.219 -0.463 0 C-N-CA 123.182 2.588 . . . . 0.0 112.557 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.709 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 12.0 pm0 -88.99 -33.01 17.34 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 123.598 0.759 . . . . 0.0 110.727 174.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.709 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 72.2 m -81.21 -38.02 27.7 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.394 -171.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.605 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.3 pt20 -69.0 -29.89 68.18 Favored 'General case' 0 C--O 1.211 -0.94 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 172.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.647 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 5.9 m -72.23 -21.26 61.42 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 113.9 -1.5 . . . . 0.0 110.304 176.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.619 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -76.03 -25.91 56.12 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.783 0.801 . . . . 0.0 109.495 168.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.605 HD12 ' HA ' ' A' ' 52' ' ' GLN . 22.7 mt -90.33 -33.46 5.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -172.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.617 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.39 -39.08 1.96 Allowed Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -172.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 52.5 Cg_endo -63.13 -31.12 75.53 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.164 1.91 . . . . 0.0 112.568 175.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.526 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 2.4 mt -93.92 -17.08 23.36 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.599 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -54.64 108.95 0.44 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.44 179.67 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.09 -23.84 34.41 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.568 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -104.46 113.88 27.74 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.096 0.474 . . . . 0.0 110.418 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.479 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.1 p -123.58 141.6 36.87 Favored Pre-proline 0 C--N 1.308 -1.21 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 168.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.535 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 77.1 Cg_exo -51.55 139.62 46.74 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.333 2.022 . . . . 0.0 111.52 170.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.28 103.52 0.5 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.015 -176.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.8 -14.16 41.6 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.889 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.535 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 24.1 m -93.31 170.36 9.68 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.187 0.518 . . . . 0.0 111.346 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.29 141.98 28.86 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 176.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.578 HG13 ' CD ' ' A' ' 40' ' ' GLU . 0.7 OUTLIER -77.69 -28.1 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 C-N-CA 118.227 -1.389 . . . . 0.0 108.95 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.783 ' O ' HG13 ' A' ' 73' ' ' VAL . 11.3 mm -58.14 -46.54 88.35 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.075 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.124 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 30.7 t -45.95 -38.33 7.5 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.188 176.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -86.2 -32.31 21.27 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 121.254 0.55 . . . . 0.0 111.046 -177.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.613 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.1 m-30 -75.27 -34.38 61.35 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.369 -176.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.829 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.6 m -72.09 -31.7 40.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.47 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -68.0 -30.87 70.23 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.25 176.461 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -63.74 -48.94 75.0 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.891 177.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.763 ' SG ' ' HB ' ' A' ' 79' ' ' ILE . 32.3 t -89.89 9.09 28.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.773 177.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.47 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 18.7 t70 -66.05 -20.74 66.27 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.349 0.595 . . . . 0.0 109.566 173.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.94 -8.08 58.24 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.831 172.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.763 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 99.0 mt -97.92 128.05 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 121.055 0.455 . . . . 0.0 111.433 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.608 ' O ' ' HD2' ' A' ' 11' ' ' LYS . . . 158.75 -25.61 0.37 Allowed Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 174.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.06 137.47 4.72 Favored Glycine 0 CA--C 1.504 -0.618 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.277 172.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 66.33 -74.35 0.06 Allowed 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.273 0.629 . . . . 0.0 111.727 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 75.1 mtm -59.59 -33.97 72.14 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 120.692 0.282 . . . . 0.0 110.61 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.588 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 4.7 t-160 -49.68 -46.45 49.9 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.836 172.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.579 ' HA ' ' HB2' ' A' ' 88' ' ' LEU . 93.8 mttt -87.01 -19.68 28.32 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.881 -172.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.64 -45.29 59.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.765 0.793 . . . . 0.0 109.399 169.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 66.6 mtt -77.59 -13.26 59.96 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.267 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.579 ' HB2' ' HA ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -57.93 -37.78 74.71 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.068 0.461 . . . . 0.0 110.988 -179.042 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 46.5 ttm -83.5 -21.92 32.65 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.936 0.398 . . . . 0.0 110.718 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -90.5 -49.76 6.32 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.013 0.435 . . . . 0.0 111.883 -175.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.647 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 24.4 mt-30 -88.71 -54.29 4.22 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.423 -172.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.442 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -50.74 -37.97 44.91 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 175.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.635 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 5.1 pt-20 . . . . . 0 C--O 1.249 1.063 0 CA-C-N 112.991 -1.913 . . . . 0.0 113.186 -176.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' PRO . . . . . 0.416 ' HB2' ' H ' ' B' ' 2' ' ' SER . 84.0 Cg_endo . . . . . 0 CA--C 1.518 -0.306 0 N-CA-C 108.863 -1.245 . . . . 0.0 108.863 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.55 ' HB2' HG23 ' B' ' 5' ' ' THR . 15.8 m -68.48 -179.74 1.43 Allowed 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 162.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.776 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -77.01 -52.24 9.69 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.29 -0.964 . . . . 0.0 108.522 166.261 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.509 ' HB2' HD11 ' B' ' 21' ' ' LEU . 2.4 p-10 -86.31 4.69 37.98 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.708 -164.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.58 ' O ' ' HG3' ' B' ' 7' ' ' ARG . 0.9 OUTLIER -63.98 -2.88 2.15 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 118.6 0.636 . . . . 0.0 111.557 -176.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.571 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 3.0 m -78.04 119.25 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 121.823 0.82 . . . . 0.0 109.845 176.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.802 ' HB3' ' O ' ' B' ' 46' ' ' ASN . 27.3 mtm180 -138.63 150.72 46.56 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 119.18 -1.008 . . . . 0.0 113.247 -170.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' GLN . . . . . 0.583 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.4 mt-30 -42.15 114.51 0.56 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 112.755 -2.02 . . . . 0.0 112.887 176.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.11 -156.96 28.73 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.13 171.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 15.6 p -51.67 100.35 0.03 OUTLIER 'General case' 0 C--O 1.235 0.306 0 CA-C-N 117.016 0.408 . . . . 0.0 111.274 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.621 ' HD2' ' O ' ' B' ' 80' ' ' GLY . 20.8 pttp 42.28 41.06 1.99 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.462 1.105 . . . . 0.0 112.225 -175.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.448 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 58.9 tt0 -59.23 136.43 88.38 Favored Pre-proline 0 C--O 1.234 0.283 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . 0.552 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 37.6 Cg_exo -51.69 123.05 11.43 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.13 1.887 . . . . 0.0 109.652 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . 0.836 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 9.5 t80 -69.6 -53.93 11.61 Favored Pre-proline 0 N--CA 1.437 -1.089 0 CA-C-O 118.313 -0.851 . . . . 0.0 112.958 -166.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.556 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 31.2 Cg_exo -55.4 -20.29 25.43 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 121.483 1.455 . . . . 0.0 111.066 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.552 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 3.1 m-20 -89.93 -39.17 13.18 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.019 -1.446 . . . . 0.0 111.023 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' PHE . . . . . 0.583 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -55.81 -45.59 78.26 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.307 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.745 HG12 ' O ' ' B' ' 14' ' ' TYR . 1.5 p -81.46 -31.69 11.48 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.063 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.576 -177.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.2 -33.83 69.71 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 121.402 -0.811 . . . . 0.0 111.737 176.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.71 ' O ' HG12 ' B' ' 24' ' ' VAL . 15.2 ptt180 -84.43 -26.47 28.24 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.604 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 6.7 tp -56.86 -46.77 81.57 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.912 172.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . 0.69 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 32.5 mt-30 -73.18 -44.31 60.05 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.835 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.725 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 20.5 t70 -49.15 -56.15 10.1 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 124.192 0.932 . . . . 0.0 111.649 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' VAL . . . . . 0.71 HG12 ' O ' ' B' ' 20' ' ' ARG . 6.5 p -80.31 -22.52 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.922 -173.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.673 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -68.15 -28.97 67.76 Favored 'General case' 0 C--O 1.203 -1.342 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 173.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . 0.463 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -80.23 -36.59 34.52 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.359 -1.291 . . . . 0.0 109.962 -178.498 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.725 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.9 mmtt -66.97 -32.35 73.53 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.502 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 16.9 m -105.5 -12.05 16.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.123 0.487 . . . . 0.0 110.765 -171.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.673 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 88.3 mt -116.44 134.24 60.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.083 -177.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.45 -4.27 34.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.382 0.611 . . . . 0.0 110.436 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.558 ' H ' HG22 ' B' ' 29' ' ' ILE . 11.3 t70 -105.43 107.68 18.79 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.722 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.568 ' OE2' ' HG3' ' B' ' 33' ' ' LYS . 0.0 OUTLIER -53.01 -32.22 45.45 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.213 179.487 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.614 ' O ' HG13 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -73.58 -50.23 22.32 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -173.593 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.587 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -62.16 -27.83 69.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.466 175.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.852 ' O ' HG13 ' B' ' 39' ' ' VAL . 3.5 tmm_? -67.43 -57.12 7.13 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.466 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 19.0 mtpt -59.11 -54.76 43.35 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.314 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.751 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 19.6 m -54.73 -33.82 28.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.073 -173.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.776 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.2 tt -86.41 -31.64 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.462 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.852 HG13 ' O ' ' B' ' 35' ' ' ARG . 3.0 m -67.43 -49.95 66.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 119.039 -1.065 . . . . 0.0 109.809 173.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.624 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 60.8 mt-10 -63.6 -26.5 68.72 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.506 0.722 . . . . 0.0 112.599 177.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.751 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.61 -52.0 6.1 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.436 -0.505 . . . . 0.0 111.469 177.487 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' MET . . . . . 0.597 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 18.7 mmt -64.66 -20.39 66.27 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.75 0.786 . . . . 0.0 109.256 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.656 ' O ' ' HB2' ' B' ' 47' ' ' ALA . . . -50.82 -28.92 10.4 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.563 171.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' TYR . . . . . 0.519 ' CG ' ' HD2' ' B' ' 59' ' ' LYS . 25.1 t80 -104.09 -68.71 0.83 Allowed 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.48 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 10.5 mm-40 -48.39 -31.92 6.86 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.091 0.87 . . . . 0.0 112.687 -175.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.802 ' O ' ' HB3' ' B' ' 7' ' ' ARG . 4.5 m-20 -103.88 -16.91 15.23 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 120.659 0.266 . . . . 0.0 111.533 -175.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -63.24 178.67 0.49 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.909 0.862 . . . . 0.0 111.978 -177.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.664 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 17.6 m-20 -60.25 142.74 89.79 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.077 172.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . 0.421 ' HB2' HD21 ' B' ' 92' ' ' LEU . 10.9 Cg_endo -56.08 -21.54 35.31 Favored 'Trans proline' 0 C--O 1.218 -0.518 0 C-N-CA 123.19 2.593 . . . . 0.0 112.516 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.688 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 11.7 pm0 -88.95 -32.9 17.44 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 123.557 0.743 . . . . 0.0 110.743 174.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.688 ' N ' ' HG2' ' B' ' 50' ' ' GLU . 72.1 m -81.31 -38.06 27.38 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.41 -171.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.6 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.3 pt20 -68.89 -30.01 68.41 Favored 'General case' 0 C--O 1.211 -0.927 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 172.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . 0.637 ' HB3' ' HB3' ' B' ' 91' ' ' GLN . 6.2 m -72.18 -21.16 61.47 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 113.941 -1.481 . . . . 0.0 110.478 176.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.595 ' HB2' HD11 ' B' ' 79' ' ' ILE . . . -76.21 -25.8 55.48 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.767 0.794 . . . . 0.0 109.466 168.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.6 HD12 ' HA ' ' B' ' 52' ' ' GLN . 22.7 mt -90.28 -33.5 5.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -172.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.619 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.41 -39.17 2.04 Favored Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -172.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 52.5 Cg_endo -62.95 -31.31 77.14 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.115 1.876 . . . . 0.0 112.554 175.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . 0.536 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 2.5 mt -93.92 -17.07 23.37 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.601 ' HA ' ' OH ' ' B' ' 72' ' ' TYR . 0.0 OUTLIER -54.7 108.96 0.44 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.47 179.71 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.03 -23.86 34.36 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.626 -177.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -104.47 113.89 27.76 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.098 0.475 . . . . 0.0 110.295 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.471 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.2 p -123.48 141.81 37.27 Favored Pre-proline 0 C--N 1.309 -1.162 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 168.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.517 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 73.0 Cg_exo -51.67 139.33 48.47 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.296 1.997 . . . . 0.0 111.631 170.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.93 103.45 0.45 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.03 -177.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.18 -14.52 40.07 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.892 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.517 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 24.0 m -93.07 170.8 9.37 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.09 0.471 . . . . 0.0 111.36 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.86 141.78 28.54 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.568 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.7 OUTLIER -77.29 -28.5 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 C-N-CA 118.201 -1.399 . . . . 0.0 108.921 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.774 ' O ' HG13 ' B' ' 73' ' ' VAL . 11.2 mm -57.91 -46.56 87.51 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.112 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.169 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 30.2 t -45.93 -38.38 7.49 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.184 176.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -86.17 -32.25 21.35 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.245 0.545 . . . . 0.0 111.001 -177.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' TYR . . . . . 0.611 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.1 m-30 -75.36 -34.21 61.13 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.374 -176.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.836 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.6 m -72.26 -31.64 39.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 172.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' B' ' 77' ' ' ASP . 0.0 OUTLIER -68.08 -30.84 70.12 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.274 176.474 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -63.72 -49.15 74.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.843 -1.072 . . . . 0.0 109.833 177.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.756 ' SG ' ' HB ' ' B' ' 79' ' ' ILE . 32.1 t -89.58 9.14 27.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.78 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . 0.457 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 21.1 t70 -66.5 -19.83 65.88 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.344 0.592 . . . . 0.0 109.681 174.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -96.5 -8.13 57.58 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.856 172.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.756 ' HB ' ' SG ' ' B' ' 76' ' ' CYS . 99.2 mt -97.95 127.87 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-O 121.192 0.52 . . . . 0.0 111.452 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . 0.621 ' O ' ' HD2' ' B' ' 11' ' ' LYS . . . 159.09 -25.63 0.35 Allowed Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.283 174.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.28 138.15 5.08 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.139 172.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 66.08 -74.79 0.06 Allowed 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 123.255 0.622 . . . . 0.0 111.807 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' MET . . . . . . . . . . . . . 75.6 mtm -59.25 -34.24 71.99 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 120.715 0.293 . . . . 0.0 110.596 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' HIS . . . . . 0.605 ' HB2' ' H ' ' B' ' 80' ' ' GLY . 4.7 t-160 -49.61 -46.29 49.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.848 172.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.577 ' HA ' ' HB2' ' B' ' 88' ' ' LEU . 93.9 mttt -87.09 -19.53 28.43 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.987 -172.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.99 -45.09 59.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.622 0.725 . . . . 0.0 109.522 169.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 66.6 mtt -77.85 -13.32 59.93 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.222 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.577 ' HB2' ' HA ' ' B' ' 85' ' ' LYS . 0.1 OUTLIER -57.89 -37.94 74.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.943 -179.055 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 47.0 ttm -83.66 -21.27 32.49 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.151 0.501 . . . . 0.0 110.707 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -90.71 -50.14 6.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.952 -175.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' GLN . . . . . 0.647 ' O ' ' HG2' ' B' ' 93' ' ' GLU . 24.3 mt-30 -88.39 -54.54 4.14 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.379 -172.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.461 ' HB2' HD12 ' B' ' 88' ' ' LEU . 0.0 OUTLIER -50.72 -37.84 43.88 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 175.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.647 ' HG2' ' O ' ' B' ' 91' ' ' GLN . 5.2 pt-20 . . . . . 0 C--O 1.248 1.005 0 CA-C-N 113.14 -1.845 . . . . 0.0 113.358 -176.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.443 ' HB2' ' H ' ' A' ' 2' ' ' SER . 87.6 Cg_endo . . . . . 0 CA--C 1.518 -0.301 0 N-CA-C 108.856 -1.248 . . . . 0.0 108.856 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.443 ' H ' ' HB2' ' A' ' 1' ' ' PRO . 15.0 m -67.26 176.33 2.29 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 162.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.79 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -73.66 -52.69 12.49 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 166.099 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.515 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 2.4 p-10 -85.63 5.78 30.35 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.858 -1.519 . . . . 0.0 113.489 -165.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.07 -4.19 3.3 Favored 'General case' 0 C--N 1.315 -0.904 0 O-C-N 121.94 -0.475 . . . . 0.0 111.615 -176.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.608 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.0 m -77.86 133.01 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.797 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -154.63 159.42 40.8 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -179.671 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.427 ' HG2' ' HB3' ' A' ' 12' ' ' GLU . 2.1 tt0 -45.31 112.75 0.48 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 113.268 -1.787 . . . . 0.0 112.57 -177.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.13 -150.59 18.56 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.507 173.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 27.2 m -51.98 95.45 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.95 0.375 . . . . 0.0 111.407 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.1 pttp 37.76 43.47 0.48 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.385 1.074 . . . . 0.0 112.254 -172.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.427 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 50.3 tt0 -56.46 138.14 75.8 Favored Pre-proline 0 C--O 1.234 0.241 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.55 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 33.8 Cg_exo -53.68 121.87 10.31 Favored 'Trans proline' 0 CA--C 1.51 -0.722 0 C-N-CA 121.806 1.671 . . . . 0.0 109.476 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.824 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 14.5 t80 -71.91 -52.21 7.98 Favored Pre-proline 0 N--CA 1.438 -1.046 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -165.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.539 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 38.7 Cg_exo -56.52 -18.2 24.73 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 121.447 1.431 . . . . 0.0 110.691 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.55 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.5 m-20 -90.21 -42.34 11.08 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 113.754 -1.566 . . . . 0.0 110.874 178.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.517 ' CE2' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -55.02 -45.55 75.16 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 176.537 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.785 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 1.8 p -78.97 -34.41 16.81 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.402 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.6 -31.82 68.41 Favored 'General case' 0 C--N 1.318 -0.761 0 O-C-N 121.529 -0.732 . . . . 0.0 111.807 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.684 ' O ' HG12 ' A' ' 24' ' ' VAL . 15.7 ptt180 -84.3 -26.78 28.28 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 175.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.553 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 5.9 tp -58.27 -46.49 85.92 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.918 173.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.785 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 26.2 mt-30 -70.69 -47.28 60.67 Favored 'General case' 0 CA--C 1.493 -1.247 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.3 177.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.729 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 8.9 t70 -49.77 -51.96 35.37 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.531 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.684 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.2 p -81.08 -23.78 10.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.181 0.515 . . . . 0.0 109.719 -174.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.785 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -72.01 -19.15 61.9 Favored 'General case' 0 C--O 1.204 -1.335 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 174.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.412 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -86.59 -36.36 18.91 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.574 178.192 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.729 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.6 mmtt -67.26 -37.86 84.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.95 -1.023 . . . . 0.0 112.015 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.405 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 44.5 m -101.76 -10.38 20.0 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.163 0.506 . . . . 0.0 110.645 -172.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.785 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 85.5 mt -112.38 130.24 66.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.819 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.23 -0.93 57.39 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.068 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.674 ' H ' HG22 ' A' ' 29' ' ' ILE . 0.9 OUTLIER -121.55 127.74 51.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.347 0.594 . . . . 0.0 111.901 -178.09 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -56.49 -31.98 64.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.86 175.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.652 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 26.1 mttt -62.29 -61.12 2.67 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -177.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.584 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -61.94 -24.55 67.05 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.348 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.862 ' O ' HG13 ' A' ' 39' ' ' VAL . 1.7 tmm_? -69.7 -57.92 4.55 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.419 ' O ' HG22 ' A' ' 39' ' ' VAL . 20.9 mtpt -57.21 -55.65 31.94 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.943 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.725 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 19.7 m -53.93 -36.02 29.7 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.312 -170.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.79 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.2 tt -87.5 -28.97 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.96 -178.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.862 HG13 ' O ' ' A' ' 35' ' ' ARG . 3.0 m -70.1 -49.22 57.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 119.11 -1.036 . . . . 0.0 109.326 175.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.639 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 66.1 mt-10 -63.49 -24.22 67.73 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.805 0.842 . . . . 0.0 112.259 176.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.725 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -86.09 -56.99 3.2 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 177.147 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.515 ' HG3' ' HB2' ' A' ' 4' ' ' ASN . 20.7 mmt -62.44 -20.74 64.82 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.585 0.707 . . . . 0.0 109.792 -177.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.67 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -49.18 -28.23 4.26 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.539 170.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.567 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 5.7 t80 -108.22 -67.92 0.94 Allowed 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 175.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.673 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 5.2 mm-40 -46.9 -31.89 3.42 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 124.421 1.075 . . . . 0.0 112.179 -173.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.797 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.9 m-20 -104.8 -21.17 13.39 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -176.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -60.4 -179.13 0.1 Allowed 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.954 0.883 . . . . 0.0 112.974 -173.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -57.01 139.72 78.41 Favored Pre-proline 0 N--CA 1.443 -0.786 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.011 175.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.95 -23.31 42.42 Favored 'Trans proline' 0 C--O 1.222 -0.304 0 C-N-CA 123.209 2.606 . . . . 0.0 112.082 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 53' ' ' SER . 0.0 OUTLIER -88.12 -30.18 20.04 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.702 0.801 . . . . 0.0 110.505 174.194 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.947 ' SG ' ' HB2' ' A' ' 76' ' ' CYS . 43.8 t -83.24 -36.76 24.32 Favored 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.548 -170.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.555 ' HB2' ' CG ' ' A' ' 44' ' ' TYR . 4.1 pt20 -67.37 -30.35 70.12 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 171.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.677 ' HB3' ' C ' ' A' ' 91' ' ' GLN . 17.1 m -69.95 -20.3 63.34 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 113.377 -1.738 . . . . 0.0 110.852 173.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.77 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -81.16 -24.75 37.36 Favored 'General case' 0 C--N 1.312 -1.039 0 O-C-N 121.399 -0.813 . . . . 0.0 110.014 167.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.536 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 25.4 mt -90.3 -30.81 5.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -171.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.615 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.37 -40.03 2.58 Favored Pre-proline 0 N--CA 1.487 1.38 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -174.458 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 49.9 Cg_endo -62.42 -27.5 77.34 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.313 2.009 . . . . 0.0 112.794 176.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.536 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.0 OUTLIER -100.52 -15.86 17.71 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.567 ' HE3' ' HB3' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -53.45 109.22 0.42 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.252 -177.924 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.468 ' N ' ' HZ3' ' A' ' 59' ' ' LYS . . . 92.43 -20.64 42.79 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.34 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -103.87 113.63 27.29 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.403 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.3 p -122.92 144.15 42.26 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 173.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.551 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 97.3 Cg_exo -46.6 139.11 13.79 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.153 1.902 . . . . 0.0 111.329 168.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.71 96.63 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.963 -173.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.54 -3.7 46.61 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.954 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.551 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 13.1 m -95.28 179.35 5.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.214 0.531 . . . . 0.0 111.227 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.759 ' OD1' ' HB ' ' A' ' 69' ' ' ILE . 5.4 t70 -87.65 137.28 32.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.378 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.604 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -79.81 -28.84 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 C-N-CA 118.224 -1.39 . . . . 0.0 109.173 179.218 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.784 ' O ' HG13 ' A' ' 73' ' ' VAL . 11.7 mm -60.57 -46.2 95.97 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.016 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.94 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.3 t -44.58 -38.93 4.56 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.146 175.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.482 ' O ' ' HE2' ' A' ' 74' ' ' LYS . 7.0 mm-40 -85.84 -32.04 21.95 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 123.55 0.74 . . . . 0.0 111.419 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.583 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.0 m-30 -75.41 -34.6 61.04 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.513 0.673 . . . . 0.0 109.421 -176.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.824 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.4 m -71.81 -32.09 43.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 172.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.482 ' HE2' ' O ' ' A' ' 71' ' ' GLU . 13.3 ttpt -71.66 -25.94 62.33 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.406 177.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -65.21 -46.6 80.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.806 174.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.947 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 40.5 t -87.46 0.8 55.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.158 178.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -66.01 -14.14 61.13 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.64 0.733 . . . . 0.0 109.579 175.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.45 -13.29 28.7 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.417 172.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.77 HD11 ' HB2' ' A' ' 54' ' ' ALA . 77.3 mt -79.78 -88.91 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 117.296 0.548 . . . . 0.0 111.377 -178.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.404 ' N ' HG22 ' A' ' 79' ' ' ILE . . . 41.29 -109.47 0.16 Allowed Glycine 0 C--N 1.338 0.676 0 O-C-N 123.525 0.515 . . . . 0.0 113.317 -175.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.37 166.29 15.85 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 111.659 -0.576 . . . . 0.0 111.659 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 68.25 -71.13 0.12 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.085 0.554 . . . . 0.0 111.756 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 79.5 mtp -66.01 -30.77 71.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.015 0.436 . . . . 0.0 110.038 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.536 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 6.8 t-160 -57.95 -31.6 67.01 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.765 173.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -82.6 -16.48 48.29 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.259 0.552 . . . . 0.0 110.148 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.26 -47.23 10.27 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.364 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 8.0 mtt -82.99 -14.17 54.54 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.629 -172.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.536 ' HB2' ' O ' ' A' ' 84' ' ' HIS . 0.5 OUTLIER -51.07 -35.43 34.79 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 123.563 0.539 . . . . 0.0 111.849 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 55.3 ttm -83.51 -18.33 38.86 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.947 0.403 . . . . 0.0 110.94 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -95.97 -54.73 3.22 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -174.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.677 ' C ' ' HB3' ' A' ' 53' ' ' SER . 22.4 mt-30 -80.93 -55.01 5.08 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.277 -174.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.408 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -49.55 -34.56 17.86 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 175.189 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.655 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 8.9 pt-20 . . . . . 0 C--O 1.252 1.235 0 CA-C-N 113.415 -1.721 . . . . 0.0 113.586 -174.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' PRO . . . . . 0.403 ' HB2' ' H ' ' B' ' 2' ' ' SER . 88.6 Cg_endo . . . . . 0 CA--C 1.518 -0.297 0 N-CA-C 108.762 -1.284 . . . . 0.0 108.762 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.403 ' H ' ' HB2' ' B' ' 1' ' ' PRO . 14.7 m -67.56 176.01 2.59 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 162.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.762 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -73.37 -52.65 13.06 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.085 -1.046 . . . . 0.0 108.286 166.265 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.524 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.4 p-10 -85.77 5.84 30.65 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 113.936 -1.483 . . . . 0.0 113.429 -165.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.92 -4.42 3.31 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 118.256 0.48 . . . . 0.0 111.707 -176.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.608 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 1.9 m -77.62 133.16 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.78 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.1 OUTLIER -155.0 159.08 40.08 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -179.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' GLN . . . . . 0.432 ' HG2' ' HB3' ' B' ' 12' ' ' GLU . 2.1 tt0 -45.01 112.65 0.46 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 113.211 -1.813 . . . . 0.0 112.584 -177.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.08 -150.52 18.3 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.411 173.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 33.3 m -52.07 95.17 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 117.023 0.411 . . . . 0.0 111.49 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 21.0 pttp 37.9 43.93 0.56 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.438 1.095 . . . . 0.0 111.99 -172.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.432 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 52.0 tt0 -56.75 138.1 77.84 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.411 177.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . 0.55 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 33.6 Cg_exo -53.67 122.12 10.75 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 121.737 1.625 . . . . 0.0 109.477 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . 0.826 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 14.6 t80 -72.17 -52.22 7.44 Favored Pre-proline 0 N--CA 1.438 -1.04 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -165.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.534 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 37.7 Cg_exo -56.52 -18.01 24.06 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 121.547 1.498 . . . . 0.0 110.685 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.55 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.6 m-20 -90.39 -42.52 10.87 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.846 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' PHE . . . . . 0.511 ' CE2' HD22 ' B' ' 21' ' ' LEU . 0.0 OUTLIER -54.91 -45.8 74.78 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.554 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.785 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 1.7 p -78.77 -34.52 17.4 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.289 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.281 -178.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.94 -31.23 68.51 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 121.485 -0.76 . . . . 0.0 111.843 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.681 ' O ' HG12 ' B' ' 24' ' ' VAL . 15.6 ptt180 -84.67 -26.41 27.78 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 175.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.562 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 5.9 tp -58.54 -46.53 86.63 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.933 172.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . 0.785 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 26.5 mt-30 -70.58 -47.29 60.99 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.256 177.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.727 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 8.3 t70 -49.85 -51.8 37.4 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 124.202 0.938 . . . . 0.0 111.576 -177.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' VAL . . . . . 0.681 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.2 p -81.17 -23.83 10.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -174.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.788 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -71.77 -19.3 62.04 Favored 'General case' 0 C--O 1.204 -1.294 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 174.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.6 -36.31 18.93 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.531 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.727 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.9 mmtt -67.36 -37.61 83.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.142 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 46.5 m -101.85 -10.63 19.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.194 0.521 . . . . 0.0 110.712 -172.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.788 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 85.4 mt -112.36 130.24 66.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.748 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.23 -0.67 57.4 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.001 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.677 ' H ' HG22 ' B' ' 29' ' ' ILE . 0.9 OUTLIER -121.82 127.85 51.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.326 0.584 . . . . 0.0 112.069 -178.172 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -56.66 -31.8 64.76 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.825 176.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.644 ' HD2' ' OD1' ' B' ' 31' ' ' ASP . 25.9 mttt -62.48 -61.0 2.74 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -177.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.562 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -62.0 -24.51 67.08 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.413 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.861 ' O ' HG13 ' B' ' 39' ' ' VAL . 1.7 tmm_? -69.83 -57.81 4.64 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.401 ' O ' HG22 ' B' ' 39' ' ' VAL . 20.6 mtpt -57.28 -55.52 33.75 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.948 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.736 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 19.8 m -54.07 -35.92 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.325 -170.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.762 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.2 tt -87.52 -29.13 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 C-N-CA 119.744 -0.783 . . . . 0.0 111.932 -178.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.861 HG13 ' O ' ' B' ' 35' ' ' ARG . 3.0 m -69.88 -49.4 57.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 119.156 -1.018 . . . . 0.0 109.318 175.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.64 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 66.4 mt-10 -63.41 -24.11 67.69 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.812 0.845 . . . . 0.0 112.377 176.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.736 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -86.21 -56.98 3.19 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 177.114 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' MET . . . . . 0.524 ' HG3' ' HB2' ' B' ' 4' ' ' ASN . 20.8 mmt -62.5 -20.76 64.92 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-O 121.524 0.678 . . . . 0.0 109.812 -177.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.67 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -48.88 -28.4 3.75 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.673 -1.148 . . . . 0.0 110.603 170.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' TYR . . . . . 0.589 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 5.6 t80 -108.17 -67.68 0.95 Allowed 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 175.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.682 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 5.0 mm-40 -46.94 -32.19 3.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 124.433 1.083 . . . . 0.0 112.109 -173.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.78 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 5.0 m-20 -104.59 -21.21 13.45 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -176.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.607 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -60.44 -179.27 0.11 Allowed 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.928 0.87 . . . . 0.0 112.95 -173.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -56.95 139.67 78.09 Favored Pre-proline 0 N--CA 1.444 -0.758 0 CA-C-N 114.403 -1.272 . . . . 0.0 108.892 175.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.78 -23.31 41.07 Favored 'Trans proline' 0 C--O 1.222 -0.321 0 C-N-CA 123.288 2.659 . . . . 0.0 112.12 -177.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' B' ' 50' ' ' GLU . 0.0 OUTLIER -88.16 -30.27 19.92 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.482 174.181 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.946 ' SG ' ' HB2' ' B' ' 76' ' ' CYS . 43.7 t -83.19 -36.53 24.61 Favored 'General case' 0 N--CA 1.426 -1.662 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.614 -170.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.562 ' HB2' ' CG ' ' B' ' 44' ' ' TYR . 4.2 pt20 -67.66 -30.24 69.74 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 171.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . 0.669 ' HB3' ' C ' ' B' ' 91' ' ' GLN . 14.7 m -69.94 -20.27 63.34 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 113.343 -1.753 . . . . 0.0 110.727 173.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.796 ' HB2' HD11 ' B' ' 79' ' ' ILE . . . -81.3 -24.73 37.0 Favored 'General case' 0 C--N 1.313 -1.018 0 O-C-N 121.448 -0.782 . . . . 0.0 109.973 167.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.541 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 25.3 mt -90.22 -30.93 5.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -171.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.615 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.29 -40.07 2.51 Favored Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -174.477 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 49.4 Cg_endo -62.39 -27.39 77.4 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.32 2.013 . . . . 0.0 112.801 176.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . 0.543 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.0 OUTLIER -100.87 -15.76 17.46 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.589 ' HE3' ' HB3' ' B' ' 44' ' ' TYR . 0.1 OUTLIER -53.41 109.34 0.43 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.172 -178.098 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.47 ' N ' ' HZ3' ' B' ' 59' ' ' LYS . . . 92.09 -20.54 42.39 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.319 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 10.4 mmmt -103.79 113.54 27.13 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.412 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.3 p -122.75 144.19 42.06 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 173.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.57 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 96.7 Cg_exo -46.79 139.25 14.24 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.14 1.893 . . . . 0.0 111.392 168.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.19 96.34 0.05 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.958 -173.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.62 -3.47 46.18 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.888 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.57 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 14.6 m -95.42 179.13 5.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.178 0.513 . . . . 0.0 111.198 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' ASP . . . . . 0.757 ' OD1' ' HB ' ' B' ' 69' ' ' ILE . 5.0 t70 -87.36 137.52 32.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.459 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.583 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.8 OUTLIER -79.87 -28.96 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 C-N-CA 118.306 -1.357 . . . . 0.0 109.178 179.302 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.779 ' O ' HG13 ' B' ' 73' ' ' VAL . 11.4 mm -60.47 -46.37 95.43 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.988 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.878 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 29.6 t -44.27 -39.09 4.26 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.034 175.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.493 ' O ' ' HE2' ' B' ' 74' ' ' LYS . 6.3 mm-40 -86.16 -31.78 21.61 Favored 'General case' 0 C--O 1.216 -0.694 0 C-N-CA 123.445 0.698 . . . . 0.0 111.364 -177.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' TYR . . . . . 0.579 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.0 m-30 -75.51 -34.65 60.82 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.574 0.702 . . . . 0.0 109.328 -177.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.826 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.4 m -71.79 -31.82 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 173.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' LYS . . . . . 0.493 ' HE2' ' O ' ' B' ' 71' ' ' GLU . 13.4 ttpt -71.76 -26.18 62.34 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.458 -1.247 . . . . 0.0 109.437 177.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -65.28 -46.46 80.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.741 174.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.946 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 39.6 t -87.43 0.55 55.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.167 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.83 -14.36 61.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.632 0.73 . . . . 0.0 109.551 174.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.13 -13.42 29.01 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.463 172.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.796 HD11 ' HB2' ' B' ' 54' ' ' ALA . 78.0 mt -79.55 -89.37 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 117.203 0.501 . . . . 0.0 111.328 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . 0.407 ' N ' HG22 ' B' ' 79' ' ' ILE . . . 41.78 -109.57 0.18 Allowed Glycine 0 C--N 1.339 0.724 0 O-C-N 123.653 0.595 . . . . 0.0 113.191 -175.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.37 166.72 15.74 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.692 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 67.87 -71.05 0.11 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.16 0.584 . . . . 0.0 111.63 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' MET . . . . . . . . . . . . . 79.5 mtp -65.81 -31.01 71.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.006 0.431 . . . . 0.0 110.036 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' HIS . . . . . 0.54 ' O ' ' HB2' ' B' ' 88' ' ' LEU . 6.9 t-80 -57.84 -31.71 66.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.844 173.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -82.47 -16.46 48.75 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.174 0.511 . . . . 0.0 110.08 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.54 -46.64 10.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.431 175.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 8.1 mtt -83.36 -14.06 53.65 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.578 -173.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.54 ' HB2' ' O ' ' B' ' 84' ' ' HIS . 0.5 OUTLIER -51.02 -35.48 34.4 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 123.588 0.555 . . . . 0.0 111.815 179.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 54.2 ttm -83.55 -18.43 38.38 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.903 0.382 . . . . 0.0 110.872 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -95.87 -54.53 3.3 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -174.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' GLN . . . . . 0.669 ' C ' ' HB3' ' B' ' 53' ' ' SER . 22.2 mt-30 -81.0 -55.31 4.87 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.135 -174.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.414 ' HB2' HD12 ' B' ' 88' ' ' LEU . 0.0 OUTLIER -49.61 -34.34 17.71 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 175.367 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.66 ' HG2' ' O ' ' B' ' 91' ' ' GLN . 8.9 pt-20 . . . . . 0 C--O 1.253 1.257 0 CA-C-N 113.415 -1.721 . . . . 0.0 113.514 -175.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.466 ' HB2' ' H ' ' A' ' 2' ' ' SER . 81.8 Cg_endo . . . . . 0 CA--C 1.518 -0.313 0 N-CA-C 108.666 -1.321 . . . . 0.0 108.666 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.466 ' H ' ' HB2' ' A' ' 1' ' ' PRO . 16.4 m -67.57 -178.9 0.97 Allowed 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 162.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.776 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -77.11 -51.84 10.33 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 164.713 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.514 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 2.3 p-10 -87.28 5.93 35.88 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 113.913 -1.494 . . . . 0.0 113.896 -164.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.458 HG23 ' HB2' ' A' ' 2' ' ' SER . 0.8 OUTLIER -63.77 -5.65 4.53 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 118.784 0.72 . . . . 0.0 111.52 -176.743 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.488 ' O ' HD13 ' A' ' 21' ' ' LEU . 2.0 m -78.16 130.31 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 176.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.746 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -155.72 158.74 38.73 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -178.37 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.463 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.6 mt-30 -39.07 116.65 0.6 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.624 -1.626 . . . . 0.0 113.551 176.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.29 -155.84 32.23 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.573 169.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.6 m -48.25 100.51 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 117.481 0.64 . . . . 0.0 111.678 -177.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.3 pttt 38.24 42.67 0.52 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.295 1.038 . . . . 0.0 112.335 -173.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.412 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 26.5 tt0 -57.46 138.26 81.43 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.267 176.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.527 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 37.0 Cg_exo -53.8 122.4 11.28 Favored 'Trans proline' 0 CA--C 1.505 -0.944 0 C-N-CA 121.84 1.693 . . . . 0.0 109.265 177.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.74 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 11.6 t80 -70.66 -53.92 8.89 Favored Pre-proline 0 N--CA 1.434 -1.241 0 CA-C-O 118.454 -0.784 . . . . 0.0 112.908 -166.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.546 ' HD3' ' HB3' ' A' ' 14' ' ' TYR . 36.3 Cg_exo -56.18 -18.2 22.86 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 121.453 1.435 . . . . 0.0 110.825 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.527 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 2.8 m-20 -89.53 -42.79 11.24 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.977 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.68 ' HE2' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -53.78 -46.55 71.06 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 176.63 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.768 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 1.3 p -79.27 -34.52 16.41 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.369 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.615 -177.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.5 -32.61 67.19 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 121.335 -0.853 . . . . 0.0 111.674 178.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.723 ' O ' HG12 ' A' ' 24' ' ' VAL . 16.6 ptt180 -84.36 -27.12 27.92 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 176.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.655 HD22 ' CE1' ' A' ' 17' ' ' PHE . 6.7 tp -56.56 -47.26 79.88 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.996 172.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.768 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 20.2 mt-30 -71.3 -47.1 58.85 Favored 'General case' 0 CA--C 1.493 -1.236 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.995 177.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.733 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 17.6 t70 -47.22 -54.83 9.82 Favored 'General case' 0 C--N 1.313 -1.015 0 O-C-N 124.297 0.998 . . . . 0.0 111.502 -178.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.723 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.5 p -81.23 -23.31 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.162 0.506 . . . . 0.0 109.983 -174.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.76 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -72.07 -19.5 61.81 Favored 'General case' 0 C--O 1.204 -1.318 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 174.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.431 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -86.25 -36.65 19.25 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.616 178.047 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.733 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 37.8 mmtt -66.9 -38.12 85.66 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.956 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.407 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 50.2 m -101.83 -8.85 21.29 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.166 0.508 . . . . 0.0 110.658 -171.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.76 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 88.7 mt -114.59 135.68 53.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.717 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.56 -2.25 42.14 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.003 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.687 ' H ' HG22 ' A' ' 29' ' ' ILE . 4.8 t0 -117.63 132.38 56.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.11 0.481 . . . . 0.0 111.048 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.603 ' OE1' ' HG3' ' A' ' 33' ' ' LYS . 1.6 pp20? -59.95 -35.39 74.85 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.285 174.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.606 ' O ' HG13 ' A' ' 37' ' ' VAL . 13.2 mttp -61.53 -58.74 6.91 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -175.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.524 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -61.9 -27.03 68.52 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.494 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.844 ' O ' HG13 ' A' ' 39' ' ' VAL . 5.0 tmm_? -70.4 -58.38 3.79 Favored 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.465 ' HD2' ' OE2' ' A' ' 32' ' ' GLU . 18.4 mtpt -56.14 -55.85 28.09 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.867 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.775 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 22.5 m -53.79 -36.49 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.228 -171.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.776 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.3 tt -87.0 -29.73 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.826 -177.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.844 HG13 ' O ' ' A' ' 35' ' ' ARG . 3.0 m -69.95 -48.95 60.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 119.089 -1.044 . . . . 0.0 109.488 175.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.582 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 54.1 mt-10 -64.93 -23.33 67.19 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.533 0.733 . . . . 0.0 112.545 176.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.775 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -85.78 -55.45 3.96 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.63 176.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.583 ' HB2' HD21 ' A' ' 21' ' ' LEU . 22.5 mmt -62.65 -20.42 64.79 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.698 0.761 . . . . 0.0 109.372 -178.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.653 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -48.28 -29.48 3.89 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.794 170.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.567 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 10.3 t80 -108.15 -66.39 1.04 Allowed 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.648 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 13.9 mm-40 -48.08 -32.66 7.05 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 124.266 0.979 . . . . 0.0 112.1 -174.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.746 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.9 m-20 -103.75 -20.6 13.89 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.326 -175.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.653 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -59.77 -179.94 0.11 Allowed 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 122.023 0.915 . . . . 0.0 112.681 -174.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.541 ' HB3' ' OE2' ' A' ' 50' ' ' GLU . 13.0 m-20 -58.6 140.52 85.0 Favored Pre-proline 0 N--CA 1.439 -1.016 0 CA-C-N 114.213 -1.358 . . . . 0.0 109.335 174.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -57.73 -20.83 44.78 Favored 'Trans proline' 0 C--O 1.222 -0.321 0 C-N-CA 123.228 2.619 . . . . 0.0 112.166 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.708 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 8.9 pm0 -88.58 -30.92 18.91 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 123.521 0.728 . . . . 0.0 110.255 173.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.986 ' SG ' ' HB2' ' A' ' 76' ' ' CYS . 49.5 t -85.46 -37.08 20.15 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.952 -168.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.567 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.7 pt20 -67.52 -28.94 68.24 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 171.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.685 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 32.8 m -71.88 -20.97 61.72 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 113.166 -1.834 . . . . 0.0 110.318 174.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.562 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -78.8 -24.32 44.64 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.41 0.624 . . . . 0.0 110.184 167.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.567 HD12 ' HA ' ' A' ' 52' ' ' GLN . 21.4 mt -90.89 -32.95 5.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -171.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.621 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.28 -38.95 1.79 Allowed Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -173.652 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 43.0 Cg_endo -61.61 -29.72 84.64 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 122.164 1.91 . . . . 0.0 112.636 175.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.539 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.5 mt -98.13 -16.51 19.49 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -179.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.575 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 0.1 OUTLIER -54.73 108.64 0.41 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.597 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.85 -25.37 28.55 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.56 -177.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.3 mmmt -103.99 113.49 27.06 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.046 0.45 . . . . 0.0 110.355 -178.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.448 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.2 p -124.42 145.53 49.22 Favored Pre-proline 0 C--N 1.313 -1.016 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 170.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.561 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 85.0 Cg_exo -50.4 138.82 38.04 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.395 2.063 . . . . 0.0 111.443 167.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.11 102.13 0.6 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.482 -175.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.17 -8.57 41.86 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.609 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.561 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 12.4 m -98.38 170.24 8.99 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.09 0.471 . . . . 0.0 111.163 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.28 136.64 35.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.345 176.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.538 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.7 OUTLIER -75.17 -27.64 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 C-N-CA 119.018 -1.073 . . . . 0.0 108.606 178.736 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.813 ' O ' HG13 ' A' ' 73' ' ' VAL . 17.7 mm -57.15 -47.02 84.7 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.211 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.332 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.9 t -46.77 -36.41 7.25 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.161 0.505 . . . . 0.0 111.237 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.652 ' O ' ' HE3' ' A' ' 74' ' ' LYS . 1.7 mm-40 -85.85 -32.91 21.46 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.45 -177.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.647 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 4.9 m-30 -75.31 -33.46 61.17 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.374 -177.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.813 HG13 ' O ' ' A' ' 69' ' ' ILE . 1.2 m -71.66 -31.15 41.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 171.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.652 ' HE3' ' O ' ' A' ' 71' ' ' GLU . 0.7 OUTLIER -72.0 -24.15 61.52 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.654 176.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -66.33 -47.34 73.84 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.404 173.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.986 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 43.9 t -88.97 7.76 33.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.051 178.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -63.31 -18.62 63.81 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.271 0.558 . . . . 0.0 109.894 172.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -98.82 -11.77 45.7 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.179 172.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.846 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 91.7 mt -92.44 143.77 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 121.071 0.462 . . . . 0.0 110.804 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.511 ' H ' ' HB2' ' A' ' 84' ' ' HIS . . . 142.7 -19.71 2.38 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 173.81 164.53 29.08 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 173.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 56.46 -85.01 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.132 0.573 . . . . 0.0 112.259 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 83.8 mtp -59.83 -39.13 84.08 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.734 -178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.511 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 5.2 t-80 -51.73 -33.92 36.77 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.37 177.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -80.09 -32.97 39.19 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.962 0.411 . . . . 0.0 110.524 -177.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.96 -43.81 51.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.57 0.7 . . . . 0.0 110.43 175.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 81.4 mtp -77.04 -13.79 59.91 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.647 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.415 HD12 ' HB2' ' A' ' 92' ' ' LEU . 0.1 OUTLIER -54.45 -58.16 8.53 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.704 176.16 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.9 ttt -70.49 -23.01 62.6 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.344 0.592 . . . . 0.0 110.712 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -87.14 -27.14 23.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.24 -173.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.685 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 24.1 mt-30 -111.77 -49.04 3.01 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.831 -175.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.415 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -51.07 -29.13 12.1 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.27 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.453 ' HG3' ' OXT' ' A' ' 93' ' ' GLU . 5.0 pt-20 . . . . . 0 C--O 1.25 1.08 0 CA-C-N 113.423 -1.717 . . . . 0.0 113.759 -174.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' PRO . . . . . 0.416 ' HB2' ' H ' ' B' ' 2' ' ' SER . 83.6 Cg_endo . . . . . 0 CA--C 1.517 -0.336 0 N-CA-C 108.725 -1.298 . . . . 0.0 108.725 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.469 ' HB2' HG23 ' B' ' 5' ' ' THR . 16.8 m -67.88 -179.24 1.13 Allowed 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 162.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.768 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -76.7 -51.95 10.53 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 164.761 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.507 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.3 p-10 -87.28 6.09 35.1 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.929 -1.487 . . . . 0.0 113.869 -164.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.469 HG23 ' HB2' ' B' ' 2' ' ' SER . 0.8 OUTLIER -63.82 -5.89 5.0 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 118.806 0.73 . . . . 0.0 111.467 -176.699 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.479 ' O ' HD13 ' B' ' 21' ' ' LEU . 1.9 m -77.89 130.23 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 176.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.732 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.1 OUTLIER -155.71 158.66 38.6 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.11 -1.036 . . . . 0.0 113.765 -178.426 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' GLN . . . . . 0.47 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.6 mt-30 -38.7 116.77 0.59 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 113.612 -1.631 . . . . 0.0 113.597 176.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.27 -155.94 32.32 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 169.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 18.4 m -48.19 100.6 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 117.437 0.619 . . . . 0.0 111.615 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 22.2 pttt 38.46 42.04 0.51 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.411 1.084 . . . . 0.0 112.401 -174.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -56.99 138.23 79.49 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.221 176.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . 0.551 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 37.2 Cg_exo -53.87 122.51 11.49 Favored 'Trans proline' 0 CA--C 1.508 -0.823 0 C-N-CA 121.88 1.72 . . . . 0.0 109.292 177.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . 0.738 ' O ' HG12 ' B' ' 18' ' ' VAL . 11.7 t80 -70.82 -54.09 8.28 Favored Pre-proline 0 N--CA 1.435 -1.217 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.833 -166.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.538 ' HD3' ' HB3' ' B' ' 14' ' ' TYR . 36.4 Cg_exo -56.05 -18.2 22.09 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 121.432 1.422 . . . . 0.0 110.841 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.551 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 2.3 m-20 -89.62 -42.48 11.36 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.146 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' PHE . . . . . 0.689 ' HE2' ' CE2' ' B' ' 14' ' ' TYR . 0.0 OUTLIER -54.23 -46.48 72.55 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 176.471 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.771 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 1.2 p -79.29 -34.55 16.4 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.366 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.563 -177.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.38 -32.71 67.07 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 121.374 -0.829 . . . . 0.0 111.702 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.708 ' O ' HG12 ' B' ' 24' ' ' VAL . 16.7 ptt180 -84.36 -27.2 27.86 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.665 HD22 ' CE1' ' B' ' 17' ' ' PHE . 6.8 tp -56.58 -47.27 79.92 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.886 172.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . 0.771 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 20.2 mt-30 -71.28 -46.86 59.86 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.028 177.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.734 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 17.4 t70 -47.54 -54.73 10.85 Favored 'General case' 0 C--N 1.315 -0.922 0 O-C-N 124.254 0.971 . . . . 0.0 111.607 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' VAL . . . . . 0.708 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.5 p -81.14 -23.27 10.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.085 0.469 . . . . 0.0 109.921 -174.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.752 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -72.15 -19.47 61.76 Favored 'General case' 0 C--O 1.204 -1.297 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 174.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . 0.428 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -86.4 -36.4 19.19 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.583 -1.189 . . . . 0.0 109.499 178.105 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.734 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.1 mmtt -66.99 -38.09 85.39 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.98 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 50.1 m -101.63 -9.57 20.82 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.269 0.557 . . . . 0.0 110.768 -171.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.752 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 88.2 mt -113.91 135.95 51.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.677 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.03 -1.84 41.66 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.916 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.665 ' H ' HG22 ' B' ' 29' ' ' ILE . 4.5 t0 -118.04 132.31 56.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.205 0.526 . . . . 0.0 111.147 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.572 ' OE1' ' HG3' ' B' ' 33' ' ' LYS . 1.5 pp20? -59.82 -35.58 75.01 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.312 174.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.6 ' O ' HG13 ' B' ' 37' ' ' VAL . 13.2 mttp -61.37 -58.75 6.95 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -175.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.511 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -61.95 -26.88 68.46 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.531 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.855 ' O ' HG13 ' B' ' 39' ' ' VAL . 5.0 tmm_? -70.54 -58.25 3.89 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.457 ' HD2' ' OE2' ' B' ' 32' ' ' GLU . 17.8 mtpt -56.3 -55.49 32.71 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.992 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.75 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 22.8 m -54.0 -36.58 31.67 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.103 -172.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.768 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.3 tt -87.06 -29.62 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.845 -177.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.855 HG13 ' O ' ' B' ' 35' ' ' ARG . 3.0 m -70.02 -49.03 59.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 119.131 -1.028 . . . . 0.0 109.488 175.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.594 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 58.8 mt-10 -64.91 -23.28 67.18 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.514 0.725 . . . . 0.0 112.604 176.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.75 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -85.92 -55.37 3.98 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.555 176.385 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' MET . . . . . 0.579 ' HB2' HD21 ' B' ' 21' ' ' LEU . 22.5 mmt -62.58 -20.48 64.74 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.614 0.721 . . . . 0.0 109.318 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.659 ' O ' ' HB2' ' B' ' 47' ' ' ALA . . . -48.26 -29.6 3.98 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.832 170.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' TYR . . . . . 0.564 ' CG ' ' HD2' ' B' ' 59' ' ' LYS . 10.4 t80 -108.06 -66.39 1.04 Allowed 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.643 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 14.6 mm-40 -47.97 -33.24 7.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 124.292 0.995 . . . . 0.0 111.905 -174.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.732 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.9 m-20 -103.2 -20.77 14.01 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.366 -175.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.659 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -59.72 179.76 0.11 Allowed 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 122.028 0.918 . . . . 0.0 112.683 -174.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.529 ' HB3' ' CD ' ' B' ' 50' ' ' GLU . 12.5 m-20 -58.24 140.45 83.37 Favored Pre-proline 0 N--CA 1.438 -1.032 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.362 175.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -57.8 -20.65 44.51 Favored 'Trans proline' 0 C--O 1.221 -0.355 0 C-N-CA 123.211 2.607 . . . . 0.0 112.182 -178.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.712 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 9.1 pm0 -88.66 -30.9 18.81 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 123.541 0.737 . . . . 0.0 110.287 173.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.99 ' SG ' ' HB2' ' B' ' 76' ' ' CYS . 49.5 t -85.52 -37.12 20.02 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.97 -168.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.555 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.9 pt20 -67.46 -29.04 68.4 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 171.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . 0.676 ' HB3' ' HB3' ' B' ' 91' ' ' GLN . 34.8 m -71.8 -21.1 61.75 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 113.176 -1.829 . . . . 0.0 110.379 174.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.558 ' HB2' HD11 ' B' ' 79' ' ' ILE . . . -78.53 -24.56 45.66 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.501 0.667 . . . . 0.0 110.159 167.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.555 HD12 ' HA ' ' B' ' 52' ' ' GLN . 21.5 mt -90.8 -32.98 5.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -171.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.619 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.19 -39.24 1.86 Allowed Pre-proline 0 N--CA 1.486 1.365 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -173.612 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 42.9 Cg_endo -61.44 -29.55 85.38 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.216 1.944 . . . . 0.0 112.728 175.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . 0.541 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.4 mt -98.23 -16.54 19.39 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.59 ' HA ' ' OH ' ' B' ' 72' ' ' TYR . 0.1 OUTLIER -54.65 108.81 0.43 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.578 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.72 -25.43 28.3 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.59 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 12.3 mmmt -103.99 113.49 27.06 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.114 0.483 . . . . 0.0 110.322 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.452 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.1 p -124.22 145.53 48.8 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.844 170.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.556 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 87.7 Cg_exo -50.44 139.41 37.39 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.277 1.985 . . . . 0.0 111.528 167.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.78 102.18 0.73 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.965 0.412 . . . . 0.0 111.466 -175.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.15 -8.37 41.72 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.668 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.556 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 13.1 m -98.35 170.22 9.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.176 0.512 . . . . 0.0 111.242 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.17 136.51 35.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.269 176.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.545 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.7 OUTLIER -75.14 -27.49 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 C-N-CA 118.795 -1.162 . . . . 0.0 108.64 178.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.817 ' O ' HG13 ' B' ' 73' ' ' VAL . 17.9 mm -57.21 -46.98 84.95 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.194 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.366 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.403 ' O ' HG22 ' B' ' 73' ' ' VAL . 30.6 t -46.87 -36.14 7.17 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.32 0.581 . . . . 0.0 111.349 177.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.648 ' O ' ' HE3' ' B' ' 74' ' ' LYS . 1.7 mm-40 -85.98 -32.83 21.32 Favored 'General case' 0 C--O 1.213 -0.817 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.499 -177.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' TYR . . . . . 0.652 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 4.9 m-30 -75.54 -33.27 60.66 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.376 -177.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.817 HG13 ' O ' ' B' ' 69' ' ' ILE . 1.2 m -71.66 -31.3 41.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 171.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' LYS . . . . . 0.648 ' HE3' ' O ' ' B' ' 71' ' ' GLU . 0.7 OUTLIER -71.89 -24.45 61.66 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.539 177.021 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -66.24 -47.14 74.75 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.438 173.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.99 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 44.2 t -89.12 7.64 34.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.831 178.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . 0.42 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 12.3 t70 -63.16 -18.69 63.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.192 0.52 . . . . 0.0 109.896 172.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -98.57 -12.39 44.57 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.206 172.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.833 ' HB ' ' SG ' ' B' ' 76' ' ' CYS . 91.7 mt -91.73 144.17 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 O-C-N 122.483 -0.421 . . . . 0.0 110.816 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . 0.519 ' H ' ' HB2' ' B' ' 84' ' ' HIS . . . 141.98 -18.93 2.53 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 173.09 164.19 28.05 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 173.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 56.68 -85.19 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.08 0.552 . . . . 0.0 112.141 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' MET . . . . . . . . . . . . . 83.7 mtp -59.86 -39.07 83.99 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.739 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' HIS . . . . . 0.519 ' HB2' ' H ' ' B' ' 80' ' ' GLY . 5.2 t-80 -51.68 -34.14 36.99 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.786 -0.188 . . . . 0.0 111.375 177.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -79.74 -33.56 40.67 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.944 0.402 . . . . 0.0 110.38 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.15 -44.39 53.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.718 0.771 . . . . 0.0 110.297 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 81.0 mtp -76.63 -13.75 60.04 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.748 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.421 HD12 ' HB2' ' B' ' 92' ' ' LEU . 0.1 OUTLIER -54.19 -58.34 7.73 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.716 175.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 26.3 ttt -70.48 -23.5 62.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.628 -175.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -86.93 -26.9 23.66 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.345 -173.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' GLN . . . . . 0.676 ' HB3' ' HB3' ' B' ' 53' ' ' SER . 24.1 mt-30 -111.75 -48.83 3.03 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -175.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.421 ' HB2' HD12 ' B' ' 88' ' ' LEU . 0.1 OUTLIER -51.25 -29.19 13.73 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.354 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.427 ' HG3' ' OXT' ' B' ' 93' ' ' GLU . 5.1 pt-20 . . . . . 0 C--O 1.249 1.069 0 CA-C-N 113.273 -1.785 . . . . 0.0 113.756 -173.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.407 ' C ' ' HA3' ' B' ' 60' ' ' GLY . 97.8 Cg_endo . . . . . 0 N--CA 1.465 -0.202 0 N-CA-C 108.91 -1.227 . . . . 0.0 108.91 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.558 ' HB2' HG23 ' A' ' 5' ' ' THR . 72.0 m -71.34 -178.86 2.23 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 161.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.719 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -77.02 -53.48 7.75 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 122.096 0.95 . . . . 0.0 109.716 172.77 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.539 ' ND2' ' HE3' ' A' ' 42' ' ' MET . 2.5 p-10 -85.69 5.85 30.26 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.141 -1.39 . . . . 0.0 113.249 -163.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.558 HG23 ' HB2' ' A' ' 2' ' ' SER . 1.1 p -66.83 -3.38 6.72 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 121.935 -0.478 . . . . 0.0 111.428 -176.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.566 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 1.9 m -78.2 133.89 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 173.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.759 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -156.54 160.84 39.86 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -177.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.421 ' HG2' ' HB3' ' A' ' 12' ' ' GLU . 2.3 tt0 -41.94 115.53 0.68 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 113.704 -1.589 . . . . 0.0 113.056 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.58 -151.72 23.78 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 172.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.479 ' C ' ' HD3' ' A' ' 11' ' ' LYS . 22.8 m -54.25 99.13 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 117.319 0.559 . . . . 0.0 111.133 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.479 ' HD3' ' C ' ' A' ' 10' ' ' SER . 0.0 OUTLIER 34.56 46.52 0.18 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.642 1.177 . . . . 0.0 112.269 -171.333 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.421 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 36.5 tt0 -59.54 139.54 89.2 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.23 175.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.568 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 52.1 Cg_exo -51.0 122.47 9.99 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 121.942 1.761 . . . . 0.0 109.651 177.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.834 ' HE2' ' SG ' ' A' ' 51' ' ' CYS . 6.1 t80 -70.4 -55.34 7.8 Favored Pre-proline 0 N--CA 1.439 -1.001 0 CA-C-O 118.569 -0.729 . . . . 0.0 112.651 -167.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.517 ' HD3' ' HB3' ' A' ' 14' ' ' TYR . 35.0 Cg_exo -55.57 -19.41 23.37 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 121.535 1.49 . . . . 0.0 111.217 -178.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.568 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 0.8 OUTLIER -90.04 -39.39 12.96 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.176 179.505 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.689 ' HE2' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -56.64 -45.68 81.43 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 175.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.75 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 1.3 p -79.01 -33.97 16.38 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.329 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.275 -178.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.64 -32.0 66.84 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 121.386 -0.821 . . . . 0.0 111.624 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.709 ' O ' HG12 ' A' ' 24' ' ' VAL . 14.5 ptt180 -84.96 -26.32 27.24 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 176.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.599 HD22 ' CE1' ' A' ' 17' ' ' PHE . 7.5 tp -56.99 -47.74 80.09 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.639 171.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.75 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 18.2 mt-30 -70.15 -46.62 64.33 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.753 176.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.73 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 18.6 t70 -46.82 -57.13 5.21 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.288 0.992 . . . . 0.0 111.67 -179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.709 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.7 p -79.22 -23.85 12.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.134 0.492 . . . . 0.0 109.816 -173.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.76 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -72.14 -19.69 61.73 Favored 'General case' 0 C--O 1.205 -1.243 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 174.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.476 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -86.66 -36.98 18.45 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.481 178.522 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.73 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.7 mmtt -66.82 -35.27 79.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.8 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.9 t -105.07 -9.11 18.04 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.166 0.508 . . . . 0.0 110.583 -171.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.76 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 88.7 mt -115.11 129.1 71.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.769 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.26 -4.65 59.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.171 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.699 ' H ' HG22 ' A' ' 29' ' ' ILE . 2.8 t0 -116.16 140.57 49.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.233 0.54 . . . . 0.0 111.276 -177.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.549 ' OE2' ' HG3' ' A' ' 33' ' ' LYS . 1.4 pp20? -66.41 -36.14 82.08 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.256 173.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.621 ' O ' HG13 ' A' ' 37' ' ' VAL . 13.0 mttp -60.45 -61.02 2.9 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -174.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.526 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -59.71 -27.04 66.11 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.623 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.859 ' O ' HG13 ' A' ' 39' ' ' VAL . 4.8 tmm_? -69.65 -59.42 2.97 Favored 'General case' 0 C--O 1.221 -0.43 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.403 ' HD2' ' OE1' ' A' ' 32' ' ' GLU . 23.6 mtpt -56.73 -55.78 29.84 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.217 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.7 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 18.9 m -53.19 -35.36 23.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 O-C-N 123.98 0.8 . . . . 0.0 111.253 -172.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.719 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.3 tt -87.46 -31.12 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 119.756 -0.778 . . . . 0.0 112.097 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 35' ' ' ARG . 3.0 m -69.19 -48.57 67.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 119.181 -1.008 . . . . 0.0 109.392 175.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.598 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 58.2 mt-10 -63.73 -23.7 67.47 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 123.624 0.77 . . . . 0.0 112.264 176.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.7 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -86.47 -54.74 4.24 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.803 176.343 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.555 ' HB2' HD21 ' A' ' 21' ' ' LEU . 18.7 mmt -62.68 -20.46 64.87 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.504 0.669 . . . . 0.0 109.919 -177.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.638 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -48.23 -29.08 3.45 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.024 171.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.662 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 2.5 t80 -109.05 -65.68 1.12 Allowed 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 175.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.553 ' CG ' HD12 ' A' ' 41' ' ' LEU . 3.3 mm-40 -46.89 -30.39 2.49 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 124.116 0.885 . . . . 0.0 112.713 -175.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.759 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.8 m-20 -106.55 -20.77 13.26 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -175.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.811 ' HB1' ' SG ' ' A' ' 51' ' ' CYS . . . -64.33 -175.96 0.2 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -172.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.525 ' HB2' ' HB3' ' A' ' 51' ' ' CYS . 18.7 m-20 -61.79 141.7 95.1 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 114.526 -1.216 . . . . 0.0 109.447 175.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -55.27 -26.6 52.9 Favored 'Trans proline' 0 C--O 1.219 -0.458 0 C-N-CA 123.592 2.861 . . . . 0.0 112.968 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.514 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -87.31 -29.29 21.7 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.381 0.672 . . . . 0.0 110.247 174.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.834 ' SG ' ' HE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -76.15 -43.67 41.78 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.547 -172.229 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.638 ' HB2' ' CG ' ' A' ' 44' ' ' TYR . 4.3 pt20 -67.75 -29.46 68.69 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 175.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.56 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 4.0 m -69.42 -20.89 63.79 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 113.703 -1.589 . . . . 0.0 110.729 173.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.697 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -80.41 -24.87 39.36 Favored 'General case' 0 C--N 1.309 -1.176 0 O-C-N 121.412 -0.805 . . . . 0.0 109.853 168.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.538 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 25.8 mt -90.73 -31.22 5.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 115.008 1.485 . . . . 0.0 115.008 -172.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.633 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.71 -39.75 2.79 Favored Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -172.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 49.6 Cg_endo -62.69 -29.76 77.83 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.327 2.018 . . . . 0.0 112.799 176.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.548 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.6 mt -97.35 -16.37 20.3 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.662 ' HE3' ' HB3' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -52.94 108.4 0.31 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.02 -178.141 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.9 -22.71 36.6 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.74 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -103.39 114.85 29.45 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.452 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.2 p -122.55 138.74 29.76 Favored Pre-proline 0 C--N 1.313 -1.015 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.42 173.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.521 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 95.7 Cg_exo -47.85 139.61 19.18 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.661 2.241 . . . . 0.0 111.891 169.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.77 101.33 0.19 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.55 -175.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.34 -13.24 43.83 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.645 177.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.521 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 47.5 m -88.41 166.0 14.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.225 0.536 . . . . 0.0 111.07 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.25 138.94 32.67 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 173.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.561 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.7 OUTLIER -74.33 -28.54 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 C-N-CA 118.462 -1.295 . . . . 0.0 108.669 -177.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.794 ' O ' HG13 ' A' ' 73' ' ' VAL . 14.3 mm -58.49 -46.82 89.56 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.278 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.327 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.533 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 40.3 t -48.77 -36.63 16.96 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.249 0.547 . . . . 0.0 111.098 178.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -86.53 -31.34 21.31 Favored 'General case' 0 CA--C 1.506 -0.719 0 C-N-CA 123.137 0.575 . . . . 0.0 110.517 -176.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.616 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.3 m-30 -75.22 -36.64 61.33 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.285 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.812 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.7 m -69.45 -32.89 54.81 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 173.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 70' ' ' SER . 0.1 OUTLIER -70.23 -32.43 70.3 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.406 178.683 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.528 ' HB2' HD11 ' A' ' 58' ' ' LEU . . . -63.43 -42.76 98.71 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.645 -1.161 . . . . 0.0 108.972 178.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 5.0 m -102.21 9.49 40.02 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.34 -175.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -58.54 -15.41 11.18 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.069 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.57 ' O ' ' HB2' ' A' ' 83' ' ' MET . . . -117.71 13.59 13.17 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.823 175.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.697 HD11 ' HB2' ' A' ' 54' ' ' ALA . 53.2 mt -94.32 -15.26 7.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.307 0.575 . . . . 0.0 111.632 -176.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.16 -12.09 42.41 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.286 -0.959 . . . . 0.0 112.943 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 176.0 154.32 11.43 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.693 174.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 68.37 -75.67 0.06 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 173.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.57 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 78.0 mtp -61.18 -30.27 70.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.235 0.541 . . . . 0.0 110.111 -177.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.521 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 8.9 t-160 -55.63 -34.59 65.06 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.918 173.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -82.51 -18.14 42.62 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.093 0.473 . . . . 0.0 110.236 -176.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.02 -44.57 12.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.629 175.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 59.0 mtm -81.4 -14.0 57.64 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.346 -176.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.521 ' HB2' ' O ' ' A' ' 84' ' ' HIS . 0.2 OUTLIER -53.16 -33.65 53.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.749 -178.121 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.7 tpt -83.39 -23.06 32.55 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.085 0.469 . . . . 0.0 110.79 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -92.5 -49.33 6.18 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -172.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.551 ' C ' ' HB3' ' A' ' 53' ' ' SER . 23.5 mt-30 -91.47 -52.12 4.94 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.774 -171.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.414 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -48.2 -35.93 12.74 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 175.047 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 6.1 pt-20 . . . . . 0 C--O 1.25 1.08 0 O-C-N 125.558 1.786 . . . . 0.0 113.941 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' PRO . . . . . 0.444 ' HB2' ' H ' ' B' ' 2' ' ' SER . 98.9 Cg_endo . . . . . 0 CA--C 1.518 -0.285 0 N-CA-C 108.811 -1.265 . . . . 0.0 108.811 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.571 ' HB2' HG23 ' B' ' 5' ' ' THR . 74.7 m -71.04 -178.75 2.06 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 161.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.727 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -77.12 -53.5 7.69 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 122.093 0.949 . . . . 0.0 109.646 172.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.519 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.5 p-10 -85.61 5.77 30.33 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.095 -1.411 . . . . 0.0 113.224 -163.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.571 HG23 ' HB2' ' B' ' 2' ' ' SER . 1.1 p -66.72 -3.75 7.37 Favored 'General case' 0 C--N 1.312 -1.045 0 O-C-N 121.953 -0.467 . . . . 0.0 111.36 -176.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.57 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.0 m -77.99 133.75 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 173.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.759 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.2 OUTLIER -156.41 160.95 40.09 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -177.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' GLN . . . . . 0.426 ' HG2' ' HB3' ' B' ' 12' ' ' GLU . 2.3 tt0 -41.98 115.22 0.64 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 113.732 -1.576 . . . . 0.0 113.16 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.44 -151.5 23.12 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 171.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . 0.487 ' C ' ' HD3' ' B' ' 11' ' ' LYS . 24.0 m -54.73 98.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.369 0.585 . . . . 0.0 111.187 -178.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.487 ' HD3' ' C ' ' B' ' 10' ' ' SER . 0.0 OUTLIER 34.99 46.6 0.21 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.799 1.24 . . . . 0.0 112.129 -171.508 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.426 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 36.6 tt0 -59.64 139.51 89.55 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.197 175.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . 0.575 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 51.2 Cg_exo -50.98 122.32 9.72 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 121.955 1.77 . . . . 0.0 109.615 177.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . 0.82 ' HE2' ' SG ' ' B' ' 51' ' ' CYS . 6.3 t80 -70.35 -55.22 8.02 Favored Pre-proline 0 N--CA 1.439 -0.98 0 CA-C-O 118.494 -0.765 . . . . 0.0 112.664 -167.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.532 ' HD3' ' HB3' ' B' ' 14' ' ' TYR . 35.2 Cg_exo -55.79 -19.21 24.0 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 121.526 1.484 . . . . 0.0 111.124 -178.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.575 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 0.8 OUTLIER -89.92 -39.79 12.79 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.226 -1.352 . . . . 0.0 111.082 179.579 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' PHE . . . . . 0.687 ' HE2' ' CE2' ' B' ' 14' ' ' TYR . 0.0 OUTLIER -56.59 -45.67 81.24 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.128 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.755 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 1.3 p -78.94 -33.97 16.53 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.354 0 CA-C-N 115.184 -0.917 . . . . 0.0 111.271 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.71 -31.8 66.77 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 121.346 -0.846 . . . . 0.0 111.701 177.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.702 ' O ' HG12 ' B' ' 24' ' ' VAL . 14.7 ptt180 -84.88 -26.61 27.22 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 175.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.607 HD22 ' CE1' ' B' ' 17' ' ' PHE . 7.6 tp -56.84 -47.73 79.67 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.603 172.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . 0.755 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 18.5 mt-30 -70.04 -47.09 63.44 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.817 176.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.741 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 19.4 t70 -46.4 -57.06 5.0 Favored 'General case' 0 C--N 1.314 -0.947 0 O-C-N 124.312 1.008 . . . . 0.0 111.721 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' VAL . . . . . 0.702 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.7 p -79.44 -23.65 12.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.169 0.509 . . . . 0.0 109.849 -173.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.764 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -72.25 -19.69 61.66 Favored 'General case' 0 C--O 1.205 -1.274 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 174.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . 0.47 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -86.73 -36.99 18.33 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.494 178.589 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.741 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.9 mmtt -66.77 -35.36 79.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.699 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 36.2 t -105.08 -8.88 18.18 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 120.946 0.403 . . . . 0.0 110.744 -171.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.764 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 88.9 mt -115.38 129.4 71.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.711 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.55 -5.02 58.95 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.102 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.681 ' H ' HG22 ' B' ' 29' ' ' ILE . 2.5 t0 -115.98 140.58 49.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.305 0.574 . . . . 0.0 111.125 -176.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.572 ' OE2' ' HG3' ' B' ' 33' ' ' LYS . 1.5 pp20? -66.48 -35.91 81.44 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.183 174.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.618 ' O ' HG13 ' B' ' 37' ' ' VAL . 12.9 mttp -60.49 -61.04 2.88 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -174.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.513 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -59.93 -26.86 66.29 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.582 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.848 ' O ' HG13 ' B' ' 39' ' ' VAL . 4.7 tmm_? -69.69 -59.39 2.98 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -178.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.42 ' HD2' ' OE1' ' B' ' 32' ' ' GLU . 23.8 mtpt -56.84 -55.44 34.4 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.246 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.691 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 19.2 m -53.52 -35.29 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.192 -172.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.727 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.3 tt -87.42 -31.12 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.159 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.848 HG13 ' O ' ' B' ' 35' ' ' ARG . 3.0 m -69.15 -48.57 68.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 119.078 -1.049 . . . . 0.0 109.418 175.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.611 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 61.9 mt-10 -63.59 -23.94 67.59 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 123.634 0.774 . . . . 0.0 112.229 176.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.691 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -86.27 -54.73 4.28 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.871 176.328 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' MET . . . . . 0.564 ' HB2' HD21 ' B' ' 21' ' ' LEU . 18.8 mmt -62.65 -20.41 64.78 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 121.553 0.692 . . . . 0.0 109.971 -177.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.627 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -48.33 -29.03 3.53 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.48 -1.237 . . . . 0.0 110.992 171.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' TYR . . . . . 0.663 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 2.4 t80 -109.05 -65.63 1.12 Allowed 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 176.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.547 ' CG ' HD12 ' B' ' 41' ' ' LEU . 3.3 mm-40 -46.89 -30.76 2.69 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 124.145 0.903 . . . . 0.0 112.678 -175.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.759 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.8 m-20 -106.13 -20.97 13.25 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -175.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.815 ' HB1' ' SG ' ' B' ' 51' ' ' CYS . . . -64.23 -175.9 0.19 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -172.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.514 ' HB2' ' HB3' ' B' ' 51' ' ' CYS . 19.4 m-20 -61.75 141.72 95.01 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.473 175.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -55.27 -26.75 53.65 Favored 'Trans proline' 0 C--O 1.219 -0.446 0 C-N-CA 123.518 2.812 . . . . 0.0 112.948 -176.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.538 ' O ' ' HG3' ' B' ' 50' ' ' GLU . 0.0 OUTLIER -87.17 -29.16 21.98 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.327 0.651 . . . . 0.0 110.351 174.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.82 ' SG ' ' HE2' ' B' ' 14' ' ' TYR . 0.0 OUTLIER -76.04 -43.78 42.27 Favored 'General case' 0 N--CA 1.42 -1.942 0 CA-C-O 121.446 0.641 . . . . 0.0 110.547 -172.229 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.648 ' HB2' ' CG ' ' B' ' 44' ' ' TYR . 4.4 pt20 -67.77 -29.47 68.69 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 175.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . 0.558 ' HB3' ' C ' ' B' ' 91' ' ' GLN . 4.0 m -69.42 -20.87 63.79 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 113.685 -1.598 . . . . 0.0 110.716 173.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.713 ' HB2' HD11 ' B' ' 79' ' ' ILE . . . -80.22 -25.26 39.69 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.289 -0.882 . . . . 0.0 109.821 168.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.546 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 25.7 mt -90.67 -31.28 5.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 -172.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.627 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.64 -39.62 2.6 Favored Pre-proline 0 N--CA 1.487 1.399 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -172.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 50.7 Cg_endo -62.81 -29.67 76.98 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.323 2.015 . . . . 0.0 112.828 176.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . 0.56 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.7 mt -97.42 -16.42 20.2 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.663 ' HE3' ' HB3' ' B' ' 44' ' ' TYR . 0.1 OUTLIER -52.92 108.73 0.34 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.955 -178.104 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.407 ' HA3' ' C ' ' A' ' 1' ' ' PRO . . . 94.55 -22.47 37.24 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.745 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -103.53 115.11 29.9 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -178.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.45 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.1 p -122.92 139.0 30.51 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.429 173.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.521 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 97.0 Cg_exo -47.96 139.43 20.09 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.708 2.272 . . . . 0.0 111.833 169.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.06 101.12 0.19 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.413 -175.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.62 -13.09 42.73 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.757 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.521 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 48.2 m -88.68 166.03 14.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.05 0.453 . . . . 0.0 110.937 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.37 139.2 32.42 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 173.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.57 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.7 OUTLIER -74.32 -28.33 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 C-N-CA 118.432 -1.307 . . . . 0.0 108.696 -177.462 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.799 ' O ' HG13 ' B' ' 73' ' ' VAL . 14.4 mm -58.61 -46.83 90.01 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.179 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.319 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.541 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 37.6 t -48.62 -36.74 16.45 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.165 0.507 . . . . 0.0 111.081 178.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -86.56 -31.23 21.33 Favored 'General case' 0 CA--C 1.506 -0.73 0 C-N-CA 123.206 0.602 . . . . 0.0 110.545 -176.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' TYR . . . . . 0.605 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.3 m-30 -75.36 -36.6 60.95 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.32 -178.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.815 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.7 m -69.36 -33.23 56.65 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 173.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' LYS . . . . . 0.541 ' HB2' ' O ' ' B' ' 70' ' ' SER . 0.1 OUTLIER -69.94 -32.31 70.51 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.517 178.473 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . 0.515 ' HB2' HD11 ' B' ' 58' ' ' LEU . . . -63.76 -42.07 97.88 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.208 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 5.1 m -102.7 9.53 39.13 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 114.101 -1.409 . . . . 0.0 111.318 -175.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -58.26 -16.19 13.04 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.046 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . 0.56 ' O ' ' HB2' ' B' ' 83' ' ' MET . . . -116.99 13.48 14.24 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.981 175.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.713 HD11 ' HB2' ' B' ' 54' ' ' ALA . 53.4 mt -94.22 -15.25 7.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.21 0.529 . . . . 0.0 111.705 -176.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.11 -11.9 41.13 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.961 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 175.77 154.17 11.18 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.678 174.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 68.46 -75.3 0.07 Allowed 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 173.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' MET . . . . . 0.56 ' HB2' ' O ' ' B' ' 78' ' ' GLY . 77.8 mtp -61.27 -30.43 70.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.152 0.501 . . . . 0.0 110.059 -177.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' HIS . . . . . 0.51 ' O ' ' HB2' ' B' ' 88' ' ' LEU . 8.8 t-160 -55.79 -34.62 65.46 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.836 173.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -82.5 -17.72 44.13 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.925 0.393 . . . . 0.0 110.26 -176.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.17 -44.88 11.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.678 175.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 58.5 mtm -81.32 -13.89 57.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.428 -176.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.51 ' HB2' ' O ' ' B' ' 84' ' ' HIS . 0.2 OUTLIER -52.79 -34.43 53.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.615 -178.322 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 15.7 tpt -83.09 -22.83 33.32 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.091 0.472 . . . . 0.0 110.736 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -92.69 -48.91 6.35 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -172.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' GLN . . . . . 0.558 ' C ' ' HB3' ' B' ' 53' ' ' SER . 23.7 mt-30 -91.65 -52.17 4.89 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.855 -171.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.426 ' HB2' HD12 ' B' ' 88' ' ' LEU . 0.0 OUTLIER -48.19 -35.84 12.54 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 174.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' B' ' 91' ' ' GLN . 6.1 pt-20 . . . . . 0 C--O 1.248 1.025 0 O-C-N 125.563 1.789 . . . . 0.0 113.864 -175.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.453 ' HB2' ' H ' ' A' ' 2' ' ' SER . 86.3 Cg_endo . . . . . 0 CA--C 1.517 -0.35 0 N-CA-C 109.024 -1.183 . . . . 0.0 109.024 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.49 ' HB2' HG23 ' A' ' 5' ' ' THR . 21.2 m -68.41 175.2 3.5 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 161.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.833 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -71.0 -52.2 21.03 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 164.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.518 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 2.3 p-10 -87.41 5.52 38.39 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.875 -1.512 . . . . 0.0 113.692 -165.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.49 HG23 ' HB2' ' A' ' 2' ' ' SER . 0.7 OUTLIER -64.35 -5.76 5.78 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 118.537 0.608 . . . . 0.0 111.116 -177.37 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.642 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.1 m -76.16 130.94 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.743 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -154.31 158.69 40.52 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.552 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 3.3 mt-30 -42.04 116.61 0.84 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 112.997 -1.91 . . . . 0.0 113.465 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.56 -153.67 21.55 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 170.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.662 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 20.8 t -57.19 99.34 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.166 0.483 . . . . 0.0 110.926 -177.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.662 ' HG2' ' O ' ' A' ' 10' ' ' SER . 4.1 ptpp? 49.18 32.71 4.38 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.602 1.161 . . . . 0.0 112.433 -177.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.431 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 38.7 tt0 -56.06 135.39 74.14 Favored Pre-proline 0 C--O 1.233 0.224 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.558 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 52.0 Cg_exo -51.05 123.08 11.09 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.46 2.107 . . . . 0.0 110.169 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.906 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 15.0 t80 -71.13 -53.51 8.18 Favored Pre-proline 0 N--CA 1.438 -1.061 0 CA-C-O 118.277 -0.868 . . . . 0.0 113.183 -167.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.541 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 33.6 Cg_exo -55.9 -18.43 22.05 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 121.425 1.416 . . . . 0.0 111.041 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.558 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.8 m-20 -89.92 -43.49 10.55 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.93 -1.486 . . . . 0.0 110.829 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.552 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -54.31 -44.43 72.0 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.727 HG12 ' O ' ' A' ' 14' ' ' TYR . 3.0 p -82.19 -31.77 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.386 -177.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . -57.89 -35.86 71.61 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 121.763 -0.585 . . . . 0.0 111.853 175.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.72 ' O ' HG12 ' A' ' 24' ' ' VAL . 15.6 ptt180 -82.97 -27.3 30.56 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 177.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.572 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 6.5 tp -56.89 -45.46 82.57 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.858 173.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.733 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 40.5 mt-30 -74.12 -43.71 56.52 Favored 'General case' 0 CA--C 1.496 -1.112 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.999 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.754 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 8.8 t70 -51.17 -51.68 51.41 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 124.137 0.898 . . . . 0.0 111.47 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.72 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.5 p -82.64 -23.15 8.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -174.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.825 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -71.66 -18.67 62.17 Favored 'General case' 0 C--O 1.206 -1.224 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 174.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.0 -39.11 15.98 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.471 -1.24 . . . . 0.0 109.766 176.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.754 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 36.5 mmtt -66.59 -40.61 88.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.065 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.403 ' HB2' ' HB3' ' A' ' 3' ' ' PHE . 43.9 m -98.81 -9.7 24.01 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.153 0.501 . . . . 0.0 110.437 -171.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.825 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 87.5 mt -115.18 125.3 72.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.759 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.56 -4.96 59.25 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.004 0.431 . . . . 0.0 110.529 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.678 ' OD1' ' HD2' ' A' ' 33' ' ' LYS . 3.9 t0 -110.62 122.43 47.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.534 -176.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.484 ' O ' ' HG2' ' A' ' 36' ' ' LYS . 12.6 pt-20 -61.85 -25.11 67.33 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.765 176.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.678 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 24.4 mttt -73.81 -46.74 43.43 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 120.901 0.381 . . . . 0.0 110.146 -176.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.08 -25.11 60.78 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.731 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.84 ' O ' HG13 ' A' ' 39' ' ' VAL . 5.0 tmm_? -64.53 -63.14 1.21 Allowed 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.642 ' HG3' HG13 ' A' ' 37' ' ' VAL . 6.5 ptmm? -51.9 -60.15 3.51 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.198 0.523 . . . . 0.0 112.224 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.642 HG13 ' HG3' ' A' ' 36' ' ' LYS . 10.4 m -56.32 -30.87 31.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.353 -170.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.833 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.2 tt -86.08 -30.45 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.247 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.84 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.3 m -70.13 -47.91 65.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 119.481 -0.887 . . . . 0.0 109.348 175.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.658 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 55.3 mt-10 -60.21 -30.27 69.27 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.665 0.786 . . . . 0.0 112.119 176.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.619 ' HG ' HD11 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -86.16 -53.15 5.22 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.484 -0.487 . . . . 0.0 112.189 179.198 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.559 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 22.0 mmt -61.95 -22.08 65.33 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.592 0.71 . . . . 0.0 109.84 -178.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.697 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -48.54 -29.02 3.78 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.043 171.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.598 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 8.4 t80 -107.02 -66.58 1.01 Allowed 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.548 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 15.5 mm-40 -48.23 -31.96 6.55 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 124.141 0.901 . . . . 0.0 112.109 -174.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.743 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.9 m-20 -103.03 -21.49 13.92 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.182 -175.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.605 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -62.42 -178.98 0.21 Allowed 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.988 0.899 . . . . 0.0 112.986 -173.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.542 ' HB3' ' OE1' ' A' ' 50' ' ' GLU . 12.2 m-20 -61.34 143.24 93.11 Favored Pre-proline 0 C--N 1.317 -0.811 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.003 175.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 48' ' ' ASN . 55.5 Cg_exo -50.83 -28.53 23.66 Favored 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 123.666 2.911 . . . . 0.0 112.996 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.689 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 15.9 pm0 -88.42 -30.99 19.04 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.758 0.823 . . . . 0.0 111.015 176.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.689 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 96.9 m -81.79 -38.99 24.73 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.242 -170.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.626 ' HA ' HD12 ' A' ' 55' ' ' ILE . 4.1 pt20 -69.93 -29.76 66.98 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 172.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.628 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 6.7 m -71.12 -20.32 62.34 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.859 -1.518 . . . . 0.0 110.755 174.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.684 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -77.88 -25.27 48.48 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.691 0.758 . . . . 0.0 109.57 167.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.626 HD12 ' HA ' ' A' ' 52' ' ' GLN . 24.1 mt -89.76 -33.05 5.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -172.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.613 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.3 -38.71 1.71 Allowed Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -173.363 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 51.5 Cg_endo -63.13 -28.69 73.86 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.188 1.925 . . . . 0.0 112.625 175.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.537 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 2.2 mt -97.58 -16.65 19.95 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.598 ' HD2' ' CG ' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -55.95 108.98 0.51 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.443 -179.146 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.72 -24.9 30.36 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.328 -177.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.0 mmmt -104.54 115.63 30.68 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.853 0.358 . . . . 0.0 110.466 -178.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.43 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.7 p -121.77 134.75 24.75 Favored Pre-proline 0 C--N 1.313 -1.0 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 168.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.411 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 85.4 Cg_exo -51.66 136.2 49.6 Favored 'Trans proline' 0 CA--C 1.518 -0.278 0 C-N-CA 122.545 2.163 . . . . 0.0 111.79 172.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.09 109.05 1.38 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.769 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.36 -17.71 39.82 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.623 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.411 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 1.8 t -91.39 -174.59 3.97 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 122.09 0.948 . . . . 0.0 110.719 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -108.03 143.09 37.21 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 113.781 -1.554 . . . . 0.0 108.308 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.58 HG22 ' HG2' ' A' ' 40' ' ' GLU . 1.2 m -76.16 -30.29 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 C-N-CA 118.553 -1.259 . . . . 0.0 108.709 -177.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.778 ' O ' HG13 ' A' ' 73' ' ' VAL . 7.0 mm -60.85 -47.88 91.38 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.158 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.413 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.498 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 34.1 t -50.51 -35.22 28.37 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.892 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.45 ' H ' ' HG2' ' A' ' 71' ' ' GLU . 3.1 mm-40 -86.58 -32.07 20.85 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.081 0.467 . . . . 0.0 110.414 -177.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.537 ' CE1' ' HB2' ' A' ' 58' ' ' LEU . 5.5 m-30 -74.1 -36.18 64.22 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.318 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.906 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 2.2 m -71.21 -32.88 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -68.51 -31.91 71.51 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.516 177.479 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.5 ' HB2' HD11 ' A' ' 58' ' ' LEU . . . -63.38 -44.49 94.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.265 178.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.532 ' SG ' ' HB3' ' A' ' 51' ' ' CYS . 3.8 m -97.77 9.46 42.56 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.11 -177.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -64.19 -29.74 70.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.653 177.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.95 6.5 76.55 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.932 174.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.684 HD11 ' HB2' ' A' ' 54' ' ' ALA . 80.0 mt -102.34 129.42 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 121.617 0.722 . . . . 0.0 111.715 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.604 ' H ' ' HB2' ' A' ' 84' ' ' HIS . . . 173.22 -50.25 0.16 Allowed Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 108.921 -1.671 . . . . 0.0 108.921 170.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.12 156.86 27.1 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 114.558 -0.821 . . . . 0.0 111.165 177.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 62.85 -78.43 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 122.987 0.515 . . . . 0.0 112.041 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.552 ' O ' ' HG3' ' A' ' 87' ' ' MET . 63.0 mtt -60.77 -38.63 85.93 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 121.118 0.485 . . . . 0.0 109.848 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.604 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 3.8 t-160 -53.6 -33.41 54.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.435 173.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -83.56 -36.6 23.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.729 0.299 . . . . 0.0 110.734 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.54 -52.89 59.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.968 0.889 . . . . 0.0 110.0 174.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.552 ' HG3' ' O ' ' A' ' 83' ' ' MET . 27.7 mtm -73.97 -12.74 60.73 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.987 -176.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.45 HD12 ' HB2' ' A' ' 92' ' ' LEU . 0.1 OUTLIER -57.19 -42.17 80.71 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.554 177.267 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 51.8 ttm -80.81 -20.03 43.39 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.355 0.598 . . . . 0.0 110.803 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -92.52 -46.49 7.61 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.981 -175.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.672 ' O ' ' HG2' ' A' ' 93' ' ' GLU . 22.1 mt-30 -92.64 -52.02 4.83 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.565 -172.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.45 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -51.46 -35.84 41.5 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 175.613 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.672 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 7.8 pt-20 . . . . . 0 C--O 1.249 1.033 0 CA-C-N 112.992 -1.913 . . . . 0.0 113.868 -177.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' PRO . . . . . 0.415 ' HB2' ' H ' ' B' ' 2' ' ' SER . 88.4 Cg_endo . . . . . 0 CA--C 1.519 -0.245 0 N-CA-C 108.797 -1.27 . . . . 0.0 108.797 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.493 ' HB2' HG23 ' B' ' 5' ' ' THR . 19.8 m -68.1 175.08 3.37 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 161.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.813 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -71.08 -52.19 20.83 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 164.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.494 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.2 p-10 -87.5 5.48 38.91 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 113.869 -1.514 . . . . 0.0 113.667 -165.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.493 HG23 ' HB2' ' B' ' 2' ' ' SER . 0.7 OUTLIER -63.88 -6.52 6.09 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 118.542 0.61 . . . . 0.0 111.086 -177.668 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.642 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.2 m -75.61 131.09 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.766 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -154.32 158.59 40.38 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' GLN . . . . . 0.543 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 3.4 mt-30 -41.82 116.88 0.85 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 113.119 -1.855 . . . . 0.0 113.369 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.77 -153.98 22.63 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.732 170.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . 0.668 ' O ' ' HG2' ' B' ' 11' ' ' LYS . 19.8 t -56.94 98.8 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 117.116 0.458 . . . . 0.0 110.952 -177.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.668 ' HG2' ' O ' ' B' ' 10' ' ' SER . 4.1 ptpp? 49.41 32.86 4.92 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.688 1.195 . . . . 0.0 112.504 -177.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.434 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 38.4 tt0 -56.12 135.41 74.49 Favored Pre-proline 0 C--O 1.234 0.251 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . 0.575 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 52.2 Cg_exo -50.97 123.0 10.88 Favored 'Trans proline' 0 CA--C 1.509 -0.77 0 C-N-CA 122.343 2.029 . . . . 0.0 110.206 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . 0.896 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 14.7 t80 -71.01 -53.53 8.37 Favored Pre-proline 0 N--CA 1.439 -1.019 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -167.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.534 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 34.2 Cg_exo -55.92 -18.48 22.3 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 121.535 1.49 . . . . 0.0 110.999 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.575 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.6 m-20 -89.96 -43.18 10.73 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 113.917 -1.492 . . . . 0.0 110.933 178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' PHE . . . . . 0.543 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -54.6 -44.43 73.07 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 176.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.714 HG12 ' O ' ' B' ' 14' ' ' TYR . 3.0 p -82.16 -31.86 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.514 -177.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.44 -36.39 71.33 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 121.793 -0.567 . . . . 0.0 111.878 175.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.713 ' O ' HG12 ' B' ' 24' ' ' VAL . 15.5 ptt180 -82.72 -27.18 31.32 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.565 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 6.6 tp -57.05 -45.21 83.36 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.87 173.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . 0.736 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 40.6 mt-30 -74.36 -44.06 53.87 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.019 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.74 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 9.5 t70 -50.9 -51.44 51.94 Favored 'General case' 0 C--N 1.314 -0.955 0 O-C-N 124.097 0.873 . . . . 0.0 111.495 -178.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' VAL . . . . . 0.713 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.4 p -82.71 -23.41 8.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.201 0.524 . . . . 0.0 109.707 -174.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.819 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -71.37 -18.76 62.35 Favored 'General case' 0 C--O 1.206 -1.206 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 173.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.1 -38.63 16.3 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.845 176.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.74 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 36.2 mmtt -66.89 -40.64 87.82 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.98 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . 0.415 ' HB2' ' HB3' ' B' ' 3' ' ' PHE . 45.2 m -98.86 -9.27 24.49 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.039 0.447 . . . . 0.0 110.552 -171.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.819 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 87.2 mt -115.33 125.68 72.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.651 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.05 -4.2 59.14 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.977 0.418 . . . . 0.0 110.468 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.676 ' H ' HG22 ' B' ' 29' ' ' ILE . 3.6 t0 -111.45 122.65 48.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.51 -176.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' B' ' 36' ' ' LYS . 12.7 pt-20 -62.03 -25.25 67.55 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.665 176.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.666 ' HD2' ' OD1' ' B' ' 31' ' ' ASP . 24.0 mttt -73.71 -46.54 45.46 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 120.834 0.349 . . . . 0.0 110.082 -176.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.32 -25.04 60.47 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.5 -0.48 . . . . 0.0 109.77 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.836 ' O ' HG13 ' B' ' 39' ' ' VAL . 5.0 tmm_? -64.44 -63.32 1.16 Allowed 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.647 ' HG3' HG13 ' B' ' 37' ' ' VAL . 6.5 ptmm? -51.71 -60.08 3.56 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.257 0.551 . . . . 0.0 112.31 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.647 HG13 ' HG3' ' B' ' 36' ' ' LYS . 10.4 m -56.58 -30.57 32.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.713 -1.131 . . . . 0.0 112.496 -170.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.813 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.2 tt -86.26 -30.45 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 C-N-CA 119.241 -0.984 . . . . 0.0 111.175 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.836 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.3 m -70.04 -47.87 65.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.411 175.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.651 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 56.6 mt-10 -60.31 -29.96 69.19 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 123.69 0.796 . . . . 0.0 112.193 176.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.635 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -86.25 -53.25 5.14 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.367 -0.533 . . . . 0.0 112.16 179.044 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' MET . . . . . 0.565 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 22.0 mmt -61.9 -22.18 65.36 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.594 0.711 . . . . 0.0 109.831 -177.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.698 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -48.5 -29.03 3.73 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.924 171.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' TYR . . . . . 0.594 ' CG ' ' HD2' ' B' ' 59' ' ' LYS . 8.3 t80 -107.24 -66.65 1.01 Allowed 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 176.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.529 ' CG ' HD12 ' B' ' 41' ' ' LEU . 14.9 mm-40 -48.1 -31.84 6.07 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 124.168 0.917 . . . . 0.0 112.243 -174.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.766 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.9 m-20 -103.21 -21.47 13.86 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 116.754 -0.203 . . . . 0.0 111.265 -175.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.602 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -62.38 -179.16 0.22 Allowed 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.982 0.896 . . . . 0.0 112.865 -173.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.564 ' HB3' ' OE1' ' B' ' 50' ' ' GLU . 12.4 m-20 -61.16 143.31 92.54 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.037 175.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -50.7 -28.75 23.59 Favored 'Trans proline' 0 C--O 1.218 -0.494 0 C-N-CA 123.54 2.827 . . . . 0.0 113.022 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.696 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 15.9 pm0 -88.26 -30.97 19.27 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.739 0.816 . . . . 0.0 111.015 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.696 ' N ' ' HG2' ' B' ' 50' ' ' GLU . 96.7 m -81.83 -39.06 24.53 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.145 -170.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.634 ' HA ' HD12 ' B' ' 55' ' ' ILE . 4.1 pt20 -69.95 -29.64 66.82 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 172.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . 0.63 ' HB3' ' HB3' ' B' ' 91' ' ' GLN . 7.0 m -71.18 -20.28 62.3 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 113.847 -1.524 . . . . 0.0 110.704 174.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.684 ' HB2' HD11 ' B' ' 79' ' ' ILE . . . -77.72 -25.38 49.26 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.604 0.716 . . . . 0.0 109.683 167.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.634 HD12 ' HA ' ' B' ' 52' ' ' GLN . 24.3 mt -89.77 -32.87 5.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 -172.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.611 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.22 -38.91 1.71 Allowed Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -173.523 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 51.5 Cg_endo -63.07 -28.85 74.51 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 122.175 1.916 . . . . 0.0 112.716 175.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . 0.535 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 2.2 mt -97.44 -16.4 20.19 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.594 ' HD2' ' CG ' ' B' ' 44' ' ' TYR . 0.1 OUTLIER -56.13 108.91 0.51 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.523 -179.254 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.0 -25.12 29.48 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.265 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 9.9 mmmt -104.52 115.52 30.49 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.961 0.41 . . . . 0.0 110.381 -177.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.427 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.7 p -121.8 134.68 24.74 Favored Pre-proline 0 C--N 1.312 -1.055 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 168.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.4 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 86.0 Cg_exo -52.0 135.85 51.87 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.502 2.135 . . . . 0.0 111.846 172.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.24 108.78 1.15 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.761 -177.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.53 -17.96 38.89 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.592 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.4 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 1.6 t -91.21 -174.85 4.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.831 0.824 . . . . 0.0 110.569 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -107.95 143.09 37.08 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.308 177.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.584 HG22 ' HG2' ' B' ' 40' ' ' GLU . 1.2 m -75.99 -30.25 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 C-N-CA 118.556 -1.258 . . . . 0.0 108.709 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.78 ' O ' HG13 ' B' ' 73' ' ' VAL . 6.9 mm -60.87 -47.94 91.14 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.208 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.306 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 35.1 t -50.41 -35.25 27.59 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.745 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.413 ' H ' ' HG2' ' B' ' 71' ' ' GLU . 3.0 mm-40 -86.55 -32.21 20.82 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.459 -177.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' TYR . . . . . 0.535 ' CE1' ' HB2' ' B' ' 58' ' ' LEU . 5.5 m-30 -74.09 -36.23 64.27 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.325 -178.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.896 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 2.2 m -71.15 -33.04 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' B' ' 70' ' ' SER . 0.0 OUTLIER -68.31 -32.2 72.16 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.459 177.474 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . 0.516 ' HB2' HD11 ' B' ' 58' ' ' LEU . . . -63.05 -44.67 95.19 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.194 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.52 ' SG ' ' HB3' ' B' ' 51' ' ' CYS . 3.8 m -97.54 9.28 42.86 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 114.22 -1.355 . . . . 0.0 111.052 -177.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -64.08 -29.67 70.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.649 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.75 6.52 77.1 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.063 174.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.684 HD11 ' HB2' ' B' ' 54' ' ' ALA . 80.0 mt -102.6 128.97 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 121.781 0.8 . . . . 0.0 111.812 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . 0.583 ' H ' ' HB2' ' B' ' 84' ' ' HIS . . . 173.88 -49.76 0.15 Allowed Glycine 0 N--CA 1.436 -1.35 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 169.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.79 156.46 26.85 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.16 -78.51 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 122.899 0.48 . . . . 0.0 112.042 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' MET . . . . . 0.547 ' O ' ' HG3' ' B' ' 87' ' ' MET . 63.6 mtt -60.94 -38.86 87.32 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' HIS . . . . . 0.583 ' HB2' ' H ' ' B' ' 80' ' ' GLY . 3.8 t-160 -53.25 -33.61 53.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.499 173.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -83.24 -36.86 24.25 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.691 0.281 . . . . 0.0 110.736 -177.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.55 -52.16 62.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 122.01 0.91 . . . . 0.0 110.192 174.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . 0.547 ' HG3' ' O ' ' B' ' 83' ' ' MET . 27.5 mtm -74.56 -12.66 60.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.127 -1.397 . . . . 0.0 110.909 -176.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.462 HD12 ' HB2' ' B' ' 92' ' ' LEU . 0.1 OUTLIER -57.11 -42.34 80.62 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.501 177.145 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 51.9 ttm -80.61 -20.18 43.78 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.179 0.514 . . . . 0.0 110.831 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -92.72 -46.31 7.63 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.862 -175.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' GLN . . . . . 0.689 ' O ' ' HG2' ' B' ' 93' ' ' GLU . 22.2 mt-30 -92.64 -52.23 4.73 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.525 -172.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.462 ' HB2' HD12 ' B' ' 88' ' ' LEU . 0.0 OUTLIER -51.32 -36.07 41.01 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 175.645 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.689 ' HG2' ' O ' ' B' ' 91' ' ' GLN . 7.8 pt-20 . . . . . 0 C--O 1.25 1.126 0 CA-C-N 112.946 -1.934 . . . . 0.0 113.941 -177.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 CA--C 1.519 -0.263 0 N-CA-C 108.721 -1.3 . . . . 0.0 108.721 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 m -67.52 -179.76 1.14 Allowed 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 163.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.747 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -75.56 -53.38 8.71 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 118.956 -1.098 . . . . 0.0 108.625 166.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.493 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 2.4 p-10 -86.91 5.04 39.02 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.247 -1.342 . . . . 0.0 113.201 -165.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.96 -5.97 5.39 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 118.166 0.439 . . . . 0.0 111.441 -176.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.592 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.4 m -75.62 131.77 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 176.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.77 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -154.63 159.48 40.84 Favored 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 118.693 -1.203 . . . . 0.0 114.228 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.487 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.5 mt-30 -42.32 116.38 0.83 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 112.965 -1.925 . . . . 0.0 112.829 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.46 -139.87 8.15 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.635 173.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.4 p -58.67 95.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.765 0.282 . . . . 0.0 111.133 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.471 ' HD2' ' O ' ' A' ' 80' ' ' GLY . 56.5 pttt 40.75 39.54 0.8 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.238 1.015 . . . . 0.0 111.986 -175.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.447 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 48.5 tt0 -56.86 139.65 77.36 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.234 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.525 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 36.9 Cg_exo -54.33 122.73 12.03 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.988 1.792 . . . . 0.0 109.781 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.825 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 13.2 t80 -70.36 -52.53 11.57 Favored Pre-proline 0 N--CA 1.438 -1.046 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 -166.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.531 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 27.6 Cg_exo -57.18 -17.32 25.11 Favored 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 121.444 1.429 . . . . 0.0 111.062 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.525 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.5 m-20 -90.04 -42.11 11.32 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.04 -1.437 . . . . 0.0 110.698 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.487 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -55.5 -44.84 76.96 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.674 HG12 ' O ' ' A' ' 14' ' ' TYR . 2.1 p -78.99 -34.06 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.274 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.88 -38.15 69.79 Favored 'General case' 0 C--N 1.319 -0.744 0 O-C-N 121.833 -0.542 . . . . 0.0 111.488 176.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.721 ' O ' HG12 ' A' ' 24' ' ' VAL . 15.5 ptt180 -80.78 -28.32 36.38 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.537 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 6.2 tp -55.87 -43.78 77.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.976 173.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.69 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 24.0 mt-30 -72.72 -52.71 14.02 Favored 'General case' 0 CA--C 1.486 -1.483 0 CA-C-N 114.702 -1.135 . . . . 0.0 111.493 178.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.732 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 38.3 m-20 -46.86 -50.75 18.08 Favored 'General case' 0 C--N 1.313 -0.996 0 O-C-N 124.375 1.047 . . . . 0.0 111.24 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.721 HG12 ' O ' ' A' ' 20' ' ' ARG . 8.3 p -79.58 -26.23 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.77 -172.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.617 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -67.45 -30.54 70.29 Favored 'General case' 0 C--O 1.207 -1.171 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 175.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.96 -34.98 59.83 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.647 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.732 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 40.7 mmtt -67.9 -36.0 79.46 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.774 178.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.46 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 16.2 m -105.52 -6.33 19.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.362 0.601 . . . . 0.0 110.564 -171.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.656 HG22 ' H ' ' A' ' 31' ' ' ASP . 89.0 mt -118.2 124.15 72.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.334 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.21 -4.07 58.58 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.219 0.533 . . . . 0.0 110.582 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.656 ' H ' HG22 ' A' ' 29' ' ' ILE . 26.0 t0 -106.59 140.48 39.41 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.565 -177.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -76.23 -32.05 58.71 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.001 174.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.571 ' O ' HG13 ' A' ' 37' ' ' VAL . 6.9 mttp -70.87 -55.51 8.3 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -176.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.605 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -57.99 -27.87 63.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.976 175.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.853 ' O ' HG13 ' A' ' 39' ' ' VAL . 1.9 tmm_? -67.22 -56.53 9.49 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.497 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 20.8 mtpt -56.22 -57.93 10.13 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.957 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.732 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 20.1 m -53.08 -34.72 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.414 -169.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.747 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.1 tt -87.97 -30.75 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 C-N-CA 119.765 -0.774 . . . . 0.0 112.316 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.853 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.9 m -67.89 -50.21 61.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 119.413 -0.915 . . . . 0.0 109.688 174.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.769 ' OE1' HG13 ' A' ' 68' ' ' VAL . 0.9 OUTLIER -63.73 -25.9 68.4 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.76 0.824 . . . . 0.0 111.622 178.46 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.732 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -85.87 -55.14 4.1 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 177.064 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.518 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 22.2 mmt -62.59 -20.87 65.16 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 121.67 0.747 . . . . 0.0 109.822 -176.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.678 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -48.68 -28.89 3.85 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.81 171.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.557 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 11.5 t80 -106.14 -66.53 0.99 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 175.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.484 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 5.7 mm-40 -48.13 -29.56 3.75 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 124.107 0.88 . . . . 0.0 112.937 -175.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.77 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.7 m-20 -106.87 -21.25 13.08 Favored 'General case' 0 N--CA 1.438 -1.071 0 O-C-N 122.22 -0.3 . . . . 0.0 111.19 -176.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -60.43 179.22 0.16 Allowed 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.889 0.852 . . . . 0.0 112.905 -174.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.498 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 11.5 m-20 -60.12 139.83 91.07 Favored Pre-proline 0 N--CA 1.443 -0.823 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.228 174.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.473 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 1.8 Cg_endo -44.35 -46.38 11.79 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.906 2.404 . . . . 0.0 112.004 -177.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.543 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 0.4 OUTLIER -71.31 -33.51 69.73 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.335 1.054 . . . . 0.0 111.841 177.173 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.525 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 98.4 m -75.7 -36.37 60.03 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 121.243 0.544 . . . . 0.0 109.967 -173.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.553 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.9 pt20 -73.03 -30.95 64.12 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 174.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.543 ' HB2' ' HA ' ' A' ' 50' ' ' GLU . 17.4 m -68.87 -20.51 64.27 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.048 173.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.715 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -76.38 -28.74 56.88 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.747 0.784 . . . . 0.0 109.958 168.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.574 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 19.2 mt -89.67 -31.85 5.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -171.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.612 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -40.17 -39.78 1.55 Allowed Pre-proline 0 N--CA 1.487 1.41 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -173.075 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 54.2 Cg_endo -63.04 -30.93 76.46 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.141 1.894 . . . . 0.0 112.781 176.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.563 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 2.6 mt -94.48 -17.06 22.8 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.576 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -55.44 108.67 0.45 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.053 179.359 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.29 -31.66 8.47 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.528 -175.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.2 mmtt -104.12 114.85 29.38 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 122.173 0.987 . . . . 0.0 111.147 -177.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.535 ' HB ' HG12 ' A' ' 68' ' ' VAL . 5.6 p -120.72 131.67 24.39 Favored Pre-proline 0 C--N 1.294 -1.824 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.826 169.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.406 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 79.4 Cg_exo -51.27 137.88 46.33 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.637 2.224 . . . . 0.0 112.078 174.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.06 108.37 1.51 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.591 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.49 -14.86 42.59 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.346 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.406 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 4.7 t -94.43 -175.78 3.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.949 0.88 . . . . 0.0 110.548 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -107.72 143.7 35.87 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 113.723 -1.58 . . . . 0.0 107.96 175.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.769 HG13 ' OE1' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -72.25 -34.85 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 118.372 -1.331 . . . . 0.0 108.916 -179.138 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.766 ' O ' HG13 ' A' ' 73' ' ' VAL . 7.2 mm -56.65 -49.77 76.66 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.065 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.676 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 23.0 t -46.14 -38.37 8.09 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.858 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.445 ' H ' ' HG2' ' A' ' 71' ' ' GLU . 2.8 mm-40 -86.45 -32.27 20.94 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.544 -176.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.576 ' OH ' ' HA ' ' A' ' 59' ' ' LYS . 5.4 m-30 -73.95 -37.53 64.52 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.681 0.753 . . . . 0.0 109.65 -177.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.825 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.7 m -70.1 -32.81 52.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 174.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -68.42 -31.36 70.64 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.567 176.45 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.471 ' HB2' HD11 ' A' ' 58' ' ' LEU . . . -64.6 -46.35 83.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.492 178.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.525 ' SG ' ' HB3' ' A' ' 51' ' ' CYS . 4.0 m -94.04 9.22 38.51 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.919 -178.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 9.6 t70 -62.35 -27.3 68.96 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.201 177.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.51 -3.52 64.68 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.176 175.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.715 HD11 ' HB2' ' A' ' 54' ' ' ALA . 96.2 mt -96.07 129.11 46.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.787 0.327 . . . . 0.0 110.898 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.471 ' O ' ' HD2' ' A' ' 11' ' ' LYS . . . 162.05 30.48 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.333 175.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.576 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 151.18 -108.3 0.38 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.152 175.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.68 -53.24 59.02 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -173.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 56.7 mtt -67.92 -30.68 70.07 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.515 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 6.6 t-80 -61.57 -35.24 77.23 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.549 175.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.576 ' HG2' ' O ' ' A' ' 81' ' ' GLY . 32.4 mmtp -80.0 -18.26 50.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.115 0.484 . . . . 0.0 110.391 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.21 -50.0 7.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.382 0.611 . . . . 0.0 110.387 176.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -77.98 -13.24 59.95 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.231 -175.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.575 ' O ' ' HB3' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -48.26 -42.93 31.91 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.562 179.134 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 50.7 ttm -83.51 -15.43 49.43 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.019 0.438 . . . . 0.0 111.067 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -95.24 -39.08 10.26 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -174.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.507 ' C ' ' HB3' ' A' ' 53' ' ' SER . 22.8 mt-30 -103.01 -53.31 2.86 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.434 -176.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.592 HD22 ' O ' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -61.69 -5.89 2.22 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.105 0.478 . . . . 0.0 110.319 178.56 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.048 -0.977 . . . . 0.0 112.189 178.991 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' PRO . . . . . 0.451 ' HB2' ' H ' ' B' ' 2' ' ' SER . 97.7 Cg_endo . . . . . 0 CA--C 1.52 -0.189 0 N-CA-C 108.815 -1.263 . . . . 0.0 108.815 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.559 ' HG ' ' HZ2' ' A' ' 59' ' ' LYS . 16.3 m -67.6 179.93 1.24 Allowed 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 163.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.752 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -75.32 -53.6 8.48 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.517 166.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.493 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.4 p-10 -86.77 4.98 38.66 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.35 -1.295 . . . . 0.0 113.271 -165.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.431 HG21 ' HG2' ' A' ' 59' ' ' LYS . 0.5 OUTLIER -63.7 -5.9 4.76 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 118.099 0.409 . . . . 0.0 111.572 -177.069 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.597 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.4 m -75.67 131.55 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.777 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -154.4 159.6 41.2 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' GLN . . . . . 0.488 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.5 mt-30 -42.37 116.21 0.81 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 112.941 -1.936 . . . . 0.0 112.852 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.17 -139.69 7.88 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.706 173.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 6.4 p -58.94 95.15 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.706 0.253 . . . . 0.0 111.143 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.475 ' HD2' ' O ' ' B' ' 80' ' ' GLY . 56.7 pttt 41.05 39.37 0.85 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.157 0.983 . . . . 0.0 111.976 -175.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.436 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 51.0 tt0 -56.61 139.57 75.61 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.241 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . 0.537 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 35.1 Cg_exo -54.15 122.77 12.04 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.0 1.8 . . . . 0.0 109.743 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . 0.839 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 13.1 t80 -70.45 -52.63 11.14 Favored Pre-proline 0 N--CA 1.438 -1.056 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -166.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.544 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 27.9 Cg_exo -56.97 -17.54 24.63 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 121.474 1.449 . . . . 0.0 111.134 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.537 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.3 m-20 -89.91 -42.42 11.22 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.682 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' PHE . . . . . 0.488 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -55.34 -44.75 76.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.803 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.688 HG12 ' O ' ' B' ' 14' ' ' TYR . 2.1 p -78.97 -34.15 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.27 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.91 -38.04 69.7 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 121.765 -0.585 . . . . 0.0 111.516 176.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.715 ' O ' HG12 ' B' ' 24' ' ' VAL . 15.6 ptt180 -80.78 -28.29 36.41 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.551 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 6.1 tp -55.78 -43.88 77.22 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.005 173.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . 0.677 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 24.1 mt-30 -72.7 -52.64 14.37 Favored 'General case' 0 CA--C 1.487 -1.472 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.48 178.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.731 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 39.5 m-20 -46.8 -50.79 17.77 Favored 'General case' 0 C--N 1.313 -1.011 0 O-C-N 124.417 1.073 . . . . 0.0 111.234 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' VAL . . . . . 0.715 HG12 ' O ' ' B' ' 20' ' ' ARG . 8.3 p -79.71 -26.06 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.836 -172.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.625 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -67.59 -30.46 70.07 Favored 'General case' 0 C--O 1.205 -1.239 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 175.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.78 -35.27 60.17 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.132 -1.395 . . . . 0.0 109.763 -178.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.731 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 40.9 mmtt -67.67 -36.54 80.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.586 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . 0.461 ' HB2' ' HB3' ' B' ' 3' ' ' PHE . 16.4 m -105.19 -6.22 19.99 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.33 0.586 . . . . 0.0 110.536 -171.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.682 HG22 ' H ' ' B' ' 31' ' ' ASP . 89.0 mt -118.21 124.26 72.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.326 178.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.49 -3.65 58.51 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.236 0.541 . . . . 0.0 110.676 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.682 ' H ' HG22 ' B' ' 29' ' ' ILE . 25.9 t0 -106.9 140.46 39.68 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.519 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -76.35 -31.97 58.37 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.867 175.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.568 ' O ' HG13 ' B' ' 37' ' ' VAL . 7.1 mttp -70.73 -55.69 8.09 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -176.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.589 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -58.08 -27.71 63.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.996 176.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.858 ' O ' HG13 ' B' ' 39' ' ' VAL . 1.9 tmm_? -67.47 -56.45 9.55 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.485 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 21.2 mtpt -56.22 -57.93 10.12 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.997 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.742 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 20.1 m -53.06 -34.66 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.53 -169.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.752 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.1 tt -88.1 -30.72 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 119.727 -0.789 . . . . 0.0 112.25 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.858 HG13 ' O ' ' B' ' 35' ' ' ARG . 3.0 m -67.87 -49.99 63.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.742 174.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.775 ' OE1' HG13 ' B' ' 68' ' ' VAL . 0.9 OUTLIER -64.06 -25.66 68.21 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.68 0.792 . . . . 0.0 111.658 178.452 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.742 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.97 -55.03 4.14 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 176.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' MET . . . . . 0.516 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 22.2 mmt -62.81 -20.66 65.25 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.697 0.76 . . . . 0.0 109.818 -176.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.667 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -48.89 -28.77 4.03 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.779 171.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' TYR . . . . . 0.562 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 11.5 t80 -106.29 -66.66 0.99 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 175.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.476 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 5.7 mm-40 -48.03 -29.49 3.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 124.138 0.899 . . . . 0.0 112.999 -175.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.777 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.6 m-20 -106.9 -21.09 13.13 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 121.031 -0.267 . . . . 0.0 111.19 -176.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -60.61 179.19 0.17 Allowed 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.844 0.831 . . . . 0.0 112.931 -174.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.512 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 11.0 m-20 -60.08 139.69 90.97 Favored Pre-proline 0 N--CA 1.441 -0.888 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.237 174.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . 0.471 ' HB2' ' CD2' ' B' ' 92' ' ' LEU . 1.8 Cg_endo -44.27 -46.35 11.63 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.847 2.365 . . . . 0.0 111.985 -177.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.548 ' HA ' ' HB2' ' B' ' 53' ' ' SER . 0.3 OUTLIER -71.32 -33.39 69.6 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.234 1.013 . . . . 0.0 111.96 177.256 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.528 ' HB3' ' SG ' ' B' ' 76' ' ' CYS . 93.0 m -75.78 -36.38 59.8 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 121.258 0.552 . . . . 0.0 110.026 -174.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.569 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.9 pt20 -72.95 -31.14 64.38 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 106.932 -1.506 . . . . 0.0 106.932 174.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . 0.548 ' HB2' ' HA ' ' B' ' 50' ' ' GLU . 17.9 m -68.64 -20.55 64.47 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.066 -1.424 . . . . 0.0 110.07 173.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.723 ' HB2' HD11 ' B' ' 79' ' ' ILE . . . -76.34 -28.83 57.01 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.813 0.816 . . . . 0.0 109.984 168.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.577 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 19.0 mt -89.76 -31.7 5.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -171.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.606 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -40.33 -39.83 1.66 Allowed Pre-proline 0 N--CA 1.488 1.452 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -173.104 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 52.0 Cg_endo -62.52 -32.19 80.11 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.001 1.801 . . . . 0.0 112.585 176.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . 0.568 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 2.6 mt -93.6 -17.08 23.71 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.565 ' HA ' ' OH ' ' B' ' 72' ' ' TYR . 0.0 OUTLIER -55.49 108.56 0.44 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.966 179.234 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.57 -31.77 8.33 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.41 -175.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 28.4 mmtt -103.84 114.92 29.53 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 122.203 1.001 . . . . 0.0 111.166 -177.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.542 ' HB ' HG12 ' B' ' 68' ' ' VAL . 5.6 p -120.71 131.88 24.33 Favored Pre-proline 0 C--N 1.294 -1.83 0 CA-C-N 113.861 -1.518 . . . . 0.0 109.786 169.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.401 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 84.1 Cg_exo -51.45 138.03 47.77 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.656 2.237 . . . . 0.0 112.103 174.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.12 108.19 1.48 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.556 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.39 -14.64 43.08 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.483 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.401 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 4.6 t -94.74 -175.81 3.69 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 122.005 0.907 . . . . 0.0 110.583 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -107.66 143.67 35.81 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 113.811 -1.54 . . . . 0.0 108.002 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.775 HG13 ' OE1' ' B' ' 40' ' ' GLU . 0.8 OUTLIER -72.04 -35.12 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 118.41 -1.316 . . . . 0.0 108.908 -179.117 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.772 ' O ' HG13 ' B' ' 73' ' ' VAL . 7.2 mm -56.53 -49.78 76.02 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.992 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.644 -178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 25.8 t -45.69 -38.82 7.23 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.815 178.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.403 ' H ' ' HG2' ' B' ' 71' ' ' GLU . 2.9 mm-40 -86.4 -32.46 20.89 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.568 -175.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' TYR . . . . . 0.568 ' CE1' ' HB2' ' B' ' 58' ' ' LEU . 5.4 m-30 -73.74 -37.53 65.04 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.6 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.839 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.7 m -70.16 -32.87 52.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 174.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' B' ' 70' ' ' SER . 0.0 OUTLIER -68.3 -31.38 70.78 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.746 -1.116 . . . . 0.0 109.573 176.34 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . 0.485 ' HB2' HD11 ' B' ' 58' ' ' LEU . . . -64.86 -46.13 83.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.567 178.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.528 ' SG ' ' HB3' ' B' ' 51' ' ' CYS . 4.0 m -94.07 9.18 38.73 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.951 -178.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . 0.401 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 11.3 t70 -62.5 -27.05 68.88 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.249 177.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.48 -3.55 64.7 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.304 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.723 HD11 ' HB2' ' B' ' 54' ' ' ALA . 96.0 mt -95.96 129.31 46.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.985 0.422 . . . . 0.0 110.9 -177.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . 0.475 ' O ' ' HD2' ' B' ' 11' ' ' LYS . . . 161.78 30.48 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.394 174.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.592 ' O ' ' HG2' ' B' ' 85' ' ' LYS . . . 151.43 -108.28 0.37 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.466 -0.873 . . . . 0.0 113.086 175.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.6 -53.3 58.16 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -173.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' MET . . . . . . . . . . . . . 56.9 mtt -68.01 -30.69 70.0 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' HIS . . . . . 0.519 ' O ' ' HB2' ' B' ' 88' ' ' LEU . 6.7 t-80 -61.41 -35.31 77.2 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.599 175.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.592 ' HG2' ' O ' ' B' ' 81' ' ' GLY . 32.3 mmtp -80.11 -17.99 51.1 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 121.978 -0.451 . . . . 0.0 110.306 -178.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.48 -50.11 7.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.453 0.644 . . . . 0.0 110.461 176.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -77.78 -13.21 59.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.183 -175.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.577 ' O ' ' HB3' ' B' ' 92' ' ' LEU . 0.3 OUTLIER -48.37 -42.95 33.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.515 179.153 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 50.3 ttm -83.54 -15.24 50.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.842 0.353 . . . . 0.0 110.991 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -95.41 -38.78 10.33 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -174.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' GLN . . . . . 0.513 ' C ' ' HB3' ' B' ' 53' ' ' SER . 23.0 mt-30 -103.32 -53.31 2.83 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.332 -176.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.598 HD22 ' O ' ' B' ' 92' ' ' LEU . 0.3 OUTLIER -61.95 -5.41 2.11 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.178 0.513 . . . . 0.0 110.324 178.533 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.199 -0.905 . . . . 0.0 112.354 179.068 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.417 ' HB2' HG21 ' A' ' 5' ' ' THR . 92.1 Cg_endo . . . . . 0 CA--C 1.517 -0.327 0 N-CA-C 109.171 -1.127 . . . . 0.0 109.171 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.414 ' HB2' ' HB ' ' A' ' 5' ' ' THR . 12.9 m -64.25 165.94 8.72 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 162.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.722 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -69.86 -54.14 14.85 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.027 -1.069 . . . . 0.0 108.614 167.607 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.519 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 3.2 p-10 -88.31 -3.05 58.91 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 113.947 -1.479 . . . . 0.0 113.403 -164.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.45 ' O ' ' HD3' ' A' ' 7' ' ' ARG . 9.8 t -66.36 -3.58 6.3 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.622 -173.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.539 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 3.0 m -70.7 135.75 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 172.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.803 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -153.86 159.12 41.68 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 -179.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.482 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.1 tt0 -41.69 112.1 0.29 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 112.832 -1.986 . . . . 0.0 112.216 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.2 -145.42 6.06 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.756 176.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.7 p -59.79 95.38 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.687 0.279 . . . . 0.0 110.737 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.403 ' HD2' ' O ' ' A' ' 80' ' ' GLY . 64.3 pttt 43.23 41.43 2.97 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.384 1.074 . . . . 0.0 112.3 -176.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.429 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 62.9 tt0 -56.58 141.25 72.94 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.801 175.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.401 ' O ' ' HB3' ' A' ' 16' ' ' ASP . 22.5 Cg_exo -51.68 123.1 11.53 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.73 1.62 . . . . 0.0 109.141 174.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.835 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 11.5 t80 -66.67 -51.47 40.01 Favored Pre-proline 0 N--CA 1.438 -1.052 0 CA-C-O 118.857 -0.592 . . . . 0.0 112.555 -171.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.494 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 20.5 Cg_exo -60.29 -13.77 26.1 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 121.69 1.593 . . . . 0.0 110.413 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.401 ' HB3' ' O ' ' A' ' 13' ' ' PRO . 17.1 t70 -89.45 -46.78 8.46 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 113.903 -1.499 . . . . 0.0 110.282 178.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.482 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -54.18 -42.88 70.16 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.84 177.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.757 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 2.1 p -81.35 -35.22 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.52 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.58 -37.67 70.93 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 121.394 -0.816 . . . . 0.0 111.223 177.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.738 ' O ' HG12 ' A' ' 24' ' ' VAL . 17.4 ptt180 -79.61 -30.05 41.31 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.548 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 7.8 tp -54.2 -46.7 72.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.258 173.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.757 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 28.7 mt-30 -69.94 -53.56 17.31 Favored 'General case' 0 CA--C 1.485 -1.523 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.55 177.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.732 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 56.3 m-20 -45.51 -52.45 10.32 Favored 'General case' 0 C--N 1.314 -0.978 0 O-C-N 124.637 1.21 . . . . 0.0 111.181 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.738 HG12 ' O ' ' A' ' 20' ' ' ARG . 8.2 p -79.67 -26.96 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.745 -171.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.679 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -66.82 -31.2 71.67 Favored 'General case' 0 C--O 1.204 -1.324 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 175.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.61 -35.59 62.95 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.909 -178.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.732 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.6 mmtt -65.86 -40.11 91.38 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.63 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.444 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 40.0 m -101.86 -10.81 19.54 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.32 0.581 . . . . 0.0 110.662 -172.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.679 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 88.4 mt -113.72 122.26 67.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.515 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.85 -1.19 57.82 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.247 0.546 . . . . 0.0 110.317 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.637 ' H ' HG22 ' A' ' 29' ' ' ILE . 11.8 t70 -107.31 119.41 39.33 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.965 -175.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -60.13 -30.35 69.23 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.08 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.588 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -74.31 -53.52 9.53 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -174.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.575 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -60.56 -27.41 67.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.773 177.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.859 ' O ' HG13 ' A' ' 39' ' ' VAL . 1.9 tmm_? -67.33 -58.47 4.73 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 32.6 mtpt -54.61 -59.24 4.98 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.123 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.725 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 16.9 m -53.56 -34.14 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.327 -170.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.722 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.3 tt -87.38 -32.08 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.871 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.7 m -67.34 -49.14 74.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.156 175.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.633 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 52.0 mt-10 -60.49 -31.72 70.74 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.298 1.039 . . . . 0.0 112.742 175.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.725 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -85.16 -51.29 6.73 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.933 -179.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.707 ' HE2' ' HE2' ' B' ' 42' ' ' MET . 20.5 mmt -64.62 -20.77 66.47 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.553 0.692 . . . . 0.0 109.462 -178.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.681 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -50.26 -30.33 11.52 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.516 171.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.529 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 15.9 t80 -102.91 -66.71 0.92 Allowed 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 174.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.478 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 47.6 mm-40 -50.26 -28.41 7.66 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.725 -1.125 . . . . 0.0 112.713 -172.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.803 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.1 m-20 -106.36 -22.04 12.92 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 121.28 -0.168 . . . . 0.0 111.055 -176.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -59.56 177.3 0.21 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.8 0.81 . . . . 0.0 112.994 -174.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.607 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 15.2 m-20 -58.89 140.55 86.37 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.93 174.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.411 ' HB2' HD21 ' A' ' 92' ' ' LEU . 9.2 Cg_endo -53.64 -23.43 25.81 Favored 'Trans proline' 0 C--O 1.221 -0.35 0 C-N-CA 123.524 2.816 . . . . 0.0 112.731 -176.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.564 ' OE1' ' HB2' ' A' ' 91' ' ' GLN . 0.3 OUTLIER -88.3 -35.37 17.27 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.942 0.897 . . . . 0.0 110.788 175.074 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.607 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 72.3 m -76.85 -35.87 57.2 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.207 -171.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.628 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.7 pt20 -72.49 -29.89 64.04 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 174.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.62 ' HB3' ' C ' ' A' ' 91' ' ' GLN . 15.9 m -71.81 -19.01 62.05 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 113.715 -1.584 . . . . 0.0 110.387 174.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.775 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -77.21 -26.95 53.26 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.813 0.816 . . . . 0.0 109.494 166.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.628 HD12 ' HA ' ' A' ' 52' ' ' GLN . 25.9 mt -89.27 -31.01 5.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -172.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.607 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.8 -38.77 2.17 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -173.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 57.2 Cg_endo -64.49 -30.08 61.87 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.165 1.91 . . . . 0.0 112.765 176.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.527 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 2.2 mt -95.29 -16.35 22.5 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.529 ' HE3' ' HB3' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -54.05 108.65 0.38 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.709 -179.522 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.77 -21.98 42.96 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.413 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.9 mmmt -104.17 115.88 31.19 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 120.932 0.396 . . . . 0.0 110.422 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.54 139.72 31.51 Favored Pre-proline 0 C--N 1.311 -1.095 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 169.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.541 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 79.4 Cg_exo -51.7 137.4 50.52 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.338 2.025 . . . . 0.0 111.423 170.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.97 106.71 1.08 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.898 -176.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.03 -14.73 44.5 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.5 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.541 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 25.1 m -94.8 172.23 8.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.319 0.58 . . . . 0.0 111.342 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -90.3 143.21 26.97 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.783 176.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.602 HG22 ' HG2' ' A' ' 40' ' ' GLU . 1.0 OUTLIER -77.38 -29.7 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 C-N-CA 118.651 -1.22 . . . . 0.0 108.813 -179.346 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.777 ' O ' HG13 ' A' ' 73' ' ' VAL . 10.4 mm -60.81 -47.53 92.86 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.117 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.125 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.0 t -46.18 -37.66 7.34 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.017 176.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.472 ' HA ' ' HB3' ' A' ' 74' ' ' LYS . 7.2 mm-40 -85.82 -31.85 22.08 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 123.375 0.67 . . . . 0.0 111.014 -177.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.612 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.3 m-30 -75.32 -34.84 61.27 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.555 0.693 . . . . 0.0 109.34 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.835 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.4 m -72.52 -30.17 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 173.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.509 ' HA ' ' HB2' ' A' ' 77' ' ' ASP . 14.8 ttpt -73.52 -25.51 60.45 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.474 177.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -65.89 -46.53 78.03 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.538 174.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.707 ' SG ' ' HB ' ' A' ' 79' ' ' ILE . 26.2 t -93.01 8.77 38.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.871 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.509 ' HB2' ' HA ' ' A' ' 74' ' ' LYS . 17.3 t70 -63.68 -19.93 65.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.302 0.572 . . . . 0.0 110.043 176.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -105.23 2.21 40.43 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.435 173.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.775 HD11 ' HB2' ' A' ' 54' ' ' ALA . 95.5 mt -101.78 137.54 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 117.411 0.606 . . . . 0.0 112.162 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.693 ' H ' ' HB2' ' A' ' 84' ' ' HIS . . . 157.08 -43.14 0.52 Allowed Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.444 170.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.663 ' O ' ' HB3' ' A' ' 84' ' ' HIS . . . -95.27 -141.58 11.92 Favored Glycine 0 CA--C 1.494 -1.263 0 CA-C-O 122.083 0.824 . . . . 0.0 114.633 -173.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.89 -29.29 70.23 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 113.609 -1.296 . . . . 0.0 110.952 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 68.1 mtm -69.89 -26.86 64.37 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.693 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 8.5 t-160 -64.67 -31.64 72.95 Favored 'General case' 0 C--O 1.219 -0.524 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -82.52 -21.8 35.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.987 0.423 . . . . 0.0 110.424 179.309 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.86 -46.99 14.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.442 0.639 . . . . 0.0 110.592 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -79.43 -14.72 58.74 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.817 -176.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 84' ' ' HIS . 0.2 OUTLIER -53.84 -32.04 51.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.29 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.3 ttt -84.43 -21.72 30.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.178 0.513 . . . . 0.0 111.16 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -96.01 -52.59 3.98 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.022 0.439 . . . . 0.0 111.953 -173.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.678 ' O ' ' HG2' ' A' ' 93' ' ' GLU . 26.1 mt-30 -80.72 -62.82 1.56 Allowed 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.726 -173.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.437 ' HB3' ' O ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -45.37 -34.41 3.01 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.625 1.203 . . . . 0.0 108.591 171.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.678 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 6.6 pt-20 . . . . . 0 C--O 1.249 1.076 0 CA-C-N 113.737 -1.574 . . . . 0.0 113.239 -173.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' PRO . . . . . 0.414 ' HB2' ' H ' ' B' ' 2' ' ' SER . 93.8 Cg_endo . . . . . 0 CA--C 1.519 -0.248 0 N-CA-C 109.133 -1.141 . . . . 0.0 109.133 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.429 ' HB2' ' HB ' ' B' ' 5' ' ' THR . 13.3 m -64.35 166.24 8.47 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 163.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.746 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -70.12 -54.02 14.81 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.108 -1.037 . . . . 0.0 108.605 167.687 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.524 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 3.2 p-10 -88.5 -2.99 58.9 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.041 -1.436 . . . . 0.0 113.408 -164.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.436 ' O ' ' HD3' ' B' ' 7' ' ' ARG . 9.5 t -66.37 -3.54 6.22 Favored 'General case' 0 C--N 1.315 -0.911 0 O-C-N 121.644 -0.66 . . . . 0.0 110.634 -173.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.526 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 3.0 m -70.63 135.7 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 171.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.799 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -153.9 159.2 41.66 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' GLN . . . . . 0.458 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.1 tt0 -41.77 112.42 0.32 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 112.776 -2.011 . . . . 0.0 112.106 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.35 -145.64 6.3 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.772 175.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 12.4 p -59.51 95.27 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.64 0.257 . . . . 0.0 110.653 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 64.2 pttt 43.17 41.36 2.84 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.44 1.096 . . . . 0.0 112.402 -176.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.424 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 62.8 tt0 -56.63 141.37 73.11 Favored Pre-proline 0 C--O 1.235 0.301 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.774 175.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' B' ' 16' ' ' ASP . 22.1 Cg_exo -51.66 122.99 11.29 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.742 1.628 . . . . 0.0 109.204 174.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . 0.839 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 11.7 t80 -66.63 -51.64 39.42 Favored Pre-proline 0 N--CA 1.437 -1.078 0 CA-C-O 118.876 -0.583 . . . . 0.0 112.406 -171.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.504 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 20.6 Cg_exo -60.14 -13.79 25.57 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.57 1.513 . . . . 0.0 110.453 -178.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.417 ' HB3' ' O ' ' B' ' 13' ' ' PRO . 18.7 t70 -89.45 -46.74 8.48 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 113.939 -1.482 . . . . 0.0 110.191 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' PHE . . . . . 0.458 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -54.15 -42.85 70.02 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.841 177.675 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.752 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 2.1 p -81.4 -35.27 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.429 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.57 -37.64 70.86 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 121.38 -0.825 . . . . 0.0 111.221 177.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.74 ' O ' HG12 ' B' ' 24' ' ' VAL . 17.4 ptt180 -79.72 -29.72 40.74 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.558 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 7.9 tp -54.47 -46.72 73.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.193 173.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . 0.752 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 28.6 mt-30 -69.81 -53.67 17.15 Favored 'General case' 0 CA--C 1.485 -1.556 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.519 177.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.728 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 48.9 m-20 -45.55 -52.49 10.39 Favored 'General case' 0 C--N 1.314 -0.959 0 O-C-N 124.628 1.205 . . . . 0.0 111.042 -178.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' VAL . . . . . 0.74 HG12 ' O ' ' B' ' 20' ' ' ARG . 8.2 p -79.64 -26.97 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.673 -171.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.667 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -66.86 -31.02 71.35 Favored 'General case' 0 C--O 1.206 -1.211 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 175.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -35.65 62.53 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.802 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.728 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.9 mmtt -65.87 -40.13 91.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.643 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . 0.454 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 37.4 m -101.66 -11.21 19.36 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.186 0.517 . . . . 0.0 110.546 -172.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.667 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 88.0 mt -113.63 122.33 67.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.569 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.93 -1.11 57.78 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.249 0.547 . . . . 0.0 110.439 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.658 ' H ' HG22 ' B' ' 29' ' ' ILE . 11.4 t70 -107.59 119.36 39.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.959 -175.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.2 -30.15 69.18 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.1 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.599 ' O ' HG13 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -74.42 -53.27 9.91 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -174.867 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.571 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -60.85 -27.32 68.0 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.87 177.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.87 ' O ' HG13 ' B' ' 39' ' ' VAL . 1.9 tmm_? -67.38 -58.52 4.63 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.431 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 32.3 mtpt -54.6 -59.3 4.89 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.081 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.722 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 17.1 m -53.69 -33.88 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.314 -170.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.746 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.3 tt -87.53 -32.08 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.808 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.87 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.7 m -67.31 -49.11 75.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.101 174.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.637 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 52.2 mt-10 -60.63 -31.72 70.9 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.259 1.023 . . . . 0.0 112.794 176.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.722 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -85.25 -51.17 6.78 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.393 -0.523 . . . . 0.0 112.02 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' MET . . . . . 0.707 ' HE2' ' HE2' ' A' ' 42' ' ' MET . 20.7 mmt -64.63 -20.7 66.43 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 121.545 0.688 . . . . 0.0 109.524 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.675 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -50.39 -30.33 12.12 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.421 171.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' TYR . . . . . 0.536 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 16.1 t80 -102.85 -66.61 0.92 Allowed 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 174.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.47 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 46.8 mm-40 -50.49 -27.99 7.61 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.696 -1.138 . . . . 0.0 112.739 -172.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.799 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.2 m-20 -106.76 -21.91 12.89 Favored 'General case' 0 N--CA 1.434 -1.265 0 O-C-N 122.371 -0.206 . . . . 0.0 111.1 -176.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -59.51 177.46 0.2 Allowed 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.81 0.814 . . . . 0.0 113.085 -175.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.61 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 15.1 m-20 -59.09 140.33 87.31 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.864 174.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . 0.404 ' HB2' HD21 ' B' ' 92' ' ' LEU . 9.2 Cg_endo -53.75 -23.21 25.78 Favored 'Trans proline' 0 C--O 1.22 -0.407 0 C-N-CA 123.502 2.801 . . . . 0.0 112.628 -176.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.562 ' OE1' ' HB2' ' B' ' 91' ' ' GLN . 0.3 OUTLIER -88.41 -35.27 17.19 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.88 0.872 . . . . 0.0 110.824 174.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.61 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 71.8 m -76.82 -35.83 57.29 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.261 -172.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.646 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.8 pt20 -72.36 -29.99 64.3 Favored 'General case' 0 C--O 1.213 -0.835 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 174.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . 0.619 ' HB3' ' C ' ' B' ' 91' ' ' GLN . 14.5 m -71.63 -19.26 62.13 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 113.7 -1.591 . . . . 0.0 110.4 174.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.797 ' HB2' HD11 ' B' ' 79' ' ' ILE . . . -77.16 -27.08 53.62 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.692 0.758 . . . . 0.0 109.484 166.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.646 HD12 ' HA ' ' B' ' 52' ' ' GLN . 25.9 mt -89.23 -30.99 5.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -172.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.604 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.96 -38.67 2.26 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -173.647 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 57.3 Cg_endo -64.7 -29.76 59.89 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 122.055 1.837 . . . . 0.0 112.688 176.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . 0.545 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 2.2 mt -95.36 -16.26 22.48 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.536 ' HE3' ' HB3' ' B' ' 44' ' ' TYR . 0.1 OUTLIER -54.18 108.7 0.39 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.746 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.45 -21.5 45.21 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.503 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 15.8 mmmt -104.49 115.84 31.06 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.865 0.365 . . . . 0.0 110.6 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.4 139.72 31.33 Favored Pre-proline 0 C--N 1.312 -1.059 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 169.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.559 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 80.7 Cg_exo -51.59 137.51 49.43 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.368 2.045 . . . . 0.0 111.523 170.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.27 106.45 1.1 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.898 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.31 -14.94 43.28 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.4 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.559 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 27.7 m -94.75 172.34 8.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.355 0.598 . . . . 0.0 111.264 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -90.34 143.47 26.73 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.241 -0.891 . . . . 0.0 108.882 176.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.583 HG22 ' HG2' ' B' ' 40' ' ' GLU . 1.0 OUTLIER -77.54 -29.75 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 C-N-CA 118.691 -1.203 . . . . 0.0 108.813 -179.444 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.774 ' O ' HG13 ' B' ' 73' ' ' VAL . 10.4 mm -60.8 -47.4 93.41 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.155 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.166 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 41.0 t -46.63 -37.29 7.99 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 123.847 0.717 . . . . 0.0 110.998 177.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.491 ' HA ' ' HB3' ' B' ' 74' ' ' LYS . 7.5 mm-40 -85.89 -31.67 22.08 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.22 0.608 . . . . 0.0 111.051 -177.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' TYR . . . . . 0.6 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.3 m-30 -75.45 -34.89 60.99 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.599 0.714 . . . . 0.0 109.441 -178.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.839 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.4 m -72.65 -30.03 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 173.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' LYS . . . . . 0.528 ' HA ' ' HB2' ' B' ' 77' ' ' ASP . 14.7 ttpt -73.71 -25.18 60.09 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.581 177.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -65.95 -46.57 77.69 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.646 173.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.716 ' SG ' ' HB ' ' B' ' 79' ' ' ILE . 28.3 t -93.03 8.58 39.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.884 177.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . 0.528 ' HB2' ' HA ' ' B' ' 74' ' ' LYS . 18.0 t70 -63.86 -19.04 64.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.296 0.57 . . . . 0.0 110.056 176.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -105.76 2.08 38.96 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.558 -0.747 . . . . 0.0 112.546 173.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.797 HD11 ' HB2' ' B' ' 54' ' ' ALA . 95.1 mt -101.84 137.63 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 117.288 0.544 . . . . 0.0 112.167 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . 0.691 ' H ' ' HB2' ' B' ' 84' ' ' HIS . . . 156.99 -43.22 0.53 Allowed Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.305 -0.862 . . . . 0.0 111.377 170.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.652 ' O ' ' HB3' ' B' ' 84' ' ' HIS . . . -95.2 -141.57 11.89 Favored Glycine 0 CA--C 1.493 -1.307 0 CA-C-O 121.869 0.705 . . . . 0.0 114.64 -173.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.79 -29.84 70.82 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 113.718 -1.241 . . . . 0.0 110.689 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' MET . . . . . . . . . . . . . 68.3 mtm -69.46 -26.67 64.7 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 175.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' HIS . . . . . 0.691 ' HB2' ' H ' ' B' ' 80' ' ' GLY . 8.4 t-160 -64.79 -31.44 72.66 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 121.211 0.529 . . . . 0.0 109.576 173.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.469 ' HD2' ' O ' ' B' ' 81' ' ' GLY . 0.1 OUTLIER -82.88 -21.8 34.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.92 0.39 . . . . 0.0 110.37 179.388 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.84 -46.95 14.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.413 0.625 . . . . 0.0 110.653 177.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -79.21 -14.81 58.83 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.89 -176.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.496 ' HB2' ' O ' ' B' ' 84' ' ' HIS . 0.2 OUTLIER -53.61 -32.21 50.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.229 0.538 . . . . 0.0 111.324 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 25.5 ttt -84.42 -21.52 30.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.049 0.452 . . . . 0.0 111.22 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -96.38 -52.19 4.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.107 0.48 . . . . 0.0 111.958 -173.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' GLN . . . . . 0.684 ' O ' ' HG2' ' B' ' 93' ' ' GLU . 26.2 mt-30 -80.87 -63.17 1.46 Allowed 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.691 -173.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.446 ' HB3' ' O ' ' B' ' 88' ' ' LEU . 0.0 OUTLIER -45.02 -34.9 2.67 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.69 1.244 . . . . 0.0 108.606 171.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.684 ' HG2' ' O ' ' B' ' 91' ' ' GLN . 7.1 pt-20 . . . . . 0 C--O 1.251 1.176 0 CA-C-N 113.828 -1.533 . . . . 0.0 113.134 -173.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.42 ' C ' ' HA3' ' B' ' 60' ' ' GLY . 84.1 Cg_endo . . . . . 0 CA--C 1.516 -0.399 0 N-CA-C 109.525 -0.99 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.8 m -65.74 165.14 13.23 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 163.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.764 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -69.9 -55.17 10.43 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 122.058 0.932 . . . . 0.0 109.907 174.142 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.566 ' ND2' ' HG3' ' A' ' 42' ' ' MET . 2.7 p-10 -86.57 -2.38 58.44 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.308 -1.314 . . . . 0.0 112.762 -164.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.417 ' O ' ' HD3' ' A' ' 7' ' ' ARG . 9.9 t -66.1 -3.03 4.75 Favored 'General case' 0 C--N 1.314 -0.942 0 O-C-N 121.708 -0.62 . . . . 0.0 110.445 -176.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.607 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.3 m -73.7 131.98 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 170.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.759 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 1.3 ptt-85 -156.68 160.04 38.97 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 118.38 -1.328 . . . . 0.0 114.375 -176.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.457 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.3 tt0 -39.12 112.33 0.24 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 113.698 -1.592 . . . . 0.0 112.624 178.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.95 -142.36 7.96 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.689 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.5 m -59.33 95.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.973 0.387 . . . . 0.0 110.837 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.401 ' O ' ' HG3' ' A' ' 11' ' ' LYS . 23.3 pttm 40.73 41.75 1.24 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.495 1.118 . . . . 0.0 112.343 -174.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 65.6 tt0 -57.79 139.65 81.95 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.674 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.518 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 34.3 Cg_exo -53.7 125.0 17.19 Favored 'Trans proline' 0 CA--C 1.511 -0.671 0 C-N-CA 122.026 1.817 . . . . 0.0 109.745 177.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.841 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 6.0 t80 -68.22 -55.48 12.62 Favored Pre-proline 0 N--CA 1.44 -0.934 0 CA-C-O 118.482 -0.77 . . . . 0.0 112.924 -167.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.528 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 26.0 Cg_exo -57.62 -17.7 29.63 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 121.456 1.437 . . . . 0.0 111.145 -177.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.518 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 5.7 m-20 -89.8 -40.16 12.64 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.057 -1.428 . . . . 0.0 110.846 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.639 ' HE2' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -56.63 -45.79 81.32 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 176.106 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.796 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 1.4 p -77.82 -33.46 18.74 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.322 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.347 -178.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.04 -31.57 67.15 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 121.179 -0.951 . . . . 0.0 111.834 177.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.738 ' O ' HG12 ' A' ' 24' ' ' VAL . 15.6 ptt180 -84.86 -28.09 26.26 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 175.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.601 HD22 ' CE1' ' A' ' 17' ' ' PHE . 11.8 tp -54.28 -48.9 70.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.962 172.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.796 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 23.0 mt-30 -70.57 -46.65 63.09 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 114.849 -1.068 . . . . 0.0 111.123 177.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.729 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 19.2 t70 -48.41 -54.63 13.34 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.282 0.989 . . . . 0.0 111.479 -178.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.738 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.4 p -81.73 -22.18 10.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.13 0.49 . . . . 0.0 109.734 -173.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.801 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -72.93 -18.85 61.35 Favored 'General case' 0 C--O 1.205 -1.259 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 174.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.401 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -86.44 -38.61 17.16 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.568 -1.196 . . . . 0.0 109.553 177.22 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.729 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.8 mmtt -67.06 -36.29 81.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.014 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.2 m -103.69 -9.1 19.4 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.088 0.47 . . . . 0.0 110.516 -171.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.801 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 84.3 mt -115.07 126.06 72.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.442 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.47 -4.8 59.27 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.242 0.544 . . . . 0.0 110.502 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.65 ' H ' HG22 ' A' ' 29' ' ' ILE . 25.8 t0 -106.28 139.16 41.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.407 -177.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -75.98 -31.45 58.99 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.445 175.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.567 ' O ' HG13 ' A' ' 37' ' ' VAL . 6.4 mttp -71.88 -55.0 8.31 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -175.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.631 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -58.75 -27.31 64.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.022 176.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.873 ' O ' HG13 ' A' ' 39' ' ' VAL . 1.9 tmm_? -66.0 -59.86 3.41 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 178.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.423 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 12.6 mtpp -54.94 -57.58 11.07 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.16 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.779 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 20.6 m -52.8 -34.33 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.975 -170.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.764 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.0 OUTLIER -88.31 -31.37 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 119.87 -0.732 . . . . 0.0 112.217 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.873 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.4 m -68.52 -48.65 71.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 119.067 -1.053 . . . . 0.0 109.513 176.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.785 ' OE1' HG13 ' A' ' 68' ' ' VAL . 0.8 OUTLIER -64.59 -28.46 69.64 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.455 0.702 . . . . 0.0 111.573 178.343 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.779 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -81.4 -54.61 5.32 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 122.19 -0.319 . . . . 0.0 111.432 178.014 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.566 ' HG3' ' ND2' ' A' ' 4' ' ' ASN . 22.3 mmt -63.43 -20.41 65.53 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.707 0.765 . . . . 0.0 109.613 -177.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.648 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -49.07 -32.98 10.61 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.86 172.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.488 ' HB2' HG21 ' A' ' 55' ' ' ILE . 17.1 t80 -99.75 -64.99 0.99 Allowed 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 175.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.566 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 39.3 mm-40 -50.06 -33.01 17.0 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.468 -1.242 . . . . 0.0 112.413 -171.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.759 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.6 m-20 -103.72 -20.42 13.96 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.087 -174.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.648 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -59.11 175.03 0.32 Allowed 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.691 0.758 . . . . 0.0 112.121 -177.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.603 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 12.3 m-20 -58.77 141.5 85.0 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.503 174.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -48.32 -29.09 12.45 Favored 'Trans proline' 0 C--O 1.22 -0.397 0 C-N-CA 123.761 2.974 . . . . 0.0 112.893 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.507 ' HG3' HD13 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -88.15 -33.82 18.08 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 123.86 0.864 . . . . 0.0 111.053 177.033 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.603 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 78.2 m -78.83 -33.8 45.76 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.504 -172.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.579 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.5 pt20 -73.08 -29.84 63.24 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 172.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.518 ' HB3' ' C ' ' A' ' 91' ' ' GLN . 16.2 m -70.47 -19.12 62.97 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 113.658 -1.61 . . . . 0.0 110.432 173.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.805 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -76.46 -27.98 56.37 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.169 -0.957 . . . . 0.0 109.458 166.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.593 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 21.8 mt -89.15 -31.5 5.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 115.651 1.722 . . . . 0.0 115.651 -171.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.587 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -40.03 -38.13 0.96 Allowed Pre-proline 0 N--CA 1.492 1.673 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -174.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.593 ' HD2' ' C ' ' A' ' 55' ' ' ILE . 57.7 Cg_endo -65.21 -26.49 56.88 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.139 1.893 . . . . 0.0 113.002 175.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.554 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.8 mt -100.89 -15.61 17.5 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.575 ' NZ ' HD13 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -49.85 109.36 0.28 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.333 -179.215 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.18 -21.4 34.73 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.075 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -103.43 114.04 28.0 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.007 0.432 . . . . 0.0 109.977 -177.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.453 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.1 p -122.42 140.67 33.16 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.05 172.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.554 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 80.6 Cg_exo -48.93 140.53 23.55 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.598 2.199 . . . . 0.0 111.848 170.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.24 103.39 0.38 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.417 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.5 -8.73 55.23 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.72 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.554 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 17.6 m -94.51 169.44 10.19 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.496 0.665 . . . . 0.0 111.497 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -84.46 133.95 34.47 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.383 174.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.785 HG13 ' OE1' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -71.46 -33.45 49.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.222 -179.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.771 ' O ' HG13 ' A' ' 73' ' ' VAL . 11.9 mm -55.71 -47.95 78.53 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.226 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.524 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.601 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 27.7 t -47.91 -36.65 12.63 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.911 178.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -86.59 -31.85 20.95 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.649 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.624 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.2 m-30 -76.13 -36.24 58.91 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.65 -177.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.841 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.8 m -69.63 -33.43 56.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 173.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.601 ' HB2' ' O ' ' A' ' 70' ' ' SER . 0.8 OUTLIER -68.36 -29.9 68.72 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.73 177.132 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -63.97 -49.04 74.08 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.741 175.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.763 ' SG ' ' HB ' ' A' ' 79' ' ' ILE . 25.4 t -89.44 7.32 36.6 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.931 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.492 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 10.5 t70 -63.2 -16.28 59.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.487 0.66 . . . . 0.0 110.004 174.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -101.29 -8.92 45.95 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.76 173.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.805 HD11 ' HB2' ' A' ' 54' ' ' ALA . 90.6 mt -96.04 146.43 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 O-C-N 122.333 -0.51 . . . . 0.0 111.118 -178.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 150.56 71.58 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.6 174.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.569 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 101.47 -110.41 3.85 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.894 -0.669 . . . . 0.0 113.087 177.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.17 -50.32 69.62 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -174.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 77.5 mtp -68.67 -28.44 66.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.884 0.373 . . . . 0.0 110.489 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.507 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 6.0 t-80 -65.94 -31.37 72.25 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.346 176.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' A' ' 81' ' ' GLY . 33.7 mmtp -81.98 -19.3 40.83 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.955 0.407 . . . . 0.0 110.311 -178.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.48 -43.4 13.61 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.786 177.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 1.3 mmt -85.4 -12.78 51.26 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.319 -176.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.507 ' HB2' ' O ' ' A' ' 84' ' ' HIS . 0.1 OUTLIER -48.6 -43.39 36.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.697 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 26.0 ttt -80.31 -16.96 53.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.989 0.423 . . . . 0.0 110.646 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -91.44 -40.89 11.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.093 -174.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.518 ' C ' ' HB3' ' A' ' 53' ' ' SER . 19.7 mt-30 -105.07 -52.52 2.83 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -170.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.507 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -42.71 -37.05 1.62 Allowed 'General case' 0 N--CA 1.471 0.593 0 O-C-N 123.93 0.769 . . . . 0.0 109.328 -179.806 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 . . . . . 0 C--O 1.248 0.998 0 CA-C-N 114.017 -1.447 . . . . 0.0 113.031 -176.717 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' PRO . . . . . 0.409 ' HB2' HG21 ' B' ' 5' ' ' THR . 84.5 Cg_endo . . . . . 0 CA--C 1.516 -0.413 0 N-CA-C 109.425 -1.029 . . . . 0.0 109.425 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 48.4 m -65.51 164.98 12.96 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 163.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.767 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -69.79 -55.1 10.78 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.909 174.061 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.56 ' ND2' ' HG3' ' B' ' 42' ' ' MET . 2.7 p-10 -86.69 -2.23 58.35 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.852 -164.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.426 ' O ' ' HD3' ' B' ' 7' ' ' ARG . 9.7 t -66.11 -3.26 5.22 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.439 -176.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.597 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.3 m -73.65 131.97 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 171.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.779 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 1.2 ptt-85 -156.62 160.15 39.14 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -176.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' GLN . . . . . 0.462 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.3 tt0 -39.16 112.28 0.24 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 113.624 -1.626 . . . . 0.0 112.745 178.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.95 -142.72 8.18 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.64 174.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 20.0 m -59.03 95.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.958 0.379 . . . . 0.0 110.85 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 23.2 pttm 41.06 41.38 1.28 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.459 1.103 . . . . 0.0 112.454 -174.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -57.54 139.73 80.75 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.635 176.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . 0.538 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 34.2 Cg_exo -53.73 125.05 17.36 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.053 1.835 . . . . 0.0 109.727 177.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . 0.849 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 6.1 t80 -68.42 -55.37 12.25 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-O 118.504 -0.76 . . . . 0.0 112.877 -167.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.539 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 25.4 Cg_exo -57.57 -17.76 29.59 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 121.375 1.383 . . . . 0.0 111.238 -177.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.538 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 5.8 m-20 -89.71 -40.1 12.74 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.966 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' PHE . . . . . 0.637 ' HE2' ' CE2' ' B' ' 14' ' ' TYR . 0.0 OUTLIER -56.68 -45.79 81.52 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.013 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.792 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 1.4 p -77.75 -33.43 18.86 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.278 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.399 -178.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.27 -31.25 67.28 Favored 'General case' 0 C--N 1.31 -1.119 0 O-C-N 121.271 -0.893 . . . . 0.0 111.83 177.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.728 ' O ' HG12 ' B' ' 24' ' ' VAL . 15.8 ptt180 -84.97 -28.31 25.89 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 174.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.593 HD22 ' CE1' ' B' ' 17' ' ' PHE . 11.8 tp -54.0 -48.84 70.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.97 172.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . 0.792 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 23.1 mt-30 -70.89 -46.38 62.68 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.077 177.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.734 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 19.1 t70 -48.4 -54.72 12.98 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 124.125 0.891 . . . . 0.0 111.574 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' VAL . . . . . 0.728 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.4 p -81.63 -22.38 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-O 121.278 0.561 . . . . 0.0 109.807 -173.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.779 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -72.85 -18.67 61.42 Favored 'General case' 0 C--O 1.205 -1.252 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 173.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . 0.419 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -86.64 -38.39 17.11 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.546 -1.207 . . . . 0.0 109.596 177.133 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.734 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.8 mmtt -67.23 -36.13 81.02 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.033 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 23.8 m -104.02 -8.73 19.35 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.203 0.525 . . . . 0.0 110.628 -171.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.779 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 83.8 mt -115.35 126.13 72.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.394 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.37 -5.55 59.3 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.109 0.48 . . . . 0.0 110.363 178.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.669 ' H ' HG22 ' B' ' 29' ' ' ILE . 26.0 t0 -105.41 139.47 39.99 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.297 -177.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -76.27 -31.5 58.3 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.499 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.581 ' O ' HG13 ' B' ' 37' ' ' VAL . 6.4 mttp -71.68 -55.01 8.51 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.624 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -58.7 -27.56 64.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.289 -0.868 . . . . 0.0 110.967 176.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.859 ' O ' HG13 ' B' ' 39' ' ' VAL . 1.9 tmm_? -65.85 -59.75 3.55 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 12.5 mtpp -55.18 -57.54 11.37 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.1 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.781 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 20.1 m -52.67 -34.5 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.068 -170.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.767 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.0 OUTLIER -88.26 -31.26 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 119.942 -0.703 . . . . 0.0 112.195 -179.436 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.859 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.4 m -68.63 -48.64 70.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 119.114 -1.035 . . . . 0.0 109.434 176.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.771 ' OE1' HG13 ' B' ' 68' ' ' VAL . 0.8 OUTLIER -64.65 -28.44 69.61 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.49 0.716 . . . . 0.0 111.541 178.388 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.781 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -81.4 -54.62 5.31 Favored 'General case' 0 C--N 1.322 -0.602 0 O-C-N 122.141 -0.349 . . . . 0.0 111.5 177.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' MET . . . . . 0.56 ' HG3' ' ND2' ' B' ' 4' ' ' ASN . 22.2 mmt -63.47 -20.45 65.59 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.691 0.758 . . . . 0.0 109.519 -177.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.659 ' O ' ' HB2' ' B' ' 47' ' ' ALA . . . -49.0 -32.99 10.17 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.832 171.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' TYR . . . . . 0.492 ' HB2' HG21 ' B' ' 55' ' ' ILE . 17.6 t80 -99.8 -64.79 1.01 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.582 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 39.4 mm-40 -50.2 -32.97 17.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.419 -1.264 . . . . 0.0 112.312 -171.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.779 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.6 m-20 -103.96 -20.21 13.96 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.031 -174.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.659 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -59.55 174.91 0.39 Allowed 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.591 0.71 . . . . 0.0 112.119 -177.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.606 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 12.0 m-20 -58.51 141.44 83.73 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 114.755 -1.112 . . . . 0.0 109.496 174.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -48.12 -29.3 12.19 Favored 'Trans proline' 0 C--O 1.221 -0.37 0 C-N-CA 123.715 2.943 . . . . 0.0 112.918 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.514 ' OE1' ' HA ' ' B' ' 84' ' ' HIS . 0.3 OUTLIER -88.05 -33.81 18.19 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 123.823 0.849 . . . . 0.0 111.095 177.213 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.606 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 78.8 m -78.8 -33.88 45.88 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.457 -172.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.596 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.7 pt20 -72.93 -29.99 63.54 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 172.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . 0.535 ' HB3' ' C ' ' B' ' 91' ' ' GLN . 15.8 m -70.45 -19.06 63.0 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 113.654 -1.612 . . . . 0.0 110.416 173.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.815 ' HB2' HD11 ' B' ' 79' ' ' ILE . . . -76.6 -27.65 55.84 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.271 -0.893 . . . . 0.0 109.545 166.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' B' ' 52' ' ' GLN . 22.0 mt -89.43 -31.41 5.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -171.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.585 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -40.2 -38.15 1.02 Allowed Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -174.756 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.589 ' HD2' ' C ' ' B' ' 55' ' ' ILE . 57.9 Cg_endo -65.21 -26.22 57.08 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.177 1.918 . . . . 0.0 113.069 175.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . 0.57 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.8 mt -100.97 -15.66 17.42 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.568 ' NZ ' HD13 ' B' ' 41' ' ' LEU . 0.2 OUTLIER -49.95 109.36 0.28 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.302 -179.103 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.42 ' HA3' ' C ' ' A' ' 1' ' ' PRO . . . 91.13 -21.23 35.46 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.05 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -103.4 114.01 27.95 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 120.994 0.426 . . . . 0.0 109.972 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.462 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.1 p -122.34 140.76 33.22 Favored Pre-proline 0 C--N 1.314 -0.964 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.075 172.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.543 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 82.3 Cg_exo -48.91 140.27 23.88 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.576 2.184 . . . . 0.0 111.906 170.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.77 103.51 0.35 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.195 -176.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.31 -9.02 55.85 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.924 176.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.543 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 18.7 m -94.11 169.75 10.03 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.676 0.751 . . . . 0.0 111.516 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -84.93 134.04 34.27 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.272 174.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.771 HG13 ' OE1' ' B' ' 40' ' ' GLU . 0.8 OUTLIER -71.69 -33.35 48.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.198 -179.475 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.772 ' O ' HG13 ' B' ' 73' ' ' VAL . 11.9 mm -55.66 -48.1 78.16 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.215 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.538 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.594 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 27.2 t -47.83 -36.6 12.17 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.943 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -86.42 -32.11 21.07 Favored 'General case' 0 CA--C 1.507 -0.685 0 C-N-CA 123.231 0.613 . . . . 0.0 110.606 -177.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' TYR . . . . . 0.613 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.2 m-30 -75.94 -36.22 59.43 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.616 -177.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.849 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.8 m -69.62 -33.59 57.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.543 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 173.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' LYS . . . . . 0.594 ' HB2' ' O ' ' B' ' 70' ' ' SER . 0.8 OUTLIER -68.11 -30.12 69.2 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.224 -1.353 . . . . 0.0 109.755 177.117 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -63.75 -49.25 73.74 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.676 175.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.766 ' SG ' ' HB ' ' B' ' 79' ' ' ILE . 24.9 t -89.31 7.05 37.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.921 178.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . 0.498 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 8.9 t70 -63.09 -16.63 60.58 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.374 0.607 . . . . 0.0 110.034 174.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -101.1 -8.47 47.54 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.471 173.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.815 HD11 ' HB2' ' B' ' 54' ' ' ALA . 90.1 mt -96.15 146.6 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 O-C-N 122.324 -0.515 . . . . 0.0 111.169 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 150.27 71.86 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.566 174.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.574 ' O ' ' HG2' ' B' ' 85' ' ' LYS . . . 101.3 -110.02 3.77 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.892 -0.67 . . . . 0.0 113.054 177.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.52 -50.42 70.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.835 0.35 . . . . 0.0 111.942 -174.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' MET . . . . . . . . . . . . . 75.8 mtp -68.41 -28.81 67.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.892 0.377 . . . . 0.0 110.476 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' HIS . . . . . 0.514 ' HA ' ' OE1' ' B' ' 50' ' ' GLU . 6.1 t-80 -65.7 -31.54 72.6 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.312 176.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.574 ' HG2' ' O ' ' B' ' 81' ' ' GLY . 33.6 mmtp -81.76 -19.38 41.45 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.04 0.448 . . . . 0.0 110.337 -178.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.49 -43.36 13.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.79 177.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 1.3 mmt -85.32 -12.78 51.51 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.323 -176.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' B' ' 84' ' ' HIS . 0.1 OUTLIER -48.58 -43.01 35.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.776 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 26.3 ttt -80.81 -17.04 52.13 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.986 0.422 . . . . 0.0 110.753 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -91.21 -41.21 11.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.996 -174.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' GLN . . . . . 0.535 ' C ' ' HB3' ' B' ' 53' ' ' SER . 20.2 mt-30 -104.57 -52.65 2.85 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -170.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.496 ' HB2' HD12 ' B' ' 88' ' ' LEU . 0.1 OUTLIER -42.52 -37.48 1.65 Allowed 'General case' 0 N--CA 1.472 0.661 0 O-C-N 123.854 0.721 . . . . 0.0 109.343 -179.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 . . . . . 0 C--O 1.25 1.103 0 CA-C-N 114.06 -1.427 . . . . 0.0 113.042 -176.627 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.4 ' HB2' ' H ' ' A' ' 2' ' ' SER . 96.0 Cg_endo . . . . . 0 CA--C 1.517 -0.345 0 N-CA-C 109.248 -1.097 . . . . 0.0 109.248 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.554 ' HB2' HG23 ' A' ' 5' ' ' THR . 39.4 m -64.93 171.13 3.71 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 162.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.837 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -69.73 -52.53 24.65 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.118 175.299 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.488 ' ND2' ' HG3' ' A' ' 42' ' ' MET . 2.2 p-10 -86.97 6.45 32.16 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.577 -1.192 . . . . 0.0 113.659 -163.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.628 ' CG2' ' HD3' ' B' ' 59' ' ' LYS . 1.1 p -63.32 -5.99 4.14 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 118.513 0.597 . . . . 0.0 111.787 -176.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.629 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.1 m -75.12 132.04 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 175.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.772 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -155.54 159.22 39.54 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -178.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.474 ' HG2' ' HB3' ' A' ' 12' ' ' GLU . 2.3 tt0 -44.29 115.14 0.79 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 112.929 -1.941 . . . . 0.0 113.02 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.73 -149.98 23.81 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.091 -0.958 . . . . 0.0 111.126 171.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.478 ' C ' ' HD3' ' A' ' 11' ' ' LYS . 6.3 p -50.97 100.36 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.61 0.364 . . . . 0.0 111.592 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER 30.25 48.0 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.764 1.226 . . . . 0.0 112.26 -171.507 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.474 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 53.5 tt0 -60.22 140.63 91.17 Favored Pre-proline 0 C--O 1.234 0.283 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.611 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.574 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 32.0 Cg_exo -54.05 121.54 9.82 Favored 'Trans proline' 0 CA--C 1.509 -0.754 0 C-N-CA 121.947 1.765 . . . . 0.0 109.623 178.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.917 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 13.8 t80 -72.75 -53.36 5.52 Favored Pre-proline 0 N--CA 1.439 -1.022 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -167.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' A' ' 14' ' ' TYR . 34.6 Cg_exo -55.66 -17.04 16.42 Favored 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.43 1.42 . . . . 0.0 110.761 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.574 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 2.2 m-20 -90.6 -43.43 10.18 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 113.981 -1.463 . . . . 0.0 111.038 177.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.491 ' CD2' ' HA ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -53.41 -46.51 69.78 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.791 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 1.8 p -79.26 -34.72 16.56 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.363 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.313 -178.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.89 -32.79 68.06 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 121.344 -0.847 . . . . 0.0 111.762 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.697 ' O ' HG12 ' A' ' 24' ' ' VAL . 14.3 ptt180 -84.28 -25.04 29.64 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 176.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.56 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 6.2 tp -59.91 -46.72 88.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.821 172.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.791 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 24.7 mt-30 -69.97 -48.28 58.92 Favored 'General case' 0 CA--C 1.492 -1.282 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.933 177.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.73 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 15.5 t70 -47.44 -54.65 10.82 Favored 'General case' 0 C--N 1.313 -1.017 0 O-C-N 124.265 0.978 . . . . 0.0 111.547 -178.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.697 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.7 p -79.18 -24.9 12.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.948 -173.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.641 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -67.89 -29.58 68.71 Favored 'General case' 0 C--O 1.205 -1.263 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.474 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -78.81 -36.32 42.89 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.723 -178.253 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.73 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 39.2 mmtt -65.92 -34.1 77.34 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.469 177.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.431 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 16.1 m -105.6 -9.89 17.14 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.271 0.558 . . . . 0.0 110.823 -170.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.641 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 87.7 mt -118.07 129.07 74.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.062 -178.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.4 -1.47 53.63 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.246 0.546 . . . . 0.0 110.524 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.615 ' H ' HG22 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -113.71 111.76 22.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.015 -177.338 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.86 -32.05 30.47 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 177.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.595 ' O ' HG13 ' A' ' 37' ' ' VAL . 14.2 mttm -58.46 -61.31 2.68 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.634 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -66.36 -22.84 66.27 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.427 -178.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.85 ' O ' HG13 ' A' ' 39' ' ' VAL . 5.3 tmm_? -72.31 -54.6 9.02 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.447 ' O ' HG22 ' A' ' 39' ' ' VAL . 16.6 mtpt -59.44 -56.5 21.26 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.345 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.81 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 20.9 m -54.15 -36.58 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.997 -171.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.837 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.2 tt -85.78 -30.36 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.811 -176.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.85 HG13 ' O ' ' A' ' 35' ' ' ARG . 3.3 m -69.47 -47.94 69.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 C-N-CA 118.915 -1.114 . . . . 0.0 109.245 174.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.619 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 58.6 mt-10 -64.66 -23.13 67.16 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 123.653 0.781 . . . . 0.0 112.383 175.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.81 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -85.48 -57.21 3.16 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.543 177.251 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.498 ' HB2' HD21 ' A' ' 21' ' ' LEU . 20.1 mmt -63.6 -20.96 66.09 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 121.462 0.649 . . . . 0.0 109.734 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.671 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -49.18 -27.65 3.78 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.288 170.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.466 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 11.4 t80 -106.12 -68.1 0.89 Allowed 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.603 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 7.2 mm-40 -47.59 -33.85 7.1 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 124.31 1.007 . . . . 0.0 112.414 -173.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.772 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.8 m-20 -103.46 -21.15 13.83 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 120.501 0.191 . . . . 0.0 110.963 -174.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.654 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -57.35 177.61 0.09 Allowed 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 121.817 0.818 . . . . 0.0 112.511 -176.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -56.21 137.64 74.35 Favored Pre-proline 0 N--CA 1.44 -0.958 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.9 174.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.432 ' HB2' HD21 ' A' ' 92' ' ' LEU . 9.7 Cg_endo -55.43 -21.75 31.36 Favored 'Trans proline' 0 C--O 1.219 -0.465 0 C-N-CA 123.273 2.649 . . . . 0.0 111.778 -177.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.516 ' O ' ' HB2' ' A' ' 53' ' ' SER . 0.7 OUTLIER -87.86 -37.4 16.54 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 124.157 0.983 . . . . 0.0 111.055 173.325 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 1.015 ' SG ' ' HB2' ' A' ' 76' ' ' CYS . 42.4 t -75.33 -36.06 61.11 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-O 121.018 0.437 . . . . 0.0 111.328 -172.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.554 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.9 pt20 -69.62 -29.74 67.32 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 175.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.636 ' HA ' ' CD ' ' A' ' 56' ' ' LYS . 30.8 m -72.48 -19.75 61.5 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 112.944 -1.935 . . . . 0.0 110.176 174.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -81.22 -22.27 38.92 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.333 166.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.554 HD12 ' HA ' ' A' ' 52' ' ' GLN . 22.5 mt -90.54 -31.84 5.26 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.787 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 -173.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.651 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.1 OUTLIER -46.14 -32.65 1.81 Allowed Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -175.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.651 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 33.0 Cg_endo -59.54 -31.04 93.9 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.17 1.913 . . . . 0.0 112.99 171.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.546 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.1 mt -102.45 -15.65 16.42 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.624 ' HD3' ' CG2' ' B' ' 5' ' ' THR . 0.1 OUTLIER -51.78 109.88 0.41 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.972 -179.717 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.35 -22.66 35.8 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.162 -177.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -103.77 114.5 28.8 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.413 0.625 . . . . 0.0 110.553 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.527 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.4 p -123.4 149.99 59.55 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.471 170.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.6 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 92.1 Cg_exo -47.29 139.52 16.23 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 121.713 1.609 . . . . 0.0 110.92 164.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.45 100.81 0.09 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -171.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.16 -2.25 71.31 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.04 176.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.6 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 2.1 m -95.7 -155.33 0.47 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.219 1.009 . . . . 0.0 112.372 -177.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -98.61 124.93 43.69 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 113.568 -1.651 . . . . 0.0 110.93 -172.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.559 HG13 ' CD ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -81.05 -28.98 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 C-N-CA 117.609 -1.637 . . . . 0.0 108.606 173.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.78 ' O ' HG13 ' A' ' 73' ' ' VAL . 10.0 mm -59.34 -48.04 88.42 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.18 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.627 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.402 ' O ' HG22 ' A' ' 73' ' ' VAL . 45.3 t -50.44 -33.96 22.93 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.355 0.598 . . . . 0.0 111.155 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -85.28 -33.64 22.1 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 123.323 0.649 . . . . 0.0 110.507 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.576 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 4.7 m-30 -75.85 -34.05 60.04 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.754 -176.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.917 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 2.2 m -68.41 -35.67 71.66 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 173.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.54 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 21.7 ttmt -70.71 -27.7 64.18 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 113.894 -1.503 . . . . 0.0 111.188 176.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -61.62 -44.34 97.17 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 171.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 1.015 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 16.6 t -85.78 3.12 42.83 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.292 176.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.54 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 29.6 t70 -65.5 1.19 1.25 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 163.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 76' ' ' CYS . . . -121.14 -10.09 6.96 Favored Glycine 0 N--CA 1.439 -1.115 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.779 175.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.66 HG12 ' CB ' ' A' ' 76' ' ' CYS . 1.1 mm -68.0 -85.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.046 0.923 . . . . 0.0 110.066 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 42.9 -130.17 5.31 Favored Glycine 0 C--N 1.339 0.719 0 CA-C-N 115.967 -0.56 . . . . 0.0 113.469 -172.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.681 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . -113.76 -66.67 0.47 Allowed Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.353 -176.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.43 -56.87 15.77 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -173.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.529 ' O ' ' HG3' ' A' ' 87' ' ' MET . 54.1 mtt -66.5 -36.6 83.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.948 0.404 . . . . 0.0 110.094 -177.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.63 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 6.2 t-80 -55.4 -34.99 64.87 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.385 176.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.681 ' HG2' ' O ' ' A' ' 81' ' ' GLY . 31.5 mmtp -80.15 -17.41 52.55 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 121.825 -0.547 . . . . 0.0 110.523 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.41 -46.06 10.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.575 0.703 . . . . 0.0 110.682 175.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.529 ' HG3' ' O ' ' A' ' 83' ' ' MET . 25.1 mtm -85.58 -14.05 46.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.38 -172.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.63 ' HB2' ' O ' ' A' ' 84' ' ' HIS . 1.3 tp -48.65 -41.93 32.82 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.619 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 53.0 ttp -82.34 -16.14 50.32 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.033 0.444 . . . . 0.0 111.114 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -97.02 -33.96 11.36 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -174.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.591 ' C ' ' HB3' ' A' ' 53' ' ' SER . 22.0 mt-30 -105.47 -56.27 2.2 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.72 -174.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.445 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -48.03 -31.4 5.36 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.605 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.428 ' HG3' ' OXT' ' A' ' 93' ' ' GLU . 5.3 pt-20 . . . . . 0 C--O 1.249 1.051 0 CA-C-N 113.59 -1.641 . . . . 0.0 113.995 -171.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo . . . . . 0 CA--C 1.517 -0.368 0 N-CA-C 109.156 -1.132 . . . . 0.0 109.156 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.561 ' HB2' HG23 ' B' ' 5' ' ' THR . 43.3 m -65.13 171.07 3.93 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 162.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.825 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -69.61 -52.54 25.06 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.155 175.349 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.488 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.2 p-10 -86.9 6.51 31.6 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.584 -1.189 . . . . 0.0 113.717 -163.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.624 ' CG2' ' HD3' ' A' ' 59' ' ' LYS . 1.1 p -63.54 -5.75 4.25 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 118.57 0.623 . . . . 0.0 111.865 -176.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.63 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.1 m -75.2 131.98 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 175.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.773 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.1 OUTLIER -155.51 159.37 39.7 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -178.702 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' GLN . . . . . 0.46 ' HG2' ' HB3' ' B' ' 12' ' ' GLU . 2.3 tt0 -44.2 115.0 0.76 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 112.939 -1.937 . . . . 0.0 113.035 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.79 -150.06 24.04 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.162 171.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . 0.488 ' C ' ' HD3' ' B' ' 11' ' ' LYS . 7.8 p -50.84 100.25 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.604 0.362 . . . . 0.0 111.677 -178.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' B' ' 11' ' ' LYS . 0.0 OUTLIER 30.37 48.19 0.05 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.673 1.189 . . . . 0.0 112.122 -171.575 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.46 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 51.9 tt0 -60.51 140.35 92.28 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.688 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . 0.577 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 31.9 Cg_exo -53.97 121.6 9.91 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 121.861 1.707 . . . . 0.0 109.602 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . 0.912 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 13.7 t80 -72.85 -53.35 5.36 Favored Pre-proline 0 N--CA 1.438 -1.049 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -167.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.521 ' HD3' ' HB3' ' B' ' 14' ' ' TYR . 32.9 Cg_exo -55.37 -17.33 15.86 Favored 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 121.57 1.514 . . . . 0.0 110.775 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.577 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.7 m-20 -90.62 -43.42 10.18 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 113.935 -1.484 . . . . 0.0 111.024 177.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' PHE . . . . . 0.502 ' CD2' ' HA ' ' B' ' 7' ' ' ARG . 0.0 OUTLIER -53.38 -46.49 69.66 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.662 0.744 . . . . 0.0 109.039 175.525 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.797 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 1.8 p -79.16 -34.83 16.79 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.334 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.298 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.91 -32.76 68.06 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 121.366 -0.834 . . . . 0.0 111.773 177.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.693 ' O ' HG12 ' B' ' 24' ' ' VAL . 14.3 ptt180 -84.61 -24.63 29.05 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.563 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 6.1 tp -60.3 -46.47 89.75 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.842 172.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . 0.797 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 24.8 mt-30 -70.2 -48.1 58.58 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.004 177.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.724 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 15.2 t70 -47.49 -54.67 10.88 Favored 'General case' 0 C--N 1.313 -1.002 0 O-C-N 124.301 1.001 . . . . 0.0 111.462 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' VAL . . . . . 0.693 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.7 p -79.28 -24.78 12.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.96 -173.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.649 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -67.96 -29.51 68.57 Favored 'General case' 0 C--O 1.205 -1.272 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 174.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . 0.463 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -78.89 -36.26 42.33 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.125 -1.398 . . . . 0.0 109.786 -178.252 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.724 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 39.1 mmtt -65.89 -34.26 77.72 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.496 177.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . 0.421 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 15.9 m -105.63 -9.66 17.24 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.884 -170.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.649 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 87.9 mt -118.2 129.28 74.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.983 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.64 -1.32 53.39 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.347 0.594 . . . . 0.0 110.585 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.607 ' H ' HG22 ' B' ' 29' ' ' ILE . 0.6 OUTLIER -113.71 111.81 22.41 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.977 -177.554 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.17 -31.71 32.65 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.092 177.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.586 ' O ' HG13 ' B' ' 37' ' ' VAL . 14.1 mttm -58.66 -61.21 2.77 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -178.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.621 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -66.21 -22.98 66.36 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.483 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.868 ' O ' HG13 ' B' ' 39' ' ' VAL . 5.2 tmm_? -72.15 -54.63 9.13 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.446 ' O ' HG22 ' B' ' 39' ' ' VAL . 16.5 mtpt -59.47 -56.48 21.43 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.461 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.8 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 21.0 m -54.18 -36.57 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.051 -171.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.825 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.2 tt -85.6 -30.55 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.757 -176.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.868 HG13 ' O ' ' B' ' 35' ' ' ARG . 3.3 m -69.39 -48.0 69.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 C-N-CA 118.927 -1.109 . . . . 0.0 109.17 174.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.621 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 58.7 mt-10 -64.63 -23.35 67.23 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.571 0.748 . . . . 0.0 112.268 176.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.8 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.29 -57.16 3.19 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.555 177.331 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' MET . . . . . 0.497 ' HB2' HD21 ' B' ' 21' ' ' LEU . 20.0 mmt -63.63 -20.96 66.1 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.521 0.677 . . . . 0.0 109.714 -177.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.681 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -49.13 -27.76 3.75 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.305 170.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' TYR . . . . . 0.478 ' CG ' ' HD2' ' B' ' 59' ' ' LYS . 11.4 t80 -106.09 -67.99 0.9 Allowed 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.608 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 7.2 mm-40 -47.85 -33.48 7.46 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 124.301 1.001 . . . . 0.0 112.491 -173.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.773 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.9 m-20 -103.67 -21.04 13.78 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 116.808 -0.178 . . . . 0.0 110.903 -175.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.644 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -57.48 178.07 0.08 Allowed 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 121.864 0.84 . . . . 0.0 112.55 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -56.42 137.53 75.91 Favored Pre-proline 0 N--CA 1.441 -0.917 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.819 174.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . 0.427 ' HB2' HD21 ' B' ' 92' ' ' LEU . 9.7 Cg_endo -55.32 -21.63 30.04 Favored 'Trans proline' 0 C--O 1.221 -0.373 0 C-N-CA 123.177 2.585 . . . . 0.0 111.911 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.509 ' O ' ' HB2' ' B' ' 53' ' ' SER . 0.7 OUTLIER -87.8 -37.47 16.56 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 124.303 1.041 . . . . 0.0 111.13 173.044 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 1.015 ' SG ' ' HB2' ' B' ' 76' ' ' CYS . 41.7 t -75.34 -36.0 61.09 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-O 121.046 0.451 . . . . 0.0 111.315 -172.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.543 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.9 pt20 -69.54 -29.92 67.62 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 175.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . 0.644 ' HA ' ' CD ' ' B' ' 56' ' ' LYS . 32.4 m -72.26 -19.99 61.6 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 112.92 -1.945 . . . . 0.0 110.29 174.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -81.04 -22.38 39.36 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.216 -0.593 . . . . 0.0 110.388 166.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' B' ' 52' ' ' GLN . 22.5 mt -90.53 -31.95 5.29 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.798 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -173.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.644 ' CD ' ' HA ' ' B' ' 53' ' ' SER . 0.1 OUTLIER -46.04 -32.76 1.8 Allowed Pre-proline 0 N--CA 1.488 1.466 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -175.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 32.7 Cg_endo -59.24 -31.44 95.22 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.219 1.946 . . . . 0.0 112.939 171.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . 0.542 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.1 mt -102.15 -15.91 16.54 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -177.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.628 ' HD3' ' CG2' ' A' ' 5' ' ' THR . 0.1 OUTLIER -51.61 109.88 0.4 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.112 -179.713 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.0 -22.09 38.26 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.329 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -103.96 114.76 29.24 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.355 0.597 . . . . 0.0 110.48 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.511 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.5 p -123.46 150.34 60.65 Favored Pre-proline 0 C--N 1.309 -1.166 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.374 170.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.612 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 93.4 Cg_exo -47.45 139.52 17.1 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 121.753 1.636 . . . . 0.0 110.915 164.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.58 100.96 0.09 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -171.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.26 -3.19 72.29 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.899 -0.591 . . . . 0.0 113.135 176.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.612 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 2.3 m -95.06 -155.21 0.46 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 122.145 0.974 . . . . 0.0 112.281 -177.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -98.67 124.75 43.67 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 113.513 -1.676 . . . . 0.0 110.898 -172.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.551 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.9 OUTLIER -80.97 -28.79 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 C-N-CA 117.548 -1.661 . . . . 0.0 108.609 173.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.789 ' O ' HG13 ' B' ' 73' ' ' VAL . 9.8 mm -59.75 -47.71 90.27 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.232 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.68 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.401 ' O ' HG22 ' B' ' 73' ' ' VAL . 42.8 t -50.52 -34.04 23.79 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.397 0.617 . . . . 0.0 111.118 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -85.18 -33.87 22.2 Favored 'General case' 0 C--O 1.213 -0.835 0 C-N-CA 123.298 0.639 . . . . 0.0 110.394 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' TYR . . . . . 0.575 ' OH ' ' HA ' ' B' ' 59' ' ' LYS . 4.7 m-30 -75.56 -33.9 60.66 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.719 -176.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.912 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 2.2 m -68.56 -35.61 71.03 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' LYS . . . . . 0.53 ' O ' ' HB3' ' B' ' 77' ' ' ASP . 22.0 ttmt -70.71 -27.52 64.04 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.253 176.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -61.81 -44.17 97.39 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 1.015 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 16.5 t -86.02 3.29 42.96 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.336 176.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . 0.53 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 28.5 t70 -65.55 1.2 1.27 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 163.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . 0.448 ' H ' ' C ' ' B' ' 76' ' ' CYS . . . -121.26 -9.7 7.11 Favored Glycine 0 N--CA 1.439 -1.122 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.7 175.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.67 HG12 ' CB ' ' B' ' 76' ' ' CYS . 1.1 mm -68.19 -84.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 118.06 0.93 . . . . 0.0 110.042 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 42.5 -130.32 4.91 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-N 115.969 -0.559 . . . . 0.0 113.511 -172.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.688 ' O ' ' HG2' ' B' ' 85' ' ' LYS . . . -113.81 -66.23 0.46 Allowed Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.386 -177.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.89 -56.48 21.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -173.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' MET . . . . . 0.531 ' O ' ' HG3' ' B' ' 87' ' ' MET . 53.8 mtt -66.64 -36.64 83.05 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -177.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' HIS . . . . . 0.632 ' O ' ' HB2' ' B' ' 88' ' ' LEU . 6.2 t-80 -55.48 -34.98 65.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.304 176.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.688 ' HG2' ' O ' ' B' ' 81' ' ' GLY . 31.6 mmtp -80.27 -17.27 52.65 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 121.819 -0.551 . . . . 0.0 110.533 -178.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.53 -45.98 10.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.571 0.7 . . . . 0.0 110.691 175.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . 0.531 ' HG3' ' O ' ' B' ' 83' ' ' MET . 24.4 mtm -85.66 -14.02 46.78 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.381 -172.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.632 ' HB2' ' O ' ' B' ' 84' ' ' HIS . 1.3 tp -48.73 -41.9 33.53 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.592 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 53.7 ttp -82.34 -16.25 49.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.944 0.402 . . . . 0.0 111.013 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -96.89 -33.76 11.5 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -174.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' GLN . . . . . 0.605 ' C ' ' HB3' ' B' ' 53' ' ' SER . 22.0 mt-30 -105.77 -56.41 2.18 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.653 -174.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.463 ' HB2' HD12 ' B' ' 88' ' ' LEU . 0.0 OUTLIER -48.05 -31.24 5.21 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 177.568 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.416 ' HG3' ' OXT' ' B' ' 93' ' ' GLU . 5.2 pt-20 . . . . . 0 C--O 1.252 1.19 0 CA-C-N 113.809 -1.541 . . . . 0.0 113.843 -171.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.427 ' HB2' ' H ' ' A' ' 2' ' ' SER . 98.1 Cg_endo . . . . . 0 CA--C 1.517 -0.341 0 N-CA-C 109.052 -1.172 . . . . 0.0 109.052 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.65 ' HB2' HG23 ' A' ' 5' ' ' THR . 50.0 m -66.37 176.82 1.68 Allowed 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 162.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.661 ' CE1' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -77.09 -53.99 7.09 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.589 -0.845 . . . . 0.0 109.743 174.338 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.56 ' ND2' ' HG3' ' A' ' 42' ' ' MET . 2.0 p-10 -82.67 6.19 18.71 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.367 -1.288 . . . . 0.0 112.548 -167.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.65 HG23 ' HB2' ' A' ' 2' ' ' SER . 0.7 OUTLIER -65.12 -4.08 4.5 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.547 -176.75 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.627 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.2 m -79.37 132.78 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 174.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.768 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -155.95 160.07 39.78 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 118.937 -1.105 . . . . 0.0 113.422 -177.798 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.497 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.4 mt-30 -40.67 112.68 0.31 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 113.568 -1.651 . . . . 0.0 112.776 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.08 -161.58 32.74 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 170.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.7 m -50.83 104.09 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 117.292 0.546 . . . . 0.0 111.029 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.624 ' HD2' ' O ' ' A' ' 80' ' ' GLY . 63.4 pttt 44.12 39.11 2.65 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.587 1.155 . . . . 0.0 112.756 -176.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.434 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 48.2 tt0 -62.36 137.97 96.2 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 177.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.512 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 39.0 Cg_exo -53.74 124.72 16.53 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.11 1.874 . . . . 0.0 109.921 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.78 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 6.7 t80 -69.26 -55.32 10.11 Favored Pre-proline 0 N--CA 1.44 -0.958 0 CA-C-O 118.38 -0.819 . . . . 0.0 113.134 -166.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.548 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 30.3 Cg_exo -57.04 -17.57 25.15 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 121.456 1.437 . . . . 0.0 111.211 -178.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 2.1 m-20 -89.52 -42.31 11.52 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.891 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.64 ' CE1' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -55.48 -44.7 76.72 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.307 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.745 HG21 HD12 ' A' ' 69' ' ' ILE . 1.7 p -80.99 -31.47 12.11 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.937 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.826 -177.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.76 -33.69 70.56 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 121.284 -0.885 . . . . 0.0 111.608 176.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.706 ' O ' HG12 ' A' ' 24' ' ' VAL . 14.6 ptt180 -84.56 -25.48 28.66 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 175.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.64 HD22 ' CE1' ' A' ' 17' ' ' PHE . 9.7 tp -57.98 -45.09 87.31 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.972 172.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.723 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 36.1 mt-30 -73.31 -44.42 59.04 Favored 'General case' 0 CA--C 1.494 -1.196 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.688 177.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.759 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 14.3 t70 -52.08 -50.93 60.58 Favored 'General case' 0 C--N 1.314 -0.945 0 O-C-N 124.087 0.867 . . . . 0.0 111.427 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.706 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.1 p -82.02 -23.96 9.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.249 0.547 . . . . 0.0 109.793 -174.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.855 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -71.69 -18.29 62.18 Favored 'General case' 0 C--O 1.206 -1.223 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 174.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.426 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -87.43 -38.92 15.7 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.958 176.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.759 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 40.2 mmtt -65.28 -43.32 91.6 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.321 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.515 ' HB2' ' HB3' ' A' ' 3' ' ' PHE . 24.9 m -98.6 -8.47 26.36 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.243 0.544 . . . . 0.0 110.419 -172.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.855 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 87.2 mt -114.91 125.48 72.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.725 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.84 -4.33 57.65 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.18 0.514 . . . . 0.0 110.01 175.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.669 ' OD1' ' HB2' ' A' ' 33' ' ' LYS . 12.4 t70 -102.59 115.71 31.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.409 -177.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.466 ' O ' ' HG2' ' A' ' 36' ' ' LYS . 12.5 pt-20 -61.59 -24.71 66.86 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.831 176.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.669 ' HB2' ' OD1' ' A' ' 31' ' ' ASP . 4.5 mptt -75.12 -52.17 11.65 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -177.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.409 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -65.29 -26.94 68.29 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.89 176.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.827 ' O ' HG13 ' A' ' 39' ' ' VAL . 3.9 tmm_? -62.59 -65.19 0.72 Allowed 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.589 ' HG3' HG13 ' A' ' 37' ' ' VAL . 7.9 ptmm? -53.11 -58.38 7.2 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.314 0.578 . . . . 0.0 112.259 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.779 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 5.4 m -56.63 -30.39 31.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.928 -172.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.497 ' O ' ' HG2' ' A' ' 42' ' ' MET . 0.1 OUTLIER -85.07 -31.43 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.407 178.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.827 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.4 m -68.33 -47.84 75.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 119.257 -0.977 . . . . 0.0 108.97 175.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.594 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 45.3 mt-10 -68.03 -22.89 64.94 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.335 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.779 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -85.42 -55.2 4.13 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.166 175.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.574 ' HB2' HD21 ' A' ' 21' ' ' LEU . 17.8 mmt -63.77 -20.42 65.75 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.567 0.698 . . . . 0.0 109.765 -176.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.627 ' HB2' ' CD1' ' A' ' 69' ' ' ILE . . . -47.9 -30.2 3.96 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.736 171.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.553 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 8.0 t80 -105.66 -66.99 0.95 Allowed 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.637 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 3.9 mm-40 -47.02 -33.79 5.09 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 124.47 1.106 . . . . 0.0 112.107 -173.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.768 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 5.3 m-20 -102.7 -21.0 14.17 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.214 -174.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.62 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -60.65 -179.62 0.13 Allowed 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 122.093 0.949 . . . . 0.0 112.966 -173.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.604 ' HB3' ' OE1' ' A' ' 50' ' ' GLU . 15.1 m-20 -61.35 141.61 94.21 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.175 174.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.21 -22.61 33.21 Favored 'Trans proline' 0 C--O 1.22 -0.425 0 C-N-CA 123.413 2.742 . . . . 0.0 112.722 -178.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.694 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 12.2 pm0 -89.37 -31.13 17.91 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 123.5 0.72 . . . . 0.0 110.599 175.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.694 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 92.7 m -82.9 -37.44 24.25 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.57 -170.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.611 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.6 pt20 -70.21 -29.94 66.91 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 172.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.574 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 11.2 m -70.91 -19.87 62.55 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 113.672 -1.604 . . . . 0.0 110.331 174.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.705 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -78.6 -25.43 45.19 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.504 -0.748 . . . . 0.0 109.686 167.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.613 HD11 ' CE2' ' A' ' 14' ' ' TYR . 22.7 mt -89.8 -32.57 5.65 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.816 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -171.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.599 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -39.92 -37.95 0.88 Allowed Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -174.361 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 52.3 Cg_endo -63.86 -29.23 67.65 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.217 1.945 . . . . 0.0 113.006 175.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.566 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.5 mt -99.09 -15.61 18.94 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.645 ' HD3' ' CG2' ' B' ' 5' ' ' THR . 0.1 OUTLIER -50.96 109.65 0.35 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.24 -178.371 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.419 ' HA3' ' C ' ' B' ' 1' ' ' PRO . . . 90.2 -20.65 35.75 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.032 -178.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -103.47 113.14 26.41 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.274 0.559 . . . . 0.0 109.785 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.474 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.5 p -123.72 148.88 57.6 Favored Pre-proline 0 C--N 1.31 -1.146 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.624 172.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.558 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 83.5 Cg_exo -47.5 137.84 19.3 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.059 1.839 . . . . 0.0 110.788 164.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.92 102.06 0.14 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.049 -171.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.78 -9.88 64.2 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.993 176.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.558 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 4.8 m -91.86 -167.88 1.88 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 122.398 1.094 . . . . 0.0 112.309 -177.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.62 ' OD2' ' HB3' ' A' ' 70' ' ' SER . 0.4 OUTLIER -88.16 126.0 34.9 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 112.862 -1.972 . . . . 0.0 111.117 -175.05 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.534 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -81.7 -32.98 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 C-N-CA 118.623 -1.231 . . . . 0.0 108.662 173.815 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.789 ' O ' HG13 ' A' ' 73' ' ' VAL . 10.7 mm -56.3 -49.98 73.92 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.349 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.495 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.62 ' HB3' ' OD2' ' A' ' 67' ' ' ASP . 32.5 t -54.66 -29.01 51.3 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.059 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -85.79 -33.27 21.42 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.394 0.616 . . . . 0.0 110.162 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.64 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.2 m-30 -75.31 -35.13 61.3 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.518 -177.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.789 HG13 ' O ' ' A' ' 69' ' ' ILE . 1.4 m -70.78 -32.05 47.79 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 172.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.538 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -67.63 -30.92 70.62 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.27 175.248 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -63.58 -46.02 87.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.056 176.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.829 ' SG ' ' HB ' ' A' ' 79' ' ' ILE . 27.5 t -93.02 9.91 33.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.141 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.538 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 3.8 t70 -58.49 -26.3 63.27 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.092 0.472 . . . . 0.0 110.854 174.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 83' ' ' MET . . . -92.12 -23.13 28.09 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.226 173.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.829 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 76.7 mt -81.25 149.57 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.1 0.476 . . . . 0.0 111.015 -177.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.624 ' O ' ' HD2' ' A' ' 11' ' ' LYS . . . 140.78 -34.63 1.93 Allowed Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.38 149.28 12.55 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 174.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 65.17 -75.06 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.014 0.526 . . . . 0.0 111.722 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.44 ' HB3' ' SD ' ' A' ' 87' ' ' MET . 59.4 mtt -59.29 -39.03 81.71 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.554 -178.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.498 ' HB2' HG23 ' A' ' 79' ' ' ILE . 5.1 t-160 -49.96 -36.86 29.73 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.621 174.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -81.48 -32.48 32.46 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.817 0.341 . . . . 0.0 110.939 -174.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.29 -44.1 47.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.595 0.712 . . . . 0.0 110.532 176.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.44 ' SD ' ' HB3' ' A' ' 83' ' ' MET . 67.9 mtp -78.28 -12.55 60.01 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.931 -1.032 . . . . 0.0 110.772 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.455 HD12 ' HB2' ' A' ' 92' ' ' LEU . 0.1 OUTLIER -50.76 -54.69 21.33 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.878 178.075 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 16.1 tpt -76.49 -15.47 59.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.098 0.475 . . . . 0.0 110.661 -176.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -88.41 -26.32 22.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.953 -176.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.574 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 16.6 mt-30 -121.35 -50.09 2.13 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -170.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.455 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -42.73 -38.55 2.12 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.902 0.751 . . . . 0.0 109.345 -177.529 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 . . . . . 0 C--O 1.251 1.154 0 CA-C-N 113.353 -1.749 . . . . 0.0 113.665 -177.498 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' PRO . . . . . 0.419 ' C ' ' HA3' ' A' ' 60' ' ' GLY . 93.2 Cg_endo . . . . . 0 CA--C 1.516 -0.384 0 N-CA-C 109.135 -1.14 . . . . 0.0 109.135 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.649 ' HB2' HG23 ' B' ' 5' ' ' THR . 50.1 m -66.91 176.97 1.84 Allowed 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 162.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.659 ' CE1' HD11 ' B' ' 29' ' ' ILE . 0.1 OUTLIER -77.03 -54.14 6.92 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.663 174.296 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.554 ' ND2' ' HG3' ' B' ' 42' ' ' MET . 2.0 p-10 -82.59 6.01 19.08 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.392 -1.276 . . . . 0.0 112.475 -166.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.649 HG23 ' HB2' ' B' ' 2' ' ' SER . 0.7 OUTLIER -65.1 -3.95 4.31 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.58 -176.698 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.629 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.2 m -79.41 132.9 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.746 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.1 OUTLIER -155.94 160.24 39.94 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.123 -1.031 . . . . 0.0 113.403 -177.79 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' GLN . . . . . 0.505 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.3 mt-30 -41.03 112.16 0.27 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 113.591 -1.64 . . . . 0.0 112.814 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.41 -161.44 31.43 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 170.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 43.5 m -50.92 104.05 0.07 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-N 117.241 0.52 . . . . 0.0 111.093 -178.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.605 ' HD2' ' O ' ' B' ' 80' ' ' GLY . 63.7 pttt 44.22 38.88 2.61 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.59 1.156 . . . . 0.0 112.714 -176.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.44 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 48.2 tt0 -62.09 137.71 95.71 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 177.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . 0.536 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 39.4 Cg_exo -53.5 124.89 16.84 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.25 1.967 . . . . 0.0 109.979 178.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . 0.791 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 6.7 t80 -69.58 -55.28 9.53 Favored Pre-proline 0 N--CA 1.44 -0.943 0 CA-C-O 118.369 -0.824 . . . . 0.0 113.074 -166.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.547 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 31.1 Cg_exo -57.05 -17.62 25.39 Favored 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 121.437 1.425 . . . . 0.0 111.176 -178.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.536 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 2.3 m-20 -89.44 -42.64 11.38 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 113.872 -1.513 . . . . 0.0 110.804 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' PHE . . . . . 0.638 ' CE1' HD22 ' B' ' 21' ' ' LEU . 0.0 OUTLIER -55.22 -44.73 75.68 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 177.351 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.728 HG21 HD12 ' B' ' 69' ' ' ILE . 1.7 p -80.99 -31.38 12.07 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.927 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.791 -177.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.69 -34.04 70.84 Favored 'General case' 0 C--N 1.315 -0.931 0 O-C-N 121.344 -0.847 . . . . 0.0 111.596 176.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.707 ' O ' HG12 ' B' ' 24' ' ' VAL . 14.7 ptt180 -84.37 -25.48 29.11 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 176.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.638 HD22 ' CE1' ' B' ' 17' ' ' PHE . 9.9 tp -58.09 -45.19 87.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.981 172.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . 0.738 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 35.5 mt-30 -73.26 -44.39 59.46 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.701 177.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.753 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 12.8 t70 -51.96 -50.8 60.52 Favored 'General case' 0 C--N 1.314 -0.941 0 O-C-N 123.956 0.785 . . . . 0.0 111.578 -178.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' VAL . . . . . 0.707 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.1 p -82.1 -24.0 9.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.218 0.532 . . . . 0.0 109.766 -174.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.855 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -71.77 -18.16 62.13 Favored 'General case' 0 C--O 1.206 -1.219 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 174.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . 0.433 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -87.59 -38.89 15.55 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.991 176.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.753 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 40.4 mmtt -65.09 -43.92 90.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.233 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . 0.537 ' HB2' ' HB3' ' B' ' 3' ' ' PHE . 36.0 m -98.15 -8.31 27.79 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.116 0.484 . . . . 0.0 110.495 -171.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.855 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 87.4 mt -114.99 125.24 72.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.813 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.59 -4.46 57.82 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.259 0.552 . . . . 0.0 110.143 175.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.644 ' OD1' ' HB2' ' B' ' 33' ' ' LYS . 12.3 t70 -102.79 115.67 31.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.445 -177.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' B' ' 36' ' ' LYS . 12.4 pt-20 -61.79 -24.49 66.88 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.857 177.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.644 ' HB2' ' OD1' ' B' ' 31' ' ' ASP . 4.5 mptt -75.1 -52.34 11.26 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -177.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.416 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -65.25 -26.94 68.32 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.848 176.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.828 ' O ' HG13 ' B' ' 39' ' ' VAL . 4.0 tmm_? -62.68 -65.09 0.74 Allowed 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.581 ' HG3' HG13 ' B' ' 37' ' ' VAL . 7.8 ptmm? -53.17 -58.33 7.42 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.308 0.575 . . . . 0.0 112.318 -178.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.776 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 5.6 m -56.83 -30.28 32.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.863 -171.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.494 ' O ' ' HG2' ' B' ' 42' ' ' MET . 0.1 OUTLIER -85.02 -31.49 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 119.891 -0.723 . . . . 0.0 111.438 178.795 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.828 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.4 m -68.33 -47.93 75.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.931 175.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.609 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 42.6 mt-10 -67.94 -22.92 65.03 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.392 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.776 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -85.42 -55.3 4.08 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.127 175.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' MET . . . . . 0.573 ' HB2' HD21 ' B' ' 21' ' ' LEU . 17.9 mmt -63.7 -20.46 65.74 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.585 0.707 . . . . 0.0 109.844 -176.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.616 ' HB2' ' CD1' ' B' ' 69' ' ' ILE . . . -47.74 -30.27 3.76 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.744 171.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' TYR . . . . . 0.548 ' CG ' ' HB2' ' B' ' 52' ' ' GLN . 7.8 t80 -105.66 -66.92 0.95 Allowed 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 176.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.634 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 3.8 mm-40 -47.0 -34.11 5.31 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 124.504 1.128 . . . . 0.0 111.997 -173.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.746 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 5.2 m-20 -102.53 -20.83 14.34 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.256 -174.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -60.54 -179.28 0.11 Allowed 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 122.058 0.932 . . . . 0.0 113.035 -173.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.608 ' HB3' ' OE1' ' B' ' 50' ' ' GLU . 14.6 m-20 -61.62 141.77 94.69 Favored Pre-proline 0 N--CA 1.442 -0.847 0 CA-C-N 114.366 -1.288 . . . . 0.0 109.144 174.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -55.33 -22.46 33.51 Favored 'Trans proline' 0 C--O 1.218 -0.512 0 C-N-CA 123.408 2.739 . . . . 0.0 112.757 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.714 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 12.5 pm0 -89.45 -31.24 17.8 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 123.576 0.75 . . . . 0.0 110.648 175.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.714 ' N ' ' HG2' ' B' ' 50' ' ' GLU . 91.7 m -82.82 -37.5 24.36 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.503 -170.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.601 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.7 pt20 -70.3 -29.74 66.55 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 172.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . 0.58 ' HB3' ' HB3' ' B' ' 91' ' ' GLN . 11.3 m -71.24 -19.76 62.33 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 113.749 -1.568 . . . . 0.0 110.248 174.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.684 ' HB2' HD11 ' B' ' 79' ' ' ILE . . . -78.62 -25.37 45.11 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.484 -0.76 . . . . 0.0 109.756 167.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.602 HD11 ' CE2' ' B' ' 14' ' ' TYR . 22.6 mt -89.81 -32.63 5.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -171.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.595 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -39.74 -38.29 0.9 Allowed Pre-proline 0 N--CA 1.491 1.609 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -174.423 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 51.6 Cg_endo -63.51 -29.74 71.01 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.169 1.913 . . . . 0.0 112.704 175.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . 0.561 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.5 mt -98.65 -15.81 19.28 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.646 ' HD3' ' CG2' ' A' ' 5' ' ' THR . 0.1 OUTLIER -51.01 109.57 0.34 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.244 -178.257 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.42 ' HA3' ' C ' ' A' ' 1' ' ' PRO . . . 90.47 -21.13 33.84 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.971 -178.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -103.12 113.19 26.46 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.191 0.52 . . . . 0.0 109.893 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.476 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.3 p -123.71 149.11 58.22 Favored Pre-proline 0 C--N 1.308 -1.208 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.564 172.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.579 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 82.6 Cg_exo -47.56 137.94 19.59 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.066 1.844 . . . . 0.0 110.774 164.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.79 101.86 0.13 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -171.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.79 -9.98 64.21 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.933 -0.576 . . . . 0.0 113.028 176.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.579 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 4.7 m -91.76 -167.73 1.85 Allowed 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 122.357 1.075 . . . . 0.0 112.261 -176.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' ASP . . . . . 0.603 ' OD2' ' HB3' ' B' ' 70' ' ' SER . 0.4 OUTLIER -88.18 126.01 34.91 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 112.971 -1.922 . . . . 0.0 111.216 -175.206 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.542 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.9 OUTLIER -81.76 -33.04 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.505 0 C-N-CA 118.612 -1.235 . . . . 0.0 108.641 173.818 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.788 ' O ' HG13 ' B' ' 73' ' ' VAL . 10.9 mm -56.12 -50.04 72.53 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.366 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.528 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.603 ' HB3' ' OD2' ' B' ' 67' ' ' ASP . 32.6 t -54.79 -28.82 51.89 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.124 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -85.79 -33.3 21.42 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.455 0.645 . . . . 0.0 110.134 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' TYR . . . . . 0.634 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.1 m-30 -75.46 -35.1 60.96 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.48 -177.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.791 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.4 m -70.81 -32.0 47.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 172.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' LYS . . . . . 0.553 ' O ' ' HB3' ' B' ' 77' ' ' ASP . 0.0 OUTLIER -67.75 -30.98 70.59 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.34 175.223 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -63.1 -46.74 85.9 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.975 176.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.824 ' SG ' ' HB ' ' B' ' 79' ' ' ILE . 28.0 t -92.39 9.61 33.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.075 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . 0.553 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 3.1 t70 -58.43 -26.22 63.07 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.072 0.463 . . . . 0.0 110.8 174.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' B' ' 83' ' ' MET . . . -92.24 -23.06 28.0 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.194 173.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.824 ' HB ' ' SG ' ' B' ' 76' ' ' CYS . 77.6 mt -81.32 149.78 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-O 121.047 0.451 . . . . 0.0 110.948 -177.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . 0.605 ' O ' ' HD2' ' B' ' 11' ' ' LYS . . . 140.32 -34.29 2.0 Allowed Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.5 149.32 12.53 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 173.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 65.14 -74.9 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 122.966 0.506 . . . . 0.0 111.7 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' MET . . . . . 0.443 ' HB3' ' SD ' ' B' ' 87' ' ' MET . 59.5 mtt -59.53 -38.92 82.3 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.558 -178.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' HIS . . . . . 0.513 ' HB2' HG23 ' B' ' 79' ' ' ILE . 5.1 t-160 -49.98 -36.69 29.29 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.639 175.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -81.65 -32.37 31.91 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.722 0.296 . . . . 0.0 110.83 -174.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.57 -43.76 46.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.652 0.739 . . . . 0.0 110.625 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . 0.443 ' SD ' ' HB3' ' B' ' 83' ' ' MET . 68.0 mtp -78.6 -12.46 60.02 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.778 -178.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.46 HD12 ' HB2' ' B' ' 92' ' ' LEU . 0.1 OUTLIER -50.62 -55.41 16.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.677 177.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 16.1 tpt -75.92 -15.41 60.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.035 0.445 . . . . 0.0 110.618 -176.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -88.42 -26.53 22.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.79 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' GLN . . . . . 0.58 ' HB3' ' HB3' ' B' ' 53' ' ' SER . 16.5 mt-30 -121.14 -50.03 2.16 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -170.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.46 ' HB2' HD12 ' B' ' 88' ' ' LEU . 0.2 OUTLIER -42.97 -38.18 2.15 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 123.927 0.767 . . . . 0.0 109.337 -177.354 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 . . . . . 0 C--O 1.248 0.992 0 CA-C-N 113.426 -1.716 . . . . 0.0 113.651 -177.736 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.424 ' C ' ' HA3' ' B' ' 60' ' ' GLY . 71.9 Cg_endo . . . . . 0 CA--C 1.517 -0.365 0 N-CA-C 109.219 -1.108 . . . . 0.0 109.219 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.55 ' HB2' HG23 ' A' ' 5' ' ' THR . 42.6 m -69.79 169.37 13.13 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 161.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.825 ' HE1' HD12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -65.55 -53.29 44.14 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 122.391 1.091 . . . . 0.0 109.633 175.496 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.553 ' HB2' HD11 ' A' ' 21' ' ' LEU . 3.2 p-10 -87.57 4.74 42.49 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 113.418 -1.719 . . . . 0.0 113.569 -161.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.675 ' CG2' ' HD3' ' B' ' 59' ' ' LYS . 0.9 OUTLIER -62.63 0.6 0.48 Allowed 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.066 0.46 . . . . 0.0 112.134 -175.322 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.571 ' HB ' ' CZ ' ' A' ' 20' ' ' ARG . 3.0 m -72.05 115.33 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 CA-C-O 121.908 0.861 . . . . 0.0 109.317 168.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.621 ' HG3' ' HB3' ' A' ' 46' ' ' ASN . 1.1 mpp_? -114.23 158.66 21.09 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 121.517 0.675 . . . . 0.0 110.989 177.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.468 ' HG2' ' HB3' ' A' ' 12' ' ' GLU . 2.2 tt0 -59.8 116.04 3.81 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.735 171.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.9 -156.75 26.28 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.378 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.46 ' C ' ' HD3' ' A' ' 11' ' ' LYS . 21.5 m -50.45 99.72 0.02 OUTLIER 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.774 0.287 . . . . 0.0 111.198 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.467 ' HB2' ' HA2' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 35.66 48.89 0.49 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.583 1.153 . . . . 0.0 111.988 -171.629 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.468 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 36.4 tt0 -62.4 136.86 95.96 Favored Pre-proline 0 C--O 1.233 0.227 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.576 178.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.553 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 38.9 Cg_exo -52.15 122.08 10.0 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.043 1.829 . . . . 0.0 109.735 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.886 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 27.4 t80 -72.7 -53.18 5.73 Favored Pre-proline 0 N--CA 1.437 -1.117 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -166.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.527 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 31.7 Cg_exo -55.07 -17.63 15.15 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 121.4 1.4 . . . . 0.0 110.692 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.553 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.0 OUTLIER -90.29 -44.11 9.92 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 113.98 -1.464 . . . . 0.0 111.089 178.178 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.436 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -53.71 -43.36 68.95 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 175.139 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.795 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 2.2 p -82.84 -35.47 12.39 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.325 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.867 -177.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.58 -33.78 70.35 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 121.316 -0.865 . . . . 0.0 111.819 177.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.706 ' O ' HG12 ' A' ' 24' ' ' VAL . 16.3 ptt180 -83.7 -27.54 28.94 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 176.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.558 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 7.4 tp -55.87 -47.57 77.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.605 -1.18 . . . . 0.0 108.87 171.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.795 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 25.4 mt-30 -70.13 -46.85 63.93 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.179 176.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.719 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 16.8 t70 -47.12 -54.33 10.76 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 124.289 0.993 . . . . 0.0 111.692 -178.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.706 HG12 ' O ' ' A' ' 20' ' ' ARG . 6.8 p -82.0 -23.54 9.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.197 0.522 . . . . 0.0 109.94 -174.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.801 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -71.32 -18.99 62.37 Favored 'General case' 0 C--O 1.204 -1.295 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 173.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.41 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -87.23 -38.88 15.94 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.955 177.559 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.719 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.4 mmtt -67.02 -39.46 87.05 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.752 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.6 m -98.01 -10.52 24.27 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.027 0.441 . . . . 0.0 110.63 -172.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.801 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 79.5 mt -116.11 129.91 71.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.795 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.01 -5.83 49.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.526 0.679 . . . . 0.0 110.136 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.601 ' H ' HG22 ' A' ' 29' ' ' ILE . 2.3 m-20 -102.51 107.33 18.25 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.067 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -53.6 -29.24 36.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.775 0.322 . . . . 0.0 110.446 175.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.552 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -68.36 -52.81 29.13 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.478 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.597 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -66.76 -23.57 66.1 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.246 178.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.836 ' O ' HG13 ' A' ' 39' ' ' VAL . 2.1 tmm_? -68.77 -58.55 4.04 Favored 'General case' 0 C--O 1.219 -0.503 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -53.38 -60.54 3.16 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.81 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 21.0 m -52.31 -34.57 18.58 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.952 -171.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.825 HD12 ' HE1' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -84.8 -33.85 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -177.218 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.836 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.7 m -72.36 -47.4 52.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 119.65 -0.82 . . . . 0.0 108.999 177.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.655 ' HG2' HG22 ' A' ' 68' ' ' VAL . 65.8 mt-10 -60.28 -26.07 66.2 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.971 0.908 . . . . 0.0 111.457 172.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.81 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -81.8 -61.68 1.85 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 178.654 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.598 ' HE3' ' HG ' ' B' ' 41' ' ' LEU . 20.1 mmt -62.79 -20.56 65.13 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.484 -177.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.728 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -49.29 -25.38 2.34 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.394 169.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.493 ' CD1' ' HB2' ' A' ' 52' ' ' GLN . 16.1 t80 -108.31 -66.44 1.04 Allowed 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 175.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.5 ' CG ' HD12 ' A' ' 41' ' ' LEU . 8.4 mm-40 -48.25 -32.47 7.28 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 123.799 0.687 . . . . 0.0 112.492 -175.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.621 ' HB3' ' HG3' ' A' ' 7' ' ' ARG . 4.9 m-20 -106.33 -11.5 15.97 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.534 0.683 . . . . 0.0 111.226 -176.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.728 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -62.53 168.53 3.59 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.496 0.665 . . . . 0.0 110.768 177.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.565 ' HB3' ' OE1' ' A' ' 50' ' ' GLU . 8.9 m-20 -57.38 144.45 71.17 Favored Pre-proline 0 C--N 1.31 -1.144 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.482 175.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.46 -19.29 28.48 Favored 'Trans proline' 0 C--O 1.219 -0.434 0 C-N-CA 122.92 2.413 . . . . 0.0 112.055 -179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.693 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 10.1 pm0 -90.87 -32.34 16.08 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.214 0.606 . . . . 0.0 110.531 174.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.935 ' SG ' ' HB2' ' A' ' 76' ' ' CYS . 37.3 t -85.1 -37.28 20.45 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.873 -171.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.549 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.5 pt20 -67.18 -26.72 66.78 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 172.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.671 ' HB3' ' C ' ' A' ' 91' ' ' GLN . 9.3 m -72.47 -22.55 61.06 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 113.141 -1.845 . . . . 0.0 110.916 174.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.65 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -78.37 -23.75 46.74 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.411 0.624 . . . . 0.0 109.527 168.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.549 HD12 ' HA ' ' A' ' 52' ' ' GLN . 24.7 mt -91.24 -33.22 5.6 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.151 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -172.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.616 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.57 -39.87 2.71 Favored Pre-proline 0 N--CA 1.493 1.688 0 CA-C-N 119.909 1.232 . . . . 0.0 113.757 -175.389 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 51.2 Cg_endo -62.6 -25.32 75.41 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 122.328 2.018 . . . . 0.0 113.045 175.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.528 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.1 mt -104.02 -15.86 15.47 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.652 ' HD3' ' CG2' ' B' ' 5' ' ' THR . 0.1 OUTLIER -50.47 109.09 0.27 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.192 -179.099 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.405 ' HA3' ' C ' ' B' ' 1' ' ' PRO . . . 89.69 -19.01 43.43 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.31 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.0 mmmt -103.7 114.65 29.07 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.162 0.506 . . . . 0.0 110.167 -178.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.463 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.6 p -123.38 143.97 42.69 Favored Pre-proline 0 C--N 1.312 -1.03 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.113 173.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.53 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 86.1 Cg_exo -50.18 140.02 34.07 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.538 2.158 . . . . 0.0 111.669 168.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.04 101.92 0.32 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.044 0.449 . . . . 0.0 111.724 -175.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.26 -17.01 41.26 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.668 178.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.53 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 14.0 m -88.71 172.7 9.05 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.902 0.382 . . . . 0.0 111.18 -178.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.28 142.36 28.59 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 176.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.655 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -78.63 -28.51 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 C-N-CA 118.934 -1.106 . . . . 0.0 108.622 178.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.757 ' O ' HG13 ' A' ' 73' ' ' VAL . 6.8 mm -60.4 -45.95 95.9 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.133 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.277 -178.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 41.7 t -48.24 -36.18 13.44 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.143 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 74' ' ' LYS . 2.0 mm-40 -86.27 -31.53 21.59 Favored 'General case' 0 C--O 1.216 -0.672 0 C-N-CA 123.31 0.644 . . . . 0.0 111.074 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.532 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.0 m-30 -76.27 -33.79 59.14 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.626 0.727 . . . . 0.0 109.285 -177.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.886 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 2.1 m -73.01 -32.63 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 173.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 70' ' ' SER . 1.8 ttmm -66.45 -30.71 71.12 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.13 -1.395 . . . . 0.0 110.0 175.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -62.52 -45.44 92.95 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.784 175.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.935 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 42.2 t -93.34 9.17 37.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.044 177.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.484 ' HB2' ' HA ' ' A' ' 74' ' ' LYS . 21.8 t70 -65.03 -17.17 64.22 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.442 0.639 . . . . 0.0 109.699 173.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -108.51 4.32 32.86 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.366 -0.833 . . . . 0.0 112.422 172.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.755 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 94.6 mt -106.89 128.7 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 121.492 0.663 . . . . 0.0 111.797 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.562 ' H ' ' HB2' ' A' ' 84' ' ' HIS . . . 176.12 -49.13 0.12 Allowed Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 171.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.48 156.48 27.01 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 62.9 -80.15 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.912 0.419 . . . . 0.0 111.341 -177.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 80.9 mtp -60.8 -38.13 84.32 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-O 120.722 0.296 . . . . 0.0 110.46 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.562 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 5.4 t-160 -49.49 -45.89 47.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.676 174.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.46 ' HA ' ' HB2' ' A' ' 88' ' ' LEU . 78.6 mttt -87.33 -14.78 39.84 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -174.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.43 -38.3 26.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.015 0.912 . . . . 0.0 109.662 171.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 3.2 mmt -85.94 -11.07 54.07 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.437 -178.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.655 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 0.1 OUTLIER -56.29 -30.75 62.91 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.228 -179.614 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.5 tmm? -83.8 -42.21 16.72 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.213 0.53 . . . . 0.0 109.811 174.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.36 -60.3 3.34 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.47 -173.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.671 ' C ' ' HB3' ' A' ' 53' ' ' SER . 7.2 mt-30 -84.48 -41.91 16.11 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 118.506 -0.759 . . . . 0.0 111.988 -169.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.655 ' HB2' ' O ' ' A' ' 88' ' ' LEU . 1.2 tt -37.17 -38.75 0.22 Allowed 'General case' 0 C--N 1.349 0.573 0 O-C-N 124.908 1.38 . . . . 0.0 109.313 -174.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 92' ' ' LEU . 12.3 mt-10 . . . . . 0 C--O 1.25 1.121 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.996 170.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' PRO . . . . . 0.405 ' C ' ' HA3' ' A' ' 60' ' ' GLY . 72.0 Cg_endo . . . . . 0 CA--C 1.515 -0.43 0 N-CA-C 109.148 -1.135 . . . . 0.0 109.148 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.57 ' HB2' HG23 ' B' ' 5' ' ' THR . 43.0 m -69.79 169.71 12.47 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 161.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.863 ' HE1' HD12 ' B' ' 38' ' ' ILE . 0.0 OUTLIER -65.65 -53.11 45.88 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 122.351 1.072 . . . . 0.0 109.683 175.316 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.55 ' HB2' HD11 ' B' ' 21' ' ' LEU . 3.2 p-10 -87.75 4.9 42.49 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.51 -1.677 . . . . 0.0 113.58 -161.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.652 ' CG2' ' HD3' ' A' ' 59' ' ' LYS . 0.9 OUTLIER -62.9 0.71 0.5 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.123 0.487 . . . . 0.0 112.036 -175.165 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.566 ' HB ' ' CZ ' ' B' ' 20' ' ' ARG . 3.0 m -72.18 115.06 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 CA-C-O 121.904 0.859 . . . . 0.0 109.284 168.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.608 ' HG3' ' CB ' ' B' ' 46' ' ' ASN . 1.1 mpp_? -114.0 158.52 21.06 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 121.593 0.711 . . . . 0.0 110.949 177.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' GLN . . . . . 0.462 ' HG2' ' HB3' ' B' ' 12' ' ' GLU . 2.2 tt0 -59.64 116.1 3.79 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.702 171.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.99 -156.95 26.88 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.483 174.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . 0.477 ' C ' ' HD3' ' B' ' 11' ' ' LYS . 23.4 m -50.29 100.05 0.02 OUTLIER 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.71 0.255 . . . . 0.0 111.086 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.477 ' HD3' ' C ' ' B' ' 10' ' ' SER . 0.0 OUTLIER 35.17 49.57 0.45 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.545 1.138 . . . . 0.0 111.865 -171.59 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.462 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 36.1 tt0 -62.78 136.87 96.55 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.555 177.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . 0.551 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 37.8 Cg_exo -52.09 121.99 9.8 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 121.991 1.794 . . . . 0.0 109.703 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . 0.893 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 27.4 t80 -72.64 -53.32 5.75 Favored Pre-proline 0 N--CA 1.437 -1.105 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -166.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.534 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 31.8 Cg_exo -54.97 -17.84 15.23 Favored 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 121.382 1.388 . . . . 0.0 110.573 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.551 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 0.9 OUTLIER -90.2 -43.74 10.22 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.111 -1.404 . . . . 0.0 111.196 178.146 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' PHE . . . . . 0.429 ' CD2' ' N ' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -53.93 -43.41 69.76 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 175.069 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.791 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 2.2 p -82.68 -35.61 12.68 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.378 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.761 -177.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.46 -33.76 70.1 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 121.308 -0.87 . . . . 0.0 111.871 177.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.692 ' O ' HG12 ' B' ' 24' ' ' VAL . 16.4 ptt180 -83.73 -27.52 28.9 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 176.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.573 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 7.4 tp -56.0 -47.24 78.13 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.882 171.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . 0.791 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 25.6 mt-30 -70.49 -46.87 62.91 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.163 176.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.736 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 17.2 t70 -47.09 -54.29 10.77 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 124.304 1.002 . . . . 0.0 111.761 -178.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' VAL . . . . . 0.692 HG12 ' O ' ' B' ' 20' ' ' ARG . 6.8 p -82.1 -23.3 9.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.157 0.503 . . . . 0.0 109.869 -174.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.791 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -71.44 -18.91 62.3 Favored 'General case' 0 C--O 1.205 -1.284 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . 0.407 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -87.18 -39.03 15.85 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.015 177.497 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.736 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.3 mmtt -66.85 -39.44 87.58 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.736 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 58.3 m -98.02 -10.48 24.33 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.106 0.479 . . . . 0.0 110.517 -172.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.791 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 79.5 mt -116.24 130.49 70.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.775 -178.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.95 -5.08 48.56 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.637 0.732 . . . . 0.0 110.014 176.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.594 ' H ' HG22 ' B' ' 29' ' ' ILE . 2.4 m-20 -102.64 106.95 17.71 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.253 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -53.42 -29.1 33.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.68 0.276 . . . . 0.0 110.449 175.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.562 ' O ' HG13 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -68.39 -52.81 28.91 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.447 -179.569 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.596 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -66.77 -23.59 66.1 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.248 178.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.865 ' O ' HG13 ' B' ' 39' ' ' VAL . 2.1 tmm_? -68.78 -58.42 4.22 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 29.7 mtpt -53.55 -60.39 3.37 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.879 177.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.812 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 20.9 m -52.42 -34.38 18.72 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 O-C-N 124.324 1.015 . . . . 0.0 110.978 -171.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.863 HD12 ' HE1' ' B' ' 3' ' ' PHE . 0.0 OUTLIER -84.78 -34.08 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -177.309 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.865 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.7 m -72.2 -47.5 53.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.012 177.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.642 ' HG2' HG22 ' B' ' 68' ' ' VAL . 66.2 mt-10 -60.33 -25.9 66.15 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.907 0.883 . . . . 0.0 111.472 172.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.812 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -82.03 -61.59 1.87 Allowed 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.992 178.734 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' MET . . . . . 0.537 ' HE3' ' HG ' ' A' ' 41' ' ' LEU . 20.1 mmt -62.83 -20.56 65.18 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.482 -177.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.71 ' O ' ' HB2' ' B' ' 47' ' ' ALA . . . -49.31 -25.4 2.38 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.406 169.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' TYR . . . . . 0.498 ' CD1' ' HB2' ' B' ' 52' ' ' GLN . 16.1 t80 -108.22 -66.44 1.04 Allowed 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 175.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.498 ' CG ' HD12 ' B' ' 41' ' ' LEU . 8.6 mm-40 -48.26 -32.83 7.78 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 123.856 0.723 . . . . 0.0 112.381 -175.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.608 ' CB ' ' HG3' ' B' ' 7' ' ' ARG . 4.9 m-20 -105.93 -11.46 16.18 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.472 0.653 . . . . 0.0 111.284 -176.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.71 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -62.57 168.6 3.56 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.391 0.615 . . . . 0.0 110.779 177.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.55 ' HB3' ' OE1' ' B' ' 50' ' ' GLU . 8.5 m-20 -57.39 144.47 71.17 Favored Pre-proline 0 C--N 1.31 -1.139 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.466 175.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -56.62 -19.2 29.06 Favored 'Trans proline' 0 C--O 1.218 -0.48 0 C-N-CA 122.963 2.442 . . . . 0.0 112.029 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.697 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 10.1 pm0 -90.83 -32.29 16.13 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 123.205 0.602 . . . . 0.0 110.644 174.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.94 ' SG ' ' HB2' ' B' ' 76' ' ' CYS . 37.5 t -85.16 -37.4 20.23 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.885 -171.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.534 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.5 pt20 -66.95 -26.71 66.97 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 172.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . 0.658 ' HB3' ' C ' ' B' ' 91' ' ' GLN . 8.9 m -72.61 -22.53 60.95 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 113.247 -1.797 . . . . 0.0 110.902 174.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.666 ' HB2' HD11 ' B' ' 79' ' ' ILE . . . -78.22 -23.81 47.31 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.493 0.663 . . . . 0.0 109.586 168.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.534 HD12 ' HA ' ' B' ' 52' ' ' GLN . 25.0 mt -91.09 -33.37 5.73 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.137 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -172.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.615 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.5 -39.76 2.56 Favored Pre-proline 0 N--CA 1.492 1.649 0 CA-C-N 119.925 1.239 . . . . 0.0 113.749 -175.34 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 51.0 Cg_endo -62.71 -25.32 74.98 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.245 1.964 . . . . 0.0 113.002 175.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . 0.541 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.2 mt -104.02 -15.81 15.49 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.675 ' HD3' ' CG2' ' A' ' 5' ' ' THR . 0.1 OUTLIER -50.46 109.12 0.27 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.702 -1.135 . . . . 0.0 111.281 -179.207 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.424 ' HA3' ' C ' ' A' ' 1' ' ' PRO . . . 89.99 -19.7 40.58 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.276 -178.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -103.21 114.81 29.4 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.099 0.476 . . . . 0.0 110.027 -178.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.465 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.8 p -123.25 144.35 43.43 Favored Pre-proline 0 C--N 1.31 -1.125 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.94 172.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.549 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 86.7 Cg_exo -50.67 140.27 37.34 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.521 2.148 . . . . 0.0 111.667 168.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.03 102.0 0.33 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.708 -175.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.02 -16.84 42.31 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.644 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.549 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 15.9 m -88.65 173.2 8.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.053 0.454 . . . . 0.0 111.15 -178.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' ASP . . . . . 0.43 ' OD1' ' HB ' ' B' ' 69' ' ' ILE . 0.8 OUTLIER -86.63 142.14 28.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.066 176.735 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.642 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.8 OUTLIER -78.48 -28.28 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 C-N-CA 119.006 -1.078 . . . . 0.0 108.568 179.08 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.756 ' O ' HG13 ' B' ' 73' ' ' VAL . 6.8 mm -60.44 -45.81 96.2 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.084 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.391 -178.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.501 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 43.2 t -48.54 -36.16 14.82 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.077 176.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' B' ' 74' ' ' LYS . 2.3 mm-40 -86.28 -31.38 21.65 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 123.211 0.604 . . . . 0.0 110.998 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' TYR . . . . . 0.541 ' CE1' ' HB2' ' B' ' 58' ' ' LEU . 5.0 m-30 -76.23 -34.13 59.21 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.654 0.74 . . . . 0.0 109.298 -177.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.893 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 2.1 m -72.67 -33.1 43.47 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 173.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' LYS . . . . . 0.501 ' HB2' ' O ' ' B' ' 70' ' ' SER . 1.8 ttmm -65.87 -30.89 71.57 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.052 175.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -62.36 -45.52 92.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.754 175.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.94 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 41.9 t -93.5 9.14 37.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.089 177.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . 0.488 ' HB2' ' HA ' ' B' ' 74' ' ' LYS . 19.9 t70 -65.27 -17.09 64.22 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.388 0.613 . . . . 0.0 109.515 174.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -109.12 5.4 31.98 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.409 172.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.743 ' HB ' ' SG ' ' B' ' 76' ' ' CYS . 94.3 mt -107.69 128.78 62.61 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 CA-C-N 117.348 0.574 . . . . 0.0 111.836 178.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . 0.566 ' H ' ' HB2' ' B' ' 84' ' ' HIS . . . 176.1 -48.38 0.12 Allowed Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 171.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -156.89 155.13 26.11 Favored Glycine 0 C--N 1.318 -0.452 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.99 -80.58 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 122.617 0.367 . . . . 0.0 111.204 -176.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' MET . . . . . . . . . . . . . 81.7 mtp -60.73 -38.17 84.23 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-O 120.775 0.321 . . . . 0.0 110.465 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' HIS . . . . . 0.566 ' HB2' ' H ' ' B' ' 80' ' ' GLY . 5.5 t-160 -49.42 -45.94 46.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.722 173.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.456 ' HA ' ' HB2' ' B' ' 88' ' ' LEU . 78.5 mttt -87.23 -14.93 39.65 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -174.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.52 -37.93 27.05 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 122.002 0.906 . . . . 0.0 109.807 171.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 3.2 mmt -86.06 -10.99 53.99 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.215 -1.357 . . . . 0.0 111.459 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.646 ' O ' ' HB2' ' B' ' 92' ' ' LEU . 0.1 OUTLIER -56.44 -30.71 63.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.147 -179.605 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 15.5 tmm? -83.75 -42.24 16.76 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.167 0.508 . . . . 0.0 109.754 174.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.21 -60.52 3.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.471 -173.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' GLN . . . . . 0.658 ' C ' ' HB3' ' B' ' 53' ' ' SER . 7.1 mt-30 -84.22 -42.12 16.24 Favored 'General case' 0 CA--C 1.491 -1.31 0 CA-C-O 118.557 -0.735 . . . . 0.0 111.899 -169.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.646 ' HB2' ' O ' ' B' ' 88' ' ' LEU . 1.2 tt -37.02 -38.97 0.21 Allowed 'General case' 0 C--N 1.349 0.563 0 O-C-N 124.859 1.35 . . . . 0.0 109.216 -174.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' B' ' 92' ' ' LEU . 12.2 mt-10 . . . . . 0 C--O 1.25 1.118 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.074 170.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.44 ' HB2' ' H ' ' A' ' 2' ' ' SER . 92.3 Cg_endo . . . . . 0 CA--C 1.517 -0.326 0 N-CA-C 109.005 -1.19 . . . . 0.0 109.005 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.756 ' HB2' HG23 ' A' ' 5' ' ' THR . 70.7 m -72.13 178.9 3.56 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 162.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.773 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -76.13 -52.45 10.09 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.8 0.809 . . . . 0.0 110.125 174.445 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.503 ' OD1' ' HG ' ' B' ' 41' ' ' LEU . 2.5 p-10 -87.61 2.93 49.57 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.403 -163.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.756 HG23 ' HB2' ' A' ' 2' ' ' SER . 3.1 p -63.51 -3.12 1.9 Allowed 'General case' 0 C--N 1.311 -1.078 0 O-C-N 122.059 -0.4 . . . . 0.0 111.832 -175.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.555 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 3.3 m -76.49 119.03 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-O 121.677 0.751 . . . . 0.0 109.924 176.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.767 ' HB3' ' O ' ' A' ' 46' ' ' ASN . 32.2 mtm180 -137.58 147.2 44.87 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -170.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.6 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.6 mt-30 -42.02 120.66 1.62 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 112.633 -2.076 . . . . 0.0 113.745 177.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.53 -159.04 35.01 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 169.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.8 t -48.44 101.46 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 117.086 0.443 . . . . 0.0 111.231 -178.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.4 pttt 37.71 42.1 0.37 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.251 1.02 . . . . 0.0 112.084 -173.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.479 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 39.5 tt0 -57.16 137.5 80.54 Favored Pre-proline 0 C--O 1.233 0.226 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.602 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 52.1 Cg_exo -49.31 121.22 6.66 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.056 1.837 . . . . 0.0 109.947 -178.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.834 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 11.3 t80 -71.89 -52.85 7.44 Favored Pre-proline 0 N--CA 1.438 -1.047 0 CA-C-O 118.512 -0.756 . . . . 0.0 113.028 -166.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.538 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 36.4 Cg_exo -55.79 -18.39 21.27 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 121.346 1.364 . . . . 0.0 110.728 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.602 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 0.9 OUTLIER -90.34 -42.35 10.99 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.317 179.66 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.6 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -54.82 -43.64 73.16 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 175.647 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.686 HG12 ' O ' ' A' ' 14' ' ' TYR . 2.7 p -82.78 -32.35 9.89 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.941 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.845 -177.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.99 -35.46 73.25 Favored 'General case' 0 C--N 1.317 -0.84 0 O-C-N 121.285 -0.885 . . . . 0.0 111.839 175.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.709 ' O ' HG12 ' A' ' 24' ' ' VAL . 16.7 ptt180 -81.9 -27.26 33.51 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 176.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.588 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 6.7 tp -57.1 -48.14 79.33 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.215 172.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.679 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 40.7 mt-30 -70.91 -44.66 65.77 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.191 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.762 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -48.89 -64.06 0.91 Allowed 'General case' 0 C--N 1.314 -0.961 0 O-C-N 124.426 1.079 . . . . 0.0 110.206 -178.622 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.709 HG12 ' O ' ' A' ' 20' ' ' ARG . 4.2 p -74.0 -20.34 17.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -171.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.622 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -64.33 -35.82 82.11 Favored 'General case' 0 C--O 1.206 -1.195 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 172.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.405 ' HB3' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -75.1 -34.99 61.79 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 113.631 -1.622 . . . . 0.0 109.896 -176.641 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.762 ' HD2' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -65.04 -44.81 87.87 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 121.972 0.891 . . . . 0.0 112.0 177.09 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.456 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 24.7 m -95.97 -9.17 31.8 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.515 -168.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.626 HG22 ' H ' ' A' ' 31' ' ' ASP . 84.8 mt -116.91 128.27 74.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.919 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.11 -2.2 56.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.42 0.628 . . . . 0.0 110.141 175.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.626 ' H ' HG22 ' A' ' 29' ' ' ILE . 2.7 m-20 -106.92 104.16 13.77 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.105 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -53.36 -27.59 24.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.664 0.268 . . . . 0.0 110.466 176.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.569 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -67.93 -54.38 19.14 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.675 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.644 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -65.28 -22.7 66.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.44 178.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.886 ' O ' HG13 ' A' ' 39' ' ' VAL . 5.3 tmm_? -69.82 -55.81 8.79 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.491 ' O ' HG22 ' A' ' 39' ' ' VAL . 21.7 mtpt -56.97 -57.55 12.03 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.98 177.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.728 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 19.8 m -54.48 -34.2 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.736 -169.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.773 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.5 tt -86.97 -28.84 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 119.649 -0.821 . . . . 0.0 111.568 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.886 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.7 m -69.61 -49.07 61.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 119.031 -1.067 . . . . 0.0 109.508 173.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.622 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 60.4 mt-10 -61.81 -28.34 69.4 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 123.556 0.742 . . . . 0.0 112.233 176.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.728 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -85.58 -52.55 5.74 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.72 178.574 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.666 ' HE2' ' HE2' ' B' ' 42' ' ' MET . 19.6 mmt -65.57 -20.72 66.44 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.667 0.746 . . . . 0.0 109.602 -177.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.687 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -50.46 -28.11 7.74 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.463 170.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.524 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 23.1 t80 -105.15 -68.4 0.86 Allowed 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 175.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.469 ' CG ' HD12 ' A' ' 41' ' ' LEU . 10.9 mm-40 -48.88 -29.82 5.12 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.829 -176.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.767 ' O ' ' HB3' ' A' ' 7' ' ' ARG . 4.2 m-20 -106.53 -16.12 14.61 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 120.718 0.295 . . . . 0.0 111.659 -176.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -65.45 179.25 0.81 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.588 0.708 . . . . 0.0 111.539 -177.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.748 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 24.2 m-20 -58.63 145.67 76.47 Favored Pre-proline 0 C--N 1.31 -1.148 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.21 171.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.795 ' O ' ' HB3' ' A' ' 53' ' ' SER . 11.1 Cg_endo -55.53 -28.96 67.29 Favored 'Trans proline' 0 C--N 1.331 -0.345 0 C-N-CA 122.987 2.458 . . . . 0.0 111.897 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.672 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 8.4 pm0 -87.4 -26.57 23.24 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.398 1.079 . . . . 0.0 111.066 175.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.748 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 86.8 m -80.21 -38.24 31.56 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -177.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.523 ' HB2' ' CD1' ' A' ' 44' ' ' TYR . 4.1 pt20 -73.17 -27.35 61.6 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 172.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.814 ' OG ' ' HB2' ' A' ' 91' ' ' GLN . 0.9 OUTLIER -67.91 -23.73 65.13 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.437 174.33 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.675 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -83.83 -23.47 31.36 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.862 172.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.54 HD11 ' CE2' ' A' ' 14' ' ' TYR . 22.7 mt -90.83 -32.56 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -173.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.655 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -45.92 -34.11 2.67 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -175.06 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.655 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 37.4 Cg_endo -60.61 -29.89 89.4 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.323 2.015 . . . . 0.0 112.946 172.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.552 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.1 mt -102.05 -15.34 16.79 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -178.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.589 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -52.84 109.83 0.45 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.899 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.09 -23.81 31.59 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.407 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.0 mmmt -103.38 111.94 24.6 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.373 0.606 . . . . 0.0 109.914 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.427 HG23 ' HD2' ' A' ' 63' ' ' PRO . 7.4 p -123.81 146.22 49.97 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 170.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.567 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 92.0 Cg_exo -47.29 141.81 13.17 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.194 1.929 . . . . 0.0 111.245 168.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.82 98.58 0.07 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.976 0.417 . . . . 0.0 111.849 -173.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.57 -7.51 57.93 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.072 176.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.567 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 10.6 m -91.59 -177.81 4.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.656 0.741 . . . . 0.0 111.905 -177.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.706 ' OD1' ' HB ' ' A' ' 69' ' ' ILE . 26.7 t70 -84.51 133.59 34.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.913 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.605 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -81.44 -30.09 10.87 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 C-N-CA 119.035 -1.066 . . . . 0.0 109.089 176.447 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.76 ' O ' HG13 ' A' ' 73' ' ' VAL . 8.5 mm -58.09 -47.37 87.13 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.168 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.825 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 43.6 t -45.58 -37.54 5.62 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.394 175.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -85.36 -32.83 22.21 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.262 0.553 . . . . 0.0 110.629 -178.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.614 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.0 m-30 -76.06 -34.42 59.6 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.488 -175.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.834 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.6 m -72.57 -31.87 39.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.533 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -66.25 -31.65 72.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.075 175.46 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -62.93 -47.53 82.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.447 176.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.704 ' SG ' ' HB ' ' A' ' 79' ' ' ILE . 14.4 t -91.07 5.43 48.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.469 0.652 . . . . 0.0 111.059 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.533 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 9.6 t70 -60.27 -16.47 34.38 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.318 175.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -120.32 21.58 8.66 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.921 174.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.704 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 41.4 mt -101.94 -11.54 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 117.667 0.733 . . . . 0.0 112.974 177.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.4 14.31 1.83 Allowed Glycine 0 CA--C 1.532 1.132 0 C-N-CA 120.353 -0.927 . . . . 0.0 115.377 -168.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.82 72.93 0.11 Allowed Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.114 -1.041 . . . . 0.0 114.423 168.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -177.92 -91.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 122.981 0.512 . . . . 0.0 110.118 174.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 65.1 mtm -65.96 -17.64 64.81 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 121.006 0.431 . . . . 0.0 110.082 177.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.517 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 6.5 t-160 -49.57 -34.63 18.19 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.474 174.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -83.22 -22.48 33.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.816 0.341 . . . . 0.0 110.908 -176.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.8 -40.57 15.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.706 0.765 . . . . 0.0 110.358 176.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.456 ' HB3' ' NE2' ' A' ' 91' ' ' GLN . 81.9 mtp -85.27 -13.73 48.87 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.562 -175.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.566 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 0.1 OUTLIER -50.48 -58.79 4.93 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.444 0.465 . . . . 0.0 110.289 179.305 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 52.9 ttm -71.72 -23.07 61.56 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.258 -173.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -88.06 -8.54 55.39 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -170.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.814 ' HB2' ' OG ' ' A' ' 53' ' ' SER . 4.2 mt-30 -132.67 -37.05 1.05 Allowed 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.886 -0.725 . . . . 0.0 111.145 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.566 ' HB2' ' O ' ' A' ' 88' ' ' LEU . 0.2 OUTLIER -50.4 -34.3 23.85 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 171.658 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 93' ' ' GLU . 6.4 pt-20 . . . . . 0 C--O 1.251 1.166 0 CA-C-N 112.632 -2.076 . . . . 0.0 113.597 -173.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' PRO . . . . . 0.41 ' HB2' ' H ' ' B' ' 2' ' ' SER . 90.1 Cg_endo . . . . . 0 CA--C 1.515 -0.426 0 N-CA-C 108.937 -1.217 . . . . 0.0 108.937 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.752 ' HB2' HG23 ' B' ' 5' ' ' THR . 71.2 m -71.52 178.72 3.34 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 162.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.752 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -76.13 -52.43 10.12 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.857 0.837 . . . . 0.0 110.079 174.444 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.483 ' OD1' ' HG ' ' A' ' 41' ' ' LEU . 2.5 p-10 -87.42 2.64 49.89 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.646 -1.161 . . . . 0.0 113.364 -163.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.752 HG23 ' HB2' ' B' ' 2' ' ' SER . 3.6 p -63.31 -3.06 1.69 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 118.057 0.389 . . . . 0.0 111.779 -175.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.561 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 3.3 m -76.48 118.96 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-O 121.678 0.751 . . . . 0.0 110.008 176.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.76 ' HB3' ' O ' ' B' ' 46' ' ' ASN . 32.1 mtm180 -137.32 147.58 45.71 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -170.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' GLN . . . . . 0.601 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.6 mt-30 -42.62 121.1 1.89 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 112.616 -2.084 . . . . 0.0 113.494 177.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.67 -158.39 34.29 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 169.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 22.9 t -49.24 101.58 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 117.115 0.457 . . . . 0.0 110.988 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 49.1 pttt 37.56 42.3 0.35 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.419 1.088 . . . . 0.0 112.109 -173.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.505 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 38.1 tt0 -57.2 137.36 80.75 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . 0.594 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 52.1 Cg_exo -49.07 121.09 6.27 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.134 1.889 . . . . 0.0 109.992 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . 0.84 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 11.3 t80 -72.09 -52.66 7.24 Favored Pre-proline 0 N--CA 1.437 -1.1 0 CA-C-O 118.507 -0.758 . . . . 0.0 112.891 -166.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.541 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 36.0 Cg_exo -55.9 -18.37 21.79 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 121.42 1.413 . . . . 0.0 110.764 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.594 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 0.9 OUTLIER -90.61 -41.84 11.11 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.035 -1.439 . . . . 0.0 111.367 179.708 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' PHE . . . . . 0.601 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -55.34 -43.52 75.08 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 175.581 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.702 HG12 ' O ' ' B' ' 14' ' ' TYR . 2.7 p -82.89 -32.27 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.907 -177.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.42 -34.75 72.87 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 121.303 -0.873 . . . . 0.0 111.861 175.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.704 ' O ' HG12 ' B' ' 24' ' ' VAL . 16.7 ptt180 -82.09 -27.43 32.89 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 176.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.599 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 6.7 tp -57.03 -48.38 78.65 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.208 173.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . 0.693 ' HA ' ' CG1' ' B' ' 39' ' ' VAL . 40.7 mt-30 -70.79 -44.68 66.13 Favored 'General case' 0 CA--C 1.488 -1.435 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.089 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.751 ' O ' ' HD2' ' B' ' 27' ' ' LYS . 0.9 OUTLIER -48.8 -64.19 0.87 Allowed 'General case' 0 C--N 1.314 -0.943 0 O-C-N 124.39 1.056 . . . . 0.0 110.325 -178.7 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' VAL . . . . . 0.704 HG12 ' O ' ' B' ' 20' ' ' ARG . 4.1 p -73.82 -20.42 17.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -171.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.609 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -64.15 -36.0 82.62 Favored 'General case' 0 C--O 1.208 -1.12 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 172.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . 0.417 ' HB3' ' O ' ' B' ' 23' ' ' ASP . 0.0 OUTLIER -74.9 -35.18 62.25 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 113.62 -1.627 . . . . 0.0 109.903 -176.608 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.751 ' HD2' ' O ' ' B' ' 23' ' ' ASP . 0.0 OUTLIER -64.85 -45.03 87.81 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.898 177.177 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . 0.444 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 26.4 m -96.15 -8.68 32.55 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.602 -168.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.609 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 84.6 mt -116.94 128.68 74.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.837 -178.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.69 -1.87 56.51 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.499 0.666 . . . . 0.0 110.128 175.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.603 ' H ' HG22 ' B' ' 29' ' ' ILE . 2.8 m-20 -106.91 104.58 14.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.092 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -53.91 -27.36 30.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.715 0.293 . . . . 0.0 110.396 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.58 ' O ' HG13 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -67.93 -54.32 19.57 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.707 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.647 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -65.46 -22.71 66.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.385 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.866 ' O ' HG13 ' B' ' 39' ' ' VAL . 5.4 tmm_? -69.69 -55.89 8.72 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.483 ' O ' HG22 ' B' ' 39' ' ' VAL . 21.8 mtpt -56.98 -57.37 12.84 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 120.826 0.346 . . . . 0.0 110.936 177.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.714 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 20.0 m -54.71 -34.13 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.661 -169.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.752 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.4 tt -86.99 -29.11 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.51 -179.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.866 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.7 m -69.31 -49.19 62.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 119.089 -1.045 . . . . 0.0 109.574 173.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.623 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 61.8 mt-10 -61.72 -28.26 69.29 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 123.506 0.722 . . . . 0.0 112.26 176.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.714 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.67 -52.55 5.72 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.713 178.685 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' MET . . . . . 0.666 ' HE2' ' HE2' ' A' ' 42' ' ' MET . 19.5 mmt -65.6 -20.68 66.41 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.574 0.702 . . . . 0.0 109.491 -177.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.679 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -50.53 -28.17 8.03 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.415 170.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' TYR . . . . . 0.537 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 23.0 t80 -105.06 -68.38 0.86 Allowed 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.479 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 11.8 mm-40 -48.85 -29.8 5.06 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.925 -176.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.76 ' O ' ' HB3' ' B' ' 7' ' ' ARG . 4.1 m-20 -106.53 -16.06 14.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 120.702 0.287 . . . . 0.0 111.568 -176.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.637 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -65.29 179.61 0.73 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.819 0.818 . . . . 0.0 111.602 -177.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.74 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 24.7 m-20 -58.99 145.54 79.7 Favored Pre-proline 0 C--N 1.309 -1.169 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.242 171.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . 0.808 ' O ' ' HB3' ' B' ' 53' ' ' SER . 11.1 Cg_endo -55.57 -28.92 67.46 Favored 'Trans proline' 0 C--N 1.332 -0.325 0 C-N-CA 123.026 2.484 . . . . 0.0 111.917 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.669 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 8.4 pm0 -87.26 -26.7 23.34 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.429 1.091 . . . . 0.0 111.133 175.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.74 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 86.2 m -80.18 -38.17 31.82 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -177.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.513 ' HB2' ' CD1' ' B' ' 44' ' ' TYR . 4.0 pt20 -73.14 -27.36 61.63 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 172.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . 0.808 ' HB3' ' O ' ' B' ' 49' ' ' PRO . 0.9 OUTLIER -68.12 -23.5 64.91 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.429 174.54 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.652 ' HB2' HD11 ' B' ' 79' ' ' ILE . . . -84.12 -23.31 30.77 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.863 172.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.544 HD11 ' CE2' ' B' ' 14' ' ' TYR . 22.6 mt -90.79 -32.73 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -174.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.646 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -45.93 -34.06 2.64 Favored Pre-proline 0 N--CA 1.487 1.388 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 -175.02 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 37.3 Cg_endo -60.24 -30.95 92.32 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 122.303 2.002 . . . . 0.0 112.902 172.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . 0.556 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.1 mt -101.17 -15.59 17.31 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -178.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.584 ' HA ' ' OH ' ' B' ' 72' ' ' TYR . 0.0 OUTLIER -52.64 109.8 0.44 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.948 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.16 -23.55 32.87 Favored Glycine 0 N--CA 1.44 -1.05 0 C-N-CA 120.768 -0.73 . . . . 0.0 111.575 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -103.59 111.91 24.59 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.411 0.624 . . . . 0.0 109.927 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.426 HG23 ' HD2' ' B' ' 63' ' ' PRO . 7.5 p -123.91 146.06 49.74 Favored Pre-proline 0 C--N 1.311 -1.104 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 170.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.581 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 91.3 Cg_exo -47.28 141.48 13.56 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.24 1.96 . . . . 0.0 111.248 168.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.53 98.78 0.07 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.024 0.44 . . . . 0.0 111.941 -173.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.71 -7.86 57.85 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.956 176.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.581 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 9.6 m -91.75 -177.61 4.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.383 0.611 . . . . 0.0 111.985 -176.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' ASP . . . . . 0.698 ' OD1' ' HB ' ' B' ' 69' ' ' ILE . 26.9 t70 -84.69 133.42 34.39 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.992 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.615 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.9 OUTLIER -81.3 -30.12 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 C-N-CA 118.891 -1.123 . . . . 0.0 109.119 176.508 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.747 ' O ' HG13 ' B' ' 73' ' ' VAL . 8.5 mm -58.01 -47.31 87.02 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.179 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.814 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 42.7 t -45.84 -37.42 6.16 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.423 175.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -85.4 -32.7 22.23 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.085 0.469 . . . . 0.0 110.649 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' TYR . . . . . 0.61 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.0 m-30 -76.09 -34.49 59.53 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.502 -175.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.84 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.6 m -72.55 -32.03 39.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 173.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' LYS . . . . . 0.521 ' O ' ' HB3' ' B' ' 77' ' ' ASP . 0.0 OUTLIER -66.17 -31.36 72.15 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.029 175.422 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -63.07 -47.77 81.5 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.362 176.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.702 ' SG ' ' HB ' ' B' ' 79' ' ' ILE . 13.7 t -90.89 5.7 47.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.573 0.701 . . . . 0.0 111.179 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . 0.521 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 10.9 t70 -60.51 -16.42 36.99 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.382 175.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -120.57 21.69 8.48 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.96 174.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.702 ' HB ' ' SG ' ' B' ' 76' ' ' CYS . 40.5 mt -101.94 -11.47 8.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 117.695 0.748 . . . . 0.0 112.934 177.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.29 14.16 1.81 Allowed Glycine 0 CA--C 1.533 1.169 0 N-CA-C 115.378 0.911 . . . . 0.0 115.378 -168.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.77 72.65 0.11 Allowed Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.255 -0.974 . . . . 0.0 114.643 168.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -177.57 -91.67 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.047 0.539 . . . . 0.0 110.03 174.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' MET . . . . . . . . . . . . . 64.8 mtm -65.95 -17.51 64.72 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 120.983 0.42 . . . . 0.0 110.096 177.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' HIS . . . . . 0.525 ' O ' ' HB2' ' B' ' 88' ' ' LEU . 6.4 t-160 -49.66 -34.88 19.59 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.32 174.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -82.78 -22.77 34.17 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.852 0.358 . . . . 0.0 110.927 -176.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.54 -40.68 16.04 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.666 0.746 . . . . 0.0 110.33 176.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . 0.474 ' HB3' ' NE2' ' B' ' 91' ' ' GLN . 81.8 mtp -85.22 -13.84 48.66 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.587 -175.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.553 ' O ' ' HB2' ' B' ' 92' ' ' LEU . 0.1 OUTLIER -50.22 -58.85 4.71 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.295 179.327 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 52.8 ttm -71.76 -23.19 61.56 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.158 -172.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -88.05 -8.5 55.47 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -170.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' GLN . . . . . 0.803 ' HB2' ' OG ' ' B' ' 53' ' ' SER . 4.0 mt-30 -132.73 -36.9 1.05 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.121 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.553 ' HB2' ' O ' ' B' ' 88' ' ' LEU . 0.2 OUTLIER -50.76 -33.77 24.54 Favored 'General case' 0 C--N 1.344 0.35 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 171.689 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' B' ' 93' ' ' GLU . 6.5 pt-20 . . . . . 0 C--O 1.248 1.006 0 CA-C-N 112.734 -2.03 . . . . 0.0 113.47 -174.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.402 ' HB2' ' H ' ' A' ' 2' ' ' SER . 92.3 Cg_endo . . . . . 0 CA--C 1.517 -0.357 0 N-CA-C 109.414 -1.033 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.402 ' H ' ' HB2' ' A' ' 1' ' ' PRO . 48.0 m -66.61 169.0 8.34 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 162.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.881 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -72.7 -55.58 6.59 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.847 177.509 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.719 ' CG ' ' HG3' ' A' ' 42' ' ' MET . 11.7 p30 -87.69 -4.75 58.91 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.442 -164.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.402 ' H ' HG22 ' A' ' 5' ' ' THR . 6.7 t -63.15 -1.43 1.0 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.43 0.633 . . . . 0.0 110.945 -173.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.655 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.4 m -74.26 133.55 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 168.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.795 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -155.55 159.8 39.99 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 115.219 1.562 . . . . 0.0 115.219 -175.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.444 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.1 tt0 -40.34 110.52 0.15 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 112.835 -1.984 . . . . 0.0 112.714 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.33 -151.5 11.13 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.558 174.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.4 t -54.38 98.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.757 0.278 . . . . 0.0 110.58 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.9 pttt 40.07 44.3 1.46 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.321 1.048 . . . . 0.0 112.527 -175.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.429 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 67.2 tt0 -60.58 141.17 92.25 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 176.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.517 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 27.2 Cg_exo -55.37 123.36 13.62 Favored 'Trans proline' 0 CA--C 1.512 -0.615 0 C-N-CA 121.939 1.759 . . . . 0.0 109.694 177.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.915 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 7.2 t80 -68.98 -53.95 13.25 Favored Pre-proline 0 N--CA 1.44 -0.969 0 CA-C-O 118.421 -0.799 . . . . 0.0 113.025 -168.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.566 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 37.2 Cg_exo -56.01 -18.15 21.69 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 121.476 1.45 . . . . 0.0 111.197 -178.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.517 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 2.6 m-20 -89.97 -42.83 10.95 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.799 179.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.444 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -55.26 -45.78 76.1 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.332 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.795 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 2.1 p -78.05 -34.49 19.23 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.229 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.142 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.83 -39.36 71.29 Favored 'General case' 0 C--N 1.316 -0.887 0 O-C-N 121.663 -0.648 . . . . 0.0 111.078 176.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.754 ' O ' HG12 ' A' ' 24' ' ' VAL . 14.5 ptt180 -79.84 -27.74 40.17 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.592 ' HB3' ' O ' ' A' ' 18' ' ' VAL . 13.3 tp -54.98 -48.87 72.7 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 114.563 -1.198 . . . . 0.0 109.268 172.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.795 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 28.5 mt-30 -67.75 -55.66 12.24 Favored 'General case' 0 CA--C 1.486 -1.51 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.356 178.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.725 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 82.8 m-20 -45.71 -50.55 13.57 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 124.824 1.327 . . . . 0.0 111.258 -177.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.754 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.1 p -78.89 -26.19 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.834 -174.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.638 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -67.3 -31.45 71.76 Favored 'General case' 0 C--O 1.206 -1.196 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.22 -34.82 63.8 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.114 -1.403 . . . . 0.0 109.525 -178.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.725 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 39.0 mmtt -67.45 -40.33 85.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.823 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.457 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 35.4 m -100.45 -9.9 21.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.241 0.543 . . . . 0.0 110.547 -171.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.692 HG22 ' H ' ' A' ' 31' ' ' ASP . 83.4 mt -111.23 130.15 65.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.522 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.55 -3.07 58.48 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.906 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.692 ' H ' HG22 ' A' ' 29' ' ' ILE . 4.9 t0 -117.81 139.66 50.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.786 0.803 . . . . 0.0 111.918 -177.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -68.76 -31.39 70.4 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.334 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.588 ' O ' HG13 ' A' ' 37' ' ' VAL . 12.0 mttp -68.37 -53.37 24.41 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -176.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.578 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -64.22 -26.06 68.34 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.504 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.842 ' O ' HG13 ' A' ' 39' ' ' VAL . 4.7 tmm_? -68.15 -58.02 5.13 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.488 ' HB3' ' OE1' ' A' ' 40' ' ' GLU . 32.5 mtpt -53.45 -60.19 3.62 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.237 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.702 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 19.8 m -52.12 -33.9 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.374 -170.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.881 HD13 ' HE1' ' A' ' 3' ' ' PHE . 0.7 OUTLIER -88.35 -35.05 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.391 -179.782 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.842 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.9 m -66.18 -46.8 86.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 119.117 -1.033 . . . . 0.0 109.414 177.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.662 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 42.7 mt-10 -61.17 -31.63 71.36 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 123.953 0.901 . . . . 0.0 112.544 176.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.714 ' HG ' HD11 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -83.78 -52.88 6.03 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.378 -179.152 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.719 ' HG3' ' CG ' ' A' ' 4' ' ' ASN . 20.1 mmt -65.71 -20.84 66.43 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.642 0.734 . . . . 0.0 109.632 -176.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.693 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -50.47 -29.01 9.39 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.23 171.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.876 ' CG ' ' HE3' ' A' ' 59' ' ' LYS . 6.2 t80 -103.34 -66.7 0.92 Allowed 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 174.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.592 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 31.4 mm-40 -49.72 -29.76 8.11 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.992 -171.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.795 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.8 m-20 -104.37 -21.44 13.49 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.441 -176.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -61.36 179.75 0.2 Allowed 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.827 0.822 . . . . 0.0 112.923 -174.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.631 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 17.2 m-20 -62.31 141.67 96.22 Favored Pre-proline 0 N--CA 1.444 -0.742 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.587 173.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.426 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 80.0 Cg_exo -41.71 -50.48 4.88 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 123.093 2.529 . . . . 0.0 112.274 -178.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.617 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 0.0 OUTLIER -74.32 -26.54 60.23 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.769 0.828 . . . . 0.0 111.429 -179.268 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.631 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 72.1 m -79.89 -40.19 28.82 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -174.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.723 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.4 pt20 -69.42 -31.13 69.29 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 172.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.826 ' O ' ' HD2' ' A' ' 56' ' ' LYS . 4.2 m -67.71 -27.89 67.2 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 113.996 -1.456 . . . . 0.0 111.305 174.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.776 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -70.96 -23.31 62.2 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 170.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.723 HD12 ' HA ' ' A' ' 52' ' ' GLN . 25.0 mt -89.82 -27.52 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -175.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.826 ' HD2' ' O ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -37.53 -48.53 2.52 Favored Pre-proline 0 N--CA 1.506 2.368 0 CA-C-N 120.628 1.558 . . . . 0.0 112.675 -178.39 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 48.5 Cg_endo -61.45 -24.89 79.06 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.826 2.351 . . . . 0.0 112.796 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.527 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.6 mt -104.86 -15.45 15.17 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.876 ' HE3' ' CG ' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -50.7 109.96 0.37 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.812 -179.072 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.28 -19.23 44.48 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.075 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.9 mmmt -104.2 115.03 29.69 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -176.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.43 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.6 p -122.86 137.11 27.54 Favored Pre-proline 0 C--N 1.315 -0.899 0 C-N-CA 121.168 -0.213 . . . . 0.0 110.48 172.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.521 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 97.5 Cg_exo -49.21 142.89 20.43 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.849 2.366 . . . . 0.0 112.227 171.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.44 104.33 0.62 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.18 -177.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.32 -16.74 44.89 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.688 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.521 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 45.6 m -89.19 170.04 10.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.261 0.553 . . . . 0.0 111.212 -179.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.404 ' OD2' ' HB ' ' A' ' 69' ' ' ILE . 2.6 t70 -88.38 145.8 25.6 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.634 174.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.583 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -78.49 -29.18 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 C-N-CA 118.792 -1.163 . . . . 0.0 108.879 179.83 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.791 ' O ' HG13 ' A' ' 73' ' ' VAL . 8.5 mm -61.12 -47.01 95.51 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.184 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.09 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.6 t -47.24 -37.83 11.17 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.98 177.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.422 ' HA ' ' HB3' ' A' ' 74' ' ' LYS . 3.3 mm-40 -86.08 -32.62 21.28 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 123.287 0.635 . . . . 0.0 111.094 -177.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.619 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.3 m-30 -74.88 -35.83 62.28 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.314 -177.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.915 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 2.3 m -70.41 -34.11 56.61 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 174.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.491 ' HA ' ' HB2' ' A' ' 77' ' ' ASP . 13.0 ttpp -70.47 -27.86 64.56 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.788 177.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -62.18 -44.65 96.13 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.047 -0.978 . . . . 0.0 109.398 173.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.757 ' SG ' ' HB ' ' A' ' 79' ' ' ILE . 39.3 t -96.04 9.31 41.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.332 178.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.491 ' HB2' ' HA ' ' A' ' 74' ' ' LYS . 10.7 t70 -61.72 -21.12 64.22 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.057 0.456 . . . . 0.0 110.507 175.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -101.96 -11.74 36.35 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.655 175.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.776 HD11 ' HB2' ' A' ' 54' ' ' ALA . 85.6 mt -86.68 136.75 22.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-N 117.202 0.501 . . . . 0.0 111.163 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 159.13 83.49 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.753 174.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.53 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 95.24 -117.83 5.72 Favored Glycine 0 CA--C 1.51 -0.259 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.824 173.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.81 -48.3 78.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.772 0.32 . . . . 0.0 111.751 -175.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 55.3 mtt -64.79 -30.69 71.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.093 0.473 . . . . 0.0 110.116 178.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.519 ' HB3' ' O ' ' A' ' 81' ' ' GLY . 6.4 t-80 -66.28 -29.51 69.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.574 177.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.53 ' HG2' ' O ' ' A' ' 81' ' ' GLY . 33.5 mmtp -84.23 -19.05 34.6 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.208 0.528 . . . . 0.0 110.461 -178.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.09 -45.84 11.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.746 176.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.421 ' HB2' ' HE2' ' A' ' 87' ' ' MET . 61.6 mtm -81.06 -12.14 59.37 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.661 -175.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.49 ' HB2' ' O ' ' A' ' 84' ' ' HIS . 0.1 OUTLIER -54.33 -22.53 12.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.488 0.661 . . . . 0.0 111.195 176.626 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 41.2 ttp -83.44 -21.71 32.84 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.01 0.433 . . . . 0.0 111.036 176.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -109.1 -63.82 1.31 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -170.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.682 ' O ' ' HB3' ' A' ' 53' ' ' SER . 13.5 mt-30 -67.08 -43.41 82.66 Favored 'General case' 0 CA--C 1.504 -0.821 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.49 -175.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.685 ' HA ' ' CB ' ' A' ' 53' ' ' SER . 2.2 tm? -44.2 -28.94 0.56 Allowed 'General case' 0 C--O 1.232 0.179 0 O-C-N 124.251 0.969 . . . . 0.0 110.093 173.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 . . . . . 0 C--O 1.248 0.992 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -175.914 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' PRO . . . . . 0.408 ' HB2' HG21 ' B' ' 5' ' ' THR . 96.3 Cg_endo . . . . . 0 CA--C 1.517 -0.366 0 N-CA-C 109.163 -1.13 . . . . 0.0 109.163 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 41.7 m -66.91 168.79 9.21 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 162.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.882 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -72.23 -55.72 6.74 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.812 177.632 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.718 ' CG ' ' HG3' ' B' ' 42' ' ' MET . 11.7 p30 -87.81 -4.67 58.86 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.332 -164.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.408 HG21 ' HB2' ' B' ' 1' ' ' PRO . 7.0 t -63.3 -1.42 1.08 Allowed 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.314 0.578 . . . . 0.0 110.87 -173.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.663 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.5 m -74.38 133.54 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 169.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.799 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -155.48 159.82 40.09 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 -175.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' GLN . . . . . 0.444 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.1 tt0 -40.27 110.38 0.15 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 112.921 -1.945 . . . . 0.0 112.786 -178.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.15 -151.5 10.76 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.631 174.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 22.7 t -54.27 99.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.837 0.319 . . . . 0.0 110.513 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 58.0 pttt 39.75 44.23 1.27 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.365 1.066 . . . . 0.0 112.485 -175.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.429 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 68.9 tt0 -60.78 140.94 93.11 Favored Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . 0.52 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 27.5 Cg_exo -55.33 123.43 13.8 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 121.855 1.703 . . . . 0.0 109.751 177.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . 0.924 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 7.2 t80 -68.94 -53.87 13.59 Favored Pre-proline 0 N--CA 1.44 -0.926 0 CA-C-O 118.458 -0.782 . . . . 0.0 113.01 -168.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.546 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 36.9 Cg_exo -55.93 -18.46 22.3 Favored 'Trans proline' 0 C--N 1.359 1.103 0 C-N-CA 121.523 1.482 . . . . 0.0 110.991 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.52 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.9 m-20 -89.82 -42.56 11.2 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 113.907 -1.497 . . . . 0.0 110.841 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' PHE . . . . . 0.444 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -55.43 -45.76 76.77 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.458 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.787 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 2.1 p -78.09 -34.38 19.03 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.18 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.172 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.59 -39.6 70.93 Favored 'General case' 0 C--N 1.316 -0.882 0 O-C-N 121.674 -0.641 . . . . 0.0 111.077 176.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.754 ' O ' HG12 ' B' ' 24' ' ' VAL . 14.7 ptt180 -79.82 -27.72 40.22 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.594 ' HB3' ' O ' ' B' ' 18' ' ' VAL . 13.2 tp -55.05 -48.68 73.14 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.191 172.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . 0.787 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 28.4 mt-30 -68.24 -55.23 12.95 Favored 'General case' 0 CA--C 1.485 -1.529 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.447 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.723 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 78.8 m-20 -45.79 -50.87 13.58 Favored 'General case' 0 C--N 1.312 -1.023 0 O-C-N 124.735 1.272 . . . . 0.0 111.264 -177.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' VAL . . . . . 0.754 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.1 p -78.66 -26.24 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.925 -174.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.641 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -67.22 -31.37 71.7 Favored 'General case' 0 C--O 1.208 -1.131 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 176.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.08 -35.15 64.21 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.174 -1.375 . . . . 0.0 109.474 -178.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.723 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 39.1 mmtt -67.31 -39.96 85.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.628 -1.169 . . . . 0.0 112.015 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . 0.449 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 38.9 m -100.45 -10.47 21.09 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.247 0.546 . . . . 0.0 110.511 -172.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.691 HG22 ' H ' ' B' ' 31' ' ' ASP . 83.9 mt -110.96 129.9 65.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.651 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.48 -3.03 58.54 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.937 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.691 ' H ' HG22 ' B' ' 29' ' ' ILE . 4.7 t0 -117.92 139.63 50.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.715 0.769 . . . . 0.0 111.912 -177.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -68.66 -31.55 70.75 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.43 175.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.597 ' O ' HG13 ' B' ' 37' ' ' VAL . 12.1 mttp -68.16 -53.62 23.77 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -176.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.578 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -63.89 -26.22 68.5 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.481 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.869 ' O ' HG13 ' B' ' 39' ' ' VAL . 4.8 tmm_? -68.27 -57.91 5.24 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.473 ' HB3' ' OE1' ' B' ' 40' ' ' GLU . 32.8 mtpt -53.53 -60.29 3.49 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.223 178.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.703 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 19.7 m -52.08 -33.85 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.366 -170.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.882 HD13 ' HE1' ' B' ' 3' ' ' PHE . 0.7 OUTLIER -88.36 -35.12 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 C-N-CA 119.769 -0.772 . . . . 0.0 112.355 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.869 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.9 m -66.05 -46.88 86.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 119.124 -1.03 . . . . 0.0 109.44 177.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.654 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 42.9 mt-10 -61.19 -31.59 71.34 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.943 0.897 . . . . 0.0 112.55 176.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.703 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -83.67 -52.98 5.98 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 121.039 -0.265 . . . . 0.0 111.446 -179.152 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' MET . . . . . 0.718 ' HG3' ' CG ' ' B' ' 4' ' ' ASN . 19.9 mmt -65.69 -20.73 66.4 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.712 0.768 . . . . 0.0 109.685 -176.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.692 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -50.51 -29.05 9.61 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.144 171.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' TYR . . . . . 0.871 ' CG ' ' HE3' ' B' ' 59' ' ' LYS . 6.1 t80 -103.4 -66.66 0.93 Allowed 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 174.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.601 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 31.0 mm-40 -49.78 -29.6 8.08 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 124.415 1.072 . . . . 0.0 112.006 -171.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.799 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.9 m-20 -104.42 -21.46 13.47 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.497 -176.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -61.49 179.89 0.21 Allowed 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.873 0.844 . . . . 0.0 113.058 -174.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.641 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 17.5 m-20 -62.28 141.87 96.1 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.545 173.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . 0.43 ' O ' ' HG2' ' B' ' 52' ' ' GLN . 75.5 Cg_exo -42.14 -50.36 5.39 Favored 'Trans proline' 0 C--N 1.332 -0.308 0 C-N-CA 122.959 2.44 . . . . 0.0 112.309 -178.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.632 ' HA ' ' HB2' ' B' ' 53' ' ' SER . 0.0 OUTLIER -74.07 -26.72 60.54 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.954 0.901 . . . . 0.0 111.349 -179.42 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.641 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 72.4 m -79.92 -40.15 28.8 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -174.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.735 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.3 pt20 -69.44 -30.86 68.87 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 172.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . 0.825 ' O ' ' HD2' ' B' ' 56' ' ' LYS . 4.3 m -67.89 -27.54 66.75 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 113.907 -1.497 . . . . 0.0 111.423 174.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.801 ' HB2' HD11 ' B' ' 79' ' ' ILE . . . -71.4 -23.09 61.81 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.005 0.907 . . . . 0.0 108.566 170.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.735 HD12 ' HA ' ' B' ' 52' ' ' GLN . 25.4 mt -89.91 -27.5 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -175.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.825 ' HD2' ' O ' ' B' ' 53' ' ' SER . 0.0 OUTLIER -37.47 -49.08 2.55 Favored Pre-proline 0 N--CA 1.507 2.404 0 CA-C-N 120.624 1.557 . . . . 0.0 112.525 -178.398 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 49.9 Cg_endo -61.27 -24.38 78.73 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.836 2.358 . . . . 0.0 112.789 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . 0.544 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.6 mt -105.28 -15.47 15.04 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.871 ' HE3' ' CG ' ' B' ' 44' ' ' TYR . 0.0 OUTLIER -50.62 109.83 0.35 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.684 -179.015 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.67 -19.63 43.58 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.11 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -103.9 115.2 30.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.911 0.386 . . . . 0.0 110.12 -176.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.436 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.6 p -122.73 137.67 28.3 Favored Pre-proline 0 C--N 1.315 -0.915 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.406 171.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.522 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 96.9 Cg_exo -49.71 142.77 24.17 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.888 2.392 . . . . 0.0 112.212 171.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.94 104.83 0.59 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.176 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.08 -16.47 50.01 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.791 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.522 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 43.2 m -89.09 170.02 10.99 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.282 0.563 . . . . 0.0 111.039 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' ASP . . . . . 0.4 ' OD2' ' HB ' ' B' ' 69' ' ' ILE . 2.9 t70 -88.61 145.66 25.56 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.621 174.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.578 HG22 ' HG2' ' B' ' 40' ' ' GLU . 1.0 OUTLIER -78.3 -29.4 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 C-N-CA 118.769 -1.172 . . . . 0.0 108.885 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.796 ' O ' HG13 ' B' ' 73' ' ' VAL . 8.6 mm -60.93 -47.12 94.93 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.164 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.091 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 43.0 t -47.13 -37.79 10.5 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.974 177.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.433 ' HA ' ' HB3' ' B' ' 74' ' ' LYS . 3.2 mm-40 -86.22 -32.52 21.13 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 123.282 0.633 . . . . 0.0 111.144 -177.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' TYR . . . . . 0.61 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.3 m-30 -74.97 -35.61 62.07 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.705 0.764 . . . . 0.0 109.348 -177.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.924 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 2.3 m -70.64 -34.16 55.91 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' LYS . . . . . 0.494 ' HA ' ' HB2' ' B' ' 77' ' ' ASP . 13.1 ttpp -70.37 -28.0 64.76 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.684 177.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -62.1 -44.56 96.38 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.431 173.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.764 ' SG ' ' HB ' ' B' ' 79' ' ' ILE . 37.7 t -96.01 9.22 41.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.182 178.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . 0.494 ' HB2' ' HA ' ' B' ' 74' ' ' LYS . 11.2 t70 -61.62 -21.0 63.98 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.034 0.445 . . . . 0.0 110.6 175.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -102.02 -11.73 36.22 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.741 175.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.801 HD11 ' HB2' ' B' ' 54' ' ' ALA . 84.9 mt -86.7 136.45 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 117.155 0.477 . . . . 0.0 111.195 -178.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 159.28 84.35 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.6 174.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.527 ' O ' ' HG2' ' B' ' 85' ' ' LYS . . . 94.56 -117.66 5.61 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.723 173.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.11 -48.16 79.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.756 0.312 . . . . 0.0 111.633 -174.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' MET . . . . . . . . . . . . . 54.4 mtt -64.78 -30.83 71.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.034 0.445 . . . . 0.0 110.124 178.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' HIS . . . . . 0.523 ' HB3' ' O ' ' B' ' 81' ' ' GLY . 6.5 t-80 -66.17 -29.73 70.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.544 177.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.527 ' HG2' ' O ' ' B' ' 81' ' ' GLY . 33.3 mmtp -84.12 -18.92 35.23 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.151 0.501 . . . . 0.0 110.432 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.13 -45.9 10.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.679 176.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . 0.405 ' HB2' ' HE2' ' B' ' 87' ' ' MET . 61.8 mtm -81.07 -12.16 59.36 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.681 -175.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.494 ' HB2' ' O ' ' B' ' 84' ' ' HIS . 0.1 OUTLIER -54.19 -22.64 11.93 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.555 0.693 . . . . 0.0 111.251 176.628 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 40.7 ttp -83.49 -21.29 32.85 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.127 0.489 . . . . 0.0 111.011 177.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -109.52 -63.7 1.33 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -170.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' GLN . . . . . 0.694 ' O ' ' HB3' ' B' ' 53' ' ' SER . 13.6 mt-30 -67.13 -43.44 82.4 Favored 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.506 -175.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.691 ' HA ' ' CB ' ' B' ' 53' ' ' SER . 2.2 tm? -44.45 -28.81 0.61 Allowed 'General case' 0 C--O 1.234 0.273 0 O-C-N 124.261 0.975 . . . . 0.0 110.017 173.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 N--CA 1.437 -1.079 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -175.989 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.422 ' HB2' ' H ' ' A' ' 2' ' ' SER . 97.3 Cg_endo . . . . . 0 CA--C 1.518 -0.3 0 N-CA-C 108.984 -1.199 . . . . 0.0 108.984 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.458 ' HB2' HG23 ' A' ' 5' ' ' THR . 16.5 m -66.88 174.17 3.15 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 163.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.731 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -70.83 -51.79 24.47 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 166.029 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.533 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 2.4 p-10 -88.18 5.64 40.47 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 113.944 -1.48 . . . . 0.0 113.781 -165.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.458 HG23 ' HB2' ' A' ' 2' ' ' SER . 0.6 OUTLIER -63.09 -8.47 7.71 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 118.52 0.6 . . . . 0.0 111.305 -177.096 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.62 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.1 m -74.48 129.4 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 176.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.741 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -155.51 158.73 38.97 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 118.053 -1.459 . . . . 0.0 114.61 -177.556 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.45 ' HG2' ' HB3' ' A' ' 12' ' ' GLU . 2.2 tt0 -47.14 106.66 0.09 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 112.865 -1.97 . . . . 0.0 112.031 -177.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.27 -135.68 1.18 Allowed Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.825 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.497 ' C ' ' HD3' ' A' ' 11' ' ' LYS . 9.1 t -65.37 99.41 0.4 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.497 ' HD3' ' C ' ' A' ' 10' ' ' SER . 0.0 OUTLIER 37.2 44.24 0.41 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.233 1.013 . . . . 0.0 112.017 -175.333 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.45 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 54.8 tt0 -60.55 144.29 89.05 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.735 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.576 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 37.9 Cg_exo -54.48 122.83 12.24 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.356 2.037 . . . . 0.0 110.114 176.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.805 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 21.9 t80 -73.19 -55.87 3.57 Favored Pre-proline 0 N--CA 1.439 -0.984 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -166.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.557 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 27.4 Cg_exo -56.98 -16.13 19.6 Favored 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 121.279 1.32 . . . . 0.0 110.627 -178.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.576 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.3 m-20 -89.16 -44.48 10.28 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 113.606 -1.634 . . . . 0.0 110.837 178.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.54 ' CE2' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -54.62 -44.76 73.43 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.515 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.78 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 1.7 p -79.63 -34.8 16.06 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.277 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.536 -178.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.33 -30.58 68.47 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 121.45 -0.781 . . . . 0.0 111.752 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.728 ' O ' HG12 ' A' ' 24' ' ' VAL . 16.5 ptt180 -84.45 -28.36 26.89 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.543 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 5.6 tp -57.26 -48.29 79.25 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.019 173.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.78 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 24.7 mt-30 -68.78 -47.9 65.02 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.085 177.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.732 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 11.4 t70 -47.19 -54.58 10.37 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 124.332 1.02 . . . . 0.0 111.656 -177.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.728 HG12 ' O ' ' A' ' 20' ' ' ARG . 6.6 p -81.84 -21.95 10.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.038 -174.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.753 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -73.07 -19.39 61.18 Favored 'General case' 0 C--O 1.205 -1.243 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 174.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.49 -38.06 17.64 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.582 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.732 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 39.8 mmtt -66.45 -35.75 81.05 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.753 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.418 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 15.7 m -104.72 -7.32 19.62 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.201 0.524 . . . . 0.0 110.657 -170.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.753 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 88.5 mt -117.8 130.12 73.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.885 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.21 -7.64 47.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.331 0.586 . . . . 0.0 110.332 175.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.54 ' H ' HG22 ' A' ' 29' ' ' ILE . 1.0 OUTLIER -100.31 106.29 17.91 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.735 -179.278 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -56.47 -25.98 52.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.679 0.276 . . . . 0.0 110.271 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.566 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -69.32 -53.57 18.96 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.172 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.622 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -64.6 -24.07 67.47 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.349 177.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.871 ' O ' HG13 ' A' ' 39' ' ' VAL . 4.7 tmm_? -68.4 -58.61 4.08 Favored 'General case' 0 C--O 1.219 -0.535 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.485 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 27.4 mtpt -52.45 -60.68 2.94 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 120.791 0.329 . . . . 0.0 110.535 177.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.785 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 21.6 m -52.16 -36.15 20.21 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.768 -168.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.731 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.5 tt -87.17 -27.69 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 119.641 -0.823 . . . . 0.0 112.111 -177.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.871 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.1 m -73.35 -47.47 46.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 119.148 -1.021 . . . . 0.0 109.267 175.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.773 ' OE2' HG13 ' A' ' 68' ' ' VAL . 0.7 OUTLIER -63.98 -24.47 67.73 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.796 0.838 . . . . 0.0 111.292 176.162 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.785 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -85.45 -57.9 2.88 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 176.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.539 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 23.2 mmt -61.49 -20.58 63.33 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.569 0.699 . . . . 0.0 109.703 -177.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.685 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -48.94 -27.89 3.45 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.928 170.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.554 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 10.2 t80 -107.13 -66.77 0.99 Allowed 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 176.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.637 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 17.1 mm-40 -48.1 -32.59 7.02 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.998 -174.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.741 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 5.2 m-20 -105.14 -19.32 13.86 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -175.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.626 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -61.01 -172.15 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -174.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.556 ' HB2' ' H ' ' A' ' 51' ' ' CYS . 11.5 m120 -52.78 141.49 36.51 Favored Pre-proline 0 C--N 1.342 0.239 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 170.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.49 ' O ' HD23 ' A' ' 92' ' ' LEU . 19.8 Cg_endo -59.92 -19.66 56.14 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 121.618 1.545 . . . . 0.0 110.452 174.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.537 ' O ' ' HB2' ' A' ' 53' ' ' SER . 0.3 OUTLIER -87.11 -34.98 18.92 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.465 174.055 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.975 ' SG ' ' HB2' ' A' ' 76' ' ' CYS . 40.8 t -80.24 -33.92 37.55 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.242 -172.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.517 ' HB2' ' CD1' ' A' ' 44' ' ' TYR . 4.2 pt20 -68.68 -29.32 67.75 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 172.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.589 ' HB3' ' C ' ' A' ' 91' ' ' GLN . 20.0 m -71.58 -19.3 62.16 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.284 -1.78 . . . . 0.0 110.017 173.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.787 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -81.06 -27.17 35.81 Favored 'General case' 0 C--N 1.311 -1.107 0 O-C-N 121.431 -0.793 . . . . 0.0 110.158 167.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.557 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 23.7 mt -90.34 -30.18 4.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 114.83 1.418 . . . . 0.0 114.83 -170.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.613 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.57 -38.81 1.99 Allowed Pre-proline 0 N--CA 1.487 1.414 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -174.034 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 54.4 Cg_endo -63.62 -30.96 70.58 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.154 1.903 . . . . 0.0 112.628 176.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.543 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.8 mt -95.08 -16.87 22.33 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.578 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 0.1 OUTLIER -54.87 109.07 0.46 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.698 -179.523 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.38 -23.04 37.58 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.403 -177.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -104.22 113.22 26.61 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.312 0.577 . . . . 0.0 110.232 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.464 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.7 p -123.09 142.53 38.52 Favored Pre-proline 0 C--N 1.309 -1.177 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 169.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.553 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 71.1 Cg_exo -51.1 138.68 44.01 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.19 1.927 . . . . 0.0 111.443 170.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.12 103.52 0.38 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.067 -177.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.12 -12.35 44.63 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.742 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.553 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 20.0 m -94.92 169.56 10.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.591 0.71 . . . . 0.0 111.635 -178.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.82 136.97 34.48 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.706 -1.133 . . . . 0.0 109.378 174.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.773 HG13 ' OE2' ' A' ' 40' ' ' GLU . 0.7 OUTLIER -72.45 -32.53 42.3 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.419 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.755 ' O ' HG13 ' A' ' 73' ' ' VAL . 10.1 mm -55.57 -46.59 79.16 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.071 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.742 -178.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 33.6 t -46.34 -38.11 8.36 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.322 0.582 . . . . 0.0 111.012 176.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -85.63 -31.96 22.29 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.749 -177.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.578 ' OH ' ' HA ' ' A' ' 59' ' ' LYS . 4.9 m-30 -76.59 -34.04 58.42 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.534 -176.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.805 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.5 m -71.41 -31.64 43.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 172.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.569 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -67.89 -29.83 69.02 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.372 175.731 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -64.77 -44.93 88.46 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.109 176.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.975 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 39.5 t -92.52 9.08 36.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.636 177.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.569 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 8.3 t70 -60.59 -21.53 62.74 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.321 0.581 . . . . 0.0 110.238 172.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 83' ' ' MET . . . -101.15 -9.89 43.75 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.611 173.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.798 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 85.0 mt -96.18 139.03 20.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 117.307 0.553 . . . . 0.0 111.201 -178.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.576 ' H ' ' HB2' ' A' ' 84' ' ' HIS . . . 164.64 -35.37 0.28 Allowed Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.685 173.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.61 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . -148.12 -103.39 0.31 Allowed Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.386 -0.912 . . . . 0.0 113.198 177.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.43 -46.32 89.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -171.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.513 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 71.5 mtp -68.9 -30.83 69.4 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.576 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 5.8 t-160 -62.39 -29.36 70.43 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.027 173.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.61 ' HG2' ' O ' ' A' ' 81' ' ' GLY . 70.7 mmtt -83.79 -20.49 33.21 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.031 0.443 . . . . 0.0 110.406 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.14 -42.48 14.72 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.591 0.71 . . . . 0.0 110.636 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 1.6 mmt -84.85 -12.72 52.94 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.898 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.605 ' O ' ' HB3' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -49.58 -40.88 40.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.433 0.635 . . . . 0.0 111.367 177.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 28.2 ttt -84.17 -15.48 46.94 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.031 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -96.59 -34.16 11.53 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.122 0.487 . . . . 0.0 112.014 -173.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.589 ' C ' ' HB3' ' A' ' 53' ' ' SER . 20.8 mt-30 -109.65 -56.86 2.25 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.293 -176.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.605 ' HB3' ' O ' ' A' ' 88' ' ' LEU . 0.3 OUTLIER -58.49 -4.69 0.43 Allowed 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.299 0.571 . . . . 0.0 110.256 176.356 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.467 ' H ' ' C ' ' A' ' 91' ' ' GLN . 5.0 pt-20 . . . . . 0 C--O 1.249 1.031 0 C-N-CA 123.967 0.907 . . . . 0.0 112.375 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo . . . . . 0 CA--C 1.518 -0.324 0 N-CA-C 108.911 -1.226 . . . . 0.0 108.911 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.462 ' HB2' HG23 ' B' ' 5' ' ' THR . 16.4 m -66.9 174.56 2.92 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 162.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.729 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -71.18 -51.76 23.03 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 165.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.525 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.4 p-10 -88.19 5.62 40.61 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 113.904 -1.498 . . . . 0.0 113.731 -165.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.462 HG23 ' HB2' ' B' ' 2' ' ' SER . 0.6 OUTLIER -63.36 -7.72 7.13 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 118.554 0.616 . . . . 0.0 111.438 -177.13 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.611 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.1 m -75.0 129.27 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.764 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.2 OUTLIER -155.48 158.77 39.07 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 118.18 -1.408 . . . . 0.0 114.626 -177.652 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' GLN . . . . . 0.459 ' HG2' ' HB3' ' B' ' 12' ' ' GLU . 2.2 tt0 -47.01 106.72 0.09 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 112.766 -2.016 . . . . 0.0 111.944 -177.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.56 -136.48 1.38 Allowed Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.631 177.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . 0.506 ' C ' ' HD3' ' B' ' 11' ' ' LYS . 8.9 t -64.81 99.38 0.33 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.506 ' HD3' ' C ' ' B' ' 10' ' ' SER . 0.0 OUTLIER 37.35 43.94 0.42 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.19 0.996 . . . . 0.0 112.095 -175.354 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.459 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 52.6 tt0 -60.28 144.27 87.91 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.855 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . 0.552 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 40.4 Cg_exo -54.56 122.78 12.17 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 122.235 1.957 . . . . 0.0 110.139 176.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . 0.802 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 21.6 t80 -73.13 -55.92 3.59 Favored Pre-proline 0 N--CA 1.44 -0.939 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -166.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.569 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 27.7 Cg_exo -57.22 -16.02 20.55 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 121.318 1.345 . . . . 0.0 110.609 -178.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.552 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.4 m-20 -89.33 -44.2 10.39 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 113.487 -1.688 . . . . 0.0 110.762 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' PHE . . . . . 0.535 ' CE2' HD22 ' B' ' 21' ' ' LEU . 0.0 OUTLIER -54.89 -44.59 74.24 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 176.744 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.767 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 1.7 p -79.58 -34.91 16.21 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.307 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.496 -178.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.39 -30.29 68.34 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 121.356 -0.84 . . . . 0.0 111.913 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.712 ' O ' HG12 ' B' ' 24' ' ' VAL . 16.6 ptt180 -84.53 -28.44 26.66 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 175.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.558 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 5.6 tp -57.24 -48.23 79.36 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.079 173.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . 0.767 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 24.3 mt-30 -69.09 -47.41 65.31 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.075 177.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.743 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 11.8 t70 -47.44 -54.74 10.58 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 124.416 1.072 . . . . 0.0 111.6 -177.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' VAL . . . . . 0.712 HG12 ' O ' ' B' ' 20' ' ' ARG . 6.5 p -81.7 -22.05 10.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.033 -174.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.759 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -72.95 -19.39 61.25 Favored 'General case' 0 C--O 1.204 -1.302 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.49 -38.25 17.45 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.555 177.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.743 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 40.1 mmtt -66.13 -35.95 81.85 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.717 178.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . 0.409 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 15.7 m -104.52 -7.64 19.62 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.24 0.543 . . . . 0.0 110.68 -170.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.759 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 88.3 mt -117.74 129.74 73.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.91 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.15 -7.29 48.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.328 0.585 . . . . 0.0 110.314 175.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.514 ' H ' HG22 ' B' ' 29' ' ' ILE . 1.1 m-20 -100.46 106.25 17.79 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.776 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -56.29 -26.04 50.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.666 0.27 . . . . 0.0 110.388 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.57 ' O ' HG13 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -69.24 -53.73 18.39 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.14 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.633 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -64.33 -24.11 67.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.402 177.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.867 ' O ' HG13 ' B' ' 39' ' ' VAL . 4.6 tmm_? -68.41 -58.75 3.87 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.479 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 27.2 mtpt -52.17 -60.7 2.9 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 120.796 0.332 . . . . 0.0 110.638 177.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.779 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 21.8 m -52.27 -35.96 20.4 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.465 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.716 -168.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.729 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.5 tt -87.24 -27.72 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 119.599 -0.84 . . . . 0.0 112.067 -177.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.867 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.1 m -73.51 -47.14 46.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.332 175.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.769 ' OE2' HG13 ' B' ' 68' ' ' VAL . 0.7 OUTLIER -64.19 -24.36 67.65 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.757 0.823 . . . . 0.0 111.348 176.084 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.779 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.46 -57.86 2.9 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 176.534 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' MET . . . . . 0.541 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 23.2 mmt -61.45 -20.75 63.47 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.591 0.71 . . . . 0.0 109.717 -177.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.68 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -48.71 -27.93 3.24 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.991 170.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' TYR . . . . . 0.554 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 10.4 t80 -107.22 -66.66 1.0 Allowed 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.638 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 17.6 mm-40 -48.21 -32.46 7.14 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.817 -1.083 . . . . 0.0 112.005 -174.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.764 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 5.1 m-20 -105.07 -19.68 13.75 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -175.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -60.71 -172.0 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -174.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.552 ' HB2' ' CB ' ' B' ' 51' ' ' CYS . 11.5 m120 -52.86 141.55 37.05 Favored Pre-proline 0 C--O 1.235 0.298 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 170.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . 0.493 ' O ' HD23 ' B' ' 92' ' ' LEU . 19.2 Cg_endo -60.04 -19.7 57.2 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 121.642 1.561 . . . . 0.0 110.471 174.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' B' ' 53' ' ' SER . 0.3 OUTLIER -87.02 -34.89 19.07 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.542 173.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.975 ' SG ' ' HB2' ' B' ' 76' ' ' CYS . 40.7 t -80.33 -33.89 37.07 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.265 -172.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.51 ' HB2' ' CD1' ' B' ' 44' ' ' TYR . 4.1 pt20 -68.6 -29.42 67.93 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 172.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . 0.591 ' HB3' ' C ' ' B' ' 91' ' ' GLN . 19.6 m -71.55 -19.41 62.17 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 113.264 -1.789 . . . . 0.0 109.986 173.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.783 ' HB2' HD11 ' B' ' 79' ' ' ILE . . . -80.86 -27.38 36.43 Favored 'General case' 0 C--N 1.311 -1.07 0 O-C-N 121.443 -0.786 . . . . 0.0 110.225 167.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.561 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 24.0 mt -90.11 -30.0 5.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 -170.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.607 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.68 -38.78 2.07 Favored Pre-proline 0 N--CA 1.487 1.377 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -174.043 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 55.6 Cg_endo -63.79 -30.78 68.83 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.196 1.931 . . . . 0.0 112.649 176.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . 0.557 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.7 mt -95.11 -16.74 22.4 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.57 ' HA ' ' OH ' ' B' ' 72' ' ' TYR . 0.1 OUTLIER -55.01 109.09 0.47 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.661 -179.483 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.65 -23.41 36.05 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.419 -177.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -104.07 113.36 26.85 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.351 0.596 . . . . 0.0 110.162 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.48 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.7 p -123.16 142.13 37.62 Favored Pre-proline 0 C--N 1.308 -1.201 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.352 169.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.546 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 74.0 Cg_exo -50.87 138.8 41.86 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.201 1.934 . . . . 0.0 111.416 171.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.31 103.88 0.44 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.01 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.28 -13.51 43.96 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.618 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.546 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 19.6 m -94.15 169.56 10.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.487 0.661 . . . . 0.0 111.596 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.0 136.97 34.32 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.564 174.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.769 HG13 ' OE2' ' B' ' 40' ' ' GLU . 0.7 OUTLIER -72.3 -32.52 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.495 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.754 ' O ' HG13 ' B' ' 73' ' ' VAL . 9.9 mm -55.65 -46.6 79.42 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.093 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.675 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 29.4 t -46.49 -37.92 8.52 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.105 176.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -85.67 -32.0 22.22 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.677 -177.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' TYR . . . . . 0.579 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 4.9 m-30 -76.46 -34.29 58.7 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.572 -176.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.802 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.5 m -71.33 -31.51 43.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 172.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' LYS . . . . . 0.569 ' O ' ' HB3' ' B' ' 77' ' ' ASP . 0.0 OUTLIER -68.08 -29.61 68.61 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.431 175.653 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -65.09 -44.59 88.34 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.175 176.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.975 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 39.1 t -92.5 9.04 36.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.729 177.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . 0.569 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 9.1 t70 -60.61 -21.73 62.99 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.173 0.511 . . . . 0.0 110.163 172.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' B' ' 83' ' ' MET . . . -101.14 -9.63 44.48 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.653 173.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.792 ' HB ' ' SG ' ' B' ' 76' ' ' CYS . 84.2 mt -96.06 138.98 20.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 117.392 0.596 . . . . 0.0 111.342 -178.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . 0.569 ' H ' ' HB2' ' B' ' 84' ' ' HIS . . . 164.38 -34.94 0.28 Allowed Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.718 173.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.6 ' O ' ' HG2' ' B' ' 85' ' ' LYS . . . -148.41 -103.4 0.31 Allowed Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.133 177.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.15 -46.75 87.63 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -171.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' MET . . . . . 0.513 ' HB2' ' O ' ' B' ' 78' ' ' GLY . 72.4 mtp -68.56 -30.85 69.72 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' HIS . . . . . 0.569 ' HB2' ' H ' ' B' ' 80' ' ' GLY . 5.8 t-160 -62.41 -29.11 70.26 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.137 173.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.6 ' HG2' ' O ' ' B' ' 81' ' ' GLY . 70.5 mmtt -84.05 -20.32 32.9 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.937 0.399 . . . . 0.0 110.421 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.09 -43.02 14.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.558 0.694 . . . . 0.0 110.508 177.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 1.6 mmt -84.48 -12.77 53.67 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.081 -176.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.61 ' O ' ' HB3' ' B' ' 92' ' ' LEU . 0.3 OUTLIER -49.52 -41.01 39.84 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.45 0.643 . . . . 0.0 111.17 177.836 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 28.2 ttt -84.06 -15.55 47.03 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.019 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -96.7 -33.63 11.66 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.983 -173.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' GLN . . . . . 0.591 ' C ' ' HB3' ' B' ' 53' ' ' SER . 20.3 mt-30 -110.21 -56.73 2.3 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.279 -176.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.61 ' HB3' ' O ' ' B' ' 88' ' ' LEU . 0.4 OUTLIER -58.41 -5.1 0.46 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 121.087 0.47 . . . . 0.0 110.186 176.355 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.452 ' H ' ' C ' ' B' ' 91' ' ' GLN . 5.1 pt-20 . . . . . 0 C--O 1.252 1.231 0 C-N-CA 123.981 0.912 . . . . 0.0 112.245 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.413 ' C ' ' HA3' ' B' ' 60' ' ' GLY . 72.3 Cg_endo . . . . . 0 CA--C 1.515 -0.451 0 N-CA-C 108.784 -1.275 . . . . 0.0 108.784 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.723 ' HG ' ' HZ2' ' B' ' 59' ' ' LYS . 13.7 m -67.11 171.42 5.64 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 162.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.812 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -69.9 -52.02 28.14 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 167.248 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.521 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 2.5 p-10 -82.34 5.37 20.48 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 113.996 -1.456 . . . . 0.0 113.423 -166.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.409 HG23 ' HB2' ' A' ' 2' ' ' SER . 0.4 OUTLIER -66.28 -3.03 5.02 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 118.521 0.6 . . . . 0.0 111.946 -175.158 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.582 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.1 m -78.57 132.72 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 174.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.783 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -155.08 160.15 40.78 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -178.881 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.411 ' N ' ' CD2' ' A' ' 17' ' ' PHE . 2.0 tt0 -44.33 109.07 0.13 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 112.902 -1.954 . . . . 0.0 112.29 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.69 -151.95 15.13 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.397 174.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.1 t -52.32 98.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 122.421 0.288 . . . . 0.0 110.692 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.7 pttm 40.52 42.14 1.25 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.511 1.124 . . . . 0.0 112.598 -175.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -60.1 141.34 90.35 Favored Pre-proline 0 C--O 1.236 0.386 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.149 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.506 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 27.4 Cg_exo -56.35 122.96 12.7 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.039 1.826 . . . . 0.0 109.712 176.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.871 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 20.2 t80 -72.38 -53.27 6.24 Favored Pre-proline 0 N--CA 1.439 -1.004 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -166.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.529 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 34.3 Cg_exo -55.36 -19.53 22.48 Favored 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 121.361 1.374 . . . . 0.0 110.749 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.506 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 3.4 m-20 -89.9 -41.19 11.93 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 113.737 -1.574 . . . . 0.0 110.948 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.506 ' CD2' ' HA ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -54.96 -46.82 75.08 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 175.73 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.7 HG12 ' O ' ' A' ' 14' ' ' TYR . 2.4 p -79.03 -32.12 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.218 -177.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.0 -36.3 72.45 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 121.639 -0.663 . . . . 0.0 111.768 175.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.705 ' O ' HG12 ' A' ' 24' ' ' VAL . 14.1 ptt180 -83.27 -23.52 32.64 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.547 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 6.6 tp -60.49 -45.63 93.06 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.767 172.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.716 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 37.2 mt-30 -73.14 -44.51 60.04 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.735 178.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.751 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 26.0 t70 -49.16 -53.72 19.67 Favored 'General case' 0 C--N 1.315 -0.893 0 O-C-N 124.155 0.909 . . . . 0.0 111.667 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.705 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.7 p -80.85 -23.19 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-O 121.09 0.472 . . . . 0.0 109.882 -174.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.774 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -71.79 -20.54 61.84 Favored 'General case' 0 C--O 1.204 -1.326 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 174.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.451 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -86.54 -37.14 18.47 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.744 178.602 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.751 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 38.0 mmtt -65.49 -35.51 81.09 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.459 178.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.5 m -104.47 -9.96 18.02 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.648 -171.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.774 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 91.1 mt -119.27 128.03 75.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.95 -178.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.99 -1.29 56.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.382 0.611 . . . . 0.0 110.488 176.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.66 ' H ' HG22 ' A' ' 29' ' ' ILE . 13.6 t70 -107.95 116.6 32.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.467 -177.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.558 ' OE2' ' HG3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -57.16 -34.05 68.06 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.272 178.332 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.612 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -70.88 -54.71 10.48 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -172.543 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.563 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -60.05 -28.92 68.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.8 176.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.878 ' O ' HG13 ' A' ' 39' ' ' VAL . 6.0 tmm_? -67.38 -58.09 5.41 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.441 ' O ' HG22 ' A' ' 39' ' ' VAL . 16.0 mtpt -56.96 -56.58 19.85 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.008 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.704 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 20.1 m -53.73 -35.03 25.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.399 -171.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.812 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.3 tt -86.6 -28.24 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 C-N-CA 119.631 -0.828 . . . . 0.0 111.732 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.878 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.5 m -70.78 -49.87 47.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 119.088 -1.045 . . . . 0.0 109.561 173.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.774 ' OE1' HG13 ' A' ' 68' ' ' VAL . 0.9 OUTLIER -62.08 -24.85 67.36 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.354 0.662 . . . . 0.0 111.653 176.654 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.704 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -86.23 -55.28 3.99 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 176.381 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.521 ' HG3' ' HB2' ' A' ' 4' ' ' ASN . 16.4 mmt -63.89 -20.35 65.77 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 121.458 0.646 . . . . 0.0 109.861 -176.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.689 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -48.78 -27.81 3.23 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.277 169.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.558 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 16.5 t80 -105.95 -66.23 1.01 Allowed 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 174.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.45 ' CG ' HD12 ' A' ' 41' ' ' LEU . 15.3 mm-40 -50.22 -26.85 5.1 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 124.228 0.955 . . . . 0.0 112.699 -172.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.783 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.8 m-20 -109.49 -20.35 12.92 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.625 -177.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -59.15 -177.52 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.183 0.992 . . . . 0.0 113.633 -174.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -62.98 140.89 97.64 Favored Pre-proline 0 N--CA 1.445 -0.713 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.639 174.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -43.65 -48.04 9.07 Favored 'Trans proline' 0 C--N 1.334 -0.226 0 C-N-CA 122.83 2.353 . . . . 0.0 112.473 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.602 ' HG3' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -76.23 -23.73 54.55 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.31 0.644 . . . . 0.0 110.657 -179.488 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.969 ' SG ' ' HB2' ' A' ' 76' ' ' CYS . 52.9 t -84.26 -40.0 18.57 Favored 'General case' 0 N--CA 1.417 -2.105 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.915 -173.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.57 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.7 pt20 -66.34 -31.18 71.81 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 172.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.757 ' O ' ' HD2' ' A' ' 56' ' ' LYS . 5.1 m -65.81 -30.05 70.62 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.88 172.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.762 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -72.33 -23.71 61.2 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.87 0.843 . . . . 0.0 109.276 172.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.57 HD12 ' HA ' ' A' ' 52' ' ' GLN . 25.1 mt -90.94 -31.33 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -173.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.757 ' HD2' ' O ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -44.03 -38.18 4.43 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-N 119.805 1.184 . . . . 0.0 113.477 -173.451 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 52.7 Cg_endo -63.06 -29.6 75.12 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 122.296 1.997 . . . . 0.0 112.85 175.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.559 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.5 mt -97.37 -16.45 20.24 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.558 ' HE3' ' HB3' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -52.76 109.68 0.43 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.376 -178.538 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.525 ' N ' ' HZ3' ' A' ' 59' ' ' LYS . . . 94.86 -21.77 41.79 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.177 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.5 mmmt -103.51 114.5 28.81 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -177.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.528 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.7 p -122.14 137.1 27.01 Favored Pre-proline 0 C--N 1.309 -1.163 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 170.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.537 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 85.5 Cg_exo -49.46 140.35 27.82 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.649 2.233 . . . . 0.0 111.702 172.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.94 102.14 0.26 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.304 -176.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.26 -13.4 44.08 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.657 178.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.537 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 29.2 m -90.22 174.28 7.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.507 0.67 . . . . 0.0 111.841 -178.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.444 ' OD2' ' HB ' ' A' ' 69' ' ' ILE . 3.0 t70 -91.25 136.18 33.28 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.774 HG13 ' OE1' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -71.87 -33.36 47.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 C-N-CA 118.055 -1.458 . . . . 0.0 108.937 -179.391 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.774 ' O ' HG13 ' A' ' 73' ' ' VAL . 7.6 mm -57.61 -47.5 85.29 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.112 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.802 -178.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.577 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 41.2 t -48.33 -36.09 13.67 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.202 0.525 . . . . 0.0 111.168 178.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.411 ' H ' ' HG2' ' A' ' 71' ' ' GLU . 2.3 mm-40 -86.56 -31.21 21.34 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.27 0.628 . . . . 0.0 110.75 -176.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.559 ' CE1' ' HB2' ' A' ' 58' ' ' LEU . 4.9 m-30 -76.28 -35.98 58.62 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.494 -178.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.871 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.7 m -69.87 -33.15 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 173.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.577 ' HB2' ' O ' ' A' ' 70' ' ' SER . 1.6 ttmm -67.9 -30.62 70.0 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.086 -1.415 . . . . 0.0 109.666 176.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -62.1 -42.81 99.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.653 174.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.969 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 41.9 t -94.86 8.59 42.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.052 178.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 12.7 t70 -61.59 -16.43 48.09 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.279 0.561 . . . . 0.0 110.024 173.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -107.47 -5.07 34.59 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.842 173.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.802 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 57.2 mt -102.11 132.47 48.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 117.321 0.56 . . . . 0.0 111.086 -178.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 161.41 62.27 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.005 174.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.21 172.19 36.79 Favored Glycine 0 CA--C 1.51 -0.245 0 N-CA-C 111.771 -0.531 . . . . 0.0 111.771 -176.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 54.51 -91.0 0.03 OUTLIER 'General case' 0 C--O 1.234 0.26 0 C-N-CA 122.937 0.495 . . . . 0.0 111.823 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 65.4 mtt -62.52 -28.51 69.89 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.452 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.479 ' HD2' ' OE2' ' A' ' 50' ' ' GLU . 8.8 t-160 -50.1 -41.56 48.61 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.347 177.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.453 ' HA ' ' HB2' ' A' ' 88' ' ' LEU . 75.0 mttt -87.32 -14.83 39.75 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -174.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.43 -43.34 14.74 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.971 0.891 . . . . 0.0 109.404 172.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 65.7 mtt -80.22 -9.71 59.73 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.249 -1.341 . . . . 0.0 111.034 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.453 ' HB2' ' HA ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -56.83 -17.68 10.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.269 0.557 . . . . 0.0 111.056 177.586 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 49.3 tpp -83.73 -24.04 31.36 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.104 0.478 . . . . 0.0 110.528 174.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.17 -56.26 2.35 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -169.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.551 ' O ' ' HB3' ' A' ' 53' ' ' SER . 19.0 mt-30 -70.49 -40.87 73.34 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -176.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.551 ' HA ' ' CB ' ' A' ' 53' ' ' SER . 1.9 tm? -46.45 -29.73 1.86 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.902 169.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.65 ' O ' ' HE3' ' A' ' 56' ' ' LYS . 43.8 mt-10 . . . . . 0 N--CA 1.438 -1.029 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' PRO . . . . . 0.43 ' HB2' ' H ' ' B' ' 2' ' ' SER . 72.4 Cg_endo . . . . . 0 CA--C 1.515 -0.449 0 N-CA-C 108.791 -1.273 . . . . 0.0 108.791 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.43 ' H ' ' HB2' ' B' ' 1' ' ' PRO . 14.4 m -67.04 171.58 5.39 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 162.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.783 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -70.03 -52.08 26.97 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 167.184 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.521 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 2.6 p-10 -82.05 5.25 20.01 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 113.95 -1.477 . . . . 0.0 113.478 -166.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.411 HG23 ' HB2' ' B' ' 2' ' ' SER . 0.4 OUTLIER -66.26 -2.87 4.81 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 121.671 -0.643 . . . . 0.0 111.939 -175.16 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.596 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.1 m -78.57 133.18 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 174.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.773 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.1 OUTLIER -155.17 160.26 40.77 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -178.825 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' GLN . . . . . 0.426 ' N ' ' CD2' ' B' ' 17' ' ' PHE . 2.0 tt0 -44.58 108.87 0.13 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 112.922 -1.944 . . . . 0.0 112.313 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.27 -152.07 14.38 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.406 174.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 9.9 t -52.44 98.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.753 0.311 . . . . 0.0 110.803 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 23.8 pttm 40.8 41.55 1.22 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.549 1.14 . . . . 0.0 112.635 -175.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -59.73 141.17 89.17 Favored Pre-proline 0 C--O 1.236 0.388 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.217 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . 0.516 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 27.6 Cg_exo -56.24 123.04 12.87 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.031 1.82 . . . . 0.0 109.644 177.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . 0.877 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 20.3 t80 -72.36 -53.37 6.19 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -166.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.527 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 35.1 Cg_exo -55.45 -19.34 22.31 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 121.305 1.337 . . . . 0.0 110.696 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.516 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 3.5 m-20 -90.1 -41.15 11.83 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.722 -1.581 . . . . 0.0 110.92 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' PHE . . . . . 0.516 ' CD2' ' HA ' ' B' ' 7' ' ' ARG . 0.0 OUTLIER -54.79 -46.71 74.5 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.569 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.699 HG12 ' O ' ' B' ' 14' ' ' TYR . 2.4 p -79.16 -32.09 14.94 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.21 -177.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.06 -36.12 72.34 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 121.634 -0.666 . . . . 0.0 111.765 175.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.697 ' O ' HG12 ' B' ' 24' ' ' VAL . 14.1 ptt180 -83.22 -23.99 32.56 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 177.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.556 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 6.5 tp -60.1 -45.64 92.26 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.802 172.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . 0.721 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 36.9 mt-30 -73.21 -44.19 60.09 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.832 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.74 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 25.9 t70 -49.43 -53.83 20.72 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.557 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' VAL . . . . . 0.697 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.7 p -80.96 -23.07 10.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.137 0.494 . . . . 0.0 109.878 -174.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.778 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -71.77 -20.5 61.86 Favored 'General case' 0 C--O 1.203 -1.37 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 174.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . 0.451 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -86.56 -37.29 18.29 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.704 178.597 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.74 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.4 mmtt -65.51 -35.58 81.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.488 178.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 19.6 m -104.34 -9.44 18.51 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.666 -171.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.778 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 91.6 mt -119.76 128.0 75.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.993 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.06 -1.43 56.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.285 0.564 . . . . 0.0 110.286 177.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.675 ' H ' HG22 ' B' ' 29' ' ' ILE . 13.8 t70 -107.62 116.84 32.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.352 -177.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.549 ' OE2' ' HG3' ' B' ' 33' ' ' LYS . 0.0 OUTLIER -57.34 -33.87 68.2 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.356 178.267 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.616 ' O ' HG13 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -70.82 -54.57 11.09 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -172.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.545 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -60.16 -28.89 68.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.784 176.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.854 ' O ' HG13 ' B' ' 39' ' ' VAL . 6.0 tmm_? -67.38 -58.28 5.07 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.438 ' O ' HG22 ' B' ' 39' ' ' VAL . 16.1 mtpt -56.84 -56.52 20.52 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.097 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.689 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 20.2 m -53.83 -34.92 26.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.386 -171.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.783 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.3 tt -86.64 -28.18 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 C-N-CA 119.649 -0.82 . . . . 0.0 111.668 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.854 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.5 m -70.91 -49.85 47.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 119.152 -1.019 . . . . 0.0 109.58 173.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.782 ' OE1' HG13 ' B' ' 68' ' ' VAL . 0.9 OUTLIER -62.12 -24.87 67.4 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.398 0.679 . . . . 0.0 111.561 176.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.689 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -86.22 -55.22 4.02 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 176.293 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' MET . . . . . 0.521 ' HG3' ' HB2' ' B' ' 4' ' ' ASN . 16.4 mmt -64.08 -20.17 65.76 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 121.537 0.684 . . . . 0.0 109.974 -176.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.68 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -48.78 -27.76 3.19 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.194 169.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' TYR . . . . . 0.561 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 16.5 t80 -106.06 -66.41 1.0 Allowed 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 174.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.46 ' CG ' HD12 ' B' ' 41' ' ' LEU . 16.4 mm-40 -50.05 -27.22 5.25 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.627 -172.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.773 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.7 m-20 -109.28 -20.22 13.02 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.602 -176.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -59.06 -177.35 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -174.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -63.26 140.93 97.77 Favored Pre-proline 0 N--CA 1.446 -0.647 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.531 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -43.76 -48.04 9.26 Favored 'Trans proline' 0 C--N 1.334 -0.235 0 C-N-CA 122.773 2.315 . . . . 0.0 112.386 -178.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.604 ' HG3' ' O ' ' B' ' 50' ' ' GLU . 0.0 OUTLIER -76.03 -23.83 55.17 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 123.43 0.692 . . . . 0.0 110.707 -179.467 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.97 ' SG ' ' HB2' ' B' ' 76' ' ' CYS . 52.8 t -84.18 -39.99 18.69 Favored 'General case' 0 N--CA 1.418 -2.038 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.94 -173.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.574 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.8 pt20 -66.5 -31.08 71.59 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 172.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . 0.745 ' O ' ' HD2' ' B' ' 56' ' ' LYS . 5.7 m -65.93 -30.14 70.67 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 113.783 -1.553 . . . . 0.0 110.809 173.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.745 ' HB2' HD11 ' B' ' 79' ' ' ILE . . . -72.09 -23.89 61.41 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 122.026 0.917 . . . . 0.0 109.374 172.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.574 HD12 ' HA ' ' B' ' 52' ' ' GLN . 25.0 mt -90.89 -31.53 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -173.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.745 ' HD2' ' O ' ' B' ' 53' ' ' SER . 0.0 OUTLIER -43.79 -38.12 3.96 Favored Pre-proline 0 N--CA 1.488 1.45 0 CA-C-N 119.801 1.182 . . . . 0.0 113.653 -173.543 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 54.3 Cg_endo -63.48 -28.84 70.85 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.391 2.061 . . . . 0.0 112.942 175.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . 0.572 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.5 mt -97.84 -16.55 19.75 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.723 ' HZ2' ' HG ' ' A' ' 2' ' ' SER . 0.0 OUTLIER -52.82 109.73 0.44 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.421 -178.501 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.413 ' HA3' ' C ' ' A' ' 1' ' ' PRO . . . 95.04 -22.02 40.73 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.255 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 11.5 mmmt -103.55 114.3 28.46 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -177.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.519 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.6 p -122.15 136.85 26.74 Favored Pre-proline 0 C--N 1.309 -1.184 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 171.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.541 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 84.8 Cg_exo -49.32 140.29 26.82 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.52 2.147 . . . . 0.0 111.841 172.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.76 102.54 0.27 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.12 -176.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.94 -13.34 45.43 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.618 178.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.541 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 29.6 m -90.71 174.13 7.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.418 0.627 . . . . 0.0 111.742 -178.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' ASP . . . . . 0.442 ' OD2' ' HB ' ' B' ' 69' ' ' ILE . 3.1 t70 -91.36 135.83 33.54 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 176.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.782 HG13 ' OE1' ' B' ' 40' ' ' GLU . 0.8 OUTLIER -71.66 -33.4 48.77 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 C-N-CA 118.085 -1.446 . . . . 0.0 108.856 -179.214 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.778 ' O ' HG13 ' B' ' 73' ' ' VAL . 7.6 mm -57.45 -47.51 84.76 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.118 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.801 -178.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.571 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 40.3 t -48.34 -36.2 13.92 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.301 0.572 . . . . 0.0 111.182 178.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -86.51 -31.28 21.38 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.592 -176.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' TYR . . . . . 0.572 ' CE1' ' HB2' ' B' ' 58' ' ' LEU . 5.0 m-30 -76.39 -35.82 58.42 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.443 -178.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.877 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.7 m -69.94 -33.13 54.21 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 173.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' LYS . . . . . 0.571 ' HB2' ' O ' ' B' ' 70' ' ' SER . 1.6 ttmm -68.04 -30.56 69.81 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.698 176.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -61.93 -42.89 99.62 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.624 174.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.97 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 43.2 t -94.99 8.66 42.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.12 177.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . 0.467 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 12.0 t70 -61.4 -17.04 52.26 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.354 0.597 . . . . 0.0 109.971 173.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -107.14 -4.65 35.54 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.887 173.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.816 ' HB ' ' SG ' ' B' ' 76' ' ' CYS . 56.6 mt -102.47 132.8 47.79 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.046 0 CA-C-N 117.391 0.596 . . . . 0.0 111.068 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 161.28 61.85 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.992 174.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.53 171.2 35.92 Favored Glycine 0 C--O 1.224 -0.482 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.95 -176.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 55.47 -91.47 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 122.697 0.399 . . . . 0.0 111.82 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' MET . . . . . . . . . . . . . 65.4 mtt -62.26 -28.95 70.07 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.469 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' HIS . . . . . 0.457 ' HD2' ' OE2' ' B' ' 50' ' ' GLU . 8.9 t-160 -49.72 -41.79 44.47 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.275 177.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.443 ' HA ' ' HB2' ' B' ' 88' ' ' LEU . 75.1 mttt -87.32 -14.52 40.59 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -174.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.58 -43.41 14.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.949 0.881 . . . . 0.0 109.333 172.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 66.4 mtt -80.21 -9.72 59.73 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.966 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.443 ' HB2' ' HA ' ' B' ' 85' ' ' LYS . 0.0 OUTLIER -56.71 -17.59 9.46 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.468 0.651 . . . . 0.0 111.042 177.499 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 50.4 tpp -83.92 -24.25 30.83 Favored 'General case' 0 C--N 1.316 -0.883 0 O-C-N 121.924 -0.485 . . . . 0.0 110.499 174.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -109.84 -56.4 2.32 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -169.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' GLN . . . . . 0.536 ' O ' ' HB3' ' B' ' 53' ' ' SER . 19.1 mt-30 -70.56 -40.64 73.23 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.299 -176.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.558 ' HA ' ' CB ' ' B' ' 53' ' ' SER . 1.8 tm? -46.62 -29.6 1.91 Allowed 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.71 0.631 . . . . 0.0 109.923 169.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.666 ' O ' ' HE3' ' B' ' 56' ' ' LYS . 43.6 mt-10 . . . . . 0 N--CA 1.437 -1.084 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 -178.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo . . . . . 0 CA--C 1.52 -0.209 0 N-CA-C 109.064 -1.168 . . . . 0.0 109.064 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.488 ' HB3' HD21 ' B' ' 41' ' ' LEU . 66.6 m -68.62 -176.85 0.85 Allowed 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 162.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.862 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -77.27 -55.47 5.38 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.107 172.675 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.812 HD21 HD11 ' B' ' 41' ' ' LEU . 1.1 p30 -76.22 -8.3 56.76 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.599 -1.182 . . . . 0.0 112.467 -167.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.532 ' CG2' ' HD3' ' B' ' 59' ' ' LYS . 0.3 OUTLIER -57.95 0.61 0.06 Allowed 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -172.197 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.58 ' HB ' ' CZ ' ' A' ' 20' ' ' ARG . 4.0 m -72.96 117.65 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 167.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.715 ' HG3' ' CB ' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -115.91 158.25 23.29 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 121.505 -0.747 . . . . 0.0 110.216 176.765 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.502 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 1.9 tt0 -56.16 113.08 1.4 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.444 173.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.35 -159.99 11.73 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 173.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.7 p -52.16 100.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.942 0.371 . . . . 0.0 111.141 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.418 ' HD2' ' O ' ' A' ' 80' ' ' GLY . 18.2 pttp 43.01 42.58 3.23 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.305 1.042 . . . . 0.0 112.041 -175.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.486 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 42.7 tt0 -60.26 137.0 91.63 Favored Pre-proline 0 C--O 1.232 0.182 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 177.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.531 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 28.1 Cg_exo -54.06 123.62 13.95 Favored 'Trans proline' 0 CA--C 1.511 -0.672 0 C-N-CA 122.075 1.85 . . . . 0.0 109.936 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.862 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 14.5 t80 -70.19 -53.43 10.79 Favored Pre-proline 0 N--CA 1.44 -0.954 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -166.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.501 ' HD3' ' HB3' ' A' ' 14' ' ' TYR . 31.8 Cg_exo -55.69 -18.51 21.06 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 121.414 1.409 . . . . 0.0 110.979 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.531 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 4.1 m-20 -89.96 -41.69 11.6 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.198 -1.365 . . . . 0.0 111.169 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.502 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -56.96 -41.54 78.51 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.533 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.703 HG12 ' O ' ' A' ' 14' ' ' TYR . 2.4 p -82.57 -33.6 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.519 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.88 -34.05 69.36 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 121.495 -0.753 . . . . 0.0 111.946 176.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.748 ' O ' HG12 ' A' ' 24' ' ' VAL . 17.5 ptt180 -84.79 -27.72 26.66 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.604 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 9.3 tp -54.96 -46.19 75.0 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.759 171.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.747 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 36.6 mt-30 -73.21 -45.72 54.53 Favored 'General case' 0 CA--C 1.497 -1.073 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.168 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.71 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 11.4 t70 -51.79 -52.42 49.09 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 124.05 0.844 . . . . 0.0 111.812 -177.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.748 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.3 p -82.06 -23.25 9.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -173.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.793 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -72.06 -18.86 61.9 Favored 'General case' 0 C--O 1.203 -1.357 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 173.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.422 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -86.55 -37.75 17.86 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.634 -1.167 . . . . 0.0 109.812 177.842 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.71 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 41.0 mmtt -67.62 -37.84 83.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.013 178.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.8 t -102.67 -7.7 21.52 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.227 0.537 . . . . 0.0 110.044 -171.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.793 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 86.8 mt -116.7 127.49 74.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.435 178.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.55 -9.54 54.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.263 0.554 . . . . 0.0 110.148 177.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.583 ' H ' HG22 ' A' ' 29' ' ' ILE . 13.8 t70 -98.75 136.04 39.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.233 -177.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -75.42 -29.55 59.78 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.761 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.592 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -77.44 -51.41 10.82 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -174.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.574 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -58.57 -27.88 65.01 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.436 175.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.884 ' O ' HG13 ' A' ' 39' ' ' VAL . 1.7 tmm_? -66.31 -60.74 2.49 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.5 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 26.0 mtpt -55.12 -56.1 23.61 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.373 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.719 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 19.7 m -54.8 -32.6 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.16 -170.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.862 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.2 tt -86.82 -34.0 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.416 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.884 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.0 m -66.14 -47.66 83.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 119.214 -0.995 . . . . 0.0 109.466 176.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.672 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 54.4 mt-10 -67.25 -23.75 65.74 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 123.875 0.87 . . . . 0.0 112.64 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.838 HD11 HD21 ' B' ' 4' ' ' ASN . 0.0 OUTLIER -86.22 -55.71 3.79 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.375 176.854 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.668 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 14.6 mmt -62.27 -20.67 64.52 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-O 121.76 0.791 . . . . 0.0 109.509 -176.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.754 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -48.61 -27.02 2.53 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.766 170.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.499 ' HB3' ' NZ ' ' A' ' 59' ' ' LYS . 9.2 t80 -105.4 -66.39 0.98 Allowed 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.485 ' HG2' HD12 ' A' ' 41' ' ' LEU . 14.0 mm-40 -48.25 -33.41 8.64 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 123.646 0.592 . . . . 0.0 112.44 -176.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.715 ' CB ' ' HG3' ' A' ' 7' ' ' ARG . 5.2 m-20 -99.84 -15.34 18.43 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.349 0.595 . . . . 0.0 111.643 -177.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.754 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -63.04 168.48 4.04 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.426 0.632 . . . . 0.0 111.501 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.554 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 11.1 m-20 -58.31 145.46 74.73 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.338 173.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -41.65 -49.1 5.45 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.688 2.258 . . . . 0.0 111.894 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.552 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 0.3 OUTLIER -71.23 -33.56 69.97 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.238 1.015 . . . . 0.0 111.854 177.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.554 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 69.8 m -73.94 -39.22 63.93 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 121.118 0.485 . . . . 0.0 110.014 -174.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.522 ' HA ' HD12 ' A' ' 55' ' ' ILE . 4.0 pt20 -73.39 -30.75 63.48 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 175.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.553 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 4.0 m -67.72 -21.02 65.32 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.306 172.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.698 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -77.1 -27.77 54.26 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.382 -0.824 . . . . 0.0 109.865 169.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.581 ' C ' ' HD2' ' A' ' 57' ' ' PRO . 20.8 mt -89.74 -31.72 5.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -171.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.606 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -40.68 -37.76 1.05 Allowed Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -173.883 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 55.2 Cg_endo -64.26 -28.89 64.0 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.358 2.039 . . . . 0.0 113.104 175.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.564 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 2.0 mt -98.63 -15.79 19.31 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.665 ' NZ ' HD13 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -52.56 109.35 0.39 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.348 -1.296 . . . . 0.0 110.422 179.6 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.88 -30.09 10.44 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.939 -175.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 35.0 mmtt -103.83 115.17 29.98 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-O 122.423 1.106 . . . . 0.0 111.612 -175.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.587 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.5 p -122.46 145.04 43.61 Favored Pre-proline 0 C--N 1.296 -1.754 0 CA-C-N 113.555 -1.657 . . . . 0.0 109.52 170.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.557 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 96.4 Cg_exo -48.55 141.25 20.3 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.282 1.988 . . . . 0.0 111.198 167.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.46 101.73 0.09 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.973 0.416 . . . . 0.0 112.073 -173.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.11 -9.31 70.08 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.137 176.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.557 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 4.6 m -89.56 -162.42 0.88 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 122.275 1.036 . . . . 0.0 112.167 -177.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.97 125.69 46.03 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 113.176 -1.829 . . . . 0.0 110.89 -173.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.587 HG12 ' HB ' ' A' ' 62' ' ' VAL . 0.9 OUTLIER -79.08 -31.27 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 C-N-CA 118.523 -1.271 . . . . 0.0 108.463 176.248 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.773 ' O ' HG13 ' A' ' 73' ' ' VAL . 6.9 mm -57.77 -49.16 81.77 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.147 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.564 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.6 t -49.07 -36.18 17.75 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.077 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.589 ' O ' ' HE3' ' A' ' 74' ' ' LYS . 1.3 mm-40 -84.88 -33.83 22.72 Favored 'General case' 0 C--O 1.216 -0.666 0 C-N-CA 123.349 0.66 . . . . 0.0 110.458 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.568 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 4.9 m-30 -74.5 -37.91 63.01 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.691 -176.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.862 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.7 m -70.64 -32.65 50.17 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 175.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.589 ' HE3' ' O ' ' A' ' 71' ' ' GLU . 2.4 ttpp -72.39 -27.68 62.52 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.816 177.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.491 ' HB2' HD11 ' A' ' 58' ' ' LEU . . . -66.21 -41.72 89.73 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.313 174.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 4.2 m -101.07 10.5 40.93 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.533 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -64.16 -27.48 69.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.132 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.569 ' O ' ' HB2' ' A' ' 83' ' ' MET . . . -82.18 -21.98 59.84 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.571 171.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.698 HD11 ' HB2' ' A' ' 54' ' ' ALA . 49.3 mt -81.17 163.77 3.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.446 ' N ' HG22 ' A' ' 79' ' ' ILE . . . 112.95 -13.24 24.39 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -174.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.86 155.36 8.03 Favored Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 175.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.55 -81.41 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.041 0.536 . . . . 0.0 112.334 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.569 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 63.1 mtt -61.75 -29.51 70.17 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-O 120.663 0.268 . . . . 0.0 110.734 -176.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.534 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 8.2 t-80 -56.78 -32.44 65.64 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.824 175.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -84.58 -19.33 33.25 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.096 0.474 . . . . 0.0 110.356 -176.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.06 -46.15 10.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.583 176.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -80.4 -13.78 58.86 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.067 -175.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.547 ' O ' ' HB3' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -50.79 -37.18 41.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.569 179.74 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 49.5 ttm -83.68 -19.9 34.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.099 0.476 . . . . 0.0 111.002 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -93.41 -43.83 8.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.151 -173.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.498 ' C ' ' HB3' ' A' ' 53' ' ' SER . 19.1 mt-30 -99.51 -51.38 3.79 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.36 -174.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.547 ' HB3' ' O ' ' A' ' 88' ' ' LEU . 0.4 OUTLIER -64.86 1.66 0.86 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.361 177.72 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.463 ' H ' ' C ' ' A' ' 91' ' ' GLN . 3.4 pt-20 . . . . . 0 C--O 1.248 1.006 0 C-N-CA 123.819 0.848 . . . . 0.0 112.196 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' PRO . . . . . 0.422 ' HB2' ' H ' ' B' ' 2' ' ' SER . 96.2 Cg_endo . . . . . 0 CA--C 1.518 -0.319 0 N-CA-C 109.113 -1.149 . . . . 0.0 109.113 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.468 ' HB3' HD21 ' A' ' 41' ' ' LEU . 71.2 m -68.78 -176.55 0.84 Allowed 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 162.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.859 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -77.24 -55.57 5.31 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.509 -0.877 . . . . 0.0 110.173 172.362 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.838 HD21 HD11 ' A' ' 41' ' ' LEU . 1.1 p30 -76.21 -8.32 56.78 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.557 -1.201 . . . . 0.0 112.413 -167.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.579 ' CG2' ' HD3' ' A' ' 59' ' ' LYS . 0.2 OUTLIER -57.85 0.5 0.06 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -172.182 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.578 ' HB ' ' CZ ' ' B' ' 20' ' ' ARG . 4.0 m -72.88 117.92 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 167.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.705 ' HG3' ' CB ' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -115.86 158.42 22.98 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 121.568 -0.708 . . . . 0.0 110.189 176.621 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' GLN . . . . . 0.509 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 1.9 tt0 -56.44 112.9 1.38 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.372 173.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.2 -159.75 10.94 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 173.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 12.3 p -52.32 100.88 0.03 OUTLIER 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.932 0.366 . . . . 0.0 111.152 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.407 ' HD2' ' O ' ' B' ' 80' ' ' GLY . 18.3 pttp 42.89 42.17 2.92 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.383 1.073 . . . . 0.0 112.255 -175.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.49 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 43.1 tt0 -59.84 136.87 90.32 Favored Pre-proline 0 C--O 1.232 0.17 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . 0.543 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 27.6 Cg_exo -54.05 123.6 13.89 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.129 1.886 . . . . 0.0 109.907 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . 0.864 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 14.8 t80 -70.07 -53.61 10.85 Favored Pre-proline 0 N--CA 1.44 -0.96 0 CA-C-O 118.335 -0.841 . . . . 0.0 113.23 -166.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.512 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 32.0 Cg_exo -55.6 -18.56 20.71 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 121.55 1.5 . . . . 0.0 110.999 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.543 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 4.4 m-20 -89.92 -41.85 11.54 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.068 -1.424 . . . . 0.0 111.071 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' PHE . . . . . 0.509 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -56.9 -41.54 78.27 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.614 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.699 HG12 ' O ' ' B' ' 14' ' ' TYR . 2.4 p -82.52 -33.61 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.521 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.28 -33.33 69.31 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.457 -0.777 . . . . 0.0 112.012 176.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.753 ' O ' HG12 ' B' ' 24' ' ' VAL . 17.5 ptt180 -85.11 -27.85 25.98 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.609 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 9.3 tp -54.84 -46.2 74.6 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.814 171.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . 0.751 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 36.3 mt-30 -73.19 -45.88 53.78 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.157 178.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.714 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 11.3 t70 -51.89 -52.24 51.14 Favored 'General case' 0 C--N 1.314 -0.96 0 O-C-N 124.067 0.854 . . . . 0.0 111.841 -177.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' VAL . . . . . 0.753 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.4 p -82.02 -23.27 9.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.302 0.572 . . . . 0.0 109.56 -174.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.801 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -72.06 -18.87 61.91 Favored 'General case' 0 C--O 1.204 -1.307 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . 0.426 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -86.7 -37.54 17.86 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.814 177.799 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.714 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 40.9 mmtt -67.96 -37.23 81.32 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.999 178.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 33.4 t -103.08 -7.49 21.31 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.403 0.621 . . . . 0.0 110.189 -171.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.801 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 86.6 mt -116.98 127.18 74.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.428 178.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.44 -9.47 54.55 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.276 0.56 . . . . 0.0 110.199 177.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.58 ' H ' HG22 ' B' ' 29' ' ' ILE . 13.7 t70 -98.68 136.13 39.19 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.258 -177.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -75.55 -29.56 59.42 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.67 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.592 ' O ' HG13 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -77.36 -51.49 10.74 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -174.944 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.55 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -58.61 -27.86 65.08 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.378 176.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.867 ' O ' HG13 ' B' ' 39' ' ' VAL . 1.7 tmm_? -66.34 -60.86 2.38 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 178.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.488 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 25.9 mtpt -55.03 -56.1 23.58 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.382 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.713 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 19.6 m -54.8 -32.37 25.96 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.258 -170.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.859 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.2 tt -86.97 -34.07 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.525 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.867 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.0 m -65.97 -47.69 84.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.438 176.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.671 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 54.6 mt-10 -67.48 -23.43 65.49 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.711 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.812 HD11 HD21 ' A' ' 4' ' ' ASN . 0.0 OUTLIER -86.33 -55.94 3.67 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.258 176.648 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' MET . . . . . 0.675 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 14.7 mmt -62.2 -20.66 64.41 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-O 121.768 0.794 . . . . 0.0 109.578 -176.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.745 ' O ' ' HB2' ' B' ' 47' ' ' ALA . . . -48.59 -27.1 2.56 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.779 170.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' TYR . . . . . 0.503 ' CG ' ' HB2' ' B' ' 52' ' ' GLN . 9.1 t80 -105.36 -66.7 0.96 Allowed 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.491 ' HG2' HD12 ' B' ' 41' ' ' LEU . 13.1 mm-40 -47.97 -33.65 8.09 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 123.636 0.585 . . . . 0.0 112.405 -176.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.705 ' CB ' ' HG3' ' B' ' 7' ' ' ARG . 5.3 m-20 -99.55 -15.3 18.68 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.297 0.57 . . . . 0.0 111.724 -177.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.745 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -63.11 168.53 4.08 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.39 0.614 . . . . 0.0 111.483 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.558 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 11.2 m-20 -58.09 145.41 73.22 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.387 173.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -41.58 -49.49 5.18 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 122.741 2.294 . . . . 0.0 111.875 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.544 ' HA ' ' HB2' ' B' ' 53' ' ' SER . 0.3 OUTLIER -70.78 -33.69 71.01 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.372 1.069 . . . . 0.0 111.801 177.737 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.558 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 70.2 m -73.9 -39.16 64.06 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.29 0.566 . . . . 0.0 110.151 -174.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.541 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.9 pt20 -73.42 -30.65 63.37 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 175.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . 0.554 ' O ' ' HE2' ' B' ' 56' ' ' LYS . 3.7 m -68.03 -20.87 65.03 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.26 172.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.709 ' HB2' HD11 ' B' ' 79' ' ' ILE . . . -76.97 -27.86 54.92 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.359 -0.838 . . . . 0.0 109.877 168.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.577 ' C ' ' HD2' ' B' ' 57' ' ' PRO . 20.9 mt -89.66 -31.78 5.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -171.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.603 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -40.62 -37.92 1.08 Allowed Pre-proline 0 N--CA 1.49 1.525 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -173.82 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 53.9 Cg_endo -64.17 -28.97 64.83 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.178 1.919 . . . . 0.0 113.022 175.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . 0.56 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 2.0 mt -98.54 -15.65 19.45 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.668 ' NZ ' HD13 ' B' ' 41' ' ' LEU . 0.3 OUTLIER -52.77 109.31 0.39 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.385 179.459 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.86 -30.24 10.15 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.944 -175.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 34.9 mmtt -103.68 115.31 30.26 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 122.244 1.021 . . . . 0.0 111.688 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.595 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.6 p -122.53 145.22 44.25 Favored Pre-proline 0 C--N 1.297 -1.681 0 CA-C-N 113.64 -1.618 . . . . 0.0 109.559 170.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.568 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 98.6 Cg_exo -48.47 141.45 19.52 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.182 1.921 . . . . 0.0 111.21 168.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.53 101.82 0.1 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.991 -173.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.08 -9.47 70.12 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.034 -0.603 . . . . 0.0 113.157 175.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.568 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 4.2 m -89.56 -162.69 0.9 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 122.349 1.071 . . . . 0.0 111.962 -177.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.8 125.9 45.8 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 113.118 -1.855 . . . . 0.0 110.858 -173.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.595 HG12 ' HB ' ' B' ' 62' ' ' VAL . 0.9 OUTLIER -79.24 -31.36 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 C-N-CA 118.567 -1.253 . . . . 0.0 108.547 176.175 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.772 ' O ' HG13 ' B' ' 73' ' ' VAL . 7.0 mm -57.73 -49.28 81.32 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.139 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.522 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 42.8 t -48.81 -36.4 16.63 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.011 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.584 ' O ' ' HE3' ' B' ' 74' ' ' LYS . 1.4 mm-40 -84.81 -33.76 22.87 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 123.442 0.697 . . . . 0.0 110.591 -178.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' TYR . . . . . 0.56 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.0 m-30 -74.79 -37.8 62.29 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.671 -176.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.864 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.7 m -70.47 -32.76 51.07 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.676 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 174.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' LYS . . . . . 0.584 ' HE3' ' O ' ' B' ' 71' ' ' GLU . 2.4 ttpp -72.58 -27.3 62.1 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.866 178.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . 0.486 ' HB2' HD11 ' B' ' 58' ' ' LEU . . . -66.39 -41.82 88.81 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.3 174.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 4.2 m -101.12 10.52 40.83 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.496 -177.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -64.02 -27.94 69.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.059 178.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . 0.568 ' O ' ' HB2' ' B' ' 83' ' ' MET . . . -81.64 -22.08 60.69 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.619 171.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.709 HD11 ' HB2' ' B' ' 54' ' ' ALA . 49.9 mt -81.25 163.99 3.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . 0.437 ' N ' HG22 ' B' ' 79' ' ' ILE . . . 112.71 -13.12 25.0 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -174.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.86 155.36 8.03 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 175.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.51 -81.67 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.09 0.556 . . . . 0.0 112.339 178.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 83' ' ' MET . . . . . 0.568 ' HB2' ' O ' ' B' ' 78' ' ' GLY . 62.9 mtt -61.5 -29.74 70.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.677 0.275 . . . . 0.0 110.632 -176.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' HIS . . . . . 0.546 ' O ' ' HB2' ' B' ' 88' ' ' LEU . 8.2 t-80 -56.62 -32.53 65.39 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 175.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -84.43 -19.4 33.52 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.132 0.492 . . . . 0.0 110.39 -176.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.74 -46.54 10.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.547 176.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -80.16 -13.89 58.9 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.111 -175.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.565 ' O ' ' HB3' ' B' ' 92' ' ' LEU . 0.4 OUTLIER -50.54 -37.42 39.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.495 179.706 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 49.8 ttm -83.49 -20.09 34.6 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.025 0.44 . . . . 0.0 110.981 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -93.43 -43.55 8.69 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.092 -173.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' GLN . . . . . 0.504 ' C ' ' HB3' ' B' ' 53' ' ' SER . 19.1 mt-30 -99.62 -51.22 3.81 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.347 -174.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.565 ' HB3' ' O ' ' B' ' 88' ' ' LEU . 0.4 OUTLIER -65.11 1.77 0.92 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 121.171 0.51 . . . . 0.0 110.338 177.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.465 ' H ' ' C ' ' B' ' 91' ' ' GLN . 3.4 pt-20 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.182 -0.913 . . . . 0.0 111.944 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo . . . . . 0 CA--C 1.518 -0.303 0 N-CA-C 109.1 -1.154 . . . . 0.0 109.1 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.735 ' HB2' HG23 ' A' ' 5' ' ' THR . 73.6 m -68.83 -177.23 0.96 Allowed 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 162.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.769 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -78.14 -53.92 6.83 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.649 172.549 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.574 ' OD1' ' HG ' ' B' ' 41' ' ' LEU . 2.2 p-10 -87.58 5.7 38.09 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.133 -0.939 . . . . 0.0 112.994 -164.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.735 HG23 ' HB2' ' A' ' 2' ' ' SER . 2.2 p -64.8 -3.83 3.73 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.069 0.462 . . . . 0.0 111.391 -176.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.52 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.6 m -75.38 131.9 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 175.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.768 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -153.18 158.91 42.47 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.443 ' HG2' ' HB3' ' A' ' 12' ' ' GLU . 2.3 tt0 -42.24 115.16 0.65 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 112.758 -2.019 . . . . 0.0 112.831 -178.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.16 -148.54 11.85 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.44 172.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.8 m -55.89 97.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.106 0.453 . . . . 0.0 110.937 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.0 pttt 40.61 40.28 0.89 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.332 1.053 . . . . 0.0 112.085 -174.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.443 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 42.3 tt0 -55.96 139.57 70.64 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.932 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.583 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 52.1 Cg_exo -51.29 122.67 10.51 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.158 1.905 . . . . 0.0 110.058 178.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.801 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 9.3 t80 -72.22 -52.88 6.8 Favored Pre-proline 0 N--CA 1.442 -0.842 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -166.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.544 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 36.7 Cg_exo -56.2 -20.01 29.73 Favored 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 121.665 1.577 . . . . 0.0 110.968 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.583 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.1 m-20 -89.76 -40.21 12.64 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 113.845 -1.525 . . . . 0.0 110.754 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.436 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -56.01 -43.79 78.04 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 175.512 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.678 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 2.4 p -80.58 -33.24 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.379 -179.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.72 -34.88 67.92 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 121.594 -0.691 . . . . 0.0 111.937 175.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.727 ' O ' HG12 ' A' ' 24' ' ' VAL . 16.7 ptt180 -84.93 -26.87 26.95 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.649 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 4.5 tp -54.35 -49.2 70.34 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 171.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.678 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 30.6 mt-30 -67.21 -52.29 43.01 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.338 177.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.779 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 23.8 t70 -47.53 -53.53 14.17 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 -175.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.727 HG12 ' O ' ' A' ' 20' ' ' ARG . 5.0 p -81.59 -28.3 10.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.452 0.644 . . . . 0.0 110.381 -168.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.918 ' HB3' ' CZ ' ' A' ' 35' ' ' ARG . . . -78.91 -17.69 55.11 Favored 'General case' 0 C--O 1.198 -1.623 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 175.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.555 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -76.21 -37.74 57.37 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 172.803 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.779 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 39.7 mmtt -64.23 -36.16 83.17 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.508 177.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.0 t -104.26 -12.93 16.37 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.086 0.469 . . . . 0.0 110.27 -172.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.633 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 91.7 mt -111.8 117.11 54.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.296 177.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.49 -1.78 56.27 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.225 0.536 . . . . 0.0 110.076 175.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.596 ' H ' HG22 ' A' ' 29' ' ' ILE . 10.8 t70 -99.52 131.67 45.37 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.29 -177.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -75.23 -25.48 58.14 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.841 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.597 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -81.08 -52.8 7.0 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -175.18 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.537 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -59.79 -24.68 64.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.54 177.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.918 ' CZ ' ' HB3' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -72.73 -57.41 4.12 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.513 ' O ' HG22 ' A' ' 39' ' ' VAL . 22.4 mtpt -52.85 -55.6 21.9 Favored 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.706 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.708 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 13.9 m -55.82 -33.08 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.195 -171.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.892 HG22 HH12 ' A' ' 35' ' ' ARG . 0.2 OUTLIER -87.35 -31.4 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 119.642 -0.823 . . . . 0.0 111.687 177.761 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.765 HG12 ' NH2' ' A' ' 35' ' ' ARG . 1.3 m -57.41 -57.05 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 118.666 -1.213 . . . . 0.0 109.168 168.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.61 ' HG2' HG22 ' A' ' 68' ' ' VAL . 46.2 mt-10 -63.19 -29.74 71.03 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 124.252 1.021 . . . . 0.0 112.611 -175.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.708 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -85.43 -49.98 7.67 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.937 179.602 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.598 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 19.7 mmt -67.5 -20.5 65.45 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.56 0.695 . . . . 0.0 109.517 -177.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.651 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -52.36 -26.74 13.18 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.655 172.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.596 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 17.2 t80 -105.98 -68.12 0.89 Allowed 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 174.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.477 ' CG ' HD12 ' A' ' 41' ' ' LEU . 8.8 mm-40 -48.47 -26.6 2.22 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 124.323 1.014 . . . . 0.0 113.024 -175.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.768 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.1 m-20 -108.15 -21.92 12.59 Favored 'General case' 0 N--CA 1.435 -1.212 0 O-C-N 122.083 -0.386 . . . . 0.0 111.567 -178.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.632 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -59.49 178.95 0.13 Allowed 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.932 0.872 . . . . 0.0 112.925 -174.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.594 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 8.7 m-20 -60.2 140.45 91.17 Favored Pre-proline 0 N--CA 1.442 -0.83 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.452 174.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.424 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 79.5 Cg_exo -42.6 -47.73 7.51 Favored 'Trans proline' 0 C--N 1.33 -0.447 0 C-N-CA 122.877 2.385 . . . . 0.0 112.091 -178.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.56 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 0.3 OUTLIER -72.85 -33.4 66.11 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.119 0.967 . . . . 0.0 111.627 178.368 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.684 ' HA ' ' CD1' ' A' ' 79' ' ' ILE . 99.1 m -74.85 -37.28 62.26 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -173.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.615 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.8 pt20 -72.54 -31.4 65.27 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 174.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.576 ' HB3' ' C ' ' A' ' 91' ' ' GLN . 12.0 m -68.49 -21.76 64.59 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.178 -1.373 . . . . 0.0 110.409 174.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.848 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -78.22 -25.18 46.86 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.756 0.789 . . . . 0.0 109.617 169.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.615 HD12 ' HA ' ' A' ' 52' ' ' GLN . 25.4 mt -89.56 -32.02 5.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -173.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.626 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -42.4 -38.94 2.81 Favored Pre-proline 0 N--CA 1.487 1.423 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -173.492 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 56.0 Cg_endo -63.57 -28.96 70.1 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 122.346 2.031 . . . . 0.0 112.958 175.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.547 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.6 mt -96.92 -16.53 20.63 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.596 ' HE3' ' HB3' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -53.36 109.41 0.43 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.189 -178.768 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.79 -20.38 47.47 Favored Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.525 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -104.11 114.19 28.26 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.477 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.3 p -123.02 140.28 33.18 Favored Pre-proline 0 C--N 1.311 -1.096 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 171.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.532 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 87.6 Cg_exo -48.58 138.73 24.57 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.429 2.086 . . . . 0.0 111.513 170.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.73 101.02 0.12 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.431 -175.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.09 -14.34 44.41 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.723 177.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.532 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 17.9 m -89.96 175.92 7.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.555 0.693 . . . . 0.0 111.673 -178.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.732 ' OD1' ' HB ' ' A' ' 69' ' ' ILE . 32.8 t70 -87.94 139.27 30.69 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.086 177.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.61 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -79.48 -30.58 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 C-N-CA 118.049 -1.46 . . . . 0.0 108.832 178.448 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.763 ' O ' HG13 ' A' ' 73' ' ' VAL . 6.2 mm -59.09 -47.9 88.52 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.978 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.789 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 43.2 t -44.83 -39.37 5.27 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.253 175.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -86.54 -28.8 23.14 Favored 'General case' 0 CA--C 1.512 -0.505 0 C-N-CA 122.771 0.428 . . . . 0.0 111.086 -177.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.601 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.3 m-30 -76.55 -35.6 58.15 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.716 0.77 . . . . 0.0 109.462 -178.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.801 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.5 m -71.39 -30.29 38.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 172.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.465 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -68.05 -32.43 72.77 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.292 175.143 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -63.03 -43.65 98.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.916 177.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.57 ' SG ' ' HB ' ' A' ' 79' ' ' ILE . 23.7 t -94.96 4.47 53.77 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.033 178.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.465 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 10.9 t70 -60.33 -26.07 66.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.233 0.54 . . . . 0.0 110.271 176.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 83' ' ' MET . . . -92.67 -28.36 12.66 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 115.452 -0.795 . . . . 0.0 112.501 174.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.848 HD11 ' HB2' ' A' ' 54' ' ' ALA . 65.0 mt -61.18 -87.01 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -172.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.449 ' N ' HG22 ' A' ' 79' ' ' ILE . . . 29.98 53.37 0.2 Allowed Glycine 0 C--N 1.339 0.707 0 N-CA-C 115.349 0.9 . . . . 0.0 115.349 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.583 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 80.52 -61.01 4.51 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.856 175.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.26 -69.55 0.14 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.41 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 65.6 mtt -73.94 -15.16 61.13 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.654 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 8.0 t-80 -58.58 -34.31 70.94 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.049 176.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.583 ' HG2' ' O ' ' A' ' 81' ' ' GLY . 31.8 mmtp -82.44 -14.85 54.42 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.229 -178.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.6 -47.13 9.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.782 0.801 . . . . 0.0 110.74 175.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 9.7 mmt -86.77 -13.26 45.69 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.612 -1.176 . . . . 0.0 112.177 -172.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.654 ' HB2' ' O ' ' A' ' 84' ' ' HIS . 0.6 OUTLIER -48.38 -39.43 22.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.194 0.521 . . . . 0.0 112.055 -179.103 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 56.7 ttp -83.23 -19.82 35.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.97 0.414 . . . . 0.0 111.045 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -91.79 -51.7 5.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.944 0.402 . . . . 0.0 111.93 -174.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.576 ' C ' ' HB3' ' A' ' 53' ' ' SER . 21.9 mt-30 -89.86 -57.54 2.83 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.168 -174.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.629 ' HB3' ' O ' ' A' ' 88' ' ' LEU . 1.2 tm? -53.27 -33.73 54.31 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 176.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 3.1 pt-20 . . . . . 0 C--O 1.25 1.116 0 O-C-N 125.147 1.53 . . . . 0.0 113.561 -177.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' PRO . . . . . 0.437 ' HB2' ' H ' ' B' ' 2' ' ' SER . 94.2 Cg_endo . . . . . 0 CA--C 1.519 -0.271 0 N-CA-C 109.115 -1.148 . . . . 0.0 109.115 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.761 ' HB2' HG23 ' B' ' 5' ' ' THR . 74.3 m -68.69 -177.77 1.04 Allowed 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 162.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.782 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -77.85 -53.82 7.05 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.64 172.827 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.55 ' OD1' ' HG ' ' A' ' 41' ' ' LEU . 2.1 p-10 -87.61 5.71 38.11 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.973 -164.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.761 HG23 ' HB2' ' B' ' 2' ' ' SER . 2.2 p -64.85 -3.75 3.71 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.038 0.447 . . . . 0.0 111.418 -176.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.529 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.6 m -75.5 132.15 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 175.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.775 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -153.32 158.76 42.05 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -179.724 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' GLN . . . . . 0.451 ' HG2' ' HB3' ' B' ' 12' ' ' GLU . 2.3 tt0 -42.32 115.14 0.65 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 112.95 -1.932 . . . . 0.0 112.845 -178.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.4 -148.58 12.29 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.424 173.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 21.6 m -55.45 97.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 117.187 0.493 . . . . 0.0 111.096 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 60.9 pttt 40.5 40.73 0.93 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.275 1.03 . . . . 0.0 111.974 -174.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.451 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 41.1 tt0 -56.4 139.53 74.02 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.891 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . 0.574 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 52.0 Cg_exo -51.19 122.45 10.07 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.25 1.967 . . . . 0.0 110.019 178.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . 0.803 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 9.3 t80 -72.19 -52.91 6.84 Favored Pre-proline 0 N--CA 1.44 -0.935 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -166.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.533 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 36.6 Cg_exo -55.94 -20.11 28.4 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 121.589 1.526 . . . . 0.0 110.979 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.574 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 0.9 OUTLIER -89.77 -39.96 12.79 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.869 -1.514 . . . . 0.0 110.826 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' PHE . . . . . 0.441 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -56.28 -43.66 79.04 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 175.575 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.672 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 2.4 p -80.61 -33.23 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.344 -178.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.78 -34.71 67.89 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 121.627 -0.671 . . . . 0.0 111.967 175.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.731 ' O ' HG12 ' B' ' 24' ' ' VAL . 16.6 ptt180 -85.04 -26.96 26.69 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.652 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 4.5 tp -54.33 -49.24 70.18 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 171.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . 0.672 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 30.9 mt-30 -67.16 -52.39 42.07 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.203 177.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.801 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 24.5 t70 -47.38 -53.67 13.24 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -175.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' VAL . . . . . 0.731 HG12 ' O ' ' B' ' 20' ' ' ARG . 4.9 p -81.55 -28.27 10.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.289 0.566 . . . . 0.0 110.405 -168.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.91 ' HB3' ' CZ ' ' B' ' 35' ' ' ARG . . . -78.86 -17.6 55.36 Favored 'General case' 0 C--O 1.198 -1.646 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 175.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . 0.548 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -76.6 -37.36 56.57 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 172.83 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.801 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 39.1 mmtt -64.79 -35.32 80.72 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.539 177.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 32.7 t -105.0 -12.38 16.2 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.026 0.441 . . . . 0.0 110.426 -172.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.647 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 91.6 mt -112.43 116.8 53.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.359 177.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.03 -1.49 54.89 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.227 0.537 . . . . 0.0 110.153 175.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.592 ' H ' HG22 ' B' ' 29' ' ' ILE . 10.5 t70 -99.61 131.59 45.51 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.164 -177.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -75.12 -25.78 58.72 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.858 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.596 ' O ' HG13 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -80.93 -53.02 6.82 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -174.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.553 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -59.6 -24.61 63.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.641 177.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.91 ' CZ ' ' HB3' ' B' ' 25' ' ' ALA . 0.0 OUTLIER -72.87 -57.29 4.18 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.964 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.517 ' O ' HG22 ' B' ' 39' ' ' VAL . 22.5 mtpt -52.91 -55.58 22.27 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.754 177.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.714 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 13.7 m -55.88 -32.91 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.402 -171.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.867 HG22 HH12 ' B' ' 35' ' ' ARG . 0.2 OUTLIER -87.35 -31.45 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.632 177.687 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.757 HG12 ' NH2' ' B' ' 35' ' ' ARG . 1.3 m -57.35 -57.02 11.8 Favored 'Isoleucine or valine' 0 C--N 1.343 0.308 0 C-N-CA 118.663 -1.215 . . . . 0.0 109.242 168.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.6 ' HG2' HG22 ' B' ' 68' ' ' VAL . 46.3 mt-10 -63.25 -29.74 71.02 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 124.282 1.033 . . . . 0.0 112.572 -175.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.714 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -85.42 -50.08 7.59 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.983 179.52 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' MET . . . . . 0.588 ' O ' ' HB2' ' B' ' 46' ' ' ASN . 19.8 mmt -67.4 -20.29 65.51 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.618 0.723 . . . . 0.0 109.672 -177.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.643 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -52.54 -26.76 14.12 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.668 172.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' TYR . . . . . 0.599 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 16.9 t80 -105.93 -68.03 0.9 Allowed 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.467 ' CG ' HD12 ' B' ' 41' ' ' LEU . 9.5 mm-40 -48.57 -26.69 2.33 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 124.259 0.975 . . . . 0.0 112.979 -175.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.775 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.2 m-20 -108.18 -21.9 12.59 Favored 'General case' 0 N--CA 1.435 -1.205 0 O-C-N 122.191 -0.318 . . . . 0.0 111.514 -178.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -59.41 179.27 0.11 Allowed 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 122.018 0.913 . . . . 0.0 112.99 -174.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.596 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 7.9 m-20 -60.43 140.42 91.98 Favored Pre-proline 0 N--CA 1.442 -0.846 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.436 174.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . 0.422 ' O ' ' HG2' ' B' ' 52' ' ' GLN . 78.3 Cg_exo -42.41 -47.62 7.25 Favored 'Trans proline' 0 C--N 1.33 -0.411 0 C-N-CA 122.832 2.355 . . . . 0.0 112.251 -178.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.564 ' HA ' ' HB2' ' B' ' 53' ' ' SER . 0.3 OUTLIER -73.09 -33.51 65.64 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 124.226 1.01 . . . . 0.0 111.654 178.435 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.686 ' HA ' ' CD1' ' B' ' 79' ' ' ILE . 98.0 m -74.72 -37.18 62.62 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 120.911 0.386 . . . . 0.0 110.024 -173.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.617 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.8 pt20 -72.52 -31.52 65.39 Favored 'General case' 0 C--O 1.211 -0.925 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 174.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . 0.591 ' HB3' ' C ' ' B' ' 91' ' ' GLN . 13.2 m -68.42 -21.91 64.64 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.389 174.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.824 ' HB2' HD11 ' B' ' 79' ' ' ILE . . . -78.17 -25.0 47.0 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.756 0.789 . . . . 0.0 109.668 169.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.617 HD12 ' HA ' ' B' ' 52' ' ' GLN . 25.2 mt -89.62 -31.88 5.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -173.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.629 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -42.51 -38.79 2.82 Favored Pre-proline 0 N--CA 1.488 1.425 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -173.477 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 56.0 Cg_endo -63.74 -29.1 68.66 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 122.261 1.974 . . . . 0.0 112.912 175.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . 0.565 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.6 mt -96.65 -16.41 20.99 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.599 ' HE3' ' HB3' ' B' ' 44' ' ' TYR . 0.0 OUTLIER -53.42 109.37 0.43 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.161 -178.801 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.76 -20.08 49.14 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.493 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -104.15 114.27 28.39 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.474 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.3 p -122.96 140.4 33.33 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 171.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.531 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 86.5 Cg_exo -48.85 138.68 26.18 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.347 2.031 . . . . 0.0 111.537 170.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.79 101.2 0.13 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.421 -175.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.96 -14.29 44.97 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.817 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.531 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 19.0 m -89.85 176.21 6.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.671 0.748 . . . . 0.0 111.497 -178.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' ASP . . . . . 0.716 ' OD1' ' HB ' ' B' ' 69' ' ' ILE . 29.8 t70 -88.03 139.45 30.49 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.172 176.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.6 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.9 OUTLIER -79.6 -30.69 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 C-N-CA 118.072 -1.451 . . . . 0.0 108.765 178.417 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.754 ' O ' HG13 ' B' ' 73' ' ' VAL . 6.1 mm -59.01 -47.92 88.33 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.079 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.832 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 41.0 t -44.9 -39.3 5.31 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.273 175.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -86.45 -29.03 23.13 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 121.101 0.477 . . . . 0.0 111.015 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' TYR . . . . . 0.593 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.3 m-30 -76.48 -35.54 58.35 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.675 0.75 . . . . 0.0 109.402 -178.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.803 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.5 m -71.46 -30.5 39.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 172.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' B' ' 70' ' ' SER . 0.4 OUTLIER -67.92 -32.31 72.68 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.235 175.134 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -63.08 -43.76 97.64 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.888 177.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.579 ' SG ' ' HB ' ' B' ' 79' ' ' ILE . 26.3 t -95.08 4.4 53.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.037 178.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . 0.46 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 8.9 t70 -60.02 -26.58 66.2 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.141 176.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' B' ' 83' ' ' MET . . . -92.36 -27.82 14.5 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.554 174.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.824 HD11 ' HB2' ' B' ' 54' ' ' ALA . 65.2 mt -61.58 -86.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -172.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . 0.438 ' N ' HG22 ' B' ' 79' ' ' ILE . . . 29.87 53.55 0.19 Allowed Glycine 0 C--N 1.339 0.721 0 N-CA-C 115.252 0.861 . . . . 0.0 115.252 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.577 ' O ' ' HG2' ' B' ' 85' ' ' LYS . . . 80.11 -60.66 4.44 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.85 -0.69 . . . . 0.0 113.893 175.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.35 -69.25 0.15 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -173.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 83' ' ' MET . . . . . 0.416 ' HB2' ' O ' ' B' ' 78' ' ' GLY . 65.5 mtt -74.24 -14.93 61.0 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' HIS . . . . . 0.649 ' O ' ' HB2' ' B' ' 88' ' ' LEU . 7.9 t-160 -58.76 -34.35 71.32 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.975 176.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.577 ' HG2' ' O ' ' B' ' 81' ' ' GLY . 31.7 mmtp -82.38 -14.71 54.78 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.179 0.514 . . . . 0.0 110.288 -178.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.48 -47.73 9.02 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.666 0.746 . . . . 0.0 110.559 175.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 9.9 mmt -86.55 -13.05 47.02 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.592 -1.185 . . . . 0.0 112.176 -172.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.649 ' HB2' ' O ' ' B' ' 84' ' ' HIS . 0.6 OUTLIER -48.26 -39.51 21.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.242 0.544 . . . . 0.0 111.968 -179.277 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 56.6 ttp -83.23 -20.16 35.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.917 0.389 . . . . 0.0 110.912 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -91.54 -51.49 5.24 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.898 -174.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' GLN . . . . . 0.591 ' C ' ' HB3' ' B' ' 53' ' ' SER . 22.0 mt-30 -89.91 -57.76 2.75 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.076 -174.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.641 ' HB3' ' O ' ' B' ' 88' ' ' LEU . 1.2 tm? -53.11 -34.03 54.92 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 176.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' B' ' 91' ' ' GLN . 2.9 pt-20 . . . . . 0 C--O 1.249 1.037 0 O-C-N 125.087 1.492 . . . . 0.0 113.606 -177.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.456 ' C ' ' HA3' ' B' ' 60' ' ' GLY . 93.5 Cg_endo . . . . . 0 CA--C 1.517 -0.344 0 N-CA-C 109.114 -1.148 . . . . 0.0 109.114 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.544 ' HB2' HG23 ' A' ' 5' ' ' THR . 58.9 m -65.31 177.78 1.04 Allowed 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 162.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.702 ' CB ' ' HA ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -77.27 -54.08 6.92 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.566 174.541 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.52 ' CG ' ' HG3' ' A' ' 42' ' ' MET . 1.8 p-10 -86.58 6.62 29.95 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.792 -165.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.627 ' CG2' ' HD3' ' B' ' 59' ' ' LYS . 0.7 OUTLIER -62.21 -4.94 1.97 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.025 0.441 . . . . 0.0 111.613 -177.507 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.662 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.4 m -75.93 130.3 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 174.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.76 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -154.79 159.64 40.75 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 118.6 -1.24 . . . . 0.0 113.643 -179.752 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.472 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.4 mt-30 -41.39 113.75 0.44 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.125 -1.852 . . . . 0.0 112.809 -178.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.98 -141.75 6.24 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.56 174.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.6 m -62.01 96.81 0.07 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 117.011 0.406 . . . . 0.0 110.528 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.2 pttt 41.54 41.94 1.8 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.423 1.089 . . . . 0.0 112.093 -176.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.413 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 71.8 tt0 -58.77 140.0 86.12 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.114 178.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.531 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 31.5 Cg_exo -54.25 123.55 13.85 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.23 1.953 . . . . 0.0 110.041 178.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.783 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 10.4 t80 -71.13 -52.4 9.35 Favored Pre-proline 0 N--CA 1.439 -0.991 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -166.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.55 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 37.5 Cg_exo -56.47 -19.38 28.91 Favored 'Trans proline' 0 C--N 1.36 1.134 0 C-N-CA 121.478 1.452 . . . . 0.0 111.116 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.531 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.4 m-20 -90.71 -39.32 12.51 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 113.952 -1.476 . . . . 0.0 110.766 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.472 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -56.78 -44.05 81.46 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.532 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.687 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 2.4 p -78.72 -32.99 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.12 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.71 -35.11 68.14 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 121.967 -0.458 . . . . 0.0 111.91 175.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.733 ' O ' HG12 ' A' ' 24' ' ' VAL . 15.3 ptt180 -85.18 -25.38 27.44 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.65 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 3.9 tp -55.57 -48.73 74.31 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.313 171.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.687 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 36.4 mt-30 -66.78 -52.05 48.59 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.658 177.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.739 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 11.4 t70 -47.79 -53.75 14.43 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -175.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 20' ' ' ARG . 4.3 p -82.53 -26.6 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 CA-C-O 122.04 0.924 . . . . 0.0 109.56 -169.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.709 ' HB3' ' CZ ' ' A' ' 35' ' ' ARG . . . -78.51 -16.88 57.01 Favored 'General case' 0 C--O 1.197 -1.699 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 176.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.471 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -80.04 -37.14 34.62 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.821 0.82 . . . . 0.0 108.88 172.875 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.739 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 44.5 mmtt -63.69 -32.73 74.31 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.429 176.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.433 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 34.7 m -106.06 -11.39 16.14 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.06 0.457 . . . . 0.0 110.622 -174.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.675 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 96.3 mt -117.58 119.43 61.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.57 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.28 -1.87 58.27 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.346 0.593 . . . . 0.0 110.08 175.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.536 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 9.6 t70 -96.65 121.83 38.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.385 -176.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -68.06 -23.02 64.91 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.999 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.563 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -82.42 -54.04 5.52 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -177.42 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.551 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -57.91 -24.96 60.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.84 178.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.917 ' NH1' ' HA ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -69.14 -62.2 1.48 Allowed 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 176.92 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.492 ' O ' HG22 ' A' ' 39' ' ' VAL . 18.0 mtpt -52.43 -53.93 38.85 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 120.809 0.338 . . . . 0.0 111.119 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.693 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 14.2 m -55.27 -35.65 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.308 -172.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.773 HG22 HH22 ' A' ' 35' ' ' ARG . 0.1 OUTLIER -87.36 -26.95 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 178.088 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.706 HG12 ' NH2' ' A' ' 35' ' ' ARG . 1.1 m -59.73 -55.97 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 119.091 -1.044 . . . . 0.0 108.316 169.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.613 ' HG2' HG22 ' A' ' 68' ' ' VAL . 41.7 mt-10 -61.52 -34.33 75.34 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.713 -178.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.693 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -74.87 -58.87 3.02 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.613 179.642 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.52 ' HG3' ' CG ' ' A' ' 4' ' ' ASN . 22.8 mmt -66.96 -20.13 65.84 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.418 0.628 . . . . 0.0 110.022 -174.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.66 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -51.75 -27.07 10.88 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.43 171.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.525 ' CG ' ' HD2' ' A' ' 59' ' ' LYS . 18.1 t80 -106.18 -67.6 0.92 Allowed 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.622 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 8.0 mm-40 -47.49 -32.91 5.66 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 124.377 1.048 . . . . 0.0 112.284 -173.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.76 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.4 m-20 -104.47 -21.06 13.51 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.413 -174.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.591 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -59.46 179.43 0.11 Allowed 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.797 0.808 . . . . 0.0 112.86 -174.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.645 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 8.6 m-20 -60.1 141.05 90.58 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.346 175.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -43.1 -44.65 9.67 Favored 'Trans proline' 0 C--N 1.331 -0.368 0 C-N-CA 122.819 2.346 . . . . 0.0 112.025 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.52 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 0.2 OUTLIER -76.79 -31.74 57.19 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.314 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.645 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 81.4 m -76.96 -36.33 56.58 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 120.901 0.382 . . . . 0.0 110.238 -173.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.561 ' HA ' HD12 ' A' ' 55' ' ' ILE . 3.6 pt20 -73.25 -30.92 63.79 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 173.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.554 ' O ' ' HE3' ' A' ' 56' ' ' LYS . 3.9 m -68.91 -19.8 64.21 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.052 -1.431 . . . . 0.0 110.446 173.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.745 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -78.75 -27.1 44.68 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.646 0.736 . . . . 0.0 109.93 167.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.561 HD12 ' HA ' ' A' ' 52' ' ' GLN . 22.7 mt -89.23 -32.48 5.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -172.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.599 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -40.57 -38.72 1.29 Allowed Pre-proline 0 N--CA 1.488 1.428 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -174.461 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 53.3 Cg_endo -64.06 -28.53 65.75 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 122.233 1.956 . . . . 0.0 112.828 175.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.549 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.0 OUTLIER -99.51 -14.6 18.99 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.722 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.63 ' HD3' ' CG2' ' B' ' 5' ' ' THR . 0.1 OUTLIER -50.0 109.78 0.32 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.404 -178.844 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.456 ' HA3' ' C ' ' B' ' 1' ' ' PRO . . . 87.18 -17.94 39.49 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.358 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt -103.59 114.9 29.52 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.504 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.3 p -123.57 142.33 38.74 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.352 174.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.522 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 72.0 Cg_exo -52.35 137.71 56.13 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.349 2.033 . . . . 0.0 111.295 169.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.8 109.66 2.98 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.969 0.414 . . . . 0.0 110.898 -176.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.23 -16.96 44.9 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.112 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.522 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 14.9 m -94.22 175.0 6.86 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.164 0.507 . . . . 0.0 111.133 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -93.23 147.34 22.98 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.476 -0.784 . . . . 0.0 108.981 176.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.613 HG22 ' HG2' ' A' ' 40' ' ' GLU . 1.1 m -81.38 -29.63 10.81 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 C-N-CA 118.33 -1.348 . . . . 0.0 108.787 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.781 ' O ' HG13 ' A' ' 73' ' ' VAL . 5.3 mm -60.14 -47.24 92.79 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.133 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.71 -178.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 40.7 t -47.68 -36.58 11.4 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.14 177.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -85.89 -31.52 22.16 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-O 121.046 0.45 . . . . 0.0 111.018 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.617 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.2 m-30 -74.49 -36.51 63.27 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.672 0.749 . . . . 0.0 109.516 -178.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.783 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.4 m -71.14 -30.72 41.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 173.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -69.7 -28.58 65.95 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.536 175.477 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -65.69 -45.81 81.38 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.766 176.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.747 ' SG ' ' HB ' ' A' ' 79' ' ' ILE . 32.0 t -93.17 9.46 35.91 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.826 177.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.478 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 5.1 t70 -58.84 -26.79 64.5 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.572 175.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.8 -20.47 31.25 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.322 174.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.747 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 83.5 mt -83.93 129.89 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 121.108 0.48 . . . . 0.0 111.45 -176.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 161.28 33.7 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.746 175.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.603 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 141.24 -102.91 0.32 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.82 176.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.92 -54.84 42.01 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -173.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 59.3 mtt -67.34 -32.02 72.69 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.907 0.384 . . . . 0.0 110.22 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.515 ' HA ' ' OE2' ' A' ' 50' ' ' GLU . 7.5 t-80 -59.04 -36.59 75.26 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.747 176.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' A' ' 81' ' ' GLY . 31.7 mmtp -80.07 -17.93 51.38 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 121.872 -0.518 . . . . 0.0 110.507 -177.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.08 -42.5 13.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.401 0.62 . . . . 0.0 110.703 176.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -85.48 -13.58 48.67 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.508 -175.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' A' ' 84' ' ' HIS . 0.2 OUTLIER -49.02 -46.82 44.69 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 123.446 0.466 . . . . 0.0 111.752 -179.391 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 27.9 ttt -79.87 -14.59 58.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.999 0.428 . . . . 0.0 110.516 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -89.69 -47.32 8.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.779 -176.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.511 ' C ' ' HB3' ' A' ' 53' ' ' SER . 22.2 mt-30 -99.24 -50.89 3.98 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -170.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.468 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -45.83 -35.97 4.87 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.559 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 . . . . . 0 C--O 1.252 1.206 0 CA-C-N 114.074 -1.421 . . . . 0.0 112.705 -176.643 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' PRO . . . . . 0.456 ' C ' ' HA3' ' A' ' 60' ' ' GLY . 95.6 Cg_endo . . . . . 0 CA--C 1.518 -0.294 0 N-CA-C 109.191 -1.119 . . . . 0.0 109.191 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.551 ' HB2' HG23 ' B' ' 5' ' ' THR . 67.7 m -65.66 177.78 1.16 Allowed 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 162.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.694 ' CB ' ' HA ' ' B' ' 25' ' ' ALA . 0.1 OUTLIER -77.17 -54.28 6.7 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.524 174.583 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.513 ' CG ' ' HG3' ' B' ' 42' ' ' MET . 1.8 p-10 -86.48 6.56 29.88 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.726 -1.125 . . . . 0.0 112.673 -165.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.63 ' CG2' ' HD3' ' A' ' 59' ' ' LYS . 0.7 OUTLIER -62.28 -4.86 1.98 Allowed 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.98 0.419 . . . . 0.0 111.591 -177.425 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.672 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.4 m -75.92 130.44 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 174.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.754 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -154.99 159.46 40.38 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 118.648 -1.221 . . . . 0.0 113.717 -179.678 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' GLN . . . . . 0.479 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.4 mt-30 -41.12 114.01 0.45 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.276 -1.783 . . . . 0.0 112.832 -178.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.13 -141.94 6.43 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.623 174.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 20.0 m -61.66 96.82 0.07 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.93 0.365 . . . . 0.0 110.572 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.402 ' HB2' ' HA2' ' B' ' 80' ' ' GLY . 62.3 pttt 41.24 42.24 1.67 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.36 1.064 . . . . 0.0 112.209 -176.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.415 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 73.2 tt0 -58.98 139.88 87.11 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.971 178.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . 0.534 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 31.4 Cg_exo -54.25 123.5 13.71 Favored 'Trans proline' 0 CA--C 1.511 -0.665 0 C-N-CA 122.219 1.946 . . . . 0.0 110.145 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . 0.781 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 10.2 t80 -70.94 -52.39 9.84 Favored Pre-proline 0 N--CA 1.44 -0.97 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -166.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.544 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 38.3 Cg_exo -56.47 -19.45 29.24 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 121.495 1.463 . . . . 0.0 111.127 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.534 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.3 m-20 -90.69 -38.93 12.75 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 113.933 -1.485 . . . . 0.0 110.895 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' PHE . . . . . 0.479 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -57.23 -43.94 83.34 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.562 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.667 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 2.4 p -78.72 -33.15 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.072 -179.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.65 -35.05 67.93 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 121.846 -0.534 . . . . 0.0 111.939 175.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.733 ' O ' HG12 ' B' ' 24' ' ' VAL . 15.3 ptt180 -85.13 -25.6 27.38 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.65 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 3.9 tp -55.26 -48.89 73.34 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 171.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . 0.667 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 36.1 mt-30 -66.65 -52.19 47.72 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.661 177.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.737 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 11.6 t70 -47.54 -54.01 12.84 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -176.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' VAL . . . . . 0.733 HG12 ' O ' ' B' ' 20' ' ' ARG . 4.2 p -82.46 -26.45 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 CA-C-O 121.975 0.893 . . . . 0.0 109.569 -169.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.715 ' HB3' ' CZ ' ' B' ' 35' ' ' ARG . . . -78.57 -16.81 56.99 Favored 'General case' 0 C--O 1.198 -1.638 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 176.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . 0.462 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -80.15 -37.29 33.77 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.025 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.737 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 45.0 mmtt -63.67 -32.83 74.44 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.333 177.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . 0.429 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 29.2 m -106.02 -11.18 16.23 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.087 0.47 . . . . 0.0 110.578 -174.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.689 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 95.9 mt -117.79 119.34 61.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.554 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.42 -1.63 58.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.309 0.576 . . . . 0.0 110.114 175.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.549 ' H ' HG22 ' B' ' 29' ' ' ILE . 9.3 t70 -96.84 121.96 39.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.457 -177.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -68.4 -22.68 64.62 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.95 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.58 ' O ' HG13 ' B' ' 37' ' ' VAL . 0.0 OUTLIER -82.54 -53.94 5.56 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -177.555 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.561 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -57.95 -24.95 60.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.881 178.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.94 ' NH1' ' HA ' ' B' ' 35' ' ' ARG . 0.0 OUTLIER -69.11 -62.21 1.47 Allowed 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.843 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.501 ' O ' HG22 ' B' ' 39' ' ' VAL . 18.0 mtpt -52.45 -54.06 37.22 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 120.715 0.293 . . . . 0.0 111.087 -178.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.689 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 14.1 m -55.1 -35.77 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.321 -172.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.755 HG22 HH22 ' B' ' 35' ' ' ARG . 0.1 OUTLIER -87.38 -26.94 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 178.142 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.706 HG12 ' NH2' ' B' ' 35' ' ' ARG . 1.1 m -59.62 -56.05 19.8 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 C-N-CA 118.987 -1.085 . . . . 0.0 108.318 168.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.628 ' HG2' HG22 ' B' ' 68' ' ' VAL . 43.7 mt-10 -61.34 -34.66 75.63 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 114.46 -1.245 . . . . 0.0 111.672 -177.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.689 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -74.53 -58.86 3.02 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.7 179.716 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' MET . . . . . 0.513 ' HG3' ' CG ' ' B' ' 4' ' ' ASN . 22.9 mmt -66.86 -20.2 65.88 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.343 0.592 . . . . 0.0 109.964 -174.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.654 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -51.77 -27.22 11.47 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.313 171.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' TYR . . . . . 0.516 ' CG ' ' HD2' ' B' ' 59' ' ' LYS . 18.1 t80 -106.08 -67.57 0.92 Allowed 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 175.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.624 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 7.8 mm-40 -47.54 -33.04 5.94 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 124.378 1.049 . . . . 0.0 112.196 -173.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.754 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.4 m-20 -104.39 -20.93 13.57 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.419 -174.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.577 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -59.62 179.43 0.12 Allowed 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.8 0.809 . . . . 0.0 112.864 -174.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.646 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 8.8 m-20 -59.99 140.98 90.24 Favored Pre-proline 0 N--CA 1.443 -0.796 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.488 175.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -43.4 -44.32 10.53 Favored 'Trans proline' 0 C--N 1.332 -0.337 0 C-N-CA 122.792 2.328 . . . . 0.0 112.016 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.526 ' HA ' ' HB2' ' B' ' 53' ' ' SER . 0.2 OUTLIER -76.94 -31.55 56.7 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.326 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.646 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 83.4 m -77.26 -36.45 54.39 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -173.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.557 ' HA ' HD12 ' B' ' 55' ' ' ILE . 3.6 pt20 -73.16 -30.94 63.93 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 173.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . 0.568 ' O ' ' HE3' ' B' ' 56' ' ' LYS . 3.7 m -68.9 -19.84 64.23 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.183 -1.371 . . . . 0.0 110.498 173.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.729 ' HB2' HD11 ' B' ' 79' ' ' ILE . . . -78.67 -27.08 45.11 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.612 0.72 . . . . 0.0 110.006 167.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.557 HD12 ' HA ' ' B' ' 52' ' ' GLN . 22.6 mt -89.39 -32.24 5.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 -171.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.598 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -40.7 -38.71 1.34 Allowed Pre-proline 0 N--CA 1.487 1.384 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -174.601 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 51.7 Cg_endo -63.72 -29.0 68.81 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.193 1.928 . . . . 0.0 112.809 175.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . 0.563 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.0 OUTLIER -99.29 -14.6 19.17 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 -179.5 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.627 ' HD3' ' CG2' ' A' ' 5' ' ' THR . 0.1 OUTLIER -49.87 109.78 0.32 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.448 -178.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.456 ' HA3' ' C ' ' A' ' 1' ' ' PRO . . . 87.09 -18.32 36.89 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.357 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -103.36 114.85 29.46 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -178.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.497 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.4 p -123.55 142.41 38.91 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.353 174.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.548 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 74.7 Cg_exo -52.22 138.03 54.85 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.41 2.073 . . . . 0.0 111.419 168.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.21 108.53 2.74 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.068 -176.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.09 -17.2 41.56 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.114 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.548 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 16.3 m -94.14 175.28 6.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.177 0.513 . . . . 0.0 111.073 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -93.12 147.35 22.94 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.628 HG22 ' HG2' ' B' ' 40' ' ' GLU . 1.1 m -81.37 -29.54 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 C-N-CA 118.371 -1.331 . . . . 0.0 108.856 178.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.777 ' O ' HG13 ' B' ' 73' ' ' VAL . 5.3 mm -60.18 -47.14 93.27 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.093 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.695 -178.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 40.8 t -48.01 -36.51 12.89 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.078 177.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -85.79 -31.25 22.44 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 122.862 0.465 . . . . 0.0 111.079 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' TYR . . . . . 0.607 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.2 m-30 -74.77 -36.72 62.55 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 121.671 0.748 . . . . 0.0 109.489 -178.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.781 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.4 m -70.9 -30.82 43.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 173.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' LYS . . . . . 0.493 ' O ' ' HB3' ' B' ' 77' ' ' ASP . 0.0 OUTLIER -69.66 -28.54 65.97 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.552 175.495 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -65.51 -46.12 80.89 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.752 176.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.741 ' SG ' ' HB ' ' B' ' 79' ' ' ILE . 32.1 t -93.02 9.78 34.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.84 178.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . 0.493 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 4.4 t70 -59.18 -26.5 64.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.637 175.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -94.21 -20.52 30.04 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.286 173.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.741 ' HB ' ' SG ' ' B' ' 76' ' ' CYS . 83.9 mt -83.58 130.03 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-O 121.133 0.492 . . . . 0.0 111.401 -176.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . 0.402 ' HA2' ' HB2' ' B' ' 11' ' ' LYS . . . 161.43 33.16 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.888 175.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.621 ' O ' ' HG2' ' B' ' 85' ' ' LYS . . . 142.03 -103.17 0.32 Allowed Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.879 176.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.83 -54.9 41.11 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -173.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 83' ' ' MET . . . . . . . . . . . . . 58.1 mtt -67.45 -32.04 72.63 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.849 0.356 . . . . 0.0 110.174 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 84' ' ' HIS . . . . . 0.513 ' HA ' ' OE2' ' B' ' 50' ' ' GLU . 7.5 t-80 -58.95 -36.68 75.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.755 176.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.621 ' HG2' ' O ' ' B' ' 81' ' ' GLY . 31.7 mmtp -80.27 -17.43 52.18 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.542 -177.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.28 -42.73 13.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.673 176.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -85.27 -13.63 49.18 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.494 -175.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' B' ' 84' ' ' HIS . 0.2 OUTLIER -49.25 -46.26 45.84 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 123.445 0.466 . . . . 0.0 111.833 -179.232 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 28.0 ttt -80.32 -14.68 58.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.116 0.484 . . . . 0.0 110.529 -178.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -89.66 -47.32 8.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.507 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 91' ' ' GLN . . . . . 0.52 ' C ' ' HB3' ' B' ' 53' ' ' SER . 21.8 mt-30 -99.1 -51.15 3.92 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -170.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.471 ' HB2' HD12 ' B' ' 88' ' ' LEU . 0.0 OUTLIER -45.55 -36.24 4.49 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 179.628 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 . . . . . 0 C--O 1.249 1.057 0 CA-C-N 113.976 -1.465 . . . . 0.0 112.578 -176.492 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo . . . . . 0 N--CA 1.464 -0.227 0 N-CA-C 108.601 -1.346 . . . . 0.0 108.601 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.2 m -70.44 -176.12 1.17 Allowed 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 163.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.618 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -77.14 -54.42 6.54 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 122.406 1.098 . . . . 0.0 109.062 171.681 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.679 ' HB2' HD11 ' A' ' 21' ' ' LEU . 2.4 p-10 -85.6 5.91 29.66 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 113.533 -1.667 . . . . 0.0 113.332 -160.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.24 -1.05 7.02 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -174.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.687 ' O ' HG23 ' A' ' 6' ' ' VAL . 24.0 m -81.41 92.84 2.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 122.259 1.028 . . . . 0.0 112.162 -174.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 1.096 ' NE ' ' HB3' ' A' ' 46' ' ' ASN . 13.8 mmm180 -107.19 150.6 26.44 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.506 -1.371 . . . . 0.0 112.978 -159.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.582 ' HG3' ' CG ' ' A' ' 17' ' ' PHE . 2.1 tt0 -44.41 109.12 0.14 Allowed 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 112.53 -2.123 . . . . 0.0 111.572 173.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.39 -152.56 9.42 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.742 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.8 m -55.81 97.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.911 0.355 . . . . 0.0 110.733 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.411 ' HB2' ' HA2' ' A' ' 80' ' ' GLY . 52.7 pttt 40.24 46.1 1.88 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.267 1.027 . . . . 0.0 111.935 -172.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.434 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 46.3 tt0 -60.34 136.49 91.71 Favored Pre-proline 0 C--O 1.236 0.381 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.452 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 38.4 Cg_exo -53.46 120.52 7.92 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.198 1.932 . . . . 0.0 110.943 -177.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.841 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 5.4 t80 -64.94 -56.05 23.54 Favored Pre-proline 0 C--N 1.313 -0.986 0 C-N-CA 119.73 -0.788 . . . . 0.0 112.737 -161.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.55 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 35.2 Cg_exo -55.89 -19.69 26.46 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.009 1.806 . . . . 0.0 111.508 -176.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.452 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.2 m-20 -89.46 -38.41 14.08 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.233 -178.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.916 ' HE1' ' NH2' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -61.74 -42.12 98.55 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.09 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.748 HG21 HD12 ' A' ' 69' ' ' ILE . 1.7 p -80.63 -31.69 12.71 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.9 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.841 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.67 -36.74 67.43 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 121.762 -0.586 . . . . 0.0 110.975 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.736 ' O ' HG12 ' A' ' 24' ' ' VAL . 15.4 ptt180 -82.29 -27.08 32.56 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.907 HD13 ' NH1' ' A' ' 7' ' ' ARG . 9.7 tp -55.24 -44.3 75.38 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.175 172.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.67 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 26.1 mt-30 -73.97 -51.57 15.57 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.309 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.744 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 45.3 m-20 -47.02 -51.28 17.67 Favored 'General case' 0 C--N 1.313 -1.006 0 O-C-N 124.532 1.145 . . . . 0.0 110.917 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.736 HG12 ' O ' ' A' ' 20' ' ' ARG . 9.9 p -79.64 -27.15 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 C-N-CA 119.936 -0.705 . . . . 0.0 109.833 -171.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.646 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -66.69 -31.57 72.33 Favored 'General case' 0 C--O 1.204 -1.301 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 175.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.418 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -74.69 -35.96 62.75 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.042 -1.435 . . . . 0.0 109.932 -178.19 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.744 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 37.3 mmtt -67.41 -36.38 81.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.466 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.506 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 21.6 m -104.89 -10.23 17.45 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.193 0.521 . . . . 0.0 110.656 -171.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.654 HG22 ' H ' ' A' ' 31' ' ' ASP . 78.1 mt -113.94 124.85 70.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.198 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.95 -1.87 57.73 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.947 0.403 . . . . 0.0 110.863 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.654 ' H ' HG22 ' A' ' 29' ' ' ILE . 4.1 t0 -114.13 140.12 48.77 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-O 121.618 0.723 . . . . 0.0 111.528 -177.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -71.02 -32.17 68.86 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.36 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.563 ' O ' HG13 ' A' ' 37' ' ' VAL . 12.0 mttp -67.07 -56.1 11.5 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -176.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.584 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -61.92 -25.49 67.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.57 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.842 ' O ' HG13 ' A' ' 39' ' ' VAL . 1.8 tmm_? -68.67 -58.62 3.97 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.43 ' HB3' ' OE2' ' A' ' 40' ' ' GLU . 15.8 mtpt -55.91 -57.0 13.96 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.205 179.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.793 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 23.9 m -52.25 -36.91 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.048 -170.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.618 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.3 tt -88.31 -30.83 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 C-N-CA 119.823 -0.751 . . . . 0.0 112.161 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.842 HG13 ' O ' ' A' ' 35' ' ' ARG . 3.2 m -67.01 -50.16 66.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 119.24 -0.984 . . . . 0.0 109.242 174.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.632 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 54.7 mt-10 -66.51 -23.58 66.27 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 123.816 0.846 . . . . 0.0 112.406 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.793 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -85.84 -56.97 3.23 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.325 176.338 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.58 ' HB2' HD21 ' A' ' 21' ' ' LEU . 25.0 mmt -59.82 -24.95 64.59 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 121.348 0.594 . . . . 0.0 109.996 -175.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.66 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -46.66 -28.3 1.44 Allowed 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.149 174.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.628 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 7.7 t80 -103.99 -68.02 0.87 Allowed 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 174.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.73 ' HB3' ' OD1' ' B' ' 46' ' ' ASN . 5.5 mm-40 -45.23 -35.45 3.34 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.25 -1.341 . . . . 0.0 112.834 -171.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 1.096 ' HB3' ' NE ' ' A' ' 7' ' ' ARG . 1.4 m-20 -111.76 -7.34 14.22 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.873 -172.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.66 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -68.01 -169.9 0.15 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.601 0.715 . . . . 0.0 112.425 -175.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.598 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 11.2 m-20 -66.03 140.42 97.04 Favored Pre-proline 0 N--CA 1.442 -0.836 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.939 171.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.479 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 3.0 Cg_endo -46.74 -46.75 17.43 Favored 'Trans proline' 0 CA--C 1.53 0.308 0 C-N-CA 122.642 2.228 . . . . 0.0 111.928 -176.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.584 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 0.3 OUTLIER -72.15 -31.31 65.84 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 124.185 0.994 . . . . 0.0 111.62 177.8 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.598 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 96.0 m -75.25 -36.36 61.29 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 120.889 0.376 . . . . 0.0 110.03 -173.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.61 ' HA ' HD12 ' A' ' 55' ' ' ILE . 4.3 pt20 -73.38 -32.21 64.36 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 174.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.6 ' HB3' ' C ' ' A' ' 91' ' ' GLN . 27.0 m -66.87 -21.46 66.01 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 114.033 -1.439 . . . . 0.0 110.064 173.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.805 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -77.85 -27.43 49.84 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.431 -0.793 . . . . 0.0 110.036 169.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.61 HD12 ' HA ' ' A' ' 52' ' ' GLN . 23.4 mt -89.11 -31.16 5.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -171.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.622 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.93 -39.27 2.64 Favored Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -173.347 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 57.3 Cg_endo -64.33 -25.98 63.9 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.457 2.104 . . . . 0.0 112.925 176.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.529 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.3 mt -99.96 -16.31 18.01 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.628 ' HE3' ' HB3' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -53.01 109.64 0.44 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.988 -178.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.29 -21.57 41.75 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.548 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -103.82 113.51 27.09 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 121.147 0.498 . . . . 0.0 110.032 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.12 143.78 43.51 Favored Pre-proline 0 C--N 1.312 -1.051 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 170.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.559 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 74.1 Cg_exo -46.35 142.85 8.73 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.767 2.311 . . . . 0.0 111.836 168.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.11 101.13 0.26 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.443 -174.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.36 -5.2 57.21 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.756 -0.656 . . . . 0.0 113.215 176.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.559 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 14.9 m -95.87 178.81 5.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.465 0.65 . . . . 0.0 111.854 -178.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.747 ' OD1' ' HB ' ' A' ' 69' ' ' ILE . 19.3 t70 -86.39 136.39 33.14 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.613 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.554 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -80.96 -30.89 11.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 C-N-CA 118.647 -1.221 . . . . 0.0 109.472 178.259 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.789 ' O ' HG13 ' A' ' 73' ' ' VAL . 14.5 mm -57.63 -46.78 86.46 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.223 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 178.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.4 t -43.24 -39.34 2.94 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.478 174.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -85.45 -33.59 21.85 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 123.413 0.685 . . . . 0.0 110.831 -177.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.656 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.2 m-30 -75.38 -35.04 61.14 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.467 -176.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.841 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.6 m -70.64 -31.92 47.73 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.518 ' HA ' ' HB2' ' A' ' 77' ' ' ASP . 23.1 ttpt -71.79 -27.53 63.01 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.616 -1.174 . . . . 0.0 109.865 176.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.463 ' HB2' HD11 ' A' ' 58' ' ' LEU . . . -64.8 -44.54 89.61 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.59 175.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.804 ' SG ' ' HB ' ' A' ' 79' ' ' ILE . 31.0 t -92.95 9.14 36.82 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.648 177.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.518 ' HB2' ' HA ' ' A' ' 74' ' ' LYS . 25.2 t70 -66.38 -11.42 51.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.507 0.67 . . . . 0.0 109.914 174.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -108.39 0.0 32.94 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.318 171.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.805 HD11 ' HB2' ' A' ' 54' ' ' ALA . 98.1 mt -103.8 137.72 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.138 0.494 . . . . 0.0 111.518 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' A' ' 11' ' ' LYS . . . 136.41 25.02 0.47 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.635 178.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.612 ' O ' ' HB3' ' A' ' 84' ' ' HIS . . . -165.83 -153.17 7.54 Favored Glycine 0 CA--C 1.49 -1.498 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.796 -176.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.2 -28.33 69.67 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.089 -1.055 . . . . 0.0 111.045 177.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 49.0 mtt -67.03 -32.2 73.26 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 175.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.612 ' HB3' ' O ' ' A' ' 81' ' ' GLY . 5.4 t-160 -63.22 -34.7 78.21 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-O 121.164 0.507 . . . . 0.0 109.876 173.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.468 ' HD2' ' O ' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -77.18 -19.42 56.79 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.986 0.422 . . . . 0.0 110.389 179.37 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.36 -49.29 8.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.489 176.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 66.7 mtt -73.12 -15.08 61.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.861 -177.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.595 ' O ' ' HB3' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -51.25 -38.9 55.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.025 179.185 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.8 ttp -84.43 -18.91 34.46 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.336 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -95.39 -37.09 11.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.017 0.437 . . . . 0.0 112.049 -172.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.6 ' C ' ' HB3' ' A' ' 53' ' ' SER . 21.7 mt-30 -105.8 -56.17 2.22 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.203 -176.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.595 ' HB3' ' O ' ' A' ' 88' ' ' LEU . 0.4 OUTLIER -61.14 -6.1 1.84 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.383 178.289 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 . . . . . 0 C--O 1.25 1.124 0 C-N-CA 123.849 0.86 . . . . 0.0 112.343 -179.585 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' PRO . . . . . 0.461 ' HB2' ' H ' ' B' ' 2' ' ' SER . 86.2 Cg_endo . . . . . 0 N--CA 1.464 -0.23 0 N-CA-C 108.679 -1.316 . . . . 0.0 108.679 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.461 ' H ' ' HB2' ' B' ' 1' ' ' PRO . 49.7 m -70.13 -176.13 1.09 Allowed 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 163.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.63 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.0 OUTLIER -77.23 -54.36 6.59 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 122.398 1.095 . . . . 0.0 109.021 171.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.663 ' HB2' HD11 ' B' ' 21' ' ' LEU . 2.4 p-10 -85.49 5.97 28.95 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 113.446 -1.706 . . . . 0.0 113.366 -160.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.44 -1.09 7.57 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -174.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.674 ' O ' HG23 ' B' ' 6' ' ' VAL . 23.3 m -81.38 92.78 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-O 122.264 1.03 . . . . 0.0 112.08 -174.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 1.102 ' NE ' ' HB3' ' B' ' 46' ' ' ASN . 13.8 mmm180 -107.17 150.71 26.31 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.512 -1.368 . . . . 0.0 113.007 -159.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' GLN . . . . . 0.572 ' HG3' ' CG ' ' B' ' 17' ' ' PHE . 2.1 tt0 -44.43 109.23 0.14 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 112.626 -2.079 . . . . 0.0 111.617 172.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.45 -152.61 9.56 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.708 176.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 19.6 m -56.15 98.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.822 0.311 . . . . 0.0 110.709 -177.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.409 ' HB2' ' HA2' ' B' ' 80' ' ' GLY . 52.7 pttt 39.86 46.79 1.74 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.054 0.942 . . . . 0.0 111.909 -172.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.453 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 46.9 tt0 -60.81 136.33 93.05 Favored Pre-proline 0 C--O 1.234 0.278 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . 0.459 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 39.8 Cg_exo -53.34 120.55 7.94 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.079 1.852 . . . . 0.0 111.012 -177.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . 0.843 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 5.5 t80 -65.07 -56.04 22.98 Favored Pre-proline 0 C--N 1.314 -0.972 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.709 -161.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.551 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 32.1 Cg_exo -55.87 -19.62 26.01 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 121.987 1.792 . . . . 0.0 111.521 -176.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.459 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.2 m-20 -89.45 -38.62 13.93 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.145 -178.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' PHE . . . . . 0.908 ' HE1' ' NH2' ' B' ' 7' ' ' ARG . 0.1 OUTLIER -61.62 -42.15 98.47 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.273 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.726 HG21 HD12 ' B' ' 69' ' ' ILE . 1.7 p -80.69 -31.48 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.947 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.96 -36.54 67.93 Favored 'General case' 0 C--N 1.315 -0.902 0 O-C-N 121.653 -0.654 . . . . 0.0 110.922 175.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.736 ' O ' HG12 ' B' ' 24' ' ' VAL . 15.5 ptt180 -82.37 -27.14 32.3 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.898 HD13 ' NH1' ' B' ' 7' ' ' ARG . 9.7 tp -55.14 -44.44 75.09 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.11 172.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . 0.658 ' HG2' ' HB ' ' B' ' 39' ' ' VAL . 25.5 mt-30 -73.97 -51.58 15.54 Favored 'General case' 0 CA--C 1.486 -1.494 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.24 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.733 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 41.7 m-20 -46.96 -51.38 17.17 Favored 'General case' 0 C--N 1.311 -1.08 0 O-C-N 124.34 1.025 . . . . 0.0 110.874 178.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' VAL . . . . . 0.736 HG12 ' O ' ' B' ' 20' ' ' ARG . 9.8 p -79.51 -27.29 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.789 -171.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.649 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -66.61 -31.66 72.5 Favored 'General case' 0 C--O 1.205 -1.288 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 175.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . 0.414 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -74.52 -36.26 63.18 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 114.0 -1.455 . . . . 0.0 109.81 -178.225 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.733 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 38.1 mmtt -67.17 -36.42 81.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.394 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . 0.491 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 25.2 m -104.69 -10.46 17.47 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.364 0.602 . . . . 0.0 110.609 -171.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.675 HG22 ' H ' ' B' ' 31' ' ' ASP . 78.3 mt -113.65 124.86 70.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.313 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.21 -1.94 57.91 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.972 0.415 . . . . 0.0 110.732 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.675 ' H ' HG22 ' B' ' 29' ' ' ILE . 4.0 t0 -113.48 140.59 47.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.58 0.705 . . . . 0.0 111.481 -177.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -71.55 -32.26 67.91 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.469 175.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.575 ' O ' HG13 ' B' ' 37' ' ' VAL . 11.8 mttp -67.08 -55.92 12.24 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -176.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.574 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -61.97 -25.52 67.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.559 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.854 ' O ' HG13 ' B' ' 39' ' ' VAL . 1.8 tmm_? -68.7 -58.66 3.91 Favored 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.44 ' HB3' ' OE2' ' B' ' 40' ' ' GLU . 15.7 mtpt -55.86 -57.04 13.73 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.227 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.802 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 23.6 m -52.25 -36.91 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.094 -170.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.63 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.3 tt -88.16 -30.85 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.218 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.854 HG13 ' O ' ' B' ' 35' ' ' ARG . 3.2 m -66.96 -50.19 66.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.309 174.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.633 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 52.1 mt-10 -66.4 -23.76 66.37 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 123.891 0.877 . . . . 0.0 112.351 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.802 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.77 -57.12 3.17 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.238 176.447 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' MET . . . . . 0.584 ' HB2' HD21 ' B' ' 21' ' ' LEU . 25.1 mmt -59.63 -25.0 64.32 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.358 0.599 . . . . 0.0 109.993 -175.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.665 ' O ' ' HB2' ' B' ' 47' ' ' ALA . . . -46.63 -28.45 1.47 Allowed 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.133 174.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' TYR . . . . . 0.62 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 7.8 t80 -103.74 -68.02 0.86 Allowed 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 174.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.75 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 5.6 mm-40 -45.22 -35.74 3.5 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.186 -1.37 . . . . 0.0 112.778 -171.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 1.102 ' HB3' ' NE ' ' B' ' 7' ' ' ARG . 1.4 m-20 -111.7 -7.21 14.26 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.846 -172.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.665 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -68.03 -169.74 0.15 Allowed 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.62 0.724 . . . . 0.0 112.498 -175.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.609 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 11.2 m-20 -66.21 140.38 96.85 Favored Pre-proline 0 N--CA 1.442 -0.843 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.083 171.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . 0.467 ' O ' ' HG2' ' B' ' 52' ' ' GLN . 2.9 Cg_endo -46.83 -46.63 17.92 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.685 2.257 . . . . 0.0 111.866 -176.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.589 ' HA ' ' HB2' ' B' ' 53' ' ' SER . 0.3 OUTLIER -72.31 -31.14 65.44 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 124.199 1.0 . . . . 0.0 111.591 177.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.609 ' SG ' ' HB2' ' B' ' 48' ' ' ASN . 94.6 m -75.3 -36.43 61.12 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 120.996 0.427 . . . . 0.0 109.993 -173.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.59 ' HB2' ' CG ' ' B' ' 44' ' ' TYR . 4.4 pt20 -73.43 -32.07 64.18 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 174.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . 0.609 ' O ' ' HE2' ' B' ' 56' ' ' LYS . 26.4 m -66.97 -21.45 65.97 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 114.014 -1.448 . . . . 0.0 109.999 173.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.781 ' HB2' HD11 ' B' ' 79' ' ' ILE . . . -78.0 -27.29 48.98 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.398 -0.814 . . . . 0.0 109.985 169.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.589 HD12 ' HA ' ' B' ' 52' ' ' GLN . 23.3 mt -89.17 -31.28 5.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 -171.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.617 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.8 -39.37 2.59 Favored Pre-proline 0 N--CA 1.488 1.435 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -173.263 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 57.5 Cg_endo -64.17 -26.25 64.99 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.383 2.055 . . . . 0.0 112.925 176.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . 0.532 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.4 mt -99.78 -16.54 18.06 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.62 ' HE3' ' HB3' ' B' ' 44' ' ' TYR . 0.0 OUTLIER -52.66 109.77 0.44 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.131 -179.093 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.97 -21.63 40.75 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.696 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -103.92 113.48 27.05 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.21 0.528 . . . . 0.0 110.051 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.411 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.6 p -124.18 143.41 42.59 Favored Pre-proline 0 C--N 1.312 -1.05 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.765 170.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.57 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 74.9 Cg_exo -46.04 142.79 7.95 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.686 2.257 . . . . 0.0 111.944 168.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.1 100.52 0.22 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.573 -174.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.21 -5.32 55.61 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.069 176.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.57 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 14.8 m -96.12 178.93 5.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.505 0.669 . . . . 0.0 111.782 -178.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' ASP . . . . . 0.748 ' OD1' ' HB ' ' B' ' 69' ' ' ILE . 19.5 t70 -86.49 136.42 33.1 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.635 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.564 HG22 ' HG2' ' B' ' 40' ' ' GLU . 0.8 OUTLIER -80.93 -30.95 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 C-N-CA 118.588 -1.245 . . . . 0.0 109.517 178.193 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.789 ' O ' HG13 ' B' ' 73' ' ' VAL . 14.3 mm -57.57 -47.04 86.14 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.181 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 30.8 t -43.38 -39.22 3.08 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.45 174.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -85.34 -33.48 22.04 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 123.503 0.721 . . . . 0.0 110.807 -177.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' TYR . . . . . 0.645 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.1 m-30 -75.44 -35.04 61.0 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.449 -176.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.843 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.6 m -70.86 -31.79 46.68 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 173.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' LYS . . . . . 0.501 ' HA ' ' HB2' ' B' ' 77' ' ' ASP . 23.0 ttpt -71.84 -27.53 62.96 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.81 176.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . 0.456 ' HB2' HD11 ' B' ' 58' ' ' LEU . . . -64.9 -44.18 90.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.651 175.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.788 ' SG ' ' HB ' ' B' ' 79' ' ' ILE . 30.7 t -93.45 9.22 37.46 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.612 177.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . 0.501 ' HB2' ' HA ' ' B' ' 74' ' ' LYS . 24.7 t70 -66.2 -11.79 51.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.576 0.703 . . . . 0.0 110.068 173.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -108.37 0.55 32.88 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.222 171.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.788 ' HB ' ' SG ' ' B' ' 76' ' ' CYS . 98.0 mt -104.06 137.82 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 121.179 0.514 . . . . 0.0 111.401 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . 0.409 ' HA2' ' HB2' ' B' ' 11' ' ' LYS . . . 136.43 24.36 0.49 Allowed Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.415 177.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.616 ' O ' ' HB3' ' B' ' 84' ' ' HIS . . . -165.28 -153.09 7.4 Favored Glycine 0 CA--C 1.49 -1.525 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.763 -176.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.89 -28.4 69.81 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.087 -1.057 . . . . 0.0 111.047 177.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 83' ' ' MET . . . . . . . . . . . . . 49.2 mtt -67.04 -32.0 72.9 Favored 'General case' 0 C--O 1.22 -0.491 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 175.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 84' ' ' HIS . . . . . 0.616 ' HB3' ' O ' ' B' ' 81' ' ' GLY . 5.3 t-160 -63.43 -34.94 78.84 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-O 121.207 0.527 . . . . 0.0 109.805 173.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.464 ' HD2' ' O ' ' B' ' 81' ' ' GLY . 0.1 OUTLIER -77.0 -19.21 57.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.045 0.45 . . . . 0.0 110.333 179.42 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.52 -49.4 8.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.482 176.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 66.7 mtt -73.26 -14.8 61.39 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.879 -177.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.593 ' O ' ' HB3' ' B' ' 92' ' ' LEU . 0.2 OUTLIER -51.28 -39.08 56.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.949 179.158 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 58.2 ttp -84.17 -19.32 34.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.215 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -95.3 -36.69 11.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.062 0.458 . . . . 0.0 112.104 -172.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 91' ' ' GLN . . . . . 0.606 ' C ' ' HB3' ' B' ' 53' ' ' SER . 21.3 mt-30 -106.17 -56.14 2.23 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.28 -176.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.593 ' HB3' ' O ' ' B' ' 88' ' ' LEU . 0.4 OUTLIER -61.15 -5.9 1.75 Allowed 'General case' 0 CA--C 1.541 0.632 0 O-C-N 123.62 0.575 . . . . 0.0 110.305 178.135 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.401 ' H ' ' C ' ' B' ' 91' ' ' GLN . 4.7 pt-20 . . . . . 0 C--O 1.25 1.095 0 C-N-CA 123.799 0.84 . . . . 0.0 112.455 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo . . . . . 0 CA--C 1.517 -0.337 0 N-CA-C 109.293 -1.08 . . . . 0.0 109.293 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.1 m -68.73 167.95 14.28 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 163.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.768 ' HE1' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -70.96 -54.38 11.52 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.992 0.901 . . . . 0.0 109.864 172.79 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.545 ' HB2' ' HG3' ' A' ' 42' ' ' MET . 3.0 p-10 -86.76 -4.04 59.13 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.419 -1.264 . . . . 0.0 113.181 -164.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.453 ' HA ' ' OE1' ' B' ' 45' ' ' GLU . 9.9 t -65.47 -2.97 3.72 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.29 0.567 . . . . 0.0 111.075 -173.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.596 ' HB ' ' NH1' ' A' ' 20' ' ' ARG . 2.7 m -73.05 135.26 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 172.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.791 ' HB3' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -154.59 159.43 40.86 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 -178.789 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.542 ' HG3' ' CB ' ' A' ' 17' ' ' PHE . 2.4 mt-30 -42.83 118.98 1.36 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 112.585 -2.098 . . . . 0.0 113.318 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.9 -161.66 37.68 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.843 169.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.5 m -48.05 102.44 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 117.097 0.448 . . . . 0.0 111.592 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.3 pttt 38.91 44.28 0.84 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.533 1.133 . . . . 0.0 112.498 -173.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.494 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 37.8 tt0 -61.96 138.04 95.59 Favored Pre-proline 0 C--O 1.234 0.26 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 177.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.59 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 50.4 Cg_exo -50.68 122.55 9.88 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.244 1.963 . . . . 0.0 110.173 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.81 ' CD1' ' HA ' ' A' ' 73' ' ' VAL . 11.3 t80 -71.28 -54.17 7.29 Favored Pre-proline 0 N--CA 1.44 -0.934 0 CA-C-O 118.471 -0.776 . . . . 0.0 113.08 -167.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.533 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 34.5 Cg_exo -55.69 -18.79 21.94 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 121.459 1.44 . . . . 0.0 111.122 -179.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.59 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 2.0 m-20 -90.13 -42.2 11.21 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.881 -1.509 . . . . 0.0 111.001 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.542 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -54.6 -44.17 72.8 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.16 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.788 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 2.0 p -80.84 -34.15 13.77 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.362 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.692 -178.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.16 -31.64 67.43 Favored 'General case' 0 C--N 1.317 -0.841 0 O-C-N 121.276 -0.89 . . . . 0.0 111.881 177.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.718 ' O ' HG12 ' A' ' 24' ' ' VAL . 16.0 ptt180 -84.03 -29.9 26.54 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 175.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.562 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 8.3 tp -53.61 -49.61 67.45 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.992 172.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.788 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 24.6 mt-30 -69.43 -48.22 61.64 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.187 177.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.734 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 18.1 t70 -47.53 -53.31 14.8 Favored 'General case' 0 C--N 1.315 -0.933 0 O-C-N 124.267 0.979 . . . . 0.0 111.532 -177.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.718 HG12 ' O ' ' A' ' 20' ' ' ARG . 7.4 p -82.1 -22.51 9.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.151 0.5 . . . . 0.0 109.79 -173.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.804 ' O ' ' HB ' ' A' ' 29' ' ' ILE . . . -72.42 -19.44 61.59 Favored 'General case' 0 C--O 1.202 -1.422 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 173.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.41 ' HB3' ' O ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -87.06 -37.44 17.44 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.707 178.18 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.734 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 37.0 mmtt -66.94 -34.48 77.87 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.694 178.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.6 m -103.58 -11.07 17.96 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.195 0.521 . . . . 0.0 110.582 -172.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.804 ' HB ' ' O ' ' A' ' 25' ' ' ALA . 88.7 mt -118.15 129.76 74.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.67 -178.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.99 -1.44 52.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.441 0.639 . . . . 0.0 110.367 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.638 ' H ' HG22 ' A' ' 29' ' ' ILE . 11.1 t70 -106.81 115.7 30.65 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.458 -177.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.646 ' OE2' ' HG3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -57.12 -33.33 67.24 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.149 178.262 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.646 ' HG3' ' OE2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -70.78 -54.72 10.62 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -173.354 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.564 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -60.68 -28.82 68.9 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.826 177.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.855 ' O ' HG13 ' A' ' 39' ' ' VAL . 2.1 tmm_? -65.4 -60.39 3.01 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.41 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 15.5 mtpt -55.41 -56.65 17.7 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.239 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.719 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 17.6 m -55.18 -33.68 30.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.112 -170.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.768 HD13 ' HE1' ' A' ' 3' ' ' PHE . 1.5 tt -87.25 -31.87 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.635 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.855 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.5 m -68.56 -48.14 73.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 119.015 -1.074 . . . . 0.0 109.178 175.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.657 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 73.0 mt-10 -63.18 -27.93 69.7 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 123.634 0.774 . . . . 0.0 112.749 176.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.719 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -86.04 -50.65 6.88 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.838 178.173 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.716 ' HE2' ' HE2' ' B' ' 42' ' ' MET . 17.8 mmt -64.85 -20.87 66.64 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.632 0.729 . . . . 0.0 109.764 -178.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.685 ' HB1' ' OH ' ' A' ' 14' ' ' TYR . . . -50.62 -28.63 9.16 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.542 171.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.593 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 19.9 t80 -103.9 -67.61 0.89 Allowed 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 174.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.453 ' CG ' HD12 ' A' ' 41' ' ' LEU . 27.2 mm-40 -50.54 -28.08 7.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.703 -1.135 . . . . 0.0 113.076 -173.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.791 ' HB3' ' HB3' ' A' ' 7' ' ' ARG . 4.1 m-20 -105.73 -22.24 13.0 Favored 'General case' 0 N--CA 1.435 -1.19 0 O-C-N 122.325 -0.234 . . . . 0.0 110.809 -177.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -60.36 178.76 0.18 Allowed 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 122.059 0.933 . . . . 0.0 112.818 -174.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.677 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 17.1 m-20 -58.2 141.63 81.93 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 114.155 -1.384 . . . . 0.0 109.245 174.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.432 ' HB2' HD21 ' A' ' 92' ' ' LEU . 10.0 Cg_endo -55.02 -23.41 35.08 Favored 'Trans proline' 0 C--O 1.218 -0.515 0 C-N-CA 123.26 2.64 . . . . 0.0 112.407 -178.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.705 ' HG2' ' N ' ' A' ' 51' ' ' CYS . 13.4 pm0 -88.93 -32.12 17.85 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 123.765 0.826 . . . . 0.0 110.85 175.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.705 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 85.8 m -80.5 -38.15 30.36 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.328 -171.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.601 ' HA ' HD12 ' A' ' 55' ' ' ILE . 4.3 pt20 -70.0 -29.72 66.86 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 172.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.616 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 4.8 m -71.36 -20.82 62.11 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.119 175.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.611 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -78.55 -25.15 45.38 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.689 0.757 . . . . 0.0 109.821 168.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.601 HD12 ' HA ' ' A' ' 52' ' ' GLN . 22.6 mt -89.97 -32.53 5.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -172.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.63 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.99 -39.5 2.9 Favored Pre-proline 0 N--CA 1.486 1.344 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -172.799 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.63 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 50.6 Cg_endo -62.18 -28.81 79.88 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.187 1.924 . . . . 0.0 112.646 176.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.547 ' HB2' ' CE1' ' A' ' 72' ' ' TYR . 1.3 mt -98.35 -15.7 19.62 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.593 ' HE3' ' HB3' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -52.39 109.17 0.36 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.078 -179.454 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.54 -22.36 39.42 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.462 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.9 mmmt -103.55 113.0 26.17 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.17 0.509 . . . . 0.0 109.831 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.443 ' HB ' HG12 ' A' ' 68' ' ' VAL . 7.4 p -124.84 146.45 53.19 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.802 172.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.552 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 92.1 Cg_exo -47.7 141.64 15.42 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.288 1.992 . . . . 0.0 111.62 166.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.12 106.17 0.48 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.643 -175.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.1 -9.91 72.19 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.022 -0.609 . . . . 0.0 113.311 175.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.552 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 8.9 m -90.51 175.86 6.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.275 0.538 . . . . 0.0 111.46 -177.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.658 ' OD2' ' HB ' ' A' ' 69' ' ' ILE . 0.4 OUTLIER -81.6 134.95 35.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.615 177.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.574 HG22 ' HG2' ' A' ' 40' ' ' GLU . 0.7 OUTLIER -78.53 -27.65 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 C-N-CA 118.863 -1.135 . . . . 0.0 108.991 177.373 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.758 ' O ' HG13 ' A' ' 73' ' ' VAL . 12.3 mm -58.12 -46.23 88.38 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.184 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.058 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 29.4 t -46.16 -37.54 7.14 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.157 176.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -85.63 -32.34 22.09 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.149 0.5 . . . . 0.0 110.705 -177.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.6 ' HB3' ' OH ' ' A' ' 14' ' ' TYR . 5.1 m-30 -75.93 -35.18 59.82 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.526 -176.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.81 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 1.5 m -71.79 -31.77 42.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 172.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -67.08 -31.77 72.48 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.339 175.459 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 72' ' ' TYR . . . -63.65 -46.98 83.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.109 177.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.805 ' SG ' ' HB ' ' A' ' 79' ' ' ILE . 24.4 t -92.44 9.35 34.67 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.902 178.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 12.1 t70 -62.56 -18.75 62.72 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.302 0.573 . . . . 0.0 110.261 175.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -101.75 -7.88 46.9 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.432 173.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.805 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 98.3 mt -92.66 115.49 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-O 121.443 0.639 . . . . 0.0 111.866 -178.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 170.7 58.06 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 174.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.35 169.01 38.94 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -171.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.47 -89.37 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 175.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.609 ' O ' ' HG3' ' A' ' 87' ' ' MET . 78.1 mtm -61.52 -35.23 77.12 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-O 120.762 0.315 . . . . 0.0 110.57 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.407 ' HB2' HG23 ' A' ' 79' ' ' ILE . 3.8 t-160 -55.2 -34.7 64.14 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.301 174.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -79.34 -31.42 43.03 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.869 0.366 . . . . 0.0 110.501 -177.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.58 -52.42 26.31 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.935 0.874 . . . . 0.0 110.286 175.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.609 ' HG3' ' O ' ' A' ' 83' ' ' MET . 19.7 mtt -75.12 -12.43 60.31 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.924 -175.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.449 HD12 ' HB2' ' A' ' 92' ' ' LEU . 0.1 OUTLIER -50.39 -57.47 7.9 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.323 177.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 26.3 ttt -74.69 -16.33 60.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.9 0.381 . . . . 0.0 110.918 -176.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -95.39 -23.5 17.13 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -173.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.616 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 20.5 mt-30 -115.17 -52.8 2.66 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.168 -177.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.449 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -49.05 -29.88 5.6 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.022 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.512 ' O ' ' HG3' ' A' ' 93' ' ' GLU . 6.4 pt-20 . . . . . 0 C--O 1.25 1.111 0 CA-C-N 113.82 -1.537 . . . . 0.0 112.597 -178.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo . . . . . 0 CA--C 1.515 -0.463 0 N-CA-C 109.364 -1.052 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 68.7 m -68.92 168.08 14.4 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 163.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.773 ' HE1' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -71.11 -54.41 11.2 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.843 0.83 . . . . 0.0 109.788 173.057 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.546 ' HB2' ' HG3' ' B' ' 42' ' ' MET . 3.1 p-10 -86.84 -4.06 59.13 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.492 -1.231 . . . . 0.0 113.13 -164.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.443 ' HA ' ' OE1' ' A' ' 45' ' ' GLU . 9.9 t -65.39 -2.97 3.6 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.185 0.517 . . . . 0.0 111.083 -173.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.609 ' HB ' ' NH1' ' B' ' 20' ' ' ARG . 2.7 m -73.1 134.96 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 172.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.772 ' HB3' ' HB3' ' B' ' 46' ' ' ASN . 0.0 OUTLIER -154.28 159.5 41.3 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -178.753 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' GLN . . . . . 0.533 ' HG3' ' CB ' ' B' ' 17' ' ' PHE . 2.4 mt-30 -42.94 119.08 1.4 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 112.684 -2.053 . . . . 0.0 113.303 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.99 -161.45 37.53 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 169.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 23.3 m -48.31 102.72 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 117.21 0.505 . . . . 0.0 111.498 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.401 ' HB2' ' HA2' ' B' ' 80' ' ' GLY . 39.2 pttt 38.83 44.42 0.83 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.611 1.164 . . . . 0.0 112.482 -173.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.488 ' HB3' ' HG2' ' B' ' 8' ' ' GLN . 37.7 tt0 -62.05 137.96 95.71 Favored Pre-proline 0 C--N 1.332 -0.182 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . 0.589 ' HB2' ' HB2' ' B' ' 16' ' ' ASP . 51.1 Cg_exo -50.71 122.46 9.74 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.227 1.951 . . . . 0.0 110.218 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . 0.817 ' CD1' ' HA ' ' B' ' 73' ' ' VAL . 11.3 t80 -71.21 -54.13 7.45 Favored Pre-proline 0 N--CA 1.438 -1.034 0 CA-C-O 118.425 -0.798 . . . . 0.0 113.048 -167.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.537 ' HG3' ' HB ' ' B' ' 73' ' ' VAL . 34.5 Cg_exo -55.77 -18.87 22.65 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 121.458 1.438 . . . . 0.0 111.072 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.589 ' HB2' ' HB2' ' B' ' 13' ' ' PRO . 1.7 m-20 -90.08 -41.98 11.37 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.037 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' PHE . . . . . 0.533 ' CB ' ' HG3' ' B' ' 8' ' ' GLN . 0.0 OUTLIER -54.82 -44.18 73.62 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 176.254 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.776 ' O ' ' HG3' ' B' ' 22' ' ' GLN . 2.0 p -80.77 -34.29 13.97 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.283 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.626 -178.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.19 -31.51 67.36 Favored 'General case' 0 C--N 1.315 -0.893 0 O-C-N 121.321 -0.862 . . . . 0.0 111.848 177.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.708 ' O ' HG12 ' B' ' 24' ' ' VAL . 16.1 ptt180 -84.03 -29.9 26.54 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 175.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.57 ' HB2' ' HA ' ' B' ' 18' ' ' VAL . 8.3 tp -53.56 -49.78 66.95 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.055 172.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . 0.776 ' HG3' ' O ' ' B' ' 18' ' ' VAL . 25.2 mt-30 -69.41 -48.24 61.68 Favored 'General case' 0 CA--C 1.493 -1.236 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.191 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.741 ' O ' ' HG2' ' B' ' 27' ' ' LYS . 18.4 t70 -47.25 -53.48 13.27 Favored 'General case' 0 C--N 1.315 -0.898 0 O-C-N 124.187 0.929 . . . . 0.0 111.489 -177.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' VAL . . . . . 0.708 HG12 ' O ' ' B' ' 20' ' ' ARG . 7.4 p -82.13 -22.46 9.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.105 0.479 . . . . 0.0 109.746 -173.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.815 ' O ' ' HB ' ' B' ' 29' ' ' ILE . . . -72.44 -19.46 61.57 Favored 'General case' 0 C--O 1.201 -1.462 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 173.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . 0.406 ' HB3' ' O ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -87.03 -37.55 17.37 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.671 178.331 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.741 ' HG2' ' O ' ' B' ' 23' ' ' ASP . 36.7 mmtt -66.59 -35.1 79.39 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.6 178.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 44.4 m -103.14 -11.15 18.27 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.327 0.584 . . . . 0.0 110.62 -172.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.815 ' HB ' ' O ' ' B' ' 25' ' ' ALA . 88.9 mt -118.13 129.4 74.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.714 -178.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.53 -1.68 52.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.518 0.675 . . . . 0.0 110.375 176.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.653 ' H ' HG22 ' B' ' 29' ' ' ILE . 11.3 t70 -106.39 115.67 30.6 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.418 -177.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.656 ' OE2' ' HG3' ' B' ' 33' ' ' LYS . 0.0 OUTLIER -57.17 -33.14 67.14 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.232 178.184 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.656 ' HG3' ' OE2' ' B' ' 32' ' ' GLU . 0.0 OUTLIER -70.96 -54.58 10.79 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -173.369 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.551 ' HA ' HG22 ' B' ' 37' ' ' VAL . . . -60.71 -28.91 69.0 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.821 177.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.868 ' O ' HG13 ' B' ' 39' ' ' VAL . 2.1 tmm_? -65.27 -60.44 2.99 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' B' ' 33' ' ' LYS . 15.6 mtpt -55.58 -56.52 19.32 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.193 -179.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.724 ' O ' ' HB2' ' B' ' 41' ' ' LEU . 17.6 m -55.26 -33.59 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.119 -170.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.773 HD13 ' HE1' ' B' ' 3' ' ' PHE . 1.5 tt -87.36 -31.71 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.596 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.868 HG13 ' O ' ' B' ' 35' ' ' ARG . 2.5 m -68.67 -48.02 73.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 118.944 -1.103 . . . . 0.0 109.193 175.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.66 ' HA ' ' CD1' ' B' ' 69' ' ' ILE . 73.2 mt-10 -63.25 -28.02 69.74 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 123.695 0.798 . . . . 0.0 112.668 176.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.724 ' HB2' ' O ' ' B' ' 37' ' ' VAL . 0.0 OUTLIER -85.99 -50.63 6.92 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.819 178.295 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' MET . . . . . 0.716 ' HE2' ' HE2' ' A' ' 42' ' ' MET . 18.0 mmt -64.92 -20.85 66.67 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.683 0.754 . . . . 0.0 109.707 -178.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.675 ' HB1' ' OH ' ' B' ' 14' ' ' TYR . . . -50.65 -28.62 9.26 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.533 171.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' TYR . . . . . 0.594 ' HB3' ' HE3' ' B' ' 59' ' ' LYS . 20.1 t80 -103.98 -67.57 0.89 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 174.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.453 ' OE1' ' HA ' ' A' ' 5' ' ' THR . 26.8 mm-40 -50.66 -27.67 7.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.75 -1.114 . . . . 0.0 113.064 -173.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.772 ' HB3' ' HB3' ' B' ' 7' ' ' ARG . 4.2 m-20 -106.06 -22.07 12.97 Favored 'General case' 0 N--CA 1.435 -1.219 0 O-C-N 122.283 -0.261 . . . . 0.0 110.845 -178.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.597 ' HB2' ' O ' ' B' ' 43' ' ' ALA . . . -60.45 178.72 0.19 Allowed 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 122.055 0.931 . . . . 0.0 112.827 -174.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.674 ' HB2' ' SG ' ' B' ' 51' ' ' CYS . 17.8 m-20 -58.11 141.62 81.44 Favored Pre-proline 0 N--CA 1.44 -0.932 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.187 174.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . 0.451 ' HB2' HD21 ' B' ' 92' ' ' LEU . 10.0 Cg_endo -55.16 -23.25 35.58 Favored 'Trans proline' 0 C--O 1.22 -0.422 0 C-N-CA 123.21 2.606 . . . . 0.0 112.286 -178.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.686 ' HG2' ' N ' ' B' ' 51' ' ' CYS . 13.5 pm0 -88.84 -32.26 17.89 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.863 0.865 . . . . 0.0 110.906 175.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.686 ' N ' ' HG2' ' B' ' 50' ' ' GLU . 83.9 m -80.43 -38.18 30.61 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.272 -171.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.577 ' HA ' HD12 ' B' ' 55' ' ' ILE . 4.4 pt20 -70.02 -29.81 66.96 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 172.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . 0.615 ' HB3' ' HB3' ' B' ' 91' ' ' GLN . 4.9 m -71.31 -20.82 62.14 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 113.897 -1.501 . . . . 0.0 110.261 175.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.627 ' HB2' HD11 ' B' ' 79' ' ' ILE . . . -78.45 -25.25 45.85 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.672 0.749 . . . . 0.0 109.824 168.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.577 HD12 ' HA ' ' B' ' 52' ' ' GLN . 22.7 mt -90.02 -32.63 5.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 -172.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.628 ' N ' ' HD2' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -41.82 -39.41 2.64 Favored Pre-proline 0 N--CA 1.487 1.388 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -172.853 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' B' ' 56' ' ' LYS . 50.9 Cg_endo -62.39 -28.4 78.29 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.308 2.005 . . . . 0.0 112.824 176.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . 0.546 ' HB2' ' CE1' ' B' ' 72' ' ' TYR . 1.3 mt -98.68 -15.78 19.27 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.594 ' HE3' ' HB3' ' B' ' 44' ' ' TYR . 0.0 OUTLIER -52.37 109.36 0.38 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.16 -179.545 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.25 -22.59 37.75 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.63 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 10.9 mmmt -103.43 112.79 25.85 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.146 0.498 . . . . 0.0 110.0 -178.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.455 ' HB ' HG12 ' B' ' 68' ' ' VAL . 7.4 p -124.73 146.21 52.13 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.076 172.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.573 ' HB2' ' HB2' ' B' ' 66' ' ' SER . 93.3 Cg_exo -47.71 141.47 15.72 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.22 1.947 . . . . 0.0 111.537 166.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.07 105.67 0.43 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.662 -175.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.67 -9.86 70.95 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.334 175.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.573 ' HB2' ' HB2' ' B' ' 63' ' ' PRO . 9.7 m -90.83 175.21 7.08 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 117.192 0.496 . . . . 0.0 111.494 -177.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' ASP . . . . . 0.655 ' OD2' ' HB ' ' B' ' 69' ' ' ILE . 0.5 OUTLIER -80.85 134.83 35.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.591 177.834 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.562 HG13 ' CD ' ' B' ' 40' ' ' GLU . 0.7 OUTLIER -78.5 -27.73 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 C-N-CA 118.912 -1.115 . . . . 0.0 109.017 177.293 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.749 ' O ' HG13 ' B' ' 73' ' ' VAL . 12.6 mm -58.08 -46.33 88.18 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.116 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.107 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' B' ' 74' ' ' LYS . 29.1 t -46.06 -37.51 6.83 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.275 175.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -85.53 -32.51 22.14 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.148 0.499 . . . . 0.0 110.689 -177.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' TYR . . . . . 0.594 ' HB3' ' OH ' ' B' ' 14' ' ' TYR . 5.1 m-30 -75.85 -34.95 60.07 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.611 -176.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.817 ' HA ' ' CD1' ' B' ' 14' ' ' TYR . 1.5 m -72.01 -31.47 40.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 172.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' B' ' 70' ' ' SER . 0.0 OUTLIER -67.25 -31.82 72.43 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.309 175.504 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' B' ' 72' ' ' TYR . . . -63.8 -46.58 84.53 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.11 177.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.819 ' SG ' ' HB ' ' B' ' 79' ' ' ILE . 27.4 t -92.81 9.53 34.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.848 178.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . 0.436 ' HB3' ' O ' ' B' ' 74' ' ' LYS . 11.7 t70 -62.97 -18.53 63.32 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.254 0.55 . . . . 0.0 110.235 175.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -101.58 -8.25 46.59 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.283 173.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.819 ' HB ' ' SG ' ' B' ' 76' ' ' CYS . 98.5 mt -92.39 115.56 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-O 121.412 0.625 . . . . 0.0 112.006 -178.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . 0.401 ' HA2' ' HB2' ' B' ' 11' ' ' LYS . . . 170.36 58.29 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 174.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.25 168.87 39.05 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 -172.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.47 -89.42 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 175.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 83' ' ' MET . . . . . 0.6 ' O ' ' HG3' ' B' ' 87' ' ' MET . 78.3 mtm -61.56 -35.05 76.68 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 120.696 0.284 . . . . 0.0 110.599 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 84' ' ' HIS . . . . . 0.406 ' HB2' HG23 ' B' ' 79' ' ' ILE . 3.8 t-160 -55.46 -34.37 64.46 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.3 174.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -79.53 -31.27 42.08 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.807 0.337 . . . . 0.0 110.489 -177.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.72 -52.74 22.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.91 0.862 . . . . 0.0 110.078 175.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . 0.6 ' HG3' ' O ' ' B' ' 83' ' ' MET . 20.0 mtt -74.87 -12.43 60.37 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.028 -175.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.437 HD12 ' HB2' ' B' ' 92' ' ' LEU . 0.1 OUTLIER -50.39 -57.53 7.77 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.452 177.87 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 26.5 ttt -74.46 -16.76 60.85 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.852 0.358 . . . . 0.0 110.923 -176.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -95.11 -23.32 17.37 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -173.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 91' ' ' GLN . . . . . 0.615 ' HB3' ' HB3' ' B' ' 53' ' ' SER . 20.6 mt-30 -115.23 -52.53 2.67 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.207 -177.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.451 HD21 ' HB2' ' B' ' 49' ' ' PRO . 0.0 OUTLIER -49.25 -29.89 6.41 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.187 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.522 ' O ' ' HG3' ' B' ' 93' ' ' GLU . 6.5 pt-20 . . . . . 0 C--O 1.248 1.019 0 CA-C-N 113.826 -1.534 . . . . 0.0 112.458 -178.808 . . . . . . . . 1 1 . 1 stop_ save_